PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Mallorqui-Fernandez, N; Manandhar, SP; Mallorqui-Fernandez, G; Uson, I; Wawrzonek, K; Kantyka, T; Sola, M; Thogersen, IB; Enghild, JJ; Potempa, J; Gomis-Ruth, FX				Mallorqui-Fernandez, Noemi; Manandhar, Surya P.; Mallorqui-Fernandez, Goretti; Uson, Isabel; Wawrzonek, Katarzyna; Kantyka, Tomasz; Sola, Maria; Thogersen, Ida B.; Enghild, Jan J.; Potempa, Jan; Gomis-Ruth, F. Xavier			A new autocatalytic activation mechanism for cysteine proteases revealed by Prevotella intermedia interpain A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PORPHYROMONAS-GINGIVALIS; CRYSTAL-STRUCTURE; PEPTIDASE; BINDING; PURIFICATION; PROTEINASE; MATURATION; RESOLUTION; SEQUENCE; MODEL	Prevotella intermedia is a major periodontopathogen contributing to human gingivitis and periodontitis. Such pathogens release proteases as virulence factors that cause deterrence of host defenses and tissue destruction. A new cysteine protease from the cysteine-histidine-dyad class, interpain A, was studied in its zymogenic and self-processed mature forms. The latter consists of a bivalved moiety made up by two subdomains. In the structure of a catalytic cysteine-to-alanine zymogen variant, the right subdomain interacts with an unusual prodomain, thus contributing to latency. Unlike the catalytic cysteine residue, already in its competent conformation in the zymogen, the catalytic histidine is swung out from its active conformation and trapped in a cage shaped by a backing helix, a zymogenic hairpin, and a latency flap in the zymogen. Dramatic rearrangement of up to 20 A of these elements triggered by a tryptophan switch occurs during activation and accounts for a new activation mechanism for proteolytic enzymes. These findings can be extrapolated to related potentially pathogenic cysteine proteases such as Streprococcus pyogenes SpeB and Porphyromonas gingivalis periodontain.	[Manandhar, Surya P.; Potempa, Jan] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Mallorqui-Fernandez, Noemi; Mallorqui-Fernandez, Goretti; Sola, Maria; Gomis-Ruth, F. Xavier] Consejo Superior Investigac Cient, Dept Biol Struct, Barcelona 08034, Spain; [Uson, Isabel] Consejo Superior Investigac Cient, Inst Catalana Recerca & Estudis Avancats, Inst Mol Biol, Barcelona 08034, Spain; [Wawrzonek, Katarzyna; Kantyka, Tomasz; Potempa, Jan] Jagiellonian Univ, Fac Biotechnol, Dept Microbiol, PL-30387 Krakow, Poland; [Thogersen, Ida B.; Enghild, Jan J.] Univ Aarhus, Dept Mol Biol, DK-8000 Aarhus C, Denmark	University System of Georgia; University of Georgia; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); ICREA; Jagiellonian University; Aarhus University	Potempa, J (corresponding author), Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA.	potempa@mol.uj.edu.pl; xgrcri@ibmb.csic.es	Potempa, Jan/AAA-6850-2021	Kantyka, Tomasz/0000-0003-3023-2382; Enghild, Jan Johannes/0000-0001-9292-9172; Sola, Maria/0000-0002-0838-9706; Gomis-Ruth, F. Xavier/0000-0002-6848-6874	NIDCR NIH HHS [DE 09761, R01 DE009761-16A2, R01 DE009761] Funding Source: Medline; ICREA Funding Source: Custom; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE009761] Funding Source: NIH RePORTER	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); ICREA(ICREA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		AIYAR A, 1997, METHOD MOL BIOL, V57, P177; *AM ASS PUBL HLTH, 1983, J PUBLIC HTLH DENT, V43, P106; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BERTI PJ, 1995, J MOL BIOL, V246, P273, DOI 10.1006/jmbi.1994.0083; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Caliandro R, 2005, ACTA CRYSTALLOGR D, V61, P556, DOI 10.1107/S090744490500404X; Chen CY, 2003, J BIOL CHEM, V278, P17336, DOI 10.1074/jbc.M209038200; Collin M, 2001, INFECT IMMUN, V69, P7187, DOI 10.1128/IAI.69.11.7187-7189.2001; Cygler M, 1996, STRUCTURE, V4, P405, DOI 10.1016/S0969-2126(96)00046-9; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Deschner J, 2003, ARCH MICROBIOL, V179, P430, DOI 10.1007/s00203-003-0548-1; DRENTH J, 1976, BIOCHEMISTRY-US, V15, P3731, DOI 10.1021/bi00662a014; Eley BM, 2003, PERIODONTOL 2000, V31, P105, DOI 10.1034/j.1600-0757.2003.03107.x; ELLIOTT SD, 1945, J EXP MED, V81, P573, DOI 10.1084/jem.81.6.573; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; Filipek R, 2004, BIOCHEMISTRY-US, V43, P14306, DOI 10.1021/bi048661m; Fine DH, 2006, PERIODONTOL 2000, V42, P114, DOI 10.1111/j.1600-0757.2006.00189.x; Fujimura S, 2003, FEMS MICROBIOL LETT, V219, P305, DOI 10.1016/S0378-1097(03)00048-X; Guan SM, 2006, ANAEROBE, V12, P279, DOI 10.1016/j.anaerobe.2006.09.001; Haffajee Anne D, 2003, Ann Periodontol, V8, P115, DOI 10.1902/annals.2003.8.1.115; HOFMANN B, 1993, ACTA CRYSTALLOGR A S, V49, pC102; Jordan RCK, 2004, PERIODONTOL 2000, V34, P217, DOI 10.1046/j.0906-6713.2002.003433.x; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kagawa TF, 2000, P NATL ACAD SCI USA, V97, P2235, DOI 10.1073/pnas.040549997; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; LOESCHE WJ, 1982, J PERIODONTOL, V53, P223, DOI 10.1902/jop.1982.53.4.223; MADDEN TE, 1995, INFECT IMMUN, V63, P238, DOI 10.1128/IAI.63.1.238-247.1995; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Nelson D, 1999, J BIOL CHEM, V274, P12245, DOI 10.1074/jbc.274.18.12245; Nguyen KA, 2007, J BACTERIOL, V189, P833, DOI 10.1128/JB.01530-06; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; PIKE R, 1994, J BIOL CHEM, V269, P406; POLGAR L, 2004, HDB PROTEOLYTIC ENZY, V3, P1072; Potempa J, 2005, MOL MICROBIOL, V57, P605, DOI 10.1111/j.1365-2958.2005.04714.x; Rawlings ND, 2004, NUCLEIC ACIDS RES, V32, pD160, DOI 10.1093/nar/gkp971; Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; Sheldrick GM, 2002, Z KRISTALLOGR, V217, P644, DOI 10.1524/zkri.217.12.644.20662; SHELDRICK GM, 2001, INT TABLES CRYSTALLO, VF, P734; Shibata Y, 2003, ORAL MICROBIOL IMMUN, V18, P196, DOI 10.1034/j.1399-302X.2003.00057.x; Sivaraman J, 1999, PROTEIN SCI, V8, P283; Tanner ACR, 2006, PERIODONTOL 2000, V42, P88, DOI 10.1111/j.1600-0757.2006.00184.x; Tyndall JDA, 2005, CHEM REV, V105, P973, DOI 10.1021/cr040669e; Walker CB, 1996, PERIODONTOL 2000, V10, P79, DOI 10.1111/j.1600-0757.1996.tb00069.x; Wenig K, 2004, P NATL ACAD SCI USA, V101, P17371, DOI 10.1073/pnas.0407965101; Zhu MF, 2004, P NATL ACAD SCI USA, V101, P302, DOI 10.1073/pnas.2036536100	47	36	37	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2871	2882		10.1074/jbc.M708481200	http://dx.doi.org/10.1074/jbc.M708481200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	17993455	hybrid, Green Accepted, Green Submitted			2022-12-27	WOS:000252622300044
J	Bhoopathi, P; Chetty, C; Kunigal, S; Vanamala, SK; Rao, JS; Lakka, SS				Bhoopathi, Praveen; Chetty, Chandramu; Kunigal, Sateesh; Vanamala, Sravan K.; Rao, Jasti S.; Lakka, Sajani S.			RETRACTED: Blockade of tumor growth due to matrix metalloproteinase-9 inhibition is mediated by sequential activation of beta 1-integrin, ERK, and NF-kappa B (Retracted article. See vol. 295, pg. 15426, 2020)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication							INDUCED APOPTOSIS; PROTEIN-KINASE; CELL-DEATH; MATRIX METALLOPROTEINASES; SIGNALING PATHWAY; CANCER; REQUIREMENT; MMP-9; PREVENTION; RESISTANCE	We previously showed that matrix metalloproteinase (MMP)-9 inhibition using an adenovirus-mediated delivery of MMP-9small interfering RNA(Ad-MMP-9), caused senescence in medulloblastoma cells. Regardless of whether or not Ad-MMP-9 would induce apoptosis, the possible signaling mechanism is still obscure. In this report, we demonstrate that Ad-MMP-9 induced apoptosis in DAOY cells as determined by propidium iodide and terminal deoxynucleotidyltransferase-mediated nick end labeling staining. Ad-MMP-9 infection induced the release of cytochrome c, activation of caspase-9 and -3, and cleavage of poly(ADP-ribose) polymerase. Ad-MMP-9 infection stimulated ERK, and electrophoretic mobility shift assay indicated an increase in NF-kappa B activation. ERK inhibition, using a kinase- dead mutant for ERK, ameliorated NF-kappa B activation and caspase- mediated apoptosis in Ad-MMP-9-infected cells. beta 1-Integrin expression in Ad-MMP-9-infected cells also increased, and this increase was reversed by the reintroduction of MMP-9. We found that the addition of beta 1 blocking antibodies inhibited Ad-MMP-9-induced ERK activation. Taken together, our results indicate that MMP-9 inhibition induces apoptosis due to altered beta 1-integrin expression in medulloblastoma. In addition, ERK activation plays an active role in this process and functions upstream of NF-kappa B activation to initiate the apoptotic signal.	[Bhoopathi, Praveen; Chetty, Chandramu; Kunigal, Sateesh; Vanamala, Sravan K.; Rao, Jasti S.; Lakka, Sajani S.] Univ Illinois, Coll Med, Dept Canc Biol & Pharmacol, Program Canc Biol, Peoria, IL 61605 USA; [Rao, Jasti S.] Univ Illinois, Coll Med, Dept Neurosurg, Peoria, IL 61605 USA	University of Illinois System; University of Illinois Peoria; University of Illinois System; University of Illinois Peoria	Lakka, SS (corresponding author), Univ Illinois, Coll Med, Dept Canc Biol & Pharmacol, Program Canc Biol, 1 Illini Dr, Peoria, IL 61605 USA.	slakka@uic.edu	bhoopathi, praveen/A-9410-2010		NCI NIH HHS [R01 CA116708, R01 CA116708-02, CA 95058, CA 75557, R01 CA092393-04, R01 CA095058-04, R01 CA095058, R01 CA075557, R01 CA092393, CA 116708, R01 CA075557-09, CA 92393] Funding Source: Medline; NINDS NIH HHS [R01 NS057529, R01 NS057529-01, NS 47699, R01 NS047699-03, NS 57529, R01 NS047699] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA075557, R01CA116708, R01CA092393, R01CA095058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047699, R01NS057529] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Allan LA, 2003, NAT CELL BIOL, V5, P647, DOI 10.1038/ncb1005; Bacus SS, 2001, ONCOGENE, V20, P147, DOI 10.1038/sj.onc.1204062; Bian X, 2001, J BIOL CHEM, V276, P48921, DOI 10.1074/jbc.M108674200; Bueno OF, 2000, EMBO J, V19, P6341, DOI 10.1093/emboj/19.23.6341; Chaturvedi MM, 2000, METHOD ENZYMOL, V319, P585; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Coussens LM, 2000, CELL, V103, P481, DOI 10.1016/S0092-8674(00)00139-2; Dempke W, 2000, ANTI-CANCER DRUG, V11, P225, DOI 10.1097/00001813-200004000-00001; Dumont A, 1999, ONCOGENE, V18, P747, DOI 10.1038/sj.onc.1202325; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Gate L, 2003, BIOCHEM PHARMACOL, V65, P1611, DOI 10.1016/S0006-2952(03)00152-7; GERSCHENSON LE, 1992, FASEB J, V6, P2450, DOI 10.1096/fasebj.6.7.1563596; Grilli M, 1996, SCIENCE, V274, P1383, DOI 10.1126/science.274.5291.1383; Hagemann C, 2001, CELL SIGNAL, V13, P863, DOI 10.1016/S0898-6568(01)00220-0; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Kim GS, 2003, J BIOL CHEM, V278, P21920, DOI 10.1074/jbc.M204598200; Kimura K, 2002, CELL DEATH DIFFER, V9, P972, DOI 10.1038/sj.cdd.4401049; Kurokawa H, 2000, CANCER RES, V60, P5887; Lakka SS, 2002, ONCOGENE, V21, P5601, DOI 10.1038/sj.onc.1205646; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Madhani HD, 1997, CELL, V91, P673, DOI 10.1016/S0092-8674(00)80454-7; Mohr S, 1998, P NATL ACAD SCI USA, V95, P5045, DOI 10.1073/pnas.95.9.5045; Muzio M, 1998, J BIOL CHEM, V273, P2926, DOI 10.1074/jbc.273.5.2926; Panet H, 2001, J NEUROCHEM, V77, P391, DOI 10.1046/j.1471-4159.2001.00213.x; Rao JS, 2007, CANCER RES, V67, P4956, DOI 10.1158/0008-5472.CAN-07-0380; Rayet B, 1999, ONCOGENE, V18, P6938, DOI 10.1038/sj.onc.1203221; Renshaw MW, 1999, J CELL BIOL, V147, P611, DOI 10.1083/jcb.147.3.611; Schneider A, 1999, NAT MED, V5, P554, DOI 10.1038/8432; Schoenwaelder SM, 1999, CURR OPIN CELL BIOL, V11, P274, DOI 10.1016/S0955-0674(99)80037-4; Shelton JG, 2003, ONCOGENE, V22, P2478, DOI 10.1038/sj.onc.1206321; Shimada K, 2002, MOL CARCINOGEN, V35, P127, DOI 10.1002/mc.10084; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Stork PJS, 2002, TRENDS CELL BIOL, V12, P258, DOI 10.1016/S0962-8924(02)02294-8; Wang XT, 2000, J BIOL CHEM, V275, P39435, DOI 10.1074/jbc.M004583200; Woessmann W, 2004, CELL BIOL INT, V28, P403, DOI 10.1016/j.cellbi.2004.03.009; Yan CYI, 1998, J NEUROSCI, V18, P4042	37	51	51	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1545	1552		10.1074/jbc.M707931200	http://dx.doi.org/10.1074/jbc.M707931200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	17991734	Green Accepted, hybrid			2022-12-27	WOS:000252282700039
J	Yoshikane, Y; Yokochi, N; Yamasaki, M; Mizutani, K; Ohnishi, K; Mikami, B; Hayashi, H; Yagi, T				Yoshikane, Yu; Yokochi, Nana; Yamasaki, Masayuki; Mizutani, Kimihiko; Ohnishi, Kouhei; Mikami, Bunzo; Hayashi, Hideyuki; Yagi, Toshiharu			Crystal structure of pyridoxamine-pyruvate aminotransferase from Mesorhizobium loti MAFF303099	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALANINE-GLYOXYLATE AMINOTRANSFERASE; ASPARTATE-AMINOTRANSFERASE; ESCHERICHIA-COLI; PHOSPHOSERINE AMINOTRANSFERASE; TRANSAMINASE; ENZYME; RESOLUTION; SITE; CRYSTALLOGRAPHY; STEREOCHEMISTRY	Pyridoxamine-pyruvate aminotransferase (PPAT; EC 2.6.1.30) is a pyridoxal 5'-phosphate-independent aminotransferase and catalyzes reversible transamination between pyridoxamine and pyruvate to form pyridoxal and L-alanine. The crystal structure of PPAT from Mesorhizobium loti has been solved in space group P4(3)2(1)2 and was refined to an R factor of 15.6% (R-free = 20.6%) at 2.0 angstrom resolution. In addition, the structures of PPAT in complexes with pyridoxamine, pyridoxal, and pyridoxyl-L-alanine have been refined to R factors of 15.6, 15.4, and 14.5% (R-free = 18.6, 18.1, and 18.4%) at 1.7, 1.7, and 2.0 angstrom resolution, respectively. PPAT is a homotetramer and each subunit is composed of a large N-terminal domain, consisting of seven beta-sheets and eight alpha-helices, and a smaller C-terminal domain, consisting of three beta-sheets and four alpha-helices. The substrate pyridoxal is bound through an aldimine linkage to Lys-197 in the active site. The alpha-carboxylate group of the substrate amino/keto acid is hydrogen-bonded to Arg-336 and Arg-345. The structures revealed that the bulky side chain of Glu-68 interfered with the binding of the phosphate moiety of pyridoxal 5'-phosphate and made PPAT specific to pyridoxal. The reaction mechanism of the enzyme is discussed based on the structures and kinetics results.	[Yoshikane, Yu; Yokochi, Nana; Yagi, Toshiharu] Kochi Univ, Fac Agr, Dept Bioresource Sci, Nanko Ku, Kochi 7838502, Japan; [Yamasaki, Masayuki; Mizutani, Kimihiko; Mikami, Bunzo] Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Kyoto 7838502, Japan; [Ohnishi, Kouhei] Kochi Univ, Res Inst Mol Genet, Nanko Ku, Kochi 7838502, Japan; [Yagi, Toshiharu] Osaka Med Coll, Dept Biochem, Osaka 5698686, Japan	Kochi University; Kyoto University; Kochi University; Osaka Medical College	Yagi, T (corresponding author), Kochi Univ, Fac Agr, Dept Bioresource Sci, Nanko Ku, Monobe Otsu 200, Kochi 7838502, Japan.	yagito@cc.kochi-u.ac.jp	Ohnishi, Kouhei/AAN-9527-2020					AYLING JE, 1968, BIOCHEMISTRY-US, V7, P1626, DOI 10.1021/bi00845a003; AYLING JE, 1968, BIOCHEMISTRY-US, V7, P4537, DOI 10.1021/bi00852a050; AYLING JE, 1968, BIOCHEMISTRY-US, V7, P1616, DOI 10.1021/bi00845a002; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen CCH, 2002, BIOCHEMISTRY-US, V41, P13162, DOI 10.1021/bi026231v; DEMPSEY WB, 1963, BIOCHEMISTRY-US, V2, P1414, DOI 10.1021/bi00906a037; Dubnovitsky AP, 2005, PROTEIN SCI, V14, P97, DOI 10.1110/ps.041029805; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FUJIOKA M, 1965, J BIOL CHEM, V240, P3044; FUJIOKA M, 1965, J BIOL CHEM, V240, P3050; GILMER PJ, 1977, BIOCHEMISTRY-US, V16, P5241, DOI 10.1021/bi00643a013; GRISHIN NV, 1995, PROTEIN SCI, V4, P1291, DOI 10.1002/pro.5560040705; Han GW, 2005, PROTEINS, V58, P971; Han Q, 2006, J BIOL CHEM, V281, P37175, DOI 10.1074/jbc.M607032200; Hayashi H, 1998, BIOCHEMISTRY-US, V37, P15076, DOI 10.1021/bi981517e; Hester G, 1999, J MOL BIOL, V286, P829, DOI 10.1006/jmbi.1998.2506; HODSDON J, 1978, BIOCHEM J, V169, P429, DOI 10.1042/bj1690429; Jansonius JN, 1998, CURR OPIN STRUC BIOL, V8, P759, DOI 10.1016/S0959-440X(98)80096-1; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Katsura Y, 2004, PROTEINS, V55, P487, DOI 10.1002/prot.20020; Kawabata T, 2003, NUCLEIC ACIDS RES, V31, P3367, DOI 10.1093/nar/gkg581; Kleywegt GJ, 2007, ACTA CRYSTALLOGR D, V63, P94, DOI [10.1107/S0907444906022657, 10.1107/S907444906022657]; KOLB H, 1968, BIOCHEMISTRY-US, V7, P2946, DOI 10.1021/bi00848a035; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Meyer P, 2005, BIOCHIMIE, V87, P1041, DOI 10.1016/j.biochi.2005.09.001; MILES EW, 1982, J BIOL CHEM, V257, P4203; Mizuguchi H, 2001, BIOCHEMISTRY-US, V40, P353, DOI 10.1021/bi001403e; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NELSON MJK, 1986, J BIOL CHEM, V261, P5115; Orengo CA, 1997, STRUCTURE, V5, P1093, DOI 10.1016/S0969-2126(97)00260-8; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; TONEY MD, 1987, J BIOL CHEM, V262, P12403; WADA H, 1962, J BIOL CHEM, V237, P133; YANO T, 1992, BIOCHEMISTRY-US, V31, P5878, DOI 10.1021/bi00140a025; Ye YZ, 2003, BIOINFORMATICS, V19, pII246, DOI 10.1093/bioinformatics/btg1086; Yoshikane Y, 2006, BIOCHEM J, V396, P499, DOI 10.1042/BJ20060078; Zhang XX, 2003, J MOL BIOL, V331, P643, DOI 10.1016/S0022-2836(03)00791-5	39	15	17	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					1120	1127		10.1074/jbc.M708061200	http://dx.doi.org/10.1074/jbc.M708061200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	17989071	Green Published, hybrid			2022-12-27	WOS:000252128100052
J	Fruscione, F; Sturla, L; Duncan, G; Van Etten, JL; Valbuzzi, P; De Flora, A; Di Zanni, E; Tonetti, M				Fruscione, Floriana; Sturla, Laura; Duncan, Garry; Van Etten, James L.; Valbuzzi, Paola; De Flora, Antonio; Di Zanni, Eleonora; Tonetti, Michela			Differential role of NADP(+) and NADPH in the activity and structure of GDP-D-mannose 4,6-dehydratase from two chlorella viruses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							D-GLUCOSE 4,6-DEHYDRATASE; UDP-GALACTOSE 4-EPIMERASE; CRYSTAL-STRUCTURE; L-FUCOSE; ARABIDOPSIS-THALIANA; D-RHAMNOSE; IDENTIFICATION; DEHYDRATASE; PROTEIN; EXPRESSION	GDP-D-mannose 4,6-dehydratase (GMD) is a key enzyme involved in the synthesis of 6-deoxyhexoses in prokaryotes and eukaryotes. Paramecium bursaria chlorella virus-1 (PBCV-1) encodes a functional GMD, which is unique among characterized GMDs because it also has a strong stereospecific NADPH-dependent reductase activity leading to GDP-D-rhamnose formation (Tonetti, M., Zanardi, D., Gurnon, J., Fruscione, F., Armirotti, A., Damonte, G., Sturla, L., De Flora, A., and Van Etten, J. L. ( 2003) J. Biol. Chem. 278, 21559-21565). In the present study we characterized a recombinant GMD encoded by another chlorella virus, Acanthocystis turfacea chlorella virus 1 (ATCV-1), demonstrating that it has the expected dehydratase activity. However, it also displayed significant differences when compared with PBCV-1 GMD. In particular, ATCV-1 GMD lacks the reductase activity present in the PBCV-1 enzyme. Using recombinant PBCV-1 and ATCV-1 GMDs, we determined that the enzymatically active proteins contain tightly bound NADPH and that NADPH is essential for maintaining the oligomerization status as well as for the stabilization and function of both enzymes. Phylogenetic analysis indicates that PBCV-1 GMD is the most evolutionary diverged of the GMDs. We conclude that this high degree of divergence was the result of the selection pressures that led to the acquisition of new reductase activity to synthesize GDP-D-rhamnose while maintaining the dehydratase activity in order to continue to synthesize GDP-L-fucose.	[Fruscione, Floriana; Sturla, Laura; De Flora, Antonio; Di Zanni, Eleonora; Tonetti, Michela] Univ Genoa, Ctr Excellence Biomed Res, Dept Expt Med, I-16132 Genoa, Italy; [Duncan, Garry] Nebraska Wesleyan Univ, Dept Biol, Lincoln, NE 68504 USA; [Van Etten, James L.; Valbuzzi, Paola] Univ Nebraska, Nebraska Ctr Virol, Dept Plant Pathol, Lincoln, NE 68583 USA	University of Genoa; University of Nebraska System; University of Nebraska Lincoln	Tonetti, M (corresponding author), Univ Genoa, Ctr Excellence Biomed Res, Dept Expt Med, Viale Benedetto XV, 1, I-16132 Genoa, Italy.	tonetti@unige.it	fruscione, floriana/AAA-8747-2020; TONETTI, MICHELA/AAF-3404-2021; Tonetti, Michela/F-3039-2018; DI ZANNI, ELEONORA/K-8643-2016	TONETTI, MICHELA/0000-0002-8829-7173; DI ZANNI, ELEONORA/0000-0003-4564-2202; fruscione, floriana/0000-0002-4054-645X	NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015635, P20RR016469] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032441] Funding Source: NIH RePORTER; NCRR NIH HHS [P20 RR 016469, P21 RR 15635] Funding Source: Medline; NIGMS NIH HHS [GM 32441] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Albermann C, 2001, GLYCOBIOLOGY, V11, P655, DOI 10.1093/glycob/11.8.655; Allard STM, 2002, STRUCTURE, V10, P81, DOI 10.1016/S0969-2126(01)00694-3; Allard STM, 2001, J MOL BIOL, V307, P283, DOI 10.1006/jmbi.2000.4470; Beis K, 2003, J AM CHEM SOC, V125, P11872, DOI 10.1021/ja035796r; Bisso A, 1999, FEBS LETT, V456, P370, DOI 10.1016/S0014-5793(99)00982-5; Bonin CP, 1997, P NATL ACAD SCI USA, V94, P2085, DOI 10.1073/pnas.94.5.2085; Brocks JJ, 1999, SCIENCE, V285, P1033, DOI 10.1126/science.285.5430.1033; Dunigan DD, 2006, VIRUS RES, V117, P119, DOI 10.1016/j.virusres.2006.01.024; Feng DF, 1997, P NATL ACAD SCI USA, V94, P13028, DOI 10.1073/pnas.94.24.13028; Fitzgerald LA, 2007, VIROLOGY, V362, P350, DOI 10.1016/j.virol.2006.12.028; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Glansdorff N, 2000, MOL MICROBIOL, V38, P177, DOI 10.1046/j.1365-2958.2000.02126.x; Goetz H, 2004, J BIOCHEM BIOPH METH, V60, P281, DOI 10.1016/j.jbbm.2004.01.007; Graves MV, 2001, VIROLOGY, V285, P332, DOI 10.1006/viro.2001.0937; HAN TM, 1992, SCIENCE, V257, P232, DOI 10.1126/science.1631544; He XM, 1996, BIOCHEMISTRY-US, V35, P4721, DOI 10.1021/bi952706p; Hegeman AD, 2001, BIOCHEMISTRY-US, V40, P6598, DOI 10.1021/bi010441a; Kallberg Y, 2002, PROTEIN SCI, V11, P636, DOI 10.1110/ps.26902; Kneidinger B, 2001, J BIOL CHEM, V276, P5577, DOI 10.1074/jbc.M010027200; LABESSE G, 1994, BIOCHEM J, V304, P95, DOI 10.1042/bj3040095; Lakowicz J.R., 1983, PRINCIPLES FLUORESCE, P44; Li B, 1996, EUR J BIOCHEM, V235, P180, DOI 10.1111/j.1432-1033.1996.00180.x; LOWRY OH, 1961, J BIOL CHEM, V236, P2756; Ma B, 2006, GLYCOBIOLOGY, V16, p158R, DOI 10.1093/glycob/cwl040; Maki M, 2003, GLYCOBIOLOGY, V13, P295, DOI 10.1093/glycob/cwg035; McCracken JA, 2004, ANAL BIOCHEM, V324, P131, DOI 10.1016/j.ab.2003.09.025; Mulichak AM, 2002, BIOCHEMISTRY-US, V41, P15578, DOI 10.1021/bi0266683; Nakayama K, 2003, GLYCOBIOLOGY, V13, P673, DOI 10.1093/glycob/cwg099; OTHS PJ, 1990, CARBOHYD RES, V198, P91, DOI 10.1016/0008-6215(90)84279-4; Rosano C, 2006, BIOCHEM BIOPH RES CO, V339, P191, DOI 10.1016/j.bbrc.2005.11.009; Somoza JR, 2000, STRUCTURE, V8, P123, DOI 10.1016/S0969-2126(00)00088-5; Sturla L, 1997, FEBS LETT, V412, P126, DOI 10.1016/S0014-5793(97)00762-X; Sullivan FX, 1998, J BIOL CHEM, V273, P8193, DOI 10.1074/jbc.273.14.8193; Sullivan MB, 2005, PLOS BIOL, V3, P790, DOI 10.1371/journal.pbio.0030144; SWAFFORD DL, 2000, PAUP PHYLOGENETIC AN; Thoden JB, 1996, BIOCHEMISTRY-US, V35, P2557, DOI 10.1021/bi952715y; Tonetti M, 1996, J BIOL CHEM, V271, P27274, DOI 10.1074/jbc.271.44.27274; Tonetti M, 1998, BIOCHIMIE, V80, P923, DOI 10.1016/S0300-9084(00)88889-6; Tonetti M, 2003, J BIOL CHEM, V278, P21559, DOI 10.1074/jbc.M301543200; Van Etten JL, 2003, ANNU REV GENET, V37, P153, DOI 10.1146/annurev.genet.37.110801.143915; VANHOOKE JL, 1994, J BIOL CHEM, V269, P31496; Vogan EM, 2004, BIOCHEMISTRY-US, V43, P3057, DOI 10.1021/bi035547f; Webb NA, 2004, PROTEIN SCI, V13, P529, DOI 10.1110/ps.03393904; WELLING GW, 1989, HPLC MACROMOLECULES, P77; Wu BY, 2001, BIOCHEM BIOPH RES CO, V285, P364, DOI 10.1006/bbrc.2001.5137	45	29	29	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					184	193		10.1074/jbc.M706614200	http://dx.doi.org/10.1074/jbc.M706614200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17974560	Green Published, hybrid			2022-12-27	WOS:000251940300021
J	Grumbt, B; Stroobant, V; Terziyska, N; Israel, L; Hell, K				Grumbt, Barbara; Stroobant, Vincent; Terziyska, Nadia; Israel, Lars; Hell, Kai			Functional characterization of Mia40p, the central component of the disulfide relay system of the mitochondrial intermembrane space	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SULFHYDRYL OXIDASE; PROTEIN IMPORT; SACCHAROMYCES-CEREVISIAE; BOND FORMATION; CYTOCHROME-C; SUPEROXIDE-DISMUTASE; IN-VIVO; COMPLEX; YEAST; TRANSLOCATION	Mia40p and Erv1p are components of a translocation pathway for the import of cysteine-rich proteins into the intermembrane space of mitochondria. We have characterized the redox behavior of Mia40p and reconstituted the disulfide transfer system of Mia40p by using recombinant functional C-terminal fragment of Mia40p, Mia40C, and Erv1p. Oxidized Mia40p contains three intramolecular disulfide bonds. One disulfide bond connects the first two cysteine residues in the CPC motif. The second and the third bonds belong to the twin CX9C motif and bridge the cysteine residues of two CX9C segments. In contrast to the stabilizing disulfide bonds of the twin CX9C motif, the first disulfide bond was easily accessible to reducing agents. Partially reduced Mia40C generated by opening of this bond as well as fully reduced Mia40C were oxidized by Erv1p in vitro. In the course of this reaction, mixed disulfides of Mia40C and Erv1p were formed. Reoxidation of fully reduced Mia40C required the presence of the first two cysteine residues in Mia40C. However, efficient reoxidation of a Mia40C variant containing only the cysteine residues of the twin CX9C motif was observed when in addition to Erv1p low amounts of wild type Mia40C were present. In the reconstituted system the thiol oxidase Erv1p was sufficient to transfer disulfide bonds to Mia40C, which then could oxidize the variant of Mia40C. In summary, we reconstituted a disulfide relay system consisting of Mia40C and Erv1p.	[Grumbt, Barbara; Terziyska, Nadia] Univ Munich, Adolf Butenandt Inst Physiol Chem, D-81377 Munich, Germany; [Stroobant, Vincent] Catholic Univ Louvain, Ludwig Inst Canc Res, Brussels Branch, Cellular Genet Unit, B-1200 Brussels, Belgium; [Israel, Lars] Univ Munich, Protein Anal Unit, D-80336 Munich, Germany	University of Munich; Ludwig Institute for Cancer Research; Universite Catholique Louvain; University of Munich	Hell, K (corresponding author), Univ Munich, Adolf Butenandt Inst Physiol Chem, Butenandtstr 5, D-81377 Munich, Germany.	hell@med.uni-muenchen.de						Allen S, 2005, J MOL BIOL, V353, P937, DOI 10.1016/j.jmb.2005.08.049; Allen S, 2003, J BIOL CHEM, V278, P38505, DOI 10.1074/jbc.M306027200; Arnesano F, 2005, STRUCTURE, V13, P713, DOI 10.1016/j.str.2005.02.015; Banci L, 2004, J BIOL CHEM, V279, P34833, DOI 10.1074/jbc.M403655200; Barros MH, 2004, J BIOL CHEM, V279, P31943, DOI 10.1074/jbc.M405014200; Beers J, 1997, J BIOL CHEM, V272, P33191, DOI 10.1074/jbc.272.52.33191; Chacinska A, 2004, EMBO J, V23, P3735, DOI 10.1038/sj.emboj.7600389; Coppock DL, 2006, ANTIOXID REDOX SIGN, V8, P300, DOI 10.1089/ars.2006.8.300; Curran SP, 2002, EMBO J, V21, P942, DOI 10.1093/emboj/21.5.942; Dimmer KS, 2002, MOL BIOL CELL, V13, P847, DOI 10.1091/mbc.01-12-0588; Endo T, 2003, J CELL SCI, V116, P3259, DOI 10.1242/jcs.00667; Farrell SR, 2005, BIOCHEMISTRY-US, V44, P1532, DOI 10.1021/bi0479555; Field LS, 2003, J BIOL CHEM, V278, P28052, DOI 10.1074/jbc.M304296200; Gabriel K, 2007, J MOL BIOL, V365, P612, DOI 10.1016/j.jmb.2006.10.038; Herrmann JM, 2005, TRENDS BIOCHEM SCI, V30, P205, DOI 10.1016/j.tibs.2005.02.005; Herrmann JM, 2007, J CELL BIOL, V176, P559, DOI 10.1083/jcb.200611060; Hofhaus G, 2003, EUR J BIOCHEM, V270, P1528, DOI 10.1046/j.1432-1033.2003.03519.x; Hofmann S, 2005, J MOL BIOL, V353, P517, DOI 10.1016/j.jmb.2005.08.064; Iwata S, 1998, SCIENCE, V281, P64, DOI 10.1126/science.281.5373.64; Jensen RE, 2002, BBA-MOL CELL RES, V1592, P25, DOI 10.1016/S0167-4889(02)00261-6; Kadokura H, 2003, ANNU REV BIOCHEM, V72, P111, DOI 10.1146/annurev.biochem.72.121801.161459; Koehler CM, 2004, ANNU REV CELL DEV BI, V20, P309, DOI 10.1146/annurev.cellbio.20.010403.105057; Koehler CM, 2004, TRENDS BIOCHEM SCI, V29, P1, DOI 10.1016/j.tibs.2003.11.003; Lamb AL, 2001, NAT STRUCT BIOL, V8, P751, DOI 10.1038/nsb0901-751; Lange H, 2001, EMBO REP, V2, P715, DOI 10.1093/embo-reports/kve161; Lee JE, 2000, FEBS LETT, V477, P62, DOI 10.1016/S0014-5793(00)01767-1; LISOWSKY T, 1992, MOL GEN GENET, V232, P58, DOI 10.1007/BF00299137; Lu H, 2005, J MOL BIOL, V353, P897, DOI 10.1016/j.jmb.2005.09.002; Lu H, 2004, J BIOL CHEM, V279, P18952, DOI 10.1074/jbc.M313045200; Mesecke N, 2005, CELL, V121, P1059, DOI 10.1016/j.cell.2005.04.011; Milenkovic D, 2007, J BIOL CHEM, V282, P22472, DOI 10.1074/jbc.M703294200; Nakamoto H, 2004, BBA-MOL CELL RES, V1694, P111, DOI 10.1016/j.bbamcr.2004.02.012; Naoe M, 2004, J BIOL CHEM, V279, P47815, DOI 10.1074/jbc.M410272200; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Nobrega MP, 2002, J BIOL CHEM, V277, P40206, DOI 10.1074/jbc.M207348200; Rissler M, 2005, J MOL BIOL, V353, P485, DOI 10.1016/j.jmb.2005.08.051; Sevier CS, 2006, ANTIOXID REDOX SIGN, V8, P797, DOI 10.1089/ars.2006.8.797; Sevier CS, 2002, NAT REV MOL CELL BIO, V3, P836, DOI 10.1038/nrm954; Sideris DP, 2007, MOL MICROBIOL, V65, P1360, DOI 10.1111/j.1365-2958.2007.05880.x; Stojanovski D, 2007, METHOD CELL BIOL, V80, P783, DOI 10.1016/S0091-679X(06)80036-1; Terziyska N, 2005, FEBS LETT, V579, P179, DOI 10.1016/j.febslet.2004.11.072; Terziyska N, 2007, FEBS LETT, V581, P1098, DOI 10.1016/j.febslet.2007.02.014; Tu BP, 2004, J CELL BIOL, V164, P341, DOI 10.1083/jcb.200311055; Vala A, 2005, J MOL BIOL, V354, P952, DOI 10.1016/j.jmb.2005.09.076; Vitu E, 2006, J MOL BIOL, V362, P89, DOI 10.1016/j.jmb.2006.06.070; Voronova A, 2007, BIOCHEM J, V408, P139, DOI 10.1042/BJ20070804; Webb CT, 2006, MOL CELL, V21, P123, DOI 10.1016/j.molcel.2005.11.010; Westerman BA, 2004, GENOMICS, V83, P1094, DOI 10.1016/j.ygeno.2003.12.006; Wilkinson B, 2004, BBA-PROTEINS PROTEOM, V1699, P35, DOI 10.1016/j.bbapap.2004.02.017; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; ZHANG RM, 1989, J BIOL CHEM, V264, P18472	51	74	75	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37461	37470		10.1074/jbc.M707439200	http://dx.doi.org/10.1074/jbc.M707439200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17959605	hybrid			2022-12-27	WOS:000251833600021
J	Nakata, S; Fujita, N; Kitagawa, Y; Okamoto, R; Ogita, H; Takai, Y				Nakata, Shinsuke; Fujita, Naoyuki; Kitagawa, Yuichi; Okamoto, Ryoko; Ogita, Hisakazu; Takai, Yoshimi			Regulation of platelet-derived growth factor activation by afadin through SHP-2 - Implications for cellular morphology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; FACTOR RECEPTOR-BETA; E-CADHERIN; ADHERENS JUNCTIONS; PDGF RECEPTOR; C-SRC; TRANS-INTERACTIONS; EPITHELIAL-CELLS; SH2 DOMAINS; PDZ DOMAIN	Upon binding of platelet-derived growth factor ( PDGF), PDGF receptor is autophosphorylated at tyrosine residues in its cytoplasmic region, which induces the activation of diverse intracellular signaling pathways such those involving Ras-ERK, c-Src, and Rap1-Rac. Signaling through activated Ras-ERK promotes cell cycle and cell proliferation. The sequential activation of Rap1 and Rac affects cellular morphology and induces the formation of leading-edge structures, including lamellipodia, peripheral ruffles, and focal complexes, resulting in the enhancement of cell movement. In addition to the promotion of cell proliferation, the Ras-ERK signaling is involved in the regulation of cellular morphology. Here, we showed a novel role of afadin in the regulation of PDGF-induced intracellular signaling and cellular morphology in NIH3T3 cells. Afadin was originally identified as an actin filament-binding protein, which binds to a cell-cell adhesion molecule nectin and is involved in the formation of cell-cell junctions. When afadin was tyrosine-phosphorylated by c-Src activated in response to PDGF, afadin physically interacted with and increased the phosphatase activity of Src homology 2 domain-containing phosphatase-2 (SHP-2), a protein-tyrosine phosphatase that dephosphorylates PDGF receptor, leading to the prevention of hyperactivation of PDGF receptor and the Ras-ERK signaling. In contrast, knockdown of afadin or SHP-2 induced the hyperactivation of PDGF receptor and Ras-ERK signaling and consequently suppressed the formation of leading-edge structures. Thus, afadin plays a critical role in the proper regulation of the PDGF-induced activation of PDGF receptor and signaling by Ras-ERK. This effect, which is mediated by SHP-2, impacts cellular morphology.	[Nakata, Shinsuke; Fujita, Naoyuki; Kitagawa, Yuichi; Okamoto, Ryoko; Ogita, Hisakazu; Takai, Yoshimi] Osaka Univ, Sch Med, Fac Med, Dept Mol Biol & Biochem, Suita, Osaka 5650871, Japan; [Takai, Yoshimi] Kobe Univ, Sch Med, Fac Med, Dept Biochem & Mol Biol, Kobe, Hyogo 6500017, Japan	Osaka University; Kobe University	Takai, Y (corresponding author), Osaka Univ, Sch Med, Fac Med, Dept Mol Biol & Biochem, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	ytakai@med.kobe-u.ac.jp	Ogita, Hisakazu/AAE-4416-2020	Ogita, Hisakazu/0000-0001-6750-1668				ALONSO G, 1995, J BIOL CHEM, V270, P9840, DOI 10.1074/jbc.270.17.9840; ARVIDSSON AK, 1994, MOL CELL BIOL, V14, P6715, DOI 10.1128/MCB.14.10.6715; Chiarugi P, 2002, J CELL SCI, V115, P2219; Chiarugi P, 1996, BIOCHEM BIOPH RES CO, V219, P21, DOI 10.1006/bbrc.1996.0174; DeMali KA, 1999, EXP CELL RES, V253, P271, DOI 10.1006/excr.1999.4669; Eck MJ, 1996, NATURE, V379, P277, DOI 10.1038/379277a0; Fragale A, 2004, HUM MUTAT, V23, P267, DOI 10.1002/humu.20005; Fujito T, 2005, J CELL BIOL, V171, P165, DOI 10.1083/jcb.200501090; Fukuhara T, 2004, J CELL BIOL, V166, P393, DOI 10.1083/jcb.200401093; Fukuyama T, 2005, J BIOL CHEM, V280, P815, DOI 10.1074/jbc.M411099200; GONZALEZMARISCAL L, 1985, J MEMBRANE BIOL, V86, P113, DOI 10.1007/BF01870778; GUMBINER B, 1988, J CELL BIOL, V107, P1575, DOI 10.1083/jcb.107.4.1575; HELDIN CH, 1995, CELL, V80, P213, DOI 10.1016/0092-8674(95)90404-2; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Heldin CH, 1998, BIOCHIM BIOPHYS ACTA, V1378, P79; Holgado-Madruga M, 2004, CANCER RES, V64, P2007, DOI 10.1158/0008-5472.CAN-03-2886; Hoshino T, 2005, J BIOL CHEM, V280, P24095, DOI 10.1074/jbc.M414447200; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Huyer G, 1997, J BIOL CHEM, V272, P843, DOI 10.1074/jbc.272.2.843; Ikeda W, 2004, J BIOL CHEM, V279, P18015, DOI 10.1074/jbc.M312969200; Izumi G, 2004, J CELL BIOL, V166, P237, DOI 10.1083/jcb.200401078; Jackson DE, 1997, J BIOL CHEM, V272, P24868, DOI 10.1074/jbc.272.40.24868; Kakunaga S, 2004, J BIOL CHEM, V279, P36419, DOI 10.1074/jbc.M406340200; Kawakatsu T, 2005, J BIOL CHEM, V280, P4940, DOI 10.1074/jbc.M408710200; Kawakatsu T, 2002, J BIOL CHEM, V277, P50749, DOI 10.1074/jbc.M209846200; KAZLAUSKAS A, 1993, P NATL ACAD SCI USA, V90, P6939, DOI 10.1073/pnas.90.15.6939; Kodama A, 2000, MOL BIOL CELL, V11, P2565, DOI 10.1091/mbc.11.8.2565; Kodama A, 2001, GENES CELLS, V6, P869, DOI 10.1046/j.1365-2443.2001.00467.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LECHLEIDER RJ, 1993, J BIOL CHEM, V268, P21478; Mandai K, 1997, J CELL BIOL, V139, P517, DOI 10.1083/jcb.139.2.517; Markova B, 2003, BIOCHEMISTRY-US, V42, P2691, DOI 10.1021/bi0265574; MCCORMICK F, 1994, CURR OPIN GENET DEV, V4, P71, DOI 10.1016/0959-437X(94)90093-0; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; Minami Y, 2007, J BIOL CHEM, V282, P18481, DOI 10.1074/jbc.M611330200; NANBERG E, 1993, J BIOL CHEM, V268, P18187; Ohnishi H, 1996, J BIOL CHEM, V271, P25569, DOI 10.1074/jbc.271.41.25569; PLUSKEY S, 1995, J BIOL CHEM, V270, P2897, DOI 10.1074/jbc.270.7.2897; Radziwill G, 2007, EMBO J, V26, P2633, DOI 10.1038/sj.emboj.7601706; Sakamoto Y, 2006, J BIOL CHEM, V281, P19631, DOI 10.1074/jbc.M600301200; Sakisaka T, 1999, ONCOGENE, V18, P1609, DOI 10.1038/sj.onc.1202451; Sato T, 2006, J BIOL CHEM, V281, P5288, DOI 10.1074/jbc.M510070200; SATOH T, 1993, MOL CELL BIOL, V13, P3706, DOI 10.1128/MCB.13.6.3706; Stein-Gerlach M, 1998, INT J BIOCHEM CELL B, V30, P559, DOI 10.1016/S1357-2725(98)00002-8; Takai Y, 2003, CANCER SCI, V94, P655, DOI 10.1111/j.1349-7006.2003.tb01499.x; Takai Y, 2003, J CELL SCI, V116, P17, DOI 10.1242/jcs.00167; Takekuni K, 2003, J BIOL CHEM, V278, P5497, DOI 10.1074/jbc.C200707200; WATABE M, 1994, J CELL BIOL, V127, P247, DOI 10.1083/jcb.127.1.247; Yamada A, 2006, ONCOGENE, V25, P5085, DOI 10.1038/sj.onc.1209525; Yap AS, 1997, ANNU REV CELL DEV BI, V13, P119, DOI 10.1146/annurev.cellbio.13.1.119; YATOHGO T, 1988, CELL STRUCT FUNCT, V13, P281, DOI 10.1247/csf1975.13.281; Yu DH, 1998, J BIOL CHEM, V273, P21125, DOI 10.1074/jbc.273.33.21125; Zhong CL, 1997, MOL BIOL CELL, V8, P2329, DOI 10.1091/mbc.8.11.2329	53	37	41	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37815	37825		10.1074/jbc.M707461200	http://dx.doi.org/10.1074/jbc.M707461200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17971444	hybrid			2022-12-27	WOS:000251833600057
J	Fongmoon, D; Shetty, AK; Basappa; Yamada, S; Sugiura, M; Kongtawelert, P; Sugahara, K				Fongmoon, Duriya; Shetty, Ajaya Kumar; Basappa; Yamada, Shuhei; Sugiura, Makiko; Kongtawelert, Prachya; Sugahara, Kazuyuki			Chondroitinase-mediated degradation of rare 3-O-sulfated glucuronic acid in functional oversulfated chondroitin sulfate K and E	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTGROWTH-PROMOTING ACTIVITY; CENTRAL-NERVOUS-SYSTEM; EMBRYONIC PIG BRAIN; NEURITE OUTGROWTH; GROWTH-FACTOR; HYBRID CHAINS; NEURITOGENIC ACTIVITY; L2/HNK-1 CARBOHYDRATE; NEUROTROPHIC FACTORS; BINDING ACTIVITIES	Chondroitin sulfate K (CS-K) from king crab cartilage rich in rare 3-O-sulfated glucuronic acid (GlcUA(3S)) displayed neuritogenic activity and affinity toward various growth factors like CS-E from squid cartilage. CS-K-mediated neuritogenesis of mouse hippocampal neurons in culture was abolished by digestion with chondroitinase (CSase) ABC, indicating the possible involvement of GlcUA(3S). However, identification of GlcUA(3S) in CS chains by conventional high performance liquid chromatography has been hampered by its CSase ABC-mediated degradation. To investigate the degradation process, an authentic CS-E tetrasaccharide, Delta(4,5)HexUA-GalNAc(4S)GlcUA-(3S)-GalNAc(4S), was digested with CSase ABC, and the end product was identified as GalNAc(4S) by electrospray ionization mass spectrometry (ESI-MS). Putative GalNAc(6S) and GalNAc(4S, 6S), derived presumably from GlcUA(3S)GalNAc(6S) and GlcUA(3S)-GalNAc(4S, 6S), respectively, were also detected by ESI-MS in the CSase ABC digest of a CS-E oligosaccharide fraction resistant to CSases AC-I and AC-II. Intermediates during the CSase ABC-mediated degradation of Delta(4,5)HexUA( 3S)-GalNAc(4S) to GalNAc(4S) were identified through ESI-MS of a partial CSase ABC digest of a CS-K tetrasaccharide, GlcUA(3S)-GalNAc(4S)-GlcUA(3S)-GalNAc(4S), and the conceivable mechanism behind the degradation of the GlcUA(3S) moiety was elucidated. Although a fucose branch was also identified in CS-K, defucosylated CS-K exhibited greater neuritogenic activity than the native CS-K, excluding the possibility of the involvement of fucose in the activity. Rather, (3S)containing disaccharides are likely involved. These findings will enable us to detect GlcUA(3S)-containing disaccharides in CS chains to better understand CS-mediated biological processes.	[Fongmoon, Duriya; Shetty, Ajaya Kumar; Basappa; Yamada, Shuhei; Sugahara, Kazuyuki] Hokkaido Univ, Grad Sch Life Sci, Lab Proteoglycan Signaling & Therapeut,Fac Adv Li, Frontier Res Ctr Post Genom Sci & Technol,Kita Ku, Sapporo, Hokkaido 0010021, Japan; [Fongmoon, Duriya; Shetty, Ajaya Kumar; Basappa; Yamada, Shuhei; Sugahara, Kazuyuki] Kobe Pharmaceut Univ, Dept Biochem, Higashinada Ku, Kobe, Hyogo 6588558, Japan; [Fongmoon, Duriya; Kongtawelert, Prachya] Chiang Mai Univ, Fac Med, Dept Biochem, Thailand Excellence Ctr Tissue Engn, Chiang Mai 50200, Thailand; [Fongmoon, Duriya] Minist Publ Hlth, Dept Med, Lampang Canc Ctr, Lampang 50200, Thailand; [Sugiura, Makiko] Kobe Pharmaceut Univ, Higashinada Ku, NMR Lab, Kobe, Hyogo 6588558, Japan; [Sugahara, Kazuyuki] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Atsugi, Kanagawa, Japan	Hokkaido University; Kobe Pharmaceutical University; Chiang Mai University; Ministry of Public Health - Thailand; Kobe Pharmaceutical University; Japan Science & Technology Agency (JST)	Sugahara, K (corresponding author), Hokkaido Univ, Grad Sch Life Sci, Lab Proteoglycan Signaling & Therapeut,Fac Adv Li, Frontier Res Ctr Post Genom Sci & Technol,Kita Ku, Nishi 11 Choume,Kita 21-Jo, Sapporo, Hokkaido 0010021, Japan.	k-sugar@sci.hokudai.ac.jp		kongtawelert, prachya/0000-0002-5963-2796; Basappa, Basappa/0000-0002-8844-468X				ARIGA T, 1987, J BIOL CHEM, V262, P848; Bao XF, 2005, J BIOL CHEM, V280, P9180, DOI 10.1074/jbc.M413423200; BLOCH B, 1992, DEV BRAIN RES, V70, P267, DOI 10.1016/0165-3806(92)90206-C; BOHLEN P, 1991, Progress in Growth Factor Research, V3, P143, DOI 10.1016/S0955-2235(05)80005-5; BRONNERFRASER M, 1987, DEV BIOL, V123, P321, DOI 10.1016/0012-1606(87)90390-3; Calabro A, 2001, OSTEOARTHR CARTILAGE, V9, pS16, DOI 10.1053/joca.2001.0439; CHOU DKH, 1986, J BIOL CHEM, V261, P1717; Clement AM, 1998, J BIOL CHEM, V273, P28444, DOI 10.1074/jbc.273.43.28444; DEBUS E, 1983, DIFFERENTIATION, V25, P193, DOI 10.1111/j.1432-0436.1984.tb01355.x; Deepa SS, 2002, J BIOL CHEM, V277, P43707, DOI 10.1074/jbc.M207105200; ERNFORS P, 1990, J NEUROSCI RES, V27, P10, DOI 10.1002/jnr.490270103; FAISSNER A, 1994, J CELL BIOL, V126, P783, DOI 10.1083/jcb.126.3.783; FONGMOON D, 2007, 19 INT S GLYC CAIRNS; HAYNES LW, 1988, MOL NEUROBIOL, V2, P263, DOI 10.1007/BF02935635; Hikino M, 2003, J BIOL CHEM, V278, P43744, DOI 10.1074/jbc.M308169200; IIJIMA Y, 1971, J BIOCHEM-TOKYO, V70, P75, DOI 10.1093/oxfordjournals.jbchem.a129628; ILYAS AA, 1986, BRAIN RES, V385, P1, DOI 10.1016/0006-8993(86)91540-4; JUNG W, 1994, J CELL BIOL, V126, P485, DOI 10.1083/jcb.126.2.485; KEILHAUER G, 1985, NATURE, V316, P728, DOI 10.1038/316728a0; Kinoshita A, 1997, J BIOL CHEM, V272, P19656, DOI 10.1074/jbc.272.32.19656; Kinoshita A, 1999, ANAL BIOCHEM, V269, P367, DOI 10.1006/abio.1999.4027; Kinoshita-Toyoda A, 2004, BIOCHEMISTRY-US, V43, P11063, DOI 10.1021/bi049622d; Kitagawa H, 1997, J BIOL CHEM, V272, P31377, DOI 10.1074/jbc.272.50.31377; Kitagawa H, 1997, BIOCHEMISTRY-US, V36, P3998, DOI 10.1021/bi962740j; KUNEMUND V, 1988, J CELL BIOL, V106, P213, DOI 10.1083/jcb.106.1.213; Li FC, 2007, J BIOL CHEM, V282, P2956, DOI 10.1074/jbc.M609296200; MARGOLIS RK, 1987, BIOCHEM BIOPH RES CO, V145, P1142, DOI 10.1016/0006-291X(87)91556-7; MARTINI R, 1992, EUR J NEUROSCI, V4, P628, DOI 10.1111/j.1460-9568.1992.tb00171.x; Mizuguchi S, 2003, NATURE, V423, P443, DOI 10.1038/nature01635; Nadanaka S, 1998, J BIOL CHEM, V273, P3296, DOI 10.1074/jbc.273.6.3296; NAKANISHI Y, 1981, J BIOL CHEM, V256, P5443; Nandini CD, 2005, J BIOL CHEM, V280, P4058, DOI 10.1074/jbc.M412074200; Nandini CD, 2004, J BIOL CHEM, V279, P50799, DOI 10.1074/jbc.M404746200; NEEDHAM LK, 1993, P NATL ACAD SCI USA, V90, P1359, DOI 10.1073/pnas.90.4.1359; Ohtake S, 2003, J BIOL CHEM, V278, P38443, DOI 10.1074/jbc.M306132200; Plaas AHK, 1997, J BIOL CHEM, V272, P20603, DOI 10.1074/jbc.272.33.20603; SENO N, 1974, BIOCHIM BIOPHYS ACTA, V343, P423, DOI 10.1016/0304-4165(74)90107-X; SENO N, 1982, CARBOHYD RES, V103, P190; Sotogaku N, 2007, J NEUROCHEM, V103, P749, DOI 10.1111/j.1471-4159.2007.04849.x; Sugahara K, 1996, J BIOL CHEM, V271, P26745, DOI 10.1074/jbc.271.43.26745; Sugahara K, 2000, CURR OPIN STRUC BIOL, V10, P518, DOI 10.1016/S0959-440X(00)00125-1; Sugahara K, 2003, CURR OPIN STRUC BIOL, V13, P612, DOI 10.1016/j.sbi.2003.09.011; Sugahara K, 2007, CURR OPIN STRUC BIOL, V17, P536, DOI 10.1016/j.sbi.2007.08.015; Ueoka C, 2000, J BIOL CHEM, V275, P37407, DOI 10.1074/jbc.M002538200; VIEIRA RP, 1991, J BIOL CHEM, V266, P13530; YAMADA S, 1992, J BIOCHEM-TOKYO, V112, P440, DOI 10.1093/oxfordjournals.jbchem.a123919; YAMAGUCHI Y, 1990, NATURE, V346, P281, DOI 10.1038/346281a0	47	27	35	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					36895	36904		10.1074/jbc.M707082200	http://dx.doi.org/10.1074/jbc.M707082200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17951579	hybrid			2022-12-27	WOS:000251646000015
J	Lo, KWH; Kogoy, JM; Rasoul, BA; King, SM; Pfister, KK				Lo, Kevin W. -H.; Kogoy, John M.; Rasoul, Bareza A.; King, Stephen M.; Pfister, K. Kevin			Interaction of the DYNLT (TCTEX1/RP3) light chains and the intermediate chains reveals novel intersubunit regulation during assembly of the dynein complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTATHIONE-S-TRANSFERASE; SLOW AXONAL-TRANSPORT; CYTOPLASMIC DYNEIN; DIFFERENTIAL EXPRESSION; SUBUNIT HETEROGENEITY; FUSION PROTEINS; MOTOR DYNEIN; HEAVY-CHAIN; LC8; TCTEX-1	The cytoplasmic dynein 1 cargo binding domain is formed by five subunits including the intermediate chain and the DYNLT, DYNLL, and DYNLRB light chain families. Six isoforms of the intermediate chain and two isoforms of each of the light chain families have been identified in mammals. There is evidence that different subunit isoforms are involved in regulating dynein function, in particular linking dynein to different cargoes. However, it is unclear how the subunit isoforms are assembled or if there is any specificity to their interactions. Co-immunoprecipitation using DYNLT-specific antibodies reveals that dynein complexes with DYNLT light chains also contain the DYNLL and DYNLRB light chains. The DYNLT light chains, but not DYNLL light chains, associate exclusively with the dynein complex. Yeast two-hybrid and co-immunoprecipitation assays demonstrate that both members of the DYNLT family are capable of forming homodimers and heterodimers. In addition, both homodimers of the DYNLT family bind all six intermediate chain isoforms. However, DYNLT heterodimers do not bind to the intermediate chain. Thus, whereas all combinations of DYNLT light chain dimers can be made, not all of the possible combinations of the isoforms are utilized during the assembly of the dynein complex.	[Lo, Kevin W. -H.; Kogoy, John M.; Rasoul, Bareza A.; Pfister, K. Kevin] Univ Virginia, Sch Med, Dept Cell Biol, Charlottesville, VA 22908 USA; [King, Stephen M.] Univ Connecticut, Ctr Hlth, Dept Mol Microbial & Struct Biol, Farmington, CT 06030 USA	University of Virginia; University of Connecticut	Pfister, KK (corresponding author), Univ Virginia, Sch Med, Dept Cell Biol, POB 800732, Charlottesville, VA 22908 USA.	kkp9w@virginia.edu			NIGMS NIH HHS [GM 51293] Funding Source: Medline; NINDS NIH HHS [NS29996] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051293] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029996] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Benison G, 2007, J MOL BIOL, V371, P457, DOI 10.1016/j.jmb.2007.05.046; CHANG JH, 1995, METHOD ENZYMOL, V254, P430; Chuang JZ, 2001, J NEUROSCI, V21, P5501, DOI 10.1523/JNEUROSCI.21-15-05501.2001; DiBella LM, 2001, J BIOL CHEM, V276, P14366, DOI 10.1074/jbc.M011456200; Dillman JF, 1996, P NATL ACAD SCI USA, V93, P141, DOI 10.1073/pnas.93.1.141; DILLMAN JF, 1994, J CELL BIOL, V127, P1671, DOI 10.1083/jcb.127.6.1671; Dillman JF, 1996, J NEUROSCI, V16, P6742; Douglas MW, 2004, J BIOL CHEM, V279, P28522, DOI 10.1074/jbc.M311671200; Espindola FS, 2000, CELL MOTIL CYTOSKEL, V47, P269, DOI 10.1002/1097-0169(200012)47:4<269::AID-CM2>3.3.CO;2-7; Gee MA, 1997, NATURE, V390, P636, DOI 10.1038/37663; GILL SR, 1994, MOL BIOL CELL, V5, P645, DOI 10.1091/mbc.5.6.645; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; Habura A, 1999, J BIOL CHEM, V274, P15447, DOI 10.1074/jbc.274.22.15447; King SJ, 2002, PROTEIN SCI, V11, P1239, DOI 10.1110/ps.2520102; King SM, 1996, J BIOL CHEM, V271, P19358, DOI 10.1074/jbc.271.32.19358; King SM, 1998, BIOCHEMISTRY-US, V37, P15033, DOI 10.1021/bi9810813; KOHLER G, 1975, NATURE, V256, P497; Li MG, 2004, MOL BIOL CELL, V15, P3005, DOI 10.1091/mbc.E04-01-0013; Lo KWH, 2007, J BIOL CHEM, V282, P11205, DOI 10.1074/jbc.M611279200; Lo KWH, 2006, J BIOL CHEM, V281, P9552, DOI 10.1074/jbc.M511721200; Lo KWH, 2005, J BIOL CHEM, V280, P8172, DOI 10.1074/jbc.M411408200; Lo KWH, 2001, J BIOL CHEM, V276, P14059, DOI 10.1074/jbc.M010320200; Makokha M, 2004, PROTEIN SCI, V13, P727, DOI 10.1110/ps.03462204; Makokha M, 2002, BIOCHEMISTRY-US, V41, P4302, DOI 10.1021/bi011970h; Mok YK, 2001, J BIOL CHEM, V276, P14067, DOI 10.1074/jbc.M011358200; Myers KR, 2007, J NEUROSCI RES, V85, P2640, DOI 10.1002/jnr.21213; Naisbitt S, 2000, J NEUROSCI, V20, P4524, DOI 10.1523/JNEUROSCI.20-12-04524.2000; Nikulina K, 2004, CELL MOTIL CYTOSKEL, V57, P233, DOI 10.1002/cm.10172; Nurminsky DI, 1998, MOL CELL BIOL, V18, P6816, DOI 10.1128/MCB.18.11.6816; PASCHAL BM, 1987, NATURE, V330, P672, DOI 10.1038/330672a0; Pfister KK, 2006, PLOS GENET, V2, P11, DOI 10.1371/journal.pgen.0020001; Pfister KK, 2005, J CELL BIOL, V171, P411, DOI 10.1083/jcb.200508078; Pfister KK, 1996, MOL BIOL CELL, V7, P331, DOI 10.1091/mbc.7.2.331; Pfister KK, 1996, J BIOL CHEM, V271, P1687, DOI 10.1074/jbc.271.3.1687; Rodriguez-Crespo I, 2001, FEBS LETT, V503, P135, DOI 10.1016/S0014-5793(01)02718-1; Sakato M, 2004, J STRUCT BIOL, V146, P58, DOI 10.1016/j.jsb.2003.09.026; Salata MW, 2001, J NEUROSCI RES, V65, P408, DOI 10.1002/jnr.1168; Samso M, 1998, J MOL BIOL, V276, P927, DOI 10.1006/jmbi.1997.1584; Schnorrer F, 2000, NAT CELL BIOL, V2, P185, DOI 10.1038/35008601; SHARROCKS AD, 1994, GENE, V138, P105, DOI 10.1016/0378-1119(94)90789-7; Susalka SJ, 2000, BBA-MOL CELL RES, V1496, P76, DOI 10.1016/S0167-4889(00)00010-0; Susalka SJ, 2002, J BIOL CHEM, V277, P32939, DOI 10.1074/jbc.M205510200; Tai AW, 1999, CELL, V97, P877, DOI 10.1016/S0092-8674(00)80800-4; Tai AW, 2001, J CELL BIOL, V153, P1499, DOI 10.1083/jcb.153.7.1499; Talbott M, 2006, BIOCHEMISTRY-US, V45, P6793, DOI 10.1021/bi0600345; Tang Q, 2002, MOL BIOL CELL, V13, P4484, DOI 10.1091/mbc.e02-05-0245; Tynan SH, 2000, J BIOL CHEM, V275, P32769, DOI 10.1074/jbc.M001537200; Tynan SH, 2000, J BIOL CHEM, V275, P32763, DOI 10.1074/jbc.M001536200; Vallee RB, 2004, J NEUROBIOL, V58, P189, DOI 10.1002/neu.10314; Vallee RB, 1996, SCIENCE, V271, P1539, DOI 10.1126/science.271.5255.1539; VAUGHAN KT, 1995, BIOCHEM SOC T, V23, P50, DOI 10.1042/bst0230050; Wang L, 2004, BIOCHEMISTRY-US, V43, P4611, DOI 10.1021/bi036328x; Wang WN, 2003, J BIOL CHEM, V278, P41491, DOI 10.1074/jbc.M307118200; Williams JC, 2005, J BIOL CHEM, V280, P21981, DOI 10.1074/jbc.M414643200; Williams JC, 2007, P NATL ACAD SCI USA, V104, P10028, DOI 10.1073/pnas.0703614104; Wilson MJ, 2001, CELL MOTIL CYTOSKEL, V49, P229, DOI 10.1002/cm.1036; Wu HW, 2005, STRUCTURE, V13, P213, DOI 10.1016/j.str.2004.11.013; Yang PF, 2001, J CELL BIOL, V153, P1315, DOI 10.1083/jcb.153.6.1315; [No title captured]	59	18	21	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					36871	36878		10.1074/jbc.M705991200	http://dx.doi.org/10.1074/jbc.M705991200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17965411	hybrid			2022-12-27	WOS:000251646000012
J	Weigel, PH; DeAngelis, PL				Weigel, Paul H.; DeAngelis, Paul L.			Hyaluronan synthases: A decade-plus of novel glycosyltransferases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							GROUP-A STREPTOCOCCUS; 2 ACTIVE-SITES; MOLECULAR-CLONING; ACID; GENE; BIOSYNTHESIS; IDENTIFICATION; EXPRESSION; DIRECTION; MECHANISM	Hyaluronan synthases ( HASs) are glycosyltransferases that catalyze polymerization of hyaluronan found in vertebrates and certain microbes. HASs transfer two distinct monosaccharides in different linkages and, in certain cases, participate in polymer transfer out of the cell. In contrast, the vast majority of glycosyltransferases form only one sugar linkage. Although our understanding of HAS biochemistry is still incomplete, very good progress has been made since the first genetic identification of a HAS in 1993. New enzymes have been discovered, and some molecular details have emerged. Important findings are the lipid dependence of Class I HASs, the function of HASs as protein monomers, and the elucidation of mechanisms of synthesis by Class II HAS. We propose three classes of HASs based on differences in protein sequences, predicted membrane topologies, potential architectures, mechanisms, and direction of polymerization.	[Weigel, Paul H.; DeAngelis, Paul L.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA; [Weigel, Paul H.; DeAngelis, Paul L.] Univ Oklahoma, Hlth Sci Ctr, Oklahoma Ctr Med Glycobiol, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Weigel, PH (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA.	paul-weigel@ouhsc.edu; paul-deangelis@ouhsc.edu			NIGMS NIH HHS [GM56497] Funding Source: Medline; PHS HHS [GTM35978] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056497] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adamia Sophia, 2005, Current Drug Targets - Cardiovascular & Haematological Disorders, V5, P3, DOI 10.2174/1568006053005056; Asplund T, 1998, BBA-GEN SUBJECTS, V1380, P377, DOI 10.1016/S0304-4165(98)00010-5; Bodevin-Authelet S, 2005, J BIOL CHEM, V280, P8813, DOI 10.1074/jbc.M412803200; Camenisch TD, 2000, J CLIN INVEST, V106, P349, DOI 10.1172/JCI10272; Chung JY, 2001, INFECT IMMUN, V69, P2487, DOI 10.1128/IAI.69.4.2487-2492.2001; DeAngelis PL, 1999, CELL MOL LIFE SCI, V56, P670, DOI 10.1007/s000180050461; DeAngelis PL, 1998, J BIOL CHEM, V273, P8454, DOI 10.1074/jbc.273.14.8454; DeAngelis PL, 1997, SCIENCE, V278, P1800, DOI 10.1126/science.278.5344.1800; DEANGELIS PL, 1994, BIOCHEMISTRY-US, V33, P9033, DOI 10.1021/bi00197a001; DeAngelis PL, 2002, ANAT RECORD, V268, P317, DOI 10.1002/ar.10163; DeAngelis PL, 1999, J BIOL CHEM, V274, P26557, DOI 10.1074/jbc.274.37.26557; DEANGELIS PL, 1993, J BIOL CHEM, V268, P19181; DeAngelis PL, 1996, J BIOL CHEM, V271, P23657, DOI 10.1074/jbc.271.39.23657; DeAngelis PL, 2002, GLYCOBIOLOGY, V12, p9R, DOI 10.1093/glycob/12.1.9R; DOUGHERTY BA, 1994, J BIOL CHEM, V269, P169; Fraser JRE, 1997, J INTERN MED, V242, P27, DOI 10.1046/j.1365-2796.1997.00170.x; Goentzel BJ, 2006, BIOCHEM J, V396, P347, DOI 10.1042/BJ20051782; Graves MV, 1999, VIROLOGY, V257, P15, DOI 10.1006/viro.1999.9628; Heldermon C, 2001, J BIOL CHEM, V276, P2037, DOI 10.1074/jbc.M002276200; Hoshi H, 2004, J BIOL CHEM, V279, P2341, DOI 10.1074/jbc.M305723200; Itano N, 1999, J BIOL CHEM, V274, P25085, DOI 10.1074/jbc.274.35.25085; Itano N, 2002, IUBMB LIFE, V54, P195, DOI 10.1080/15216540214929; Itano N, 1996, J BIOL CHEM, V271, P9875, DOI 10.1074/jbc.271.17.9875; Itano N, 1996, BIOCHEM BIOPH RES CO, V222, P816, DOI 10.1006/bbrc.1996.0827; Jing W, 2000, GLYCOBIOLOGY, V10, P883, DOI 10.1093/glycob/10.9.883; Jing W, 2004, J BIOL CHEM, V279, P42345, DOI 10.1074/jbc.M402744200; Jing W, 2003, GLYCOBIOLOGY, V13, P661, DOI 10.1093/glycob/cwg085; Kaback HR, 2005, CR BIOL, V328, P557, DOI 10.1016/j.crvi.2005.03.008; Kumari K, 1997, J BIOL CHEM, V272, P32539, DOI 10.1074/jbc.272.51.32539; Kumari K, 2006, J BIOL CHEM, V281, P11755, DOI 10.1074/jbc.M600727200; Kumari K, 2005, GLYCOBIOLOGY, V15, P529, DOI 10.1093/glycob/cwi030; Kumari K, 2002, J BIOL CHEM, V277, P13943, DOI 10.1074/jbc.M110638200; LAURENT TC, 1992, FASEB J, V6, P2397, DOI 10.1096/fasebj.6.7.1563592; Lee JY, 2000, CURR OPIN CELL BIOL, V12, P581, DOI 10.1016/S0955-0674(00)00135-6; MARKOVITZ A, 1959, J BIOL CHEM, V234, P2343; McDonald JA, 2002, GLYCOCONJUGATE J, V19, P331, DOI 10.1023/A:1025369004783; MEYER K, 1958, FED PROC, V17, P1075; Meyer MF, 1996, P NATL ACAD SCI USA, V93, P4543, DOI 10.1073/pnas.93.10.4543; Ouskova G, 2004, GLYCOBIOLOGY, V14, P931, DOI 10.1093/glycob/cwh115; Prehm P, 2004, BIOCHEM PHARMACOL, V68, P1401, DOI 10.1016/j.bcp.2004.06.017; PREHM P, 1983, BIOCHEM J, V211, P191, DOI 10.1042/bj2110191; Prehm P, 2006, BIOCHEM J, V398, P469, DOI 10.1042/BJ20060431; Pummill PE, 2003, J BIOL CHEM, V278, P19808, DOI 10.1074/jbc.M301097200; Pummill PE, 2001, J BIOL CHEM, V276, P39832, DOI 10.1074/jbc.M105489200; Rilla K, 2005, J BIOL CHEM, V280, P31890, DOI 10.1074/jbc.M504736200; ROBBINS PW, 1967, SCIENCE, V158, P1536, DOI 10.1126/science.158.3808.1536; SAXENA IM, 1995, J BACTERIOL, V177, P1419, DOI 10.1128/jb.177.6.1419-1424.1995; Shyjan AM, 1996, J BIOL CHEM, V271, P23395, DOI 10.1074/jbc.271.38.23395; Silver RP, 2001, RES MICROBIOL, V152, P357, DOI 10.1016/S0923-2508(01)01207-4; Spicer AP, 1998, J BIOL CHEM, V273, P1923, DOI 10.1074/jbc.273.4.1923; Spicer AP, 1996, J BIOL CHEM, V271, P23400, DOI 10.1074/jbc.271.38.23400; Spicer AP, 1997, J BIOL CHEM, V272, P8957; Stern R, 2003, GLYCOBIOLOGY, V13, p105R, DOI 10.1093/glycob/cwg112; STOOLMILLER AC, 1969, J BIOL CHEM, V244, P236; Takeo S, 2004, J BIOL CHEM, V279, P18920, DOI 10.1074/jbc.M314293200; Tlapak-Simmons VL, 2005, J BIOL CHEM, V280, P13012, DOI 10.1074/jbc.M409788200; Tlapak-Simmons VL, 1998, J BIOL CHEM, V273, P26100, DOI 10.1074/jbc.273.40.26100; Tlapak-Simmons VL, 2004, BIOCHEMISTRY-US, V43, P9234, DOI 10.1021/bi049468v; Tlapak-Simmons VL, 1999, J BIOL CHEM, V274, P4239, DOI 10.1074/jbc.274.7.4239; Toole BP, 2000, J CLIN INVEST, V106, P335, DOI 10.1172/JCI10706; Toyoda H, 2000, J BIOL CHEM, V275, P2269, DOI 10.1074/jbc.275.4.2269; TRISCOTT MX, 1986, J BIOL CHEM, V261, P6004; Watanabe K, 1996, J BIOL CHEM, V271, P22945, DOI 10.1074/jbc.271.38.22945; Weigel PH, 2006, J BIOL CHEM, V281, P36542, DOI 10.1074/jbc.M606529200; Weigel PH, 1997, J BIOL CHEM, V272, P13997, DOI 10.1074/jbc.272.22.13997; Weigel PH, 2002, IUBMB LIFE, V54, P201, DOI 10.1080/15216540214931; WESSELS MR, 1994, P NATL ACAD SCI USA, V91, P12238, DOI 10.1073/pnas.91.25.12238; Widner B, 2005, APPL ENVIRON MICROB, V71, P3747, DOI 10.1128/AEM.71.7.3747-3752.2005; Williams KJ, 2006, J BIOL CHEM, V281, P5391, DOI 10.1074/jbc.M510439200; Yoshida M, 2000, J BIOL CHEM, V275, P497, DOI 10.1074/jbc.275.1.497	70	246	258	6	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					36777	36781		10.1074/jbc.R700036200	http://dx.doi.org/10.1074/jbc.R700036200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17981795	hybrid			2022-12-27	WOS:000251646000001
J	Ha, SD; Ng, D; Pelech, SL; Kim, SO				Ha, Soon-Duck; Ng, Dennis; Pelech, Steven L.; Kim, Sung Ouk			Critical role of the phosphatidylinositol 3-kinase/Akt/glycogen synthase kinase-3 beta signaling pathway in recovery from anthrax lethal toxin-induced cell cycle arrest and MEK cleavage in macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLONY-STIMULATING FACTOR; T-LYMPHOCYTE ACTIVATION; BACILLUS-ANTHRACIS; DNA-DAMAGE; PROTECTIVE ANTIGEN; IN-VIVO; EXPRESSION; CHECKPOINT; RECEPTOR; KINASE	Anthrax lethal toxin (LeTx) is a virulence factor causing immune suppression and toxic shock of Bacillus anthracis infected host. It inhibits cytokine production and cell proliferation/ differentiation in various immune cells. This study showed that a brief exposure of LeTx caused a continual MEK1 cleavage and prevented tumor necrosis factor-alpha (TNF) production in response to lipopolysaccharide (LPS) in non-proliferating cells such as human peripheral blood mononuclear cells or mouse primary peritoneal macrophages. In human monocytic cell lines U-937 and THP-1, LeTx induced cell cycle arrest in G(0)-G1 phase by rapid down-regulation of cyclin D1/ D2 and checkpoint kinase 1 through MEK1 inhibition. However, THP-1 cells adaptively adjusted to LeTx and overrode cell cycle arrest by activating the phosphatidylinositol 3-kinase/Akt signaling pathway. Inhibitory Ser-9 phosphorylation of glycogen synthase kinase 3 beta(GSK3 beta) by Akt prevented proteasome-mediated cyclin D1 degradation and induced cell cycle progress in LeTx-intoxicated THP-1 cells. Recovery from cell cycle arrest was required before recovering from on-going MEK1 cleavage and suppression of TNF production. Furthermore, pretreatment with LeTx or the GSK3-specific inhibitor SB-216763, or transfection with dominant active mutant Akt or degradation-defected mutant cyclin D1 protected cells from LeTx-induced cell cycle arrest, on-going MEK1 cleavage and suppression of TNF production. These results indicate that modulation of phosphatidylinositol 3-kinase/ Akt/ GSK3 beta signaling cascades can be beneficial for protecting or facilitating recovery from cellular LeTx intoxication in cells that depend on basal MEK1 activity for proliferation.	Univ Western Ontario, Dept Microbiol & Immunol, Siebens Drake Res Inst, London, ON N6G 2V4, Canada; Univ Western Ontario, Infect Dis Res Grp, Siebens Drake Res Inst, London, ON N6G 2V4, Canada; Kinexus Bioinformat Corp, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Dept Med, Vancouver, BC V6T 2B5, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); University of British Columbia	Kim, SO (corresponding author), Univ Western Ontario, Dept Microbiol & Immunol, Siebens Drake Res Inst, 1400 W Rd,Rm 119, London, ON N6G 2V4, Canada.	sung.kim@schulich.uwo.ca	KIM, Sung Ouk/A-1309-2008; Kim, Sung Ouk/AAO-1795-2020	Kim, Sung Ouk/0000-0002-0282-6661				ALBANESE C, 1995, J BIOL CHEM, V270, P23589, DOI 10.1074/jbc.270.40.23589; Bonuccelli G, 2005, AM J PHYSIOL-CELL PH, V288, pC1402, DOI 10.1152/ajpcell.00582.2004; Boyden ED, 2006, NAT GENET, V38, P240, DOI 10.1038/ng1724; Bradley KA, 2001, NATURE, V414, P225, DOI 10.1038/n35101999; Chen ZH, 2003, MOL CANCER THER, V2, P543; Comalada M, 2004, EUR J IMMUNOL, V34, P2257, DOI 10.1002/eji.200425110; Comer JE, 2005, INFECT IMMUN, V73, P8275, DOI 10.1128/IAI.73.12.8275-8281.2005; Cordoba-Rodriguez R, 2004, J BIOL CHEM, V279, P20563, DOI 10.1074/jbc.C300539200; Cote CK, 2006, INFECT IMMUN, V74, P469, DOI 10.1128/IAI.74.1.469-480.2006; Cote CK, 2004, MICROB PATHOGENESIS, V37, P169, DOI 10.1016/j.micpath.2004.06.013; Diehl JA, 1997, GENE DEV, V11, P957, DOI 10.1101/gad.11.8.957; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Dixon TC, 1999, NEW ENGL J MED, V341, P815, DOI 10.1056/NEJM199909093411107; Drysdale M, 2005, EMBO J, V24, P221, DOI 10.1038/sj.emboj.7600495; Eapen AK, 2001, MOL CELL BIOL, V21, P6113, DOI 10.1128/MCB.21.18.6113-6121.2001; FALK LA, 1988, J LEUKOCYTE BIOL, V43, P148, DOI 10.1002/jlb.43.2.148; Fang H, 2005, J IMMUNOL, V174, P4966, DOI 10.4049/jimmunol.174.8.4966; Fang H, 2006, J IMMUNOL, V176, P6155, DOI 10.4049/jimmunol.176.10.6155; FRIEDLANDER AM, 1986, J BIOL CHEM, V261, P7123; GREEN BD, 1985, INFECT IMMUN, V49, P291, DOI 10.1128/IAI.49.2.291-297.1985; Ha SD, 2007, J BIOL CHEM, V282, P26275, DOI 10.1074/jbc.M703668200; Hu HJ, 2006, CELL MICROBIOL, V8, P1634, DOI 10.1111/j.1462-5822.2006.00738.x; Kalogeropoulos N, 2004, CELL CYCLE, V3, P1196; Kassam A, 2005, CELL MICROBIOL, V7, P281, DOI 10.1111/j.1462-5822.2004.00458.x; Kim SO, 2003, J BIOL CHEM, V278, P7413, DOI 10.1074/jbc.M209279200; Kim SO, 2007, BIOTECHNIQUES, V42, P493, DOI 10.2144/000112390; Koo HM, 2002, P NATL ACAD SCI USA, V99, P3052, DOI 10.1073/pnas.052707699; LEPPLA SH, 1982, P NATL ACAD SCI-BIOL, V79, P3162, DOI 10.1073/pnas.79.10.3162; Li Y, 2007, EXPERT OPIN BIOL TH, V7, P843, DOI 10.1517/14712598.7.6.843; MATSUSHIME H, 1992, CELL, V71, P323, DOI 10.1016/0092-8674(92)90360-O; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; MIKESELL P, 1983, INFECT IMMUN, V39, P371, DOI 10.1128/IAI.39.1.371-376.1983; Miller CJ, 1999, BIOCHEMISTRY-US, V38, P10432, DOI 10.1021/bi990792d; Muehlbauer SM, 2007, CELL CYCLE, V6, P758, DOI 10.4161/cc.6.6.3991; Paccani SR, 2005, J EXP MED, V201, P325, DOI 10.1084/jem.20041557; Page K, 2000, AM J RESP CELL MOL, V23, P436, DOI 10.1165/ajrcmb.23.4.3953; Paulsen RD, 2007, DNA REPAIR, V6, P953, DOI 10.1016/j.dnarep.2007.02.015; Piatelli MJ, 2002, J BIOL CHEM, V277, P12144, DOI 10.1074/jbc.M200102200; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Popov SG, 2002, FEBS LETT, V527, P211, DOI 10.1016/S0014-5793(02)03228-3; Rmali KA, 2004, INT J MOL MED, V14, P75; Salles II, 2003, P NATL ACAD SCI USA, V100, P12426, DOI 10.1073/pnas.2134042100; Sanchez I, 2005, SEMIN CELL DEV BIOL, V16, P311, DOI 10.1016/j.semcdb.2005.02.007; Sanchez Y, 1997, SCIENCE, V277, P1497, DOI 10.1126/science.277.5331.1497; Scobie HM, 2003, P NATL ACAD SCI USA, V100, P5170, DOI 10.1073/pnas.0431098100; Shaw M, 1997, FEBS LETT, V416, P307, DOI 10.1016/S0014-5793(97)01235-0; Song JX, 2004, NAT IMMUNOL, V5, P150, DOI 10.1038/ni1030; Takuwa N, 1999, MOL CELL BIOL, V19, P1346; Tang JB, 2006, P NATL ACAD SCI USA, V103, P11964, DOI 10.1073/pnas.0604987103; Tournier JN, 2007, CELL MICROBIOL, V9, P555, DOI 10.1111/j.1462-5822.2006.00866.x; WELKOS SL, 1986, INFECT IMMUN, V51, P795, DOI 10.1128/IAI.51.3.795-800.1986; Wesche J, 1998, BIOCHEMISTRY-US, V37, P15737, DOI 10.1021/bi981436i; Zachos G, 2003, EMBO J, V22, P713, DOI 10.1093/emboj/cdg060	53	25	25	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36230	36239		10.1074/jbc.M707622200	http://dx.doi.org/10.1074/jbc.M707622200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17951252	hybrid			2022-12-27	WOS:000251458300013
J	Reisler, E; Egelman, EH				Reisler, Emil; Egelman, Edward H.			Actin structure and function: What we still do not understand	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							CROSS-LINKED ACTIN; F-ACTIN; CRYSTAL-STRUCTURE; PHALLOIDIN BINDING; FILAMENT DYNAMICS; ATPASE FRAGMENT; HEXOKINASE I; BETA-ACTIN; POLYMERIZATION; INSTABILITY		Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22909 USA; Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	University of Virginia; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Egelman, EH (corresponding author), Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22909 USA.	egelman@virginia.edu	Egelman, Edward H/A-2488-2009	Egelman, Edward/0000-0003-4844-5212	NIGMS NIH HHS [GM077190, GM081303] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077190, R01GM081303] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aleshin AE, 1998, J MOL BIOL, V282, P345, DOI 10.1006/jmbi.1998.2017; Aleshin AE, 2000, J MOL BIOL, V296, P1001, DOI 10.1006/jmbi.1999.3494; Allingham JS, 2007, J MOL BIOL, V371, P959, DOI 10.1016/j.jmb.2007.05.056; Allingham JS, 2005, P NATL ACAD SCI USA, V102, P14527, DOI 10.1073/pnas.0502089102; Andrianantoandro E, 2006, MOL CELL, V24, P13, DOI 10.1016/j.molcel.2006.08.006; Belmont LD, 1999, P NATL ACAD SCI USA, V96, P29, DOI 10.1073/pnas.96.1.29; Blanchoin L, 2002, BIOCHEMISTRY-US, V41, P597, DOI 10.1021/bi011214b; Blanchoin L, 1999, J BIOL CHEM, V274, P15538, DOI 10.1074/jbc.274.22.15538; BORK P, 1992, P NATL ACAD SCI USA, V89, P7290, DOI 10.1073/pnas.89.16.7290; BREMER A, 1994, J MOL BIOL, V242, P683, DOI 10.1006/jmbi.1994.1617; Bubb MR, 2002, J BIOL CHEM, V277, P20999, DOI 10.1074/jbc.M201371200; Cao WX, 2006, J MOL BIOL, V361, P257, DOI 10.1016/j.jmb.2006.06.019; Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; Chik JK, 1996, J MOL BIOL, V263, P607, DOI 10.1006/jmbi.1996.0602; De La Cruz EM, 1996, BIOCHEMISTRY-US, V35, P14054, DOI 10.1021/bi961047t; DE LA CRUZ EM, 1995, BIOCHEMISTRY-US, V34, P5452, DOI 10.1021/bi00016a016; DE LA CRUZ EM, 1994, BIOCHEMISTRY-US, V33, P14387, DOI 10.1021/bi00252a003; DEROSIER DJ, 1980, NATURE, V287, P291, DOI 10.1038/287291a0; DOOLITTLE RF, 1995, PHILOS T R SOC B, V349, P235, DOI 10.1098/rstb.1995.0107; EGELMAN EH, 1982, NATURE, V298, P131, DOI 10.1038/298131a0; Feuer G., 1948, HUNGARICA ACTA PHYSIOL, V1, P150; FLAHERTY KM, 1991, P NATL ACAD SCI USA, V88, P5041, DOI 10.1073/pnas.88.11.5041; FLAHERTY KM, 1990, NATURE, V346, P623, DOI 10.1038/346623a0; Galkin VE, 2003, J CELL BIOL, V163, P1057, DOI 10.1083/jcb.200308144; Galkin VE, 2002, CURR BIOL, V12, P570, DOI 10.1016/S0960-9822(02)00742-X; Galkin VE, 2001, J CELL BIOL, V153, P75, DOI 10.1083/jcb.153.1.75; Garner EC, 2004, SCIENCE, V306, P1021, DOI 10.1126/science.1101313; Hara F, 2007, J BACTERIOL, V189, P2039, DOI 10.1128/JB.01454-06; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; KASAI M, 1965, BIOCHIM BIOPHYS ACTA, V94, P494, DOI 10.1016/0926-6585(65)90058-0; Kim E, 1998, BIOCHEMISTRY-US, V37, P17801, DOI 10.1021/bi981286b; Kim E, 2000, J MOL BIOL, V299, P421, DOI 10.1006/jmbi.2000.3727; Kim E, 2002, BIOCHEMISTRY-US, V41, P86, DOI 10.1021/bi0113824; Klenchin VA, 2006, J MOL BIOL, V362, P140, DOI 10.1016/j.jmb.2006.07.001; Kudryashov DS, 2005, P NATL ACAD SCI USA, V102, P13105, DOI 10.1073/pnas.0506429102; Levitsky DI, 1998, BIOCHEMISTRY-MOSCOW+, V63, P322; McCormack EA, 2001, J STRUCT BIOL, V135, P198, DOI 10.1006/jsbi.2001.4385; McGough A, 1997, J CELL BIOL, V138, P771, DOI 10.1083/jcb.138.4.771; MCLAUGHLIN PJ, 1993, NATURE, V364, P685, DOI 10.1038/364685a0; Michelot A, 2007, CURR BIOL, V17, P825, DOI 10.1016/j.cub.2007.04.037; MUHLRAD A, 1994, J BIOL CHEM, V269, P11852; Musib R, 2002, J BIOL CHEM, V277, P22699, DOI 10.1074/jbc.M203096200; Nishimasu H, 2007, J BIOL CHEM, V282, P9923, DOI 10.1074/jbc.M610678200; Noguchi TQP, 2007, J BIOL CHEM, V282, P27721, DOI 10.1074/jbc.M703165200; Nolen BJ, 2007, MOL CELL, V26, P449, DOI 10.1016/j.molcel.2007.04.017; Orlova A, 2004, P NATL ACAD SCI USA, V101, P17664, DOI 10.1073/pnas.0407525102; ORLOVA A, 1993, J MOL BIOL, V232, P334, DOI 10.1006/jmbi.1993.1393; Orlova A, 2001, J MOL BIOL, V312, P95, DOI 10.1006/jmbi.2001.4945; Orlova A, 2000, BIOPHYS J, V78, P2180, DOI 10.1016/S0006-3495(00)76765-8; Orlova A, 2007, NAT STRUCT MOL BIOL, V14, P921, DOI 10.1038/nsmb1300; Otomo T, 2005, NATURE, V433, P488, DOI 10.1038/nature03251; Otterbein LR, 2001, SCIENCE, V293, P708, DOI 10.1126/science.1059700; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; Prochniewicz E, 2005, J MOL BIOL, V353, P990, DOI 10.1016/j.jmb.2005.09.021; Prochniewicz E, 1997, BIOCHEMISTRY-US, V36, P12845, DOI 10.1021/bi971201r; Roeben A, 2006, J MOL BIOL, V358, P145, DOI 10.1016/j.jmb.2006.01.096; Rould MA, 2006, J BIOL CHEM, V281, P31909, DOI 10.1074/jbc.M601973200; Schmid MF, 2004, NATURE, V431, P104, DOI 10.1038/nature02881; SCHUTT CE, 1993, NATURE, V365, P810, DOI 10.1038/365810a0; Scoville D, 2006, BIOCHEMISTRY-US, V45, P13576, DOI 10.1021/bi061229f; SHETERLINE P, 1995, PROTEIN PROFILE, V2, P1; Shvetsov A, 2002, BIOCHEMISTRY-US, V41, P10787, DOI 10.1021/bi020205f; Shvetsov A, 2006, BIOCHEMISTRY-US, V45, P6541, DOI 10.1021/bi052558v; Simanshu DK, 2005, J MOL BIOL, V352, P876, DOI 10.1016/j.jmb.2005.07.069; van den Ent F, 2001, NATURE, V413, P39, DOI 10.1038/35092500; van den Ent F, 2002, EMBO J, V21, P6935, DOI 10.1093/emboj/cdf672; Zheng XG, 2007, BIOPHYS J, V93, P1277, DOI 10.1529/biophysj.107.109215	69	71	77	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36133	36137		10.1074/jbc.R700030200	http://dx.doi.org/10.1074/jbc.R700030200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17965017	hybrid			2022-12-27	WOS:000251458300002
J	Carlson, EC; Lin, M; Liu, CY; Kao, WWY; Perez, VL; Pearlman, E				Carlson, Eric C.; Lin, Michelle; Liu, Chia-Yang; Kao, Winston W-Y.; Perez, Victor L.; Pearlman, Eric			Keratocan and lumican regulate neutrophil infiltration and corneal clarity in lipopolysaccharide-induced keratitis by direct interaction with CXCL1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO; EXPRESSION; GENE; ACTIVATION; PROLIFERATION; VISUALIZATION; DELIVERY; OPACITY; PROTEIN; STROMA	Keratocan and lumican are keratan-sulfate proteoglycans (KSPG), which have a critical role in maintaining corneal clarity. To determine whether these KSPGs have a role in corneal inflammation, we examined Kera(-/-) and Lum(-/-) mice in a model of lipopolysaccharide (LPS)-induced keratitis in which wild-type mice develop increased corneal thickness and haze due to neutrophil infiltration to the corneal stroma. Corneal thickness increases caused by LPS mice were significantly lower in Kera(-/-) and Lum(-/-) than wild-type mice. Further, LPS-injected Lum(-/-) mice had elevated corneal haze levels compared with that of Kera(-/-) and wild-type. At 24 h post-injection, total enhanced green fluorescent protein-positive bone marrow-derived inflammatory cells in chimeric mice was significantly lower in Kera(-/-) mice and Lum(-/-) mice compared with wildtype mice. Neutrophil infiltration was inhibited in Kera(-/-) and Lum(-/-) mice at 6 and 24 h post-stimulation, with Lum(-/-) corneas having the most profound defect in neutrophil migration. Reconstitution of keratocan and lumican expression in corneas of Kera(-/-) and Lum(-/-) mice using adeno-keratocan and adeno-lumican viral vectors, respectively, resulted in normal neutrophil infiltration in response to LPS. Immunoprecipitation/Western blot analysis showed that lumican and keratocan core proteins bind the CXC chemokine KC during a corneal inflammatory response, indicating that corneal KSPGs mediate neutrophil recruitment to the cornea by regulating chemokine gradient formation. Together, these data support a significant role for lumican and keratocan in a corneal inflammatory response with respect to edema, corneal clarity, and cellular infiltration.	Case Western Reserve Univ, Dept Ophthalmol, Cleveland, OH 44106 USA; Univ Cincinnati, Dept Ophthalmol, Cincinnati, OH 45267 USA; Univ Miami, Dept Ophthalmol, Miami, FL 33136 USA	Case Western Reserve University; University System of Ohio; University of Cincinnati; University of Miami	Carlson, EC (corresponding author), Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, 10900 Euclid Ave, Cleveland, OH 44106 USA.	Eric.Carlson@case.edu	Perez, Victor L./AAY-8633-2020	Liu, Chia-yang/0000-0002-8398-5516; Lin, Michelle/0000-0001-5367-1930	NATIONAL EYE INSTITUTE [R01EY010320, K08EY014912, P30EY011373, R01EY014362, R01EY011845] Funding Source: NIH RePORTER; NEI NIH HHS [P30 EY011373, EY11845, EY11373, R01 EY010320, EY1032, R01 EY011845, K08 EY014912, R01 EY014362] Funding Source: Medline; PHS HHS [R01 12486] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Auletta JJ, 2004, BIOL BLOOD MARROW TR, V10, P834, DOI 10.1016/j.bbmt.2004.08.003; Carlson EC, 2006, INVEST OPHTH VIS SCI, V47, P241, DOI 10.1167/iovs.04-0741; Carlson EC, 2005, J BIOL CHEM, V280, P25541, DOI 10.1074/jbc.M500249200; Carlson EC, 2004, INVEST OPHTH VIS SCI, V45, P2194, DOI 10.1167/iovs.03-1224; Carlson EC, 2003, MOL VIS, V9, P615; Carlson EC, 2003, BIOCHEM J, V369, P461, DOI 10.1042/BJ20020593; Chakravarti S, 2000, INVEST OPHTH VIS SCI, V41, P3365; Chakravarti S, 1998, J CELL BIOL, V141, P1277, DOI 10.1083/jcb.141.5.1277; Chen J, 2001, J IMMUNOL, V167, P1297, DOI 10.4049/jimmunol.167.3.1297; Funderburgh JL, 1997, INVEST OPHTH VIS SCI, V38, P1159; Gueders MM, 2005, J IMMUNOL, V175, P2589, DOI 10.4049/jimmunol.175.4.2589; Johnson AC, 2005, INVEST OPHTH VIS SCI, V46, P589, DOI 10.1167/iovs.04-1077; Khan S, 2007, J LEUKOCYTE BIOL, V81, P315, DOI 10.1189/jlb.0506344; Khatri S, 2002, INVEST OPHTH VIS SCI, V43, P2278; Kozu T, 1996, BIOCHIMIE, V78, P1067, DOI 10.1016/S0300-9084(97)86731-4; Li QL, 2002, CELL, V111, P635, DOI 10.1016/S0092-8674(02)01079-6; Lin M, 2007, J LEUKOCYTE BIOL, V81, P786, DOI 10.1189/jlb.0806502; Liu CY, 2003, J BIOL CHEM, V278, P21672, DOI 10.1074/jbc.M301169200; Liu CY, 2000, GENE, V250, P85, DOI 10.1016/S0378-1119(00)00165-7; Liu Y, 2007, BIOMATERIALS, V28, P1393, DOI 10.1016/j.biomaterials.2006.11.019; Oshima T, 2006, BRIT J OPHTHALMOL, V90, P218, DOI 10.1136/bjo.2005.077875; Pearlman E, 2000, PARASITE IMMUNOL, V22, P625, DOI 10.1046/j.1365-3024.2000.00345.x; PING LY, 2002, J PATHOL, V196, P324; Saika S, 2000, J BIOL CHEM, V275, P2607, DOI 10.1074/jbc.275.4.2607; Stechschulte SU, 2001, INVEST OPHTH VIS SCI, V42, P1975; Szliter E A, 2006, Eye Contact Lens, V32, P12, DOI 10.1097/01.icl.0000167611.03883.58; Van Parijs L, 1999, IMMUNITY, V11, P281, DOI 10.1016/S1074-7613(00)80103-X; Vij N, 2005, INVEST OPHTH VIS SCI, V46, P88, DOI 10.1167/iovs.04-0833; Wu F, 2007, J BIOL CHEM, V282, P26409, DOI 10.1074/jbc.M702402200; Ying SX, 1997, J BIOL CHEM, V272, P30306, DOI 10.1074/jbc.272.48.30306	30	58	58	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35502	35509		10.1074/jbc.M705823200	http://dx.doi.org/10.1074/jbc.M705823200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17911102	hybrid, Green Accepted			2022-12-27	WOS:000251458100009
J	Lin, BC; Sullivan, R; Lee, Y; Moran, S; Glover, E; Bradfield, CA				Lin, Bernice C.; Sullivan, Ruth; Lee, Youngsook; Moran, Susan; Glover, Edward; Bradfield, Christopher A.			Deletion of the aryl hydrocarbon receptor-associated protein 9 leads to cardiac malformation and embryonic lethality	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-INTERACTING-PROTEIN; X-ASSOCIATED PROTEIN-2; CONGENITAL HEART-DISEASE; AH RECEPTOR; PITUITARY-ADENOMA; NUCLEAR-PROTEIN; GENE-MUTATIONS; OUTFLOW TRACT; PPAR-ALPHA; MICE	The aryl hydrocarbon receptor-associated protein 9, ARA9 ( also known as XAP2 or AIP1), is a chaperone that is found in complexes with certain xenobiotic receptors, such as the aryl hydrocarbon receptor (AHR) and the peroxisome proliferator-activated receptor alpha(PPAR alpha). In an effort to better understand the physiological role of ARA9 outside of its role in xenobiotic signal transduction, we generated a null allele at the Ara9 locus in mice. Mice with a homozygous deletion of this gene die at various time points throughout embryonic development. Embryonic lethality is accompanied by decreased blood flow to head and limbs, as well as a range of heart deformations, including double outlet right ventricle, ventricular-septal defects, and pericardial edema. The early cardiovascular defects observed in Ara9-null mice suggest an essential role for the ARA9 protein in cardiac development. The observation that the developmental aberrations in Ara9-null mice are distinct from those observed for disrupted alleles at Ahr or Ppar alpha indicates that the role of ARA9 in cardiac development is independent of its interactions with its known xenobiotic receptor partners.	Univ Wisconsin, McArdle Lab Canc Res, Madison, WI 53706 USA; Univ Wisconsin, Ctr Comprehens Canc, Madison, WI 53792 USA; Univ Wisconsin, Dept Anat, Sch Med & Publ Hlth, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Bradfield, CA (corresponding author), Univ Wisconsin, McArdle Lab Canc Res, 1400 Univ Ave, Madison, WI 53706 USA.	bradfield@oncology.wisc.edu			NCI NIH HHS [P30-CA014520, T32-CA009135] Funding Source: Medline; NIEHS NIH HHS [R01-ES006883, R01 ES006883] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA014520, T32CA009135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES006883] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Adida C, 1998, AM J PATHOL, V152, P43; Bajolle F, 2006, CIRC RES, V98, P421, DOI 10.1161/01.RES.0000202800.85341.6e; Benson D. Woodrow, 2002, Cardiology Clinics, V20, P385, DOI 10.1016/S0733-8651(02)00009-7; BERNSTEIN D, 1996, CARDIOVASCULAR SYSTE, P1286; Bolger GB, 2003, J BIOL CHEM, V278, P33351, DOI 10.1074/jbc.M303269200; Braissant O, 1996, ENDOCRINOLOGY, V137, P354, DOI 10.1210/en.137.1.354; Brand T, 2003, DEV BIOL, V258, P1, DOI 10.1016/S0012-1606(03)00112-X; BROACH JR, 1982, CELL, V29, P227, DOI 10.1016/0092-8674(82)90107-6; Broekhuizen MLA, 1999, ULTRASOUND OBST GYN, V13, P437, DOI 10.1046/j.1469-0705.1999.13060437.x; Bunger MK, 2003, J BIOL CHEM, V278, P17767, DOI 10.1074/jbc.M209594200; Campione M, 2002, COLD SPRING HARB SYM, V67, P89, DOI 10.1101/sqb.2002.67.89; Carver LA, 1997, J BIOL CHEM, V272, P11452; Carver LA, 1998, J BIOL CHEM, V273, P33580, DOI 10.1074/jbc.273.50.33580; Chen BB, 2000, NAT GENET, V24, P296, DOI 10.1038/73528; Chen J, 1998, DEVELOPMENT, V125, P1943; Christiansen JH, 2006, NUCLEIC ACIDS RES, V34, pD637, DOI 10.1093/nar/gkj006; Conway SJ, 2003, GENESIS, V35, P1, DOI 10.1002/gene.10152; Daly AF, 2007, J CLIN ENDOCR METAB, V92, P1891, DOI 10.1210/jc.2006-2513; de Oliveira SK, 2007, J BIOL CHEM, V282, P13656, DOI 10.1074/jbc.M610942200; Dees E, 2002, CURR OPIN PEDIATR, V14, P627, DOI 10.1097/00008480-200210000-00011; DICARLO J, 1994, PEDIATR CLIN N AM, V41, P525; DOLWICK KM, 1993, MOL PHARMACOL, V44, P911; Dymecki SM, 1996, P NATL ACAD SCI USA, V93, P6191, DOI 10.1073/pnas.93.12.6191; EISEN HJ, 1983, BIOCHEM ACTION HORM, V10, P227; FernandezSalguero PM, 1996, TOXICOL APPL PHARM, V140, P173, DOI 10.1006/taap.1996.0210; Fishman MC, 1997, DEVELOPMENT, V124, P2099; Franco D, 2003, TRENDS CARDIOVAS MED, V13, P157, DOI 10.1016/S1050-1738(03)00039-2; FUKUNAGA BN, 1995, J BIOL CHEM, V270, P29270, DOI 10.1074/jbc.270.49.29270; Georgitsi M, 2007, BRIT J CANCER, V96, P352, DOI 10.1038/sj.bjc.6603573; Georgitsi M, 2007, P NATL ACAD SCI USA, V104, P4101, DOI 10.1073/pnas.0700004104; HARDING MW, 1989, NATURE, V341, P758, DOI 10.1038/341758a0; Hemminki K, 2007, ENDOCR-RELAT CANCER, V14, P103, DOI 10.1677/ERC-06-0008; Hogers B, 1997, CIRC RES, V80, P473, DOI 10.1161/01.RES.80.4.473; Jain S, 1998, MECH DEVELOP, V73, P117, DOI 10.1016/S0925-4773(98)00038-0; Kang BH, 2006, J BIOL CHEM, V281, P24721, DOI 10.1074/jbc.M603175200; Kashuba E, 2000, ONCOGENE, V19, P1801, DOI 10.1038/sj.onc.1203501; Katz SG, 2003, P NATL ACAD SCI USA, V100, P14030, DOI 10.1073/pnas.1936250100; KURIHARA Y, 1995, J CLIN INVEST, V96, P293, DOI 10.1172/JCI118033; Kuzhandaivelu N, 1996, NUCLEIC ACIDS RES, V24, P4741, DOI 10.1093/nar/24.23.4741; LaPres JJ, 2000, J BIOL CHEM, V275, P6153, DOI 10.1074/jbc.275.9.6153; LEE SST, 1995, MOL CELL BIOL, V15, P3012; Lee Y, 2000, CIRC RES, V86, P932, DOI 10.1161/01.RES.86.9.932; Lees MJ, 2003, J BIOL CHEM, V278, P35878, DOI 10.1074/jbc.M302430200; Lin CR, 1999, NATURE, V401, P279, DOI 10.1038/45803; Ma ACH, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-50; Ma Q, 1997, J BIOL CHEM, V272, P8878; Meyer BK, 1998, MOL CELL BIOL, V18, P978, DOI 10.1128/MCB.18.2.978; Meyers EN, 1998, NAT GENET, V18, P136, DOI 10.1038/ng0298-136; Michalik L, 2001, J CELL BIOL, V154, P799, DOI 10.1083/jcb.200011148; MORRISONGRAHAM K, 1992, DEVELOPMENT, V115, P133; Motojima K, 2006, FEBS J, V273, P292, DOI 10.1111/j.1742-4658.2005.05060.x; Petrulis JR, 2000, J BIOL CHEM, V275, P37448, DOI 10.1074/jbc.M006873200; Sanford LP, 1997, DEVELOPMENT, V124, P2659; Schmidt JV, 1996, P NATL ACAD SCI USA, V93, P6731, DOI 10.1073/pnas.93.13.6731; Srivastava D, 2000, NATURE, V407, P221, DOI 10.1038/35025190; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Su JL, 1998, HYBRIDOMA, V17, P47, DOI 10.1089/hyb.1998.17.47; Sumanasekera WK, 2003, J BIOL CHEM, V278, P4467, DOI 10.1074/jbc.M211261200; Vierimaa O, 2006, SCIENCE, V312, P1228, DOI 10.1126/science.1126100; Waldo K, 1998, DEV BIOL, V196, P129, DOI 10.1006/dbio.1998.8860; Watanabe S, 2005, AM J PHYSIOL-RENAL, V288, pF40, DOI 10.1152/ajprenal.00218.2004; Ya J, 1998, CIRC RES, V83, P986, DOI 10.1161/01.RES.83.10.986; Yanagisawa H, 1998, J CLIN INVEST, V102, P22, DOI 10.1172/JCI2698; ZWERTS F, 2007, BLOOD	64	67	69	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35924	35932		10.1074/jbc.M705471200	http://dx.doi.org/10.1074/jbc.M705471200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17916558	hybrid			2022-12-27	WOS:000251458100053
J	Mizuno, Y; Moorhead, GBG; Ng, KKS				Mizuno, Yutaka; Moorhead, Greg B. G.; Ng, Kenneth K. -S.			Structural basis for the regulation of N-acetylglutamate kinase by PII in Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION PROTEIN; L-GLUTAMATE KINASE; ARGININE-BIOSYNTHESIS; CRYSTAL-STRUCTURE; COMPLEX-FORMATION; PLASTID CARBON; NITROGEN; REVEALS; GLNK; AMTB	PII is a highly conserved regulatory protein found in organisms across the three domains of life. In cyanobacteria and plants, PII relieves the feedback inhibition of the rate-limiting step in arginine biosynthesis catalyzed by N-acetylglutamate kinase (NAGK). To understand the molecular structural basis of enzyme regulation by PII, we have determined a 2.5-angstrom resolution crystal structure of a complex formed between two homotrimers of PII and a single hexamer of NAGK from Arabidopsis thaliana bound to the metabolites N-acetylglutamate, ADP, ATP, and arginine. In PII, the T-loop and Trp(22) at the start of the alpha 1-helix, which are both adjacent to the ATP-binding site of PII, contact two beta-strands as well as the ends of two central helices (alpha E and alpha G) in NAGK, the opposing ends of which form major portions of the ATP and N-acetylglutamate substrate-binding sites. The binding of Mg2+ center dot ATP to PII stabilizes a conformation of the T-loop that favors interactions with both open and closed conformations of NAGK. Interactions between PII and NAGK appear to limit the degree of opening and closing of the active-site cleft in opposition to a domain-separating inhibitory effect exerted by arginine, thus explaining the stimulatory effect of PII on the kinetics of arginine-inhibited NAGK.	Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; Univ Calgary, Alberta Ingenu Ctr Carbohydrate Sci, Calgary, AB T2N 1N4, Canada	University of Calgary; University of Calgary	Ng, KKS (corresponding author), Univ Calgary, Dept Biol Sci, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	ngk@ucalgary.ca		Ng, Kenneth K.S./0000-0001-7280-8445				Arcondeguy T, 2001, MICROBIOL MOL BIOL R, V65, P80, DOI 10.1128/MMBR.65.1.80-105.2001; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burillo S, 2004, J BACTERIOL, V186, P3346, DOI 10.1128/JB.186.11.3346-3354.2004; Chen YM, 2006, J BIOL CHEM, V281, P5726, DOI 10.1074/jbc.M510945200; Conroy MJ, 2007, P NATL ACAD SCI USA, V104, P1213, DOI 10.1073/pnas.0610348104; DeLano W.L, PYMOL MOL GRAPHICS S; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Ferrario-Mery S, 2006, FEBS LETT, V580, P2015, DOI 10.1016/j.febslet.2006.02.075; Ferrario-Mery S, 2005, PLANTA, V223, P28, DOI 10.1007/s00425-005-0063-5; Forchhammer K, 2004, FEMS MICROBIOL REV, V28, P319, DOI 10.1016/j.femsre.2003.11.001; Gil-Ortiz F, 2003, J MOL BIOL, V331, P231, DOI 10.1016/S0022-2836(03)00716-2; Gruswitz F, 2007, P NATL ACAD SCI USA, V104, P42, DOI 10.1073/pnas.0609796104; Hayward S, 2002, J MOL GRAPH MODEL, V21, P181, DOI 10.1016/S1093-3263(02)00140-7; Heinrich A, 2004, MOL MICROBIOL, V52, P1303, DOI 10.1111/j.1365-2958.2004.04058.x; Hsieh MH, 1998, P NATL ACAD SCI USA, V95, P13965, DOI 10.1073/pnas.95.23.13965; Jiang P, 1997, J BACTERIOL, V179, P4342, DOI 10.1128/jb.179.13.4342-4353.1997; Maheswaran M, 2004, J BIOL CHEM, V279, P55202, DOI 10.1074/jbc.M410971200; MATTHEWS BW, 1985, METHOD ENZYMOL, V114, P176; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Mizuno Y, 2007, BIOCHEMISTRY-US, V46, P1477, DOI 10.1021/bi062149e; Moorhead GBG, 2003, PLANT PHYSIOL, V133, P492, DOI 10.1104/pp.103.025627; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ninfa AJ, 2000, TRENDS MICROBIOL, V8, P172, DOI 10.1016/S0966-842X(00)01709-1; Ninfa AJ, 2005, CURR OPIN MICROBIOL, V8, P168, DOI 10.1016/j.mib.2005.02.011; Osanai T, 2007, PLANT CELL PHYSIOL, V48, P908, DOI 10.1093/pcp/pcm072; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ramon-Maiques S, 2006, J MOL BIOL, V356, P695, DOI 10.1016/j.jmb.2005.11.079; Ramon-Maiques S, 2002, STRUCTURE, V10, P329, DOI 10.1016/S0969-2126(02)00721-9; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Sakai H, 2005, J STRUCT BIOL, V149, P99, DOI 10.1016/j.jsb.2004.08.007; Smith CS, 2004, BBA-PROTEINS PROTEOM, V1699, P145, DOI 10.1016/j.bbapap.2004.02.009; Smith CS, 2003, PLANT J, V33, P353, DOI 10.1046/j.1365-313X.2003.01634.x; Sugiyama K, 2004, PLANT CELL PHYSIOL, V45, P1768, DOI 10.1093/pcp/pch199; Xu YB, 1998, J MOL BIOL, V282, P149, DOI 10.1006/jmbi.1998.1979; Xu YB, 2001, EUR J BIOCHEM, V268, P2028, DOI 10.1046/j.1432-1327.2001.02074.x; Yildiz O, 2007, EMBO J, V26, P589, DOI 10.1038/sj.emboj.7601492	38	49	51	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35733	35740		10.1074/jbc.M707127200	http://dx.doi.org/10.1074/jbc.M707127200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17913711	hybrid			2022-12-27	WOS:000251458100034
J	Ishii, K; Hamamoto, H; Kamimura, M; Sekimizu, K				Ishii, Kenichi; Hamamoto, Hiroshi; Kamimura, Manabu; Sekimizu, Kazuhisa			Activation of the silkworm cytokine by bacterial and fungal cell wall components via a reactive oxygen species-triggered mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-1,3-GLUCAN RECOGNITION PROTEIN; PLASMATOCYTE SPREADING PEPTIDE; PATTERN-RECOGNITION; PARALYTIC PEPTIDE; IMMUNE-RESPONSE; IN-VITRO; MANDUCA-SEXTA; ANTIMICROBIAL PEPTIDES; LEPIDOPTERAN INSECT; CYTOTOXIC MOLECULES	The insect cytokine paralytic peptide ( PP) induces muscle contraction in silkworm larvae. Here we demonstrate that bacterial and fungal cell wall components peptidoglycan and glucan stimulate muscle contraction via activation of PP in the hemolymph. Anti-PP antibody suppressed the muscle contraction induced by PP, peptidoglycan, or glucan. The contraction was also inhibited by free radical scavengers and serine protease inhibitors. Moreover, injecting live silkworms with peptidoglycan or glucan generated the active form of PP. The active form of PP was also produced in vitro when peptidoglycan or glucan was incubated with hemolymph containing the PP precursor. Generation of the active form of PP was suppressed by free radical scavengers and serine protease inhibitors. Furthermore, PP activation in isolated hemolymph was inhibited by potassium cyanide, suggesting that cellular activity is involved. Stimulation by peptidoglycan promoted the generation of reactive oxygen species by silkworm hemocytes. The addition of either the active form of PP or anti-PP antibody to Staphylococcus aureus injected into silkworm larvae delayed or enhanced, respectively, the killing effect of S. aureus, suggesting that activated PP contributes to host resistance to infectious pathogens. These findings suggest that immunologic stimulants such as peptidoglycan or glucan induce reactive oxygen species production from larval hemocytes, followed by the activation of serine protease, which mediates the PP processing reaction and leads to defensive responses.	[Ishii, Kenichi; Sekimizu, Kazuhisa] Univ Tokyo, Grad Sch Pharmaceut Sci, Microbiol Lab, Bunkyo Ku, Tokyo 1130033, Japan; [Hamamoto, Hiroshi] Genome Pharnaceut Inst Co Ltd, Tokyo 1130033, Japan; [Kamimura, Manabu] Natl Inst Agrobiol Sci, Tsukuba 3058634, Japan	University of Tokyo; National Institute of Agrobiological Sciences - Japan	Sekimizu, K (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Microbiol Lab, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	sekimizu@mol.f.u-tokyo.ac.jp	Hamamoto, Hiroshi/G-6397-2019; Ishii, Kenichi/H-5469-2019	Hamamoto, Hiroshi/0000-0001-9315-7442; 				Aizawa H, 2006, INTERNAL MED, V45, P1, DOI 10.2169/internalmedicine.45.1491; Arumugam M, 2000, EUR J CELL BIOL, V79, P513, DOI 10.1078/0171-9335-00068; Bach JF, 2003, ANN NY ACAD SCI, V998, P161, DOI 10.1196/annals.1254.017; Bergin D, 2005, INFECT IMMUN, V73, P4161, DOI 10.1128/IAI.73.7.4161-4170.2005; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Bogdan C, 2000, CURR OPIN IMMUNOL, V12, P64, DOI 10.1016/S0952-7915(99)00052-7; Bulet P, 2004, IMMUNOL REV, V198, P169, DOI 10.1111/j.0105-2896.2004.0124.x; Canto E, 2006, CLIN IMMUNOL, V119, P156, DOI 10.1016/j.clim.2005.12.005; CASEY LC, 1993, ANN INTERN MED, V119, P771, DOI 10.7326/0003-4819-119-8-199310150-00001; Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x; Ferrandon D, 2004, SEMIN IMMUNOL, V16, P43, DOI 10.1016/j.smim.2003.10.008; Forman Henry Jay, 2001, Molecular Aspects of Medicine, V22, P189; Forman HJ, 2002, AM J RESP CRIT CARE, V166, pS4, DOI 10.1164/rccm.2206007; Garcia-Lara J, 2005, FEMS IMMUNOL MED MIC, V43, P311, DOI 10.1016/j.femsim.2004.11.003; Gorman MJ, 2001, INSECT BIOCHEM MOLEC, V31, P257, DOI 10.1016/S0965-1748(00)00145-4; Ha SD, 1999, PEPTIDES, V20, P561, DOI 10.1016/S0196-9781(99)00008-X; Hamamoto H, 2004, ANTIMICROB AGENTS CH, V48, P774, DOI 10.1128/AAC.48.3.774-779.2004; Hillyer JF, 2003, CELL TISSUE RES, V313, P117, DOI 10.1007/s00441-003-0744-y; Hoebe K, 2004, NAT IMMUNOL, V5, P971, DOI 10.1038/ni1004-971; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Ji CY, 2004, J BIOL CHEM, V279, P34101, DOI 10.1074/jbc.M404584200; Jones SA, 2005, J IMMUNOL, V175, P3463, DOI 10.4049/jimmunol.175.6.3463; Kaito C, 2005, MOL MICROBIOL, V56, P934, DOI 10.1111/j.1365-2958.2005.04596.x; Kamimura M, 2001, BIOCHEM BIOPH RES CO, V286, P67, DOI 10.1006/bbrc.2001.5365; Kaneko T, 2006, NAT IMMUNOL, V7, P715, DOI 10.1038/ni1356; Kanost MR, 2004, IMMUNOL REV, V198, P97, DOI 10.1111/j.0105-2896.2004.0121.x; Khan WI, 2006, CLIN EXP IMMUNOL, V143, P389, DOI 10.1111/j.1365-2249.2005.02979.x; Khan WI, 2001, INFECT IMMUN, V69, P838, DOI 10.1128/IAI.69.2.838-844.2001; Kobayashi KS, 2004, J LEUKOCYTE BIOL, V75, P428, DOI 10.1189/jlb.0703321; Kurata S, 2006, IMMUNOBIOLOGY, V211, P237, DOI 10.1016/j.imbio.2005.10.016; Lee WJ, 1996, P NATL ACAD SCI USA, V93, P7888, DOI 10.1073/pnas.93.15.7888; Lehrer RI, 1999, CURR OPIN IMMUNOL, V11, P23, DOI 10.1016/S0952-7915(99)80005-3; Luster AD, 2002, CURR OPIN IMMUNOL, V14, P129, DOI 10.1016/S0952-7915(01)00308-9; Marcinkiewicz J, 2007, INT J EXP PATHOL, V88, P155, DOI 10.1111/j.1365-2613.2007.00530.x; Marmaras VJ, 1996, ARCH INSECT BIOCHEM, V31, P119, DOI 10.1002/(SICI)1520-6327(1996)31:2&lt;119::AID-ARCH1&gt;3.0.CO;2-V; Michel T, 2001, NATURE, V414, P756, DOI 10.1038/414756a; Miura K, 2002, PEPTIDES, V23, P2111, DOI 10.1016/S0196-9781(02)00254-1; Nakahara Y, 2003, ARCH INSECT BIOCHEM, V52, P163, DOI 10.1002/arch.10080; Nappi AJ, 2000, BIOESSAYS, V22, P469, DOI 10.1002/(SICI)1521-1878(200005)22:5<469::AID-BIES9>3.3.CO;2-W; NAPPI AJ, 1993, PIGM CELL RES, V6, P117, DOI 10.1111/j.1600-0749.1993.tb00590.x; Natori S, 1999, DEV COMP IMMUNOL, V23, P317, DOI 10.1016/S0145-305X(99)00014-2; Ochiai M, 1999, J BIOL CHEM, V274, P11854, DOI 10.1074/jbc.274.17.11854; OCHIAI M, 1988, J BIOL CHEM, V263, P12056; Ochiai M, 2000, J BIOL CHEM, V275, P4995, DOI 10.1074/jbc.275.7.4995; Pereira LS, 2001, EXP PARASITOL, V99, P66, DOI 10.1006/expr.2001.4657; Sekimizu K, 2005, J BIOCHEM, V137, P199, DOI 10.1093/jb/mvi019; Siwik DA, 2001, AM J PHYSIOL-CELL PH, V280, pC53, DOI 10.1152/ajpcell.2001.280.1.C53; SKINNER WS, 1991, J BIOL CHEM, V266, P12873; SKINNER WS, 1993, COMP BIOCHEM PHYS C, V104, P133, DOI 10.1016/0742-8413(93)90124-4; Strand MR, 2008, INSECT IMMUNOLOGY, P25, DOI 10.1016/S0965-1748(02)00092-9; Strand MR, 2000, J INSECT PHYSIOL, V46, P817, DOI 10.1016/S0022-1910(99)00171-7; SUN SC, 1995, EUR J BIOCHEM, V231, P93, DOI 10.1111/j.1432-1033.1995.0093f.x; Tanji T, 2006, BIOCHEM J, V396, P127, DOI 10.1042/BJ20051921; Ujita M, 2005, BIOSCI BIOTECH BIOCH, V69, P1178, DOI 10.1271/bbb.69.1178; Umemura M, 2007, J IMMUNOL, V178, P3786, DOI 10.4049/jimmunol.178.6.3786; Wang Y, 1999, INSECT BIOCHEM MOLEC, V29, P1075, DOI 10.1016/S0965-1748(99)00086-7; Whitten MMA, 2004, J IMMUNOL, V172, P2177, DOI 10.4049/jimmunol.172.4.2177; Whitten MMA, 1999, J INSECT PHYSIOL, V45, P667, DOI 10.1016/S0022-1910(99)00039-6; Yamakawa M, 1999, DEV COMP IMMUNOL, V23, P281, DOI 10.1016/S0145-305X(99)00011-7; Yoshida H, 1996, J BIOL CHEM, V271, P13854, DOI 10.1074/jbc.271.23.13854; Yu XQ, 2002, INSECT BIOCHEM MOLEC, V32, P1287, DOI 10.1016/S0965-1748(02)00091-7	62	65	79	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					2185	2191		10.1074/jbc.M705480200	http://dx.doi.org/10.1074/jbc.M705480200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	17947232	hybrid			2022-12-27	WOS:000252501000046
J	Garvey, GS; McCormick, SP; Rayment, I				Garvey, Graeme S.; McCormick, Susan P.; Rayment, Ivan			Structural and functional characterization of the TRI101 trichothecene 3-O-acetyltransferase from Fusarium sporotrichioides and Fusarium graminearum - Kinetic insights to combating fusarium head blight	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYCOTOXIN DEOXYNIVALENOL; VINORINE SYNTHASE; CRYSTAL-STRUCTURE; GENE; BIOSYNTHESIS; EXPRESSION; ENCODES; PROTEIN; BAHD; ACETYLTRANSFERASE	Fusarium head blight (FHB) is a plant disease with serious economic and health impacts. It is caused by fungal species belonging to the genus Fusarium and the mycotoxins they produce. Although it has proved difficult to combat this disease, one strategy that has been examined is the introduction of an indigenous fungal protective gene into cereals such as wheat barley and rice. Thus far the gene of choice has been tri101 whose gene product catalyzes the transfer of an acetyl group from acetyl coenzyme A to the C3 hydroxyl moiety of several trichothecene mycotoxins. In vitro this has been shown to reduce the toxicity of the toxins by similar to 100-fold but has demonstrated limited resistance to FHB in transgenic cereal. To understand the molecular basis for the differences between in vitro and in vivo resistance the three-dimensional structures and kinetic properties of two TRI101 orthologs isolated from Fusarium sporotrichioides and Fusarium graminearum have been determined. The kinetic results reveal important differences in activity of these enzymes toward B-type trichothecenes such as deoxynivalenol. These differences in activity can be explained in part by the three-dimensional structures for the ternary complexes for both of these enzymes with coenzyme A and trichothecene mycotoxins. The structural and kinetic results together emphasize that the choice of an enzymatic resistance gene in transgenic crop protection strategies must take into account the kinetic profile of the selected protein.	[Garvey, Graeme S.; Rayment, Ivan] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [McCormick, Susan P.] USDA ARS, Natl Ctr Agr Utilizat Res, Mycotoxin Res Unit, Peoria, IL 61604 USA	University of Wisconsin System; University of Wisconsin Madison; United States Department of Agriculture (USDA)	Rayment, I (corresponding author), Univ Wisconsin, Dept Biochem, 433 Babcock Dr, Madison, WI 53706 USA.	ivan_rayment@biochem.wisc.edu	rayment, ivan/A-2720-2008	rayment, ivan/0000-0001-9279-7835; McCormick, Susan/0000-0002-7824-6372	NIAMS NIH HHS [AR 35186] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR035186] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Alexander NJ, 1999, MOL GEN GENET, V261, P977, DOI 10.1007/s004380051046; ANDERSON DW, 1989, J MED CHEM, V32, P555, DOI 10.1021/jm00123a008; Atlas RM., 1995, HDB MEDIA ENV MICROB; Bayer A, 2004, BIOORGAN MED CHEM, V12, P2787, DOI 10.1016/j.bmc.2004.02.029; Buglino J, 2004, J BIOL CHEM, V279, P30634, DOI 10.1074/jbc.M404011200; CUNDLIFFE E, 1974, P NATL ACAD SCI USA, V71, P30, DOI 10.1073/pnas.71.1.30; D'Auria JC, 2006, CURR OPIN PLANT BIOL, V9, P331, DOI 10.1016/j.pbi.2006.03.016; DeLano W.L, PYMOL MOL GRAPHICS S; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; HOHN TM, 1986, ARCH BIOCHEM BIOPHYS, V251, P756, DOI 10.1016/0003-9861(86)90386-3; Kim HS, 2003, MYCOL RES, V107, P190, DOI 10.1017/S0953756203007317; Kimura M, 1998, J BIOL CHEM, V273, P1654, DOI 10.1074/jbc.273.3.1654; Kimura M, 1998, BIOSCI BIOTECH BIOCH, V62, P1033, DOI 10.1271/bbb.62.1033; Larsen JC, 2004, TOXICOL LETT, V153, P1, DOI 10.1016/j.toxlet.2004.04.020; Manoharan M, 2006, PLANT SCI, V171, P699, DOI 10.1016/j.plantsci.2006.07.004; McCormick SP, 1999, APPL ENVIRON MICROB, V65, P5252; McCormick SP, 2002, APPL ENVIRON MICROB, V68, P2959, DOI 10.1128/AEM.68.6.2959-2964.2002; McCormick SP, 2006, CAN J MICROBIOL, V52, P636, DOI 10.1139/W06-011; Muhitch MJ, 2000, PLANT SCI, V157, P201, DOI 10.1016/S0168-9452(00)00282-X; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nganje WE, 2004, REV AGR ECON, V26, P332, DOI 10.1111/j.1467-9353.2004.00183.x; Ohsato S, 2007, PLANT CELL REP, V26, P531, DOI 10.1007/s00299-006-0251-1; Okubara PA, 2002, THEOR APPL GENET, V106, P74, DOI 10.1007/s00122-002-1066-2; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pestka JJ, 2005, J TOXICOL ENV HEAL B, V8, P39, DOI 10.1080/10937400590889458; Poppenberger B, 2003, J BIOL CHEM, V278, P47905, DOI 10.1074/jbc.M307552200; Rynkiewicz MJ, 2001, P NATL ACAD SCI USA, V98, P13543, DOI 10.1073/pnas.231313098; Shih YP, 2005, PROTEIN SCI, V14, P936, DOI 10.1110/ps.041129605; Shima J, 1997, APPL ENVIRON MICROB, V63, P3825, DOI 10.1128/AEM.63.10.3825-3830.1997; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Tokai T, 2005, MICROBIOL-SGM, V151, P509, DOI 10.1099/mic.0.27435-0; Tokai T, 2007, BIOCHEM BIOPH RES CO, V353, P412, DOI 10.1016/j.bbrc.2006.12.033; Tsodikov OV, 2002, J COMPUT CHEM, V23, P600, DOI 10.1002/jcc.10061; UENO Y, 1975, APPL MICROBIOL, V30, P4, DOI 10.1128/AEM.30.1.4-9.1975; Unno H, 2007, J BIOL CHEM, V282, P15812, DOI 10.1074/jbc.M700638200; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127	40	69	78	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1660	1669		10.1074/jbc.M705752200	http://dx.doi.org/10.1074/jbc.M705752200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	17923480	hybrid			2022-12-27	WOS:000252282700053
J	Owen, D; Campbell, LJ; Littlefield, K; Evetts, KA; Li, ZG; Sacks, DB; Lowe, PN; Mott, HR				Owen, Darerca; Campbell, Louise J.; Littlefield, Keily; Evetts, Katrina A.; Li, Zhigang; Sacks, David B.; Lowe, Peter N.; Mott, Helen R.			The IQGAP1-Rac1 and IQGAP1-Cdc42 interactions - Interfaces differ between the complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING-PROTEIN; RASGAP-RELATED PROTEIN; BINDING DOMAIN; CRYSTAL-STRUCTURE; INSERT REGION; CDC42; EFFECTOR; RAC1; CALMODULIN; IDENTIFICATION	IQGAP1 contains a domain related to the catalytic portion of the GTPase-activating proteins (GAPs) for the Ras small G proteins, yet it has no RasGAP activity and binds to the Rho family small G proteins Cdc42 and Rac1. It is thought that IQGAP1 is an effector of Rac1 and Cdc42, regulating cell-cell adhesion through the E-cadherin-catenin complex, which controls formation and maintenance of adherens junctions. This study investigates the binding interfaces of the Rac1-IQGAP1 and Cdc42-IQGAP1 complexes. We mutated Rac1 and Cdc42 and measured the effects of mutations on their affinity for IQGAP1. We have identified similarities and differences in the relative importance of residues used by Rac1 and Cdc42 to bind IQGAP1. Furthermore, the residues involved in the complexes formed with IQGAP1 differ from those formed with other effector proteins and GAPs. Relatively few mutations in switch I of Cdc42 or Rac1 affect IQGAP1 binding; only mutations in residues 32 and 36 significantly decrease affinity for IQGAP1. Switch II mutations also affect binding to IQGAP1 although the effects differ between Rac1 and Cdc42; mutation of either Asp-63, Arg-68, or Leu-70 abrogate Rac1 binding, whereas no switch II mutations affect Cdc42 binding to IQGAP1. The Rho family "insert loop" does not contribute to the binding affinity of Rac1/Cdc42 for IQGAP1. We also present thermodynamic data pertaining to the Rac1/Cdc42-RhoGAP complexes. Switch II contributes a large portion of the total binding energy to these complexes, whereas switch I mutations also affect binding. In addition we identify "cold spots" in the Rac1/Cdc42-RhoGAP/ IQGAP1 interfaces. Competition data reveal that the binding sites for IQGAP1 and RhoGAP on the small G proteins overlap only partially. Overall, the data presented here suggest that, despite their 71% identity, Cdc42 and Rac1 appear to have only partially overlapping binding sites on IQGAP1, and each uses different determinants to achieve high affinity binding.	[Owen, Darerca; Campbell, Louise J.; Littlefield, Keily; Evetts, Katrina A.; Lowe, Peter N.; Mott, Helen R.] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England; [Li, Zhigang; Sacks, David B.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Li, Zhigang; Sacks, David B.] Harvard Univ, Sch Med, Boston, MA 02115 USA	University of Cambridge; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Owen, D (corresponding author), Univ Cambridge, Dept Biochem, 80 Tennis Court Rd, Cambridge CB2 1GA, England.	do@bioc.cam.ac.uk; hrm28@bioc.cam.ac.uk	Mott, Helen/AAV-3873-2020	Mott, Helen/0000-0002-7890-7097; Sacks, David/0000-0003-3100-0735	NCI NIH HHS [R01 CA 93645] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA093645] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abdul-Manan N, 1999, NATURE, V399, P379, DOI 10.1038/20726; Bahler M, 2002, FEBS LETT, V513, P107, DOI 10.1016/S0014-5793(01)03239-2; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Briggs MW, 2003, EMBO REP, V4, P571, DOI 10.1038/sj.embor.embor867; Briggs MW, 2002, J BIOL CHEM, V277, P7453, DOI 10.1074/jbc.M104315200; Brill S, 1996, MOL CELL BIOL, V16, P4869; Brown MD, 2006, TRENDS CELL BIOL, V16, P242, DOI 10.1016/j.tcb.2006.03.002; Collinson AD, 2004, ASSAY DRUG DEV TECHN, V2, P659, DOI 10.1089/adt.2004.2.659; Elliot-Smith AE, 2005, BIOCHEMISTRY-US, V44, P12373, DOI 10.1021/bi0506021; ELLIOTSMITH AE, 2007, IN PRESS BIOCHEMISTR; FELTHAM JL, 1995, PROTEIN ENG, V8, P33; Feltham JL, 1997, BIOCHEMISTRY-US, V36, P8755, DOI 10.1021/bi970694x; Ford B, 2005, J BIOL CHEM, V280, P25697, DOI 10.1074/jbc.M502240200; Freeman JL, 1996, J BIOL CHEM, V271, P19794, DOI 10.1074/jbc.271.33.19794; Fukata M, 2001, NAT REV MOL CELL BIO, V2, P887, DOI 10.1038/35103068; Fukata M, 2002, CELL, V109, P873, DOI 10.1016/S0092-8674(02)00800-0; Fukata M, 1999, J BIOL CHEM, V274, P26044, DOI 10.1074/jbc.274.37.26044; Fukata M, 2001, MOL CELL BIOL, V21, P2165, DOI 10.1128/MCB.21.6.2165-2183.2001; Fukata M, 1997, J BIOL CHEM, V272, P29579, DOI 10.1074/jbc.272.47.29579; Geyer M, 1999, BIOCHEMISTRY-US, V38, P11250, DOI 10.1021/bi9904306; Geyer M, 1996, BIOCHEMISTRY-US, V35, P10308, DOI 10.1021/bi952858k; Goldberg J, 1999, CELL, V96, P893, DOI 10.1016/S0092-8674(00)80598-X; Graham DL, 1999, BIOCHEMISTRY-US, V38, P985, DOI 10.1021/bi9821770; Graham DL, 1999, BIOCHEMISTRY-US, V38, P14981, DOI 10.1021/bi991358e; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hart MJ, 1996, EMBO J, V15, P2997, DOI 10.1002/j.1460-2075.1996.tb00663.x; Hirshberg M, 1997, NAT STRUCT BIOL, V4, P147, DOI 10.1038/nsb0297-147; Ho YD, 1999, J BIOL CHEM, V274, P464, DOI 10.1074/jbc.274.1.464; Joneson T, 1996, SCIENCE, V271, P810, DOI 10.1126/science.271.5250.810; Joneson T, 1998, J BIOL CHEM, V273, P17991, DOI 10.1074/jbc.273.29.17991; Joyal JL, 1997, FASEB J, V11, pA1236; Karnoub AE, 2001, MOL CELL BIOL, V21, P2847, DOI 10.1128/MCB.21.8.2847-2857.2001; Kholmanskikh SS, 2006, NAT NEUROSCI, V9, P50, DOI 10.1038/nn1619; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kuroda S, 1996, J BIOL CHEM, V271, P23363, DOI 10.1074/jbc.271.38.23363; Kuroda S, 1998, SCIENCE, V281, P832, DOI 10.1126/science.281.5378.832; LANCASTER CA, 1994, J BIOL CHEM, V269, P1137; Li R, 1999, J BIOL CHEM, V274, P29648, DOI 10.1074/jbc.274.42.29648; Li ZG, 2003, J BIOL CHEM, V278, P4347, DOI 10.1074/jbc.M208579200; Li ZG, 1999, J BIOL CHEM, V274, P37885, DOI 10.1074/jbc.274.53.37885; Linnemann T, 1999, J BIOL CHEM, V274, P13556, DOI 10.1074/jbc.274.19.13556; MACH H, 1992, ANAL BIOCHEM, V200, P74, DOI 10.1016/0003-2697(92)90279-G; MANSER E, 1993, NATURE, V363, P364, DOI 10.1038/363364a0; Martinez GL, 2000, J ELECTRON MATER, V29, P325, DOI 10.1007/s11664-000-0072-x; Mataraza JM, 2003, BIOCHEM BIOPH RES CO, V305, P315, DOI 10.1016/S0006-291X(03)00759-9; Mateer SC, 2002, J BIOL CHEM, V277, P12324, DOI 10.1074/jbc.M109535200; McCallum SJ, 1996, J BIOL CHEM, V271, P21732, DOI 10.1074/jbc.271.36.21732; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Morreale A, 2000, NAT STRUCT BIOL, V7, P384; Mott HR, 1999, NATURE, V399, P384, DOI 10.1038/20732; MOTT HR, 2003, HDB CELL SIGNALLING; Nassar N, 1998, NAT STRUCT BIOL, V5, P1047, DOI 10.1038/4156; Owen D, 2005, PROTEINS CELL REG, V3, P31; Owen D, 2003, J BIOL CHEM, V278, P50578, DOI 10.1074/jbc.M304313200; Owen D, 2000, BIOCHEMISTRY-US, V39, P1243, DOI 10.1021/bi991567z; Ren JG, 2005, J BIOL CHEM, V280, P34548, DOI 10.1074/jbc.M507321200; Ridley AJ, 2001, TRENDS CELL BIOL, V11, P471, DOI 10.1016/S0962-8924(01)02153-5; Rittinger K, 1997, NATURE, V389, P758, DOI 10.1038/39651; Rittinger K, 1997, NATURE, V388, P693, DOI 10.1038/41805; Roy M, 2005, MOL CELL BIOL, V25, P7940, DOI 10.1128/MCB.25.18.7940-7952.2005; Roy M, 2004, J BIOL CHEM, V279, P17329, DOI 10.1074/jbc.M308405200; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Seewald MJ, 2002, NATURE, V415, P662, DOI 10.1038/415662a; Sokol SY, 2001, J BIOL CHEM, V276, P48425, DOI 10.1074/jbc.M107975200; Swart-Mataraza JM, 2002, J BIOL CHEM, V277, P24753, DOI 10.1074/jbc.M111165200; Symons M, 1996, CELL, V84, P723, DOI 10.1016/S0092-8674(00)81050-8; Thompson G, 1998, BIOCHEMISTRY-US, V37, P7885, DOI 10.1021/bi980140+; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Wang SJ, 2007, J CELL SCI, V120, P567, DOI 10.1242/jcs.03356; Watanabe T, 2004, DEV CELL, V7, P871, DOI 10.1016/j.devcel.2004.10.017; WEISSBACH L, 1994, J BIOL CHEM, V269, P20517; WHITE MA, 1995, CELL, V80, P533, DOI 10.1016/0092-8674(95)90507-3; Winkler DG, 1997, J BIOL CHEM, V272, P24402, DOI 10.1074/jbc.272.39.24402; Wu WJ, 1997, J BIOL CHEM, V272, P26153, DOI 10.1074/jbc.272.42.26153; Zhang BL, 1997, J BIOL CHEM, V272, P21999, DOI 10.1074/jbc.272.35.21999; Zhang BL, 1998, J BIOL CHEM, V273, P8776, DOI 10.1074/jbc.273.15.8776	77	48	49	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1692	1704		10.1074/jbc.M707257200	http://dx.doi.org/10.1074/jbc.M707257200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	17984089	hybrid			2022-12-27	WOS:000252282700056
J	Baranov, SV; Stavrovskaya, IG; Brown, AM; Tyryshkin, AM; Kristal, BS				Baranov, Sergei V.; Stavrovskaya, Irina G.; Brown, Abraham M.; Tyryshkin, Alexei M.; Kristal, Bruce S.			Kinetic model for Ca2+-induced permeability transition in energized liver mitochondria discriminates between inhibitor mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C RELEASE; BRAIN MITOCHONDRIA; CYCLOSPORINE-A; IN-VITRO; MEMBRANE; TARGET; HEART; RAT; INVOLVEMENT; DYSFUNCTION	Cytotoxicity associated with pathophysiological Ca2+ overload (e. g. in stroke) appears mediated by an event termed the mitochondrial permeability transition (mPT). We built and solved a kinetic model of the mPT in populations of isolated rat liver mitochondria that quantitatively describes Ca2+- induced mPT as a two-step sequence of pre-swelling induction followed by Ca2+- driven, positive feedback, autocatalytic propagation. The model was formulated as two differential equations, each directly related to experimental parameters (Ca2+ flux/ mitochondrial swelling). These parameters were simultaneously assessed using a spectroscopic approach to monitor multiple mitochondrial properties. The derived kinetic model correctly identifies a correlation between initial Ca2+ concentration and delay interval prior to mPT induction. Within the model's framework, Ru-360 (a ruthenium complex) and Mg2+ were shown to compete with the Ca2+- stimulated initiation phase of mPT induction, consistent with known inhibition at the phenomenological level of the Ca2+ uniporter. The model further reveals that Mg2+, but not Ru-360, inhibits Ca2+- induced effects on a downstream stage of mPT induction at a site distinct from the uniporter. The analytical approach was then applied to promethazine, an FDA-approved drug previously shown to inhibit both mPT and ischemia-reperfusion injury. Kinetic analysis revealed that promethazine delayed mPT induction in a manner qualitatively distinct from that of lower concentrations of Mg2+. In summary, we have developed a kinetic model to aid in the quantitative characterization of mPT induction. This model is consistent with/informative about the biochemistry of several mPT inhibitors, and its success suggests that this kinetic approach can aid in the classification of agents or targets that modulate mPT induction.	[Baranov, Sergei V.; Stavrovskaya, Irina G.; Kristal, Bruce S.] Brigham & Womens Hosp, Dept Neurosurg, Boston, MA 02115 USA; [Baranov, Sergei V.; Stavrovskaya, Irina G.; Brown, Abraham M.; Kristal, Bruce S.] Burke Med Res Inst, White Plains, NY 10605 USA; [Brown, Abraham M.] Cornell Univ, Coll Med, Dept Biochem, New York, NY 10021 USA; [Kristal, Bruce S.] Cornell Univ, Coll Med, Dept Neurosci, New York, NY 10021 USA; [Tyryshkin, Alexei M.] Princeton Univ, Dept Elect Engn, Princeton, NJ 08544 USA	Harvard University; Brigham & Women's Hospital; Cornell University; Cornell University; Princeton University	Kristal, BS (corresponding author), Brigham & Womens Hosp, Dept Neurosurg, 221 Longwood Ave,LM322B, Boston, MA 02115 USA.	bkristal@partners.org	brown, abraham/R-8823-2019; Tyryshkin, Alexei/A-5219-2008; Tyryshkin, Alexei M/GQH-9902-2022	Tyryshkin, Alexei M/0000-0003-2625-6250				Andreyev AY, 1998, FEBS LETT, V439, P373, DOI 10.1016/S0014-5793(98)01394-5; Bernardi P, 2006, FEBS J, V273, P2077, DOI 10.1111/j.1742-4658.2006.05213.x; Bernardi P, 1999, EUR J BIOCHEM, V264, P687, DOI 10.1046/j.1432-1327.1999.00725.x; Brustovetsky N, 2000, J NEUROSCI, V20, P8229, DOI 10.1523/JNEUROSCI.20-22-08229.2000; CROMPTON M, 1985, BIOCHEM SOC T, V13, P667; Dedov VN, 1999, BIOCHEMISTRY-MOSCOW+, V64, P809; Dolder M, 2003, J BIOL CHEM, V278, P17760, DOI 10.1074/jbc.M208705200; Friberg H, 2002, BIOCHIMIE, V84, P241, DOI 10.1016/S0300-9084(02)01381-0; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; GRIFFITHS EJ, 1995, BIOCHEM J, V307, P93, DOI 10.1042/bj3070093; HALESTRAP AP, 2001, MITOCHONDRIA PATHOGE, P177; Hansson MJ, 2004, J NEUROCHEM, V89, P715, DOI 10.1111/j.1471-4159.2004.02400.x; HUNTER DR, 1979, ARCH BIOCHEM BIOPHYS, V195, P453, DOI 10.1016/0003-9861(79)90371-0; Krasnikov BF, 2005, BBA-BIOENERGETICS, V1708, P375, DOI 10.1016/j.bbabio.2005.05.009; Kristian T, 2002, J NEUROCHEM, V83, P1297, DOI 10.1046/j.1471-4159.2002.01238.x; Massari S, 1996, J BIOL CHEM, V271, P31942; Matlib MA, 1998, J BIOL CHEM, V273, P10223, DOI 10.1074/jbc.273.17.10223; Matsumoto S, 1999, J CEREBR BLOOD F MET, V19, P736, DOI 10.1097/00004647-199907000-00002; NICHOLLS D, 1982, BIOCHIM BIOPHYS ACTA, V683, P57, DOI 10.1016/0304-4173(82)90013-1; Nicholls DG, 2005, CELL CALCIUM, V38, P311, DOI 10.1016/j.ceca.2005.06.011; NOVGORODOV SA, 1992, J BIOL CHEM, V267, P16274; Paradies G, 2004, CIRC RES, V94, P53, DOI 10.1161/01.RES.0000109416.56608.64; Pokhilko AV, 2006, J THEOR BIOL, V243, P152, DOI 10.1016/j.jtbi.2006.05.025; RAJDEV S, 1993, NEUROSCI LETT, V162, P149, DOI 10.1016/0304-3940(93)90582-6; Ricchelli F, 2005, INT J BIOCHEM CELL B, V37, P1858, DOI 10.1016/j.biocel.2005.04.001; Scaduto RC, 1999, BIOPHYS J, V76, P469, DOI 10.1016/S0006-3495(99)77214-0; Schinder AF, 1996, J NEUROSCI, V16, P6125; Stavrovskaya IG, 2005, FREE RADICAL BIO MED, V38, P687, DOI 10.1016/j.freeradbiomed.2004.11.032; Stavrovskaya IG, 2004, J EXP MED, V200, P211, DOI 10.1084/jem.20032053; Zhang SZ, 2006, LIFE SCI, V78, P738, DOI 10.1016/j.lfs.2005.05.076; Zhu S, 2002, NATURE, V417, P74, DOI 10.1038/417074a; ZORATTI M, 1995, BBA-REV BIOMEMBRANES, V1241, P139, DOI 10.1016/0304-4157(95)00003-A; [No title captured]	33	29	30	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					665	676		10.1074/jbc.M703484200	http://dx.doi.org/10.1074/jbc.M703484200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	17962193	hybrid			2022-12-27	WOS:000252128100003
J	Gahring, LC; Osborne-Hereford, AV; Vasquez-Opazo, GA; Rogers, SW				Gahring, Lorise C.; Osborne-Hereford, Amber V.; Vasquez-Opazo, Gustavo A.; Rogers, Scott W.			Tumor necrosis factor alpha enhances nicotinic receptor up-regulation via a p38(MAPK)-dependent pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-SITES; ACETYLCHOLINE-RECEPTORS; BRAIN; PHARMACOLOGY; SUBUNIT; SUBTYPE; ALPHA-4-BETA-2; EXPRESSION; CELLS; NEUROPROTECTION	A response by key neuronal nicotinic acetylcholine receptors (nAChRs) to sustained nicotine exposure is up-regulation. Although this unusual receptor characteristic contributes to processes ranging from aging to addiction, the normal physiologic reason for this response is unknown. We find that up-regulation of [3H] epibatidine binding and function in HEK293 cells stably expressing alpha 4 beta 2-nAChR is significantly enhanced by co-application of the proinflammatory cytokine, tumor necrosis factor alpha. The mechanism of tumor necrosis factor alpha-enhanced up-regulation requires transcription, new protein synthesis, and signaling through p38(MAPK) as demonstrated by complete inhibition using SB 202190. This finding extends the possibilities for nAChR-inflammatory interactions in normal physiological processes and offers novel insights into endogenous mechanisms that can modify up-regulation.	[Gahring, Lorise C.; Vasquez-Opazo, Gustavo A.] Univ Utah, Sch Med, Dept Internal Med, Salt Lake City, UT 84132 USA; [Osborne-Hereford, Amber V.] Univ Utah, Dept Pathol, Salt Lake City, UT 84132 USA; [Rogers, Scott W.] Univ Utah, Dept Neurobiol & Anat, Salt Lake City, UT 84132 USA; [Gahring, Lorise C.; Rogers, Scott W.] Salt Lake City Vet Affairs Geriat Res Educ & Clin, Salt Lake City, UT 84148 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Geriatric Research Education & Clinical Center	Gahring, LC (corresponding author), Univ Utah, Sch Med, Dept Internal Med, 2C132,30 N 1900 E, Salt Lake City, UT 84132 USA.	Lorise.Gahring@hsc.utah.edu			NHLBI NIH HHS [P01 HL72903] Funding Source: Medline; NIA NIH HHS [AG17517] Funding Source: Medline; NIDA NIH HHS [DA015148] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL072903] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG017517] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015148] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		BENWELL MEM, 1988, J NEUROCHEM, V50, P1243, DOI 10.1111/j.1471-4159.1988.tb10600.x; Carlson NG, 1998, J NEUROBIOL, V35, P29, DOI 10.1002/(SICI)1097-4695(199804)35:1<29::AID-NEU3>3.0.CO;2-D; Carlson NG, 1999, J IMMUNOL, V163, P3963; FLORES CM, 1992, MOL PHARMACOL, V41, P31; Gahring LC, 2005, J NEUROIMMUNOL, V166, P88, DOI 10.1016/j.jneuroim.2005.05.007; Gahring LC, 2005, NEUROBIOL AGING, V26, P973, DOI 10.1016/j.neurobiolaging.2004.07.005; Gopalakrishnan M, 1997, MOL PHARMACOL, V52, P524, DOI 10.1124/mol.52.3.524; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Hogg RC, 2003, REV PHYSIOL BIOCH P, V147, P1, DOI 10.1007/s10254-003-0005-1; Hommes DW, 2003, GUT, V52, P144, DOI 10.1136/gut.52.1.144; Karihaloo A, 2001, J BIOL CHEM, V276, P9166, DOI 10.1074/jbc.M009963200; KELLAR KJ, 1987, BRAIN RES, V436, P62, DOI 10.1016/0006-8993(87)91556-3; Kishi M, 2006, MOL PHARMACOL, V70, P2037, DOI 10.1124/mol.106.029298; Lukas RJ, 1999, PHARMACOL REV, V51, P397; MacEwan DJ, 2002, CELL SIGNAL, V14, P477, DOI 10.1016/S0898-6568(01)00262-5; MARKS MJ, 1985, J PHARMACOL EXP THER, V235, P619; Orr-Urtreger A, 2005, NEUROREPORT, V16, P1123, DOI 10.1097/00001756-200507130-00018; Perry DC, 2002, J NEUROCHEM, V82, P468, DOI 10.1046/j.1471-4159.2002.00951.x; Rogers SW, 1998, J NEUROSCI, V18, P4825; Rogers SW, 2001, GLIA, V33, P306, DOI 10.1002/1098-1136(20010315)33:4<306::AID-GLIA1029>3.3.CO;2-N; Ross SA, 2000, J NEUROSCI, V20, P6431, DOI 10.1523/JNEUROSCI.20-17-06431.2000; SCHRODER H, 1991, ANN NY ACAD SCI, V640, P189; SCHULZ DW, 1993, J NEUROCHEM, V61, P2225, DOI 10.1111/j.1471-4159.1993.tb07463.x; SCHWARTZ RD, 1985, J NEUROCHEM, V45, P427, DOI 10.1111/j.1471-4159.1985.tb04005.x; Vallejo YF, 2005, J NEUROSCI, V25, P5563, DOI 10.1523/JNEUROSCI.5240-04.2005; Wang H, 2004, NAT MED, V10, P1216, DOI 10.1038/nm1124; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Wu J, 2006, J PHYSIOL-LONDON, V576, P103, DOI 10.1113/jphysiol.2006.114645; Xiao YX, 2004, BIOORG MED CHEM LETT, V14, P1845, DOI 10.1016/j.bmcl.2003.09.105; Xiao YX, 2004, J PHARMACOL EXP THER, V310, P98, DOI 10.1124/jpet.104.066787; Xiao YX, 1998, MOL PHARMACOL, V54, P322, DOI 10.1124/mol.54.2.322; Zoli M, 1998, J NEUROSCI, V18, P4461	32	13	13	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					693	699		10.1074/jbc.M707330200	http://dx.doi.org/10.1074/jbc.M707330200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	17977823	hybrid			2022-12-27	WOS:000252128100006
J	Reibarkh, M; Yamamoto, Y; Singh, CR; del Rio, F; Fahmy, A; Lee, B; Luna, RE; Ii, M; Wagner, G; Asano, K				Reibarkh, Mikhail; Yamamoto, Yasufumi; Singh, Chingakham Ranjit; del Rio, Federico; Fahmy, Amr; Lee, Bumjun; Luna, Rafael E.; Ii, Miki; Wagner, Gerhard; Asano, Katsura			Eukaryotic initiation factor (eIF) 1 carries two distinct eIF5-binding faces important for multifactor assembly and AUG selection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							40S RIBOSOMAL-SUBUNIT; C-TERMINAL DOMAIN; TRANSLATION INITIATION; START CODON; PREINITIATION COMPLEX; CRYSTAL-STRUCTURE; EIF1; BINDING; YEAST; RECOGNITION	Eukaryotic initiation factor (eIF) 1 is a small protein (12 kDa) governing fidelity in translation initiation. It is recruited to the 40 S subunit in a multifactor complex with Met-tRNA(i)(Met), eIF2, eIF3, and eIF5 and binds near the P-site. eIF1 release in response to start codon recognition is an important signal to produce an 80 S initiation complex. Although the ribosome-binding face of eIF1 was identified, interfaces to other preinitiation complex components and their relevance to eIF1 function have not been determined. Exploiting the solution structure of yeast eIF1, here we locate the binding site for eIF5 in its N-terminal tail and at a basic/hydrophobic surface area termed KH, distinct from the ribosome-binding face. Genetic and biochemical studies indicate that the eIF1 N-terminal tail plays a stimulatory role in cooperative multifactor assembly. A mutation altering the basic part of eIF1-KH is lethal and shows a dominant phenotype indicating relaxed start codon selection. Cheung et al. recently demonstrated that the alteration of hydrophobic residues of eIF1 disrupts a critical link to the preinitiation complex that suppresses eIF1 release before start codon selection (Cheung, Y.-N., Maag, D., Mitchell, S. F., Fekete, C. A., Algire, M. A., Takacs, J. E., Shirokikh, N., Pestova, T., Lorsch, J. R., and Hinnebusch, A. (2007) Genes Dev. 21, 1217-1230). Interestingly, eIF1-KH includes the altered hydrophobic residues. Thus, eIF5 is an excellent candidate for the direct partner of eIF1- KH that mediates the critical link. The direct interaction at eIF1-KH also places eIF5 near the decoding site of the 40 S subunit.	[Reibarkh, Mikhail; del Rio, Federico; Fahmy, Amr; Luna, Rafael E.; Wagner, Gerhard] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Yamamoto, Yasufumi; Singh, Chingakham Ranjit; Lee, Bumjun; Ii, Miki; Asano, Katsura] Kansas State Univ, Div Biol, Mol Cellular & Dev Biol Program, Manhattan, KS 66506 USA	Harvard University; Harvard Medical School; Kansas State University	Wagner, G (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	gerhard_wagner@hms.harvard.edu; kasano@ksu.edu	del Rio Portilla, Federico/B-4351-2015	del Rio Portilla, Federico/0000-0001-8672-0567; Reibarkh, Mikhail/0000-0002-6589-707X	NATIONAL CANCER INSTITUTE [R01CA068262] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM047467, R01GM064781] Funding Source: NIH RePORTER; NCI NIH HHS [CA68262] Funding Source: Medline; NIGMS NIH HHS [P01 GM047467, GM64781, GM47467] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Algire MA, 2005, MOL CELL, V20, P251, DOI 10.1016/j.molcel.2005.09.008; Asano K, 2000, GENE DEV, V14, P2534, DOI 10.1101/gad.831800; Asano K, 1998, J BIOL CHEM, V273, P18573, DOI 10.1074/jbc.273.29.18573; Asano K, 1999, EMBO J, V18, P1673, DOI 10.1093/emboj/18.6.1673; Asano K, 2001, EMBO J, V20, P2326, DOI 10.1093/emboj/20.9.2326; Bieniossek C, 2006, J MOL BIOL, V360, P457, DOI 10.1016/j.jmb.2006.05.021; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; Cheung YN, 2007, GENE DEV, V21, P1217, DOI 10.1101/gad.1528307; Fekete CA, 2007, EMBO J, V26, P1602, DOI 10.1038/sj.emboj.7601613; Fletcher CM, 1999, EMBO J, V18, P2631, DOI 10.1093/emboj/18.9.2631; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; He H, 2003, MOL CELL BIOL, V23, P5431, DOI 10.1128/MCB.23.15.5431-5445.2003; Hinnebusch A.G., 2007, TRANSLATIONAL CONTRO, P225; Huang HK, 1997, GENE DEV, V11, P2396, DOI 10.1101/gad.11.18.2396; Lomakin IB, 2003, GENE DEV, V17, P2786, DOI 10.1101/gad.1141803; Maag D, 2005, MOL CELL, V17, P265, DOI 10.1016/j.molcel.2004.11.051; Marintchev A, 2003, P NATL ACAD SCI USA, V100, P1535, DOI 10.1073/pnas.0437845100; Nielsen KH, 2004, EMBO J, V23, P1166, DOI 10.1038/sj.emboj.7600116; Passmore LA, 2007, MOL CELL, V26, P41, DOI 10.1016/j.molcel.2007.03.018; Pestova TV, 2002, GENE DEV, V16, P2906, DOI 10.1101/gad.1020902; Pestova TV, 2007, TRANSLATIONAL CONTRO, V4, P87; Qiu HF, 1998, MOL CELL BIOL, V18, P2697, DOI 10.1128/MCB.18.5.2697; Singh CR, 2005, MOL CELL BIOL, V25, P5480, DOI 10.1128/MCB.25.13.5480-5491.2005; Singh CR, 2004, J BIOL CHEM, V279, P49644, DOI 10.1074/jbc.M409609200; Singh CR, 2004, J BIOL CHEM, V279, P31910, DOI 10.1074/jbc.M313940200; Valasek L, 2004, MOL CELL BIOL, V24, P9437, DOI 10.1128/MCB.24.21.9437-9455.2004; Wei ZY, 2006, J MOL BIOL, V359, P1, DOI 10.1016/j.jmb.2006.03.037; Yamamoto Y, 2005, P NATL ACAD SCI USA, V102, P16164, DOI 10.1073/pnas.0507960102; YOON HJ, 1992, MOL CELL BIOL, V12, P248, DOI 10.1128/MCB.12.1.248; Zhou P, 2001, J BIOMOL NMR, V20, P11, DOI 10.1023/A:1011258906244	30	49	49	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					1094	1103		10.1074/jbc.M708155200	http://dx.doi.org/10.1074/jbc.M708155200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	17974565	hybrid			2022-12-27	WOS:000252128100049
J	Pan, H; Luo, C; Li, R; Qiao, A; Zhang, L; Mines, M; Nyanda, AM; Zhang, J; Fan, GH				Pan, Heng; Luo, Cherry; Li, Runsheng; Qiao, Aimin; Zhang, Li; Mines, Marjelo; Nyanda, Alfred M.; Zhang, Jingwu; Fan, Guo-Huang			Cyclophilin a is required for CXCR4-mediated nuclear export of heterogeneous nuclear ribonucleoprotein a2, activation and nuclear translocation of ERK1/2, and chemotactic cell migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEPTIDYL-PROLYL ISOMERASE; CHEMOKINE RECEPTOR CXCR4; DEPENDENT MACROPHAGE PROLIFERATION; HEMATOPOIETIC PROGENITOR CELLS; REGULATED KINASE ACTIVATION; CYCLOSPORINE-A; EXTRACELLULAR SIGNAL; BINDING-PROTEIN; LUNG-CANCER; MAP KINASE	The chemokine receptor CXCR4-mediated signaling cascades play an important role in cell proliferation and migration, but the underlying mechanisms by which the receptor signaling is regulated remain incompletely understood. Here, we demonstrate that CXCR4 was co-immunoprecipitated with cyclophilin A (CyPA) from the lysate of HEK293 cells stably expressing CXCR4. Although both the glutathione S-transferase-CXCR4N- and C-terminal fusion proteins were associated with the purified CyPA, truncation of the C-terminal domain of CXCR4 robustly inhibited the receptor co-immunoprecipitation with CyPA in intact cells, thereby suggesting a critical role of the receptor C terminus in this interaction. Ligand stimulation of CXCR4 induced CyPA phosphorylation and nuclear translocation, both of which were inhibited by truncation of the C-terminal domain of CXCR4. CyPA was associated with transportin 1, and knockdown of transportin 1 by RNA interference(RNAi) blocked CXCL12-induced nuclear translocation of CyPA, thereby suggesting a transportin 1-mediated nuclear import of CyPA. CyPA formed a complex with heterogeneous nuclear ribonucleoprotein ( hnRNP) A2, which underwent nuclear export in response to activation of CXCR4. Interestingly, the CXCR4-mediated nuclear export of hnRNP A2 was blocked by RNAi of CyPA. Moreover, CXCR4-evoked activation of extracellular signal-regulated kinase 1/2 (ERK1/2) was attenuated by CyPA RNAi, by overexpression of a PPIase-deficient mutant of CyPA (CyPA-R55A), and by pretreatment of the immunosuppressive drugs, cyclosporine A and sanglifehrin A. Finally, CXCL12-induced chemotaxis of HEK293 cells stably expressing CXCR4 or Jurkat T cells was inhibited by CyPA RNAi or CsA treatment.	[Luo, Cherry; Qiao, Aimin; Mines, Marjelo; Nyanda, Alfred M.; Fan, Guo-Huang] Meharry Med Coll, Dept Vet Affairs, Dept Neurobiol & Neurotoxicol, Nashville, TN 37208 USA; [Pan, Heng; Li, Runsheng; Zhang, Jingwu] Shanghai Jiao Tong Univ, Chinese Acad Sci, Sch Med, Inst Hlth Sci,Shanghai Inst Biol Sci, Shanghai 200025, Peoples R China; [Zhang, Li] Vanderbilt Univ, Sch Med, Dept Pathol, Nashville, TN 37212 USA	Meharry Medical College; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Vanderbilt University	Fan, GH (corresponding author), Meharry Med Coll, Dept Vet Affairs, Dept Neurobiol & Neurotoxicol, Nashville, TN 37208 USA.	gfan@mmc.edu			NCRR NIH HHS [RR 03032-19] Funding Source: Medline	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Adachi M, 1999, EMBO J, V18, P5347, DOI 10.1093/emboj/18.19.5347; Aiuti A, 1997, J EXP MED, V185, P111, DOI 10.1084/jem.185.1.111; Ansari H, 2002, MOL CELL BIOL, V22, P6993, DOI 10.1128/MCB.22.20.6993-7003.2002; Arai A, 2006, CELL SIGNAL, V18, P2162, DOI 10.1016/j.cellsig.2006.05.001; Bodner A, 2003, J NEUROIMMUNOL, V140, P1, DOI 10.1016/S0165-5728(03)00162-0; Brazin KN, 2002, P NATL ACAD SCI USA, V99, P1899, DOI 10.1073/pnas.042529199; Burger JA, 2006, BLOOD, V107, P1761, DOI 10.1182/blood-2005-08-3182; Burger M, 2003, ONCOGENE, V22, P8093, DOI 10.1038/sj.onc.1207097; Chen TY, 2004, BLOOD, V103, P413, DOI 10.1182/blood-2003-07-2412; Colgan J, 2004, IMMUNITY, V21, P189, DOI 10.1016/j.immuni.2004.07.005; Comalada M, 2003, EUR J IMMUNOL, V33, P3091, DOI 10.1002/eji.200324074; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; de Parseval A, 2001, J VIROL, V75, P4528, DOI 10.1128/JVI.75.10.4528-4539.2001; Ding Y, 2006, MOL PHARMACOL, V69, P1269, DOI 10.1124/mol.105.020271; Dornan J, 2003, CURR TOP MED CHEM, V3, P1392, DOI 10.2174/1568026033451899; Dragic T, 2001, J GEN VIROL, V82, P1807, DOI 10.1099/0022-1317-82-8-1807; DREYFUSS G, 1993, ANNU REV BIOCHEM, V62, P289, DOI 10.1146/annurev.bi.62.070193.001445; Floridi F, 2003, J NEUROIMMUNOL, V135, P38, DOI 10.1016/S0165-5728(02)00432-0; Fridell RA, 1997, J CELL SCI, V110, P1325; Fukuda M, 1997, EMBO J, V16, P1901, DOI 10.1093/emboj/16.8.1901; Galigniana MD, 2004, J BIOL CHEM, V279, P55754, DOI 10.1074/jbc.M406259200; Gerard C, 2001, NAT IMMUNOL, V2, P108, DOI 10.1038/84209; Golding H, 2005, J BIOL CHEM, V280, P29570, DOI 10.1074/jbc.M500236200; HANDSCHUMACHER RE, 1984, SCIENCE, V226, P544, DOI 10.1126/science.6238408; Haribabu B, 1997, J BIOL CHEM, V272, P28726, DOI 10.1074/jbc.272.45.28726; Hartmann TN, 2004, J BIOL REG HOMEOS AG, V18, P126; Huse M, 1999, CELL, V96, P425, DOI 10.1016/S0092-8674(00)80555-3; Inoue A, 2005, J CELL SCI, V118, P2303, DOI 10.1242/jcs.02345; Inoue A, 2007, P NATL ACAD SCI USA, V104, P8983, DOI 10.1073/pnas.0607595104; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Lenormand P, 1998, J CELL BIOL, V142, P625, DOI 10.1083/jcb.142.3.625; Leopold PL, 2000, HUM GENE THER, V11, P151, DOI 10.1089/10430340050016238; Leverson JD, 1998, MOL CELL, V2, P417, DOI 10.1016/S1097-2765(00)80141-0; Li RS, 2006, J BIOL CHEM, V281, P37616, DOI 10.1074/jbc.M607266200; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; LUBAN J, 1993, CELL, V73, P1067, DOI 10.1016/0092-8674(93)90637-6; Luo C, 2006, J BIOL CHEM, V281, P30081, DOI 10.1074/jbc.M605837200; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Majka M, 2000, EUR J HAEMATOL, V64, P164, DOI 10.1034/j.1600-0609.2000.90112.x; Munro TP, 1999, J BIOL CHEM, V274, P34389, DOI 10.1074/jbc.274.48.34389; Nakielny S, 1999, EMBO J, V18, P1982, DOI 10.1093/emboj/18.7.1982; Neuhaus T, 2003, CELL PROLIFERAT, V36, P75, DOI 10.1046/j.1365-2184.2003.00262.x; Pan JD, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-56; Peng SB, 2005, MOL CANCER RES, V3, P227; Pollard VW, 1996, CELL, V86, P985, DOI 10.1016/S0092-8674(00)80173-7; PRICE ER, 1991, P NATL ACAD SCI USA, V88, P1903, DOI 10.1073/pnas.88.5.1903; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Rebane A, 2004, RNA, V10, P590, DOI 10.1261/rna.5224304; Rycyzyn MA, 2000, MOL ENDOCRINOL, V14, P1175, DOI 10.1210/me.14.8.1175; Sanchez-Tillo E, 2006, EUR J IMMUNOL, V36, P2515, DOI 10.1002/eji.200535270; Sanglier JJ, 1999, J ANTIBIOT, V52, P466, DOI 10.7164/antibiotics.52.466; SCHREIBER SL, 1992, IMMUNOL TODAY, V13, P136, DOI 10.1016/0167-5699(92)90111-J; Sotsios Y, 1999, J IMMUNOL, V163, P5954; Stamnes MA, 1990, CURR OPIN CELL BIOL, V2, P1104, DOI 10.1016/0955-0674(90)90163-9; Suikkanen S, 2003, J VIROL, V77, P10270, DOI 10.1128/JVI.77.19.10270-10279.2003; Syed F, 2003, ENDOCRINE, V20, P83, DOI 10.1385/ENDO:20:1-2:83; Tsai HR, 2004, EUR J PHARMACOL, V498, P45, DOI 10.1016/j.ejphar.2004.07.077; Uchida D, 2003, EXP CELL RES, V290, P289, DOI 10.1016/S0014-4827(03)00344-6; Weber KSC, 2001, MOL BIOL CELL, V12, P3074, DOI 10.1091/mbc.12.10.3074; Wedlich-Soldner R, 2000, EMBO J, V19, P1974, DOI 10.1093/emboj/19.9.1974; Wu MQ, 2006, INT J MOL MED, V17, P749; Wysoczynski M, 2005, BLOOD, V105, P40, DOI 10.1182/blood-2004-04-1430; YANG WM, 1995, J BIOL CHEM, V270, P15187, DOI 10.1074/jbc.270.25.15187; Yoo SH, 1997, J MOL BIOL, V269, P780, DOI 10.1006/jmbi.1997.1051; Yoo YD, 2006, J BIOL CHEM, V281, P15352, DOI 10.1074/jbc.M511825200; Zagar Y, 2004, J BIOL CHEM, V279, P2403, DOI 10.1074/jbc.M309132200; Zenke G, 2001, J IMMUNOL, V166, P7165, DOI 10.4049/jimmunol.166.12.7165; Zhang YY, 2004, STEM CELLS, V22, P1015, DOI 10.1634/stemcells.22-6-1015; Zhao M, 2006, MOL PHARMACOL, V69, P66, DOI 10.1124/mol.105.016923; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	70	85	90	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					623	637		10.1074/jbc.M704934200	http://dx.doi.org/10.1074/jbc.M704934200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17991743	hybrid			2022-12-27	WOS:000251940300067
J	van der Velden, JLJ; Schols, AMWJ; Willems, J; Kelders, MCJM; Langen, RCJ				van der Velden, Jos L. J.; Schols, Annemie M. W. J.; Willems, Jodil; Kelders, Marco C. J. M.; Langen, Ramon C. J.			Glycogen synthase kinase 3 beta suppresses myogenic differentiation through negative regulation of NFATc3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; SKELETAL-MUSCLE; CARDIAC-HYPERTROPHY; CALCINEURIN; ACTIVATION; EXPRESSION; PATHWAY; KINASE; PROTEIN; CELLS	Skeletal muscle atrophy is a prominent and disabling feature in many chronic diseases. Prevention or reversal of muscle atrophy by stimulation of skeletal muscle growth could be an important therapeutic strategy. Glycogen synthase kinase 3 beta (GSK-3 beta) has been implicated in the negative regulation of skeletal muscle growth. Since myogenic differentiation is an essential part of muscle growth, we investigated if inhibition of GSK-3 beta is sufficient to stimulate myogenic differentiation and whether this depended on regulation of the transcription factor nuclear factor of activated T-cells (NFAT). In both myogenically converted mouse embryonic fibroblasts and C2C12 myoblasts, deficiency of GSK-3 beta protein ( activity) resulted in enhanced myotube formation and muscle-specific gene expression during differentiation, which was reversed by reintroduction of wild type but not kinase-inactive (K85R) GSK-3 beta. In addition, GSK-3 beta inhibition restored myogenic differentiation following calcineurin blockade, which suggested the involvement of NFAT. GSK-3 beta-deficient mouse embryonic fibroblasts or myoblasts displayed enhanced nuclear translocation of NFATc3 and elevated NFAT-sensitive promoter transactivation, which was reduced by reintroducing wild type, but not K85R GSK-3 beta. Overexpression of NFATc3 increased muscle gene promoter transactivation, which was abolished by co-expression of wild type GSK-3 beta. Finally, stimulation of muscle gene expression observed following GSK-3 beta inhibition was strongly attenuated in NFATc3- deficient myoblasts, indicating that this response requires NFATc3. Collectively, our data demonstrate negative regulation of myogenic differentiation by GSK-3 beta through a transcriptional mechanism that depends on NFATc3. Inhibition of GSK-3 beta may be a potential strategy in prevention or treatment of muscle atrophy.	[van der Velden, Jos L. J.; Schols, Annemie M. W. J.; Willems, Jodil; Kelders, Marco C. J. M.; Langen, Ramon C. J.] Maastricht Univ, Nutr & Toxicol Res Inst Maastricht, Dept Resp Med, NL-6202 AZ Maastricht, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC)	Langen, RCJ (corresponding author), Maastricht Univ, Nutr & Toxicol Res Inst Maastricht, Dept Resp Med, PO Box 5800, NL-6202 AZ Maastricht, Netherlands.	r.langen@pul.unimaas.nl		van der Velden, Jos/0000-0002-2451-3180				Abbott KL, 1998, MOL BIOL CELL, V9, P2905, DOI 10.1091/mbc.9.10.2905; Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Allen DL, 1999, MUSCLE NERVE, V22, P1350, DOI 10.1002/(SICI)1097-4598(199910)22:10<1350::AID-MUS3>3.0.CO;2-8; ALLEN DL, 1995, J APPL PHYSIOL, V78, P1969, DOI 10.1152/jappl.1995.78.5.1969; Antos CL, 2002, P NATL ACAD SCI USA, V99, P907, DOI 10.1073/pnas.231619298; Beals CR, 1997, SCIENCE, V275, P1930, DOI 10.1126/science.275.5308.1930; Beylkin DH, 2006, DEV BIOL, V294, P541, DOI 10.1016/j.ydbio.2006.02.049; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brummelkamp TR, 2002, CANCER CELL, V2, P243, DOI 10.1016/S1535-6108(02)00122-8; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Chin ER, 1998, GENE DEV, V12, P2499, DOI 10.1101/gad.12.16.2499; CORIN SJ, 1995, P NATL ACAD SCI USA, V92, P6185, DOI 10.1073/pnas.92.13.6185; Cossu G, 1999, EMBO J, V18, P6867, DOI 10.1093/emboj/18.24.6867; Delling U, 2000, MOL CELL BIOL, V20, P6600, DOI 10.1128/MCB.20.17.6600-6611.2000; Diehn M, 2002, P NATL ACAD SCI USA, V99, P11796, DOI 10.1073/pnas.092284399; DOMINGUEZ I, 1995, P NATL ACAD SCI USA, V92, P8498, DOI 10.1073/pnas.92.18.8498; Dunn SE, 1999, J BIOL CHEM, V274, P21908, DOI 10.1074/jbc.274.31.21908; EMBI N, 1980, EUR J BIOCHEM, V107, P519, DOI 10.1111/j.1432-1033.1980.tb06059.x; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Friday BB, 2001, J CELL SCI, V114, P303; Haq S, 2000, J CELL BIOL, V151, P117, DOI 10.1083/jcb.151.1.117; Hardt SE, 2002, CIRC RES, V90, P1055, DOI 10.1161/01.RES.0000018952.70505.F1; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Horsley V, 2001, J CELL BIOL, V153, P329, DOI 10.1083/jcb.153.2.329; Jefferson LS, 1999, INT J BIOCHEM CELL B, V31, P191, DOI 10.1016/S1357-2725(98)00141-1; Kegley KM, 2001, DEV BIOL, V232, P115, DOI 10.1006/dbio.2001.0179; Langen RCJ, 2004, FASEB J, V18, P227, DOI 10.1096/fj.03-0251com; Lopez-Rodriguez C, 1999, P NATL ACAD SCI USA, V96, P7214, DOI 10.1073/pnas.96.13.7214; Miyazaki M, 2006, MED SCI SPORT EXER, V38, P1065, DOI 10.1249/01.mss.0000222833.43520.6e; Murphy LLS, 2002, J IMMUNOL, V169, P3717, DOI 10.4049/jimmunol.169.7.3717; Musaro A, 1999, NATURE, V400, P581, DOI 10.1038/23060; Neal JW, 2001, J BIOL CHEM, V276, P3666, DOI 10.1074/jbc.M004888200; O'Connor RS, 2007, J CELL SCI, V120, P149, DOI 10.1242/jcs.03307; Olson EN, 2000, BIOESSAYS, V22, P510, DOI 10.1002/(SICI)1521-1878(200006)22:6<510::AID-BIES4>3.3.CO;2-T; Ridgeway AG, 2000, J BIOL CHEM, V275, P32398, DOI 10.1074/jbc.M004349200; Rochat A, 2004, MOL BIOL CELL, V15, P4544, DOI 10.1091/mbc.E03-11-0816; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Schols AMWJ, 2005, AM J CLIN NUTR, V82, P53, DOI 10.1093/ajcn/82.1.53; Schols AMWJ, 1998, AM J RESP CRIT CARE, V157, P1791, DOI 10.1164/ajrccm.157.6.9705017; Schulz RA, 2004, DEV BIOL, V266, P1, DOI 10.1016/j.ydbio.2003.10.008; SZASZ G, 1976, CLIN CHEM, V22, P650; van der Velden JLJ, 2006, AM J PHYSIOL-CELL PH, V290, pC453, DOI 10.1152/ajpcell.00068.2005; van Rooij E, 2002, J BIOL CHEM, V277, P48617, DOI 10.1074/jbc.M206532200; Vestbo J, 2006, AM J RESP CRIT CARE, V173, P79, DOI 10.1164/rccm.200505-969OC; Vyas DR, 2002, AM J PHYSIOL-CELL PH, V283, pC545, DOI 10.1152/ajpcell.00049.2002; WEINTRAUB H, 1989, P NATL ACAD SCI USA, V86, P5434, DOI 10.1073/pnas.86.14.5434; Yang J, 2000, CIRC RES, V87, pE61, DOI 10.1161/01.RES.87.12.e61	49	54	64	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					358	366		10.1074/jbc.M707812200	http://dx.doi.org/10.1074/jbc.M707812200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17977834	hybrid			2022-12-27	WOS:000251940300040
J	Li, LB; Xu, KX; Bonini, NM				Li, Ling-Bo; Xu, Kexiang; Bonini, Nancy M.			Suppression of polyglutamine toxicity by the yeast sup35 prion domain in Drosophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO; SACCHAROMYCES-CEREVISIAE; EXPANDED POLYGLUTAMINE; MUTANT HUNTINGTIN; TRANSGENIC MICE; PSI+ PRION; PROTEIN; AGGREGATION; DISEASE; INHERITANCE	The propensity of proteins to form beta-sheet-rich amyloid fibrils is related to a variety of biological phenomena, including a number of human neurodegenerative diseases and prions. A subset of amyloidogenic proteins forms amyloid fibrils through glutamine/ asparagine (Q/N)-rich domains, such as pathogenic polyglutamine (poly(Q)) proteins involved in neurodegenerative disease, as well as yeast prions. In the former, the propensity of an expanded poly(Q) tract to abnormally fold confers toxicity on the respective protein, leading to neuronal dysfunction. In the latter, Q/N-rich prion domains mediate protein aggregation important for epigenetic regulation. Here, we investigated the relationship between the pathogenic ataxin-3 protein of the human disease spinocerebellar ataxia type 3 (SCA3) and the yeast prion Sup35, using Drosophila as a model system. We found that the capacity of the Sup35 prion domain to mediate protein aggregation is conserved in Drosophila. Although select yeast prions enhance poly(Q) toxicity in yeast, the Sup35N prion domain suppressed poly(Q) toxicity in the fly. Suppression required the oligopeptide repeat of the Sup35N prion domain, which is critical for prion properties in yeast. These results suggest a trans effect of prion domains on pathogenic poly(Q) disease proteins in a multicellular environment and raise the possibility that Drosophila may allow studies of prion mechanisms.	[Li, Ling-Bo; Xu, Kexiang] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Bonini, Nancy M.] Univ Penn, Howard Hughes Med Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; Howard Hughes Medical Institute; University of Pennsylvania	Bonini, NM (corresponding author), Univ Penn, Howard Hughes Med Inst, Dept Biol, Leidy Lab 306, 415 S Univ Ave, Philadelphia, PA 19104 USA.	nbonini@sas.upenn.edu						Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Bonini NM, 2002, P NATL ACAD SCI USA, V99, P16407, DOI 10.1073/pnas.152330499; Borchsenius AS, 2001, EMBO J, V20, P6683, DOI 10.1093/emboj/20.23.6683; Bradley ME, 2002, P NATL ACAD SCI USA, V99, P16392, DOI 10.1073/pnas.152330699; Burnett B, 2003, HUM MOL GENET, V12, P3195, DOI 10.1093/hmg/ddg344; Chai YH, 2004, J BIOL CHEM, V279, P3605, DOI 10.1074/jbc.M310939200; Chan HYE, 2000, HUM MOL GENET, V9, P2811, DOI 10.1093/hmg/9.19.2811; Chien P, 2004, ANNU REV BIOCHEM, V73, P617, DOI 10.1146/annurev.biochem.72.121801.161837; Deleault NR, 2003, J NEUROCHEM, V85, P1614, DOI 10.1046/j.1471-4159.2003.01819.x; DePace AH, 1998, CELL, V93, P1241, DOI 10.1016/S0092-8674(00)81467-1; Derkatch IL, 2004, P NATL ACAD SCI USA, V101, P12934, DOI 10.1073/pnas.0404968101; Donaldson KM, 2003, P NATL ACAD SCI USA, V100, P8892, DOI 10.1073/pnas.1530212100; Duennwald ML, 2006, P NATL ACAD SCI USA, V103, P11051, DOI 10.1073/pnas.0604548103; Emamian ES, 2003, NEURON, V38, P375, DOI 10.1016/S0896-6273(03)00258-7; Ganusova EE, 2006, MOL CELL BIOL, V26, P617, DOI 10.1128/MCB.26.2.617-629.2006; Glover JR, 1997, CELL, V89, P811, DOI 10.1016/S0092-8674(00)80264-0; Gokhale KC, 2005, J BIOL CHEM, V280, P22809, DOI 10.1074/jbc.M500390200; Goti D, 2004, J NEUROSCI, V24, P10266, DOI 10.1523/JNEUROSCI.2734-04.2004; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; Gsponer J, 2003, P NATL ACAD SCI USA, V100, P5154, DOI 10.1073/pnas.0835307100; Gusella JF, 2000, NAT REV NEUROSCI, V1, P109, DOI 10.1038/35039051; Ikeda H, 1996, NAT GENET, V13, P196, DOI 10.1038/ng0696-196; Jones GW, 2005, BIOESSAYS, V27, P823, DOI 10.1002/bies.20267; Liu JJ, 1999, NATURE, V400, P573, DOI 10.1038/23048; Meriin AB, 2002, J CELL BIOL, V157, P997, DOI 10.1083/jcb.200112104; Osherovich LZ, 2004, PLOS BIOL, V2, P442, DOI 10.1371/journal.pbio.0020086; Osherovich LZ, 2001, CELL, V106, P183, DOI 10.1016/S0092-8674(01)00440-8; Osherovich LZ, 2002, DEV CELL, V2, P143, DOI 10.1016/S1534-5807(02)00118-1; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; Paulson HL, 1997, NEURON, V19, P333, DOI 10.1016/S0896-6273(00)80943-5; Paushkin SV, 1997, SCIENCE, V277, P381, DOI 10.1126/science.277.5324.381; Perutz MF, 2002, P NATL ACAD SCI USA, V99, P5596, DOI 10.1073/pnas.042681599; RAEBER AJ, 1995, MECH DEVELOP, V51, P317, DOI 10.1016/0925-4773(95)00379-7; Ross CA, 2003, P NATL ACAD SCI USA, V100, P1, DOI 10.1073/pnas.0237018100; Salnikova AB, 2005, J BIOL CHEM, V280, P8808, DOI 10.1074/jbc.M410150200; Shewmaker F, 2007, GENETICS, V176, P1557, DOI 10.1534/genetics.107.074153; Shorter J, 2005, NAT REV GENET, V6, P435, DOI 10.1038/nrg1616; Thakur AK, 2002, P NATL ACAD SCI USA, V99, P17014, DOI 10.1073/pnas.252523899; Tsuda H, 2005, CELL, V122, P633, DOI 10.1016/j.cell.2005.06.012; Uptain SM, 2002, ANNU REV MICROBIOL, V56, P703, DOI 10.1146/annurev.micro.56.013002.100603; Vitrenko YA, 2007, J BIOL CHEM, V282, P1779, DOI 10.1074/jbc.M609269200; Warrick JM, 2005, MOL CELL, V18, P37, DOI 10.1016/j.molcel.2005.02.030; Wickner RB, 2007, NAT REV MICROBIOL, V5, P611, DOI 10.1038/nrmicro1708; Zhou P, 2001, MOL MICROBIOL, V39, P37, DOI 10.1046/j.1365-2958.2001.02224.x; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	45	11	13	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37694	37701		10.1074/jbc.M705211200	http://dx.doi.org/10.1074/jbc.M705211200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17956866	hybrid			2022-12-27	WOS:000251833600045
J	Yamada, K; Fukao, Y; Hayashi, M; Fukazawa, M; Suzuki, I; Nishimura, M				Yamada, Kenji; Fukao, Yoichiro; Hayashi, Makoto; Fukazawa, Mitsue; Suzuki, Iku; Nishimura, Mikio			Cytosolic HSP90 regulates the heat shock response that is responsible for heat acclimation in Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRESS TRANSCRIPTION FACTORS; MOLECULAR CHAPERONE HSP90; DISEASE RESISTANCE; BINDING-PROTEIN; GENE-EXPRESSION; DNA-BINDING; FACTOR HSF1; THERMOTOLERANCE; YEAST; COMPLEX	Plant survival requires the ability to acclimate to heat. plants are subjected to heat shock, the expression of genes is induced, and the plants become tolerant of higher We found that transient treatment with and radicicol, two heat shock protein 90 (HSP90) induced heat-inducible genes and heat acclimation in thaliana seedlings. Heat shock reduced the activity exogenously expressed glucocorticoid receptor (GR). Since activity depends on HSP90, this suggests that heat reduces cytosolic HSP90 activity in vivo. Microarray revealed that many of the genes that are up-regulated by heat shock and HSP90 inhibitors are involved in protein and degradation, suggesting that the activation of a maintenance system is a crucial part of this response. Most these genes have heat shock response element-like motifs their promoters, which suggests that heat shock factor (HSF) is involved in the response to HSP90 Several HSF genes are expressed constitutively in A. including AtHsfA1d. Recombinant AtHsfA1d protein the heat shock response element motif and interacts with thaliana cytosolic HSP90, HSP90.2. Overexpression of a negative form of HSP90.2 induced the heat-induciblegene. Thus, appears that in the absence of heat shock, cytosolic HSP90 regulates heat-inducible genes by actively suppressing function. Upon heat shock, cytosolic HSP90 is transiently which may lead to HSF activation.	[Fukao, Yoichiro] Natl Inst Basic Biol, Dept Cell Biol, Okazaki, Aichi 4008511, Japan; [Fukao, Yoichiro] Nara Inst Sci & Technol, Grad Sch Biol Sci, Ikoma, Nara 6300101, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Nara Institute of Science & Technology	Nishimura, M (corresponding author), Natl Inst Basic Biol, Dept Cell Biol, Nishigo-Naka 38, Okazaki, Aichi 4008511, Japan.	mikosome@nibb.ac.jp	Fukao, Yoichiro/E-7137-2013; Yamada, Kenji/C-4336-2018	Yamada, Kenji/0000-0003-4872-3729; Nishimura, Mikio/0000-0001-7960-9721				Aoyama T, 1997, PLANT J, V11, P605, DOI 10.1046/j.1365-313X.1997.11030605.x; Baniwal SK, 2007, J BIOL CHEM, V282, P3605, DOI 10.1074/jbc.M609545200; Barzilay E, 2004, J BIOL CHEM, V279, P6847, DOI 10.1074/jbc.M312799200; Bharti K, 2004, PLANT CELL, V16, P1521, DOI 10.1105/tpc.019927; Charng YY, 2007, PLANT PHYSIOL, V143, P251, DOI 10.1104/pp.106.091322; CHENG LL, 1992, BIOCHIM BIOPHYS ACTA, V1132, P26, DOI 10.1016/0167-4781(92)90048-5; Diaz-Martin J, 2005, PLANT PHYSIOL, V139, P1483, DOI 10.1104/pp.105.069963; Duina AA, 1998, J BIOL CHEM, V273, P18974, DOI 10.1074/jbc.273.30.18974; Fu SN, 2002, PLANT CELL, V14, P3119, DOI 10.1105/tpc.006726; Hong SW, 2003, PLANT PHYSIOL, V132, P757, DOI 10.1104/pp.102.017145; Hong SW, 2000, P NATL ACAD SCI USA, V97, P4392, DOI 10.1073/pnas.97.8.4392; HUBEL A, 1994, PLANT MOL BIOL, V26, P353, DOI 10.1007/BF00039545; Hubert DA, 2003, EMBO J, V22, P5679, DOI 10.1093/emboj/cdg547; Kamada T, 2003, PLANT CELL PHYSIOL, V44, P1275, DOI 10.1093/pcp/pcg173; Kamauchi S, 2005, FEBS J, V272, P3461, DOI 10.1111/j.1742-4658.2005.04770.x; Kim BH, 2002, J EXP BOT, V53, P371, DOI 10.1093/jexbot/53.367.371; Kotak S, 2004, PLANT J, V39, P98, DOI 10.1111/j.1365-313X.2004.02111.x; Kovacs JJ, 2005, MOL CELL, V18, P601, DOI 10.1016/j.molcel.2005.04.021; Liu YL, 2004, J BIOL CHEM, V279, P2101, DOI 10.1074/jbc.M310029200; Lohmann C, 2004, MOL GENET GENOMICS, V271, P11, DOI 10.1007/s00438-003-0954-8; Lu R, 2003, EMBO J, V22, P5690, DOI 10.1093/emboj/cdg546; Martinez IM, 2003, PLANT CELL, V15, P561, DOI 10.1105/tpc.007609; McLellan CA, 2007, PLANT PHYSIOL, V145, P174, DOI 10.1104/pp.107.101808; Mishra SK, 2002, GENE DEV, V16, P1555, DOI 10.1101/gad.228802; Molina C, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-25; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; NADEAU K, 1993, J BIOL CHEM, V268, P1479; Never L, 1996, CELL STRESS CHAPERON, V1, P215, DOI 10.1379/1466-1268(1996)001<0215:THWCAP>2.3.CO;2; Nishizawa A, 2006, PLANT J, V48, P535, DOI 10.1111/j.1365-313X.2006.02889.x; Nover L, 2001, CELL STRESS CHAPERON, V6, P177, DOI 10.1379/1466-1268(2001)006<0177:AATHST>2.0.CO;2; Panaretou B, 1998, EMBO J, V17, P4829, DOI 10.1093/emboj/17.16.4829; Picard D, 2002, CELL MOL LIFE SCI, V59, P1640, DOI 10.1007/PL00012491; Pratt WB, 2004, CELL SIGNAL, V16, P857, DOI 10.1016/j.cellsig.2004.02.004; PROT M, 2004, PLANT PHYSIOL, V135, P1457; Qbadou S, 2006, EMBO J, V25, P1836, DOI 10.1038/sj.emboj.7601091; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; Queitsch C, 2000, PLANT CELL, V12, P479, DOI 10.1105/tpc.12.4.479; Reindl A, 1997, PLANT PHYSIOL, V115, P93, DOI 10.1104/pp.115.1.93; Roe SM, 1999, J MED CHEM, V42, P260, DOI 10.1021/jm980403y; Sakuma Y, 2006, P NATL ACAD SCI USA, V103, P18822, DOI 10.1073/pnas.0605639103; Sangster TA, 2005, CURR OPIN PLANT BIOL, V8, P86, DOI 10.1016/j.pbi.2004.11.012; Sangster TA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000648; Schoffl F, 1998, PLANT PHYSIOL, V117, P1135, DOI 10.1104/pp.117.4.1135; Schramm F, 2006, PLANT MOL BIOL, V60, P759, DOI 10.1007/s11103-005-5750-x; Soldano KL, 2003, J BIOL CHEM, V278, P48330, DOI 10.1074/jbc.M308661200; SORGER PK, 1987, EMBO J, V6, P3035, DOI 10.1002/j.1460-2075.1987.tb02609.x; SORGER PK, 1989, CELL, V59, P807, DOI 10.1016/0092-8674(89)90604-1; SORGER PK, 1988, CELL, V54, P855, DOI 10.1016/S0092-8674(88)91219-6; Takahashi A, 2003, P NATL ACAD SCI USA, V100, P11777, DOI 10.1073/pnas.2033934100; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; Wandinger SK, 2006, EMBO J, V25, P367, DOI 10.1038/sj.emboj.7600930; Wang WX, 2004, TRENDS PLANT SCI, V9, P244, DOI 10.1016/j.tplants.2004.03.006; YABE N, 1994, PLANT CELL PHYSIOL, V35, P1207, DOI 10.1093/oxfordjournals.pcp.a078715; Yamada K, 2005, PLANT J, V41, P888, DOI 10.1111/j.1365-313X.2005.02349.x; Zou JY, 1998, CELL, V94, P471, DOI 10.1016/S0092-8674(00)81588-3	55	156	176	1	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37794	37804		10.1074/jbc.M707168200	http://dx.doi.org/10.1074/jbc.M707168200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17965410	hybrid			2022-12-27	WOS:000251833600055
J	Elliott, E; Tsvetkov, P; Ginzburg, I				Elliott, Evan; Tsvetkov, Peter; Ginzburg, Irith			BAG-1 associates with Hsc70 center dot Tau complex and regulates the proteasomal degradation of Tau protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROTUBULE-ASSOCIATED PROTEIN; PHOSPHORYLATED TAU; ALZHEIMERS-DISEASE; NEURONAL CELLS; CHIP; RNA; AGGREGATION; EXPRESSION; SYNAPSES; SURVIVAL	Intraneuronal accumulation of phosphorylated Tau protein is a molecular pathology found in many forms of dementia, including Alzheimer disease. Research into possible mechanisms leading to the accumulation of modified Tau protein and the possibility of removing Tau protein from the system have revealed that the chaperone protein system can interact with Tau and mediate its degradation. Hsp70/Hsc70, a member of the chaperone protein family, interacts with Tau protein and mediates proper folding of Tau and can promote degradation of Tau protein under certain circumstances. However, because Hsp70/Hsc70 has many binding partners that can mediate its activity, there is still much to discover about how Hsp70 acts in vivo to regulate Tau protein. BAG-1, an Hsp70/Hsc70 binding partner, has been implicated as a mediator of neuronal function. In this work we show that BAG-1 associates with Tau protein in an Hsc70-dependent manner. Overexpression of BAG-1 induced an increase in Tau levels, which is shown to be due to an inhibition of protein degradation. We further show that BAG-1 can inhibit the degradation of Tau protein by the 20 S proteasome but does not affect the ubiquitination of Tau protein. RNA-mediated interference depletion of BAG-1 leads to a decrease in total Tau protein levels as well as promoting hyperphosphorylation of the remaining protein. Induction of Hsp70 by heat shock enhanced the increase of Tau levels in cells overexpressing BAG-1 but induced a decrease of Tau levels in cells that were depleted of BAG-1. Finally, BAG-1 is highly expressed in neurons bearing Tau tangles in a mouse model of Alzheimer disease. This data suggests a molecular mechanism through which Tau protein levels are regulated in the cell and possible consequences for the pathology and treatment of Alzheimer disease.	[Elliott, Evan; Ginzburg, Irith] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Tsvetkov, Peter] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science	Ginzburg, I (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	irith.ginzburg@weizmann.ac.il	Tsvetkov, Peter/J-9878-2019; Tsvetkov, Peter/D-6458-2011	Tsvetkov, Peter/0000-0002-7577-2342; Elliott, Evan/0000-0002-1630-969X				Aranda-Abreu GE, 1999, J NEUROSCI, V19, P6907, DOI 10.1523/JNEUROSCI.19-16-06907.1999; Aronov S, 2001, J NEUROSCI, V21, P6577, DOI 10.1523/JNEUROSCI.21-17-06577.2001; Asher G, 2005, GENE DEV, V19, P316, DOI 10.1101/gad.319905; CLEVELAND DW, 1977, J MOL BIOL, V116, P207, DOI 10.1016/0022-2836(77)90213-3; David DC, 2002, J NEUROCHEM, V83, P176, DOI 10.1046/j.1471-4159.2002.01137.x; Dickey CA, 2007, J CLIN INVEST, V117, P648, DOI 10.1172/JCI29715; Dickey CA, 2006, EXPERT OPIN THER TAR, V10, P665, DOI 10.1517/14728222.10.5.665; Dickey CA, 2006, FASEB J, V20, P753, DOI 10.1096/fj.05-5343fje; Dickey CA, 2006, J NEUROSCI, V26, P6985, DOI 10.1523/JNEUROSCI.0746-06.2006; Dou F, 2003, P NATL ACAD SCI USA, V100, P721, DOI 10.1073/pnas.242720499; Gotz R, 2005, NAT NEUROSCI, V8, P1169, DOI 10.1038/nn1524; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Hatakeyama S, 2004, J NEUROCHEM, V91, P299, DOI 10.1111/j.1471-4159.2004.02713.x; Kojima SI, 2004, BIOTECHNIQUES, V36, P74, DOI 10.2144/04361ST02; Liman J, 2005, MOL CELL BIOL, V25, P3715, DOI 10.1128/MCB.25.9.3715-3725.2005; Luders J, 2000, J BIOL CHEM, V275, P14817, DOI 10.1074/jbc.275.20.14817; Luders J, 2000, J BIOL CHEM, V275, P4613, DOI 10.1074/jbc.275.7.4613; Mandelkow EM, 2003, NEUROBIOL AGING, V24, P1079, DOI 10.1016/j.neurobiolaging.2003.04.007; Mukrasch MD, 2007, J BIOL CHEM, V282, P12230, DOI 10.1074/jbc.M607159200; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Petrucelli L, 2004, HUM MOL GENET, V13, P703, DOI 10.1093/hmg/ddh083; Shimura H, 2004, J BIOL CHEM, V279, P4869, DOI 10.1074/jbc.M305838200; Stamer K, 2002, J CELL BIOL, V156, P1051, DOI 10.1083/jcb.200108057; Takayama S, 1998, CANCER RES, V58, P3116; Thies E, 2007, J NEUROSCI, V27, P2896, DOI 10.1523/JNEUROSCI.4674-06.2007; Xie HQ, 1998, BRAIN RES, V798, P173, DOI 10.1016/S0006-8993(98)00407-7	26	81	87	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					37276	37284		10.1074/jbc.M706379200	http://dx.doi.org/10.1074/jbc.M706379200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17954934	hybrid			2022-12-27	WOS:000251646000053
J	Hines, JK; Chen, XM; Nix, JC; Fromm, HJ; Honzatko, RB				Hines, Justin K.; Chen, Xiaoming; Nix, Jay C.; Fromm, Herbert J.; Honzatko, Richard B.			Structures of mammalian and bacterial fructose-1,6-bisphosphatase reveal the basis for synergism in AMP/fructose 2,6-bisphosphate inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FRUCTOSE 2,6-BISPHOSPHATE; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; LIVER FRUCTOSE-1,6-BISPHOSPHATASE; ALLOSTERIC INHIBITION; DYNAMIC LOOP; RECOMBINANT PORCINE; NEUTRAL FORM; 1,6-BISPHOSPHATASE; AMP	Fructose-1,6-bisphosphatase (FBPase) operates at a control point in mammalian gluconeogenesis, being inhibited synergistically by fructose 2,6-bisphosphate (Fru-2,6- P-2) and AMP. AMP and Fru-2,6-P-2 bind to allosteric and active sites, respectively, but the mechanism responsible for AMP/Fru-2,6-P-2 synergy is unclear. Demonstrated here for the first time is a global conformational change in porcine FBPase induced by Fru-2,6-P-2 in the absence of AMP. The Fru-2,6-P-2 complex exhibits a subunit pair rotation of 13 degrees from the R-state ( compared with the 15 rotation of the T-state AMP complex) with active site loops in the disengaged conformation. A three-state thermodynamic model in which Fru2,6-P-2 drives a conformational change to a T-like intermediate state can account for AMP/Fru-2,6-P-2 synergism in mammalian FBPases. AMP and Fru-2,6-P-2 are not synergistic inhibitors of the Type I FBPase from Escherichia coli, and consistent with that model, the complex of E. coli FBPase with Fru-2,6-P-2 remains in the R-state with dynamic loops in the engaged conformation. Evidently in porcine FBPase, the actions of AMP at the allosteric site and Fru-2,6- P2 at the active site displace engaged dynamic loops by distinct mechanisms, resulting in similar quaternary end-states. Conceivably, Type I FBPases from alleukaryotes may undergo similar global conformational changes in response to Fru-2,6-P-2 ligation.	Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Adv Light Source, Berkeley, CA 94720 USA	Iowa State University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Honzatko, RB (corresponding author), Iowa State Univ, Dept Biochem Biophys & Mol Biol, 4206 Mol Biol Bldg, Ames, IA 50011 USA.	honzatko@iastate.edu			NINDS NIH HHS [NS10546, R01 NS010546] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS010546, R01NS010546] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BENKOVIC SJ, 1982, ADV ENZYMOL RAMB, V53, P45; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Choe JY, 2000, BIOCHEMISTRY-US, V39, P8565, DOI 10.1021/bi000574g; Choe JY, 1998, BIOCHEMISTRY-US, V37, P11441, DOI 10.1021/bi981112u; Choe JY, 2003, J BIOL CHEM, V278, P51176, DOI 10.1074/jbc.M308396200; CORREDOR C, 1984, FEBS LETT, V167, P199, DOI 10.1016/0014-5793(84)80126-X; Donahue JL, 2000, J BACTERIOL, V182, P5624, DOI 10.1128/JB.182.19.5624-5627.2000; ELMAGHRABI MR, 1992, J BIOL CHEM, V267, P6526; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; Erion MD, 2005, P NATL ACAD SCI USA, V102, P7970, DOI 10.1073/pnas.0502983102; EVANS P, 1992, PDBSET; FRAENKEL DG, 1966, ARCH BIOCHEM BIOPHYS, V114, P4, DOI 10.1016/0003-9861(66)90298-0; FRAENKEL DG, 1965, J BACTERIOL, V90, P837, DOI 10.1128/JB.90.4.837-842.1965; FRANCOIS J, 1983, EUR J BIOCHEM, V134, P269, DOI 10.1111/j.1432-1033.1983.tb07561.x; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; GANSON NJ, 1982, BIOCHEM BIOPH RES CO, V108, P233, DOI 10.1016/0006-291X(82)91856-3; GIDHJAIN M, 1994, J BIOL CHEM, V269, P27732; GOTTSCHALK ME, 1982, J BIOL CHEM, V257, P8016; GUYNN RW, 1972, J BIOL CHEM, V247, P7325; Hines JK, 2007, J BIOL CHEM, V282, P24697, DOI 10.1074/jbc.M703580200; Hines JK, 2007, J BIOL CHEM, V282, P11696, DOI 10.1074/jbc.M611104200; Hines JK, 2006, J BIOL CHEM, V281, P18386, DOI 10.1074/jbc.M602553200; HUE L, 1987, BIOCHEM J, V245, P313, DOI 10.1042/bj2450313; HUE L, 1984, BIOCHEM J, V224, P779, DOI 10.1042/bj2240779; Iancu CV, 2005, J BIOL CHEM, V280, P19737, DOI 10.1074/jbc.M501011200; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; KE H, 1990, J MOL BIOL, V212, P513, DOI 10.1016/0022-2836(90)90329-K; KE HM, 1991, P NATL ACAD SCI USA, V88, P2989, DOI 10.1073/pnas.88.8.2989; KE HM, 1990, P NATL ACAD SCI USA, V87, P5243, DOI 10.1073/pnas.87.14.5243; KE HM, 1991, BIOCHEMISTRY-US, V30, P4412, DOI 10.1021/bi00232a007; KE HM, 1989, P NATL ACAD SCI USA, V86, P1475, DOI 10.1073/pnas.86.5.1475; KEMP RG, 1990, FRUCTOSE 2 6 BISPHOS, P17; KITAJIMA S, 1983, J BIOL CHEM, V258, P7352; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kurbanov FT, 1998, J BIOL CHEM, V273, P17511, DOI 10.1074/jbc.273.28.17511; KUWAJIMA M, 1984, J CLIN INVEST, V74, P1108, DOI 10.1172/JCI111479; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEDERER B, 1981, BIOCHEM BIOPH RES CO, V103, P1281, DOI 10.1016/0006-291X(81)90261-8; LIANG JY, 1992, P NATL ACAD SCI USA, V89, P2404, DOI 10.1073/pnas.89.6.2404; LIU F, 1990, J BIOL CHEM, V265, P7401; MARCUS F, 1984, BIOCHEM BIOPH RES CO, V119, P1103, DOI 10.1016/0006-291X(84)90888-X; MCGRANE MM, 1983, J BIOL CHEM, V258, P445; McRee DE, 1992, J MOL GRAPHICS, V10, P44, DOI DOI 10.1016/0263-7855(92)80022-6; MEEK DW, 1983, FEBS LETT, V160, P105, DOI 10.1016/0014-5793(83)80946-6; MIZUNUMA H, 1983, ARCH BIOCHEM BIOPHYS, V226, P257, DOI 10.1016/0003-9861(83)90292-8; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Nelson SW, 2004, J BIOL CHEM, V279, P18481, DOI 10.1074/jbc.M308811200; Nelson SW, 2002, J BIOL CHEM, V277, P15539, DOI 10.1074/jbc.M112304200; Nelson SW, 2000, BIOCHEMISTRY-US, V39, P11100, DOI 10.1021/bi000609c; Nelson SW, 2000, J BIOL CHEM, V275, P29986, DOI 10.1074/jbc.M000473200; NODA T, 1984, J BIOL CHEM, V259, P7191; Okar DA, 1999, BIOFACTORS, V10, P1, DOI 10.1002/biof.5520100101; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; PILKIS SJ, 1981, J BIOL CHEM, V256, P3619; PILKIS SJ, 1981, J BIOL CHEM, V256, P3171; PONTREMOLI S, 1982, ARCH BIOCHEM BIOPHYS, V218, P609, DOI 10.1016/0003-9861(82)90386-1; Radziuk J, 2001, DIABETES-METAB RES, V17, P250, DOI 10.1002/dmrr.217; REYES A, 1985, BIOCHEM BIOPH RES CO, V127, P373, DOI 10.1016/S0006-291X(85)80169-8; REYES A, 1987, J BIOL CHEM, V262, P8451; Roden M, 2001, RECENT PROG HORM RES, V56, P219, DOI 10.1210/rp.56.1.219; Sato T, 2004, J BACTERIOL, V186, P5799, DOI 10.1128/JB.186.17.5799-5807.2004; SCHEFFLER JE, 1986, BIOCHEMISTRY-US, V25, P6659, DOI 10.1021/bi00369a050; SHIRAKIHARA Y, 1988, J MOL BIOL, V204, P973, DOI 10.1016/0022-2836(88)90056-3; TAKETA K, 1965, J BIOL CHEM, V240, P651; TEJWANI GA, 1983, ADV ENZYMOL RAMB, V54, P121; UYEDA K, 1981, J BIOL CHEM, V256, P8394; van Poelje PD, 2007, CURR OPIN DRUG DISC, V10, P430; van Poelje PD, 2006, DIABETES, V55, P1747, DOI 10.2337/db05-1443; VANSCHAFTINGEN E, 1981, P NATL ACAD SCI-BIOL, V78, P3483; VANSCHAFTINGEN E, 1981, P NATL ACAD SCI-BIOL, V78, P2861; VANSCHAFTINGEN E, 1987, ADV ENZYMOL RAMB, V59, P315; VANSCHAFTINGEN E, 1980, BIOCHEM J, V192, P897, DOI 10.1042/bj1920897; VANSCHAFTINGEN E, 1990, FRUCTOSE 2 6 BISPHOS, P229; VANSCHAFTINGEN E, 1990, FRUCTOSE 2 6 BISPHOS, P65; Wright SW, 2002, J MED CHEM, V45, P3865, DOI 10.1021/jm010496a; XUE YF, 1994, P NATL ACAD SCI USA, V91, P12482, DOI 10.1073/pnas.91.26.12482	78	16	18	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					36121	36131		10.1074/jbc.M707302200	http://dx.doi.org/10.1074/jbc.M707302200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17933867	hybrid			2022-12-27	WOS:000251458100071
J	Lundgren, S; Andersen, B; Piskur, J; Dobritzsch, D				Lundgren, Stina; Andersen, Birgit; Piskur, Jure; Dobritzsch, Doreen			Crystal structures of yeast beta-alanine synthase complexes reveal the mode of substrate binding and large scale domain closure movements	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYRIMIDINE DEGRADATION; UREIDOPROPIONASE; PURIFICATION; CARNOSINE; PROTEINS; CATALYSIS; ROTATION; ENZYMES; ERRORS; ACID	beta-Alanine synthase is the final enzyme of the reductive pyrimidine catabolic pathway, which is responsible for the breakdown of uracil and thymine in higher organisms. The fold of the homodimeric enzyme from the yeast Saccharomyces kluyveri identifies it as a member of the AcyI/M20 family of metallopeptidases. Its subunit consists of a catalytic domain harboring a di-zinc center and a smaller dimerization domain. The present site-directed mutagenesis studies identify Glu(159) and Arg(322) as crucial for catalysis and His(262) and His(397) as functionally important but not essential. We determined the crystal structures of wild-type beta-alanine synthase in complex with the reaction product beta-alanine, and of the mutant E159A with the substrate N-carbamyl-beta-alanine, revealing the closed state of a dimeric AcyI/M20 metallopeptidase-like enzyme. Subunit closure is achieved by a similar to 30 degrees rigid body domain rotation, which completes the active site by integration of substrate binding residues that belong to the dimerization domain of the same or the partner subunit. Substrate binding is achieved via a salt bridge, a number of hydrogen bonds, and coordination to one of the zinc ions of the di-metal center.	Karolinska Inst, Dept Med Biochem & Biophys, SE-17177 Stockholm, Sweden; Lund Univ, Dept Cell & Organism Biol, SE-22362 Lund, Sweden	Karolinska Institutet; Lund University	Dobritzsch, D (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Tomtebodavagen 6, SE-17177 Stockholm, Sweden.	Doreen.Dobritzsch@ki.se	Dobritzsch, Doreen/H-7334-2018					Agarwal R, 2007, J MOL BIOL, V368, P450, DOI 10.1016/j.jmb.2007.02.028; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Biagini A, 2001, COMP BIOCHEM PHYS B, V128, P469, DOI 10.1016/S1096-4959(00)00341-9; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; DeLano W.L, PYMOL MOL GRAPHICS S; Dobritzsch D, 2003, ACTA CRYSTALLOGR D, V59, P1267, DOI 10.1107/S0907444903009120; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; Gojkovic Z, 2001, GENETICS, V158, P999; Hakansson K, 2002, EUR J BIOCHEM, V269, P443, DOI 10.1046/j.0014-2956.2001.02665.x; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; HEGGIE GD, 1987, CANCER RES, V47, P2203; HIGGINS JJ, 1994, NEUROLOGY, V44, P1728, DOI 10.1212/WNL.44.9.1728; Hipkiss AR, 1997, NEUROSCI LETT, V238, P135, DOI 10.1016/S0304-3940(97)00873-2; Janssen B, 2005, DIABETES, V54, P2320, DOI 10.2337/diabetes.54.8.2320; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jozic D, 2002, STRUCTURE, V10, P1097, DOI 10.1016/S0969-2126(02)00805-5; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lindner HA, 2005, BIOCHEMISTRY-US, V44, P15645, DOI 10.1021/bi051180y; Lindner HA, 2003, J BIOL CHEM, V278, P44496, DOI 10.1074/jbc.M304233200; Lohkamp B., 2005, CCP4 NEWSLETTER, V42; Lu GG, 2000, J APPL CRYSTALLOGR, V33, P176, DOI 10.1107/S0021889899012339; Lundgren S, 2003, J BIOL CHEM, V278, P51851, DOI 10.1074/jbc.M308674200; Martinez-Rodriguez S, 2006, BIOCHIMIE, V88, P837, DOI 10.1016/j.biochi.2006.01.012; Munch G, 1997, BBA-MOL BASIS DIS, V1360, P17, DOI 10.1016/S0925-4439(96)00062-2; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Rawlings ND, 2004, BIOCHEM J, V378, P705, DOI 10.1042/BJ20031825; Rowsell S, 1997, STRUCTURE, V5, P337, DOI 10.1016/S0969-2126(97)00191-3; SANDBERG M, 1981, J NEUROCHEM, V37, P1353, DOI 10.1111/j.1471-4159.1981.tb04691.x; SANNO Y, 1970, J BIOL CHEM, V245, P5668; Stvolinsky SL, 1999, CELL MOL NEUROBIOL, V19, P45, DOI 10.1023/A:1006960407008; TAMAKI N, 1987, EUR J BIOCHEM, V169, P21, DOI 10.1111/j.1432-1033.1987.tb13575.x; Traut TW, 1996, PROG NUCLEIC ACID RE, V53, P1, DOI 10.1016/S0079-6603(08)60142-7; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Van Kuilenburg ABP, 1999, ANAL BIOCHEM, V272, P250, DOI 10.1006/abio.1999.4181; vanGennip AH, 1997, J INHERIT METAB DIS, V20, P203, DOI 10.1023/A:1005356806329; Vistoli G, 2006, J MED CHEM, V49, P3269, DOI 10.1021/jm0602099; Waldmann G, 2005, PROTEIN PEPTIDE LETT, V12, P69, DOI 10.2174/0929866053405904; WASTERNACK C, 1979, BIOCHIM BIOPHYS ACTA, V570, P341, DOI 10.1016/0005-2744(79)90154-2; WASTERNACK C, 1980, PHARMACOL THERAPEUT, V8, P629, DOI 10.1016/0163-7258(80)90079-0; White WH, 2001, J BIOL CHEM, V276, P10794, DOI 10.1074/jbc.M009804200; Widemann BC, 2006, ONCOLOGIST, V11, P694, DOI 10.1634/theoncologist.11-6-694; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Ye QZ, 2006, P NATL ACAD SCI USA, V103, P9470, DOI 10.1073/pnas.0602433103	48	20	21	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					36037	36047		10.1074/jbc.M705517200	http://dx.doi.org/10.1074/jbc.M705517200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17916556	hybrid			2022-12-27	WOS:000251458100063
J	Saavedra, L; Mohamed, A; Ma, V; Kar, S; de Chaves, EP				Saavedra, Lucila; Mohamed, Amany; Ma, Victoria; Kar, Satyabrata; de Chaves, Elena Posse			Internalization of beta-amyloid peptide by primary neurons in the absence of apolipoprotein E	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-RELATED PROTEIN; NICOTINIC ACETYLCHOLINE-RECEPTOR; INTRANEURONAL A-BETA-42 ACCUMULATION; INTRACELLULAR A-BETA; ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; COMPARTMENTALIZED CULTURES; ULTRASTRUCTURALLY LOCALIZE; SYMPATHETIC NEURONS; GM1 GANGLIOSIDE	Extracellular accumulation of beta-amyloid peptide (A beta) has been linked to the development of Alzheimer disease. The importance of intraneuronal A beta has been recognized more recently. Although considerable evidence indicates that extracellular A beta contributes to the intracellular pool of A beta, the mechanisms involved in A beta uptake by neurons are poorly understood. We examined the molecular mechanisms involved in A beta-(1-42) internalization by primary neurons in the absence of apolipoprotein E. We demonstrated that A beta-(1-42) is more efficiently internalized by axons than by cell bodies of sympathetic neurons, suggesting that A beta-(1 42) uptake might be mediated by proteins enriched in the axons. Although the acetylcholine receptor alpha 7nAChR, previously suggested to be involved in A beta internalization, is enriched in axons, our results indicate that it does not mediate A beta-(1-42) internalization. Moreover, receptors of the low density lipoprotein receptor family are not essential for A beta-(1-42) uptake in the absence of apolipoprotein E because receptor-associated protein had no effect on A beta uptake. By expressing the inactive dynamin mutant dynK44A and the clathrin hub we found that A beta-(1-42) internalization is independent of clathrin but dependent on dynamin, which suggests an endocytic pathway involving caveolae/lipid rafts. Confocal microscopy studies showing that A beta did not co-localize with the early endosome marker EEA1 further support a clathrin-independent mechanism. The lack of co-localization of A beta with caveolin in intracellular vesicles and the normal uptake of A beta by neurons that do not express caveolin indicate that A beta does not require caveolin either. Instead partial co-localization of A beta-(1-42) with cholera toxin subunit B and sensitivity to reduction of cellular cholesterol and sphingolipid levels suggest a caveolae-independent, raft-mediated mechanism. Understanding the molecular events involved in neuronal A beta internalization might identify potential therapeutic targets for Alzheimer disease.	Univ Alberta, Fac Med & Dent, Dept Pharmacol, Edmonton, AB T6G 2H7, Canada; Univ Alberta, Fac Med & Dent, Dept Med, Edmonton, AB T6G 2H7, Canada; Univ Alberta, Fac Med & Dent, Ctr Neurosci, Edmonton, AB T6G 2H7, Canada	University of Alberta; University of Alberta; University of Alberta	de Chaves, EP (corresponding author), Univ Alberta, Fac Med, Dept Pharmacol, 9-28 Med Sci Bldg, Edmonton, AB T6G 2H7, Canada.	elena.chaves@ualberta.ca	Saavedra, Lucila/AAS-9970-2020					Altschuler Y, 1998, J CELL BIOL, V143, P1871, DOI 10.1083/jcb.143.7.1871; Arispe N, 2002, FASEB J, V16, P1526, DOI 10.1096/fj.02-0829com; Bahr BA, 1998, J COMP NEUROL, V397, P139; Bi X, 2002, NEUROSCIENCE, V112, P827, DOI 10.1016/S0306-4522(02)00132-X; Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; Breese CR, 1997, J COMP NEUROL, V387, P385, DOI 10.1002/(SICI)1096-9861(19971027)387:3<385::AID-CNE5>3.0.CO;2-X; Bu GJ, 1998, TRENDS CELL BIOL, V8, P272, DOI 10.1016/S0962-8924(98)01283-5; Bu GJ, 2000, TRENDS CARDIOVAS MED, V10, P148, DOI 10.1016/S1050-1738(00)00045-1; BURDICK D, 1992, J BIOL CHEM, V267, P546; Burdick D, 1997, BRAIN RES, V746, P275, DOI 10.1016/S0006-8993(96)01262-0; Busciglio J, 2002, NEURON, V33, P677, DOI 10.1016/S0896-6273(02)00604-9; CAMPENOT RB, 1982, DEV BIOL, V93, P13, DOI 10.1016/0012-1606(82)90233-0; CAMPENOT RB, 1982, DEV BIOL, V93, P1, DOI 10.1016/0012-1606(82)90232-9; Cuello AC, 2005, BRAIN PATHOL, V15, P66; D'Andrea MR, 2001, HISTOPATHOLOGY, V38, P120, DOI 10.1046/j.1365-2559.2001.01082.x; D'Andrea MR, 2002, NEUROSCI LETT, V333, P163, DOI 10.1016/S0304-3940(02)00875-3; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; de Chaves EIP, 1997, J BIOL CHEM, V272, P30766, DOI 10.1074/jbc.272.49.30766; de Chaves EIP, 2000, J BIOL CHEM, V275, P19883, DOI 10.1074/jbc.275.26.19883; deChaves EIP, 1997, J BIOL CHEM, V272, P3028, DOI 10.1074/jbc.272.5.3028; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Dineley KT, 2002, J BIOL CHEM, V277, P25056, DOI 10.1074/jbc.M200066200; Ditaranto K, 2001, NEUROBIOL DIS, V8, P19, DOI 10.1006/nbdi.2000.0364; Echeverria V, 2002, MOL NEUROBIOL, V26, P299, DOI 10.1385/MN:26:2-3:299; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; Fassbender K, 2001, P NATL ACAD SCI USA, V98, P5856, DOI 10.1073/pnas.081620098; Glabe C, 2001, J MOL NEUROSCI, V17, P137, DOI 10.1385/JMN:17:2:137; Gouras GK, 2000, AM J PATHOL, V156, P15, DOI 10.1016/S0002-9440(10)64700-1; Gouras GK, 2005, NEUROBIOL AGING, V26, P1235, DOI 10.1016/j.neurobiolaging.2005.05.022; Gylys KH, 2007, NEUROBIOL AGING, V28, P8, DOI 10.1016/j.neurobiolaging.2005.10.018; Gylys KH, 2003, J NEUROCHEM, V84, P1442, DOI 10.1046/j.1471-4159.2003.01643.x; Gyure KA, 2001, ARCH PATHOL LAB MED, V125, P489; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Harrison T, 2004, CURR OPIN DRUG DISC, V7, P709; Head BP, 2007, TRENDS CELL BIOL, V17, P51, DOI 10.1016/j.tcb.2006.11.008; Helguera P, 2005, J NEUROSCI, V25, P2295, DOI 10.1523/JNEUROSCI.5107-04.2005; HERZ J, 1991, J BIOL CHEM, V266, P21232; Ida N, 1996, FEBS LETT, V394, P174, DOI 10.1016/0014-5793(96)00948-9; Jhamandas JH, 2004, J NEUROSCI, V24, P5579, DOI 10.1523/JNEUROSCI.1051-04.2004; Jordan J, 1998, J NEUROSCI, V18, P195; Kang DE, 2000, J CLIN INVEST, V106, P1159, DOI 10.1172/JCI11013; Kawarabayashi T, 2004, J NEUROSCI, V24, P3801, DOI 10.1523/JNEUROSCI.5543-03.2004; Kirkham M, 2005, BBA-MOL CELL RES, V1745, P273, DOI 10.1016/j.bbamcr.2005.06.002; Kokubo H, 2005, BRAIN RES, V1045, P224, DOI 10.1016/j.brainres.2005.03.017; Kokubo H, 2005, BRAIN RES, V1031, P222, DOI 10.1016/j.brainres.2004.10.041; Kuner P, 1998, J NEUROSCI RES, V54, P798, DOI 10.1002/(SICI)1097-4547(19981215)54:6<798::AID-JNR7>3.3.CO;2-K; Kuruvilla R, 2004, CELL, V118, P243, DOI 10.1016/j.cell.2004.06.021; LaDu MJ, 2000, J BIOL CHEM, V275, P33974, DOI 10.1074/jbc.M000602200; LAFERLA FM, 1995, NAT GENET, V9, P21, DOI 10.1038/ng0195-21; Le PU, 2003, J CELL SCI, V116, P1059, DOI 10.1242/jcs.00327; Marsh M, 1999, SCIENCE, V285, P215, DOI 10.1126/science.285.5425.215; Matsuzaki K, 1999, BIOCHEMISTRY-US, V38, P4137, DOI 10.1021/bi982345o; Mori C, 2002, AMYLOID, V9, P88, DOI 10.3109/13506120208995241; Muresan Z, 2006, MOL CELL BIOL, V26, P4982, DOI 10.1128/MCB.00371-06; Nagele RG, 2002, NEUROSCIENCE, V110, P199, DOI 10.1016/S0306-4522(01)00460-2; NAMBA Y, 1991, BRAIN RES, V541, P163, DOI 10.1016/0006-8993(91)91092-F; Narita M, 1997, J NEUROCHEM, V68, P587; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Pelkmans L, 2001, NAT CELL BIOL, V3, P473, DOI 10.1038/35074539; Permanne B, 1997, BIOCHEM BIOPH RES CO, V240, P715, DOI 10.1006/bbrc.1997.7727; Qiu ZH, 1999, J NEUROCHEM, V73, P1393, DOI 10.1046/j.1471-4159.1999.0731393.x; Rubino M, 2000, J BIOL CHEM, V275, P3745, DOI 10.1074/jbc.275.6.3745; Samuel N, 1997, NEUROSCI LETT, V222, P179, DOI 10.1016/S0304-3940(97)13377-8; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schneider A, 2006, NEUROBIOL DIS, V23, P573, DOI 10.1016/j.nbd.2006.04.015; Selkoe DJ, 2001, J ALZHEIMERS DIS, V3, P75, DOI 10.3233/JAD-2001-3111; Selkoe DJ, 2004, ANN INTERN MED, V140, P627, DOI 10.7326/0003-4819-140-8-200404200-00047; Selkoe DJ, 1999, NATURE, V399, pA23, DOI 10.1038/399a023; Shie FS, 2003, NEUROREPORT, V14, P123, DOI 10.1097/00001756-200301200-00023; Simons M, 1998, P NATL ACAD SCI USA, V95, P6460, DOI 10.1073/pnas.95.11.6460; Skovronsky DM, 1998, J CELL BIOL, V141, P1031, DOI 10.1083/jcb.141.4.1031; Small DH, 2007, J NEUROCHEM, V101, P1527, DOI 10.1111/j.1471-4159.2006.04444.x; Song MS, 2006, NEUROBIOL AGING, V27, P1224, DOI 10.1016/j.neurobiolaging.2005.06.007; Song MS, 2003, NEUROPHARMACOLOGY, V45, P1130, DOI 10.1016/S0028-3908(03)00284-3; Soriano S, 1999, J BIOL CHEM, V274, P32295, DOI 10.1074/jbc.274.45.32295; Takahashi RH, 2002, AM J PATHOL, V161, P1869, DOI 10.1016/S0002-9440(10)64463-X; Tienari PJ, 1997, P NATL ACAD SCI USA, V94, P4125, DOI 10.1073/pnas.94.8.4125; Tseng HC, 2002, FEBS LETT, V523, P58, DOI 10.1016/S0014-5793(02)02934-4; TUMER RS, 1996, J BIOL CHEM, V271, P8966; Vaucher E, 2002, EXP NEUROL, V175, P398, DOI 10.1006/exnr.2002.7915; Wakabayashi M, 2005, BIOCHEM BIOPH RES CO, V328, P1019, DOI 10.1016/j.bbrc.2005.01.060; Walsh DM, 2000, BIOCHEMISTRY-US, V39, P10831, DOI 10.1021/bi001048s; Wang HY, 2000, J BIOL CHEM, V275, P5626, DOI 10.1074/jbc.275.8.5626; Wang HY, 2000, J NEUROCHEM, V75, P1155, DOI 10.1046/j.1471-4159.2000.0751155.x; Wirths O, 2001, NEUROSCI LETT, V316, P145, DOI 10.1016/S0304-3940(01)02399-0; WISNIEWSKI T, 1993, BIOCHEM BIOPH RES CO, V192, P359, DOI 10.1006/bbrc.1993.1423; Wolfe MS, 2004, SCIENCE, V305, P1119, DOI 10.1126/science.1096187; Xia WM, 1998, BIOCHEMISTRY-US, V37, P16465, DOI 10.1021/bi9816195; Yamauchi K, 2002, ANN CLIN LAB SCI, V32, P65; Yanagisawa K, 2005, NEUROSCIENTIST, V11, P250, DOI 10.1177/1073858405275177; Yang DS, 1999, NEUROSCIENCE, V90, P1217, DOI 10.1016/S0306-4522(98)00561-2; Yip CM, 2001, J MOL BIOL, V311, P723, DOI 10.1006/jmbi.2001.4881; Zhang Y, 2002, J CELL BIOL, V156, P519, DOI 10.1083/jcb.200110119	93	99	103	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35722	35732		10.1074/jbc.M701823200	http://dx.doi.org/10.1074/jbc.M701823200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17911110	hybrid			2022-12-27	WOS:000251458100033
J	Liao, P; Yu, D; Li, G; Yong, TF; Soon, JL; Chua, YL; Soong, TW				Liao, Ping; Yu, Dejie; Li, Guang; Yong, Tan Fong; Soon, Jia Lin; Chua, Yeow Leng; Soong, Tuck Wah			A smooth muscle Ca(v)1.2 calcium channel splice variant underlies hyperpolarized window current and enhanced state-dependent inhibition by nifedipine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA(1C) SUBUNIT; ALPHA-1 SUBUNIT; CA2+ CHANNEL; FUNCTIONAL EXPRESSION; ISOFORM; INACTIVATION; SENSITIVITY; SELECTIVITY; ANTAGONISTS; ISRADIPINE	Native smooth muscle L-type Ca(v)1.2 calcium channels have been shown to support a fraction of Ca2+ currents with a window current that is close to resting potential. The smooth muscle L-type Ca2+ channels are also more susceptible to inhibition by dihydropyridines (DHPs) than the cardiac channels. It was hypothesized that smooth muscle Cav1.2 channels exhibiting hyperpolarized shift in steady-state inactivation would contribute to larger inhibition by DHP, in addition to structural differences of the channels generated by alternative splicing that modulate DHP sensitivities. In addition, it has also been shown that alternative splicing modulates DHP sensitivities by generating structural differences in the Cav1.2 channels. Here, we report a smooth muscle L-type Cav1.2 calcium channel splice variant, Ca(v)1.2SM (1/8/9*/32/Delta 33), that when expressed in HEK 293 cells display hyperpolarized shifts for steady-state inactivation and activation potentials when compared with the established Ca(v)1.2b clone ( 1/8/9*/32/Delta 33). This variant activates from more negative potentials and generates a window current closer to resting membrane potential. We also identified the predominant cardiac isoform Ca(v)1.2CM clone ( 1a/8a/Delta 9*/32/33) that is different from the established Ca(v)1.2a (1a/8a/Delta 9*/31/33). Importantly, Cav1.2SM channels were shown to be more sensitive to nifedipine blockade than Cav1.2b and cardiac Cav1.2CM channels when currents were recorded in either 5 mM Ba2+ or 1.8 mM Ca2+ external solutions. This is the first time that a smooth muscle Cav1.2 splice variant has been identified functionally to possess biophysical property that can be linked to enhanced state-dependent block by DHP.	Natl Univ Singapore, Dept Physiol, Yong Loo Lin Sch Med, Singapore 117597, Singapore; Natl Heart Ctr, Dept Cardiothorac Surg, Singapore 168752, Singapore; Natl Inst Neurosci, Singapore 308433, Singapore; Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21205 USA	National University of Singapore; National Heart Centre Singapore; National Neuroscience Institute (NNI); Johns Hopkins University	Soong, TW (corresponding author), Natl Univ Singapore, Dept Physiol, Yong Loo Lin Sch Med, Block MD9,2 Med Dr, Singapore 117597, Singapore.	phsstw@nus.edu.sg	Tuluc, Petronel/C-2527-2011					Abernethy DR, 2002, J PHARMACOL EXP THER, V300, P724, DOI 10.1124/jpet.300.3.724; BEAN BP, 1984, P NATL ACAD SCI-BIOL, V81, P6388, DOI 10.1073/pnas.81.20.6388; BIEL M, 1990, FEBS LETT, V269, P409, DOI 10.1016/0014-5793(90)81205-3; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Chemin J, 2000, FEBS LETT, V478, P166, DOI 10.1016/S0014-5793(00)01832-9; Dai BS, 2002, BIOCHEM BIOPH RES CO, V296, P429, DOI 10.1016/S0006-291X(02)00894-X; DIEBOLD RJ, 1992, P NATL ACAD SCI USA, V89, P1497, DOI 10.1073/pnas.89.4.1497; FERON O, 1994, EUR J BIOCHEM, V222, P195, DOI 10.1111/j.1432-1033.1994.tb18857.x; FLEISCHMANN BK, 1994, P NATL ACAD SCI USA, V91, P11914, DOI 10.1073/pnas.91.25.11914; GIDHJAIN M, 1995, BIOCHEM BIOPH RES CO, V216, P892, DOI 10.1006/bbrc.1995.2705; HESS P, 1984, NATURE, V311, P538, DOI 10.1038/311538a0; HIRST GDS, 1989, PHYSIOL REV, V69, P546, DOI 10.1152/physrev.1989.69.2.546; Hu H, 1998, MOL PHARMACOL, V53, P902; Lacinova L, 2000, PFLUG ARCH EUR J PHY, V440, P50, DOI 10.1007/s004240051021; LANGTON PD, 1993, J PHYSIOL-LONDON, V469, P535, DOI 10.1113/jphysiol.1993.sp019828; Ledoux J, 2006, PHYSIOLOGY, V21, P69, DOI 10.1152/physiol.00040.2005; Liao P, 2005, CARDIOVASC RES, V68, P197, DOI 10.1016/j.cardiores.2005.06.024; Liao P, 2004, J BIOL CHEM, V279, P50329, DOI 10.1074/jbc.M409436200; MIKAMI A, 1989, NATURE, V340, P230, DOI 10.1038/340230a0; Morel N, 1998, BRIT J PHARMACOL, V125, P1005, DOI 10.1038/sj.bjp.0702162; NELSON MT, 1988, NATURE, V336, P382, DOI 10.1038/336382a0; NELSON MT, 1990, AM J PHYSIOL, V259, pC3; Richard S, 2005, DRUGS, V65, P1; Saada N, 2003, BIOCHEM BIOPH RES CO, V302, P23, DOI 10.1016/S0006-291X(03)00097-4; Saada NI, 2005, CELL CALCIUM, V37, P301, DOI 10.1016/j.ceca.2004.11.003; Sanders KM, 2001, J APPL PHYSIOL, V91, P1438, DOI 10.1152/jappl.2001.91.3.1438; SANGUINETTI MC, 1984, CIRC RES, V55, P336, DOI 10.1161/01.RES.55.3.336; Scholz H, 1997, CARDIOVASC DRUG THER, V10, P869, DOI 10.1007/BF00051613; Shi CZ, 2002, J BIOL CHEM, V277, P6813, DOI 10.1074/jbc.M110524200; SLISH DF, 1989, FEBS LETT, V250, P509, DOI 10.1016/0014-5793(89)80786-0; Soong TW, 2002, J NEUROSCI, V22, P10142; Splawski I, 2004, CELL, V119, P19, DOI 10.1016/j.cell.2004.09.011; Splawski I, 2005, P NATL ACAD SCI USA, V102, P8089, DOI 10.1073/pnas.0502506102; Striessnig J, 1999, CELL PHYSIOL BIOCHEM, V9, P242, DOI 10.1159/000016320; SUN JP, 1995, J PHARMACOL EXP THER, V274, P419; Tang ZZ, 2007, CELL CALCIUM, V41, P417, DOI 10.1016/j.ceca.2006.08.002; Tang ZZ, 2004, J BIOL CHEM, V279, P44335, DOI 10.1074/jbc.M407023200; Triggle DJ, 2003, CELL MOL NEUROBIOL, V23, P293, DOI 10.1023/A:1023632419813; TRIGGLE DJ, 1991, J CARDIOVASC PHARM, V18, pS1; Welling A, 1997, CIRC RES, V81, P526, DOI 10.1161/01.RES.81.4.526; Yang YB, 2000, J MOL CELL CARDIOL, V32, P973, DOI 10.1006/jmcc.2000.1138; Zuhlke RD, 1998, FEBS LETT, V427, P220, DOI 10.1016/S0014-5793(98)00425-6; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	43	81	82	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					35133	35142		10.1074/jbc.M705478200	http://dx.doi.org/10.1074/jbc.M705478200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17916557	hybrid			2022-12-27	WOS:000251155200058
J	Sato, T; Diehl, TS; Narayanan, S; Funamoto, S; Ihara, Y; De Strooper, B; Steiner, H; Haass, C; Wolfe, MS				Sato, Toru; Diehl, Thekla S.; Narayanan, Saravanakumar; Funamoto, Satoru; Ihara, Yasuo; De Strooper, Bart; Steiner, Harald; Haass, Christian; Wolfe, Michael S.			Active gamma-secretase complexes contain only one of each component	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; SIGNAL PEPTIDE PEPTIDASE; PRESENILIN PROTEINS; ASPARTIC PROTEASE; NICASTRIN; APH-1; DISEASE; PEN-2; IDENTIFICATION; STABILIZATION	gamma-Secretase is an intramembrane aspartyl protease complex that cleaves type I integral membrane proteins, including the amyloid beta-protein precursor and the Notch receptor, and is composed of presenilin, Pen-2, nicastrin, and Aph-1. Although all four of these membrane proteins are essential for assembly and activity, the stoichiometry of the complex is unknown, with the number of presenilin molecules present being especially controversial. Here we analyze functional gamma-secretase complexes, isolated by immunoprecipitation from solubilized membrane fractions and able to produce amyloid beta-peptides and amyloid beta-protein precursor intracellular domain. We show that the active isolated protease contains only one presenilin per complex, which excludes certain models of the active site that require aspartate dyads formed between two presenilin molecules. We also quantified components in the isolated complexes by Western blot using protein standards and found that the amounts of Pen-2 and nicastrin were the same as that of presenilin. Moreover, we found that one Aph-1 was not co-immunoprecipitated with another in active complexes, evidence that Aph-1 is likewise present as a monomer. Taken together, these results demonstrate that the stoichiometry of gamma-components presenilin: Pen-2:nicastrin:Aph-1 is 1:1:1:1.	Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Univ Tokyo, Fac Med, Dept Neuropathol, Tokyo 1130033, Japan; Katholieke Univ Leuven VIB, Dept Mol & Dev Genet, B-3000 Louvain, Belgium; Katholieke Univ Leuven, Ctr Human Genet, B-3000 Louvain, Belgium; Univ Munich, Adolf Butenandt Inst, Dept Biochem, Lab Alzheimers & Parkinsons Dis Res, D-80336 Munich, Germany; Univ Munich, Adolf Butenandt Inst, Dept Biochem, Ctr Integrated Prot Sci, D-80336 Munich, Germany	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Tokyo; Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; University of Munich; University of Munich	Wolfe, MS (corresponding author), Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA.	mwolfe@rics.bwh.harvard.edu	De Strooper, Bart/F-6507-2012; de+Strooper, Bart/Z-1638-2019	De Strooper, Bart/0000-0001-5455-5819; 	NATIONAL INSTITUTE ON AGING [R01AG017574] Funding Source: NIH RePORTER; NIA NIH HHS [AG 17574] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bentahir M, 2006, J NEUROCHEM, V96, P732, DOI 10.1111/j.1471-4159.2005.03578.x; Blum R, 1996, J BIOL CHEM, V271, P17183, DOI 10.1074/jbc.271.29.17183; Capell A, 1998, J BIOL CHEM, V273, P3205, DOI 10.1074/jbc.273.6.3205; Cervantes S, 2004, J BIOL CHEM, V279, P36519, DOI 10.1074/jbc.M404832200; Chen FS, 2006, NATURE, V440, P1208, DOI 10.1038/nature04667; Clarke EE, 2006, J BIOL CHEM, V281, P31279, DOI 10.1074/jbc.M605051200; Das C, 2003, J AM CHEM SOC, V125, P11794, DOI 10.1021/ja037131v; Deng Y, 2006, J NEUROSCI, V26, P3845, DOI 10.1523/JNEUROSCI.5384-05.2006; DeStrooper B, 1997, J BIOL CHEM, V272, P3590, DOI 10.1074/jbc.272.6.3590; Edbauer D, 2002, P NATL ACAD SCI USA, V99, P8666, DOI 10.1073/pnas.132277899; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Esler WP, 2002, P NATL ACAD SCI USA, V99, P2720, DOI 10.1073/pnas.052436599; Evin G, 2005, BIOCHEMISTRY-US, V44, P4332, DOI 10.1021/bi0481702; Fraering PC, 2004, BIOCHEMISTRY-US, V43, P323, DOI 10.1021/bi035748j; Gu YJ, 2004, J BIOL CHEM, V279, P31329, DOI 10.1074/jbc.M401548200; Hebert SS, 2004, NEUROBIOL DIS, V17, P260, DOI 10.1016/j.nbd.2004.08.002; Herreman A, 2000, NAT CELL BIOL, V2, P461, DOI 10.1038/35017105; Herreman A, 2003, J CELL SCI, V116, P1127, DOI 10.1242/jcs.00292; Herreman A, 1999, P NATL ACAD SCI USA, V96, P11872, DOI 10.1073/pnas.96.21.11872; Kimberly WT, 2005, J NEUROSCI, V25, P5533, DOI 10.1523/JNEUROSCI.4883-04.2005; Kimberly WT, 2003, P NATL ACAD SCI USA, V100, P6382, DOI 10.1073/pnas.1037392100; Kimberly WT, 2003, BIOCHEMISTRY-US, V42, P137, DOI 10.1021/bi026888g; Kornilova AY, 2003, J BIOL CHEM, V278, P16470, DOI 10.1074/jbc.C300019200; LaVoie MJ, 2003, J BIOL CHEM, V278, P37213, DOI 10.1074/jbc.M303941200; Lazarov VK, 2006, P NATL ACAD SCI USA, V103, P6889, DOI 10.1073/pnas.0602321103; Li YM, 2000, P NATL ACAD SCI USA, V97, P6138, DOI 10.1073/pnas.110126897; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nakaya Y, 2005, J BIOL CHEM, V280, P19070, DOI 10.1074/jbc.M501130200; Narayanan S, 2007, J BIOL CHEM, V282, P20172, DOI 10.1074/jbc.M701536200; Niimura M, 2005, J BIOL CHEM, V280, P12967, DOI 10.1074/jbc.M409829200; Nyborg AC, 2004, J BIOL CHEM, V279, P15153, DOI 10.1074/jbc.M309305200; Ogura T, 2006, BIOCHEM BIOPH RES CO, V343, P525, DOI 10.1016/j.bbrc.2006.02.158; Onishi M, 1996, EXP HEMATOL, V24, P324; Podlisny MB, 1997, NEUROBIOL DIS, V3, P325, DOI 10.1006/nbdi.1997.0129; Prokop S, 2004, J BIOL CHEM, V279, P23255, DOI 10.1074/jbc.M401789200; Ratovitski T, 1997, J BIOL CHEM, V272, P24536, DOI 10.1074/jbc.272.39.24536; Sato T, 2003, J BIOL CHEM, V278, P24294, DOI 10.1074/jbc.M211161200; Sato T, 2006, BIOCHEMISTRY-US, V45, P8649, DOI 10.1021/bi060597g; Schroeter EH, 2003, P NATL ACAD SCI USA, V100, P13075, DOI 10.1073/pnas.1735338100; Seeger M, 1997, P NATL ACAD SCI USA, V94, P5090, DOI 10.1073/pnas.94.10.5090; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; Shirotani K, 2004, J BIOL CHEM, V279, P41340, DOI 10.1074/jbc.M405768200; Shirotani K, 2004, J NEUROCHEM, V89, P1520, DOI 10.1111/j.1471-4159.2004.02447.x; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Wang R, 1996, J BIOL CHEM, V271, P31894, DOI 10.1074/jbc.271.50.31894; Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925; Wolfe MS, 2007, EMBO REP, V8, P136, DOI 10.1038/sj.embor.7400896; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Yu G, 1998, J BIOL CHEM, V273, P16470, DOI 10.1074/jbc.273.26.16470	50	140	143	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					33985	33993		10.1074/jbc.M705248200	http://dx.doi.org/10.1074/jbc.M705248200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17911105	hybrid, Green Published			2022-12-27	WOS:000251145700012
J	Frolov, RV; Berim, IG; Singh, S				Frolov, Roman V.; Berim, Ilya G.; Singh, Satpal			Inhibition of delayed rectifier potassium channels and induction of arrhythmia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; K+-CHANNELS; GASTROINTESTINAL TOXICITY; GENE-EXPRESSION; DROSOPHILA; KV2.1; CYCLOOXYGENASE-2; ACTIVATION; MUTATIONS; CELECOXIB	Selective inhibitors of cyclooxygenase-2 (COX-2), such as rofecoxib (Vioxx), celecoxib (Celebrex), and valdecoxib (Bextra), have been developed for treating arthritis and other musculoskeletal complaints. Selective inhibition of COX-2 over COX-1 results in preferential decrease in prostacyclin production over thromboxane A2 production, thus leading to less gastric effects than those seen with nonselective COX inhibitors such as acetylsalicylic acid (aspirin). Here we show a novel effect of celecoxib via a mechanism that is independent of COX-2 inhibition. The drug inhibited the delayed rectifier (Kv2) potassium channels from Drosophila, rats, and humans and led to pronounced arrhythmia in Drosophila heart and arrhythmic beating of rat heart cells in culture. These effects occurred despite the genomic absence of cyclooxygenases in Drosophila and the failure of acetylsalicylic acid, a potent inhibitor of both COX-1 and COX-2, to inhibit rat Kv2.1 channels. A genetically null mutant of Drosophila Shab (Kv2) channels reproduced the cardiac effect of celecoxib, and the drug was unable to further enhance the effect of the mutation. These observations reveal an unanticipated effect of celecoxib on Drosophila hearts and on heart cells from rats, implicating the inhibition of Kv2 channels as the mechanism underlying this effect.	[Frolov, Roman V.; Singh, Satpal] SUNY Buffalo, Dept Pharmacol & Toxicol, Buffalo, NY 14214 USA; [Berim, Ilya G.] SUNY Buffalo, Dept Med, Buffalo, NY 14214 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Singh, S (corresponding author), SUNY Buffalo, Dept Pharmacol & Toxicol, 102 Farber Hall, Buffalo, NY 14214 USA.	singhs@buffalo.edu	Frolov, Roman/H-8099-2012; Frolov, Roman/I-3889-2016	Frolov, Roman/0000-0002-7431-5297				Baines RA, 2001, J NEUROSCI, V21, P1523, DOI 10.1523/JNEUROSCI.21-05-01523.2001; BATE M, 1990, DEVELOPMENT, V110, P791; Bombardier C, 2000, NEW ENGL J MED, V343, P1520, DOI 10.1056/NEJM200011233432103; CATTERALL WA, 2002, IUPHAR COMPENDIUM VO, P86; Chen QH, 2005, BIOORGAN MED CHEM, V13, P2459, DOI 10.1016/j.bmc.2005.01.039; Cheng Y, 2002, SCIENCE, V296, P539, DOI 10.1126/science.1068711; Chopra M, 2000, J NEUROGENET, V14, P107, DOI 10.3109/01677060009083478; Clancy CE, 2003, ANNU REV PHARMACOL, V43, P441, DOI 10.1146/annurev.pharmtox.43.100901.140245; Davies NM, 2000, CLIN PHARMACOKINET, V38, P225, DOI 10.2165/00003088-200038030-00003; Er F, 2003, CIRCULATION, V107, P485, DOI 10.1161/01.CIR.0000045672.32920.CB; FitzGerald GA, 2004, NEW ENGL J MED, V351, P1709, DOI 10.1056/NEJMp048288; FITZGERALD PT, HEART RHYTHM, V2, pS3005; Flower RJ, 2003, NAT REV DRUG DISCOV, V2, P179, DOI 10.1038/nrd1034; Gaborit N, 2007, J PHYSIOL-LONDON, V582, P675, DOI 10.1113/jphysiol.2006.126714; Ganetzky B, 2000, KIDNEY INT, V57, P766, DOI 10.1046/j.1523-1755.2000.00913.x; Graham DJ, 2005, LANCET, V365, P475, DOI 10.1016/S0140-6736(05)17864-7; GU GG, 1995, J NEUROBIOL, V28, P269, DOI 10.1002/neu.480280302; Hegde P, 1999, J BIOL CHEM, V274, P22109, DOI 10.1074/jbc.274.31.22109; Herrera VLM, 2005, CURR OPIN LIPIDOL, V16, P179, DOI 10.1097/01.mol.0000162323.77666.5e; Hodge JJL, 2005, J NEUROBIOL, V63, P235, DOI 10.1002/neu.20126; James MJ, 2006, CURR OPIN CLIN NUTR, V9, P89, DOI 10.1097/01.mco.0000214565.67439.83; Ju M, 2003, J BIOL CHEM, V278, P12769, DOI 10.1074/jbc.M212973200; Kalgutkar AS, 1998, SCIENCE, V280, P1268, DOI 10.1126/science.280.5367.1268; Kang JX, 1997, P NATL ACAD SCI USA, V94, P2724, DOI 10.1073/pnas.94.6.2724; KIETER JR, 2000, NATURE, V405, P97; Kositprapa C, 2000, MOL CELL BIOCHEM, V214, P47, DOI 10.1023/A:1007160702275; Kozak KR, 2001, J BIOL CHEM, V276, P30072, DOI 10.1074/jbc.M104467200; Kraliz D, 1997, J NEUROBIOL, V32, P1; Kraliz D, 1998, J NEUROGENET, V12, P25, DOI 10.3109/01677069809108553; Kurumbail RG, 1996, NATURE, V384, P644, DOI 10.1038/384644a0; Leung YM, 2003, J BIOL CHEM, V278, P17532, DOI 10.1074/jbc.M213088200; Liu WS, 2007, GENETICS, V176, P937, DOI 10.1534/genetics.107.071688; MacDonald PE, 2002, MOL ENDOCRINOL, V16, P2452, DOI 10.1210/me.2002-0058; Melman YF, 2002, TRENDS CARDIOVAS MED, V12, P182, DOI 10.1016/S1050-1738(02)00158-5; Misonou H, 2004, NAT NEUROSCI, V7, P711, DOI 10.1038/nn1260; Mitchell JA, 2006, NAT REV DRUG DISCOV, V5, P75, DOI 10.1038/nrd1929; Nerbonne JM, 1998, J NEUROBIOL, V37, P37, DOI 10.1002/(SICI)1097-4695(199810)37:1<37::AID-NEU4>3.0.CO;2-9; Nichols R, 2006, PEPTIDES, V27, P1130, DOI 10.1016/j.peptides.2005.07.032; O-Uchi J, 2005, P NATL ACAD SCI USA, V102, P9400, DOI 10.1073/pnas.0503569102; Ocorr K, 2007, TRENDS CARDIOVAS MED, V17, P177, DOI 10.1016/j.tcm.2007.04.001; Ordog B, 2006, INT J CARDIOL, V111, P386, DOI 10.1016/j.ijcard.2005.07.063; Park KS, 2006, SCIENCE, V313, P976, DOI 10.1126/science.1124254; Petersen CI, 2004, P NATL ACAD SCI USA, V101, P11773, DOI 10.1073/pnas.0306005101; Podlowski S, 1998, CIRCULATION, V98, P2470, DOI 10.1161/01.CIR.98.22.2470; Psaty BM, 2007, NEW ENGL J MED, V356, P328, DOI 10.1056/NEJMp068286; Roberts R, 2006, NAT CLIN PRACT CARD, V3, P276, DOI 10.1038/ncpcardio0509; Ruiz-Canada C, 2002, J NEUROCHEM, V82, P1490, DOI 10.1046/j.1471-4159.2002.01092.x; Scholle A, 2004, J MEMBRANE BIOL, V198, P103, DOI 10.1007/s00232-004-0664-0; Sesti F, 2000, P NATL ACAD SCI USA, V97, P10613, DOI 10.1073/pnas.180223197; Silverstein FE, 2000, JAMA-J AM MED ASSOC, V284, P1247, DOI 10.1001/jama.284.10.1247; Singh A, 1999, J NEUROSCI, V19, P6838, DOI 10.1523/JNEUROSCI.19-16-06838.1999; Singh S, 1999, INT REV NEUROBIOL, V43, P191, DOI 10.1016/S0074-7742(08)60546-2; Solomon SD, 2005, NEW ENGL J MED, V352, P1071, DOI 10.1056/NEJMoa050405; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; Wolf MJ, 2006, P NATL ACAD SCI USA, V103, P1394, DOI 10.1073/pnas.0507359103; WU CF, 1988, INT CONGR SER, V832, P311; WU CF, 1983, SCIENCE, V220, P1076, DOI 10.1126/science.6302847; Xu HD, 1999, CIRC RES, V85, P623, DOI 10.1161/01.RES.85.7.623	58	35	35	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1518	1524		10.1074/jbc.M708100200	http://dx.doi.org/10.1074/jbc.M708100200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	17984087	hybrid			2022-12-27	WOS:000252282700036
J	Beeton, C; Smith, BJ; Sabo, JK; Crossley, G; Nugent, D; Khaytin, I; Chi, V; Chandy, KG; Pennington, MW; Norton, RS				Beeton, Christine; Smith, Brian J.; Sabo, Jennifer K.; Crossley, George; Nugent, Daniel; Khaytin, Ilya; Chi, Victor; Chandy, K. George; Pennington, Michael W.; Norton, Raymond S.			The D-diastereomer of ShK toxin selectively blocks voltage-gated K+ channels and inhibits T lymphocyte proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYELIN BASIC-PROTEIN; SEA-ANEMONE TOXIN; POTASSIUM-CHANNEL; AUTOIMMUNE-DISEASES; NMR-SPECTROSCOPY; STICHODACTYLA-HELIANTHUS; MULTIPLE-SCLEROSIS; CHEMICAL-SYNTHESIS; PEPTIDE INHIBITOR; SELF-ASSOCIATION	The polypeptide toxin ShK is a potent blocker of Kv1.3 potassium channels, which are crucial in the activation of human effector memory T cells (T-EM); selective blockers constitute valuable therapeutic leads for the treatment of autoimmune diseases mediated by TEM cells, such as multiple sclerosis, rheumatoid arthritis, and type-1 diabetes. The critical motif on the toxin for potassium channel blockade consists of neighboring lysine and tyrosine residues. Because this motif is sufficient for activity, an ShK analogue was designed based on D-amino acids. D-Allo-ShK has a structure essentially identical with that of ShK and is resistant to proteolysis. It blocked Kv1.3 with K-d 36 nM (2,800-fold lower affinity than ShK), was 2-fold selective for Kv1.3 over Kv1.1, and was inactive against other K+ channels tested. D-Allo-ShK inhibited human TEM cell proliferation at 100-fold higher concentration than ShK. Its circulating half-life was only slightly longer than that of ShK, implying that renal clearance is the major determinant of its plasma levels. D-Allo-ShK did not bind to the closed state of the channel, unlike ShK. Models of D-allo-ShK bound to Kv1.3 show that it can block the pore as effectively as ShK but makes different interactions with the vestibule, some of which are less favorable than for native ShK. The finding that an all-D analogue of a polypeptide toxin retains biological activity and selectivity is highly unusual. Being resistant to proteolysis and nonantigenic, this analogue should be useful in K+ channel studies; all-D analogues with improved Kv1.3 potency and specificity may have therapeutic advantages.	[Smith, Brian J.; Sabo, Jennifer K.; Norton, Raymond S.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Beeton, Christine; Chi, Victor; Chandy, K. George] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA; [Crossley, George; Nugent, Daniel; Khaytin, Ilya; Pennington, Michael W.] Bachem Biosci Inc, King Of Prussia, PA 19406 USA	Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of California System; University of California Irvine	Norton, RS (corresponding author), Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia.	ray.norton@wehi.edu.au	Smith, Brian J/F-8282-2011	Smith, Brian J/0000-0003-0498-1910; Beeton, Christine/0000-0002-2500-5874; pennington, michael/0000-0001-5446-3447; Norton, Raymond/0000-0001-8893-0584	NINDS NIH HHS [NS-48252] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048252] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AIYAR J, 1995, NEURON, V15, P1169, DOI 10.1016/0896-6273(95)90104-3; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; Beeton C, 2005, MOL PHARMACOL, V67, P1369, DOI 10.1124/mol.104.008193; Beeton C, 2003, J BIOL CHEM, V278, P9928, DOI 10.1074/jbc.M212868200; Beeton C, 2001, P NATL ACAD SCI USA, V98, P13942, DOI 10.1073/pnas.241497298; BEETON C, 2007, J VISUALIZED EXP, V7; BEETON C, 2007, J VISUALIZED EXP, V6; BEETON C, 2007, J VISUALIZED EXP, V8; Beeton C, 2006, P NATL ACAD SCI USA, V103, P17414, DOI 10.1073/pnas.0605136103; BERAUD E, 1993, J NEUROIMMUNOL, V47, P41, DOI 10.1016/0165-5728(93)90283-5; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; BONTEMS F, 1992, BIOCHEMISTRY-US, V31, P7756, DOI 10.1021/bi00149a003; CASTANEDA O, 1995, TOXICON, V33, P603, DOI 10.1016/0041-0101(95)00013-C; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Dauplais M, 1997, J BIOL CHEM, V272, P4302, DOI 10.1074/jbc.272.7.4302; DEIBLER GE, 1972, PREP BIOCHEM, V2, P139, DOI 10.1080/00327487208061467; DINGLEY AJ, 1995, J BIOMOL NMR, V6, P321; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Ghanshani S, 2000, J BIOL CHEM, V275, P37137, DOI 10.1074/jbc.M003941200; GIBBS SJ, 1991, J MAGN RESON, V93, P395, DOI 10.1016/0022-2364(91)90014-K; GRISSMER S, 1990, P NATL ACAD SCI USA, V87, P9411, DOI 10.1073/pnas.87.23.9411; GRISSMER S, 1994, MOL PHARMACOL, V45, P1227; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; HIDALGO P, 1995, SCIENCE, V268, P307, DOI 10.1126/science.7716527; Hubbard S. J., 1993, NACCESS; HUMPHREY W, 1996, J MOL GRAPHICS, V14, P27, DOI DOI 10.1016/0263-7855(96)00018-5; JOHNSON BA, 1994, BIOCHEMISTRY-US, V33, P15061, DOI 10.1021/bi00254a015; JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001; Kalman K, 1998, J BIOL CHEM, V273, P32697, DOI 10.1074/jbc.273.49.32697; KING DS, 1990, INT J PEPT PROT RES, V36, P255; Lanigan MD, 2002, BIOCHEMISTRY-US, V41, P11963, DOI 10.1021/bi026400b; LEONARD RJ, 1992, P NATL ACAD SCI USA, V89, P10094, DOI 10.1073/pnas.89.21.10094; Li L, 2003, PROTEINS, V53, P693, DOI 10.1002/prot.10460; LIN CS, 1993, J EXP MED, V177, P637, DOI 10.1084/jem.177.3.637; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; MILTON RCD, 1992, SCIENCE, V256, P1445, DOI 10.1126/science.1604320; NIELSEN KJ, 1994, PROTEIN SCI, V3, P291; Norton RS, 2004, CURR MED CHEM, V11, P3041, DOI 10.2174/0929867043363947; PENNINGTON MW, 1995, INT J PEPT PROT RES, V46, P354; Pennington MW, 1999, BIOCHEMISTRY-US, V38, P14549, DOI 10.1021/bi991282m; Pennington MW, 1996, BIOCHEMISTRY-US, V35, P16407, DOI 10.1021/bi962463g; Pennington MW, 1996, BIOCHEM BIOPH RES CO, V219, P696, DOI 10.1006/bbrc.1996.0297; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Pohl Jan, 1995, Letters in Peptide Science, V1, P291, DOI 10.1007/BF00119770; PRICE M, 1989, P NATL ACAD SCI USA, V86, P10171, DOI 10.1073/pnas.86.24.10171; Rauer H, 2000, J BIOL CHEM, V275, P1201, DOI 10.1074/jbc.275.2.1201; Rauer H, 1999, J BIOL CHEM, V274, P21885, DOI 10.1074/jbc.274.31.21885; RIVIER J, 1983, J CHROMATOGR, V268, P112, DOI 10.1016/S0021-9673(01)95395-6; Soler D, 2003, BLOOD, V101, P1677, DOI 10.1182/blood-2002-07-2348; Suchyna TM, 2004, NATURE, V430, P235, DOI 10.1038/nature02743; Tudor JE, 1996, NAT STRUCT BIOL, V3, P317, DOI 10.1038/nsb0496-317; Tudor JE, 1998, EUR J BIOCHEM, V251, P133, DOI 10.1046/j.1432-1327.1998.2510133.x; Wulff H, 2003, J CLIN INVEST, V111, P1703, DOI 10.1172/JCI200316921; Yan LZ, 2005, MOL PHARMACOL, V67, P1513, DOI 10.1124/mol.105.011064; Yao SG, 2000, J BIOMOL NMR, V16, P109, DOI 10.1023/A:1008382624724; ZAWADZKE LE, 1993, PROTEINS, V16, P301, DOI 10.1002/prot.340160308; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	59	51	58	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					988	997		10.1074/jbc.M706008200	http://dx.doi.org/10.1074/jbc.M706008200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	17984097	hybrid			2022-12-27	WOS:000252128100038
J	Wong, J; Quinn, CM; Gelissen, IC; Brown, AJ				Wong, Jenny; Quinn, Carmel M.; Gelissen, Ingrid C.; Brown, Andrew J.			Endogenous 24(S),25-epoxycholesterol fine-tunes acute control of cellular cholesterol homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2,3-OXIDOSQUALENE CYCLASE INHIBITOR; LOW-DENSITY-LIPOPROTEIN; LIVER-X RECEPTORS; 3-HYDROXY-3-METHYLGLUTARYL-COA REDUCTASE; ENDOPLASMIC-RETICULUM; LANOSTEROL CYCLASE; OXYSTEROLS; BIOSYNTHESIS; ABCA1; METABOLISM	Certain oxysterols, when added to cultured cells, are potent regulators of cholesterol homeostasis, decreasing cholesterol synthesis and uptake and increasing cholesterol efflux. However, very little is known about whether or not endogenous oxysterol(s) plays a significant role in cholesterol homeostasis. 24(S), 25-Epoxycholesterol (24,25EC) is unique among oxysterols in that it is produced in a shunt of the mevalonate pathway which also produces cholesterol. We investigated the role of endogenously produced 24,25EC using a novel strategy of over-expressing the enzyme 2,3-oxidosqualene cyclase in Chinese hamster ovary cells to selectively inhibit the synthesis of this oxysterol. First, loss of 24,25EC decreased expression of the LXR target gene, ABCA1, substantiating its role as an endogenous ligand for LXR. Second, loss of 24,25EC increased acute cholesterol synthesis, which was rationalized by a concomitant increase in HMG-CoA reductase gene expression at the level of SREBP-2 processing. Therefore, in the absence of 24,25EC, fine-tuning of the acute regulation of cholesterol homeostasis is lost, supporting the hypothesis that 24,25EC functions to protect the cell against the accumulation of newly synthesized cholesterol.	[Wong, Jenny; Brown, Andrew J.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia; [Quinn, Carmel M.; Gelissen, Ingrid C.] Univ New S Wales, Ctr Vasc Res, Kensington, NSW 2033, Australia; [Quinn, Carmel M.; Gelissen, Ingrid C.] Prince Wales Hosp, Dept Haematol, Sydney, NSW 2032, Australia	University of New South Wales Sydney; University of New South Wales Sydney	Brown, AJ (corresponding author), Univ New S Wales, Sch Biotechnol & Biomol Sci, Biosci Bldg D26, Sydney, NSW 2052, Australia.	aj.brown@unsw.edu.au						Adams CM, 2004, J BIOL CHEM, V279, P52772, DOI 10.1074/jbc.M410302200; Beyea MM, 2007, J BIOL CHEM, V282, P5207, DOI 10.1074/jbc.M611063200; Bjorkhem I, 2002, J CLIN INVEST, V110, P725, DOI 10.1172/JCI200216388; Bjorkhem I, 2004, ARTERIOSCL THROM VAS, V24, P2209, DOI 10.1161/01.ATV.0000148704.72481.28; BLOCH K, 1965, SCIENCE, V150, P19, DOI 10.1126/science.150.3692.19; BOUTAUD O, 1992, BIOCHEM BIOPH RES CO, V188, P898, DOI 10.1016/0006-291X(92)91140-L; Brown AJ, 2002, MOL CELL, V10, P237, DOI 10.1016/S1097-2765(02)00591-9; Chen WL, 2007, CELL METAB, V5, P73, DOI 10.1016/j.cmet.2006.11.012; Costet P, 2000, J BIOL CHEM, V275, P28240; DOLLIS D, 1994, BIOCHEM PHARMACOL, V48, P49, DOI 10.1016/0006-2952(94)90222-4; Eisele B, 1997, J LIPID RES, V38, P564; Feng B, 2003, NAT CELL BIOL, V5, P781, DOI 10.1038/ncb1035; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; Horton JD, 1998, J CLIN INVEST, V101, P2331, DOI 10.1172/JCI2961; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Janowski BA, 2001, J BIOL CHEM, V276, P45408, DOI 10.1074/jbc.M108348200; Janowski BA, 1999, P NATL ACAD SCI USA, V96, P266, DOI 10.1073/pnas.96.1.266; KANDUTSCH AA, 1978, SCIENCE, V201, P498, DOI 10.1126/science.663671; Kielar D, 2001, CLIN CHEM, V47, P2089; Lehmann JM, 1997, J BIOL CHEM, V272, P3137, DOI 10.1074/jbc.272.6.3137; Mark M, 1996, J LIPID RES, V37, P148; Morand OH, 1997, J LIPID RES, V38, P373; NELSON JA, 1981, J BIOL CHEM, V256, P1067; Nguyen AD, 2007, J BIOL CHEM, V282, P27436, DOI 10.1074/jbc.M704976200; Ory DS, 2004, CIRC RES, V95, P660, DOI 10.1161/01.RES.0000143422.83209.be; PANINI SR, 1986, J LIPID RES, V27, P1190; Radhakrishnan A, 2004, MOL CELL, V15, P259, DOI 10.1016/j.molcel.2004.06.019; Radhakrishnan A, 2007, P NATL ACAD SCI USA, V104, P6511, DOI 10.1073/pnas.0700899104; Rowe AH, 2003, CIRC RES, V93, P717, DOI 10.1161/01.RES.0000097606.43659.F4; SAUCIER SE, 1985, J BIOL CHEM, V260, P4571; SAUCIER SE, 1989, J BIOL CHEM, V264, P6863; Schmitz G, 2005, BBA-MOL CELL BIOL L, V1735, P1, DOI 10.1016/j.bbalip.2005.04.004; Schroepfer GJ, 2000, PHYSIOL REV, V80, P361, DOI 10.1152/physrev.2000.80.1.361; Song BL, 2005, CELL METAB, V1, P179, DOI 10.1016/j.cmet.2005.01.001; Song BL, 2004, J BIOL CHEM, V279, P28798, DOI 10.1074/jbc.M402442200; Soumian S, 2005, VASC MED, V10, P109, DOI 10.1191/1358863x05vm593ra; SPENCER TA, 1985, J BIOL CHEM, V260, P3391; TAYLOR FR, 1986, J BIOL CHEM, V261, P5039; Telford DE, 2005, ARTERIOSCL THROM VAS, V25, P2608, DOI 10.1161/01.ATV.0000189158.28455.94; Wong J, 2004, ARTERIOSCL THROM VAS, V24, P2365, DOI 10.1161/01.ATV.0000148707.93054.7d; WONG J, 2007, IN PRESS ATHEROSCLER; Wong J, 2007, LIPIDS HEALTH DIS, V6, DOI 10.1186/1476-511X-6-10; Wong J, 2006, BIOCHEM J, V400, P485, DOI 10.1042/BJ20060914; Yang CD, 2006, J BIOL CHEM, V281, P27816, DOI 10.1074/jbc.M603781200; YANG JX, 1994, GENE DEV, V8, P1910, DOI 10.1101/gad.8.16.1910; Zelcer N, 2006, J CLIN INVEST, V116, P607, DOI 10.1172/JCI27883	47	67	71	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					700	707		10.1074/jbc.M706416200	http://dx.doi.org/10.1074/jbc.M706416200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	17981807	hybrid			2022-12-27	WOS:000252128100007
J	Kawato, M; Shirakawa, R; Kondo, H; Higashi, T; Ikeda, T; Okawa, K; Fukai, S; Nureki, O; Kita, T; Horiuchi, H				Kawato, Mitsunori; Shirakawa, Ryutaro; Kondo, Hirokazu; Higashi, Tomohito; Ikeda, Tomoyuki; Okawa, Katsuya; Fukai, Shuya; Nureki, Osamu; Kita, Toru; Horiuchi, Hisanori			Regulation of platelet dense granule secretion by the Ral GTPase-exocyst pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+-INDUCED ALPHA-GRANULE; BINDING PROTEIN; GROWTH-FACTOR; COMPLEX; ACTIVATION; MEMBRANE; EFFECTOR; CORE; IDENTIFICATION; DELIVERY	Non-hydrolyzable GTP analogues, such as guanosine 5'-(beta,gamma-imido) triphosphate (GppNHp), induce granule secretion from permeabilized platelets in the absence of increased intracellular Ca2+. Here, we show that the GppNHp-induced dense granule secretion from permeabilized platelets occurred concomitantly with the activation of small GTPase Ral. This secretion was inhibited by the addition of GTP-Ral-binding domain (RBD) of Sec5, which is a component of the exocyst complex known to function as a tethering factor at the plasma membrane for vesicles. We generated an antibody against Sec5-RBD, which abolished the interaction between GTP-Ral and the exocyst complex in vitro. The addition of this antibody inhibited the GppNHp-induced secretion. These data indicate that Ral mediates the GppNHp-induced dense granule secretion from permeabilized platelets through interaction with its effector, the exocyst complex. Furthermore, GppNHp enhanced the Ca2+ sensitivity of dense granule secretion from permeabilized platelets, and this enhancement was inhibited by Sec5-RBD. In intact platelets, the association between Ral and the exocyst complex was induced by thrombin stimulation with a time course similar to that of dense granule secretion and Ral activation. Taken together, our results suggest that the Ral-exocyst pathway participates in the regulation of platelet dense granule secretion by enhancing the Ca2+ sensitivity of the secretion.	[Kawato, Mitsunori; Shirakawa, Ryutaro; Kondo, Hirokazu; Higashi, Tomohito; Ikeda, Tomoyuki; Kita, Toru; Horiuchi, Hisanori] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto 6068507, Japan; [Okawa, Katsuya] Kyoto Univ, Grad Sch Med, Frontier Technol Ctr, Kyoto 6068507, Japan; [Fukai, Shuya; Nureki, Osamu] Tokyo Inst Technol, Dept Biosci & Biotechnol, Yokohama, Kanagawa 2268501, Japan; [Fukai, Shuya] Univ Tokyo, Synchrotron Radiat Res Org, Div Life Sci, Tokyo 1130032, Japan	Kyoto University; Kyoto University; Tokyo Institute of Technology; University of Tokyo	Horiuchi, H (corresponding author), Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto 6068507, Japan.	horiuchi@kuhp.kyoto-u.ac.jp	NUREKI, OSAMU/G-4960-2014; Higashi, Tomohito/AHE-7942-2022; Fukai, Shuya/X-4838-2018	Fukai, Shuya/0000-0002-1241-1443; Higashi, Tomohito/0000-0001-5616-1477				BHULLAR RP, 1990, FEBS LETT, V260, P48, DOI 10.1016/0014-5793(90)80063-O; Bos JL, 1998, EMBO J, V17, P6776, DOI 10.1093/emboj/17.23.6776; BRASS LF, 2005, HEMATOLOGY MOL BASIS, P1889; Brymora A, 2001, J BIOL CHEM, V276, P29792, DOI 10.1074/jbc.C100320200; Burgoyne RD, 2003, PHYSIOL REV, V83, P581, DOI 10.1152/physrev.00031.2002; Christoforidis S, 1999, NATURE, V397, P621, DOI 10.1038/17618; COORSSEN JR, 1990, CELL REGUL, V1, P1027, DOI 10.1091/mbc.1.13.1027; FABIATO A, 1979, J PHYSIOL-PARIS, V75, P463; Feig LA, 2003, TRENDS CELL BIOL, V13, P419, DOI 10.1016/S0962-8924(03)00152-1; Fukai S, 2003, EMBO J, V22, P3267, DOI 10.1093/emboj/cdg329; Gerges NZ, 2006, EMBO J, V25, P1623, DOI 10.1038/sj.emboj.7601065; Grindstaff KK, 1998, CELL, V93, P731, DOI 10.1016/S0092-8674(00)81435-X; Guo W, 1999, EMBO J, V18, P1071, DOI 10.1093/emboj/18.4.1071; HASLAM RJ, 1984, FEBS LETT, V174, P90, DOI 10.1016/0014-5793(84)81084-4; HASLAM RJ, 1985, NATURE, V313, P821, DOI 10.1038/313821a0; HASLAM RJ, 1984, J RECEPTOR RES, V4, P605, DOI 10.3109/10799898409042576; Hofer F, 1998, CURR BIOL, V8, P839, DOI 10.1016/S0960-9822(98)70327-6; Horiuchi H, 2006, ANN MED, V38, P162, DOI 10.1080/07853890600640657; Inoue M, 2006, MOL BIOL CELL, V17, P2303, DOI 10.1091/mbc.E06-01-0030; Inoue M, 2003, NATURE, V422, P629, DOI 10.1038/nature01533; Jin RS, 2005, EMBO J, V24, P2064, DOI 10.1038/sj.emboj.7600699; Kondo H, 2006, J BIOL CHEM, V281, P28657, DOI 10.1074/jbc.M603227200; Lipschutz JH, 2002, CURR BIOL, V12, pR212, DOI 10.1016/S0960-9822(02)00753-4; Mark BL, 1996, BIOCHEM BIOPH RES CO, V225, P40, DOI 10.1006/bbrc.1996.1128; Moskalenko S, 2003, J BIOL CHEM, V278, P51743, DOI 10.1074/jbc.M308702200; Moskalenko S, 2002, NAT CELL BIOL, V4, P66, DOI 10.1038/ncb728; Nesbitt WS, 2003, J CELL BIOL, V160, P1151, DOI 10.1083/jcb.200207119; Nishi E, 2006, J BIOL CHEM, V281, P31164, DOI 10.1074/jbc.M601316200; Offermanns S, 2006, CIRC RES, V99, P1293, DOI 10.1161/01.RES.0000251742.71301.16; Padfield PJ, 1996, BIOCHEM J, V314, P123, DOI 10.1042/bj3140123; Palmer M, 1998, EMBO J, V17, P1598, DOI 10.1093/emboj/17.6.1598; Sans N, 2003, NAT CELL BIOL, V5, P520, DOI 10.1038/ncb990; SARGEANT P, 1994, PHARMACOL THERAPEUT, V64, P395, DOI 10.1016/0163-7258(94)90019-1; Shipitsin M, 2004, MOL CELL BIOL, V24, P5746, DOI 10.1128/MCB.24.13.5746-5756.2004; Shirakawa R, 2000, J BIOL CHEM, V275, P33844, DOI 10.1074/jbc.M002834200; Shirakawa R, 2005, METHOD ENZYMOL, V403, P778, DOI 10.1016/S0076-6879(05)03067-3; Shirakawa R, 2004, J BIOL CHEM, V279, P10730, DOI 10.1074/jbc.M309426200; Sugihara K, 2002, NAT CELL BIOL, V4, P73, DOI 10.1038/ncb720; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; TerBush DR, 1996, EMBO J, V15, P6483, DOI 10.1002/j.1460-2075.1996.tb01039.x; Tsuboi T, 2005, J BIOL CHEM, V280, P25565, DOI 10.1074/jbc.M501674200; van Dam EM, 2006, INT J BIOCHEM CELL B, V38, P1841, DOI 10.1016/j.biocel.2006.04.006; Wang L, 2004, J BIOL CHEM, V279, P19875, DOI 10.1074/jbc.M400522200; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; Wolthuis RMF, 1998, CURR BIOL, V8, P471, DOI 10.1016/S0960-9822(98)70183-6; Wolthuis RMF, 1998, MOL CELL BIOL, V18, P2486, DOI 10.1128/MCB.18.5.2486; Yoshioka A, 2001, ANN NY ACAD SCI, V947, P403; Yoshioka A, 2001, J BIOL CHEM, V276, P39379, DOI 10.1074/jbc.M102933200	48	29	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					166	174		10.1074/jbc.M705340200	http://dx.doi.org/10.1074/jbc.M705340200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17938170	Green Submitted, hybrid			2022-12-27	WOS:000251940300019
J	Powlesland, AS; Fisch, T; Taylor, ME; Smith, DF; Tissot, B; Dell, A; Poehlmann, S; Drickamer, K				Powlesland, Alex S.; Fisch, Tanja; Taylor, Maureen E.; Smith, David F.; Tissot, Berangere; Dell, Anne; Poehlmann, Stefan; Drickamer, Kurt			A novel mechanism for LSECtin binding to Ebola virus surface glycoprotein through truncated glycans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TYPE LECTIN; RESPIRATORY SYNDROME CORONAVIRUS; N-ACETYLGALACTOSAMINE BINDING; DC-SIGN; CARBOHYDRATE-RECOGNITION; ASIALOGLYCOPROTEIN RECEPTOR; VIRION GLYCOPROTEINS; STRUCTURAL BASIS; LIGAND-BINDING; PROTEINS	LSECtin is a member of the C-type lectin family of glycan-binding receptors that is expressed on sinusoidal endothelial cells of the liver and lymph nodes. To compare the sugar and pathogen binding properties of LSECtin with those of related but more extensively characterized receptors, such as DC-SIGN, a soluble fragment of LSECtin consisting of the C-terminal carbohydrate-recognition domain has been expressed in bacteria. A biotin-tagged version of the protein was also generated and complexed with streptavidin to create tetramers. These forms of the carbohydrate-recognition domain were used to probe a glycan array and to characterize binding to oligosaccharide and glycoprotein ligands. LSECtin binds with high selectivity to glycoproteins terminating in GlcNAc beta 1-2Man. The inhibition constant for this disaccharide is 3.5 mu M, making it one of the best low molecular weight ligands known for any C-type lectin. As a result of the selective binding of this disaccharide unit, the receptor recognizes glycoproteins with a truncated complex and hybrid N-linked glycans on glycoproteins. Glycan analysis of the surface glycoprotein of Ebola virus reveals the presence of such truncated glycans, explaining the ability of LSECtin to facilitate infection by Ebola virus. High mannose glycans are also present on the viral glycoprotein, which explains why DC-SIGN also binds to this virus. Thus, multiple receptors interact with surface glycoproteins of enveloped viruses that bear different types of relatively poorly processed glycans.	[Powlesland, Alex S.; Taylor, Maureen E.; Tissot, Berangere; Dell, Anne; Drickamer, Kurt] Imperial Coll London, Div Mol Biol, London SW7 2AZ, England; [Fisch, Tanja; Poehlmann, Stefan] Univ Erlangen Nurnberg, Nikolaus Fiebiger Ctr Mol Med, Inst Virol, D-91054 Erlangen, Germany; [Poehlmann, Stefan] Hannover Med Sch, Inst Virol, D-30625 Hannover, Germany; [Smith, David F.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA	Imperial College London; University of Erlangen Nuremberg; Hannover Medical School; Emory University	Drickamer, K (corresponding author), Imperial Coll London, Div Mol Biol, Biochem Bldg, London SW7 2AZ, England.	k.drickamer@imperial.ac.uk	Pöhlmann, Stefan/H-2395-2011	Pöhlmann, Stefan/0000-0001-6086-9136; Drickamer, Kurt/0000-0001-5026-5996; Taylor, Maureen/0000-0001-8300-4987	NIGMS NIH HHS [GM 62116, U54 GM062116] Funding Source: Medline; Wellcome Trust [075565, 041845] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alvarez CP, 2002, J VIROL, V76, P6841, DOI 10.1128/JVI.76.13.6841-6844.2002; Arnold JN, 2007, ANNU REV IMMUNOL, V25, P21, DOI 10.1146/annurev.immunol.25.022106.141702; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Chapman-Smith A, 1999, TRENDS BIOCHEM SCI, V24, P359, DOI 10.1016/S0968-0004(99)01438-3; Comelli EM, 2006, GLYCOBIOLOGY, V16, P117, DOI 10.1093/glycob/cwj048; Dominguez-Soto A, 2007, BLOOD, V109, P5337, DOI 10.1182/blood-2006-09-048058; DRICKAMER K, 1991, CELL, V67, P1029, DOI 10.1016/0092-8674(91)90278-7; Drickamer K., 2006, INTRO GLYCOBIOLOGY; DUBUISSON J, 1994, J VIROL, V68, P6147, DOI 10.1128/JVI.68.10.6147-6160.1994; Fadden AJ, 2003, GLYCOBIOLOGY, V13, P529, DOI 10.1093/glycob/cwg068; Feinberg H, 2000, J BIOL CHEM, V275, P35176, DOI 10.1074/jbc.M005557200; FORNSTEDT N, 1975, FEBS LETT, V57, P187, DOI 10.1016/0014-5793(75)80713-7; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Gramberg T, 2005, VIROLOGY, V340, P224, DOI 10.1016/j.virol.2005.06.026; GRAYEB J, 1984, EMBO J, V3, P2437; GREENWOOD FC, 1963, BIOCHEM J, V89, P123; Guo Y, 2004, NAT STRUCT MOL BIOL, V11, P591, DOI 10.1038/nsmb784; IOBST ST, 1994, J BIOL CHEM, V269, P15505; Jeffers SA, 2002, J VIROL, V76, P12463, DOI 10.1128/JVI.76.24.12463-12472.2002; Jones AJS, 2007, GLYCOBIOLOGY, V17, P529, DOI 10.1093/glycob/cwm017; Kolatkar AR, 1998, J BIOL CHEM, V273, P19502, DOI 10.1074/jbc.273.31.19502; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Krokhin O, 2003, MOL CELL PROTEOMICS, V2, P346, DOI 10.1074/mcp.M300048-MCP200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lai WK, 2006, AM J PATHOL, V169, P200, DOI 10.2353/ajpath.2006.051191; Lee SJ, 2002, SCIENCE, V295, P1898, DOI 10.1126/science.1069540; Liu WL, 2004, J BIOL CHEM, V279, P18748, DOI 10.1074/jbc.M311227200; Lupas A, 1996, TRENDS BIOCHEM SCI, V21, P375, DOI 10.1016/0968-0004(96)10052-9; Marzi A, 2004, J VIROL, V78, P12090, DOI 10.1128/JVI.78.21.12090-12095.2004; Marzi A, 2006, J VIROL, V80, P6305, DOI 10.1128/JVI.02545-05; McGreal EP, 2005, CURR OPIN IMMUNOL, V17, P18, DOI 10.1016/j.coi.2004.12.001; Pohlmann S, 2001, TRENDS IMMUNOL, V22, P643, DOI 10.1016/S1471-4906(01)02081-6; Powlesland AS, 2006, J BIOL CHEM, V281, P20440, DOI 10.1074/jbc.M601925200; RINI JM, 1995, ANNU REV BIOPH BIOM, V24, P551, DOI 10.1146/annurev.biophys.24.1.551; Sanchez A, 1998, J VIROL, V72, P6442, DOI 10.1128/JVI.72.8.6442-6447.1998; Sanchez A, 1996, P NATL ACAD SCI USA, V93, P3602, DOI 10.1073/pnas.93.8.3602; Scanlan CN, 2002, J VIROL, V76, P7306, DOI 10.1128/JVI.76.14.7306-7321.2002; SCHATZ PJ, 1993, BIO-TECHNOL, V11, P1138, DOI 10.1038/nbt1093-1138; Simmons G, 2003, VIROLOGY, V305, P115, DOI 10.1006/viro.2002.1730; Stambach NS, 2003, GLYCOBIOLOGY, V13, P401, DOI 10.1093/glycob/cwg045; SUTTONSMITH M, 2005, CELL BIOL LAB HDB, V4, P415; van Gisbergen KPJM, 2005, J EXP MED, V201, P1281, DOI 10.1084/jem.20041276; Varki A., 1999, ESSENTIALS GLYCOBIOL; Vigerust DJ, 2007, TRENDS MICROBIOL, V15, P211, DOI 10.1016/j.tim.2007.03.003; Ward EM, 2006, J BIOL CHEM, V281, P15450, DOI 10.1074/jbc.M511502200; Weis WI, 1996, ANNU REV BIOCHEM, V65, P441, DOI 10.1146/annurev.bi.65.070196.002301; Weis WI, 1998, IMMUNOL REV, V163, P19, DOI 10.1111/j.1600-065X.1998.tb01185.x; Wragg S, 1999, J BIOL CHEM, V274, P35400, DOI 10.1074/jbc.274.50.35400; Yang ZY, 2004, J VIROL, V78, P5642, DOI 10.1128/JVI.78.11.5642-5650.2004	51	78	86	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					593	602		10.1074/jbc.M706292200	http://dx.doi.org/10.1074/jbc.M706292200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17984090	Green Accepted, hybrid			2022-12-27	WOS:000251940300064
J	Weixel, KM; Edinger, RS; Kester, L; Guerriero, CJ; Wang, HM; Fang, L; Kleyman, TR; Welling, PA; Weisz, OA; Johnson, JP				Weixel, Kelly M.; Edinger, Robert S.; Kester, Lauren; Guerriero, Christopher J.; Wang, Huamin; Fang, Liang; Kleyman, Thomas R.; Welling, Paul A.; Weisz, Ora A.; Johnson, John P.			Phosphatidylinositol 4-phosphate 5-kinase reduces cell surface expression of the epithelial sodium channel (ENaC) in cultured collecting duct cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANINE KIDNEY-CELLS; CLATHRIN-MEDIATED ENDOCYTOSIS; NA+ CHANNEL; SORTING SIGNALS; PLASMA-MEMBRANE; KINASE; TRANSPORT; UBIQUITINATION; TRAFFICKING; INSERTION	Ubiquitination of ENaC subunits has been shown to negatively regulate the cell surface expression of ENaC channels. We have previously demonstrated that epsin links ubiquitinated ENaC to clathrin adaptors for clathrin-mediated endocytosis. Epsin is thought to directly modify the curvature of membranes upon binding to phosphatidylinositol 4,5-bisphosphate (PIP2) where it recruits clathrin and stimulates lattice assembly. Murine phosphatidylinositol 4-phosphate 5-kinase alpha (PI5KI alpha) has been shown to enhance endocytosis in a PIP2-dependent manner. We tested the hypothesis that PI5KI alpha-mediated PIP2 production would negatively regulate ENaC current by enhancing epsin-mediated endocytosis of the channel. Expression of PI5KI alpha decreased ENaC currents in Xenopus oocytes by 80%, entirely because of a decrease in cell surface ENaC levels. Catalytically inactive mutants of PI5K alpha had no effect on ENaC activity. Expression of the PIP2 binding region of epsin increased ENaC current in oocytes, an effect completely reversed by co-expression of PI5KI alpha. Overexpression of epsin reduced amiloride-sensitive current in CCD cells. Overexpression of PI5KI alpha enhanced membrane PIP2 levels and reduced apical surface expression of ENaC in CCD cells, down-regulating amiloride-sensitive current. Knockdown of PI5KI alpha with isoform-specific siRNA resulted in a 4-fold enhancement of ENaC activity. PI5KI alpha localized exclusively to the apical plasma membrane domain when overexpressed in mouse CCD cells, consistent for a role in regulating PIP2 production at the apical plasma membrane. We conclude that membrane turnover events regulating ENaC surface expression and activity in oocytes and CCD cells can be regulated by PI5KI alpha.	Univ Pittsburgh, Dept Med, Div Renal & Electrolyte, Pittsburgh, PA 15261 USA; Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University System of Maryland; University of Maryland Baltimore	Johnson, JP (corresponding author), Univ Pittsburgh, Dept Med, Div Renal & Electrolyte, 3500 Terrace St, Pittsburgh, PA 15261 USA.	Johnson@dom.pitt.edu		Guerriero, Christopher/0000-0002-1046-2300	NIDDK NIH HHS [DK 064613, DK 57718, DK 65161, DK-54231, DK-63049, DK47874, T32 DK61296] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054231, R01DK065161, R56DK065161, R01DK057718, R01DK063049, R01DK064613, T32DK061296, R01DK047874] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		APODACA G, 1994, J CELL BIOL, V125, P67, DOI 10.1083/jcb.125.1.67; Bairstow SF, 2006, J BIOL CHEM, V281, P20632, DOI 10.1074/jbc.M601465200; Barbieri MA, 2001, J BIOL CHEM, V276, P47212, DOI 10.1074/jbc.C100490200; Bens M, 1999, J AM SOC NEPHROL, V10, P923; Blazer-Yost BL, 2001, AM J PHYSIOL-CELL PH, V281, pC624, DOI 10.1152/ajpcell.2001.281.2.C624; BREITFELD PP, 1989, METHOD CELL BIOL, V32, P329; Bruns JR, 2002, J BIOL CHEM, V277, P2012, DOI 10.1074/jbc.M108571200; Butterworth MB, 2005, J GEN PHYSIOL, V125, P81, DOI 10.1085/jgp.2004.09124; Coppolino MG, 2002, J BIOL CHEM, V277, P43849, DOI 10.1074/jbc.M209046200; Eaton DC, 2001, J MEMBRANE BIOL, V184, P313, DOI 10.1007/s00232-001-0098-x; Flores SY, 2003, PFLUG ARCH EUR J PHY, V446, P334, DOI 10.1007/s00424-003-1027-x; Ford MGJ, 2001, SCIENCE, V291, P1051, DOI 10.1126/science.291.5506.1051; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Guerriero CJ, 2006, J BIOL CHEM, V281, P15376, DOI 10.1074/jbc.M601239200; Henkel JR, 1998, MOL BIOL CELL, V9, P2477, DOI 10.1091/mbc.9.9.2477; Hilgemann D W, 2001, Sci STKE, V2001, pre19, DOI 10.1126/stke.2001.111.re19; Itoh T, 2001, SCIENCE, V291, P1047, DOI 10.1126/science.291.5506.1047; KLEYMAN TR, 1994, AM J PHYSIOL, V266, pC1105, DOI 10.1152/ajpcell.1994.266.4.C1105; Krauss M, 2006, P NATL ACAD SCI USA, V103, P11934, DOI 10.1073/pnas.0510306103; Kunzelmann K, 2005, FASEB J, V19, P969, DOI 10.1096/fj.04-2469fje; Lebowitz J, 2004, J BIOL CHEM, V279, P41985, DOI 10.1074/jbc.M403923200; Leung SM, 1999, MOL BIOL CELL, V10, P4369, DOI 10.1091/mbc.10.12.4369; Ling K, 2007, J CELL BIOL, V176, P343, DOI 10.1083/jcb.200606023; Lu C, 2007, TRAFFIC, V8, P1246, DOI 10.1111/j.1600-0854.2007.00602.x; Ma HP, 2005, J AM SOC NEPHROL, V16, P3182, DOI 10.1681/ASN.2005040434; MALIK B, 2005, AM J PHYSL RENAL PHY; Padron D, 2003, J CELL BIOL, V162, P693, DOI 10.1083/jcb.200302051; Pochynyuk O, 2006, AM J PHYSIOL-RENAL, V290, pF949, DOI 10.1152/ajprenal.00386.2005; Pochynyuk O, 2006, J BIOL CHEM, V281, P26520, DOI 10.1074/jbc.M603716200; Raiborg C, 2003, CURR OPIN CELL BIOL, V15, P446, DOI 10.1016/S0955-0674(03)00080-2; Rapoport I, 1997, EMBO J, V16, P2240, DOI 10.1093/emboj/16.9.2240; Rohde G, 2002, J CELL BIOL, V158, P209, DOI 10.1083/jcb.200203103; Rossier BC, 2002, ANNU REV PHYSIOL, V64, P877, DOI 10.1146/annurev.physiol.64.082101.143243; Rotin D, 2000, J MEMBRANE BIOL, V176, P1; Rotin D, 2001, AM J PHYSIOL-RENAL, V281, pF391, DOI 10.1152/ajprenal.2001.281.3.F391; Sakisaka T, 1997, MOL CELL BIOL, V17, P3841, DOI 10.1128/MCB.17.7.3841; Shibasaki Y, 1997, J BIOL CHEM, V272, P7578, DOI 10.1074/jbc.272.12.7578; Snyder PM, 2005, ENDOCRINOLOGY, V146, P5079, DOI 10.1210/en.2005-0894; Snyder PM, 2002, ENDOCR REV, V23, P258, DOI 10.1210/er.23.2.258; Snyder PM, 2002, J BIOL CHEM, V277, P5, DOI 10.1074/jbc.C100623200; Staruschenko A, 2005, J BIOL CHEM, V280, P39161, DOI 10.1074/jbc.M509608200; Staruschenko A, 2004, J BIOL CHEM, V279, P49989, DOI 10.1074/jbc.M409812200; Swift Pauline A, 2004, Am J Pharmacogenomics, V4, P161, DOI 10.2165/00129785-200404030-00003; Tolias KF, 2000, CURR BIOL, V10, P153, DOI 10.1016/S0960-9822(00)00315-8; Wang H, 2006, J BIOL CHEM, V281, P14129, DOI 10.1074/jbc.M512511200; Wenk MR, 2001, NEURON, V32, P79, DOI 10.1016/S0896-6273(01)00456-1; Wiemuth D, 2007, BIOCHEM J, V405, P147, DOI 10.1042/BJ20060747; Yoo D, 2003, J BIOL CHEM, V278, P23066, DOI 10.1074/jbc.M212301200; Yue G, 2002, J BIOL CHEM, V277, P11965, DOI 10.1074/jbc.M108951200; Zhou RF, 2005, J BIOL CHEM, V280, P4518, DOI 10.1074/jbc.M411053200; Zhou RF, 2007, J BIOL CHEM, V282, P20207, DOI 10.1074/jbc.M611329200	51	25	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36534	36542		10.1074/jbc.M703970200	http://dx.doi.org/10.1074/jbc.M703970200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17940289	hybrid			2022-12-27	WOS:000251458300046
J	Frey, S; Leskovar, A; Reinstein, J; Buchner, J				Frey, Stephan; Leskovar, Adriane; Reinstein, Jochen; Buchner, Johannes			The ATPase cycle of the endoplasmic chaperone Grp94	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HSP90 MOLECULAR CHAPERONE; N-TERMINAL DOMAIN; BINDING-SITE; CRYSTAL-STRUCTURE; PEPTIDE BINDING; LIGAND-BINDING; IN-VIVO; PROTEIN; RETICULUM; NUCLEOTIDE	Grp94, the Hsp90 paralog of the endoplasmic reticulum, plays a crucial role in protein secretion. Like cytoplasmic Hsp90, Grp94 is regulated by nucleotide binding to its N-terminal domain. However, the question of whether Grp94 hydrolyzes ATP was controversial. This sets Grp94 apart from other members of the Hsp90 family where a slow but specific turnover of ATP has been unambiguously established. In this study we aimed at analyzing the nucleotide binding properties and the potential ATPase activity of Grp94. We show here that Grp94 has an ATPase activity comparable with that of yeast Hsp90 with a k(cat) of 0.36 min(-1) at 25 degrees C. Kinetic and equilibrium constants of the partial reactions of the ATPase cycle were determined using transient kinetic methods. Nucleotide binding appears to be tighter compared with other Hsp90s investigated, with dissociation constants (K-D) of similar to 4 mu M for ADP, ATP, and AMP-PCP. Interestingly, all nucleotides and inhibitors (radicicol, 5 '-N-ethylcarboxamidoadenosine) studied here bind with similar rate constants for association (0.2-0.3 x 10(6) M-1 s(-1) ). Furthermore, there is a marked difference from cytosolic Hsp90s in that after binding, the ATP molecule does not seem to become trapped by conformational changes in Grp94. Grp94 stays predominantly in the open state concerning the nucleotide-binding pocket as evidenced by kinetic analyses. Thus, Grp94 shows mechanistically important differences in the interaction with adenosine nucleotides, but the basic hydrolysis reaction seems to be conserved between cytosolic and endoplasmic members of the Hsp90 family.	Tech Univ Munich, Ctr Integrated Prot Sci, D-85747 Garching, Germany; Tech Univ Munich, Dept Chem, D-85747 Garching, Germany; Max Planck Inst Med Res, Dept Biomol Mech, D-69120 Heidelberg, Germany	Technical University of Munich; Technical University of Munich; Max Planck Society	Buchner, J (corresponding author), Lichtenbergstr 4, D-85747 Garching, Germany.	johannes.buchner@ch.tum.de	Buchner, Johannes/A-2651-2010	Buchner, Johannes/0000-0003-1282-7737				ALI JA, 1993, BIOCHEMISTRY-US, V32, P2717, DOI 10.1021/bi00061a033; Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; CALA SE, 1994, J BIOL CHEM, V269, P5926; CLAIRMONT CA, 1992, J BIOL CHEM, V267, P3983; CSERMELY P, 1995, J BIOL CHEM, V270, P6381, DOI 10.1074/jbc.270.11.6381; Descoteaux A, 2002, EMBO J, V21, P4458, DOI 10.1093/emboj/cdf447; Dollins DE, 2005, J BIOL CHEM, V280, P30438, DOI 10.1074/jbc.M503761200; Dutta R, 2000, TRENDS BIOCHEM SCI, V25, P24, DOI 10.1016/S0968-0004(99)01503-0; Gidalevitz T, 2004, J BIOL CHEM, V279, P16543, DOI 10.1074/jbc.M313060200; GUPTA RS, 1995, MOL BIOL EVOL, V12, P1063; GUTFREUND Y, 1995, J PHYSIOL-LONDON, V483, P621, DOI 10.1113/jphysiol.1995.sp020611; HUTCHISON KA, 1989, J BIOL CHEM, V264, P19898; HUTCHISON KA, 1990, BIOCHEMISTRY-US, V29, P5138, DOI 10.1021/bi00473a020; Immormino RM, 2004, J BIOL CHEM, V279, P46162, DOI 10.1074/jbc.M405253200; KANG HS, 1991, J BIOL CHEM, V266, P5643; KIM KS, 1990, DIFFERENTIATION, V42, P153, DOI 10.1111/j.1432-0436.1990.tb00756.x; LI ZH, 1993, EMBO J, V12, P3143, DOI 10.1002/j.1460-2075.1993.tb05983.x; McLaughlin SH, 2004, J MOL BIOL, V344, P813, DOI 10.1016/j.jmb.2004.09.055; McLaughlin SH, 2002, J MOL BIOL, V315, P787, DOI 10.1006/jmbi.2001.5245; MELNICK J, 1994, NATURE, V370, P373, DOI 10.1038/370373a0; Nieland TJF, 1996, P NATL ACAD SCI USA, V93, P6135, DOI 10.1073/pnas.93.12.6135; Obermann WMJ, 1998, J CELL BIOL, V143, P901, DOI 10.1083/jcb.143.4.901; OBrien MC, 1996, J BIOL CHEM, V271, P15874, DOI 10.1074/jbc.271.27.15874; Panaretou B, 1998, EMBO J, V17, P4829, DOI 10.1093/emboj/17.16.4829; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Picard D, 2006, TRENDS ENDOCRIN MET, V17, P229, DOI 10.1016/j.tem.2006.06.003; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Prodromou C, 2000, EMBO J, V19, P4383, DOI 10.1093/emboj/19.16.4383; Prodromou C, 1997, CELL, V90, P65, DOI 10.1016/S0092-8674(00)80314-1; Randow F, 2001, NAT CELL BIOL, V3, P891, DOI 10.1038/ncb1001-891; Reed RC, 2002, J BIOL CHEM, V277, P25082, DOI 10.1074/jbc.M203195200; REINSTEIN J, 1990, BIOCHEMISTRY-US, V29, P7440, DOI 10.1021/bi00484a013; Richter K, 2006, J BIOL CHEM, V281, P11301, DOI 10.1074/jbc.M510142200; Richter K, 2002, J BIOL CHEM, V277, P44905, DOI 10.1074/jbc.M208457200; Richter K, 2001, J BIOL CHEM, V276, P33689, DOI 10.1074/jbc.M103832200; RICHTER K, 2005, PROTEIN FOLDING HDB, V2, P768; Riggs DL, 2004, CRIT REV BIOCHEM MOL, V39, P279, DOI 10.1080/10409230490892513; Roe SM, 1999, J MED CHEM, V42, P260, DOI 10.1021/jm980403y; Rosser MFN, 2000, J BIOL CHEM, V275, P22798, DOI 10.1074/jbc.M001477200; Scheibel T, 1998, P NATL ACAD SCI USA, V95, P1495, DOI 10.1073/pnas.95.4.1495; SCHLEE S, 2005, PROTEIN FOLDING HDB, V2, P105; Schulte TW, 1999, MOL ENDOCRINOL, V13, P1435, DOI 10.1210/me.13.9.1435; Shiau AK, 2006, CELL, V127, P329, DOI 10.1016/j.cell.2006.09.027; SHIU RPC, 1977, P NATL ACAD SCI USA, V74, P3840, DOI 10.1073/pnas.74.9.3840; Soldano KL, 2003, J BIOL CHEM, V278, P48330, DOI 10.1074/jbc.M308661200; SORGER PK, 1987, J MOL BIOL, V194, P341, DOI 10.1016/0022-2836(87)90380-9; Srivastava P K, 1996, Semin Immunol, V8, P295, DOI 10.1006/smim.1996.0038; STANCATO LF, 1993, J BIOL CHEM, V268, P21711; Stebbins CE, 1997, CELL, V89, P239, DOI 10.1016/S0092-8674(00)80203-2; Theyssen H, 1996, J MOL BIOL, V263, P657, DOI 10.1006/jmbi.1996.0606; Thrall SH, 1996, BIOCHEMISTRY-US, V35, P4609, DOI 10.1021/bi9526387; Vogen S, 2002, J BIOL CHEM, V277, P40742, DOI 10.1074/jbc.M205323200; Wearsch PA, 1996, PROTEIN EXPRES PURIF, V7, P114, DOI 10.1006/prep.1996.0015; Wearsch PA, 1996, BIOCHEMISTRY-US, V35, P16760, DOI 10.1021/bi962068q; Wearsch PA, 1997, J BIOL CHEM, V272, P5152, DOI 10.1074/jbc.272.8.5152; Weikl T, 2000, J MOL BIOL, V303, P583, DOI 10.1006/jmbi.2000.4157	56	83	86	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35612	35620		10.1074/jbc.M704647200	http://dx.doi.org/10.1074/jbc.M704647200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17925398	hybrid			2022-12-27	WOS:000251458100021
J	Mene-Saffrane, L; Davoine, C; Stolz, S; Majcherczyk, P; Farmer, EE				Mene-Saffrane, Laurent; Davoine, Celine; Stolz, Stephanie; Majcherczyk, Paul; Farmer, Edward E.			Genetic removal of tri-unsaturated fatty acids suppresses - Developmental and molecular phenotypes of an Arabidopsis tocopherol-deficient mutant	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATOGRAPHY-MASS-SPECTROMETRY; LIPID-PEROXIDATION; MALONDIALDEHYDE; EXPRESSION; DEFENSE; TEMPERATURE; LEAVES; ASSAY	Malondialdehyde (MDA) is a small, ubiquitous, and potentially toxic aldehyde that is produced in vivo by lipid oxidation and that is able to affect gene expression. Tocopherol deficiency in the vitamin E2 mutant vte2-1 of Arabidopsis thaliana leads to massive lipid oxidation and MDA accumulation shortly after germination. MDA accumulation correlates with a strong visual phenotype (growth reduction, cotyledon bleaching) and aberrant GST1 (glutathione (S) under bar-(t) under bar ransferase (1) under bar) expression. We suppressed MDA accumulation in the vte2-1 background by genetically removing tri-unsaturated fatty acids. The resulting quadruple mutant, fad3-2 fad7-2 fad8 vte2-1, did not display the visual phenotype or the aberrant GST1 expression observed in vte2-1. Moreover, cotyledon bleaching in vte2-1 was chemically phenocopied by treatment of wild-type plants with MDA. These data suggest that products of tri-unsaturated fatty acid oxidation underlie the vte2-1 seedling phenotype, including cellular toxicity and gene regulation properties. Generation of the quadruple mutant facilitated the development of an in situ fluorescence assay based on the formation of adducts of MDA with 2-thiobarbituric acid at 37 degrees C. Specificity was verified by measuring pentafluorophenylhydrazine derivatives of MDA and by liquid chromatography analysis of MDA-2-thiobarbituric acid adducts. Potentially applicable to other organisms, this method allowed the localization of MDA pools throughout the body of Arabidopsis and revealed an undiscovered pool of the compound unlikely to be derived from trienoic fatty acids in the vicinity of the root tip quiescent center.	Univ Lausanne, Dept Plant Mol Biol, CH-1015 Lausanne, Switzerland; Univ Lausanne, Dept Fundamental Microbiol, CH-1015 Lausanne, Switzerland	University of Lausanne; University of Lausanne	Farmer, EE (corresponding author), Univ Lausanne, Dept Plant Mol Biol, Batiment Biophore, CH-1015 Lausanne, Switzerland.	edward.farmer@unil.ch	Farmer, Edward E/H-1635-2011; Mène-Saffrané, Laurent/A-7440-2013	Mène-Saffrané, Laurent/0000-0002-1763-7871				Almeras E, 2003, PLANT J, V34, P202, DOI 10.1046/j.1365-313X.2003.01718.x; Alvarez ME, 1998, CELL, V92, P773, DOI 10.1016/S0092-8674(00)81405-1; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Falcone Deane L., 2004, BMC Plant Biology, V4, P17, DOI 10.1186/1471-2229-4-17; Farmer EE, 2007, CURR OPIN PLANT BIOL, V10, P380, DOI 10.1016/j.pbi.2007.04.019; Frankel E. N., 2005, OILY PRESS LIPID LIB, V18; HARWOOD JL, 1982, BIOCH PLANTS, V4, P1; JANERO DR, 1990, FREE RADICAL BIO MED, V9, P515, DOI 10.1016/0891-5849(90)90131-2; Jardine D, 2002, J AGR FOOD CHEM, V50, P1720, DOI 10.1021/jf011336a; Jiang K, 2003, DEVELOPMENT, V130, P1429, DOI 10.1242/dev.00359; Larkindale J, 2005, PLANT PHYSIOL, V138, P882, DOI 10.1104/pp.105.062257; Loeffler C, 2005, PLANT PHYSIOL, V137, P328, DOI 10.1104/pp.104.051714; Malkin R., 2000, BIOCH MOL BIOL PLANT, P568; McConn M, 1996, PLANT CELL, V8, P403, DOI 10.1105/tpc.8.3.403; MIQUEL M, 1992, J BIOL CHEM, V267, P1502; Muckenschnabel I, 2002, J EXP BOT, V53, P207, DOI 10.1093/jexbot/53.367.207; Mueller MJ, 2004, CURR OPIN PLANT BIOL, V7, P441, DOI 10.1016/j.pbi.2004.04.001; Sattler SE, 2006, PLANT CELL, V18, P3706, DOI 10.1105/tpc.106.044065; Sattler SE, 2004, PLANT CELL, V16, P1419, DOI 10.1105/tpc.021360; Scott IM, 2004, PLANT PHYSIOL, V135, P1040, DOI 10.1104/pp.104.041293; SINNHUBER RO, 1958, FOOD TECHNOL-CHICAGO, V12, P59; Vollenweider S, 2000, PLANT J, V24, P467, DOI 10.1046/j.1365-313x.2000.00897.x; Wasternack C, 2007, ANN BOT-LONDON, V100, P681, DOI 10.1093/aob/mcm079; Weber H, 2004, PLANT J, V37, P877, DOI 10.1111/j.1365-313X.2003.02013.x; WILBUR KM, 1949, ARCH BIOCHEM, V24, P305; YAGI K, 1976, BIOCHEM MED METAB B, V15, P212, DOI 10.1016/0006-2944(76)90049-1; Yeo HC, 1999, METHOD ENZYMOL, V300, P70	27	41	41	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35749	35756		10.1074/jbc.M706838200	http://dx.doi.org/10.1074/jbc.M706838200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17928299	hybrid			2022-12-27	WOS:000251458100036
J	Sakaguchi, M; Murata, H; Sonegawa, H; Sakaguchi, Y; Futami, J; Kitazoe, M; Yamada, H; Huh, N				Sakaguchi, Masakiyo; Murata, Hitoshi; Sonegawa, Hiroyuki; Sakaguchi, Yoshihiko; Futami, Jun-ichiro; Kitazoe, Midori; Yamada, Hidenori; Huh, Nam-ho			Truncation of annexin A1 is a regulatory lever for linking epidermal growth factor signaling with cytosolic phospholipase A2 in normal and malignant squamous epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN KERATINOCYTES; ARACHIDONIC-ACID; PROSTATE-CANCER; FACTOR RECEPTOR; LIPOCORTIN-I; PROTEIN; INHIBITION; PHOSPHORYLATION; EXPRESSION; BINDING	Regulation of cell growth and apoptosis is one of the pleiotropic functions of annexin A1 (ANXA1). Although previous reports on the overexpression of ANXA1 in many human cancers and on growth suppression and/or induction of apoptosis by ANXA1 may indicate the tumor-suppressive nature of ANXA1, molecular mechanisms of the function of ANXA1 remain largely unknown. Here we provide evidence that ANXA1 mechanistically links the epidermal growth factor-triggered growth signal pathway with cytosolic phospholipase A(2) (cPLA(2)), an initiator enzyme of the arachidonic acid cascade, through interaction with S100A11 in normal human keratinocytes (NHK). Ca2+ -dependent binding of S100A11 to ANXA1 facilitated the binding of the latter to cPLA2, resulting in inhibition of cPLA2 activity, which is essential for the growth of NHK. On exposure of NHK to epidermal growth factor, ANXA1 was cleaved solely at Trp(12), and this cleavage was executed by cathepsin D. In squamous cancer cells, this pathway was shown to be constitutively activated. The newly found mechanistic intersection may be a promising target for establishing new measures against human cancer and other cell growth disorders.	Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Cell Biol, Okayama 7008558, Japan; Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Bacteriol, Okayama 7008558, Japan; Okayama Univ, Grad Sch Nat Sci & Technol, Dept Biosci & Biotechnol, Okayama 7008530, Japan	Okayama University; Okayama University; Okayama University	Huh, N (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Cell Biol, Okayama 7008558, Japan.	namu@md.okayama-u.ac.jp	MURATA, Hitoshi/B-2327-2011; Sakaguchi, Masakiyo/B-2280-2011; YAMADA, Hidenori/B-2639-2011; FUTAMI, Junichiro/B-2578-2011	FUTAMI, Junichiro/0000-0002-0020-2855				ANDO Y, 1989, J BIOL CHEM, V264, P6948; CROXTALL JD, 1995, BIOCHEM PHARMACOL, V50, P465, DOI 10.1016/0006-2952(95)00156-T; Cuervo AM, 2000, J BIOL CHEM, V275, P33329, DOI 10.1074/jbc.M005655200; DAVIDSON FF, 1987, J BIOL CHEM, V262, P1698; FLOWER RJ, 1976, BIOCHEM PHARMACOL, V25, P285, DOI 10.1016/0006-2952(76)90216-1; FUTTER CE, 1993, J CELL BIOL, V120, P77, DOI 10.1083/jcb.120.1.77; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; HAIGLER HT, 1987, J BIOL CHEM, V262, P6921; Hsiang CH, 2006, PROSTATE, V66, P1413, DOI 10.1002/pros.20457; Hu N, 2004, CLIN CANCER RES, V10, P6013, DOI 10.1158/1078-0432.CCR-04-0317; Kang JS, 2002, CLIN CANCER RES, V8, P117; KIM KM, 1994, FEBS LETT, V343, P251, DOI 10.1016/0014-5793(94)80566-0; Li JL, 1997, BIOL REPROD, V57, P929, DOI 10.1095/biolreprod57.4.929; Lim LHK, 2007, FASEB J, V21, P968, DOI 10.1096/fj.06-7464rev; Lo HH, 1998, CANCER RES, V58, P4624; Mailliard WS, 1996, J BIOL CHEM, V271, P719, DOI 10.1074/jbc.271.2.719; Movitz C, 1999, BBA-BIOMEMBRANES, V1416, P101, DOI 10.1016/S0005-2736(98)00212-0; Nakanishi M, 2006, BBA-MOL CELL BIOL L, V1761, P1335, DOI 10.1016/j.bbalip.2006.09.005; Ohuchida K, 2006, CLIN CANCER RES, V12, P5417, DOI 10.1158/1078-0432.CCR-06-0222; Parente L, 2004, INFLAMM RES, V53, P125, DOI 10.1007/s00011-003-1235-z; PEPINSKY RB, 1986, NATURE, V321, P81, DOI 10.1038/321081a0; Radke S, 2004, FEBS LETT, V578, P95, DOI 10.1016/j.febslet.2004.10.078; SAKAGUCH M, 2007, IN PRESS MOL BIOL CE; Sakaguchi M, 2005, P NATL ACAD SCI USA, V102, P13921, DOI 10.1073/pnas.0500630102; Sakaguchi M, 2004, J CELL BIOL, V164, P979, DOI 10.1083/jcb.200312041; Sakaguchi M, 2003, J CELL BIOL, V163, P825, DOI 10.1083/jcb.200304017; Seemann J, 1996, BIOCHEM J, V319, P123, DOI 10.1042/bj3190123; Shen DJ, 2005, BIOCHEM BIOPH RES CO, V326, P218, DOI 10.1016/j.bbrc.2004.10.214; Sonegawa H, 2007, J MOL MED, V85, P753, DOI 10.1007/s00109-007-0180-7; Vishwanatha JK, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-8; White IJ, 2006, EMBO J, V25, P1, DOI 10.1038/sj.emboj.7600759	31	46	55	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35679	35686		10.1074/jbc.M707538200	http://dx.doi.org/10.1074/jbc.M707538200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17932043	hybrid			2022-12-27	WOS:000251458100028
J	Nguyen, MTA; Favelyukis, S; Nguyen, AK; Reichart, D; Scott, PA; Jenn, A; Liu-Bryan, R; Glass, CK; Neels, JG; Olefsky, JM				Nguyen, M. T. Audrey; Favelyukis, Svetlana; Nguyen, Anh-Khoi; Reichart, Donna; Scott, Peter A.; Jenn, Alan; Liu-Bryan, Ru; Glass, Christopher K.; Neels, Jaap G.; Olefsky, Jerrold M.			A subpopulation of macrophages infiltrates hypertrophic adipose tissue and is activated by free fatty acids via toll-like receptors 2 and 4 and JNK-dependent pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED INSULIN-RESISTANCE; DIET-INDUCED OBESITY; GENE-EXPRESSION; INFLAMMATION; TLR4; ACCUMULATION; RECEPTORS; MONOCYTES; MICE	Obesity and type 2 diabetes are characterized by decreased insulin sensitivity, elevated concentrations of free fatty acids (FFAs), and increased macrophage infiltration in adipose tissue ( AT). Here, we show that FFAs can cause activation of RAW264.7 cells primarily via the JNK signaling cascade and that TLR2 and TLR4 are upstream of JNK and help transduce FFA proinflammatory signals. We also demonstrate that F4/80(+/-) CD11b(+/-) CD11c(+/-) bone marrow-derived dendritic cells (BMDCs) have heightened proinflammatory activity compared with F4/80(+/-) CD11b(+) CD11c(+) bone marrow-derived macrophages and that the proinflammatory activity and JNK phosphorylation of BMDCs, but not bone marrow-derived macrophages, was further increased by FFA treatment. F4/80(+) CD11b(+) CD11c(+) cells were found in AT, and the proportion and number of these cells in AT is increased in ob/ob mice and by feeding wild type mice a high fat diet for 1 and 12 weeks. AT F4/80(+) CD11b(+) CD11c(+) cells express increased inflammatory markers compared with F4/80(+) CD11b(+) CD11c(-) cells, and FFA treatment increased inflammatory responses in these cells. In addition, we found that CD11c expression is increased in skeletal muscle of high fat diet-fed mice and that conditioned medium from FFA-treated wild type BMDCs, but not TLR2/4 DKO BMDCs, can induce insulin resistance in L6 myotubes. Together our results show that FFAs can activate CD11c(+) myeloid proinflammatory cells via TLR2/4 and JNK signaling pathways, thereby promoting inflammation and subsequent cellular insulin resistance.	Univ Calif San Diego, Div Endocrinol Metab, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Vet Affairs Med Ctr, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Nguyen, MTA (corresponding author), Univ Calif San Diego, Div Endocrinol Metab, 9500 Gilman Dr, La Jolla, CA 92093 USA.	m9nguyen@ucsd.edu	Glass, Christopher/AAI-3933-2021; Nguyen, Minh Tho/N-9582-2019; Scott, Peter/GYA-5335-2022; Neels, Jaap G/F-5534-2010	Glass, Christopher/0000-0003-4344-3592; Nguyen, Minh Tho/0000-0002-3803-0569; Neels, Jaap G/0000-0002-5900-8395; Jenn, Alan/0000-0003-4232-0697	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR049416] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK033651, P01DK074868, R01DK033651] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR049416] Funding Source: Medline; NIDDK NIH HHS [DK33651, DK074868] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Boden G, 2002, CURR OPIN CLIN NUTR, V5, P545, DOI 10.1097/00075197-200209000-00014; Boden G, 1997, DIABETES, V46, P3, DOI 10.2337/diabetes.46.1.3; Boschmann M, 2005, HYPERTENSION, V46, P130, DOI 10.1161/01.HYP.0000171477.63859.b2; Bouloumie A, 2005, CURR OPIN CLIN NUTR, V8, P347, DOI 10.1097/01.mco.0000172571.41149.52; Brake DK, 2006, AM J PHYSIOL-CELL PH, V291, pC1232, DOI 10.1152/ajpcell.00008.2006; Bruun JM, 2006, AM J PHYSIOL-ENDOC M, V290, pE961, DOI 10.1152/ajpendo.00506.2005; Cancello R, 2005, DIABETES, V54, P2277, DOI 10.2337/diabetes.54.8.2277; Curat CA, 2006, DIABETOLOGIA, V49, P744, DOI 10.1007/s00125-006-0173-z; Dandona P, 2004, TRENDS IMMUNOL, V25, P4, DOI 10.1016/j.it.2003.10.013; Daynes RA, 2002, NAT REV IMMUNOL, V2, P748, DOI 10.1038/nri912; Delerive P, 2001, J ENDOCRINOL, V169, P453, DOI 10.1677/joe.0.1690453; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Ghanim H, 2004, CIRCULATION, V110, P1564, DOI 10.1161/01.CIR.0000142055.53122.FA; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hoshino K, 1999, J IMMUNOL, V162, P3749; Kolb H, 2005, DIABETOLOGIA, V48, P1038, DOI 10.1007/s00125-005-1764-9; Kraegen EW, 2001, EXP CLIN ENDOCR DIAB, V109, pS189, DOI 10.1055/s-2001-18581; Lai L, 1998, J IMMUNOL, V160, P3861; Lee JY, 2004, J BIOL CHEM, V279, P16971, DOI 10.1074/jbc.M312990200; Lesniewski LA, 2007, NAT MED, V13, P455, DOI 10.1038/nm1550; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Mantovani A, 2005, IMMUNITY, V23, P344, DOI 10.1016/j.immuni.2005.10.001; Mohanty P, 2004, J CLIN ENDOCR METAB, V89, P2728, DOI 10.1210/jc.2003-032103; Nguyen MTA, 2005, J BIOL CHEM, V280, P35361, DOI 10.1074/jbc.M504611200; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; SPECTOR AA, 1969, J LIPID RES, V10, P56; Tripathy D, 2003, DIABETES, V52, P2882, DOI 10.2337/diabetes.52.12.2882; Tsukumo DML, 2007, DIABETES, V56, P1986, DOI 10.2337/db06-1595; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620	37	733	759	0	51	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					35279	35292		10.1074/jbc.M706762200	http://dx.doi.org/10.1074/jbc.M706762200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17916553	hybrid			2022-12-27	WOS:000251155200072
J	Wang, H; Zhao, Y; Li, L; McNutt, MA; Wu, LP; Lu, SL; Yu, Y; Zhou, W; Feng, J; Chai, GL; Yang, Y; Zhu, WG				Wang, Haiying; Zhao, Ying; Li, Lian; McNutt, Michael A.; Wu, Lipeng; Lu, Shaoli; Yu, Yu; Zhou, Wen; Feng, Jingnan; Chai, Guolin; Yang, Yang; Zhu, Wei-Guo			An ATM- and Rad3-related (ATR) signaling pathway and a phosphorylation-acetylation cascade are involved in activation of p53/p21(Waf1/Cip1) in response to 5-aza-2 '-deoxycytidine treatment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DAMAGE-INDUCED PHOSPHORYLATION; CELL-CYCLE ARREST; DOUBLE-STRAND BREAKS; DNA-DAMAGE; IONIZING-RADIATION; P53 ACETYLATION; TRANSCRIPTIONAL ACTIVITY; ATAXIA-TELANGIECTASIA; TUMOR-SUPPRESSOR; MAMMALIAN-CELLS	Most agents that damage DNA act through posttranslational modifications of p53 and activate its downstream targets. However, whether cellular responses to nucleoside analogue-induced DNA damage also operate through p53 posttranslational modification has not been reported. In this study, the relationship between p53 activation and its posttranslational modifications was investigated in the human cancer cell lines A549 and HCT116 in response to 5-aza-2 '-deoxycytidine (5-aza-CdR) or cytarabine treatment. 5-Aza-CdR induces p53 posttranslational modifications through activation of an ATM- and Rad3-related (ATR) signaling pathway, and 5-aza-CdR-induced association of replication protein A with chromatin is required for the binding of ATR to chromatin. Upon treatment with 5-aza-CdR, ATR activation is clearly associated with p53 phosphorylation at Ser(15), but not at Thr(18), Ser(20), or Ser(37). This specific p53 phosphorylation at Ser15 in turn results in acetylation of p53 at Lys(320) and Lys(373)/Lys(382) through transcriptional cofactors p300/CBP-associated factor and p300, respectively. These p53 posttranslational modifications are directly responsible for 5-aza-CdR induced p21(Waf1/Cip1) expression because the binding activity of acetylated p53 at Lys(320)/Lys(373)/ Lys(382) to the p21(Waf1/Cip1) promoter, as well as p21(Waf1/Cip1) expression itself are significantly increased after 5-aza-CdR treatment. It is of interest that p53 phosphorylation at Ser15 and acetylations at Lys(320)/Lys(373)/ Lys382 mutually interact in the 5-aza-CdR induced p21(Waf1)/(Cip1) expression shown by transfection of artificially mutated p53 expression vectors including S15A, K320R, and K373R/K382 into p53-null H1299 cells. These data taken together show for the first time that 5-aza-CdR activates the ATR signaling pathway, which elicits a specific p53 phosphorylation-acetylation cascade to induce p21(Waf1/Cip1) expression.	[Wang, Haiying; Zhao, Ying; Li, Lian; Wu, Lipeng; Lu, Shaoli; Yu, Yu; Zhou, Wen; Feng, Jingnan; Chai, Guolin; Yang, Yang; Zhu, Wei-Guo] Peking Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Beijing 100083, Peoples R China; [McNutt, Michael A.] Peking Univ, Hlth Sci Ctr, Dept Pathol, Beijing 100083, Peoples R China; [Zhu, Wei-Guo] Peking Univ, Hlth Sci Ctr, Canc Res Ctr, Beijing 100083, Peoples R China	Peking University; Peking University; Peking University	Zhu, WG (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, 38 Xueyuan Rd, Beijing 100083, Peoples R China.	zhuweiguo@bjmu.edu.cn	Zhou, Wen/A-5763-2010; zhu, wei-guo/E-1334-2012	Zhou, Wen/0000-0002-5496-5815; Wang, Haiying/0000-0001-7729-0649; Yang, Yang/0000-0002-8737-590X; Zhu, Wei-Guo/0000-0001-8385-6581				Abida WM, 2007, J BIOL CHEM, V282, P1797, DOI 10.1074/jbc.M609001200; Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Andegeko Y, 2001, J BIOL CHEM, V276, P38224; Appella E, 2001, EUR J BIOCHEM, V268, P2764, DOI 10.1046/j.1432-1327.2001.02225.x; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Chao C, 2006, MOL CELL BIOL, V26, P6859, DOI 10.1128/MCB.00062-06; Chen DL, 2005, CELL, V121, P1071, DOI 10.1016/j.cell.2005.03.037; Cliby WA, 1998, EMBO J, V17, P159, DOI 10.1093/emboj/17.1.159; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; Costanzo V, 2003, MOL CELL, V11, P203, DOI 10.1016/S1097-2765(02)00799-2; COVEY JM, 1986, CANCER RES, V46, P5511; DINCALCI M, 1985, CANCER RES, V45, P3197; Dornan D, 2001, EMBO REP, V2, P139, DOI 10.1093/embo-reports/kve025; Dornan D, 2004, NATURE, V429, P86, DOI 10.1038/nature02514; Dumaz N, 1999, EMBO J, V18, P7002, DOI 10.1093/emboj/18.24.7002; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Guo ZJ, 2000, GENE DEV, V14, P2745, DOI 10.1101/gad.842500; HAAF T, 1995, PHARMACOL THERAPEUT, V65, P19, DOI 10.1016/0163-7258(94)00053-6; Harper JW, 2004, CELL, V118, P2, DOI 10.1016/j.cell.2004.06.015; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hekmat-Nejad M, 2000, CURR BIOL, V10, P1565, DOI 10.1016/S0960-9822(00)00855-1; Hofmann TG, 2002, NAT CELL BIOL, V4, P1, DOI 10.1038/ncb715; HUPP TR, 1995, CELL, V83, P237, DOI 10.1016/0092-8674(95)90165-5; Ito A, 2001, EMBO J, V20, P1331, DOI 10.1093/emboj/20.6.1331; Ito A, 2002, EMBO J, V21, P6236, DOI 10.1093/emboj/cdf616; Karpf AR, 2001, MOL PHARMACOL, V59, P751, DOI 10.1124/mol.59.4.751; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; KHANNA KK, 1993, ONCOGENE, V8, P3307; Knights CD, 2006, J CELL BIOL, V173, P533, DOI 10.1083/jcb.200512059; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Lambert PF, 1998, J BIOL CHEM, V273, P33048, DOI 10.1074/jbc.273.49.33048; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Leng RP, 2003, CELL, V112, P779, DOI 10.1016/S0092-8674(03)00193-4; Li MY, 2002, J BIOL CHEM, V277, P50607, DOI 10.1074/jbc.C200578200; Lill NL, 1997, NATURE, V387, P823, DOI 10.1038/42981; Liu L, 1999, MOL CELL BIOL, V19, P1202; Luo JY, 2004, P NATL ACAD SCI USA, V101, P2259, DOI 10.1073/pnas.0308762101; MAYR GA, 1995, CANCER RES, V55, P2410; McKinney K, 2004, MOL CELL, V16, P413, DOI 10.1016/j.molcel.2004.09.032; Nag A, 2007, J BIOL CHEM, V282, P8812, DOI 10.1074/jbc.M610443200; Ou YH, 2005, MOL BIOL CELL, V16, P1684, DOI 10.1091/mbc.E04-08-0689; Pandita TK, 2000, ONCOGENE, V19, P1386, DOI 10.1038/sj.onc.1203444; Paulsen RD, 2007, DNA REPAIR, V6, P953, DOI 10.1016/j.dnarep.2007.02.015; Roy S, 2005, CELL DEATH DIFFER, V12, P482, DOI 10.1038/sj.cdd.4401581; Saito S, 2002, J BIOL CHEM, V277, P12491, DOI 10.1074/jbc.C200093200; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; Sakaguchi K, 1997, BIOCHEMISTRY-US, V36, P10117, DOI 10.1021/bi970759w; Sakaguchi K, 2000, J BIOL CHEM, V275, P9278, DOI 10.1074/jbc.275.13.9278; Scacheri PC, 2004, P NATL ACAD SCI USA, V101, P1892, DOI 10.1073/pnas.0308698100; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Shiotani B, 2006, MOL CANCER RES, V4, P125, DOI 10.1158/1541-7786.MCR-05-0104; Siliciano JD, 1997, GENE DEV, V11, P3471, DOI 10.1101/gad.11.24.3471; Sykes SM, 2006, MOL CELL, V24, P841, DOI 10.1016/j.molcel.2006.11.026; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; Unger T, 1999, EMBO J, V18, P1805, DOI 10.1093/emboj/18.7.1805; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; WANG Y, 1995, NATURE, V376, P88, DOI 10.1038/376088a0; Wong DS, 2004, J BIOL CHEM, V279, P55667, DOI 10.1074/jbc.M408174200; Wright JA, 1998, P NATL ACAD SCI USA, V95, P7445, DOI 10.1073/pnas.95.13.7445; Xirodimas DP, 2004, CELL, V118, P83, DOI 10.1016/j.cell.2004.06.016; Yang J, 2003, CARCINOGENESIS, V24, P1571, DOI 10.1093/carcin/bgg137; Yih LH, 2000, CANCER RES, V60, P6346; Zhang YP, 2001, SCIENCE, V292, P1910, DOI 10.1126/science.1058637; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001; Zhao Y, 2006, MOL CELL BIOL, V26, P2782, DOI 10.1128/MCB.26.7.2782-2790.2006; Zhu WG, 2004, J BIOL CHEM, V279, P15161, DOI 10.1074/jbc.M311703200; Zou L, 2002, GENE DEV, V16, P198, DOI 10.1101/gad.950302; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	73	43	51	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2564	2574		10.1074/jbc.M702454200	http://dx.doi.org/10.1074/jbc.M702454200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	17977830	hybrid			2022-12-27	WOS:000252622300013
J	Amir-Zilberstein, L; Dikstein, R				Amir-Zilberstein, Liat; Dikstein, Rivka			Interplay between E-box and NF-kappa B in regulation of A20 gene by DRB sensitivity-inducing factor (DSIF)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; UPSTREAM STIMULATORY FACTOR; P-TEFB; TRANSCRIPTION ELONGATION; PROMOTER; REPRESSION; COMPLEX; CELLS; SPT5	The NF-kappa B target gene A20 serves as a paradigm for gene-specific control of transcription elongation. This gene is regulated by the elongation factor DSIF (DRB sensitivity-inducing factor) under basal and NF-kappa B-activated states by two distinct mechanisms. Prior to NF-kappa B stimulation, the A20 gene is occupied by polymerase II, and elongation is inhibited by DSIF. This inhibition is mediated by an upstream promoter element termed ELIE (elongation inhibitory element). Upon NF-kappa B activation, inhibition of the A20 gene by DSIF persists, but now NF-kappa B and the core promoter regulate DSIF instead of ELIE. Here we investigated the regulation of DSIF by ELIE and the regulatory switch from ELIE to NF-kappa B following NF-kappa B induction. Electrophoretic mobility shift assays revealed two distinct protein complexes that specifically interact with ELIE, one of which is the E-box protein USF1. Interestingly, USF1 is displaced from the A20 promoter upon induction of NF-kappa B. A mutation in the E-box section of ELIE diminished the binding of USF1 and DSIF recruitment. Consistent with these findings, the E-box is crucial for DSIF inhibition in resting, but not NF-kappa B stimulated, cells. These findings reveal a dynamic regulation of DSIF involving either E-box or NF-kappa B depending on the physiological circumstances.	[Amir-Zilberstein, Liat; Dikstein, Rivka] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Dikstein, R (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	rivka.dikstein@weizmann.ac.il						Ainbinder E, 2004, MOL CELL BIOL, V24, P2444, DOI 10.1128/MCB.24.6.2444-2454.2004; Ainbinder E, 2002, MOL CELL BIOL, V22, P6354, DOI 10.1128/MCB.22.18.6354-6362.2002; Amir-Zilberstein L, 2007, MOL CELL BIOL, V27, P5246, DOI 10.1128/MCB.00586-07; Andrulis ED, 2000, GENE DEV, V14, P2635, DOI 10.1101/gad.844200; Barboric M, 2001, MOL CELL, V8, P327, DOI 10.1016/S1097-2765(01)00314-8; Chang JTC, 2005, MOL CARCINOGEN, V44, P183, DOI 10.1002/mc.20129; Goueli BS, 2003, ONCOGENE, V22, P8042, DOI 10.1038/sj.onc.1206847; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Luecke HF, 2005, GENE DEV, V19, P1116, DOI 10.1101/gad.1297105; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Pinaud S, 1998, J MOL BIOL, V280, P785, DOI 10.1006/jmbi.1998.1905; Price DH, 2000, MOL CELL BIOL, V20, P2629, DOI 10.1128/MCB.20.8.2629-2634.2000; Renner DB, 2001, J BIOL CHEM, V276, P42601, DOI 10.1074/jbc.M104967200; ROUGVIE AE, 1990, MOL CELL BIOL, V10, P6041, DOI 10.1128/MCB.10.11.6041; Selva DM, 2005, J BIOL CHEM, V280, P4462, DOI 10.1074/jbc.M409616200; Shilatifard A, 2003, ANNU REV BIOCHEM, V72, P693, DOI 10.1146/annurev.biochem.72.121801.161551; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; SPENCER CA, 1991, ADV CANCER RES, V56, P1; Wada T, 1998, EMBO J, V17, P7395, DOI 10.1093/emboj/17.24.7395; Wada T, 1998, GENE DEV, V12, P343, DOI 10.1101/gad.12.3.343; Wang XL, 2007, GENE DEV, V21, P1031, DOI 10.1101/gad.1521207; Yamada T, 2006, MOL CELL, V21, P227, DOI 10.1016/j.molcel.2005.11.024; Yamaguchi Y, 1999, CELL, V97, P41, DOI 10.1016/S0092-8674(00)80713-8	23	21	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1317	1323		10.1074/jbc.M706767200	http://dx.doi.org/10.1074/jbc.M706767200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	17962196	hybrid			2022-12-27	WOS:000252282700014
J	Chen, Y; Cai, T; Yang, CJ; Turner, DA; Giovannucci, DR; Xie, ZJ				Chen, Ying; Cai, Ting; Yang, Changjun; Turner, David A.; Giovannucci, David R.; Xie, Zijian			Regulation of inositol 1,4,5-trisphosphate receptor-mediated calcium release by the Na/K-ATPase in cultured renal epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+/K+-ATPASE; SIGNALING MICRODOMAINS; ENDOPLASMIC-RETICULUM; LLC-PK1 CELLS; IP3 RECEPTORS; KIDNEY-CELLS; HOMER BINDS; CAVEOLAE; NA,K-ATPASE; COMPLEX	It is known that the Na/K-ATPase alpha 1 subunit interacts directly with inositol 1,4,5-triphosphate (IP3) receptors. In this study we tested whether this interaction is required for extracellular stimuli to efficiently regulate endoplasmic reticulum ( ER) Ca2+ release. Using cultured pig kidney LLC-PK1 cells as a model, we demonstrated that graded knockdown of the cellular Na/K-ATPase alpha 1 subunit resulted in a parallel attenuation of ATP-induced ER Ca2+ release. When the knockdown cells were rescued by knocking in a rat alpha 1, the expression of rat alpha 1 restored not only the cellular Na/K-ATPase but also ATP-induced ER Ca2+ release. Mechanistically, this defect in ATP-induced ER Ca2+ release was neither due to the changes in the amount or the function of cellular IP3 and P2Y receptors nor the ER Ca2+ content. However, the alpha 1 knockdown did redistribute cellular IP3 receptors. The pool of IP3 receptors that resided close to the plasma membrane was abolished. Because changes in the plasma membrane proximity could reduce the efficiency of signal transmission from P2Y receptors to the ER, we further determined the dose-dependent effects of ATP on protein kinase C is an element of activation and ER Ca2+ release. The data showed that the alpha 1 knockdown de-sensitized the ATP-induced ER Ca2+ release but not PKC is an element of activation. Moreover, expression of the N terminus of Na/K-ATPase alpha 1 subunit not only disrupted the formation of the Na/K-ATPase-IP3 receptor complex but also abolished the ATP-induced Ca2+ release. Finally, we observed that the alpha 1 knockdown was also effective in attenuating ER Ca2+ release provoked by angiotensin II and epidermal growth factor.	[Chen, Ying; Cai, Ting; Yang, Changjun; Xie, Zijian] Univ Toledo, Coll Med, Dept Physiol & Pharmacol, Toledo, OH 43614 USA; [Turner, David A.; Giovannucci, David R.] Univ Toledo, Coll Med, Dept Neurosci, Toledo, OH 43614 USA	University of Toledo; University of Toledo	Xie, ZJ (corresponding author), Univ Toledo, Coll Med, Dept Physiol & Pharmacol, 3035 Arlington Ave, Toledo, OH 43614 USA.	Zi-Jian.Xie@utoledo.edu	Yang, Changjun/N-3767-2014; Giovannucci, David R/A-5657-2018	Yang, Changjun/0000-0002-4354-4943; Chen, Ying/0000-0002-6862-5678	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL036573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078565] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-67936, HL-36573] Funding Source: Medline; NIGMS NIH HHS [GM-78565] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; Blaustein MR, 2001, TRENDS NEUROSCI, V24, P602, DOI 10.1016/S0166-2236(00)01891-9; Bosanac I, 2004, BBA-MOL CELL RES, V1742, P89, DOI 10.1016/j.bbamcr.2004.09.016; BUSH KT, 1994, J BIOL CHEM, V269, P23694; Chen R, 2004, J CELL BIOL, V166, P193, DOI 10.1083/jcb.200309146; Chini B, 2004, J MOL ENDOCRINOL, V32, P325, DOI 10.1677/jme.0.0320325; Cui J, 2004, J BIOL CHEM, V279, P16311, DOI 10.1074/jbc.M400206200; Delmas P, 2002, NEURON, V36, P787, DOI 10.1016/S0896-6273(02)01097-8; Delmas P, 2002, NEURON, V34, P209, DOI 10.1016/S0896-6273(02)00641-4; Filipovic DM, 1998, AM J PHYSIOL-RENAL, V274, pF1070, DOI 10.1152/ajprenal.1998.274.6.F1070; Haas A, 2002, J BIOL CHEM, V277, P18694, DOI 10.1074/jbc.M111357200; HARADA H, 1993, AM J PHYSIOL, V264, pC956, DOI 10.1152/ajpcell.1993.264.4.C956; Hirose K, 1999, SCIENCE, V284, P1527, DOI 10.1126/science.284.5419.1527; Hur EM, 2005, J CELL BIOL, V169, P657, DOI 10.1083/jcb.200411034; Isshiki M, 2002, J CELL SCI, V115, P475; Jacob SN, 2005, J NEUROSCI, V25, P2853, DOI 10.1523/JNEUROSCI.4313-04.2005; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; Kogo H, 1997, ACTA HISTOCHEM CYTOC, V30, P593, DOI 10.1267/ahc.30.593; Lea JP, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000022029.50356.2C; Lencesova L, 2004, J BIOL CHEM, V279, P2885, DOI 10.1074/jbc.M310365200; Li CL, 2003, AM J PHYSIOL-RENAL, V285, pF889, DOI 10.1152/ajprenal.00170.2003; Liang M, 2007, J BIOL CHEM, V282, P10585, DOI 10.1074/jbc.M609181200; Liang M, 2006, J BIOL CHEM, V281, P19709, DOI 10.1074/jbc.M512240200; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; Michikawa T, 1999, NEURON, V23, P799, DOI 10.1016/S0896-6273(01)80037-4; Missiaen L, 2000, MOL PHARMACOL, V57, P564, DOI 10.1124/mol.57.3.564; Miyakawa-Naito A, 2003, J BIOL CHEM, V278, P50355, DOI 10.1074/jbc.M305378200; Mobasheri Ali, 2003, Cancer Cell Int, V3, P8, DOI 10.1186/1475-2867-3-8; Mohammadi K, 2001, J BIOL CHEM, V276, P42050, DOI 10.1074/jbc.M107892200; Mohler PJ, 2005, PLOS BIOL, V3, P2158, DOI 10.1371/journal.pbio.0030423; Nguyen ANT, 2007, J AM SOC NEPHROL, V18, P46, DOI 10.1681/ASN.2006010086; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Piepenhagen PA, 1998, MOL BIOL CELL, V9, P3161, DOI 10.1091/mbc.9.11.3161; Ralevic V, 1998, PHARMACOL REV, V50, P413; Razani B, 2002, PHARMACOL REV, V54, P431, DOI 10.1124/pr.54.3.431; Tanimura A, 2000, J BIOL CHEM, V275, P27488; Tian J, 2006, MOL BIOL CELL, V17, P317, DOI 10.1091/mbc.E05-08-0735; Tu JC, 1998, NEURON, V21, P717, DOI 10.1016/S0896-6273(00)80589-9; Vermassen E, 2004, BIOL CELL, V96, P3, DOI 10.1016/j.biolcel.2003.11.004; Wang HJ, 2004, J BIOL CHEM, V279, P17250, DOI 10.1074/jbc.M313239200; WODOPIA R, 2000, AM J PSYSL, V278, pL1110; Xie ZJ, 2002, EUR J BIOCHEM, V269, P2434, DOI 10.1046/j.1432-1033.2002.02910.x; Yuan JP, 2003, CELL, V114, P777, DOI 10.1016/S0092-8674(03)00716-5; Yuan ZK, 2005, MOL BIOL CELL, V16, P4034, DOI 10.1091/mbc.E05-04-0295; Zhang SB, 2003, J BIOL CHEM, V278, P4048, DOI 10.1074/jbc.M209960200; Zhang SB, 2006, J BIOL CHEM, V281, P21954, DOI 10.1074/jbc.M601578200; Zhang ZS, 1998, J BIOL CHEM, V273, P18681, DOI 10.1074/jbc.273.30.18681	47	29	29	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					1128	1136		10.1074/jbc.M708025200	http://dx.doi.org/10.1074/jbc.M708025200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	17993456	hybrid			2022-12-27	WOS:000252128100053
J	Gallegos, JR; Litersky, J; Lee, H; Sun, Y; Nakayama, K; Nakayama, K; Lu, H				Gallegos, Jayme R.; Litersky, Joel; Lee, Hunjoo; Sun, Yi; Nakayama, Keiichi; Nakayama, Keiko; Lu, Hua			SCF beta TrCP1 activates and ubiquitylates TAp63 gamma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							I-KAPPA-B; UBIQUITIN LIGASE; TRANSCRIPTIONAL ACTIVITY; PROTEIN STABILITY; P53 HOMOLOG; P63; DEGRADATION; GENE; E3; MORPHOGENESIS	p63 is a member of the p53 tumor suppressor family that is critical for epithelial differentiation and also has an important role in cancer progression. Currently, the molecular mechanisms governing regulation of p63 function remain largely unclear. This study identifies a unique E3 ubiquitin ligase for p63, SCF beta TrCP1. SCF beta TrCP1 is able to bind p63 gamma isoforms, with a higher affinity for the TAp63 gamma isoform. Strikingly, co-expression of TAp63 gamma and beta TrCP1 leads to the stabilization of TAp63 gamma. This stabilization of TAp63 gamma leads to up-regulation of p21 at the mRNA and protein level by increased binding of TAp63 gamma at the p21 promoter. The up-regulation of p21 causes a subsequent increase in G(1) phase cell cycle arrest. Last, SCF beta TrCP1 is able to ubiquitylate TAp63 gamma, and this ubiquitylation, as well as the increased activity of TAp63 gamma, is ablated with the expression of a ubiquitin-deficient mutant of beta TrCP1 (Delta F beta TrCP1). Therefore, our study reveals that SCF beta TrCP1 is an E3 ligase that activates p63 through ubiquitylation.	[Lu, Hua] Indiana Univ, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Gallegos, Jayme R.; Litersky, Joel; Lee, Hunjoo; Lu, Hua] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; [Sun, Yi] Univ Michigan, Ctr Comprehens Canc, Dept Radiat Oncol, Ann Arbor, MI 48109 USA; [Nakayama, Keiichi; Nakayama, Keiko] Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Higashi Ku, Fukuoka 8128582, Japan; [Nakayama, Keiichi] CREST, Japan Sci & Technol Agcy, Kawagoe, Saitama 3320012, Japan; [Nakayama, Keiko] Tohoku Univ, Ctr Translat & Adv Anim Res, Grad Sch Med, Aoba Ku, Sendai, Miyagi 9808575, Japan	Indiana University System; Indiana University-Purdue University Indianapolis; Oregon Health & Science University; University of Michigan System; University of Michigan; Kyushu University; Japan Science & Technology Agency (JST); Tohoku University	Lu, H (corresponding author), Indiana Univ, Dept Biochem & Mol Biol, 635 Barnhill Dr, Indianapolis, IN 46202 USA.	hualu@iupui.edu	Sun, Yi/K-1025-2014	Sun, Yi/0000-0002-5841-4287	NCI NIH HHS [CA 079721, CA 93614, CA 095441] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA095441, R01CA079721, R01CA093614] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Belaidouni N, 2005, ONCOGENE, V24, P2271, DOI 10.1038/sj.onc.1208418; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Bourdon JC, 2005, GENE DEV, V19, P2122, DOI 10.1101/gad.1339905; Fuchs SY, 2004, ONCOGENE, V23, P2028, DOI 10.1038/sj.onc.1207389; Gomes NP, 2006, GENE DEV, V20, P601, DOI 10.1101/gad.1398206; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Iordanov MS, 2002, MOL CELL BIOL, V22, P5380, DOI 10.1128/MCB.22.15.5380-5394.2002; Jin JP, 2003, GENE DEV, V17, P3062, DOI 10.1101/gad.1157503; Jin YT, 2004, J BIOL CHEM, V279, P20035, DOI 10.1074/jbc.M309916200; Kim HT, 2007, J BIOL CHEM, V282, P17375, DOI 10.1074/jbc.M609659200; Kim SY, 2003, MOL CELL, V11, P1177, DOI 10.1016/S1097-2765(03)00173-4; King KE, 2006, CARCINOGENESIS, V27, P53, DOI 10.1093/carcin/bgi200; Krappmann D, 2005, EMBO REP, V6, P321, DOI 10.1038/sj.embor.7400380; Kulesz-Martin M, 2005, J INVEST DERM SYMP P, V10, P142, DOI 10.1111/j.1087-0024.2005.200405.x; Le Cam L, 2006, CELL, V127, P775, DOI 10.1016/j.cell.2006.09.031; Li YP, 2007, J BIOL CHEM, V282, P6936, DOI 10.1074/jbc.M603822200; MacPartlin M, 2005, J BIOL CHEM, V280, P30604, DOI 10.1074/jbc.M503352200; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Moll UM, 2004, MOL CANCER RES, V2, P371; Nakayama K, 2003, P NATL ACAD SCI USA, V100, P8752, DOI 10.1073/pnas.1133216100; Osada M, 2005, MOL CELL BIOL, V25, P6077, DOI 10.1128/MCB.25.14.6077-6089.2005; Osada M, 1998, NAT MED, V4, P839, DOI 10.1038/nm0798-839; Peters JM, 2003, MOL CELL, V11, P1420, DOI 10.1016/S1097-2765(03)00233-8; Querido E, 2001, GENE DEV, V15, P3104, DOI 10.1101/gad.926401; Rossi M, 2006, P NATL ACAD SCI USA, V103, P12753, DOI 10.1073/pnas.0603449103; Sil AK, 2004, NATURE, V428, P660, DOI 10.1038/nature02421; Tan MJ, 2006, NEOPLASIA, V8, P1042, DOI 10.1593/neo.06568; von der Lehr N, 2003, CELL CYCLE, V2, P403, DOI 10.4161/cc.2.5.484; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Zeng SX, 2002, EMBO J, V21, P5487, DOI 10.1093/emboj/cdf540	31	25	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					66	75		10.1074/jbc.M704686200	http://dx.doi.org/10.1074/jbc.M704686200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17965458	hybrid			2022-12-27	WOS:000251940300009
J	Galuska, SP; Geyer, R; Gerardy-Schahn, R; Muhlenhoff, M; Geyer, H				Galuska, Sebastian P.; Geyer, Rudolf; Gerardy-Schahn, Rita; Muehlenhoff, Martina; Geyer, Hildegard			Enzyme-dependent variations in the polysialylation of the neural cell adhesion molecule (NCAM) in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL-NERVOUS-SYSTEM; ST8SIA II STX; PERFORMANCE LIQUID-CHROMATOGRAPHY; DEVELOPMENTALLY-REGULATED MEMBER; ULTRASENSITIVE CHEMICAL METHOD; POLYSIALIC ACID SYNTHESIS; MASS-SPECTROMETRY; MOUSE-BRAIN; COOPERATIVE POLYSIALYLATION; HUMAN POLYSIALYLTRANSFERASE	Polysialic acid (polySia), an alpha 2,8-linked polymer of N-acetylneuraminic acid, represents an essential regulator of neural cell adhesion molecule ( NCAM) functions. Two polysialyltransferases, ST8SiaII and ST8SiaIV, account for polySia synthesis, but their individual roles in vivo are still not fully understood. Previous in vitro studies defined differences between the two enzymes in their usage of the two NCAM N-glycosylation sites affected and suggested a synergistic effect. Using mutant mice, lacking either enzyme, we now assessed in vivo the contribution of ST8SiaII and ST8SiaIV to polysialylation of NCAM. PolySia-NCAM was isolated from mouse brains and trypsinized, and polysialylated glycopeptides as well as glycans were analyzed in detail. Our results revealed an identical glycosylation and almost complete polysialylation of N-glycosylation sites 5 and 6 in polySia-NCAM irrespective of the enzyme present. The same sets of glycans were substituted by identical numbers of polySia chains in vivo, the length distribution of which, however, differed with the enzyme setting. Expression of ST8SiaIV alone led to higher amounts of short polySia chains and gradual decrease with length, whereas exclusive action of ST8SiaII evoked a slight reduction in long polySia chains only. These variations were most pronounced at N-glycosylation site 5, whereas the polysialylation pattern at N-glycosylation site 6 did not differ between NCAM from wild-type and ST8SiaII- or ST8SiaIV-deficient mice. Thus, our fine structure analyses suggest a comparable quality of polysialylation by ST8SiaII and ST8SiaIV and a distinct synergistic action of the two enzymes in the synthesis of long polySia chains at N-glycosylation site 5 in vivo.	[Galuska, Sebastian P.; Geyer, Rudolf; Geyer, Hildegard] Univ Giessen, Fac Med, Inst Biochem, D-35392 Giessen, Germany; [Gerardy-Schahn, Rita; Muehlenhoff, Martina] Hannover Med Sch, Inst Cellular Chem, D-30625 Hannover, Germany	Justus Liebig University Giessen; Hannover Medical School	Geyer, H (corresponding author), Univ Giessen, Fac Med, Inst Biochem, Friedrichstrasse 24, D-35392 Giessen, Germany.	hildegard.geyer@biochemie.med.uni-giessen.de						Angata K, 2003, BIOCHIMIE, V85, P195, DOI 10.1016/S0300-9084(03)00051-8; Angata K, 1998, J BIOL CHEM, V273, P28524, DOI 10.1074/jbc.273.43.28524; Angata K, 2004, J BIOL CHEM, V279, P32603, DOI 10.1074/jbc.M403429200; Angata K, 2000, J BIOL CHEM, V275, P18594, DOI 10.1074/jbc.M910204199; Angata K, 1997, J BIOL CHEM, V272, P7182, DOI 10.1074/jbc.272.11.7182; Angata K, 2002, J BIOL CHEM, V277, P36808, DOI 10.1074/jbc.M204632200; Angata K, 2007, MOL CELL BIOL, V27, P6659, DOI 10.1128/MCB.00205-07; Anumula Kalyan Rao, 1993, Journal of Molecular Recognition, V6, P139, DOI 10.1002/jmr.300060306; BIEMANN K, 1988, BIOMED ENVIRON MASS, V16, P99, DOI 10.1002/bms.1200160119; Bruses JL, 2001, BIOCHIMIE, V83, P635, DOI 10.1016/S0300-9084(01)01293-7; Close BE, 2003, J BIOL CHEM, V278, P30796, DOI 10.1074/jbc.M305390200; Conchonaud F, 2007, J BIOL CHEM, V282, P26266, DOI 10.1074/jbc.M608590200; ECKHARDT M, 1995, NATURE, V373, P715, DOI 10.1038/373715a0; Eckhardt M, 2000, J NEUROSCI, V20, P5234, DOI 10.1523/JNEUROSCI.20-14-05234.2000; El Maarouf A, 2005, P NATL ACAD SCI USA, V102, P11516, DOI 10.1073/pnas.0504718102; El Maarouf A, 2006, P NATL ACAD SCI USA, V103, P16989, DOI 10.1073/pnas.0608036103; Franceschini I, 2001, GLYCOBIOLOGY, V11, P231, DOI 10.1093/glycob/11.3.231; FROSCH M, 1985, P NATL ACAD SCI USA, V82, P1194, DOI 10.1073/pnas.82.4.1194; Fujimoto I, 2001, J BIOL CHEM, V276, P31745, DOI 10.1074/jbc.M104525200; Galuska SP, 2006, J BIOL CHEM, V281, P31605, DOI 10.1074/jbc.M606516200; Gascon E, 2007, BRAIN RES REV, V56, P101, DOI 10.1016/j.brainresrev.2007.05.014; Geyer H, 2005, J BIOL CHEM, V280, P40731, DOI 10.1074/jbc.M505985200; Geyer H, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh131; Geyer H, 2001, EUR J BIOCHEM, V268, P6587, DOI 10.1046/j.0014-2956.2001.02613.x; HALLENBECK PC, 1987, J BIOL CHEM, V262, P3553; HARA S, 1987, ANAL BIOCHEM, V164, P138, DOI 10.1016/0003-2697(87)90377-0; Hayrinen J, 2002, MOL IMMUNOL, V39, P399, DOI 10.1016/S0161-5890(02)00202-X; HE HT, 1987, J CELL BIOL, V105, P2489, DOI 10.1083/jcb.105.6.2489; Hildebrandt H, 1998, J NEUROCHEM, V71, P2339; Hinsby AM, 2004, FRONT BIOSCI-LANDMRK, V9, P2227, DOI 10.2741/1393; HIRN M, 1981, BRAIN RES, V214, P433, DOI 10.1016/0006-8993(81)91208-7; Inoue S, 2000, J BIOL CHEM, V275, P29968, DOI 10.1074/jbc.M004150200; Inoue S, 2003, METHOD ENZYMOL, V362, P543; Inoue S, 2001, BIOCHIMIE, V83, P605, DOI 10.1016/S0300-9084(01)01307-4; Inoue S, 2001, J BIOL CHEM, V276, P31863, DOI 10.1074/jbc.M103336200; Inoue S, 2001, GLYCOBIOLOGY, V11, P759, DOI 10.1093/glycob/11.9.759; Johnson CP, 2005, J BIOL CHEM, V280, P137, DOI 10.1074/jbc.M410216200; Johnson CP, 2004, P NATL ACAD SCI USA, V101, P6963, DOI 10.1073/pnas.0307567100; Kitazume-Kawaguchi S, 2001, J BIOL CHEM, V276, P15696, DOI 10.1074/jbc.M010371200; Kleene R, 2004, NAT REV NEUROSCI, V5, P195, DOI 10.1038/nrn1349; KOJIMA N, 1995, FEBS LETT, V360, P1, DOI 10.1016/0014-5793(95)00059-I; Kojima N, 1997, J BIOCHEM-TOKYO, V122, P1265; Kojima N, 1996, J BIOL CHEM, V271, P19457, DOI 10.1074/jbc.271.32.19457; Kudo M, 1998, GLYCOBIOLOGY, V8, P771, DOI 10.1093/glycob/8.8.771; KURAYA N, 1992, J BIOCHEM, V112, P122, DOI 10.1093/oxfordjournals.jbchem.a123850; Kurosawa N, 1997, J NEUROCHEM, V69, P494; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liedtke S, 2001, GLYCOBIOLOGY, V11, P373, DOI 10.1093/glycob/11.5.373; LIVINGSTON BD, 1993, J BIOL CHEM, V268, P11504; Mendiratta SS, 2006, J BIOL CHEM, V281, P36052, DOI 10.1074/jbc.M608073200; Muhlenhoff M, 1996, CURR BIOL, V6, P1188, DOI 10.1016/S0960-9822(02)70687-8; Nakata D, 2005, J BIOL CHEM, V280, P38305, DOI 10.1074/jbc.M508762200; NAKAYAMA J, 1995, P NATL ACAD SCI USA, V92, P7031, DOI 10.1073/pnas.92.15.7031; Nakayama J, 1996, J BIOL CHEM, V271, P1829, DOI 10.1074/jbc.271.4.1829; NELSON RW, 1995, J BIOL CHEM, V270, P17171, DOI 10.1074/jbc.270.29.17171; Ong E, 1998, GLYCOBIOLOGY, V8, P415, DOI 10.1093/glycob/8.4.415; PELKONEN S, 1989, J VIROL, V63, P4409, DOI 10.1128/JVI.63.10.4409-4416.1989; ROEPSTORFF P, 1984, BIOMED MASS SPECTROM, V11, P601, DOI 10.1002/bms.1200111109; Sato C, 2004, TRENDS GLYCOSCI GLYC, V16, P331, DOI 10.4052/tigg.16.331; SCHEIDEGGER EP, 1995, J BIOL CHEM, V270, P22685, DOI 10.1074/jbc.270.39.22685; SIMANIS V, 1985, VIROLOGY, V144, P88, DOI 10.1016/0042-6822(85)90308-3; Stensballe A, 2004, RAPID COMMUN MASS SP, V18, P1721, DOI 10.1002/rcm.1542; Stummeyer K, 2005, NAT STRUCT MOL BIOL, V12, P90, DOI 10.1038/nsmb874; TANG J, 1992, NEURON, V8, P1031, DOI 10.1016/0896-6273(92)90125-W; von der Ohe M, 2002, GLYCOBIOLOGY, V12, P47, DOI 10.1093/glycob/12.1.47; Walsh FS, 1997, ANNU REV CELL DEV BI, V13, P425, DOI 10.1146/annurev.cellbio.13.1.425; Weinhold B, 2005, J BIOL CHEM, V280, P42971, DOI 10.1074/jbc.M511097200; Wood GK, 1997, MOL BRAIN RES, V51, P69, DOI 10.1016/S0169-328X(97)00209-X; Wuhrer M, 2003, BIOCHIMIE, V85, P207, DOI 10.1016/S0300-9084(03)00043-9; YOSHIDA Y, 1995, J BIOCHEM-TOKYO, V118, P658, DOI 10.1093/oxfordjournals.jbchem.a124960; Zhang Y, 1999, J BIOL CHEM, V274, P6183, DOI 10.1074/jbc.274.10.6183	71	45	46	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					17	28		10.1074/jbc.M707024200	http://dx.doi.org/10.1074/jbc.M707024200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17986444	hybrid			2022-12-27	WOS:000251940300004
J	Hayashi, M; Maeda, S; Aburatani, H; Kitamura, K; Miyoshi, H; Miyazono, K; Imamura, T				Hayashi, Makoto; Maeda, Shingo; Aburatani, Hiroyuki; Kitamura, Kunio; Miyoshi, Hiroyuki; Miyazono, Kohei; Imamura, Takeshi			Pitx2 prevents osteoblastic transdifferentiation of myoblasts by bone morphogenetic proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR PITX2; PATHWAY; GENE; DIFFERENTIATION; INHIBITION	Muscle cells are often exposed to bone morphogenetic proteins (BMPs) in pathological muscle and/or bone conditions. Because BMPs function as strong bone inducers as well as myogenesis inhibitors, certain molecules likely prevent muscle cells from converting into pathologic bone; without these molecules, de novo bone would form as observed in myositis ossificans traumatica. When C2C12 myoblasts are exposed to BMPs, they differentiate into osteoblastic cells but cannot mature into bone cells. As the Osterix gene, a transcription factor for osteoblast differentiation, is only transiently induced upon BMP stimulation in C2C12 cells, we hypothesized that unknown transcriptional repressor(s) inhibit Osterix expression and prevent complete osteoblastic differentiation. Gene microarray analyses were performed to identify putative inhibitors for osteoblastic differentiation, and the paired-like homeodomain transcription factor Pitx2 (also termed Rieg), which plays an important regulatory role in left-right asymmetry, was identified. Pitx2 was induced 2 days after BMP stimulation in C2C12 cells in concert with Osterix down-regulation. Overexpression of Pitx2 repressed Osterix expression and subsequent osteoblastic differentiation, whereas Runx2, the most upstream regulator of osteogenesis, was unaffected. Conversely, the induction of short hairpin RNA for Pitx2 in C2C12 cells enhanced Osterix expression and osteoblastic maturation upon BMP stimulation. Moreover, mouse embryonic fibroblasts containing myoblasts from Pitx2-null embryos showed enhanced Osterix expression upon BMP stimulation. These findings suggest that Pitx2 suppresses osteogenic signals induced by BMPs in myoblasts to prevent their osteoblastic conversion.	[Hayashi, Makoto; Maeda, Shingo; Imamura, Takeshi] Japanese Fdn Canc Res, Inst Canc, Dept Biochem, Koto Ku, Tokyo 1358550, Japan; [Hayashi, Makoto] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Biol Sci, Midori Ku, Yokohama, Kanagawa 2268501, Japan; [Aburatani, Hiroyuki] Univ Tokyo, RCAST, Genome Sci Div, Meguro Ku, Tokyo 1538904, Japan; [Kitamura, Kunio] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mental Retardat & Birth Defect Res, Kodaira, Tokyo 1878502, Japan; [Miyoshi, Hiroyuki] RIKEN, Bioresources Ctr, Subteam Manipulat Cell Fate, Tsukuba, Ibaraki 3050074, Japan; [Miyazono, Kohei] Univ Tokyo, Grad Sch Med, Dept Mol Pathol, Bunkyo Ku, Tokyo 1130033, Japan	Japanese Foundation for Cancer Research; Tokyo Institute of Technology; University of Tokyo; National Center for Neurology & Psychiatry - Japan; RIKEN; University of Tokyo	Maeda, S (corresponding author), Japanese Fdn Canc Res, Inst Canc, Dept Biochem, Koto Ku, 3-10-6 Ariake, Tokyo 1358550, Japan.	shingo.maeda@jfcr.or.jp	Miyoshi, Hiroyuki/G-9808-2013					Dahlqvist C, 2003, DEVELOPMENT, V130, P6089, DOI 10.1242/dev.00834; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Gage PJ, 1999, DEVELOPMENT, V126, P4643; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; Katayama K, 2004, FEBS LETT, V560, P178, DOI 10.1016/S0014-5793(04)00100-0; Kioussi C, 2002, CELL, V111, P673, DOI 10.1016/S0092-8674(02)01084-X; Kitamura K, 1999, DEVELOPMENT, V126, P5749; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Logan M, 1998, CELL, V94, P307, DOI 10.1016/S0092-8674(00)81474-9; Lu MF, 1999, NATURE, V401, P276, DOI 10.1038/45797; Maeda S, 2004, EMBO J, V23, P552, DOI 10.1038/sj.emboj.7600067; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/s0092-8674(01)00622-5; Onishi T, 1998, BONE, V22, P605, DOI 10.1016/S8756-3282(98)00056-8; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Semina EV, 1996, NAT GENET, V14, P392, DOI 10.1038/ng1296-392; Shafritz AB, 1998, CLIN ORTHOP RELAT R, P46; Shih HP, 2007, GENE EXPR PATTERNS, V7, P441, DOI 10.1016/j.modgep.2006.11.004; Shirakawa K, 2006, MOL CELL BIOL, V26, P6105, DOI 10.1128/MCB.02429-05; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; Valentin-Opran A, 2002, CLIN ORTHOP RELAT R, P110; Yoshioka H, 1998, CELL, V94, P299, DOI 10.1016/S0092-8674(00)81473-7	21	23	27	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					565	571		10.1074/jbc.M708154200	http://dx.doi.org/10.1074/jbc.M708154200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17951577	hybrid			2022-12-27	WOS:000251940300061
J	Shen, XH; Franzini-Armstrong, C; Lopez, JR; Jones, LR; Kobayashi, YM; Wang, Y; Kerrick, WGL; Caswell, AH; Potter, JD; Miller, T; Allen, PD; Perez, CF				Shen, Xiaohua; Franzini-Armstrong, Clara; Lopez, Jose R.; Jones, Larry R.; Kobayashi, Yvonne M.; Wang, Ying; Kerrick, W. Glenn L.; Caswell, Anthony H.; Potter, James D.; Miller, Todd; Allen, Paul D.; Perez, Claudio F.			Triadins modulate intracellular Ca2+ homeostasis but are not essential for excitation-contraction coupling in skeletal muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							JUNCTIONAL SARCOPLASMIC-RETICULUM; RYANODINE RECEPTOR; DIHYDROPYRIDINE RECEPTOR; CARDIAC-MUSCLE; FOOT PROTEIN; CALSEQUESTRIN; CALCIUM; BINDING; OVEREXPRESSION; LOCALIZATION	To unmask the role of triadin in skeletal muscle we engineered pan-triadin-null mice by removing the first exon of the triadin gene. This resulted in a total lack of triadin expression in both skeletal and cardiac muscle. Triadin knockout was not embryonic or birth-lethal, and null mice presented no obvious functional phenotype. Western blot analysis of sarcoplasmic reticulum (SR) proteins in skeletal muscle showed that the absence of triadin expression was associated with down-regulation of Junctophilin-1, junctin, and calsequestrin but resulted in no obvious contractile dysfunction. Ca2+ imaging studies in null lumbricalis muscles and myotubes showed that the lack of triadin did not prevent skeletal excitation-contraction coupling but reduced the amplitude of their Ca2+ transients. Additionally, null myotubes and adult fibers had significantly increased myoplasmic resting free Ca2+. [H-3] Ryanodine binding studies of skeletal muscle SR vesicles detected no differences in Ca2+ activation or Ca2+ and Mg2+ inhibition between wild-type and triadin-null animals. Subtle ultrastructural changes, evidenced by the appearance of longitudinally oriented triads and the presence of calsequestrin in the sacs of the longitudinal SR, were present in fast but not slow twitch-null muscles. Overall, our data support an indirect role for triadin in regulating myoplasmic Ca2+ homeostasis and organizing the molecular complex of the triad but not in regulating skeletal-type excitation-contraction coupling.	[Shen, Xiaohua; Lopez, Jose R.; Allen, Paul D.; Perez, Claudio F.] Brigham & Womens Hosp, Dept Anesthesiol, Boston, MA 02115 USA; [Franzini-Armstrong, Clara] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Jones, Larry R.; Kobayashi, Yvonne M.] Indiana Univ, Sch Med, Krannert Inst Cardiol, Dept Med, Indianapolis, IN 46202 USA; [Wang, Ying; Kerrick, W. Glenn L.] Univ Miami, Miller Sch Med, Dept Physiol & Biophys, Miami, FL 33101 USA; [Caswell, Anthony H.; Potter, James D.; Miller, Todd] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33101 USA	Harvard University; Brigham & Women's Hospital; University of Pennsylvania; Indiana University System; Indiana University-Purdue University Indianapolis; University of Miami; University of Miami	Perez, CF (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.	cperez@zeus.bwh.harvard.edu			NIAMS NIH HHS [P01 AR47605] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR047605] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Beard NA, 2005, BIOPHYS J, V88, P3444, DOI 10.1529/biophysj.104.051441; Beard NA, 2002, BIOPHYS J, V82, P310, DOI 10.1016/S0006-3495(02)75396-4; BRANDT NR, 1990, J MEMBRANE BIOL, V113, P237, DOI 10.1007/BF01870075; BRANDT NR, 1992, FEBS LETT, V299, P57, DOI 10.1016/0014-5793(92)80100-U; Brown LD, 2007, AM J PHYSIOL-CELL PH, V292, pC1156, DOI 10.1152/ajpcell.00397.2006; CARL SL, 1995, MUSCLE NERVE, V18, P1232, DOI 10.1002/mus.880181104; Caswell AH, 1999, BIOCHEMISTRY-US, V38, P90, DOI 10.1021/bi981306+; Flucher BE, 1996, P NATL ACAD SCI USA, V93, P8101, DOI 10.1073/pnas.93.15.8101; FranziniArmstrong C, 1997, PHYSIOL REV, V77, P699, DOI 10.1152/physrev.1997.77.3.699; Glover L, 2001, BBA-BIOMEMBRANES, V1515, P120, DOI 10.1016/S0005-2736(01)00406-0; Goonasekera SA, 2007, J GEN PHYSIOL, V130, P365, DOI 10.1085/jgp.200709790; Groh S, 1999, J BIOL CHEM, V274, P12278, DOI 10.1074/jbc.274.18.12278; Gu W, 1996, SOC GEN PHY, V51, P19; GUO W, 1995, J BIOL CHEM, V270, P9027, DOI 10.1074/jbc.270.16.9027; Gyorke I, 2004, BIOPHYS J, V86, P2121, DOI 10.1016/S0006-3495(04)74271-X; Hong CS, 2001, GENE, V278, P193, DOI 10.1016/S0378-1119(01)00718-1; Ito K, 2001, J CELL BIOL, V154, P1059, DOI 10.1083/jcb.200105040; Jones LR, 1995, J BIOL CHEM, V270, P30787, DOI 10.1074/jbc.270.51.30787; KIM KC, 1990, BIOCHEMISTRY-US, V29, P9281, DOI 10.1021/bi00491a025; KNUDSON CM, 1993, J BIOL CHEM, V268, P12637; Kobayashi YM, 2000, J BIOL CHEM, V275, P17639, DOI 10.1074/jbc.M002091200; Kobayashi YM, 1999, J BIOL CHEM, V274, P28660, DOI 10.1074/jbc.274.40.28660; Komazaki S, 2002, FEBS LETT, V524, P225, DOI 10.1016/S0014-5793(02)03042-9; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Lee EH, 2006, BIOCHEM BIOPH RES CO, V351, P909, DOI 10.1016/j.bbrc.2006.10.115; Lee JM, 2004, J BIOL CHEM, V279, P6994, DOI 10.1074/jbc.M312446200; Lopez JR, 2000, ANESTHESIOLOGY, V92, P1799, DOI 10.1097/00000542-200006000-00040; MARTY I, 1994, P NATL ACAD SCI USA, V91, P2270, DOI 10.1073/pnas.91.6.2270; MARTY I, 1995, BIOCHEM J, V307, P769, DOI 10.1042/bj3070769; Marty I, 2000, J BIOL CHEM, V275, P8206, DOI 10.1074/jbc.275.11.8206; Marty I, 2004, CELL MOL LIFE SCI, V61, P1850, DOI 10.1007/s00018-004-4196-7; Meissner G, 2002, FRONT BIOSCI, V7, pD2072, DOI 10.2741/meissner; MOTOIKE HK, 1994, J MUSCLE RES CELL M, V15, P493, DOI 10.1007/BF00121156; Murray BE, 1997, BIOCHEM J, V324, P689, DOI 10.1042/bj3240689; Ohkura M, 1998, BIOCHEMISTRY-US, V37, P12987, DOI 10.1021/bi972803d; PAOLINI C, 2007, J PHYSL, V583, P676; PENG M, 1994, FEBS LETT, V348, P17, DOI 10.1016/0014-5793(94)00556-7; Perez CF, 2005, AM J PHYSIOL-CELL PH, V288, pC640, DOI 10.1152/ajpcell.00407.2004; Rando TA, 1997, METHOD CELL BIOL, V52, P261, DOI 10.1016/S0091-679X(08)60382-9; Rezgui SS, 2005, J BIOL CHEM, V280, P39302, DOI 10.1074/jbc.M506566200; Sato T, 1968, J Electron Microsc (Tokyo), V17, P158; SOMMER JR, 1994, PROC ANN MEET MSA, P192; Takekura H, 2003, J MUSCLE RES CELL M, V24, P439, DOI 10.1023/A:1027356912404; Thevenon D, 2003, BIOCHEM BIOPH RES CO, V303, P669, DOI 10.1016/S0006-291X(03)00406-6; Tijskens P, 2003, J MOL CELL CARDIOL, V35, P961, DOI 10.1016/S0022-2828(03)00181-0; Vassilopoulos S, 2005, J BIOL CHEM, V280, P28601, DOI 10.1074/jbc.M501484200; Wang Y, 1999, J MUSCLE RES CELL M, V20, P645, DOI 10.1023/A:1005559613516; WANG Y, 2007, BIOPHYS J S A, V20; Yuan QQ, 2007, CIRCULATION, V115, P300, DOI 10.1161/CIRCULATIONAHA.106.654699; Zhang L, 1997, J BIOL CHEM, V272, P23389, DOI 10.1074/jbc.272.37.23389; Zhang L, 2001, J MOL CELL CARDIOL, V33, P233, DOI 10.1006/jmcc.2000.1295	52	59	59	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37864	37874		10.1074/jbc.M705702200	http://dx.doi.org/10.1074/jbc.M705702200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17981799	hybrid			2022-12-27	WOS:000251833600062
J	Bhandari, D; Trejo, J; Benovic, JL; Marchese, A				Bhandari, Deepali; Trejo, JoAnn; Benovic, Jeffrey L.; Marchese, Adriano			Arrestin-2 interacts with the ubiquitin-protein isopeptide ligase atrophin-interacting protein 4 and mediates endosomal sorting of the chemokine receptor CXCR4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-ARRESTIN; COUPLED RECEPTORS; INTERNALIZATION; TRAFFICKING; MICE; AIP4	The chemokine receptor CXCR4 is rapidly targeted for lysosomal degradation by the E3 ubiquitin ligase atrophin-interacting protein 4 (AIP4). Although it is known that AIP4 mediates ubiquitination and degradation of CXCR4 and that perturbations in these events contribute to disease, the mechanisms mediating AIP4-dependent regulation of CXCR4 degradation remain poorly understood. Here we show that AIP4 directly interacts with the amino-terminal half of nonvisual arrestin-2 via its WW domains. We show that depletion of arrestin-2 by small interfering RNA blocks agonist-promoted degradation of CXCR4 by preventing CXCR4 trafficking from early endosomes to lysosomes. Surprisingly, CXCR4 internalization and ubiquitination remain intact, suggesting that the interaction between arrestin-2 and AIP4 is not required for ubiquitination of the receptor at the plasma membrane but perhaps for a later post-internalization event. Accordingly, we show that activation of CXCR4 promotes the interaction between AIP4 and arrestin-2 that is consistent with a time when AIP4 co-localizes with arrestin-2 on endocytic vesicles. Taken together, our data suggest that the AIP4.arrestin-2 complex functions on endosomes to regulate sorting of CXCR4 into the degradative pathway.	[Bhandari, Deepali; Marchese, Adriano] Loyola Univ, Stritch Sch Med, Dept Pharmacol, Program Mol Biol, Maywood, IL 60153 USA; [Marchese, Adriano] Loyola Univ, Stritch Sch Med, Dept Pharmacol & Expt Therapeut, Maywood, IL 60153 USA; [Trejo, JoAnn] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Benovic, Jeffrey L.] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA	Loyola University Chicago; Loyola University Chicago; University of North Carolina; University of North Carolina Chapel Hill; Jefferson University	Marchese, A (corresponding author), Loyola Univ, Stritch Sch Med, Dept Pharmacol, Program Mol Biol, 2160 S 1st Ave,Bldg 101,Rm 2721, Maywood, IL 60153 USA.	amarchese@lumc.edu		TREJO, JOANN/0000-0003-4405-6228	NIGMS NIH HHS [R01 GM047417, GM075159, R01 GM075159-02, R01 GM068857, GM47417, R01 GM075159] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068857, R01GM075159, R01GM047417, R37GM047417] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Angers A, 2004, J BIOL CHEM, V279, P11471, DOI 10.1074/jbc.M309934200; Cheng ZJ, 2000, J BIOL CHEM, V275, P2479, DOI 10.1074/jbc.275.4.2479; Diaz GA, 2005, CURR ALLERGY ASTHM R, V5, P350, DOI 10.1007/s11882-005-0005-0; Fong AM, 2002, P NATL ACAD SCI USA, V99, P7478, DOI 10.1073/pnas.112198299; Gurevich VV, 2006, PHARMACOL THERAPEUT, V110, P465, DOI 10.1016/j.pharmthera.2005.09.008; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Ingham RJ, 2005, MOL CELL BIOL, V25, P7092, DOI 10.1128/MCB.25.16.7092-7106.2005; Marchese A, 2003, TRENDS BIOCHEM SCI, V28, P369, DOI 10.1016/S0968-0004(03)00134-8; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; Marchese A, 2003, DEV CELL, V5, P709, DOI 10.1016/S1534-5807(03)00321-6; Marchese Adriano, 2004, Methods Mol Biol, V259, P299; Milano SK, 2002, BIOCHEMISTRY-US, V41, P3321, DOI 10.1021/bi015905j; Orsini MJ, 1999, J BIOL CHEM, V274, P31076, DOI 10.1074/jbc.274.43.31076; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Raiborg C, 2002, NAT CELL BIOL, V4, P394, DOI 10.1038/ncb791; Sachse M, 2002, MOL BIOL CELL, V13, P1313, DOI 10.1091/mbc.01-10-0525; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shenoy SK, 2005, J BIOL CHEM, V280, P15315, DOI 10.1074/jbc.M412418200; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Slagsvold T, 2006, EMBO J, V25, P3738, DOI 10.1038/sj.emboj.7601267; Slagsvold T, 2006, TRENDS CELL BIOL, V16, P317, DOI 10.1016/j.tcb.2006.04.004; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Winberg G, 2000, MOL CELL BIOL, V20, P8526, DOI 10.1128/MCB.20.22.8526-8535.2000; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	24	155	158	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					36971	36979		10.1074/jbc.M705085200	http://dx.doi.org/10.1074/jbc.M705085200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17947233	Green Published, hybrid			2022-12-27	WOS:000251646000023
J	Tong, Y; Chugha, P; Hota, PK; Alviani, RS; Li, M; Tempel, W; Shen, L; Park, HW; Buck, M				Tong, Yufeng; Chugha, Preeti; Hota, Prasanta K.; Alviani, Rebecca S.; Li, Mei; Tempel, Wolfram; Shen, Limin; Park, Hee-Won; Buck, Matthias			Binding of Rac1, Rnd1, and RhoD to a novel Rho GTPase interaction motif destabilizes dimerization of the plexin-B1 effector domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVE RAC; STRUCTURE VALIDATION; ACTIVATING PROTEIN; RECEPTOR PLEXIN-B1; LIGAND-BINDING; AXON GUIDANCE; R-RAS; SEMAPHORINS; GROWTH; RESOLUTION	Plexins are the first known transmembrane receptors that interact directly with small GTPases. On binding to certain Rho family GTPases, the receptor regulates the remodeling of the actin cytoskeleton and alters cell movement in response to semaphorin guidance cues. In a joint solution NMR spectroscopy and x-ray crystallographic study, we characterize a 120-residue cytoplasmic independent folding domain of plexin-B1 that directly binds three Rho family GTPases, Rac1, Rnd1, and RhoD. The NMR data show that, surprisingly, the Cdc42/Rac interactive binding-like motif of plexin-B1 is not involved in this interaction. Instead, all three GTPases interact with the same region, beta-strands 3 and 4 and a short alpha-helical segment of the plexin domain. The 2.0 angstrom resolution x-ray structure shows that these segments are brought together by the tertiary structure of the ubiquitin-like fold. In the crystal, the protein is dimerized with C2 symmetry through a four-stranded antiparallel beta-sheet that is formed outside the fold by a long loop between the monomers. This region is adjacent to the GTPase binding motifs identified by NMR. Destabilization of the dimer in solution by binding of any one of the three GTPases suggests a model for receptor regulation that involves bidirectional signaling. The model implies a multifunctional role for the GTPase-plexin interaction that includes conformational change and a localization of active receptors in the signaling mechanism.	[Tong, Yufeng; Chugha, Preeti; Hota, Prasanta K.; Alviani, Rebecca S.; Li, Mei; Buck, Matthias] Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, Cleveland, OH 44106 USA; [Buck, Matthias] Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA; [Buck, Matthias] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Park, Hee-Won] Univ Toronto, Dept Pharmacol, Toronto, ON M5G 1L5, Canada; [Tong, Yufeng; Tempel, Wolfram; Shen, Limin; Park, Hee-Won] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L5, Canada	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; University of Toronto; University of Toronto; Structural Genomics Consortium	Buck, M (corresponding author), Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, 10900 Euclid Ave, Cleveland, OH 44106 USA.	Matthias.Buck@case.edu	Hota, Prasanta Kumar/J-4319-2019; Buck, Matthias/B-2106-2017; Tong, Yufeng/D-2785-2011	Hota, Prasanta Kumar/0000-0002-4057-1831; Buck, Matthias/0000-0002-2958-0403; Tong, Yufeng/0000-0001-7740-1812	NHLBI NIH HHS [K02 HL084384-01, T32 HL007653, K02HL084384, K02 HL084384] Funding Source: Medline; NIGMS NIH HHS [R01GM73071, R01 GM073071-01, R01 GM073071] Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007653, K02HL084384] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073071] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Antipenko A, 2003, NEURON, V39, P589, DOI 10.1016/S0896-6273(03)00502-6; Artigiani S, 1999, IUBMB LIFE, V48, P477, DOI 10.1080/713803563; Aspenstrom P, 2004, BIOCHEM J, V377, P327, DOI 10.1042/BJ20031041; Basile JR, 2004, CANCER RES, V64, P5212, DOI 10.1158/0008-5472.CAN-04-0126; Battiste JL, 2000, BIOCHEMISTRY-US, V39, P5355, DOI 10.1021/bi000060h; Bouguet-Bonnet S, 2006, J BIOMOL NMR, V36, P51, DOI 10.1007/s10858-006-9029-6; Buck M, 2004, J MOL BIOL, V338, P271, DOI 10.1016/j.jmb.2004.02.036; BURBELO PD, 1995, J BIOL CHEM, V270, P29071, DOI 10.1074/jbc.270.49.29071; Driessens MHE, 2001, CURR BIOL, V11, P339, DOI 10.1016/S0960-9822(01)00092-6; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fournier AE, 2000, J CELL BIOL, V149, P411, DOI 10.1083/jcb.149.2.411; Giordano S, 2002, NAT CELL BIOL, V4, P720, DOI 10.1038/ncb843; Gitler AD, 2004, DEV CELL, V7, P107, DOI 10.1016/j.devcel.2004.06.002; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Hu HL, 2001, NEURON, V32, P39, DOI 10.1016/S0896-6273(01)00453-6; Kruger RR, 2005, NAT REV MOL CELL BIO, V6, P789, DOI 10.1038/nrm1740; Love CA, 2003, NAT STRUCT BIOL, V10, P843, DOI 10.1038/nsb977; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Murphy C, 2001, EUR J CELL BIOL, V80, P391, DOI 10.1078/0171-9335-00173; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; Oinuma I, 2004, J NEUROSCI, V24, P11473, DOI 10.1523/JNEUROSCI.3257-04.2004; Oinuma I, 2004, SCIENCE, V305, P862, DOI 10.1126/science.1097545; Oinuma I, 2003, J BIOL CHEM, V278, P25671, DOI 10.1074/jbc.M303047200; Patel BN, 2002, CURR OPIN CELL BIOL, V14, P221, DOI 10.1016/S0955-0674(02)00308-3; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Rohm B, 2000, FEBS LETT, V486, P68, DOI 10.1016/S0014-5793(00)02240-7; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P195, DOI 10.1107/S0907444901019291; Serini G, 2003, NATURE, V424, P391, DOI 10.1038/nature01784; Shimada I, 2005, METHOD ENZYMOL, V394, P483, DOI 10.1016/S0076-6879(05)94020-2; Swiercz JM, 2004, J CELL BIOL, V165, P869, DOI 10.1083/jcb.200312094; Swiercz JM, 2002, NEURON, V35, P51, DOI 10.1016/S0896-6273(02)00750-X; Takahashi H, 2000, NAT STRUCT BIOL, V7, P220; Takahashi T, 2001, NEURON, V29, P429, DOI 10.1016/S0896-6273(01)00216-1; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Tong YF, 2005, J BIOMOL NMR, V31, P369, DOI 10.1007/s10858-005-0943-9; Tong YF, 2005, STRUCTURE, V13, P7, DOI 10.1016/j.str.2004.10.018; Torres-Vazquez J, 2004, DEV CELL, V7, P117, DOI 10.1016/j.devcel.2004.06.008; Toyofuku T, 2004, GENE DEV, V18, P435, DOI 10.1101/gad.1167304; Tsubakimoto K, 1999, ONCOGENE, V18, P2431, DOI 10.1038/sj.onc.1202604; Turner LJ, 2004, J BIOL CHEM, V279, P33199, DOI 10.1074/jbc.M402943200; Vikis HG, 2000, P NATL ACAD SCI USA, V97, P12457, DOI 10.1073/pnas.220421797; Vikis HG, 2002, GENE DEV, V16, P836, DOI 10.1101/gad.966402; WANG BC, 1985, METHOD ENZYMOL, V115, P90; Wennerberg K, 2003, CURR BIOL, V13, P1106, DOI 10.1016/S0960-9822(03)00418-4; Wong AW, 2003, NAT IMMUNOL, V4, P891, DOI 10.1038/ni960; Zanata SM, 2002, J NEUROSCI, V22, P471, DOI 10.1523/JNEUROSCI.22-02-00471.2002	49	102	105	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					37215	37224		10.1074/jbc.M703800200	http://dx.doi.org/10.1074/jbc.M703800200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17916560	Green Accepted, hybrid			2022-12-27	WOS:000251646000047
J	Diet, A; Abbas, K; Bouton, C; Guillon, B; Tomasello, F; Fourquet, S; Toledano, MB; Drapier, JC				Diet, Alexandre; Abbas, Kahina; Bouton, Cecile; Guillon, Blanche; Tomasello, Flora; Fourquet, Simon; Toledano, Michel B.; Drapier, Jean-Claude			Regulation of peroxiredoxins by nitric oxide in immunostimulated macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-SULFINIC ACID; CELL-CYCLE ARREST; OXIDATIVE STRESS; REVERSIBLE OXIDATION; HYDROGEN-PEROXIDE; GENE-EXPRESSION; REACTIVE OXYGEN; ACTIVE-SITE; PEROXYNITRITE REDUCTASE; REDOX REGULATION	Reactive oxygen species and nitric oxide (NO) are capable of both mediating redox-sensitive signal transduction and eliciting cell injury. The interplay between these messengers is quite complex, and intersection of their signaling pathways as well as regulation of their fluxes requires tight control. In this regard, peroxiredoxins (Prxs), a recently identified family of six thiol peroxidases, are central because they reduce H2O2, organic peroxides, and peroxynitrite. Here we provide evidence that endogenously produced NO participates in protection of murine primary macrophages against oxidative and nitrosative stress by inducing Prx I and VI expression at mRNA and protein levels. We also show that NO prevented the sulfinylation-dependent inactivation of 2-Cys Prxs, a reversible overoxidation that controls H2O2 signaling. In addition, studies using macrophages from sulfiredoxin (Srx)-deficient mice indicated that regeneration of 2-Cys Prxs to the active form was dependent on Srx. Last, we show that NO increased Srx expression and hastened Srx-dependent recovery of 2-Cys Prxs. We therefore propose that modulation by NO of Prx expression and redox state, as well as up-regulation of Srx expression, constitutes a novel pathway that contributes to antioxidant response and control of H2O2 mediated signal transduction in mammals.	CNRS, ICSN, F-91190 Gif Sur Yvette, France; Commiss Energie Atom Saclay, Inst Biol & Technol Saclay, Lab Stress Oxydants & Canc, F-91190 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay	Drapier, JC (corresponding author), CNRS, ICSN, Bat 27,Ave Terrasse, F-91190 Gif Sur Yvette, France.	drapier@icsn.cnrs-gif.fr	Bouton, Cecile/J-8663-2013; Flora, Tomasello Marianna/E-9527-2018	Flora, Tomasello Marianna/0000-0001-6745-2181				Becker K, 1998, NAT STRUCT BIOL, V5, P267, DOI 10.1038/nsb0498-267; Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075; Blanc A, 2003, INT J MOL MED, V11, P229; Bloodsworth A, 2000, ARTERIOSCL THROM VAS, V20, P1707, DOI 10.1161/01.ATV.20.7.1707; Bossis G, 2006, MOL CELL, V21, P349, DOI 10.1016/j.molcel.2005.12.019; Bryk R, 2000, NATURE, V407, P211, DOI 10.1038/35025109; Budanov AV, 2004, SCIENCE, V304, P596, DOI 10.1126/science.1095569; Chang TS, 2004, J BIOL CHEM, V279, P50994, DOI 10.1074/jbc.M409482200; Chevallet M, 2003, J BIOL CHEM, V278, P37146, DOI 10.1074/jbc.M305161200; Cho SH, 2004, FEBS LETT, V560, P7, DOI 10.1016/S0014-5793(04)00112-7; Cordray P, 2007, J BIOL CHEM, V282, P32623, DOI 10.1074/jbc.M704369200; Dhakshinamoorthy S, 2004, J BIOL CHEM, V279, P20096, DOI 10.1074/jbc.M312492200; Dubuisson M, 2004, FEBS LETT, V571, P161, DOI 10.1016/j.febslet.2004.06.080; Espey MG, 2002, ANN NY ACAD SCI, V962, P195, DOI 10.1111/j.1749-6632.2002.tb04068.x; Fernandez-Tome P, 1999, NEUROPHARMACOLOGY, V38, P1307, DOI 10.1016/S0028-3908(99)00069-6; Finkel T, 1998, CURR OPIN CELL BIOL, V10, P248, DOI 10.1016/S0955-0674(98)80147-6; Forman Henry Jay, 2001, Molecular Aspects of Medicine, V22, P189; Forman HJ, 2002, MOL CELL BIOCHEM, V234, P49, DOI 10.1023/A:1015913229650; Gallagher BM, 2007, FREE RADICAL BIO MED, V42, P1270, DOI 10.1016/j.freeradbiomed.2007.01.023; Gorbunov NV, 1997, J BIOL CHEM, V272, P12328, DOI 10.1074/jbc.272.19.12328; Hogg N, 1999, BBA-BIOENERGETICS, V1411, P378, DOI 10.1016/S0005-2728(99)00027-4; Immenschuh S, 1999, HEPATOLOGY, V30, P118, DOI 10.1002/hep.510300142; Ishii T, 2000, J BIOL CHEM, V275, P16023, DOI 10.1074/jbc.275.21.16023; KANNER J, 1991, ARCH BIOCHEM BIOPHYS, V289, P130, DOI 10.1016/0003-9861(91)90452-O; Kim YJ, 2007, CANCER RES, V67, P546, DOI 10.1158/0008-5472.CAN-06-2401; Klatt P, 2000, EUR J BIOCHEM, V267, P4928, DOI 10.1046/j.1432-1327.2000.01601.x; Kwak MK, 2003, J BIOL CHEM, V278, P8135, DOI 10.1074/jbc.M211898200; Kwon J, 2004, P NATL ACAD SCI USA, V101, P16419, DOI 10.1073/pnas.0407396101; Lee SR, 1998, J BIOL CHEM, V273, P15366, DOI 10.1074/jbc.273.25.15366; Leslie NR, 2003, EMBO J, V22, P5501, DOI 10.1093/emboj/cdg513; Moncada S, 2006, J NEUROCHEM, V97, P1676, DOI 10.1111/j.1471-4159.2006.03988.x; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; Nathan C, 2004, SCI STKE, V2004, pe52; Noguchi T, 2003, BIOCHEMISTRY-US, V42, P11642, DOI 10.1021/bi035260i; Park EY, 2005, METHOD ENZYMOL, V396, P341, DOI 10.1016/S0076-6879(05)96028-X; Parsonage D, 2005, BIOCHEMISTRY-US, V44, P10583, DOI 10.1021/bi050448i; Pervin S, 2001, P NATL ACAD SCI USA, V98, P3583, DOI 10.1073/pnas.041603998; Peskin AV, 2007, J BIOL CHEM, V282, P11885, DOI 10.1074/jbc.M700339200; Phalen TJ, 2006, J CELL BIOL, V175, P779, DOI 10.1083/jcb.200606005; Rabilloud T, 2002, J BIOL CHEM, V277, P19396, DOI 10.1074/jbc.M106585200; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; Rhee SG, 2005, CURR OPIN CELL BIOL, V17, P183, DOI 10.1016/j.ceb.2005.02.004; Sun JH, 2006, ANTIOXID REDOX SIGN, V8, P1693, DOI 10.1089/ars.2006.8.1693; Thomas DD, 2002, METHOD ENZYMOL, V359, P84; Thomas DD, 2006, J BIOL CHEM, V281, P25984, DOI 10.1074/jbc.M602242200; West MB, 2006, FASEB J, V20, P1715, DOI 10.1096/fj.06-5843fje; WINK DA, 1993, P NATL ACAD SCI USA, V90, P9813, DOI 10.1073/pnas.90.21.9813; Woo HA, 2005, J BIOL CHEM, V280, P3125, DOI 10.1074/jbc.C400496200; Woo HA, 2003, J BIOL CHEM, V278, P47361, DOI 10.1074/jbc.C300428200; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Yang KS, 2002, J BIOL CHEM, V277, P38029, DOI 10.1074/jbc.M206626200	52	81	84	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36199	36205		10.1074/jbc.M706420200	http://dx.doi.org/10.1074/jbc.M706420200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17921138	hybrid			2022-12-27	WOS:000251458300009
J	Kim, HS; Park, BO; Yoo, JH; Jung, MS; Lee, SM; Han, HJ; Kim, KE; Kim, SH; Lim, CO; Yun, DJ; Lee, SY; Chung, WS				Kim, Ho Soo; Park, Byung Ouk; Yoo, Jae Hyuk; Jung, Mi Soon; Lee, Sang Min; Han, Hay Ju; Kim, Kyung Eun; Kim, Sun Ho; Lim, Chae Oh; Yun, Dae-Jin; Lee, Sang Yeol; Chung, Woo Sik			Identification of a calmodulin-binding NAC protein as a transcriptional repressor in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TARGET RECOGNITION; SIGNAL-TRANSDUCTION; PATHOGEN DEFENSE; CELL-DEATH; PLANTS; GENE; CALCIUM; PROMOTER; SPECIFICITY; ACTIVATION	Calmodulin (CaM), a ubiquitous calcium- binding protein, regulates diverse cellular functions by modulating the activity of a variety of proteins. However, little is known about how CaM directly regulates transcription. Screening of an Arabidopsis cDNA expression library using horseradish peroxidase- conjugated calmodulin as a probe identified a calmodulin- binding NAC protein (CBNAC). Using gel overlay assays, a Ca2+-dependent CaM-binding domain was identified in the C terminus of this protein. Specific binding of CaM to CaM-binding domain was corroborated by site-directed mutagenesis and a split-ubiquitin assay. Using a PCR-mediated random binding site selection method, we identified a DNA-binding sequence (CBNACBS) for CBNAC, which consisted of a GCTT core sequence flanked on both sides by other frequently repeating sequences (TTGCTTANNNNNNAAG). CBNAC was able to bind to CBNACBS, which resulted in the repression of transcription in Arabidopsis protoplasts. Interestingly, the transcriptional repression mediated by CBNAC was enhanced by CaM. These results suggest that CBNAC may be a CaM-regulated transcriptional repressor in Arabidopsis.	Gyeongsang Natl Univ, Div Appl Life Sci, BK21 Program, Plant Mol Biol & Biotechnol Res Ctr, Jinju 660701, South Korea; Gyeongsang Natl Univ, Environm Biotechnol Natl Core Res Ctr, Jinju 660701, South Korea	Gyeongsang National University; Gyeongsang National University	Chung, WS (corresponding author), Gyeongsang Natl Univ, Div Appl Life Sci, BK21 Program, Plant Mol Biol & Biotechnol Res Ctr, Jinju 660701, South Korea.	chungws@gnu.ac.kr		Yun, Dae-Jin/0000-0002-3638-6043				Aida M, 1997, PLANT CELL, V9, P841, DOI 10.1105/tpc.9.6.841; Blume B, 2000, PLANT CELL, V12, P1425, DOI 10.1105/tpc.12.8.1425; Choi MS, 2005, J BIOL CHEM, V280, P40820, DOI 10.1074/jbc.M504616200; Collinge M, 2001, PLANT MOL BIOL, V46, P521, DOI 10.1023/A:1010639225091; Corcoran EE, 2001, J BIOL CHEM, V276, P2975, DOI 10.1074/jbc.R000027200; CORNELIUSSEN B, 1994, NATURE, V368, P760, DOI 10.1038/368760a0; CRIVICI A, 1995, ANNU REV BIOPH BIOM, V24, P85, DOI 10.1146/annurev.bb.24.060195.000505; Delessert C, 2005, PLANT J, V43, P745, DOI 10.1111/j.1365-313X.2005.02488.x; Duval M, 2002, PLANT MOL BIOL, V50, P237, DOI 10.1023/A:1016028530943; Fujita M, 2004, PLANT J, V39, P863, DOI 10.1111/j.1365-313X.2004.02171.x; Gadgil H, 1999, J CHROMATOGR A, V848, P131, DOI 10.1016/S0021-9673(99)00338-6; Grant M, 2000, PLANT J, V23, P441, DOI 10.1046/j.1365-313x.2000.00804.x; Harmon AC, 2000, TRENDS PLANT SCI, V5, P154, DOI 10.1016/S1360-1385(00)01577-6; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; Jin HL, 2000, EMBO J, V19, P6150, DOI 10.1093/emboj/19.22.6150; Jin JB, 2001, PLANT CELL, V13, P1511, DOI 10.1105/tpc.13.7.1511; Kim MC, 2002, J BIOL CHEM, V277, P19304, DOI 10.1074/jbc.M108478200; Laser H, 2000, P NATL ACAD SCI USA, V97, P13732, DOI 10.1073/pnas.250400997; Lee SH, 1999, BBA-PROTEIN STRUCT M, V1433, P56, DOI 10.1016/S0167-4838(99)00149-1; Liu ZB, 1997, PLANT PHYSIOL, V115, P397, DOI 10.1104/pp.115.2.397; Luan S, 2002, PLANT CELL, V14, pS389, DOI 10.1105/tpc.001115; MEADOR WE, 1992, SCIENCE, V257, P1251, DOI 10.1126/science.1519061; Meijer AH, 1997, PLANT J, V11, P263, DOI 10.1046/j.1365-313X.1997.11020263.x; Miao Y, 2004, PLANT MOL BIOL, V55, P853, DOI 10.1007/s11103-005-2142-1; Mitsuda N, 2005, PLANT CELL, V17, P2993, DOI 10.1105/tpc.105.036004; Motohashi H, 2000, CELL, V103, P865, DOI 10.1016/S0092-8674(00)00190-2; Nakamura M, 2006, PLANT PHYSIOL, V141, P1363, DOI 10.1104/pp.106.077388; OLIPHANT AR, 1989, MOL CELL BIOL, V9, P2944, DOI 10.1128/MCB.9.7.2944; Olsen AN, 2005, TRENDS PLANT SCI, V10, P79, DOI 10.1016/j.tplants.2004.12.010; ONEIL KT, 1990, TRENDS BIOCHEM SCI, V15, P59, DOI 10.1016/0968-0004(90)90177-D; Onions J, 1997, J BIOL CHEM, V272, P23930, DOI 10.1074/jbc.272.38.23930; Onions J, 2000, BIOCHEMISTRY-US, V39, P4366, DOI 10.1021/bi992533u; Osawa M, 1999, NAT STRUCT BIOL, V6, P819; Park CY, 2005, FEBS LETT, V579, P1545, DOI 10.1016/j.febslet.2005.01.057; POLLOCK R, 1990, NUCLEIC ACIDS RES, V18, P6197, DOI 10.1093/nar/18.21.6197; Raghothama KG, 1997, PLANT MOL BIOL, V34, P393, DOI 10.1023/A:1005812217945; Raventos D, 1998, J BIOL CHEM, V273, P23313, DOI 10.1074/jbc.273.36.23313; Reddy VS, 2004, PHYTOCHEMISTRY, V65, P1745, DOI 10.1016/j.phytochem.2004.04.033; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Riechmann JL, 2000, CURR OPIN PLANT BIOL, V3, P423, DOI 10.1016/S1369-5266(00)00107-2; Robatzek S, 2002, GENE DEV, V16, P1139, DOI 10.1101/gad.222702; Sato N, 2001, NUCLEIC ACIDS RES, V29, P2244, DOI 10.1093/nar/29.11.2244; Sheen J, 1996, SCIENCE, V274, P1900, DOI 10.1126/science.274.5294.1900; Shinozaki K, 1997, PLANT PHYSIOL, V115, P327, DOI 10.1104/pp.115.2.327; Snedden WA, 2001, NEW PHYTOL, V151, P35, DOI 10.1046/j.1469-8137.2001.00154.x; Souer E, 1996, CELL, V85, P159, DOI 10.1016/S0092-8674(00)81093-4; Stagljar I, 1998, P NATL ACAD SCI USA, V95, P5187, DOI 10.1073/pnas.95.9.5187; SUNDARESAN V, 1995, GENE DEV, V9, P1797, DOI 10.1101/gad.9.14.1797; Tran LSP, 2004, PLANT CELL, V16, P2481, DOI 10.1105/tpc.104.022699; Varshavsky A, 1996, P NATL ACAD SCI USA, V93, P12142, DOI 10.1073/pnas.93.22.12142; White PJ, 2003, ANN BOT-LONDON, V92, P487, DOI 10.1093/aob/mcg164; Xie Q, 2000, GENE DEV, V14, P3024, DOI 10.1101/gad.852200; Yang TB, 2003, TRENDS PLANT SCI, V8, P505, DOI 10.1016/j.tplants.2003.09.004; Yoo JH, 2005, J BIOL CHEM, V280, P3697, DOI 10.1074/jbc.M408237200; Yoo JH, 2004, J BIOL CHEM, V279, P848, DOI 10.1074/jbc.M310709200; Zielinski RE, 1998, ANNU REV PLANT PHYS, V49, P697, DOI 10.1146/annurev.arplant.49.1.697	56	93	108	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36292	36302		10.1074/jbc.M705217200	http://dx.doi.org/10.1074/jbc.M705217200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17947243	hybrid			2022-12-27	WOS:000251458300020
J	Muller, P; Ewers, C; Bertsche, U; Anstett, M; Kallis, T; Breukink, E; Fraipont, C; Terrak, M; Nguyen-Disteche, M; Vollmer, W				Mueller, Patrick; Ewers, Carolin; Bertsche, Ute; Anstett, Maria; Kallis, Tanja; Breukink, Eefjan; Fraipont, Claudine; Terrak, Mohammed; Nguyen-Disteche, Martine; Vollmer, Waldemar			The essential cell division protein FtsN interacts with the murein (peptidoglycan) synthase PBP1B in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PENICILLIN-BINDING PROTEINS; LYTIC TRANSGLYCOSYLASE; Z-RING; MEMBRANE; LOCALIZATION; CLONING; MIDCELL; DIMERS; 1B; TRANSPEPTIDASE	Bacterial cell division requires the coordinated action of cell division proteins and murein (peptidoglycan) synthases. Interactions involving the essential cell division protein FtsN and murein synthases were studied by affinity chromatography with membrane fraction. The murein synthases PBP1A, PBP1B, and PBP3 had an affinity to immobilized FtsN. FtsN and PBP3, but not PBP1A, showed an affinity to immobilized PBP1B. The direct interaction between FtsN and PBP1B was confirmed by pulldown experiments and surface plasmon resonance. The interaction was also detected by bacterial two-hybrid analysis. FtsN and PBP1B could be cross-linked in intact cells of the wild type and in cells depleted of PBP3 or FtsW. FtsN stimulated the in vitro murein synthesis activities of PBP1B. Thus, FtsN could have a role in controlling or modulating the activity of PBP1B during cell division in Escherichia coli.	Univ Tubingen, D-72076 Tubingen, Germany; Univ Utrecht, Ctr Biomembranes & Lipid Enzymol, Biomembrane Inst, Dept Biochem Membranes, NL-3584 CH Utrecht, Netherlands; Univ Liege, Ctr Ingn Proteines, Inst Chim B6a, B-4000 Liege, Belgium	Eberhard Karls University of Tubingen; Utrecht University; University of Liege	Vollmer, W (corresponding author), Univ Newcastle Upon Tyne, Sch Med, Inst Cell & Mol Biosci, Catherine Cookson Bldg,Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	W.Vollmer@ncl.ac.uk	Breukink, Eefjan/I-3039-2016	Breukink, Eefjan/0000-0002-7311-0660; Ewers, Christa/0000-0001-6167-1340				Addinall SG, 1997, MOL MICROBIOL, V25, P303, DOI 10.1046/j.1365-2958.1997.4641833.x; Bernard CS, 2007, MOL MICROBIOL, V64, P1289, DOI 10.1111/j.1365-2958.2007.05738.x; Bernhardt TG, 2003, MOL MICROBIOL, V48, P1171, DOI 10.1046/j.1365-2958.2003.03511.x; Bertsche U, 2005, J BIOL CHEM, V280, P38096, DOI 10.1074/jbc.M508646200; Bertsche U, 2006, MOL MICROBIOL, V61, P675, DOI 10.1111/j.1365-2958.2006.05280.x; Born P, 2006, J BIOL CHEM, V281, P26985, DOI 10.1074/jbc.M604083200; Buddelmeijer N, 2004, MOL MICROBIOL, V52, P1315, DOI 10.1111/j.1365-2958.2004.04044.x; CASADABAN MJ, 1980, J MOL BIOL, V138, P179, DOI 10.1016/0022-2836(80)90283-1; Chalut C, 1999, J BACTERIOL, V181, P2970, DOI 10.1128/JB.181.9.2970-2972.1999; Charpentier X, 2002, J BACTERIOL, V184, P3749, DOI 10.1128/JB.184.13.3749-3752.2002; Chen JC, 2001, MOL MICROBIOL, V42, P395, DOI 10.1046/j.1365-2958.2001.02640.x; Corbin BD, 2004, J BACTERIOL, V186, P7736, DOI 10.1128/JB.186.22.7736-7744.2004; DAI K, 1993, J BACTERIOL, V175, P3790, DOI 10.1128/JB.175.12.3790-3797.1993; Daniel RA, 2003, CELL, V113, P767, DOI 10.1016/S0092-8674(03)00421-5; Dougherty TJ, 1996, J BACTERIOL, V178, P6110, DOI 10.1128/jb.178.21.6110-6115.1996; Draper GC, 1998, J BACTERIOL, V180, P4621, DOI 10.1128/JB.180.17.4621-4627.1998; Geissler B, 2005, MOL MICROBIOL, V58, P596, DOI 10.1111/j.1365-2958.2005.04858.x; Gerding MA, 2007, MOL MICROBIOL, V63, P1008, DOI 10.1111/j.1365-2958.2006.05571.x; GLAUNER B, 1988, ANAL BIOCHEM, V172, P451, DOI 10.1016/0003-2697(88)90468-X; Goehring NW, 2007, J BACTERIOL, V189, P646, DOI 10.1128/JB.00992-06; Goehring NW, 2006, MOL MICROBIOL, V61, P33, DOI 10.1111/j.1365-2958.2006.05206.x; Goehring NW, 2005, CURR BIOL, V15, pR514, DOI 10.1016/j.cub.2005.06.038; Goehring NW, 2005, GENE DEV, V19, P127, DOI 10.1101/gad.1253805; Heidrich C, 2001, MOL MICROBIOL, V41, P167, DOI 10.1046/j.1365-2958.2001.02499.x; Jobling MG, 2000, P NATL ACAD SCI USA, V97, P14662, DOI 10.1073/pnas.011442598; Karimova G, 2005, J BACTERIOL, V187, P2233, DOI 10.1128/JB.187.7.2233-2243.2005; Mercer KLN, 2002, J BACTERIOL, V184, P904, DOI 10.1128/jb.184.4.904-912.2002; Nguyen-Disteche M, 1998, CELL MOL LIFE SCI, V54, P309, DOI 10.1007/s000180050157; Pastoret S, 2004, J BACTERIOL, V186, P8370, DOI 10.1128/JB.186.24.8370-8379.2004; Piette A, 2004, J BACTERIOL, V186, P6110, DOI 10.1128/jb.186.18.6110-6117.2004; ROMEIS T, 1994, J BIOL CHEM, V269, P21603; Schiffer G, 1999, J BIOL CHEM, V274, P32031, DOI 10.1074/jbc.274.45.32031; Spelbrink REJ, 2005, J BIOL CHEM, V280, P28742, DOI 10.1074/jbc.M501617200; SUZUKI H, 1978, P NATL ACAD SCI USA, V75, P664, DOI 10.1073/pnas.75.2.664; Terrak M, 1999, MOL MICROBIOL, V34, P350, DOI 10.1046/j.1365-2958.1999.01612.x; Ursinus A, 2004, J BACTERIOL, V186, P6728, DOI 10.1128/JB.186.20.6728-6737.2004; van Straaten KE, 2005, J MOL BIOL, V352, P1068, DOI 10.1016/j.jmb.2005.07.067; Vicente M, 2006, J BACTERIOL, V188, P19, DOI 10.1128/JB.188.1.19-27.2006; Vollmer W, 1999, J BIOL CHEM, V274, P6726, DOI 10.1074/jbc.274.10.6726; VOLLMER W, 2007, IN PRESS BIOCHIMICA; vonRechenberg M, 1996, MICROB DRUG RESIST, V2, P155, DOI 10.1089/mdr.1996.2.155; Weiss DS, 1999, J BACTERIOL, V181, P508, DOI 10.1128/JB.181.2.508-520.1999; Wissel MC, 2004, J BACTERIOL, V186, P490, DOI 10.1128/JB.186.2.490-502.2004; Yang JC, 2004, MOL MICROBIOL, V52, P651, DOI 10.1111/j.1365-2958.2004.03991.x; ZIJDERVELD CAL, 1995, J BACTERIOL, V177, P1860, DOI 10.1128/jb.177.7.1860-1863.1995; ZIJDERVELD CAL, 1991, J BACTERIOL, V173, P5740, DOI 10.1128/jb.173.18.5740-5746.1991	46	103	106	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36394	36402		10.1074/jbc.M706390200	http://dx.doi.org/10.1074/jbc.M706390200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17938168	hybrid			2022-12-27	WOS:000251458300031
J	Grunberg, S; Bartlett, MS; Naji, S; Thomm, M				Grunberg, Sebastian; Bartlett, Michael S.; Naji, Souad; Thomm, Michael			Transcription factor E is a part of transcription elongation complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; ARCHAEAL TRANSCRIPTION; PREINITIATION COMPLEX; BASAL TRANSCRIPTION; INITIATION COMPLEX; TFIIE-ALPHA; PROMOTER CLEARANCE; CROSS-LINKING; DNA; REVEALS	A homologue of the N-terminal domain of the alpha subunit of the general eukaryotic transcription factor TFE is encoded in the genomes of all sequenced archaea, but the position of archaeal TFE in transcription complexes has not yet been defined. We show here that TFE binds nonspecifically to single-stranded DNA, and photochemical cross-linking revealed TFE binding to a preformed open transcription bubble. In preinitiation complexes, the N-terminal part of TFE containing a winged helix-turn-helix motif is cross-linked specifically to DNA of the non-template DNA strand at positions -9 and -11. In complexes stalled at +20, TFE cross-linked specifically to positions +9, +11, and +16 of the non-template strand. Analyses of transcription complexes stalled at position +20 revealed a TFE-dependent increase of the resumption efficiency of stalled RNA polymerase and a TFE-induced enhanced permanganate sensitivity of thymine residues in the transcription bubble. These results demonstrate the presence of TFE in early elongation complexes and suggest a role of TFE in stabilization of the transcription bubble during elongation.	Portland State Univ, Dept Biol, Portland, OR 97207 USA; Univ Regensburg, Lehrstuhl Mikrobiol, D-93053 Regensburg, Germany	Portland State University; University of Regensburg	Bartlett, MS (corresponding author), Portland State Univ, Dept Biol, POB 751, Portland, OR 97207 USA.	micb@pdx.edu		Grunberg, Sebastian/0000-0002-5694-0574				Bartholomew B, 1995, METHOD ENZYMOL, V262, P476; Bartlett MS, 2000, NAT STRUCT BIOL, V7, P782, DOI 10.1038/79020; Bartlett MS, 2005, CURR OPIN MICROBIOL, V8, P677, DOI 10.1016/j.mib.2005.10.016; Bartlett MS, 2004, J BIOL CHEM, V279, P5894, DOI 10.1074/jbc.M311429200; Bell SD, 2001, EMBO REP, V2, P133, DOI 10.1093/embo-reports/kve021; Chen HT, 2007, NAT STRUCT MOL BIOL, V14, P696, DOI 10.1038/nsmb1272; Dvir A, 1997, J BIOL CHEM, V272, P28175, DOI 10.1074/jbc.272.45.28175; Dvir A, 1997, P NATL ACAD SCI USA, V94, P9006, DOI 10.1073/pnas.94.17.9006; Dvir A, 2002, BBA-GENE STRUCT EXPR, V1577, P208, DOI 10.1016/S0167-4781(02)00453-0; Forget D, 2004, MOL CELL BIOL, V24, P1122, DOI 10.1128/MCB.24.3.1122-1131.2004; Geiduschek EP, 2005, MOL MICROBIOL, V56, P1397, DOI 10.1111/j.1365-2958.2005.04627.x; GOODRICH JA, 1994, CELL, V77, P145, DOI 10.1016/0092-8674(94)90242-9; Hanzelka BL, 2001, J BACTERIOL, V183, P1813, DOI 10.1128/JB.183.5.1813-1818.2001; Holstege FCP, 1996, EMBO J, V15, P1666, DOI 10.1002/j.1460-2075.1996.tb00512.x; Kim TK, 2000, SCIENCE, V288, P1418, DOI 10.1126/science.288.5470.1418; Kuldell NH, 1997, MOL CELL BIOL, V17, P5288, DOI 10.1128/MCB.17.9.5288; MAXON ME, 1994, GENE DEV, V8, P515, DOI 10.1101/gad.8.5.515; Meinhart A, 2003, J BIOL CHEM, V278, P48267, DOI 10.1074/jbc.M307874200; Miller G, 2006, NAT STRUCT MOL BIOL, V13, P603, DOI 10.1038/nsmb1117; Naji S, 2007, J BIOL CHEM, V282, P11047, DOI 10.1074/jbc.M611674200; OHKUMA Y, 1994, NATURE, V368, P160, DOI 10.1038/368160a0; OHKUMA Y, 1990, P NATL ACAD SCI USA, V87, P9163, DOI 10.1073/pnas.87.23.9163; OHKUMA Y, 1995, MOL CELL BIOL, V15, P4856; Ohkuma Y, 1997, J BIOCHEM-TOKYO, V122, P481; Ouhammouch M, 2004, J BIOL CHEM, V279, P51719, DOI 10.1074/jbc.C400446200; PARVIN JD, 1993, CELL, V73, P53; Robert F, 1996, J BIOL CHEM, V271, P8517, DOI 10.1074/jbc.271.15.8517; Spitalny P, 2003, J BIOL CHEM, V278, P30497, DOI 10.1074/jbc.M303633200; Thomm M, 2007, ARCHAEA: MOLECULAR AND CELLULAR BIOLOGY, P139; Werner F, 2005, MOL CELL BIOL, V25, P8344, DOI 10.1128/MCB.25.18.8344-8355.2005; ZAWEL L, 1995, GENE DEV, V9, P1479, DOI 10.1101/gad.9.12.1479	31	41	41	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35482	35490		10.1074/jbc.M707371200	http://dx.doi.org/10.1074/jbc.M707371200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17921145	hybrid			2022-12-27	WOS:000251458100007
J	Yun, S; Moller, A; Chae, SK; Hong, WP; Bae, YJ; Bowtell, DDL; Ryu, SH; Suh, PG				Yun, Sanguk; Moeller, Andreas; Chae, Suhn-Kee; Hong, Won-Pyo; Bae, Young Ju; Bowtell, David D. L.; Ryu, Sung Ho; Suh, Pann-Ghill			Siah proteins induce the epidermal growth factor-dependent degradation of phospholipase C epsilon	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEASOME PATHWAY; PRIMARY-CELLS; CYCLIC-AMP; GENE; ABSENTIA; RECEPTOR; ACTIVATION; APOPTOSIS; P53; HOMOLOGS	Phospholipase C epsilon (PLC epsilon) is activated by various growth factors or G-protein-coupled receptor ligands via different activation mechanisms. The Ras association ( RA) domain of PLC epsilon is known to be important for its ability to bind with Ras-family GTPase upon growth factor stimulation. In the present study, we identified Siah1 and Siah2 as novel binding partners of the PLC epsilon RA domain. Both Siah1 and Siah2 interacted with the RA2 domain of PLC epsilon, and the mutation of Lys-2186 of the PLC epsilon RA2 domain abolished this association. Moreover, Siah induced the ubiquitination and degradation of PLC epsilon upon epidermal growth factor (EGF) stimulation, and Siah proteins were phosphorylated on multiple tyrosine residues via an Src-dependent pathway upon EGF treatment. The Src inhibitor abolished the EGF-dependent ubiquitination of PLC epsilon, and the Siah1 phosphorylation-deficient mutant could not increase the EGF-dependent ubiquitination and degradation of PLC epsilon. The EGF-dependent degradation of PLC epsilon was blocked in mouse embryonic fibroblast (MEF) cells derived from Siah1a/Siah2 double knockout mice, and the extrinsic expression of wild-type Siah1 restored the degradation of PLC epsilon, whereas the phosphorylation-deficient mutant did not. Siah1 expression abolished PLC epsilon-dependent potentiation of EGF-dependent cell growth. In addition, the expression of wild-type Siah1 in Siah1a/Siah2-double knockout MEF cells inhibited EGF-dependent cell growth, and this inhibition was abolished by PLC epsilon knockdown. Our results suggest that the Siah-dependent degradation of PLC epsilon plays a role in the regulation of growth factor-dependent cell growth.	[Yun, Sanguk; Hong, Won-Pyo; Bae, Young Ju; Ryu, Sung Ho; Suh, Pann-Ghill] Pohang Univ Sci & Technol, Div Mol & Life Sci, Dept Life Sci, Pohang 790784, Kyung Buk, South Korea; [Moeller, Andreas; Bowtell, David D. L.] Peter MacCallum Canc Ctr, Canc Genom & Biochem Lab, Dept Res, Melbourne, Vic 3002, Australia; [Moeller, Andreas; Bowtell, David D. L.] Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3010, Australia; [Chae, Suhn-Kee] Paichai Univ, Dept Biochem, Taejon 302735, South Korea; [Chae, Suhn-Kee] Paichai Univ, Biomed Res Ctr, Taejon 302735, South Korea	Pohang University of Science & Technology (POSTECH); Peter Maccallum Cancer Center; University of Melbourne; Pai Chai University; Pai Chai University	Suh, PG (corresponding author), Pohang Univ Sci & Technol, Div Mol & Life Sci, Dept Life Sci, Pohang 790784, Kyung Buk, South Korea.	pgs@postech.ac.kr	Suh, Pann-Ghill/F-3610-2010; Bowtell, David/H-1007-2016; Möller, Andreas/O-1063-2015	Bowtell, David/0000-0001-9089-7525; Möller, Andreas/0000-0002-8618-6998; Chae, Suhn-Kee/0000-0003-2164-1053; Ryu, Sung Ho/0000-0003-0913-3048				Amson RB, 1996, P NATL ACAD SCI USA, V93, P3953, DOI 10.1073/pnas.93.9.3953; Bai YF, 2004, CANCER RES, V64, P8808, DOI 10.1158/0008-5472.CAN-04-3143; Boehm J, 2001, EMBO J, V20, P4153, DOI 10.1093/emboj/20.15.4153; Bruzzoni-Giovanelli H, 1999, ONCOGENE, V18, P7101, DOI 10.1038/sj.onc.1203187; Bunney TD, 2006, MOL CELL, V21, P495, DOI 10.1016/j.molcel.2006.01.008; Bunney TD, 2006, TRENDS CELL BIOL, V16, P640, DOI 10.1016/j.tcb.2006.10.007; CARTHEW RW, 1990, CELL, V63, P561, DOI 10.1016/0092-8674(90)90452-K; Cockcroft S, 2006, TRENDS BIOCHEM SCI, V31, P4, DOI 10.1016/j.tibs.2005.11.003; Coward P, 1998, P NATL ACAD SCI USA, V95, P352, DOI 10.1073/pnas.95.1.352; DELLA NG, 1993, DEVELOPMENT, V117, P1333; Evellin S, 2002, J BIOL CHEM, V277, P16805, DOI 10.1074/jbc.M112024200; Frew IJ, 2002, MOL CELL BIOL, V22, P8155, DOI 10.1128/MCB.22.23.8155-8164.2002; Germani A, 2000, ONCOGENE, V19, P5997, DOI 10.1038/sj.onc.1204002; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Hains MD, 2006, MOL PHARMACOL, V69, P2068, DOI 10.1124/mol.105.017921; Hinkes B, 2006, NAT GENET, V38, P1397, DOI 10.1038/ng1918; Hu G, 1997, GENOMICS, V46, P103, DOI 10.1006/geno.1997.4997; Hu G, 1997, GENE DEV, V11, P2701, DOI 10.1101/gad.11.20.2701; Kelley GG, 2006, J BIOL CHEM, V281, P2639, DOI 10.1074/jbc.M507681200; Khurana A, 2006, J BIOL CHEM, V281, P35316, DOI 10.1074/jbc.M606568200; Kim CJ, 2004, ONCOGENE, V23, P8591, DOI 10.1038/sj.onc.1208113; Li SH, 1997, CELL, V90, P469, DOI 10.1016/S0092-8674(00)80507-3; Liu J, 2001, MOL CELL, V7, P927, DOI 10.1016/S1097-2765(01)00241-6; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Matsuzawa S, 2001, MOL CELL, V7, P915, DOI 10.1016/S1097-2765(01)00242-8; Moriyoshi K, 2004, P NATL ACAD SCI USA, V101, P8614, DOI 10.1073/pnas.0403042101; Relaix F, 2000, P NATL ACAD SCI USA, V97, P2105, DOI 10.1073/pnas.040378897; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Roperch JP, 1999, P NATL ACAD SCI USA, V96, P8070, DOI 10.1073/pnas.96.14.8070; Schmidt M, 2001, NAT CELL BIOL, V3, P1020, DOI 10.1038/ncb1101-1020; Seifert JP, 2004, J BIOL CHEM, V279, P47992, DOI 10.1074/jbc.M407111200; Song C, 2001, J BIOL CHEM, V276, P2752, DOI 10.1074/jbc.M008324200; Song CH, 2002, ONCOGENE, V21, P8105, DOI 10.1038/sj.onc.1206003; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Tadano M, 2005, MOL CELL BIOL, V25, P2191, DOI 10.1128/MCB.25.6.2191-2199.2005; Wang H, 2005, CIRC RES, V97, P1305, DOI 10.1161/01.RES.0000196578.15385.bb; Xu ZH, 2006, J BIOL CHEM, V281, P303, DOI 10.1074/jbc.M509060200; Zhang JS, 1998, GENE DEV, V12, P1775, DOI 10.1101/gad.12.12.1775	38	14	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					1034	1042		10.1074/jbc.M705874200	http://dx.doi.org/10.1074/jbc.M705874200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	17998205	hybrid			2022-12-27	WOS:000252128100043
J	Bibert, S; Roy, S; Schaer, D; Horisberger, JD; Geering, K				Bibert, Stephanie; Roy, Sophie; Schaer, Daniele; Horisberger, Jean-Daniel; Geering, Kaethi			Phosphorylation of phospholemman (FXYD1) by protein kinases A and C modulates distinct Na,K-ATPase isozymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT CARDIAC MYOCYTES; NA-K-ATPASE; BETA-SUBUNIT; VENTRICULAR MYOCYTES; FUNCTIONAL INTERACTIONS; ALPHA-SUBUNIT; ION-TRANSPORT; PUMP FUNCTION; HIGH-AFFINITY; SODIUM-PUMP	Phospholemman (FXYD1), mainly expressed in heart and skeletal muscle, is a member of the FXYD protein family, which has been shown to decrease the apparent K+ and Na+ affinity of Na,K-ATPase (Crambert, G., Fuzesi, M., Garty, H., Karlish, S., and Geering, K. ( 2002) Proc. Natl. Acad. Sci. U. S. A. 99, 11476 11481). In this study, we use the Xenopus oocyte expression system to study the role of phospholemman phosphorylation by protein kinases A and C in the modulation of different Na, K-ATPase isozymes present in the heart. Phosphorylation of phospholemman by protein kinase A has no effect on the maximal transport activity or on the apparent K+ affinity of Na, K-ATPase alpha 1/beta 1 and alpha 2/beta 1 isozymes but increases their apparent Na+ affinity, dependent on phospholemman phosphorylation at Ser(68). Phosphorylation of phospholemman by protein kinase C affects neither the maximal transport activity of alpha 1/beta 1 isozymes nor the K+ affinity of alpha 1/beta 1 and alpha 2/beta 1 isozymes. However, protein kinase C phosphorylation of phospholemman increases the maximal Na, K-pump current of alpha 2/beta 1 isozymes by an increase in their turnover number. Thus, our results indicate that protein kinase A phosphorylation of phospholemman has similar functional effects on Na, K-ATPase alpha 1/beta and alpha 2/beta isozymes and increases their apparent Na+ affinity, whereas protein kinase C phosphorylation of phospholemman modulates the transport activity of Na, K-ATPase alpha 2/beta but not of alpha 1/beta isozymes. The complex and distinct regulation of Na, K-ATPase isozymes by phosphorylation of phospholemman may be important for the efficient control of heart contractility and excitability.	Univ Lausanne, Dept Pharmacol & Toxicol, CH-1005 Lausanne, Switzerland	University of Lausanne	Geering, K (corresponding author), Univ Lausanne, Dept Pharmacol & Toxicol, 27 Rue du Bugnon, CH-1005 Lausanne, Switzerland.	Kaethi.Geering@unil.ch	Horisberger, Jean-Daniel/A-2538-2009	Bibert, Stephanie/0000-0001-5170-7506				Asahi M, 2000, J BIOL CHEM, V275, P15034, DOI 10.1074/jbc.275.20.15034; Beguin P, 2001, EMBO J, V20, P3993, DOI 10.1093/emboj/20.15.3993; BERLIN JR, 1992, ANN NY ACAD SCI, V671, P440, DOI 10.1111/j.1749-6632.1992.tb43823.x; Bossuyt J, 2005, CIRC RES, V97, P558, DOI 10.1161/01.RES.0000181172.27931.c3; Bossuyt J, 2006, J BIOL CHEM, V281, P32765, DOI 10.1074/jbc.M606254200; Chen LSK, 1997, GENOMICS, V41, P435, DOI 10.1006/geno.1997.4665; Crambert G, 2000, J BIOL CHEM, V275, P1976, DOI 10.1074/jbc.275.3.1976; Crambert G, 2002, P NATL ACAD SCI USA, V99, P11476, DOI 10.1073/pnas.182267299; Despa S, 2005, CIRC RES, V97, P252, DOI 10.1161/01.RES.0000176532.97731.e5; Despa S, 2007, AM J PHYSIOL-CELL PH, V293, pC321, DOI 10.1152/ajpcell.00597.2006; Feschenko MS, 2003, J NEUROSCI, V23, P2161; Fuller W, 2004, FASEB J, V18, P197, DOI 10.1096/fj.03-0213fje; Fuller W, 2006, CIRC RES, V99, P1290, DOI 10.1161/01.RES.0000253090.54488.81; GAO J, 1995, J GEN PHYSIOL, V106, P995, DOI 10.1085/jgp.106.5.995; Garty H, 2006, ANNU REV PHYSIOL, V68, P431, DOI 10.1146/annurev.physiol.68.040104.131852; Geering K, 1996, J CELL BIOL, V133, P1193, DOI 10.1083/jcb.133.6.1193; Geering K, 2006, AM J PHYSIOL-RENAL, V290, pF241, DOI 10.1152/ajprenal.00126.2005; GIRARDET M, 1981, BIOCHEMISTRY-US, V20, P6684, DOI 10.1021/bi00526a025; Han F, 2006, CIRC RES, V99, P1376, DOI 10.1161/01.RES.0000251667.73461.fb; Hasler U, 1998, J BIOL CHEM, V273, P30826, DOI 10.1074/jbc.273.46.30826; JAISSER F, 1994, J GEN PHYSIOL, V103, P605, DOI 10.1085/jgp.103.4.605; James PF, 1999, MOL CELL, V3, P555, DOI 10.1016/S1097-2765(00)80349-4; JEWELL EA, 1991, J BIOL CHEM, V266, P16925; Jia LG, 2005, AM J PHYSIOL-HEART C, V288, pH1982, DOI 10.1152/ajpheart.00142.2004; KOBILKA BK, 1987, P NATL ACAD SCI USA, V84, P46, DOI 10.1073/pnas.84.1.46; Li CM, 2005, J BIOL CHEM, V280, P42738, DOI 10.1074/jbc.M508451200; Li CM, 2004, J BIOL CHEM, V279, P38895, DOI 10.1074/jbc.M406697200; Lifshitz Y, 2006, J BIOL CHEM, V281, P15790, DOI 10.1074/jbc.M601993200; Mahmmoud YA, 2000, J BIOL CHEM, V275, P35969, DOI 10.1074/jbc.M005168200; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; MOGUL DJ, 1989, CIRC RES, V64, P1063, DOI 10.1161/01.RES.64.6.1063; MOORMAN JR, 1995, NATURE, V377, P737, DOI 10.1038/377737a0; PALMER CJ, 1991, J BIOL CHEM, V266, P11126; Pavlovic D, 2007, FASEB J, V21, P1539, DOI 10.1096/fj.06-7269com; Rembold CM, 2005, J VASC RES, V42, P483, DOI 10.1159/000088102; SHULL GE, 1986, NATURE, V321, P429, DOI 10.1038/321429a0; SHULL GE, 1986, BIOCHEMISTRY-US, V25, P8125, DOI 10.1021/bi00373a001; Silverman BD, 2005, CARDIOVASC RES, V65, P93, DOI 10.1016/j.cardiores.2004.09.005; Sweadner KJ, 2000, GENOMICS, V68, P41, DOI 10.1006/geno.2000.6274; Swift F, 2007, CARDIOVASC RES, V75, P109, DOI 10.1016/j.cardiores.2007.03.017; Therien AG, 2000, AM J PHYSIOL-CELL PH, V279, pC541, DOI 10.1152/ajpcell.2000.279.3.C541; VASILETS LA, 1991, J BIOL CHEM, V266, P16285; WALAAS SI, 1994, BIOCHEM J, V304, P635, DOI 10.1042/bj3040635; Zhang XQ, 2006, J APPL PHYSIOL, V100, P212, DOI 10.1152/japplphysiol.00757.2005	44	87	88	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					476	486		10.1074/jbc.M705830200	http://dx.doi.org/10.1074/jbc.M705830200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17991751	hybrid			2022-12-27	WOS:000251940300053
J	Kervinen, J; Abad, M; Crysler, C; Kolpak, M; Mahan, AD; Masucci, JA; Bayoumy, S; Cummings, MD; Yao, X; Olson, M; de Garavilla, L; Kuo, L; Deckman, I; Spurlino, J				Kervinen, Jukka; Abad, Marta; Crysler, Carl; Kolpak, Michael; Mahan, Andrew D.; Masucci, John A.; Bayoumy, Shariff; Cummings, Maxwell D.; Yao, Xiang; Olson, Matthew; de Garavilla, Lawrence; Kuo, Lawrence; Deckman, Ingrid; Spurlino, John			Structural basis for elastolytic substrate specificity in rodent alpha-chymases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAST-CELL CHYMASE; ANGSTROM CRYSTAL-STRUCTURE; HAMSTER-CHEEK POUCH; SERINE PROTEASES; MAMMALIAN EVOLUTION; ACTIVE-SITE; CATHEPSIN-G; INHIBITOR; CLONING; INFLAMMATION	Divergence of substrate specificity within the context of a common structural framework represents an important mechanism by which new enzyme activity naturally evolves. We present enzymological and x-ray structural data for hamster chymase-2 (HAM2) that provides a detailed explanation for the unusual hydrolytic specificity of this rodent alpha-chymase. In enzymatic characterization, hamster chymase-1 (HAM1) showed typical chymase proteolytic activity. In contrast, HAM2 exhibited atypical substrate specificity, cleaving on the carboxyl side of the P1 substrate residues Ala and Val, characteristic of elastolytic rather than chymotryptic specificity. The 2.5-angstrom resolution crystal structure of HAM2 complexed to the peptidyl inhibitor MeOSuc-Ala-Ala-Pro-Ala-chloromethylketone revealed a narrow and shallow S1 substrate binding pocket that accommodated only a small hydrophobic residue ( e. g. Ala or Val). The different substrate specificities of HAM2 and HAM1 are explained by changes in four S1 substrate site residues ( positions 189, 190, 216, and 226). Of these, Asn(189), Val(190), and Val(216) form an easily identifiable triplet in all known rodent alpha-chymases that can be used to predict elastolytic specificity for novel chymase-like sequences. Phylogenetic comparison defines guinea pig and rabbit chymases as the closest orthologs to rodent alpha-chymases.	[Kervinen, Jukka; Abad, Marta; Crysler, Carl; Kolpak, Michael; Bayoumy, Shariff; Cummings, Maxwell D.; Olson, Matthew; Kuo, Lawrence; Deckman, Ingrid; Spurlino, John] Johnson & Johnson Pharmaceut Res & Dev, Exton, PA 19341 USA; [Mahan, Andrew D.; Masucci, John A.; de Garavilla, Lawrence] Res & Early Dev, Spring House, PA 19477 USA; [Yao, Xiang] W Coast Res & Early Dev, San Diego, CA 92121 USA	Johnson & Johnson; Johnson & Johnson USA	Kervinen, J (corresponding author), 665 Stockton Dr, Exton, PA 19341 USA.	jkervine@prdus.jnj.com; jspurli1@prdus.jnj.com						Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Andoh A, 2006, ONCOL REP, V16, P103; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Blank U, 2007, IMMUNOL REV, V217, P79, DOI 10.1111/j.1600-065X.2007.00503.x; Bradding P, 2006, J ALLERGY CLIN IMMUN, V117, P1277, DOI 10.1016/j.jaci.2006.02.039; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Caughey GH, 2007, IMMUNOL REV, V217, P141, DOI 10.1111/j.1600-065X.2007.00509.x; Caughey GH, 2000, BBA-PROTEIN STRUCT M, V1480, P245, DOI 10.1016/S0167-4838(00)00076-5; Caughey GH, 2002, MOL IMMUNOL, V38, P1353, DOI 10.1016/S0161-5890(02)00087-1; Chandrasekharan UM, 1996, SCIENCE, V271, P502, DOI 10.1126/science.271.5248.502; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; de Garavilla L, 2005, J BIOL CHEM, V280, P18001, DOI 10.1074/jbc.M501302200; DErchia AM, 1996, NATURE, V381, P597, DOI 10.1038/381597a0; Gallwitz M, 2006, IMMUNOGENETICS, V58, P655, DOI 10.1007/s00251-006-0126-1; Gallwitz M, 2006, IMMUNOGENETICS, V58, P641, DOI 10.1007/s00251-006-0123-4; Greco MN, 2007, J MED CHEM, V50, P1727, DOI 10.1021/jm0700619; HEDSTROM L, 1992, SCIENCE, V255, P1249, DOI 10.1126/science.1546324; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Hof P, 1996, EMBO J, V15, P5481, DOI 10.1002/j.1460-2075.1996.tb00933.x; IDE H, 1995, BIOCHEM J, V311, P675, DOI 10.1042/bj3110675; Itoh H, 1996, BIOCHEM J, V314, P923, DOI 10.1042/bj3140923; Karlson U, 2003, J BIOL CHEM, V278, P39625, DOI 10.1074/jbc.M301512200; Kovanen PT, 2007, IMMUNOL REV, V217, P105, DOI 10.1111/j.1600-065X.2007.00515.x; Krem MM, 2000, TRENDS CARDIOVAS MED, V10, P171, DOI 10.1016/S1050-1738(00)00068-2; Kunori Y, 2002, EUR J BIOCHEM, V269, P5921, DOI 10.1046/j.1432-1033.2002.03316.x; McAleese SM, 1998, BIOCHEM J, V333, P801, DOI 10.1042/bj3330801; MCNEIL HP, 1991, J BIOL CHEM, V266, P20316; Miyazaki M, 2006, PHARMACOL THERAPEUT, V112, P668, DOI 10.1016/j.pharmthera.2006.05.008; Muramatsu M, 2002, BRIT J PHARMACOL, V137, P554, DOI 10.1038/sj.bjp.0704893; Orito K, 2004, TOHOKU J EXP MED, V203, P287, DOI 10.1620/tjem.203.287; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pereira PJB, 1999, J MOL BIOL, V286, P163, DOI 10.1006/jmbi.1998.2462; Perona JJ, 1997, J BIOL CHEM, V272, P29987, DOI 10.1074/jbc.272.48.29987; Pham CTN, 2006, NAT REV IMMUNOL, V6, P541, DOI 10.1038/nri1841; POWERS JC, 1989, J CELL BIOCHEM, V39, P33, DOI 10.1002/jcb.240390105; RAWLINGS ND, 2004, HDB PROTEOLYTIC ENZY, P1417; Sakaguchi M, 2004, EUR J PHARMACOL, V493, P173, DOI 10.1016/j.ejphar.2004.04.024; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Shimizu M, 2006, J VET MED SCI, V68, P271, DOI 10.1292/jvms.68.271; Shiota N, 1997, J HYPERTENS, V15, P431, DOI 10.1097/00004872-199715040-00014; Shiota N, 1998, BIOCHEM J, V333, P417, DOI 10.1042/bj3330417; Sichler K, 2002, FEBS LETT, V530, P220, DOI 10.1016/S0014-5793(02)03495-6; Solivan S, 2002, FEBS LETT, V512, P133, DOI 10.1016/S0014-5793(02)02242-1; Takai S, 1996, LIFE SCI, V58, P591, DOI 10.1016/0024-3205(95)02328-3; Takao K, 2001, BBA-PROTEIN STRUCT M, V1545, P146, DOI 10.1016/S0167-4838(00)00272-7; Tchougounova E, 2003, J EXP MED, V198, P423, DOI 10.1084/jem.20030671; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; WANG DC, 1985, J MOL BIOL, V185, P595, DOI 10.1016/0022-2836(85)90074-9; Wang ZM, 1998, BIOL CHEM, V379, P167, DOI 10.1515/bchm.1998.379.2.167; Wernersson S, 2006, DEV COMP IMMUNOL, V30, P901, DOI 10.1016/j.dci.2005.10.014; Wouters MA, 2003, MOL CELL, V12, P343, DOI 10.1016/S1097-2765(03)00308-3	51	17	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					427	436		10.1074/jbc.M707157200	http://dx.doi.org/10.1074/jbc.M707157200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17981788	hybrid			2022-12-27	WOS:000251940300047
J	Liu, S; Wang, H; Currie, BM; Molinolo, A; Leung, HJ; Moayeri, M; Basile, JR; Alfano, RW; Gutkind, JS; Frankel, AE; Bugge, TH; Leppla, SH				Liu, Shihui; Wang, Hailun; Currie, Brooke M.; Molinolo, Alfredo; Leung, Howard J.; Moayeri, Mahtab; Basile, John R.; Alfano, Randall W.; Gutkind, J. Silvio; Frankel, Arthur E.; Bugge, Thomas H.; Leppla, Stephen H.			Matrix metalloproteinase-activated anthrax lethal toxin demonstrates high potency in targeting tumor vasculature	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE-KINASE; MELANOMA-CELLS; SUSCEPTIBILITY; ANGIOGENESIS; INACTIVATION; SENSITIVITY; DIPHTHAMIDE; MUTATIONS; MICE	Anthrax lethal toxin ( LT), a virulence factor secreted by Bacillus anthracis, is selectively toxic to human melanomas with the BRAF V600E activating mutation because of its proteolytic activities toward the mitogen-activated protein kinase kinases (MEKs). To develop LT variants with lower in vivo toxicity and high tumor specificity, and therefore greater potential for clinical use, we generated a mutated LT that requires activation by matrix metalloproteinases (MMPs). This engineered toxin was less toxic than wild-type LT to mice because of the limited expression of MMPs by normal cells. Moreover, the systemically administered toxin produced greater anti-tumor effects than wild-type LT toward human xenografted tumors. This was shown to result from its greater bioavailability, a consequence of the limited uptake and clearance of the modified toxin by normal cells. Furthermore, the MMP-activated LT had very potent anti-tumor activity not only to human melanomas containing the BRAF mutation but also to other tumor types, including lung and colon carcinomas regardless of their BRAF status. Tumor histology and in vivo angiogenesis assays showed that this antitumor activity is due largely to the indirect targeting of tumor vasculature and angiogenic processes. Thus, even tumors genetically deficient in anthrax toxin receptors were still susceptible to the toxin therapy in vivo. Moreover, the modified toxin also displayed lower immunogenicity compared with the wild-type toxin. All these properties suggest that this MMP-activated antitumor toxin has potential for use in cancer therapy.	[Currie, Brooke M.; Molinolo, Alfredo; Basile, John R.; Gutkind, J. Silvio; Bugge, Thomas H.] NIH, NIDCR, Oral & Pharyngeal Canc Branch, Bethesda, MD 20892 USA; [Liu, Shihui; Wang, Hailun; Leung, Howard J.; Moayeri, Mahtab; Leppla, Stephen H.] NIH, NIAID, Lab Bacterial Dis, Bethesda, MD 20892 USA; [Alfano, Randall W.; Frankel, Arthur E.] Scott & White Mem Hosp & Clin, Canc Res Inst, Temple, TX 76502 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Scott & White Medical Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Bugge, TH (corresponding author), NIH, NIDCR, Oral & Pharyngeal Canc Branch, Bldg 10, Bethesda, MD 20892 USA.	thomas.bugge@nih.gov; sleppla@niaid.nih.gov	Gutkind, J. Silvio/A-1053-2009; Gutkind, J. Silvio/J-1201-2016	Gutkind, J. Silvio/0000-0002-5150-4482; Moayeri, Mahtab/0000-0002-4448-8883; Liu, Shihui/0000-0003-3444-1069	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000929] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000551, Z01DE000699] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 AI000929-05] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Abi-Habib RJ, 2006, CLIN CANCER RES, V12, P7437, DOI 10.1158/1078-0432.CCR-06-2019; Abi-Habib RJ, 2005, MOL CANCER THER, V4, P1303, DOI 10.1158/1535-7163.MCT-05-0145; Baldari CT, 2006, TRENDS IMMUNOL, V27, P434, DOI 10.1016/j.it.2006.07.002; Batty S, 2006, CELL MICROBIOL, V8, P130, DOI 10.1111/j.1462-5822.2005.00606.x; Boyden ED, 2006, NAT GENET, V38, P240, DOI 10.1038/ng1724; Bugge TH, 1996, CELL, V87, P709, DOI 10.1016/S0092-8674(00)81390-2; Collier RJ, 2001, TOXICON, V39, P1793, DOI 10.1016/S0041-0101(01)00165-9; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; FRIEDLANDER AM, 1986, J BIOL CHEM, V261, P7123; Guedez L, 2003, AM J PATHOL, V162, P1431, DOI 10.1016/S0002-9440(10)64276-9; Koo HM, 2002, P NATL ACAD SCI USA, V99, P3052, DOI 10.1073/pnas.052707699; LEPPLA SH, 2006, COMPREHENSIVE SOURCE, P323; Liu SH, 2000, CANCER RES, V60, P6061; Liu SH, 2005, NAT BIOTECHNOL, V23, P725, DOI 10.1038/nbt1091; Liu SH, 2004, MOL CELL BIOL, V24, P9487, DOI 10.1128/MCB.24.21.9487-9497.2004; Liu SH, 2003, MOL CELL, V12, P603, DOI 10.1016/j.molcel.2003.08.003; Liu SH, 2003, EXPERT OPIN BIOL TH, V3, P843, DOI 10.1517/14712598.3.5.843; Liu SH, 2003, J BIOL CHEM, V278, P5227, DOI 10.1074/jbc.M210321200; Liu SH, 2003, P NATL ACAD SCI USA, V100, P657, DOI 10.1073/pnas.0236849100; Liu SH, 2001, J BIOL CHEM, V276, P17976, DOI 10.1074/jbc.M011085200; Liu SH, 2007, CELL MICROBIOL, V9, P977, DOI 10.1111/j.1462-5822.2006.00845.x; Mizukami Y, 2005, NAT MED, V11, P992, DOI 10.1038/nm1294; Moayeri M, 2003, J CLIN INVEST, V112, P670, DOI [10.1172/JCI200317991, 10.1172/JCI17991]; Moayeri M, 2007, INFECT IMMUN, V75, P5175, DOI 10.1128/IAI.00719-07; Mogridge J, 2002, P NATL ACAD SCI USA, V99, P7045, DOI 10.1073/pnas.052160199; Olsen E, 2001, J CLIN ONCOL, V19, P376, DOI 10.1200/JCO.2001.19.2.376; Sebolt-Leopold JS, 2004, NAT REV CANCER, V4, P937, DOI 10.1038/nrc1503; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Sparmann A, 2004, CANCER CELL, V6, P447, DOI 10.1016/j.ccr.2004.09.028; SWANSON MS, 1995, INFECT IMMUN, V63, P3609, DOI 10.1128/IAI.63.9.3609-3620.1995; Vitale G, 1998, BIOCHEM BIOPH RES CO, V248, P706, DOI 10.1006/bbrc.1998.9040; Vitale G, 2000, BIOCHEM J, V352, P739, DOI 10.1042/0264-6021:3520739; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Zeng QH, 2005, CANCER CELL, V8, P13, DOI 10.1016/j.ccr.2005.06.004	40	68	72	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					529	540		10.1074/jbc.M707419200	http://dx.doi.org/10.1074/jbc.M707419200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17974567	hybrid, Green Accepted			2022-12-27	WOS:000251940300058
J	Meske, V; Albert, F; Ohm, TG				Meske, Volker; Albert, Frank; Ohm, Thomas Georg			Coupling of mammalian target of rapamycin with phosphoinositide 3-kinase signaling pathway regulates protein phosphatase 2A- and glycogen synthase kinase-3 beta-dependent phosphorylation of Tau	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAIRED HELICAL FILAMENTS; PROTEIN PHOSPHATASE 2A; GLYCOGEN-SYNTHASE KINASE-3-BETA; GROWTH-FACTOR-I; ALZHEIMERS-DISEASE; DIABETES-MELLITUS; CELL-GROWTH; RAT-BRAIN; KINASE; INSULIN	Tau is an important microtubule-stabilizing protein in neurons. In its hyperphosphorylated form, Tau protein loses its ability to bind to microtubules and then accumulates and is part of pathological lesions characterizing tauopathies, e. g. Alzheimer disease. Glycogen synthase kinase-3 beta (GSK-3 beta), antagonized by protein phosphatase 2A (PP2A), regulates Tau phosphorylation at many sites. Diabetes mellitus is linked to an increased risk of developing Alzheimer disease. This could be partially caused by dysregulated GSK-3 beta. In a long term experiment (-16 h) using primary murine neuron cultures, we interfered in the insulin/phosphoinositide3-kinase (PI3K) (LY294002 treatment and insulin boost) and mammalian target of rapamycin (mTor) (AICAR and rapamycin treatment) signaling pathways and examined consequent changes in the activities of PP2A, GSK-3 beta, and Tau phosphorylation. We found that the coupling of PI3K with mTor signaling, in conjunction with a regulatory interaction between PP2A and SK-3 beta, changed activities of both enzymes always in the same direction. These balanced responses seem to ensure the steady Tau phosphorylation at GSK/PP2A-dependent sites observed over a long period of time (>= 6 h). This may help in preventing severe changes in Tau phosphorylation under conditions when neurons undergo transient fluctuations either in insulin or nutrient supply. On the other hand, the investigation of Tau protein at Ser-262 showed that interference in the insulin/PI3K and mTor signaling potentially influenced the Tau phosphorylation status at sites where only one of two enzymes (in this case PP2A) is involved in the regulation.	[Meske, Volker; Albert, Frank; Ohm, Thomas Georg] Inst Integrat Neuroanat, Ctr Anat, Dept Clin Cell & Neurobiol, D-10098 Berlin, Germany		Meske, V (corresponding author), Inst Integrat Neuroanat, Ctr Anat, Dept Clin Cell & Neurobiol, Charite Platz 1, D-10098 Berlin, Germany.	V.Meske@gmx.de						AGOSTINIS P, 1992, EUR J BIOCHEM, V205, P241, DOI 10.1111/j.1432-1033.1992.tb16774.x; ALONSO AD, 1994, P NATL ACAD SCI USA, V91, P5562, DOI 10.1073/pnas.91.12.5562; Berg CE, 2002, BIOCHEM BIOPH RES CO, V293, P1021, DOI 10.1016/S0006-291X(02)00333-9; BIERNAT J, 1993, NEURON, V11, P153, DOI 10.1016/0896-6273(93)90279-Z; Bishop JD, 2006, J ENDOCRINOL, V190, P307, DOI 10.1677/joe.1.06368; BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0; Carling D, 2004, CURR BIOL, V14, pR220, DOI 10.1016/j.cub.2004.02.048; CEGIELSKA A, 1994, MOL CELL BIOL, V14, P4616, DOI 10.1128/MCB.14.7.4616; Chen J, 1998, BIOCHEM BIOPH RES CO, V247, P827, DOI 10.1006/bbrc.1998.8792; Chiang GG, 2005, J BIOL CHEM, V280, P25485, DOI 10.1074/jbc.M501707200; Clodfelder-Miller BJ, 2006, DIABETES, V55, P3320, DOI 10.2337/db06-0485; Dan HC, 2002, J BIOL CHEM, V277, P35364, DOI 10.1074/jbc.M205838200; DRECHSEL DN, 1992, MOL BIOL CELL, V3, P1141, DOI 10.1091/mbc.3.10.1141; DREWES G, 1993, FEBS LETT, V336, P425, DOI 10.1016/0014-5793(93)80850-T; FLEMING LM, 1995, BIOCHEM J, V309, P41, DOI 10.1042/bj3090041; Freude S, 2005, DIABETES, V54, P3343, DOI 10.2337/diabetes.54.12.3343; GARVER TD, 1994, J NEUROCHEM, V63, P2279; Gong CX, 2005, J NEURAL TRANSM, V112, P813, DOI 10.1007/s00702-004-0221-0; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Hartley D, 2002, J CELL BIOCHEM, V85, P304, DOI 10.1002/jcb.10135; Haruta T, 2000, MOL ENDOCRINOL, V14, P783, DOI 10.1210/me.14.6.783; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Hong M, 1997, J BIOL CHEM, V272, P19547, DOI 10.1074/jbc.272.31.19547; IMAOKA T, 1983, J BIOL CHEM, V258, P1526; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; IQBAL K, 1994, FEBS LETT, V349, P104, DOI 10.1016/0014-5793(94)00650-4; ISHIGURO K, 1992, J BIOL CHEM, V267, P10897; Jamsa A, 2004, BIOCHEM BIOPH RES CO, V319, P993, DOI 10.1016/j.bbrc.2004.05.075; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; King TD, 2006, BIOCHEM PHARMACOL, V71, P1637, DOI 10.1016/j.bcp.2006.03.005; KUNZ J, 1993, CELL, V73, P585, DOI 10.1016/0092-8674(93)90144-F; Lee YI, 2005, J BIOL CHEM, V280, P22044, DOI 10.1074/jbc.M413987200; Leibson C L, 1997, Ann N Y Acad Sci, V826, P422, DOI 10.1111/j.1749-6632.1997.tb48496.x; Lesort M, 1999, J NEUROCHEM, V72, P576, DOI 10.1046/j.1471-4159.1999.0720576.x; Lesort M, 2000, NEUROSCIENCE, V99, P305, DOI 10.1016/S0306-4522(00)00200-1; LINDWALL G, 1984, J BIOL CHEM, V259, P5301; Liu F, 2005, EUR J NEUROSCI, V22, P1942, DOI 10.1111/j.1460-9568.2005.04391.x; Lovestone S, 1999, BIOL PSYCHIAT, V45, P995, DOI 10.1016/S0006-3223(98)00183-8; MANDELKOW EM, 1992, FEBS LETT, V314, P315, DOI 10.1016/0014-5793(92)81496-9; MATSUO ES, 1994, NEURON, V13, P989, DOI 10.1016/0896-6273(94)90264-X; MAYERJAEKEL RE, 1994, J CELL SCI, V107, P2609; MUMBY MC, 1987, J BIOL CHEM, V262, P6257; MunozMontano JR, 1997, FEBS LETT, V411, P183, DOI 10.1016/S0014-5793(97)00688-1; Murata K, 1997, P NATL ACAD SCI USA, V94, P10624, DOI 10.1073/pnas.94.20.10624; Nanahoshi M, 1998, BIOCHEM BIOPH RES CO, V251, P520, DOI 10.1006/bbrc.1998.9493; Ott A, 1999, NEUROLOGY, V53, P1937, DOI 10.1212/WNL.53.9.1937; Ott A, 1996, DIABETOLOGIA, V39, P1392, DOI 10.1007/s001250050588; Peterson RT, 1999, P NATL ACAD SCI USA, V96, P4438, DOI 10.1073/pnas.96.8.4438; Planel E, 2004, J NEUROSCI, V24, P2401, DOI 10.1523/JNEUROSCI.5561-03.2004; Plattner F, 2006, J BIOL CHEM, V281, P25457, DOI 10.1074/jbc.M603469200; Sengupta A, 2006, NEUROCHEM RES, V31, P1473, DOI 10.1007/s11064-006-9205-9; Shi YJ, 2005, MOL CANCER THER, V4, P1533, DOI 10.1158/1535-7163.MCT-05-0068; SUTHERLAND C, 1993, BIOCHEM J, V296, P15, DOI 10.1042/bj2960015; Tian Q, 2002, NEUROSIGNALS, V11, P262, DOI 10.1159/000067425; Tremblay F, 2005, ENDOCRINOLOGY, V146, P1328, DOI 10.1210/en.2004-0777; Wang XM, 2006, PHYSIOLOGY, V21, P362, DOI 10.1152/physiol.00024.2006; YOSHIDA H, 1993, J NEUROCHEM, V61, P1183, DOI 10.1111/j.1471-4159.1993.tb03642.x	60	76	80	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					100	109		10.1074/jbc.M704292200	http://dx.doi.org/10.1074/jbc.M704292200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17971449	hybrid			2022-12-27	WOS:000251940300012
J	Mohri-Shiomi, A; Garsin, DA				Mohri-Shiomi, Akiko; Garsin, Danielle A.			Insulin signaling and the heat shock response modulate protein homeostasis in the Caenorhabditis elegans intestine during infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-ELEGANS; MODEL HOST; LIFE-SPAN; PATHOGENESIS; AGGREGATION; DAF-16; INTERFERENCE; EXPRESSION; LONGEVITY; GENETICS	During infection, damage can occur to the host as an outcome of both pathogen virulence mechanisms and host defense strategies. Using aggregation of a model polyglutamine-containing protein as an indicator in Caenorhabditis elegans, we show that protein damage occurs specifically at the site of the host-pathogen interaction, the intestine, in response to various bacterial pathogens. We demonstrate that the insulin signaling pathway and the heat shock transcription factor (HSF-1) influence the amount of aggregation that occurs, in addition to heat shock proteins and oxidative stress enzymes. We also show that addition of the antioxidants epigallocatechin gallate and alpha-lipoic acid reduces polyglutamine aggregation. The influence of oxidative stress enzymes and exogenous antioxidants on protein aggregation suggests that reactive oxygen species produced by the host are a source of protein damage during infection. We propose a model in which heat shock proteins and oxidative stress enzymes regulated by insulin signaling and HSF-1 are required for tissue protection during infection, to minimize the effects of protein damage occurring as a result of host-pathogen interactions.	[Mohri-Shiomi, Akiko; Garsin, Danielle A.] Univ Texas Hlth Sci Ctr Houston, Dept Microbiol & Mol Genet, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Garsin, DA (corresponding author), 6431 Fannin St,MSB 1, Houston, TX 77030 USA.	Danielle.A.Garsin@uth.tmc.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076406] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI076406] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aballay A, 2000, CURR BIOL, V10, P1539, DOI 10.1016/S0960-9822(00)00830-7; Altun-Gultekin Z, 2001, DEVELOPMENT, V128, P1951; BRENNER S, 1974, GENETICS, V77, P71; Brignull HR, 2007, ADV EXP MED BIOL, V594, P167; Brignull HR, 2006, METHOD ENZYMOL, V412, P256, DOI 10.1016/S0076-6879(06)12016-9; Brown MK, 2006, PHARMACOL BIOCHEM BE, V85, P620, DOI 10.1016/j.pbb.2006.10.017; Buchner J, 1996, FASEB J, V10, P10, DOI 10.1096/fasebj.10.1.8566529; Chavez V, 2007, GENETICS, V176, P1567, DOI 10.1534/genetics.107.072587; DUNNY GM, 1978, P NATL ACAD SCI USA, V75, P3479, DOI 10.1073/pnas.75.7.3479; Finch CE, 2001, ANNU REV GENOM HUM G, V2, P435, DOI 10.1146/annurev.genom.2.1.435; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; Garigan D, 2002, GENETICS, V161, P1101; Garsin DA, 2001, P NATL ACAD SCI USA, V98, P10892, DOI 10.1073/pnas.191378698; Garsin DA, 2003, SCIENCE, V300, P1921, DOI 10.1126/science.1080147; Gidalevitz T, 2006, SCIENCE, V311, P1471, DOI 10.1126/science.1124514; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; HOPE IA, 1999, C ELEGANS PRACTICAL, P51; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Iandolo JJ, 2000, GRAM-POSITIVE PATHOGENS, P317; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kelly WG, 1997, GENETICS, V146, P227; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; KRAMER JM, 1990, MOL CELL BIOL, V10, P2081, DOI 10.1128/MCB.10.5.2081; Labrousse A, 2000, CURR BIOL, V10, P1543, DOI 10.1016/S0960-9822(00)00833-2; Mahajan-Miklos S, 1999, CELL, V96, P47, DOI 10.1016/S0092-8674(00)80958-7; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532; Morley JF, 2002, P NATL ACAD SCI USA, V99, P10417, DOI 10.1073/pnas.152161099; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Nelson DW, 2003, GENE DEV, V17, P813, DOI 10.1101/gad.1090203; Nollen EAA, 2004, P NATL ACAD SCI USA, V101, P6403, DOI 10.1073/pnas.0307697101; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Sakahira H, 2002, P NATL ACAD SCI USA, V99, P16412, DOI 10.1073/pnas.182426899; Satyal SH, 2000, P NATL ACAD SCI USA, V97, P5750, DOI 10.1073/pnas.100107297; Singh V, 2006, P NATL ACAD SCI USA, V103, P13092, DOI 10.1073/pnas.0604050103; Srivastava P, 2002, NAT REV IMMUNOL, V2, P185, DOI 10.1038/nri749; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Van Montfort R, 2002, ADV PROTEIN CHEM, V59, P105; Wang JJ, 2002, DEVELOPMENT, V129, P4989; WRAY C, 1978, RES VET SCI, V25, P139, DOI 10.1016/S0034-5288(18)32968-0; Zugel U, 1999, CLIN MICROBIOL REV, V12, P19, DOI 10.1128/CMR.12.1.19	45	78	98	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					194	201		10.1074/jbc.M707956200	http://dx.doi.org/10.1074/jbc.M707956200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17951251	hybrid			2022-12-27	WOS:000251940300022
J	Wu, D; Huang, W; Richardson, PM; Priestley, JV; Liu, M				Wu, Dongsheng; Huang, Wenlong; Richardson, Peter M.; Priestley, John V.; Liu, Min			TRPC4 in rat dorsal root ganglion neurons is increased after nerve injury and is necessary for neurite outgrowth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRIMARY SENSORY NEURONS; RECEPTOR POTENTIAL CHANNELS; GROWTH CONES; NEUROTROPHIC FACTOR; CATION CHANNEL; CYCLIC-AMP; CA2+ ENTRY; IN-VITRO; EXPRESSION; REGENERATION	Canonical transient receptor potential (TRPC) receptors are Ca2+-permeable cation channels that have a variety of physiological functions and may be involved in neuronal development and plasticity. We investigated the expression profile of TRPC channels in adult rat dorsal root ganglia (DRG) after nerve injury and examined the role of TRPC4 in neurite outgrowth in cultured DRG neurons. Sciatic nerve transection and microinjection of dibutyryl cAMP were employed to induce axonal regeneration in vivo. TRPC4 mRNA was significantly increased whereas TRPC1, TRPC3, TRPC6, and TRPC7 remained unaltered after nerve injury or dibutyryl-cAMP microinjection. The increases in TRPC4 transcript and protein were transient with maximal levels reached at 2 or 7 days, respectively. In addition, TRPC4 transcript in ND7/23 and NDC cells, hybrid cell lines derived from neonatal DRG and neuroblastoma, was substantially increased on differentiation, characterized by neurite outgrowth. In adult DRG, TRPC4 immunoreactivity was found in small and large neurons, and nerve injury increased the number of TRPC4-immunoreactive cells, particularly in large neurons. TRPC4 immunoreactivity was present in growth cones at various stages of DRG neurite outgrowth in vitro. Suppression of TRPC4 by a specific small interfering RNA or antisense significantly reduced the length of neurites in cultured DRG neurons. Expression of short hairpin RNA significantly down-regulated TRPC4 protein level and shortened neurite lengths in differentiated ND7/23 cells. The reduction in neurite lengths in ND7/23 cells was rescued by overexpression of human TRPC4. Our results suggest that TRPC4 contributes to axonal regeneration after nerve injury.	[Wu, Dongsheng; Huang, Wenlong; Richardson, Peter M.; Priestley, John V.; Liu, Min] Queen Mary Univ London, Ctr Neurosci, Inst Cell & Mol Sci, London E1 2AT, England	University of London; Queen Mary University London	Liu, M (corresponding author), 4 Newark St, London E1 2AT, England.	m.liu@qmul.ac.uk	Huang, Wenlong/P-2025-2016					Agell N, 2002, CELL SIGNAL, V14, P649, DOI 10.1016/S0898-6568(02)00007-4; Alvarez VA, 2006, J NEUROSCI, V26, P7820, DOI 10.1523/JNEUROSCI.1957-06.2006; Bezzerides VJ, 2004, NAT CELL BIOL, V6, P709, DOI 10.1038/ncb1150; Caroni P, 2001, EMBO J, V20, P4332, DOI 10.1093/emboj/20.16.4332; Costigan M, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-16; Fatherazi S, 2007, PFLUG ARCH EUR J PHY, V453, P879, DOI 10.1007/s00424-006-0156-4; Fukuchi M, 2005, J PHARMACOL SCI, V98, P212, DOI 10.1254/jphs.FMJ05001X4; Glazebrook PA, 2005, PFLUG ARCH EUR J PHY, V451, P125, DOI 10.1007/s00424-005-1468-5; Gomez TM, 2006, NAT REV NEUROSCI, V7, P115, DOI 10.1038/nrn1844; Greka A, 2003, NAT NEUROSCI, V6, P837, DOI 10.1038/nn1092; HARPER AA, 1985, J PHYSIOL-LONDON, V359, P31, DOI 10.1113/jphysiol.1985.sp015573; Haruta T, 1997, BIOCHEM J, V325, P455, DOI 10.1042/bj3250455; Henley J, 2004, TRENDS CELL BIOL, V14, P320, DOI 10.1016/j.tcb.2004.04.006; Hofmann T, 2002, P NATL ACAD SCI USA, V99, P7461, DOI 10.1073/pnas.102596199; Huang WC, 2007, CELL CALCIUM, V42, P1, DOI 10.1016/j.ceca.2006.11.002; Inada H, 2006, BIOCHEM BIOPH RES CO, V350, P762, DOI 10.1016/j.bbrc.2006.09.111; Kunert-Keil C, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-159; Lautermilch NJ, 2000, J NEUROSCI, V20, P315, DOI 10.1523/JNEUROSCI.20-01-00315.2000; Laux T, 2000, J CELL BIOL, V149, P1455, DOI 10.1083/jcb.149.7.1455; Leclere PG, 2007, J NEUROSCI, V27, P1190, DOI 10.1523/JNEUROSCI.5089-06.2007; Li HS, 1999, NEURON, V24, P261, DOI 10.1016/S0896-6273(00)80838-7; Li Y, 2005, NATURE, V434, P894, DOI 10.1038/nature03477; Liu M, 2004, NEUROSCIENCE, V127, P659, DOI 10.1016/j.neuroscience.2004.05.041; Maroto R, 2005, NAT CELL BIOL, V7, P179, DOI 10.1038/ncb1218; Mehta D, 2003, J BIOL CHEM, V278, P33492, DOI 10.1074/jbc.M302401200; Michael GJ, 1999, EUR J NEUROSCI, V11, P3539, DOI 10.1046/j.1460-9568.1999.00767.x; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; MURPHY PG, 1995, J NEUROSCI, V15, P5130; Murphy PG, 2000, EUR J NEUROSCI, V12, P1891, DOI 10.1046/j.1460-9568.2000.00074.x; Neumann S, 2005, P NATL ACAD SCI USA, V102, P16848, DOI 10.1073/pnas.0508538102; Neumann S, 2002, NEURON, V34, P885, DOI 10.1016/S0896-6273(02)00702-X; Poteser M, 2006, J BIOL CHEM, V281, P13588, DOI 10.1074/jbc.M512205200; Qiu J, 2002, NEURON, V34, P895, DOI 10.1016/S0896-6273(02)00730-4; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Riccio A, 2002, MOL BRAIN RES, V109, P95, DOI 10.1016/S0169-328X(02)00527-2; RICHARDSON PM, 1984, NATURE, V309, P791, DOI 10.1038/309791a0; Shim S, 2005, NAT NEUROSCI, V8, P730, DOI 10.1038/nn1459; Singh I, 2007, J BIOL CHEM, V282, P7833, DOI 10.1074/jbc.M608288200; Strubing C, 2003, J BIOL CHEM, V278, P39014, DOI 10.1074/jbc.M306705200; Strubing C, 2001, NEURON, V29, P645, DOI 10.1016/S0896-6273(01)00240-9; Tanabe K, 2003, J NEUROSCI, V23, P9675; Tonra JR, 1998, J NEUROSCI, V18, P4374; Wang GX, 2005, NATURE, V434, P898, DOI 10.1038/nature03478; Williams KL, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-24; WOOD JN, 1990, P ROY SOC B-BIOL SCI, V241, P187, DOI 10.1098/rspb.1990.0084; Wu DS, 2007, EXP NEUROL, V204, P66, DOI 10.1016/j.expneurol.2006.09.017; Wu XY, 2004, J BIOL CHEM, V279, P43392, DOI 10.1074/jbc.M408959200; Xiao HS, 2002, P NATL ACAD SCI USA, V99, P8360, DOI 10.1073/pnas.122231899; Yu Y, 2004, P NATL ACAD SCI USA, V101, P13861, DOI 10.1073/pnas.0405908101	49	66	69	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					416	426		10.1074/jbc.M703177200	http://dx.doi.org/10.1074/jbc.M703177200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17928298	hybrid			2022-12-27	WOS:000251940300046
J	Yun, S; Hong, WP; Choi, JH; Yi, KS; Chae, SK; Ryu, SH; Suh, PG				Yun, Sanguk; Hong, Won-Pyo; Choi, Jang Hyun; Yi, Kye Sook; Chae, Suhn-Kee; Ryu, Sung Ho; Suh, Pann-Ghill			Phospholipase C-epsilon augments epidermal growth factor-dependent cell growth by inhibiting epidermal growth factor receptor down-regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLATHRIN; RAS; AP-2; TRAFFICKING; ENDOCYTOSIS; EXPRESSION; EFFECTOR; ADAPTERS; SUBUNIT; DOMAINS	The down-regulation of the epidermal growth factor (EGF) receptor is critical for the termination of EGF-dependent signaling, and the dysregulation of this process can lead to oncogenesis. In the present study, we suggest a novel mechanism for the regulation of EGF receptor down-regulation by phospholipase C-epsilon. The overexpression of PLC-epsilon led to an increase in receptor recycling and decreased the down-regulation of the EGF receptor in COS-7 cells. Adaptor protein complex 2 (AP2) was identified as a novel binding protein that associates with the PLC-epsilon RA2 domain independently of Ras. The interaction of PLC-epsilon with AP2 was responsible for the suppression of EGF receptor down-regulation, since a perturbation in this interaction abolished this effect. Enhanced EGF receptor stability by PLC-epsilon led to the potentiation of EGF-dependent growth in COS-7 cells. Finally, the knockdown of PLC-epsilon in mouse embryo fibroblast cells elicited a severe defect in EGF-dependent growth. Our results indicated that PLC-epsilon could promote EGF-dependent cell growth by suppressing receptor down-regulation.	[Yun, Sanguk; Hong, Won-Pyo; Choi, Jang Hyun; Yi, Kye Sook; Ryu, Sung Ho; Suh, Pann-Ghill] Pohang Univ Sci & Technol, Dept Life Sci, Div Mol & Life Sci, Pohang 790784, South Korea; [Chae, Suhn-Kee] Paichai Univ, Ctr Biomed Res, Dept Biochem, Taejon 302735, South Korea	Pohang University of Science & Technology (POSTECH); Pai Chai University	Suh, PG (corresponding author), Pohang Univ Sci & Technol, Dept Life Sci, Div Mol & Life Sci, Pohang 790784, South Korea.	pgs@postech.ac.kr	Suh, Pann-Ghill/F-3610-2010; Choi, Jang Hyun/B-3055-2012	Ryu, Sung Ho/0000-0003-0913-3048				Babst M, 2000, TRAFFIC, V1, P248, DOI 10.1034/j.1600-0854.2000.010307.x; Bache KG, 2004, EMBO J, V23, P2707, DOI 10.1038/sj.emboj.7600292; Bai YF, 2004, CANCER RES, V64, P8808, DOI 10.1158/0008-5472.CAN-04-3143; BECK KA, 1992, J CELL BIOL, V119, P787, DOI 10.1083/jcb.119.4.787; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Bunney TD, 2006, MOL CELL, V21, P495, DOI 10.1016/j.molcel.2006.01.008; Choi JH, 2004, J CELL SCI, V117, P3785, DOI 10.1242/jcs.01220; Collins BM, 2002, CELL, V109, P523, DOI 10.1016/S0092-8674(02)00735-3; Coward P, 1998, P NATL ACAD SCI USA, V95, P352, DOI 10.1073/pnas.95.1.352; Del Valle JM, 2003, J BIOL CHEM, V278, P17430, DOI 10.1074/jbc.M301569200; Gaidarov I, 1999, J CELL BIOL, V146, P755, DOI 10.1083/jcb.146.4.755; GALLUSSER A, 1993, EMBO J, V12, P5237, DOI 10.1002/j.1460-2075.1993.tb06219.x; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; GOODMAN OB, 1995, J BIOL CHEM, V270, P23768, DOI 10.1074/jbc.270.40.23768; Huang FT, 2003, J BIOL CHEM, V278, P43411, DOI 10.1074/jbc.M306072200; Jin TG, 2001, J BIOL CHEM, V276, P30301, DOI 10.1074/jbc.M103530200; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Kelley GG, 2006, J BIOL CHEM, V281, P2639, DOI 10.1074/jbc.M507681200; Kelley GG, 2001, EMBO J, V20, P743, DOI 10.1093/emboj/20.4.743; Kirchhausen T, 1997, CURR OPIN CELL BIOL, V9, P488, DOI 10.1016/S0955-0674(97)80024-5; LEGENDREGUILLEM.V, 2002, J BIOL CHEM, V277, P28212; Li LM, 1996, CELL, V85, P319, DOI 10.1016/S0092-8674(00)81111-3; Lopez I, 2001, J BIOL CHEM, V276, P2758, DOI 10.1074/jbc.M008119200; Matsuda M, 2001, J CELL BIOL, V153, P599, DOI 10.1083/jcb.153.3.599; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; Palmieri D, 2006, BREAST CANCER RES TR, V100, P127, DOI 10.1007/s10549-006-9244-6; Ponting CP, 1996, TRENDS BIOCHEM SCI, V21, P422, DOI 10.1016/S0968-0004(96)30038-8; Rao DS, 2003, CANCER CELL, V3, P471, DOI 10.1016/S1535-6108(03)00107-7; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Rhee SG, 1997, J BIOL CHEM, V272, P15045, DOI 10.1074/jbc.272.24.15045; ROBINSON MS, 1994, CURR OPIN CELL BIOL, V6, P538, DOI 10.1016/0955-0674(94)90074-4; Shibatohge M, 1998, J BIOL CHEM, V273, P6218, DOI 10.1074/jbc.273.11.6218; Song C, 2001, J BIOL CHEM, V276, P2752, DOI 10.1074/jbc.M008324200; Song CH, 2002, ONCOGENE, V21, P8105, DOI 10.1038/sj.onc.1206003; Sorkina T, 1999, J CELL SCI, V112, P317; Sorli SC, 2005, ONCOGENE, V24, P90, DOI 10.1038/sj.onc.1208168; Tran DD, 2003, DEV CELL, V5, P245, DOI 10.1016/S1534-5807(03)00207-7	37	10	11	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					341	349		10.1074/jbc.M704180200	http://dx.doi.org/10.1074/jbc.M704180200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17956867	hybrid			2022-12-27	WOS:000251940300038
J	Butterworth, MB; Edinger, RS; Ovaa, H; Burg, D; Johnson, JP; Frizzell, RA				Butterworth, Michael B.; Edinger, Robert S.; Ovaa, Huib; Burg, Danny; Johnson, John P.; Frizzell, Raymond A.			The deubiquitinating enzyme UCH-L3 regulates the apical membrane recycling of the epithelial sodium channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; CARBOXYL-TERMINAL HYDROLASE; UBIQUITIN-LIKE PROTEINS; SITE-DIRECTED PROBES; NA+ CHANNEL; CELL-SURFACE; SUBSTRATE-SPECIFICITY; PY MOTIF; ENAC; TRAFFICKING	The epithelial sodium channel ( ENaC) is ubiquitinated by the E3 ligase Nedd4-2 at the apical membranes of polarized cortical collecting duct (CCD) epithelial cells. This leads to ENaC endocytosis and possible degradation. Because ENaC is known to recycle at the apical membranes of CCD cells, deubiquitinating enzymes (DUBs) are likely involved in regulating ENaC surface density by facilitating ENaC recycling as opposed to degradation. Using a chemical probe approach to tag active DUBs, we identified ubiquitin C-terminal hydrolase (UCH) isoform L3 as the predominant DUB in endosomal compartments of CCD cells. Blocking UCH-L3 activity or reducing its expression by selective knockdown increased ENaC ubiquitination and resulted in its removal from the apical membranes of CCD cells. Functionally this caused a rapid reduction in transepithelial Na+ currents across the CCD epithelia. Surface biotinylation demonstrated the loss of ENaC from the apical surface when UCH-L3 was inhibited. Whole cell or apical surface immuno-precipitation demonstrated increased ENaC ubiquitination with UCH-L3 inhibition. This constitutes a novel function for UCH in epithelia and in the regulation of ion channels and demonstrates the dynamic regulation of apically located ENaC by recycling, which is facilitated by this DUB.	[Butterworth, Michael B.; Frizzell, Raymond A.] Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA; [Edinger, Robert S.; Johnson, John P.] Univ Pittsburgh, Sch Med, Div Renal & Electrolyte, Pittsburgh, PA 15261 USA; [Ovaa, Huib; Burg, Danny] Netherlands Canc Inst, Div Cellular Biochem, NL-1066 CX Amsterdam, Netherlands	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Netherlands Cancer Institute	Butterworth, MB (corresponding author), Univ Pittsburgh, Dept Cell Biol & Physiol, 537S BST,3500 Terrace St, Pittsburgh, PA 15261 USA.	michael7@pitt.edu	; ovaa, huib/M-2334-2016	Butterworth, Michael/0000-0002-2173-8333; ovaa, huib/0000-0002-0068-054X	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057718, R01DK047874, R01DK054814] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK57718, DK47874, DK54814] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abriel H, 2005, PHYSIOLOGY, V20, P398, DOI 10.1152/physiol.00033.2005; Amerik AY, 2004, BBA-MOL CELL RES, V1695, P189, DOI 10.1016/j.bbamcr.2004.10.003; Butterworth MB, 2005, AM J PHYSIOL-RENAL, V289, pF969, DOI 10.1152/ajprenal.00390.2003; Butterworth MB, 2005, J GEN PHYSIOL, V125, P81, DOI 10.1085/jgp.2004.09124; Clague MJ, 2006, TRENDS CELL BIOL, V16, P551, DOI 10.1016/j.tcb.2006.09.002; Debonneville C, 2004, MOL CELL BIOL, V24, P2397, DOI 10.1128/MCB.24.6.2397-2409.2004; Fakitsas P, 2007, J AM SOC NEPHROL, V18, P1084, DOI 10.1681/ASN.2006080902; Gormley K, 2003, BIOCHEM J, V371, P1, DOI 10.1042/BJ20021375; Goulet CC, 1998, J BIOL CHEM, V273, P30012, DOI 10.1074/jbc.273.45.30012; Hanwell D, 2002, J BIOL CHEM, V277, P9772, DOI 10.1074/jbc.M110904200; Hemelaar J, 2004, J PROTEOME RES, V3, P268, DOI 10.1021/pr0341080; Hemelaar J, 2004, MOL CELL BIOL, V24, P84, DOI 10.1128/MCB.24.1.84-95.2004; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Huang SH, 2007, CELL METAB, V5, P237, DOI 10.1016/j.cmet.2007.03.006; Hurley JH, 2006, ANNU REV BIOPH BIOM, V35, P277, DOI 10.1146/annurev.biophys.35.040405.102126; Kurihara LJ, 2000, MOL CELL BIOL, V20, P2498, DOI 10.1128/MCB.20.7.2498-2504.2000; Kwon J, 2004, BIOL REPROD, V71, P515, DOI 10.1095/biolreprod.104.027565; Larsen CN, 1998, BIOCHEMISTRY-US, V37, P3358, DOI 10.1021/bi972274d; Liu YC, 2003, CHEM BIOL, V10, P837, DOI 10.1016/j.chembiol.2003.08.010; LOWE J, 1990, J PATHOL, V161, P153, DOI 10.1002/path.1711610210; Lu C, 2007, TRAFFIC, V8, P1246, DOI 10.1111/j.1600-0854.2007.00602.x; Malik B, 2001, J BIOL CHEM, V276, P12903, DOI 10.1074/jbc.M010626200; Metzler M, 2001, J BIOL CHEM, V276, P39271, DOI 10.1074/jbc.C100401200; Millard SM, 2006, J CELL BIOL, V173, P463, DOI 10.1083/jcb.200602082; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Osaka H, 2003, HUM MOL GENET, V12, P1945, DOI 10.1093/hmg/ddg211; Ovaa H, 2005, METHOD ENZYMOL, V399, P468, DOI 10.1016/S0076-6879(05)99032-0; Ovaa H, 2004, P NATL ACAD SCI USA, V101, P2253, DOI 10.1073/pnas.0308411100; Ovaa H, 2003, ANGEW CHEM INT EDIT, V42, P3626, DOI 10.1002/anie.200351314; Ovaa H, 2007, NAT REV CANCER, V7, P613, DOI 10.1038/nrc2128; Snyder PM, 2001, J BIOL CHEM, V276, P28321, DOI 10.1074/jbc.M011487200; Soboleva TA, 2004, CURR PROTEIN PEPT SC, V5, P191, DOI 10.2174/1389203043379765; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; Staub O, 2000, KIDNEY INT, V57, P809, DOI 10.1046/j.1523-1755.2000.00919.x; Wang H, 2006, J BIOL CHEM, V281, P14129, DOI 10.1074/jbc.M512511200; Wiemuth D, 2007, BIOCHEM J, V405, P147, DOI 10.1042/BJ20060747; WILKINSON KD, 1989, SCIENCE, V246, P670, DOI 10.1126/science.2530630; Zhou RF, 2007, J BIOL CHEM, V282, P20207, DOI 10.1074/jbc.M611329200	38	81	87	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37885	37893		10.1074/jbc.M707989200	http://dx.doi.org/10.1074/jbc.M707989200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17967898	hybrid			2022-12-27	WOS:000251833600064
J	Garmier, M; Priault, P; Vidal, G; Driscoll, S; Djebbar, R; Boccara, M; Mathieu, C; Foyer, CH; De Paepe, R				Garmier, Marie; Priault, Pierrick; Vidal, Guillaume; Driscoll, Simon; Djebbar, Reda; Boccara, Martine; Mathieu, Chantal; Foyer, Christine H.; De Paepe, Rosine			Light and oxygen are not required for harpin-induced cell death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED HYPERSENSITIVE RESPONSE; PHOTOSYNTHETIC ELECTRON-TRANSPORT; CHLOROPLAST ENVELOPE MEMBRANES; SYSTEMIC ACQUIRED-RESISTANCE; ERWINIA-AMYLOVORA HARPIN; REACTIVE OXYGEN; HYDROGEN-PEROXIDE; ALTERNATIVE OXIDASE; PLANT-MITOCHONDRIA; DISEASE RESISTANCE	Nicotiana sylvestris leaves challenged by the bacterial elicitor harpin N-Ea were used as a model system in which to determine the respective roles of light, oxygen, photosynthesis, and respiration in the programmed cell death response in plants. The appearance of cell death markers, such as membrane damage, nuclear fragmentation, and induction of the stress-responsive element Tnt1, was observed in all conditions. However, the cell death process was delayed in the dark compared with the light, despite a similar accumulation of superoxide and hydrogen peroxide in the chloroplasts. In contrast, harpin- induced cell death was accelerated under very low oxygen (<0.1% O-2) compared with air. Oxygen deprivation impaired accumulation of chloroplastic reactive oxygen species (ROS) and the induction of cytosolic antioxidant genes in both the light and the dark. It also attenuates the collapse of photosynthetic capacity and the respiratory burst driven by mitochondrial alternative oxidase activity observed in air. Since alternative oxidase is known to limit overreduction of the respiratory chain, these results strongly suggest that mitochondrial ROS accumulate in leaves elicited under low oxygen. We conclude that the harpin- induced cell death does not require ROS accumulation in the apoplast or in the chloroplasts but that mitochondrial ROS could be important in the orchestration of the cell suicide program.	[Garmier, Marie; Vidal, Guillaume; Mathieu, Chantal; De Paepe, Rosine] Univ Paris 11, CNRS, Inst Plant Biotechnol, UMR 8618, F-91405 Orsay, France; [Priault, Pierrick] Univ Paris 11, CNRS, UMR 8079, F-91405 Orsay, France; [Driscoll, Simon; Foyer, Christine H.] Newcastle Univ, Sch Agr, Agr Bldg, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Djebbar, Reda] Univ Sci & Technol Houari Boumedienne, Fac Biol Sci, Lab Physiol Vegetale, Algiers 16111, Algeria	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Paris Saclay; Newcastle University - UK; University Science & Technology Houari Boumediene	De Paepe, R (corresponding author), Univ Paris 11, CNRS, Inst Plant Biotechnol, UMR 8618, Batiment 630, F-91405 Orsay, France.	rosine.de-paepe@u-psud.fr	Pierrick, PRIAULT/ABE-6051-2021; Priault, Pierrick/AAI-7273-2020; mathieu, chantal/ABD-5505-2021; Foyer, Christine/K-2143-2012; Djebbar, Réda/P-7720-2016	Pierrick, PRIAULT/0000-0002-7386-4198; mathieu, chantal/0000-0002-4055-5233; Djebbar, Réda/0000-0003-3166-3299; Foyer, Christine/0000-0001-5989-6989				Adam AL, 1997, PLANT PHYSIOL, V115, P853, DOI 10.1104/pp.115.2.853; Allen JF, 2001, TRENDS PLANT SCI, V6, P317, DOI 10.1016/S1360-1385(01)02010-6; Ameisen JC, 2002, CELL DEATH DIFFER, V9, P367, DOI 10.1038/sj.cdd.4400950; Andi S, 2001, PLANT CELL PHYSIOL, V42, P446, DOI 10.1093/pcp/pce056; Baek D, 2004, PLANT MOL BIOL, V56, P15, DOI 10.1007/s11103-004-3096-4; Bailey-Serres J, 2005, ANN BOT-LONDON, V96, P507, DOI 10.1093/aob/mci206; BAKER CJ, 1993, PLANT PHYSIOL, V102, P1341, DOI 10.1104/pp.102.4.1341; Basset G, 2002, PLANT PHYSIOL, V128, P1149, DOI 10.1104/pp.010612; Bechtold U, 2005, PLANT CELL ENVIRON, V28, P1046, DOI 10.1111/j.1365-3040.2005.01340.x; Bent AF, 2007, ANNU REV PHYTOPATHOL, V45, P399, DOI 10.1146/annurev.phyto.45.062806.094427; Bienert GP, 2007, J BIOL CHEM, V282, P1183, DOI 10.1074/jbc.M603761200; Blokhina OB, 2001, J EXP BOT, V52, P1179, DOI 10.1093/jexbot/52.359.1179; Boccara M, 2001, PLANT J, V28, P663, DOI 10.1046/j.1365-313x.2001.01186.x; Boccara M, 2007, PLANT J, V50, P338, DOI 10.1111/j.1365-313X.2007.03051.x; Bolwell GP, 2002, J EXP BOT, V53, P1367, DOI 10.1093/jexbot/53.372.1367; Bonfig KB, 2006, PLANTA, V225, P1, DOI 10.1007/s00425-006-0303-3; Brunelle JK, 2005, CELL METAB, V1, P409, DOI 10.1016/j.cmet.2005.05.002; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Chew O, 2003, J BIOL CHEM, V278, P46869, DOI 10.1074/jbc.M307525200; Clifton R, 2006, BBA-BIOENERGETICS, V1757, P730, DOI 10.1016/j.bbabio.2006.03.009; Cross AR, 2004, BBA-BIOENERGETICS, V1657, P1, DOI 10.1016/j.bbabio.2004.03.008; Curtis MJ, 2002, PLANT J, V29, P295, DOI 10.1046/j.0960-7412.2001.01213.x; Dat JF, 2003, PLANT J, V33, P621, DOI 10.1046/j.1365-313X.2003.01655.x; Dayakar BV, 2003, PLANT MOL BIOL, V51, P913, DOI 10.1023/A:1023061303755; Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1; Dietrich P, 2001, J EXP BOT, V52, P1959, DOI 10.1093/jexbot/52.363.1959; Dong HS, 1999, PLANT J, V20, P207, DOI 10.1046/j.1365-313x.1999.00595.x; Draper J, 1997, TRENDS PLANT SCI, V2, P162, DOI 10.1016/S1360-1385(97)01030-3; Drew MC, 1997, ANNU REV PLANT PHYS, V48, P223, DOI 10.1146/annurev.arplant.48.1.223; Dutilleul C, 2003, PLANT CELL, V15, P1212, DOI 10.1105/tpc.009464; Dutilleul C, 2003, PLANT PHYSIOL, V131, P264, DOI 10.1104/pp.011155; Ferro M, 2003, MOL CELL PROTEOMICS, V2, P325, DOI 10.1074/mcp.M300030-MCP200; Foyer CH, 2000, NEW PHYTOL, V146, P359, DOI 10.1046/j.1469-8137.2000.00667.x; Foyer CH, 2005, PLANT CELL ENVIRON, V28, P1056, DOI 10.1111/j.1365-3040.2005.01327.x; Foyer CH, 2003, PHYSIOL PLANTARUM, V119, P355, DOI 10.1034/j.1399-3054.2003.00223.x; Garmier M, 2002, PLANT PHYSIOL BIOCH, V40, P561, DOI 10.1016/S0981-9428(02)01399-2; GARMIER M, 2003, THESIS U PARIS SUD 1; Gaudriault S, 1998, FEBS LETT, V428, P224, DOI 10.1016/S0014-5793(98)00534-1; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; Hail N, 2006, APOPTOSIS, V11, P889, DOI 10.1007/s10495-006-6712-8; HE SY, 1994, MOL PLANT MICROBE IN, V7, P289, DOI 10.1094/MPMI-7-0289; HE SY, 1993, CELL, V73, P1255, DOI 10.1016/0092-8674(93)90354-S; Huang HE, 2007, MOL PLANT PATHOL, V8, P129, DOI 10.1111/J.1364-3703.2006.00378.X; Ichinose Y, 2001, PLANT PHYSIOL BIOCH, V39, P771, DOI 10.1016/S0981-9428(01)01300-6; Igamberdiev AU, 1998, PHYSIOL PLANTARUM, V104, P431, DOI 10.1034/j.1399-3054.1998.1040319.x; JagerVottero P, 1997, P NATL ACAD SCI USA, V94, P1597, DOI 10.1073/pnas.94.4.1597; JAKOBEK JL, 1993, PLANT CELL, V5, P49, DOI 10.1105/tpc.5.1.49; KAISER WM, 1979, PLANTA, V145, P377, DOI 10.1007/BF00388364; Karpinski S, 1997, PLANT CELL, V9, P627, DOI 10.1105/tpc.9.4.627; Karpinski S, 2003, CURR OPIN PLANT BIOL, V6, P390, DOI 10.1016/S1369-5266(03)00061-X; Kemp PJ, 2006, EXP PHYSIOL, V91, P829, DOI 10.1113/expphysiol.2006.034587; Krause M, 2004, MOL PLANT MICROBE IN, V17, P131, DOI 10.1094/MPMI.2004.17.2.131; Lam E, 2001, NATURE, V411, P848, DOI 10.1038/35081184; Lamb C, 1997, ANNU REV PLANT PHYS, V48, P251, DOI 10.1146/annurev.arplant.48.1.251; Lawlor DW, 2002, ANN BOT-LONDON, V89, P871, DOI 10.1093/aob/mcf110; LI YM, 1993, BIOCHEM PHARMACOL, V46, P1435, DOI 10.1016/0006-2952(93)90109-A; Liu YD, 2007, PLANT J, V51, P941, DOI 10.1111/j.1365-313X.2007.03191.x; Lu ZG, 2005, P NATL ACAD SCI USA, V102, P2778, DOI 10.1073/pnas.0405374102; Matsumura H, 2003, P NATL ACAD SCI USA, V100, P15718, DOI 10.1073/pnas.2536670100; MILLAR AH, 1994, PLANT PHYSIOL BIOCH, V32, P847; Mishina TE, 2007, PLANT J, V50, P500, DOI 10.1111/j.1365-313X.2007.03067.x; Moller IM, 2001, ANNU REV PLANT PHYS, V52, P561, DOI 10.1146/annurev.arplant.52.1.561; Nulton-Persson AC, 2001, J BIOL CHEM, V276, P23357, DOI 10.1074/jbc.M100320200; Oh CS, 2005, FEMS MICROBIOL LETT, V253, P185, DOI 10.1016/j.femsle.2005.09.051; Pike SM, 1998, PHYSIOL MOL PLANT P, V53, P39, DOI 10.1006/pmpp.1998.0167; Pitzschke A, 2006, PLANT PHYSIOL, V141, P351, DOI 10.1104/pp.106.079160; POUTEAU S, 1994, PLANT J, V5, P535, DOI 10.1046/j.1365-313X.1994.5040535.x; Purvis AC, 1997, PHYSIOL PLANTARUM, V100, P165, DOI 10.1034/j.1399-3054.1997.1000119.x; RIBAS-CARBO M, 1995, PLANT PHYSIOL, V109, P829, DOI 10.1104/pp.109.3.829; RIBAS-CARBO M, 1994, BBA-BIOENERGETICS, V1188, P205, DOI 10.1016/0005-2728(94)90037-X; Sagi M, 2001, PLANT PHYSIOL, V126, P1281, DOI 10.1104/pp.126.3.1281; Samuel MA, 2005, PLANT J, V42, P406, DOI 10.1111/j.1365-313X.2005.02382.x; Scharte J, 2005, PLANT CELL ENVIRON, V28, P1421, DOI 10.1111/j.1365-3040.2005.01380.x; SCHREIBER U, 1986, PHOTOSYNTH RES, V10, P51, DOI 10.1007/BF00024185; Shulaev V, 2006, PLANT PHYSIOL, V141, P367, DOI 10.1104/pp.106.077925; Simons BH, 1999, PLANT PHYSIOL, V120, P529, DOI 10.1104/pp.120.2.529; Sweetlove LJ, 2004, ADV PHOTO RESPIRAT, V17, P307; TAKAHASHI T, 2005, BIOCHIM BIOPHYS ACTA, V1703, P352; Torres MA, 2005, NAT GENET, V37, P1130, DOI 10.1038/ng1639; Torres MA, 2006, PLANT PHYSIOL, V141, P373, DOI 10.1104/pp.106.079467; VERNIQUET F, 1991, BIOCHEM J, V276, P643, DOI 10.1042/bj2760643; Vidal G, 2007, PLANT CELL, V19, P640, DOI 10.1105/tpc.106.044461; WEI ZM, 1992, SCIENCE, V257, P85, DOI 10.1126/science.1621099; Xie ZX, 2000, MOL PLANT MICROBE IN, V13, P183, DOI 10.1094/MPMI.2000.13.2.183; Zhang LX, 2002, FEBS LETT, V512, P13, DOI 10.1016/S0014-5793(02)02218-4	85	26	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37556	37566		10.1074/jbc.M707226200	http://dx.doi.org/10.1074/jbc.M707226200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17951254	Green Published, hybrid			2022-12-27	WOS:000251833600031
J	Huecas, S; Schaffner-Barbero, C; Garcia, W; Yebenes, H; Palacios, JM; Diaz, JF; Menendez, M; Andreu, JM				Huecas, Sonia; Schaffner-Barbero, Claudia; Garcia, Wanius; Yebenes, Hugo; Palacios, Juan Manuel; Diaz, Jose Fernando; Menendez, Margarita; Andreu, Jose Manuel			The interactions of cell division protein FtsZ with guanine Nucleotides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASSEMBLY DYNAMICS; ESCHERICHIA-COLI; IN-VITRO; BACTERIAL CYTOKINESIS; CRYSTAL-STRUCTURE; TARGETING FTSZ; GTP HYDROLYSIS; SMALL-MOLECULE; TUBULIN; RING	Prokaryotic cell division protein FtsZ, an assembling GTPase, directs the formation of the septosome between daughter cells. FtsZ is an attractive target for the development of new antibiotics. Assembly dynamics of FtsZ is regulated by the binding, hydrolysis, and exchange of GTP. Wehave determined the energetics of nucleotide binding to model apoFtsZ from Methanococcus jannaschii and studied the kinetics of 2'/3 '-O-( N-methylanthraniloyl) ( mant)-nucleotide binding and dissociation from FtsZ polymers, employing calorimetric, fluorescence, and stopped-flow methods. FtsZ binds GTP and GDP with Kb values ranging from 20 to 300 mu M -1 under various conditions. GTP.Mg2+ and GDP . Mg2+ bind with slightly reduced affinity. Bound GTP and the coordinated Mg2+ ion play a minor structural role in FtsZ monomers, but Mg2+-assisted GTP hydrolysis triggers polymer disassembly. Mant-GTP binds and dissociates quickly from FtsZ monomers, with similar to 10-fold lower affinity than GTP. Mant-GTP displacement measured by fluorescence anisotropy provides a method to test the binding of any competing molecules to the FtsZ nucleotide site. Mant-GTP is very slowly hydrolyzed and remains exchangeable in FtsZ polymers, but it becomes kinetically stabilized, with a 30-fold slower k(+) and similar to 500-fold slower k -than in monomers. The mant-GTP dissociation rate from FtsZ polymers is comparable with the GTP hydrolysis turnover and with the reported subunit turnover in Escherichia coli FtsZ polymers. Although FtsZ polymers can exchange nucleotide, unlike its eukaryotic structural homologue tubulin, GDP dissociation may be slow enough for polymer disassembly to take place first, resulting in FtsZ polymers cycling with GTP hydrolysis similarly to microtubules.	[Huecas, Sonia; Schaffner-Barbero, Claudia; Garcia, Wanius; Yebenes, Hugo; Palacios, Juan Manuel; Diaz, Jose Fernando; Andreu, Jose Manuel] CSIC, Ctr Invest Biol, E-28040 Madrid, Spain; [Menendez, Margarita] CSIC, Inst Quim Fis Rocasolano, E-28006 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR)	Huecas, S (corresponding author), CSIC, Ctr Invest Biol, Ramiro Da Maeztu,9, E-28040 Madrid, Spain.	sonia@cib.csic.es; j.m.andreu@cib.csic.es	Menendez, Margarita/M-1795-2014; Huecas, Sonia/P-2542-2019; Huecas, Sonia/K-1754-2014; Silva, Wanius J. G./L-3948-2016; Díaz, J. Fernando/M-6853-2019; Díaz, J. Fernando/U-3532-2017	Menendez, Margarita/0000-0002-3267-4443; Huecas, Sonia/0000-0002-6419-441X; Huecas, Sonia/0000-0002-6419-441X; Díaz, J. Fernando/0000-0003-2743-3319; Díaz, J. Fernando/0000-0003-2743-3319; Yebenes, Hugo/0000-0002-0448-217X; Andreu, Jose M/0000-0001-8064-6933				Aldaz H, 2005, NATURE, V435, P523, DOI 10.1038/nature03586; Anderson DE, 2004, J BACTERIOL, V186, P5775, DOI 10.1128/JB.186.17.5775-5781.2004; Andreu JM, 2002, J BIOL CHEM, V277, P43262, DOI 10.1074/jbc.M206723200; Andreu JM, 2001, BIOCHEMISTRY-US, V40, P11975, DOI 10.1021/bi010869+; BARSHOP BA, 1983, ANAL BIOCHEM, V130, P134, DOI 10.1016/0003-2697(83)90660-7; Beuria TK, 2005, BIOCHEMISTRY-US, V44, P16584, DOI 10.1021/bi050767+; Bevington P. R., 1969, DATA REDUCTION ERROR, P235; BI E, 1991, NATURE, V354, P161, DOI 10.1038/354161a0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buey RM, 2006, BIOCHEMISTRY-US, V45, P5933, DOI 10.1021/bi060334m; Burbank KS, 2006, CURR BIOL, V16, pR516, DOI 10.1016/j.cub.2006.06.044; Chen Y, 2007, J BIOL CHEM, V282, P27736, DOI 10.1074/jbc.M703788200; Chen YD, 2005, J BIOL CHEM, V280, P22549, DOI 10.1074/jbc.M500895200; Chung KM, 2007, J BIOL CHEM, V282, P14891, DOI 10.1074/jbc.M605177200; CORREIA JJ, 1987, J BIOL CHEM, V262, P17278; Diaz Jose Fernando, 2007, Methods Mol Med, V137, P245, DOI 10.1007/978-1-59745-442-1_17; Domadia P, 2007, BIOCHEM PHARMACOL, V74, P831, DOI 10.1016/j.bcp.2007.06.029; FRIGON RP, 1975, BIOCHEMISTRY-US, V14, P4567, DOI 10.1021/bi00692a002; Huang Q, 2006, J MED CHEM, V49, P463, DOI 10.1021/jm050920y; Huecas S, 2004, FEBS LETT, V569, P43, DOI 10.1016/j.febslet.2004.05.048; Huecas S, 2003, J BIOL CHEM, V278, P46146, DOI 10.1074/jbc.M307128200; HUECAS S, 2007, BIOPHYS J, DOI DOI 10.1529/BIOPHYSJ.107.107896; Ito H, 2006, MICROBIOL IMMUNOL, V50, P759, DOI 10.1111/j.1348-0421.2006.tb03851.x; Jaiswal R, 2007, BIOCHEMISTRY-US, V46, P4211, DOI 10.1021/bi602573e; Jameson DM, 1997, METHOD ENZYMOL, V278, P363; Kong CG, 2004, MOL CELL, V14, P233, DOI 10.1016/S1097-2765(04)00206-0; Lappchen T, 2005, BIOCHEMISTRY-US, V44, P7879, DOI 10.1021/bi047297o; Larsen RA, 2007, GENE DEV, V21, P1340, DOI 10.1101/gad.1546107; Lutkenhaus J, 2007, ANNU REV BIOCHEM, V76, P539, DOI 10.1146/annurev.biochem.75.103004.142652; Margalit DN, 2004, P NATL ACAD SCI USA, V101, P11821, DOI 10.1073/pnas.0404439101; MEDRANO FJ, 1991, BIOCHEMISTRY-US, V30, P3770, DOI 10.1021/bi00229a026; Menendez M, 1998, J BIOL CHEM, V273, P167, DOI 10.1074/jbc.273.1.167; Michie KA, 2006, ANNU REV BIOCHEM, V75, P467, DOI 10.1146/annurev.biochem.75.103004.142452; Mingorance J, 2001, MOL MICROBIOL, V41, P83, DOI 10.1046/j.1365-2958.2001.02498.x; Nogales E, 1998, NAT STRUCT BIOL, V5, P451, DOI 10.1038/nsb0698-451; Nogales E, 1999, CELL MOL LIFE SCI, V56, P133, DOI 10.1007/s000180050012; Ohashi Y, 1999, J BACTERIOL, V181, P1348, DOI 10.1128/JB.181.4.1348-1351.1999; Oliva MA, 2004, NAT STRUCT MOL BIOL, V11, P1243, DOI 10.1038/nsmb855; Oliva MA, 2003, J BIOL CHEM, V278, P33562, DOI 10.1074/jbc.M303798200; Oosawa F., 1975, THERMODYNAMICS POLYM; Paradis-Bleau C, 2007, BIOORGAN MED CHEM, V15, P1330, DOI 10.1016/j.bmc.2006.11.015; Pisareva VP, 2007, BIOCHEMISTRY-US, V46, P2622, DOI 10.1021/bi062134g; Possoz C, 2007, ANTIMICROB AGENTS CH, V51, P252, DOI 10.1128/AAC.00892-06; Reynolds RC, 2004, BIOORG MED CHEM LETT, V14, P3161, DOI 10.1016/j.bmcl.2004.04.012; Romberg L, 2004, BIOCHEMISTRY-US, V43, P282, DOI 10.1021/bi035465r; Rothfield L, 2005, NAT REV MICROBIOL, V3, P959, DOI 10.1038/nrmicro1290; Santra MK, 2004, J BIOL CHEM, V279, P25959, DOI 10.1074/jbc.M312473200; Schlieper D, 2005, P NATL ACAD SCI USA, V102, P9170, DOI 10.1073/pnas.0502859102; Simon I, 1996, J BIOL CHEM, V271, P20470, DOI 10.1074/jbc.271.34.20470; Sontag CA, 2005, J CELL BIOL, V169, P233, DOI 10.1083/jcb.200410027; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Stokes NR, 2005, J BIOL CHEM, V280, P39709, DOI 10.1074/jbc.M506741200; Stricker J, 2002, P NATL ACAD SCI USA, V99, P3171, DOI 10.1073/pnas.052595099; Thanbichler M, 2006, CELL, V126, P147, DOI 10.1016/j.cell.2006.05.038; Urgaonkar S, 2005, ORG LETT, V7, P5609, DOI 10.1021/ol052269z; Vicente M, 2006, MOL MICROBIOL, V61, P5, DOI 10.1111/j.1365-2958.2006.05233.x; Vollmer W, 2006, APPL MICROBIOL BIOT, V73, P37, DOI 10.1007/s00253-006-0586-0; Wang J, 2003, J BIOL CHEM, V278, P44424, DOI 10.1074/jbc.M307625200; Weart RB, 2007, CELL, V130, P335, DOI 10.1016/j.cell.2007.05.043; Zhang BL, 2000, J BIOL CHEM, V275, P25299, DOI 10.1074/jbc.M001027200	60	56	65	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37515	37528		10.1074/jbc.M706399200	http://dx.doi.org/10.1074/jbc.M706399200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17977836	hybrid, Green Published			2022-12-27	WOS:000251833600027
J	Shavinskaya, A; Boulant, S; Penin, F; McLauchlan, J; Bartenschlager, R				Shavinskaya, Anna; Boulant, Steeve; Penin, Francois; McLauchlan, John; Bartenschlager, Ralf			The lipid droplet binding domain of hepatitis C virus core protein is a major determinant for efficient virus assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL PEPTIDE PEPTIDASE; RNA REPLICATION; CELL-LINES; ASSOCIATION; EXPRESSION; PARTICLES; INFECTION; CLEAVAGE; INSIGHTS; CULTURE	Hepatitis C virus core protein forms the viral capsid and is targeted to lipid droplets (LDs) by its domain 2 (D2). By using a comparative analysis of two hepatitis C virus genomes (JFH1 and Jc1) differing in their level of virus production in cultured human hepatoma cells, we demonstrate that the core of the genotype 2a isolate J6 that is present in Jc1 mediates efficient assembly and release of infectious virions. Mapping studies identified a single amino acid residue in D2 as a major determinant for enhanced assembly and release of infectious Jc1 particles. Confocal microscopy analyses demonstrate that core protein in JFH1-replicating cells co-localizes perfectly with LDs and induces their accumulation in the perinuclear area, whereas no such accumulation of LDs and only a partial co-localization of core and LDs were found with the Jc1 genome. By using a fluorescence recovery after photobleaching assay, we found that green fluorescent protein-tagged D2 variants are mobile on LDs and that J6- and JFH1-D2 differ in their mobility. Taken together, our results demonstrate that the binding strength of the D2 domain of core for LDs is crucial for determining the efficiency of virus assembly.	[Shavinskaya, Anna; Bartenschlager, Ralf] Univ Heidelberg, Dept Mol Virol, D-69120 Heidelberg, Germany; [Boulant, Steeve; McLauchlan, John] Inst Virol, Med Res Council Virol Unit, Glasgow G11 5JR, Lanark, Scotland; [Penin, Francois] Univ Lyon, CNRS, UMR 5086, IFR 128,Inst Biol & Chim Prot, F-69397 Lyon, France	Ruprecht Karls University Heidelberg; University of Glasgow; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Bartenschlager, R (corresponding author), Univ Heidelberg, Dept Mol Virol, Neuenheimer Feld 345, D-69120 Heidelberg, Germany.	ralf_bartenschlager@med.uni-heidelberg.de	PENIN, Francois/A-7315-2008; Boulant, Steeve/W-3754-2019; Bartenschlager, Ralf/L-2582-2015	Boulant, Steeve/0000-0001-8614-4993; Bartenschlager, Ralf/0000-0001-5601-9307	MRC [MC_U130184143] Funding Source: UKRI; Medical Research Council [MC_UU_12014/1, MC_U130184143] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Appel N, 2006, J BIOL CHEM, V281, P9833, DOI 10.1074/jbc.R500026200; Barba G, 1997, P NATL ACAD SCI USA, V94, P1200, DOI 10.1073/pnas.94.4.1200; Bartenschlager R, 2004, ADV VIRUS RES, V63, P71, DOI 10.1016/S0065-3527(04)63002-8; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Boulant S, 2005, J VIROL, V79, P11353, DOI 10.1128/JVI.79.17.11353-11365.2005; Boulant S, 2007, J GEN VIROL, V88, P2204, DOI 10.1099/vir.0.82898-0; Boulant S, 2006, J BIOL CHEM, V281, P22236, DOI 10.1074/jbc.M601031200; Combet C, 2007, NUCLEIC ACIDS RES, V35, pD363, DOI 10.1093/nar/gkl970; Delgrange D, 2007, J GEN VIROL, V88, P2495, DOI 10.1099/vir.0.82872-0; Friebe P, 2005, J VIROL, V79, P380, DOI 10.1128/JVI.79.1.380-392.2005; Gastaminza P, 2006, J VIROL, V80, P11074, DOI 10.1128/JVI.01150-06; Giannini C, 2003, CELL DEATH DIFFER, V10, pS27, DOI 10.1038/sj.cdd.4401121; Hope RG, 2000, J GEN VIROL, V81, P1913, DOI 10.1099/0022-1317-81-8-1913; Huang H, 2007, P NATL ACAD SCI USA, V104, P5848, DOI 10.1073/pnas.0700760104; Hussy P, 1996, VIROLOGY, V224, P93, DOI 10.1006/viro.1996.0510; Jolivet M, 1997, Patent application, Patent No. [1015481, EP 1015481]; JOLIVET M, 1998, Patent No. 9839360; KAUL A, 2007, J VIROL         0907; Koutsoudakis G, 2007, J VIROL, V81, P588, DOI 10.1128/JVI.01534-06; Koutsoudakis G, 2006, J VIROL, V80, P5308, DOI 10.1128/JVI.02460-05; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; McHutchison John G, 2003, Clin Liver Dis, V7, P149, DOI 10.1016/S1089-3261(02)00077-6; McLauchlan J, 2000, J VIRAL HEPATITIS, V7, P2; McLauchlan J, 2002, EMBO J, V21, P3980, DOI 10.1093/emboj/cdf414; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Moradpour D, 1996, VIROLOGY, V222, P51, DOI 10.1006/viro.1996.0397; Moradpour D, 1996, J MED VIROL, V48, P234, DOI 10.1002/(SICI)1096-9071(199603)48:3<234::AID-JMV4>3.0.CO;2-9; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Poynard T, 2003, LANCET, V362, P2095, DOI 10.1016/S0140-6736(03)15109-4; SAYLE RA, 1995, TRENDS BIOCHEM SCI, V20, P374, DOI 10.1016/S0968-0004(00)89080-5; Schaller T, 2007, J VIROL, V81, P4591, DOI 10.1128/JVI.02144-06; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; Spearman C, 1908, BRIT J PSYCHOL, V2, P227, DOI 10.1111/j.2044-8295.1908.tb00176.x; Steinmann E, 2007, PLOS PATHOG, V3, P962, DOI 10.1371/journal.ppat.0030103; Targett-Adams P, 2003, J BIOL CHEM, V278, P15998, DOI 10.1074/jbc.M211289200; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VANREGENMORTEL MHV, 2000, VIRUS TAXONOMY 7 REP, P872; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Weihofen A, 2000, J BIOL CHEM, V275, P30951, DOI 10.1074/jbc.M005980200; Weihofen A, 2003, J BIOL CHEM, V278, P16528, DOI 10.1074/jbc.M301372200; White SH, 1998, BBA-REV BIOMEMBRANES, V1376, P339, DOI 10.1016/S0304-4157(98)00021-5; Xu ZM, 2001, EMBO J, V20, P3840, DOI 10.1093/emboj/20.14.3840; Zhong J, 2006, J VIROL, V80, P11082, DOI 10.1128/JVI.01307-06	44	199	206	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					37158	37169		10.1074/jbc.M707329200	http://dx.doi.org/10.1074/jbc.M707329200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17942391	hybrid			2022-12-27	WOS:000251646000042
J	Hovhannisyan, RH; Carstens, RP				Hovhannisyan, Ruben H.; Carstens, Russ P.			Heterogeneous ribonucleoprotein M is a splicing regulatory protein that can enhance or silence splicing of alternatively spliced Exons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-MESSENGER-RNA; TRACT-BINDING-PROTEIN; FACTOR RECEPTOR 2; HNRNP-M PROTEINS; IN-VIVO; IDENTIFICATION; SPECIFICITY; ACTIVATION; REPRESSION; EXPRESSION	Splicing of fibroblast growth factor receptor 2 (FGFR2) alternative exons IIIb and IIIc is regulated by the auxiliary RNA cis-element ISE/ISS-3 that promotes splicing of exons IIIb and silencing of exon IIIc. Using RNA affinity chromatography, we have identified heterogeneous nuclear ribonucleoprotein M (hnRNP M) as a splicing regulatory factor that binds to ISE/ISS-3 in a sequence-specific manner. Overexpression of hnRNP M promoted exon IIIc skipping in a cell line that normally includes it, and association of hnRNP M with ISE/ISS-3 was shown to contribute to this splicing regulatory function. Thus hnRNP M, along with other members of the hnRNP family of RNA-binding proteins, plays a combinatorial role in regulation of FGFR2 alternative splicing. We also determined that hnRNP M can affect the splicing of several other alternatively spliced exons. This activity of hnRNP M included the ability not only to induce exon skipping but also to promote exon inclusion. This is the first report demonstrating a role for this abundant hnRNP family member in alternative splicing in mammals and suggests that this protein may broadly contribute to the fidelity of splice site recognition and alternative splicing regulation.	Univ Penn, Sch Med, Dept Med, Renal Electrolyte & Hypertens Div, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Carstens, RP (corresponding author), Univ Penn, Sch Med, Dept Med, Renal Electrolyte & Hypertens Div, 480 Hill Pavil,380 S Univ Ave, Philadelphia, PA 19104 USA.	russcars@mail.med.upenn.edu			NCI NIH HHS [CA093769] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA093769] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Baraniak AP, 2006, MOL CELL BIOL, V26, P1209, DOI 10.1128/MCB.26.4.1209-1222.2006; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Blanchette M, 1999, EMBO J, V18, P1939, DOI 10.1093/emboj/18.7.1939; Buratti E, 2001, EMBO J, V20, P1774, DOI 10.1093/emboj/20.7.1774; Caputi M, 2004, J VIROL, V78, P6517, DOI 10.1128/JVI.78.12.6517-6526.2004; Carstens RP, 1998, MOL CELL BIOL, V18, P2205, DOI 10.1128/MCB.18.4.2205; Carstens RP, 2000, MOL CELL BIOL, V20, P7388, DOI 10.1128/MCB.20.19.7388-7400.2000; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Cooper TA, 1998, MOL CELL BIOL, V18, P4519, DOI 10.1128/MCB.18.8.4519; Cooper TA, 1999, METH MOL B, V118, P391; DATAR KV, 1993, NUCLEIC ACIDS RES, V21, P439, DOI 10.1093/nar/21.3.439; Del Gato-Konczak F, 2000, MOL CELL BIOL, V20, P6287, DOI 10.1128/MCB.20.17.6287-6299.2000; Del Gatto-Konczak F, 1999, MOL CELL BIOL, V19, P251; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Gattoni R, 1996, NUCLEIC ACIDS RES, V24, P2535, DOI 10.1093/nar/24.13.2535; Geng J, 2006, PROTEIN EXPRES PURIF, V48, P142, DOI 10.1016/j.pep.2006.01.021; Han J, 2005, NUCLEIC ACIDS RES, V33, P2769, DOI 10.1093/nar/gki561; Hase ME, 2006, J BIOL CHEM, V281, P39135, DOI 10.1074/jbc.M604235200; Hovhannisyan RH, 2006, NUCLEIC ACIDS RES, V34, P373, DOI 10.1093/nar/gkj407; Hovhannisyan RH, 2005, MOL CELL BIOL, V25, P250, DOI 10.1128/MCB.25.1.250-263.2005; Hui JY, 2005, EMBO J, V24, P1988, DOI 10.1038/sj.emboj.7600677; Jin W, 1999, J BIOL CHEM, V274, P28035, DOI 10.1074/jbc.274.39.28035; Jin Y, 2003, EMBO J, V22, P905, DOI 10.1093/emboj/cdg089; Jurica MS, 2002, METHODS, V28, P336, DOI 10.1016/S1046-2023(02)00240-2; Kafasla P, 2002, BIOCHEM J, V363, P793, DOI 10.1042/0264-6021:3630793; Kiesler E, 2005, J CELL BIOL, V168, P1013, DOI 10.1083/jcb.200407173; LADD AN, 2002, GENOME BIOL; Le Guienr C, 2001, J BIOL CHEM, V276, P40638, DOI 10.1074/jbc.M105642200; Le Guiner C, 2001, J BIOL CHEM, V276, P43677, DOI 10.1074/jbc.M107381200; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Muh SJ, 2002, J BIOL CHEM, V277, P50143, DOI 10.1074/jbc.M207409200; NASIM FH, 1990, GENE DEV, V4, P1172, DOI 10.1101/gad.4.7.1172; Neubauer G, 1998, NAT GENET, V20, P46, DOI 10.1038/1700; Newman EA, 2006, RNA, V12, P1129, DOI 10.1261/rna.34906; Ornitz DM, 1996, J BIOL CHEM, V271, P15292, DOI 10.1074/jbc.271.25.15292; PINOLROMA S, 1988, GENE DEV, V2, P215, DOI 10.1101/gad.2.2.215; Rappsilber J, 2002, GENOME RES, V12, P1231, DOI 10.1101/gr.473902; Smith CWJ, 2000, TRENDS BIOCHEM SCI, V25, P381, DOI 10.1016/S0968-0004(00)01604-2; SWANSON MS, 1988, EMBO J, V7, P3519, DOI 10.1002/j.1460-2075.1988.tb03228.x; SWANSON MS, 1988, MOL CELL BIOL, V8, P2237, DOI 10.1128/MCB.8.5.2237; Tsai A, 2006, NAT PROTOC, V1, P2820, DOI 10.1038/nprot.2006.371; Ule J, 2006, NATURE, V444, P580, DOI 10.1038/nature05304; Wagner EJ, 2001, MOL CELL BIOL, V21, P3281, DOI 10.1128/MCB.21.10.3281-3288.2001; Walker J, 1998, METH MOL B, V77, P365; Yeh BK, 2003, P NATL ACAD SCI USA, V100, P2266, DOI 10.1073/pnas.0436500100; Zhang WQ, 2002, RNA, V8, P671, DOI 10.1017/S1355838202027036	46	57	62	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36265	36274		10.1074/jbc.M704188200	http://dx.doi.org/10.1074/jbc.M704188200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17959601	hybrid			2022-12-27	WOS:000251458300017
J	Zeng, XM; Kucharczyk, R; di Rago, JP; Tzagoloff, A				Zeng, Xiaomei; Kucharczyk, Roza; di Rago, Jean-Paul; Tzagoloff, Alexander			The leader peptide of yeast Atp6p is required for efficient interaction with the Atp9p ring of the mitochondrial ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; MEMBRANE SYSTEM; F1F0-ATP SYNTHASE; GENE; SEQUENCE; SUBUNIT-6; COMPLEX; BIOGENESIS; MORPHOLOGY; MUTANTS	Atp6p (subunit 6) of the Saccharomyces cerevisiae mitochondrial ATPase is synthesized with an N-terminal 10-amino acid presequence that is cleaved during assembly of the complex. This study has examined the role of the Atp6p presequence in the function and assembly of the ATPase complex. Two mutants were constructed in which the codons for amino acids 2-9 or 2 -10 of the Atp6p precursor were deleted from the mitochondrial ATP6 gene. The concentration of Atp6p and ATPase complex was approximately 2 times less in the mutants. The lower concentration of ATPase complex in the leaderless mutants correlated with less Atp6p complexed with the Atp9p ring of the F-o sector and with accumulation of an Atp6p-Atp8p complex that aggregated into polymers destined for eventual proteolytic elimination. We propose that the presequence either targets Atp6p to the Atp9p or signals insertion of the Atp6p precursor into a microcompartment of the membrane for more efficient interaction with the Atp9p ring. Despite the ATPase deficiency, growth of the leaderless atp6 mutants on respiratory substrates and the efficiency of oxidative phosphorylation were similar to that of wild type, indicating that the mutations did not affect the proton permeability of mitochondria.	Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; Univ Victor Segalen, Inst Biochim & Genet Cellulaires, F-33077 Bordeaux, France	Columbia University; UDICE-French Research Universities; Universite de Bordeaux	Tzagoloff, A (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	spud@cubpet2.bio.columbia.edu	Kucharczyk, Roza/H-8154-2012	Kucharczyk, Roza/0000-0002-8712-7535	NHLBI NIH HHS [R01 HL022174, HL2274] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL022174] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ackerman SH, 2005, PROG NUCLEIC ACID RE, V80, P95, DOI 10.1016/S0079-6603(05)80003-0; Bonnefoy N, 2001, METHOD CELL BIOL, V65, P381, DOI 10.1016/S0091-679X(01)65022-2; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; EMAUS RK, 1986, BIOCHIM BIOPHYS ACTA, V850, P436, DOI 10.1016/0005-2728(86)90112-X; FAYE G, 1974, J MOL BIOL, V88, P105, DOI 10.1016/0022-2836(74)90304-0; Fillingame RH, 2000, NAT STRUCT BIOL, V7, P1002, DOI 10.1038/80902; Foury F, 1998, FEBS LETT, V440, P325, DOI 10.1016/S0014-5793(98)01467-7; Guerin B, 1979, Methods Enzymol, V55, P149; HADIKUSUMO RG, 1988, BIOCHIM BIOPHYS ACTA, V933, P212, DOI 10.1016/0005-2728(88)90072-2; Hell K, 2000, J BIOL CHEM, V275, P4571, DOI 10.1074/jbc.275.7.4571; HENSGENS LAM, 1979, P NATL ACAD SCI USA, V76, P1663, DOI 10.1073/pnas.76.4.1663; King EJ, 1932, BIOCHEM J, V26, P292, DOI 10.1042/bj0260292; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MACINO G, 1979, J BIOL CHEM, V254, P4617; MACINO G, 1980, CELL, V20, P507, DOI 10.1016/0092-8674(80)90637-6; MACREADIE IG, 1983, NUCLEIC ACIDS RES, V11, P4435, DOI 10.1093/nar/11.13.4435; MICHON T, 1988, EUR J BIOCHEM, V172, P621, DOI 10.1111/j.1432-1033.1988.tb13934.x; MUKHOPADHYAY A, 1994, FEBS LETT, V343, P160, DOI 10.1016/0014-5793(94)80310-2; MYERS AM, 1985, EMBO J, V4, P2087, DOI 10.1002/j.1460-2075.1985.tb03896.x; Osman C, 2007, MOL BIOL CELL, V18, P627, DOI 10.1091/mbc.E06-09-0839; Paumard P, 2002, EMBO J, V21, P221, DOI 10.1093/emboj/21.3.221; Rak M, 2007, J BIOL CHEM, V282, P10853, DOI 10.1074/jbc.M608692200; RIGOULET M, 1979, FEBS LETT, V102, P18, DOI 10.1016/0014-5793(79)80919-9; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Senior AE, 2002, BBA-BIOENERGETICS, V1553, P188, DOI 10.1016/S0005-2728(02)00185-8; Steele DF, 1996, P NATL ACAD SCI USA, V93, P5253, DOI 10.1073/pnas.93.11.5253; Stephens AN, 2003, J BIOL CHEM, V278, P17867, DOI 10.1074/jbc.M300967200; Torello AT, 1997, GENETICS, V145, P903; TZAGOLOFF A, 1975, J BIOL CHEM, V250, P8228; Velours J, 2000, J BIOENERG BIOMEMBR, V32, P383, DOI 10.1023/A:1005580020547; Zeng XM, 2007, MOL BIOL CELL, V18, P617, DOI 10.1091/mbc.E06-09-0801	33	21	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36167	36176		10.1074/jbc.M705436200	http://dx.doi.org/10.1074/jbc.M705436200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17940284	hybrid			2022-12-27	WOS:000251458300006
J	Cobb, N; Hemann, C; Polsinelli, GA; Ridge, JP; McEwan, AG; Hille, R				Cobb, Nathan; Hemann, Craig; Polsinelli, Gregory A.; Ridge, Justin P.; McEwan, Alastair G.; Hille, Russ			Spectroscopic and kinetic studies of Y114F and W116F mutants of Me2SO reductase from Rhodobacter capsulatus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIMETHYL-SULFOXIDE REDUCTASE; RAY-ABSORPTION SPECTROSCOPY; THALIANA SULFITE OXIDASE; F-SP DENITRIFICANS; DIMETHYLSULFOXIDE REDUCTASE; CRYSTAL-STRUCTURE; RAMAN-SPECTROSCOPY; DMSO REDUCTASE; MOLYBDENUM; SPHAEROIDES	Mutants of the active site residues Trp-116 and Tyr-114 of the molybdenum-containing Me2SO reductase from Rhodobacter capsulatus have been examined spectroscopically and kinetically. The Y114F mutant has an increased rate constant for oxygen atom transfer from Me2SO to reduced enzyme, the result of lower stability of the E-red center dot Me2SO complex. The absorption spectrum of this species ( but not that of either oxidized or reduced enzyme) is significantly perturbed in the mutant relative to wildtype enzyme, consistent with Tyr-114 interacting with bound Me2SO. The as-isolated W116F mutant is only five-coordinate, with one of the two equivalents of the pyranopterin cofactor found in the enzyme dissociated from the molybdenum and replaced by a second Mo=O group. Reduction of the mutant with sodium dithionite and reoxidation with Me2SO, however, regenerates the long-wavelength absorbance of functional enzyme, although the wavelength maximum is shifted to 670 nm from the 720 nm of wild-type enzyme. This "redox-cycled" mutant exhibits a Me2SO reducing activity and overall reaction mechanism similar to that of wild-type enzyme but rapidly reverts to the inactive five-coordinate form in the course of turnover.	Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA; Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; Univ Queensland, Sch Mol & Microbial Sci, St Lucia, Qld 4072, Australia	University of California System; University of California Riverside; University System of Ohio; Ohio State University; University of Queensland	Hille, R (corresponding author), Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA.	russ.hille@ucr.edu	Ridge, Justin P/A-4994-2008	Hemann, Craig/0000-0002-7380-4072; McEwan, Alastair/0000-0002-2419-1003	NIEHS NIH HHS [ES 12658] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012658] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Adams B, 1999, BIOCHEMISTRY-US, V38, P8501, DOI 10.1021/bi9902034; BASTIAN NR, 1991, J BIOL CHEM, V266, P45; Baugh PE, 1997, J BIOL INORG CHEM, V2, P634, DOI 10.1007/s007750050178; Bell AF, 2001, BIOCHEMISTRY-US, V40, P440, DOI 10.1021/bi002065k; BENNETT B, 1994, EUR J BIOCHEM, V225, P321, DOI 10.1111/j.1432-1033.1994.00321.x; Bray RC, 2001, BIOCHEMISTRY-US, V40, P9810, DOI 10.1021/bi010559r; Bray RC, 2000, BIOCHEMISTRY-US, V39, P11258, DOI 10.1021/bi0000521; Cobb N, 2005, J BIOL CHEM, V280, P11007, DOI 10.1074/jbc.M412050200; Eilers T, 2001, J BIOL CHEM, V276, P46989, DOI 10.1074/jbc.M108078200; Garton SD, 1997, J AM CHEM SOC, V119, P12906, DOI 10.1021/ja972109l; George GN, 1996, J AM CHEM SOC, V118, P1113, DOI 10.1021/ja953317l; George GN, 1999, J AM CHEM SOC, V121, P1256, DOI 10.1021/ja982843k; Helton ME, 2001, J AM CHEM SOC, V123, P10389, DOI 10.1021/ja0100470; Hemann C, 2005, J AM CHEM SOC, V127, P16567, DOI 10.1021/ja0530873; Hille R, 1996, CHEM REV, V96, P2757, DOI 10.1021/cr950061t; Hille R, 2002, TRENDS BIOCHEM SCI, V27, P360, DOI 10.1016/S0968-0004(02)02107-2; Hilton JC, 1996, BBA-PROTEIN STRUCT M, V1294, P111, DOI 10.1016/0167-4838(96)00015-5; Johnson KE, 2001, J BIOL CHEM, V276, P13178, DOI 10.1074/jbc.M010965200; Li HK, 2000, J AM CHEM SOC, V122, P7673, DOI 10.1021/ja000643e; McAlpine AS, 1997, J BIOL INORG CHEM, V2, P690, DOI 10.1007/s007750050185; McAlpine AS, 1998, J MOL BIOL, V275, P613, DOI 10.1006/jmbi.1997.1513; MEWAN AG, 2002, GEOMICROBIOL J, V19, P1; Ridge JP, 2004, FEBS LETT, V563, P197, DOI 10.1016/S0014-5793(04)00301-1; Ridge JP, 2002, BIOCHEMISTRY-US, V41, P15762, DOI 10.1021/bi0266582; SATOH T, 1987, J BIOCHEM-TOKYO, V102, P191, DOI 10.1093/oxfordjournals.jbchem.a122032; Schindelin H, 1996, SCIENCE, V272, P1615, DOI 10.1126/science.272.5268.1615; Schneider F, 1996, J MOL BIOL, V263, P53, DOI 10.1006/jmbi.1996.0555; Shaw AL, 1996, BBA-BIOENERGETICS, V1276, P176, DOI 10.1016/0005-2728(96)00092-8; YAMAMOTO I, 1995, BIOSCI BIOTECH BIOCH, V59, P1850, DOI 10.1271/bbb.59.1850	29	14	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35519	35529		10.1074/jbc.M704458200	http://dx.doi.org/10.1074/jbc.M704458200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17921142	hybrid			2022-12-27	WOS:000251458100011
J	Gromadski, KB; Schummer, T; Stromgaard, A; Knudsen, CR; Kinzy, TG; Rodnina, MV				Gromadski, Kirill B.; Schuemmer, Tobias; Stromgaard, Anne; Knudsen, Charlotte R.; Kinzy, Terri Goss; Rodnina, Marina V.			Kinetics of the interactions between yeast elongation factors 1A and 1B alpha, guanine nucleotides, and aminoacyl-tRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELONGATION-FACTOR TU; SIGNAL RECOGNITION PARTICLE; CRYSTAL-STRUCTURE; EF-TU; TERNARY COMPLEX; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; FACTOR TS; GUANOSINE NUCLEOTIDES; EXCHANGE FACTOR	The interactions of elongation factor 1A (eEF1A) from Saccharomyces cerevisiae with elongation factor 1B alpha (eEF1B alpha), guanine nucleotides, and aminoacyl-tRNA were studied kinetically by fluorescence stopped-flow. eEF1A has similar affinities for GDP and GTP, 0.4 and 1.1 mu M, respectively. Dissociation of nucleotides from eEF1A in the absence of the guanine nucleotide exchange factor is slow ( about 0.1s(-1)) and is accelerated by eEF1B alpha by 320-fold and 250-fold for GDP and GTP, respectively. The rate constant of eEF1B alpha binding to eEF1A (10(7)-10(8) M-1 s(-1)) is independent of guanine nucleotides. At the concentrations of nucleotides and factors prevailing in the cell, the overall exchange rate is expected to be in the range of 6 s(-1), which is compatible with the rate of protein synthesis in the cell. eEF1A center dot GTP binds Phe-tRNA(Phe) with a K-d of 3 nM, whereas eEF1A center dot GDP shows no significant binding, indicating that eEF1A has similar tRNA binding properties as its prokaryotic homolog, EF-Tu.	Univ Witten Herdecke, Inst Phys Biochem, D-58448 Witten, Germany; Aarhus Univ, Dept Mol Biol, DK-8000 Aarhus C, Denmark; Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Microbiol Mol Genet & Immunol, Piscataway, NJ 08854 USA	Witten Herdecke University; Aarhus University; Rutgers State University New Brunswick; Rutgers State University Medical Center	Rodnina, MV (corresponding author), Univ Witten Herdecke, Inst Phys Biochem, Stockumer Str 10, D-58448 Witten, Germany.	rodnina@uni-wh.de	Rodnina, Marina V./AAD-4667-2019	Rodnina, Marina V./0000-0003-0105-3879; Knudsen, Charlotte/0000-0003-2356-4821; Kinzy, Terri/0000-0003-1394-9226	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057483] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM057483, R01 GM057483-10] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abel K, 1996, STRUCTURE, V4, P1153, DOI 10.1016/S0969-2126(96)00123-2; Al-Karadaghi S, 1996, STRUCTURE, V4, P555, DOI 10.1016/S0969-2126(96)00061-5; Al-Maghrebi M, 2002, NUCLEIC ACIDS RES, V30, P5017, DOI 10.1093/nar/gkf656; Andersen GR, 2000, MOL CELL, V6, P1261, DOI 10.1016/S1097-2765(00)00122-2; Andersen GR, 2001, NAT STRUCT BIOL, V8, P531, DOI 10.1038/88598; BERCHTOLD H, 1993, NATURE, V365, P126, DOI 10.1038/365126a0; BOEHLKE KW, 1975, J BACTERIOL, V121, P429, DOI 10.1128/JB.121.2.429-433.1975; BONVEN B, 1979, MOL GEN GENET, V170, P225, DOI 10.1007/BF00337800; Clark BFC, 1997, CURR OPIN STRUC BIOL, V7, P110, DOI 10.1016/S0959-440X(97)80014-0; CRECHET JB, 1986, EUR J BIOCHEM, V161, P647, DOI 10.1111/j.1432-1033.1986.tb10489.x; Czworkowski J, 1997, BIOCHEMISTRY-US, V36, P10327, DOI 10.1021/bi970610k; CZWORKOWSKI J, 1994, EMBO J, V13, P3661, DOI 10.1002/j.1460-2075.1994.tb06675.x; Dahl LD, 2006, J BIOL CHEM, V281, P21139, DOI 10.1074/jbc.M602068200; Dale T, 2004, BIOCHEMISTRY-US, V43, P6159, DOI 10.1021/bi036290o; DELL VA, 1990, BIOCHEMISTRY-US, V29, P1757, DOI 10.1021/bi00459a014; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; Gao HX, 2007, CELL, V129, P929, DOI 10.1016/j.cell.2007.03.050; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gromadski KB, 2002, BIOCHEMISTRY-US, V41, P162, DOI 10.1021/bi015712w; Hansson S, 2005, FEBS LETT, V579, P4492, DOI 10.1016/j.febslet.2005.07.016; Hemsath L, 2005, METHODS, V37, P173, DOI 10.1016/j.ymeth.2005.05.014; IKEMURA T, 1982, J MOL BIOL, V158, P573, DOI 10.1016/0022-2836(82)90250-9; JAGADISH MN, 1978, J CELL SCI, V31, P71; Jagath JR, 1998, BIOCHEMISTRY-US, V37, P15408, DOI 10.1021/bi981523a; JAMESON DM, 1987, BIOCHEMISTRY-US, V26, P3894, DOI 10.1021/bi00387a023; JANSSEN GMC, 1988, J BIOL CHEM, V263, P1773; JANSSEN GMC, 1988, EUR J BIOCHEM, V171, P119, DOI 10.1111/j.1432-1033.1988.tb13766.x; JOHN J, 1990, BIOCHEMISTRY-US, V29, P6058, DOI 10.1021/bi00477a025; Kapp LD, 2004, J MOL BIOL, V335, P923, DOI 10.1016/j.jmb.2003.11.025; Kawashima T, 1996, NATURE, V379, P511, DOI 10.1038/379511a0; KINZY TG, 1995, GENETICS, V141, P481; KLEBE C, 1995, BIOCHEMISTRY-US, V34, P12543, DOI 10.1021/bi00039a008; Laurberg M, 2000, J MOL BIOL, V303, P593, DOI 10.1006/jmbi.2000.4168; Leibundgut M, 2005, EMBO J, V24, P11, DOI 10.1038/sj.emboj.7600505; Liu G, 1996, J CELL BIOL, V135, P953, DOI 10.1083/jcb.135.4.953; Merrick WC, 2000, COLD SPRING HARBOR M, V39, P89; Milon P, 2006, P NATL ACAD SCI USA, V103, P13962, DOI 10.1073/pnas.0606384103; Moser C, 1997, P NATL ACAD SCI USA, V94, P11339, DOI 10.1073/pnas.94.21.11339; Nissen P, 1999, STRUCTURE, V7, P143, DOI 10.1016/S0969-2126(99)80021-5; NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464; Olarewaju Olubunmi, 2004, RNA Biol, V1, P89, DOI 10.4161/rna.1.2.1033; Pedersen L, 2001, ACTA CRYSTALLOGR D, V57, P159, DOI 10.1107/S0907444900015559; Perez JMJ, 1999, STRUCTURE, V7, P217, DOI 10.1016/S0969-2126(99)80027-6; Petrushenko ZM, 2002, EUR J BIOCHEM, V269, P4811, DOI 10.1046/j.1432-1033.2002.03178.x; Pisareva VP, 2007, BIOCHEMISTRY-US, V46, P2622, DOI 10.1021/bi062134g; Pisareva VP, 2006, J BIOL CHEM, V281, P40224, DOI 10.1074/jbc.M607461200; Pittman YR, 2006, J BIOL CHEM, V281, P19457, DOI 10.1074/jbc.M601076200; Polekhina G, 1996, STRUCTURE, V4, P1141, DOI 10.1016/S0969-2126(96)00122-0; RENSLAND H, 1995, BIOCHEMISTRY-US, V34, P593, DOI 10.1021/bi00002a026; RICHTER D, 1970, BIOCHEM BIOPH RES CO, V38, P864, DOI 10.1016/0006-291X(70)90800-4; Rodnina MV, 1996, J BIOL CHEM, V271, P646, DOI 10.1074/jbc.271.2.646; RODNINA MV, 1994, BIOCHEMISTRY-US, V33, P12267, DOI 10.1021/bi00206a033; SAHA SK, 1986, J BIOL CHEM, V261, P2599; Sanders J, 1996, J CELL SCI, V109, P1113; Schummer T, 2007, BIOCHEMISTRY-US, V46, P4977, DOI 10.1021/bi602486c; SCOPES RK, 1974, ANAL BIOCHEM, V59, P277, DOI 10.1016/0003-2697(74)90034-7; Thanbichler M, 2000, J BIOL CHEM, V275, P20458, DOI 10.1074/jbc.M002496200; TOMBS MP, 1959, BIOCHEM J, V73, P167, DOI 10.1042/bj0730167; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; WAGNER A, 1995, BIOCHEMISTRY-US, V34, P12535, DOI 10.1021/bi00039a007; WALDRON C, 1975, J BACTERIOL, V122, P855, DOI 10.1128/JB.122.3.855-865.1975; Wang Y, 1997, NAT STRUCT BIOL, V4, P650, DOI 10.1038/nsb0897-650; Wieden HJ, 2002, J BIOL CHEM, V277, P6032, DOI 10.1074/jbc.M110888200; Wilden B, 2006, P NATL ACAD SCI USA, V103, P13670, DOI 10.1073/pnas.0606099103; Wintermeyer W, 1974, Methods Enzymol, V29, P667; Zavialov AV, 2001, CELL, V107, P115, DOI 10.1016/S0092-8674(01)00508-6; Zhang YL, 1996, FEBS LETT, V391, P330, DOI 10.1016/0014-5793(96)00789-2; Zhang YL, 1998, J BIOL CHEM, V273, P4556, DOI 10.1074/jbc.273.8.4556	68	29	30	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35629	35637		10.1074/jbc.M707245200	http://dx.doi.org/10.1074/jbc.M707245200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17925388	Green Accepted, Green Published, hybrid			2022-12-27	WOS:000251458100023
J	Albright, RA; Joh, K; Morais-Cabral, JH				Albright, Ronald A.; Joh, Kyu; Morais-Cabral, Joao H.			Probing the structure of the dimeric KtrB membrane protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THIOL CROSS-LINKING; K+-UPTAKE SYSTEM; VIBRIO-ALGINOLYTICUS; ESCHERICHIA-COLI; POTASSIUM CHANNEL; LACTOSE PERMEASE; MOLECULAR RULERS; GLYCINE RESIDUES; TRANSPORTERS; SELECTIVITY	The KtrAB ion transporter is a complex of two proteins, KtrB and KtrA. The integral membrane protein KtrB is expected to adopt the structural architecture typified by the pore domain of potassium channels. Here we show that homo-dimerization of KtrB proteins is most likely a general property of this family of transporters. Using cysteine mutants and bifunctional cross-linkers we define regions of the Bacillus subtilis KtrB molecule that are close to the molecular 2-fold axis and to the dimer interface. Fitting of the cross-linking data to a potassium channel-like model suggests structural similarities between potassium channels and KtrB proteins in the extracellular half of the molecule and differences in the cytoplasmic regions.	Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Yale University	Morais-Cabral, JH (corresponding author), Inst Biol Mol & Celular, R Campo Alegre 823, P-4150180 Oporto, Portugal.	jcabral@ibmc.up.pt	Morais-Cabral, Joao H/J-4914-2013	Morais-Cabral, Joao H/0000-0002-4461-9716	NIGMS NIH HHS [GM 068585] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068585] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Albright RA, 2006, CELL, V126, P1147, DOI 10.1016/j.cell.2006.08.028; Aller SG, 2004, J BIOL CHEM, V279, P53435, DOI 10.1074/jbc.M409421200; Amin DN, 2006, J BACTERIOL, V188, P894, DOI 10.1128/JB.188.3.894-901.2006; ARAKAWA T, 1992, ANAL BIOCHEM, V203, P53, DOI 10.1016/0003-2697(92)90042-6; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Durell SR, 1999, BIOPHYS J, V77, P775, DOI 10.1016/S0006-3495(99)76931-6; Ermolova N, 2003, P NATL ACAD SCI USA, V100, P10187, DOI 10.1073/pnas.1434239100; Folta-Stogniew E, 1999, J Biomol Tech, V10, P51; Folta-Stogniew Ewa, 2006, V328, P97; Green NS, 2001, PROTEIN SCI, V10, P1293, DOI 10.1110/ps.51201; Guan L, 2002, P NATL ACAD SCI USA, V99, P3475, DOI 10.1073/pnas.052703699; HAYASHI Y, 1989, METHOD ENZYMOL, V172, P514; Heginbotham L, 1998, J GEN PHYSIOL, V111, P741, DOI 10.1085/jgp.111.6.741; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Kato Y, 2001, P NATL ACAD SCI USA, V98, P6488, DOI 10.1073/pnas.101556598; Kroning N, 2007, J BIOL CHEM, V282, P14018, DOI 10.1074/jbc.M609084200; Loo TW, 2001, J BIOL CHEM, V276, P36877, DOI 10.1074/jbc.C100467200; Maser P, 2002, P NATL ACAD SCI USA, V99, P6428, DOI 10.1073/pnas.082123799; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Nakamura T, 1998, J BACTERIOL, V180, P3491, DOI 10.1128/JB.180.13.3491-3494.1998; RUBIO F, 1995, SCIENCE, V270, P1660, DOI 10.1126/science.270.5242.1660; Russ WP, 1999, P NATL ACAD SCI USA, V96, P863, DOI 10.1073/pnas.96.3.863; Sorgen PL, 2002, P NATL ACAD SCI USA, V99, P14037, DOI 10.1073/pnas.182552199; Tholema N, 2005, J BIOL CHEM, V280, P41146, DOI 10.1074/jbc.M507647200; Tholema N, 1999, FEBS LETT, V450, P217, DOI 10.1016/S0014-5793(99)00504-9; Yernool D, 2003, BIOCHEMISTRY-US, V42, P12981, DOI 10.1021/bi030161q; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	27	20	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					35046	35055		10.1074/jbc.M704260200	http://dx.doi.org/10.1074/jbc.M704260200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17932047	hybrid			2022-12-27	WOS:000251155200049
J	Sun, YH; Rolan, HG; Tsolis, RM				Sun, Yao-Hui; Rolan, Hortensia Garcia; Tsolis, Renee M.			Injection of flagellin into the host cell cytosol by Salmonella enterica serotype Typhimurium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTOR-5; PHAGOSOME MATURATION; BACTERIAL FLAGELLIN; III SECRETION; LEGIONELLA; MACROPHAGES; EXPRESSION; CASPASE-1; INFLAMMASOME; RESTRICTION	Bacterial flagellins are potent inducers of innate immunity. Three signaling pathways have been implicated in the sensing of flagellins; these involve toll- like receptor 5 (TLR5) and the cytosolic proteins Bircle/Naip5 and Ipaf. Although the structural basis of TLR5-flagellin interaction is known, little is known about how flagellin enters the host cell cytosol to induce signaling via Bircle/Naip5 and Ipaf. Here we demonstrate for the first time the translocation of bacterial flagellin into the cytosol of host macrophages by the vacuolar pathogen, Salmonella enterica serotype Typhimurium. Translocation of flagellin into the host cell cytosol was directly demonstrated using beta-lactamase reporter constructs. Flagellin translocation required the Salmonella Pathogenicity Island 1 Type III secretion system ( SPI-1 T3SS) but not the flagellar T3SS.	Univ Calif Davis, Dept Med Microbiol & Immunol, Davis, CA 95616 USA	University of California System; University of California Davis	Tsolis, RM (corresponding author), Univ Calif Davis, Dept Med Microbiol & Immunol, 1 Shields Ave, Davis, CA 95616 USA.	rmtsolis@ucdavis.edu		Tsolis, Renee/0000-0001-9131-6657	NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR012088] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050553, R21AI065739] Funding Source: NIH RePORTER; NCRR NIH HHS [C06 RR 12088] Funding Source: Medline; NIAID NIH HHS [AI 065739, AI 50553] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Amer A, 2006, J BIOL CHEM, V281, P35217, DOI 10.1074/jbc.M604933200; Andersen-Nissen E, 2007, J EXP MED, V204, P393, DOI 10.1084/jem.20061400; Auvray F, 2001, J MOL BIOL, V308, P221, DOI 10.1006/jmbi.2001.4597; Baumler AJ, 1997, INFECT IMMUN, V65, P2254; Brennan MA, 2000, MOL MICROBIOL, V38, P31, DOI 10.1046/j.1365-2958.2000.02103.x; Chen LM, 1996, MOL MICROBIOL, V21, P1101, DOI 10.1046/j.1365-2958.1996.471410.x; Coers J, 2007, CELL MICROBIOL, V9, P2344, DOI 10.1111/j.1462-5822.2007.00963.x; Cookson BT, 2001, TRENDS MICROBIOL, V9, P113, DOI 10.1016/S0966-842X(00)01936-3; Cummings LA, 2005, J IMMUNOL, V174, P7929, DOI 10.4049/jimmunol.174.12.7929; Cummings LA, 2006, MOL MICROBIOL, V61, P795, DOI 10.1111/j.1365-2958.2006.05271.x; Fortier A, 2007, CELL MICROBIOL, V9, P910, DOI 10.1111/j.1462-5822.2006.00839.x; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; GALAN JE, 1989, P NATL ACAD SCI USA, V86, P6383, DOI 10.1073/pnas.86.16.6383; Gewirtz AT, 2001, J IMMUNOL, V167, P1882, DOI 10.4049/jimmunol.167.4.1882; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; KOVACH ME, 1994, BIOTECHNIQUES, V16, P800; KUWAJIMA G, 1989, P NATL ACAD SCI USA, V86, P4953, DOI 10.1073/pnas.86.13.4953; Lara-Tejero M, 2006, J EXP MED, V203, P1407, DOI 10.1084/jem.20060206; Lindgren SW, 1996, P NATL ACAD SCI USA, V93, P4197, DOI 10.1073/pnas.93.9.4197; Lyons S, 2004, J CELL SCI, V117, P5771, DOI 10.1242/jcs.01500; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Miao EA, 2000, P NATL ACAD SCI USA, V97, P7539, DOI 10.1073/pnas.97.13.7539; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Molofsky AB, 2006, J EXP MED, V203, P1093, DOI 10.1084/jem.20051659; Monack DM, 1996, P NATL ACAD SCI USA, V93, P9833, DOI 10.1073/pnas.93.18.9833; OBRIEN EJ, 1972, J MOL BIOL, V70, P133, DOI 10.1016/0022-2836(72)90168-4; Raffatellu M, 2005, INFECT IMMUN, V73, P3367, DOI 10.1128/IAI.73.6.3367-3374.2005; Raffatellu M, 2005, INFECT IMMUN, V73, P7817, DOI 10.1128/IAI.73.12.7817-7826.2005; Ren T, 2006, PLOS PATHOG, V2, P175, DOI 10.1371/journal.ppat.0020018; Schlumberger MC, 2005, P NATL ACAD SCI USA, V102, P12548, DOI 10.1073/pnas.0503407102; Smith KD, 2003, NAT IMMUNOL, V4, P1247, DOI 10.1038/ni1011; Sory MP, 1995, P NATL ACAD SCI USA, V92, P11998, DOI 10.1073/pnas.92.26.11998; STOJILJKOVIC I, 1995, J BACTERIOL, V177, P1357, DOI 10.1128/jb.177.5.1357-1366.1995; Uematsu S, 2006, NAT IMMUNOL, V7, P868, DOI 10.1038/ni1362; van der Velden AWM, 2003, J IMMUNOL, V171, P6742, DOI 10.4049/jimmunol.171.12.6742; Vegh BM, 2006, BIOCHEM BIOPH RES CO, V345, P93, DOI 10.1016/j.bbrc.2006.04.055; Vijay-Kumar M, 2006, AM J PATHOL, V169, P1686, DOI 10.2353/ajpath.2006.060345; Zamboni DS, 2006, NAT IMMUNOL, V7, P318, DOI 10.1038/ni1305; Zlokarnik G, 1998, SCIENCE, V279, P84, DOI 10.1126/science.279.5347.84	39	127	128	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					33897	33901		10.1074/jbc.C700181200	http://dx.doi.org/10.1074/jbc.C700181200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17911114	hybrid			2022-12-27	WOS:000251145700001
J	Suzuki, T; Seth, A; Rao, R				Suzuki, Takuya; Seth, Ankur; Rao, Radhakrishna			Role of phospholipase C gamma-induced activation of protein kinase C epsilon (PKC epsilon) and PKC beta I in epidermal growth factor-mediated protection of tight junctions from acetaldehyde in caco-2 cell monolayers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARACELLULAR PERMEABILITY; TYROSINE PHOSPHORYLATION; OXIDATIVE STRESS; POSSIBLE INVOLVEMENT; INDUCED DISRUPTION; HYDROGEN-PEROXIDE; EPITHELIAL-CELLS; INDUCED INCREASE; OCCLUDIN; BARRIER	Epidermal growth factor (EGF) protects the intestinal epithelial tight junctions from acetaldehyde-induced insult. The role of phospholipase C gamma (PLC gamma) and protein kinase C (PKC) iso-forms in the mechanism of EGF-mediated protection of tight junction from acetaldehyde was evaluated in Caco-2 cell monolayers. EGF-mediated prevention of acetaldehyde-induced decrease in transepithelial electrical resistance and an increase in inulin permeability, and subcellular redistribution of occludin and ZO-1 was attenuated by reduced expression of PLC gamma 1 by short hairpin RNA. EGF induced a rapid activation of PLC gamma 1 and PLC-dependent membrane translocation of PKC epsilon and PKC alpha I. Inhibition of PKC activity or selective interference of membrane translocation of PKC epsilon andPKC beta I by RACK interference peptides attenuated EGF-mediated prevention of acetaldehyde-induced increase in inulin permeability and redistribution of occludin and ZO-1. BAPTA-AM and thapsigargin blocked EGF-induced membrane translocation of PKC beta I and attenuated EGF-mediated prevention of acetaldehyde-induced disruption of tight junctions. EGF-induced translocation of PKC epsilon and PKC beta I was associated with organization of F-actin near the perijunctional region. This study shows that PLC gamma-mediated activation of PKC epsilon and PKC beta I and intracellular calcium is involved in EGF-mediated protection of tight junctions from acetaldehyde-induced insult.	[Suzuki, Takuya; Seth, Ankur; Rao, Radhakrishna] Univ Tennessee, Ctr Hlth Sci, Dept Physiol, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center	Rao, R (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Physiol, 894 Union Ave, Memphis, TN 38163 USA.	rkrao@physio1.utmem.edu	Seth, Ankur/AAE-1800-2020; Suzuki, Takuya/H-3750-2019	Suzuki, Takuya/0000-0003-3709-543X; Seth, Ankur/0000-0003-0140-4691	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055532] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA012307] Funding Source: NIH RePORTER; NIAAA NIH HHS [R01-AA12307, R01 AA012307] Funding Source: Medline; NIDDK NIH HHS [R01 DK055532, R01-DK55532] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDERSON JM, 1995, AM J PHYSIOL-GASTR L, V269, pG467, DOI 10.1152/ajpgi.1995.269.4.G467; Atkinson KJ, 2001, AM J PHYSIOL-GASTR L, V280, pG1280, DOI 10.1152/ajpgi.2001.280.6.G1280; Banan A, 2001, AM J PHYSIOL-GASTR L, V281, pG412, DOI 10.1152/ajpgi.2001.281.2.G412; Basuroy S, 2006, BIOCHEM J, V393, P69, DOI 10.1042/BJ20050959; Basuroy S, 2003, J BIOL CHEM, V278, P11916, DOI 10.1074/jbc.M211710200; Chen ML, 2002, J BIOL CHEM, V277, P4247, DOI 10.1074/jbc.M109254200; Chen YH, 2002, MOL BIOL CELL, V13, P1227, DOI 10.1091/mbc.01-08-0423; Clarke H, 2000, J CELL SCI, V113, P3187; Clayburgh DR, 2006, J CLIN INVEST, V116, P2682, DOI 10.1172/JCI29218; FLEMING TP, 1993, DEVELOPMENT, V117, P1135; FURUSE M, 1993, J CELL BIOL, V123, P1777, DOI 10.1083/jcb.123.6.1777; FURUSE M, 1994, J CELL BIOL, V127, P1617, DOI 10.1083/jcb.127.6.1617; Haskins J, 1998, J CELL BIOL, V141, P199, DOI 10.1083/jcb.141.1.199; Hirase T, 2001, J BIOL CHEM, V276, P10423, DOI 10.1074/jbc.M007136200; HOLLANDER D, 1994, GUT, V26, P1621; Homann N, 2000, CARCINOGENESIS, V21, P663, DOI 10.1093/carcin/21.4.663; ISHIKAWA S, 1994, AM J PHYSIOL-GASTR L, V267, pG1067, DOI 10.1152/ajpgi.1994.267.6.G1067; Kale G, 2003, BIOCHEM BIOPH RES CO, V302, P324, DOI 10.1016/S0006-291X(03)00167-0; Koivisto T, 1996, ALCOHOL CLIN EXP RES, V20, P551, DOI 10.1111/j.1530-0277.1996.tb01091.x; KONTUREK PK, 1990, GASTROENTEROLOGY, V99, P1607, DOI 10.1016/0016-5085(90)90464-C; Lee DBN, 2006, AM J PHYSIOL-RENAL, V290, pF20, DOI 10.1152/ajprenal.00052.2005; Martin-Padura I, 1998, J CELL BIOL, V142, P117, DOI 10.1083/jcb.142.1.117; Matthay MA, 2002, CHEST, V122, p340S, DOI 10.1378/chest.122.6_suppl.340S; Nunbhakdi-Craig V, 2002, J CELL BIOL, V158, P967, DOI 10.1083/jcb.200206114; NUSRAT A, 1995, P NATL ACAD SCI USA, V92, P10629, DOI 10.1073/pnas.92.23.10629; Poschl G, 2004, ALCOHOL ALCOHOLISM, V39, P155, DOI 10.1093/alcalc/agh057; Rao R, 1996, EUR J PHARMACOL, V303, P209, DOI 10.1016/0014-2999(96)00186-0; Rao R, 1999, BIOCHEM PHARMACOL, V57, P685, DOI 10.1016/S0006-2952(98)00333-5; Rao RK, 2002, BIOCHEM J, V368, P471, DOI 10.1042/BJ20011804; RAO RK, 1991, LIFE SCI, V48, P1685, DOI 10.1016/0024-3205(91)90205-P; Rao RK, 1998, ALCOHOL CLIN EXP RES, V22, P1724, DOI 10.1097/00000374-199811000-00015; Rao RK, 2000, AM J PHYSIOL-GASTR L, V279, pG332, DOI 10.1152/ajpgi.2000.279.2.G332; Ries J, 1997, AM J PHYSIOL-CELL PH, V272, pC794, DOI 10.1152/ajpcell.1997.272.3.C794; RYEOM SV, 1998, P NATL ACAD SCI USA, V96, P319; Sakakibara A, 1997, J CELL BIOL, V137, P1393, DOI 10.1083/jcb.137.6.1393; Schechtman D, 2001, ONCOGENE, V20, P6339, DOI 10.1038/sj.onc.1204778; Seth A, 2004, AM J PHYSIOL-GASTR L, V287, pG510, DOI 10.1152/ajpgi.00058.2004; Seth A, 2007, J BIOL CHEM, V282, P11487, DOI 10.1074/jbc.M610597200; Sheth P, 2004, ALCOHOL CLIN EXP RES, V28, P797, DOI 10.1097/01.ALC.0000125358.92335.90; Sheth P, 2003, J BIOL CHEM, V278, P49239, DOI 10.1074/jbc.M305654200; Sheth P, 2007, BIOCHEM J, V402, P291, DOI 10.1042/BJ20060665; Shifflett DE, 2005, LAB INVEST, V85, P1308, DOI 10.1038/labinvest.3700330; Simonovic I, 2000, CELL MICROBIOL, V2, P305, DOI 10.1046/j.1462-5822.2000.00055.x; STUART RO, 1995, P NATL ACAD SCI USA, V92, P6072, DOI 10.1073/pnas.92.13.6072; Tillonen J, 2000, ALCOHOL CLIN EXP RES, V24, P570, DOI 10.1111/j.1530-0277.2000.tb02026.x; Tsukita S, 1999, TRENDS CELL BIOL, V9, P268, DOI 10.1016/S0962-8924(99)01578-0; Utech M, 2005, MOL BIOL CELL, V16, P5040, DOI 10.1091/mbc.E05-03-0193; WAHL MI, 1989, CANCER CELL-MON REV, V1, P101; Walsh SV, 2001, GASTROENTEROLOGY, V121, P566, DOI 10.1053/gast.2001.27060; Ward PD, 2003, J PHARMACOL EXP THER, V304, P689, DOI 10.1124/jpet.102.043638; Ward PD, 2002, J BIOL CHEM, V277, P35760, DOI 10.1074/jbc.M203134200; ZHANG Y, 1993, J CELL BIOL, V120, P477	52	64	68	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3574	3583		10.1074/jbc.M709141200	http://dx.doi.org/10.1074/jbc.M709141200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	17991733	hybrid			2022-12-27	WOS:000253083000063
J	Clarke, RM; Lyons, A; O'Connell, F; Deighan, BF; Barry, CE; Anyakoha, NG; Nicolaou, A; Lynch, MA				Clarke, Rachael M.; Lyons, Anthony; O'Connell, Florence; Deighan, Brian F.; Barry, Claire E.; Anyakoha, Ngozi G.; Nicolaou, Anna; Lynch, Marina A.			A pivotal role for interleukin-4 in atorvastatin-associated neuroprotection in rat brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; COA REDUCTASE INHIBITOR; SMOOTH-MUSCLE-CELLS; NITRIC-OXIDE SYNTHASE; CD40 GENE-EXPRESSION; MICROGLIAL ACTIVATION; EICOSAPENTAENOIC ACID; INFLAMMATORY CHANGES; ALZHEIMERS-DISEASE; CONTROLLED TRIAL	Inflammatory changes, characterized by an increase in proinflammatory cytokine production and up-regulation of the corresponding signaling pathways, have been described in the brains of aged rats and rats treated with the potent immune modulatory molecule lipopolysaccharide ( LPS). These changes have been coupled with a deficit in long-term potentiation ( LTP) in hippocampus. The evidence suggests that anti-inflammatory agents, which attenuate the LPS-induced and age-associated increase in hippocampal interleukin-1 beta (IL-1 beta) concentration, lead to restoration of LTP. Here we report that atorvastatin, a member of the family of agents that act as inhibitors of 3-hydroxy-3-methylglutaryl-CoA reductase, exerts powerful anti-inflammatory effects in brain and that these effects are mediated by IL-4 and independent of its cholesterol-lowering actions. Treatment of rats with atorvastatin increased IL-4 concentration in hippocampal tissue prepared from LPS-treated and aged rats and abrogated the age-related and LPS-induced increases in pro-inflammatory cytokines, interferon-gamma ( IFN gamma) and IL-1 beta, and the accompanying deficit in LTP. The effect of atorvastatin on the LPS-induced increases in IFN gamma and IL-1 beta was absent in tissue prepared from IL-4(-/-) mice. The increase in IL-1 beta in LPS-treated and aged rats is associated with increased microglial activation, assessed by analysis of major histocompatibility complex II expression, and the evidence suggests that IFN gamma may trigger this activation. We propose that the primary effect of atorvastatin is to increase IL-4, which antagonizes the effects of IFN gamma, the associated increase in microglial activation, and the subsequent cascade of events.	[Anyakoha, Ngozi G.; Nicolaou, Anna] Univ Bradford, Sch Pharm, Bradford BD7 DP, W Yorkshire, England; [Clarke, Rachael M.; Lyons, Anthony; O'Connell, Florence; Deighan, Brian F.; Barry, Claire E.; Lynch, Marina A.] Trinity Coll Dublin, Inst Neurol, Dept Physiol, Dublin 2, Ireland	University of Bradford; Trinity College Dublin	Lynch, MA (corresponding author), Trinity Coll Dublin, Inst Neurol, Dept Physiol, Dublin 2, Ireland.	lynchma@tcd.ie	Nicolaou, Anna/D-4025-2018	Nicolaou, Anna/0000-0002-1314-413X; Lynch, Marina/0000-0002-4631-0499				ADOSRAKU RK, 1994, J LIPID RES, V35, P1925; Barry CE, 2005, J NEUROCHEM, V93, P221, DOI 10.1111/j.1471-4159.2004.03011.x; Bi XN, 2004, J BIOL CHEM, V279, P48238, DOI 10.1074/jbc.M405442200; Block ML, 2005, PROG NEUROBIOL, V76, P77, DOI 10.1016/j.pneurobio.2005.06.004; Bosel J, 2005, J NEUROCHEM, V92, P1386, DOI 10.1111/j.1471-4159.2004.02980.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Caballero J, 2004, J CLIN PHARM THER, V29, P209, DOI 10.1111/j.1365-2710.2004.00560.x; Chauhan NB, 2004, J NEUROSCI RES, V78, P732, DOI 10.1002/jnr.20298; Clarke RM, 2007, NEUROPHARMACOLOGY, V52, P136, DOI 10.1016/j.neuropharm.2006.07.031; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Cordle A, 2005, J BIOL CHEM, V280, P34202, DOI 10.1074/jbc.M505268200; Crisby M, 2002, ALZ DIS ASSOC DIS, V16, P131, DOI 10.1097/00002093-200207000-00001; Delgado M, 2003, J BIOL CHEM, V278, P27620, DOI 10.1074/jbc.M303199200; Endres M, 2004, STROKE, V35, P2708, DOI 10.1161/01.STR.0000143319.73503.38; Endres M, 1998, P NATL ACAD SCI USA, V95, P8880, DOI 10.1073/pnas.95.15.8880; Greisenegger S, 2004, J NEUROL SCI, V221, P5, DOI 10.1016/j.jns.2004.01.015; Griffin R, 2006, J NEUROCHEM, V99, P1263, DOI 10.1111/j.1471-4159.2006.04165.x; Hattori Y, 2002, CARDIOVASC RES, V54, P649, DOI 10.1016/S0008-6363(02)00266-3; Huang KC, 2003, FEBS LETT, V555, P385, DOI 10.1016/S0014-5793(03)01297-3; Ito M, 2004, CIRCULATION, V110, P412, DOI 10.1161/01.CIR.0000136088.18960.E6; Jick H, 2000, LANCET, V356, P1627, DOI 10.1016/S0140-6736(00)03155-X; Kawashima S, 2003, STROKE, V34, P157, DOI 10.1161/01.STR.0000048213.18751.52; Kelly A, 2003, J BIOL CHEM, V278, P19453, DOI 10.1074/jbc.M301938200; King DS, 2003, PHARMACOTHERAPY, V23, P1663, DOI 10.1592/phco.23.15.1663.31953; Kobayashi M, 2006, INT J PHARMACEUT, V317, P19, DOI 10.1016/j.ijpharm.2006.02.043; Law M, 2006, AM J CARDIOL, V97, p52C, DOI 10.1016/j.amjcard.2005.12.010; Lindberg C, 2005, J NEUROSCI RES, V82, P10, DOI 10.1002/jnr.20615; Lonergan PE, 2004, J NEUROCHEM, V91, P20, DOI 10.1111/j.1471-4159.2004.02689.x; Lynch AM, 2007, NEUROBIOL AGING, V28, P845, DOI 10.1016/j.neurobiolaging.2006.04.006; LYNCH MA, 1985, NEUROSCI LETT, V62, P123, DOI 10.1016/0304-3940(85)90295-2; Maher FO, 2006, J NEUROCHEM, V96, P1560, DOI 10.1111/j.1471-4159.2006.03664.x; Maher FO, 2005, NEUROBIOL AGING, V26, P717, DOI 10.1016/j.neurobiolaging.2004.07.002; Marti-Fabregas J, 2004, STROKE, V35, P1117, DOI 10.1161/01.STR.0000125863.93921.3f; Martin DSD, 2002, J BIOL CHEM, V277, P34239, DOI 10.1074/jbc.M205289200; Matsumoto M, 2004, J IMMUNOL, V172, P7377, DOI 10.4049/jimmunol.172.12.7377; Menschikowski M, 2005, BBA-MOL CELL BIOL L, V1733, P157, DOI 10.1016/j.bbalip.2005.01.001; Milner R, 2003, J IMMUNOL, V170, P3850, DOI 10.4049/jimmunol.170.7.3850; Minogue AM, 2003, J BIOL CHEM, V278, P27971, DOI 10.1074/jbc.M302530200; Moore AH, 2002, ADV DRUG DELIVER REV, V54, P1627, DOI 10.1016/S0169-409X(02)00162-X; Moore ME, 2005, BIOCHEM SOC T, V33, P573, DOI 10.1042/BST0330573; Nguyen VT, 2000, J IMMUNOL, V165, P6235, DOI 10.4049/jimmunol.165.11.6235; Nguyen VT, 1998, EUR J IMMUNOL, V28, P2537, DOI 10.1002/(SICI)1521-4141(199808)28:08<2537::AID-IMMU2537>3.0.CO;2-1; Nolan Y, 2005, NEUROIMMUNOMODULAT, V12, P113, DOI 10.1159/000083583; Nolan Y, 2005, J BIOL CHEM, V280, P9354, DOI 10.1074/jbc.M412170200; Noula C, 2000, BBA-MOL CELL BIOL L, V1487, P15, DOI 10.1016/S1388-1981(00)00078-0; Ortego M, 2005, J CARDIOVASC PHARM, V45, P468, DOI 10.1097/01.fjc.0000159042.50488.e5; Senokuchi T, 2005, J BIOL CHEM, V280, P6627, DOI 10.1074/jbc.M412531200; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; Sparks D L, 2002, J Nutr Health Aging, V6, P324; Stuve O, 2003, CELL MOL LIFE SCI, V60, P2483, DOI 10.1007/s00018-003-3146-0; Summers MJ, 2007, PHARMACOTHERAPY, V27, P183, DOI 10.1592/phco.27.2.183; Townsend KP, 2004, J NEUROSCI RES, V78, P167, DOI 10.1002/jnr.20234; Vaughan CJ, 2003, AM J CARDIOL, V91, p23B, DOI 10.1016/S0002-9149(02)03270-8; Vereker E, 2000, J NEUROSCI, V20, P6811, DOI 10.1523/JNEUROSCI.20-18-06811.2000; von Bardeleben R, 2003, BIOCHEM BIOPH RES CO, V307, P401, DOI 10.1016/S0006-291X(03)01205-1; Wagstaff LR, 2003, PHARMACOTHERAPY, V23, P871, DOI 10.1592/phco.23.7.871.32720; Wang HR, 2005, CLIN CHIM ACTA, V353, P53, DOI 10.1016/j.cccn.2004.10.007; Wolozin B, 2000, ARCH NEUROL-CHICAGO, V57, P1439, DOI 10.1001/archneur.57.10.1439; Youssef S, 2002, NATURE, V420, P78, DOI 10.1038/nature01158	59	78	79	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					1808	1817		10.1074/jbc.M707442200	http://dx.doi.org/10.1074/jbc.M707442200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	17981803	hybrid			2022-12-27	WOS:000252501000006
J	Eckstein, N; Servan, K; Girard, L; Cai, D; von Jonquieres, G; Jaehde, U; Kassack, MU; Gazdar, AF; Minna, JD; Royer, HD				Eckstein, Niels; Servan, Kati; Girard, Luc; Cai, Di; von Jonquieres, Georg; Jaehde, Ulrich; Kassack, Matthias U.; Gazdar, Adi F.; Minna, John D.; Royer, Hans-Dieter			Epidermal growth factor receptor pathway analysis identifies amphiregulin as a key factor for cisplatin resistance of human breast cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESTROGEN-RECEPTOR; EGF RECEPTOR; IN-VITRO; P53; PHOSPHORYLATION; EXPRESSION; AKT; PROLIFERATION; ACTIVATION; MOTILITY	The use of platinum complexes for the therapy of breast cancer is an emerging new treatment modality. To gain insight into the mechanisms underlying cisplatin resistance in breast cancer, we used estrogen receptor-positive MCF-7 cells as a model system. We generated cisplatin-resistant MCF-7 cells and determined the functional status of epidermal growth factor receptor ( EGFR), MAPK, and AKT signaling pathways by phosphoreceptor tyrosine kinase and phospho-MAPK arrays. The cisplatin-resistant MCF-7 cells are characterized by increased EGFR phosphorylation, high levels of AKT1 kinase activity, and ERK1 phosphorylation. In contrast, the JNK and p38 MAPK modules of the MAPK signaling pathway were inactive. These conditions were associated with inactivation of the p53 pathway and increased BCL-2 expression. We investigated the expression of genes encoding the ligands for the ERBB signaling cascade and found a selective up-regulation of amphiregulin expression, which occurred at later stages of cisplatin resistance development. Amphiregulin is a specific ligand of the EGFR (ERBB1) and a potent mitogen for epithelial cells. After exposure to cisplatin, the resistant MCF-7 cells secreted amphiregulin protein over extended periods of time, and knockdown of amphiregulin expression by specific short interfering RNA resulted in a nearly complete reversion of the resistant phenotype. To demonstrate the generality and importance of our findings, we examined amphiregulin expression and cisplatin resistance in a variety of human breast cancer cell lines and found a highly significant correlation. In contrast, amphiregulin levels did not significantly correlate with cisplatin resistance in a panel of lung cancer cell lines. We have thus identified a novel function of amphiregulin for cisplatin resistance in human breast cancer cells.	[Eckstein, Niels; Servan, Kati; von Jonquieres, Georg; Royer, Hans-Dieter] Stiftung Ctr Adv European Studies & Res, D-53175 Bonn, Germany; [Girard, Luc; Cai, Di; Gazdar, Adi F.; Minna, John D.] Univ Texas SW Med Ctr Dallas, Hamon Ctr Therapeut Oncol Res, Dallas, TX 75390 USA; [Jaehde, Ulrich] Univ Bonn, Dept Clin Pharm, D-53121 Bonn, Germany; [Kassack, Matthias U.] Univ Dusseldorf, Inst Pharmaceut & Med Chem, D-40225 Dusseldorf, Germany	Center of Advanced European Studies & Research (CAESAR); University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Bonn; Heinrich Heine University Dusseldorf	Royer, HD (corresponding author), Stiftung Ctr Adv European Studies & Res, Ludwig Erhard Allee 2, D-53175 Bonn, Germany.	royer@caesar.de	Royer, Hans-dieter/AAH-6293-2019; von Jonquieres, Georg/W-1781-2019	von Jonquieres, Georg/0000-0002-7423-3355	NATIONAL CANCER INSTITUTE [P50CA070907] Funding Source: NIH RePORTER; NCI NIH HHS [P50 CA070907-11, P50 CA070907-109001, P50CA70907, P50 CA070907-09, P50 CA070907-110009, P50 CA070907, P50 CA070907-10] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Beerli RR, 1996, J BIOL CHEM, V271, P6071, DOI 10.1074/jbc.271.11.6071; Benhar M, 2002, ONCOGENE, V21, P8723, DOI 10.1038/sj.onc.1205980; Bessard A, 2007, J CELL PHYSIOL, V212, P526, DOI 10.1002/jcp.21049; BROOKS SC, 1973, J BIOL CHEM, V248, P6251; Brown CL, 1998, J BIOL CHEM, V273, P17258, DOI 10.1074/jbc.273.27.17258; Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; Gazdar AF, 1998, INT J CANCER, V78, P766, DOI 10.1002/(SICI)1097-0215(19981209)78:6<766::AID-IJC15>3.0.CO;2-L; Gschwind A, 2003, EMBO J, V22, P2411, DOI 10.1093/emboj/cdg231; Harris RC, 2003, EXP CELL RES, V284, P2, DOI 10.1016/S0014-4827(02)00105-2; Heron-Milhavet L, 2006, MOL CELL BIOL, V26, P8267, DOI 10.1128/MCB.00201-06; Hortobagyi GN, 1998, NEW ENGL J MED, V339, P974, DOI 10.1056/NEJM199810013391407; Hurley J, 2006, J CLIN ONCOL, V24, P1831, DOI 10.1200/JCO.2005.02.8886; Iyer R, 2003, LEUKEMIA RES, V27, P73, DOI 10.1016/S0145-2126(02)00064-4; JOHNSON GR, 1993, J BIOL CHEM, V268, P2924; Kim AH, 2001, MOL CELL BIOL, V21, P893, DOI 10.1128/MCB.21.3.893-901.2001; Kiyatkin A, 2006, J BIOL CHEM, V281, P19925, DOI 10.1074/jbc.M600482200; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; LEJEUNE S, 1993, CANCER RES, V53, P3597; Li XQ, 2005, BREAST CANCER RES, V7, pR589, DOI 10.1186/bcr1259; Liu LZ, 2007, CANCER RES, V67, P6325, DOI 10.1158/0008-5472.CAN-06-4261; Ma L, 2001, J PATHOL, V194, P413, DOI 10.1002/path.902; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mattoon DR, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-24; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; Oda K, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100014; Ott I, 2007, ANTI-CANCER AGENT ME, V7, P95, DOI 10.2174/187152007779314071; Panico L, 1996, INT J CANCER, V65, P51, DOI 10.1002/(SICI)1097-0215(19960103)65:1<51::AID-IJC9>3.0.CO;2-0; Pommier Y, 2004, ONCOGENE, V23, P2934, DOI 10.1038/sj.onc.1207515; Ravdin PM, 2007, NEW ENGL J MED, V356, P1670, DOI 10.1056/NEJMsr070105; Robert N, 2006, J CLIN ONCOL, V24, P2786, DOI 10.1200/JCO.2005.04.1764; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; SEIBERT K, 1983, CANCER RES, V43, P2223; SHOYAB M, 1988, P NATL ACAD SCI USA, V85, P6528, DOI 10.1073/pnas.85.17.6528; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Silvy M, 2001, BRIT J CANCER, V84, P936, DOI 10.1054/bjoc.2000.1678; TAKAHARA PM, 1995, NATURE, V377, P649, DOI 10.1038/377649a0; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Tomita Y, 2006, J BIOL CHEM, V281, P8600, DOI 10.1074/jbc.M507611200; Wang SL, 2006, CANCER RES, V66, P6982, DOI 10.1158/0008-5472.CAN-06-0511; Willmarth NE, 2006, J BIOL CHEM, V281, P37728, DOI 10.1074/jbc.M606532200; Winograd-Katz SE, 2006, ONCOGENE, V25, P7381, DOI 10.1038/sj.onc.1209737; Wong L, 1999, J BIOL CHEM, V274, P8900, DOI 10.1074/jbc.274.13.8900; Wu YL, 2001, ONCOGENE, V20, P240, DOI 10.1038/sj.onc.1204067; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yoeli-Lerner M, 2006, CELL CYCLE, V5, P603, DOI 10.4161/cc.5.6.2561; Zeng PY, 2005, CANCER BIOL THER, V4, P961, DOI 10.4161/cbt.4.9.1912; Zhou BHP, 2001, NAT CELL BIOL, V3, P973, DOI 10.1038/ncb1101-973	49	75	81	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					739	750		10.1074/jbc.M706287200	http://dx.doi.org/10.1074/jbc.M706287200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	17942395	hybrid, Green Accepted			2022-12-27	WOS:000252128100012
J	Hifumi, E; Morihara, F; Hatiuchi, K; Okuda, T; Nishizono, A; Uda, T				Hifumi, Emi; Morihara, Fumiko; Hatiuchi, Kenji; Okuda, Takuro; Nishizono, Akira; Uda, Taizo			Catalytic features and eradication ability of antibody light-chain UA15-L against Helicobacter pylori	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCLONAL-ANTIBODIES; ORAL VACCINATION; UREASE; INFECTION; IMMUNIZATION; HYDROLYSIS; SUBUNITS; PEPTIDE	We have successfully developed a catalytic antibody capable of degrading the active site of the urease of Helicobacter pylori and eradicating the bacterial infection in a mouse stomach. This monoclonal antibody UA15 was generated using a designed recombinant protein UreB, which contained the crucial region of the H. pylori urease beta-subunit active site, for immunization. The light chain of this antibody (UA15-L) by itself showed a proteolytic activity to substantially degrade both UreB and the intact urease. Oral administration of UA15-L also significantly reduced the number of H. pylori in a mouse stomach. This is the first example of a monoclonal catalytic antibody capable of functioning in vivo, and such an antibody may have a therapeutic utility in the future.	[Hifumi, Emi; Hatiuchi, Kenji; Okuda, Takuro; Uda, Taizo] Japan Sci & Technol Corp, CREST, JST, Kawaguchi, Saitama 3320012, Japan; [Hifumi, Emi] Oita Univ, Res Ctr Appl Med Engn, Oita 8701192, Japan; [Uda, Taizo] Oita Univ, Fac Engn, Dept Appl Biochem, Oita 8701192, Japan; [Morihara, Fumiko] Fukuyama Med Lab Co, Fukuyama, Hiroshima 7208510, Japan; [Nishizono, Akira] Oita Univ, Dept Infect Dis, Fac Med, Oita 8795593, Japan	Japan Science & Technology Agency (JST); Oita University; Oita University; Oita University	Uda, T (corresponding author), Japan Sci & Technol Corp, CREST, JST, Kawaguchi, Saitama 3320012, Japan.	uda@cc.oita-u.ac.jp		Uda, Taizo/0000-0001-8146-7902				ANCHIN JM, 1994, J MOL GRAPHICS, V12, P257, DOI 10.1016/0263-7855(94)80102-9; CORTHESYTHEULAZ I, 1995, GASTROENTEROLOGY, V109, P115, DOI 10.1016/0016-5085(95)90275-9; ERHAN S, 1974, NATURE, V251, P353, DOI 10.1038/251353a0; Fujii R, 2004, BIOTECHNOL BIOENG, V86, P737, DOI 10.1002/bit.20047; GAO QS, 1994, J BIOL CHEM, V269, P32389; GOODWIN CS, 1986, J ANTIMICROB CHEMOTH, V17, P309, DOI 10.1093/jac/17.3.309; GRAHAM DY, 1991, GASTROENTEROLOGY, V100, P1495, DOI 10.1016/0016-5085(91)90644-Z; Ha NC, 2001, NAT STRUCT BIOL, V8, P505, DOI 10.1038/88563; Hatiuchi K, 2003, IMMUNOL LETT, V86, P249, DOI 10.1016/S0165-2478(03)00030-0; Hifumi E, 2005, FEBS J, V272, P4497, DOI 10.1111/j.1742-4658.2005.04869.x; Hifumi E, 2003, BIOTECHNOL BIOENG, V84, P485, DOI 10.1002/bit.10806; Hifumi E, 2002, J IMMUNOL METHODS, V269, P283, DOI 10.1016/S0022-1759(02)00242-9; HU LT, 1990, INFECT IMMUN, V58, P992, DOI 10.1128/IAI.58.4.992-998.1990; Huo XH, 2006, WORLD J GASTROENTERO, V12, P3105, DOI 10.3748/wjg.v12.i19.3105; Ikeda Y, 1998, J FERMENT BIOENG, V86, P271, DOI 10.1016/S0922-338X(98)80129-3; Ikewaki J, 2000, MICROBIOL IMMUNOL, V44, P29, DOI 10.1111/j.1348-0421.2000.tb01243.x; Kolesnikov AV, 2000, P NATL ACAD SCI USA, V97, P13526, DOI 10.1073/pnas.200360497; Lacroix-Desmazes S, 1999, NAT MED, V5, P1044, DOI 10.1038/12483; MARSHALL BJ, 1988, LANCET, V2, P1437; MEI S, 1991, J BIOL CHEM, V266, P15571; Mitsuda Y, 2005, IMMUNOL LETT, V96, P63, DOI 10.1016/j.imlet.2004.07.018; Mitsuda Y, 2004, BIOTECHNOL BIOENG, V86, P217, DOI 10.1002/bit.20031; NAGATA K, 1993, ANTIMICROB AGENTS CH, V37, P769, DOI 10.1128/AAC.37.4.769; Paul S, 2004, J BIOL CHEM, V279, P39611, DOI 10.1074/jbc.M406719200; Raghavan S, 2002, INFECT IMMUN, V70, P6383, DOI 10.1128/IAI.70.11.6383-6388.2002; Raghavan S, 2002, INFECT IMMUN, V70, P4621, DOI 10.1128/IAI.70.8.4621-4627.2002; SHUSTER AM, 1992, SCIENCE, V256, P665, DOI 10.1126/science.1585181; Uda T, 2004, J BIOSCI BIOENG, V97, P143, DOI 10.1016/S1389-1723(04)70183-8	28	48	52	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					899	907		10.1074/jbc.M705674200	http://dx.doi.org/10.1074/jbc.M705674200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	17991752	hybrid			2022-12-27	WOS:000252128100030
J	Shen, MQ; Reitman, ZJ; Zhao, Y; Moustafa, I; Wang, QX; Arnold, JJ; Pathak, HB; Cameron, CE				Shen, Miaoqing; Reitman, Zachary J.; Zhao, Yan; Moustafa, Ibrahim; Wang, Qixin; Arnold, Jamie J.; Pathak, Harsh B.; Cameron, Craig E.			Picornavirus genome replication - Identification of the surface of the poliovirus (PV) 3C dimer that interacts with PV 3Dpol during VPg uridylylation and construction of a structural model for the PV3C(2)-3Dpol complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT RNA-POLYMERASE; POSITIVE-STRAND; NEGATIVE-STRAND; IN-VITRO; CLOVERLEAF RNA; PROTEINASE 3C; VIRAL-RNA; PROTEOLYTIC ACTIVITIES; MOLECULAR-DYNAMICS; 5-NONCODING REGION	Picornaviruses have a peptide termed VPg covalently linked to the 5 '-end of the genome. Attachment of VPg to the genome occurs in at least two steps. First, Tyr-3 of VPg, or some precursor thereof, is used as a primer by the viral RNA-dependent RNA polymerase, 3Dpol, to produce VPg-pUpU. Second, VPg-pUpU is used as a primer to produce full-length genomic RNA. Production of VPg-pUpU is templated by a single adenylate residue located in the loop of an RNA stem-loop structure termed oriI by using a slide-back mechanism. Recruitment of 3Dpol to and its stability on oriI have been suggested to require an interaction between the back of the thumb subdomain of 3Dpol and an undefined region of the 3C domain of viral protein 3CD. We have performed surface acidic-to-alanine-scanning mutagenesis of 3C to identify the surface of 3C with which 3Dpol interacts. This analysis identified numerous viable poliovirus mutants with reduced growth kinetics that correlated to reduced kinetics of RNA synthesis that was attributable to a change in VPg-pUpU production. Importantly, these 3C derivatives were all capable of binding to oriI as well as wild-type 3C. Synthetic lethality was observed for these mutants when placed in the context of a poliovirus mutant containing 3Dpol-R455A, a residue on the back of the thumb required for VPg uridylylation. These data were used to guide molecular docking of the structures for a poliovirus 3C dimer and 3Dpol, leading to a structural model for the 3C2-3Dpol complex that extrapolates well to all picornaviruses.	[Shen, Miaoqing; Reitman, Zachary J.; Zhao, Yan; Moustafa, Ibrahim; Wang, Qixin; Arnold, Jamie J.; Pathak, Harsh B.; Cameron, Craig E.] Penn State Univ, Dept Biochem & Mol Biol, Althouse Lab 201, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Cameron, CE (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, Althouse Lab 201, University Pk, PA 16802 USA.	cec9@psu.edu		Reitman, Zachary/0000-0002-9122-9550	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI053531, R56AI053531] Funding Source: NIH RePORTER; NIAID NIH HHS [AI053531, R01 AI053531, R56 AI053531, R37 AI053531, R01 AI053531-05] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ANDINO R, 1993, EMBO J, V12, P3587, DOI 10.1002/j.1460-2075.1993.tb06032.x; Barton DJ, 1996, METHOD ENZYMOL, V275, P35; Belov GA, 2005, J VIROL, V79, P7207, DOI 10.1128/JVI.79.11.7207-7216.2005; Belov GA, 2007, J VIROL, V81, P9259, DOI 10.1128/JVI.00840-07; Belov GA, 2007, J VIROL, V81, P558, DOI 10.1128/JVI.01820-06; Belov GA, 2007, CELL CYCLE, V6, P36, DOI 10.4161/cc.6.1.3683; Bergmann EM, 1997, J VIROL, V71, P2436, DOI 10.1128/JVI.71.3.2436-2448.1997; Blair WS, 1998, RNA, V4, P215; Blair WS, 1996, VIROLOGY, V218, P1, DOI 10.1006/viro.1996.0160; CALIGUIRI LA, 1968, VIROLOGY, V35, P408, DOI 10.1016/0042-6822(68)90219-5; Cuconati A, 1998, J VIROL, V72, P6456, DOI 10.1128/JVI.72.8.6456-6464.1998; DIAMOND SE, 1994, J VIROL, V68, P863, DOI 10.1128/JVI.68.2.863-876.1994; Dmitrieva TM, 2007, VIROLOGY, V365, P79, DOI 10.1016/j.virol.2007.02.038; DOEDENS J, 1994, ARCH VIROL, P159; Ferrer-Orta C, 2006, EMBO J, V25, P880, DOI 10.1038/sj.emboj.7600971; Franco D, 2005, J VIROL, V79, P6358, DOI 10.1128/JVI.79.10.6358-6367.2005; Franco D, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-86; Gamarnik AV, 2000, J VIROL, V74, P2219, DOI 10.1128/JVI.74.5.2219-2226.2000; Gerber K, 2001, J VIROL, V75, P10979, DOI 10.1128/JVI.75.22.10979-10990.2001; Gohara DW, 2000, J BIOL CHEM, V275, P25523, DOI 10.1074/jbc.M002671200; Gohara DW, 1999, PROTEIN EXPRES PURIF, V17, P128, DOI 10.1006/prep.1999.1100; Goodfellow I, 2000, J VIROL, V74, P4590, DOI 10.1128/JVI.74.10.4590-4600.2000; HAMMERLE T, 1992, J VIROL, V66, P6028; HAMMERLE T, 1991, J BIOL CHEM, V266, P5412; Hansen JL, 1997, STRUCTURE, V5, P1109, DOI 10.1016/S0969-2126(97)00261-X; HARRIS KS, 1992, J VIROL, V66, P7481, DOI 10.1128/JVI.66.12.7481-7489.1992; HARRIS KS, 1994, J BIOL CHEM, V269, P27004; Herold J, 2000, J VIROL, V74, P6394, DOI 10.1128/JVI.74.14.6394-6400.2000; Hobson SD, 2001, EMBO J, V20, P1153, DOI 10.1093/emboj/20.5.1153; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kistler AL, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-40; Kusov YY, 1997, RNA, V3, P291; LEONG LEC, 1993, J BIOL CHEM, V268, P25735; Lyle JM, 2002, SCIENCE, V296, P2218, DOI 10.1126/science.1070585; Lyons T, 2001, J VIROL, V75, P10696, DOI 10.1128/JVI.75.22.10696-10708.2001; Marcotte LL, 2007, J VIROL, V81, P3583, DOI 10.1128/JVI.02306-06; MAYNELL LA, 1992, J VIROL, V66, P1985, DOI 10.1128/JVI.66.4.1985-1994.1992; Morasco BJ, 2003, J VIROL, V77, P5136, DOI 10.1128/JVI.77.9.5136-5144.2003; Mosimann SC, 1997, J MOL BIOL, V273, P1032, DOI 10.1006/jmbi.1997.1306; Murray KE, 2003, J VIROL, V77, P4739, DOI 10.1128/JVI.77.8.4739-4750.2003; Nayak A, 2005, J VIROL, V79, P7698, DOI 10.1128/JVI.79.12.7698-7706.2005; NOBLE J, 1970, VIROLOGY, V40, P634, DOI 10.1016/0042-6822(70)90208-4; Ohlenschlager O, 2004, STRUCTURE, V12, P237, DOI 10.1016/j.str.2004.01.014; Parsley TB, 1997, RNA, V3, P1124; PATA JD, 1995, RNA, V1, P466; Pathak HB, 2007, J BIOL CHEM, V282, P16202, DOI 10.1074/jbc.M610608200; Pathak HB, 2002, J BIOL CHEM, V277, P31551, DOI 10.1074/jbc.M204408200; PATHAK HB, 2006, UNIFIED MODEL INITIA; Paul Aniko V., 2002, P227; Paul AV, 2000, J VIROL, V74, P10359, DOI 10.1128/JVI.74.22.10359-10370.2000; Paul AV, 2003, J BIOL CHEM, V278, P43951, DOI 10.1074/jbc.M307441200; Paul AV, 1998, NATURE, V393, P280, DOI 10.1038/30529; Peters H, 2005, BIOCHEM J, V385, P363, DOI 10.1042/BJ20041153; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Racaniello V.R., 2001, FIELDS VIROLOGY, P455; Rieder E, 2000, J VIROL, V74, P10371, DOI 10.1128/JVI.74.22.10371-10380.2000; Semler BL, 2002, MOL BIOL PICORNAVIRU; Shen M, 2007, J VIROL, V81, P12485, DOI 10.1128/JVI.00972-07; Shih SR, 2004, J BIOMED SCI, V11, P239, DOI 10.1159/000076036; Tellez AB, 2006, J MOL BIOL, V357, P665, DOI 10.1016/j.jmb.2005.12.044; TERSHAK DR, 1982, J VIROL, V41, P313, DOI 10.1128/JVI.41.1.313-318.1982; Thiviyanathan V, 2004, P NATL ACAD SCI USA, V101, P12688, DOI 10.1073/pnas.0403079101; Thompson AA, 2004, EMBO J, V23, P3462, DOI 10.1038/sj.emboj.7600357; Tovchigrechko A, 2006, NUCLEIC ACIDS RES, V34, pW310, DOI 10.1093/nar/gkl206; van Ooij MJM, 2006, J GEN VIROL, V87, P103, DOI 10.1099/vir.0.81297-0; WALKER PK, 1995, J BIOL CHEM, V270, P14510, DOI 10.1074/jbc.270.24.14510; WIMMER E, 1993, ANNU REV GENET, V27, P353, DOI 10.1146/annurev.ge.27.120193.002033; XIANG WK, 1995, J VIROL, V69, P3658, DOI 10.1128/JVI.69.6.3658-3667.1995; Yang Y, 2004, J BIOL CHEM, V279, P12659, DOI 10.1074/jbc.M312992200; Yin J, 2003, J VIROL, V77, P5152, DOI 10.1128/JVI.77.9.5152-5166.2003; Zell R, 2002, RNA, V8, P188, DOI 10.1017/S1355838202012785	72	33	36	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					875	888		10.1074/jbc.M707907200	http://dx.doi.org/10.1074/jbc.M707907200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	17993457	Green Accepted, hybrid			2022-12-27	WOS:000252128100028
J	Song, WL; Wang, M; Ricciotti, E; Fries, S; Yu, Y; Grosser, T; Reilly, M; Lawson, JA; FitzGerald, GA				Song, Wen-Liang; Wang, Miao; Ricciotti, Emanuela; Fries, Susanne; Yu, Ying; Grosser, Tilo; Reilly, Muredach; Lawson, John A.; FitzGerald, Garret A.			Tetranor PGDM, an abundant urinary metabolite reflects biosynthesis of prostaglandin D-2 in mice and humans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATOGRAPHY-MASS-SPECTROMETRY; NICOTINIC-ACID; D SYNTHASE; INDUCIBLE CYCLOOXYGENASE; PLATELET ACTIVATION; ASPIRIN CHALLENGE; BRONCHIAL-ASTHMA; CELL ACTIVATION; PPAR-GAMMA; EXPRESSION	Prostaglandin D-2 (PGD(2)) is a cyclooxygenase (COX) product of arachidonic acid that activates D prostanoid receptors to modulate vascular, platelet, and leukocyte function in vitro. However, little is known about its enzymatic origin or its formation in vivo in cardiovascular or inflammatory disease.11,15-Dioxo-9 alpha-hydroxy-2,3,4,5-tetranorprostan-1,20-dioic acid (tetranor PGDM) was identified by mass spectrometry as a metabolite of infused PGD2 that is detectable in mouse and human urine. Using liquid chromatography-tandem mass spectrometry, tetranor PGDM was much more abundant than the PGD(2) metabolites, 11 beta-PGF(2 alpha) and 2,3-dinor-11 beta-PGF(2 alpha), in human urine and was the only endogenous metabolite detectable in mouse urine. Infusion of PGD2 dose dependently increased urinary tetranor PGDM > 2,3-dinor-11 beta-PGF(2 alpha) > 11 beta-PGF(2 alpha) in mice. Deletion of either lipocalin-type or hemopoietic PGD synthase enzymes decreased urinary tetranor PGDM. Deletion or knockdown of COX-1, but not deletion of COX-2, decreased urinary tetranor PGDM in mice. Correspondingly, both PGDM and 2,3-dinor-11 beta-PGF(2 alpha) were suppressed by inhibition of COX-1 and COX-2, but not by selective inhibition of COX-2 in humans. PGD2 has been implicated in both the development and resolution of inflammation. Administration of bacterial lipopolysaccharide coordinately elevated tetranor PGDM and 2,3-dinor-11 beta-PGF(2 alpha) in volunteers, coincident with a pyrexial and systemic inflammatory response, but both metabolites fell during the resolution phase. Niacin increased tetranor PGDM and 2,3-dinor-11 beta-PGF(2 alpha), in humans coincident with facial flushing. Tetranor PGDM is an abundant metabolite in urine that reflects modulated biosynthesis of PGD(2) in humans and mice.	[Song, Wen-Liang; Wang, Miao; Ricciotti, Emanuela; Fries, Susanne; Yu, Ying; Grosser, Tilo; Reilly, Muredach; Lawson, John A.; FitzGerald, Garret A.] Univ Penn, Sch Med, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	FitzGerald, GA (corresponding author), Univ Penn, Sch Med, Inst Translat Med & Therapeut, 153 Johnson Pavilion,Hamilton Walk, Philadelphia, PA 19104 USA.	garret@spirit.gcrc.upenn.edu	Ricciotti, Emanuela/AAH-2729-2019; Grosser, Tilo/A-1057-2007; FitzGerald, Garret A/A-4222-2010	Grosser, Tilo/0000-0001-8569-8396; Song, Wenliang/0000-0002-1866-0635; Reilly, Muredach/0000-0002-3035-9386; Wang, Miao/0000-0002-0532-6312	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL083799, R01HL073278] Funding Source: NIH RePORTER; NCRR NIH HHS [RR-023567] Funding Source: Medline; NHLBI NIH HHS [HL R01 073278, HL 83799] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BANDERLAAN PA, 2005, J LIPID RES, V46, P829; Barr RG, 2007, AM J RESP CRIT CARE, V175, P120, DOI 10.1164/rccm.200603-411OC; BEASLEY CRW, 1987, J CLIN INVEST, V79, P978, DOI 10.1172/JCI112909; Bell-Parikh LC, 2003, J CLIN INVEST, V112, P945, DOI 10.1172/JCI200318012; Bochenek G, 2004, THORAX, V59, P459, DOI 10.1136/thx.2003.013573; Bochenek G, 2003, J ALLERGY CLIN IMMUN, V111, P743, DOI 10.1067/mai.2003.1387; BUSHFIELD M, 1985, BIOCHEM J, V232, P267, DOI 10.1042/bj2320267; Carlson LA, 2005, J INTERN MED, V258, P94, DOI 10.1111/j.1365-2796.2005.01528.x; CATELLA F, 1986, P NATL ACAD SCI USA, V83, P5861, DOI 10.1073/pnas.83.16.5861; Catella-Lawson F, 2001, NEW ENGL J MED, V345, P1809, DOI 10.1056/NEJMoa003199; Cheng K, 2006, P NATL ACAD SCI USA, V103, P6682, DOI 10.1073/pnas.0601574103; Cheng Y, 2006, J CLIN INVEST, V116, P1391, DOI 10.1172/JCI27540; Dieter P, 2000, BIOCHEM BIOPH RES CO, V276, P488, DOI 10.1006/bbrc.2000.3496; Eguchi Y, 1997, P NATL ACAD SCI USA, V94, P14689, DOI 10.1073/pnas.94.26.14689; FITZGERALD GA, 1984, NEW ENGL J MED, V310, P1065, DOI 10.1056/NEJM198404263101701; FITZGERALD GA, 1983, J CLIN INVEST, V71, P676, DOI 10.1172/JCI110814; Flower DR, 1996, BIOCHEM J, V318, P1; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Fries S, 2006, GASTROENTEROLOGY, V130, P55, DOI 10.1053/j.gastro.2005.10.002; GILES H, 1989, BRIT J PHARMACOL, V96, P291, DOI 10.1111/j.1476-5381.1989.tb11816.x; Gilroy DW, 2003, FASEB J, V17, P2269, DOI 10.1096/fj.02-1162fje; Gilroy DW, 1999, NAT MED, V5, P698, DOI 10.1038/9550; HAMBERG M, 1976, BIOCHIM BIOPHYS ACTA, V431, P189, DOI 10.1016/0005-2760(76)90273-3; Inoue T, 2001, THROMB HAEMOSTASIS, V85, P165; LISTON TE, 1985, J BIOL CHEM, V260, P3172; MACDERMOT J, 1984, PROSTAGLANDINS, V27, P163, DOI 10.1016/0090-6980(84)90071-6; Matsuoka T, 2000, SCIENCE, V287, P2013, DOI 10.1126/science.287.5460.2013; McAdam BF, 1999, P NATL ACAD SCI USA, V96, P272, DOI 10.1073/pnas.96.1.272; McAdam BF, 2000, J CLIN INVEST, V105, P1473, DOI 10.1172/JCI9523; Misso NLA, 2004, CLIN EXP ALLERGY, V34, P624, DOI 10.1111/j.1365-2222.2004.1912.x; MORROW JD, 1989, PROSTAGLANDINS, V38, P263, DOI 10.1016/0090-6980(89)90088-9; MORROW JD, 1995, J INVEST DERMATOL, V104, P937, DOI 10.1111/1523-1747.ep12606209; Nagata K, 1999, FEBS LETT, V459, P195, DOI 10.1016/S0014-5793(99)01251-X; Nagata K, 1999, J IMMUNOL, V162, P1278; O'Sullivan S, 1999, PROSTAG OTH LIPID M, V57, P149, DOI 10.1016/S0090-6980(98)00076-8; OELZ O, 1977, PROSTAGLANDINS, V13, P225, DOI 10.1016/0090-6980(77)90004-1; OSullivan S, 1996, J ALLERGY CLIN IMMUN, V98, P421, DOI 10.1016/S0091-6749(96)70167-7; PARSONS WG, 1988, J IMMUNOL, V141, P2413; PICKETT WC, 1981, ANAL BIOCHEM, V111, P115, DOI 10.1016/0003-2697(81)90237-2; Reddy ST, 1997, J BIOL CHEM, V272, P3231, DOI 10.1074/jbc.272.6.3231; ROBERTS LJ, 1980, NEW ENGL J MED, V303, P1400, DOI 10.1056/NEJM198012113032405; Song WL, 2007, METHOD ENZYMOL, V433, P51, DOI 10.1016/S0076-6879(07)33003-6; Sun J, 2007, J CLIN INVEST, V117, P3359, DOI 10.1172/JCI31311; Sun JS, 2007, NAT MED, V13, P719, DOI 10.1038/nm1601; Taba Y, 2000, CIRC RES, V86, P967, DOI 10.1161/01.RES.86.9.967; Trivedi SG, 2006, P NATL ACAD SCI USA, V103, P5179, DOI 10.1073/pnas.0507175103; Urade Y, 2000, VITAM HORM, V58, P89, DOI 10.1016/S0083-6729(00)58022-4; WATANABE K, 1986, P NATL ACAD SCI USA, V83, P1583, DOI 10.1073/pnas.83.6.1583; WILLIAMS TJ, 1977, NATURE, V270, P530, DOI 10.1038/270530a0; Yu Y, 2005, J CLIN INVEST, V115, P986, DOI 10.1172/JCI23683	50	68	72	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					1179	1188		10.1074/jbc.M706839200	http://dx.doi.org/10.1074/jbc.M706839200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	17993463	hybrid			2022-12-27	WOS:000252128100058
J	Jurd, R; Thornton, C; Wang, J; Luong, K; Phamluong, K; Kharazia, V; Gibb, SL; Ron, D				Jurd, Rachel; Thornton, Claire; Wang, Jun; Luong, Ken; Phamluong, Khanhky; Kharazia, Viktor; Gibb, Stuart L.; Ron, Dorit			Mind bomb-2 is an E3 ligase that ubiquitinates the N-methyl-D-aspartate receptor NR2B subunit in a phosphorylation-dependent manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; NMDA-RECEPTOR; TYROSINE PHOSPHORYLATION; SCAFFOLDING PROTEIN; FYN-KINASE; DEGRADATION; ACTIVATION; TRAFFICKING; SENSITIVITY; PATHOPHYSIOLOGY	The N-methyl-D-aspartate receptor ( NMDAR) plays a critical role in synaptic plasticity. Post-translational modifications of NMDARs, such as phosphorylation, alter both the activity and trafficking properties of NMDARs. Ubiquitination is increasingly being recognized as another post-translational modification that can alter synaptic protein composition and function. We identified Mind bomb-2 as an E3 ubiquitin ligase that interacts with and ubiquitinates the NR2B subunit of the NMDAR in mammalian cells. The protein-protein interaction and the ubiquitination of the NR2B subunit were found to be enhanced in a Fyn phosphorylation-dependent manner. Immunocytochemical studies reveal that Mind bomb-2 is localized to postsynaptic sites and colocalizes with the NMDAR in apical dendrites of hippocampal neurons. Furthermore, we show that NMDAR activity is down-regulated by Mind bomb-2. These results identify a specific E3 ubiquitin ligase as a novel interactant with the NR2B subunit and suggest a possible mechanism for the regulation of NMDAR function involving both phosphorylation and ubiquitination.	[Jurd, Rachel; Thornton, Claire; Wang, Jun; Luong, Ken; Phamluong, Khanhky; Kharazia, Viktor; Gibb, Stuart L.; Ron, Dorit] Univ Calif San Francisco, Gallo Res Ctr, Emeryville, CA 94608 USA	University of California System; University of California San Francisco	Ron, D (corresponding author), Gallo Res Ctr, 5858 Horton St,Suite 200, Emeryville, CA 94608 USA.	dorit.ron@ucsf.edu	Wang, Jun/M-2337-2016; Thornton, Claire/AAF-7481-2019; Wang, Jun/N-8472-2015	Wang, Jun/0000-0002-0085-4722; Thornton, Claire/0000-0001-7676-3272; Wang, Jun/0000-0002-0085-4722; Kharazia, Viktor/0000-0003-0642-6080	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA013438] Funding Source: NIH RePORTER; NIAAA NIH HHS [R01 AA013438-01A1, R01 AA 013438-01A1, R01 AA013438] Funding Source: Medline	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Arundine M, 2003, CELL CALCIUM, V34, P325, DOI 10.1016/S0143-4160(03)00141-6; Ashique AM, 2006, BRAIN RES, V1069, P31, DOI 10.1016/j.brainres.2005.11.018; Bedford FK, 2001, NAT NEUROSCI, V4, P908, DOI 10.1038/nn0901-908; Bingol B, 2006, NATURE, V441, P1144, DOI 10.1038/nature04769; Bradley J, 2006, J NEUROSCI, V26, P1065, DOI 10.1523/JNEUROSCI.3347-05.2006; Buttner C, 2001, J BIOL CHEM, V276, P42978, DOI 10.1074/jbc.M102121200; Chen WB, 2004, DEV BIOL, V267, P361, DOI 10.1016/j.ydbio.2003.11.010; Choe EA, 2007, J NEUROSCI, V27, P9503, DOI 10.1523/JNEUROSCI.1408-07.2007; Chung HJ, 2004, J NEUROSCI, V24, P10248, DOI 10.1523/JNEUROSCI.0546-04.2004; Colledge M, 2003, NEURON, V40, P595, DOI 10.1016/S0896-6273(03)00687-1; Coyle JT, 2003, ANN NY ACAD SCI, V1003, P318, DOI 10.1196/annals.1300.020; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; Dunah AW, 2001, J NEUROSCI, V21, P5546, DOI 10.1523/JNEUROSCI.21-15-05546.2001; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Fallon L, 2002, J BIOL CHEM, V277, P486, DOI 10.1074/jbc.M109806200; Fonseca R, 2006, NEURON, V52, P239, DOI 10.1016/j.neuron.2006.08.015; Fuller KJ, 1998, BIOTECHNIQUES, V25, P85, DOI 10.2144/98251st04; Gurd JW, 1997, J NEUROCHEM, V69, P623; Gutala R, 2004, ALCOHOL CLIN EXP RES, V28, P1779, DOI 10.1097/01.ALC.0000148117.17707.B4; Hallett PJ, 2006, J NEUROSCI, V26, P4690, DOI 10.1523/JNEUROSCI.0792-06.2006; Harrison SC, 2003, CELL, V112, P737, DOI 10.1016/S0092-8674(03)00196-X; HEGDE AN, 1993, P NATL ACAD SCI USA, V90, P7436, DOI 10.1073/pnas.90.16.7436; Itoh M, 2003, DEV CELL, V4, P67, DOI 10.1016/S1534-5807(02)00409-4; Kassenbrock CK, 2002, J BIOL CHEM, V277, P24967, DOI 10.1074/jbc.M201026200; Kato A, 2005, P NATL ACAD SCI USA, V102, P5600, DOI 10.1073/pnas.0501769102; Kemp JA, 2002, NAT NEUROSCI, V5, P1039, DOI 10.1038/nn936; Kohr G, 1996, J PHYSIOL-LONDON, V492, P445; Koo BK, 2005, J BIOL CHEM, V280, P22335, DOI 10.1074/jbc.M501631200; Lai EC, 2002, CURR BIOL, V12, pR74, DOI 10.1016/S0960-9822(01)00679-0; Lu YM, 1998, SCIENCE, V279, P1363, DOI 10.1126/science.279.5355.1363; Martin S, 2007, NATURE, V447, P321, DOI 10.1038/nature05736; Miyakawa T, 1997, SCIENCE, V278, P698, DOI 10.1126/science.278.5338.698; Moore DJ, 2005, ANNU REV NEUROSCI, V28, P57, DOI 10.1146/annurev.neuro.28.061604.135718; Nakazawa T, 2001, J BIOL CHEM, V276, P693, DOI 10.1074/jbc.M008085200; Nakazawa T, 2006, EMBO J, V25, P2867, DOI 10.1038/sj.emboj.7601156; Pace MC, 2006, J CELL PHYSIOL, V209, P8, DOI 10.1002/jcp.20693; Patrick GN, 2003, CURR BIOL, V13, P2073, DOI 10.1016/j.cub.2003.10.028; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Planells-Cases R, 2006, CURR PHARM DESIGN, V12, P3583, DOI 10.2174/138161206778522092; Prybylowski K, 2005, NEURON, V47, P845, DOI 10.1016/j.neuron.2005.08.016; Ron D, 2004, NEUROSCIENTIST, V10, P325, DOI 10.1177/1073858404263516; Rosenblum K, 1996, P NATL ACAD SCI USA, V93, P10457, DOI 10.1073/pnas.93.19.10457; Rostas JAP, 1996, P NATL ACAD SCI USA, V93, P10452, DOI 10.1073/pnas.93.19.10452; Salter MW, 2004, NAT REV NEUROSCI, V5, P317, DOI 10.1038/nrn1368; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; SUZUKI T, 1995, BIOCHEM BIOPH RES CO, V216, P582, DOI 10.1006/bbrc.1995.2662; Takagi N, 2003, J NEUROCHEM, V84, P67, DOI 10.1046/j.1471-4159.2003.01500.x; Thornton C, 2004, J BIOL CHEM, V279, P31357, DOI 10.1074/jbc.M402316200; Thornton C, 2003, J BIOL CHEM, V278, P23823, DOI 10.1074/jbc.M302389200; Wang J, 2007, J NEUROSCI, V27, P3593, DOI 10.1523/JNEUROSCI.4749-06.2007; WANG YT, 1994, NATURE, V369, P233, DOI 10.1038/369233a0; Wechsler A, 1998, EMBO J, V17, P3931, DOI 10.1093/emboj/17.14.3931; Wenthold RJ, 2003, ANNU REV PHARMACOL, V43, P335, DOI 10.1146/annurev.pharmtox.43.100901.135803; Wu HY, 2007, J BIOL CHEM, V282, P20075, DOI 10.1074/jbc.M700624200; Yaka R, 2003, J NEUROSCI, V23, P3623; Yaka R, 2003, J BIOL CHEM, V278, P9630, DOI 10.1074/jbc.M209141200; Yaka R, 2002, P NATL ACAD SCI USA, V99, P5710, DOI 10.1073/pnas.062046299; Yi JJ, 2007, PHARMACOL REV, V59, P14, DOI 10.1124/pr.59.1.4	59	60	62	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					301	310		10.1074/jbc.M705580200	http://dx.doi.org/10.1074/jbc.M705580200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17962190	Green Accepted, hybrid			2022-12-27	WOS:000251940300034
J	Li, W; Wang, R; Li, M; Li, L; Wang, C; Welti, R; Wang, X				Li, Weiqi; Wang, Ruiping; Li, Maoyin; Li, Lixia; Wang, Chuanming; Welti, Ruth; Wang, Xuemin			Differential degradation of extraplastidic and plastidic lipids during freezing and post-freezing recovery in Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPASE D-ALPHA; COLD-ACCLIMATION; SENESCENCE; TOLERANCE; PLANTS; GENES; DELTA; ACID	Changes in membrane lipid composition play important roles in plant adaptation to and survival after freezing. Plant response to cold and freezing involves three distinct phases: cold acclimation, freezing, and post-freezing recovery. Considerable progress has been made toward understanding lipid changes during cold acclimation and freezing, but little is known about lipid alteration during post-freezing recovery. We previously showed that phospholipase D (PLD) is involved in lipid hydrolysis and Arabidopsis thaliana freezing tolerance. This study was undertaken to determine how lipid species change during post-freezing recovery and to determine the effect of two PLDs, PLD alpha 1 and PLD delta, on lipid changes during post-freezing recovery. During post-freezing recovery, hydrolysis of plastidic lipids, monogalactosyldiacylglycerol and plastidic phosphatidylglycerol, is the most prominent change. In contrast, during freezing, hydrolysis of extraplastidic phospholipids, phosphatidylcholine and phosphatidylethanolamine, occurs. Suppression of PLD alpha 1 decreased phospholipid hydrolysis and phosphatidic acid production in both the freezing and post-freezing phases, whereas ablation of PLD delta increased lipid hydrolysis and phosphatidic acid production during post-freezing recovery. Thus, distinctly different changes in lipid hydrolysis occur in freezing and post-freezing recovery. The presence of PLD alpha 1 correlates with phospholipid hydrolysis in both freezing and post-freezing phases, whereas the presence of PLD delta correlates with reduced lipid hydrolysis during post-freezing recovery. These data suggest a negative role for PLD alpha 1 and a positive role for PLD delta in freezing tolerance.	[Li, Weiqi; Wang, Ruiping; Li, Lixia] Chinese Acad Sci, Kunming Inst Bot, Kunming 650204, Peoples R China; [Li, Maoyin; Wang, Xuemin] Univ Missouri, Donald Danforth Plant Sci Ctr, Dept Biol, St Louis, MO 63121 USA; [Wang, Chuanming] Honghe Univ, Dept Biol, Yunnan 661100, Peoples R China; [Welti, Ruth] Kansas State Univ, Kansas Lipidom Res Ctr, Div Biol, Manhattan, KS 66506 USA	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Donald Danforth Plant Science Center; University of Missouri System; University of Missouri Saint Louis; Honghe University; Kansas State University	Li, W (corresponding author), Chinese Acad Sci, Kunming Inst Bot, 132 Lanhei Rd, Kunming 650204, Peoples R China.	weiqili@mail.kib.ac.cn	Wang, Xuemin/M-2853-2013	Welti, Ruth/0000-0003-4373-2538; wang, xuemin/0000-0002-6251-6745; Li, Maoyin/0000-0002-9976-1349; Wang, chuanming/0000-0002-7942-0352	NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016475] Funding Source: NIH RePORTER; NCRR NIH HHS [P20 RR 016475] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Abdrakhamanova A, 2003, PLANT CELL PHYSIOL, V44, P676, DOI 10.1093/pcp/pcg097; BOYER JS, 1982, SCIENCE, V218, P443, DOI 10.1126/science.218.4571.443; Cook D, 2004, P NATL ACAD SCI USA, V101, P15243, DOI 10.1073/pnas.0406069101; Devaiah SP, 2006, PHYTOCHEMISTRY, V67, P1907, DOI 10.1016/j.phytochem.2006.06.005; Dhonukshe P, 2003, PLANT CELL, V15, P2666, DOI 10.1105/tpc.014977; Fan L, 1997, PLANT CELL, V9, P2183, DOI 10.1105/tpc.9.12.2183; Gardiner JC, 2001, PLANT CELL, V13, P2143, DOI 10.1105/tpc.13.9.2143; Hsu FF, 2007, J AM SOC MASS SPECTR, V18, P783, DOI 10.1016/j.jasms.2006.12.012; LEVITT J, 1980, RESPONSES PLANTS ENV, V1, P254; Li WQ, 2004, NAT BIOTECHNOL, V22, P427, DOI 10.1038/nbt949; Marechal E, 1997, PHYSIOL PLANTARUM, V100, P65, DOI 10.1034/j.1399-3054.1997.1000106.x; Pappan K, 1998, ARCH BIOCHEM BIOPHYS, V353, P131, DOI 10.1006/abbi.1998.0640; Qin CB, 2002, PLANT PHYSIOL, V128, P1057, DOI 10.1104/pp.010928; Ryu SB, 1997, P NATL ACAD SCI USA, V94, P12717, DOI 10.1073/pnas.94.23.12717; SAKAI A, 1987, FROST SURVIVAL PLANT, P41; Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x; SOMERVILLE C, 1995, P NATL ACAD SCI USA, V92, P6215, DOI 10.1073/pnas.92.14.6215; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; UEMURA M, 1995, PLANT PHYSIOL, V109, P15, DOI 10.1104/pp.109.1.15; Wang XM, 2004, CURR OPIN PLANT BIOL, V7, P329, DOI 10.1016/j.pbi.2004.03.012; Wang XM, 2000, PROG LIPID RES, V39, P109, DOI 10.1016/S0163-7827(00)00002-3; Welti R, 2002, J BIOL CHEM, V277, P31994, DOI 10.1074/jbc.M205375200; Xu CC, 2002, PLANT PHYSIOL, V129, P594, DOI 10.1104/pp.002725; Zhang WH, 2003, PLANT CELL, V15, P2285, DOI 10.1105/tpc.013961	24	113	133	1	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					461	468		10.1074/jbc.M706692200	http://dx.doi.org/10.1074/jbc.M706692200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17962199	Green Published, hybrid			2022-12-27	WOS:000251940300051
J	Matsuda, Y; Koshiba, T; Osaki, T; Suyama, H; Arisaka, F; Toh, Y; Kawabata, SI				Matsuda, Yasuyuki; Koshiba, Takumi; Osaki, Tsukasa; Suyama, Haruka; Arisaka, Fumio; Toh, Yoshihiro; Kawabata, Shun-ichiro			An arthropod cuticular chitin-binding protein endows injured sites with transglutaminase-dependent mesh	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORNIFIED CELL-ENVELOPE; LIMULUS HEMOCYTE TRANSGLUTAMINASE; HORSESHOE-CRAB; CROSS-LINKING; CLOTTING PROTEIN; CLOTTABLE PROTEIN; MOLECULAR-BASIS; RECOGNITION; FIBRINOGEN; INVERTEBRATES	In mammals, the cornified cell envelope forms beneath the plasma membrane in epithelia and provides a vital physical barrier consisting of insoluble proteins cross-linked by transglutaminase (TGase). In the horseshoe crab Tachypleus tridentatus, TGase is stored in hemocytes and secreted in response to the simulation of bacterial lipopolysaccharides. Here we characterized a TGase substrate designated as caraxin that was identified in horseshoe crab cuticle. One of the homologs, caraxin-1, possessed a unique domain structure consisting of N- and C-terminal heptad repeats and a central domain with a tandem-repeated structure of a pentapeptide. Western blotting showed the specific localization of caraxin-1 in sub-cuticular epidermis. Moreover, we identified the pentapeptide motif to be a chitin-binding unit. Analytical ultracentrifugation revealed that caraxin-1 exists as an oligomer with 310-350 kDa, which is similar to 20-mer based on the molecular mass of the monomer. The oligomers were cross-linked by TGase to form an elaborate mesh with honeycomb structures, which was electron-microscopically found to be different from the clotting mesh triggered by lipopolysaccharide-induced hemocyte exocytosis. We determined several cross-linking sites in the N- and C-terminal domains of caraxin-1. The replacements of Leu to Pro at positions 36 and 118 in caraxin-1 reduced the alpha-helix content, which destroyed the TGase-dependent mesh, thus indicating the importance of the N- and C-terminal domains for the proper mesh formation. In arthropods, TGase-dependent protein cross-linking may be involved in the initial stage of host defense at the sub-cuticular epidermis, as in the case of mammalian skin.	[Matsuda, Yasuyuki; Koshiba, Takumi; Osaki, Tsukasa; Suyama, Haruka; Toh, Yoshihiro; Kawabata, Shun-ichiro] Kyushu Univ, Fac Sci, Dept Biol, Higashi Ku, Fukuoka 812, Japan; [Arisaka, Fumio] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Biomol Engn, Midori Ku, Yokohama, Kanagawa 226, Japan	Kyushu University; Tokyo Institute of Technology	Kawabata, SI (corresponding author), Kyushu Univ, Fac Sci, Dept Biol, Higashi Ku, 6-10-1 Hakozaki, Fukuoka 812, Japan.	skawascb@mbox.nc.kyushu-u.ac.jp	Koshiba, Takumi/A-3996-2013	Koshiba, Takumi/0000-0001-8535-5043; Osaki, Tsukasa/0000-0002-9487-3253				Aeschlimann D, 2000, CONNECT TISSUE RES, V41, P1, DOI 10.3109/03008200009005638; Arakawa T, 2006, BIOPROCESS INT, V4, P42; Arakawa T., 2007, BIOPROCESS INT, V5, P36; Ariki S, 2004, P NATL ACAD SCI USA, V101, P953, DOI 10.1073/pnas.0306904101; ARMSTRONG PB, 1985, BLOOD CELLS MARINE I, P77; Bergner A, 1996, EMBO J, V15, P6789, DOI 10.1002/j.1460-2075.1996.tb01070.x; BURSEY CR, 1977, CAN J ZOOL, V55, P1158, DOI 10.1139/z77-150; Candi E, 1998, P NATL ACAD SCI USA, V95, P2067, DOI 10.1073/pnas.95.5.2067; DOOLITTLE RF, 1984, ANNU REV BIOCHEM, V53, P195, DOI 10.1146/annurev.bi.53.070184.001211; Elvin CM, 1996, J BIOL CHEM, V271, P8925, DOI 10.1074/jbc.271.15.8925; Folk J E, 1977, Adv Protein Chem, V31, P1, DOI 10.1016/S0065-3233(08)60217-X; FURIE B, 1988, CELL, V53, P505, DOI 10.1016/0092-8674(88)90567-3; Gokudan S, 1999, P NATL ACAD SCI USA, V96, P10086, DOI 10.1073/pnas.96.18.10086; Hamodrakas SJ, 2002, INSECT BIOCHEM MOLEC, V32, P1577, DOI 10.1016/S0965-1748(02)00079-6; ICHINOSE A, 1990, J BIOL CHEM, V265, P13411; Iijima M, 2005, FEBS J, V272, P4774, DOI 10.1111/j.1742-4658.2005.04891.x; Isakova V, 2003, BIOL BULL-US, V205, P203, DOI 10.2307/1543253; Iwanaga S, 1998, J BIOCHEM, V123, P1; Kajava AV, 2000, FEBS LETT, V473, P127, DOI 10.1016/S0014-5793(00)01502-7; Kalinin A, 2001, J CELL SCI, V114, P3069; Kalinin AE, 2002, BIOESSAYS, V24, P789, DOI 10.1002/bies.10144; Kawabata S, 2002, BBA-GEN SUBJECTS, V1572, P414, DOI 10.1016/S0304-4165(02)00322-7; Kawasaki H, 2000, J BIOL CHEM, V275, P35297, DOI 10.1074/jbc.M006856200; KOPACEK P, 1993, EUR J BIOCHEM, V213, P591, DOI 10.1111/j.1432-1033.1993.tb17798.x; Koshiba T, 2004, SCIENCE, V305, P858, DOI 10.1126/science.1099793; Koshiba T, 2003, J BIOL CHEM, V278, P7573, DOI 10.1074/jbc.M211154200; Koshiba T, 2007, J BIOL CHEM, V282, P3962, DOI 10.1074/jbc.M609198200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lorand L, 2001, ANN NY ACAD SCI, V936, P291; Lorand L, 1980, Prog Hemost Thromb, V5, P245; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Osaki T, 2004, CELL MOL LIFE SCI, V61, P1257, DOI 10.1007/s00018-004-3396-5; Osaki T, 2002, J BIOL CHEM, V277, P40084, DOI 10.1074/jbc.M206773200; REBERS JE, 1988, J MOL BIOL, V203, P411, DOI 10.1016/0022-2836(88)90009-5; SATO T, 1994, BIOCHEM BIOPH RES CO, V204, P551, DOI 10.1006/bbrc.1994.2494; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Scherfer C, 2004, CURR BIOL, V14, P625, DOI 10.1016/j.cub.2004.03.030; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shen ZC, 1999, J MOL EVOL, V48, P341, DOI 10.1007/PL00006478; SHIGENAGA T, 1993, J BIOCHEM-TOKYO, V114, P307, DOI 10.1093/oxfordjournals.jbchem.a124173; SHINOHARA Y, 1995, J BIOCHEM-TOKYO, V117, P1076; Suetake T, 2000, J BIOL CHEM, V275, P17929, DOI 10.1074/jbc.C000184200; Theopold U, 2004, TRENDS IMMUNOL, V25, P289, DOI 10.1016/j.it.2004.03.004; TOKUNAGA F, 1993, J BIOL CHEM, V268, P252; TOKUNAGA F, 1993, J BIOL CHEM, V268, P262; Willis JH, 1999, AM ZOOL, V39, P600; Wolf E, 1997, PROTEIN SCI, V6, P1179, DOI 10.1002/pro.5560060606	47	19	20	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37316	37324		10.1074/jbc.M705731200	http://dx.doi.org/10.1074/jbc.M705731200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17967901	hybrid			2022-12-27	WOS:000251833600006
J	Winger, AM; Taylor, NL; Heazlewood, JL; Day, DA; Millar, AH				Winger, Alison M.; Taylor, Nicolas L.; Heazlewood, Joshua L.; Day, David A.; Millar, A. Harvey			The cytotoxic lipid peroxidation product 4-hydroxy-2-nonenal covalently modifies a selective range of proteins linked to respiratory function in plant mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C-OXIDASE; ALPHA-KETOGLUTARATE DEHYDROGENASE; TANDEM MASS-SPECTROMETRY; OXIDATIVE STRESS; 4-HYDROXY-TRANS-2-NONENAL HNE; ARABIDOPSIS-MITOCHONDRIA; POLYACRYLAMIDE GELS; ELECTRON-TRANSPORT; RAT-HEART; INHIBITION	Plants encounter a variety of environmental stresses that affect their cellular machinery and that they adapt to on a daily basis. Lipid peroxidation is one consequence, at the cellular level, of such stresses and yields cytotoxic lipid aldehydes, including 4-hydroxy-2-nonenal (HNE), that react with specific sites in proteins, leading to diverse changes in protein function and/or stability. We have assessed the sensitivity of plant mitochondrial proteins to HNE modification, using one-dimensional and two-dimensional denaturing PAGE and blue native-PAGE coupled to immunological detection and tandem mass spectrometry identification. A select range of proteins was modified by exogenous application of HNE to mitochondria isolated from Arabidopsis cell cultures. These included a number of proteins that directly interact with the ubiquinone pool, as well as a number of soluble matrix proteins. Mitochondria isolated from cell cultures following hydrogen peroxide, antimycin A, or menadione treatment had significantly reduced respiratory capacity and elevated levels of HNE adduction to specific subsets of proteins. Targets identified included the proteins affected by direct application of HNE but also some new proteins, including a number of matrix dehydrogenases, the inner membrane adenine nucleotide translocator, and the outer membrane voltage-dependent anion channel. Degradation products of some proteins were also found to be HNE adducted, suggesting a link between HNE adduction and protein turnover. Some of the major enzyme complexes that were HNE adducted did not show demonstrable changes in their maximal activity measured with artificial acceptors, but changes did occur in associations between respiratory chain complexes following stress treatments.	[Winger, Alison M.; Taylor, Nicolas L.; Heazlewood, Joshua L.; Millar, A. Harvey] Univ Western Australia, Australian Res Council Ctr Excellence Plant Energ, Nedlands, WA 6009, Australia; [Day, David A.] Univ Sydney, Sch Biol Sci, Australian Res Council Ctr, Sydney, NSW 2006, Australia	University of Western Australia; University of Sydney	Millar, AH (corresponding author), Univ Western Australia, Australian Res Council Ctr Excellence Plant Energ, 35 Stirling Highway, Nedlands, WA 6009, Australia.	hmillar@cyllene.uwa.edu.au	Day, David/F-6325-2011; Heazlewood, Joshua L/A-2554-2008; Taylor, Nicolas L/A-5731-2008; Millar, A. Harvey/A-5452-2008	Day, David/0000-0001-7967-2173; Heazlewood, Joshua L/0000-0002-2080-3826; Taylor, Nicolas L/0000-0003-2004-5217; Millar, A. Harvey/0000-0001-9679-1473				Aldini G, 2005, J MASS SPECTROM, V40, P946, DOI 10.1002/jms.872; Aldini G, 2006, J MASS SPECTROM, V41, P1149, DOI 10.1002/jms.1067; Balmer Y, 2004, P NATL ACAD SCI USA, V101, P2642, DOI 10.1073/pnas.0308583101; Baxter CJ, 2007, PLANT PHYSIOL, V143, P312, DOI 10.1104/pp.106.090431; Carbone DL, 2005, J PHARMACOL EXP THER, V315, P8, DOI 10.1124/jpet.105.088088; Carbone DL, 2005, CHEM RES TOXICOL, V18, P1324, DOI 10.1021/tx050078z; Carini M, 2004, MASS SPECTROM REV, V23, P281, DOI 10.1002/mas.10076; Chen JJ, 1998, BBA-GEN SUBJECTS, V1380, P336, DOI 10.1016/S0304-4165(98)00002-6; Chen JJ, 2001, J MOL CELL CARDIOL, V33, P1919, DOI 10.1006/jmcc.2001.1454; Chew O, 2003, J BIOL CHEM, V278, P46869, DOI 10.1074/jbc.M307525200; Choksi KB, 2004, BBA-MOL BASIS DIS, V1688, P95, DOI 10.1016/j.bbadis.2003.11.007; Clifton R, 2005, PLANT MOL BIOL, V58, P193, DOI 10.1007/s11103-005-5514-7; Clifton R, 2006, BBA-BIOENERGETICS, V1757, P730, DOI 10.1016/j.bbabio.2006.03.009; Deighton N, 1997, FREE RADICAL RES, V27, P255, DOI 10.3109/10715769709065764; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Fenaille F, 2003, J AM SOC MASS SPECTR, V14, P215, DOI 10.1016/S1044-0305(02)00911-X; Finkemeier I, 2005, J BIOL CHEM, V280, P12168, DOI 10.1074/jbc.M413189200; FRIGUET B, 1994, ARCH BIOCHEM BIOPHYS, V311, P168, DOI 10.1006/abbi.1994.1222; Friguet B, 1997, FEBS LETT, V405, P21, DOI 10.1016/S0014-5793(97)00148-8; Giege P, 2003, PLANT CELL, V15, P2140, DOI 10.1105/tpc.012500; Hancock JT, 2005, PLANT PHYSIOL BIOCH, V43, P828, DOI 10.1016/j.plaphy.2005.07.012; Humphries KM, 1998, BIOCHEMISTRY-US, V37, P15835, DOI 10.1021/bi981512h; Humphries KM, 1998, BIOCHEMISTRY-US, V37, P552, DOI 10.1021/bi971958i; Ishizaki K, 2005, PLANT CELL, V17, P2587, DOI 10.1105/tpc.105.035162; Isom AL, 2004, J AM SOC MASS SPECTR, V15, P1136, DOI 10.1016/j.jasms.2004.03.013; Kristensen BK, 2004, PHYTOCHEMISTRY, V65, P1839, DOI 10.1016/j.phytochem.2004.04.007; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lashin OM, 2006, FREE RADICAL BIO MED, V40, P886, DOI 10.1016/j.freeradbiomed.2005.10.040; MARCILLAT O, 1988, BIOCHEM J, V254, P677, DOI 10.1042/bj2540677; MENZ RI, 1992, EUR J BIOCHEM, V208, P481, DOI 10.1111/j.1432-1033.1992.tb17211.x; Millar AH, 2001, METHOD CELL BIOL, V65, P53, DOI 10.1016/S0091-679X(01)65004-0; Millar AH, 2000, FEBS LETT, V481, P117, DOI 10.1016/S0014-5793(00)01976-1; Moller IM, 2007, ANNU REV PLANT BIOL, V58, P459, DOI 10.1146/annurev.arplant.58.032806.103946; Moller IM, 2006, FREE RADICAL BIO MED, V40, P430, DOI 10.1016/j.freeradbiomed.2005.08.036; Moller IM, 2001, ANNU REV PLANT PHYS, V52, P561, DOI 10.1146/annurev.arplant.52.1.561; Moreau R, 2003, ANTIOXID REDOX SIGN, V5, P517, DOI 10.1089/152308603770310167; Musatov A, 2002, BIOCHEMISTRY-US, V41, P8212, DOI 10.1021/bi025896u; Perluigi M, 2005, FREE RADICAL BIO MED, V38, P960, DOI 10.1016/j.freeradbiomed.2004.12.021; Picklo MJ, 1999, J NEUROCHEM, V72, P1617, DOI 10.1046/j.1471-4159.1999.721617.x; Raha S, 2000, TRENDS BIOCHEM SCI, V25, P502, DOI 10.1016/S0968-0004(00)01674-1; RASMUSSON AG, 1991, PHYSIOL PLANTARUM, V83, P357, DOI 10.1111/j.1399-3054.1991.tb00106.x; Sabar M, 2005, PLANT J, V44, P893, DOI 10.1111/j.1365-313X.2005.02577.x; SAYRE LM, 1993, CHEM RES TOXICOL, V6, P19, DOI 10.1021/tx00031a002; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Schneider C, 2001, J BIOL CHEM, V276, P20831, DOI 10.1074/jbc.M101821200; SINGER TP, 1973, PLANT PHYSIOL, V52, P616, DOI 10.1104/pp.52.6.616; Smith AMO, 2004, J BIOL CHEM, V279, P51944, DOI 10.1074/jbc.M408920200; Sweetlove LJ, 2002, PLANT J, V32, P891, DOI 10.1046/j.1365-313X.2002.01474.x; Taylor NL, 2005, MOL CELL PROTEOMICS, V4, P1122, DOI 10.1074/mcp.M400210-MCP200; Taylor NL, 2002, J BIOL CHEM, V277, P42663, DOI 10.1074/jbc.M204761200; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Vanlerberghe GC, 1997, ANNU REV PLANT PHYS, V48, P703, DOI 10.1146/annurev.arplant.48.1.703; Vieira HLA, 2001, ONCOGENE, V20, P4305, DOI 10.1038/sj.onc.1204575; Winger AM, 2005, BIOCHEM J, V387, P865, DOI 10.1042/BJ20042044; Zerbetto E, 1997, ELECTROPHORESIS, V18, P2059, DOI 10.1002/elps.1150181131	55	67	69	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37436	37447		10.1074/jbc.M702385200	http://dx.doi.org/10.1074/jbc.M702385200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17947244	hybrid			2022-12-27	WOS:000251833600018
J	Zhang, J; Suzuki, K; Hitomi, T; Siragahan, RP				Zhang, Juan; Suzuki, Katsuhiro; Hitomi, Tomohiro; Siragahan, Reuben P.			TOM1L1 is a Lyn substrate involved in Fc epsilon RI signaling in mast cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AFFINITY IGE RECEPTOR; PROTEIN-TYROSINE KINASE; BASOPHILIC LEUKEMIA-CELLS; ANTIGEN RECEPTOR; ADAPTER PROTEIN; CROSS-LINKING; VHS DOMAIN; SYK; ACTIVATION; PHOSPHORYLATION	Protein- tyrosine kinase Lyn and Syk are critical for antigenreceptor-induced signal transduction in mast cells. To identify novel Lyn/Syk substrates, we screened an RBL-2H3 bacterial expression library for proteins that were tyrosine phosphorylated with baculoviral expressed Lyn or Syk. Five clones as potential Lyn substrates and eight clones as Syk substrates were identified including known substrates such as SLP-76, LAT, and alpha-tubulin. A potential substrate of Lyn identified was the molecule TOM1L1, which has several domains thought to be important for membrane trafficking and protein-protein interactions. Because the function of TOM1L1 is unclear, the rat TOM1L1 full-length cDNAwas isolated and used to express the protein in COS-1 and RBL-2H3 mast cells. In COS-1 cells, the co-transfection of TOM1L1 and Lyn, but not Syk, resulted in the tyrosine phosphorylation of TOM1L1. In RBL-2H3 mast cells, the overexpressed TOM1L1 was strongly tyrosine phosphorylated in non-stimulated cells, and this phosphorylation was enhanced by Fc epsilon RI aggregation. By subcellular fractionation, wild-type TOM1L1 was mainly in the cytoplasm with a small fraction constitutively associated with the membrane; this association was markedly reduced in deletion mutants lacking several of the protein interaction domains. The overexpression of TOM1L1 enhanced antigen-induced tumor necrosis factor (TNF) alpha generation and release. Both protein interaction domains (VHS and the coiled-coil domains) were required for the increased TNF alpha release, but not the increased TNF alpha generation. These results suggest that TOM1L1 is a novel protein involved in the Fc epsilon RI signal transduction for the generation of cytokines.	[Zhang, Juan; Suzuki, Katsuhiro; Hitomi, Tomohiro; Siragahan, Reuben P.] NIH, NIDCR, RAST Sect, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Siragahan, RP (corresponding author), NIH, NIDCR, RAST Sect, OIIB,Bldg 10,Rm 1N106, Bethesda, MD 20892 USA.	rs53x@nih.gov			NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [ZIADE000696, Z01DE000696] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		BASCIANO LK, 1986, J BIOL CHEM, V261, P1823; Beitz LO, 1999, J BIOL CHEM, V274, P32662, DOI 10.1074/jbc.274.46.32662; BENHAMOU M, 1990, P NATL ACAD SCI USA, V87, P5327, DOI 10.1073/pnas.87.14.5327; BENHAMOU M, 1993, J BIOL CHEM, V268, P23318; Billin AN, 1999, J BIOL CHEM, V274, P36344, DOI 10.1074/jbc.274.51.36344; Deckert M, 1998, IMMUNITY, V9, P595, DOI 10.1016/S1074-7613(00)80657-3; Franco M, 2006, MOL CELL BIOL, V26, P1932, DOI 10.1128/MCB.26.5.1932-1947.2006; Goitsuka R, 2000, INT IMMUNOL, V12, P573, DOI 10.1093/intimm/12.4.573; HendricksTaylor LR, 1997, J BIOL CHEM, V272, P1363, DOI 10.1074/jbc.272.2.1363; Hitomi T, 1999, FEBS LETT, V445, P371, DOI 10.1016/S0014-5793(99)00153-2; JabrilCuenod B, 1996, J BIOL CHEM, V271, P16268, DOI 10.1074/jbc.271.27.16268; JOUVIN MHE, 1994, J BIOL CHEM, V269, P5918; Katoh Y, 2006, BIOCHEM BIOPH RES CO, V341, P143, DOI 10.1016/j.bbrc.2005.12.156; Katoh Y, 2004, J BIOL CHEM, V279, P24435, DOI 10.1074/jbc.M400059200; Kawakami Y, 2000, P NATL ACAD SCI USA, V97, P7423, DOI 10.1073/pnas.120175097; Kawakami Y, 2000, J IMMUNOL, V165, P1210, DOI 10.4049/jimmunol.165.3.1210; KIHARA H, 1994, J BIOL CHEM, V269, P22427; Larbolette O, 1999, MOL CELL BIOL, V19, P1539; Latour S, 1997, MOL CELL BIOL, V17, P4434, DOI 10.1128/MCB.17.8.4434; Li WJ, 2005, J BIOL CHEM, V280, P6036, DOI 10.1074/jbc.M406546200; Lock P, 1998, EMBO J, V17, P4346, DOI 10.1093/emboj/17.15.4346; Lohi O, 2002, FEBS LETT, V513, P19, DOI 10.1016/S0014-5793(01)03287-2; Lohi O, 1998, FEBS LETT, V440, P255, DOI 10.1016/S0014-5793(98)01401-X; Lupher ML, 1998, J BIOL CHEM, V273, P35273, DOI 10.1074/jbc.273.52.35273; MINOGUCHI K, 1994, J BIOL CHEM, V269, P16902; NISHIKATA H, 1992, J IMMUNOL, V149, P862; Okazaki H, 1997, J BIOL CHEM, V272, P32443, DOI 10.1074/jbc.272.51.32443; Peters JD, 1996, J BIOL CHEM, V271, P4755; PIROZZI G, 1995, J IMMUNOL, V155, P5811; Puertollano R, 2005, J BIOL CHEM, V280, P9258, DOI 10.1074/jbc.M412481200; Rawlings DJ, 1996, SCIENCE, V271, P822, DOI 10.1126/science.271.5250.822; Saitoh S, 2000, IMMUNITY, V12, P525, DOI 10.1016/S1074-7613(00)80204-6; Seroussi E, 1999, GENOMICS, V57, P380, DOI 10.1006/geno.1998.5739; Seykora JT, 2002, J BIOL CHEM, V277, P2812, DOI 10.1074/jbc.M106813200; SONGYANG Z, 1994, MOL CELL BIOL, V14, P2777, DOI 10.1128/MCB.14.4.2777; TAKATA M, 1994, EMBO J, V13, P1341, DOI 10.1002/j.1460-2075.1994.tb06387.x; Teramoto H, 1997, J BIOL CHEM, V272, P10751; Yamanashi Y, 1997, J EXP MED, V185, P1387, DOI 10.1084/jem.185.7.1387; Zhang J, 1996, J EXP MED, V184, P71, DOI 10.1084/jem.184.1.71; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	40	7	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37669	37677		10.1074/jbc.M705168200	http://dx.doi.org/10.1074/jbc.M705168200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17977829	hybrid			2022-12-27	WOS:000251833600043
J	Olsen, SK; Ota, N; Kishishita, S; Kukimoto-Niino, M; Murayama, K; Uchiyama, H; Toyama, M; Terada, T; Shirouzu, M; Kanagawa, O; Yokoyama, S				Olsen, Shaun K.; Ota, Naruhisa; Kishishita, Seiichiro; Kukimoto-Niino, Mutsuko; Murayama, Kazutaka; Uchiyama, Hidemi; Toyama, Mitsutoshi; Terada, Takaho; Shirouzu, Mikako; Kanagawa, Osami; Yokoyama, Shigeyuki			Crystal structure of the interleukin-15 center dot interleukin-15 receptor alpha complex - Insights into trans and cis presentation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOKINE-RECEPTOR; GAMMA-CHAIN; HUMAN INTERLEUKIN-15; IL-2 RECEPTOR; BETA-CHAIN; LIGAND-BINDING; IN-VIVO; CELL; PROTEIN; IL-15R-ALPHA	Interleukin (IL)-15 is a pleiotropic cytokine that plays a pivotal role in both innate and adaptive immunity. IL-15 is unique among cytokines due to its participation in a trans signaling mechanism in which IL-15 receptor alpha(IL-15R alpha) from one subset of cells presents IL-15 to neighboring IL-2R beta/gamma(c)-expressing cells. Here we present the crystal structure of IL-15 in complex with the sushi domain of IL-15R alpha. The structure reveals that the alpha receptor-binding epitope of IL-15 adopts a unique conformation, which, together with amino acid substitutions, permits specific interactions with IL-15R alpha that account for the exceptionally high affinity of the IL-15 center dot IL-15R alpha complex. Interestingly, analysis of the topology of IL-15 and IL-15R alpha at the IL-15 center dot IL-15R alpha interface suggests that IL-15 should be capable of participating in a cis signaling mechanism similar to that of the related cytokine IL-2. Indeed, we present biochemical data demonstrating that IL-15 is capable of efficiently signaling in cis through IL-15R alpha and IL-2R beta/gamma(c) expressed on the surface of a single cell. Based on our data we propose that cis presentation of IL-15 may be important in certain biological contexts and that flexibility of IL-15R alpha permits IL-15 and its three receptor components to be assembled identically at the ligand-receptor interface whether IL-15 is presented in cis or trans. Finally, we have gained insights into IL-15 center dot IL-15R alpha center dot IL-2R beta center dot gamma(c) quaternary complex assembly through the use of molecular modeling.	[Olsen, Shaun K.; Kishishita, Seiichiro; Kukimoto-Niino, Mutsuko; Murayama, Kazutaka; Toyama, Mitsutoshi; Terada, Takaho; Shirouzu, Mikako; Yokoyama, Shigeyuki] RIKEN Yokohama Inst, RIKEN Gen Sci Ctr, Kanagawa 2300045, Japan; [Ota, Naruhisa; Uchiyama, Hidemi; Kanagawa, Osami] RIKEN Yokohama Inst, RIKEN Res Ctr Allergy & Immunol, Kanagawa 2300045, Japan; [Murayama, Kazutaka] Tohoku Univ, Biomed Engn Res Org, Sendai, Miyagi 9808575, Japan; [Yokoyama, Shigeyuki] Univ Tokyo, Dept Biophys & Biochem, Tokyo 1130033, Japan	RIKEN; RIKEN; Tohoku University; University of Tokyo	Yokoyama, S (corresponding author), RIKEN Yokohama Inst, RIKEN Gen Sci Ctr, 1-7-22 Suehiro Cho, Kanagawa 2300045, Japan.	yokoyama@biochem.s.u-tokyo.ac.jp	Shirouzu, Mikako/A-6521-2016; Toyama, Marcos H/P-4673-2017; Kishishita, Seiichiro/H-1836-2011; Kukimoto-Niino, Mutsuko/C-6704-2017; Yokoyama, Shigeyuki/N-6911-2015	Toyama, Marcos H/0000-0001-6836-3084; Kishishita, Seiichiro/0000-0001-7587-2581; Kukimoto-Niino, Mutsuko/0000-0002-4178-1611; Yokoyama, Shigeyuki/0000-0003-3133-7338; Olsen, Shaun/0000-0002-1265-7101				ANDERSON DM, 1995, J BIOL CHEM, V270, P29862; Aritomi M, 1999, NATURE, V401, P713, DOI 10.1038/44394; BAMFORD RN, 1994, P NATL ACAD SCI USA, V91, P4940, DOI 10.1073/pnas.91.11.4940; Bernard J, 2004, J BIOL CHEM, V279, P24313, DOI 10.1074/jbc.M312458200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Budagian V, 2004, J BIOL CHEM, V279, P40368, DOI 10.1074/jbc.M404125200; Budagian V, 2006, CYTOKINE GROWTH F R, V17, P259, DOI 10.1016/j.cytogfr.2006.05.001; Bulanova E, 2003, J IMMUNOL, V170, P5045, DOI 10.4049/jimmunol.170.10.5045; Bulanova E, 2007, J BIOL CHEM, V282, P13167, DOI 10.1074/jbc.M610036200; Burkett PR, 2004, J EXP MED, V200, P825, DOI 10.1084/jem.20041389; Chirifu M, 2007, NAT IMMUNOL, V8, P1001, DOI 10.1038/ni1492; deJong JLO, 1996, J IMMUNOL, V156, P1339; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; DEXTER TM, 1980, J EXP MED, V152, P1036, DOI 10.1084/jem.152.4.1036; Dubois S, 1999, J BIOL CHEM, V274, P26978, DOI 10.1074/jbc.274.38.26978; Dubois S, 2002, IMMUNITY, V17, P537, DOI 10.1016/S1074-7613(02)00429-6; Eisenman J, 2002, CYTOKINE, V20, P121, DOI 10.1006/cyto.2002.1989; GIRI JG, 1995, EMBO J, V14, P3654, DOI 10.1002/j.1460-2075.1995.tb00035.x; GIRI JG, 1994, EMBO J, V13, P2822, DOI 10.1002/j.1460-2075.1994.tb06576.x; GRABSTEIN KH, 1994, SCIENCE, V264, P965, DOI 10.1126/science.8178155; Hage T, 1999, CELL, V97, P271, DOI 10.1016/S0092-8674(00)80736-9; JOHNSTON JA, 1995, P NATL ACAD SCI USA, V92, P8705, DOI 10.1073/pnas.92.19.8705; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kigawa Takanori, 2002, Journal of Structural and Functional Genomics, V2, P29, DOI 10.1023/A:1013203532303; Kobayashi H, 2005, BLOOD, V105, P721, DOI 10.1182/blood-2003-12-4187; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leonard WJ, 1995, IMMUNOL REV, V148, P97, DOI 10.1111/j.1600-065X.1995.tb00095.x; Liparoto SF, 1999, J MOL RECOGNIT, V12, P316, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<316::AID-JMR468>3.0.CO;2-1; Lorenzen I, 2006, J BIOL CHEM, V281, P6642, DOI 10.1074/jbc.M513118200; Mortier E, 2006, J BIOL CHEM, V281, P1612, DOI 10.1074/jbc.M508624200; Myszka DG, 1996, PROTEIN SCI, V5, P2468, DOI 10.1002/pro.5560051209; Neely GG, 2001, J IMMUNOL, V167, P5011, DOI 10.4049/jimmunol.167.9.5011; NORMAN DG, 1991, J MOL BIOL, V219, P717, DOI 10.1016/0022-2836(91)90666-T; Olosz F, 2000, J BIOL CHEM, V275, P30100, DOI 10.1074/jbc.M004976200; Olosz F, 2002, J BIOL CHEM, V277, P12047, DOI 10.1074/jbc.M110520200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; PETIT DK, 1997, J BIOL CHEM, V272, P2312; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; QUERMENER A, 2006, PROTEINS, V65, P623; Rickert M, 2005, SCIENCE, V308, P1477, DOI 10.1126/science.1109745; ROZWARSKI DA, 1994, STRUCTURE, V2, P159, DOI 10.1016/S0969-2126(00)00018-6; Rubinstein MP, 2006, P NATL ACAD SCI USA, V103, P9166, DOI 10.1073/pnas.0600240103; Ruchatz H, 1998, J IMMUNOL, V160, P5654; Sandau MM, 2004, J IMMUNOL, V173, P6537, DOI 10.4049/jimmunol.173.11.6537; Sato N, 2007, P NATL ACAD SCI USA, V104, P588, DOI 10.1073/pnas.0610115104; Schluns KS, 2005, INT J BIOCHEM CELL B, V37, P1567, DOI 10.1016/j.biocel.2005.02.017; Stauber DJ, 2006, P NATL ACAD SCI USA, V103, P2788, DOI 10.1073/pnas.0511161103; Stoklasek TA, 2006, J IMMUNOL, V177, P6072, DOI 10.4049/jimmunol.177.9.6072; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Waldmann TA, 2001, IMMUNITY, V14, P105, DOI 10.1016/S1074-7613(01)00093-0; Waldmann TA, 2006, NAT REV IMMUNOL, V6, P595, DOI 10.1038/nri1901; Wang XQ, 2005, SCIENCE, V310, P1159, DOI 10.1126/science.1117893; Wei XQ, 2001, J IMMUNOL, V167, P277, DOI 10.4049/jimmunol.167.1.277; Yoon C, 2000, EMBO J, V19, P3530, DOI 10.1093/emboj/19.14.3530	56	68	76	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					37191	37204		10.1074/jbc.M706150200	http://dx.doi.org/10.1074/jbc.M706150200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17947230	hybrid			2022-12-27	WOS:000251646000045
J	Golubkov, VS; Chekanov, AV; Shiryaev, SA; Aleshin, AE; Ratnikov, BI; Gawlik, K; Radichev, I; Motamedchaboki, K; Smith, JW; Strongin, AY				Golubkov, Vladislav S.; Chekanov, Alexei V.; Shiryaev, Sergey A.; Aleshin, Alexander E.; Ratnikov, Boris I.; Gawlik, Katarzyna; Radichev, Ilian; Motamedchaboki, Khatereh; Smith, Jeffrey W.; Strongin, Alex Y.			Proteolysis of the membrane type-1 matrix metalloproteinase prodomain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							1-MATRIX METALLOPROTEINASE; INTRACELLULAR ACTIVATION; PERICELLULAR PROTEOLYSIS; CYSTEINE SWITCH; CELL-MIGRATION; IV COLLAGENASE; MT1-MMP; COMPLEX; FURIN; INVASION	Membrane type-1 matrix metalloproteinase (MT1-MMP) exerts its enhanced activity in multiple cancer types. Understanding the activation process of MT1-MMP is essential for designing novel and effective cancer therapies. Like all of the other MMPs, MT1-MMP is synthesized as a zymogen, the latency of which is maintained by its inhibitory prodomain. Proteolytic processing of the prodomain transforms the zymogen into a catalytically active enzyme. A sequential, two-step activation process is normally required for MMPs. Our in silico modeling suggests that the prodomain of MT1-MMP exhibits a conserved three helix-bundled structure and a " bait" loop region linking helixes 1 and 2. We hypothesized and then confirmed that in addition to furin cleavage there is also a cleavage at the bait region in the activation process of MT1-MMP. A two-step sequential activation of MT1-MMP is likely to include the MMP-dependent cleavage at either P(47)GD down arrow L-50 or P(58)QS down arrow L-61 or at both sites of the bait region. This event results in the activation intermediate. The activation process is then completed by a proprotein convertase cleaving the inhibitory prodomain at the (RRKR111)-R-108 down arrow Y-112 site, where Tyr(112) is the N-terminal residue of the mature MT1-MMP enzyme. Our findings suggest that the most efficient activation results from a two-step mechanism that eventually is required for the degradation of the inhibitory prodomain and the release of the activated, mature MT1-MMP enzyme. These findings shed more light on the functional role of the inhibitory prodomain and on the proteolytic control of MT1-MMP activation, a crucial process that may be differentially regulated in normal and cancer cells.	Burnham Inst Med Res, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Strongin, AY (corresponding author), 10901 N Torrey Pines Rd, La Jolla, CA USA.	strongin@burnham.org	Golubkov, Vladislav/L-6828-2017; Strongin, Alex/R-6609-2019	Strongin, Alex/0000-0003-3765-3016	NATIONAL CANCER INSTITUTE [R01CA083017, R01CA077470] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020843] Funding Source: NIH RePORTER; NCI NIH HHS [CA83017, R01 CA083017, CA77470, R01 CA077470] Funding Source: Medline; NCRR NIH HHS [RR020843, U54 RR020843] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		BECKER JW, 1995, PROTEIN SCI, V4, P1966, DOI 10.1002/pro.5560041002; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Deryugina EI, 1997, J CELL SCI, V110, P2473; Elkins PA, 2002, ACTA CRYSTALLOGR D, V58, P1182, DOI 10.1107/S0907444902007849; Eswar N, 2003, NUCLEIC ACIDS RES, V31, P3375, DOI 10.1093/nar/gkg543; Fernandez-Catalan C, 1998, EMBO J, V17, P5238, DOI 10.1093/emboj/17.17.5238; Fugere M, 2002, J BIOL CHEM, V277, P7648, DOI 10.1074/jbc.M107467200; Golubkov VS, 2005, J BIOL CHEM, V280, P25079, DOI 10.1074/jbc.M502779200; HANGLOW AC, 1993, AGENTS ACTIONS, V39, P148; Holmbeck K, 2004, J CELL PHYSIOL, V200, P11, DOI 10.1002/jcp.20065; Hotary KB, 2003, CELL, V114, P33, DOI 10.1016/S0092-8674(03)00513-0; Itoh Y, 2006, J CELL PHYSIOL, V206, P1, DOI 10.1002/jcp.20431; Itoh Y, 2006, IUBMB LIFE, V58, P589, DOI 10.1080/15216540600962818; Jozic D, 2005, J BIOL CHEM, V280, P9578, DOI 10.1074/jbc.M411084200; Kang TB, 2002, CANCER RES, V62, P675; Kotra LP, 2001, J AM CHEM SOC, V123, P3108, DOI 10.1021/ja001896a; Kridel SJ, 2002, J BIOL CHEM, V277, P23788, DOI 10.1074/jbc.M111574200; Maskos K, 2005, BIOCHIMIE, V87, P249, DOI 10.1016/j.biochi.2004.11.019; Morgunova E, 1999, SCIENCE, V284, P1667, DOI 10.1126/science.284.5420.1667; Mott JD, 2004, CURR OPIN CELL BIOL, V16, P558, DOI 10.1016/j.ceb.2004.07.010; Murphy G, 1999, APMIS, V107, P38, DOI 10.1111/j.1699-0463.1999.tb01524.x; Osenkowski P, 2004, J CELL PHYSIOL, V200, P2, DOI 10.1002/jcp.20064; PARK AJ, 1991, J BIOL CHEM, V266, P1584; PEI DQ, 1995, NATURE, V375, P244, DOI 10.1038/375244a0; Ratnikov B, 2000, ANAL BIOCHEM, V286, P149, DOI 10.1006/abio.2000.4798; Remacle AG, 2006, ONCOGENE, V25, P5648, DOI 10.1038/sj.onc.1209572; Rozanov DV, 2004, J BIOL CHEM, V279, P4260, DOI 10.1074/jbc.M311569200; Rozanov DV, 2001, J BIOL CHEM, V276, P25705, DOI 10.1074/jbc.M007921200; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; Seiki M, 2003, CANCER SCI, V94, P569, DOI 10.1111/j.1349-7006.2003.tb01484.x; Seiki M, 2003, CANCER LETT, V194, P1, DOI 10.1016/S0304-3835(02)00699-7; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; STRONGIN AY, 1993, J BIOL CHEM, V268, P14033; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VANWART HE, 1990, P NATL ACAD SCI USA, V87, P5578, DOI 10.1073/pnas.87.14.5578; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Wewer UM, 2006, J BIOL CHEM, V281, P9418, DOI 10.1074/jbc.M513580200; Wolf K, 2007, NAT CELL BIOL, V9, P893, DOI 10.1038/ncb1616; Yana I, 2002, CLIN EXP METASTAS, V19, P209, DOI 10.1023/A:1015527220537; Yana I, 2000, MOL BIOL CELL, V11, P2387, DOI 10.1091/mbc.11.7.2387; Zdobnov EM, 2002, BIOINFORMATICS, V18, P368, DOI 10.1093/bioinformatics/18.2.368; Zucker S, 2003, CURR TOP DEV BIOL, V54, P1, DOI 10.1016/S0070-2153(03)54004-2	42	27	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36283	36291		10.1074/jbc.M706290200	http://dx.doi.org/10.1074/jbc.M706290200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17938169	hybrid			2022-12-27	WOS:000251458300019
J	Hagihara, Y; Mine, S; Uegaki, K				Hagihara, Yoshihisa; Mine, Shouhei; Uegaki, Koichi			Stabilization of an immunoglobulin fold domain by an engineered disulfide bond at the buried hydrophobic region	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBONIC-ANHYDRASE-II; AMINO-ACID PAIRS; ANTIBODY FRAGMENTS; CONFORMATIONAL STABILITY; GLOBULAR-PROTEINS; CRYSTAL-STRUCTURE; CHAIN; DISPLAY; THERMOSTABILITY; RESIDUES	We report for the first time the stabilization of an immunoglobulin fold domain by an engineered disulfide bond. In the llama single-domain antibody, which has human chorionic gonadotropin as its specific antigen, Ala(49) and Ile(70) are buried in the structure. A mutant with an artificial disulfide bond at this position showed a 10 degrees C higher midpoint temperature of thermal unfolding than that without the extra disulfide bond. The modified domains exhibited an antigen binding affinity comparable with that of the wild-type domain. Ala(49) and Ile(70) are conserved in camel and llama single-domain antibody frameworks. Therefore, domains against different antigens are expected to be stabilized by the engineered disulfide bond examined here. In addition to the effect of the loop constraints in the unfolded state, thermodynamic analysis indicated that internal interaction and hydration also control the stability of domains with disulfide bonds. The change in physical properties resulting from mutation often causes unpredictable and destabilizing effects on these interactions. The introduction of a hydrophobic cystine into the hydrophobic region maintains the hydrophobicity of the protein and is expected to minimize the unfavorable mutational effects.	Natl Inst Adv Ind Sci & Technol, Res Inst Cell Engn, Ikeda, Osaka 5638577, Japan	National Institute of Advanced Industrial Science & Technology (AIST)	Hagihara, Y (corresponding author), Natl Inst Adv Ind Sci & Technol, Res Inst Cell Engn, 1-8-31 Midorigaoka, Ikeda, Osaka 5638577, Japan.	hagihara-kappael@aist.go.jp	HAGIHARA, Yoshihisa/K-4996-2016	HAGIHARA, Yoshihisa/0000-0002-5980-1764	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001081] Funding Source: NIH RePORTER; NCRR NIH HHS [P41 RR-01081] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		BETZ SF, 1992, BIOCHEMISTRY-US, V31, P12337, DOI 10.1021/bi00164a007; Burton RE, 2000, PROTEIN SCI, V9, P776; Dani VS, 2003, PROTEIN ENG, V16, P187, DOI 10.1093/proeng/gzg024; Desmyter A, 1996, NAT STRUCT BIOL, V3, P803, DOI 10.1038/nsb0996-803; Desmyter A, 2001, J BIOL CHEM, V276, P26285, DOI 10.1074/jbc.M102107200; Doering DS, 1996, BIOCHEMISTRY-US, V35, P12677, DOI 10.1021/bi9615699; Dolk E, 2005, APPL ENVIRON MICROB, V71, P442, DOI 10.1128/AEM.71.1.442-450.2005; Dumoulin M, 2002, PROTEIN SCI, V11, P500, DOI 10.1110/ps.34602; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; ELLMAN GL, 1958, ARCH BIOCHEM BIOPHYS, V74, P443, DOI 10.1016/0003-9861(58)90014-6; FAUCHERE JL, 1983, EUR J MED CHEM, V18, P369; GOTO Y, 1979, J BIOCHEM-TOKYO, V86, P1433, DOI 10.1093/oxfordjournals.jbchem.a132661; Hagihara Y, 2005, J BIOL CHEM, V280, P24752, DOI 10.1074/jbc.M503963200; Hagihara Y, 2002, J BIOL CHEM, V277, P51043, DOI 10.1074/jbc.M208893200; Hagihara Y, 2002, P NATL ACAD SCI USA, V99, P6619, DOI 10.1073/pnas.102172099; Hagihara Y, 1997, J BIOCHEM-TOKYO, V121, P128; Johnson CM, 1997, J MOL BIOL, V268, P198, DOI 10.1006/jmbi.1997.0928; Ko JH, 1996, BIOCHEM BIOPH RES CO, V221, P631, DOI 10.1006/bbrc.1996.0647; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Ladenson RC, 2006, ANAL CHEM, V78, P4501, DOI 10.1021/ac058044j; Lipovsek D, 2007, J MOL BIOL, V368, P1024, DOI 10.1016/j.jmb.2007.02.029; Makhatadze GI, 1995, ADV PROTEIN CHEM, V47, P307, DOI 10.1016/S0065-3233(08)60548-3; Martensson LG, 2002, BIOCHEMISTRY-US, V41, P15867, DOI 10.1021/bi020433+; MITCHINSON C, 1989, BIOCHEMISTRY-US, V28, P4807, DOI 10.1021/bi00437a043; Muyldermans S, 2001, J Biotechnol, V74, P277; Nagano N, 1999, FEBS LETT, V458, P69, DOI 10.1016/S0014-5793(99)01122-9; Ohhashi Y, 2002, J BIOCHEM, V131, P45, DOI 10.1093/oxfordjournals.jbchem.a003076; PACE CN, 1988, J BIOL CHEM, V263, P11820; Perez JMJ, 2001, BIOCHEMISTRY-US, V40, P74, DOI 10.1021/bi0009082; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; POLAND DC, 1965, BIOPOLYMERS, V3, P379, DOI 10.1002/bip.1965.360030404; Reading NS, 2000, BIOTECHNOL PROGR, V16, P326, DOI 10.1021/bp0000151; ROSE GD, 1985, SCIENCE, V229, P834, DOI 10.1126/science.4023714; Spinelli S, 1996, NAT STRUCT BIOL, V3, P752, DOI 10.1038/nsb0996-752; THORNTON JM, 1981, J MOL BIOL, V151, P261, DOI 10.1016/0022-2836(81)90515-5; van der Linden RHJ, 1999, BBA-PROTEIN STRUCT M, V1431, P37, DOI 10.1016/S0167-4838(99)00030-8; WAKARCHUK WW, 1994, PROTEIN ENG, V7, P1379, DOI 10.1093/protein/7.11.1379; Zavodszky M, 2001, PROTEIN SCI, V10, P149, DOI 10.1110/ps.26801	38	78	82	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36489	36495		10.1074/jbc.M707078200	http://dx.doi.org/10.1074/jbc.M707078200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17932041	hybrid			2022-12-27	WOS:000251458300041
J	Kim, HJ; Li, Q; Tjon-Kon-Sang, S; So, I; Kiselyov, K; Muallem, S				Kim, Hyun Jin; Li, Qin; Tjon-Kon-Sang, Sandra; So, Insuk; Kiselyov, Kirill; Muallem, Shmuel			Gain-of-function mutation in TRPML3 causes the mouse varitint-waddler phenotype	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-HELIX; CHANNELS	TRPML3 is a member of the TRPML subfamily of the transient receptor potential cation channel superfamily. The TRPML3(A419P) mutation causes a severe form, whereas the TRPML3(I362T/A419P) mutation results in a mild form of the varitint-waddler phenotype. The channel properties of TRPML3 and how the mutations cause each phenotype are not known. In this study, we report the first channel properties of TRPML3 as a strongly inward rectifying cation channel with a novel regulation by extracytosolic Na+. Preincubating the extracytosolic face of TRPML3 in Na+ free medium is required for channel activation, but then the channel slowly inactivates. The A419P mutation locks the channel in an open unregulated state. Similar gain of function was observed with the A419G mutation, which, like A419P, is expected to destabilize the alpha-helical fifth transmembrane domain of TRPML3. The I362T mutation results in an inactive channel, but the channel properties of TRPML3(I362T/A419P) are similar to those of TRPML3(A419P). However, the surface expression and current density of TRPML3(I362T/A419P) are lower than those of TRPML3(A419P). The A419P mutation also affects channel glycosylation and causes massive cell death. These findings show that the varitint-waddler phenotype is due to a gain of function of TRPML3( A419P) that is reduced by the TRPML3(I362T/A419P) mutant, resulting in a milder phenotype.	Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; Seoul Natl Univ, Coll Med, Dept Physiol & Biophys, Seoul 110799, South Korea; Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Seoul National University (SNU); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Muallem, S (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA.	Shmuel.Muallem@UTSouthwestern.edu	So, Insuk/J-2762-2012	Kiselyov, Kirill/0000-0001-6683-2895	NIDCR NIH HHS [DE12309] Funding Source: Medline; NIDDK NIH HHS [DK38938] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE012309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038938] Funding Source: NIH RePORTER	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Atiba-Davies M, 2007, BBA-MOL BASIS DIS, V1772, P1028, DOI 10.1016/j.bbadis.2007.01.007; Aurora R, 1997, J BIOL CHEM, V272, P1413, DOI 10.1074/jbc.272.3.1413; Bargal R, 2000, NAT GENET, V26, P118, DOI 10.1038/79095; Di Palma F, 2002, P NATL ACAD SCI USA, V99, P14994, DOI 10.1073/pnas.222425399; Kiselyov K, 2007, J PHYSIOL-LONDON, V578, P641, DOI 10.1113/jphysiol.2006.119024; Pedersen SF, 2005, CELL CALCIUM, V38, P233, DOI 10.1016/j.ceca.2005.06.028; SAMATEY FA, 1995, P NATL ACAD SCI USA, V92, P4577, DOI 10.1073/pnas.92.10.4577; Song YM, 2006, EUR J CELL BIOL, V85, P1253, DOI 10.1016/j.ejcb.2006.08.004; Venkatachalam K, 2006, J BIOL CHEM, V281, P17517, DOI 10.1074/jbc.M600807200	9	89	90	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36138	36142		10.1074/jbc.C700190200	http://dx.doi.org/10.1074/jbc.C700190200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17962195	hybrid			2022-12-27	WOS:000251458300003
J	Barron, RM; Campbell, SL; King, D; Bellon, A; Chapman, KE; Williamson, RA; Manson, JC				Barron, Rona M.; Campbell, Susan L.; King, Declan; Bellon, Anne; Chapman, Karen E.; Williamson, R. Anthony; Manson, Jean C.			High titers of transmissible spongiform encephalopathy infectivity associated with extremely low levels of PrPSc in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CREUTZFELDT-JAKOB-DISEASE; ABNORMAL PRION PROTEIN; SINGLE AMINO-ACID; TRANSGENIC MICE; BLOOD-TRANSFUSION; INCUBATION-TIME; INSERTIONAL MUTATION; SCRAPIE AGENT; MUTANT PRP; BSE AGENT	Diagnosis of transmissible spongiform encephalopathy (TSE) disease in humans and ruminants relies on the detection in postmortem brain tissue of the protease-resistant form of the host glycoprotein PrP. The presence of this abnormal isoform (PrPSc) in tissues is taken as indicative of the presence of TSE infectivity. Here we demonstrate conclusively that high titers of TSE infectivity can be present in brain tissue of animals that show clinical and vacuolar signs of TSE disease but contain low or undetectable levels of PrPSc. This work questions the correlation between PrPSc level and the titer of infectivity and shows that tissues containing little or no proteinase K-resistant PrP can be infectious and harbor high titers of TSE infectivity. Reliance on protease-resistant PrPSc as a sole measure of infectivity may therefore in some instances significantly underestimate biological properties of diagnostic samples, thereby undermining efforts to contain and eradicate TSEs.	Roslin Inst, Neuropathogenesis Unit, Edinburgh EH9 3JF, Midlothian, Scotland; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Univ Edinburgh, Queens Med Res Inst, Ctr Cardiovasc Sci, Edinburgh EH16 4TJ, Midlothian, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; Scripps Research Institute; University of Edinburgh	Barron, RM (corresponding author), Roslin Inst, Neuropathogenesis Unit, Ogston Bldg,W Mains Rd, Edinburgh EH9 3JF, Midlothian, Scotland.	rona.barron@bbsrc.ac.uk	King, Declan/AAA-7145-2021; Barron, Rona M/C-7703-2013; Barron, Rona/AAP-9360-2020	manson, jean/0000-0002-0175-9890; King, Declan/0000-0002-2434-9317; Chapman, Karen/0000-0001-7777-6817; Barron, Rona/0000-0003-4512-9177	Biotechnology and Biological Sciences Research Council [BBS/E/I/00001155] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Barron RM, 2003, J GEN VIROL, V84, P3165, DOI 10.1099/vir.0.19147-0; Barron RM, 2001, EMBO J, V20, P5070, DOI 10.1093/emboj/20.18.5070; Beekes M, 1996, J GEN VIROL, V77, P1925, DOI 10.1099/0022-1317-77-8-1925; Bishop MT, 2006, LANCET NEUROL, V5, P393, DOI 10.1016/S1474-4422(06)70413-6; Brown P, 2000, NEUROLOGY, V55, P1075, DOI 10.1212/WNL.55.8.1075; Bruce ME, 2007, VET REC, V160, P665, DOI 10.1136/vr.160.19.665; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; Buschmann A, 2004, J GEN VIROL, V85, P2727, DOI 10.1099/vir.0.79997-0; Buschmann A, 2004, J VIROL METHODS, V117, P27, DOI 10.1016/j.jviromet.2003.11.017; Chiesa R, 2000, P NATL ACAD SCI USA, V97, P5574, DOI 10.1073/pnas.97.10.5574; Chiesa R, 2001, NEUROBIOL DIS, V8, P743, DOI 10.1006/nbdi.2001.0433; Chiesa R, 1998, NEURON, V21, P1339, DOI 10.1016/S0896-6273(00)80653-4; DICKINSON AG, 1968, J COMP PATHOL, V78, P293, DOI 10.1016/0021-9975(68)90005-4; Hegde RS, 1999, NATURE, V402, P822, DOI 10.1038/45574; Hilton DA, 2004, J PATHOL, V203, P733, DOI 10.1002/path.1580; Houston F, 2000, LANCET, V356, P999, DOI 10.1016/S0140-6736(00)02719-7; HSIAO KK, 1994, P NATL ACAD SCI USA, V91, P9126, DOI 10.1073/pnas.91.19.9126; Hunter N, 2002, J GEN VIROL, V83, P2897, DOI 10.1099/0022-1317-83-11-2897; IRONSIDE J, 2006, BMJ-BRIT MED J, V332, P1164; Karber G., 1931, ARCH EXP PATHOL PH, V162, P480, DOI DOI 10.1007/BF01863914; KITAMOTO T, 1993, BIOCHEM BIOPH RES CO, V192, P525, DOI 10.1006/bbrc.1993.1447; Lasmezas CI, 1997, SCIENCE, V275, P402, DOI 10.1126/science.275.5298.402; Le Dur A, 2005, P NATL ACAD SCI USA, V102, P16031, DOI 10.1073/pnas.0502296102; Llewelyn CA, 2004, LANCET, V363, P417, DOI 10.1016/S0140-6736(04)15486-X; Ma JY, 2002, SCIENCE, V298, P1781, DOI 10.1126/science.1073725; Ma JY, 2002, SCIENCE, V298, P1785, DOI 10.1126/science.1073619; Manson JC, 1999, EMBO J, V18, P6855, DOI 10.1093/emboj/18.23.6855; MCKINLEY MP, 1983, CELL, V35, P57, DOI 10.1016/0092-8674(83)90207-6; Moroncini G, 2004, P NATL ACAD SCI USA, V101, P10404, DOI 10.1073/pnas.0403522101; Nazor KE, 2005, EMBO J, V24, P2472, DOI 10.1038/sj.emboj.7600717; Peden AH, 2004, LANCET, V364, P527, DOI 10.1016/S0140-6736(04)16811-6; Pincock Stephen, 2004, BMJ, V329, P251, DOI 10.1136/bmj.329.7460.251-a; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 1996, TRENDS BIOCHEM SCI, V21, P482, DOI 10.1016/S0968-0004(96)10063-3; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Safar JG, 2005, P NATL ACAD SCI USA, V102, P3501, DOI 10.1073/pnas.0409651102; Safar JG, 2002, NAT BIOTECHNOL, V20, P1147, DOI 10.1038/nbt748; Solforosi L, 2007, J BIOL CHEM, V282, P7465, DOI 10.1074/jbc.M610051200; Stewart RS, 2005, J NEUROSCI, V25, P3469, DOI 10.1523/JNEUROSCI.0105-05.2005; Tremblay P, 2004, J VIROL, V78, P2088, DOI 10.1128/JVI.78.4.2088-2099.2004; Wroe SJ, 2006, LANCET, V368, P2061, DOI 10.1016/S0140-6736(06)69835-8; Zanusso G, 1999, J BIOL CHEM, V274, P23396, DOI 10.1074/jbc.274.33.23396; Zanusso G, 1998, P NATL ACAD SCI USA, V95, P8812, DOI 10.1073/pnas.95.15.8812	43	135	140	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35878	35886		10.1074/jbc.M704329200	http://dx.doi.org/10.1074/jbc.M704329200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17923484	hybrid			2022-12-27	WOS:000251458100049
J	Techau, ME; Valdez-Taubas, J; Popoff, JF; Francis, R; Seaman, M; Blackwell, JM				Techau, Michala Eichner; Valdez-Taubas, Javier; Popoff, Jean-Francois; Francis, Richard; Seaman, Matthew; Blackwell, Jenefer M.			Evolution of differences in transport function in Slc11a family members	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MACROPHAGE PROTEIN-1 NRAMP1; MESSENGER-RNA STABILITY; UBIQUITIN LIGASE RSP5; NATURAL-RESISTANCE; FORMERLY NRAMP1; SUBCELLULAR-LOCALIZATION; MEMBRANE-PROTEINS; IRON TRANSPORT; SUPEROXIDE-DISMUTASE; GENOMIC ORGANIZATION	Slc11a1 ( formerly Nramp1) is a proton/divalent cation transporter that regulates cation homeostasis in macrophages. Slc11a2 mediates divalent cation uptake via the gut and delivery into cells. The mode of action of the two transporters remains controversial. Heterologous expression in frog oocytes shows Slc11a2 is a symporter, whereas Slc11a1 is an antiporter fluxing divalent cations against the proton gradient. This explains why Slc11a2, but not Slc11a1, can complement EGTA sensitivity in smf1 Delta/smf2 Delta/smf3 Delta yeast. However, some studies of transport in mammalian cells suggest Slc11a1 is a symporter. We now demonstrate that Slc11a1, but not Slc11a2, complements a divalent cation stress phenotype in bsd2 Delta/ rer1 Delta yeast. This is the first description of a yeast complementation assay for Slc11a1 function. Given the prior demonstration in frog oocytes that Slc11a1 acts as an antiporter, the most plausible interpretation of the data is that Slc11a1 is rescuing bsd2 Delta/ rer1 Delta yeast by exporting divalent cations. Chimaeras define the N terminus, and a segment of the protein core preceding transmembrane domain 9 through transmembrane domain 12, as important in rescuing the divalent cation stress phenotype. EGTA sensitivity and divalent cation stress phenotypes in yeast expressing Slc11a orthologues show that symport activity is ancestral. Molecular changes that mediate rescue of the divalent cation stress phenotype post- date frogs and co- evolved with Slc11a1 orthologues that regulate divalent cation homeostasis in macrophages and resistance to infection in chickens and mammals.	Univ Cambridge, Addenbrookes Hosp, Sch Clin Med, Inst Med Res, Cambridge CB2 2XY, England; MRC, Mol Biol Lab, Cambridge CB2 0QH, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; MRC Laboratory Molecular Biology	Blackwell, JM (corresponding author), Univ Cambridge, Addenbrookes Hosp, Sch Clin Med, Inst Med Res, Hills Rd,Wellcome Trust MRC Bldg, Cambridge CB2 2XY, England.	jennie.blackwell@cimr.cam.ac.uk	Francis, Richard/K-2812-2019	Francis, Richard/0000-0003-1580-7934; Valdez Taubas, Javier/0000-0002-2806-9419	MRC [G117/452] Funding Source: UKRI; Medical Research Council [G117/452] Funding Source: Medline; Wellcome Trust [065642] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Agranoff D, 1999, J EXP MED, V190, P717, DOI 10.1084/jem.190.5.717; Atkinson PGP, 1998, FEBS LETT, V425, P239, DOI 10.1016/S0014-5793(98)00236-1; Atkinson PGP, 1999, IMMUNOLOGY, V96, P656; BARTON CH, 1994, J EXP MED, V179, P1683, DOI 10.1084/jem.179.5.1683; Blackwell JM, 2004, MOL B INT U, P53; BLACKWELL JM, 1995, MOL MED, V1, P194, DOI 10.1007/BF03401567; Blackwell JM, 2001, CELL MICROBIOL, V3, P773, DOI 10.1046/j.1462-5822.2001.00150.x; BLACKWELL JM, 2004, CELL MICROBIOL, P53; Brown DH, 1997, INFECT IMMUN, V65, P597, DOI 10.1128/IAI.65.2.597-603.1997; Canonne-Hergaux F, 2002, BLOOD, V100, P268, DOI 10.1182/blood.V100.1.268; Canonne-Hergaux F, 2001, BLOOD, V98, P3823, DOI 10.1182/blood.V98.13.3823; Canonne-Hergaux F, 1999, BLOOD, V93, P4406, DOI 10.1182/blood.V93.12.4406.412k21_4406_4417; CELLIER M, 1994, J EXP MED, V180, P1741, DOI 10.1084/jem.180.5.1741; Chung J, 2004, P NATL ACAD SCI USA, V101, P2700, DOI 10.1073/pnas.0306622101; Delaby C, 2005, BLOOD, V106, P3979, DOI 10.1182/blood-2005-06-2398; Delaby C, 2005, EXP CELL RES, V310, P43, DOI 10.1016/j.yexcr.2005.07.002; Dorschner MO, 1999, DNA CELL BIOL, V18, P573, DOI 10.1089/104454999315123; Ellis CD, 2004, J CELL BIOL, V166, P325, DOI 10.1083/jcb.200401157; Fleming MD, 1997, NAT GENET, V16, P383, DOI 10.1038/ng0897-383; Fleming MD, 1998, P NATL ACAD SCI USA, V95, P1148, DOI 10.1073/pnas.95.3.1148; Forbes JR, 2003, BLOOD, V102, P1884, DOI 10.1182/blood-2003-02-0425; Garrick MD, 2006, BIOL RES, V39, P79, DOI 10.4067/S0716-97602006000100009; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Goswami T, 2001, BIOCHEM J, V354, P511, DOI 10.1042/0264-6021:3540511; GRUENHEID S, 1995, GENOMICS, V25, P514, DOI 10.1016/0888-7543(95)80053-O; Gruenheid S, 1997, J EXP MED, V185, P717, DOI 10.1084/jem.185.4.717; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Hettema EH, 2004, EMBO J, V23, P1279, DOI 10.1038/sj.emboj.7600137; HU J, 1995, MAMM GENOME, V6, P809, DOI 10.1007/BF00539010; Hu JX, 1997, GENOME RES, V7, P693, DOI 10.1101/gr.7.7.693; Hu JX, 1996, DNA CELL BIOL, V15, P113, DOI 10.1089/dna.1996.15.113; Jabado N, 2000, J EXP MED, V192, P1237, DOI 10.1084/jem.192.9.1237; Ke SH, 1997, NUCLEIC ACIDS RES, V25, P3371, DOI 10.1093/nar/25.16.3371; Knutson MD, 2005, P NATL ACAD SCI USA, V102, P1324, DOI 10.1073/pnas.0409409102; Knutson MD, 2003, BLOOD, V102, P4191, DOI 10.1182/blood-2003-04-1250; Kramer J, 2003, ANIM GENET, V34, P339, DOI 10.1046/j.1365-2052.2003.01027.x; Kuhn DE, 1999, J LEUKOCYTE BIOL, V66, P113, DOI 10.1002/jlb.66.1.113; Kuhn DE, 2001, J LEUKOCYTE BIOL, V69, P43; Lafuse WP, 2000, BIOCHEM J, V351, P687, DOI 10.1042/0264-6021:3510687; Lafuse WP, 2002, CELL IMMUNOL, V215, P195, DOI 10.1016/S0008-8749(02)00026-6; Lam-Yuk-Tseung S, 2005, BIOCHEMISTRY-US, V44, P12149, DOI 10.1021/bi050911r; Lam-Yuk-Tseung S, 2003, BLOOD, V101, P3699, DOI 10.1182/blood-2002-07-2108; Liu XF, 1999, J BIOL CHEM, V274, P4863, DOI 10.1074/jbc.274.8.4863; LIU XF, 1992, J BIOL CHEM, V267, P18298; LIU XF, 1994, MOL CELL BIOL, V14, P7037, DOI 10.1128/MCB.14.11.7037; MacDiarmid CW, 2000, EMBO J, V19, P2845, DOI 10.1093/emboj/19.12.2845; Mercer JFB, 2001, TRENDS MOL MED, V7, P64, DOI 10.1016/S1471-4914(01)01920-7; Mete A, 2005, BLOOD CELL MOL DIS, V34, P151, DOI 10.1016/j.bcmd.2004.12.001; Miyabe S, 2000, BIOCHEM BIOPH RES CO, V276, P879, DOI 10.1006/bbrc.2000.3580; Mulero V, 2002, BIOCHEM J, V363, P89, DOI 10.1042/0264-6021:3630089; Olivier M, 1998, EUR J BIOCHEM, V251, P734, DOI 10.1046/j.1432-1327.1998.2510734.x; PENDLETON JW, 1993, P NATL ACAD SCI USA, V90, P6300, DOI 10.1073/pnas.90.13.6300; Pinner E, 1997, J BIOL CHEM, V272, P28933, DOI 10.1074/jbc.272.46.28933; Reddy JV, 2001, MOL BIOL CELL, V12, P3242, DOI 10.1091/mbc.12.10.3242; RODRIGUES V, 1995, EMBO J, V14, P3007, DOI 10.1002/j.1460-2075.1995.tb07303.x; Sato K, 2003, MOL BIOL CELL, V14, P3605, DOI 10.1091/mbc.E02-12-0777; Sato K, 2001, J CELL BIOL, V152, P935, DOI 10.1083/jcb.152.5.935; Searle S, 1998, J CELL SCI, V111, P2855; Sibthorpe D, 2004, DNA CELL BIOL, V23, P45, DOI 10.1089/104454904322745925; Stober CB, 2007, INFECT IMMUN, V75, P5059, DOI 10.1128/IAI.00153-07; Strausak D, 2001, BRAIN RES BULL, V55, P175, DOI 10.1016/S0361-9230(01)00454-3; Sullivan JA, 2007, MOL BIOL CELL, V18, P2429, DOI 10.1091/mbc.e07-01-0011; Tabuchi M, 1999, BIOCHEM J, V344, P211, DOI 10.1042/0264-6021:3440211; Tabuchi M, 2002, MOL BIOL CELL, V13, P4371, DOI 10.1091/mbc.E02-03-0165; Touret N, 2003, J BIOL CHEM, V278, P25548, DOI 10.1074/jbc.M212374200; VIDAL S, 1995, MAMM GENOME, V6, P224, DOI 10.1007/BF00352405; VIDAL SM, 1993, CELL, V73, P469, DOI 10.1016/0092-8674(93)90135-D; White JK, 2005, J LEUKOCYTE BIOL, V77, P311, DOI 10.1189/jlb.0904546; White JK, 2004, BIOCHEM J, V382, P811, DOI 10.1042/BJ20040808; Wyllie S, 2002, MICROBES INFECT, V4, P351, DOI 10.1016/S1286-4579(02)01548-4; Zwilling BS, 1999, INFECT IMMUN, V67, P1386, DOI 10.1128/IAI.67.3.1386-1392.1999	71	36	37	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35646	35656		10.1074/jbc.M707057200	http://dx.doi.org/10.1074/jbc.M707057200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17932044	hybrid			2022-12-27	WOS:000251458100025
J	Xiao, JM; Tian, XX; Jones, PP; Bolstad, J; Kong, HH; Wang, RW; Zhang, L; Duff, HJ; Gillis, AM; Fleischer, S; Kotlikoff, M; Copello, JA; Chen, SRW				Xiao, Jianmin; Tian, Xixi; Jones, Peter P.; Bolstad, Jeff; Kong, Huihui; Wang, Ruiwu; Zhang, Lin; Duff, Henry J.; Gillis, Anne M.; Fleischer, Sidney; Kotlikoff, Michael; Copello, Julio A.; Chen, S. R. Wayne			Removal of FKBP12.6 does not alter the conductance and activation of the cardiac ryanodine receptor or the susceptibility to stress-induced ventricular arrhythmias	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-RELEASE CHANNEL; FK506-BINDING PROTEIN FKBP12.6; FK-506 BINDING-PROTEIN; RETICULUM CA2+ CONTENT; SARCOPLASMIC-RETICULUM; SKELETAL-MUSCLE; IMMUNOSUPPRESSANT FK506; PHOSPHORYLATION SITE; CONTRACTION; MOUSE	The 12.6-kDa FK506-binding protein (FKBP12.6) is considered to be a key regulator of the cardiac ryanodine receptor (RyR2), but its precise role in RyR2 function is complex and controversial. In the present study we investigated the impact of FKBP12.6 removal on the properties of the RyR2 channel and the propensity for spontaneous Ca2(+) release and the occurrence of ventricular arrhythmias. Single channel recordings in lipid bilayers showed that FK506 treatment of recombinant RyR2 co-expressed with or without FKBP12.6 or native canine RyR2 did not induce long-lived subconductance states. [H-3] Ryanodine binding studies revealed that coexpression with or without FKBP12.6 or treatment with or without FK506 did not alter the sensitivity of RyR2 to activation by Ca2(+) or caffeine. Furthermore, single cell Ca2(+) imaging analyses demonstrated that HEK293 cells co-expressing RyR2 and FKBP12.6 or expressing RyR2 alone displayed the same propensity for spontaneous Ca2(+) release or store overload-induced Ca2(+) release (SOICR). FK506 increased the amplitude and decreased the frequency of SOICR in HEK293 cells expressing RyR2 with or without FKBP12.6, indicating that the action of FK506 on SOICR is independent of FKBP12.6. As with recombinant RyR2, the conductance and ligand-gating properties of single RyR2 channels from FKBP12.6-null mice were indistinguishable from those of single wild type channels. Moreover, FKBP12.6-null mice did not exhibit enhanced susceptibility to stress-induced ventricular arrhythmias, in contrast to previous reports. Collectively, our results demonstrate that the loss of FKBP12.6 has no significant effect on the conduction and activation of RyR2 or the propensity for spontaneous Ca2(+) release and stress-induced ventricular arrhythmias.	Univ Calgary, Libin Cardiovasc Inst Alberta, Dept Physiol & Biophys, Calgary, AB T2N 4N1, Canada; Vanderbilt Univ, Dept Sci Biol, Nashville, TN 37240 USA; Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY 14853 USA; So Illinois Univ, Sch Med, Dept Pharmacol, Springfield, IL 62794 USA	Libin Cardiovascular Institute Of Alberta; University of Calgary; Vanderbilt University; Cornell University; Southern Illinois University System; Southern Illinois University	Chen, SRW (corresponding author), Univ Calgary, Libin Cardiovasc Inst Alberta, Dept Physiol & Biophys, Calgary, AB T2N 4N1, Canada.	swchen@ucalgary.ca	Kong, Huihui/F-9024-2012; Jones, Peter P/G-2618-2013	Jones, Pete/0000-0001-7977-1737; Duff, Henry/0000-0001-9292-5411	NHLBI NIH HHS [R01 HL075210-04, R01HL75210, R01 HL075210] Funding Source: Medline; PHS HHS [R01TM078665] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075210] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Barg S, 1997, AM J PHYSIOL-CELL PH, V272, pC1726, DOI 10.1152/ajpcell.1997.272.5.C1726; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bultynck G, 2000, J PHYSIOL-LONDON, V525, P681, DOI 10.1111/j.1469-7793.2000.t01-1-00681.x; Cerrone M, 2005, CIRC RES, V96, pE77, DOI 10.1161/01.RES.0000169067.51055.72; Chelu MG, 2004, TRENDS CARDIOVAS MED, V14, P227, DOI 10.1016/j.tcm.2004.06.003; Copello JA, 2001, CELL CALCIUM, V30, P269, DOI 10.1054/ceca.2001.0235; duBell WH, 1997, J PHYSIOL-LONDON, V501, P509, DOI 10.1111/j.1469-7793.1997.509bm.x; Eisner DA, 1998, CARDIOVASC RES, V38, P589, DOI 10.1016/S0008-6363(98)00062-5; FABIATO A, 1979, J PHYSIOL-PARIS, V75, P463; George CH, 2007, J MOL CELL CARDIOL, V42, P34, DOI 10.1016/j.yjmcc.2006.08.115; Gomez AM, 2004, AM J PHYSIOL-HEART C, V287, pH1987, DOI 10.1152/ajpheart.00409.2004; Gomez AM, 1997, SCIENCE, V276, P800, DOI 10.1126/science.276.5313.800; GUO T, 2007, BIOPHYS J, V92, P2825; Hove-Madsen L, 2004, CIRCULATION, V110, P1358, DOI 10.1161/01.CIR.0000141296.59876.87; Hunt DJ, 2007, BIOCHEM J, V404, P431, DOI 10.1042/BJ20070135; Jiang DW, 2005, CIRC RES, V97, P1173, DOI 10.1161/01.RES.0000192146.85173.4b; Jiang MT, 2002, CIRC RES, V91, P1015, DOI 10.1161/01.RES.0000043663.08689.05; Kaftan E, 1996, CIRC RES, V78, P990, DOI 10.1161/01.RES.78.6.990; KANEKO N, 1994, DRUG DEVELOP RES, V33, P429, DOI 10.1002/ddr.430330406; Kumagai K, 2003, J CARDIOVASC ELECTR, V14, P880, DOI 10.1046/j.1540-8167.2003.03050.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAM E, 1995, J BIOL CHEM, V270, P26511, DOI 10.1074/jbc.270.44.26511; LEA JP, 1994, KIDNEY INT, V46, P647, DOI 10.1038/ki.1994.317; Li P, 2001, J GEN PHYSIOL, V118, P33, DOI 10.1085/jgp.118.1.33; Liu N, 2006, CIRC RES, V99, P292, DOI 10.1161/01.RES.0000235869.50747.e1; Loughrey CM, 2004, J PHYSIOL-LONDON, V556, P919, DOI 10.1113/jphysiol.2003.057166; Lukyanenko V, 1998, J PHYSIOL-LONDON, V507, P667, DOI 10.1111/j.1469-7793.1998.667bs.x; Lukyanenko V, 2001, BIOPHYS J, V81, P785, DOI 10.1016/S0006-3495(01)75741-4; Marx SO, 2000, CELL, V101, P365, DOI 10.1016/S0092-8674(00)80847-8; MAYRLEITNER M, 1994, CELL CALCIUM, V15, P99, DOI 10.1016/0143-4160(94)90048-5; McCall E, 1996, CIRC RES, V79, P1110, DOI 10.1161/01.RES.79.6.1110; Milting H, 2001, EUR J PHARMACOL, V430, P299, DOI 10.1016/S0014-2999(01)01387-5; Mohamed U, 2007, J CARDIOVASC ELECTR, V18, P791, DOI 10.1111/j.1540-8167.2007.00766.x; Ono K, 2000, CARDIOVASC RES, V48, P323, DOI 10.1016/S0008-6363(00)00191-7; Overend CL, 1998, J PHYSIOL-LONDON, V507, P759, DOI 10.1111/j.1469-7793.1998.759bs.x; Prestle J, 2001, CIRC RES, V88, P188; Shimoni Y, 2004, J PHYSIOL-LONDON, V555, P345, DOI 10.1113/jphysiol.2003.055590; Stange M, 2003, J BIOL CHEM, V278, P51693, DOI 10.1074/jbc.M310406200; Su Z, 2003, J PHARMACOL EXP THER, V304, P334, DOI 10.1124/jpet.102.041210; Ter Keurs HEDJ, 2007, PHYSIOL REV, V87, P457, DOI 10.1152/physrev.00011.2006; Timerman AP, 1996, J BIOL CHEM, V271, P20385, DOI 10.1074/jbc.271.34.20385; TIMERMAN AP, 1993, J BIOL CHEM, V268, P22992; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Vest JA, 2005, CIRCULATION, V111, P2025, DOI 10.1161/01.CIR.0000162461.67140.4C; Wehrens XHT, 2004, SCIENCE, V304, P292, DOI 10.1126/science.1094301; Wehrens XHT, 2003, CELL, V113, P829, DOI 10.1016/S0092-8674(03)00434-3; WITCHER DR, 1991, J BIOL CHEM, V266, P11144; Xiao BL, 2005, CIRC RES, V96, P847, DOI 10.1161/01.RES.0000163276.26083.e8; Xiao BL, 2004, CIRC RES, V94, P487, DOI 10.1161/01.RES.0000115945.89741.22; Xiao RP, 1997, J PHYSIOL-LONDON, V500, P343, DOI 10.1113/jphysiol.1997.sp022025; Xin HB, 2002, NATURE, V416, P334, DOI 10.1038/416334a; Yano M, 2000, CIRCULATION, V102, P2131, DOI 10.1161/01.CIR.102.17.2131; Yano M, 2006, NAT CLIN PRACT CARD, V3, P43, DOI 10.1038/ncpcardio0419; Yano M, 2003, CIRCULATION, V107, P477, DOI 10.1161/01.CIR.0000044917.74408.BE	54	78	84	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					34828	34838		10.1074/jbc.M707423200	http://dx.doi.org/10.1074/jbc.M707423200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17921453	Green Accepted, hybrid			2022-12-27	WOS:000251155200025
J	Kim, H; Han, JR; Park, J; Oh, M; James, SE; Chang, S; Lu, Q; Lee, KY; Ki, H; Song, WJ; Kim, K				Kim, Hangun; Han, Jeong-Ran; Park, Jaejun; Oh, Minsoo; James, Sarah E.; Chang, Sunghoe; Lu, Qun; Lee, Kwang Youl; Ki, Hyunkyoung; Song, Woo-Joo; Kim, Kwonseop			delta-catenin-induced dendritic morphogenesis - An essential role of p190RhoGEF interaction through Akt1-mediated phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPEAT PROTEIN/DELTA-CATENIN; RHO-FAMILY GTPASES; BINDING PROTEIN; SPINE MORPHOLOGY; P120 CATENIN; SYNAPTIC PLASTICITY; ACTIN CYTOSKELETON; EXCHANGE FACTOR; IDENTIFICATION; KINASE	delta-Catenin was first identified through its interaction with Presenilin-1 and has been implicated in the regulation of dendrogenesis and cognitive function. However, the molecular mechanisms by which delta-catenin promotes dendritic morphogenesis were unclear. In this study, we demonstrated delta-catenin interaction with p190RhoGEF, and the importance of Akt1-mediated phosphorylation at Thr-454 residue of delta-catenin in this interaction. We have also found that delta-catenin overexpression decreased the binding between p190RhoGEF and RhoA, and significantly lowered the levels of GTP-RhoA but not those of GTP-Rac1 and -Cdc42. delta-Catenin T454A, a defective form in p190RhoGEF binding, did not decrease the binding between p190RhoGEF and RhoA. delta-Catenin T454A also did not lower GTP-RhoA levels and failed to induce dendrite-like process formation in NIH 3T3 fibroblasts. Furthermore, delta-catenin T454A significantly reduced the length and number of mature mushroom shaped spines in primary hippocampal neurons. These results highlight signaling events in the regulation of delta-catenin-induced dendrogenesis and spine morphogenesis.	[Kim, Hangun; Han, Jeong-Ran; Oh, Minsoo; Lee, Kwang Youl; Ki, Hyunkyoung; Kim, Kwonseop] Chonnam Natl Univ, Coll Pharm, Kwangju 500757, South Korea; [Kim, Hangun; Han, Jeong-Ran; Oh, Minsoo; Lee, Kwang Youl; Ki, Hyunkyoung; Kim, Kwonseop] Chonnam Natl Univ, Res Inst Drug Dev, Kwangju 500757, South Korea; [Park, Jaejun; Chang, Sunghoe] Gwangju Inst Sci & Technol, Dept Life Sci, Kwangju 500712, South Korea; [James, Sarah E.; Lu, Qun] E Carolina Univ, Brody Sch Med, Dept Anat & Cell Biol, Greenville, NC 27834 USA; [Song, Woo-Joo] Inje Univ, Grad Program Neurosci, Taejon 614735, South Korea; [Song, Woo-Joo] Inje Univ, Inst Brain Sci & Technol, Taejon 614735, South Korea	Chonnam National University; Chonnam National University; Gwangju Institute of Science & Technology (GIST); University of North Carolina; East Carolina University; Inje University; Inje University	Kim, K (corresponding author), Chonnam Natl Univ, Coll Pharm, Bldg 1-1211,300 Yongbong Dong, Kwangju 500757, South Korea.	koskim@chonnam.ac.kr	Chang, Sunghoe/J-2784-2012	chang, sunghoe/0000-0002-3446-7288	NCI NIH HHS [R01 CA111891-02, CA11891, R01 CA111891-03, R01 CA111891-01A1, R01 CA111891] Funding Source: Medline; NIA NIH HHS [R03 AG026630, R03 AG026630-02, R03 AG026630-01, AG026630] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA111891] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG026630] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Abe K, 2004, NAT NEUROSCI, V7, P357, DOI 10.1038/nn1212; Anastasiadis PZ, 2000, NAT CELL BIOL, V2, P637, DOI 10.1038/35023588; Bamji SX, 2003, NEURON, V40, P719, DOI 10.1016/S0896-6273(03)00718-9; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Bernards A, 2004, TRENDS CELL BIOL, V14, P377, DOI 10.1016/j.tcb.2004.05.003; BONDESON J, 1990, BIOCHIM BIOPHYS ACTA, V1026, P186, DOI 10.1016/0005-2736(90)90063-T; Brouns MR, 2001, NAT CELL BIOL, V3, P361, DOI 10.1038/35070042; Canete-Soler R, 2001, J BIOL CHEM, V276, P32046, DOI 10.1074/jbc.M104104200; Carlisle HJ, 2005, TRENDS NEUROSCI, V28, P182, DOI 10.1016/j.tins.2005.01.008; Chang S, 2001, NAT NEUROSCI, V4, P787, DOI 10.1038/90489; Deguchi M, 2000, J BIOL CHEM, V275, P29875, DOI 10.1074/jbc.M005384200; Elia LP, 2006, NEURON, V51, P43, DOI 10.1016/j.neuron.2006.05.018; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Fiala JC, 2002, BRAIN RES REV, V39, P29, DOI 10.1016/S0165-0173(02)00158-3; Franke TF, 1997, CELL, V88, P435, DOI 10.1016/S0092-8674(00)81883-8; Fujita T, 2004, BIOCHEM J, V382, P717, DOI 10.1042/BJ20040141; Gebbink MFBG, 1997, J CELL BIOL, V137, P1603, DOI 10.1083/jcb.137.7.1603; Goswami A, 2005, MOL CELL, V20, P33, DOI 10.1016/j.molcel.2005.08.016; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; Henle F, 2006, J BIOL CHEM, V281, P24955, DOI 10.1074/jbc.M604114200; Hoffman GR, 2000, CELL, V100, P345, DOI 10.1016/S0092-8674(00)80670-4; Ide N, 1999, BIOCHEM BIOPH RES CO, V256, P456, DOI 10.1006/bbrc.1999.0364; Israely I, 2004, CURR BIOL, V14, P1657, DOI 10.1016/j.cub.2004.08.065; Izawa I, 2002, J BIOL CHEM, V277, P5345, DOI 10.1074/jbc.M110052200; Jiang TY, 2003, J BIOL CHEM, V278, P15789, DOI 10.1074/jbc.M212525200; Jones SB, 2002, NEUROSCIENCE, V115, P1009, DOI 10.1016/S0306-4522(02)00532-8; Kim H, 2005, J BIOL CHEM, V280, P22462, DOI 10.1074/jbc.M502769200; Kim K, 2002, EXP CELL RES, V275, P171, DOI 10.1006/excr.2002.5503; Kovacina KS, 2003, J BIOL CHEM, V278, P10189, DOI 10.1074/jbc.M210837200; Kumar V, 2005, J NEUROSCI, V25, P11288, DOI 10.1523/JNEUROSCI.2284-05.2005; Laura RP, 2002, J BIOL CHEM, V277, P12906, DOI 10.1074/jbc.M200818200; Li WJ, 2005, DEV DYNAM, V234, P512, DOI 10.1002/dvdy.20496; Lu Q, 2002, J NEUROSCI RES, V67, P618, DOI 10.1002/jnr.10151; Lu Q, 1999, J CELL BIOL, V144, P519, DOI 10.1083/jcb.144.3.519; Mackie S, 2005, FEBS J, V272, P4202, DOI 10.1111/j.1742-4658.2005.04832.x; Mackintosh C, 2004, BIOCHEM J, V381, P329, DOI 10.1042/BJ20031332; Martinez MC, 2003, J CELL BIOL, V162, P99, DOI 10.1083/jcb.200211025; Medina M, 2000, GENOMICS, V63, P157, DOI 10.1006/geno.1999.6090; Meng YH, 2003, REV NEUROSCIENCE, V14, P233; Meyer D, 1999, J BIOL CHEM, V274, P35113, DOI 10.1074/jbc.274.49.35113; Noren NK, 2000, J CELL BIOL, V150, P567, DOI 10.1083/jcb.150.3.567; Okamura K, 2004, J CELL BIOL, V167, P961, DOI 10.1083/jcb.200406030; Paffenholz R, 1997, DIFFERENTIATION, V61, P293, DOI 10.1046/j.1432-0436.1997.6150293.x; Perez-Moreno M, 2006, CELL, V124, P631, DOI 10.1016/j.cell.2005.11.043; Powell DW, 2002, J BIOL CHEM, V277, P21639, DOI 10.1074/jbc.M203167200; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Reynolds AB, 1996, EXP CELL RES, V225, P328, DOI 10.1006/excr.1996.0183; Rodova M, 2004, MOL CELL BIOL, V24, P7188, DOI 10.1128/MCB.24.16.7188-7196.2004; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Schubert V, 2006, J CELL BIOL, V172, P453, DOI 10.1083/jcb.200506136; Silverman JB, 2007, J NEUROSCI, V27, P8505, DOI 10.1523/JNEUROSCI.1395-07.2007; Tanahashi H, 1999, NEUROREPORT, V10, P563, DOI 10.1097/00001756-199902250-00022; Tashiro A, 2000, CEREB CORTEX, V10, P927, DOI 10.1093/cercor/10.10.927; Threadgill R, 1997, NEURON, V19, P625, DOI 10.1016/S0896-6273(00)80376-1; Tigyi G, 1996, J NEUROCHEM, V66, P537; Togashi H, 2002, NEURON, V35, P77, DOI 10.1016/S0896-6273(02)00748-1; van Horck FPG, 2001, J BIOL CHEM, V276, P4948, DOI 10.1074/jbc.M003839200; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wang QH, 2003, NEURON, V38, P915, DOI 10.1016/S0896-6273(03)00356-8; Zhai JB, 2003, J BIOL CHEM, V278, P24865, DOI 10.1074/jbc.M302381200; Zhai JB, 2001, J BIOL CHEM, V276, P41318, DOI 10.1074/jbc.M107709200; Zhou JH, 1997, NEUROREPORT, V8, P2085, DOI 10.1097/00001756-199705260-00054; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	64	56	64	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					977	987		10.1074/jbc.M707158200	http://dx.doi.org/10.1074/jbc.M707158200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	17993462	hybrid, Green Submitted, Green Accepted			2022-12-27	WOS:000252128100037
J	Fuller, MD; Thompson, CH; Zhang, ZR; Freeman, CS; Schay, E; Szakacs, G; Bakos, E; Sarkadi, B; McMaster, D; French, RJ; Pohl, J; Kubanek, J; McCarty, NA				Fuller, Matthew D.; Thompson, Christopher H.; Zhang, Zhi-Ren; Freeman, Cody S.; Schay, Eszter; Szakacs, Gergely; Bakos, Eva; Sarkadi, Balazs; McMaster, Denis; French, Robert J.; Pohl, Jan; Kubanek, Julia; McCarty, Nael A.			State-dependent inhibition of cystic fibrosis transmembrane conductance regulator chloride channels by a novel peptide toxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTESTINAL FLUID SECRETION; HIGH-AFFINITY; ATP HYDROLYSIS; SCORPION-VENOM; CL-CHANNEL; ORGANIC-ANIONS; CFTR; CHLOROTOXIN; POTASSIUM; BINDING	Peptide toxins from animal venom have been used for many years for the identification and study of cation-permeable ion channels. However, no peptide toxins have been identified that interact with known anion-selective channels, including cystic fibrosis transmembrane conductance regulator (CFTR), the protein defective in cystic fibrosis and a member of the ABC transporter superfamily. Here, we describe the identification and initial characterization of a novel 3.7-kDa peptide toxin, GaTx1, which is a potent and reversible inhibitor of CFTR, acting from the cytoplasmic side of the membrane. Thus, GaTx1 is the first peptide toxin identified that inhibits a chloride channel of known molecular identity. GaTx1 exhibited high specificity, showing no effect on a panel of nine transport proteins, including Cl- and K+ channels, and ABC transporters. GaTx1-mediated inhibition of CFTR channel activity is strongly state-dependent; both potency and efficacy are reduced under conditions of elevated [ATP], suggesting that GaTx1 may function as a non-competitive inhibitor of ATP-dependent channel gating. This tool will allow the application of new quantitative approaches to study CFTR structure and function, particularly with respect to the conformational changes that underlie transitions between open and closed states.	[Fuller, Matthew D.; French, Robert J.] Emory Univ, Program Mol & Syst Pharmacol, Atlanta, GA 30322 USA; [Fuller, Matthew D.; Thompson, Christopher H.; Zhang, Zhi-Ren; Freeman, Cody S.; Kubanek, Julia; McCarty, Nael A.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Schay, Eszter; Szakacs, Gergely; Bakos, Eva] Hungarian Acad Sci, Inst Enzymol, H-1113 Budapest, Hungary; [Szakacs, Gergely; Sarkadi, Balazs] Hungarian Acad Sci, Natl Med Ctr, Inst Haematol & Immunol, H-1113 Budapest, Hungary; [French, Robert J.] Univ Calgary, Peptide Synth Core Facil, Calgary, AB T2N 4N1, Canada; [French, Robert J.] Univ Calgary, Dept Physiol & Biophys, Calgary, AB T2N 4N1, Canada; [Pohl, Jan] Emory Univ, Microchem & Proteom Facil, Atlanta, GA 30322 USA; [Kubanek, Julia] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA	Emory University; University System of Georgia; Georgia Institute of Technology; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Hungarian Academy of Sciences; University of Calgary; University of Calgary; Emory University; University System of Georgia; Georgia Institute of Technology	McCarty, NA (corresponding author), Emory Univ, Program Mol & Syst Pharmacol, Atlanta, GA 30322 USA.	mccarty@gatech.edu	Sarkadi, Balazs/I-5024-2013; Szakacs, Gergely/A-2580-2009	Szakacs, Gergely/0000-0002-9311-7827; Kubanek, Julia/0000-0003-4482-1831				Ai-Awqati Q, 2002, J CLIN INVEST, V110, P1599, DOI 10.1172/JCI200217301; Al-Nakkash L, 1999, PFLUG ARCH EUR J PHY, V437, P553, DOI 10.1007/s004240050817; ANDERSON MP, 1991, CELL, V67, P775, DOI 10.1016/0092-8674(91)90072-7; Bakos E, 1998, J BIOL CHEM, V273, P32167, DOI 10.1074/jbc.273.48.32167; Bakos E, 2000, MOL PHARMACOL, V57, P760, DOI 10.1124/mol.57.4.760; BAUKROWITZ T, 1994, NEURON, V12, P473, DOI 10.1016/0896-6273(94)90206-2; BECKER S, 1992, BIOCHEMISTRY-US, V31, P8229, DOI 10.1021/bi00150a016; BECQ F, 1994, P NATL ACAD SCI USA, V91, P9160, DOI 10.1073/pnas.91.19.9160; Berger W, 1997, INT J CANCER, V71, P108, DOI 10.1002/(SICI)1097-0215(19970328)71:1<108::AID-IJC18>3.0.CO;2-E; Bodo A, 2003, J BIOL CHEM, V278, P23529, DOI 10.1074/jbc.M303515200; CARSON MR, 1993, AM J PHYSIOL, V265, pL27, DOI 10.1152/ajplung.1993.265.1.L27; CASTLE NA, 1989, TRENDS NEUROSCI, V12, P59, DOI 10.1016/0166-2236(89)90137-9; Chang NS, 1998, BIOCHEMISTRY-US, V37, P4407, DOI 10.1021/bi9724927; Csanady L, 2000, J GEN PHYSIOL, V116, P477, DOI 10.1085/jgp.116.3.477; CUI G, 2006, PATCH CLAMP ANAL ADV, P353; Dalton S, 2003, GLIA, V42, P325, DOI 10.1002/glia.10212; Dassa E., 2003, ABC PROTEINS BACTERI, P3; DEBIN JA, 1993, AM J PHYSIOL, V264, pC361, DOI 10.1152/ajpcell.1993.264.2.C361; DEBIN JA, 1991, TOXICON, V29, P1403, DOI 10.1016/0041-0101(91)90128-E; Deshane J, 2003, J BIOL CHEM, V278, P4135, DOI 10.1074/jbc.M205662200; Devuyst O, 2002, AM J PHYSIOL-RENAL, V283, pF1176, DOI 10.1152/ajprenal.00184.2002; Esteve E, 2005, J BIOL CHEM, V280, P12833, DOI 10.1074/jbc.M412521200; French R J, 1999, Methods Enzymol, V294, P575; Froy O, 1999, J MOL EVOL, V48, P187, DOI 10.1007/PL00006457; Fuller MD, 2005, BIOPHYS J, V89, P3960, DOI 10.1529/biophysj.105.060731; Fuller MD, 2004, AM J PHYSIOL-CELL PH, V287, pC1328, DOI 10.1152/ajpcell.00162.2004; Gadsby David C., 1999, Physiological Reviews, V79, pS77; Gadsby DC, 2006, NATURE, V440, P477, DOI 10.1038/nature04712; GADSBY DC, 1997, TRENDS BIOCHEM SCI, V19, P512; GOLDSTEIN SAN, 1992, BIOPHYS J, V62, P5, DOI 10.1016/S0006-3495(92)81760-5; Gross A, 1996, NEURON, V16, P399, DOI 10.1016/S0896-6273(00)80057-4; Guggino WB, 2006, NAT REV MOL CELL BIO, V7, P426, DOI 10.1038/nrm1949; Harrington MA, 1999, J BIOL CHEM, V274, P27536, DOI 10.1074/jbc.274.39.27536; Haug K, 2003, NAT GENET, V33, P527, DOI 10.1038/ng1121; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; Hui KY, 2003, J GEN PHYSIOL, V122, P63, DOI 10.1085/jgp.200308842; HWANG TC, 1994, P NATL ACAD SCI USA, V91, P4698, DOI 10.1073/pnas.91.11.4698; Ikuma M, 2000, P NATL ACAD SCI USA, V97, P8675, DOI 10.1073/pnas.140220597; Jentsch TJ, 2002, PHYSIOL REV, V82, P503, DOI 10.1152/physrev.00029.2001; LEWIS RJ, 2003, NAT REV DRUG DISCOV, V2, P1; LIPPENS G, 1995, BIOCHEMISTRY-US, V34, P13, DOI 10.1021/bi00001a003; LOMIZE AL, 1991, BIOORG KHIM+, V17, P1613; Lyons SA, 2002, GLIA, V39, P162, DOI 10.1002/glia.10083; Ma TH, 2002, J CLIN INVEST, V110, P1651, DOI 10.1172/JCI200216112; MACKINNON R, 1990, NEURON, V5, P767, DOI 10.1016/0896-6273(90)90335-D; Maertens C, 2000, BRIT J PHARMACOL, V129, P791, DOI 10.1038/sj.bjp.0703102; Muanprasat C, 2004, J GEN PHYSIOL, V124, P125, DOI 10.1085/jgp.200409059; PARK CS, 1991, P NATL ACAD SCI USA, V88, P2046, DOI 10.1073/pnas.88.6.2046; Possani LD, 2000, BIOCHIMIE, V82, P861, DOI 10.1016/S0300-9084(00)01167-6; Posson DJ, 2005, NATURE, V436, P848, DOI 10.1038/nature03819; RIORDAN JR, 1989, SCIENCE, V245, P1066; Routaboul C, 2007, J PHARMACOL EXP THER, V322, P1023, DOI 10.1124/jpet.107.123307; Schultz BD, 1999, PHYSL REV S, V79, P109; SMIT LS, 1993, P NATL ACAD SCI USA, V90, P9963, DOI 10.1073/pnas.90.21.9963; Sonawane ND, 2007, GASTROENTEROLOGY, V132, P1234, DOI 10.1053/j.gastro.2007.02.018; Soroceanu L, 1999, J NEUROSCI, V19, P5942, DOI 10.1523/JNEUROSCI.19-14-05942.1999; STAMPE P, 1994, BIOCHEMISTRY-US, V33, P443, DOI 10.1021/bi00168a008; Taddei A, 2004, FEBS LETT, V558, P52, DOI 10.1016/S0014-5793(04)00011-0; Thompson CH, 2005, J MEMBRANE BIOL, V208, P65, DOI 10.1007/s00232-005-0818-8; TRAVIS SM, 1993, J BIOL CHEM, V268, P15336; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; Wang F, 1998, J GEN PHYSIOL, V111, P477, DOI 10.1085/jgp.111.3.477; Zhang ZR, 2004, J MEMBRANE BIOL, V201, P139, DOI 10.1007/s00232-004-0712-9; Zhang ZR, 2004, J MEMBRANE BIOL, V199, P15, DOI 10.1007/s00232-004-0672-0; Zhou Z, 2005, J PHYSIOL-LONDON, V569, P447, DOI 10.1113/jphysiol.2005.095083; Zou XQ, 2001, BIOCHEMISTRY-US, V40, P5579, DOI 10.1021/bi010133c	67	35	39	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37545	37555		10.1074/jbc.M708079200	http://dx.doi.org/10.1074/jbc.M708079200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17951250	hybrid			2022-12-27	WOS:000251833600030
J	Konrad, S; Engling, L; Schmidt, RE; Gessner, JE				Konrad, Stephanie; Engling, Linda; Schmidt, Reinhold E.; Gessner, J. Engelbert			Characterization of the murine IgG Fc receptor III and IIB gene promoters - A single two-nucleotide difference determines their inverse responsiveness to C5a	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA RECEPTORS; ARTHUS REACTION; COMPLEMENT; AUTOIMMUNITY; NEUTROPHILS; TRANSCRIPTION; INHIBITION; ACTIVATION; STAT3	The two low affinity IgG Fc receptors (Fc gamma R), Fc gamma RIII and Fc gamma RIIB, are coexpressed on myeloid effector cells, and their genes, as reported here, are positively and negatively regulated by both C5a and interferon-gamma through different signaling mechanisms. Two 48- and 43- bp sequences (C5a- inductive region (CIR) and C5a-suppressive region (CSR)) in the Fc gamma RIII and Fc RIIB 5'- flanking regions that are necessary for C5a induction and suppression, respectively, are defined. Sequence analysis of the CIR and CSR, which localize apart from the interferon gamma- responsive regions in each gene, revealed the presence of a novel element that differs by two nucleotides between Fc gamma RIII and Fc gamma RIIB. Mutation analysis of the CIR and CSR showed that this small difference determines inverse responsiveness in an Fc gamma R gene context-dependent manner. Our study suggests that C5a uses similar DNA motifs (defined as GTGAXXTCCA) in both pathways of transcriptional induction and suppression of Fc gamma RIII and Fc gamma RIIB.	[Konrad, Stephanie; Engling, Linda; Schmidt, Reinhold E.; Gessner, J. Engelbert] Hannover Med Sch, Dept Clin Immunol & Rheumatol, D-30625 Hannover, Germany	Hannover Medical School	Gessner, JE (corresponding author), Hannover Med Sch, Dept Clin Immunol & Rheumatol, Carl-Neuberg-Str 1, D-30625 Hannover, Germany.	gessner.johannes@mh-hannover.de						Atkinson JP, 2006, J CLIN INVEST, V116, P304, DOI 10.1172/JCI27759; Baumann U, 2000, J IMMUNOL, V164, P1065, DOI 10.4049/jimmunol.164.2.1065; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; FEINMAN R, 1994, EMBO J, V13, P3852, DOI 10.1002/j.1460-2075.1994.tb06696.x; Fitch JCK, 1999, CIRCULATION, V100, P2499, DOI 10.1161/01.CIR.100.25.2499; Girardi G, 2003, J CLIN INVEST, V112, P1644, DOI 10.1172/JCI200318817; Godau J, 2004, J IMMUNOL, V173, P3437, DOI 10.4049/jimmunol.173.5.3437; Ji H, 2002, IMMUNITY, V16, P157, DOI 10.1016/S1074-7613(02)00275-3; Kumar V, 2006, J CLIN INVEST, V116, P512, DOI 10.1172/JCI25536; Kuroki M, 1999, BIOCHEM J, V341, P691, DOI 10.1042/0264-6021:3410691; la Sala A, 2005, J IMMUNOL, V175, P2994, DOI 10.4049/jimmunol.175.5.2994; Lo RKH, 2003, J BIOL CHEM, V278, P52154, DOI 10.1074/jbc.M307299200; MONK PN, 2007, BR J PHARM; Nimmerjahn F, 2006, IMMUNITY, V24, P19, DOI 10.1016/j.immuni.2005.11.010; Perianayagam MC, 2006, EUR J CLIN INVEST, V36, P353, DOI 10.1111/j.1365-2362.2006.01637.x; Radeke HH, 2002, J BIOL CHEM, V277, P27535, DOI 10.1074/jbc.M200419200; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; Ravetch JV, 2002, J CLIN INVEST, V110, P1759, DOI 10.1172/JCI200217349; Schmidt RE, 2005, IMMUNOL LETT, V100, P56, DOI 10.1016/j.imlet.2005.06.022; Shushakova N, 2002, J CLIN INVEST, V110, P1823, DOI 10.1172/JCI200216577; Skokowa J, 2005, J IMMUNOL, V174, P3041, DOI 10.4049/jimmunol.174.5.3041; STEVENS JH, 1986, J CLIN INVEST, V77, P1812, DOI 10.1172/JCI112506; Takai T, 2002, NAT REV IMMUNOL, V2, P580, DOI 10.1038/nri856; Vakeva AP, 1998, CIRCULATION, V97, P2259, DOI 10.1161/01.CIR.97.22.2259; Volanakis J. E., 1998, HUMAN COMPLEMENT SYS; WEINSHANK RL, 1988, J EXP MED, V167, P1909, DOI 10.1084/jem.167.6.1909; Xiu Y, 2002, J IMMUNOL, V169, P4340, DOI 10.4049/jimmunol.169.8.4340	27	16	16	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37906	37912		10.1074/jbc.M707937200	http://dx.doi.org/10.1074/jbc.M707937200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17956862	hybrid			2022-12-27	WOS:000251833600066
J	Vavilin, D; Yao, D; Vermaas, W				Vavilin, Dmitrii; Yao, Danny; Vermaas, Wim			Small cab-like proteins retard degradation of photosystem II-associated chlorophyll in Synechocystis sp PCC 6803 - Kinetic analysis of pigment labeling with N-15 AND C-13	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-INDUCIBLE POLYPEPTIDES; DNA MICROARRAY ANALYSIS; A/B-BINDING-PROTEINS; SP STRAIN PCC-6803; GENE-EXPRESSION; OXYGENIC PHOTOSYNTHESIS; OSMOTIC-STRESS; PCC 6803; CYANOBACTERIA; PCC6803	Isotope ((NaNO3)-N-15, ((NH4)-N-15) SO4 or [C-13] glucose) labeling was used to analyze chlorophyll synthesis and degradation rates in a set of Synechocystis mutants that lacked single or multiple small Cab-like proteins (SCPs), as well as photosystem I or II. Whenall five small Cab-like proteins were inactivated in the wild-type background, chlorophyll stability was not affected unless the scpABCDE -strain was grown at a moderately high light intensity of 100 -300 mu mol photons m(-2) s(-1). However, the half-life time of chlorophyll was 5-fold shorter in the photosystem I-less/ scpABCDE -strain than in the photosystem I-less strain even when grown at low light intensity (similar to 3 mu mol photons m(-2) s(-1)) (32 +/- 5 and 161 +/- 25 h, respectively). In other photosystem I-less mutants that lacked one to four of the scp genes the chlorophyll lifetime was in between these two values, with the chlorophyll lifetime generally decreasing with an increasing number of inactivated scps. In contrast, the chlorophyll biosynthesis rate was only marginally affected by inactivation of scps except when all five scp genes were deleted. Small Cab-like protein deficiency did not significantly affect photoinhibition or turnover of photosystem II-associated beta-carotene. It is concluded that SCPs do not alter the stability of functional photosystem II complexes but retard the degradation of photosystem II-associated chlorophyll, consistent with the proposed involvement of SCPs in photosystem II re-assembly or/ and repair processes by temporarily binding chlorophyll while photosystem II protein components are being replaced.	[Vavilin, Dmitrii; Yao, Danny; Vermaas, Wim] Arizona State Univ, Sch Life Sci, Ctr Bioenergy & Photosynth, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe	Vavilin, D (corresponding author), Arizona State Univ, Sch Life Sci, Ctr Bioenergy & Photosynth, Box 874501, Tempe, AZ 85287 USA.	wim@asu.edu						Allakhverdiev SI, 2002, PLANT PHYSIOL, V130, P1443, DOI 10.1104/pp.011114; Baena-Gonzalez E, 2002, PHILOS T R SOC B, V357, P1451, DOI 10.1098/rstb.2002.1141; Bhaya D, 2002, FEMS MICROBIOL LETT, V215, P209, DOI 10.1111/j.1574-6968.2002.tb11393.x; Bricker TM, 1998, BBA-BIOENERGETICS, V1409, P50, DOI 10.1016/S0005-2728(98)00148-0; Bumba L, 2005, BBA-BIOENERGETICS, V1708, P1, DOI 10.1016/j.bbabio.2005.02.005; Clokie MRJ, 2006, ENVIRON MICROBIOL, V8, P2074, DOI 10.1111/j.1462-2920.2006.01171.x; Depka B, 1998, FEBS LETT, V424, P267, DOI 10.1016/S0014-5793(98)00188-4; Funk C, 1999, BIOCHEMISTRY-US, V38, P9397, DOI 10.1021/bi990545+; Grossman AR, 1995, ANNU REV GENET, V29, P231, DOI 10.1146/annurev.ge.29.120195.001311; Havaux M, 2003, BBA-BIOENERGETICS, V1557, P21, DOI 10.1016/S0005-2728(02)00391-2; He QF, 2001, J BIOL CHEM, V276, P306, DOI 10.1074/jbc.M008686200; Heddad M, 2002, COMP FUNCT GENOM, V3, P504, DOI 10.1002/cfg.221; Hihara Y, 2003, J BACTERIOL, V185, P1719, DOI 10.1128/JB.185.5.1719-1725.2003; Hihara Y, 2001, PLANT CELL, V13, P793, DOI 10.1105/tpc.13.4.793; Hu Q, 2000, APPL ENVIRON MICROB, V66, P133, DOI 10.1128/AEM.66.1.133-139.2000; JANSSON S, 1994, BBA-BIOENERGETICS, V1184, P1, DOI 10.1016/0005-2728(94)90148-1; Kashino Y, 2002, BIOCHEMISTRY-US, V41, P8004, DOI 10.1021/bi026012+; Komenda J, 2004, J BIOL CHEM, V279, P48620, DOI 10.1074/jbc.M405725200; Komenda J, 2000, PLANT MOL BIOL, V42, P635, DOI 10.1023/A:1006305308196; Li H, 2004, J BACTERIOL, V186, P3331, DOI 10.1128/JB.186.11.3331-3345.2004; Li ZL, 2000, BBA-BIOENERGETICS, V1460, P384, DOI 10.1016/S0005-2728(00)00207-3; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; Mikami K, 2002, MOL MICROBIOL, V46, P905, DOI 10.1046/j.1365-2958.2002.03202.x; Nishiyama Y, 2005, PHOTOSYNTH RES, V84, P1, DOI 10.1007/s11120-004-6434-0; Ohta H, 2005, PHOTOSYNTH RES, V84, P225, DOI 10.1007/s11120-004-7761-x; Osanai T, 2006, DNA RES, V13, P185, DOI 10.1093/dnares/dsl010; Paithoonrangsarid K, 2004, J BIOL CHEM, V279, P53078, DOI 10.1074/jbc.M410162200; Promnares K, 2006, J BIOL CHEM, V281, P32705, DOI 10.1074/jbc.M606360200; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Rocap G, 2003, NATURE, V424, P1042, DOI 10.1038/nature01947; Shumskaya MA, 2005, J BIOL CHEM, V280, P21531, DOI 10.1074/jbc.m412174200; Sun J, 1998, METHOD ENZYMOL, V297, P124; Szabo I, 2005, EMBO REP, V6, P629, DOI 10.1038/sj.embor.7400460; TANG XS, 1994, BIOCHEMISTRY-US, V33, P4594, DOI 10.1021/bi00181a021; Tomo T, 2005, PHOTOSYNTH RES, V84, P77, DOI 10.1007/s11120-005-1302-0; Tu CJ, 2004, J BACTERIOL, V186, P3889, DOI 10.1128/JB.186.12.3889-3902.2004; Vavilin D, 2005, BBA-BIOENERGETICS, V1708, P91, DOI 10.1016/j.bbabio.2004.12.011; VAVILIN D, 2007, IN PRESS PHOTOSYNTHE; VAVILIN D, 2005, PHOTOSYNTHESIS FUNDA, V1, P896; Vavilin D, 2007, BBA-BIOENERGETICS, V1767, P920, DOI 10.1016/j.bbabio.2007.03.010; Xu H, 2004, J BIOL CHEM, V279, P27971, DOI 10.1074/jbc.M403307200; Xu H, 2002, PLANT MOL BIOL, V49, P149, DOI 10.1023/A:1014900806905; Yao D, 2007, J BIOL CHEM, V282, P267, DOI 10.1074/jbc.M605463200	43	51	51	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37660	37668		10.1074/jbc.M707133200	http://dx.doi.org/10.1074/jbc.M707133200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17971445	hybrid			2022-12-27	WOS:000251833600042
J	Ong, PC; McGowan, S; Pearce, MC; Irving, JA; Kan, WT; Grigoryev, SA; Turk, B; Silverman, GA; Brix, K; Bottomley, SP; Whisstock, JC; Pike, RN				Ong, Poh Chee; McGowan, Sheena; Pearce, Mary C.; Irving, James A.; Kan, Wan-Ting; Grigoryev, Sergei A.; Turk, Boris; Silverman, Gary A.; Brix, Klaudia; Bottomley, Stephen P.; Whisstock, James C.; Pike, Robert N.			DNA accelerates the inhibition of human cathepsin V by serpins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE PROTEINASES; ENDOSOMAL PROTEOLYSIS; CHROMATIN-STRUCTURE; CRYSTAL-STRUCTURE; PAPAIN; MENT; HETEROCHROMATIN; CANCER; LOCALIZATION; PROTEASES	A balance between proteolytic activity and protease inhibition is crucial to the appropriate function of many biological processes. There is mounting evidence for the presence of both papain-like cysteine proteases and serpins with a corresponding inhibitory activity in the nucleus. Well characterized examples of cofactors fine tuning serpin activity in the extracellular milieu are known, but such modulation has not been studied for protease-serpin interactions within the cell. Accordingly, we present an investigation into the effect of a DNA-rich environment on the interaction between model serpins ( MENT and SCCA-1), cysteine proteases ( human cathepsin V and human cathepsin L), and cystatin A. DNA was indeed found to accelerate the rate at which MENT inhibited cathepsin V, a human orthologue of mammalian cathepsin L, up to 50-fold, but unexpectedly this effect was primarily effected via the protease and secondarily by the recruitment of the DNA as a "template" onto which cathepsin V and MENT are bound. Notably, the protease-mediated effect was found to correspond both with an altered substrate turnover and a conformational change within the protease. Consistent with this, cystatin inhibition, which relies on occlusion of the active site rather than the substrate-like behavior of serpins, was unaltered by DNA. This represents the first example of modulation of serpin inhibition of cysteine proteases by a cofactor and reveals a mechanism for differential regulation of cathepsin proteolytic activity in a DNA-rich environment.	[Ong, Poh Chee; McGowan, Sheena; Pearce, Mary C.; Irving, James A.; Kan, Wan-Ting; Bottomley, Stephen P.; Whisstock, James C.; Pike, Robert N.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Irving, James A.] Univ Oxford, Div Struct Biol, Wellcome Ctr Human Genet, Oxford OX3 7BN, England; [Grigoryev, Sergei A.] Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA; [Turk, Boris] Jozef Stefan Inst, Dept Biochem & Mol Biol, SI-1000 Ljubljana, Slovenia; [Silverman, Gary A.] Univ Pittsburgh, Sch Med, Newborn Med Program, Pittsburgh, PA 15261 USA; [Brix, Klaudia] Jacobs Univ Bremen, Sch Sci & Engn, D-28759 Bremen, Germany	Monash University; University of Oxford; Wellcome Centre for Human Genetics; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Jacobs University	Pike, RN (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia.	rob.pike@med.monash.edu.au	Silverman, Gary/AAJ-1269-2020; Brix, Klaudia/F-5072-2013; Irving, James A/I-8467-2015; Irving, James/P-3860-2019; McGowan, Sheena/C-4797-2014	Brix, Klaudia/0000-0002-4476-0357; Irving, James/0000-0003-3204-6356; Pike, Robert/0000-0002-2083-0269; Turk, Boris/0000-0002-9007-5764; McGowan, Sheena/0000-0001-6863-1106; Whisstock, James/0000-0003-4200-5611	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059118] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-59118] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baici A, 2006, BIOL CHEM, V387, P1017, DOI 10.1515/BC.2006.125; BARRETT AJ, 1981, METHOD ENZYMOL, V80, P535; Bird CH, 2001, MOL CELL BIOL, V21, P5396, DOI 10.1128/MCB.21.16.5396-5407.2001; Brix K, 2001, BIOL CHEM, V382, P717, DOI 10.1515/BC.2001.087; Bromme D, 1999, BIOCHEMISTRY-US, V38, P2377, DOI 10.1021/bi982175f; Bulynko YA, 2006, MOL CELL BIOL, V26, P4172, DOI 10.1128/MCB.00135-06; Chandran K, 2005, SCIENCE, V308, P1643, DOI 10.1126/science.1110656; Dehrmann FM, 1995, ARCH BIOCHEM BIOPHYS, V324, P93, DOI 10.1006/abbi.1995.9924; Estrada S, 1998, BIOCHEMISTRY-US, V37, P7551, DOI 10.1021/bi980026r; Friedrichs B, 2003, J CLIN INVEST, V111, P1733, DOI 10.1172/JCI200315990; Goulet B, 2004, MOL CELL, V14, P207, DOI 10.1016/S1097-2765(04)00209-6; GRIGORYEV SA, 1992, EXP CELL RES, V198, P268, DOI 10.1016/0014-4827(92)90379-M; Grigoryev SA, 1998, J BIOL CHEM, V273, P3082, DOI 10.1074/jbc.273.5.3082; Hagemann S, 2004, EUR J CELL BIOL, V83, P775, DOI 10.1078/0171-9335-00404; Huntington JA, 1999, J MOL BIOL, V293, P449, DOI 10.1006/jmbi.1999.3184; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; Huntington JA, 2006, TRENDS BIOCHEM SCI, V31, P427, DOI 10.1016/j.tibs.2006.06.005; Irving JA, 2002, J BIOL CHEM, V277, P13192, DOI 10.1074/jbc.M108460200; Irving JA, 2002, BIOCHEMISTRY-US, V41, P4998, DOI 10.1021/bi0159985; JERALA R, 1994, PROTEIN ENG, V7, P977, DOI 10.1093/protein/7.8.977; Katagiri C, 2006, J CELL BIOL, V172, P983, DOI 10.1083/jcb.200508064; KATUNUMA N, 1995, METHOD ENZYMOL, V251, P382, DOI 10.1016/0076-6879(95)51142-3; LEHRER SS, 1971, BIOCHEMISTRY-US, V10, P3254, DOI 10.1021/bi00793a015; Li W, 2004, NAT STRUCT MOL BIOL, V11, P857, DOI 10.1038/nsmb811; LINDAHL P, 1988, BIOCHEMISTRY-US, V27, P5074, DOI 10.1021/bi00414a019; McGowan S, 2006, EMBO J, V25, P3144, DOI 10.1038/sj.emboj.7601201; Mohamed MM, 2006, NAT REV CANCER, V6, P764, DOI 10.1038/nrc1949; Olson ST, 2002, TRENDS CARDIOVAS MED, V12, P331, DOI 10.1016/S1050-1738(02)00183-4; Pike RN, 2005, FEBS J, V272, P4842, DOI 10.1111/j.1742-4658.2005.04880.x; Popova EY, 2006, EXP HEMATOL, V34, P453, DOI 10.1016/j.exphem.2006.01.003; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Qiu ZZ, 2006, J VIROL, V80, P5768, DOI 10.1128/JVI.00442-06; Reinheckel T, 2001, BIOL CHEM, V382, P735, DOI 10.1515/BC.2001.089; Rossi A, 2004, BIOL CHEM, V385, P363, DOI 10.1515/BC.2004.040; Schick C, 1998, BIOCHEMISTRY-US, V37, P5258, DOI 10.1021/bi972521d; Simmons G, 2005, P NATL ACAD SCI USA, V102, P11876, DOI 10.1073/pnas.0505577102; Somoza JR, 2000, BIOCHEMISTRY-US, V39, P12543, DOI 10.1021/bi000951p; Springhetti EM, 2003, J BIOL CHEM, V278, P43384, DOI 10.1074/jbc.M307635200; Szpaderska AM, 2001, CANCER RES, V61, P3493; Tepel C, 2000, J CELL SCI, V113, P4487; Turk B, 1997, BIOL CHEM, V378, P141; Turk V, 2001, EMBO J, V20, P4629, DOI 10.1093/emboj/20.17.4629; Vasiljeva O, 2006, CANCER RES, V66, P5242, DOI 10.1158/0008-5472.CAN-05-4463	44	33	35	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					36980	36986		10.1074/jbc.M706991200	http://dx.doi.org/10.1074/jbc.M706991200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17923478	hybrid			2022-12-27	WOS:000251646000024
J	Teichert, RW; Jimenez, EC; Twede, V; Watkins, M; Hollmann, M; Bulaj, G; Olivera, BM				Teichert, Russell W.; Jimenez, Elsie C.; Twede, Vernon; Watkins, Maren; Hollmann, Michael; Bulaj, Grzegorz; Olivera, Baldomero M.			Novel conantokins from Conus parius venom are specific antagonists of N-methyl-D-aspartate receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-CARBOXYGLUTAMATE; RAT MODEL; IN-VITRO; PEPTIDES; BINDING; CALCIUM	We report the discovery and characterization of three conantokin peptides from the venom of Conus parius. Each peptide (conantokin-Pr1, -Pr2, and -Pr3) contains 19 amino acids with three gamma-carboxyglutamate (Gla) residues, a post-translationally modified amino acid characteristic of conantokins. The new peptides contain several amino acid residues that differ from previous conantokin consensus sequences. Notably, the new conantokins lack Gla at the 3rd position from the N terminus, where the Gla residue is replaced by either aspartate or by another post-translationally modified residue, 4-trans-hydroxyproline. Conantokin-Pr3 is the first conantokin peptide to have three different post-translational modifications. Conantokins-Pr1 and -Pr2 adopt alpha-helical conformations in the presence of divalent cations ( Mg2+ and Ca2+) but are generally unstructured in the absence of divalent cations. Conantokin-Pr3 adopts an alpha-helical conformation even in the absence of divalent cations. Like other conantokins, the new peptides induced sleep in young mice and hyperactivity in older mice upon intracranial injection. Electrophysiological assays confirmed that conantokins-Pr1, -Pr2, and -Pr3 are N-methyl-D-aspartate ( NMDA) receptor antagonists, with highest potency for NR2B-containing NMDA receptors. Conantokin-Pr3 demonstrated similar to 10-fold selectivity for NR2B-containing NMDA receptors. However, conantokin-Pr2 showed minimal differences in potency between NR2B and NR2D. Conantokins-Pr1, -Pr2, and -Pr3 all demonstrated high specificity of block for NMDA receptors, when tested against various ligand-gated ion channels. Conus parius conantokins allow for a better definition of structural and functional features of conantokins as ligands targeting NMDA receptors.	[Teichert, Russell W.; Jimenez, Elsie C.; Twede, Vernon; Olivera, Baldomero M.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Watkins, Maren] Univ Utah, Dept Pathol, Salt Lake City, UT 84112 USA; [Bulaj, Grzegorz] Univ Utah, Dept Med Chem, Salt Lake City, UT 84112 USA; [Jimenez, Elsie C.] Univ Philippines Baguio, Coll Sci, Dept Phys Sci, Baguio 2600, Philippines; [Hollmann, Michael] Ruhr Univ Bochum, Fac Chem & Biochem, Dept Biochem Receptor Biochem 1, D-44780 Bochum, Germany	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of the Philippines System; University of the Philippines Baguio; Ruhr University Bochum	Teichert, RW (corresponding author), 257 S 1400 E, Salt Lake City, UT 84112 USA.	russ_teichert@yahoo.com	Teichert, Russell W/H-2213-2013; Jimenez, Elsie/AAA-7347-2019	Teichert, Russell/0000-0002-9985-5214	NIGMS NIH HHS [GM48677] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM048677] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Blandl T, 1999, J PEPT RES, V53, P453, DOI 10.1034/j.1399-3011.1999.00042.x; Blandl T, 2001, J BIOL CHEM, V276, P7391, DOI 10.1074/jbc.M006648200; Bleakman D, 2006, SEMIN CELL DEV BIOL, V17, P592, DOI 10.1016/j.semcdb.2006.10.008; Cartier GE, 1996, J BIOL CHEM, V271, P7522, DOI 10.1074/jbc.271.13.7522; Chen ZG, 1998, J BIOL CHEM, V273, P16248, DOI 10.1074/jbc.273.26.16248; CLARK C, 1981, TOXICON, V19, P691, DOI 10.1016/0041-0101(81)90106-9; CRUZ L J, 1976, Veliger, V18, P302; Donevan SD, 2000, MOL PHARMACOL, V58, P614, DOI 10.1124/mol.58.3.614; EDMAN P, 1967, EUR J BIOCHEM, V1, P80, DOI 10.1111/j.1432-1033.1967.tb00047.x; HAACK JA, 1990, J BIOL CHEM, V265, P6025; HAMMERLAND LG, 1992, EUR J PHARM-MOLEC PH, V226, P239, DOI 10.1016/0922-4106(92)90067-6; Heading Christine E, 2002, Curr Opin Investig Drugs, V3, P915; Jacobsen R, 1998, J PEPT RES, V51, P173; Jimenez EC, 2002, EPILEPSY RES, V51, P73, DOI 10.1016/S0920-1211(02)00101-8; Layer RT, 2004, CURR MED CHEM, V11, P3073, DOI 10.2174/0929867043363901; Malmberg AB, 2003, PAIN, V101, P109, DOI 10.1016/S0304-3959(02)00303-2; MCINTOSH JM, 1984, J BIOL CHEM, V259, P4343; MENA EE, 1990, NEUROSCI LETT, V118, P241, DOI 10.1016/0304-3940(90)90637-O; Olivera BM, 1999, CURR OPIN NEUROBIOL, V9, P772, DOI 10.1016/S0959-4388(99)00033-1; Prorok M, 1996, BIOCHEMISTRY-US, V35, P16528, DOI 10.1021/bi9621122; Prorok M, 2001, CURR DRUG TARGETS, V2, P313, DOI 10.2174/1389450013348542; Prorok M, 2007, CURR DRUG TARGETS, V8, P633, DOI 10.2174/138945007780618481; Wei JJ, 2006, NEUROSCI LETT, V405, P137, DOI 10.1016/j.neulet.2006.06.040; White H. S., 1997, Society for Neuroscience Abstracts, V23, P2164; White HS, 2000, J PHARMACOL EXP THER, V292, P425; Williams AJ, 2002, NEUROREPORT, V13, P821, DOI 10.1097/00001756-200205070-00017; Williams AJ, 2000, J PHARMACOL EXP THER, V294, P378	27	41	48	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					36905	36913		10.1074/jbc.M706611200	http://dx.doi.org/10.1074/jbc.M706611200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17962189	hybrid			2022-12-27	WOS:000251646000016
J	Kipp, JJL; Kilen, SM; Woodruff, TK; Mayo, KE				Kipp, Jingjing L.; Kilen, Signe M.; Woodruff, Teresa K.; Mayo, Kelly E.			Activin regulates estrogen receptor gene expression in the mouse ovary	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INHIBIN ALPHA-SUBUNIT; RAT GRANULOSA-CELLS; BREAST-CANCER CELLS; GROWTH-FACTOR-BETA; FOLLICLE-STIMULATING-HORMONE; TGF-BETA; TRANSCRIPTION FACTOR; MESSENGER-RNA; REPRODUCTIVE PHENOTYPES; SUPERFAMILY MEMBERS	Activin, a member of the transforming growth factor-beta superfamily, is an important modulator of follicle-stimulating hormone synthesis and secretion in the pituitary and plays autocrine/paracrine roles in the regulation of ovarian follicle development. From a microarray study on mouse ovarian granulosa cells, we discovered that the estrogen receptor beta(ER beta) is inducible by activin. We previously demonstrated that estrogen suppresses activin gene expression, suggesting a feedback relationship between these two follicle-regulating hormones. The purpose of this study was to investigate fully activin A regulation of ER expression. Real time reverse transcription-PCR assays on cultured granulosa cells showed that both ER alpha and ER alpha mRNAs were induced by activin A at 4, 12, and 24 h in a dose-responsive manner. Western blots confirmed an increase in their protein levels. Consistent with increased ER alpha and ER alpha expression, activin A stimulated estradiol-induced estrogen response element promoter activity. Activin A stimulation of ER expression was a direct effect at the level of gene transcription, as it was not abolished by cycloheximide but was abolished by actinomycin D, and in transfected granulosa cells activin A stimulated ER alpha promoter activity. To investigate the effect of activin in vivo and, thus, its biological significance, we examined ER expression in inhibin transgenic mice that have decreased activin expression and discovered that these mice had decreased ER alpha and ER alpha expression in the ovary. We also found that ER mRNA levels were decreased in Mullerian inhibiting substance promoter (MIS)-Smad2 dominant negative mice that have impaired activin signaling through Smad2, and small interfering RNAs targeting Smad2 or Smad3 suppressed ER alpha promoter activation, suggesting that Smad2 and Smad3 are involved in regulating ER levels. Therefore, this study reveals an important role for activin in inducing the expression of ERs in the mouse ovary and suggests important interplay between activin and estrogen signaling.	Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA; Northwestern Univ, Dept Obstet & Gynecol, Evanston, IL 60208 USA; Northwestern Univ, Ctr Reprod Sci, Evanston, IL 60208 USA	Northwestern University; Northwestern University; Northwestern University	Mayo, KE (corresponding author), 2205 Tech Dr,Hogan 4-112, Evanston, IL 60208 USA.	k-mayo@northwestern.edu		Woodruff, Teresa/0000-0002-1197-3399	NICHD NIH HHS [HD91291] Funding Source: Medline; NIDDK NIH HHS [T32 DK007169] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007169] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bernard DJ, 2001, MOL CELL ENDOCRINOL, V180, P55, DOI 10.1016/S0303-7207(01)00500-7; BOITANI C, 1995, ENDOCRINOLOGY, V136, P5438, DOI 10.1210/en.136.12.5438; Bristol-Gould SK, 2005, ENDOCRINOLOGY, V146, P5228, DOI 10.1210/en.2005-0697; Britt KL, 2004, BIOL REPROD, V71, P1712, DOI 10.1095/biolreprod.104.028175; Britt KL, 2002, J ENDOCRINOL, V175, P269, DOI 10.1677/joe.0.1750269; Britt KL, 2001, J STEROID BIOCHEM, V79, P181, DOI 10.1016/S0960-0760(01)00158-3; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Burdette JE, 2005, CANCER RES, V65, P7968, DOI 10.1158/0008-5472.CAN-04-3553; Burkart AD, 2006, MOL ENDOCRINOL, V20, P584, DOI 10.1210/me.2005-0204; Burkart AD, 2005, ENDOCRINOLOGY, V146, P1909, DOI 10.1210/en.2004-0842; CARROLL RS, 1991, ENDOCRINOLOGY, V129, P3299, DOI 10.1210/endo-129-6-3299; CICATIELLO L, 1995, MOL ENDOCRINOL, V9, P1077, DOI 10.1210/me.9.8.1077; de Kretser DM, 2001, MOL CELL ENDOCRINOL, V180, P87, DOI 10.1016/S0303-7207(01)00502-0; deGraffenried LA, 2004, BREAST CANCER RES TR, V85, P111, DOI 10.1023/B:BREA.0000025398.93829.78; deGraffenried LA, 2002, J STEROID BIOCHEM, V82, P7, DOI 10.1016/S0960-0760(02)00151-6; DEKRETSER DM, 1989, BIOL REPROD, V40, P33, DOI 10.1095/biolreprod40.1.33; DePaolo LV, 1997, P SOC EXP BIOL MED, V214, P328; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Drummond AE, 2002, ENDOCRINOLOGY, V143, P1423, DOI 10.1210/en.143.4.1423; Dupont J, 2003, BIOL REPROD, V68, P1877, DOI 10.1095/biolreprod.102.012005; Dupont S, 2000, DEVELOPMENT, V127, P4277; DYKEMA JC, 1991, SERONO SYMP, P99; DYKEMA JC, 1994, ENDOCRINOLOGY, V135, P702, DOI 10.1210/en.135.2.702; Feng XH, 2000, EMBO J, V19, P5178, DOI 10.1093/emboj/19.19.5178; Findlay JK, 1999, TRENDS ENDOCRIN MET, V10, P183, DOI 10.1016/S1043-2760(98)00144-1; Findlay JK, 2002, MOL CELL ENDOCRINOL, V191, P35, DOI 10.1016/S0303-7207(02)00053-9; FINDLAY JK, 1993, BIOL REPROD, V48, P15, DOI 10.1095/biolreprod48.1.15; Findlay JK, 2001, MOL CELL ENDOCRINOL, V180, P139, DOI 10.1016/S0303-7207(01)00521-4; Frederick JP, 2004, MOL CELL BIOL, V24, P2546, DOI 10.1128/MCB.24.6.2546-2559.2004; Gehm BD, 1997, P NATL ACAD SCI USA, V94, P14138, DOI 10.1073/pnas.94.25.14138; GREEN S, 1986, NATURE, V320, P134, DOI 10.1038/320134a0; GREENE GL, 1986, SCIENCE, V231, P1150, DOI 10.1126/science.3753802; Guo SQ, 2004, MOL CELL BIOL, V24, P8681, DOI 10.1128/MCB.24.19.8681-8690.2004; HASHIMOTO M, 1993, ENDOCRINOLOGY, V133, P1934, DOI 10.1210/en.133.5.1934; Igarashi M, 1988, Nihon Sanka Fujinka Gakkai Zasshi, V40, P973; Jaatinen R, 2002, J CLIN ENDOCR METAB, V87, P1254, DOI 10.1210/jc.87.3.1254; Javelaud D, 2005, ONCOGENE, V24, P5742, DOI 10.1038/sj.onc.1208928; Jefferson WN, 2000, BIOL REPROD, V62, P310, DOI 10.1095/biolreprod62.2.310; Kipp JL, 2007, ENDOCRINOLOGY, V148, P1968, DOI 10.1210/en.2006-1083; Knight PG, 2003, ANIM REPROD SCI, V78, P165, DOI 10.1016/S0378-4320(03)00089-7; Knight PG, 2001, REPRODUCTION, V121, P503, DOI 10.1530/reprod/121.4.503; Knight PG, 2006, REPRODUCTION, V132, P191, DOI 10.1530/rep.1.01074; KOIKE S, 1987, NUCLEIC ACIDS RES, V15, P2499, DOI 10.1093/nar/15.6.2499; Krege JH, 1998, P NATL ACAD SCI USA, V95, P15677, DOI 10.1073/pnas.95.26.15677; KRUST A, 1986, EMBO J, V5, P891, DOI 10.1002/j.1460-2075.1986.tb04300.x; Kuiper GGJM, 1996, P NATL ACAD SCI USA, V93, P5925, DOI 10.1073/pnas.93.12.5925; LAPOLT PS, 1989, MOL ENDOCRINOL, V3, P1666, DOI 10.1210/mend-3-10-1666; Lee SO, 2005, CANCER RES, V65, P3487, DOI 10.1158/0008-5472.CAN-04-3267; Lewis KA, 2000, NATURE, V404, P411, DOI 10.1038/35006129; LORENZEN JR, 1981, AM J PHYSIOL, V240, pE209, DOI 10.1152/ajpendo.1981.240.2.E209; LUBAHN DB, 1993, P NATL ACAD SCI USA, V90, P11162, DOI 10.1073/pnas.90.23.11162; MacConell LA, 2002, ENDOCRINOLOGY, V143, P1066, DOI 10.1210/en.143.3.1066; Madureira PA, 2006, J BIOL CHEM, V281, P25167, DOI 10.1074/jbc.M603906200; Mather JP, 1997, P SOC EXP BIOL MED, V215, P209; Matsuda T, 2001, J BIOL CHEM, V276, P42908, DOI 10.1074/jbc.M105316200; Matzuk MM, 2002, NAT CELL BIOL, V4, pS41; McMullen ML, 2001, ENDOCRINOLOGY, V142, P5005, DOI 10.1210/en.142.11.5005; MEUNIER H, 1988, MOL ENDOCRINOL, V2, P1352, DOI 10.1210/mend-2-12-1352; MEUNIER H, 1988, P NATL ACAD SCI USA, V85, P247, DOI 10.1073/pnas.85.1.247; Monroe DG, 2000, MOL CELL BIOL, V20, P4626, DOI 10.1128/MCB.20.13.4626-4634.2000; Mosselman S, 1996, FEBS LETT, V392, P49, DOI 10.1016/0014-5793(96)00782-X; Moustakas A, 1998, P NATL ACAD SCI USA, V95, P6733, DOI 10.1073/pnas.95.12.6733; Mowa CN, 2000, J ENDOCRINOL, V167, P363, DOI 10.1677/joe.0.1670363; Mukherjee A, 1996, ENDOCRINOLOGY, V137, P3234, DOI 10.1210/en.137.8.3234; Palter SF, 2001, ENDOCR REV, V22, P389, DOI 10.1210/er.22.3.389; Pangas SA, 2002, J CLIN ENDOCR METAB, V87, P2644, DOI 10.1210/jc.87.6.2644; PARKSARGE OK, 1994, ENDOCRINOLOGY, V134, P709, DOI 10.1210/en.134.2.709; PEI L, 1991, MOL ENDOCRINOL, V5, P521, DOI 10.1210/mend-5-4-521; Peterson TJ, 2007, MOL CELL BIOL, V27, P5933, DOI 10.1128/MCB.00237-07; Petrel TA, 2003, J CELL BIOCHEM, V88, P181, DOI 10.1002/jcb.10353; Risbridger GP, 2001, ENDOCR REV, V22, P836, DOI 10.1210/er.22.6.836; SCHWARTZ NB, 1977, P NATL ACAD SCI USA, V74, P5721, DOI 10.1073/pnas.74.12.5721; SOKOL SY, 1992, DEV BIOL, V154, P348, DOI 10.1016/0012-1606(92)90073-P; Symonds D, 2003, ANAT REC PART A, V273A, P681, DOI 10.1002/ar.a.10090; ten Dijke P, 2004, TRENDS BIOCHEM SCI, V29, P265, DOI 10.1016/j.tibs.2004.03.008; Tremblay GB, 1997, MOL ENDOCRINOL, V11, P353, DOI 10.1210/me.11.3.353; VALE WHA, 1990, GROWTH FACTORS THEIR, P211; van den Wijngaard A, 2000, MOL ENDOCRINOL, V14, P623, DOI 10.1210/me.14.5.623; WHITE R, 1987, MOL ENDOCRINOL, V1, P735, DOI 10.1210/mend-1-10-735; Woodruff TK, 2005, ENDOCRINOLOGY, V146, P3244, DOI 10.1210/en.2005-0630; WOODRUFF TK, 1990, ANNU REV PHYSIOL, V52, P807, DOI 10.1146/annurev.ph.52.030190.004111; WOODRUFF TK, 1988, SCIENCE, V239, P1296, DOI 10.1126/science.3125611; Yamamoto T, 2002, ENDOCRINOLOGY, V143, P2635, DOI 10.1210/en.143.7.2635; Yan CN, 2001, MOL ENDOCRINOL, V15, P854, DOI 10.1210/me.15.6.854; YING SY, 1988, ENDOCR REV, V9, P267, DOI 10.1210/edrv-9-2-267; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1	86	49	53	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36755	36765		10.1074/jbc.M705143200	http://dx.doi.org/10.1074/jbc.M705143200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17951260	hybrid, Green Submitted			2022-12-27	WOS:000251458300068
J	Lv, CX; Chen, MR; Gan, GL; Wang, LF; Xu, T; Ding, JP				Lv, Caixia; Chen, Maorong; Gan, Geliang; Wang, Lifen; Xu, Tao; Ding, Jiuping			Four-turn alpha-helical segment prevents surface expression of the auxiliary h beta 2 subunit of BK-type channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+-ACTIVATED K+ CHANNEL; ACTIVATED POTASSIUM CHANNEL; ENDOCYTIC TRAFFICKING SIGNALS; BETA-SUBUNIT; LARGE-CONDUCTANCE; CRYSTAL-STRUCTURE; CHROMAFFIN CELLS; MOLECULAR-BASIS; SPLICE VARIANT; VOLTAGE	Large conductance, voltage- and Ca2+- activated K+ (BK) channels encoded by the mslo alpha and beta 2 subunits exist abundantly in rat chromaffin cells, pancreatic beta cells, and DRG neurons. The extracellular loop of h beta 2 acting as the channel regulator influences the rectification and toxin sensitivity of BK channels, and the inactivation domain at its N terminus induces rapid inactivation. However, the regulatory mechanism, especially the trafficking mechanism of h beta 2, is still unknown. With the help of immunofluorescence and patch clamp techniques, we determine that the h beta 2 subunit alone resides in the endoplasmic reticulum, suggesting that trafficking mechanism of h beta 2 differs from that of h beta 1 opposite to what we predicted previously. We further demonstrate that a four-turn alpha helical segment at the N terminus of h beta 2 prevents the surface expression of h beta 2, that is, the helical segment itself is a retention signal. Using the c-Myc epitope-tagged extracellular loop of h beta 2, we reveal that the most accessible site by antibody is located at the middle of the extracellular loop, which might provide clues to understand how the auxiliary beta subunits regulates the toxin sensitivity and the rectification of BK-type channels.	[Lv, Caixia; Chen, Maorong; Gan, Geliang; Wang, Lifen; Xu, Tao; Ding, Jiuping] Huazhong Univ Sci & Technol, Minist Educ, Key Lab Mol Biophys, Wuhan 430074, Hubei, Peoples R China; [Xu, Tao] Chinese Acad Sci, Inst Biophys, Natl lab Biomacromol, Beijing 100101, Peoples R China	Huazhong University of Science & Technology; Chinese Academy of Sciences; Institute of Biophysics, CAS	Ding, JP (corresponding author), Huazhong Univ Sci & Technol, Minist Educ, Key Lab Mol Biophys, Wuhan 430074, Hubei, Peoples R China.	xutao@ibp.ac.cn; jpding@mail.hust.edu.cn	Chen, Maorong/AAF-4006-2019; Xu, Tao/G-5474-2010	Chen, Maorong/0000-0003-3744-8864; 				Behrens R, 2000, FEBS LETT, V474, P99, DOI 10.1016/S0014-5793(00)01584-2; Bentrop D, 2001, J BIOL CHEM, V276, P42116, DOI 10.1074/jbc.M107118200; Brenner R, 2000, NATURE, V407, P870, DOI 10.1038/35038011; Brenner R, 2000, J BIOL CHEM, V275, P6453, DOI 10.1074/jbc.275.9.6453; Bright JN, 2002, BIOPOLYMERS, V64, P303, DOI 10.1002/bip.10197; Deutsch C, 2003, NEURON, V40, P265, DOI 10.1016/S0896-6273(03)00506-3; Ding JP, 1998, BIOPHYS J, V74, P268, DOI 10.1016/S0006-3495(98)77785-9; Dworetzky SI, 1996, J NEUROSCI, V16, P4543; Hanner M, 1998, J BIOL CHEM, V273, P16289, DOI 10.1074/jbc.273.26.16289; Hu S, 2003, PHYSIOL GENOMICS, V15, P191, DOI 10.1152/physiolgenomics.00110.2003; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jin P, 2002, J BIOL CHEM, V277, P43724, DOI 10.1074/jbc.M205795200; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Li W, 2007, J CELL PHYSIOL, V212, P348, DOI 10.1002/jcp.21007; Li ZW, 1999, J NEUROPHYSIOL, V81, P611, DOI 10.1152/jn.1999.81.2.611; Meera P, 2000, P NATL ACAD SCI USA, V97, P5562, DOI 10.1073/pnas.100118597; Nimigean CM, 1999, J GEN PHYSIOL, V113, P425, DOI 10.1085/jgp.113.3.425; Qian X, 2002, J GEN PHYSIOL, V120, P829, DOI 10.1085/jgp.20028692; Savalli N, 2007, J GEN PHYSIOL, V130, P117, DOI 10.1085/jgp.200709803; Toro B, 2006, NEUROSCIENCE, V142, P661, DOI 10.1016/j.neuroscience.2006.06.061; TsengCrank J, 1996, P NATL ACAD SCI USA, V93, P9200, DOI 10.1073/pnas.93.17.9200; Wallner M, 1999, P NATL ACAD SCI USA, V96, P4137, DOI 10.1073/pnas.96.7.4137; Wallner M, 1996, P NATL ACAD SCI USA, V93, P14922, DOI 10.1073/pnas.93.25.14922; Xia XM, 2003, J GEN PHYSIOL, V121, P125, DOI 10.1085/jgp.20028667; Xia XM, 1999, J NEUROSCI, V19, P5255, DOI 10.1523/jneurosci.19-13-05255.1999; Xia XM, 2000, J NEUROSCI, V20, P4890; Zarei MM, 2007, NEUROSCIENCE, V147, P80, DOI 10.1016/j.neuroscience.2007.04.019; Zarei MM, 2004, P NATL ACAD SCI USA, V101, P10072, DOI 10.1073/pnas.0302919101; Zarei MM, 2001, J BIOL CHEM, V276, P16232, DOI 10.1074/jbc.M008852200; Zeng XH, 2003, NAT STRUCT BIOL, V10, P448, DOI 10.1038/nsb932; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; Zhang Z, 2006, J NEUROSCI, V26, P11833, DOI 10.1523/JNEUROSCI.3812-06.2006	32	9	10	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2709	2715		10.1074/jbc.M704440200	http://dx.doi.org/10.1074/jbc.M704440200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	17991741	hybrid			2022-12-27	WOS:000252622300028
J	Kennard, S; Liu, H; Lilly, B				Kennard, Simone; Liu, Hua; Lilly, Brenda			Transforming growth factor-beta(TGF-beta 1) down-regulates Notch3 in fibroblasts to promote smooth muscle gene expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; SERUM RESPONSE FACTOR; TGF-BETA; CELL DIFFERENTIATION; NEURAL CREST; ALPHA-ACTIN; SM22-ALPHA TRANSCRIPTION; DEPENDENT TRANSCRIPTION; VASCULAR DEVELOPMENT; 10T1/2 CELLS	Select signaling pathways have emerged as key players in regulating smooth muscle gene expression during myofibroblast and smooth muscle differentiation, an event that is important for wound healing and vascular remodeling. These include the transforming growth factor-beta (TGF-beta 1) signaling cascade, which has been assigned multiple roles in these cells, and the Notch pathway. Notch family members have been implicated in governing cell fate in a variety of cells; however, the mechanisms are not well understood. We sought to explore how these prominent signaling mediators regulate differentiation, and in particular, how they might converge to control the transcription of smooth muscle genes. Using TGF-beta 1 to induce the differentiation of 10T1/2 fibroblasts, we investigated the specific function of Notch3. Overexpression of activated Notch3 caused repression of TGF-beta 1-induced smooth muscle-specific genes, whereas knockdown of Notch3 by small interfering RNA did not convincingly alter their expression. Surprisingly, the addition of TGF-beta 1 caused a significant decrease in Notch3 RNA and protein and a reciprocal increase in Hes1 gene transcription. The repression of Notch3 was mediated by SMAD activity and p38 mitogen-activated protein ( MAP) kinase, whereas analysis of the Hes1 promoter revealed direct activation by Smad2 but not Smad3. Furthermore, the Hes1 repressor protein augmented Smad3 transactivation of the SM22 alpha promoter. These results offer a novel mechanism by which TGF-beta 1 promotes the expression of smooth muscle differentiation genes through the inhibition of Notch3 and activation of Hes1.	[Kennard, Simone; Liu, Hua; Lilly, Brenda] Med Coll Georgia, Vasc Biol Ctr, Augusta, GA 30912 USA; [Kennard, Simone; Liu, Hua; Lilly, Brenda] Med Coll Georgia, Dept Obstet & Gynecol, Augusta, GA 30912 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University	Lilly, B (corresponding author), Med Coll Georgia, Vasc Biol Ctr, 1459 Laney Walker Blvd, Augusta, GA 30912 USA.	blilly@mcg.edu	LILLY, BRENDA/N-6867-2015	LILLY, BRENDA/0000-0002-3125-7496; Kennard, Simone/0000-0002-7564-9192	NHLBI NIH HHS [HL 00086] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Anderson LM, 2007, J CLIN INVEST, V117, P299, DOI 10.1172/JCI31288; Bertolino P, 2005, CHEST, V128, p585S, DOI 10.1378/chest.128.6_suppl.585S; Bianchi S, 2006, J CELL PHYSIOL, V207, P300, DOI 10.1002/jcp.20542; Blokzijl A, 2003, J CELL BIOL, V163, P723, DOI 10.1083/jcb.200305112; Bobik A, 2006, ARTERIOSCL THROM VAS, V26, P1712, DOI 10.1161/01.ATV.0000225287.20034.2c; Bolos V, 2007, ENDOCR REV, V28, P339, DOI 10.1210/er.2006-0046; Camoretti-Mercado B, 2006, J BIOL CHEM, V281, P20383, DOI 10.1074/jbc.M602748200; Campos AH, 2002, CIRC RES, V91, P999, DOI 10.1161/01.RES.0000044944.99984.25; Chen SY, 2006, J BIOL CHEM, V281, P1765, DOI 10.1074/jbc.M507771200; Chen SY, 2004, CIRC RES, V94, P1195, DOI 10.1161/01.RES.0000126897.41658.81; Chen SY, 2003, NUCLEIC ACIDS RES, V31, P1302, DOI 10.1093/nar/gkg224; de Jong DS, 2004, BIOCHEM BIOPH RES CO, V320, P100, DOI 10.1016/j.bbrc.2004.05.150; Deaton RA, 2005, J BIOL CHEM, V280, P31172, DOI 10.1074/jbc.M504774200; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Doi H, 2005, ARTERIOSCL THROM VAS, V25, P2328, DOI 10.1161/01.ATV.0000185829.47163.32; Doi H, 2006, J BIOL CHEM, V281, P28555, DOI 10.1074/jbc.M602749200; Domenga V, 2004, GENE DEV, V18, P2730, DOI 10.1101/gad.308904; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Gridley T, 2007, DEVELOPMENT, V134, P2709, DOI 10.1242/dev.004184; Harlow E., 1999, USING ANTIBODIES LAB; Hautmann MB, 1997, J BIOL CHEM, V272, P10948; High FA, 2007, J CLIN INVEST, V117, P353, DOI 10.1172/JCI30070; Hinson JS, 2007, AM J PHYSIOL-HEART C, V292, pH1170, DOI 10.1152/ajpheart.00864.2006; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; Hirschi KK, 1998, J CELL BIOL, V141, P805, DOI 10.1083/jcb.141.3.805; Hoffman LM, 2006, J CELL BIOL, V172, P771, DOI 10.1083/jcb.200512115; Iso T, 2003, ARTERIOSCL THROM VAS, V23, P543, DOI 10.1161/01.ATV.0000060892.81529.8F; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; Ju BG, 2004, CELL, V119, P815, DOI 10.1016/j.cell.2004.11.017; Kamaraju SK, 2005, J BIOL CHEM, V280, P1024, DOI 10.1074/jbc.M403960200; Kumar MS, 2003, ARTERIOSCL THROM VAS, V23, P737, DOI 10.1161/01.ATV.0000065197.07635.BA; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Li FM, 2007, J BIOL CHEM, V282, P10133, DOI 10.1074/jbc.C600225200; Li L, 1996, J CELL BIOL, V132, P849, DOI 10.1083/jcb.132.5.849; Lien SC, 2006, CELL SIGNAL, V18, P1270, DOI 10.1016/j.cellsig.2005.10.013; Lindner V, 2001, AM J PATHOL, V159, P875, DOI 10.1016/S0002-9440(10)61763-4; LOGAN C, 1993, DEVELOPMENT, V117, P905; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Morrow D, 2005, AM J PHYSIOL-CELL PH, V289, pC1188, DOI 10.1152/ajpcell.00198.2005; Noseda M, 2006, CIRC RES, V98, P1468, DOI 10.1161/01.RES.0000229683.81357.26; Ong CT, 2006, J BIOL CHEM, V281, P5106, DOI 10.1074/jbc.M506108200; Ono Y, 2007, J CELL PHYSIOL, V210, P358, DOI 10.1002/jcp.20838; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; OWENS GK, 1995, PHYSIOL REV, V75, P487; Park JT, 2006, CANCER RES, V66, P6312, DOI 10.1158/0008-5472.CAN-05-3610; Proweller A, 2005, J BIOL CHEM, V280, P8994, DOI 10.1074/jbc.M413316200; Qiu P, 2003, J MOL CELL CARDIOL, V35, P1407, DOI 10.1016/j.yjmcc.2003.09.002; Qiu P, 2002, CIRC RES, V90, P858, DOI 10.1161/01.RES.0000016504.08608.B9; Qiu P, 2005, CIRC RES, V97, P983, DOI 10.1161/01.RES.0000190604.90049.71; Qiu P, 2006, BIOCHEM BIOPH RES CO, V348, P351, DOI 10.1016/j.bbrc.2006.07.009; Singh NN, 2006, CYTOKINE GROWTH F R, V17, P487, DOI 10.1016/j.cytogfr.2006.09.002; Sinha S, 2004, AM J PHYSIOL-CELL PH, V287, pC1560, DOI 10.1152/ajpcell.00221.2004; SOIW RC, 2001, ANGIOGENESIS PROTOCO, P237; Subramanian SV, 2004, MOL BIOL CELL, V15, P4532, DOI 10.1091/mbc.E04-04-0348; TAKEBAYASHI K, 1994, J BIOL CHEM, V269, P5150; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang WL, 2002, J BIOL CHEM, V277, P23165, DOI 10.1074/jbc.M201409200; Yang CH, 2007, GENE, V389, P52, DOI 10.1016/j.gene.2006.09.029; Yoshida T, 2004, ARTERIOSCL THROM VAS, V24, P1596, DOI 10.1161/01.ATV.0000137190.63214.c5; Yoshida T, 2003, CIRC RES, V92, P856, DOI 10.1161/01.RES.0000068405.49081.09; Zhang Y, 1996, NATURE, V383, P168, DOI 10.1038/383168a0; Zhou JL, 2004, J BIOL CHEM, V279, P15929, DOI 10.1074/jbc.M313822200	63	88	95	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1324	1333		10.1074/jbc.M706651200	http://dx.doi.org/10.1074/jbc.M706651200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	17981798	hybrid			2022-12-27	WOS:000252282700015
J	Putkey, JA; Waxham, MN; Gaertner, TR; Brewer, KJ; Goldsmith, M; Kubota, Y; Kleerekoper, QK				Putkey, John A.; Waxham, M. Neal; Gaertner, Tara R.; Brewer, Kari J.; Goldsmith, Michael; Kubota, Yoshihisa; Kleerekoper, Quinn K.			Acidic/IQ motif regulator of calmodulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-II; CALCIUM-BINDING; CA2+ BINDING; IQ MOTIF; NEUROGRANIN; DYNAMICS; DOMAIN; SITES; DISSOCIATION; RECOGNITION	The small IQ motif proteins PEP-19 (62 amino acids) and RC3 (78 amino acids) greatly accelerate the rates of Ca2+ binding to sites III and IV in the C-domain of calmodulin (CaM). We show here that PEP-19 decreases the degree of cooperativity of Ca2+ binding to sites III and IV, and we present a model showing that this could increase Ca2+ binding rate constants. Comparative sequence analysis showed that residues 28 to 58 from PEP-19 are conserved in other proteins. This region includes the IQ motif (amino acids 39-62), and an adjacent acidic cluster of amino acids (amino acids 28-40). A synthetic peptide spanning residues 28-62 faithfully mimics intact PEP-19 with respect to increasing the rates of Ca2+ association and dissociation, as well as binding preferentially to the C-domain of CaM. In contrast, a peptide encoding only the core IQ motif does not modulate Ca2+ binding, and binds to multiple sites on CaM. A peptide that includes only the acidic region does not bind to CaM. These results show that PEP-19 has a novel acidic/IQ CaM regulatory motif in which the IQ sequence provides a targeting function that allows binding of PEP-19 to CaM, whereas the acidic residues modify the nature of this interaction, and are essential for modulating Ca2+ binding to the C-domain of CaM.	[Putkey, John A.; Brewer, Kari J.; Goldsmith, Michael; Kleerekoper, Quinn K.] Univ Texas Houston, Sch Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Waxham, M. Neal; Gaertner, Tara R.; Kubota, Yoshihisa] Univ Texas Houston, Sch Med, Dept Neurobiol & Anat, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Putkey, JA (corresponding author), 6431 Fannin St, Houston, TX 77030 USA.	john.putkey@uth.tmc.edu		Brewer Savannah, Kari/0000-0002-8908-7004; Waxham, M. Neal/0000-0003-4801-1190	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069611] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS038310] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM069611, GM 069611] Funding Source: Medline; NINDS NIH HHS [P01 NS038310, NS 038310] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bahler M, 2002, FEBS LETT, V513, P107, DOI 10.1016/S0014-5793(01)03239-2; Bayley PM, 1996, PROTEIN SCI, V5, P1215, DOI 10.1002/pro.5560050701; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Biekofsky RR, 1998, BIOCHEMISTRY-US, V37, P7617, DOI 10.1021/bi9800449; Bootman MD, 2001, J CELL SCI, V114, P2213; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Cui YF, 2003, ANAL BIOCHEM, V315, P175, DOI 10.1016/S0003-2697(03)00007-1; Evenas J, 2001, STRUCTURE, V9, P185, DOI 10.1016/S0969-2126(01)00575-5; Evenas J, 1997, BIOCHEMISTRY-US, V36, P3448, DOI 10.1021/bi9628275; Fallon JL, 2005, STRUCTURE, V13, P1881, DOI 10.1016/j.str.2005.09.021; Gaertner TR, 2004, J BIOL CHEM, V279, P39374, DOI 10.1074/jbc.M405352200; HAIECH J, 2002, CALCIUM BINDING PROT, V2, P25; Johnson JD, 1996, J BIOL CHEM, V271, P761, DOI 10.1074/jbc.271.2.761; Liang HY, 2003, NEURON, V39, P951, DOI 10.1016/S0896-6273(03)00560-9; LINSE S, 1991, J BIOL CHEM, V266, P8050; MARTIN SR, 1992, EUR J BIOCHEM, V205, P1107, DOI 10.1111/j.1432-1033.1992.tb16879.x; MAUNE JF, 1992, J BIOL CHEM, V267, P5286; MEADOR WE, 1993, SCIENCE, V262, P1718, DOI 10.1126/science.8259515; Pak JH, 2000, P NATL ACAD SCI USA, V97, P11232, DOI 10.1073/pnas.210184697; PEDIGO S, 1995, BIOCHEMISTRY-US, V34, P10676, DOI 10.1021/bi00033a044; Peersen OB, 1997, PROTEIN SCI, V6, P794; PENG JW, 2004, BIOCHEMISTRY-US, V34, P16733; Persechini A, 1996, J BIOL CHEM, V271, P62, DOI 10.1074/jbc.271.1.62; PUTKEY JA, 1987, METHOD ENZYMOL, V139, P303; Putkey JA, 1996, J BIOL CHEM, V271, P29619, DOI 10.1074/jbc.271.47.29619; Putkey JA, 2003, J BIOL CHEM, V278, P49667, DOI 10.1074/jbc.C300372200; Rakhilin SV, 2004, SCIENCE, V306, P698, DOI 10.1126/science.1099961; Slemmon JR, 2000, MOL NEUROBIOL, V22, P99, DOI 10.1385/MN:22:1-3:099; Slemmon JR, 1996, J BIOL CHEM, V271, P15911, DOI 10.1074/jbc.271.27.15911; Sorensen BR, 1998, BIOCHEMISTRY-US, V37, P4244, DOI 10.1021/bi9718200; Torok K, 2001, BIOCHEMISTRY-US, V40, P14878, DOI 10.1021/bi010920+; Trybus KM, 2007, J BIOL CHEM, V282, P23316, DOI 10.1074/jbc.M701636200; Ulmer TS, 2003, J BIOL CHEM, V278, P29261, DOI 10.1074/jbc.M302837200; van Dalen JJW, 2003, EUR J NEUROSCI, V18, P13, DOI 10.1046/j.1460-9568.2003.02720.x; Van Petegem F, 2005, NAT STRUCT MOL BIOL, V12, P1108, DOI 10.1038/nsmb1027; VanScyoc WS, 2002, BIOPHYS J, V83, P2767, DOI 10.1016/S0006-3495(02)75286-7; Waxham MN, 1998, J BIOL CHEM, V273, P17579, DOI 10.1074/jbc.273.28.17579; Wu JF, 2002, J BIOL CHEM, V277, P19498, DOI 10.1074/jbc.M109082200; Xiong LW, 2005, J BIOL CHEM, V280, P7070, DOI 10.1074/jbc.M410558200	39	28	29	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1401	1410		10.1074/jbc.M703831200	http://dx.doi.org/10.1074/jbc.M703831200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	17991744	hybrid, Green Accepted			2022-12-27	WOS:000252282700023
J	Dreier, R; Gunther, BK; Mainz, T; Nemere, I; Bruckner, P				Dreier, Rita; Guenther, Birgit Kathrin; Mainz, Tom; Nemere, Ilka; Bruckner, Peter			Terminal differentiation of chick embryo chondrocytes requires shedding of a cell surface protein that binds 1,25-dihydroxyvitamin D3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBCHONDRAL VASCULAR SYSTEM; COLLAGEN GENE-EXPRESSION; VITAMIN-D METABOLITES; ENDOCHONDRAL OSSIFICATION; GROWTH-PLATE; CARTILAGE DIFFERENTIATION; RESTING CHONDROCYTES; EXTRACELLULAR-MATRIX; MEMBRANE-RECEPTOR; BONE-DEVELOPMENT	Endochondral ossification comprises a cascade of cell differentiation culminating in chondrocyte hypertrophy and is negatively controlled by soluble environmental mediators at several checkpoints. Proteinases modulate this control by processing protein signals and/or their receptors. Here, we show that insulin-like growth factor I can trigger hypertrophic development by stimulating production and/or activation of proteinases in some populations of chick embryo chondrocytes. Cell surface targets of the enzymes include 1,25-dihydroxyvitamin D3 membrane-associated rapid response steroid receptor ( 1,25 D3 MARRS receptor), also known as ERp57/GRp58/ERp60. This protein is anchored to the outer surface of plasma membranes and inhibits late chondrocyte differentiation after binding of 1,25-dihydroxyvitamin D3. Upon treatment with insulin-like growth factor I, 1,25 D3 MARRS receptor is cleaved into two fragments of similar to 30 and 22 kDa. This process is abrogated along with hypertrophic development by E-64 or cystatin C, inhibitors of cysteine proteinases. Cell differentiation is enhanced by treatment with antibodies to 1,25 D3 MARRS receptor that either block binding of the inhibitory ligand 1,25-dihydroxyvitamin D3 or inactivate 1,25 D3 MARRS receptor left intact after treatment with proteinase inhibitors. Therefore, proteolytic shedding of 1,25 D3 MARRS receptor constitutes a molecular mechanism eliminating the 1,25-dihydroxyvitamin D3-induced barrier against late cartilage differentiation and is a potentially important step during endochondral ossification or cartilage degeneration in osteoarthritis.	[Dreier, Rita; Guenther, Birgit Kathrin; Mainz, Tom; Bruckner, Peter] Munster Univ Hosp, Inst Physiol Chem & Pathobiochem, D-48149 Munster, Germany; [Nemere, Ilka] Utah State Univ, Logan, UT 84322 USA	University of Munster; Utah System of Higher Education; Utah State University	Bruckner, P (corresponding author), Munster Univ Hosp, Inst Physiol Chem & Pathobiochem, Waldeyerstr 15, D-48149 Munster, Germany.	peter.bruckner@uni-muenster.de	Bruckner, Peter/F-4817-2019; Nemere, Ilka/A-7077-2008	Bruckner, Peter/0000-0002-5566-5611; 				Babarina AV, 2001, MATRIX BIOL, V20, P205, DOI 10.1016/S0945-053X(01)00132-9; BESSEY OA, 1946, J BIOL CHEM, V164, P321; Bittner K, 1998, EXP CELL RES, V238, P491, DOI 10.1006/excr.1997.3849; BOHME K, 1992, J CELL BIOL, V116, P1035, DOI 10.1083/jcb.116.4.1035; BOHME K, 1995, EXP CELL RES, V216, P191, DOI 10.1006/excr.1995.1024; Boyan BD, 2007, J STEROID BIOCHEM, V103, P467, DOI 10.1016/j.jsbmb.2006.11.003; BOYAN BD, 1990, CONNECT TISSUE RES, V24, P67, DOI 10.3109/03008209009152423; Boyan BD, 2003, CONNECT TISSUE RES, V44, P130, DOI 10.1080/03008200390152214; Boyan BD, 2003, J CELL BIOCHEM, V90, P1207, DOI 10.1002/jcb.10716; Boyan BD, 2002, CRIT REV ORAL BIOL M, V13, P143, DOI 10.1177/154411130201300205; BRUCKNER P, 1989, J CELL BIOL, V109, P2537, DOI 10.1083/jcb.109.5.2537; Cancedda R, 2000, INT J DEV BIOL, V44, P707; CANCEDDA R, 1995, INT REV CYTOL, V159, P265, DOI 10.1016/S0074-7696(08)62109-9; CAPASSO O, 1984, MOL CELL BIOL, V4, P1163, DOI 10.1128/MCB.4.6.1163; Erdmann S, 1996, J CELL BIOL, V135, P1179, DOI 10.1083/jcb.135.4.1179; Farjanel J, 2001, OSTEOARTHR CARTILAGE, V9, pS55, DOI 10.1053/joca.2001.0445; Felbor U, 2000, EMBO J, V19, P1187, DOI 10.1093/emboj/19.6.1187; GIBSON GJ, 1982, J CELL BIOL, V93, P767, DOI 10.1083/jcb.93.3.767; Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652; IYAMA K, 1991, ANAT RECORD, V229, P462, DOI 10.1002/ar.1092290405; Khanal RC, 2007, CURR MED CHEM, V14, P1087, DOI 10.2174/092986707780362871; Khanal RC, 2007, CRIT REV EUKAR GENE, V17, P31, DOI 10.1615/CritRevEukarGeneExpr.v17.i1.30; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; MULLERGLAUSER W, 1986, J CELL BIOL, V102, P1931, DOI 10.1083/jcb.102.5.1931; Nakase T, 2000, HISTOCHEM CELL BIOL, V114, P21; Nemere I, 2000, AM J PHYSIOL-ENDOC M, V278, pE1104, DOI 10.1152/ajpendo.2000.278.6.E1104; Nemere K, 2005, STEROIDS, V70, P455, DOI 10.1016/j.steroids.2005.02.005; Nemere K, 2004, J STEROID BIOCHEM, V89-90, P281, DOI 10.1016/j.jsbmb.2004.03.031; NORMAN AW, 1993, J NUTR, V123, P310, DOI 10.1093/jn/123.suppl_2.310; Ortega N, 2003, ANN NY ACAD SCI, V995, P109, DOI 10.1111/j.1749-6632.2003.tb03214.x; Potts W, 2004, INT J EXP PATHOL, V85, P85, DOI 10.1111/j.0959-9673.2004.00373.x; Provot S, 2005, BIOCHEM BIOPH RES CO, V328, P658, DOI 10.1016/j.bbrc.2004.11.068; SAFTIG P, 1995, EMBO J, V14, P3599, DOI 10.1002/j.1460-2075.1995.tb00029.x; SCHMID TM, 1982, J BIOL CHEM, V257, P2444; Schwartz Z, 2002, ENDOCRINOLOGY, V143, P2775, DOI 10.1210/en.143.7.2775; SCHWARTZ Z, 1992, ENDOCRINOLOGY, V130, P2495, DOI 10.1210/en.130.5.2495; Soderstrom M, 1999, BBA-GENE STRUCT EXPR, V1446, P35, DOI 10.1016/S0167-4781(99)00068-8; Szuts V, 1998, MATRIX BIOL, V17, P435, DOI 10.1016/S0945-053X(98)90103-2; Teillaud C, 2005, J CELL BIOCHEM, V94, P139, DOI 10.1002/jcb.20275; TSCHAN T, 1990, J CELL BIOL, V111, P257, DOI 10.1083/jcb.111.1.257; VONDERMARK K, 1992, ARTHRITIS RHEUM-US, V35, P806, DOI 10.1002/art.1780350715; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; Zijlstra A, 2004, J BIOL CHEM, V279, P27633, DOI 10.1074/jbc.M313617200	43	21	22	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					1104	1112		10.1074/jbc.M703336200	http://dx.doi.org/10.1074/jbc.M703336200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	17984094	hybrid			2022-12-27	WOS:000252128100050
J	Farley, SM; Purdy, DE; Ryabinina, OP; Schneider, P; Magun, BE; Iordanov, MS				Farley, Sherry M.; Purdy, David E.; Ryabinina, Olga P.; Schneider, Pascal; Magun, Bruce E.; Iordanov, Mihail S.			Fas ligand-induced proinflammatory transcriptional responses in reconstructed human epidermis - Recruitment of the epidermal growth factor receptor and activation of map kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KERATINOCYTE APOPTOSIS; CD95 LIGAND; INHIBITION; DEATH; CASPASES; FAMILY; PLAYS; CELLS; GAMMA; SKIN	Fas ligand ( FasL) exerts potent proapoptotic and proinflammatory actions on epidermal keratinocytes and has been implicated in the pathogenesis of eczema, toxic epidermal necrolysis, and drug-induced skin eruptions. We used reconstructed human epidermis to investigate the mechanisms of FasL-induced inflammatory responses and their relationships with FasL-triggered caspase activity. Caspase activity was a potent antagonist of the pro-inflammatory gene expression triggered by FasL prior to the onset of cell death. Furthermore, we found that FasL-stimulated autocrine production of epidermal growth factor receptor ( EGFR) ligands, and the subsequent activation of EGFR and ERK1 and ERK2 mitogen-activated protein kinases, were obligatory extracellular steps for the FasL-induced expression of a subset of inflammatory mediators, including CXCL8/interleukin (IL)-8, ICAM-1, IL-1 alpha, IL-1 beta, CCL20/MIP-3 alpha, and thymic stromal lymphopoietin. These results expand the known physiological role of EGFR and its ligands from promoting keratinocyte mitogenesis and survival to mediating FasL-induced epidermal inflammation.	[Farley, Sherry M.; Purdy, David E.; Ryabinina, Olga P.; Magun, Bruce E.; Iordanov, Mihail S.] Oregon Hlth & Sci Univ, Dept Cell & Dev Biol, Portland, OR 97239 USA; [Schneider, Pascal] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland	Oregon Health & Science University; University of Lausanne	Magun, BE (corresponding author), Oregon Hlth & Sci Univ, Dept Cell & Dev Biol, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	magunb@ohsu.edu; iordanov@ohsu.edu		Schneider, Pascal/0000-0003-0677-9409	NATIONAL CANCER INSTITUTE [R01CA093718] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI059335, R01AI059335] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK066439] Funding Source: NIH RePORTER; NCI NIH HHS [CA-93718] Funding Source: Medline; NIAID NIH HHS [AI059335] Funding Source: Medline; NIDDK NIH HHS [DK066439] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AIMOUSTAFA AE, 1999, CLIN CANC, V5, P681; Akdis M, 2003, FASEB J, V17, P1026, DOI 10.1096/fj.02-1070com; Baselga J, 2002, J CLIN ONCOL, V20, P4292, DOI 10.1200/JCO.2002.03.100; BELLGRAU D, 1995, NATURE, V377, P630, DOI 10.1038/377630a0; Bodmer JL, 2002, TRENDS BIOCHEM SCI, V27, P19, DOI 10.1016/S0968-0004(01)01995-8; Chatterjee M, 2004, BLOOD, V104, P3712, DOI 10.1182/blood-2004-04-1670; Choi HJ, 2006, BRIT J DERMATOL, V154, P419, DOI 10.1111/j.1365-2133.2005.07057.x; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Eidsmo L, 2005, AM J PATHOL, V166, P1099, DOI 10.1016/S0002-9440(10)62330-9; Farley SM, 2006, J INVEST DERMATOL, V126, P2438, DOI 10.1038/sj.jid.5700477; Garcia-Calvo M, 1998, J BIOL CHEM, V273, P32608, DOI 10.1074/jbc.273.49.32608; Giustizieri ML, 2001, J ALLERGY CLIN IMMUN, V107, P871, DOI 10.1067/mai.2001.114707; Holler N, 2003, MOL CELL BIOL, V23, P1428, DOI 10.1128/MCB.23.4.1428-1440.2003; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Iordanov MS, 2005, J INVEST DERMATOL, V125, P134, DOI 10.1111/j.0022-202X.2005.23804.x; Iordanov MS, 2002, MOL CELL BIOL, V22, P5380, DOI 10.1128/MCB.22.15.5380-5394.2002; KAWAMOTO T, 1992, IN VITRO CELL DEV-AN, V28A, P782; Klunker S, 2003, J IMMUNOL, V171, P1078, DOI 10.4049/jimmunol.171.2.1078; Krammer PH, 2000, NATURE, V407, P789, DOI 10.1038/35037728; Kurth I, 2001, J EXP MED, V194, P855, DOI 10.1084/jem.194.6.855; Langley RGB, 1996, J AM ACAD DERMATOL, V35, P187, DOI 10.1016/S0190-9622(96)90320-5; Lloyd Alison C, 2006, J Biol, V5, P13, DOI 10.1186/jbiol46; Michel G, 1996, BIOCHEM PHARMACOL, V51, P1315, DOI 10.1016/0006-2952(96)00039-1; Newman JC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-r81; OSHEROV N, 1994, EUR J BIOCHEM, V225, P1047, DOI 10.1111/j.1432-1033.1994.1047b.x; Pastore S, 1998, J ALLERGY CLIN IMMUN, V101, P538, DOI 10.1016/S0091-6749(98)70361-6; Poumay Y, 2004, ARCH DERMATOL RES, V296, P203, DOI 10.1007/s00403-004-0507-y; Raj D, 2006, J INVEST DERMATOL, V126, P243, DOI 10.1038/sj.jid.5700008; Ristow HJ, 1996, GROWTH REGULAT, V6, P96; Schaerli P, 2005, IMMUNITY, V23, P331, DOI 10.1016/j.immuni.2005.08.012; Schwarz T, 2000, J CLIN INVEST, V106, P9, DOI 10.1172/JCI10438; Shi YG, 2002, MOL CELL, V9, P459, DOI 10.1016/S1097-2765(02)00482-3; Sparmann A, 2004, CANCER CELL, V6, P447, DOI 10.1016/j.ccr.2004.09.028; Straus SE, 1999, ANN INTERN MED, V130, P591, DOI 10.7326/0003-4819-130-7-199904060-00020; Stuart PM, 1997, J CLIN INVEST, V99, P396, DOI 10.1172/JCI119173; Stur K, 2007, J INVEST DERMATOL, V127, P802, DOI 10.1038/sj.jid.5700648; Suda T, 1997, J EXP MED, V186, P2045, DOI 10.1084/jem.186.12.2045; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Trautmann A, 2000, J CLIN INVEST, V106, P25, DOI 10.1172/JCI9199; Trautmann A, 2001, J INVEST DERMATOL, V117, P927, DOI 10.1046/j.0022-202x.2001.01474.x; Vantaggiato Chiara, 2006, J Biol, V5, P14, DOI 10.1186/jbiol38; Viard I, 1998, SCIENCE, V282, P490, DOI 10.1126/science.282.5388.490; Wu JG, 1996, J CLIN INVEST, V98, P1107, DOI 10.1172/JCI118892	43	31	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					919	928		10.1074/jbc.M705852200	http://dx.doi.org/10.1074/jbc.M705852200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	17977827	Green Published, hybrid			2022-12-27	WOS:000252128100032
J	Nie, L; Wu, HQ; Sun, XH				Nie, Lei; Wu, Huaqing; Sun, Xiao-Hong			Ubiquitination and degradation of Tal1/SCL are induced by Notch signaling and depend on Skp2 and CHIP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELL LEUKEMIA; PROTEIN; SCL; LIGASE; GENE; TRANSCRIPTION; EXPRESSION; HSC70; BOX; IDENTIFICATION	Notch signaling controls diverse eukaryotic differentiation processes in multiple cell types, thus demanding versatile tools with which Notch triggers downstream events. Ubiquitin-mediated proteolysis has previously been shown to be one such tool with which Notch regulates the turnover of the basic helix-loop-helix transcription factor, E47. Here, we show that Notch signaling also accelerated the degradation of Tal1/SCL ( T cell acute leukemia 1/stem cell leukemia) protein, a basic helix-loop-helix protein involved in the development of hematopoietic, vascular, and neuronal tissues. Notch-induced Tal1/SCL degradation was mediated by ubiquitination and proteasomes. The sequence responsible for Tal1 degradation was localized to a region in the C terminus of Tal1, which is evolutionarily conserved, thus suggesting a functional significance. Analogous to the situation for E47, Notch-induced Tal1/SCL degradation not only required Skp2, a substrate-binding subunit of SCF ubiquitin ligase complexes, but also relied on CHIP, a chaperone-binding protein with a ubiquitin ligase activity. In contrast to the fact that the N-terminal tetratricopeptide region (TPR) domain of CHIP is necessary and sufficient for E47 ubiquitination and degradation, CHIP promoted Tal1 degradation with both chaperone binding and ubiquitin ligase activities, which are mediated by its TPR domain and U box, respectively. Although the TPR domain was not involved in Tal1/SCL binding, it was required for enhancing its degradation. Likewise, the ubiquitin ligase activity of CHIP was dispensable for Tal1/SCL binding but essential for degradation. These findings provide both novel mechanistic insights into the operation of cullin-based ubiquitin ligase complexes and potential means by which Notch and Tal1/SCL regulate eukaryotic development.	[Nie, Lei; Wu, Huaqing; Sun, Xiao-Hong] Oklahoma Med Res Fdn, Immunobiol & Canc Program, Oklahoma City, OK 73104 USA	Oklahoma Medical Research Foundation	Sun, XH (corresponding author), Oklahoma Med Res Fdn, Immunobiol & Canc Program, 825 NE 13th St, Oklahoma City, OK 73104 USA.	sunx@omrf.ouhsc.edu			NCI NIH HHS [CA77553, R01 CA077553] Funding Source: Medline; NIAID NIH HHS [AI056129, R01 AI056129] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA077553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056129] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Allman D, 2002, CELL, V109, pS1, DOI 10.1016/S0092-8674(02)00689-X; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; BEGLEY CG, 1989, P NATL ACAD SCI USA, V86, P10128, DOI 10.1073/pnas.86.24.10128; Bradley CK, 2006, EUR J NEUROSCI, V23, P1677, DOI 10.1111/j.1460-9568.2006.04712.x; BROWN L, 1990, EMBO J, V9, P3343, DOI 10.1002/j.1460-2075.1990.tb07535.x; Burns CE, 2005, GENE DEV, V19, P2331, DOI 10.1101/gad.1337005; CHEN Q, 1990, EMBO J, V9, P415, DOI 10.1002/j.1460-2075.1990.tb08126.x; Chiba S, 2006, STEM CELLS, V24, P2437, DOI 10.1634/stemcells.2005-0661; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Cornell RA, 2005, SEMIN CELL DEV BIOL, V16, P663, DOI 10.1016/j.semcdb.2005.06.009; Curtis DJ, 2004, BLOOD, V103, P3342, DOI 10.1182/blood-2003-09-3202; Elefanty AG, 1999, BLOOD, V94, P3754, DOI 10.1182/blood.V94.11.3754.423k05_3754_3763; Ganoth D, 2001, NAT CELL BIOL, V3, P321, DOI 10.1038/35060126; Harper JW, 2001, CURR BIOL, V11, pR431, DOI 10.1016/S0960-9822(01)00253-6; Hatakeyama S, 2001, J BIOL CHEM, V276, P33111, DOI 10.1074/jbc.M102755200; Herberth B, 2005, INT J DEV NEUROSCI, V23, P449, DOI 10.1016/j.ijdevneu.2005.05.008; HSU HL, 1994, P NATL ACAD SCI USA, V91, P5947, DOI 10.1073/pnas.91.13.5947; Huang Z, 2004, MOL CELL BIOL, V24, P8951, DOI 10.1128/MCB.24.20.8951-8962.2004; Imai Y, 2002, MOL CELL, V10, P55, DOI 10.1016/S1097-2765(02)00583-X; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Jackson PK, 2002, MOL CELL, V9, P923, DOI 10.1016/S1097-2765(02)00538-5; Jiang JH, 2001, J BIOL CHEM, V276, P42938, DOI 10.1074/jbc.M101968200; Kamura T, 2004, GENE DEV, V18, P3055, DOI 10.1101/gad.1252404; Kim SY, 2003, MOL CELL, V11, P1177, DOI 10.1016/S1097-2765(03)00173-4; King AM, 2007, J IMMUNOL, V178, P3521, DOI 10.4049/jimmunol.178.6.3521; Kunisato A, 2004, BLOOD, V103, P3336, DOI 10.1182/blood-2003-06-1935; Mahajan MA, 1996, ONCOGENE, V12, P2343; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Mikkola HKA, 2003, NATURE, V421, P547, DOI 10.1038/nature01345; Murata S, 2001, EMBO REP, V2, P1133, DOI 10.1093/embo-reports/kve246; Nie L, 2003, EMBO J, V22, P5780, DOI 10.1093/emboj/cdg567; Ohishi K, 2003, SEMIN CELL DEV BIOL, V14, P143, DOI 10.1016/S1084-9521(02)00183-0; Park ST, 1998, J BIOL CHEM, V273, P7030, DOI 10.1074/jbc.273.12.7030; Peng CY, 2007, NEURON, V53, P813, DOI 10.1016/j.neuron.2007.02.019; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Pickart CM, 2001, MOL CELL, V8, P499, DOI 10.1016/S1097-2765(01)00347-1; Porcher C, 1996, CELL, V86, P47, DOI 10.1016/S0092-8674(00)80076-8; Radtke F, 2005, BIOESSAYS, V27, P1117, DOI 10.1002/bies.20315; Reynaud D, 2005, BLOOD, V106, P2318, DOI 10.1182/blood-2005-02-0557; Spruck C, 2001, MOL CELL, V7, P639, DOI 10.1016/S1097-2765(01)00210-6; Tamura K, 1995, CURR BIOL, V5, P1416, DOI 10.1016/S0960-9822(95)00279-X; Xu WP, 2002, P NATL ACAD SCI USA, V99, P12847, DOI 10.1073/pnas.202365899; Xue Y, 2005, NUCLEIC ACIDS RES, V33, pW184, DOI 10.1093/nar/gki393	44	25	28	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					684	692		10.1074/jbc.M704981200	http://dx.doi.org/10.1074/jbc.M704981200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	17962192	hybrid			2022-12-27	WOS:000252128100005
J	Rennolds, J; Tower, C; Musgrove, L; Fan, L; Maloney, K; Clancy, JP; Kirk, KL; Sztul, E; Cormet-Boyaka, E				Rennolds, Jessica; Tower, Cristy; Musgrove, Lois; Fan, Lijuan; Maloney, Kevin; Clancy, John Paul; Kirk, Kevin L.; Sztul, Elizabeth; Cormet-Boyaka, Estelle			Cystic fibrosis transmembrane conductance regulator trafficking is mediated by the COPI coat in epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; EXCHANGE FACTOR; PLASMA-MEMBRANE; GOLGI; TRANSPORT; CFTR; ANTEROGRADE; DYNAMICS; PROTEIN; CARGO	Cystic fibrosis (CF) is caused by defects in the CF transmembrane conductance regulator (CFTR) that functions as a chloride channel in epithelial cells. The most common cause of CF is the abnormal trafficking of CFTR mutants. Therefore, understanding the cellular machineries that transit CFTR from the endoplasmic reticulum to the plasma membrane (PM) is important. The coat protein complex I (COPI) has been implicated in the anterograde and retrograde transport of proteins and lipids between the endoplasmic reticulum and the Golgi. Here, we investigated the role of COPI in CFTR trafficking. Blocking COPI recruitment to membranes by expressing an inactive form of the GBF1 guanine nucleotide exchange factor for ADP-ribosylation factor inhibits CFTR trafficking to the PM. Similarly, inhibiting COPI dissociation from membranes by expressing a constitutively active ADP-ribosylation factor 1 mutant arrests CFTR within disrupted Golgi elements. To definitively explore the relationship between COPI and CFTR in epithelial cells, we depleted beta-COP from the human colonic epithelial cell HT-29Cl.19A using small interfering RNA. beta-COP depletion did not affect CFTR synthesis but impaired its trafficking to the PM. The arrest occurred pre-Golgi as shown by reduced level of glycosylation. Importantly, decreased trafficking of CFTR had a functional consequence as cells depleted of beta-COP showed decreased cAMP-activated chloride currents. To explore the mechanism of COPI action in CFTR traffic we tested whether CFTR was COPI cargo. We discovered that the alpha-, beta-, and gamma-subunits of COPI co-immunoprecipitated with CFTR. Our results indicate that the COPI complex plays a critical role in CFTR trafficking to the PM.	[Cormet-Boyaka, Estelle] 201 Davis Heart & Lung Res Inst, Columbus, OH 43201 USA; [Rennolds, Jessica; Maloney, Kevin; Cormet-Boyaka, Estelle] Ohio State Univ, Div Pulm Crit Care & Sleep Med, Columbus, OH 43210 USA; [Tower, Cristy; Sztul, Elizabeth] Univ Alabama Birmingham, Dept Cell Biol, Birmingham, AL 35294 USA; [Musgrove, Lois; Kirk, Kevin L.] Univ Alabama Birmingham, Dept Phys & Biophys, Birmingham, AL 35294 USA; [Fan, Lijuan; Clancy, John Paul] Univ Alabama Birmingham, Dept Pediat, Birmingham, AL 35294 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Cormet-Boyaka, E (corresponding author), 201 Davis Heart & Lung Res Inst, 473 W 12th Ave, Columbus, OH 43201 USA.	estelle.boyaka@osumc.edu	Cormet-Boyaka, Estelle/H-5624-2011	Tower-Gilchrist, Cristy/0000-0002-5236-5170				Aoe T, 1998, P NATL ACAD SCI USA, V95, P1624, DOI 10.1073/pnas.95.4.1624; Bannykh SI, 2000, TRAFFIC, V1, P852, DOI 10.1034/j.1600-0854.2000.011105.x; Chang XB, 1999, MOL CELL, V4, P137, DOI 10.1016/S1097-2765(00)80196-3; COBB RB, 2002, AM J PHYSIOL, V282, pL12; COSSON P, 1994, SCIENCE, V263, P1629, DOI 10.1126/science.8128252; DASCHER C, 1994, J BIOL CHEM, V269, P1437; DENNING GM, 1992, J CLIN INVEST, V89, P339, DOI 10.1172/JCI115582; ELAZAR Z, 1994, J CELL BIOL, V124, P415, DOI 10.1083/jcb.124.4.415; Eugster A, 2004, MOL BIOL CELL, V15, P1011, DOI 10.1091/mbc.E03-10-0724; Faulstich D, 1996, J CELL BIOL, V135, P53, DOI 10.1083/jcb.135.1.53; Fu LW, 2003, J CELL BIOL, V160, P157, DOI 10.1083/jcb.200210086; Garcia-Mata R, 2003, MOL BIOL CELL, V14, P2250, DOI 10.1091/mbc.E02-11-0730; Gilbert A, 1998, EXP CELL RES, V242, P144, DOI 10.1006/excr.1998.4101; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Heda GD, 2001, AM J PHYSIOL-CELL PH, V280, pC166, DOI 10.1152/ajpcell.2001.280.1.C166; Hermosilla R, 2004, TRAFFIC, V5, P993, DOI 10.1111/j.1600-0854.2004.00239.x; LESUFFLEUR T, 1991, INT J CANCER, V49, P731, DOI 10.1002/ijc.2910490517; LETOURNEUR F, 1994, CELL, V79, P1199, DOI 10.1016/0092-8674(94)90011-6; Lippincott-Schwartz Jennifer, 2006, Trends Cell Biol, V16, pe1, DOI 10.1016/j.tcb.2006.08.008; Liu W, 2005, J CELL BIOL, V168, P1053, DOI 10.1083/jcb.200410142; LUKACS GL, 1993, J BIOL CHEM, V268, P21592; Malsam J, 2005, SCIENCE, V307, P1095, DOI 10.1126/science.1108061; Moelleken J, 2007, P NATL ACAD SCI USA, V104, P4425, DOI 10.1073/pnas.0611360104; Nickel W, 1998, SEMIN CELL DEV BIOL, V9, P493, DOI 10.1006/scdb.1998.0256; Nickel W, 1998, J CELL SCI, V111, P3081; Niu TK, 2005, MOL BIOL CELL, V16, P1213, DOI 10.1091/mbc.E04-07-0599; O'Kelly I, 2002, CELL, V111, P577, DOI 10.1016/S0092-8674(02)01040-1; Orci L, 2000, P NATL ACAD SCI USA, V97, P10400, DOI 10.1073/pnas.190292497; Paulsson KM, 2002, J BIOL CHEM, V277, P18266, DOI 10.1074/jbc.M201388200; Pepperkok R, 2000, J CELL SCI, V113, P135; Rechards M, 2003, TRAFFIC, V4, P553, DOI 10.1034/j.1600-0854.2003.t01-1-00114.x; Szul T, 2005, TRAFFIC, V6, P374, DOI 10.1111/j.1600-0854.2005.00282.x; Varga K, 2004, J BIOL CHEM, V279, P22578, DOI 10.1074/jbc.M401522200; Wang XD, 2004, J CELL BIOL, V167, P65, DOI 10.1083/jcb.200401035; WATERS M G, 1991, Current Opinion in Cell Biology, V3, P615, DOI 10.1016/0955-0674(91)90031-S; Yoo JS, 2002, J BIOL CHEM, V277, P11401, DOI 10.1074/jbc.M110263200; Yu Y, 2007, BIOL CELL, V99, P433, DOI 10.1042/BC20060114	37	26	27	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					833	839		10.1074/jbc.M706504200	http://dx.doi.org/10.1074/jbc.M706504200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	17932045	hybrid			2022-12-27	WOS:000252128100023
J	Ansari, S; Alahyan, M; Marston, SB; EL-Mezgueldi, M				Ansari, Saira; Alahyan, Mustapha; Marston, Steven B.; EL-Mezgueldi, Mohammed			Role of caldesmon in the Ca2+ regulation of smooth muscle thin filaments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN-TROPOMYOSIN ACTIVATION; MYOSIN SUBFRAGMENT 1; ATPASE ACTIVITY; TROPONIN-TROPOMYOSIN; COOPERATIVE BINDING; ACTOMYOSIN ATPASE; SKELETAL-MUSCLE; MECHANICAL-PROPERTIES; HEAVY-MEROMYOSIN; ELEMENTARY STEPS	Smooth muscle thin filaments are made up of actin, tropomyosin, caldesmon, and a Ca2+-binding protein and their interaction with myosin is Ca2+-regulated. We suggested that Ca2+ regulation by caldesmon and Ca2+-calmodulin is achieved by controlling the state of thin filament through a cooperative-allosteric mechanism homologous to troponin-tropomyosin in striated muscles. In the present work, we have tested this hypothesis. We monitored directly the thin filament transition between the ON and OFF state using the excimer fluorescence of pyrene iodoacetamide (PIA)-labeled smooth muscle alpha alpha-tropomyosin homodimers. In steady state fluorescence measurements, myosin subfragment 1 (S1) cooperatively switches the thin filaments to the ON state, and this is exhibited as an increase in the excimer fluorescence. In contrast, caldesmon decreases the excimer fluorescence, indicating a switch of the thin filament to the OFF state. Addition of Ca2+-calmodulin increases the excimer fluorescence, indicating a switch of the thin filament to the ON state. The excimer fluorescence was also used to monitor the kinetics of the ON-OFF transition in a stopped-flow apparatus. When ATP induces S1 dissociation from actin-PIA-tropomyosin, the transition to the OFF state is delayed until all S1 molecules are dissociated actin. In contrast, caldesmon switches the thin filament to the OFF state in a cooperative way, and no lag is displayed in the time course of the caldesmon-induced fluorescence decrease. We have also studied caldesmon and Ca2+-calmodulin-caldesmon binding to actin-tropomyosin in the ON and OFF states. The results are used to discuss both caldesmon inhibition and Ca2+-calmodulin- caldesmon activation of actin-tropomyosin.	[EL-Mezgueldi, Mohammed] Univ Leicester, Dept Biochem, Henry Wellcome Bldg, Leicester LE1 9HN, Leics, England; [Ansari, Saira; Alahyan, Mustapha; Marston, Steven B.] Imperial Coll London, Natl Heart & Lung Inst, London SW3 6LY, England	University of Leicester; Imperial College London	EL-Mezgueldi, M (corresponding author), Univ Leicester, Dept Biochem, Henry Wellcome Bldg, Lancaster Rd, Leicester LE1 9HN, Leics, England.	mem16@le.ac.uk			Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Alahyan M, 2006, J BIOL CHEM, V281, P19433, DOI 10.1074/jbc.M507602200; Ansari S, 2003, J MUSCLE RES CELL M, V24, P513, DOI 10.1023/B:JURE.0000009812.74980.13; Borovikov YS, 2001, INT J BIOCHEM CELL B, V33, P1151, DOI 10.1016/S1357-2725(01)00091-7; Burton DJ, 1999, PFLUG ARCH EUR J PHY, V437, P267, DOI 10.1007/s004240050779; CHALOVICH JM, 1982, J BIOL CHEM, V257, P2432; CHALOVICH JM, 1988, CELL BIOPHYS, V12, P73, DOI 10.1007/BF02918351; Chalovich JM, 1998, ACTA PHYSIOL SCAND, V164, P427; CHALOVICH JM, 1990, ANN NY ACAD SCI, V599, P85; Changeux JP, 2005, SCIENCE, V308, P1424, DOI 10.1126/science.1108595; CHEN YD, 1992, BIOPHYS J, V63, P1063, DOI 10.1016/S0006-3495(92)81687-9; DABROWSKA R, 1985, BIOCHIM BIOPHYS ACTA, V842, P70, DOI 10.1016/0304-4165(85)90295-8; Earley JJ, 1998, CIRC RES, V83, P661, DOI 10.1161/01.RES.83.6.661; FRASER IDC, 1995, J BIOL CHEM, V270, P19688, DOI 10.1074/jbc.270.34.19688; Fraser IDC, 1997, BIOCHEMISTRY-US, V36, P5483, DOI 10.1021/bi962969z; FRASER IDC, 1995, THESIS LONDON U; Fredricksen S, 2003, BIOCHEMISTRY-US, V42, P6136, DOI 10.1021/bi0274017; Gao Y, 1999, BIOCHEMISTRY-US, V38, P15459, DOI 10.1021/bi991383k; GEEVES MA, 1987, BIOPHYS J, V52, P215, DOI 10.1016/S0006-3495(87)83208-3; GEEVES MA, 1994, BIOPHYS J, V67, P273, DOI 10.1016/S0006-3495(94)80478-3; GOPALAKRISHNA R, 1982, BIOCHEM BIOPH RES CO, V104, P830, DOI 10.1016/0006-291X(82)90712-4; GREENE LE, 1980, P NATL ACAD SCI-BIOL, V77, P2616, DOI 10.1073/pnas.77.5.2616; Heeley DH, 2002, P NATL ACAD SCI USA, V99, P16731, DOI 10.1073/pnas.252236399; HEMRIC ME, 1988, J BIOL CHEM, V263, P1878; HILL TL, 1980, P NATL ACAD SCI-BIOL, V77, P3186, DOI 10.1073/pnas.77.6.3186; Hodgkinson JL, 1997, BIOPHYS J, V72, P2398, DOI 10.1016/S0006-3495(97)78885-4; Horiuchi KY, 1995, BIOCHEMISTRY-US, V34, P16815, DOI 10.1021/bi00051a032; HORIUCHI KY, 1989, BIOCHEMISTRY-US, V28, P9111, DOI 10.1021/bi00449a023; Huber PAJ, 1998, BIOCHEMISTRY-US, V37, P2314, DOI 10.1021/bi971727b; Huber PAJ, 1996, BIOCHEM J, V316, P413, DOI 10.1042/bj3160413; ISHII Y, 1987, BIOCHEMISTRY-US, V26, P4922, DOI 10.1021/bi00390a005; Lehman W, 1997, J MOL BIOL, V274, P310, DOI 10.1006/jmbi.1997.1422; Lehrer SS, 1997, BIOCHEMISTRY-US, V36, P13449, DOI 10.1021/bi971568w; Lehrer SS, 1998, J MOL BIOL, V277, P1081, DOI 10.1006/jmbi.1998.1654; Malmquist U, 1996, PFLUG ARCH EUR J PHY, V432, P241, DOI 10.1007/s004240050130; MARGOSSIAN SS, 1982, METHOD ENZYMOL, V85, P55; Marston S, 1998, ACTA PHYSIOL SCAND, V164, P401, DOI 10.1111/j.1365-201X.1998.tb10696.x; MARSTON S, 1990, BIOCHEM J, V272, P305, DOI 10.1042/bj2720305; MARSTON S, 2002, J MUSC RES CELL MOTI, V23, P38; MARSTON SB, 1984, J MUSCLE RES CELL M, V5, P559, DOI 10.1007/BF00713261; MARSTON SB, 1994, J BIOL CHEM, V269, P32104; MARSTON SB, 1992, J BIOL CHEM, V267, P16796; MARSTON SB, 1985, J MUSCLE RES CELL M, V6, P669, DOI 10.1007/BF00712237; MARSTON SB, 1986, BIOCHEM J, V237, P605, DOI 10.1042/bj2370605; MARSTON SB, 1993, J BIOL CHEM, V268, P12317; MARSTON SB, 1980, BIOCHEM J, V185, P355, DOI 10.1042/bj1850355; MARSTON SB, 1985, ADV PROTEIN PHOSPHAT, V2, P171; MCKILLOP DFA, 1991, BIOCHEM J, V279, P711, DOI 10.1042/bj2790711; Mirza M, 2007, J BIOL CHEM, V282, P13487, DOI 10.1074/jbc.M701071200; NGAI PK, 1984, J BIOL CHEM, V259, P3656; Notarianni G, 2000, J MUSCLE RES CELL M, V21, P537, DOI 10.1023/A:1026589704750; PRITCHARD K, 1989, BIOCHEM J, V257, P839, DOI 10.1042/bj2570839; REDWOOD CS, 1990, FEBS LETT, V270, P53, DOI 10.1016/0014-5793(90)81233-E; REDWOOD CS, 1993, J BIOL CHEM, V268, P10969; REDWOOD CS, 1992, IDENTIFICATION FUNCT; SANDERS C, 1986, J BIOL CHEM, V261, P2774; SMITH CWJ, 1987, J BIOL CHEM, V262, P116; SMITH CWJ, 1985, FEBS LETT, V184, P115, DOI 10.1016/0014-5793(85)80665-7; SOBUE K, 1982, BIOMED RES-TOKYO, V3, P188, DOI 10.2220/biomedres.3.188; Straub F.B., 1942, STUDIES I MED CHEM U, P3; SWARTZ DR, 1992, J BIOL CHEM, V267, P20497; SZCZESNA D, 1994, BIOCHEMISTRY-US, V33, P6716, DOI 10.1021/bi00187a043; TAUSSKY HH, 1953, J BIOL CHEM, V202, P675; TRYBUS KM, 1980, P NATL ACAD SCI-BIOL, V77, P7209, DOI 10.1073/pnas.77.12.7209; VELAZ L, 1990, J BIOL CHEM, V265, P2929; VELAZ L, 1993, BIOPHYS J, V65, P892, DOI 10.1016/S0006-3495(93)81113-5; VELAZ L, 1989, J BIOL CHEM, V264, P9602; YAMASHIRO S, 1995, J BIOL CHEM, V270, P4023, DOI 10.1074/jbc.270.8.4023; Zhou X, 2000, BIOCHEMISTRY-US, V39, P1128, DOI 10.1021/bi992327m	68	17	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					47	56		10.1074/jbc.M706771200	http://dx.doi.org/10.1074/jbc.M706771200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17933868	hybrid			2022-12-27	WOS:000251940300007
J	Gagarina, V; Carlberg, AL; Pereira-Mouries, L; Hall, DJ				Gagarina, Viktoria; Carlberg, Alyssa L.; Pereira-Mouries, Lucilia; Hall, David J.			Cartilage oligomeric matrix protein protects cells against death by elevating members of the IAP family of survival proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE EPIPHYSEAL DYSPLASIA; 5-STRANDED COILED-COIL; SYNOVIAL-FLUID; IX COLLAGEN; COMP; MUTATIONS; APOPTOSIS; PSEUDOACHONDROPLASIA; THROMBOSPONDIN-5; ACTIVATION	Cartilage oligomeric matrix protein (COMP) is a component of cartilage, synovium, ligament, and tendon, yet its normal function is largely unknown. To identify its function we have expressed it in 293 and HeLa cell lines and in primary human chondrocytes. We find that COMP protects these cells against death, either in the presence or absence of tumor necrosis factor alpha and is able to block activation of caspase 3, a critical effector caspase. This effect appears to be mediated by the IAP (inhibitor of apoptosis protein) family of anti-apoptotic proteins because the levels of XIAP, survivin, cIAP1 and cIAP2 are significantly elevated in the COMP-expressing cells and down-regulation of survivin and XIAP protein levels by small interfering RNAs blocks the ability of COMP to enhance survival. The mRNAs for most of the IAP family members were not increased by COMP, indicating that a translational/post-translational mechanism was involved in their induction. However, in both HeLa cells and chondrocytes, COMP induced survivin mRNA by 5-fold. Thus survivin is the first gene identified to be up-regulated transcriptionally by COMP. The carboxyl-terminal half of the protein comprising the type 3 repeats and the RGD sequence (CaCTD domain) was sufficient to promote survival and to elevate the IAPs. Further, an RGD peptide was able to block the prosurvival effect of COMP and the induction of XIAP and survivin, indicating that survival is likely mediated through integrin signaling. These data point to a new role for COMP in protecting cells against death.	NIH, NIAMS, Cartilage Mol Genet Grp, Cartilage Biol & Orthoped Branch, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Hall, DJ (corresponding author), NIH, NIAMS, Cartilage Mol Genet Grp, Cartilage Biol & Orthoped Branch, Bldg 13 Rm 3W17,9000 Rockville Pike, Bethesda, MD 20892 USA.	halld@mail.nih.gov		Pereira Mouries, Lucilia/0000-0001-5836-6011	Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [Z01AR041141, ZIAAR041141] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Adams JC, 2001, ANNU REV CELL DEV BI, V17, P25, DOI 10.1146/annurev.cellbio.17.1.25; Briggs MD, 1998, AM J HUM GENET, V62, P311, DOI 10.1086/301713; BRIGGS MD, 1995, NAT GENET, V10, P330, DOI 10.1038/ng0795-330; CARVALHOBITTENC.M, 2002, J GENE MED, V4, P14; Chen FH, 2007, J BIOL CHEM, V282, P24591, DOI 10.1074/jbc.M611390200; Chen FH, 2005, J BIOL CHEM, V280, P32655, DOI 10.1074/jbc.M504778200; Clark AG, 1999, ARTHRITIS RHEUM, V42, P2356, DOI 10.1002/1529-0131(199911)42:11<2356::AID-ANR14>3.0.CO;2-R; Deere M, 1998, AM J MED GENET, V80, P510, DOI 10.1002/(SICI)1096-8628(19981228)80:5<510::AID-AJMG14>3.0.CO;2-F; Di Cesare PE, 2002, MATRIX BIOL, V21, P461, DOI 10.1016/S0945-053X(02)00015-X; DICESARE PE, 1995, J ORTHOPAED RES, V13, P422, DOI 10.1002/jor.1100130316; Dickinson SC, 2003, MATRIX BIOL, V22, P267, DOI 10.1016/S0945-053X(03)00034-9; Dodge GR, 1998, OSTEOARTHR CARTILAGE, V6, P435, DOI 10.1053/joca.1998.0147; Ebert O, 1999, CYTOKINES CELL MOL T, V5, P165; EFIMOV VP, 1994, FEBS LETT, V341, P54, DOI 10.1016/0014-5793(94)80239-4; Farina G, 2006, MATRIX BIOL, V25, P213, DOI 10.1016/j.matbio.2006.01.007; Fotin-Mleczek M, 2004, J BIOL CHEM, V279, P677, DOI 10.1074/jbc.M310969200; Friess H, 2001, ANN SURG, V234, P769, DOI 10.1097/00000658-200112000-00008; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Guo Y, 1998, EMBO J, V17, P5265, DOI 10.1093/emboj/17.18.5265; Hammes HP, 1996, NAT MED, V2, P529, DOI 10.1038/nm0596-529; Hashimoto Y, 2003, AM J PATHOL, V163, P101, DOI 10.1016/S0002-9440(10)63634-6; He LS, 2006, J BIOL CHEM, V281, P11235, DOI 10.1074/jbc.M508779200; Hecht JT, 2004, J ORTHOP RES, V22, P759, DOI 10.1016/j.orthres.2003.11.010; Hecht JT, 1998, MATRIX BIOL, V17, P625, DOI 10.1016/S0945-053X(98)90113-5; HECHT JT, 1995, NAT GENET, V10, P325, DOI 10.1038/ng0795-325; HEDBOM E, 1992, J BIOL CHEM, V267, P6132; Holcik M, 2001, APOPTOSIS, V6, P253, DOI 10.1023/A:1011379307472; Holden P, 2001, J BIOL CHEM, V276, P6046, DOI 10.1074/jbc.M009507200; Ishii Y, 2006, SPINE, V31, P1539, DOI 10.1097/01.brs.0000221994.61882.4a; Jones JL, 1999, J CLIN PATHOL-MOL PA, V52, P208, DOI 10.1136/mp.52.4.208; JordanSciutto KL, 1997, EXP CELL RES, V236, P527, DOI 10.1006/excr.1997.3762; Kipnes J, 2003, OSTEOARTHR CARTILAGE, V11, P442, DOI 10.1016/S1063-4584(03)00055-4; LaCasse EC, 1998, ONCOGENE, V17, P3247, DOI 10.1038/sj.onc.1202569; LAWLER J, 2002, ENCY MOL MED, P481; Lohmander LS, 1999, ARTHRITIS RHEUM, V42, P534, DOI 10.1002/1529-0131(199904)42:3<534::AID-ANR19>3.0.CO;2-J; Malashkevich VN, 1996, SCIENCE, V274, P761, DOI 10.1126/science.274.5288.761; Mann HH, 2004, J BIOL CHEM, V279, P25294, DOI 10.1074/jbc.M403778200; MORGELIN M, 1992, J BIOL CHEM, V267, P6137; Murphy JM, 1999, MATRIX BIOL, V18, P487, DOI 10.1016/S0945-053X(99)00042-6; Neidhart M, 1997, BRIT J RHEUMATOL, V36, P1151; Petersson IF, 1998, BRIT J RHEUMATOL, V37, P46; RENZING J, 1995, ONCOGENE, V10, P1865; Riessen R, 2001, ARTERIOSCL THROM VAS, V21, P47, DOI 10.1161/01.ATV.21.1.47; Rodriguez A, 1999, ANAL BIOCHEM, V272, P171, DOI 10.1006/abio.1999.4156; Rosenberg K, 1998, J BIOL CHEM, V273, P20397, DOI 10.1074/jbc.273.32.20397; SAXNE T, 1992, BRIT J RHEUMATOL, V31, P583; Shi YG, 2002, MOL CELL, V9, P459, DOI 10.1016/S1097-2765(02)00482-3; Stennicke HR, 2002, TRENDS BIOCHEM SCI, V27, P94, DOI 10.1016/S0968-0004(01)02045-X; Vilim V, 1997, ARCH BIOCHEM BIOPHYS, V341, P8, DOI 10.1006/abbi.1997.9941; Lipinski KV, 2006, CIRC RES, V98, P1490, DOI 10.1161/01.RES.0000229267.77982.0d; Xiao Y, 2004, J GASTROEN HEPATOL, V19, P296, DOI 10.1111/j.1440-1746.2003.03268.x; Yang Y, 2000, SCIENCE, V288, P874, DOI 10.1126/science.288.5467.874	53	34	39	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					648	659		10.1074/jbc.M704035200	http://dx.doi.org/10.1074/jbc.M704035200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17993464	hybrid			2022-12-27	WOS:000251940300069
J	Kario, E; Tirosh, B; Ploegh, HL; Navon, A				Kario, Edith; Tirosh, Boaz; Ploegh, Hidde L.; Navon, Ami			N-linked glycosylation does not impair proteasomal degradation but affects class I major histocompatibility complex presentation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED-PROTEIN RESPONSE; MHC CLASS-I; ER-ASSOCIATED DEGRADATION; ENERGY-DEPENDENT PROTEASES; RECOGNIZES SUGAR CHAINS; E3 UBIQUITIN LIGASE; ENDOPLASMIC-RETICULUM; MEMBRANE-PROTEIN; SACCHAROMYCES-CEREVISIAE; MISFOLDED GLYCOPROTEINS	The addition of N-linked glycans to nascent polypeptides occurs cotranslationally in the endoplasmic reticulum (ER). For many proteins the state of the glycans serves as an indicator, which allows the ER quality control system to monitor the conformation of polypeptides upon folding. Proteins that fail to fold in the ER are often dislocated to the cytoplasm, where they are subjected to proteasomal degradation. Although the addition of N-linked glycans occurs within the ER, non-lysosomal removal of the glycans occurs in the cytosol by the action of peptide N-glycanase (PNGase). In this study, we investigated the interplay between PNGase action and proteasomal degradation of ER misfolded proteins (i.e. whether PNGase acts prior to or following proteasomal degradation). Interestingly, we found that glycan removal from N-terminally extended peptides modulates the presentation of class I major histocompatibility complex-restricted epitopes. Our findings provide direct evidence that the proteasome is capable of degrading glycoproteins without prior removal of their glycans. This degradation is independent of either the identity of the glycosylated protein or the type and number of N-linked glycans it harbors. We also captured and characterized glycopeptides generated following proteasomal degradation of RNaseB. Although the carbohydrate moiety reduced the variability of the degradation products that include the glycosylated residue ( local effect), the overall global digestion pattern of RNaseB was unaffected. Together with earlier findings by others, our data support a model in which PNGase may act both upstream and downstream to proteasomal degradation and demonstrates its important role in class I major histocompatibility complex antigen presentation.	[Kario, Edith; Navon, Ami] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel; [Tirosh, Boaz] Hebrew Univ Jerusalem, Fac Med, Sch Pharm, Dept Pharmacol, IL-91120 Jerusalem, Israel; [Ploegh, Hidde L.] Whitehead Inst Biomed Res, Cambridge, MA 02124 USA	Weizmann Institute of Science; Hebrew University of Jerusalem; Massachusetts Institute of Technology (MIT); Whitehead Institute	Navon, A (corresponding author), Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel.	ami.navon@weizmann.ac.il						Altrich-VanLith ML, 2006, J IMMUNOL, V177, P5440, DOI 10.4049/jimmunol.177.8.5440; Ben-Shahar S, 1999, J BIOL CHEM, V274, P21963, DOI 10.1074/jbc.274.31.21963; Biswas S, 2004, BIOCHEM BIOPH RES CO, V323, P149, DOI 10.1016/j.bbrc.2004.08.061; Blom D, 2004, EMBO J, V23, P650, DOI 10.1038/sj.emboj.7600090; Bonifacino JS, 2003, NAT REV MOL CELL BIO, V4, P409, DOI 10.1038/nrm1099; Casagrande R, 2000, MOL CELL, V5, P729, DOI 10.1016/S1097-2765(00)80251-8; Cascio P, 2001, EMBO J, V20, P2357, DOI 10.1093/emboj/20.10.2357; CHEN WS, 1994, J EXP MED, V180, P1471, DOI 10.1084/jem.180.4.1471; CONFALONIERI F, 1995, BIOESSAYS, V17, P639, DOI 10.1002/bies.950170710; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; Friedlander R, 2000, NAT CELL BIOL, V2, P379, DOI 10.1038/35017001; GOLDBERG AL, 1995, SCIENCE, V268, P522, DOI 10.1126/science.7725095; Gottesman S, 1997, CELL, V91, P435, DOI 10.1016/S0092-8674(00)80428-6; GOTTESMAN S, 1992, MICROBIOL REV, V56, P592, DOI 10.1128/MMBR.56.4.592-621.1992; Groll M, 2000, NAT STRUCT BIOL, V7, P1062, DOI 10.1038/80992; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Hanna J, 2003, MOL CELL BIOL, V23, P9251, DOI 10.1128/MCB.23.24.9251-9261.2003; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hirsch C, 2003, EMBO J, V22, P1036, DOI 10.1093/emboj/cdg107; Hirsch C, 2004, EMBO REP, V5, P201, DOI 10.1038/sj.embor.7400066; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Hoppe T, 2000, CELL, V102, P577, DOI 10.1016/S0092-8674(00)00080-5; Hudrisier D, 1999, J BIOL CHEM, V274, P36274, DOI 10.1074/jbc.274.51.36274; Huppa JB, 1997, IMMUNITY, V7, P113, DOI 10.1016/S1074-7613(00)80514-2; JOAO HC, 1993, EUR J BIOCHEM, V218, P239, DOI 10.1111/j.1432-1033.1993.tb18370.x; Katiyar S, 2004, P NATL ACAD SCI USA, V101, P13774, DOI 10.1073/pnas.0405663101; Kisselev AF, 2002, J BIOL CHEM, V277, P22260, DOI 10.1074/jbc.M112360200; Kohler A, 2001, MOL CELL, V7, P1143, DOI 10.1016/S1097-2765(01)00274-X; Kostova Z, 2005, J CELL SCI, V118, P1485, DOI 10.1242/jcs.01740; Lam YA, 2002, NATURE, V416, P763, DOI 10.1038/416763a; Lee BS, 2005, RAPID COMMUN MASS SP, V19, P1545, DOI 10.1002/rcm.1956; Lee JH, 2005, P NATL ACAD SCI USA, V102, P9144, DOI 10.1073/pnas.0502082102; Liu CW, 2003, SCIENCE, V299, P408, DOI 10.1126/science.1079293; LOWE J, 1995, SCIENCE, V268, P533, DOI 10.1126/science.7725097; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Misaghi S, 2004, CHEM BIOL, V11, P1677, DOI 10.1016/j.chembiol.2004.11.010; Mori K, 2000, CELL, V101, P451, DOI 10.1016/S0092-8674(00)80855-7; Navon A, 2001, MOL CELL, V8, P1339, DOI 10.1016/S1097-2765(01)00407-5; Park H, 2001, P NATL ACAD SCI USA, V98, P11163, DOI 10.1073/pnas.201393498; Piwko W, 2006, NAT STRUCT MOL BIOL, V13, P691, DOI 10.1038/nsmb1122; Porgador A, 1997, IMMUNITY, V6, P715, DOI 10.1016/S1074-7613(00)80447-1; Rehm A, 2001, EMBO J, V20, P1573, DOI 10.1093/emboj/20.7.1573; Reits E, 2003, IMMUNITY, V18, P97, DOI 10.1016/S1074-7613(02)00511-3; Rock KL, 2004, NAT IMMUNOL, V5, P670, DOI 10.1038/ni1089; Romisch K, 1997, P NATL ACAD SCI USA, V94, P6730, DOI 10.1073/pnas.94.13.6730; Schott E, 2002, P NATL ACAD SCI USA, V99, P13735, DOI 10.1073/pnas.212515399; Sidrauski C, 1996, CELL, V87, P405, DOI 10.1016/S0092-8674(00)81361-6; Skipper JCA, 1996, J EXP MED, V183, P527, DOI 10.1084/jem.183.2.527; Spear ED, 2005, J CELL BIOL, V169, P73, DOI 10.1083/jcb.200411136; Suzuki T, 2001, J BIOL CHEM, V276, P21601, DOI 10.1074/jbc.M100826200; Suzuki T, 2000, J CELL BIOL, V149, P1039, DOI 10.1083/jcb.149.5.1039; Tirosh B, 2005, J VIROL, V79, P2768, DOI 10.1128/JVI.79.5.2768-2779.2005; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Urano F, 2002, J CELL BIOL, V158, P639, DOI 10.1083/jcb.200203086; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Walz J, 1998, J STRUCT BIOL, V121, P19, DOI 10.1006/jsbi.1998.3958; Whitby FG, 2000, NATURE, V408, P115, DOI 10.1038/35040607; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; Yewdell JW, 2003, NAT REV IMMUNOL, V3, P952, DOI 10.1038/nri1250; Yoshida Y, 2002, NATURE, V418, P438, DOI 10.1038/nature00890; Yoshida Y, 2003, J BIOL CHEM, V278, P43877, DOI 10.1074/jbc.M304157200; Yu H, 1997, J BIOL CHEM, V272, P20800, DOI 10.1074/jbc.272.33.20800	64	39	39	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					244	254		10.1074/jbc.M706237200	http://dx.doi.org/10.1074/jbc.M706237200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17951257	hybrid			2022-12-27	WOS:000251940300028
J	Zhou, D; Shen, R; Ye, JJ; Li, Y; Tsark, W; Isbell, D; Tso, P; Chen, S				Zhou, Dujin; Shen, Ruoqing; Ye, Jing Jing; Li, Yuping; Tsark, Walter; Isbell, Donna; Tso, Patrick; Chen, Shiuan			Nuclear receptor coactivator PNRC2 regulates energy expenditure and adiposity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROLIFERATOR-ACTIVATED RECEPTOR; PPAR-GAMMA; TRANSCRIPTIONAL REGULATION; ADIPOCYTE DIFFERENTIATION; GLUCOSE-HOMEOSTASIS; LIPOPROTEIN-LIPASE; LIPID HOMEOSTASIS; SKELETAL-MUSCLE; FAT-METABOLISM; BILE-ACID	PNRC2 was identified in our laboratory as a general cofactor for nuclear receptors. To better characterize the physiological function of PNRC2, we used gene-targeting technology to generate PNRC2-null mice ( PNRC2(-/-) mice). These PNRC2(-/-) mice are viable and fertile. PNRC2-null mice, especially male mice, are lean and are resistant to high fat diet-induced obesity but without the induction of insulin resistance. Male mice devoid of PNRC2 protein have a higher metabolic rate than wild-type mice. They consume more oxygen and produce more heat. Consistent with reduced adipose mass, the levels of leptin are lower in PNRC2(-/-) mice. This study provides evidence that PNRC2 plays one or more important roles in controlling the energy balance between energy storage and energy expenditure. PNRC2 may be a new target in the treatment of obesity and related metabolic diseases.	[Zhou, Dujin; Shen, Ruoqing; Ye, Jing Jing; Li, Yuping; Chen, Shiuan] Beckman Res Inst, Dept Surg Res, Duarte, CA 91010 USA; [Tsark, Walter] Beckman Res Inst, Transgen Mouse Facil, Duarte, CA 91010 USA; [Isbell, Donna] Beckman Res Inst, Anim Resources Ctr, Duarte, CA 91010 USA; [Tso, Patrick] Univ Cincinnati, Dept Pathol & Lab Med, Cincinnati, OH 45267 USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; University System of Ohio; University of Cincinnati	Chen, S (corresponding author), Beckman Res Inst, Dept Surg Res, Duarte, CA 91010 USA.	schen@coh.org	Li, Yuping/J-3138-2018		NATIONAL CANCER INSTITUTE [P30CA033572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK059630, R01DK060560] Funding Source: NIH RePORTER; NCI NIH HHS [CA 33572] Funding Source: Medline; NIDDK NIH HHS [DK 60560, DK 59630] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ahima RS, 2005, TRENDS ENDOCRIN MET, V16, P307, DOI 10.1016/j.tem.2005.07.010; Albers M, 2005, MOL CELL PROTEOMICS, V4, P205, DOI 10.1074/mcp.M400169-MCP200; Berkenstam A, 2004, MECH AGEING DEV, V125, P707, DOI 10.1016/j.mad.2004.05.005; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Chiang John Y L, 2005, Curr Opin Investig Drugs, V6, P994; Cooke PS, 2005, BIRTH DEFECTS RES A, V73, P472, DOI 10.1002/bdra.20142; Coppari R, 2005, CELL METAB, V1, P63, DOI 10.1016/j.cmet.2004.12.004; D'Eon TM, 2005, J BIOL CHEM, V280, P35983, DOI 10.1074/jbc.M507339200; Darlington GJ, 1998, J BIOL CHEM, V273, P30057, DOI 10.1074/jbc.273.46.30057; DUYAO MP, 1995, SCIENCE, V269, P407, DOI 10.1126/science.7618107; Elmquist JK, 2005, J COMP NEUROL, V493, P63, DOI 10.1002/cne.20786; ENERBACK S, 1993, BIOCHIM BIOPHYS ACTA, V1169, P107, DOI 10.1016/0005-2760(93)90196-G; Farmer S R, 2004, Obes Rev, V5, P189, DOI 10.1111/j.1467-789X.2004.00157.x; Fayard E, 2004, TRENDS CELL BIOL, V14, P250, DOI 10.1016/j.tcb.2004.03.008; FOLCH J, 1951, J BIOL CHEM, V191, P833; Francis GA, 2003, ANNU REV PHYSIOL, V65, P261, DOI 10.1146/annurev.physiol.65.092101.142528; Handschin C, 2005, ARCH BIOCHEM BIOPHYS, V433, P387, DOI 10.1016/j.abb.2004.08.030; Havel PJ, 2002, CURR OPIN LIPIDOL, V13, P51, DOI 10.1097/00041433-200202000-00008; Hentschke M, 2003, BIOCHEM BIOPH RES CO, V312, P975, DOI 10.1016/j.bbrc.2003.11.025; Huss JM, 2004, MOL CELL BIOL, V24, P9079, DOI 10.1128/MCB.24.20.9079-9091.2004; Ishibashi S, 1996, J BIOL CHEM, V271, P18017, DOI 10.1074/jbc.271.30.18017; Jakel H, 2006, DRUG NEWS PERSPECT, V19, P91, DOI 10.1358/dnp.2006.19.2.977445; Kalaany NY, 2006, ANNU REV PHYSIOL, V68, P159, DOI 10.1146/annurev.physiol.68.033104.152158; Kamei Y, 2003, P NATL ACAD SCI USA, V100, P12378, DOI 10.1073/pnas.2135217100; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; Lau P, 2004, J BIOL CHEM, V279, P36828, DOI 10.1074/jbc.M404927200; Leonardsson G, 2004, P NATL ACAD SCI USA, V101, P8437, DOI 10.1073/pnas.0401013101; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Makowski L, 2005, CURR OPIN LIPIDOL, V16, P543, DOI 10.1097/01.mol.0000180166.08196.07; Mayes J S, 2004, Obes Rev, V5, P197, DOI 10.1111/j.1467-789X.2004.00152.x; Moats Rex A, 2003, Mol Imaging, V2, P150, DOI 10.1162/153535003322556895; Moverare-Skrtic S, 2006, OBESITY, V14, P662, DOI 10.1038/oby.2006.75; Nedergaard J, 2005, BBA-MOL BASIS DIS, V1740, P293, DOI 10.1016/j.bbadis.2005.02.003; Palin SL, 2003, METABOLISM, V52, P383, DOI 10.1053/meta.2003.50088; Picard F, 2002, CELL, V111, P931, DOI 10.1016/S0092-8674(02)01169-8; Reddy JK, 2001, ANNU REV NUTR, V21, P193, DOI 10.1146/annurev.nutr.21.1.193; Ricquier D, 2005, P NUTR SOC, V64, P47, DOI 10.1079/PNS2004408; ROSEN, 1999, MOL CELL, V4, P611; Rosen ED, 2000, GENE DEV, V14, P1293; Schreiber SN, 2004, P NATL ACAD SCI USA, V101, P6472, DOI 10.1073/pnas.0308686101; Semple RK, 2006, J CLIN INVEST, V116, P581, DOI 10.1172/JCI28003; Shulman GI, 2004, PHYSIOLOGY, V19, P183, DOI 10.1152/physiol.00007.2004; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Spiegelman BM, 2000, INT J OBESITY, V24, pS8, DOI 10.1038/sj.ijo.0801492; Staels B, 2001, J AM ACAD DERMATOL, V45, pS158, DOI 10.1067/mjd.2001.113718; Tontonoz P, 2003, MOL ENDOCRINOL, V17, P985, DOI 10.1210/me.2003-0061; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Wang L, 2005, CELL METAB, V2, P227, DOI 10.1016/j.cmet.2005.08.010; Wang YX, 2003, CELL, V113, P159, DOI 10.1016/S0092-8674(03)00269-1; Xu JM, 1998, SCIENCE, V279, P1922, DOI 10.1126/science.279.5358.1922; Zhang M, 2001, J BIOL CHEM, V276, P41690, DOI 10.1074/jbc.M105117200; Zhou DJ, 2005, GENE, V361, P89, DOI 10.1016/j.gene.2005.07.012; Zhou DJ, 2001, NUCLEIC ACIDS RES, V29, P3939, DOI 10.1093/nar/29.19.3939; Zhou DJ, 2000, MOL ENDOCRINOL, V14, P986, DOI 10.1210/me.14.7.986	55	13	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					541	553		10.1074/jbc.M703234200	http://dx.doi.org/10.1074/jbc.M703234200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17971453	hybrid			2022-12-27	WOS:000251940300059
J	Perrin, MH; Grace, CRR; DiGruccio, MR; Fischer, WH; Maji, SK; Cantle, JP; Smith, S; Manning, G; Vale, WW; Riek, R				Perrin, Marilyn H.; Grace, Christy R. R.; DiGruccio, Michael R.; Fischer, Wolfgang H.; Maji, Samir K.; Cantle, Jeffrey P.; Smith, Sean; Manning, Gerard; Vale, Wylie W.; Riek, Roland			Distinct structural and functional roles of conserved residues in the first extracellular domain of receptors for corticotropin-releasing factor and related G-protein-coupled receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL DOMAIN; 1ST EXTRACELLULAR DOMAIN; TYPE-2 RECEPTOR; CONSTITUTIVE ACTIVATION; CHIMERIC RECEPTORS; CRYSTAL-STRUCTURE; LIGAND-BINDING; MOLTEN GLOBULE; PEPTIDE LIGAND; ASPARTIC-ACID	The G-protein-coupled receptor B1 family includes corticotropin-releasing factor (CRF), growth hormone-releasing hormone, incretin, and pituitary adenylate cyclase-activating polypeptide receptors. The three-dimensional NMR structure of the first extracellular domain (ECD1) of CRF receptor 2 beta ( CRF-R2 beta), free and complexed with astressin, comprises a Sushi domain. This domain is stabilized in part by a salt bridge between Asp(65) and Arg(101). Analogous residues are conserved in other members of the B1 family. To address the importance of the salt bridge residues within this receptor family, we studied the effects of mutating the residues in full-length CRF-R2 beta and isolated ECD1. Mutation D65A or D65R/ R101D resulted in loss of the canonical disulfide arrangement, whereas R101A retained the Cys(4) -Cys(6) disulfide bond. The mutations resulted in misfolding within the ECD1 as determined by NMR and 1-anilino8-naphthalenesulfonate binding but did not prevent cell surface expression. The D65A mutation in CRF-R2 beta greatly reduced binding and activation, but the R101A substitution had only a small effect. Similar effects were seen on astressin binding to the ECD1. The different interactions of Asp65 and Arg101, deduced from the three-dimensional structure of the complex, are consistent with the differential effects seen in the mutants. The reduction in binding of Asp65 mutants is a consequence of a distinct Asp65 -Trp(71) interaction, which stabilizes the ligand-binding loop. Hence, loss of the salt bridge leads to disruption of the overall fold but does not abolish function. Because homologous mutations in other B1 receptors produce similar effects, these conserved residues may play similar roles in the entire receptor family.	[Perrin, Marilyn H.; DiGruccio, Michael R.; Fischer, Wolfgang H.; Cantle, Jeffrey P.; Smith, Sean; Vale, Wylie W.] Clayton Fdn Labs Peptide Biol, La Jolla, CA 92037 USA; [Grace, Christy R. R.; Maji, Samir K.; Riek, Roland] Struct Biol Lab, La Jolla, CA 92037 USA; [Manning, Gerard] Razavi Newman Ctr Bioinformat, Salk Inst, La Jolla, CA 92037 USA; [Riek, Roland] ETH, Phys Chem Lab, Zurich, Switzerland	Salk Institute; Swiss Federal Institutes of Technology Domain; ETH Zurich	Perrin, MH (corresponding author), Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	perrin@salk.edu; riek@salk.edu	Manning, Gerard/C-8308-2009; Maji, Samir K. K./B-9640-2019	Maji, Samir K. K./0000-0002-9110-1565; DiGruccio, Michael/0000-0002-9375-2425; Riek, Roland/0000-0002-6333-066X; Manning, Gerard/0000-0002-5087-9151	NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004164] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK026741] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA014195] Funding Source: Medline; NHGRI NIH HHS [R01 HG004164, R01 HG004164-01] Funding Source: Medline; NIDDK NIH HHS [P01 DK26741] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		CAO YJ, 1995, BIOCHEM BIOPH RES CO, V212, P673, DOI 10.1006/bbrc.1995.2021; CARRUTHERS CJL, 1994, J BIOL CHEM, V269, P29321; Chauhan M, 2005, BIOCHEMISTRY-US, V44, P782, DOI 10.1021/bi049153f; COUVINEAU A, 1995, BIOCHEM BIOPH RES CO, V206, P246, DOI 10.1006/bbrc.1995.1034; Couvineau A, 2006, ANN NY ACAD SCI, V1070, P205, DOI 10.1196/annals.1317.015; Dautzenberg FM, 1999, J NEUROCHEM, V73, P821, DOI 10.1046/j.1471-4159.1999.0730821.x; Dautzenberg FM, 2002, MOL PHARMACOL, V61, P1132, DOI 10.1124/mol.61.5.1132; de Maturana RL, 2003, J BIOL CHEM, V278, P10195, DOI 10.1074/jbc.M212147200; Di Paolo E, 1999, PEPTIDES, V20, P1187, DOI 10.1016/S0196-9781(99)00122-9; Gaudin P, 1998, J BIOL CHEM, V273, P4990, DOI 10.1074/jbc.273.9.4990; Grace CRR, 2007, P NATL ACAD SCI USA, V104, P4858, DOI 10.1073/pnas.0700682104; Grace CRR, 2004, P NATL ACAD SCI USA, V101, P12836, DOI 10.1073/pnas.0404702101; Grauschopf U, 2000, BIOCHEMISTRY-US, V39, P8878, DOI 10.1021/bi0001426; Hoare SRJ, 2005, PEPTIDES, V26, P457, DOI 10.1016/j.peptides.2004.10.019; Hoare SRJ, 2004, BIOCHEMISTRY-US, V43, P3996, DOI 10.1021/bi036110a; HOLTMANN MH, 1995, J BIOL CHEM, V270, P14394, DOI 10.1074/jbc.270.24.14394; Ittner LM, 2004, BIOCHEM BIOPH RES CO, V319, P1203, DOI 10.1016/j.bbrc.2004.05.103; Kee F, 2005, GEN COMP ENDOCR, V140, P41, DOI 10.1016/j.ygcen.2004.09.010; LIN SC, 1993, NATURE, V364, P208, DOI 10.1038/364208a0; Negro A, 2006, P NATL ACAD SCI USA, V103, P15889, DOI 10.1073/pnas.0607499103; Nielsen SM, 2000, P NATL ACAD SCI USA, V97, P10277, DOI 10.1073/pnas.97.18.10277; Parthier C, 2007, P NATL ACAD SCI USA, V104, P13942, DOI 10.1073/pnas.0706404104; Perrin MH, 2003, J BIOL CHEM, V278, P15595, DOI 10.1074/jbc.M210476200; Perrin MH, 2001, J BIOL CHEM, V276, P31528, DOI 10.1074/jbc.M101838200; Perrin MH, 1998, ENDOCRINOLOGY, V139, P566, DOI 10.1210/en.139.2.566; Perrin MH, 1999, J PHARMACOL EXP THER, V288, P729; Redfield C, 2004, METHODS, V34, P121, DOI 10.1016/j.ymeth.2004.03.009; Schwarzenbacher R, 1999, EMBO J, V18, P6228, DOI 10.1093/emboj/18.22.6228; Sun CH, 2007, P NATL ACAD SCI USA, V104, P7875, DOI 10.1073/pnas.0611397104; Vamvaca K, 2004, P NATL ACAD SCI USA, V101, P12860, DOI 10.1073/pnas.0404109101; Wilmen A, 1996, FEBS LETT, V398, P43, DOI 10.1016/S0014-5793(96)01214-8; [No title captured]	32	18	18	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37529	37536		10.1074/jbc.M703748200	http://dx.doi.org/10.1074/jbc.M703748200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17940290	hybrid			2022-12-27	WOS:000251833600028
J	Gupta, M; Copeland, PR				Gupta, Malavika; Copeland, Paul R.			Functional analysis of the interplay between translation termination, selenocysteine codon context, and selenocysteine insertion sequence-binding protein 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT SELENOPROTEIN-P; OPEN READING FRAME; STOP CODON; MAMMALIAN SELENOCYSTEINE; UGA CODONS; EFFICIENCY; MACHINERY; MECHANISM; ELEMENT; GENE	A selenocysteine insertion sequence ( SECIS) element in the 3'-untranslated region and an in-frame UGA codon are the requisite cis-acting elements for the incorporation of selenocysteine into selenoproteins. Equally important are the trans-acting factors SBP2, Sec-tRNA([Ser] Sec), and eEFSec. Multiple in-frame UGAs and two SECIS elements make the mRNA encoding selenoprotein P ( Sel P) unique. To study the role of codon context in determining the efficiency of UGA readthrough at each of the 10 rat Sel P Sec codons, we individually cloned 27-nucleotide-long fragments representing each UGA codon context into a luciferase reporter construct harboring both Sel P SECIS elements. Significant differences, spanning an 8-fold range of UGA readthrough efficiency, were observed, but these differences were dramatically reduced in the presence of excess SBP2. Mutational analysis of the "fourth base" of contexts 1 and 5 revealed that only the latter followed the established rules for hierarchy of translation termination. In addition, mutations in either or both of the Sel P SECIS elements resulted in differential effects on UGA readthrough. Interestingly, even when both SECIS elements harbored a mutation of the core region required for Sec incorporation, context 5 retained a significantly higher level of readthrough than context 1. We also show that SBP2-dependent Sec incorporation is able to repress G418-induced UGA readthrough as well as eRF1-induced stimulation of termination. We conclude that a large codon context forms a cis-element that works together with Sec incorporation factors to determine readthrough efficiency.	[Gupta, Malavika; Copeland, Paul R.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Microbiol Mol Genet & Immunol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Copeland, PR (corresponding author), 675 Hoes Lane, Piscataway, NJ 08854 USA.	paul.copeland@umdnj.edu		Copeland, Paul/0000-0003-3343-0587	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068077] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM068077-01, R01 GM068077, GM068077] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Berry MJ, 2005, NAT STRUCT MOL BIOL, V12, P389, DOI 10.1038/nsmb0505-389; Berry MJ, 2001, BIOFACTORS, V14, P17, DOI 10.1002/biof.5520140104; Caban K, 2006, CELL MOL LIFE SCI, V63, P73, DOI 10.1007/s00018-005-5402-y; Caban K, 2007, MOL CELL BIOL, V27, P6350, DOI 10.1128/MCB.00632-07; Chavatte L, 2005, NAT STRUCT MOL BIOL, V12, P408, DOI 10.1038/nsmb922; Copeland PR, 2000, EMBO J, V19, P306, DOI 10.1093/emboj/19.2.306; Copeland PR, 2003, GENE, V312, P17, DOI 10.1016/S0378-1119(03)00588-2; Cridge AG, 2006, NUCLEIC ACIDS RES, V34, P1959, DOI 10.1093/nar/gkl074; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Driscoll DM, 2003, ANNU REV NUTR, V23, P17, DOI 10.1146/annurev.nutr.23.011702.073318; Grundner-Culemann E, 1999, RNA, V5, P625, DOI 10.1017/S1355838299981542; Grundner-Culemann E, 2001, J MOL BIOL, V310, P699, DOI 10.1006/jmbi.2001.4809; Handy DE, 2006, J BIOL CHEM, V281, P3382, DOI 10.1074/jbc.M511295200; HILL KE, 1993, P NATL ACAD SCI USA, V90, P537, DOI 10.1073/pnas.90.2.537; HILL KE, 1991, J BIOL CHEM, V266, P10050; Howard MT, 2007, RNA, V13, P912, DOI 10.1261/rna.473907; Jacobs GH, 2006, NUCLEIC ACIDS RES, V34, pD37, DOI 10.1093/nar/gkj159; Kinzy SA, 2005, NUCLEIC ACIDS RES, V33, P5172, DOI 10.1093/nar/gki826; LEE BJ, 1990, MOL CELL BIOL, V10, P1940, DOI 10.1128/MCB.10.5.1940; Lesoon A, 1997, MOL CELL BIOL, V17, P1977, DOI 10.1128/MCB.17.4.1977; Ma SG, 2002, J BIOL CHEM, V277, P12749, DOI 10.1074/jbc.M111462200; Manuvakhova M, 2000, RNA, V6, P1044, DOI 10.1017/S1355838200000716; MCCAUGHAN KK, 1995, P NATL ACAD SCI USA, V92, P5431, DOI 10.1073/pnas.92.12.5431; Mehta A, 2004, J BIOL CHEM, V279, P37852, DOI 10.1074/jbc.M404639200; MOTTAGUITABAR S, 1994, EMBO J, V13, P249, DOI 10.1002/j.1460-2075.1994.tb06255.x; Namy O, 2001, EMBO REP, V2, P787, DOI 10.1093/embo-reports/kve176; Nasim MT, 2000, J BIOL CHEM, V275, P14846, DOI 10.1074/jbc.275.20.14846; POOLE ES, 1995, EMBO J, V14, P151, DOI 10.1002/j.1460-2075.1995.tb06985.x; Stoytcheva Z, 2006, MOL CELL BIOL, V26, P9177, DOI 10.1128/MCB.00856-06	29	21	22	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					36797	36807		10.1074/jbc.M707061200	http://dx.doi.org/10.1074/jbc.M707061200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17954931	hybrid, Green Accepted			2022-12-27	WOS:000251646000004
J	Obiozo, UM; Brondijk, THC; White, AJ; van Boxel, G; Dafforn, TR; White, SA; Jackson, JB				Obiozo, U. Mirian; Brondijk, T. Harma C.; White, Andrew J.; van Boxel, Gijs; Dafforn, Tim R.; White, Scott A.; Jackson, J. Baz			Substitution of tyrosine 146 in the dI component of proton-translocating transhydrogenase leads to reversible dissociation of the active dimer into inactive monomers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINAMIDE NUCLEOTIDE TRANSHYDROGENASE; MOBILE-LOOP REGION; AMINO-ACID-RESIDUES; RHODOSPIRILLUM-RUBRUM; DOMAIN-I; SUBUNIT STRUCTURE; HYDRIDE TRANSFER; NADP(H)-BINDING COMPONENT; NAD(H)-BINDING COMPONENT; CONFORMATIONAL-CHANGES	Transhydrogenase couples the redox reaction between NADH and NADP(+) to proton translocation across a membrane. The protein has three components:dI binds NADH, dIII binds NADP(+), and dII spans the membrane. Transhydrogenase is a "dimer" of two dI-dII-dIII "monomers"; x-ray structures suggested that the two catalytic sites alternate during turnover. Invariant Tyr(146) in recombinant dI of Rhodospirillum rubrum transhydrogenase was substituted with Phe and Ala (proteins designated dI.Y146F and dI.Y146A, respectively). Analytical ultracentrifuge experiments and differential scanning calorimetry show that dI.Y146A more readily dissociates into monomers than wild-type dI. Analytical ultracentrifuge and Trp fluorescence experiments indicate that the dI.Y146A monomers bind NADH much more weakly than dimers. Wild-type dI and dI.Y146F reconstituted activity to dI-depleted membranes with similar characteristics. However, dI.Y146A reconstituted activity in its dimeric form but not in its monomeric form, this despite monomers retaining their native fold and binding to the dI-depleted membranes. It is suggested that transhydrogenase reconstructed with monomers of dI.Y146A is catalytically compromised, at least partly as a consequence of the lowered affinity for NADH, and this results from lost interactions between the nucleotide binding site and the protein beta-hairpin upon dissociation of the dI dimer. The importance of these interactions and their coupling to dI domain rotation in the mechanism of action of transhydrogenase is emphasized. Two peaks in the H-1 NMR spectrum of wild-type dI are broadened in dI. Y146A and are tentatively assigned to S-methyl groups of Met resonances in the beta-hairpin, consistent with the segmental mobility of this feature in the structure.	Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Jackson, JB (corresponding author), Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England.	j.b.jackson@bham.ac.uk	Brondijk, Harma/AAD-6485-2019; Dafforn, Tim/A-9072-2015	Brondijk, Harma/0000-0002-0234-673X; White, Scott/0000-0002-0202-6154; Dafforn, Tim/0000-0003-2257-6679				AMBARTSOUMIAN G, 1994, MICROBIOL-UK, V140, P1737, DOI 10.1099/13500872-140-7-1737; ANDERSON WM, 1981, BIOCHIM BIOPHYS ACTA, V635, P194, DOI 10.1016/0005-2728(81)90018-9; Arkblad EL, 2005, FREE RADICAL BIO MED, V38, P1518, DOI 10.1016/j.freeradbiomed.2005.02.012; BALBO A, 2006, OFFICE RES SERVICES; Bhakta T, 2007, BIOCHEMISTRY-US, V46, P3304, DOI 10.1021/bi061843r; Bizouarn T, 1996, EUR J BIOCHEM, V239, P737, DOI 10.1111/j.1432-1033.1996.0737u.x; Bizouarn T, 1997, BBA-BIOENERGETICS, V1320, P265, DOI 10.1016/S0005-2728(97)00030-3; Brondijk THC, 2006, J BIOL CHEM, V281, P13345, DOI 10.1074/jbc.M513230200; Broos J, 2003, J BIOL CHEM, V278, P47578, DOI 10.1074/jbc.M309287200; Buckley PA, 2000, STRUCTURE, V8, P809, DOI 10.1016/S0969-2126(00)00171-4; Chaillan-Huntington C, 2001, J MOL BIOL, V314, P465, DOI 10.1006/jmbi.2001.5136; CLAYTON RK, 1963, BIOCHIM BIOPHYS ACTA, V75, P312, DOI 10.1016/0006-3002(63)90618-8; Cotton NPJ, 2001, STRUCTURE, V9, P165, DOI 10.1016/S0969-2126(01)00571-8; CUNNINGHAM IJ, 1992, BIOCHIM BIOPHYS ACTA, V1100, P332, DOI 10.1016/0167-4838(92)90490-5; DIGGLE C, 1995, EUR J BIOCHEM, V232, P315, DOI 10.1111/j.1432-1033.1995.tb20814.x; DIGGLE C, 1995, EUR J BIOCHEM, V228, P719, DOI 10.1111/j.1432-1033.1995.0719m.x; Diggle C, 1996, EUR J BIOCHEM, V241, P162, DOI 10.1111/j.1432-1033.1996.0162t.x; FERSHT A, 1999, STRUCTURE MECH PROTE, P158; FISHER RR, 1971, J BIOL CHEM, V246, P4679; Freeman H, 2006, CELL METAB, V3, P35, DOI 10.1016/j.cmet.2005.10.008; Grimley RL, 1997, BIOCHEMISTRY-US, V36, P14762, DOI 10.1021/bi971832l; Gupta S, 1998, BBA-BIOENERGETICS, V1409, P25, DOI 10.1016/S0005-2728(98)00146-7; HANSON RL, 1980, J BACTERIOL, V141, P401, DOI 10.1128/JB.141.1.401-404.1980; Hickman JW, 2002, J BACTERIOL, V184, P400, DOI 10.1128/JB.184.2.400-409.2002; HOU C, 1990, BIOCHIM BIOPHYS ACTA, V1018, P61, DOI 10.1016/0005-2728(90)90110-P; Jackson JB, 2005, RSC BIOMOLEC SCI, P376; Jackson JB, 2003, FEBS LETT, V545, P18, DOI 10.1016/S0014-5793(03)00388-0; Jackson JB, 2002, BIOCHEMISTRY-US, V41, P4173, DOI 10.1021/bi012078d; Jeeves M, 1999, J BIOMOL NMR, V13, P305, DOI 10.1023/A:1008300609352; Johansson T, 2005, J MOL BIOL, V352, P299, DOI 10.1016/j.jmb.2005.07.022; JONES S, 1995, PROG BIOPHYS MOL BIO, V63, P31, DOI 10.1016/0079-6107(94)00008-W; Lian L. Y., 1993, NMR MACROMOLECULES P, P153; Mather OC, 2004, BIOCHEMISTRY-US, V43, P10952, DOI 10.1021/bi0497594; MEJBAUMKATZENELLENBOGEN W, 1959, CLIN CHIM ACTA, V4, P515, DOI 10.1016/0009-8981(59)90158-5; OSHINO N, 1977, BIOCHEM J, V162, P509, DOI 10.1042/bj1620509; PERSSON B, 1987, ARCH BIOCHEM BIOPHYS, V259, P341, DOI 10.1016/0003-9861(87)90500-5; PHELPS DC, 1984, BIOCHEMISTRY-US, V23, P4475, DOI 10.1021/bi00314a037; PHELPS DC, 1985, BIOCHEMISTRY-US, V24, P3503, DOI 10.1021/bi00335a017; Prasad GS, 2002, BIOCHEMISTRY-US, V41, P12745, DOI 10.1021/bi020251f; Quirk PG, 1999, FEBS LETT, V446, P127, DOI 10.1016/S0014-5793(99)00198-2; Quirk PG, 1999, BBA-BIOENERGETICS, V1412, P139, DOI 10.1016/S0005-2728(99)00057-2; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Singh A, 2003, J BIOL CHEM, V278, P33208, DOI 10.1074/jbc.M303061200; Sundaresan V, 2005, J MOL BIOL, V346, P617, DOI 10.1016/j.jmb.2004.11.070; van Boxel GI, 2003, BIOCHEMISTRY-US, V42, P1217, DOI 10.1021/bi027032e; Venning JD, 2001, J BIOL CHEM, V276, P30678, DOI 10.1074/jbc.M104429200; WILSON R, 2006, BIOCH BIOPHY ACTA, V1537, P215; WU LNY, 1983, J BIOL CHEM, V258, P7847	49	3	3	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36434	36443		10.1074/jbc.M705433200	http://dx.doi.org/10.1074/jbc.M705433200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17911104	hybrid			2022-12-27	WOS:000251458300035
J	Defer, N; Azroyan, A; Pecker, F; Pavoine, C				Defer, Nicole; Azroyan, Anie; Pecker, Francoise; Pavoine, Catherine			TNFR1 and TNFR2 signaling interplay in cardiac myocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; KINASE-C-ZETA; NF-KAPPA-B; FACTOR-ALPHA; PHOSPHOLAMBAN PHOSPHORYLATION; NEUTRAL SPHINGOMYELINASE; ACETYLCYSTEINE TREATMENT; PKC-ZETA; ACTIVATION; CONTRACTION	Tumor necrosis factor alpha(TNF alpha) plays a major role in chronic heart failure, signaling through two different receptor subtypes, TNFR1 and TNFR2. Our aim was to further delineate the functional role and signaling pathways related to TNFR1 and TNFR2 in cardiac myocytes. In cardiac myocytes isolated from control rats, TNF alpha induced ROS production, exerted a dual positive and negative action on [Ca2+] transient and cell fractional shortening, and altered cell survival. Neutralizing anti-TNFR2 antibodies exacerbated TNF alpha responses on ROS production and cell death, arguing for a major protective role of the TNFR2 pathway. Treatment with either neutralizing anti-TNFR1 antibodies or the glutathione precursor, N-acetylcysteine (NAC), favored the emergence of TNFR2 signaling that mediated a positive effect of TNF alpha on [Ca2+] transient and cell fractional shortening. The positive effect of TNF alpha relied on TNFR2-dependent activation of the cPLA(2) activity, independently of serine 505 phosphorylation of the enzyme. Together with cPLA2 redistribution and AA release, TNF alpha induced a time-dependent phosphorylation of ERK, MSK1, PKC zeta, CaMKII, and phospholamban on the threonine 17 residue. Taken together, our results characterized a TNFR2-dependent signaling and illustrated the close interplay between TNFR1 and TNFR2 pathways in cardiac myocytes. Although apparently predominant, TNFR1-dependent responses were under the yoke of TNFR2, acting as a critical limiting factor. In vivo NAC treatment proved to be a unique tool to selectively neutralize TNFR1-mediated effects of TNF alpha while releasing TNFR2 pathways.	Hop Henri Mondor, INSERM, Unite 841, Inst Mondor Rech Biomed,Equipe 19, F-94010 Creteil, France; Univ Paris 12, F-94010 Creteil, France	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC)	Pavoine, C (corresponding author), Hop Henri Mondor, INSERM, Unite 841, Inst Mondor Rech Biomed,Equipe 19, F-94010 Creteil, France.	catherine.pavoine@creteil.inserm.fr	Pavoine, Catherine/N-4405-2018	Pavoine, Catherine/0000-0002-0598-5545				Adamy C, 2007, J MOL CELL CARDIOL, V43, P344, DOI 10.1016/j.yjmcc.2007.06.010; Aimond F, 2000, J BIOL CHEM, V275, P39110, DOI 10.1074/jbc.M008192200; Ait-Mamar B, 2005, J BIOL CHEM, V280, P18881, DOI 10.1074/jbc.M410305200; Amadou A, 2002, AM J PHYSIOL-CELL PH, V282, pC1339, DOI 10.1152/ajpcell.00471.2001; Bossen C, 2006, J BIOL CHEM, V281, P13964, DOI 10.1074/jbc.M601553200; Bourraindeloup M, 2004, CIRCULATION, V110, P2003, DOI 10.1161/01.CIR.0000143630.14515.7C; Cailleret M, 2004, CIRCULATION, V109, P406, DOI 10.1161/01.CIR.0000109499.00587.FF; Cingolani HE, 2006, HYPERTENSION, V47, P727, DOI 10.1161/01.HYP.0000208302.62399.68; Gullestad L, 2005, AM J CARDIOL, V95, p17C, DOI 10.1016/j.amjcard.2005.03.008; Hagemann D, 2002, TRENDS CARDIOVAS MED, V12, P51, DOI 10.1016/S1050-1738(01)00145-1; Haq S, 2003, NAT MED, V9, P944, DOI 10.1038/nm891; Hartshorne DJ, 2004, J BIOL CHEM, V279, P37211, DOI 10.1074/jbc.R400018200; Hayakawa M, 2003, EMBO J, V22, P3356, DOI 10.1093/emboj/cdg332; Higuchi Y, 2004, CIRCULATION, V109, P1892, DOI 10.1161/01.CIR.0000124227.00670.AB; Hirai T, 2003, J BIOCHEM, V133, P1, DOI 10.1093/jb/mvg017; Jupp OJ, 2003, BIOCHEM J, V374, P453, DOI 10.1042/BJ20030705; Kurrelmeyer KM, 2000, P NATL ACAD SCI USA, V97, P5456, DOI 10.1073/pnas.070036297; LaVallie ER, 2006, J BIOL CHEM, V281, P24124, DOI 10.1074/jbc.M601905200; LEVINE B, 1990, NEW ENGL J MED, V323, P236, DOI 10.1056/NEJM199007263230405; Liu B, 1998, J BIOL CHEM, V273, P11313, DOI 10.1074/jbc.273.18.11313; Mann D L, 1996, J Card Fail, V2, pS165, DOI 10.1016/S1071-9164(96)80073-X; Massion PB, 2003, CIRC RES, V93, P388, DOI 10.1161/01.RES.0000088351.58510.21; Mattiazzi A, 2005, CARDIOVASC RES, V68, P366, DOI 10.1016/j.cardiores.2005.08.010; Mehra VC, 2005, J LEUKOCYTE BIOL, V78, P805, DOI 10.1189/jlb.0405182; Meldrum DR, 1998, AM J PHYSIOL-REG I, V274, pR577, DOI 10.1152/ajpregu.1998.274.3.R577; Moscat J, 2006, CELL DEATH DIFFER, V13, P702, DOI 10.1038/sj.cdd.4401823; Pavoine C, 2005, CELL SIGNAL, V17, P141, DOI 10.1016/j.cellsig.2004.09.001; Phillipson A, 2005, AM J PHYSIOL-HEART C, V289, pH898, DOI 10.1152/ajpheart.00883.2003; Prabhu SD, 2004, CIRC RES, V95, P1140, DOI 10.1161/01.RES.0000150734.79804.92; Ramani R, 2004, AM J PHYSIOL-HEART C, V287, pH1369, DOI 10.1152/ajpheart.00641.2003; Sack MN, 2000, CARDIOVASC RES, V45, P688, DOI 10.1016/S0008-6363(99)00228-X; Sack MN, 2002, PHARMACOL THERAPEUT, V94, P123, DOI 10.1016/S0163-7258(02)00176-6; Sauvadet A, 1997, J BIOL CHEM, V272, P12437, DOI 10.1074/jbc.272.19.12437; Shen HM, 2006, FASEB J, V20, P1589, DOI 10.1096/fj.05-5603rev; TORREAMIONE G, 1995, CIRCULATION, V92, P1487, DOI 10.1161/01.CIR.92.6.1487; Vanderheyden M, 2005, HEART, V91, P926, DOI 10.1136/hrt.2004.035733; Xin MG, 2007, J BIOL CHEM, V282, P21268, DOI 10.1074/jbc.M701613200	37	72	79	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35564	35573		10.1074/jbc.M704003200	http://dx.doi.org/10.1074/jbc.M704003200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17913704	hybrid			2022-12-27	WOS:000251458100016
J	Lecchi, S; Nelson, CJ; Allen, KE; Swaney, DL; Thompson, KL; Coon, JJ; Sussman, MR; Slayman, CW				Lecchi, Silvia; Nelson, Clark J.; Allen, Kenneth E.; Swaney, Danielle L.; Thompson, Katie L.; Coon, Joshua J.; Sussman, Michael R.; Slayman, Carolyn W.			Tandem phosphorylation of Ser-911 and Thr-912 at the C terminus of yeast plasma membrane H+-ATPase leads to glucose-dependent activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-TRANSFER DISSOCIATION; PROTEIN-SEQUENCE ANALYSIS; MASS-SPECTROMETRY; SACCHAROMYCES-CEREVISIAE; REGULATORY DOMAIN; ION/ION REACTIONS; CALCIUM-PUMP; IDENTIFICATION; PHOSPHOLAMBAN; PEPTIDE	In recent years there has been growing interest in the post translational regulation of P-type ATPases by protein kinase mediated phosphorylation. Pma1 H+-ATPase, which is responsible for H+-dependent nutrient uptake in yeast ( Saccharomyces cerevisiae), is one such example, displaying a rapid 5-10-fold increase in activity when carbon-starved cells are exposed to glucose. Activation has been linked to Ser/Thr phosphorylation in the C-terminal tail of the ATPase, but the specific phosphorylation sites have not previously been mapped. The present study has used nanoflow high pressure liquid chromatography coupled with electrospray electron transfer dissociation tandem mass spectrometry to identify Ser-911 and Thr-912 as two major phosphorylation sites that are clearly related to glucose activation. In carbon-starved cells with low Pma1 activity, peptide 896-918, which was derived from the C terminus upon Lys-C proteolysis, was found to be singly phosphorylated at Thr-912, whereas in glucose-metabolizing cells with high ATPase activity, the same peptide was doubly phosphorylated at Ser-911 and Thr-912. Reciprocal N-14/N-15 metabolic labeling of cells was used to measure the relative phosphorylation levels at the two sites. The addition of glucose to carbon-starved cells led to a 3-fold reduction in the singly phosphorylated form and an 11-fold increase in the doubly phosphorylated form. These results point to a mechanism in which the stepwise phosphorylation of two tandemly positioned residues near the C terminus mediates glucose-dependent activation of the H+-ATPase.	Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA; Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; Univ Wisconsin, Dept Chem, Madison, WI 53706 USA; Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA	Yale University; Yale University; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Slayman, CW (corresponding author), Yale Univ, Sch Med, Dept Genet, 333 Cedar St, New Haven, CT 06510 USA.	carolyn.slayman@yale.edu		Nelson, Clark/0000-0002-8796-8326	NHGRI NIH HHS [HG 002706] Funding Source: Medline; NIGMS NIH HHS [GM 80148, GM 15761] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM015761, R37GM015761, R01GM080148] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Axelsen KB, 1999, BIOCHEMISTRY-US, V38, P7227, DOI 10.1021/bi982482l; CARAFOLI E, 1994, J NEUROBIOL, V25, P312, DOI 10.1002/neu.480250311; CHANG A, 1991, J CELL BIOL, V115, P289, DOI 10.1083/jcb.115.2.289; Chu GX, 2000, J BIOL CHEM, V275, P38938, DOI 10.1074/jbc.M004079200; Coon JJ, 2005, P NATL ACAD SCI USA, V102, P9463, DOI 10.1073/pnas.0503189102; Coon JJ, 2005, BIOTECHNIQUES, V38, P519, DOI 10.2144/05384TE01; Coon JJ, 2004, INT J MASS SPECTROM, V236, P33, DOI 10.1016/j.ijms.2004.05.005; ERASO P, 1994, J BIOL CHEM, V269, P10393; Fuglsang AT, 1999, J BIOL CHEM, V274, P36774, DOI 10.1074/jbc.274.51.36774; Goossens A, 2000, MOL CELL BIOL, V20, P7654, DOI 10.1128/MCB.20.20.7654-7661.2000; JIMENEZ CR, 1998, CURRENT PROTOCOLS PR, P41; Karim CB, 2006, J MOL BIOL, V358, P1032, DOI 10.1016/j.jmb.2006.02.051; Kuhlbrandt W, 2002, SCIENCE, V297, P1692, DOI 10.1126/science.1072574; Lecchi S, 2005, BIOCHEMISTRY-US, V44, P16624, DOI 10.1021/bi051555f; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Luo WS, 1998, J BIOL CHEM, V273, P4734, DOI 10.1074/jbc.273.8.4734; LUTSENKO S, 1995, BIOCHEMISTRY-US, V34, P15607, DOI 10.1021/bi00048a001; MacLennan DH, 2003, NAT REV MOL CELL BIO, V4, P566, DOI 10.1038/nrm1151; MANDALA SM, 1989, J BIOL CHEM, V264, P16276; Martin SE, 2000, ANAL CHEM, V72, P4266, DOI 10.1021/ac000497v; Mason AB, 1998, BBA-BIOMEMBRANES, V1372, P261, DOI 10.1016/S0005-2736(98)00065-0; McAlister GC, 2007, ANAL CHEM, V79, P3525, DOI 10.1021/ac070020k; Morsomme P, 2000, BBA-REV BIOMEMBRANES, V1469, P133, DOI 10.1016/S0304-4157(00)00015-0; Nelson CJ, 2007, PROTEOMICS, V7, P1279, DOI 10.1002/pmic.200600832; PALMGREN MG, 1991, J BIOL CHEM, V266, P20470; Pantano S, 2007, PROTEINS, V66, P930, DOI 10.1002/prot.21239; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; PERLIN DS, 1989, J BIOL CHEM, V264, P21857; Portillo F, 2000, BBA-REV BIOMEMBRANES, V1469, P31, DOI 10.1016/S0304-4157(99)00011-8; PORTILLO F, 1991, FEBS LETT, V287, P71, DOI 10.1016/0014-5793(91)80018-X; PORTILLO F, 1989, FEBS LETT, V247, P381, DOI 10.1016/0014-5793(89)81375-4; SCHLESSER A, 1988, J BIOL CHEM, V263, P19480; SERRANO R, 1983, FEBS LETT, V156, P11, DOI 10.1016/0014-5793(83)80237-3; SIMMERMAN HKB, 1986, J BIOL CHEM, V261, P3333; Syka JEP, 2004, P NATL ACAD SCI USA, V101, P9528, DOI 10.1073/pnas.0402700101; Thiede B, 2000, RAPID COMMUN MASS SP, V14, P496, DOI 10.1002/(SICI)1097-0231(20000331)14:6<496::AID-RCM899>3.0.CO;2-1; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2003, P NATL ACAD SCI USA, V100, P467, DOI 10.1073/pnas.0237326100; Traaseth NJ, 2006, J MOL BIOL, V358, P1041, DOI 10.1016/j.jmb.2006.02.047; van Hemert MJ, 2001, YEAST, V18, P889, DOI 10.1002/yea.739; Wang DG, 2003, PLANT PHYSIOL, V132, P2152, DOI 10.1104/pp.103.021485; Williams-Hart T, 2002, GENETICS, V160, P1423	42	88	89	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35471	35481		10.1074/jbc.M706094200	http://dx.doi.org/10.1074/jbc.M706094200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17932035	hybrid			2022-12-27	WOS:000251458100006
J	Mio, K; Kubo, Y; Ogura, T; Yamamoto, T; Arisaka, F; Sato, C				Mio, Kazuhiro; Kubo, Yoshihiro; Ogura, Toshihiko; Yamamoto, Tomomi; Arisaka, Fumio; Sato, Chikara			The motor protein prestin is a bullet-shaped molecule with inner cavities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER HAIR CELL; AUTOMATIC PARTICLE PICKUP; PLASMA-MEMBRANE; MECHANICAL RESPONSES; NEURAL-NETWORK; RECONSTRUCTION; MICROSCOPY; RESOLUTION; TOPOLOGY; RECEPTOR	Prestin is a transmembrane motor protein localized at the outer hair cells (OHCs) of the mammalian inner ear. Voltage-dependent conformational changes in prestin generate changes in the length of OHCs. A loss of prestin function is reported to induce severe auditory deficiencies, suggesting prestin-dependent changes of OHC length may be at least a part of cochlear amplification. Here we expressed the recombinant FLAG-fused prestin proteins in Sf9 cells and purified to particles of a uniform size in EM. The square-shaped top view of purified prestin, the binding of multiple anti-FLAG antibodies to each prestin particle, the native-PAGE analysis, and the much larger molecular weight obtained from size exclusion chromatography than the estimation for the monomer all support that prestin is a tetramer (Zheng, J., Du, G. G., Anderson, C. T., Keller, J. P., Orem, A., Dallos, P., and Cheatham, M. (2006) J. Biol. Chem. 281, 19916-19924). From negatively stained prestin particles, the three-dimensional structure was reconstructed at 2 nm resolution assuming 4-fold symmetry. Prestin is shown to be a bullet-shaped particle with a large cytoplasmic domain. The surface representation demonstrates indentations on the molecule, and the slice images indicate the inner cavities of sparse densities. The dimensions, 77 x 77 x 115 angstrom, are consistent with the previously reported sizes of motor proteins on the surface of OHCs.	[Mio, Kazuhiro; Ogura, Toshihiko; Sato, Chikara] Natl Inst Adv Ind Sci & Technol, Neurosci Res Inst, Tsukuba, Ibaraki 3058568, Japan; [Mio, Kazuhiro; Ogura, Toshihiko; Sato, Chikara] Natl Inst Adv Ind Sci & Technol, Biol Informat Res Ctr, Tsukuba, Ibaraki 3058568, Japan; [Kubo, Yoshihiro; Yamamoto, Tomomi] Natl Inst Physiol Sci, Div Biophys & Neurobiol, Dept Mol Physiol, Aichi 4448585, Japan; [Kubo, Yoshihiro] Tokyo Med & Dent Univ, Grad Sch, Bunkyo Ku, COE Program Brain Integrad & Disorders, Tokyo 1138519, Japan; [Kubo, Yoshihiro] Japan Sci & Technol Corp, SORST, Kawaguchi, Saitama 3320012, Japan; [Ogura, Toshihiko] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Arisaka, Fumio] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa 2268501, Japan	National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST); National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Tokyo Medical & Dental University (TMDU); Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST); Tokyo Institute of Technology	Sato, C (corresponding author), Natl Inst Adv Ind Sci & Technol, Neurosci Res Inst, Umezono 1-1-4, Tsukuba, Ibaraki 3058568, Japan.	ti-sato@aist.go.jp	Sato, Chikara/M-7183-2016; Ogura, Toshihiko/M-4089-2018; Mio, Kazuhiro/L-7488-2018	Sato, Chikara/0000-0001-5543-4496; Mio, Kazuhiro/0000-0002-1655-8231; Kubo, Yoshihiro/0000-0001-6707-0837				ASHMORE JF, 1987, J PHYSIOL-LONDON, V388, P323, DOI 10.1113/jphysiol.1987.sp016617; Belyantseva IA, 2000, J NEUROSCI, V20, part. no.; BROWNELL WE, 1985, SCIENCE, V227, P194, DOI 10.1126/science.3966153; Cazals Y, 2000, PROG NEUROBIOL, V62, P583, DOI 10.1016/S0301-0082(00)00027-7; Cheatham MA, 2004, J PHYSIOL-LONDON, V560, P821, DOI 10.1113/jphysiol.2004.069559; DALLOS P, 1992, J NEUROSCI, V12, P4575; DAVIS BJ, 1964, ANN NY ACAD SCI, V121, P404, DOI 10.1111/j.1749-6632.1964.tb14213.x; Eskandari S, 1998, P NATL ACAD SCI USA, V95, P11235, DOI 10.1073/pnas.95.19.11235; Frank J, 2006, 3 DIMENSIONAL ELECT; Geleoc GSG, 1999, NAT NEUROSCI, V2, P713, DOI 10.1038/11174; Geleoc GSG, 2003, TRENDS NEUROSCI, V26, P115, DOI 10.1016/S0166-2236(03)00030-4; Greeson JN, 2006, BRAIN RES, V1091, P140, DOI 10.1016/j.brainres.2006.02.084; HARAUZ G, 1986, OPTIK, V73, P146; Henderson R, 2004, Q REV BIOPHYS, V37, P3, DOI 10.1017/S0033583504003920; KACHAR B, 1986, NATURE, V322, P365, DOI 10.1038/322365a0; KALINEC F, 1992, P NATL ACAD SCI USA, V89, P8671, DOI 10.1073/pnas.89.18.8671; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAURENT TC, 1964, J CHROMATOGR, V14, P317, DOI 10.1016/S0021-9673(00)86637-6; Le Grimellec C, 2002, J COMP NEUROL, V451, P62, DOI 10.1002/cne.10338; Liberman MC, 2002, NATURE, V419, P300, DOI 10.1038/nature01059; Liu XZ, 2003, HUM MOL GENET, V12, P1155, DOI 10.1093/hmg/ddg127; Ludwig J, 2001, P NATL ACAD SCI USA, V98, P4178, DOI 10.1073/pnas.071613498; Mio K, 2005, BIOCHEM BIOPH RES CO, V337, P998, DOI 10.1016/j.bbrc.2005.09.141; Mio K, 2005, BIOCHEM BIOPH RES CO, V333, P768, DOI 10.1016/j.bbrc.2005.05.181; Murakoshi M, 2006, JARO-J ASSOC RES OTO, V7, P267, DOI 10.1007/s10162-006-0041-z; Navaratnam D, 2005, BIOPHYS J, V89, P3345, DOI 10.1529/biophysj.105.068759; Ogura T, 2003, J STRUCT BIOL, V143, P185, DOI 10.1016/j.jsb.2003.08.005; Ogura T, 2004, J STRUCT BIOL, V145, P63, DOI 10.1016/S1047-8477(03)00139-4; Ogura T, 2004, J STRUCT BIOL, V146, P344, DOI 10.1016/j.jsb.2004.01.007; Ogura T, 2001, J STRUCT BIOL, V136, P227, DOI 10.1006/jsbi.2002.4442; Ogura T, 2006, J STRUCT BIOL, V156, P371, DOI 10.1016/j.jsb.2006.05.016; Oliver D, 2001, SCIENCE, V292, P2340, DOI 10.1126/science.1060939; PENCZEK P, 1992, ULTRAMICROSCOPY, V40, P33, DOI 10.1016/0304-3991(92)90233-A; PENCZEK PA, 1994, ULTRAMICROSCOPY, V53, P251, DOI 10.1016/0304-3991(94)90038-8; Robles L, 2001, PHYSIOL REV, V81, P1305, DOI 10.1152/physrev.2001.81.3.1305; SANTOS-SACCHI J, 1988, HEARING RES, V35, P143, DOI 10.1016/0378-5955(88)90113-X; Sato C, 2004, J MOL BIOL, V336, P155, DOI 10.1016/j.jmb.2003.11.024; Sato C, 2001, NATURE, V409, P1047, DOI 10.1038/35059098; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; van Heel M, 2000, Q REV BIOPHYS, V33, P307, DOI 10.1017/S0033583500003644; Weber T, 2002, P NATL ACAD SCI USA, V99, P2901, DOI 10.1073/pnas.052609899; Yu N, 2006, BRAIN RES, V1095, P51, DOI 10.1016/j.brainres.2006.04.017; Zheng J, 2000, NATURE, V405, P149, DOI 10.1038/35012009; Zheng J, 2001, NEUROREPORT, V12, P1929, DOI 10.1097/00001756-200107030-00032; Zheng J, 2006, J BIOL CHEM, V281, P19916, DOI 10.1074/jbc.M513854200	45	52	53	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					1137	1145		10.1074/jbc.M702681200	http://dx.doi.org/10.1074/jbc.M702681200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	17998209	hybrid			2022-12-27	WOS:000252128100054
J	Wang, H; Wen, S; Bunnett, NW; Leduc, R; Hollenberg, MD; MacNaughton, WK				Wang, Hongying; Wen, Shoubin; Bunnett, Nigel W.; Leduc, Richard; Hollenberg, Morley D.; MacNaughton, Wallace K.			Proteinase-activated receptor-2 induces cyclooxygenase-2 expression through beta-catenin and cyclic AMP-response element-binding protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GASTRIC-CANCER CELLS; COLON-CANCER; REGULATES EXPRESSION; COLORECTAL-CANCER; MOLECULAR-CLONING; COX-2 INHIBITORS; EPITHELIAL-CELLS; CARCINOMA CELLS; PROLIFERATION; PHOSPHORYLATION	Chronic inflammation of mucosae is associated with an increased cancer risk. Tumorigenesis in these tissues is associated with the activity of some proteinases, cyclooxygenase-2 (COX-2), and beta-catenin. Serine proteinases participate in both inflammation and tumorigenesis through the activation of proteinase-activated receptor-2 (PAR(2)), which up-regulates COX-2 by an unknown mechanism. We sought to determine whether beta-catenin participated in PAR2-induced COX-2 expression and through what cellular mechanism. In A549 epithelial cells, we showed that PAR2 activation increased COX-2 expression through the beta-catenin/T cell factor transcription pathway. This effect was dependent upon ERK1/2 MAPK, which inhibited the beta-catenin-regulating protein, glycogen synthase kinase-3 beta, and induced the activity of the cAMP-response element-binding protein ( CREB). Knockdown of CREB by small interfering RNA revealed that PAR(2)-induced beta-catenin transcriptional activity and COX-2 expression were CREB-dependent. A co-immunoprecipitation assay revealed a physical interaction between CREB and beta-catenin. Thus, PAR2 up-regulated COX-2 expression via an ERK1/2-mediated activation of the beta-catenin/Tcf-4 and CREB pathways. These findings reveal new cellular mechanisms by which serine proteinases may participate in tumor development and are particularly relevant to cancers associated with chronic mucosal inflammation, where serine proteinases are abundant and COX-2 overexpression is a common feature.	[Wang, Hongying; Wen, Shoubin; Hollenberg, Morley D.; MacNaughton, Wallace K.] Univ Calgary, Dept Physiol & Biophys, Calgary, AB T2N 4N1, Canada; [MacNaughton, Wallace K.] Univ Calgary, Dept Physiol & Biophys, Calgary, AB T2N 4N1, Canada; [Hollenberg, Morley D.] Univ Calgary, Dept Pharmacol & Therapeut, Calgary, AB T2N 4N1, Canada; [Bunnett, Nigel W.] Univ Calif San Francisco, Dept Surg & Physiol, San Francisco, CA 94143 USA; [Leduc, Richard] Univ Sherbrooke, Sherbrooke, PQ J1K 2R1, Canada	University of Calgary; University of Calgary; University of Calgary; University of California System; University of California San Francisco; University of Sherbrooke	MacNaughton, WK (corresponding author), Univ Calgary, Dept Physiol & Biophys, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	wmacnaug@ucalgary.ca	Hollenberg, Morley/AFV-6966-2022	Bunnett, Nigel W./0000-0003-3367-0644; Wang, Hongying/0000-0001-8443-3839				Amir M, 2005, PHARMAZIE, V60, P563; APPLEBY SB, 1994, BIOCHEM J, V302, P723, DOI 10.1042/bj3020723; Araki Y, 2003, CANCER RES, V63, P728; Blanke C, 2004, CANCER INVEST, V22, P271, DOI 10.1081/CNV-120030216; Brown JR, 2005, J CLIN ONCOL, V23, P2840, DOI 10.1200/JCO.2005.09.051; Caruso R, 2006, AM J PATHOL, V169, P268, DOI 10.2353/ajpath.2006.050841; Chow LWC, 2005, BIOMED PHARMACOTHER, V59, pS281, DOI 10.1016/S0753-3322(05)80046-0; Cocks TM, 2000, TRENDS PHARMACOL SCI, V21, P103, DOI 10.1016/S0165-6147(99)01440-6; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Darmoul D, 2004, J BIOL CHEM, V279, P20927, DOI 10.1074/jbc.M401430200; Darmoul D, 2001, BRIT J CANCER, V85, P772, DOI 10.1054/bjoc.2001.1976; Dery O, 1998, AM J PHYSIOL-CELL PH, V274, pC1429, DOI 10.1152/ajpcell.1998.274.6.C1429; Desilets A, 2006, FEBS LETT, V580, P2227, DOI 10.1016/j.febslet.2006.03.030; Ding QQ, 2005, MOL CELL, V19, P159, DOI 10.1016/j.molcel.2005.06.009; GIARDIELLO FM, 1993, NEW ENGL J MED, V328, P1313, DOI 10.1056/NEJM199305063281805; Guger KA, 2000, DEV BIOL, V223, P441, DOI 10.1006/dbio.2000.9770; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hsi LC, 1999, CARCINOGENESIS, V20, P2045, DOI 10.1093/carcin/20.11.2045; Johannessen M, 2004, CELL SIGNAL, V16, P1211, DOI 10.1016/j.cellsig.2004.05.001; Kawao N, 2005, J PHARMACOL EXP THER, V315, P576, DOI 10.1124/jpet.105.089490; Kim SJ, 2002, BIOCHEM BIOPH RES CO, V296, P221, DOI 10.1016/S0006-291X(02)00824-0; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Krysan Kostyantyn, 2006, Anti-Cancer Agents in Medicinal Chemistry, V6, P209, DOI 10.2174/187152006776930882; Lee HK, 2006, NUCLEIC ACIDS RES, V34, P5705, DOI 10.1093/nar/gkl698; Lu ZM, 2003, CANCER CELL, V4, P499, DOI 10.1016/S1535-6108(03)00304-0; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; McManus EJ, 2005, EMBO J, V24, P1571, DOI 10.1038/sj.emboj.7600633; Nath N, 2003, P NATL ACAD SCI USA, V100, P12584, DOI 10.1073/pnas.2134840100; Nelson RW, 1999, J CELL BIOL, V147, P367, DOI 10.1083/jcb.147.2.367; Nishibori M, 2005, J PHARMACOL SCI, V97, P25, DOI 10.1254/jphs.FMJ04005X5; NYSTEDT S, 1995, J BIOL CHEM, V270, P5950, DOI 10.1074/jbc.270.11.5950; NYSTEDT S, 1994, P NATL ACAD SCI USA, V91, P9208, DOI 10.1073/pnas.91.20.9208; Oberst M, 2001, AM J PATHOL, V158, P1301, DOI 10.1016/S0002-9440(10)64081-3; Ohta T, 2003, INT J ONCOL, V23, P61; Oshima M, 1996, CELL, V87, P803, DOI 10.1016/S0092-8674(00)81988-1; Pradeep A, 2004, ONCOGENE, V23, P3689, DOI 10.1038/sj.onc.1207454; PRESCOTT SM, 2000, BIOCHIM BIOPHYS ACTA, V1470, P69, DOI [10.1016/s0304-419x(00)00006-8), DOI 10.1016/S0304-419X(00)00006-8]; Seeley S, 2003, CHEM BIOL, V10, P1033, DOI 10.1016/j.chembiol.2003.10.014; Sendo T, 2003, CELL SIGNAL, V15, P773, DOI 10.1016/S0898-6568(03)00014-7; Sheehan KM, 1999, JAMA-J AM MED ASSOC, V282, P1254, DOI 10.1001/jama.282.13.1254; Staal FJT, 2002, EMBO REP, V3, P63, DOI 10.1093/embo-reports/kvf002; Steinhoff M, 1999, EXP DERMATOL, V8, P282; Takeuchi T, 2000, J BIOL CHEM, V275, P26333, DOI 10.1074/jbc.M002941200; Tang QB, 2001, ONCOGENE, V20, P5164, DOI 10.1038/sj.onc.1204667; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; van Noort M, 2002, J BIOL CHEM, V277, P17901, DOI 10.1074/jbc.M111635200; Wang HY, 2005, CANCER RES, V65, P8604, DOI 10.1158/0008-5472.CAN-05-1169; Xu LF, 2000, GENE DEV, V14, P585	49	41	42	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					809	815		10.1074/jbc.M703021200	http://dx.doi.org/10.1074/jbc.M703021200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	17962194	hybrid			2022-12-27	WOS:000252128100020
J	Choi, H; Leto, TL; Hunyady, L; Catt, KJ; Bae, YS; Rhee, SG				Choi, Hyun; Leto, Thomas L.; Hunyady, Laszlo; Catt, Kevin J.; Bae, Yun Soo; Rhee, Sue Goo			Mechanism of angiotensin II-induced superoxide production in cells reconstituted with angiotensin type 1 receptor and the components of NADPH oxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; NUCLEOTIDE EXCHANGE FACTOR; ACTIVATED PROTEIN-KINASE; SIGNAL-TRANSDUCTION PATHWAYS; INDUCED CARDIAC-HYPERTROPHY; PHOSPHOLIPASE-D ACTIVATION; COLON EPITHELIAL-CELLS; GROWTH-FACTOR RECEPTOR; SMALL GTPASE RAC; REACTIVE OXYGEN	The mechanism of angiotensin II (Ang II)-induced superoxide production was investigated with HEK293 or Chinese hamster ovary cells reconstituted with the angiotensin type 1 receptor (AT(1)R) and NADPH oxidase (either Nox1 or Nox2) along with a pair of adaptor subunits (either NOXO1 with NOXA1 or p47(phox) with p67(phox)). Ang II enhanced the activity of both Nox1 and Nox2 supported by either adaptor pair, with more effective activation of Nox1 in the presence of NOXO1 and NOXA1 and of Nox2 in the presence of p47(phox) and p67(phox). Expression of several AT(1)R mutants showed that interaction of the receptor with G proteins but not that with beta-arrestin or with other proteins (Jak2, phospholipase C-gamma 1, SH2 domain-containing phosphatase 2) that bind to the COOH-terminal region of AT(1)R, was necessary for Ang II-induced superoxide production. The effects of constitutively active alpha subunits of G proteins and of various pharmacological agents implicated signaling by a pathway comprising AT1R, G alpha(q/11), phospholipase C-beta, and protein kinase C as largely, but not exclusively, responsible for Ang II-induced activation of Nox1 and Nox2 in the reconstituted cells. A contribution of G alpha(12/13), phospholipase D, and phosphatidylinositol 3-kinase to Ang II-induced superoxide generation was also suggested, whereas Src and the epidermal growth factor receptor did not appear to participate in this effect of Ang II. In reconstituted cells stimulated with Ang II, Nox2 exhibited a more sensitive response than Nox1 to the perturbation of protein kinase C, phosphatidylinositol 3-kinase, or the small GTPase Rac1.	[Choi, Hyun; Bae, Yun Soo; Rhee, Sue Goo] Ewha Womans Univ, Div Life & Pharmaceut Sci, Seoul 120750, South Korea; [Leto, Thomas L.] NIH, NIAID, Host Def Lab, Bethesda, MD 20892 USA; [Hunyady, Laszlo] Semmelweis Univ, Dept Physiol, H-1088 Budapest, Hungary; [Catt, Kevin J.] NIH, NICHD, Endocrinol & Reprod Res Branch, Bethesda, MD 20892 USA	Ewha Womans University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Semmelweis University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Bae, YS (corresponding author), Ewha Womans Univ, Div Life & Pharmaceut Sci, 1-1-1 Daehyundong,Seodamoongu, Seoul 120750, South Korea.	baeys@ewha.ac.kr; rheesg@ewha.ac.kr			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000184] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [ZIAHD000193, Z01HD000193, Z01HD000184] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000614, Z01AI000614] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ali MS, 1997, J BIOL CHEM, V272, P23382, DOI 10.1074/jbc.272.37.23382; Ambasta RK, 2004, J BIOL CHEM, V279, P45935, DOI 10.1074/jbc.M406486200; Babior BM, 1999, BLOOD, V93, P1464, DOI 10.1182/blood.V93.5.1464.405a32_1464_1476; Banfi B, 2003, J BIOL CHEM, V278, P3510, DOI 10.1074/jbc.C200613200; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bendall JK, 2002, CIRCULATION, V105, P293, DOI 10.1161/hc0302.103712; Bokoch GM, 2006, ANTIOXID REDOX SIGN, V8, P1533, DOI 10.1089/ars.2006.8.1533; Bokoch GM, 2003, TRENDS BIOCHEM SCI, V28, P502, DOI 10.1016/S0968-0004(03)00194-4; BONSER RW, 1991, BRIT J PHARMACOL, V103, P1237, DOI 10.1111/j.1476-5381.1991.tb12330.x; Booden MA, 2002, MOL CELL BIOL, V22, P4053, DOI 10.1128/MCB.22.12.4053-4061.2002; Brenner S, 2003, BLOOD, V102, P2789, DOI 10.1182/blood-2002-05-1482; Brown GE, 2003, MOL CELL, V11, P35, DOI 10.1016/S1097-2765(03)00005-4; Byrne JA, 2003, CIRC RES, V93, P802, DOI 10.1161/01.RES.0000099504.30207.F5; Cai H, 2003, TRENDS PHARMACOL SCI, V24, P471, DOI 10.1016/S0165-6147(03)00233-5; Cheng GJ, 2004, J BIOL CHEM, V279, P4737, DOI 10.1074/jbc.M305968200; Chikumi H, 2002, J BIOL CHEM, V277, P27130, DOI 10.1074/jbc.M204715200; Daaka Y, 1998, J BIOL CHEM, V273, P685, DOI 10.1074/jbc.273.2.685; de Gasparo M, 2000, PHARMACOL REV, V52, P415; DEMENDEZ I, 1995, BLOOD, V85, P1104, DOI 10.1182/blood.V85.4.1104.bloodjournal8541104; Diaz O, 2002, J BIOL CHEM, V277, P39368, DOI 10.1074/jbc.M202376200; Du GW, 2004, MOL BIOL CELL, V15, P1024, DOI 10.1091/mbc.E03-09-0673; Exton JH, 1997, PHYSIOL REV, V77, P303, DOI 10.1152/physrev.1997.77.2.303; Fan GF, 2003, J BIOL CHEM, V278, P52432, DOI 10.1074/jbc.M310982200; Frank GD, 2003, ANTIOXID REDOX SIGN, V5, P771, DOI 10.1089/152308603770380070; Gaborik Z, 2001, MOL PHARMACOL, V59, P239, DOI 10.1124/mol.59.2.239; Gavazzi G, 2006, FEBS LETT, V580, P497, DOI 10.1016/j.febslet.2005.12.049; Geiszt M, 2004, J BIOL CHEM, V279, P51715, DOI 10.1074/jbc.R400024200; Geiszt M, 2003, J IMMUNOL, V171, P299, DOI 10.4049/jimmunol.171.1.299; Geiszt M, 2003, J BIOL CHEM, V278, P20006, DOI 10.1074/jbc.M301289200; Geiszt M, 2000, P NATL ACAD SCI USA, V97, P8010, DOI 10.1073/pnas.130135897; Gorin Y, 2003, AM J PHYSIOL-RENAL, V285, pF219, DOI 10.1152/ajprenal.00414.2002; Griendling KK, 2000, ARTERIOSCL THROM VAS, V20, P2175, DOI 10.1161/01.ATV.20.10.2175; GRIENDLING KK, 1994, CIRC RES, V74, P1141, DOI 10.1161/01.RES.74.6.1141; Hanna IR, 2002, ANTIOXID REDOX SIGN, V4, P899, DOI 10.1089/152308602762197443; Hattori Y, 2005, DIABETOLOGIA, V48, P1066, DOI 10.1007/s00125-005-1766-7; Hoyal CR, 2003, P NATL ACAD SCI USA, V100, P5130, DOI 10.1073/pnas.1031526100; HUNYADY L, 1994, J BIOL CHEM, V269, P31378; HUNYADY L, 1994, J BIOL CHEM, V269, P24798; Hunyady L, 1996, P NATL ACAD SCI USA, V93, P10040, DOI 10.1073/pnas.93.19.10040; Hunyady L, 2000, REGUL PEPTIDES, V91, P29, DOI 10.1016/S0167-0115(00)00137-3; Inanami O, 1998, J BIOL CHEM, V273, P9539, DOI 10.1074/jbc.273.16.9539; Kanai F, 2001, NAT CELL BIOL, V3, P675, DOI 10.1038/35083070; Karathanassis D, 2002, EMBO J, V21, P5057, DOI 10.1093/emboj/cdf519; Karlsson A, 2000, J LEUKOCYTE BIOL, V67, P396, DOI 10.1002/jlb.67.3.396; Kazama K, 2004, CIRC RES, V95, P1019, DOI 10.1161/01.RES.0000148637.85595.c5; Kim JH, 2005, MOL CELL BIOL, V25, P3194, DOI 10.1128/MCB.25.8.3194-3208.2005; Koga H, 1999, J BIOL CHEM, V274, P25051, DOI 10.1074/jbc.274.35.25051; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Landmesser U, 2002, HYPERTENSION, V40, P511, DOI 10.1161/01.HYP.0000032100.23772.98; Lassegue B, 2003, AM J PHYSIOL-REG I, V285, pR277, DOI 10.1152/ajpregu.00758.2002; Lassegue B, 2001, CIRC RES, V88, P888, DOI 10.1161/hh0901.090299; Lavigne MC, 2001, CIRCULATION, V104, P79, DOI 10.1161/01.CIR.104.1.79; LEVITZKI A, 1995, SCIENCE, V267, P1782, DOI 10.1126/science.7892601; Levkowitz G, 1998, GENE DEV, V12, P3663, DOI 10.1101/gad.12.23.3663; Li JM, 2004, CIRCULATION, V109, P1307, DOI 10.1161/01.CIR.0000118463.23388.B9; Lutz S, 2005, J BIOL CHEM, V280, P11134, DOI 10.1074/jbc.M411322200; Martyn KD, 2006, CELL SIGNAL, V18, P69, DOI 10.1016/j.cellsig.2005.03.023; Matsuno K, 2005, CIRCULATION, V112, P2677, DOI 10.1161/CIRCULATIONAHA.105.573709; Miyano K, 2006, J BIOL CHEM, V281, P21857, DOI 10.1074/jbc.M513665200; Mollnau H, 2002, CIRC RES, V90, pE58, DOI 10.1161/01.RES.0000012569.55432.02; Morawietz H, 2001, BIOCHEM BIOPH RES CO, V285, P1130, DOI 10.1006/bbrc.2001.5312; Offermanns S, 2003, PROG BIOPHYS MOL BIO, V83, P101, DOI 10.1016/S0079-6107(03)00052-X; Parekh DB, 2000, EMBO J, V19, P496, DOI 10.1093/emboj/19.4.496; Park HS, 2004, MOL CELL BIOL, V24, P4384, DOI 10.1128/MCB.24.10.4384-4394.2004; Price MO, 2002, J BIOL CHEM, V277, P19220, DOI 10.1074/jbc.M200061200; Price MO, 2002, BLOOD, V99, P2653, DOI 10.1182/blood.V99.8.2653; PURI PL, 1995, J BIOL CHEM, V270, P22129, DOI 10.1074/jbc.270.38.22129; Quinn MT, 2004, J LEUKOCYTE BIOL, V76, P760, DOI 10.1189/jlb.0404216; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Saito Y, 2001, J MOL CELL CARDIOL, V33, P3, DOI 10.1006/jmcc.2000.1272; Sayeski PP, 1998, REGUL PEPTIDES, V78, P19, DOI 10.1016/S0167-0115(98)00137-2; Servitja JM, 2003, J BIOL CHEM, V278, P34339, DOI 10.1074/jbc.M302960200; Seshiah PN, 2002, CIRC RES, V91, P406, DOI 10.1161/01.RES.0000033523.08033.16; Seta K, 2002, J BIOL CHEM, V277, P9268, DOI 10.1074/jbc.M109221200; Shiose A, 2001, J BIOL CHEM, V276, P1417, DOI 10.1074/jbc.M007597200; Smith RD, 1998, MOL PHARMACOL, V54, P935, DOI 10.1124/mol.54.6.935; Spat A, 2004, PHYSIOL REV, V84, P489, DOI 10.1152/physrev.00030.2003; Takeya R, 2003, J BIOL CHEM, V278, P25234, DOI 10.1074/jbc.M212856200; Thomas WG, 2003, TRENDS ENDOCRIN MET, V14, P130, DOI 10.1016/S1043-2760(03)00023-7; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; Touyz RM, 2002, CIRC RES, V90, P1205, DOI 10.1161/01.RES.0000020404.01971.2F; Touyz RM, 2000, PHARMACOL REV, V52, P639; Touyz RM, 1999, HYPERTENSION, V34, P976, DOI 10.1161/01.HYP.34.4.976; Ueyama T, 2006, MOL CELL BIOL, V26, P2160, DOI 10.1128/MCB.26.6.2160-2174.2006; Ushio-Fukai M, 2001, ARTERIOSCL THROM VAS, V21, P489, DOI 10.1161/01.ATV.21.4.489; Ushio-Fukai M, 1998, J BIOL CHEM, V273, P15022, DOI 10.1074/jbc.273.24.15022; Venema RC, 1998, J BIOL CHEM, V273, P7703, DOI 10.1074/jbc.273.13.7703; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Wang HD, 2001, CIRC RES, V88, P947, DOI 10.1161/hh0901.089987; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100; Welch HCE, 2002, CELL, V108, P809, DOI 10.1016/S0092-8674(02)00663-3; Wingler M, 2001, FREE RADICAL BIO MED, V31, P1456, DOI 10.1016/S0891-5849(01)00727-4; Yang CF, 2003, TRENDS PHARMACOL SCI, V24, P602, DOI 10.1016/j.tips.2003.09.003	93	50	51	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					255	267		10.1074/jbc.M708000200	http://dx.doi.org/10.1074/jbc.M708000200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17981802	hybrid			2022-12-27	WOS:000251940300029
J	Maillard, RA; Jordan, M; Beasley, DWC; Barrett, ADT; Lee, JC				Maillard, Rodrigo A.; Jordan, Matthew; Beasley, David W. C.; Barrett, Alan D. T.; Lee, J. Ching			Long range communication in the envelope protein domain III and its effect on the resistance of West Nile virus to antibody-mediated neutralization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BORNE ENCEPHALITIS-VIRUS; ACCESSIBLE SURFACE-AREAS; CIRCULAR-DICHROISM; ANTIGENIC DETERMINANTS; MONOCLONAL-ANTIBODY; BINDING SITE; FLUORESCENCE; GLYCOPROTEIN; CONFORMATION; TYROSINE	The envelope protein domain III (ED3) of West Nile virus is the major virus-specific neutralization domain and harbors most of the critical mutations that induce resistance against antibody-mediated neutralization. We investigated the molecular mechanisms of neutralization resistance by studying the biophysical perturbations of monoclonal antibody (mAb)-resistant mutations on ED3 wild type. Our results showed that although the solution structure between ED3 wild type and mutants was preserved, the mutations that confer the highest degree of resistance to mAbs showed low protein stability and high local dynamic motions. Interestingly, the latter was observed in regions outside the mutation sites, indicating long range communications within ED3. Thus, we hypothesized that the mechanisms involved in resistance to mAb neutralization may include, in addition to mutations in the epitope, long range effects among distant structural elements. This hypothesis is consistent with reported mutations in other flaviviruses whose surfaces are not exposed for the interaction with other macromolecules, yet they confer mAb neutralization resistance.	[Maillard, Rodrigo A.; Jordan, Matthew; Lee, J. Ching] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Beasley, David W. C.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Barrett, Alan D. T.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA; [Beasley, David W. C.; Barrett, Alan D. T.] Univ Texas Med Branch, Sealy Ctr Vaccine Dev, Galveston, TX 77555 USA; [Beasley, David W. C.; Barrett, Alan D. T.] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Lee, JC (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.	jclee@utmb.edu	Lee, James C/A-7849-2009		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077551] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 77551] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barrett ADT, 2001, ANN NY ACAD SCI, V951, P262; Beasley DWC, 2002, J VIROL, V76, P13097, DOI 10.1128/JVI.76.24.13097-13100.2002; BERMAN HA, 1978, BIOCHEMISTRY-US, V17, P1704, DOI 10.1021/bi00602a019; Bhardwaj S, 2001, J VIROL, V75, P4002, DOI 10.1128/JVI.75.8.4002-4007.2001; BOLEN DW, 1988, BIOCHEMISTRY-US, V27, P8069, DOI 10.1021/bi00421a015; BRAHMS S, 1977, P NATL ACAD SCI USA, V74, P3208, DOI 10.1073/pnas.74.8.3208; BUCKLEY A, 1985, J GEN VIROL, V66, P2523, DOI 10.1099/0022-1317-66-12-2523; BUJALOWSKI W, 1994, J BIOL CHEM, V269, P31359; CECILIA D, 1991, VIROLOGY, V181, P70, DOI 10.1016/0042-6822(91)90471-M; CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245; CHANG CT, 1978, ANAL BIOCHEM, V91, P13, DOI 10.1016/0003-2697(78)90812-6; Crill WD, 2001, J VIROL, V75, P7769, DOI 10.1128/JVI.75.16.7769-7773.2001; Davies DR, 1996, P NATL ACAD SCI USA, V93, P7, DOI 10.1073/pnas.93.1.7; DONOVAN JW, 1969, J BIOL CHEM, V244, P1961; EFTINK MR, 1977, BIOCHIM BIOPHYS ACTA, V491, P473, DOI 10.1016/0005-2795(77)90290-2; FIESER TM, 1987, P NATL ACAD SCI USA, V84, P8568, DOI 10.1073/pnas.84.23.8568; Fraczkiewicz R, 1998, J COMPUT CHEM, V19, P319, DOI 10.1002/(SICI)1096-987X(199802)19:3<319::AID-JCC6>3.0.CO;2-W; GILL JE, 1969, PHOTOCHEM PHOTOBIOL, V9, P313, DOI 10.1111/j.1751-1097.1969.tb07295.x; Holzmann H, 1997, J GEN VIROL, V78, P31, DOI 10.1099/0022-1317-78-1-31; Johnson WC, 1999, PROTEINS, V35, P307, DOI 10.1002/(SICI)1097-0134(19990515)35:3<307::AID-PROT4>3.0.CO;2-3; Kaufmann B, 2006, P NATL ACAD SCI USA, V103, P12400, DOI 10.1073/pnas.0603488103; KAWAHARA K, 1966, J BIOL CHEM, V241, P3228; Lacowicz J.R., 1999, PRINCIPLES FLUORESCE; Li L, 2005, VIROLOGY, V335, P99, DOI 10.1016/j.virol.2005.02.011; Lin CW, 2003, J VIROL, V77, P2600, DOI 10.1128/JVI.77.4.2600-2606.2003; LONGWORTH JW, 1967, BIOCHIM BIOPHYS ACTA, V147, P526, DOI 10.1016/0005-2795(67)90012-8; MAKHATADZE GI, 1993, J MOL BIOL, V232, P639, DOI 10.1006/jmbi.1993.1416; Mandl CW, 2000, J VIROL, V74, P9601, DOI 10.1128/JVI.74.20.9601-9609.2000; McMinn PC, 1997, J GEN VIROL, V78, P2711, DOI 10.1099/0022-1317-78-11-2711; Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100; Mukhopadhyay S, 2003, SCIENCE, V302, P248, DOI 10.1126/science.1089316; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; NOVOTNY J, 1986, P NATL ACAD SCI USA, V83, P226, DOI 10.1073/pnas.83.2.226; Nybakken GE, 2005, NATURE, V437, P764, DOI 10.1038/nature03956; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; PARKER CA, 1960, ANALYST, V85, P587, DOI 10.1039/an9608500587; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; RAGONE R, 1984, BIOCHEMISTRY-US, V23, P1871, DOI 10.1021/bi00303a044; REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; SCHELLMAN JA, 1978, BIOPOLYMERS, V17, P1305, DOI 10.1002/bip.1978.360170515; Stern O, 1919, PHYS Z, V20, P183; TAINER JA, 1984, NATURE, V312, P127, DOI 10.1038/312127a0; Volk DE, 2004, J BIOL CHEM, V279, P38755, DOI 10.1074/jbc.M402385200; WESTHOF E, 1984, NATURE, V311, P123, DOI 10.1038/311123a0; WETLAUFER DB, 1958, J BIOL CHEM, V233, P1421; Yu S, 2004, BIOCHEMISTRY-US, V43, P9168, DOI 10.1021/bi049324g	47	14	15	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					613	622		10.1074/jbc.M706031200	http://dx.doi.org/10.1074/jbc.M706031200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17986445	hybrid			2022-12-27	WOS:000251940300066
J	Schevzov, G; Fath, T; Vrhovski, B; Vlahovich, N; Rajan, S; Hook, J; Joya, JE; Lemckert, F; Puttur, F; Lin, JJC; Hardeman, EC; Wieczorek, DF; O'Neill, GM; Gunning, PW				Schevzov, Galina; Fath, Thomas; Vrhovski, Bernadette; Vlahovich, Nicole; Rajan, Sudarsan; Hook, Jeff; Joya, Josephine E.; Lemckert, Frances; Puttur, Franz; Lin, Jim J. -C.; Hardeman, Edna C.; Wieczorek, David F.; O'Neill, Geraldine M.; Gunning, Peter W.			Divergent regulation of the sarcomere and the cytoskeleton	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALTERNATIVELY SPLICED EXONS; ACTIN-BINDING PROTEINS; ALPHA-TROPOMYOSIN GENE; PRE-MESSENGER-RNA; NONMUSCLE TROPOMYOSIN; BETA-TROPOMYOSIN; SKELETAL-MUSCLE; SMOOTH-MUSCLE; F-ACTIN; CULTURING HIPPOCAMPAL	The existence of a feedback mechanism regulating the precise amounts of muscle structural proteins, such as actin and the actin-associated protein tropomyosin (Tm), in the sarcomeres of striated muscles is well established. However, the regulation of nonmuscle or cytoskeletal actin and Tms in nonmuscle cell structures has not been elucidated. Unlike the thin filaments of striated muscles, the actin cytoskeleton in nonmuscle cells is intrinsically dynamic. Given the differing requirements for the structural integrity of the actin thin filaments of the sarcomere compared with the requirement for dynamicity of the actin cytoskeleton in nonmuscle cells, we postulated that different regulatory mechanisms govern the expression of sarcomeric versus cytoskeletal Tms, as key regulators of the properties of the actin cytoskeleton. Comprehensive analyses of tissues from transgenic and knock-out mouse lines that overexpress the cytoskeletal Tms, Tm3 and Tm5NM1, and a comparison with sarcomeric Tms provide evidence for this. Moreover, we show that overexpression of a cytoskeletal Tm drives the amount of filamentous actin.	[Schevzov, Galina; Fath, Thomas; Vrhovski, Bernadette; Hook, Jeff; Lemckert, Frances; Puttur, Franz; O'Neill, Geraldine M.; Gunning, Peter W.] Childrens Hosp Westmead, Oncol Res Unit, Westmead, NSW 2145, Australia; [Schevzov, Galina; Fath, Thomas; O'Neill, Geraldine M.; Gunning, Peter W.] Univ Sydney, Discipline Paediat & Child Hlth, Sydney, NSW 2006, Australia; [Hardeman, Edna C.] Univ Sydney, Fac Med, Sydney, NSW 2006, Australia; [Vlahovich, Nicole; Joya, Josephine E.; Hardeman, Edna C.] Childrens Med Res Inst, Muscle Dev Unit, Westmead, NSW 2145, Australia; [Rajan, Sudarsan; Wieczorek, David F.] Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA; [Lin, Jim J. -C.] Univ Iowa, Dept Biol Sci, Iowa City, IA 52242 USA	University of Sydney; University of Sydney; University of Sydney; Children's Medical Research Institute - Australia; University System of Ohio; University of Cincinnati; University of Iowa	Gunning, PW (corresponding author), Childrens Hosp Westmead, Oncol Res Unit, Westmead, NSW 2145, Australia.	PeterG3@chw.edu.au	Hardeman, Edna C/F-8872-2012; Rajan, Sudarsan/A-6780-2008; O'Neill, Geraldine/F-3112-2014; Gunning, Peter W/E-9058-2010; Schevzov, Galina/G-5117-2013	Schevzov, Galina/0000-0002-0793-2279; Fath, Thomas/0000-0002-6877-7567; Gunning, Peter/0000-0003-0833-3128; Hardeman, Edna/0000-0003-1649-7712; O'Neill, Geraldine/0000-0001-9997-8794	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071952] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 71952] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Almenar-Queralt A, 1999, J BIOL CHEM, V274, P28466, DOI 10.1074/jbc.274.40.28466; Ayscough KR, 1998, CURR OPIN CELL BIOL, V10, P102, DOI 10.1016/S0955-0674(98)80092-6; BERNSTEIN BW, 1982, CELL MOTIL CYTOSKEL, V2, P1, DOI 10.1002/cm.970020102; Blanchard EM, 1997, CIRC RES, V81, P1005; Blanchoin L, 2001, CURR BIOL, V11, P1300, DOI 10.1016/S0960-9822(01)00395-5; BROSCHAT KO, 1986, J BIOL CHEM, V261, P3350; Bryce NS, 2003, MOL BIOL CELL, V14, P1002, DOI 10.1091/mbc.E02-04-0244; Cooley BC, 2001, ARCH BIOCHEM BIOPHYS, V390, P71, DOI 10.1006/abbi.2001.2347; Corbett MA, 2005, ANN NEUROL, V57, P42, DOI 10.1002/ana.20305; Crawford K, 2002, MOL CELL BIOL, V22, P5887, DOI 10.1128/MCB.22.16.5887-5896.2002; DesMarais V, 2002, J CELL SCI, V115, P4649, DOI 10.1242/jcs.00147; Dufour C, 1998, J BIOL CHEM, V273, P18547, DOI 10.1074/jbc.273.29.18547; Fewell JG, 1998, J CLIN INVEST, V101, P2630, DOI 10.1172/JCI2825; Giganti Adeline, 2003, Prog Cell Cycle Res, V5, P511; GIMONA M, 1994, CELL MOTIL CYTOSKEL, V27, P108, DOI 10.1002/cm.970270203; Gimona M, 1996, P NATL ACAD SCI USA, V93, P9618, DOI 10.1073/pnas.93.18.9618; Gulick J, 1997, CIRC RES, V80, P655, DOI 10.1161/01.RES.80.5.655; Gunning PW, 2005, TRENDS CELL BIOL, V15, P333, DOI 10.1016/j.tcb.2005.04.007; GUNNING PW, 2007, IN PRESS PHYSL REV; HAD L, 1994, J CELL SCI, V107, P2961; Hannan AJ, 1998, MOL CELL NEUROSCI, V11, P289, DOI 10.1006/mcne.1998.0693; HEALD RW, 1988, J BIOL CHEM, V263, P5254; Heimann K, 1999, J BIOL CHEM, V274, P10743, DOI 10.1074/jbc.274.16.10743; Hughes JAI, 2003, GLIA, V42, P25, DOI 10.1002/glia.10174; ISHIKAWA R, 1989, J BIOL CHEM, V264, P7490; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kee AJ, 2004, J CELL BIOL, V166, P685, DOI 10.1083/jcb.200406181; Kumar A, 2004, TRANSGENIC RES, V13, P531, DOI 10.1007/s11248-004-2823-6; Kumar A, 1997, P NATL ACAD SCI USA, V94, P4406, DOI 10.1073/pnas.94.9.4406; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEESMILLER JP, 1990, MOL CELL BIOL, V10, P1729, DOI 10.1128/MCB.10.4.1729; LESSARD JL, 1988, CELL MOTIL CYTOSKEL, V10, P349, DOI 10.1002/cm.970100302; LIN JJC, 1985, HYBRIDOMA, V4, P223, DOI 10.1089/hyb.1985.4.223; MATSUMURA F, 1985, J BIOL CHEM, V260, P3851; Meberg PJ, 2003, METHOD CELL BIOL, V71, P111, DOI 10.1016/S0091-679X(03)01007-0; Minamide LS, 2000, NAT CELL BIOL, V2, P628, DOI 10.1038/35023579; Moraczewska J, 1999, BIOCHEMISTRY-US, V38, P15885, DOI 10.1021/bi991816j; Muthuchamy M, 1999, CIRC RES, V85, P47; MUTHUCHAMY M, 1993, MOL CELL BIOL, V13, P3311, DOI 10.1128/MCB.13.6.3311; Muthuchamy M, 1995, J BIOL CHEM, V270, P30593, DOI 10.1074/jbc.270.51.30593; NOVY RE, 1993, BIOCHIM BIOPHYS ACTA, V1162, P255, DOI 10.1016/0167-4838(93)90289-4; NOVY RE, 1993, CELL MOTIL CYTOSKEL, V26, P248, DOI 10.1002/cm.970260308; Ono S, 2002, J CELL BIOL, V156, P1065, DOI 10.1083/jcb.200110013; Palermo J, 1996, CIRC RES, V78, P504, DOI 10.1161/01.RES.78.3.504; Pawlak G, 2001, CURR OPIN GENET DEV, V11, P41, DOI 10.1016/S0959-437X(00)00154-4; Pelham RJ, 1996, J CELL SCI, V109, P981; Percival JM, 2004, MOL BIOL CELL, V15, P268, DOI 10.1091/mbc.e03-03-0176; Perry SV, 2001, J MUSCLE RES CELL M, V22, P5, DOI 10.1023/A:1010303732441; PITTENGER MF, 1995, J CELL SCI, V108, P3253; PITTENGER MF, 1992, J CELL BIOL, V118, P841, DOI 10.1083/jcb.118.4.841; Prabhakar R, 2001, J MOL CELL CARDIOL, V33, P1815, DOI 10.1006/jmcc.2001.1445; Qin H, 1997, J BIOCHEM BIOPH METH, V36, P63, DOI 10.1016/S0165-022X(97)00045-6; Rethinasamy P, 1998, CIRC RES, V82, P116; Schevzov G, 1997, MOL CELL NEUROSCI, V8, P439, DOI 10.1006/mcne.1997.0599; Schevzov G, 2005, MOL BIOL CELL, V16, P3425, DOI 10.1091/mbc.E04-10-0951; Schevzov G, 2005, J HISTOCHEM CYTOCHEM, V53, P557, DOI 10.1369/jhc.4A6505.2005; Schildmeyer LA, 2000, FASEB J, V14, P2213, DOI 10.1096/fj.99-0927com; Stehn JR, 2006, CURR CANCER DRUG TAR, V6, P245, DOI 10.2174/156800906776842948; TemmGrove CJ, 1996, CELL MOTIL CYTOSKEL, V33, P223, DOI 10.1002/(SICI)1097-0169(1996)33:3<223::AID-CM6>3.0.CO;2-B; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VLAHOVICH N, 2007, IN PRESS CELL MOTIL, DOI DOI 10.1002/CM20245; Vrhovski B, 2003, J NEUROSCI RES, V72, P373, DOI 10.1002/jnr.10586; WANG YC, 1992, J BIOL CHEM, V267, P12004; WARREN KS, 1995, J CELL BIOL, V129, P697, DOI 10.1083/jcb.129.3.697; Warren RH, 1997, EXP CELL RES, V236, P294, DOI 10.1006/excr.1997.3728	65	32	32	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					275	283		10.1074/jbc.M704392200	http://dx.doi.org/10.1074/jbc.M704392200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17951248	hybrid			2022-12-27	WOS:000251940300031
J	Belak, ZR; Ovsenek, N				Belak, Zachery R.; Ovsenek, Nick			Assembly of the Yin Yang 1 transcription factor into messenger ribonucleoprotein particles requires direct RNA binding activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLD-SHOCK DOMAIN; XENOPUS-OOCYTES; ZINC-FINGER; TRANSLATIONAL REPRESSION; GENE-EXPRESSION; FACTOR YY1; C-MYC; PROTEIN; LAEVIS; RECOGNITION	The early stages of vertebrate development depend heavily on control of maternally transcribed mRNAs that are stored for long periods in complexes termed messenger ribonucleoprotein particles (mRNPs) and utilized selectively following maturation and fertilization. The transcription factor Yin Yang 1 (YY1) is associated with cytoplasmic mRNPs in vertebrate oocytes; however, the mechanism by which any of the mRNP proteins associate with mRNA in the oocyte is unknown. Here we demonstrate the mechanism by which YY1 associates with mRNPs depends on its direct RNA binding activity. High affinity binding for U-rich single-stranded RNA and A: U RNA duplexes was observed in the nanomolar range, similar to the affinity for the cognate double-stranded DNA-binding element. Similar RNA binding affinity was observed with endogenous YY1 isolated from native mRNP complexes. In vivo expression experiments reveal epitope-tagged YY1 assembled into high molecular mass mRNPs, and assembly was blocked by microinjection of high affinity RNA substrate competitor. These findings present the first clues to how mRNPs assemble during early development.	[Belak, Zachery R.; Ovsenek, Nick] Univ Saskatchewan, Coll Med, Dept Anat & Cell Biol, Saskatoon, SK S7N 5E5, Canada	University of Saskatchewan	Ovsenek, N (corresponding author), Univ Saskatchewan, Coll Med, Dept Anat & Cell Biol, A308 Hlth Sci Bldg,107 Wiggins Rd, Saskatoon, SK S7N 5E5, Canada.	nick.ovsenek@usask.ca						Austen M, 1997, J BIOL CHEM, V272, P1709, DOI 10.1074/jbc.272.3.1709; BECKER KG, 1994, GENE, V150, P259, DOI 10.1016/0378-1119(94)90435-9; BOUVET P, 1994, CELL, V77, P931, DOI 10.1016/0092-8674(94)90141-4; BRADDOCK M, 1994, NUCLEIC ACIDS RES, V22, P5255, DOI 10.1093/nar/22.24.5255; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brzostowski J, 2000, EMBO J, V19, P3683, DOI 10.1093/emboj/19.14.3683; BUSHMEYER S, 1995, J BIOL CHEM, V270, P30213; Donohoe ME, 1999, MOL CELL BIOL, V19, P7237; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; DUMONT JN, 1972, J MORPHOL, V136, P153, DOI 10.1002/jmor.1051360203; Favot L, 2005, AM J PATHOL, V167, P1497, DOI 10.1016/S0002-9440(10)61236-9; Ficzycz A, 2002, J BIOL CHEM, V277, P8382, DOI 10.1074/jbc.M110304200; Ficzycz A, 2001, J BIOL CHEM, V276, P22819, DOI 10.1074/jbc.M011188200; Galvin KM, 1997, MOL CELL BIOL, V17, P3723, DOI 10.1128/MCB.17.7.3723; Graumann PL, 1998, TRENDS BIOCHEM SCI, V23, P286, DOI 10.1016/S0968-0004(98)01255-9; Hall TMT, 2005, CURR OPIN STRUC BIOL, V15, P367, DOI 10.1016/j.sbi.2005.04.004; Hiromura M, 2003, J BIOL CHEM, V278, P14046, DOI 10.1074/jbc.M300789200; Houbaviy HB, 1996, P NATL ACAD SCI USA, V93, P13577, DOI 10.1073/pnas.93.24.13577; Houbaviy HB, 2001, CHEM BIOL, V8, P179, DOI 10.1016/S1074-5521(00)90066-8; Krippner-Heidenreich A, 2005, MOL CELL BIOL, V25, P3704, DOI 10.1128/MCB.25.9.3704-3714.2005; Kwon HJ, 2003, BIOCHEM BIOPH RES CO, V306, P1008, DOI 10.1016/S0006-291X(03)01071-4; Ladomery M, 1997, NUCLEIC ACIDS RES, V25, P965, DOI 10.1093/nar/25.5.965; LEE TC, 1994, ONCOGENE, V9, P1047; Lieb B, 1998, EXP CELL RES, V245, P272, DOI 10.1006/excr.1998.4249; Lu D, 2003, NATURE, V426, P96, DOI 10.1038/nature02088; MARELLO K, 1992, NUCLEIC ACIDS RES, V20, P5593, DOI 10.1093/nar/20.21.5593; Matsumoto K, 1996, J BIOL CHEM, V271, P22706, DOI 10.1074/jbc.271.37.22706; Matsumoto K, 2000, NUCLEIC ACIDS RES, V28, P4689, DOI 10.1093/nar/28.23.4689; Minshall N, 2001, RNA, V7, P1728, DOI 10.1017/S135583820101158X; Minshall N, 2004, NUCLEIC ACIDS RES, V32, P1325, DOI 10.1093/nar/gkh303; Moller HM, 2005, J MOL BIOL, V351, P718, DOI 10.1016/j.jmb.2005.06.032; MOMOEDA M, 1995, PROTEIN EXPRES PURIF, V6, P169, DOI 10.1006/prep.1995.1021; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Morgan MJ, 2004, J BIOL CHEM, V279, P46826, DOI 10.1074/jbc.M406140200; OConnor MJ, 1996, J VIROL, V70, P6529, DOI 10.1128/JVI.70.10.6529-6539.1996; Palko L, 2004, J CELL SCI, V117, P465, DOI 10.1242/jcs.00870; Pestova TV, 2001, COLD SPRING HARB SYM, V66, P389, DOI 10.1101/sqb.2001.66.389; Pestova TV, 2001, P NATL ACAD SCI USA, V98, P7029, DOI 10.1073/pnas.111145798; Petkova V, 2001, J BIOL CHEM, V276, P7932, DOI 10.1074/jbc.M007411200; PISANESCHI G, 1994, BIOCHEM BIOPH RES CO, V205, P1236, DOI 10.1006/bbrc.1994.2797; Rincon-Arano H, 2005, J MOL BIOL, V349, P961, DOI 10.1016/j.jmb.2005.04.040; ROMANIUK PJ, 1985, NUCLEIC ACIDS RES, V13, P5369, DOI 10.1093/nar/13.14.5369; Satijn DPE, 2001, MOL CELL BIOL, V21, P1360, DOI 10.1128/MCB.21.4.1360-1369.2001; SETO E, 1993, NATURE, V365, P462, DOI 10.1038/365462a0; SHI Y, 1991, CELL, V67, P377, DOI 10.1016/0092-8674(91)90189-6; SHI Y, 1997, BIOCHIM BIOPHYS ACTA, V1332, P49; SHRIVASTAVA A, 1993, SCIENCE, V262, P1889, DOI 10.1126/science.8266081; Tanaka KJ, 2006, J BIOL CHEM, V281, P40096, DOI 10.1074/jbc.M609059200; Thomas MJ, 1999, GENE, V236, P197, DOI 10.1016/S0378-1119(99)00261-9; Wang CY, 2004, J BIOL CHEM, V279, P17750, DOI 10.1074/jbc.M310532200; Yang WH, 2006, RNA, V12, P547, DOI 10.1261/rna.2302706; YANT SR, 1995, NUCLEIC ACIDS RES, V23, P4353, DOI 10.1093/nar/23.21.4353; Yao YL, 2001, MOL CELL BIOL, V21, P5979, DOI 10.1128/MCB.21.17.5979-5991.2001; Yurkova MS, 1997, J BIOL CHEM, V272, P10870	54	18	20	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37913	37920		10.1074/jbc.M708057200	http://dx.doi.org/10.1074/jbc.M708057200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17974562	hybrid			2022-12-27	WOS:000251833600067
J	Clark, MB; Janicke, M; Gottesbuhren, U; Kleffmann, T; Legge, M; Poole, ES; Tate, WP				Clark, Michael B.; Jaenicke, Martina; Gottesbuehren, Undine; Kleffmann, Torsten; Legge, Michael; Poole, Elizabeth S.; Tate, Warren P.			Mammalian gene PEG10 expresses two reading frames by high efficiency-1 frameshifting in embryonic-associated tissues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LTR RETROTRANSPOSONS; ESCHERICHIA-COLI; MESSENGER-RNAS; PROTEINS; GAG; POL; IDENTIFICATION; ALIGNMENT; HIV-1; SEQUENCES	Paternally expressed gene 10 ( PEG10) is a mammalian gene that is essential for embryonic development in mice. The gene contains two overlapping open reading frames ( ORF1 and ORF2) and is derived from a retroelement that acquired a cellular function. It is not known if both reading frames are required for PEG10 function. Synthesis of ORF2 would be possible only if programmed-1 frameshifting occurred during ORF1 translation. In this study the frameshifting activity of PEG10 was analyzed in vivo, and a potential role for ORF2 was investigated. Phylogenetic analysis demonstrated that PEG10 is highly conserved in therian mammals, with all species retaining the elements necessary for frameshifting as well as functional motifs in each ORF. The frameshift site of PEG10 was highly active in cultured cells and produced the ORF1-2 protein. In mice, endogenous ORF1 and an ORF1-2 frameshift protein were detected in the developing placenta and amniotic membrane from 9.5 days post-coitus through to term with a very high frameshift efficiency (> 60%). Mutagenesis of the active site motif of a putative protease within ORF2 showed that this enzyme is active and participates in post-translational processing of PEG10 ORF1-2. Both PEG10 proteins were also detected in first trimester human placenta. By contrast, neither protein expression nor frameshifting was detected in adult mouse tissues. These studies imply that the ORF1-2 protein, synthesized utilizing the most efficient-1 frameshift mechanism yet documented in vivo, will have an essential function that is intrinsic to the importance of PEG10 in mammals.	[Clark, Michael B.; Jaenicke, Martina; Gottesbuehren, Undine; Kleffmann, Torsten; Legge, Michael; Poole, Elizabeth S.; Tate, Warren P.] Univ Otago, Dept Biochem, Dunedin 9054, New Zealand	University of Otago	Tate, WP (corresponding author), Univ Otago, Dept Biochem, PO Box 56, Dunedin 9054, New Zealand.	warren.tate@stonebow.otago.ac.nz		Tate, Warren/0000-0002-6971-7734; Clark, Michael/0000-0002-2903-9537; Kleffmann, Torsten/0000-0001-9305-5980				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brandt J, 2005, GENE, V345, P101, DOI 10.1016/j.gene.2004.11.022; Brandt J, 2005, CYTOGENET GENOME RES, V110, P307, DOI 10.1159/000084963; Brierley I, 2006, VIRUS RES, V119, P29, DOI 10.1016/j.virusres.2005.10.008; Butler M, 2001, J MOL EVOL, V52, P260, DOI 10.1007/s002390010154; Campillos M, 2006, TRENDS GENET, V22, P585, DOI 10.1016/j.tig.2006.09.006; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Cobucci-Ponzano B, 2006, NUCLEIC ACIDS RES, V34, P4258, DOI 10.1093/nar/gkl574; CRAIGEN WJ, 1985, P NATL ACAD SCI USA, V82, P3616, DOI 10.1073/pnas.82.11.3616; Doma MK, 2006, NATURE, V440, P561, DOI 10.1038/nature04530; Freyer C, 2002, J ANAT, V201, P101, DOI 10.1046/j.1469-7580.2002.00084.x; Gao X, 2003, RNA, V9, P1422, DOI 10.1261/rna.5105503; GESTELAND RF, 1992, SCIENCE, V257, P1640, DOI 10.1126/science.1529352; Hill M, 2005, CURR HIV RES, V3, P73, DOI 10.2174/1570162052772942; Hu CS, 2006, J IMMUNOL, V177, P6713, DOI 10.4049/jimmunol.177.10.6713; Ingr M, 2003, PROTEIN SCI, V12, P2173, DOI 10.1110/ps.03171903; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; JACKS T, 1988, NATURE, V331, P280, DOI 10.1038/331280a0; Jacobs JL, 2007, NUCLEIC ACIDS RES, V35, P165, DOI 10.1093/nar/gkl1033; Kaufman M. H., 2001, ATLAS MOUSE DEV; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Kikuno R, 1999, DNA Res, V6, P197, DOI 10.1093/dnares/6.3.197; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KOZAK M, 1991, J CELL BIOL, V115, P887, DOI 10.1083/jcb.115.4.887; Li CM, 2006, CANCER RES, V66, P665, DOI 10.1158/0008-5472.CAN-05-1553; Lux A, 2005, J BIOL CHEM, V280, P8482, DOI 10.1074/jbc.M409197200; Manktelow E, 2005, NUCLEIC ACIDS RES, V33, P1553, DOI 10.1093/nar/gki299; Mi S, 2000, NATURE, V403, P785, DOI 10.1038/35001608; Murphy WJ, 2001, SCIENCE, V294, P2348, DOI 10.1126/science.1067179; Namy O, 2004, MOL CELL, V13, P157, DOI 10.1016/S1097-2765(04)00031-0; Namy O, 2006, NATURE, V441, P244, DOI 10.1038/nature04735; O'Rahilly R., 1987, DEV STAGES HUMAN EMB; Okabe H, 2003, CANCER RES, V63, P3043; Ono R, 2006, NAT GENET, V38, P101, DOI 10.1038/ng1699; Ono R, 2003, GENOME RES, V13, P1696, DOI 10.1101/gr.906803; Ono R, 2001, GENOMICS, V73, P232, DOI 10.1006/geno.2001.6494; Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570; Scarlett DJG, 2003, J BIOL CHEM, V278, P15095, DOI 10.1074/jbc.M211024200; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shigemoto K, 2001, NUCLEIC ACIDS RES, V29, P4079, DOI 10.1093/nar/29.19.4079; Smallwood A, 2003, BIOL REPROD, V69, P286, DOI 10.1095/biolreprod.102.013078; Springer MS, 2004, TRENDS ECOL EVOL, V19, P430, DOI 10.1016/j.tree.2004.05.006; Suzuki S, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030055; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Volff JN, 2001, MOL BIOL EVOL, V18, P266, DOI 10.1093/oxfordjournals.molbev.a003801; Wills NM, 2006, J BIOL CHEM, V281, P7082, DOI 10.1074/jbc.M511629200; Zhang FW, 2007, J ANIM SCI, V85, P886, DOI 10.2527/jas.2006-278	48	64	70	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37359	37369		10.1074/jbc.M705676200	http://dx.doi.org/10.1074/jbc.M705676200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17942406	hybrid			2022-12-27	WOS:000251833600010
J	Thijs, L; Vinck, E; Bolli, A; Trandafir, F; Wan, XH; Hoogewijs, D; Coletta, M; Fago, A; Weber, RE; Van Doorslaer, S; Ascenzi, P; Alam, M; Moens, L; Dewilde, S				Thijs, Liesbet; Vinck, Evi; Bolli, Alessandro; Trandafir, Florin; Wan, Xuehua; Hoogewijs, David; Coletta, Massimiliano; Fago, Angela; Weber, Roy E.; Van Doorslaer, Sabine; Ascenzi, Paolo; Alam, Maqsudul; Moens, Luc; Dewilde, Sylvia			Characterization of a globin-coupled oxygen sensor with a gene-regulating function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							HEME-BASED SENSORS; ELECTRON-PARAMAGNETIC-RES; TRUNCATED HEMOGLOBIN-O; HYDROGEN-BOND NETWORK; CYCLIC DI-GMP; NITRIC-OXIDE; LIGAND-BINDING; BACILLUS-SUBTILIS; RESONANCE RAMAN; MYCOBACTERIUM-LEPRAE	Globin-coupled sensors (GCSs) are multiple-domain transducers, consisting of a regulatory globin-like heme-binding domain and a linked transducer domain(s). GCSs have been described in both Archaea and bacteria. They are generally assumed to bind O-2 (and perhaps other gaseous ligands) and to transmit a conformational change signal through the transducer domain in response to fluctuating O2 levels. In this study, the heme-binding domain, AvGReg178, and the full protein, AvGReg of the Azotobacter vinelandii GCS, were cloned, expressed, and purified. After purification, the heme iron of AvGReg178 was found to bind O2. This form was stable over many hours. In contrast, the predominant presence of a bis-histidinecoordinate heme in ferric AvGReg was revealed. Differences in the hemepocket structure were also observed for the deoxygenated ferrous state of these proteins. The spectra showed that the deoxygenated ferrous derivatives of AvGReg178 and AvGReg are characterized by a penta-coordinate and hexa-coordinate heme iron, respectively. O2 binding isotherms indicate that AvGReg178 and AvGReg show a high affinity for O-2 with P-50 values at 20 degrees C of 0.04 and 0.15 torr, respectively. Kinetics of CO binding indicate that AvGReg178 carbonylation conforms to a monophasic process, comparable with that of myoglobin, whereas AvGReg carbonylation conforms to a three-phasic reaction, as observed for several proteins with bis-histidine heme iron coordination. Besides sensing ligands, in vitro data suggest that AvGReg(178) may have a role in O-2-mediated NO-detoxification, yielding metAvGReg(178) and nitrate.	[Thijs, Liesbet; Dewilde, Sylvia] Univ Antwerp, Dept Biomed Sci, B-2610 Antwerp, Belgium; [Vinck, Evi; Trandafir, Florin; Van Doorslaer, Sabine] Univ Antwerp, Dept Phys, B-2610 Antwerp, Belgium; [Bolli, Alessandro; Ascenzi, Paolo] Univ Roma Tre, Dipartimento Biol, Lab Interdipartimentale Microscopia Elettron, I-00146 Rome, Italy; [Wan, Xuehua; Alam, Maqsudul] Univ Hawaii, Dept Microbiol, Honolulu, HI 96822 USA; [Hoogewijs, David] Univ Ghent, Ctr Mol Phylogeny & Evolut, Dept Biol, B-9000 Ghent, Belgium; [Coletta, Massimiliano] Univ Roma Tor Vergata, Dept Expt Med & Biochem Sci, I-00133 Rome, Italy; [Fago, Angela; Weber, Roy E.] Aarhus Univ, Dept Sci Biol, DK-8000 Aarhus, Denmark; [Ascenzi, Paolo] Ist Nazl Malattie infet Lazzaro spallanzani, I-00149 Rome, Italy	University of Antwerp; University of Antwerp; Roma Tre University; University of Hawaii System; Ghent University; University of Rome Tor Vergata; Aarhus University	Dewilde, S (corresponding author), Univ Antwerp, Dept Biomed Sci, Campus Drie Eiken,Universiteitsplein 1, B-2610 Antwerp, Belgium.	sylvia.dewilde@ua.ac.be	Hoogewijs, David/L-5144-2016; Van Doorslaer, Sabine/E-5050-2017; Coletta, Massimo/N-9049-2015; Coletta, Massimiliano/GSN-5927-2022; Wan, Xuehua/D-5433-2016; Fago, Angela/J-5946-2013	Van Doorslaer, Sabine/0000-0002-1685-9202; Wan, Xuehua/0000-0002-6367-848X; Fago, Angela/0000-0001-7315-2628; COLETTA, Massimiliano/0000-0002-5489-9467; Bolli, Alessandro/0000-0001-7259-5785; Vinck, Evi/0000-0001-6167-1068				AMIKAM D, 1989, J BACTERIOL, V171, P6649, DOI 10.1128/jb.171.12.6649-6655.1989; ANTONINI E, 1971, BIOCHIM BIOPHYS ACTA, V310, P309; Aono S, 2002, J BIOL CHEM, V277, P13528, DOI 10.1074/jbc.M112256200; ArredondoPeter R, 1997, PLANT PHYSIOL, V115, P1259, DOI 10.1104/pp.115.3.1259; Ascenzi P, 2006, BIOCHEM BIOPH RES CO, V339, P450, DOI 10.1016/j.bbrc.2005.11.031; ASCENZI P, 2008, IN PRESS METHODS ENZ; Ascenzi P, 2007, IUBMB LIFE, V59, P600, DOI 10.1080/15216540701308424; Ascenzi P, 2007, BIOCHEM BIOPH RES CO, V357, P809, DOI 10.1016/j.bbrc.2007.04.024; Blumberg WE, 1971, PROBES STRUCTURE FUN, V2, P215; Brucker EA, 1998, PROTEINS, V30, P352, DOI 10.1002/(SICI)1097-0134(19980301)30:4<352::AID-PROT2>3.0.CO;2-L; BRUNORI M, 1969, J BIOL CHEM, V244, P4046; Brunori M, 2005, P NATL ACAD SCI USA, V102, P8483, DOI 10.1073/pnas.0408766102; Brunori M, 2004, J STRUCT BIOL, V147, P223, DOI 10.1016/j.jsb.2004.04.008; Brunori M, 2001, TRENDS BIOCHEM SCI, V26, P209, DOI 10.1016/S0968-0004(01)01824-2; BRUNORI M, 1986, SUPERMOLECULES BIOL, P55; Chan MK, 2001, CURR OPIN CHEM BIOL, V5, P216, DOI 10.1016/S1367-5931(00)00193-9; Chan NL, 1998, BIOCHEMISTRY-US, V37, P16459, DOI 10.1021/bi9816711; Chang AL, 2001, BIOCHEMISTRY-US, V40, P3420, DOI 10.1021/bi0100236; Conrad R, 1996, MICROBIOL REV, V60, P609, DOI 10.1128/MMBR.60.4.609-640.1996; Copeland DM, 2003, PROTEINS, V53, P182, DOI 10.1002/prot.10495; Das TK, 1999, BIOCHEMISTRY-US, V38, P15360, DOI 10.1021/bi991237e; Das TK, 2000, BIOCHEMISTRY-US, V39, P14330, DOI 10.1021/bi001681d; de Sanctis D, 2004, IUBMB LIFE, V56, P643, DOI 10.1080/15216540500059640; Dewilde S, 2001, J BIOL CHEM, V276, P38949, DOI 10.1074/jbc.M106438200; Duff SMG, 1997, J BIOL CHEM, V272, P16746, DOI 10.1074/jbc.272.27.16746; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Fago A, 2004, J BIOL CHEM, V279, P44417, DOI 10.1074/jbc.M407126200; Fasano M, 2006, BIOCHEM BIOPH RES CO, V345, P704, DOI 10.1016/j.bbrc.2006.04.154; Flogel U, 2001, P NATL ACAD SCI USA, V98, P735, DOI 10.1073/pnas.011460298; Frauenfelder H, 2003, P NATL ACAD SCI USA, V100, P8615, DOI 10.1073/pnas.1633688100; Freitas TAK, 2005, J INORG BIOCHEM, V99, P23, DOI 10.1016/j.jinorgbio.2004.10.024; Freitas TAK, 2003, FEBS LETT, V552, P99, DOI 10.1016/S0014-5793(03)00923-2; Frey AD, 2005, TRENDS BIOTECHNOL, V23, P69, DOI 10.1016/j.tibtech.2004.12.002; Galperin MY, 2001, FEMS MICROBIOL LETT, V203, P11, DOI 10.1111/j.1574-6968.2001.tb10814.x; Gardner AM, 2000, J BIOL CHEM, V275, P12581, DOI 10.1074/jbc.275.17.12581; Gardner PR, 2006, J INORG BIOCHEM, V100, P542, DOI 10.1016/j.jinorgbio.2005.12.012; Geuens E, 2003, J BIOL CHEM, V278, P30417, DOI 10.1074/jbc.C300203200; GIBSON QH, 1986, J BIOL CHEM, V261, P228; Gilles-Gonzalez MA, 2005, J INORG BIOCHEM, V99, P1, DOI 10.1016/j.jinorgbio.2004.11.006; Gow AJ, 1999, P NATL ACAD SCI USA, V96, P9027, DOI 10.1073/pnas.96.16.9027; Hargrove MS, 1997, J MOL BIOL, V266, P1032, DOI 10.1006/jmbi.1996.0833; HAYASHI A, 1973, BIOCHIM BIOPHYS ACTA, V310, P309, DOI 10.1016/0005-2795(73)90110-4; HECHT GB, 1995, EMBO J, V14, P3915, DOI 10.1002/j.1460-2075.1995.tb00063.x; Herold S, 2005, J BIOL INORG CHEM, V10, P935, DOI 10.1007/s00775-005-0046-9; Herold S, 2005, BIOCHEMISTRY-US, V44, P6223, DOI 10.1021/bi0475929; Herold S, 2001, BIOCHEMISTRY-US, V40, P3385, DOI 10.1021/bi002407m; Hoshino M, 1996, J AM CHEM SOC, V118, P5702, DOI 10.1021/ja953311w; Hou SB, 2000, NATURE, V403, P540, DOI 10.1038/35000570; Hu SZ, 1996, J AM CHEM SOC, V118, P12638, DOI 10.1021/ja962239e; Ilari A, 2002, J BIOL CHEM, V277, P23725, DOI 10.1074/jbc.M202228200; Jain R, 2003, J BIOL INORG CHEM, V8, P1, DOI 10.1007/s00775-002-0405-8; Kharitonov VG, 1997, BIOCHEMISTRY-US, V36, P6814, DOI 10.1021/bi970201o; Martin E, 2006, J BIOL CHEM, V281, P27836, DOI 10.1074/jbc.M601078200; Mendes P, 1997, TRENDS BIOCHEM SCI, V22, P361, DOI 10.1016/S0968-0004(97)01103-1; MENDES P, 1993, COMPUT APPL BIOSCI, V9, P563; Mendes P, 1998, BIOINFORMATICS, V14, P869, DOI 10.1093/bioinformatics/14.10.869; Milani M, 2005, J INORG BIOCHEM, V99, P97, DOI 10.1016/j.jinorgbio.2004.10.035; Milani M, 2003, P NATL ACAD SCI USA, V100, P5766, DOI 10.1073/pnas.1037676100; MOORE EG, 1976, J BIOL CHEM, V251, P2788; Nicholas K.B., 1997, EMBNETNEWS, V4, P1; Ouellet H, 2003, BIOCHEMISTRY-US, V42, P5764, DOI 10.1021/bi0270337; Ouellett H, 2002, P NATL ACAD SCI USA, V99, P5902, DOI 10.1073/pnas.092017799; Paoli M, 1999, NAT STRUCT BIOL, V6, P926; PEISACH J, 1971, J BIOL CHEM, V246, P5877; Pesce A, 2003, STRUCTURE, V11, P1087, DOI 10.1016/S0969-2126(03)00166-7; Peterson ES, 1998, BIOCHEMISTRY-US, V37, P12301, DOI 10.1021/bi980752u; Poole RK, 2005, BIOCHEM SOC T, V33, P176, DOI 10.1042/BST0330176; QUINN R, 1987, J AM CHEM SOC, V109, P3301, DOI 10.1021/ja00245a019; Roberts GP, 2005, J INORG BIOCHEM, V99, P280, DOI 10.1016/j.jinorgbio.2004.10.032; Rodgers KR, 2005, J INORG BIOCHEM, V99, P963, DOI 10.1016/j.jinorgbio.2005.02.016; Rodgers KR, 1999, CURR OPIN CHEM BIOL, V3, P158, DOI 10.1016/S1367-5931(99)80028-3; Romling U, 2005, CELL MOL LIFE SCI, V62, P1234, DOI 10.1007/s00018-005-4557-x; ROSS P, 1991, MICROBIOL REV, V55, P35, DOI 10.1128/MMBR.55.1.35-58.1991; Ryjenkov DA, 2005, J BACTERIOL, V187, P1792, DOI 10.1128/JB.187.5.1792-1798.2005; SAGE JT, 1991, BIOCHEMISTRY-US, V30, P1227, DOI 10.1021/bi00219a010; Sawai H, 2005, BIOCHEMISTRY-US, V44, P13257, DOI 10.1021/bi050997o; Sawai H, 2003, BIOCHEMISTRY-US, V42, P5133, DOI 10.1021/bi027067e; Schmidt AJ, 2005, J BACTERIOL, V187, P4774, DOI 10.1128/JB.187.14.4774-4781.2005; Simm R, 2004, MOL MICROBIOL, V53, P1123, DOI 10.1111/j.1365-2958.2004.04206.x; Smagghe BJ, 2006, BIOCHEMISTRY-US, V45, P561, DOI 10.1021/bi051902l; Sousa EHS, 2005, BIOCHEMISTRY-US, V44, P15359, DOI 10.1021/bi051661h; Spiro TG, 2001, CURR OPIN CHEM BIOL, V5, P715, DOI 10.1016/S1367-5931(01)00271-X; SPRINGER BA, 1994, CHEM REV, V94, P699, DOI 10.1021/cr00027a007; Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013; Svistunenko DA, 2000, BIOCHEM J, V351, P595, DOI 10.1042/0264-6021:3510595; Tal R, 1998, J BACTERIOL, V180, P4416, DOI 10.1128/JB.180.17.4416-4425.1998; TAYLOR CPS, 1977, BIOCHIM BIOPHYS ACTA, V491, P137, DOI 10.1016/0005-2795(77)90049-6; Trent JT, 2001, BIOCHEMISTRY-US, V40, P6155, DOI 10.1021/bi0100790; Uchida T, 2005, ACCOUNTS CHEM RES, V38, P662, DOI 10.1021/ar030267d; Uzan J, 2004, BIOPHYS J, V87, P1196, DOI 10.1529/biophysj.104.042168; Vallone B, 2004, PROTEINS, V56, P85, DOI 10.1002/prot.20113; Vallone B, 2004, P NATL ACAD SCI USA, V101, P17351, DOI 10.1073/pnas.0407633101; Van Doorslaer S, 2003, J BIOL CHEM, V278, P4919, DOI 10.1074/jbc.M210617200; Vinogradov SN, 2005, P NATL ACAD SCI USA, V102, P11385, DOI 10.1073/pnas.0502103102; Visca P, 2002, BIOCHEM BIOPH RES CO, V294, P1064, DOI 10.1016/S0006-291X(02)00593-4; WALKER FA, 1986, J AM CHEM SOC, V108, P5288, DOI 10.1021/ja00277a038; WEBER RE, 1992, J APPL PHYSIOL, V72, P1611, DOI 10.1152/jappl.1992.72.4.1611; WHITE DK, 1979, J AM CHEM SOC, V101, P2443, DOI 10.1021/ja00503a034; Wright E, 2004, PROTEIN EXPRES PURIF, V35, P373, DOI 10.1016/j.pep.2004.02.003; YE RW, 1994, APPL ENVIRON MICROB, V60, P1053, DOI 10.1128/AEM.60.4.1053-1058.1994; Yoshimura H, 2006, BIOCHEMISTRY-US, V45, P8301, DOI 10.1021/bi060315c; Youn H, 2004, J BACTERIOL, V186, P1320, DOI 10.1128/JB.186.5.1320-1329.2004; Zhang W, 2005, BIOPHYS J, V88, P2801, DOI 10.1529/biophysj.104.047936; Zhang W, 2003, STRUCTURE, V11, P1097, DOI 10.1016/S0969-2126(03)00169-2	104	32	32	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37325	37340		10.1074/jbc.M705541200	http://dx.doi.org/10.1074/jbc.M705541200			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17925395	hybrid			2022-12-27	WOS:000251833600007
J	Smith, BC; Denu, JM				Smith, Brian C.; Denu, John M.			Acetyl-lysine analog peptides as mechanistic probes of protein deacetylases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIR2 HISTONE/PROTEIN DEACETYLASES; HISTONE DEACETYLASE; ADP-RIBOSYLTRANSFERASE; NAD(+)-DEPENDENT DEACETYLASES; DEPENDENT DEACETYLASE; TRANSCRIPTION FACTORS; CALORIE RESTRICTION; CELL-SURVIVAL; NAD; FAMILY	Class III histone deacetylases (Sir2 or sirtuins) catalyze the NAD(+) -dependent conversion of acetyl-lysine residues to nicotinamide, 2 '-O-acetyl-ADP-ribose (OAADPr), and deacetylated lysine. Class I and II HDACs utilize a different deacetylation mechanism, utilizing an active site zinc to direct hydrolysis of acetyl-lysine residues to lysine and acetate. Here, using ten acetyl-lysine analog peptides, we have probed the substrate binding pockets of sirtuins and investigated the catalytic differences among sirtuins and class I and II deacetylases. For the sirtuin Hst2, acetyl-lysine analog peptide binding correlated with the hydrophobic substituent parameter pi with a slope of -0.35 from a plot of log K-d versus pi. Interestingly, propionyl-and butyryl-lysine peptides were found to bind tighter to Hst2 compared with acetyl-lysine peptide and showed measurable rates of catalysis with Hst2, Sirt1, Sirt2, and Sirt3, suggesting propionyl- and butyryl-lysine proteins may be sirtuin substrates in vivo. Unique among the acetyl-lysine analog peptides examined, homocitrulline peptide produced ADP-ribose instead of the corresponding OAADPr analog. The electron-withdrawing nature of each acetyl analog had a profound impact on the deacylation rate between deacetylase classes. The rate of catalysis with the acetyl-lysine analog peptides varied over five orders of magnitude with the class III deacetylase Hst2, revealing a linear free energy relationship with a slope of -1.57 when plotted versus the Taft constant, sigma*. HDAC8, a class I deacetylase, displayed the opposite trend with a slope of +0.79. These results are applicable toward the development of selective substrates and other mechanistic probes of protein deacetylases.	[Smith, Brian C.] Univ Wisconsin Madison, Dept Chem, Madison, WI 53706 USA; [Denu, John M.] Univ Wisconsin Madison, Dept Biomol Chem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Smith, BC (corresponding author), Univ Wisconsin Madison, Dept Chem, Madison, WI 53706 USA.		Smith, Brian C/D-9949-2013	Smith, Brian C/0000-0001-6330-2768	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065386, T32GM008349] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM065386, 5 T32 GM08349] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Berndsen CE, 2007, BIOCHEMISTRY-US, V46, P623, DOI 10.1021/bi602513x; Blair DE, 2006, BIOCHEMISTRY-US, V45, P9416, DOI 10.1021/bi0606694; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Borra MT, 2004, METHOD ENZYMOL, V376, P171; Borra MT, 2004, BIOCHEMISTRY-US, V43, P9877, DOI 10.1021/bi049592e; Borra MT, 2002, J BIOL CHEM, V277, P12632, DOI 10.1074/jbc.M111830200; Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Chen Y, 2007, MOL CELL PROTEOMICS, V6, P812, DOI 10.1074/mcp.M700021-MCP200; Cho CH, 1999, J PHYS CHEM B, V103, P1991, DOI 10.1021/jp9842953; CLELAND WW, 1975, BIOCHEMISTRY-US, V14, P3220, DOI 10.1021/bi00685a029; Daitoku H, 2004, P NATL ACAD SCI USA, V101, P10042, DOI 10.1073/pnas.0400593101; Dennis RJ, 2006, NAT STRUCT MOL BIOL, V13, P365, DOI 10.1038/nsmb1079; Denu JM, 2005, CURR OPIN CHEM BIOL, V9, P431, DOI 10.1016/j.cbpa.2005.08.010; Ford E, 2006, GENE DEV, V20, P1075, DOI 10.1101/gad.1399706; Frye RA, 1999, BIOCHEM BIOPH RES CO, V260, P273, DOI 10.1006/bbrc.1999.0897; Garcia-Salcedo JA, 2003, EMBO J, V22, P5851, DOI 10.1093/emboj/cdg553; GARRITY J, 2007, J BIOL CHEM; Gregoretti IV, 2004, J MOL BIOL, V338, P17, DOI 10.1016/j.jmb.2004.02.006; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Hansch C, 1979, SUBSTITUENT CONSTANT; Holbert MA, 2005, CURR OPIN STRUC BIOL, V15, P673, DOI 10.1016/j.sbi.2005.10.006; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jackson AD, 2002, J BIOL CHEM, V277, P18535, DOI 10.1074/jbc.M200671200; Jackson MD, 2003, J BIOL CHEM, V278, P50985, DOI 10.1074/jbc.M306552200; JONES CS, 1980, J BIOL CHEM, V255, P1861; Khan AN, 2006, J BIOL CHEM, V281, P11702, DOI 10.1074/jbc.M511482200; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Langley E, 2002, EMBO J, V21, P2383, DOI 10.1093/emboj/21.10.2383; Lee H, 2004, MOL CELL BIOL, V24, P765, DOI 10.1128/MCB.24.2.765-773.2004; Liszt G, 2005, J BIOL CHEM, V280, P21313, DOI 10.1074/jbc.M413296200; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Macauley MS, 2005, J AM CHEM SOC, V127, P17202, DOI 10.1021/ja0567687; Macauley MS, 2005, J BIOL CHEM, V280, P25313, DOI 10.1074/jbc.M413819200; Marks PA, 2007, NAT BIOTECHNOL, V25, P84, DOI 10.1038/nbt1272; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Onyango P, 2002, P NATL ACAD SCI USA, V99, P13653, DOI 10.1073/pnas.222538099; OPPENHEIMER NJ, 1978, FEBS LETT, V94, P368, DOI 10.1016/0014-5793(78)80979-X; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Sauve AA, 2003, BIOCHEMISTRY-US, V42, P9249, DOI 10.1021/bi034959l; Sauve AA, 2001, BIOCHEMISTRY-US, V40, P15456, DOI 10.1021/bi011858j; Sauve AA, 2006, ANNU REV BIOCHEM, V75, P435, DOI 10.1146/annurev.biochem.74.082803.133500; Schwer B, 2002, J CELL BIOL, V158, P647, DOI 10.1083/jcb.200205057; Schwer B, 2006, P NATL ACAD SCI USA, V103, P10224, DOI 10.1073/pnas.0603968103; Smith BC, 2006, BIOCHEMISTRY-US, V45, P272, DOI 10.1021/bi052014t; Smith BC, 2007, J AM CHEM SOC, V129, P5802, DOI 10.1021/ja070162w; Tanny JC, 1999, CELL, V99, P735, DOI 10.1016/S0092-8674(00)81671-2; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Vocadlo DJ, 2005, BIOCHEMISTRY-US, V44, P12809, DOI 10.1021/bi051121k; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Zhao KH, 2004, P NATL ACAD SCI USA, V101, P8563, DOI 10.1073/pnas.0401057101	58	111	113	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					37256	37265		10.1074/jbc.M707878200	http://dx.doi.org/10.1074/jbc.M707878200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17951578	hybrid			2022-12-27	WOS:000251646000051
J	Cao, DF; Lu, HL; Lewis, TL; Li, L				Cao, Dongfeng; Lu, Hailin; Lewis, Terry L.; Li, Ling			Intake of sucrose-sweetened water induces insulin resistance and exacerbates memory deficits and amyloidosis in a transgenic mouse model of Alzheimer disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIABETES-MELLITUS; LEARNING-DEFICITS; US CHILDREN; HIGH-FAT; IN-VIVO; DIET; MICE; OBESITY; PRESENILINS; PROTEIN	Compelling evidence indicates that excess consumption of sugar-sweetened beverages plays an important role in the epidemic of obesity, a major risk factor for type 2 diabetes mellitus. Type 2 diabetes mellitus has been associated with a higher incidence of Alzheimer disease (AD). High fat diets promote AD-like pathology in mice. It is not known whether consumption of excess sugar as in calorically sweetened beverages with an otherwise normal diet affects the development of AD. In the present study, we provided 10% sucrose-sweetened water to a transgenic mouse model of AD with a normal rodent diet. Compared with the control mice with no sucrose added in the water, the sucrose group gained more body weight and developed glucose intolerance, hyperinsulinemia, and hypercholesterolemia. These metabolic changes were associated with the exacerbation of memory impairment and a 2 -3-fold increase in insoluble amyloid-beta protein levels and deposition in the brain. We further showed that the levels of expression and secretase-cleaved products of amyloid-beta precursor protein were not affected by sucrose intake. The steady-state levels of insulin-degrading enzyme did not change significantly, whereas there was a 2.5-fold increase in brain apoE levels. Therefore, we concluded that the up-regulation of apoE accelerated the aggregation of A beta, resulting in the exacerbation of cerebral amyloidosis in sucrose-treated mice. These data underscore the potential role of dietary sugar in the pathogenesis of AD and suggest that controlling the consumption of sugar-sweetened beverages may be an effective way to curtail the risk of developing AD.	Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Neurobiol, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Genet, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Li, L (corresponding author), 1808 7th Ave S,BDB 658, Birmingham, AL 35294 USA.	lili@uab.edu		Li, Ling/0000-0002-9245-7387	NIA NIH HHS [AG025949] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R21AG025949] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		AOYAMA Y, 1974, J NUTR, V104, P741, DOI 10.1093/jn/104.6.741; Bales KR, 1997, NAT GENET, V17, P263, DOI 10.1038/ng1197-263; Black RNA, 2006, DIABETES, V55, P3566, DOI 10.2337/db06-0220; Bray GA, 2004, AM J CLIN NUTR, V79, P537; Cao DF, 2006, NEUROBIOL AGING, V27, P1632, DOI 10.1016/j.neurobiolaging.2005.09.011; Craft S, 2004, LANCET NEUROL, V3, P169, DOI 10.1016/S1474-4422(04)00681-7; Dietschy JM, 2004, J LIPID RES, V45, P1375, DOI 10.1194/jlr.R400004-JLR200; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; FRAYN KN, 1995, AM J CLIN NUTR, V62, p250S, DOI 10.1093/ajcn/62.1.250S; Gonsolin D, 2007, MOL CELL BIOCHEM, V295, P217, DOI 10.1007/s11010-006-9291-7; Grundy SM, 1998, AM J CLIN NUTR, V67, p563S, DOI 10.1093/ajcn/67.3.563S; Haan MN, 2006, NAT CLIN PRACT NEURO, V2, P159, DOI 10.1038/ncpneuro0124; Hardy J, 1997, TRENDS NEUROSCI, V20, P154, DOI 10.1016/S0166-2236(96)01030-2; Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847; Ho L, 2004, FASEB J, V18, P902, DOI 10.1096/fj.03-0978fje; Holtzman DM, 2000, ANN NEUROL, V47, P739, DOI 10.1002/1531-8249(200006)47:6<739::AID-ANA6>3.0.CO;2-8; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Jankowsky JL, 2001, BIOMOL ENG, V17, P157, DOI 10.1016/S1389-0344(01)00067-3; Kiens B, 1996, AM J CLIN NUTR, V63, P47, DOI 10.1093/ajcn/63.1.47; Leibson CL, 1997, AM J EPIDEMIOL, V145, P301; Levin-Allerhand J A, 2002, J Nutr Health Aging, V6, P315; Li L, 2003, AM J PATHOL, V163, P2155, DOI 10.1016/S0002-9440(10)63572-9; Li L, 2006, ANN NEUROL, V60, P729, DOI 10.1002/ana.21053; Malik VS, 2006, AM J CLIN NUTR, V84, P274; Marckmann P, 2000, METABOLISM, V49, P731, DOI 10.1053/meta.2000.6237; Mattson MP, 2003, ANN INTERN MED, V139, P441, DOI 10.7326/0003-4819-139-5_Part_2-200309021-00012; Ogden CL, 2002, JAMA-J AM MED ASSOC, V288, P1728, DOI 10.1001/jama.288.14.1728; Pedersen WA, 2006, EXP NEUROL, V199, P265, DOI 10.1016/j.expneurol.2006.01.018; PFEUFFER M, 1992, J NUTR, V122, P1582, DOI 10.1093/jn/122.7.1582; Refolo LM, 2000, NEUROBIOL DIS, V7, P321, DOI 10.1006/nbdi.2000.0304; REISER S, 1979, AM J CLIN NUTR, V32, P2206, DOI 10.1093/ajcn/32.11.2206; Ryu MH, 2003, J BIOCHEM MOL BIOL, V36, P312; Selkoe DJ, 2000, NEUROL CLIN, V18, P903, DOI 10.1016/S0733-8619(05)70232-2; Selkoe DJ, 2001, NEURON, V32, P177, DOI 10.1016/S0896-6273(01)00475-5; Shie FS, 2002, NEUROREPORT, V13, P455, DOI 10.1097/00001756-200203250-00019; Stolk RP, 1997, DIABETES CARE, V20, P792, DOI 10.2337/diacare.20.5.792; STROBL W, 1989, J BIOL CHEM, V264, P1190; Sumiyoshi M, 2006, J NUTR, V136, P582, DOI 10.1093/jn/136.3.582; WALLUM BJ, 1987, J CLIN ENDOCR METAB, V64, P190, DOI 10.1210/jcem-64-1-190; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301; Zhao WQ, 2001, MOL CELL ENDOCRINOL, V177, P125, DOI 10.1016/S0303-7207(01)00455-5	41	263	266	2	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36275	36282		10.1074/jbc.M703561200	http://dx.doi.org/10.1074/jbc.M703561200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17942401	hybrid			2022-12-27	WOS:000251458300018
J	Edlich, F; Maestre-Martinez, M; Jarczowski, F; Weiwad, M; Moutty, MC; Malesevic, M; Jahreis, G; Fischer, G; Lucke, C				Edlich, Frank; Maestre-Martinez, Mitcheell; Jarczowski, Franziska; Weiwad, Matthias; Moutty, Marie-Christine; Malesevic, Miroslav; Jahreis, Gunther; Fischer, Gunter; Luecke, Christian			A novel calmodulin-Ca2+ target recognition activates the Bcl-2 regulator FKBP38	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; BINDING DOMAIN; INTACT-CELLS; CALCIUM; STIMULATION; SEQUENCE; BRAIN; NEUROMODULIN; COMPLEX; CYCLASE	The FK506-binding protein 38 (FKBP38) affects neuronal apoptosis control by suppressing the anti-apoptotic function of Bcl-2. The direct interaction between FKBP38 and Bcl-2, however, requires a prior activation of FKBP38 by the Ca2+ sensor calmodulin (CaM). Here we demonstrate for the first time that the formation of a complex between FKBP38 and CaM-Ca2+ involves two separate interaction sites, thus revealing a novel scenario of target protein regulation by CaM-Ca2+. The C-terminal FKBP38 residues Ser(290)-Asn(313) bind to the target protein-binding cleft of the Ca2+-coordinated C-terminal CaM domain, thereby enabling the N-terminal CaM domain to interact with the catalytic domain of FKBP38 in a Ca2+-independent manner. Only the latter interaction between the catalytic FKBP38 domain and the N-terminal CaM domain activates FKBP38 and, as a consequence, also regulates Bcl-2.	Max Planck Res Unit Enzymol Prot Folding, D-06120 Halle, Germany	Max Planck Society	Fischer, G (corresponding author), Max Planck Res Unit Enzymol Prot Folding, Weinbergweg 22, D-06120 Halle, Germany.	fischer@enzyme-halle.mpg.de	Malesevic, Miroslav/D-8128-2012	Malesevic, Miroslav/0000-0002-1484-3709				Barth S, 2007, MOL CELL BIOL, V27, P3758, DOI 10.1128/MCB.01324-06; BAUDIER J, 1991, J BIOL CHEM, V266, P229; Black DJ, 2004, CELL CALCIUM, V35, P415, DOI 10.1016/j.ceca.2003.10.005; Brokx RD, 2001, J BIOL CHEM, V276, P14083, DOI 10.1074/jbc.M011026200; Bulgakov OV, 2004, DEVELOPMENT, V131, P2149, DOI 10.1242/dev.01122; CHAPMAN ER, 1991, J BIOL CHEM, V266, P207; CHAZIN WJ, 1995, NAT STRUCT BIOL, V2, P707, DOI 10.1038/nsb0995-707; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Collier RJ, 2003, ANNU REV CELL DEV BI, V19, P45, DOI 10.1146/annurev.cellbio.19.111301.140655; Drum CL, 2002, NATURE, V415, P396, DOI 10.1038/415396a; Edlich F, 2005, EMBO J, V24, P2688, DOI 10.1038/sj.emboj.7600739; Edlich F, 2007, J BIOL CHEM, V282, P15341, DOI 10.1074/jbc.M611594200; Edlich F, 2006, J BIOL CHEM, V281, P14961, DOI 10.1074/jbc.M600452200; FRANK R, 1992, TETRAHEDRON, V48, P9217, DOI 10.1016/S0040-4020(01)85612-X; GREENLEE DV, 1982, BIOCHEMISTRY-US, V21, P2759, DOI 10.1021/bi00540a028; GRIFFITH JP, 1995, CELL, V82, P507, DOI 10.1016/0092-8674(95)90439-5; Griffith LC, 2004, J NEUROSCI, V24, P8394, DOI 10.1523/JNEUROSCI.3604-04.2004; GUERINI D, 1984, J BIOL CHEM, V259, P5172; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; IKURA M, 1990, BIOCHEMISTRY-US, V29, P4659, DOI 10.1021/bi00471a022; IKURA M, 1992, SCIENCE, V256, P632, DOI 10.1126/science.1585175; Jurado LA, 1999, PHYSIOL REV, V79, P661, DOI 10.1152/physrev.1999.79.3.661; KUBONIWA H, 1995, NAT STRUCT BIOL, V2, P768, DOI 10.1038/nsb0995-768; Maestre-Martinez M, 2006, J BIOMOL NMR, V34, P197, DOI 10.1007/s10858-006-0018-6; Persechini A, 1999, J BIOL CHEM, V274, P6827, DOI 10.1074/jbc.274.11.6827; POTTER JD, 1983, METHOD ENZYMOL, V102, P135; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Romoser VA, 1997, J BIOL CHEM, V272, P13270, DOI 10.1074/jbc.272.20.13270; Rosner M, 2003, ONCOGENE, V22, P4786, DOI 10.1038/sj.onc.1206776; Sinars CR, 2003, P NATL ACAD SCI USA, V100, P868, DOI 10.1073/pnas.0231020100; TESHIMA Y, 1978, J CYCLIC NUCL PROT, V4, P219; Tran QK, 2003, J BIOL CHEM, V278, P24247, DOI 10.1074/jbc.C300165200; Ulmer TS, 2003, J BIOL CHEM, V278, P29261, DOI 10.1074/jbc.M302837200; Wu BL, 2004, P NATL ACAD SCI USA, V101, P8348, DOI 10.1073/pnas.0305969101; YAMAKI T, 1980, BIOCHEM BIOPH RES CO, V94, P727, DOI 10.1016/0006-291X(80)91293-0; ZHANG M, 1995, NAT STRUCT BIOL, V2, P758, DOI 10.1038/nsb0995-758	36	26	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36496	36504		10.1074/jbc.M705061200	http://dx.doi.org/10.1074/jbc.M705061200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17942410	hybrid			2022-12-27	WOS:000251458300042
J	Gomez, MA; Li, S; Tremblay, ML; Olivier, M				Gomez, Maria Adelaida; Li, Samantha; Tremblay, Michel L.; Olivier, Martin			NRAMP-1 expression modulates protein-tyrosine phosphatase activity in macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA STABILITY; NATURAL-RESISTANCE; INTRACELLULAR PARASITES; MURINE LEISHMANIASIS; REVERSIBLE OXIDATION; NEGATIVE REGULATOR; GENETIC-REGULATION; INNATE RESISTANCE; BALB/C MICE; IFN-GAMMA	NRAMP-1 (natural resistance-associated macrophage protein1) has been associated with innate resistance to unrelated intracellular pathogen infections, up-regulation of proinflammatory phagocyte functions, and susceptibility to autoimmune diseases. It is still unclear how the divalent cation transport function of NRAMP-1 accounts for the associated pleiotropic effects. In this study, we evaluated the impact of murine macrophage NRAMP-1 expression on the activity of protein-tyrosine phosphatases (PTPs) as an upstream event contributing to the NRAMP-1 regulation of signal transduction and control of effector macrophage functions. Functional expression of NRAMP-1 results in lower macrophage PTP activity and increased protein phosphorylation. Decreased PTP activity is not a result of changes in protein expression but rather a reversible regulatory mechanism involving the interaction with NRAMP-1 metal substrates. In the context of intracellular infections, NRAMP-1 expression prevents full macrophage PTP induction by Leishmania infection, correlating with higher nitric oxide production and lower parasite survival. We suggest that NRAMP-1 divalent cation transport leads to transient inhibition of PTPs via direct PTP-metal interaction and/or by reactive oxygen species-dependent PTP oxidation, consequently promoting positive signal transduction, as a backbone for the induction of proinflammatory phagocyte functions.	McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2B4, Canada; McGill Univ, Dept Med, Montreal, PQ H3A 2B4, Canada; McGill Univ, Ctr Hlth, Ctr Study Host Resistance, Montreal, PQ H3G 1A4, Canada; McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ H3G 1A4, Canada; McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada	McGill University; McGill University; McGill University; McGill University; McGill University	Olivier, M (corresponding author), McGill Univ, Dept Microbiol & Immunol, Duff Med Bldg,Rm 610,3775 Univ St, Montreal, PQ H3A 2B4, Canada.	martin.olivier@mcgill.ca		Gomez, Maria Adelaida/0000-0001-8792-1563				Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Atkinson PGP, 1999, IMMUNOLOGY, V96, P656; BARRERA LF, 1994, IMMUNOLOGY, V82, P457; Barrera LF, 1997, MOL IMMUNOL, V34, P343, DOI 10.1016/S0161-5890(97)00018-7; BARTON CH, 1995, MOL MED, V1, P267, DOI 10.1007/BF03401551; Bisti S, 2000, EUR J IMMUNOL, V30, P3732, DOI 10.1002/1521-4141(200012)30:12&lt;3732::AID-IMMU3732&gt;3.0.CO;2-D; Bisti S, 2006, MICROBES INFECT, V8, P1473, DOI 10.1016/j.micinf.2006.01.004; Blackwell JM, 1999, IMMUNOL LETT, V65, P73, DOI 10.1016/S0165-2478(98)00127-8; Blackwell JM, 2004, MOL B INT U, P53; BLACKWELL JM, 1991, IMMUNOL LETT, V30, P241, DOI 10.1016/0165-2478(91)90032-6; Blanchette J, 1999, EUR J IMMUNOL, V29, P3737, DOI 10.1002/(SICI)1521-4141(199911)29:11&lt;3737::AID-IMMU3737&gt;3.0.CO;2-S; BLISKA JB, 1992, J EXP MED, V176, P1625, DOI 10.1084/jem.176.6.1625; BLISKA JB, 1993, TRENDS GENET, V9, P85, DOI 10.1016/0168-9525(93)90229-B; Bourdeau A, 2005, CURR OPIN CELL BIOL, V17, P203, DOI 10.1016/j.ceb.2005.02.001; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown DH, 1997, INFECT IMMUN, V65, P597, DOI 10.1128/IAI.65.2.597-603.1997; BRUN R, 1979, ACTA TROP, V36, P289; BURRIDGE K, 1995, ANAL BIOCHEM, V232, P56, DOI 10.1006/abio.1995.9961; BUSCHMAN E, 1988, IMMUNOL LETT, V19, P199, DOI 10.1016/0165-2478(88)90143-5; Canonne-Hergaux F, 2002, BLOOD, V100, P268, DOI 10.1182/blood.V100.1.268; Cote JF, 2002, J BIOL CHEM, V277, P2973, DOI 10.1074/jbc.M106428200; CROCKER PR, 1984, INFECT IMMUN, V43, P1033, DOI 10.1128/IAI.43.3.1033-1040.1984; DECHASTELLIER C, 1993, INFECT IMMUN, V61, P3775, DOI 10.1128/IAI.61.9.3775-3784.1993; DENIS M, 1988, CLIN EXP IMMUNOL, V73, P370; DeVinney R, 2000, TRENDS MICROBIOL, V8, P29, DOI 10.1016/S0966-842X(99)01657-1; Forbes JR, 2003, BLOOD, V102, P1884, DOI 10.1182/blood-2003-02-0425; Forbes JR, 2001, TRENDS MICROBIOL, V9, P397, DOI 10.1016/S0966-842X(01)02098-4; Forget G, 2005, EUR J IMMUNOL, V35, P1906, DOI 10.1002/eji.200526037; Forget G, 2001, EUR J IMMUNOL, V31, P3185, DOI 10.1002/1521-4141(200111)31:11&lt;3185::AID-IMMU3185&gt;3.0.CO;2-J; Forget G, 2006, INFECT IMMUN, V74, P6272, DOI 10.1128/IAI.00853-05; Frehel C, 2002, CELL MICROBIOL, V4, P541, DOI 10.1046/j.1462-5822.2002.00213.x; Fritsche G, 2003, J IMMUNOL, V171, P1994, DOI 10.4049/jimmunol.171.4.1994; Furuya T, 1998, MOL BIOCHEM PARASIT, V92, P339, DOI 10.1016/S0166-6851(97)00246-6; Goswami T, 2001, BIOCHEM J, V354, P511, DOI 10.1042/0264-6021:3540511; Govoni G, 1999, INFECT IMMUN, V67, P2225, DOI 10.1128/IAI.67.5.2225-2232.1999; GROS P, 1981, J IMMUNOL, V127, P2417; Gruenheid S, 1997, J EXP MED, V185, P717, DOI 10.1084/jem.185.4.717; Haase H, 2005, J TRACE ELEM MED BIO, V19, P37, DOI 10.1016/j.jtemb.2005.02.004; Haase H, 2005, BIOMETALS, V18, P333, DOI 10.1007/s10534-005-3707-9; Haase H, 2003, EXP CELL RES, V291, P289, DOI 10.1016/S0014-4827(03)00406-3; Hackam DJ, 1998, J EXP MED, V188, P351, DOI 10.1084/jem.188.2.351; Heinonen KM, 2006, P NATL ACAD SCI USA, V103, P2776, DOI 10.1073/pnas.0508563103; Ibarra-Sanchez MD, 2001, ONCOGENE, V20, P4728, DOI 10.1038/sj.onc.1204648; Jabado N, 2000, J EXP MED, V192, P1237, DOI 10.1084/jem.192.9.1237; Jaramillo M, 2005, J IMMUNOL, V174, P475, DOI 10.4049/jimmunol.174.1.475; Kissler S, 2006, NAT GENET, V38, P479, DOI 10.1038/ng1766; KLINGMULLER U, 1995, CELL, V80, P729, DOI 10.1016/0092-8674(95)90351-8; Lafuse WP, 2000, BIOCHEM J, V351, P687, DOI 10.1042/0264-6021:3510687; Lafuse WP, 2002, CELL IMMUNOL, V215, P195, DOI 10.1016/S0008-8749(02)00026-6; Lahti A, 2000, J PHARMACOL EXP THER, V294, P1188; LISSNER CR, 1983, J IMMUNOL, V131, P3006; Markova B, 2005, METHODS, V35, P22, DOI 10.1016/j.ymeth.2004.07.004; Matte C, 2000, EUR J IMMUNOL, V30, P2555, DOI 10.1002/1521-4141(200009)30:9&lt;2555::AID-IMMU2555&gt;3.0.CO;2-X; Meng TC, 2004, J BIOL CHEM, V279, P37716, DOI 10.1074/jbc.M404606200; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; Mustelin T, 2005, NAT REV IMMUNOL, V5, P43, DOI 10.1038/nri1530; Myers MP, 2001, J BIOL CHEM, V276, P47771, DOI 10.1074/jbc.C100583200; Olivier M, 1998, EUR J BIOCHEM, V251, P734, DOI 10.1046/j.1432-1327.1998.2510734.x; OLIVIER M, 1987, INFECT IMMUN, V55, P467, DOI 10.1128/IAI.55.2.467-471.1987; Olivier M, 2005, CLIN MICROBIOL REV, V18, P293, DOI 10.1128/CMR.18.2.293-305.2005; Olivier M, 1998, J BIOL CHEM, V273, P13944, DOI 10.1074/jbc.273.22.13944; Picard V, 2000, J BIOL CHEM, V275, P35738, DOI 10.1074/jbc.M005387200; POSNER BI, 1994, J BIOL CHEM, V269, P4596; Richer E, 2004, MOL B INT U, P178; ROACH TIA, 1994, INFECT IMMUN, V62, P1176, DOI 10.1128/IAI.62.4.1176-1184.1994; ROACH TIA, 1991, INFECT IMMUN, V59, P3935, DOI 10.1128/IAI.59.11.3935-3944.1991; Rojas M, 1999, J IMMUNOL, V162, P6122; Roy G, 2000, MOL BIOCHEM PARASIT, V110, P195, DOI 10.1016/S0166-6851(00)00270-X; Saxena M, 2000, SEMIN IMMUNOL, V12, P387, DOI 10.1006/smim.2000.0219; Schaible ME, 2004, NAT REV MICROBIOL, V2, P946, DOI 10.1038/nrmicro1046; Simoncic PD, 2002, CURR BIOL, V12, P446, DOI 10.1016/S0960-9822(02)00697-8; Stoker AW, 2005, J ENDOCRINOL, V185, P19, DOI 10.1677/joe.1.06069; Suh SJ, 2006, ARCH BIOCHEM BIOPHYS, V447, P136, DOI 10.1016/j.abb.2006.01.016; Teixeira JE, 2002, INFECT IMMUN, V70, P1816, DOI 10.1128/IAI.70.4.1816-1823.2002; ten Hoeve J, 2002, MOL CELL BIOL, V22, P5662, DOI 10.1128/MCB.22.16.5662-5668.2002; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Tonks NK, 2003, FEBS LETT, V546, P140, DOI 10.1016/S0014-5793(03)00603-3; Tonks NK, 2005, CELL, V121, P667, DOI 10.1016/j.cell.2005.05.016; VIDAL S, 1995, J LEUKOCYTE BIOL, V58, P382, DOI 10.1002/jlb.58.4.382; VIDAL S, 1995, J EXP MED, V182, P655, DOI 10.1084/jem.182.3.655; VIDAL SM, 1993, CELL, V73, P469, DOI 10.1016/0092-8674(93)90135-D; Wojciechowski W, 1999, J IMMUNOL, V163, P2688; XIE QW, 1994, J BIOL CHEM, V269, P4705; Yamamoto T, 2002, BIOCHEM BIOPH RES CO, V297, P811, DOI 10.1016/S0006-291X(02)02291-X; You M, 1999, MOL CELL BIOL, V19, P2416, DOI 10.1128/mcb.19.3.2416; Zwilling BS, 1999, INFECT IMMUN, V67, P1386, DOI 10.1128/IAI.67.3.1386-1392.1999	86	27	31	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36190	36198		10.1074/jbc.M703140200	http://dx.doi.org/10.1074/jbc.M703140200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17942403	hybrid			2022-12-27	WOS:000251458300008
J	List, K; Currie, B; Scharschmidt, TC; Szabo, R; Shireman, J; Molinolo, A; Cravatt, BF; Segre, J; Bugge, TH				List, Karin; Currie, Brooke; Scharschmidt, Tiffany C.; Szabo, Roman; Shireman, Jessica; Molinolo, Alfredo; Cravatt, Benjamin F.; Segre, Julia; Bugge, Thomas H.			Autosomal ichthyosis with hypotrichosis syndrome displays low matriptase proteolytic activity and is phenocopied in ST14 hypomorphic mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE SERINE-PROTEASE; EPIDERMAL BARRIER FUNCTION; NETHERTON-SYNDROME; FILAGGRIN; SKIN; DIFFERENTIATION; CANCER; PROFILAGGRIN; DEGRADATION; INITIATION	Human autosomal recessive ichthyosis with hypotrichosis (ARIH) is an inherited disorder recently linked to homozygosity for a point mutation in the ST14 gene that causes a G827R mutation in the matriptase serine protease domain (G216 in chymotrypsin numbering). Here we show that human G827R matriptase has strongly reduced proteolytic activity toward small molecule substrates, as well as toward its candidate epidermal target, prostasin. To further investigate the possible contribution of low matriptase activity to ARIH, we generated an ST14 hypomorphic mouse strain that displays a 100-fold reduction in epidermal matriptase mRNA levels. Interestingly, unlike ST14 null mice, ST14 hypomorphic mice were viable and fertile but displayed a spectrum of abnormalities that strikingly resembled ARIH. Thus, ST14 hypomorphic mice developed hyperproliferative and retention ichthyosis with impaired desquamation, hypotrichosis with brittle, thin, uneven, and sparse hair, and tooth defects. Biochemical analysis of ST14 hypomorphic epidermis revealed reduced prostasin proteolytic activation and profilaggrin proteolytic processing, compatible with a primary role of matriptase in this process. This work strongly indicates that reduced activity of a matriptase-prostasin proteolytic cascade is the etiological origin of human ARIH and provides an important mouse model for the exploration of matriptase function in ARIH, as well as multiple other physiological and pathological processes.	NIDCR, Proteases & Tissue Remodeling Unit, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD 20892 USA; NHGRI, NIH, Bethesda, MD 20892 USA; Howard Hughes Med Inst, Res Scholars Program, Chevy Chase, MD 20815 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Howard Hughes Medical Institute; Scripps Research Institute; Scripps Research Institute	Bugge, TH (corresponding author), NIDCR, Proteases & Tissue Remodeling Unit, Oral & Pharyngeal Canc Branch, NIH, 30 Convent Dr,Rm 211, Bethesda, MD 20892 USA.	thomas.bugge@nih.gov		Scharschmidt, Tiffany/0000-0001-5517-089X	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG000180, ZIAHG000180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000699] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Alonso L, 2003, P NATL ACAD SCI USA, V100, P11830, DOI 10.1073/pnas.1734203100; Basel-Vanagaite L, 2007, AM J HUM GENET, V80, P467, DOI 10.1086/512487; Bhatt AS, 2007, P NATL ACAD SCI USA, V104, P5771, DOI 10.1073/pnas.0606514104; Bugge TH, 2007, FRONT BIOSCI-LANDMRK, V12, P5060, DOI 10.2741/2448; Chavanas S, 2000, NAT GENET, V25, P141, DOI 10.1038/75977; Chen LM, 2001, J BIOL CHEM, V276, P21434, DOI 10.1074/jbc.M011423200; CRAIK CS, 1985, SCIENCE, V228, P291, DOI 10.1126/science.3838593; DANO K, 1985, ADV CANCER RES, V44, P139, DOI 10.1016/S0065-230X(08)60028-7; DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001; Descargues P, 2005, NAT GENET, V37, P56, DOI 10.1038/ng1493; Dreher F, 1998, ACTA DERM-VENEREOL, V78, P186; Egelrud T, 2000, ACTA DERM-VENEREOL, P44; Friedrich R, 2002, J BIOL CHEM, V277, P2160, DOI 10.1074/jbc.M109830200; Hewett DR, 2005, HUM MOL GENET, V14, P335, DOI 10.1093/hmg/ddi030; Hobson JP, 2004, J BIOL CHEM, V279, P46981, DOI 10.1074/jbc.M403299200; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jessani N, 2002, P NATL ACAD SCI USA, V99, P10335, DOI 10.1073/pnas.162187599; Kilpatrick LM, 2006, BLOOD, V108, P2616, DOI 10.1182/blood-2006-02-001073; Kim MG, 1999, IMMUNOGENETICS, V49, P420, DOI 10.1007/s002510050515; KITAMOTO Y, 1994, P NATL ACAD SCI USA, V91, P7588, DOI 10.1073/pnas.91.16.7588; Leyvraz C, 2005, J CELL BIOL, V170, P487, DOI 10.1083/jcb.200501038; Lin CY, 1999, J BIOL CHEM, V274, P18237, DOI 10.1074/jbc.274.26.18237; List K, 2006, AM J PATHOL, V168, P1513, DOI 10.2353/ajpath.2006.051071; List K, 2002, ONCOGENE, V21, P3765, DOI 10.1038/sj.onc.1205502; List K, 2003, J CELL BIOL, V163, P901, DOI 10.1083/jcb.200304161; List K, 2007, J CELL PHYSIOL, V213, P237, DOI 10.1002/jcp.21115; List K, 2006, MOL MED, V12, P1, DOI 10.2119/2006-00022.List; Liu YS, 1999, P NATL ACAD SCI USA, V96, P14694, DOI 10.1073/pnas.96.26.14694; MARCHETTI G, 1993, BRIT J HAEMATOL, V84, P285, DOI 10.1111/j.1365-2141.1993.tb03066.x; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; Nemes Z, 1999, EXP MOL MED, V31, P5, DOI 10.1038/emm.1999.2; Netzel-Arnett S, 2006, J BIOL CHEM, V281, P32941, DOI 10.1074/jbc.C600208200; Parry GCN, 1998, J CLIN INVEST, V101, P560, DOI 10.1172/JCI814; Presland RB, 2000, J INVEST DERMATOL, V115, P1072, DOI 10.1046/j.1523-1747.2000.00178.x; Presland RB, 2000, CRIT REV ORAL BIOL M, V11, P383, DOI 10.1177/10454411000110040101; Puente XS, 2003, NAT REV GENET, V4, P544, DOI 10.1038/nrg1111; RAWLINGS ND, 1994, METHOD ENZYMOL, V244, P19; RESING KA, 1984, J CELL BIOL, V99, P1372, DOI 10.1083/jcb.99.4.1372; Rogers GE, 2004, INT J DEV BIOL, V48, P163, DOI 10.1387/ijdb.15272381; ROOP D, 1995, SCIENCE, V267, P474, DOI 10.1126/science.7529942; Satomi S, 2001, BIOCHEM BIOPH RES CO, V287, P995, DOI 10.1006/bbrc.2001.5686; Segre JA, 2006, J CLIN INVEST, V116, P1150, DOI 10.1172/JCI28521; Selwood T, 2002, BIOCHEMISTRY-US, V41, P3329, DOI 10.1021/bi015662v; Szabo R, 2007, ONCOGENE, V26, P1546, DOI 10.1038/sj.onc.1209966; Uhland K, 2006, CELL MOL LIFE SCI, V63, P2968, DOI 10.1007/s00018-006-6298-x; Yang T, 2004, GENE DEV, V18, P2354, DOI 10.1101/gad.1232104; Zeeuwen PLJM, 2004, EUR J CELL BIOL, V83, P761, DOI 10.1078/0171-9335-00388	47	76	78	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36714	36723		10.1074/jbc.M705521200	http://dx.doi.org/10.1074/jbc.M705521200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17940283	hybrid			2022-12-27	WOS:000251458300064
J	Knapp, AM; Ramsey, JE; Wang, SX; Strauch, AR; Kelm, RJ				Knapp, Anna M.; Ramsey, Jon E.; Wang, Shu-Xia; Strauch, Arthur R.; Kelm, Robert J., Jr.			Structure-function analysis of mouse pur beta II - Conformation altering mutations disrupt single-stranded DNA and protein interactions crucial to smooth muscle alpha-actin gene repression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-BINDING PROTEIN; MYOSIN HEAVY-CHAIN; CELL-CYCLE; MESSENGER-RNA; NIH3T3 CELLS; IN-VITRO; EXPRESSION; ATHEROSCLEROSIS; MYOFIBROBLAST; FIBROBLASTS	Previous studies from our laboratories have implicated two members of the Pur family of single-stranded DNA/RNA-binding proteins, Pur alpha and Pur beta, in transcriptional repression of the smooth muscle alpha-actin gene in vascular cell types. Although Pur alpha and Pur beta share substantial sequence homology and nucleic acid binding properties, genomic promoter and cis-element occupancy studies reported herein suggest that Pur beta is the dominant factor in gene regulation. To dissect the molecular basis of Pur beta repressor activity, site-directed mutagenesis was used to map amino acids critical to the physical and functional interaction of Pur beta with the smooth muscle alpha-actin promoter. Of all the various acidic, basic, and aromatic residues studied, mutation of positionally conserved arginines in the class I or class II repeat modules significantly attenuated Pur beta repressor activity in transfected vascular smooth muscle cells and fibroblasts. DNA binding and protein-protein interaction assays were conducted with purified recombinant Pur beta and selected mutants to reveal the physical basis for loss-of-function. Mutants R57E, R57E/R96E, and R57A/R96A each exhibited reduced single-stranded DNA binding affinity for an essential promoter element and diminished interaction with corepressor YB-1/MSY1. Structural analyses of the R57A/R96A and R57E/R96E double mutants in comparison to the wildtype Pur beta homodimer revealed aberrant self-association into higher order oligomeric complexes, which correlated with decreased alpha-helical content and defective DNA and protein binding in vitro. These findings point to a previously unrecognized structural role for certain core arginine residues in forming a conformationally stable Pur beta protein capable of physical interactions necessary for smooth muscle alpha-actin gene repression.	Univ Vermont, Coll Med, Dept Biochem, Cardiovasc Res Inst, Burlington, VT 05405 USA; Univ Vermont, Coll Med, Dept Med, Cardiovasc Res Inst, Burlington, VT 05405 USA; Ohio State Univ, Dept Physiol & Cell Biol, Dorothy M Davis Heart & Lung Res Inst, Coll Med & Publ Hlth, Columbus, OH 43210 USA	University of Vermont; University of Vermont; University System of Ohio; Ohio State University	Kelm, RJ (corresponding author), Colchester Res Fac, 208 S Pk Dr, Colchester, VT 05446 USA.	Robert.Kelm@uvm.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007594, R01HL054281] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL054281, T32 HL007594] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Barr SM, 2001, J CELL BIOCHEM, V81, P621, DOI 10.1002/jcb.1099; Becker NA, 2000, J BIOL CHEM, V275, P15384, DOI 10.1074/jbc.M909687199; Brill SJ, 1998, MOL CELL BIOL, V18, P7225, DOI 10.1128/MCB.18.12.7225; Carlini LE, 2002, J BIOL CHEM, V277, P8682, DOI 10.1074/jbc.M109754200; Clement S, 2007, J CELL SCI, V120, P229, DOI 10.1242/jcs.03340; Darbinian N, 2001, J CELL BIOCHEM, V80, P589, DOI 10.1002/1097-4644(20010315)80:4<589::AID-JCB1013>3.0.CO;2-0; Darbinian N, 2001, J CELL PHYSIOL, V189, P334, DOI 10.1002/jcp.10029; Desmouliere A, 2005, WOUND REPAIR REGEN, V13, P7, DOI 10.1111/j.1067-1927.2005.130102.x; Ding Y, 1997, NEUROCHEM INT, V31, P45, DOI 10.1016/S0197-0186(96)00127-1; Falk E, 2006, J AM COLL CARDIOL, V47, pC7, DOI 10.1016/j.jacc.2005.09.068; Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427; Gallia GL, 2001, J CELL BIOCHEM, V83, P355, DOI 10.1002/jcb.1247; Gallia GL, 2000, NUCLEIC ACIDS RES, V28, P3197, DOI 10.1093/nar/28.17.3197; Gaudreault I, 2004, NUCLEIC ACIDS RES, V32, P316, DOI 10.1093/nar/gkh170; Greenfield NJ, 2006, NAT PROTOC, V1, P2527, DOI 10.1038/nprot.2006.204; Gupta M, 2003, J BIOL CHEM, V278, P44935, DOI 10.1074/jbc.M307696200; Gupta M, 2007, CAN J PHYSIOL PHARM, V85, P349, DOI 10.1139/Y07-009; Hu YH, 2004, J CLIN INVEST, V113, P1258, DOI 10.1172/JCI200419628; Itoh H, 1998, CELL GROWTH DIFFER, V9, P651; Ji J, 2007, MOL CELL BIOL, V27, P1531, DOI 10.1128/MCB.00629-06; Johnson EM, 2003, ANTICANCER RES, V23, P2093; Johnson EM, 2006, J NEUROSCI RES, V83, P929, DOI 10.1002/jnr.20806; JOHNSON EM, 1995, J BIOL CHEM, V270, P24352, DOI 10.1074/jbc.270.41.24352; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Kelm RJ, 2003, J BIOL CHEM, V278, P38749, DOI 10.1074/jbc.M306163200; Kelm RJ, 1999, J BIOL CHEM, V274, P14238, DOI 10.1074/jbc.274.20.14238; Kelm RJ, 1999, J BIOL CHEM, V274, P38268, DOI 10.1074/jbc.274.53.38268; Kelm RJ, 1997, J BIOL CHEM, V272, P26727, DOI 10.1074/jbc.272.42.26727; Khalili K, 2003, MOL CELL BIOL, V23, P6857, DOI 10.1128/MCB.23.19.6857-6875.2003; Knapp AM, 2006, J BIOL CHEM, V281, P7907, DOI 10.1074/jbc.M509682200; Kumar MS, 2003, ARTERIOSCL THROM VAS, V23, P737, DOI 10.1161/01.ATV.0000065197.07635.BA; Liu H, 2005, BIOCHEM BIOPH RES CO, V328, P851, DOI 10.1016/j.bbrc.2005.01.038; Liu H, 2002, NUCLEIC ACIDS RES, V30, P2417, DOI 10.1093/nar/30.11.2417; MACDONALD GH, 1995, J BIOL CHEM, V270, P3527, DOI 10.1074/jbc.270.8.3527; Rahmani M, 2006, CIRC RES, V99, P801, DOI 10.1161/01.RES.0000246086.93555.f3; Ramsey JE, 2007, J BIOL CHEM, V282, P1552, DOI 10.1074/jbc.M609356200; RonnovJessen L, 1996, J CELL BIOL, V134, P67, DOI 10.1083/jcb.134.1.67; ROSS R, 1995, ANNU REV PHYSIOL, V57, P791, DOI 10.1146/annurev.ph.57.030195.004043; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Sartore S, 2001, CIRC RES, V89, P1111, DOI 10.1161/hh2401.100844; Schildmeyer LA, 2000, FASEB J, V14, P2213, DOI 10.1096/fj.99-0927com; Serini G, 1999, EXP CELL RES, V250, P273, DOI 10.1006/excr.1999.4543; Shimotai Y, 2006, BIOCHEM BIOPH RES CO, V340, P517, DOI 10.1016/j.bbrc.2005.12.032; Stacey DW, 1999, ONCOGENE, V18, P4254, DOI 10.1038/sj.onc.1202795; Subramanian SV, 2004, MOL BIOL CELL, V15, P4532, DOI 10.1091/mbc.E04-04-0348; Subramanian SV, 2002, CARDIOVASC RES, V54, P539, DOI 10.1016/S0008-6363(02)00270-5; Takeji M, 2006, J BIOL CHEM, V281, P40193, DOI 10.1074/jbc.M602182200; Tomasek JJ, 2006, INVEST OPHTH VIS SCI, V47, P2693, DOI 10.1167/iovs.05-1297; Virmani R, 2006, J AM COLL CARDIOL, V47, pC13, DOI 10.1016/j.jacc.2005.10.065; Wang JW, 1997, J CLIN INVEST, V100, P1425, DOI 10.1172/JCI119663; Wang SX, 2005, J BIOL CHEM, V280, P6204, DOI 10.1074/jbc.M409506200; Wortman MJ, 2005, BBA-MOL CELL RES, V1743, P64, DOI 10.1016/j.bbamcr.2004.08.010; Yoshida T, 2005, CIRC RES, V96, P280, DOI 10.1161/01.RES.0000155951.62152.2e	53	10	10	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35899	35909		10.1074/jbc.M706617200	http://dx.doi.org/10.1074/jbc.M706617200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17906292	hybrid			2022-12-27	WOS:000251458100051
J	Romero-Perez, L; Chen, L; Lambertson, D; Madura, K				Romero-Perez, Lizbeth; Chen, Li; Lambertson, David; Madura, Kiran			Sts1 can overcome the loss of Rad23 and Rpn10 and represents a novel regulator of the ubiquitin/proteasome pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; PROTEOLYTIC PATHWAY; PROTEIN-DEGRADATION; BINDING PROTEIN; PROTEASOME; UBIQUITIN; YEAST; DESTRUCTION; RECEPTORS; REPAIR	A rad23 Delta rpn10 Delta double mutant accumulates multi-Ub proteins, is deficient in proteolysis, and displays sensitivity to drugs that generate damaged proteins. Overexpression of Sts1 restored normal growth in rad23 Delta rpn10 Delta but did not overcome the DNA repair defect of rad23 Delta. To understand the nature of Sts1 suppression, we characterized sts1-2, a temperature-sensitive mutant. We determined that sts1-2 was sensitive to translation inhibitors, accumulated high levels of multi-Ub proteins, and caused stabilization of proteolytic substrates. Additionally, ubiquitinated proteins that were detected in proteasomes were inefficiently cleared in sts1-2. Despite these proteolytic defects, overall proteasome activity was increased in sts1-2. We propose that Sts1 is a new regulatory factor in the ubiquitin/proteasome pathway that controls the turnover of proteasome substrates.	Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Madura, K (corresponding author), Robert Wood Johnson Med Sch, Dept Biochem, 683 Hoes Ln,SPH-Rm 383, Piscataway, NJ 08854 USA.	maduraki@umdnj.edu			NCI NIH HHS [CA83875] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA083875] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Amrani N, 1996, MOL GEN GENET, V252, P552, DOI 10.1007/BF02172401; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; Chen L, 2002, MOL CELL BIOL, V22, P4902, DOI 10.1128/MCB.22.13.4902-4913.2002; Chuang SM, 2005, MOL CELL BIOL, V25, P403, DOI 10.1128/MCB.25.1.403-413.2005; Clarke DJ, 2001, MOL CELL BIOL, V21, P1997, DOI 10.1128/MCB.21.6.1997-2007.2001; Diaz-Martinez LA, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-28; Elsasser S, 2004, J BIOL CHEM, V279, P26817, DOI 10.1074/jbc.M404020200; Enenkel C, 1998, EMBO J, V17, P6144, DOI 10.1093/emboj/17.21.6144; Enenkel C, 1999, MOL BIOL REP, V26, P131, DOI 10.1023/A:1006973803960; Funakoshi M, 2002, P NATL ACAD SCI USA, V99, P745, DOI 10.1073/pnas.012585199; Ghaboosi N, 2007, MOL BIOL CELL, V18, P1953, DOI 10.1091/mbc.E06-10-0965; Glickman MH, 1998, MOL CELL BIOL, V18, P3149, DOI 10.1128/MCB.18.6.3149; Glickman MH, 1999, MOL BIOL REP, V26, P21, DOI 10.1023/A:1006928316738; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; HOUMAN F, 1994, MOL CELL BIOL, V14, P6350, DOI 10.1128/MCB.14.9.6350; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Kim I, 2004, MOL BIOL CELL, V15, P3357, DOI 10.1091/mbc.E03-11-0835; Lambertson D, 1999, GENETICS, V153, P69; Lehmann A, 2002, J MOL BIOL, V317, P401, DOI 10.1006/jmbi.2002.5443; LIANG S, 1993, EUR J CELL BIOL, V62, P270; LIU HP, 1992, GENETICS, V132, P665; Ortolan TG, 2004, NUCLEIC ACIDS RES, V32, P6490, DOI 10.1093/nar/gkh987; Prakash S, 2000, MUTAT RES-FUND MOL M, V451, P13, DOI 10.1016/S0027-5107(00)00037-3; Rao H, 2002, J BIOL CHEM, V277, P11691, DOI 10.1074/jbc.M200245200; Saeki Y, 2002, BIOCHEM BIOPH RES CO, V293, P986, DOI 10.1016/S0006-291X(02)00340-6; Schauber C, 1998, NATURE, V391, P715, DOI 10.1038/35661; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; SEUFERT W, 1990, EMBO J, V9, P543, DOI 10.1002/j.1460-2075.1990.tb08141.x; Tabb MM, 2000, MOL CELL BIOL, V20, P6062, DOI 10.1128/MCB.20.16.6062-6073.2000; Takeda K, 2005, CELL, V122, P393, DOI 10.1016/j.cell.2005.05.023; Tatebe H, 2000, CURR BIOL, V10, P1329, DOI 10.1016/S0960-9822(00)00773-9; Turner GC, 2000, SCIENCE, V289, P2117, DOI 10.1126/science.289.5487.2117; vanNocker S, 1996, MOL CELL BIOL, V16, P6020; Verma R, 2004, CELL, V118, P99, DOI 10.1016/j.cell.2004.06.014	34	11	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35574	35582		10.1074/jbc.M704857200	http://dx.doi.org/10.1074/jbc.M704857200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17916559	hybrid			2022-12-27	WOS:000251458100017
J	Yan, AX; Guan, ZQ; Raetz, CRH				Yan, Aixin; Guan, Ziqiang; Raetz, Christian R. H.			An undecaprenyl phosphate-aminoarabinose flippase required for polymyxin resistance in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2-COMPONENT REGULATORY SYSTEM; SALMONELLA-TYPHIMURIUM; LIPID-A; INNER MEMBRANE; MULTIDRUG TRANSPORTER; PMRA-MUTANTS; TRANSBILAYER MOVEMENT; EFFLUX TRANSPORTER; ABC-TRANSPORTERS; 4-AMINO-4-DEOXY-L-ARABINOSE	Modification of lipid A with the 4-amino-4-deoxy-L-arabinose (L-Ara4N) moiety is required for resistance to polymyxin and cationic antimicrobial peptides in Escherichia coli and Salmonella typhimurium. An operon of seven genes (designated pmrHFIJKLM in S. typhimurium), which is regulated by the PmrA transcription factor and is also present in E. coli, is necessary for the maintenance of polymyxin resistance. We previously elucidated the roles of pmrHFIJK in the biosynthesis and attachment of L-Ara4N to lipid A and renamed these genes arn-BCADT, respectively. We now propose functions for the last two genes of the operon, pmrL and pmrM. Chromosomal inactivation of each of these genes in an E. coli pmrAc parent switched its phenotype from polymyxin-resistant to polymyxin-sensitive. Lipid A was no longer modified with L-Ara4N, even though the levels of the lipid-linked donor of the L-Ara4N moiety, undecaprenyl phosphate-alpha-L-Ara4N, were not reduced in the mutants. However, the undecaprenyl phosphate-alpha-L-Ara4N present in the mutants was less concentrated on the periplasmic surface of the inner membrane, as judged by 4-5-fold reduced labeling with the inner membrane-impermeable amine reagent N-hydroxysulfosuccin-imidobiotin. In an arnT mutant of the same pmrAc parent, which lacks the enzyme that transfers the L-Ara4N unit to lipid A but retains the same high levels of undecaprenyl phosphate-alpha-L-Ara4N as the parent, N-hydroxysulfosuccin-imidobiotin labeling was not reduced. These results implicate pmrL and pmrM, but not arnT, in transporting undecaprenyl phosphate-alpha-L-Ara4N across the inner membrane. PmrM and PmrL, now renamed ArnE and ArnF because of their involvement in L-Ara4N modification of lipid A, may be subunits of an undecaprenyl phosphate-alpha-L-Ara4N flippase.	Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	Duke University	Raetz, CRH (corresponding author), Duke Univ, Med Ctr, Dept Biochem, POB 3711, Durham, NC 27710 USA.	raetz@biochem.duke.edu	Guan, Ziqiang/AAE-5110-2019; /A-2734-2010	/0000-0003-0310-5492	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051310, U54GM069338] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-069338, R01 GM051310-13, U54 GM069338, R01 GM051310, GM-51310] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alaimo C, 2006, EMBO J, V25, P967, DOI 10.1038/sj.emboj.7601024; Berge KE, 2000, SCIENCE, V290, P1771, DOI 10.1126/science.290.5497.1771; Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; Bishop RE, 2000, EMBO J, V19, P5071, DOI 10.1093/emboj/19.19.5071; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Borst P, 2002, ANNU REV BIOCHEM, V71, P537, DOI 10.1146/annurev.biochem.71.102301.093055; Breazeale SD, 2005, J BIOL CHEM, V280, P14154, DOI 10.1074/jbc.M414265200; Breazeale SD, 2003, J BIOL CHEM, V278, P24731, DOI 10.1074/jbc.M304043200; Breazeale SD, 2002, J BIOL CHEM, V277, P2886, DOI 10.1074/jbc.M109377200; BRETSCHER MS, 1972, J MOL BIOL, V71, P523, DOI 10.1016/0022-2828(72)90028-4; CAROFF M, 1988, CARBOHYD RES, V175, P273, DOI 10.1016/0008-6215(88)84149-1; Chung Y J, 2001, Curr Opin Drug Discov Devel, V4, P237; Curnow P, 2004, J MOL BIOL, V343, P213, DOI 10.1016/j.jmb.2004.08.032; Daley DO, 2005, SCIENCE, V308, P1321, DOI 10.1126/science.1109730; Derbise A, 2003, FEMS IMMUNOL MED MIC, V38, P113, DOI 10.1016/S0928-8244(03)00181-0; Doerrler WT, 2004, J BIOL CHEM, V279, P45102, DOI 10.1074/jbc.M408106200; Doerrler WT, 2002, J BIOL CHEM, V277, P36697, DOI 10.1074/jbc.M205857200; Doerrler WT, 2001, J BIOL CHEM, V276, P11461, DOI 10.1074/jbc.C100091200; DULBECCO R, 1954, J EXP MED, V99, P167, DOI 10.1084/jem.99.2.167; Esmon CT, 2000, BBA-PROTEIN STRUCT M, V1477, P349, DOI 10.1016/S0167-4838(99)00266-6; Feldman MF, 1999, J BIOL CHEM, V274, P35129, DOI 10.1074/jbc.274.49.35129; Gatzeva-Topalova PZ, 2005, STRUCTURE, V13, P929, DOI 10.1016/j.str.2005.03.018; Gay NJ, 2007, ANNU REV BIOCHEM, V76, P141, DOI 10.1146/annurev.biochem.76.060305.151318; Gibbons HS, 2000, J BIOL CHEM, V275, P32940, DOI 10.1074/jbc.M005779200; Gibbons HS, 2005, MOL MICROBIOL, V55, P425, DOI 10.1111/j.1365-2958.2004.04409.x; Granseth E, 2005, J MOL BIOL, V352, P489, DOI 10.1016/j.jmb.2005.07.053; Groisman EA, 2001, J BACTERIOL, V183, P1835, DOI 10.1128/JB.183.6.1835-1842.2001; Groisman EA, 1997, J BACTERIOL, V179, P7040, DOI 10.1128/jb.179.22.7040-7045.1997; Gummadi SN, 2002, J BIOL CHEM, V277, P25337, DOI 10.1074/jbc.M203809200; Gunn JS, 2000, INFECT IMMUN, V68, P6139, DOI 10.1128/IAI.68.11.6139-6146.2000; Gunn JS, 1996, J BACTERIOL, V178, P6857, DOI 10.1128/jb.178.23.6857-6864.1996; Gunn JS, 1998, MOL MICROBIOL, V27, P1171, DOI 10.1046/j.1365-2958.1998.00757.x; Guo L, 1997, SCIENCE, V276, P250, DOI 10.1126/science.276.5310.250; HELANDER IM, 1994, MOL MICROBIOL, V11, P481, DOI 10.1111/j.1365-2958.1994.tb00329.x; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Helenius J, 2002, NATURE, V415, P447, DOI 10.1038/415447a; Hvorup RN, 2003, EUR J BIOCHEM, V270, P799, DOI 10.1046/j.1432-1033.2003.03418.x; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; Kanjilal-Kolar S, 2006, J BIOL CHEM, V281, P12879, DOI 10.1074/jbc.M513865200; KORNBERG RD, 1971, BIOCHEMISTRY-US, V10, P1111; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lazar K, 2002, CURR OPIN CHEM BIOL, V6, P786, DOI 10.1016/S1367-5931(02)00355-1; Lee H, 2004, J BACTERIOL, V186, P4124, DOI 10.1128/JB.186.13.4124-4133.2004; Li XZ, 2003, ANTIMICROB AGENTS CH, V47, P27, DOI 10.1128/AAC.47.1.27-33.2003; Lien E, 2002, CRIT CARE MED, V30, pS1, DOI 10.1097/00003246-200201001-00001; Liu D, 1996, J BACTERIOL, V178, P2102, DOI 10.1128/jb.178.7.2102-2107.1996; Ma C, 2004, P NATL ACAD SCI USA, V101, P2852, DOI 10.1073/pnas.0400137101; Ma C, 2007, P NATL ACAD SCI USA, V104, P3668, DOI 10.1073/pnas.0700711104; Muller W A, 1994, Methods Mol Biol, V27, P31; NIKAIDO H, 1985, MICROBIOL REV, V49, P1; Noland BW, 2002, STRUCTURE, V10, P1569, DOI 10.1016/S0969-2126(02)00879-1; NUMMILA K, 1995, MOL MICROBIOL, V16, P271, DOI 10.1111/j.1365-2958.1995.tb02299.x; Ohl ME, 2001, ANNU REV MED, V52, P259, DOI 10.1146/annurev.med.52.1.259; Paulsen IT, 1996, MOL MICROBIOL, V19, P1167, DOI 10.1111/j.1365-2958.1996.tb02462.x; Pornillos O, 2005, SCIENCE, V310, P1950, DOI 10.1126/science.1119776; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rapp M, 2006, NAT STRUCT MOL BIOL, V13, P112, DOI 10.1038/nsmb1057; Rapp M, 2007, SCIENCE, V315, P1282, DOI 10.1126/science.1135406; Reeves PR, 1996, TRENDS MICROBIOL, V4, P495, DOI 10.1016/S0966-842X(97)82912-5; Reynolds CM, 2006, J BIOL CHEM, V281, P21974, DOI 10.1074/jbc.M603527200; Rick PD, 1998, GLYCOBIOLOGY, V8, P557, DOI 10.1093/glycob/8.6.557; Rick PD, 2003, J BIOL CHEM, V278, P16534, DOI 10.1074/jbc.M301750200; Riley M, 2006, NUCLEIC ACIDS RES, V34, P1, DOI 10.1093/nar/gkj405; ROLAND KL, 1993, J BACTERIOL, V175, P4154, DOI 10.1128/JB.175.13.4154-4164.1993; Rotem D, 2004, J BIOL CHEM, V279, P48787, DOI 10.1074/jbc.M408187200; ROTHMAN JE, 1977, P NATL ACAD SCI USA, V74, P1821, DOI 10.1073/pnas.74.5.1821; Sambrook J., 2001, MOL CLONING LAB MANU; Schmitz G, 2006, FEBS LETT, V580, P5597, DOI 10.1016/j.febslet.2006.08.014; Schuldiner S, 2007, TRENDS BIOCHEM SCI, V32, P252, DOI 10.1016/j.tibs.2007.04.002; SMIT JJM, 1993, CELL, V75, P451, DOI 10.1016/0092-8674(93)90380-9; STRAIN SM, 1985, J BIOL CHEM, V260, P6089; Tate CG, 2006, CURR OPIN STRUC BIOL, V16, P457, DOI 10.1016/j.sbi.2006.06.005; Trent M. Stephen, 2002, Journal of Endotoxin Research, V8, P158; Trent MS, 2001, J BIOL CHEM, V276, P43132, DOI 10.1074/jbc.M106962200; Trent MS, 2001, J BIOL CHEM, V276, P43122, DOI 10.1074/jbc.M106961200; Trent MS, 2001, J BIOL CHEM, V276, P9083, DOI 10.1074/jbc.M010730200; VAARA M, 1992, MICROBIOL REV, V56, P395, DOI 10.1128/MMBR.56.3.395-411.1992; VAARA M, 1981, FEBS LETT, V129, P145, DOI 10.1016/0014-5793(81)80777-6; VOLK WA, 1970, EUR J BIOCHEM, V17, P223; Wacker M, 2002, SCIENCE, V298, P1790, DOI 10.1126/science.298.5599.1790; WANG RF, 1991, GENE, V100, P195, DOI 10.1016/0378-1119(91)90366-J; Wang XY, 2004, J BIOL CHEM, V279, P49470, DOI 10.1074/jbc.M409078200; Williams GJ, 2005, J BIOL CHEM, V280, P23000, DOI 10.1074/jbc.M501534200; Winfield MD, 2004, P NATL ACAD SCI USA, V101, P17162, DOI 10.1073/pnas.0406038101; Yan AX, 2005, GLYCOBIOLOGY, V15, P1407, DOI 10.1093/glycob/cwj026; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597; Zahringer U, 1999, ENDOTOXIN IN HEALTH AND DISEASE, P93; Zhang ZG, 2007, BIOCHEMISTRY-US, V46, P5218, DOI 10.1021/bi7001604; Zhou ZM, 2001, J BIOL CHEM, V276, P43111, DOI 10.1074/jbc.M106960200; Zhou ZM, 1999, J BIOL CHEM, V274, P18503, DOI 10.1074/jbc.274.26.18503; Zhou ZM, 2000, J BIOL CHEM, V275, P13542, DOI 10.1074/jbc.275.18.13542	95	96	108	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					36077	36089		10.1074/jbc.M706172200	http://dx.doi.org/10.1074/jbc.M706172200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17928292	Green Accepted, hybrid, Green Submitted			2022-12-27	WOS:000251458100067
J	Wayne, N; Bolon, DN				Wayne, Natalie; Bolon, Daniel N.			Dimerization of Hsp90 is required for in vivo function: Design and analysis of monomers and dimers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK-PROTEIN; N-TERMINAL DOMAIN; MOLECULAR CHAPERONE; STEROID-RECEPTOR; ATPASE ACTIVITY; SACCHAROMYCES-CEREVISIAE; PROGESTERONE-RECEPTOR; CRYSTAL-STRUCTURE; COCHAPERONE AHA1; CLIENT PROTEIN	Heat shock protein 90 (Hsp90) plays a central role in signal transduction and has emerged as a promising target for anticancer therapeutics, but its molecular mechanism is poorly understood. At physiological concentration, Hsp90 predominantly forms dimers, but the function of full-length monomers in cells is not clear. Hsp90 contains three domains: the N-terminal and middle domains contribute directly to ATP binding and hydrolysis and the C domain mediates dimerization. To study the function of Hsp90 monomers, we used a single-chain strategy that duplicated the C-terminal dimerization domain. This novel monomerization strategy had the dual effect of stabilizing the C domain to denaturation and hindering intermolecular association of the ATPase domain. The resulting construct was predominantly monomeric at physiological concentration and did not function to support yeast viability as the sole Hsp90. The monomeric construct was also defective at ATP hydrolysis and the activation of a kinase and steroid receptor substrate in yeast cells. The ability to support yeast growth was rescued by the addition of a coiled-coil dimerization domain, indicating that the parental single-chain construct is functionally defective because it is monomeric.	Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Bolon, DN (corresponding author), Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA.	Dan.Bolon@umassmed.edu		Bolon, Daniel/0000-0001-5857-6676				Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; Arlander SJH, 2006, J BIOL CHEM, V281, P2989, DOI 10.1074/jbc.M508687200; Birnby DA, 2000, GENETICS, V155, P85; BORKOVICH KA, 1989, MOL CELL BIOL, V9, P3919, DOI 10.1128/MCB.9.9.3919; Bornberg-Bauer E, 1999, P NATL ACAD SCI USA, V96, P10689, DOI 10.1073/pnas.96.19.10689; BOWIE JU, 1989, BIOCHEMISTRY-US, V28, P7139, DOI 10.1021/bi00444a001; Cantor C.R., 1980, BIOPHYS CHEM; Chadli A, 2000, P NATL ACAD SCI USA, V97, P12524, DOI 10.1073/pnas.220430297; CHANG HCJ, 1994, J BIOL CHEM, V269, P24983; KANG KI, 1994, P NATL ACAD SCI USA, V91, P340, DOI 10.1073/pnas.91.1.340; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Larabell CA, 2004, MOL BIOL CELL, V15, P957, DOI 10.1091/mbc.E03-07-0522; Llauger-Bufi L, 2003, BIOORG MED CHEM LETT, V13, P3975, DOI 10.1016/j.bmcl.2003.08.065; Louvion JF, 1996, P NATL ACAD SCI USA, V93, P13937, DOI 10.1073/pnas.93.24.13937; Maroney AC, 2006, BIOCHEMISTRY-US, V45, P5678, DOI 10.1021/bi0524969; Martin A, 2005, NATURE, V437, P1115, DOI 10.1038/nature04031; McLaughlin SH, 2006, J MOL BIOL, V356, P746, DOI 10.1016/j.jmb.2005.11.085; McLaughlin SH, 2004, J MOL BIOL, V344, P813, DOI 10.1016/j.jmb.2004.09.055; McLaughlin SH, 2002, J MOL BIOL, V315, P787, DOI 10.1006/jmbi.2001.5245; Meyer P, 2003, MOL CELL, V11, P647, DOI 10.1016/S1097-2765(03)00065-0; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Nathan DF, 1997, P NATL ACAD SCI USA, V94, P12949, DOI 10.1073/pnas.94.24.12949; NATHAN DF, 1995, MOL CELL BIOL, V15, P3917; NORBY JG, 1988, METHOD ENZYMOL, V156, P116; Obermann WMJ, 1998, J CELL BIOL, V143, P901, DOI 10.1083/jcb.143.4.901; Panaretou B, 1998, EMBO J, V17, P4829, DOI 10.1093/emboj/17.16.4829; Panaretou B, 2002, MOL CELL, V10, P1307, DOI 10.1016/S1097-2765(02)00785-2; PICARD D, 1990, NATURE, V348, P166, DOI 10.1038/348166a0; Plescia J, 2005, CANCER CELL, V7, P457, DOI 10.1016/j.ccr.2005.03.035; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Prodromou C, 2000, EMBO J, V19, P4383, DOI 10.1093/emboj/19.16.4383; Prodromou C, 1999, EMBO J, V18, P754, DOI 10.1093/emboj/18.3.754; Prodromou C, 1997, CELL, V90, P65, DOI 10.1016/S0092-8674(00)80314-1; Prodromou C, 1997, NAT STRUCT BIOL, V4, P477, DOI 10.1038/nsb0697-477; Richter K, 2004, J MOL BIOL, V342, P1403, DOI 10.1016/j.jmb.2004.07.064; Richter K, 2001, J BIOL CHEM, V276, P33689, DOI 10.1074/jbc.M103832200; Robinson CR, 1998, P NATL ACAD SCI USA, V95, P5929, DOI 10.1073/pnas.95.11.5929; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; SMITH DF, 1992, J BIOL CHEM, V267, P1350; SMITH DF, 1990, MOL ENDOCRINOL, V4, P1704, DOI 10.1210/mend-4-11-1704; UEHARA Y, 1986, MOL CELL BIOL, V6, P2198, DOI 10.1128/MCB.6.6.2198; Vaughan CK, 2006, MOL CELL, V23, P697, DOI 10.1016/j.molcel.2006.07.016; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; Wegele H, 2003, J BIOL CHEM, V278, P39303, DOI 10.1074/jbc.M305751200; WHITESELL L, 1994, P NATL ACAD SCI USA, V91, P8324, DOI 10.1073/pnas.91.18.8324; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; XU Y, 1993, P NATL ACAD SCI USA, V90, P7074, DOI 10.1073/pnas.90.15.7074; Yue L, 1999, GENETICS, V151, P1065; Zhao RM, 2005, CELL, V120, P715, DOI 10.1016/j.cell.2004.12.024	49	71	71	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					35386	35395		10.1074/jbc.M703844200	http://dx.doi.org/10.1074/jbc.M703844200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17908693	hybrid			2022-12-27	WOS:000251155200081
J	Wang, Y; Loo, TW; Bartlett, MC; Clarke, DM				Wang, Ying; Loo, Tip W.; Bartlett, M. Claire; Clarke, David M.			Correctors promote maturation of cystic fibrosis transmembrane conductance regulator (CFTR)-processing mutants by binding to the protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN P-GLYCOPROTEIN; DELTA-F508 MUTATION; SIDE-CHAIN; CFTR; RESCUE; IDENTIFICATION; SIGNATURE; SEGMENTS; DOMAIN	The most common cause of cystic fibrosis (CF) is defective folding of a cystic fibrosis transmembrane conductance regulator (CFTR) mutant lacking Phe(508) (Delta F508). The Delta F508 protein appears to be trapped in a prefolded state with incomplete packing of the transmembrane (TM) segments, a defect that can be repaired by expression in the presence of correctors such as corr-4a, VRT-325, and VRT-532. To determine whether the mechanism of correctors involves direct interactions with CFTR, our approach was to test whether correctors blocked disulfide cross-linking between cysteines introduced into the two halves of a Cys-less CFTR. Although replacement of the 18 endogenous cysteines of CFTR with Ser or Ala yields a Cys-less mutant that does not mature at 37 C, we found that maturation could be restored if Val(510) was changed to Ala, Cys, Ser, Thr, Gly, Ala, or Asp. The V510D mutation also promoted maturation of Delta F508 CFTR. The Cys-less/V510A mutant was used for subsequent cross-linking analysis as it yielded relatively high levels of mature protein that was functional in iodide efflux assays. We tested for cross-linking between cysteines introduced into TM6 and TM7 of Cys-less CFTR/V510A because cross-linking between TM6 and TM7 of P-glycoprotein, the sister protein of CFTR, was inhibited with the corrector VRT-325. Cys-less CFTR/V510A mutant containing cysteines at I340C(TM6) and S877C(TM7) could be cross-linked with a homobifunctional cross-linker. Correctors and the CFTR channel blocker benzbromarone, but not P-glycoprotein substrates, inhibited cross-linking of mutant I340C(TM6)/S877C(TM7). These results suggest that corrector molecules such as corr-4a interact directly with CFTR.	Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Toronto; University of Toronto	Clarke, DM (corresponding author), Univ Toronto, Dept Med, 100 Coll St, Toronto, ON M5S 1A8, Canada.	david.clarke@utoronto.ca	Clarke, David M./A-1112-2008	Clarke, David M./0000-0003-4335-7184; Loo, Tip W/0000-0003-2108-0188				Chen EY, 2004, J BIOL CHEM, V279, P39620, DOI 10.1074/jbc.M407887200; Cui L, 2006, J PHYSIOL-LONDON, V572, P347, DOI 10.1113/jphysiol.2005.099457; deCarvalho ACV, 2002, J BIOL CHEM, V277, P35896, DOI 10.1074/jbc.M205644200; Diena T, 2007, EUR J PHARMACOL, V560, P127, DOI 10.1016/j.ejphar.2007.01.051; HOOF T, 1994, J BIOL CHEM, V269, P20575; Kleizen B, 2005, MOL CELL, V20, P277, DOI 10.1016/j.molcel.2005.09.007; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Lewis HA, 2005, J BIOL CHEM, V280, P1346, DOI 10.1074/jbc.M410968200; Loo TW, 2005, MOL PHARMACEUT, V2, P407, DOI 10.1021/mp0500521; Loo TW, 1997, J BIOL CHEM, V272, P709, DOI 10.1074/jbc.272.2.709; Loo TW, 2003, J BIOL CHEM, V278, P39706, DOI 10.1074/jbc.M308559200; Loo TW, 1996, J BIOL CHEM, V271, P27482, DOI 10.1074/jbc.271.44.27482; Mense M, 2002, J GEN PHYSIOL, V120, p25A; Mense M, 2006, EMBO J, V25, P4728, DOI 10.1038/sj.emboj.7601373; Pedemonte N, 2005, J CLIN INVEST, V115, P2564, DOI 10.1172/JCI24898; RIORDAN JR, 1989, SCIENCE, V245, P1066; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; TEEM JL, 1993, CELL, V73, P335, DOI 10.1016/0092-8674(93)90233-G; Thibodeau PH, 2005, NAT STRUCT MOL BIOL, V12, P10, DOI 10.1038/nsmb881; Treharne KJ, 2007, J BIOL CHEM, V282, P10804, DOI 10.1074/jbc.M610956200; Van Goor F, 2006, AM J PHYSIOL-LUNG C, V290, pL1117, DOI 10.1152/ajplung.00169.2005; Wang Y, 2007, BIOCHEM J, V406, P257, DOI 10.1042/BJ20070478; Wang Y, 2007, MOL PHARMACOL, V71, P751, DOI 10.1124/mol.106.029926; Wang Y, 2006, MOL PHARMACOL, V70, P297, DOI 10.1124/mol.106.023994; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041; Zhang H, 2006, J BIOL CHEM, V281, P11312, DOI 10.1074/jbc.M512013200	26	123	126	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46					33247	33251		10.1074/jbc.C700175200	http://dx.doi.org/10.1074/jbc.C700175200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17911111	hybrid			2022-12-27	WOS:000250840200003
J	Padgett, CL; Lummis, SCR				Padgett, Claire L.; Lummis, Sarah C. R.			The F-loop of the GABA(A) receptor gamma(2) subunit contributes to benzodiazepine modulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GABA(A) RECEPTOR; STRUCTURAL DETERMINANTS; NICOTINIC RECEPTORS; AGONIST-BINDING; A RECEPTORS; CHANNEL; RESIDUES; SITE; MUTAGENESIS; SUBUNIT	GABA(A) receptors can be modulated by benzodiazepines, although these compounds do not directly activate or inhibit the receptors. The prototypic benzodiazepine, diazepam, potentiates responses to GABA in GABAA receptors that contain a gamma subunit. Here we have used mutagenesis, radioligand binding, voltage clamp electrophysiology, and homology modeling to probe the role of the F-loop residues Asp(192)-Arg(197) in the GABAA receptor gamma(2) subunit in diazepam potentiation of the GABA response. Substitution of all of these residues with Ala and/or a residue with similar chemical properties to the wild type residue decreased the level of diazepam potentiation, and one mutation (D192A) resulted in its complete ablation. None of the mutations changed the GABA EC50 or the [H-3] flumazenil binding affinity, suggesting they do not affect GABA or benzodiazepine binding characteristics; we therefore propose that they are involved in the diazepam-mediated conformational change that results in an increased response to GABA. Homology models of the receptor binding pocket in agonist-bound and unbound states suggest that the F-loop is flexible and has different orientations in the two states. Considering our data in relation to these models, we find that the F-loop residues could contribute to hydrogen bond networks and hydrophobic interactions with neighboring residues that change during receptor activation.	[Padgett, Claire L.; Lummis, Sarah C. R.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England	University of Cambridge	Lummis, SCR (corresponding author), Univ Cambridge, Dept Biochem, Tennis Court Rd, Cambridge CB2 1QW, England.	sl120@cam.ac.uk			Wellcome Trust [051097] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Boileau AJ, 1999, J NEUROSCI, V19, P10213; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Buhr A, 1996, MOL PHARMACOL, V49, P1080; Campo-Soria C, 2006, BRIT J PHARMACOL, V148, P984, DOI 10.1038/sj.bjp.0706796; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Corringer PJ, 2000, ANNU REV PHARMACOL, V40, P431, DOI 10.1146/annurev.pharmtox.40.1.431; CZAJKOWSKI C, 1995, J BIOL CHEM, V270, P3160, DOI 10.1074/jbc.270.7.3160; Downing SS, 2005, BRIT J PHARMACOL, V145, P894, DOI 10.1038/sj.bjp.0706251; Jones-Davis DM, 2005, J NEUROSCI, V25, P8056, DOI 10.1523/JNEUROSCI.0348-05.2005; Jordan M, 1996, NUCLEIC ACIDS RES, V24, P596, DOI 10.1093/nar/24.4.596; KAROBATH M, 1983, ADV BIOCHEM PSYCHOPH, V38, P37; Kash TL, 2003, NATURE, V421, P272, DOI 10.1038/nature01280; KLEIN RL, 1994, J NEUROCHEM, V63, P2349; Kloda JH, 2007, MOL PHARMACOL, V71, P483, DOI 10.1124/mol.106.028662; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Lummis SCR, 2005, NATURE, V438, P248, DOI 10.1038/nature04130; LUMMIS SCR, 1993, EUR J PHARMACOL, V243, P7, DOI 10.1016/0014-2999(93)90160-J; Mercado J, 2006, J NEUROSCI, V26, P2031, DOI 10.1523/JNEUROSCI.4555-05.2006; Newell JG, 2003, J BIOL CHEM, V278, P13166, DOI 10.1074/jbc.M211905200; OSLEN RW, 1982, ANN REV PHARM TOXICO, V22, P245; Reeves DC, 2003, BIOPHYS J, V84, P2338, DOI 10.1016/S0006-3495(03)75039-5; Rusch D, 2005, ANESTHESIOLOGY, V102, P783; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sancar F, 2007, MOL PHARMACOL, V71, P38, DOI 10.1124/mol.106.029595; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Thompson AJ, 2006, J BIOL CHEM, V281, P16576, DOI 10.1074/jbc.M601265200; Turchin A, 1999, BIOTECHNIQUES, V26, P672, DOI 10.2144/99264st02; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031	30	23	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2702	2708		10.1074/jbc.M705699200	http://dx.doi.org/10.1074/jbc.M705699200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	17974564	hybrid			2022-12-27	WOS:000252622300027
J	Johnston, JW; Coussens, NP; Allen, S; Houtman, JCD; Turner, KH; Zaleski, A; Ramaswamy, S; Gibson, BW; Apicella, MA				Johnston, Jason W.; Coussens, Nathan P.; Allen, Simon; Houtman, Jon C. D.; Turner, Keith H.; Zaleski, Anthony; Ramaswamy, S.; Gibson, Bradford W.; Apicella, Michael A.			Characterization of the N-acetyl-5-neuraminic acid-binding site of the extracytoplasmic solute receptor (SiaP) of nontypeable Haemophilus influenzae strain 2019	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIALIC-ACID; STRUCTURAL-CHARACTERIZATION; SERUM RESISTANCE; LIPOPOLYSACCHARIDE; LIPOOLIGOSACCHARIDES; TRANSPORTER; IDENTIFICATION; SIALYLATION; ATCC-25586; COMPLEMENT	Nontypeable Haemophilus influenzae is an opportunistic human pathogen causing otitis media in children and chronic bronchitis and pneumonia in patients with chronic obstructive pulmonary disease. The outer membrane of nontypeable H. influenzae is dominated by lipooligosaccharides (LOS), many of which incorporate sialic acid as a terminal nonreducing sugar. Sialic acid has been demonstrated to be an important factor in the survival of the bacteria within the host environment. H. influenzae is incapable of synthesizing sialic acid and is dependent on scavenging free sialic acid from the host environment. To achieve this, H. influenzae utilizes a tripartite ATP-independent periplasmic transporter. In this study, we characterize the binding site of the extracytoplasmic solute receptor (SiaP) from nontypeable H. influenzae strain 2019. A crystal structure of N-acetyl-5-neuraminic acid (Neu5Ac)-bound SiaP was determined to 1.4 angstrom resolution. Thermodynamic characterization of Neu5Ac binding shows this interaction is enthalpically driven with a substantial unfavorable contribution from entropy. This is expected because the binding of SiaP to Neu5Ac is mediated by numerous hydrogen bonds and has several buried water molecules. Point mutations targeting specific amino acids were introduced in the putative binding site. Complementation with the mutated siaP constructs resulted either in full, partial, or no complementation, depending on the role of specific residues. Mass spectrometry analysis of the O-deacylated LOS of the R127K point mutation confirmed the observation of reduced incorporation of Neu5Ac into the LOS. The decreased ability of H. influenzae to import sialic acid had negative effects on resistance to complement-mediated killing and viability of biofilms in vitro, confirming the importance of sialic acid transport to the bacterium.	[Johnston, Jason W.; Houtman, Jon C. D.; Zaleski, Anthony; Apicella, Michael A.] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA; [Coussens, Nathan P.; Turner, Keith H.; Ramaswamy, S.] Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA; [Allen, Simon; Gibson, Bradford W.] Buck Inst Age Res, Novato, CA 94945 USA	University of Iowa; University of Iowa; Buck Institute for Research on Aging	Apicella, MA (corresponding author), 51 Newton Rd, Iowa City, IA 52242 USA.	michael-apicella@uiowa.edu	Subramanian, Ramaswamy/Q-8671-2019; Turner, Keith/AAJ-6890-2021	Subramanian, Ramaswamy/0000-0002-6709-190X; Turner, Keith/0000-0002-3993-3831; Houtman, Jon/0000-0002-5307-9854	NIAID NIH HHS [AI07260-21, AI30040, AI024616] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI024616, T32AI007260, R56AI024616, R37AI024616] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALEXEYEV MF, 1995, BIOTECHNIQUES, V18, P52; Allen S, 2005, INFECT IMMUN, V73, P5291, DOI 10.1128/IAI.73.9.5291-5300.2005; ANDREONI J, 1993, J INFECT DIS, V168, P227, DOI 10.1093/infdis/168.1.227; CAMPAGNARI AA, 1987, INFECT IMMUN, V55, P882, DOI 10.1128/IAI.55.4.882-887.1987; Dam J, 2005, BIOPHYS J, V89, P651, DOI 10.1529/biophysj.105.059584; Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Figueira MA, 2007, INFECT IMMUN, V75, P325, DOI 10.1128/IAI.01054-06; Gibson BW, 1997, J AM SOC MASS SPECTR, V8, P645, DOI 10.1016/S1044-0305(97)00042-1; Greiner LL, 2004, INFECT IMMUN, V72, P4249, DOI 10.1128/IAI.72.7.4249-4260.2004; Hood DW, 1999, MOL MICROBIOL, V33, P679, DOI 10.1046/j.1365-2958.1999.01509.x; Hood DW, 2001, MOL MICROBIOL, V39, P341, DOI 10.1046/j.1365-2958.2001.02204.x; Johnston JW, 2007, MOL MICROBIOL, V66, P26, DOI 10.1111/j.1365-2958.2007.05890.x; Jones PA, 2002, J BIOL CHEM, V277, P14598, DOI 10.1074/jbc.M110986200; Kapatral V, 2003, GENOME RES, V13, P1180, DOI 10.1101/gr.566003; Kapatral V, 2002, J BACTERIOL, V184, P2005, DOI 10.1128/JB.184.7.2005-2018.2002; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; MANDRELL RE, 1992, INFECT IMMUN, V60, P1322, DOI 10.1128/IAI.60.4.1322-1328.1992; Mansson M, 2001, EUR J BIOCHEM, V268, P2148, DOI 10.1046/j.1432-1327.2001.02094.x; MARTINEZ J, 1995, J BACTERIOL, V177, P6005, DOI 10.1128/jb.177.20.6005-6010.1995; Masoud H, 1997, BIOCHEMISTRY-US, V36, P2091, DOI 10.1021/bi961989y; Mizan S, 2000, J BACTERIOL, V182, P6874, DOI 10.1128/JB.182.24.6874-6883.2000; Muller A, 2006, J BIOL CHEM, V281, P22212, DOI 10.1074/jbc.M603463200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; PHILLIPS NJ, 1992, BIOCHEMISTRY-US, V31, P4515, DOI 10.1021/bi00133a019; Post DMB, 2005, INFECT IMMUN, V73, P6727, DOI 10.1128/IAI.73.10.6727-6735.2005; Rao VK, 1999, FEMS MICROBIOL REV, V23, P99, DOI 10.1016/S0168-6445(98)00039-4; SCHWEDA EKH, 1993, CARBOHYD RES, V246, P319, DOI 10.1016/0008-6215(93)84043-6; Severi E, 2005, MOL MICROBIOL, V58, P1173, DOI 10.1111/j.1365-2958.2005.04901.x; Vimr E, 2000, MOL MICROBIOL, V36, P1113, DOI 10.1046/j.1365-2958.2000.01925.x; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V	32	58	59	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					855	865		10.1074/jbc.M706603200	http://dx.doi.org/10.1074/jbc.M706603200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	17947229	hybrid			2022-12-27	WOS:000252128100026
J	Makabe, K; Nakanishi, T; Tsumoto, K; Tanaka, Y; Kondo, H; Umetsu, M; Sone, Y; Asano, R; Kumagai, I				Makabe, Koki; Nakanishi, Takeshi; Tsumoto, Kouhei; Tanaka, Yoshikazu; Kondo, Hidemasa; Umetsu, Mitsuo; Sone, Yukiko; Asano, Ryutaro; Kumagai, Izumi			Thermodynamic consequences of mutations in Vernier zone residues of a humanized anti-human epidermal growth factor receptor murine antibody-528	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLEMENTARITY-DETERMINING REGIONS; RESHAPING HUMAN-ANTIBODIES; MOUSE MONOCLONAL-ANTIBODY; CANCER-IMMUNOTHERAPY; STRUCTURAL CONSEQUENCES; AFFINITY MATURATION; FRAMEWORK RESIDUES; LYSOZYME ANTIBODY; FAB FRAGMENTS; EGF-R	To investigate the role of Vernier zone residues, which are comprised in the framework regions and underlie the complementarity-determining regions (CDRs) of antibodies, in the specific, high affinity interactions of antibodies with their targets, we focused on the variable domain fragment of murine antihuman epidermal growth factor receptor antibody 528 (m528Fv). Grafting of the CDRs of m528Fv onto a selected framework region of human antibodies, referred to as humanization, reduced the antibody's affinity for its target by a factor of 1/40. The reduction in affinity was due to a substantial reduction in the negative enthalpy change associated with binding. Crystal structures of the ligand-free antibody fragments showed no noteworthy conformational changes due to humanization, and the loop structures of the CDRs of the humanized antibodies were identical to those of the parent antibodies. Several mutants of the CDR-grafted (humanized) variable domain fragment (h528Fv), in which some of the Vernier zone residues in the heavy chain were replaced with the parental murine residues, were constructed and prepared using a bacterial expression system. Thermodynamic analyses of the interactions between the mutants and the soluble extracellular domain of epidermal growth factor receptor showed that several single mutations and a double mutation increased the negative enthalpy and heat capacity changes. Combination of these mutations, however, led to somewhat reduced negative enthalpy and heat capacity changes. The affinity of each mutant for the target was within the range for the wild-type h528Fv, and this similarity was due to enthalpy-entropy compensation. These results suggest that Vernier zone residues make enthalpic contributions to antigen binding and that the regulation of conformational entropy changes upon humanization of murine antibodies must be carefully considered and optimized.	[Makabe, Koki; Nakanishi, Takeshi; Tsumoto, Kouhei; Tanaka, Yoshikazu; Umetsu, Mitsuo; Sone, Yukiko; Asano, Ryutaro; Kumagai, Izumi] Tohoku Univ, Grad Sch Engn, Dept Biomol Engn, Aoba Ku, Sendai, Miyagi 9808579, Japan; [Kondo, Hidemasa] Natl Inst Adv Ind Sci & Technol, Res Inst Genome Based Biofactory, Toyohira Ku, Sapporo, Hokkaido 0628517, Japan	Tohoku University; National Institute of Advanced Industrial Science & Technology (AIST)	Kumagai, I (corresponding author), Tohoku Univ, Grad Sch Engn, Dept Biomol Engn, Aoba Ku, Aoba Yama 6-6-11-606, Sendai, Miyagi 9808579, Japan.	kmiz@kuma.che.tohoku.ac.jp	Asano, Ryutaro/G-7822-2016; Kondo, Hidemasa/M-7465-2018	Kondo, Hidemasa/0000-0003-2799-1775; Tanaka, Yoshikazu/0000-0002-7893-3236				AlLazikani B, 1997, J MOL BIOL, V273, P927, DOI 10.1006/jmbi.1997.1354; Asano R, 2002, J BIOCHEM, V132, P903, DOI 10.1093/oxfordjournals.jbchem.a003303; Asano R, 2002, FEBS LETT, V528, P70, DOI 10.1016/S0014-5793(02)03254-4; Asano R, 2006, CLIN CANCER RES, V12, P4036, DOI 10.1158/1078-0432.CCR-06-0059; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baselga J, 2005, J CLIN ONCOL, V23, P2445, DOI 10.1200/JCO.2005.11.890; BHAT TN, 1990, NATURE, V347, P483, DOI 10.1038/347483a0; BRADEN BC, 1995, FASEB J, V9, P9, DOI 10.1096/fasebj.9.1.7821765; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burgess AW, 2003, MOL CELL, V12, P541, DOI 10.1016/S1097-2765(03)00350-2; Ciardiello F, 2001, CLIN CANCER RES, V7, P2958; Clark M, 2000, IMMUNOL TODAY, V21, P397, DOI 10.1016/S0167-5699(00)01680-7; CO MS, 1991, P NATL ACAD SCI USA, V88, P2869, DOI 10.1073/pnas.88.7.2869; CO MS, 1992, J IMMUNOL, V148, P1149; Cooper A, 1999, CURR OPIN CHEM BIOL, V3, P557, DOI 10.1016/S1367-5931(99)00008-3; Davies DR, 1996, P NATL ACAD SCI USA, V93, P7, DOI 10.1073/pnas.93.1.7; DUNITZ JD, 1995, CHEM BIOL, V2, P709, DOI 10.1016/1074-5521(95)90097-7; DUNITZ JD, 1994, SCIENCE, V264, P670, DOI 10.1126/science.264.5159.670; Ewert S, 2004, METHODS, V34, P184, DOI 10.1016/j.ymeth.2004.04.007; FOOTE J, 1992, J MOL BIOL, V224, P487, DOI 10.1016/0022-2836(92)91010-M; Furukawa K, 1999, IMMUNITY, V11, P329, DOI 10.1016/S1074-7613(00)80108-9; Hayashi H, 2004, CANCER IMMUNOL IMMUN, V53, P497, DOI 10.1007/s00262-003-0465-9; Herbst RS, 2004, INT J RADIAT ONCOL, V59, P21, DOI 10.1016/j.ijrobp.2003.11.041; Holmes MA, 1997, J IMMUNOL, V158, P2192; Holmes MA, 2001, J IMMUNOL, V167, P296, DOI 10.4049/jimmunol.167.1.296; Jirholt P, 1998, GENE, V215, P471, DOI 10.1016/S0378-1119(98)00317-5; JONES PT, 1986, NATURE, V321, P522, DOI 10.1038/321522a0; Kabat EA, 1991, SEQUENCES PROTEINS I; Katayose Y, 1996, CANCER RES, V56, P4205; KAWAMOTO T, 1983, P NATL ACAD SCI-BIOL, V80, P1337, DOI 10.1073/pnas.80.5.1337; KETTLEBOROUGH CA, 1991, PROTEIN ENG, V4, P773, DOI 10.1093/protein/4.7.773; KIRKHAM PM, 1992, EMBO J, V11, P603, DOI 10.1002/j.1460-2075.1992.tb05092.x; KLIJN JGM, 1992, ENDOCR REV, V13, P3, DOI 10.1210/er.13.1.3; Kodama H, 2002, IMMUNOL LETT, V81, P99, DOI 10.1016/S0165-2478(01)00343-1; Kondo H, 1999, J BIOL CHEM, V274, P27623, DOI 10.1074/jbc.274.39.27623; Kumagai I, 2003, J BIOL CHEM, V278, P24929, DOI 10.1074/jbc.M301149200; Lachenmann MJ, 2004, PROTEIN SCI, V13, P3115, DOI 10.1110/ps.04866404; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; LIVINGSTONE JR, 1991, BIOCHEMISTRY-US, V30, P4237, DOI 10.1021/bi00231a019; Lockhart C, 2005, SEMIN ONCOL, V32, P52, DOI 10.1053/j.seminoncol.2004.09.036; MARIUZZA RA, 1993, CURR OPIN IMMUNOL, V5, P50, DOI 10.1016/0952-7915(93)90080-C; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Mendelsohn J, 2002, J CLIN ONCOL, V20, p1S, DOI 10.1200/JCO.2002.07.121; Morton CJ, 1996, PROTEIN SCI, V5, P2115, DOI 10.1002/pro.5560051018; Moyer JD, 1997, CANCER RES, V57, P4838; MURPHY KP, 1995, PROTEINS, V21, P83, DOI 10.1002/prot.340210202; MURPHY KP, 1992, ADV PROTEIN CHEM, V43, P313, DOI 10.1016/S0065-3233(08)60556-2; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Myszka DG, 2000, P NATL ACAD SCI USA, V97, P9026, DOI 10.1073/pnas.97.16.9026; Nicaise M, 2004, PROTEIN SCI, V13, P1882, DOI 10.1110/ps.03540504; Nishibori N, 2006, MOL IMMUNOL, V43, P634, DOI 10.1016/j.molimm.2005.04.002; NONOMURA A, 1988, LIVER, V8, P157; OHTOMO T, 1995, MOL IMMUNOL, V32, P407, DOI 10.1016/0161-5890(95)00017-9; OOBATAKE M, 1993, PROG BIOPHYS MOL BIO, V59, P237, DOI 10.1016/0079-6107(93)90002-2; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Padlan EA, 1996, ADV PROTEIN CHEM, V49, P57, DOI 10.1016/S0065-3233(08)60488-X; QUEEN C, 1989, P NATL ACAD SCI USA, V86, P10029, DOI 10.1073/pnas.86.24.10029; RIECHMANN L, 1988, NATURE, V332, P323, DOI 10.1038/332323a0; ROSS PD, 1981, BIOCHEMISTRY-US, V20, P3096, DOI 10.1021/bi00514a017; SALOMON DS, 1995, CRIT REV ONCOL HEMAT, V19, P183, DOI 10.1016/1040-8428(94)00144-I; SATO K, 1994, MOL IMMUNOL, V31, P371; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; SCHROEDER HW, 1990, INT IMMUNOL, V2, P41, DOI 10.1093/intimm/2.1.41; Shinoda M, 1998, CANCER RES, V58, P2838; SLIEKER LJ, 1985, J BIOL CHEM, V260, P687; Soderlind E, 2000, NAT BIOTECHNOL, V18, P852, DOI 10.1038/78458; SODERQUIST AM, 1984, J BIOL CHEM, V259, P2586; SPOLAR RS, 1994, SCIENCE, V263, P777, DOI 10.1126/science.8303294; Stern M, 2005, CRIT REV ONCOL HEMAT, V54, P11, DOI 10.1016/j.critrevonc.2004.10.011; Stockwin LH, 2003, BIOCHEM SOC T, V31, P433, DOI 10.1042/BST0310433; TAKAHASHI H, 1994, J MOL BIOL, V243, P494, DOI 10.1006/jmbi.1994.1675; Takemura S, 2002, CANCER IMMUNOL IMMUN, V51, P33, DOI 10.1007/s00262-001-0245-3; TORIGOE H, 1995, J BIOL CHEM, V270, P22218, DOI 10.1074/jbc.270.38.22218; TSUMOTO K, 1995, J BIOL CHEM, V270, P18551, DOI 10.1074/jbc.270.31.18551; Tsumoto K, 1998, J IMMUNOL METHODS, V219, P119, DOI 10.1016/S0022-1759(98)00127-6; VERHOEYEN M, 1988, SCIENCE, V239, P1534, DOI 10.1126/science.2451287; WEBER G, 1993, J PHYS CHEM-US, V97, P7108, DOI 10.1021/j100129a031; Wedemayer GJ, 1997, SCIENCE, V276, P1665, DOI 10.1126/science.276.5319.1665; Wells A, 2000, ADV CANCER RES, V78, P31; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Xie HF, 2001, BIOCHEMISTRY-US, V40, P5700, DOI 10.1021/bi010034z; Yokota A, 2003, J BIOL CHEM, V278, P5410, DOI 10.1074/jbc.M210182200; Yoon SO, 2006, J BIOL CHEM, V281, P6985, DOI 10.1074/jbc.M511165200; Zolotnitsky G, 2004, P NATL ACAD SCI USA, V101, P11275, DOI 10.1073/pnas.0404311101	84	67	93	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					1156	1166		10.1074/jbc.M706190200	http://dx.doi.org/10.1074/jbc.M706190200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	17947238	hybrid			2022-12-27	WOS:000252128100056
J	Bloomer, WAC; VanDongen, HMA; VanDongen, AMJ				Bloomer, Wendy A. C.; VanDongen, Hendrika M. A.; VanDongen, Antonius M. J.			Arc/Arg3.1 translation is controlled by convergent N-methyl-D-aspartate and G(s)-coupled receptor signaling pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; IMMEDIATE-EARLY GENE; ARC MESSENGER-RNA; KINASE/EXTRACELLULAR REGULATED KINASE; CYTOSKELETON-ASSOCIATED PROTEIN; I ADENYLYL-CYCLASE; NMDA RECEPTOR; RESPONSE ELEMENT; EXPRESSION; ACTIVATION	Arc/Arg3.1 is an immediate early gene whose expression is necessary for the late-phase of long-term potentiation (LTP) and memory consolidation. Whereas pathways regulating Arc transcription have been extensively investigated, less is known about the role of post-transcriptional mechanisms in Arc expression. Fluorescence microscopy experiments in cultured hippocampal neurons revealed that Arc protein level was dramatically increased by activation of the cAMP-dependent protein kinase (PKA) pathway, which is implicated in long-term memory. A PKA-dependent increase in Arc protein level was observed after pharmacological or synaptic activation of N-methyl-D-aspartate (NMDA) receptors, which play a critical role in both LTP induction and learning. Arc protein was also up-regulated by activation of PKA through G(s)-coupled dopamine and beta-adrenergic receptors, which regulate the late-phase of LTP and memory. When agonists for the NMDA and G(s)-coupled receptors were co-applied, they had an additive effect on Arc protein expression. Interestingly, G(s)-coupled receptor stimulation was ineffective in the presence of an NMDA receptor antagonist, suggesting calcium influx through the NMDA receptor plays a gating role in this pathway. Stimulation of the cAMP/PKA pathway did not affect Arc mRNA level or protein stability, identifying translational efficacy as the main determinant of Arc protein expression level. It is concluded that efficient Arc translation requires NMDA receptor activity, whereas a further enhancement can be achieved with activation of G(s)-coupled receptors. These experiments have, therefore, revealed remarkable similarities in the signaling pathways that control Arc expression and those that regulate LTP, learning, and memory.	Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA	Duke University	VanDongen, AMJ (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, PO Box 3813, Durham, NC 27710 USA.	vando005@mc.duke.edu		VanDongen, Antonius/0000-0002-9923-3407				Ainger K, 1997, J CELL BIOL, V138, P1077, DOI 10.1083/jcb.138.5.1077; Bagni C, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-10-j0004.2000; Bailey CH, 2000, NAT REV NEUROSCI, V1, P11, DOI 10.1038/35036191; Bock J, 2005, NEUROSCIENCE, V133, P625, DOI 10.1016/j.neuroscience.2005.02.048; Chawla MK, 2005, HIPPOCAMPUS, V15, P579, DOI 10.1002/hipo.20091; Chotiner JK, 2003, NEUROSCIENCE, V116, P743, DOI 10.1016/S0306-4522(02)00797-2; Chowdhury S, 2006, NEURON, V52, P445, DOI 10.1016/j.neuron.2006.08.033; Corner MA, 2002, NEUROSCI BIOBEHAV R, V26, P127, DOI 10.1016/S0149-7634(01)00062-8; Dong E, 2003, P NATL ACAD SCI USA, V100, P5479, DOI 10.1073/pnas.1031602100; Fiorentini C, 2003, J BIOL CHEM, V278, P20196, DOI 10.1074/jbc.M213140200; FOSNAUGH JS, 1995, J NEUROCHEM, V64, P2377; Guzowski JF, 1999, NAT NEUROSCI, V2, P1120, DOI 10.1038/16046; Guzowski JF, 2000, J NEUROSCI, V20, P3993; HABETS AMMC, 1987, EXP BRAIN RES, V69, P43, DOI 10.1007/BF00247027; Kelly MP, 2002, NEUROSCIENCE, V110, P617, DOI 10.1016/S0306-4522(01)00605-4; Kobayashi H, 2005, EUR J NEUROSCI, V22, P2977, DOI 10.1111/j.1460-9568.2005.04508.x; Kosturko LD, 2006, MOL BIOL CELL, V17, P3521, DOI 10.1091/mbc.E05-10-0946; Kremerskothen J, 2002, NEUROSCI LETT, V321, P153, DOI 10.1016/S0304-3940(01)02532-0; Krichevsky AM, 2001, NEURON, V32, P683, DOI 10.1016/S0896-6273(01)00508-6; Lee FJS, 2002, CELL, V111, P219, DOI 10.1016/S0092-8674(02)00962-5; Li L, 2005, MOL CELL BIOL, V25, P10286, DOI 10.1128/MCB.25.23.10286-10300.2005; Liao DZ, 2001, J NEUROSCI, V21, P6008, DOI 10.1523/JNEUROSCI.21-16-06008.2001; Lin H, 2004, BIOCHEM BIOPH RES CO, V316, P501, DOI 10.1016/j.bbrc.2004.02.086; LINK W, 1995, P NATL ACAD SCI USA, V92, P5734, DOI 10.1073/pnas.92.12.5734; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; McIntyre CK, 2005, P NATL ACAD SCI USA, V102, P10718, DOI 10.1073/pnas.0504436102; Montag-Sallaz M, 1999, J NEUROBIOL, V38, P234, DOI 10.1002/(SICI)1097-4695(19990205)38:2<234::AID-NEU6>3.0.CO;2-G; Pei L, 2004, J NEUROSCI, V24, P1149, DOI 10.1523/JNEUROSCI.3922-03.2004; Pei Q, 2000, NEUROPHARMACOLOGY, V39, P463, DOI 10.1016/S0028-3908(99)00148-3; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; Ramirez-Amaya V, 2005, J NEUROSCI, V25, P1761, DOI 10.1523/JNEUROSCI.4342-04.2005; Rao A, 1997, NEURON, V19, P801, DOI 10.1016/S0896-6273(00)80962-9; Rodriguez JJ, 2005, EUR J NEUROSCI, V21, P2384, DOI 10.1111/j.1460-9568.2005.04068.x; Scheetz AJ, 2000, NAT NEUROSCI, V3, P211, DOI 10.1038/72915; Schiltz CA, 2005, EUR J NEUROSCI, V21, P1703, DOI 10.1111/j.1460-9568.2005.04001.x; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Shan JG, 2000, J BIOL CHEM, V275, P38286, DOI 10.1074/jbc.M007642200; Shepherd JD, 2006, NEURON, V52, P475, DOI 10.1016/j.neuron.2006.08.034; Steward O, 2001, NEURON, V30, P227, DOI 10.1016/S0896-6273(01)00275-6; Steward O, 1998, NEURON, V21, P741, DOI 10.1016/S0896-6273(00)80591-7; Sutton MA, 2005, J NEUROBIOL, V64, P116, DOI 10.1002/neu.20152; Teber I, 2004, MOL BRAIN RES, V121, P131, DOI 10.1016/j.molbrainres.2003.11.017; Thomas GM, 2005, P NATL ACAD SCI USA, V102, P15006, DOI 10.1073/pnas.0507476102; Tolias KF, 2005, NEURON, V45, P525, DOI 10.1016/j.neuron.2005.01.024; Ven TJV, 2005, J NEUROSCI, V25, P9488, DOI 10.1523/JNEIROSCI.2450-05.2005; Waltereit R, 2001, J NEUROSCI, V21, P5484, DOI 10.1523/JNEUROSCI.21-15-05484.2001; Wang C, 2005, INT J GREEN ENERGY, V2, P91, DOI 10.1081/GE-200051313; Wang HB, 2002, J NEUROCHEM, V83, P946, DOI 10.1046/j.1471-4159.2002.01206.x; WAYMAN GA, 1994, J BIOL CHEM, V269, P25400; Wiedenmann J, 2004, P NATL ACAD SCI USA, V101, P15905, DOI 10.1073/pnas.0403668101; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Wu L, 1998, NEURON, V21, P1129, DOI 10.1016/S0896-6273(00)80630-3; Yin Y, 2002, P NATL ACAD SCI USA, V99, P2368, DOI 10.1073/pnas.042693699; Ying SW, 2002, J NEUROSCI, V22, P1532, DOI 10.1523/JNEUROSCI.22-05-01532.2002; Young JZ, 2006, EUR J NEUROSCI, V23, P1784, DOI 10.1111/j.1460-9568.2006.04707.x; Zalfa F, 2003, CELL, V112, P317, DOI 10.1016/S0092-8674(03)00079-5	57	55	64	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					582	592		10.1074/jbc.M702451200	http://dx.doi.org/10.1074/jbc.M702451200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17981809	Green Published, hybrid			2022-12-27	WOS:000251940300063
J	Liu, SL; Fewkes, N; Ricketson, D; Penkert, RR; Prehoda, KE				Liu, Su-Ling; Fewkes, Natasha; Ricketson, Derek; Penkert, Rhiannon R.; Prehoda, Kenneth E.			Filament-dependent and -independent localization modes of Drosophila non-muscle myosin II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; HEAVY-CHAIN; CAENORHABDITIS-ELEGANS; PAR PROTEINS; PHOSPHORYLATION; DICTYOSTELIUM; CYTOKINESIS; TRANSPORT; EMBRYOS; DOMAIN	Myosin II assembles into force- generating filaments that drive cytokinesis and the organization of the cell cortex. Regulation of myosin II activity can occur through modulation of filament assembly and by targeting to appropriate cellular sites. Here we show, using salt-dependent solubility and a novel fluorescence resonance energy transfer assay, that assembly of the Drosophila non-muscle myosin II heavy chain, zipper, is mediated by a 90-residue region (1849-1940) of the coiled-coil tail domain. This filament assembly domain, transiently expressed in Drosophila S2 cells, does not localize to the interphase cortex or the cytokinetic cleavage furrow, whereas a 500-residue region (1350-1865) that overlaps the NH2 terminus of the assembly domain localizes to the interphase cortex but not the cytokinetic cleavage furrow. Targeting to these two sites appears to utilize distinct localization mechanisms as the assembly domain is required for cleavage furrow recruitment of a truncated coiled-coil tail region but not targeting to the interphase cortex. These results delineate the requirements for zipper filament assembly and indicate that the ability to form filaments is necessary for targeting to the cleavage furrow but not to the interphase cortex.	[Liu, Su-Ling; Fewkes, Natasha; Ricketson, Derek; Penkert, Rhiannon R.; Prehoda, Kenneth E.] Univ Oregon, Inst Mol Biol, Dept Chem, Eugene, OR USA	University of Oregon	Prehoda, KE (corresponding author), Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA.	prehoda@molbio.uoregon.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007759, R01GM068032] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM068032-05S1, GM 068032, R01 GM068032-04, R01 GM068032, R01 GM068032-05, R01 GM068032-03S1, T32 GM007759] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ATKINSON SJ, 1992, J MOL BIOL, V226, P7, DOI 10.1016/0022-2836(92)90118-4; Barros CS, 2003, DEV CELL, V5, P829, DOI 10.1016/S1534-5807(03)00359-9; Betschinger J, 2004, CURR BIOL, V14, pR674, DOI 10.1016/j.cub.2004.08.017; Dean SO, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000131; Dean SO, 2005, P NATL ACAD SCI USA, V102, P13473, DOI 10.1073/pnas.0506810102; Edwards KA, 1996, DEVELOPMENT, V122, P1499; Even-Faitelson L, 2006, MOL BIOL CELL, V17, P2869, DOI 10.1091/mbc.e05-11-1001; Frank S, 2000, J BIOL CHEM, V275, P11672, DOI 10.1074/jbc.275.16.11672; Glotzer M, 2005, SCIENCE, V307, P1735, DOI 10.1126/science.1096896; GOLDMAN Y, 2000, CELL, V93, P1; Guo S, 1996, NATURE, V382, P455, DOI 10.1038/382455a0; Hostetter D, 2004, PLOS BIOL, V2, P1880, DOI 10.1371/journal.pbio.0020356; Ikebe M, 2001, J BIOL CHEM, V276, P30293, DOI 10.1074/jbc.M101969200; LEE RJ, 1994, J CELL SCI, V107, P2875; Liang WC, 1999, J CELL BIOL, V147, P1039, DOI 10.1083/jcb.147.5.1039; Munro E, 2004, DEV CELL, V7, P413, DOI 10.1016/j.devcel.2004.08.001; Murakami N, 1995, BIOCHEMISTRY-US, V34, P16046, DOI 10.1021/bi00049a019; Nakasawa T, 2005, BIOCHEMISTRY-US, V44, P174, DOI 10.1021/bi048807h; Nance J, 2003, DEVELOPMENT, V130, P5339, DOI 10.1242/dev.00735; OHALLORAN TJ, 1990, J CELL BIOL, V110, P63, DOI 10.1083/jcb.110.1.63; Ohshiro T, 2000, NATURE, V408, P593, DOI 10.1038/35046087; Peng CY, 2000, NATURE, V408, P596, DOI 10.1038/35046094; Peterson FC, 2004, MOL CELL, V13, P665, DOI 10.1016/S1097-2765(04)00086-3; Pollard T.D., 1981, Journal of Cell Biology, V91, P156; Robinson DN, 2004, CURR OPIN CELL BIOL, V16, P182, DOI 10.1016/j.ceb.2004.02.002; Royou A, 2004, MOL BIOL CELL, V15, P838, DOI 10.1091/mbc.E03-06-0440; Royou A, 2002, J CELL BIOL, V158, P127, DOI 10.1083/jcb.200203148; Severson AF, 2003, J CELL BIOL, V161, P21, DOI 10.1083/jcb.200210171; Shoffner JD, 1996, BIOCHEM BIOPH RES CO, V218, P860, DOI 10.1006/bbrc.1996.0153; Sohn RL, 1997, J MOL BIOL, V266, P317, DOI 10.1006/jmbi.1996.0790; STRAND D, 1994, J CELL BIOL, V127, P1361, DOI 10.1083/jcb.127.5.1361; Su ZW, 2001, BIOCHEMISTRY-US, V40, P3606, DOI 10.1021/bi010082j; Turbedsky K, 2005, J MOL BIOL, V345, P351, DOI 10.1016/j.jmb.2004.10.049; WHEATLEY S, 1995, DEVELOPMENT, V121, P1937; YOUNG PE, 1993, GENE DEV, V7, P29, DOI 10.1101/gad.7.1.29; Yumura S, 2005, MOL BIOL CELL, V16, P4256, DOI 10.1091/mbc.E05-03-0219; Yumura S, 2001, J CELL BIOL, V154, P137, DOI 10.1083/jcb.200011013; Zang JH, 1998, P NATL ACAD SCI USA, V95, P13652, DOI 10.1073/pnas.95.23.13652	38	12	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					380	387		10.1074/jbc.M703924200	http://dx.doi.org/10.1074/jbc.M703924200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17989074	hybrid			2022-12-27	WOS:000251940300042
J	Siafakas, AR; Sorrell, TC; Wright, LC; Wilson, C; Larsen, M; Boadle, R; Williamson, PR; Djordjevic, JT				Siafakas, A. Rosemary; Sorrell, Tania C.; Wright, Lesley C.; Wilson, Christabel; Larsen, Michelle; Boadle, Ross; Williamson, Peter R.; Djordjevic, Julianne T.			Cell wall-linked cryptococcal phospholipase B1 is a source of secreted enzyme and a determinant of cell wall integrity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; ALPHA-AGGLUTININ; VIRULENCE FACTOR; CANDIDA-ALBICANS; NEOFORMANS; PROTEIN; YEAST; IDENTIFICATION; MANNOPROTEINS; LYSOPHOSPHOLIPASE	Phospholipase B (plb1) is secreted by pathogenic fungi and is a proven virulence determinant in Cryptococcus neoformans. Cell-associated plb1 is presumptively involved in fungal membrane biogenesis and remodelling. We have also identified it in cryptococcal cell walls. Motif scanning programs predict that Plb1 is attached to cryptococcal membranes via a glycosylphosphatidylinositol (GPI) anchor, which could regulate Plb1 export and secretion. A functional GPI anchor was identified in cellassociated Plb1 by (G) PI-specific phospholipase C (PLC)-induced release of Plb1 from strain H99 membrane rafts and inhibition of GPI anchor synthesis by YW3548, which prevented Plb1 secretion and transport to membranes and cell walls. Plb1 containing beta-1,6-linked glucan was released from H99 (wildtype strain) cell walls by beta-1,3 glucanase, consistent with covalent attachment of Plb1 via beta-1,6-linked glucans to beta-1,3-linked glucan in the central scaffold of the wall. Naturally secreted Plb1 also contained beta-1,6-linked glucan, confirming that it originated from the cell wall. Plb1 maintains cell wall integrity because a H99 deletion mutant, Delta PLB1, exhibited a morphological defect and was more susceptible than H99 to cell wall disruption by SDS and Congo red. Growth of Delta PLB1 was unaffected by caffeine, excluding an effect of Plb1 on cell wall biogenesis-related signaling pathways. Environmental (heat) stress caused Plb1 accumulation in cell walls, with loss from membranes and reduced secretion, further supporting the importance of Plb1 in cell wall integrity. This is the first demonstration that Plb1 contributes to fungal survival by maintaining cell wall integrity and that the cell wall is a source of secreted enzyme.	[Siafakas, A. Rosemary; Sorrell, Tania C.; Wright, Lesley C.; Wilson, Christabel; Larsen, Michelle; Djordjevic, Julianne T.] Univ Sydney, Westmead Hosp, Ctr Infect Dis & Microbiol, Westmead Millennium Inst, Sydney, NSW 2145, Australia; [Boadle, Ross] Westmead Hosp, Westmead Millennium Inst, ICPMR, Electron Microscope Lab, Sydney, NSW 2145, Australia; [Williamson, Peter R.] Univ Illinois, Coll Med, Dept Med, Infect Dis Sect, Chicago, IL 60612 USA	University of Sydney; Westmead Institute for Medical Research; University of Sydney; Westmead Institute for Medical Research; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Djordjevic, JT (corresponding author), Univ Sydney, Westmead Hosp, Ctr Infect Dis & Microbiol, Westmead Millennium Inst, Level 3 ICPMR Bldg, Sydney, NSW 2145, Australia.	julie_djordjevic@wmi.usyd.edu.au	Sorrell, Tania/AAZ-5286-2020	Espedido, Aritee Rosemary/0000-0002-8059-1757; Sorrell, Tania/0000-0001-9460-0960; Djordjevic, Julianne/0000-0003-4207-4115				Banks IR, 2005, EUKARYOT CELL, V4, P1902, DOI 10.1128/EC.4.11.1902-1912.2005; Bates S, 2006, J BIOL CHEM, V281, P90, DOI 10.1074/jbc.M510360200; BORDIER C, 1981, J BIOL CHEM, V256, P1604; Brul S, 1997, ANTON LEEUW INT J G, V72, P229, DOI 10.1023/A:1000429208049; Chen SCA, 1997, J INFECT DIS, V175, P414, DOI 10.1093/infdis/175.2.414; Chen SCA, 1997, INFECT IMMUN, V65, P405, DOI 10.1128/IAI.65.2.405-411.1997; Chen SCA, 2000, BIOCHEM J, V347, P431, DOI 10.1042/0264-6021:3470431; Cox GM, 2001, MOL MICROBIOL, V39, P166, DOI 10.1046/j.1365-2958.2001.02236.x; DENOBEL JG, 1990, YEAST, V6, P491, DOI 10.1002/yea.320060606; Djordjevic JT, 2005, BIOCHEM J, V389, P803, DOI 10.1042/BJ20050063; Eigenheer RA, 2007, FEMS YEAST RES, V7, P499, DOI 10.1111/j.1567-1364.2006.00198.x; Fujii T, 1999, BBA-GEN SUBJECTS, V1427, P133, DOI 10.1016/S0304-4165(99)00012-4; Hamilton AJ, 1997, INFECT IMMUN, V65, P488, DOI 10.1128/IAI.65.2.488-494.1997; Heung LJ, 2005, J BIOL CHEM, V280, P28547, DOI 10.1074/jbc.M503404200; Himmelreich U, 2003, MICROBES INFECT, V5, P285, DOI 10.1016/S1286-4579(03)00028-5; Kapteyn JC, 1996, GLYCOBIOLOGY, V6, P337, DOI 10.1093/glycob/6.3.337; Kollar R, 1997, J BIOL CHEM, V272, P17762, DOI 10.1074/jbc.272.28.17762; Kraus PR, 2003, MOL MICROBIOL, V48, P1377, DOI 10.1046/j.1365-2958.2003.03508.x; Kuranda K, 2006, MOL MICROBIOL, V61, P1147, DOI 10.1111/j.1365-2958.2006.05300.x; LEE KS, 1994, J BIOL CHEM, V269, P19725; Levitz SM, 2006, FEMS YEAST RES, V6, P513, DOI 10.1111/j.1567-1364.2006.00071.x; Lipke PN, 1998, J BACTERIOL, V180, P3735, DOI 10.1128/JB.180.15.3735-3740.1998; LU CF, 1995, J CELL BIOL, V128, P333, DOI 10.1083/jcb.128.3.333; LU CF, 1994, MOL CELL BIOL, V14, P4825, DOI 10.1128/MCB.14.7.4825; Macekova D, 2006, J BASIC MICROB, V46, P470, DOI 10.1002/jobm.200610143; Martinez-Lopez R, 2004, MICROBIOL-SGM, V150, P3341, DOI 10.1099/mic.0.27320-0; Muller G, 1996, MOL CELL BIOL, V16, P442; Muller G, 2000, BIOCHEMISTRY-US, V39, P1475, DOI 10.1021/bi9920432; Ram AFJ, 2006, NAT PROTOC, V1, P2253, DOI 10.1038/nprot.2006.397; Reese AJ, 2003, MOL MICROBIOL, V50, P1401, DOI 10.1046/j.1365-2958.2003.03780.x; Rodrigues ML, 2007, EUKARYOT CELL, V6, P48, DOI 10.1128/EC.00318-06; Santangelo R, 2004, INFECT IMMUN, V72, P2229, DOI 10.1128/IAI.72.4.2229-2239.2004; Santangelo RT, 1999, J MED MICROBIOL, V48, P731, DOI 10.1099/00222615-48-8-731; Siafakas AR, 2006, EUKARYOT CELL, V5, P488, DOI 10.1128/EC.5.3.488-498.2006; Sutterlin C, 1997, EMBO J, V16, P6374, DOI 10.1093/emboj/16.21.6374; Sutterlin C, 1997, J CELL SCI, V110, P2703; WOJCIECHOWICZ D, 1993, MOL CELL BIOL, V13, P2554, DOI 10.1128/MCB.13.4.2554; Zhu XD, 2001, INFECT IMMUN, V69, P5589, DOI 10.1128/IAI.69.9.5589-5596.2001	38	62	64	5	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37508	37514		10.1074/jbc.M707913200	http://dx.doi.org/10.1074/jbc.M707913200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17947228	hybrid			2022-12-27	WOS:000251833600026
J	Knutson, CG; Wang, H; Rizzo, CJ; Marnett, LJ				Knutson, Charles G.; Wang, Hao; Rizzo, Carmelo J.; Marnett, Lawrence J.			Metabolism and elimination of the endogenous DNA adduct, 3-(2-deoxy-beta-D-erythropentofuranosyl)-pyrimido[1,2-alpha]purine-10(3H)-one, in the rat	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TANDEM MASS-SPECTROMETRY; IN-VIVO; MALONDIALDEHYDE; DEOXYGUANOSINE; URINE; ACIDS; CARCINOGENESIS; PEROXIDATION; INFLAMMATION; NUCLEOSIDES	Endogenously occurring damage to DNA is a contributing factor to the onset of several genetic diseases, including cancer. Monitoring urinary levels of DNA adducts is one approach to assess genomic exposure to endogenous damage. However, metabolism and alternative routes of elimination have not been considered as factors that may limit the detection of DNA adducts in urine. We recently demonstrated that the peroxidation-derived deoxyguanosine adduct, 3-(2-deoxy-beta-D-erythropentofuranosyl)-pyrimido[1,2-alpha] purine-10(3H)one (M(1)dG), is subject to enzymatic oxidation in vivo resulting in the formation of a major metabolite, 6-oxo-M(1)dG. Based on the administration of [C-14] M1dG (22 mu Ci/kg) to Sprague-Dawley rats (n = 4), we now report that 6-oxo-M1dG is the principal metabolite of M(1)dG in vivo representing 45% of the total administered dose. When [C-14] 6-oxo-M(1)dG was administered to Sprague-Dawley rats, 6-oxo-M(1)dG was recovered unchanged (> 97% stability). These studies also revealed that M(1)dG and 6- oxo-M(1)dG are subject to biliary elimination. Additionally, both M(1)dG and 6- oxo-M(1)dG exhibited a long residence time following administration (> 48 h), and the major species observed in urine at late collections was 6-oxo-M(1)dG.	Vanderbilt Univ, Sch Med,AB Hancock Jr Mem Lab Canc Res, Dept Biochem,Vanderbilt Ingram Canc Ctr, Vanderbilt Inst Chem Biol,Ctr Mol Toxicol, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Chem,Vanderbilt Ingram Canc Ctr, Vanderbilt Inst Chem Biol,Ctr Mol Toxicol, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Pharmacol,Vanderbilt Ingram Canc Ctr, Vanderbilt Inst Chem Biol,Ctr Mol Toxicol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Marnett, LJ (corresponding author), Vanderbilt Univ, Sch Med,AB Hancock Jr Mem Lab Canc Res, Dept Biochem,Vanderbilt Ingram Canc Ctr, Vanderbilt Inst Chem Biol,Ctr Mol Toxicol, 850 A Robinson Res Bldg, Nashville, TN 37232 USA.	larry.marnett@vanderbilt.edu		Rizzo, Carmelo/0000-0001-9005-611X	NCI NIH HHS [CA87819] Funding Source: Medline; NIEHS NIH HHS [T32 ES007028] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA087819, R37CA087819] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007028] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		BASU AK, 1988, CHEM RES TOXICOL, V1, P53, DOI 10.1021/tx00001a010; BASU AK, 1983, CARCINOGENESIS, V4, P331, DOI 10.1093/carcin/4.3.331; CHAUDHARY AK, 1994, SCIENCE, V265, P1580, DOI 10.1126/science.8079172; Dedon PC, 1998, P NATL ACAD SCI USA, V95, P11113, DOI 10.1073/pnas.95.19.11113; Dedon PC, 2004, ARCH BIOCHEM BIOPHYS, V423, P12, DOI 10.1016/j.abb.2003.12.017; DICZFALUSY U, 1977, FEBS LETT, V84, P271, DOI 10.1016/0014-5793(77)80704-7; Fink SP, 1997, P NATL ACAD SCI USA, V94, P8652, DOI 10.1073/pnas.94.16.8652; HAMBERG M, 1967, J BIOL CHEM, V242, P5344; Hamilton SR, 2001, J BIOL CHEM, V276, P27981, DOI 10.1074/jbc.M100518200; Hoberg AM, 2004, J MASS SPECTROM, V39, P38, DOI 10.1002/jms.547; Jeong YC, 2005, FREE RADICAL BIO MED, V39, P1021, DOI 10.1016/j.freeradbiomed.2005.05.018; Johnson KA, 1997, J BIOL CHEM, V272, P11434; King AE, 2006, TRENDS PHARMACOL SCI, V27, P416, DOI 10.1016/j.tips.2006.06.004; Klaunig JE, 2004, ANNU REV PHARMACOL, V44, P239, DOI 10.1146/annurev.pharmtox.44.101802.121851; Knutson CG, 2007, CHEM RES TOXICOL, V20, P550, DOI 10.1021/tx600334x; MEYER C, 1993, SYNLETT, P386; Niedernhofer LJ, 2003, J BIOL CHEM, V278, P31426, DOI 10.1074/jbc.M212549200; Ohshima H, 2003, ARCH BIOCHEM BIOPHYS, V417, P3, DOI 10.1016/S0003-9861(03)00283-2; Otteneder M, 2003, ANAL BIOCHEM, V315, P147, DOI 10.1016/S0003-2697(02)00697-8; Otteneder MB, 2006, P NATL ACAD SCI USA, V103, P6665, DOI 10.1073/pnas.0602017103; SETO H, 1983, B CHEM SOC JPN, V56, P1799, DOI 10.1246/bcsj.56.1799; Sundaram M, 2001, J BIOL CHEM, V276, P45270, DOI 10.1074/jbc.M107169200; SZEKELY J, 2007, IN PRESS NUCLEOSIDES, V26; VanderVeen LA, 2003, P NATL ACAD SCI USA, V100, P14247, DOI 10.1073/pnas.2332176100; Wada S, 2000, J PHARMACOL EXP THER, V294, P844; Wang MY, 1997, CHEM RES TOXICOL, V10, P772, DOI 10.1021/tx960193x; World Health Organization, 2001, IPCS ENV HLTH CRIT 2; Zhou XF, 2005, J BIOL CHEM, V280, P25377, DOI 10.1074/jbc.M503079200	28	12	12	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36257	36264		10.1074/jbc.M706814200	http://dx.doi.org/10.1074/jbc.M706814200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17951255	hybrid			2022-12-27	WOS:000251458300016
J	Lamour, V; Detry, C; Sanchez, C; Henrotin, Y; Castronovo, V; Bellahcene, A				Lamour, Virginie; Detry, Cedric; Sanchez, Christelle; Henrotin, Yves; Castronovo, Vincent; Bellahcene, Akeila			Runx2-and histone deacetylase 3-mediated repression is relieved in differentiating human osteoblast cells to allow high bone sialoprotein expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MINERALIZED TISSUE FORMATION; MESSENGER-RNA EXPRESSION; TRANSCRIPTION FACTOR; OSTEOSARCOMA CELL; CANCER-CELLS; HUMAN BREAST; OSTEOCALCIN PROMOTER; MATRIX PROTEIN; MARROW CELLS; LINE SAOS-2	Bone sialoprotein (BSP) is a bone matrix glycoprotein whose expression coincides with terminal osteoblastic differentiation and the onset of mineralization. In this study we show that BSP expression is considerably increased in confluent Saos-2 human osteosarcoma cells and in differentiating normal human osteoblasts, concomitantly with the decrease of Runx2, a key transcription factor controlling bone formation. Therefore, we investigated the role of Runx2 in the regulation of BSP expression in Saos-2 cells. Using a mobility shift assay, we demonstrated that Runx2 binds to the BSP promoter only in preconfluent cells. Histone deacetylase 3 (HDAC3) has been recently shown to act as a Runx2 co-repressor. Chromatin immunoprecipitation assays demonstrated that both Runx2 and HDAC3 are detectable at the BSP promoter in preconfluent Saos-2 cells but not when they are confluent and overexpress BSP. Consistently, nuclear Runx2 protein level is down-regulated, whereas Saos-2 cells became increasingly confluent. Finally, the suppression of HDAC3, Runx2, or both by RNA interference induced the expression of BSP at both mRNA and protein levels in Saos-2 cells. Our data demonstrate that Runx2 and HDAC3 repress BSP gene expression and that this repression is suspended upon osteoblastic cell differentiation. Both the nuclear disappearance of Runx2 and the non-recruitment of HDAC3 represent new means to relieve Runx2-mediated suppression of BSP expression, thus allowing the acquisition of a fully differentiated and mineralization-competent phenotype by osteoblast cells.	Univ Liege, Metastasis Res Lab, Ctr Expt Canc Res, B-4000 Liege, Belgium; Univ Liege, Bone & Cartilage Metab Res Unit, B-4000 Liege, Belgium	University of Liege; University of Liege	Bellahcene, A (corresponding author), Univ Liege, Metastasis Res Lab, Ctr Expt Canc Res, Bat B23, B-4000 Liege, Belgium.	a.bellahcene@ulg.ac.be		Henrotin, Yves/0000-0003-1073-449X; sanchez, christelle/0000-0002-1005-8172				Bae SC, 2006, GENE, V366, P58, DOI 10.1016/j.gene.2005.10.017; Banerjee C, 2001, ENDOCRINOLOGY, V142, P4026, DOI 10.1210/en.142.9.4026; Banerjee C, 1997, J CELL BIOCHEM, V66, P1, DOI 10.1002/(SICI)1097-4644(19970701)66:1<1::AID-JCB1>3.0.CO;2-V; Barnes GL, 2003, CANCER RES, V63, P2631; Beck GR, 2003, J CELL BIOCHEM, V90, P234, DOI 10.1002/jcb.10622; Bellahcene A, 2007, BREAST CANCER RES TR, V101, P135, DOI 10.1007/s10549-006-9279-8; BELLAHCENE A, 1994, CANCER RES, V54, P2823; Benson MD, 1999, J BONE MINER RES, V14, P396, DOI 10.1359/jbmr.1999.14.3.396; BIANCO P, 1991, CALCIFIED TISSUE INT, V49, P421, DOI 10.1007/BF02555854; Brenner O, 2004, P NATL ACAD SCI USA, V101, P16016, DOI 10.1073/pnas.0407180101; Chaplet ML, 2004, BIOCHEM J, V384, P591, DOI 10.1042/BJ20040380; Chen J, 2003, CONNECT TISSUE RES, V44, P279, DOI 10.1080/03008200390181771; CHEN JK, 1992, J BONE MINER RES, V7, P987; CHEN JK, 1991, MATRIX, V11, P133, DOI 10.1016/S0934-8832(11)80217-9; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Drissi H, 1999, CANCER RES, V59, P3705; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Ducy P, 1999, GENE DEV, V13, P1025, DOI 10.1101/gad.13.8.1025; Eberharter A, 2002, EMBO REP, V3, P224, DOI 10.1093/embo-reports/kvf053; FISHER LW, 1990, J BIOL CHEM, V265, P2347; FLORES ME, 1992, EXP CELL RES, V201, P526, DOI 10.1016/0014-4827(92)90305-R; Floyd ZE, 2001, J BIOL CHEM, V276, P22468, DOI 10.1074/jbc.M009388200; Fujita T, 2001, BIOCHEM BIOPH RES CO, V280, P348, DOI 10.1006/bbrc.2000.4108; Ganss B, 1999, CRIT REV ORAL BIOL M, V10, P79, DOI 10.1177/10454411990100010401; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Hassig CA, 1997, CURR OPIN CHEM BIOL, V1, P300, DOI 10.1016/S1367-5931(97)80066-X; Hoshi K, 1999, BONE, V25, P639, DOI 10.1016/S8756-3282(99)00223-9; Huang G, 2001, EMBO J, V20, P723, DOI 10.1093/emboj/20.4.723; HUNTER GK, 1994, BIOCHEM J, V302, P175, DOI 10.1042/bj3020175; IBARAKI K, 1992, J BONE MINER RES, V7, P743; IKEDA K, 1990, BIOCHEM BIOPH RES CO, V168, P889, DOI 10.1016/0006-291X(90)91112-6; Javed A, 2001, MOL CELL BIOL, V21, P2891, DOI 10.1128/MCB.21.8.2891-2905.2001; Javed A, 2000, J CELL SCI, V113, P2221; Jimenez MJG, 1999, MOL CELL BIOL, V19, P4431; KASUGAI S, 1991, J CELL PHYSIOL, V147, P111, DOI 10.1002/jcp.1041470115; Kim RH, 1996, BIOCHEM J, V318, P219, DOI 10.1042/bj3180219; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Komori T, 2006, J CELL BIOCHEM, V99, P1233, DOI 10.1002/jcb.20958; LEE DY, 1993, CELL, V72, P73, DOI 10.1016/0092-8674(93)90051-Q; Lee HW, 2006, MOL ENDOCRINOL, V20, P2432, DOI 10.1210/me.2006-0061; Levanon D, 1998, P NATL ACAD SCI USA, V95, P11590, DOI 10.1073/pnas.95.20.11590; Li QL, 2002, CELL, V109, P113, DOI 10.1016/S0092-8674(02)00690-6; Lian JB, 2003, J CELL PHYSIOL, V196, P301, DOI 10.1002/jcp.10316; Liu WG, 2001, J CELL BIOL, V155, P157, DOI 10.1083/jcb.200105052; MCQUILLAN DJ, 1995, BONE, V16, P415; MURRAY E, 1987, J BONE MINER RES, V2, P231; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; OLDBERG A, 1988, J BIOL CHEM, V263, P19433; OLDBERG A, 1989, J CELL BIOL, V109, P3183, DOI 10.1083/jcb.109.6.3183; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Porte D, 1999, ONCOGENE, V18, P667, DOI 10.1038/sj.onc.1202333; Pratap J, 2005, MOL CELL BIOL, V25, P8581, DOI 10.1128/MCB.25.19.8581-8591.2005; Prince M, 2001, J CELL BIOCHEM, V80, P424, DOI 10.1002/1097-4644(20010301)80:3<424::AID-JCB160>3.0.CO;2-6; Roca H, 2005, J BIOL CHEM, V280, P30845, DOI 10.1074/jbc.M503942200; RODAN SB, 1987, CANCER RES, V47, P4961; ROSS FP, 1993, J BIOL CHEM, V268, P9901; Sanchez C, 2005, OSTEOARTHR CARTILAGE, V13, P988, DOI 10.1016/j.joca.2005.07.012; Sato M, 1998, ONCOGENE, V17, P1517, DOI 10.1038/sj.onc.1202064; Schroeder TM, 2005, J BONE MINER RES, V20, P2254, DOI 10.1359/JBMR.050813; Schroeder TM, 2004, J BIOL CHEM, V279, P41998, DOI 10.1074/jbc.M403702200; Shen J, 2003, MOL ENDOCRINOL, V17, P743, DOI 10.1210/me.2002-0122; Shen R, 2006, J BIOL CHEM, V281, P16347, DOI 10.1074/jbc.M603439200; Shirangi TR, 2002, FASEB J, V16, P420, DOI 10.1096/fj.01-0617fje; Shui CX, 2003, J BONE MINER RES, V18, P213, DOI 10.1359/jbmr.2003.18.2.213; Song A, 1998, MOL CELL BIOL, V18, P4994, DOI 10.1128/MCB.18.9.4994; Sudhakar S, 2001, BIOCHEM BIOPH RES CO, V286, P74, DOI 10.1006/bbrc.2001.5363; VILLARREAL XC, 1989, BIOCHEMISTRY-US, V28, P6483, DOI 10.1021/bi00441a049; Waltregny D, 2000, J BONE MINER RES, V15, P834, DOI 10.1359/jbmr.2000.15.5.834; Yang J, 2001, CANCER RES, V61, P5652; YAO KL, 1994, J BONE MINER RES, V9, P231; Yeung F, 2002, J BIOL CHEM, V277, P2468, DOI 10.1074/jbc.M105947200; Yoshida CA, 2004, GENE DEV, V18, P952, DOI 10.1101/gad.1174704; Zhang JH, 2003, INT J ONCOL, V23, P1043	73	55	60	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36240	36249		10.1074/jbc.M705833200	http://dx.doi.org/10.1074/jbc.M705833200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17956871	hybrid			2022-12-27	WOS:000251458300014
J	Moffatt, P; Thomas, G; Sellin, K; Bessette, MC; Lafreniere, F; Akhouayri, O; St-Arnaud, R; Lanctot, C				Moffatt, Pierre; Thomas, Gethin; Sellin, Karine; Bessette, Marie-Claude; Lafreniere, Francois; Akhouayri, Omar; St-Arnaud, Rene; Lanctot, Christian			Osteocrin is a specific ligand of the natriuretic peptide clearance receptor that modulates bone growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-RECEPTOR; CHONDROCYTE PROLIFERATION; SKELETAL OVERGROWTH; MESSENGER-RNA; EXPRESSION; OSTEOBLAST; ANP; DIFFERENTIATION; STIMULATION; MUSCLIN	Osteocrin (Ostn) is a recently discovered secreted protein produced by cells of the osteoblast lineage that shows a well conserved homology with members of the natriuretic peptide (NP) family. We hypothesized that Ostn could interact with the NP receptors, thereby modulating NP actions on the skeleton. Ostn binds specifically and saturably to the NP peptide receptor-C (NPR-C) receptor with a K-d of similar to 5 nM with no binding to the GC-A or GC-B receptors. Deletion of several of the residues deemed important for NP binding to NPR-C led to abolition of Ostn binding, confirming the presence of a "natriuretic motif." Functionally, Ostn was able to augment C-type natriuretic peptide-stimulated cGMP production in both pre-chondrocytic (ATDC5) and osteoblastic (UMR106) cells, suggesting increased NP levels due to attenuation of NPR-C associated NP clearance. Ostn-transgenic mice displayed elongated bones and a marked kyphosis associated with elevated bone cGMP levels, suggesting that elevated natriuretic peptide activity contributed to the increased bone length possibly through an increase in growth plate chondrocyte proliferation. Thus, we have demonstrated that Ostn is a naturally occurring ligand of the NPR-C clearance receptor and may act to locally modulate the actions of the natriuretic system in bone by blocking the clearance action of NPR-C, thus locally elevating levels of C-type natriuretic peptide.	Shriners Hosp Children, Montreal, PQ H3G 1A6, Canada; McGill Univ, Dept Human Genet, Montreal, PQ H3A 2T5, Canada; Enobia Pharma, Montreal, PQ H1W 4A4, Canada; Univ Queensland, Princess Alexandra Hosp, Diamantina Inst Canc Immunol & Metab Med, Brisbane, Qld, Australia; Phenogene Therapeut, Montreal, PQ H3A 1L2, Canada	McGill University; McGill University; University of Queensland	Moffatt, P (corresponding author), Shriners Hosp Children, 1529 Cedar Ave, Montreal, PQ H3G 1A6, Canada.	pmoffatt@shriners.mcgill.ca	Thomas, Gethin P/A-3624-2011	Lanctot, Christian/0000-0003-3211-3061; Thomas, Gethin/0000-0001-9081-3686; Moffatt, Pierre/0000-0002-5793-1944	CIHR [68826-1] Funding Source: Medline	CIHR(Canadian Institutes of Health Research (CIHR))		ANANDSRIVASTAVA MB, 1990, J BIOL CHEM, V265, P8566; ATSUMI T, 1990, CELL DIFFER DEV, V30, P109, DOI 10.1016/0922-3371(90)90079-C; Banzet S, 2007, BIOCHEM BIOPH RES CO, V353, P713, DOI 10.1016/j.bbrc.2006.12.074; Bartels CF, 2004, AM J HUM GENET, V75, P27, DOI 10.1086/422013; Bord S, 2005, J HISTOCHEM CYTOCHEM, V53, P1181, DOI 10.1369/jhc.4C6561.2005; BOURQUE WT, 1993, J HISTOCHEM CYTOCHEM, V41, P1429, DOI 10.1177/41.9.7689084; Chauhan SD, 2003, P NATL ACAD SCI USA, V100, P1426, DOI 10.1073/pnas.0336365100; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; Chusho H, 2000, ENDOCRINOLOGY, V141, P3807, DOI 10.1210/en.141.10.3807; Chusho H, 2001, P NATL ACAD SCI USA, V98, P4016, DOI 10.1073/pnas.071389098; Dacic S, 2001, J BONE MINER RES, V16, P1228, DOI 10.1359/jbmr.2001.16.7.1228; FLANAGAN JG, 1990, CELL, V63, P185, DOI 10.1016/0092-8674(90)90299-T; Flanagan JG, 2000, METHOD ENZYMOL, V327, P198, DOI 10.1016/S0076-6879(00)27277-7; Flanagan JG, 2000, METHOD ENZYMOL, V327, P19, DOI 10.1016/S0076-6879(00)27264-9; FLETCHER AE, 1986, FEBS LETT, V208, P263, DOI 10.1016/0014-5793(86)81029-8; Fujishige K, 1999, BBA-MOL CELL RES, V1452, P219, DOI 10.1016/S0167-4889(99)00141-X; Hagiwara H, 1996, J BIOCHEM-TOKYO, V119, P264; HAGIWARA H, 1994, J BIOL CHEM, V269, P10729; Hagiwara H, 1996, AM J PHYSIOL-CELL PH, V270, pC1311, DOI 10.1152/ajpcell.1996.270.5.C1311; He XL, 2001, SCIENCE, V293, P1657, DOI 10.1126/science.1062246; HIRATA Y, 1985, BIOCHEM BIOPH RES CO, V128, P538, DOI 10.1016/0006-291X(85)90080-4; Hirose S, 2001, CAN J PHYSIOL PHARM, V79, P665, DOI 10.1139/cjpp-79-8-665; Hogan B, 1994, MANIPULATING MOUSE E; Inoue A, 1996, BIOCHEM BIOPH RES CO, V221, P703, DOI 10.1006/bbrc.1996.0660; Jaubert J, 1999, P NATL ACAD SCI USA, V96, P10278, DOI 10.1073/pnas.96.18.10278; JOHN SWM, 1995, SCIENCE, V267, P679, DOI 10.1126/science.7839143; Kaneki H, 2001, J BONE MINER RES, V16, pS498; KISHIMOTO I, 1994, J BIOL CHEM, V269, P28300; KOYAMA S, 1994, INT J PEPT PROT RES, V43, P332; Krejci P, 2005, J CELL SCI, V118, P5089, DOI 10.1242/jcs.02618; Levin ER, 1998, NEW ENGL J MED, V339, P321; LEVIN ER, 1993, AM J PHYSIOL, V264, pE483, DOI 10.1152/ajpendo.1993.264.4.E483; MAACK T, 1987, SCIENCE, V238, P675, DOI 10.1126/science.2823385; Matsukawa N, 1999, P NATL ACAD SCI USA, V96, P7403, DOI 10.1073/pnas.96.13.7403; Matsuo H, 2001, CAN J PHYSIOL PHARM, V79, P736; MISONO KS, 1984, BIOCHEM BIOPH RES CO, V119, P524, DOI 10.1016/S0006-291X(84)80279-X; Miyazawa T, 2002, ENDOCRINOLOGY, V143, P3604, DOI 10.1210/en.2002-220307; MOSS ML, 1965, ACTA ANAT, V60, P262; Nashida T, 1996, BIOCHEM MOL BIOL INT, V40, P1243; Nishimoto SK, 2003, J BIOL CHEM, V278, P11843, DOI 10.1074/jbc.M211449200; Nishizawa H, 2004, J BIOL CHEM, V279, P19391, DOI 10.1074/jbc.C400066200; OLINS GM, 1988, J BIOL CHEM, V263, P10989; Pagano M, 2001, J BIOL CHEM, V276, P22064, DOI 10.1074/jbc.M101587200; PAVLIN D, 1992, J CELL BIOL, V116, P227, DOI 10.1083/jcb.116.1.227; Potter LR, 2006, ENDOCR REV, V27, P47, DOI 10.1210/er.2005-0014; Rose RA, 2004, AM J PHYSIOL-HEART C, V286, pH1970, DOI 10.1152/ajpheart.00893.2003; Rouger K, 2002, AM J PHYSIOL-CELL PH, V283, pC773, DOI 10.1152/ajpcell.00112.2002; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SMYTH EM, 1994, LIFE SCI, V54, P1, DOI 10.1016/0024-3205(94)00571-0; Staiger H, 2006, HORM METAB RES, V38, P614, DOI 10.1055/s-2006-951310; Suda M, 2002, J BONE MINER METAB, V20, P136, DOI 10.1007/s007740200019; Suda M, 1996, BIOCHEM BIOPH RES CO, V223, P1, DOI 10.1006/bbrc.1996.0836; Suda M, 1998, P NATL ACAD SCI USA, V95, P2337, DOI 10.1073/pnas.95.5.2337; SUGA SI, 1992, ENDOCRINOLOGY, V130, P229, DOI 10.1210/en.130.1.229; Tamura N, 2000, P NATL ACAD SCI USA, V97, P4239, DOI 10.1073/pnas.070371497; Thomas G, 2003, J BIOL CHEM, V278, P50563, DOI 10.1074/jbc.M307310200; Tsuji T, 2005, J BIOL CHEM, V280, P14288, DOI 10.1074/jbc.C500024200; Veale CA, 2000, BIOORG MED CHEM LETT, V10, P1949, DOI 10.1016/S0960-894X(00)00387-5; Yamashita Y, 2000, J BIOCHEM-TOKYO, V127, P177, DOI 10.1093/oxfordjournals.jbchem.a022591; Yanaka N, 1998, AM J PHYSIOL-ENDOC M, V275, pE965, DOI 10.1152/ajpendo.1998.275.6.E965; Yasoda A, 2004, NAT MED, V10, P80, DOI 10.1038/nm971; Yasoda A, 1998, J BIOL CHEM, V273, P11695, DOI 10.1074/jbc.273.19.11695	62	60	70	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36454	36462		10.1074/jbc.M708596200	http://dx.doi.org/10.1074/jbc.M708596200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17951249	hybrid			2022-12-27	WOS:000251458300037
J	Geders, TW; Gu, LC; Mowers, JC; Liu, HC; Gerwick, WH; Hakansson, K; Sherman, DH; Smith, JL				Geders, Todd W.; Gu, Liangcai; Mowers, Jonathan C.; Liu, Haichuan; Gerwick, William H.; Hakansson, Kristina; Sherman, David H.; Smith, Janet L.			Crystal structure of the ECH2 catalytic domain of CurF from Lyngbya majuscula - Insights into a decarboxylase involved in polyketide chain beta-branching	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							1.8 ANGSTROM RESOLUTION; GENE-CLUSTER; CROTONASE SUPERFAMILY; COENZYME-A; CURACIN-A; PSEUDOMONAS-FLUORESCENS; NATURAL-PRODUCT; HIGH-THROUGHPUT; BIOSYNTHESIS; ENZYME	Curacin A is a mixed polyketide/nonribosomal peptide possessing anti-mitotic and anti-proliferative activity. In the biosynthesis of curacin A, the N-terminal domain of the CurF multifunctional protein catalyzes decarboxylation of 3-methylglutaconyl-acyl carrier protein (ACP) to 3-methyl-crotonyl-ACP, the postulated precursor of the cyclopropane ring of curacin A. This decarboxylase is encoded within an "HCS cassette" that is used by several other polyketide biosynthetic systems to generate chemical diversity by introduction of a beta-branch functional group to the natural product. The crystal structure of the CurF N-terminal ECH2 domain establishes that the protein is a crotonase superfamily member. Ala(78) and Gly(118) form an oxyanion hole in the active site that includes only three polar side chains as potential catalytic residues. Site-directed mutagenesis and a biochemical assay established critical functions for His(240) and Lys(86), whereas Tyr(82) was nonessential. A decarboxylation mechanism is proposed in which His(240) serves to stabilize the substrate carboxylate and Lys(86) donates a proton to C-4 of the acyl-ACP enolate intermediate to form the Delta(2) unsaturated isopentenoyl-ACP product. The CurF ECH2 domain showed a 20-fold selectivity for ACP-over CoA-linked substrates. Specificity for ACP-linked substrates has not been reported for any other crotonase superfamily decarboxylase. Tyr(73) may select against CoA-linked substrates by blocking a contact of Arg(38) with the CoA adenosine 5'-phosphate.	Univ Michigan, Inst Life Sci, Dept Biol Chem, Ann Arbor, MI 48109 USA; Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; Univ Michigan, Inst Life Sci, Dept Med Chem, Ann Arbor, MI 48109 USA; Univ Michigan, Inst Life Sci, Dept Chem, Ann Arbor, MI 48109 USA; Univ Michigan, Inst Life Sci, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA	University of Michigan System; University of Michigan; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of California System; University of California San Diego; Scripps Institution of Oceanography	Sherman, DH (corresponding author), Univ Michigan, Inst Life Sci, Dept Biol Chem, 210 Washtenaw Ave, Ann Arbor, MI 48109 USA.	davidhs@umich.edu; JanetSmith@umich.edu	Gu, Liangcai/U-6908-2019; Gu, Liangcai/E-4600-2010; Hakansson, Kristina/G-9428-2016	Hakansson, Kristina/0000-0003-1926-0542	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK042303, R01DK042303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076477] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK42303] Funding Source: Medline; NIGMS NIH HHS [GM076477] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Benning MM, 1996, BIOCHEMISTRY-US, V35, P8103, DOI 10.1021/bi960768p; Benning MM, 2000, BIOCHEMISTRY-US, V39, P4630, DOI 10.1021/bi9928896; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Butcher RA, 2007, P NATL ACAD SCI USA, V104, P1506, DOI 10.1073/pnas.0610503104; Calderone CT, 2007, CHEM BIOL, V14, P835, DOI 10.1016/j.chembiol.2007.06.008; Calderone CT, 2006, P NATL ACAD SCI USA, V103, P8977, DOI 10.1073/pnas.0603148103; Chang ZX, 2004, J NAT PROD, V67, P1356, DOI 10.1021/np0499261; DeLano W.L, PYMOL MOL GRAPHICS S; Edwards DJ, 2004, CHEM BIOL, V11, P817, DOI 10.1016/j.chembiol.2004.03.030; El-Sayed AK, 2003, CHEM BIOL, V10, P419, DOI 10.1016/S1074-5521(03)00091-7; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engel CK, 1996, EMBO J, V15, P5135, DOI 10.1002/j.1460-2075.1996.tb00897.x; Fortman JL, 2005, CHEMBIOCHEM, V6, P960, DOI 10.1002/cbic.200400428; GERWICK WH, 1994, J ORG CHEM, V59, P1243, DOI 10.1021/jo00085a006; Gu LC, 2007, SCIENCE, V318, P970, DOI 10.1126/science.1148790; Gu LC, 2006, J AM CHEM SOC, V128, P9014, DOI 10.1021/ja0626382; Guerrero SA, 2001, APPL MICROBIOL BIOT, V56, P718, DOI 10.1007/s002530100690; Hill AM, 2006, NAT PROD REP, V23, P256, DOI 10.1039/b301028g; Holden HM, 2001, ACCOUNTS CHEM RES, V34, P145, DOI 10.1021/ar000053l; Holm L, 1998, PROTEINS, V33, P88, DOI 10.1002/(SICI)1097-0134(19981001)33:1<88::AID-PROT8>3.0.CO;2-H; Hubbard PA, 2005, PROTEIN SCI, V14, P1545, DOI 10.1110/ps.041303705; Ishikawa M, 2004, EMBO J, V23, P2745, DOI 10.1038/sj.emboj.7600298; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Leonard PM, 2006, ACTA CRYSTALLOGR D, V62, P1494, DOI 10.1107/S0907444906039199; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Mursula AM, 2001, J MOL BIOL, V309, P845, DOI 10.1006/jmbi.2001.4671; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Partanen ST, 2004, J MOL BIOL, V342, P1197, DOI 10.1016/j.jmb.2004.07.039; Piel J, 2005, J NAT PROD, V68, P472, DOI 10.1021/np049612d; Pulsawat N, 2007, GENE, V393, P31, DOI 10.1016/j.gene.2006.12.035; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Senko MW, 1996, RAPID COMMUN MASS SP, V10, P1839, DOI 10.1002/(SICI)1097-0231(199611)10:14<1839::AID-RCM718>3.0.CO;2-V; Sherman DH, 2006, ACS CHEM BIOL, V1, P505, DOI 10.1021/cb600376r; Simunovic V, 2007, CHEMBIOCHEM, V8, P497, DOI 10.1002/cbic.200700017; Sleeman MC, 2005, J BIOL CHEM, V280, P34956, DOI 10.1074/jbc.M507196200; Staunton J, 2001, NAT PROD REP, V18, P380, DOI 10.1039/a909079g; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Sudek S, 2007, J NAT PROD, V70, P67, DOI 10.1021/np060361d; Tang GL, 2004, CHEM BIOL, V11, P33, DOI 10.1016/j.chembiol.2003.12.014; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Truglio JJ, 2003, J BIOL CHEM, V278, P42352, DOI 10.1074/jbc.M307399200; Verdier-Pinard P, 1999, ARCH BIOCHEM BIOPHYS, V370, P51, DOI 10.1006/abbi.1999.1363; Walsh CT, 2004, SCIENCE, V303, P1805, DOI 10.1126/science.1094318; Whittingham JL, 2003, J BIOL CHEM, V278, P1744, DOI 10.1074/jbc.M211188200	52	38	39	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35954	35963		10.1074/jbc.M703921200	http://dx.doi.org/10.1074/jbc.M703921200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17928301	hybrid			2022-12-27	WOS:000251458100056
J	Lee, SA; Belyaeva, OV; Popov, IK; Kedishvili, NY				Lee, Seung-Ah; Belyaeva, Olga V.; Popov, Ivan K.; Kedishvili, Natalia Y.			Overproduction of bioactive retinoic acid in cells expressing disease-associated mutants of retinol dehydrogenase 12	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEBER CONGENITAL AMAUROSIS; RETINOBLASTOMA CELLS; RDH12 MUTATIONS; PHOTORECEPTOR DEVELOPMENT; ALDEHYDE DEHYDROGENASES; RETINALDEHYDE-BINDING; VISUAL CYCLE; RAT RETINA; DEGENERATION; ORIENTATION	Retinol dehydrogenase 12 (RDH12) is an NADP(+)-dependent oxidoreductase that in vitro catalyzes the reduction of all-trans-retinaldehyde to all-trans-retinol or the oxidation of retinol to retinaldehyde depending on substrate and cofactor availability. Recent studies have linked the mutations in RDH12 to severe early-onset autosomal recessive retinal dystrophy. The biochemical basis of photoreceptor cell death caused by mutations in RDH12 is not clear because the physiological role of RDH12 is not yet fully understood. Here we demonstrate that, although bi-directional in vitro, in living cells, RDH12 acts exclusively as a retinaldehyde reductase, shifting the retinoid homeostasis toward the increased levels of retinol and decreased levels of bioactive retinoic acid. The retinaldehyde reductase activity of RDH12 protects the cells from retinaldehyde-induced cell death, especially at high retinaldehyde concentrations, and this protective effect correlates with the lower levels of retinoic acid in RDH12-expressing cells. Disease-associated mutants of RDH12, T49M and I51N, exhibit significant residual activity in vitro, but are unable to control retinoic acid levels in the cells because of their dramatically reduced affinity for NADPH and much lower protein expression levels. These results suggest that RDH12 acts as a regulator of retinoic acid biosynthesis and protects photoreceptors against overproduction of retinoic acid from all-trans-retinaldehyde, which diffuses into the inner segments of photoreceptors from illuminated rhodopsin. These results provide a novel insight into the mechanism of retinal degeneration associated with mutations in RDH12 and are consistent with the observation that RDH12-null mice are highly susceptible to light-induced retinal apoptosis in cone and rod photoreceptors.	Univ Alabama, Sch Med & Dent, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Kedishvili, NY (corresponding author), Univ Alabama, Sch Med, Dept Biochem & Mol Genet, 720 20th St S,440B Kaul Genet Bldg, Birmingham, AL 35294 USA.	nkedishvili@uab.edu		Kedishvili, Natalia/0000-0001-6917-4891; Beliaeva, Olga/0000-0003-2512-925X	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA012153] Funding Source: NIH RePORTER; NIAAA NIH HHS [R01 AA012153-07, AA12153, R01 AA012153] Funding Source: Medline	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		BAULDRY SA, 1992, J BIOL CHEM, V267, P323; Belyaeva OV, 2005, BIOCHEMISTRY-US, V44, P7035, DOI 10.1021/bi050226k; Belyaeva OV, 2003, BIOCHEMISTRY-US, V42, P14838, DOI 10.1021/bi035288u; BIRNBACH CD, 1997, INVEST OPHTH VIS SCI, V38, pS311; Boatright JH, 2002, VISION RES, V42, P933, DOI 10.1016/S0042-6989(02)00037-8; Chen Y, 2003, MOL VIS, V9, P345; DELEEUW AM, 1990, J NEUROCYTOL, V19, P253, DOI 10.1007/BF01217303; Drager UC, 1998, J NUTR, V128, p463S, DOI 10.1093/jn/128.2.463S; GERLIER D, 1986, J IMMUNOL METHODS, V94, P57, DOI 10.1016/0022-1759(86)90215-2; Hyatt GA, 1996, P NATL ACAD SCI USA, V93, P13298, DOI 10.1073/pnas.93.23.13298; Hyatt GA, 1997, INVEST OPHTH VIS SCI, V38, P1471; Janecke AR, 2004, NAT GENET, V36, P850, DOI 10.1038/ng1394; KALTER H, 1959, PHYSIOL REV, V39, P69, DOI 10.1152/physrev.1959.39.1.69; Kastner P, 1997, DEVELOPMENT, V124, P313; Kurth I, 2007, MOL CELL BIOL, V27, P1370, DOI 10.1128/MCB.01486-06; Levine EM, 2000, CELL MOL LIFE SCI, V57, P224, DOI 10.1007/PL00000686; Li AM, 2003, INVEST OPHTH VIS SCI, V44, P996, DOI 10.1167/iovs.02-0434; Li AM, 2002, INVEST OPHTH VIS SCI, V43, P1375; Maeda A, 2006, J BIOL CHEM, V281, P37697, DOI 10.1074/jbc.M608375200; Mangelsdorf David J., 1994, P319; MATSCHINSKY FM, 1968, J NEUROCHEM, V15, P643, DOI 10.1111/j.1471-4159.1968.tb08963.x; Napoli JL, 1999, BBA-MOL CELL BIOL L, V1440, P139, DOI 10.1016/S1388-1981(99)00117-1; Odermatt A, 1999, J BIOL CHEM, V274, P28762, DOI 10.1074/jbc.274.40.28762; Perrault I, 2004, AM J HUM GENET, V75, P639, DOI 10.1086/424889; Pinazo-Duran MD, 2000, OPHTHALMIC RES, V32, P61, DOI 10.1159/000055591; Saari JC, 2000, INVEST OPHTH VIS SCI, V41, P337; Saari John C., 1994, P351; SMITH SB, 1995, INVEST OPHTH VIS SCI, V36, P2193; Soderpalm AK, 2000, INVEST OPHTH VIS SCI, V41, P937; Sun WY, 2007, VISION RES, V47, P2055, DOI 10.1016/j.visres.2007.04.005; Thompson DA, 2005, HUM MOL GENET, V14, P3865, DOI 10.1093/hmg/ddi411; VEECH RL, 1969, BIOCHEM J, V115, P609, DOI 10.1042/bj1150609a; Wagner E, 2000, DEV BIOL, V222, P460, DOI 10.1006/dbio.2000.9719	33	32	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35621	35628		10.1074/jbc.M706372200	http://dx.doi.org/10.1074/jbc.M706372200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17925390	hybrid			2022-12-27	WOS:000251458100022
J	Yamauchi, Y; Reid, PC; Sperry, JB; Furukawa, K; Takeya, M; Chang, CCY; Chang, TY				Yamauchi, Yoshio; Reid, Patrick C.; Sperry, Jeffrey B.; Furukawa, Koichi; Takeya, Motohiro; Chang, Catherine C. Y.; Chang, Ta-Yuan			Plasma membrane rafts complete cholesterol synthesis by participating in retrograde movement of precursor sterols	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; OVARY CELL MUTANTS; OXYSTEROL-BINDING-PROTEIN; PICK C1 PROTEIN; ENDOPLASMIC-RETICULUM; LIPID RAFTS; HUMAN FIBROBLASTS; TRANSPORT; TRAFFICKING; ENDOCYTOSIS	Mammalian cells synthesize significant amounts of precursor sterols, in addition to cholesterol, at the endoplasmic reticulum (ER). The newly synthesized sterols rapidly move to the plasma membrane (PM). The mechanism by which precursor sterols move back to the ER for their enzymatic processing to cholesterol is essentially unknown. Here we performed pulse-chase experiments and showed that the C29/C30 sterols rapidly move from the PM to the ER and are converted to cholesterol. The retrograde precursor sterol transport is largely independent of the Niemann-Pick type C proteins, which play important roles in late endosomal cholesterol transport. In contrast, disrupting lipid rafts significantly retards the conversion of C29/C30 and C28 sterols to cholesterol, causing the accumulation of precursor sterols at the PM. Our results reveal a previously undisclosed function of the PM lipid rafts: they bring cholesterol biosynthesis to completion by participating in the retrograde movement of precursor sterols back to the ER.	Dartmouth Med Sch, Dept Biochem, Hanover, NH 03755 USA; Dartmouth Med Sch, Dept Chem, Hanover, NH 03755 USA; Kumamoto Univ, Grad Sch Med Sci, Dept Cell Pathol, Kumamoto 8608556, Japan; Nagoya Univ, Grad Sch Med, Dept Biochem, Nagoya, Aichi 4668550, Japan	Dartmouth College; Dartmouth College; Kumamoto University; Nagoya University	Chang, TY (corresponding author), Dartmouth Med Sch, Dept Biochem, 7200 Vail Bldg,Rm 304, Hanover, NH 03755 USA.	Ta.Yuan.Chang@Dartmouth.edu	Yamauchi, Yoshio/I-7539-2014	Yamauchi, Yoshio/0000-0001-5559-4596; Chang, Ta-Yuan/0000-0002-3249-0468	NHLBI NIH HHS [HL36709] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL036709, R01HL036709] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AKIYAMA T, 1987, J BIOL CHEM, V262, P5592; BERRY DJ, 1982, BIOCHEMISTRY-US, V21, P573, DOI 10.1021/bi00532a025; CADIGAN KM, 1990, J CELL BIOL, V110, P295, DOI 10.1083/jcb.110.2.295; CADIGAN KM, 1988, J BIOL CHEM, V263, P274; Chang TY, 2006, ANNU REV CELL DEV BI, V22, P129, DOI 10.1146/annurev.cellbio.22.010305.104656; CHANG TY, 1980, J BIOL CHEM, V255, P7787; Cheng ZJ, 2006, MOL BIOL CELL, V17, P3197, DOI 10.1091/mbc.E05-12-1101; Cooper MK, 1998, SCIENCE, V280, P1603, DOI 10.1126/science.280.5369.1603; Cruz JC, 2000, J BIOL CHEM, V275, P4013, DOI 10.1074/jbc.275.6.4013; Damm EM, 2005, J CELL BIOL, V168, P477, DOI 10.1083/jcb.200407113; ECHEVARRIA F, 1990, J BIOL CHEM, V265, P8484; Field FJ, 1998, J LIPID RES, V39, P333; Fielding CJ, 2004, BIOCHEM SOC T, V32, P65, DOI 10.1042/BST0320065; Frolov A, 2003, J BIOL CHEM, V278, P25517, DOI 10.1074/jbc.M302588200; Garver WS, 2002, J LIPID RES, V43, P579; GURR MI, 1991, LIPID BIOCH, P297; Hao MM, 2002, J BIOL CHEM, V277, P609, DOI 10.1074/jbc.M108861200; Heino S, 2000, P NATL ACAD SCI USA, V97, P8375, DOI 10.1073/pnas.140218797; Higaki K, 2001, J BIOCHEM-TOKYO, V129, P875, DOI 10.1093/oxfordjournals.jbchem.a002932; Hua XX, 1996, CELL, V87, P415, DOI 10.1016/S0092-8674(00)81362-8; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; KAMMEREC.R, 1967, J LIPID RES, V8, P282; KAPLAN MR, 1985, J CELL BIOL, V101, P446, DOI 10.1083/jcb.101.2.446; LANGE Y, 1991, J BIOL CHEM, V266, P21439; Li YF, 2004, J BIOL CHEM, V279, P45226, DOI 10.1074/jbc.M407600200; LIMANEK JS, 1978, P NATL ACAD SCI USA, V75, P5452, DOI 10.1073/pnas.75.11.5452; Metherall JE, 1996, J BIOL CHEM, V271, P2627, DOI 10.1074/jbc.271.5.2627; Metherall JE, 1996, J BIOL CHEM, V271, P2634, DOI 10.1074/jbc.271.5.2634; Ohgami N, 2004, P NATL ACAD SCI USA, V101, P12473, DOI 10.1073/pnas.0405255101; Olkkonen VM, 2004, CURR OPIN LIPIDOL, V15, P321, DOI 10.1097/00041433-200406000-00013; Pelkmans L, 2003, CURR OPIN CELL BIOL, V15, P414, DOI 10.1016/S0955-0674(03)00081-4; PENTCHEV PG, 1986, J BIOL CHEM, V261, P2772; Pike LJ, 2006, J LIPID RES, V47, P1597, DOI 10.1194/jlr.E600002-JLR200; Pike LJ, 2004, BIOCHEM J, V378, P281, DOI 10.1042/BJ20031672; Pipalia NH, 2007, TRAFFIC, V8, P130, DOI 10.1111/j.1600-0854.2006.00513.x; Porter FD, 2002, J CLIN INVEST, V110, P715, DOI 10.1172/JCI200216386; Puri V, 2001, J CELL BIOL, V154, P535, DOI 10.1083/jcb.200102084; Raychaudhuri S, 2006, J CELL BIOL, V173, P107, DOI 10.1083/jcb.200510084; Reid PC, 2003, J LIPID RES, V44, P1010, DOI 10.1194/jlr.M300009-JLR200; Smart EJ, 1996, J BIOL CHEM, V271, P29427, DOI 10.1074/jbc.271.46.29427; Soccio RE, 2003, J BIOL CHEM, V278, P22183, DOI 10.1074/jbc.R300003200; Song BL, 2005, CELL METAB, V1, P179, DOI 10.1016/j.cmet.2005.01.001; Sugii S, 2003, J BIOL CHEM, V278, P27180, DOI 10.1074/jbc.M300542200; SUGLI S, 2006, J BIOL CHEM, V281, P23191; TAVANI DM, 1982, J LIPID RES, V23, P774; Walter M, 2003, J LIPID RES, V44, P243, DOI 10.1194/jlr.M200230-JLR200; WANG LH, 1993, J CELL BIOL, V123, P1107, DOI 10.1083/jcb.123.5.1107; Wojtanik KM, 2003, J BIOL CHEM, V278, P14850, DOI 10.1074/jbc.M300488200; Xu XL, 2000, BIOCHEMISTRY-US, V39, P843, DOI 10.1021/bi992543v; Yamauchi Y, 2004, J LIPID RES, V45, P1943, DOI 10.1194/jlr.M400264-JLR200; Yang CD, 2006, J BIOL CHEM, V281, P27816, DOI 10.1074/jbc.M603781200; Yang HY, 2006, TRENDS CELL BIOL, V16, P427, DOI 10.1016/j.tcb.2006.07.002	52	19	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					34994	35004		10.1074/jbc.M703653200	http://dx.doi.org/10.1074/jbc.M703653200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17916561	hybrid			2022-12-27	WOS:000251155200044
J	Whitford, PC; Gosavi, S; Onuchic, JN				Whitford, Paul C.; Gosavi, Shachi; Onuchic, Jose N.			Conformational transitions in adenylate kinase - Allosteric communication reduces misligation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-DYNAMICS; FUNCTIONAL TRANSITIONS; ENERGY LANDSCAPES; SINGLE-PARAMETER; DOMAIN CLOSURE; NETWORK MODEL; PROTEINS; MECHANISMS; FRUSTRATION; CATALYSIS	Large conformational changes in the LID and NMP domains of adenylate kinase (AKE) are known to be key to ligand binding and catalysis, yet the order of binding events and domain motion is not well understood. Combining the multiple available structures for AKE with the energy landscape theory for protein folding, a theoretical model was developed for allostery, order of binding events, and efficient catalysis. Coarse-grained models and nonlinear normal mode analysis were used to infer that intrinsic structural fluctuations dominate LID motion, whereas ligand-protein interactions and cracking ( local unfolding) are more important during NMP motion. In addition, LID-NMP domain interactions are indispensable for efficient catalysis. LID domain motion precedes NMP domain motion, during both opening and closing. These findings provide a mechanistic explanation for the observed 1: 1: 1 correspondence between LID domain closure, NMP domain closure, and substrate turnover. This catalytic cycle has likely evolved to reduce misligation, and thus inhibition, of AKE. The separation of allosteric motion into intrinsic structural fluctuations and ligand-induced contributions can be generalized to further our understanding of allosteric transitions in other proteins.	[Whitford, Paul C.; Gosavi, Shachi; Onuchic, Jose N.] Univ Calif San Diego, Ctr Theoret Biol Phys, La Jolla, CA 92093 USA; [Whitford, Paul C.; Gosavi, Shachi; Onuchic, Jose N.] Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Onuchic, JN (corresponding author), Univ Calif San Diego, Ctr Theoret Biol Phys, 9500 Gilman Dr, La Jolla, CA 92093 USA.	jonuchic@ucsd.edu			NIGMS NIH HHS [T32 GM08326] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008326] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bae E, 2006, P NATL ACAD SCI USA, V103, P2132, DOI 10.1073/pnas.0507527103; Bae E, 2004, J BIOL CHEM, V279, P28202, DOI 10.1074/jbc.M401865200; Bahar I, 1997, FOLD DES, V2, P173, DOI 10.1016/S1359-0278(97)00024-2; BRYNGELSON JD, 1995, PROTEINS, V21, P167, DOI 10.1002/prot.340210302; BRYNGELSON JD, 1987, P NATL ACAD SCI USA, V84, P7524, DOI 10.1073/pnas.84.21.7524; Clementi C, 2000, J MOL BIOL, V298, P937, DOI 10.1006/jmbi.2000.3693; DIEDERICHS K, 1991, J MOL BIOL, V217, P541, DOI 10.1016/0022-2836(91)90756-V; Eisenmesser EZ, 2005, NATURE, V438, P117, DOI 10.1038/nature04105; FERSHT AR, 1994, CURR OPIN STRUC BIOL, V4, P67, DOI 10.1016/S0959-440X(94)90061-2; GERSTEIN M, 1994, BIOCHEMISTRY-US, V33, P6739, DOI 10.1021/bi00188a001; HORIUCHI T, 1991, PROTEINS, V10, P106, DOI 10.1002/prot.340100204; Kong YF, 2006, J MOL BIOL, V356, P237, DOI 10.1016/j.jmb.2005.10.064; Krishnamurthy H, 2005, PROTEINS, V58, P88, DOI 10.1002/prot.20301; LEOPOLD PE, 1992, P NATL ACAD SCI USA, V89, P8721, DOI 10.1073/pnas.89.18.8721; Levy Y, 2005, J MOL BIOL, V346, P1121, DOI 10.1016/j.jmb.2004.12.021; Levy Y, 2005, P NATL ACAD SCI USA, V102, P2373, DOI 10.1073/pnas.0409572102; Lieser SA, 2006, J BIOL CHEM, V281, P38004, DOI 10.1074/jbc.M607824200; Lou HF, 2006, J PHYS CHEM B, V110, P24121, DOI 10.1021/jp064303c; Maragakis P, 2005, J MOL BIOL, V352, P807, DOI 10.1016/j.jmb.2005.07.031; MCLACHLAN AD, 1982, ACTA CRYSTALLOGR A, V38, P871, DOI 10.1107/S0567739482001806; Miyashita O, 2005, J PHYS CHEM B, V109, P1959, DOI 10.1021/jp046736q; Miyashita O, 2003, P NATL ACAD SCI USA, V100, P12570, DOI 10.1073/pnas.2135471100; Moritsugu K, 2004, J PHYS CHEM B, V108, P3890, DOI 10.1021/jp037155o; MULLER CW, 1992, J MOL BIOL, V224, P159, DOI 10.1016/0022-2836(92)90582-5; Muller CW, 1996, STRUCTURE, V4, P147, DOI 10.1016/S0969-2126(96)00018-4; Nymeyer H, 1998, P NATL ACAD SCI USA, V95, P5921, DOI 10.1073/pnas.95.11.5921; Onuchic JN, 2004, CURR OPIN STRUC BIOL, V14, P70, DOI 10.1016/j.sbi.2004.01.009; SANDERS CR, 1989, BIOCHEMISTRY-US, V28, P9028, DOI 10.1021/bi00449a011; Schlauderer GJ, 1996, J MOL BIOL, V256, P223, DOI 10.1006/jmbi.1996.0080; Sinev MA, 1996, BIOCHEMISTRY-US, V35, P6425, DOI 10.1021/bi952687j; Snow C, 2007, PROTEINS, V67, P325, DOI 10.1002/prot.21280; Sobolev V, 1996, PROTEINS, V25, P120, DOI 10.1002/(SICI)1097-0134(199605)25:1<120::AID-PROT10>3.3.CO;2-1; Tama F, 2001, PROTEIN ENG, V14, P1, DOI 10.1093/protein/14.1.1; Temiz NA, 2004, PROTEINS, V57, P468, DOI 10.1002/prot.20226; Tirion MM, 1996, PHYS REV LETT, V77, P1905, DOI 10.1103/PhysRevLett.77.1905; Whitford PC, 2007, J MOL BIOL, V366, P1661, DOI 10.1016/j.jmb.2006.11.085; Wolf-Watz M, 2004, NAT STRUCT MOL BIOL, V11, P945, DOI 10.1038/nsmb821; Yang SC, 2004, P NATL ACAD SCI USA, V101, P13786, DOI 10.1073/pnas.0403724101	38	88	89	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					2042	2048		10.1074/jbc.M707632200	http://dx.doi.org/10.1074/jbc.M707632200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	17998210	hybrid			2022-12-27	WOS:000252501000031
J	Ernst, OP; Murcia, PAS; Daldrop, P; Tsunoda, SP; Kateriya, S; Hegemann, P				Ernst, Oliver P.; Murcia, Pedro A. Sanchez; Daldrop, Peter; Tsunoda, Satoshi P.; Kateriya, Suneel; Hegemann, Peter			Photoactivation of channelrhodopsin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCLONAL-ANTIBODIES; OPTICAL CONTROL; LIGHT; RHODOPSIN; CHLAMYDOMONAS; ACTIVATION; PHOTOISOMERIZATION; CHROMOPHORE; PHOTOTAXIS; RESPONSES	Channelrhodopsins (ChRs) are light-gated ion channels that control photomovement of microalgae. In optogenetics, ChRs are widely applied for light-triggering action potentials in cells, tissues, and living animals, yet the spectral properties and photocycle of ChR remain obscure. In this study, we cloned a ChR from the colonial alga Volvox carteri, VChR. After electrophysiological characterization in Xenopus oocytes, VChR was expressed in COS-1 cells and purified. Time-resolved UV-visible spectroscopy revealed a pH-dependent equilibrium of two dark species, D-470/D-480. Laser flashes converted both with tau approximate to 200 mu s into major photointermediates P-510/P-530, which reverted back to the dark states with tau approximate to 15-100 ms. Both intermediates were assigned to conducting states. Three early intermediates P-500/P-515 and P-390 were detected on a ns to mu s time scale. The spectroscopic and electrical data were unified in a photocycle model. The functional expression of VChR we report here paves the way toward a broader structure/function analysis of the recently identified class of light-gated ion channels.	[Ernst, Oliver P.; Murcia, Pedro A. Sanchez] Charite Univ Med Berlin, Inst Med Phys & Biophys, D-10117 Berlin, Germany; [Daldrop, Peter; Tsunoda, Satoshi P.; Hegemann, Peter] Humboldt Univ, Inst Biol Expt Biophys, D-10115 Berlin, Germany; [Kateriya, Suneel] Univ Delhi S Campus, Dept Biochem, New Delhi 110021, India	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Humboldt University of Berlin; University of Delhi	Ernst, OP (corresponding author), Charite Univ Med Berlin, Inst Med Phys & Biophys, Charitepl 1, D-10117 Berlin, Germany.	oliver.ernst@charite.de; hegemape@rz.hu-berlin.de	Sánchez-Murcia, Pedro A./I-2473-2015; Sánchez-Murcia, Pedro Alejandro/AAM-6790-2020; Tsunoda, Satoshi/AAN-7023-2021; Daldrop, Peter/A-6001-2013	Sánchez-Murcia, Pedro A./0000-0001-8415-870X; Sánchez-Murcia, Pedro Alejandro/0000-0001-8415-870X; Tsunoda, Satoshi/0000-0003-3636-1521				Abbott A, 2007, NATURE, V446, P588, DOI 10.1038/446588a; Bi AD, 2006, NEURON, V50, P23, DOI 10.1016/j.neuron.2006.02.026; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Braun FJ, 1999, BIOPHYS J, V76, P1668, DOI 10.1016/S0006-3495(99)77326-1; Ehlenbeck S, 2002, BIOPHYS J, V82, P740, DOI 10.1016/S0006-3495(02)75436-2; FRANKE RR, 1988, J BIOL CHEM, V263, P2119; Fritze O, 2003, P NATL ACAD SCI USA, V100, P2290, DOI 10.1073/pnas.0435715100; GROENENDIJK GWT, 1979, ANAL BIOCHEM, V99, P304, DOI 10.1016/S0003-2697(79)80011-1; Hausser M, 2007, NATURE, V446, P617, DOI 10.1038/446617a; Hegemann P, 2005, BIOPHYS J, V89, P3911, DOI 10.1529/biophysj.105.069716; HEGEMANN P, 1991, BIOPHYS J, V60, P1477, DOI 10.1016/S0006-3495(91)82183-X; Herlitze S, 2007, CURR OPIN NEUROBIOL, V17, P87, DOI 10.1016/j.conb.2006.12.002; Holland EM, 1996, BIOPHYS J, V70, P924, DOI 10.1016/S0006-3495(96)79635-2; Huber R, 2005, BIOCHEMISTRY-US, V44, P1800, DOI 10.1021/bi048318h; Ishizuka T, 2006, NEUROSCI RES, V54, P85, DOI 10.1016/j.neures.2005.10.009; LAWSON MA, 1991, BIOPHYS J, V60, P1490, DOI 10.1016/S0006-3495(91)82184-1; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; MACKENZIE D, 1984, BIOCHEMISTRY-US, V23, P6544, DOI 10.1021/bi00321a041; Meyer CK, 2000, J BIOL CHEM, V275, P19713, DOI 10.1074/jbc.M000603200; MOLDAY RS, 1983, BIOCHEMISTRY-US, V22, P653, DOI 10.1021/bi00272a020; Nagel G, 2002, SCIENCE, V296, P2395, DOI 10.1126/science.1072068; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; Nikolic Konstantin, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P1626; Schroll C, 2006, CURR BIOL, V16, P1741, DOI 10.1016/j.cub.2006.07.023; Sineshchekov OA, 2002, P NATL ACAD SCI USA, V99, P8689, DOI 10.1073/pnas.122243399; SINESHCHEKOV OA, 1990, BIOPHYS J, V57, P33, DOI 10.1016/S0006-3495(90)82504-2; SINESHCHEKOV OA, 2006, HDB PHOTOSENSORY REC, P25; SONG L, 1993, SCIENCE, V261, P891, DOI 10.1126/science.261.5123.891; Tsunoda SP, 2006, BIOPHYS J, V91, P1471, DOI 10.1529/biophysj.106.086421; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zhang F, 2006, NAT METHODS, V3, P785, DOI 10.1038/nmeth936	32	120	155	2	56	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1637	1643		10.1074/jbc.M708039200	http://dx.doi.org/10.1074/jbc.M708039200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	17993465	hybrid			2022-12-27	WOS:000252282700050
J	John, SA; Clements, JL; Russell, LM; Garrett-Sinha, LA				John, Shinu A.; Clements, James L.; Russell, Lisa M.; Garrett-Sinha, Lee Ann			Ets-1 regulates plasma cell differentiation by interfering with the activity of the transcription factor Blimp-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B-CELL; EXPRESSION; GENE; ACTIVATION; REPRESSION; DNA; PROTEINS; GATA-1; PAX-5; PU.1	Development of immunoglobulin-secreting plasma cells from B cells is a tightly regulated process controlled by the action of a number of transcription factors. In particular, the transcription factor Blimp-1 is a key positive regulator of plasmacytic differentiation via its ability to suppress expression of genes involved in the mature B cell program. The transcription factor Ets-1 is a negative regulator of plasmacytic differentiation, as indicated by the development of increased numbers of IgM-secreting plasma cells in Ets-1 knock-out mice. We have previously shown that Ets-1-deficient B cells undergo enhanced differentiation into IgM-secreting plasma cells in response to Toll-like receptor 9 (TLR9) signaling. We now explore the mechanism by which Ets-1 limits differentiation downstream of TLR9. Our results indicate that Ets-1 physically interacts with Blimp-1, which leads to a block in Blimp-1 DNA binding activity and a reduction in the ability of Blimp-1 to repress target genes without interfering with Blimp-1 protein levels. In addition, we show that Ets-1 induces the expression of several target genes that are repressed by Blimp-1, including Pax-5. These results reveal a previously unknown mechanism for the control of Blimp-1 activity by Ets-1 and suggest that expression of Ets-1 must be down-regulated before plasmacytic differentiation can occur.	[John, Shinu A.; Russell, Lisa M.; Garrett-Sinha, Lee Ann] SUNY Buffalo, Dept Biochem, Buffalo, NY 14214 USA; [Clements, James L.] Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Roswell Park Cancer Institute	Garrett-Sinha, LA (corresponding author), 140 Farber Hall,3435 Main St, Buffalo, NY 14214 USA.	leesinha@buffalo.edu	Garrett-Sinha, Lee Ann/K-5911-2019	Garrett-Sinha, Lee Ann/0000-0001-7806-4352				Barton K, 1998, IMMUNITY, V9, P555, DOI 10.1016/S1074-7613(00)80638-X; BORIES JC, 1995, NATURE, V377, P635, DOI 10.1038/377635a0; Calame K, 2006, IMMUNOL REV, V211, P269, DOI 10.1111/j.0105-2896.2006.00377.x; Choi YS, 2006, BIOCHEM J, V398, P497, DOI 10.1042/BJ20060375; Clements JL, 2006, J IMMUNOL, V177, P905, DOI 10.4049/jimmunol.177.2.905; Delogu A, 2006, IMMUNITY, V24, P269, DOI 10.1016/j.immuni.2006.01.012; Gavin AL, 2006, SCIENCE, V314, P1936, DOI 10.1126/science.1135299; Grund EM, 2005, J IMMUNOL METHODS, V296, P31, DOI 10.1016/j.jim.2004.10.008; Kim Y, 2007, J CELL PHYSIOL, V211, P253, DOI 10.1002/jcp.20933; Klein U, 2006, NAT IMMUNOL, V7, P773, DOI 10.1038/ni1357; Lin KI, 2002, MOL CELL BIOL, V22, P4771, DOI 10.1128/MCB.22.13.4771-4780.2002; Lin Y, 1997, SCIENCE, V276, P596, DOI 10.1126/science.276.5312.596; Maier H, 2003, NUCLEIC ACIDS RES, V31, P5483, DOI 10.1093/nar/gkg785; Maier H, 2003, MOL CELL BIOL, V23, P1946, DOI 10.1128/MCB.23.6.1946-1960.2003; Messika EJ, 1998, J EXP MED, V188, P515, DOI 10.1084/jem.188.3.515; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Naviaux RK, 1996, J VIROL, V70, P5701, DOI 10.1128/JVI.70.8.5701-5705.1996; Nera KP, 2006, SCAND J IMMUNOL, V64, P190, DOI 10.1111/j.1365-3083.2006.01809.x; Nera KP, 2006, IMMUNITY, V24, P283, DOI 10.1016/j.immuni.2006.02.003; Nerlov C, 2000, BLOOD, V95, P2543, DOI 10.1182/blood.V95.8.2543.008k19_2543_2551; O'Riordan M, 2000, IMMUNOL REV, V175, P94, DOI 10.1034/j.1600-065X.2000.017503.x; Ochiai K, 2006, J BIOL CHEM, V281, P38226, DOI 10.1074/jbc.M607592200; Pasare C, 2005, NATURE, V438, P364, DOI 10.1038/nature04267; Pear WS, 1998, BLOOD, V92, P3780, DOI 10.1182/blood.V92.10.3780.422k15_3780_3792; Piskurich JF, 1998, J IMMUNOL, V160, P233; Piskurich JF, 2000, NAT IMMUNOL, V1, P526, DOI 10.1038/82788; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Rekhtman N, 1999, GENE DEV, V13, P1398, DOI 10.1101/gad.13.11.1398; ROUSSEL MF, 1994, ONCOGENE, V9, P405; Ruprecht CR, 2006, EUR J IMMUNOL, V36, P810, DOI 10.1002/eji.200535744; Schliephake DE, 1996, EUR J IMMUNOL, V26, P268, DOI 10.1002/eji.1830260142; Shaffer AL, 2000, IMMUNITY, V13, P199, DOI 10.1016/S1074-7613(00)00020-0; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; Shapiro-Shelef M, 2005, J EXP MED, V202, P1471, DOI 10.1084/jem.20051611; Shapiro-Shelef M, 2003, IMMUNITY, V19, P607, DOI 10.1016/S1074-7613(03)00267-X; Starck J, 2003, MOL CELL BIOL, V23, P1390, DOI 10.1128/MCB.23.4.1390-1402.2003; Tunyaplin C, 2004, J IMMUNOL, V173, P1158, DOI 10.4049/jimmunol.173.2.1158; TURNER CA, 1994, CELL, V77, P297, DOI 10.1016/0092-8674(94)90321-2; Usui T, 1997, J IMMUNOL, V158, P3197; Wang D, 2005, INT IMMUNOL, V17, P1179, DOI 10.1093/intimm/dxh295; Zhang P, 2000, BLOOD, V96, P2641; Zhang P, 1999, P NATL ACAD SCI USA, V96, P8705, DOI 10.1073/pnas.96.15.8705	42	64	67	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					951	962		10.1074/jbc.M705262200	http://dx.doi.org/10.1074/jbc.M705262200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	17977828	hybrid			2022-12-27	WOS:000252128100035
J	D'Alessio, S; Ferrari, G; Cinnante, K; Scheerer, W; Galloway, AC; Roses, DF; Rozanov, DV; Remacle, AG; Oh, ES; Shiryaev, SA; Strongin, AY; Pintucci, G; Mignatti, P				D'Alessio, Silvia; Ferrari, Giovanni; Cinnante, Karma; Scheerer, William; Galloway, Aubrey C.; Roses, Daniel F.; Rozanov, Dmitri V.; Remacle, Albert G.; Oh, Eok-Soo; Shiryaev, Sergey A.; Strongin, Alex Y.; Pintucci, Giuseppe; Mignatti, Paolo			Tissue inhibitor of metalloproteinases-2 binding to membrane-type 1 matrix metalloproteinase induces MAPK activation and cell growth by a non-proteolytic mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3-DIMENSIONAL EXTRACELLULAR-MATRIX; INVASIVE BREAST CARCINOMAS; ENDOTHELIAL-CELLS; TUMOR-CELLS; PRO-MMP-2 ACTIVATION; PROMOTING ACTIVITY; PEPTIDE SEQUENCE; CATALYTIC DOMAIN; MT1-MMP; TIMP-2	Membrane-type 1 matrix metalloproteinase (MT1-MMP), a transmembrane proteinase with a short cytoplasmic domain and an extracellular catalytic domain, controls a variety of physiological and pathological processes through the proteolytic degradation of extracellular or transmembrane proteins. MT1-MMP forms a complex on the cell membrane with its physiological protein inhibitor, tissue inhibitor of metalloproteinases-2 (TIMP-2). Here we show that, in addition to extracellular proteolysis, MT1-MMP and TIMP-2 control cell proliferation and migration through a non-proteolytic mechanism. TIMP-2 binding to MT1-MMP induces activation of ERK1/2 by a mechanism that does not require the proteolytic activity and is mediated by the cytoplasmic tail of MT1-MMP. MT1-MMP-mediated activation of ERK1/2 up-regulates cell migration and proliferation in vitro independently of extracellular matrix proteolysis. Proteolytically inactive MT1-MMP promotes tumor growth in vivo, whereas proteolytically active MT1-MMP devoid of cytoplasmic tail does not have this effect. These findings illustrate a novel role for MT1-MMP-TIMP-2 interaction, which controls cell functions by a mechanism independent of extracellular matrix degradation.	[D'Alessio, Silvia; Ferrari, Giovanni; Cinnante, Karma; Scheerer, William; Galloway, Aubrey C.; Pintucci, Giuseppe; Mignatti, Paolo] NYU, Sch Med, Dept Cardiothorac Surg, New York, NY 10016 USA; [Mignatti, Paolo] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; [Roses, Daniel F.] NYU, Sch Med, Dept Surg, New York, NY 10016 USA; [Rozanov, Dmitri V.; Remacle, Albert G.; Oh, Eok-Soo; Shiryaev, Sergey A.; Strongin, Alex Y.] Burnham Inst, Med Res, La Jolla, CA 92037 USA	New York University; New York University; New York University; Sanford Burnham Prebys Medical Discovery Institute	Mignatti, P (corresponding author), NYU, Ctr Med, 550 1St Ave, New York, NY 10016 USA.	mignap01@med.nyu.edu	Strongin, Alex/R-6609-2019; Danese, Silvio/ABH-9571-2020	Strongin, Alex/0000-0003-3765-3016; Danese, Silvio/0000-0001-7341-1351; Ferrari, Giovanni/0000-0002-8863-2496; Galoway, Aubrey/0000-0001-5461-3820; Mignatti, Paolo/0000-0002-8157-457X	NCI NIH HHS [CA 77470, CA 83017] Funding Source: Medline; NCRR NIH HHS [RR 020843] Funding Source: Medline; NHLBI NIH HHS [R01 HL 070203] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA083017, R01CA077470] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020843] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070203] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALBINI A, 1991, J NATL CANCER I, V83, P775, DOI 10.1093/jnci/83.11.775; Alfonso-Jaume MA, 2006, AM J PHYSIOL-HEART C, V291, pH1838, DOI 10.1152/ajpheart.00026.2006; Anilkumar N, 2005, FASEB J, V19, P1326, DOI 10.1096/fj.04-3651fje; Apte SS, 1997, J BIOL CHEM, V272, P25511, DOI 10.1074/jbc.272.41.25511; Baker EA, 2006, BRIT J ORAL MAX SURG, V44, P482, DOI 10.1016/j.bjoms.2005.10.005; Cao J, 1998, J BIOL CHEM, V273, P34745, DOI 10.1074/jbc.273.52.34745; Cao J, 2004, J BIOL CHEM, V279, P14129, DOI 10.1074/jbc.M312120200; Chun TH, 2004, J CELL BIOL, V167, P757, DOI 10.1083/jcb.200405001; CORCORAN ML, 1995, J BIOL CHEM, V270, P13453, DOI 10.1074/jbc.270.22.13453; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Deryugina EI, 2001, EXP CELL RES, V263, P209, DOI 10.1006/excr.2000.5118; Feldman AL, 2004, CANCER RES, V64, P4481, DOI 10.1158/0008-5472.CAN-03-2929; Filippov S, 2005, J EXP MED, V202, P663, DOI 10.1084/jem.20050607; Gingras D, 2001, FEBS LETT, V507, P231, DOI 10.1016/S0014-5793(01)02985-4; HAYAKAWA T, 1994, J CELL SCI, V107, P2373; HAYAKAWA T, 1992, FEBS LETT, V298, P29, DOI 10.1016/0014-5793(92)80015-9; Hoegy SE, 2001, J BIOL CHEM, V276, P3203, DOI 10.1074/jbc.M008157200; Holmbeck K, 2003, J CELL BIOL, V163, P661, DOI 10.1083/jcb.200307061; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; Hotary KB, 2003, CELL, V114, P33, DOI 10.1016/S0092-8674(03)00513-0; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Jiang YF, 2002, ONCOGENE, V21, P2245, DOI 10.1038/sj.onc.1205291; Labrecque L, 2004, J BIOL CHEM, V279, P52132, DOI 10.1074/jbc.M409617200; Lark AL, 2005, MODERN PATHOL, V18, P1289, DOI 10.1038/modpathol.3800424; Lehti K, 2000, J BIOL CHEM, V275, P15006, DOI 10.1074/jbc.M910220199; Lehti K, 2005, GENE DEV, V19, P979, DOI 10.1101/gad.1294605; MIGNATTI P, 1993, PHYSIOL REV, V73, P161, DOI 10.1152/physrev.1993.73.1.161; Mignatti P, 2000, ADV CANCER RES, V78, P103; Murawaki Y, 1999, CLIN CHIM ACTA, V281, P109, DOI 10.1016/S0009-8981(98)00215-0; Nyalendo C, 2007, J BIOL CHEM, V282, P15690, DOI 10.1074/jbc.M608045200; Oblander SA, 2005, DEV BIOL, V277, P255, DOI 10.1016/j.ydbio.2004.09.033; Overall CM, 2000, J BIOL CHEM, V275, P39497, DOI 10.1074/jbc.M005932200; Pasieka Zbigniew, 2004, Endocr Regul, V38, P57; Pintucci G, 2003, J CELL BIOCHEM, V90, P1015, DOI 10.1002/jcb.10721; Pintucci G, 2002, FASEB J, V16, P598, DOI 10.1096/fj.01-0815fje; Potapova O, 1996, INT J CANCER, V66, P669, DOI 10.1002/(SICI)1097-0215(19960529)66:5<669::AID-IJC15>3.0.CO;2-#; Ratnikov B, 2000, ANAL BIOCHEM, V286, P149, DOI 10.1006/abio.2000.4798; Rozanov DV, 2004, J BIOL CHEM, V279, P4260, DOI 10.1074/jbc.M311569200; Rozanov DV, 2003, J BIOL CHEM, V278, P8257, DOI 10.1074/jbc.M213246200; Rozanov DV, 2002, FEBS LETT, V527, P51, DOI 10.1016/S0014-5793(02)03153-8; Rozanov DV, 2001, J BIOL CHEM, V276, P25705, DOI 10.1074/jbc.M007921200; Sabeh F, 2004, J CELL BIOL, V167, P769, DOI 10.1083/jcb.200408028; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; Seo DW, 2006, J BIOL CHEM, V281, P3711, DOI 10.1074/jbc.M509932200; Seo DW, 2003, CELL, V114, P171, DOI 10.1016/S0092-8674(03)00551-8; Sounni NE, 2004, J BIOL CHEM, V279, P13564, DOI 10.1074/jbc.M307688200; STETLERSTEVENSON WG, 1992, FEBS LETT, V296, P231, DOI 10.1016/0014-5793(92)80386-U; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; Tsunezuka Y, 1996, CANCER RES, V56, P5678; Ueno H, 1997, CANCER RES, V57, P2055; Uhich D, 2004, PLAST RECONSTR SURG, V114, P229, DOI 10.1097/01.PRS.0000129079.19089.6C; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Wang ZP, 2000, J BIOL CHEM, V275, P26411, DOI 10.1074/jbc.M001270200; Will H, 1996, J BIOL CHEM, V271, P17119, DOI 10.1074/jbc.271.29.17119; Zhai YL, 2005, CANCER RES, V65, P6543, DOI 10.1158/0008-5472.CAN-05-0231; Zhao HR, 2004, J BIOL CHEM, V279, P8592, DOI 10.1074/jbc.M308708200; Zhou ZJ, 2000, P NATL ACAD SCI USA, V97, P4052, DOI 10.1073/pnas.060037197; Zucker S, 1998, J BIOL CHEM, V273, P1216, DOI 10.1074/jbc.273.2.1216	58	93	94	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					87	99		10.1074/jbc.M705492200	http://dx.doi.org/10.1074/jbc.M705492200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17991754	hybrid			2022-12-27	WOS:000251940300011
J	Grzela, R; Szolajska, E; Ebel, C; Madern, D; Favier, A; Wojtal, I; Zagorski, W; Chroboczek, J				Grzela, Renata; Szolajska, Ewa; Ebel, Christine; Madern, Dominique; Favier, Adrien; Wojtal, Izabela; Zagorski, Wlodzimierz; Chroboczek, Jadwiga			Virulence factor of potato virus Y, genome-attached terminal protein VPg, is a highly disordered protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRINSICALLY UNSTRUCTURED PROTEINS; TOBACCO ETCH POTYVIRUS; INITIATION-FACTOR EIF4E; TURNIP-MOSAIC-VIRUS; FACTOR ISO 4E; LINKED PROTEIN; FELINE CALICIVIRUS; UNFOLDED PROTEINS; COAT PROTEIN; TRANSLATION	Potato virus Y (PVY) is a common potyvirus of agricultural importance, belonging to the picornavirus superfamily of RNA plus-stranded viruses. A covalently linked virus-encoded protein VPg required for virus infectivity is situated at the 5' end of potyvirus RNA. VPg seems to be involved in multiple interactions, both with other viral products and host proteins. VPgs of potyviruses have no known homologs, and there is no atomic structure available. To understand the molecular basis of VPg multifunctionality, we have analyzed structural features of VPg from PVY using structure prediction programs, functional assays, and biochemical and biophysical analyses. Structure predictions suggest that VPg exists in a natively unfolded conformation. In contrast with ordered proteins, PVY VPg is not denatured by elevated temperatures, has sedimentation values incompatible with a compact globular form, and shows a CD spectrum of a highly disordered protein, and HET-HETSOFAST NMR analysis suggests the presence of large unstructured regions. Although VPg has a propensity to form dimers, no functional differences were seen between the monomer and dimer. These data strongly suggest that the VPg of PVY should be classified among intrinsically disordered proteins. Intrinsic disorder lies at the basis of VPg multifunctionality, which is necessary for virus survival in the host.	[Grzela, Renata; Ebel, Christine; Madern, Dominique; Favier, Adrien; Chroboczek, Jadwiga] CNRS, CEA, Inst Biol Struct, F-38027 Grenoble, France; [Grzela, Renata; Szolajska, Ewa; Wojtal, Izabela; Zagorski, Wlodzimierz] Polish Acad Sci, Inst Biochem & Biophys, PL-02106 Warsaw, Poland	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences	Chroboczek, J (corresponding author), Univ Grenoble 1, CNRS, CEA, Inst Biol Struct, 41 Rue Jules Horowitz, F-38027 Grenoble, France.	wisia@ibs.fr	Chroboczek, Jadwiga/M-6554-2014	Grzela, Renata/0000-0002-1971-6012; Szolajska, Ewa/0000-0002-7400-4333; Ebel, Christine/0000-0002-6912-500X				Beauchemin C, 2007, J VIROL, V81, P775, DOI 10.1128/JVI.01277-06; Bernado P, 2005, P NATL ACAD SCI USA, V102, P17002, DOI 10.1073/pnas.0506202102; Borgstrom B, 2001, MOL PLANT MICROBE IN, V14, P707, DOI 10.1094/MPMI.2001.14.6.707; Bourhis JM, 2004, VIRUS RES, V99, P157, DOI 10.1016/j.virusres.2003.11.007; Bourhis JM, 2005, PROTEIN SCI, V14, P1975, DOI 10.1110/ps.051411805; CARRINGTON JC, 1991, PLANT CELL, V3, P953, DOI 10.1105/tpc.3.9.953; Chen JW, 2006, J PROTEOME RES, V5, P888, DOI 10.1021/pr060049p; DELPHIN C, 1994, EUR J BIOCHEM, V223, P683, DOI 10.1111/j.1432-1033.1994.tb19041.x; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; DUNKER AK, 1998, PAC S BIOCOMP, V3, P473; Dunoyer P, 2004, J VIROL, V78, P2301, DOI 10.1128/JVI.78.5.2301-2309.2004; Duprat A, 2002, PLANT J, V32, P927, DOI 10.1046/j.1365-313X.2002.01481.x; EBEL C, 2007, PROTEIN STRUCTURES M; Fellers J, 1998, J GEN VIROL, V79, P2043, DOI 10.1099/0022-1317-79-8-2043; Graumann J, 2001, STRUCTURE, V9, P377, DOI 10.1016/S0969-2126(01)00599-8; Grzela R, 2006, BIOCHIMIE, V88, P887, DOI 10.1016/j.biochi.2006.02.012; Gunasekaran K, 2003, TRENDS BIOCHEM SCI, V28, P81, DOI 10.1016/S0968-0004(03)00003-3; Herbert TP, 1997, J GEN VIROL, V78, P1033, DOI 10.1099/0022-1317-78-5-1033; HONG YL, 1995, VIROLOGY, V214, P159, DOI 10.1006/viro.1995.9944; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; Iakoucheva LM, 2002, J MOL BIOL, V323, P573, DOI 10.1016/S0022-2836(02)00969-5; Ivanov KI, 2001, J BIOL CHEM, V276, P13530, DOI 10.1074/jbc.M009551200; Kang BC, 2005, PLANT J, V42, P392, DOI 10.1111/j.1365-313X.2005.02381.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lellis AD, 2002, CURR BIOL, V12, P1046, DOI 10.1016/S0960-9822(02)00898-9; Leonard S, 2000, J VIROL, V74, P7730, DOI 10.1128/JVI.74.17.7730-7737.2000; Leonard S, 2004, J GEN VIROL, V85, P1055, DOI 10.1099/vir.0.19706-0; Liang Y, 2006, MOL CELLS, V22, P13; LUCIANO CS, 1991, J GEN VIROL, V72, P205, DOI 10.1099/0022-1317-72-1-205; Matsuo H, 1997, NAT STRUCT BIOL, V4, P717, DOI 10.1038/nsb0997-717; Mitra T, 2004, J VIROL, V78, P4931, DOI 10.1128/JVI.78.9.4931-4935.2004; Murphy JF, 1996, VIROLOGY, V220, P535, DOI 10.1006/viro.1996.0344; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Puustinen P, 2004, J BIOL CHEM, V279, P38103, DOI 10.1074/jbc.M402910200; Puustinen P, 2002, J VIROL, V76, P12703, DOI 10.1128/JVI.76.24.12703-12711.2002; RESTREPO MA, 1990, PLANT CELL, V2, P987, DOI 10.1105/tpc.2.10.987; RESTREPOHARTWIG MA, 1994, J VIROL, V68, P2388, DOI 10.1128/JVI.68.4.2388-2397.1994; Romero P, 1998, Pac Symp Biocomput, P437; Ruffel S, 2002, PLANT J, V32, P1067, DOI 10.1046/j.1365-313X.2002.01499.x; Sanchez-Puig N, 2005, PROTEIN SCI, V14, P1410, DOI 10.1110/ps.051368005; Satheshkumar PS, 2005, J BIOL CHEM, V280, P30291, DOI 10.1074/jbc.M504122200; Schaad MC, 1996, J VIROL, V70, P7039, DOI 10.1128/JVI.70.10.7039-7048.1996; Schaad MC, 1997, J VIROL, V71, P8624, DOI 10.1128/JVI.71.11.8624-8631.1997; Schanda P, 2006, MAGN RESON CHEM, V44, pS177, DOI 10.1002/mrc.1825; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Spudich GM, 1996, P NATL ACAD SCI USA, V93, P7512, DOI 10.1073/pnas.93.15.7512; Sreerama N, 2003, PROTEIN SCI, V12, P384, DOI 10.1110/ps.0235003; THOMAS PD, 1993, PROTEIN SCI, V2, P2050, DOI 10.1002/pro.5560021206; Tompa P, 2003, BIOESSAYS, V25, P847, DOI 10.1002/bies.10324; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Tompa P, 2005, FEBS LETT, V579, P3346, DOI 10.1016/j.febslet.2005.03.072; Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; VANDEVEN FJM, 1990, EUR J BIOCHEM, V190, P583, DOI 10.1111/j.1432-1033.1990.tb15613.x; Wittmann S, 1997, VIROLOGY, V234, P84, DOI 10.1006/viro.1997.8634; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Yambao MLM, 2003, J GEN VIROL, V84, P2861, DOI 10.1099/vir.0.19312-0	58	53	56	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					213	221		10.1074/jbc.M705666200	http://dx.doi.org/10.1074/jbc.M705666200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17971447	hybrid			2022-12-27	WOS:000251940300024
J	Muretta, JM; Romenskaia, I; Mastick, CC				Muretta, Joseph M.; Romenskaia, Irina; Mastick, Cynthia Corley			Insulin releases Glut4 from static storage compartments into cycling endosomes and increases the rate constant for Glut4 exocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3T3-L1 ADIPOCYTES; GLUCOSE-TRANSPORTER; RESPONSIVE AMINOPEPTIDASE; SUBCELLULAR TRAFFICKING; REGULATED TRANSPORT; ADIPOSE-CELLS; LOCALIZATION; RETENTION; MECHANISM; MEMBRANE	In adipocytes, insulin triggers the redistribution of Glut4 from intracellular compartments to the plasma membrane. Two models have been proposed to explain the effect of insulin on Glut4 localization. In the first, termed dynamic exchange, Glut4 continually cycles between the plasma membrane and intracellular compartments in basal cells, and the major effect of insulin is through changes in the exocytic and endocytic rate constants, k(ex) and k(en). In the second model, termed static retention, Glut4 is packaged in specialized storage vesicles (GSVs) in basal cells and does not traffic through the plasma membrane or endosomes. Insulin triggers GSV exocytosis, increasing the amount of Glut4 in the actively cycling pool. Using a flow cytometry-based assay, we found that Glut4 is regulated by both static and dynamic retention mechanisms. In basal cells, 75-80% of the Glut4 is packaged in noncycling GSVs. Insulin increased the amount of Glut4 in the actively cycling pool 4-5-fold. Insulin also increased kex in the cycling pool 3-fold. After insulin withdrawal, Glut4 is rapidly cleared from the plasma membrane (t(1/2) of 20 min) by rapid adjustments in kex and ken and recycled into static compartments. Complete recovery of the static pool required more than 3 h, however. We conclude that in fully differentiated confluent adipocytes, both the dynamic and static retention mechanisms are important for the regulation of plasma membrane Glut4 content. However, cell culture conditions affect Glut4 trafficking. For example, replating after differentiation inhibited the static retention of Glut4, which may explain differences in previous reports.	[Muretta, Joseph M.; Romenskaia, Irina; Mastick, Cynthia Corley] Univ Nevada, Dept Biochem & Mol Biol, Reno, NV 89557 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno	Mastick, CC (corresponding author), Univ Nevada, Dept Biochem & Mol Biol, Mailstop 330, Reno, NV 89557 USA.	cmastick@unr.edu	Mastick, Cynthia/G-9841-2017	Mastick, Cynthia/0000-0003-4769-5412	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056197] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 56197] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; CAIN CC, 1991, J BIOL CHEM, V266, P11746; CAIN CC, 1988, J CELL BIOL, V106, P269, DOI 10.1083/jcb.106.2.269; CAIN CC, 1989, P NATL ACAD SCI USA, V86, P544, DOI 10.1073/pnas.86.2.544; Carlotti F, 2004, MOL THER, V9, P209, DOI 10.1016/j.ymthe.2003.11.021; Carvalho E, 2004, J BIOL CHEM, V279, P21598, DOI 10.1074/jbc.M312269200; Coster ACF, 2004, TRAFFIC, V5, P763, DOI 10.1111/j.1600-0854.2004.00218.x; Dawson K, 2001, BIOCHEM BIOPH RES CO, V287, P445, DOI 10.1006/bbrc.2001.5620; Foster LJ, 2000, AM J PHYSIOL-CELL PH, V279, pC877, DOI 10.1152/ajpcell.2000.279.4.C877; FROST SC, 1985, J BIOL CHEM, V260, P2646; Furusawa Chikara, 2005, Biophysics (Nagoya-shi), V1, P25, DOI 10.2142/biophysics.1.25; GIBBS EM, 1986, J BIOL CHEM, V261, P6597; Govers R, 2004, MOL CELL BIOL, V24, P6456, DOI 10.1128/MCB.24.14.6456-6466.2004; HOLMAN GD, 1994, J BIOL CHEM, V269, P17516; JHUN BH, 1992, J BIOL CHEM, V267, P17710; Karylowski O, 2004, MOL BIOL CELL, V15, P870, DOI 10.1091/mbc.E03-07-0517; Martin OJ, 2006, J BIOL CHEM, V281, P484, DOI 10.1074/jbc.M505944200; Muretta JM, 2007, J CELL SCI, V120, P1168, DOI 10.1242/jcs.03413; SATOH S, 1993, J BIOL CHEM, V268, P17820; SLOT JW, 1991, J CELL BIOL, V113, P123, DOI 10.1083/jcb.113.1.123; Waters SB, 1997, J BIOL CHEM, V272, P23323, DOI 10.1074/jbc.272.37.23323; Zeigerer A, 2002, MOL BIOL CELL, V13, P2421, DOI 10.1091/mbc.E02-02-0071; Zeigerer A, 2004, MOL BIOL CELL, V15, P4406, DOI 10.1091/mbc.e04-04-0333	23	61	61	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					311	323		10.1074/jbc.M705756200	http://dx.doi.org/10.1074/jbc.M705756200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17967900	hybrid			2022-12-27	WOS:000251940300035
J	Geurtsen, J; Angevaare, E; Janssen, M; Hamstra, HJ; ten Hove, J; de Haan, A; Kuipers, B; Tommassen, J; van der Ley, P				Geurtsen, Jeroen; Angevaare, Eline; Janssen, Marlieke; Hamstra, Hendrik-Jan; ten Hove, Jan; de Haan, Alex; Kuipers, Betsy; Tommassen, Jan; van der Ley, Peter			A novel secondary acyl chain in the lipopolysaccharide of Bordetella pertussis required for efficient infection of human macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID-A BIOSYNTHESIS; ESCHERICHIA-COLI ENCODES; INTRACELLULAR SURVIVAL; MULTICOPY SUPPRESSOR; MSBB GENE; HTRB GENE; SALMONELLA; EXPRESSION; SEQUENCE; MUTATION	Lipopolysaccharide is one of the major constituents of the Gram-negative bacterial outer membrane and is a potent stimulator of the host innate immune response. The biosynthesis of the lipid A moiety of lipopolysaccharide is a complex process in which multiple gene products are involved. Two late lipid A acyl transferases, LpxL and LpxM, were first identified in Escherichia coli and shown to be responsible for the addition of secondary acyl chains to the 2' and 3' positions of lipid A, respectively. Here, we describe the identification of two lpxL homologues in the genome of Bordetella pertussis. We show that one of them, LpxL2, is responsible for the addition of the secondary myristate group that is normally present at the 2' position of B. pertussis lipid A, whereas the other one, LpxL1, mediates the addition of a previously unrecognized secondary 2-hydroxy laurate at the 2 position. Increased expression of lpxL1 results in the appearance of a hexa-acylated lipopolysaccharide form with strongly increased endotoxic activity. In addition, we show that an lpxL1-deficient mutant of B. pertussis displays a defect in the infection of human macrophages.	[Geurtsen, Jeroen; Angevaare, Eline; Hamstra, Hendrik-Jan; ten Hove, Jan; de Haan, Alex; Kuipers, Betsy; van der Ley, Peter] Nehterlands Vaccine Inst, NL-3720 AL Bilthoven, Netherlands; [Geurtsen, Jeroen; Janssen, Marlieke; Tommassen, Jan] Univ Utrecht, Dept Mol Microbiol, NL-3584 CH Utrecht, Netherlands	Utrecht University	van der Ley, P (corresponding author), Nehterlands Vaccine Inst, PO Box 457, NL-3720 AL Bilthoven, Netherlands.	peter.van.der.ley@nvi-vaccin.nl	Tommassen, Jan/I-1690-2016	Tommassen, Jan/0000-0001-7633-4945				ALEXEYEV MF, 1995, GENE, V160, P63, DOI 10.1016/0378-1119(95)00108-I; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Babinski KJ, 2002, J BIOL CHEM, V277, P25937, DOI 10.1074/jbc.M204067200; CAROFF M, 1994, J BACTERIOL, V176, P5156, DOI 10.1128/jb.176.16.5156-5159.1994; CHEERS C, 1969, IMMUNOLOGY, V17, P875; CLEMENTZ T, 1991, J BIOL CHEM, V266, P9687; Clementz T, 1996, J BIOL CHEM, V271, P12095, DOI 10.1074/jbc.271.20.12095; Clementz T, 1997, J BIOL CHEM, V272, P10353; Cognet I, 2003, J IMMUNOL METHODS, V272, P199, DOI 10.1016/S0022-1759(02)00506-9; COLEMAN J, 1988, J BACTERIOL, V170, P1268, DOI 10.1128/jb.170.3.1268-1274.1988; CROWELL DN, 1987, J BACTERIOL, V169, P5727, DOI 10.1128/jb.169.12.5727-5734.1987; FRIEDMAN RL, 1992, INFECT IMMUN, V60, P4578, DOI 10.1128/IAI.60.11.4578-4585.1992; FURSTE JP, 1986, GENE, V48, P119, DOI 10.1016/0378-1119(86)90358-6; Garrett TA, 1997, J BIOL CHEM, V272, P21855, DOI 10.1074/jbc.272.35.21855; Geurtsen J, 2006, INFECT IMMUN, V74, P5574, DOI 10.1128/IAI.00834-06; Gibbons HS, 2000, J BIOL CHEM, V275, P32940, DOI 10.1074/jbc.M005779200; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Isobe T, 1999, J BACTERIOL, V181, P2648, DOI 10.1128/JB.181.8.2648-2651.1999; KAROW M, 1992, J BACTERIOL, V174, P702, DOI 10.1128/jb.174.3.702-710.1992; KAROW M, 1991, J BACTERIOL, V173, P741, DOI 10.1128/jb.173.2.741-750.1991; KASUGA T, 1953, KITASATO ARCH EXP ME, V27, P21; KELLY TM, 1993, J BIOL CHEM, V268, P19866; KOLASKAR AS, 1985, NUCLEIC ACIDS RES, V13, P185, DOI 10.1093/nar/13.1.185; LEE NG, 1995, J BIOL CHEM, V270, P27151, DOI 10.1074/jbc.270.45.27151; Low KB, 1999, NAT BIOTECHNOL, V17, P37, DOI 10.1038/5205; Mattoo S, 2005, CLIN MICROBIOL REV, V18, P326, DOI 10.1128/CMR.18.2.326-382.2005; Palsson-McDermott EM, 2004, IMMUNOLOGY, V113, P153, DOI 10.1111/j.1365-2567.2004.01976.x; Post DMB, 2002, INFECT IMMUN, V70, P909, DOI 10.1128/IAI.70.2.909-920.2002; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rebeil R, 2006, J BACTERIOL, V188, P1381, DOI 10.1128/JB.188.4.1381-1388.2006; Rutten L, 2006, P NATL ACAD SCI USA, V103, P7071, DOI 10.1073/pnas.0509392103; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Skorupski K, 1996, GENE, V169, P47, DOI 10.1016/0378-1119(95)00793-8; Sunshine MG, 1997, J BACTERIOL, V179, P5521, DOI 10.1128/jb.179.17.5521-5533.1997; Sweet CR, 2002, J BIOL CHEM, V277, P18281, DOI 10.1074/jbc.M201057200; TAKADA H, 1989, CRIT REV MICROBIOL, V16, P477, DOI 10.3109/10408418909104475; Thalen M, 1999, J BIOTECHNOL, V75, P147, DOI 10.1016/S0168-1656(99)00155-8; TOMMASSEN J, 1983, EMBO J, V2, P1275, DOI 10.1002/j.1460-2075.1983.tb01581.x; van der Ley P, 2001, INFECT IMMUN, V69, P5981, DOI 10.1128/IAI.69.10.5981-5990.2001; WELCH DF, 1991, CLIN MICROBIOL REV, V4, P422, DOI 10.1128/CMR.4.4.422-438.1991; WESTPHAL O, 1965, METHODS CARBOHYDR RE, V5, P91; Wilm M, 1996, ANAL CHEM, V68, P1, DOI 10.1021/ac9509519; WINKLER KC, 1948, ARCH BIOCHEM, V18, P97; Young K, 1995, J BIOL CHEM, V270, P30384, DOI 10.1074/jbc.270.51.30384; ZIEGLERHEITBROCK HWL, 1988, INT J CANCER, V41, P456, DOI 10.1002/ijc.2910410324	45	19	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37875	37884		10.1074/jbc.M706391200	http://dx.doi.org/10.1074/jbc.M706391200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17967899	hybrid, Green Published			2022-12-27	WOS:000251833600063
J	Olichon, A; Surrey, T				Olichon, Aurelien; Surrey, Thomas			Selection of genetically encoded fluorescent single domain antibodies engineered for efficient expression in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAIN FV ANTIBODIES; FUSION PROTEIN; PHAGE DISPLAY; FRAGMENTS; LIBRARIES; DSBC; BINDING; CELLS	Genetically encoded fluorescent antibodies are desirable for many applications in biotechnology and proteomics. However, the efficient production of single chain antibodies fused to fluorescent proteins like green fluorescent protein is still a major challenge. This is due to the opposite redox requirements of recombinant antibodies and fluorescent proteins for proper folding. To overcome this obstacle, we designed a novel strategy to directly select functional fluorescent antibodies (fluobodies) engineered for efficient cytosolic expression in Escherichia coli, starting from a llama heavy chain antibody (VHH) library. We used this strategy to produce several VHH fluobodies directed against microtubules. After biochemical characterization in vitro, we used a selected fluobody as a convenient biomarker of the microtubule cytoskeleton in eukaryotic cells and engineered its properties. This work provides a reliable approach for the production of fluobodies in wild- type E. coli and furthermore suggests that fusions of recombinant VHH with other cytosolic proteins are now possible, creating new opportunities for biotechnology and biomedical research.	European Mol Biol Lab, Cell Biol & Biophys Unit, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Surrey, T (corresponding author), European Mol Biol Lab, Cell Biol & Biophys Unit, Meyerhofstr 1, D-69117 Heidelberg, Germany.	surrey@embl.de	Olichon, Aurelien/M-3115-2014; Surrey, Thomas/AAC-4608-2021; Olichon, Aurelien/Q-5425-2019	Olichon, Aurelien/0000-0002-0821-3612; Surrey, Thomas/0000-0001-9082-1870				Bazl MR, 2007, HYBRIDOMA, V26, P1, DOI 10.1089/hyb.2006.037; BELL PB, 1995, SCANNING MICROSCOPY, V9, P843; Binz HK, 2003, J MOL BIOL, V332, P489, DOI 10.1016/S0022-2836(03)00896-9; Bradbury ARM, 2004, J IMMUNOL METHODS, V290, P29, DOI 10.1016/j.jim.2004.04.007; Casey JL, 2000, PROTEIN ENG, V13, P445, DOI 10.1093/protein/13.6.445; Conrath KE, 2001, ANTIMICROB AGENTS CH, V45, P2807, DOI 10.1128/AAC.45.10.2807-2812.2001; Conrath KE, 2001, J BIOL CHEM, V276, P7346, DOI 10.1074/jbc.M007734200; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Feilmeier BJ, 2000, J BACTERIOL, V182, P4068, DOI 10.1128/JB.182.14.4068-4076.2000; Frenken LGJ, 2000, J BIOTECHNOL, V78, P11, DOI 10.1016/S0168-1656(99)00228-X; Ghahroudi MA, 1997, FEBS LETT, V414, P521, DOI 10.1016/S0014-5793(97)01062-4; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Griep RA, 1999, J IMMUNOL METHODS, V230, P121, DOI 10.1016/S0022-1759(99)00131-3; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Holt LJ, 2003, TRENDS BIOTECHNOL, V21, P484, DOI 10.1016/j.tibtech.2003.08.007; Hoogenboom HR, 2005, NAT BIOTECHNOL, V23, P1105, DOI 10.1038/nbt1126; Jurado P, 2002, J MOL BIOL, V320, P1, DOI 10.1016/S0022-2836(02)00405-9; Liska AJ, 2004, PROTEOMICS, V4, P2707, DOI 10.1002/PMIC.200300813; MISSIAKAS D, 1994, EMBO J, V13, P2013, DOI 10.1002/j.1460-2075.1994.tb06471.x; Morino K, 2001, J IMMUNOL METHODS, V257, P175, DOI 10.1016/S0022-1759(01)00462-8; Muyldermans S, 1999, J MOL RECOGNIT, V12, P131, DOI 10.1002/(SICI)1099-1352(199903/04)12:2<131::AID-JMR454>3.0.CO;2-M; Muyldermans S, 2001, J Biotechnol, V74, P277; Muyldermans S, 2001, TRENDS BIOCHEM SCI, V26, P230, DOI 10.1016/S0968-0004(01)01790-X; Nizak C, 2003, SCIENCE, V300, P984, DOI 10.1126/science.1083911; Oelschlaeger P, 2002, ANAL BIOCHEM, V309, P27, DOI 10.1016/S0003-2697(02)00290-7; Olichon A, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-7; PLUCKTHUN A, 1989, METHOD ENZYMOL, V178, P497; Rondot S, 2001, NAT BIOTECHNOL, V19, P75, DOI 10.1038/83567; Rothbauer U, 2006, NAT METHODS, V3, P887, DOI 10.1038/NMETH953; Schwalbach G, 2000, PROTEIN EXPRES PURIF, V18, P121, DOI 10.1006/prep.1999.1185; Segatori L, 2004, P NATL ACAD SCI USA, V101, P10018, DOI 10.1073/pnas.0403003101; Sidhu SS, 2000, CURR OPIN BIOTECH, V11, P610, DOI 10.1016/S0958-1669(00)00152-X; SKERRA A, 1988, SCIENCE, V240, P1038, DOI 10.1126/science.3285470; Spinelli S, 1996, NAT STRUCT BIOL, V3, P752, DOI 10.1038/nsb0996-752; WALLIS KT, 1993, J BIOL CHEM, V268, P15158; Worn A, 1998, FEBS LETT, V427, P357, DOI 10.1016/S0014-5793(98)00463-3; Zarebski LM, 2005, J MOL BIOL, V349, P814, DOI 10.1016/j.jmb.2005.03.072; Zhang Z, 2002, PROTEIN EXPRES PURIF, V26, P218, DOI 10.1016/S1046-5928(02)00502-8	38	63	68	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36314	36320		10.1074/jbc.M704908200	http://dx.doi.org/10.1074/jbc.M704908200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17921141	hybrid			2022-12-27	WOS:000251458300022
J	Anantha, RW; Vassin, VM; Borowiec, JA				Anantha, Rachel W.; Vassin, Vitaly M.; Borowiec, James A.			Sequential and synergistic modification of human RPA stimulates chromosomal DNA repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION PROTEIN-A; SINGLE-STRANDED-DNA; NUCLEOTIDE EXCISION-REPAIR; CYCLIN-DEPENDENT KINASES; S-PHASE CHECKPOINT; IN-VITRO; INDUCED PHOSPHORYLATION; P34 SUBUNIT; CELL-CYCLE; HOMOLOGOUS RECOMBINATION	The activity of human replication protein A (RPA) in DNA replication and repair is regulated by phosphorylation of the middle RPA2 subunit. It has previously been shown that up to nine different N-terminal residues are modified in vivo and in response to genotoxic stress. Using a novel antibody against phospho-Ser(29), a moiety formed by cyclin-Cdk, we observed that RPA2 was phosphorylated during mitosis in nonstressed cells. Robust phosphorylation of Ser(29) was also seen in interphase cells following treatment with the DNA-damaging agent camptothecin, a rare example of stress stimulating the modification of a repair factor by cyclin-Cdk. RPA2 phosphorylation is regulated both in cis and trans. Cis-phosphorylation follows a preferred pathway. (That is, the initial modification of Ser(33) by ATR stimulates subsequent phosphorylation of Cdk sites Ser(23) and Ser29). These events then facilitate modification of Thr(21) and extreme N-terminal sites Ser(4) and Ser(8), probably by DNA-PK. Our data also indicate that the phosphorylation of one RPA molecule can influence the phosphorylation of other RPA molecules in trans. Cells in which endogenous RPA2 was "replaced" with a double S23A/S29A-RPA2 mutant were seen to have an abnormal cell cycle distribution both in normal and in stressed cells. Such cells also showed aberrant DNA damage-dependent RPA foci and had persistent staining of gamma H2AX following DNA damage. Our data indicate that RPA phosphorylation facilitates chromosomal DNA repair. We postulate that the RPA phosphorylation pattern provides a means to regulate the DNA repair pathway utilized.	NYU, Sch Med, Dept Biochem, New York, NY 10016 USA; NYU, Sch Med, New York Univ Canc Inst, New York, NY USA	New York University; New York University	Borowiec, JA (corresponding author), NYU, Sch Med, Dept Biochem, 550 1st Ave, New York, NY 10016 USA.	james.borowiec@med.nyu.edu		Borowiec, James/0000-0003-4117-0826	NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI029963] Funding Source: NIH RePORTER; NCI NIH HHS [P30CA16087] Funding Source: Medline; NIAID NIH HHS [AI29963] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abraham J, 2000, J MOL BIOL, V295, P853, DOI 10.1006/jmbi.1999.3415; Araujo SJ, 1999, MUTAT RES-DNA REPAIR, V435, P23, DOI 10.1016/S0921-8777(99)00042-7; Binz SK, 2004, DNA REPAIR, V3, P1015, DOI 10.1016/j.dnarep.2004.03.028; Blaydes JP, 2001, J BIOL CHEM, V276, P4699, DOI 10.1074/jbc.M003485200; Block WD, 2004, NUCLEIC ACIDS RES, V32, P997, DOI 10.1093/nar/gkh265; Bochkareva E, 2002, EMBO J, V21, P1855, DOI 10.1093/emboj/21.7.1855; Bochkareva E, 2005, P NATL ACAD SCI USA, V102, P15412, DOI 10.1073/pnas.0504614102; Bouquet F, 2006, CELL CYCLE, V5, P1116, DOI 10.4161/cc.5.10.2799; Chaudhuri J, 2004, NATURE, V430, P992, DOI 10.1038/nature02821; Chehab NH, 2000, GENE DEV, V14, P278; Dent P, 2003, ONCOGENE, V22, P5885, DOI 10.1038/sj.onc.1206701; Dodson GE, 2004, J BIOL CHEM, V279, P34010, DOI 10.1074/jbc.C400242200; DUTTA A, 1992, EMBO J, V11, P2189, DOI 10.1002/j.1460-2075.1992.tb05278.x; FANG F, 1993, J CELL SCI, V106, P983; FOTEDAR R, 1992, EMBO J, V11, P2177, DOI 10.1002/j.1460-2075.1992.tb05277.x; Gibbs E, 1996, J BIOL CHEM, V271, P22847, DOI 10.1074/jbc.271.37.22847; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P24203; Iftode C, 1999, CRIT REV BIOCHEM MOL, V34, P141, DOI 10.1080/10409239991209255; Ira G, 2004, NATURE, V431, P1011, DOI 10.1038/nature02964; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Kim K, 2005, MOL CELL BIOL, V25, P2463, DOI 10.1128/MCB.25.6.2463-2474.2005; LEE SH, 1995, J BIOL CHEM, V270, P12801, DOI 10.1074/jbc.270.21.12801; LEESMILLER SP, 1995, SCIENCE, V267, P1183, DOI 10.1126/science.7855602; Lin YL, 1998, J BIOL CHEM, V273, P1453, DOI 10.1074/jbc.273.3.1453; McGowan CH, 2004, CURR OPIN CELL BIOL, V16, P629, DOI 10.1016/j.ceb.2004.09.005; McIlwraith MJ, 2000, J MOL BIOL, V304, P151, DOI 10.1006/jmbi.2000.4180; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; Morgan SE, 1997, CANCER RES, V57, P3386; Namiki Y, 2006, P NATL ACAD SCI USA, V103, P580, DOI 10.1073/pnas.0510223103; New JH, 1998, NATURE, V391, P407, DOI 10.1038/34950; Niu HW, 1997, J BIOL CHEM, V272, P12634, DOI 10.1074/jbc.272.19.12634; Nuss JE, 2005, BIOCHEMISTRY-US, V44, P8428, DOI 10.1021/bi0480584; Oakley GG, 2003, BIOCHEMISTRY-US, V42, P3255, DOI 10.1021/bi026377u; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Olson E, 2006, J BIOL CHEM, V281, P39517, DOI 10.1074/jbc.M605121200; PAN ZQ, 1994, P NATL ACAD SCI USA, V91, P8343, DOI 10.1073/pnas.91.18.8343; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; POVIRK LF, 1977, NUCLEIC ACIDS RES, V4, P3573, DOI 10.1093/nar/4.10.3573; Prakash S, 2000, MUTAT RES-FUND MOL M, V451, P13, DOI 10.1016/S0027-5107(00)00037-3; Ramilo C, 2002, MOL CELL BIOL, V22, P2037, DOI 10.1128/MCB.22.7.2037-2046.2002; Shao RG, 1999, EMBO J, V18, P1397, DOI 10.1093/emboj/18.5.1397; Shinohara A, 1998, GENES CELLS, V3, P145, DOI 10.1046/j.1365-2443.1998.00176.x; Sugiyama T, 1998, P NATL ACAD SCI USA, V95, P6049, DOI 10.1073/pnas.95.11.6049; Takata M, 1998, EMBO J, V17, P5497, DOI 10.1093/emboj/17.18.5497; Vassin VM, 2004, MOL CELL BIOL, V24, P1930, DOI 10.1128/MCB.24.5.1930-1943.2004; Wang HY, 2001, CANCER RES, V61, P8554; Wong JMS, 2003, ONCOGENE, V22, P28, DOI 10.1038/sj.onc.1206071; Yang HJ, 2005, NATURE, V433, P653, DOI 10.1038/nature03234; Yuzhakov A, 1999, EMBO J, V18, P6189, DOI 10.1093/emboj/18.21.6189; ZernikKobak M, 1997, J BIOL CHEM, V272, P23896, DOI 10.1074/jbc.272.38.23896; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	51	117	120	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35910	35923		10.1074/jbc.M704645200	http://dx.doi.org/10.1074/jbc.M704645200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17928296	hybrid			2022-12-27	WOS:000251458100052
J	Fujiwara, N; Nakano, M; Kato, S; Yoshihara, D; Ookawara, T; Eguchi, H; Taniguchi, N; Suzuki, K				Fujiwara, Noriko; Nakano, Miyako; Kato, Shinsuke; Yoshihara, Daisaku; Ookawara, Tomomi; Eguchi, Hironobu; Taniguchi, Naoyuki; Suzuki, Keiichiro			Oxidative modification to cysteine sulfonic acid of Cys(111) in human copper-zinc superoxide dismutase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; CU,ZN-SUPEROXIDE DISMUTASE; HYDROGEN-PEROXIDE; SULFINIC ACID; RECOMBINANT HUMAN; WILD-TYPE; MOLECULAR EVOLUTION; FAMILIAL ALS; ACTIVE-SITE; MUTANT	Copper-zinc superoxide dismutase (SOD1) plays a protective role against oxidative stress. On the other hand, recent studies suggest that SOD1 itself is a major target of oxidative damage and has its own pathogenicity in various neurodegenerative diseases, including familial amyotrophic lateral sclerosis. Only human and great ape SOD1s among mammals have the highly reactive free cysteine residue, Cys(111), at the surface of the SOD1 molecule. The purpose of this study was to investigate the role of Cys(111) in the oxidative damage of the SOD1 protein, by comparing the oxidative susceptibility of recombinant human SOD1 modified with 2-mercaptoethanol at Cys(111) (2-ME-SOD1) to wild-type SOD1. Wild-type SOD1 was more sensitive to oxidation by hydrogen peroxide-generating fragments, oligomers, and charge isomers compared with 2-ME-SOD1. Moreover, wild-type SOD1, but not 2-ME-SOD1, generated an upper shifted band in reducing SDS-PAGE even by air oxidation. Using mass spectrometry and limited proteolysis, this upper band was identified as an oxidized subunit of SOD1; the sulfhydryl group (Cys-SH) of Cys(111) was selectively oxidized to cysteine sulfinic acid (Cys-SO2H) and to cysteine sulfonic acid (Cys-SO3H). The antibody raised against a synthesized peptide containing Cys(111)-SO3H reacted with only the Cys(111)-peroxidized SOD1 by Western blot analysis and labeled Lewy bodylike hyaline inclusions and vacuole rims in the spinal cord of human SOD1-mutated amyotrophic lateral sclerosis mice by immunohistochemical analysis. These results suggest that Cys(111) is a primary target for oxidative modification and plays an important role in oxidative damage to human SOD1, including familial amyotrophic lateral sclerosis mutants.	Hyogo Coll Med, Dept Biochem, Nishinomiya, Hyogo 6638501, Japan; Osaka Univ, Dept Biochem, Sch Med, Suita, Osaka 5650871, Japan; Grad Sch Med, Suita, Osaka 5650871, Japan; Tottori Univ, Fac Med, Dept Neuropathol, Inst Neurol Sci, Yonago, Tottori 6838504, Japan; Osaka Univ, Dept Dis Glycom, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan	Hyogo College of Medicine; Osaka University; Tottori University; Osaka University	Fujiwara, N (corresponding author), Hyogo Coll Med, Dept Biochem, Nishinomiya, Hyogo 6638501, Japan.	noriko-f@hyo-med.ac.jp	Yoshihara, Daisaku/L-6664-2019; Taniguchi, Naoyuki/A-7086-2016; Taniguchi, Naoyuki/I-4182-2014	Taniguchi, Naoyuki/0000-0001-5889-5968				Abou Ezzi S, 2007, J NEUROCHEM, V102, P170, DOI 10.1111/j.1471-4159.2007.04531.x; Basso M, 2006, J BIOL CHEM, V281, P33325, DOI 10.1074/jbc.M603489200; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; Chang TS, 2004, J BIOL CHEM, V279, P50994, DOI 10.1074/jbc.M409482200; Choi J, 2005, J BIOL CHEM, V280, P11648, DOI 10.1074/jbc.M414327200; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; DE Beus MD, 2004, PROTEIN SCI, V13, P1347, DOI 10.1110/ps.03576904; DENG HX, 1993, SCIENCE, V261, P1047, DOI 10.1126/science.8351519; Deng HX, 2006, P NATL ACAD SCI USA, V103, P7142, DOI 10.1073/pnas.0602046103; Ferri A, 2006, P NATL ACAD SCI USA, V103, P13860, DOI 10.1073/pnas.0605814103; Fink RC, 2002, ARCH BIOCHEM BIOPHYS, V399, P19, DOI 10.1006/abbi.2001.2739; Forman HJ, 2002, MOL CELL BIOCHEM, V234, P49, DOI 10.1023/A:1015913229650; Fujiwara N, 2005, J BIOL CHEM, V280, P5061, DOI 10.1074/jbc.M406106200; Fukuhara R, 2002, GENE, V296, P99, DOI 10.1016/S0378-1119(02)00837-5; Furukawa Y, 2005, J BIOL CHEM, V280, P17266, DOI 10.1074/jbc.M500482200; Furukawa Y, 2006, P NATL ACAD SCI USA, V103, P7148, DOI 10.1073/pnas.0602048103; GETZOFF ED, 1989, PROTEINS, V5, P322, DOI 10.1002/prot.340050408; Ghadge GD, 1997, J NEUROSCI, V17, P8756; Goto JJ, 1998, J BIOL CHEM, V273, P30104, DOI 10.1074/jbc.273.46.30104; HALLEWELL RA, 1991, BIOCHEM BIOPH RES CO, V181, P474, DOI 10.1016/S0006-291X(05)81443-3; HODGSON EK, 1975, BIOCHEMISTRY-US, V14, P5299, DOI 10.1021/bi00695a011; Jacob C, 2004, ORG BIOMOL CHEM, V2, P1953, DOI 10.1039/b406180b; Johnston JA, 2000, P NATL ACAD SCI USA, V97, P12571, DOI 10.1073/pnas.220417997; Julien JP, 2001, CELL, V104, P581, DOI 10.1016/S0092-8674(01)00244-6; KAJIHARA J, 1998, J BIOCHEM-TOKYO, V104, P851; KAJIHARA J, 1998, J BIOCHEM-TOKYO, V104, P638; Kato S, 2005, ACTA NEUROPATHOL, V110, P101, DOI 10.1007/s00401-005-1019-3; Kim JR, 2000, ANAL BIOCHEM, V283, P214, DOI 10.1006/abio.2000.4623; Kurahashi T, 2001, J AM CHEM SOC, V123, P9268, DOI 10.1021/ja015953r; Liu HB, 2000, BIOCHEMISTRY-US, V39, P8125, DOI 10.1021/bi000846f; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Okado-Matsumoto A, 2006, FREE RADICAL BIO MED, V41, P1837, DOI 10.1016/j.freeradbiomed.2006.09.011; OOKAWARA T, 1992, J BIOL CHEM, V267, P18505; PARGE HE, 1992, P NATL ACAD SCI USA, V89, P6109, DOI 10.1073/pnas.89.13.6109; Rakhit R, 2002, J BIOL CHEM, V277, P47551, DOI 10.1074/jbc.M207356200; RAKHIT R, 2006, BIOCHIM BIOPHYS ACTA, V1726, P1025; REPOCK JR, 1990, J BIOL CHEM, V265, P21612; Rhee SG, 2001, IUBMB LIFE, V52, P35, DOI 10.1080/15216540252774748; RIPPS ME, 1995, P NATL ACAD SCI USA, V92, P689, DOI 10.1073/pnas.92.3.689; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; SALO DC, 1990, J BIOL CHEM, V265, P11919; Stanton JL, 1996, DNA SEQUENCE, V6, P357, DOI 10.3109/10425179609047575; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; TAINER JA, 1982, J MOL BIOL, V160, P181, DOI 10.1016/0022-2836(82)90174-7; UCHIDA K, 1994, J BIOL CHEM, V269, P2405; Valentine JS, 2003, P NATL ACAD SCI USA, V100, P3617, DOI 10.1073/pnas.0730423100; Watanabe S, 2007, FREE RADICAL BIO MED, V42, P1534, DOI 10.1016/j.freeradbiomed.2007.02.004; WiedauPazos M, 1996, SCIENCE, V271, P515, DOI 10.1126/science.271.5248.515; Woo HA, 2005, J BIOL CHEM, V280, P3125, DOI 10.1074/jbc.C400496200; Woo HA, 2003, SCIENCE, V300, P653, DOI 10.1126/science.1080273; Yang KS, 2002, J BIOL CHEM, V277, P38029, DOI 10.1074/jbc.M206626200; Yim MB, 1996, P NATL ACAD SCI USA, V93, P5709, DOI 10.1073/pnas.93.12.5709; Zhang H, 2003, J BIOL CHEM, V278, P24078, DOI 10.1074/jbc.M302051200	53	108	110	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35933	35944		10.1074/jbc.M702941200	http://dx.doi.org/10.1074/jbc.M702941200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17913710	Green Published, hybrid			2022-12-27	WOS:000251458100054
J	Shutes, A; Onesto, C; Picard, V; Leblond, B; Schweighoffer, F; Der, CJ				Shutes, Adam; Onesto, Cercina; Picard, Virginie; Leblond, Bertrand; Schweighoffer, Fabien; Der, Channing J.			Specificity and mechanism of action of EHT 1864, a novel small molecule inhibitor of rac family small GTPases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHO-GTPASES; NUCLEOTIDE EXCHANGE; SPLICE VARIANT; BREAST-CANCER; PROTEIN; BINDING; ACTIVATION; EXPRESSION; TRANSFORMATION; COMPLEX	There is now considerable experimental evidence that aberrant activation of Rho family small GTPases promotes the uncontrolled proliferation, invasion, and metastatic properties of human cancer cells. Therefore, there is considerable interest in the development of small molecule inhibitors of Rho GTPase function. However, to date, most efforts have focused on inhibitors that indirectly block Rho GTPase function, by targeting either enzymes involved in post-translational processing or downstream protein kinase effectors. We recently determined that the EHT 1864 small molecule can inhibit Rac function in vivo. In this study, we evaluated the biological and biochemical specificities and biochemical mechanism of action of EHT 1864. We determined that EHT 1864 specifically inhibited Rac1-dependent platelet-derived growth factor-induced lamellipodia formation. Furthermore, our biochemical analyses with recombinant Rac proteins found that EHT 1864 possesses high affinity binding to Rac1, as well as the related Rac1b, Rac2, and Rac3 isoforms, and this association promoted the loss of bound nucleotide, inhibiting both guanine nucleotide association and Tiam1 Rac guanine nucleotide exchange factor-stimulated exchange factor activity in vitro. EHT 1864 therefore places Rac in an inert and inactive state, preventing its engagement with downstream effectors. Finally, we evaluated the ability of EHT 1864 to block Rac-dependent growth transformation, and we determined that EHT 1864 potently blocked transformation caused by constitutively activated Rac1, as well as Rac-dependent transformation caused by Tiam1 or Ras. Taken together, our results suggest that EHT 1864 selectively inhibits Rac downstream signaling and transformation by a novel mechanism involving guanine nucleotide displacement.	Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; ExonHit Therapeut, F-75013 Paris, France	University of North Carolina; University of North Carolina Chapel Hill	Der, CJ (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, 450 West Dr,CB 7295, Chapel Hill, NC 27599 USA.	cjder@med.unc.edu	Leblond, Bertrand/A-3076-2015	Leblond, Bertrand/0000-0003-2585-9834; Der, Channing/0000-0002-7751-2747	NCI NIH HHS [CA67771, CA92240, CA063071] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA063071, U19CA067771, R01CA092240] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANDO S, 1992, J BIOL CHEM, V267, P25709; Bar-Sagi D, 2000, CELL, V103, P227, DOI 10.1016/S0092-8674(00)00115-X; Basso AD, 2006, J LIPID RES, V47, P15, DOI 10.1194/jlr.R500012-JLR200; Bernards A, 2004, TRENDS CELL BIOL, V14, P377, DOI 10.1016/j.tcb.2004.05.003; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Boettner B, 2002, GENE, V286, P155, DOI 10.1016/S0378-1119(02)00426-2; Chan AY, 2005, ONCOGENE, V24, P7821, DOI 10.1038/sj.onc.1208909; CHEN SY, 1994, ONCOGENE, V9, P2691; CHUANG TH, 1993, J BIOL CHEM, V268, P775; DeNicola G, 2005, CANCER BIOL THER, V4, P509, DOI 10.4161/cbt.4.5.1781; Deroanne C, 2003, J CELL SCI, V116, P1367, DOI 10.1242/jcs.00308; Desire L, 2005, J BIOL CHEM, V280, P37516, DOI 10.1074/jbc.M507913200; Feig LA, 1999, NAT CELL BIOL, V1, pE25, DOI 10.1038/10018; Fernandez-Zapico ME, 2005, CANCER CELL, V7, P39, DOI 10.1016/j.ccr.2004.11.024; Ferraro D, 2006, ONCOGENE, V25, P3689, DOI 10.1038/sj.onc.1209409; Fiegen D, 2004, J BIOL CHEM, V279, P4743, DOI 10.1074/jbc.M310281200; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Goodison S, 2005, CANCER RES, V65, P6042, DOI 10.1158/0008-5472.CAN-04-3043; Haeusler LC, 2006, METHOD ENZYMOL, V406, P1, DOI 10.1016/S0076-6879(06)06001-0; HANSEN MB, 1989, J IMMUNOL METHODS, V119, P203, DOI 10.1016/0022-1759(89)90397-9; HART M, 1995, METHOD ENZYMOL, V255, P129; HIRAOKA K, 1992, BIOCHEM BIOPH RES CO, V182, P921, DOI 10.1016/0006-291X(92)91820-G; Hwang SL, 2005, J CLIN NEUROSCI, V12, P571, DOI 10.1016/j.jocn.2004.08.013; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jordan P, 1999, ONCOGENE, V18, P6835, DOI 10.1038/sj.onc.1203233; Joyce PL, 2003, CANCER RES, V63, P7959; Karnoub AE, 2001, NAT STRUCT BIOL, V8, P1037, DOI 10.1038/nsb719; KHOSRAVIFAR R, 1995, MOL CELL BIOL, V15, P6443; KhosraviFar R, 1996, MOL CELL BIOL, V16, P3923; Kleer CG, 2005, BREAST CANCER RES TR, V93, P101, DOI 10.1007/s10549-005-4170-6; KOZMA R, 1995, MOL CELL BIOL, V15, P1942; Lambert JM, 2002, NAT CELL BIOL, V4, P621, DOI 10.1038/ncb833; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; MANNE V, 1984, P NATL ACAD SCI-BIOL, V81, P6953, DOI 10.1073/pnas.81.22.6953; Matos P, 2003, J BIOL CHEM, V278, P50442, DOI 10.1074/jbc.M308215200; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; MICHIELS F, 1995, NATURE, V375, P338, DOI 10.1038/375338a0; ONOZAWA T, 1995, YEAST, V11, P801, DOI 10.1002/yea.320110902; Phillips RA, 2003, BIOCHEMISTRY-US, V42, P3956, DOI 10.1021/bi027316z; Reid TS, 2004, J MOL BIOL, V343, P417, DOI 10.1016/j.jmb.2004.08.056; Renshaw MW, 1996, CURR BIOL, V6, P76, DOI 10.1016/S0960-9822(02)00424-4; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Ridley AJ, 2004, BREAST CANCER RES TR, V84, P13, DOI 10.1023/B:BREA.0000018423.47497.c6; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; SASAKI T, 1993, J BIOL CHEM, V268, P23959; Schnelzer A, 2000, ONCOGENE, V19, P3013, DOI 10.1038/sj.onc.1203621; Sebti SM, 2000, ONCOGENE, V19, P6584, DOI 10.1038/sj.onc.1204146; Shutes A, 2002, BIOCHEMISTRY-US, V41, P3828, DOI 10.1021/bi0119464; Singh A, 2004, ONCOGENE, V23, P9369, DOI 10.1038/sj.onc.1208182; Thapar R, 2002, BIOCHEMISTRY-US, V41, P3875, DOI 10.1021/bi0120087; vanLeeuwen FN, 1995, ONCOGENE, V11, P2215; Wennerberg K, 2002, J BIOL CHEM, V277, P47810, DOI 10.1074/jbc.M203816200; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; Wennerberg K, 2004, J CELL SCI, V117, P1301, DOI 10.1242/jcs.01118; Westwick JK, 1997, MOL CELL BIOL, V17, P1324, DOI 10.1128/MCB.17.3.1324; Worthylake DK, 2000, NATURE, V408, P682, DOI 10.1038/35047014; YAMASHITA T, 1988, J BIOL CHEM, V263, P17181; Zohn IE, 1998, MOL CELL BIOL, V18, P1225, DOI 10.1128/MCB.18.3.1225	60	224	235	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35666	35678		10.1074/jbc.M703571200	http://dx.doi.org/10.1074/jbc.M703571200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17932039	hybrid, Green Published			2022-12-27	WOS:000251458100027
J	Jensen, M; Hansen, B; De Meyts, P; Schaffer, L; Urso, B				Jensen, Maja; Hansen, Bente; De Meyts, Pierre; Schaeffer, Lauge; Urso, Birgitte			Activation of the insulin receptor by insulin and a synthetic peptide leads to divergent metabolic and mitogenic signaling and responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-II; CELL-PROLIFERATION; PROTEIN-KINASE; ISOFORM-A; INTERNALIZATION; SHC; PHOSPHORYLATION; TRANSDUCTION; SUBSTRATE-1; EXPRESSION	Recently, single chain peptides have been designed that target the insulin receptor and mimic insulin action. The aim of this study is to explore if activation of the insulin receptor with such an optimized peptide (S597) leads to the same activation of signaling pathways and biological endpoints i.e. stimulation of glycogen synthesis and cell proliferation as stimulation with insulin. We find that surface activation of the insulin receptor A-isoform with S597 leads to activation of protein kinase B (PKB) and glycogen synthesis comparable to activation by insulin, even though the level of insulin receptor phosphorylation is lower. In contrast, both Src homology 2/alpha collagen-related (Shc) and extracellular signal-regulated kinase (ERK) 2 activation are virtually absent upon stimulation with S597. Cell proliferation is only stimulated slightly by S597, suggesting that it depends on signals from Shc and ERK. The differences in signaling response could explain both the earlier reported differences in gene expression, and the reported differences in cell proliferation and glycogen synthesis induced by insulin and S597. In conclusion, despite binding equipotency, insulin, and S597 initiate different signaling and biological responses through the same insulin receptor isoform. We show for the first time that it is possible to design insulin receptor ligand mimetics with metabolic equipotency but low mitogenicity.	Hagedorn Res Inst, Receptor Syst Biol Lab, DK-2820 Gentofte, Denmark; Novo Nordisk AS, Dept Canc & ImmunoBiol, DK-2760 Malov, Denmark; Novo Nordisk AS, Diabet Prot Engn, DK-2760 Malov, Denmark	Novo Nordisk; Hagedorn Research Institute; Novo Nordisk; Novo Nordisk	Jensen, M (corresponding author), Hagedorn Res Inst, Receptor Syst Biol Lab, Niels Steensensvej 6, DK-2820 Gentofte, Denmark.	mjjn@novonordisk.com		De Meyts, Pierre/0000-0001-6214-0824				Biener Y, 1996, J BIOL CHEM, V271, P29489, DOI 10.1074/jbc.271.46.29489; Ceresa BP, 1998, MOL CELL BIOL, V18, P3862, DOI 10.1128/MCB.18.7.3862; Chow JC, 1998, J BIOL CHEM, V273, P4672, DOI 10.1074/jbc.273.8.4672; EBINA Y, 1985, CELL, V40, P747, DOI 10.1016/0092-8674(85)90334-4; Foti Michelangelo, 2004, Novartis Found Symp, V262, P125; Frasca F, 1999, MOL CELL BIOL, V19, P3278, DOI 10.1128/mcb.19.5.3278; Gousseva N, 2001, J CELL BIOCHEM, V81, P523, DOI 10.1002/1097-4644(20010601)81:3<523::AID-JCB1066>3.0.CO;2-E; Hamer I, 2002, DIABETOLOGIA, V45, P657, DOI 10.1007/s00125-002-0798-5; Hansen BF, 1996, BIOCHEM J, V315, P271; Harada S, 1996, J BIOL CHEM, V271, P30222, DOI 10.1074/jbc.271.47.30222; Kurtzhals P, 2000, DIABETES, V49, P999, DOI 10.2337/diabetes.49.6.999; Leof EB, 2000, TRENDS CELL BIOL, V10, P343, DOI 10.1016/S0962-8924(00)01795-5; Morrione A, 1997, P NATL ACAD SCI USA, V94, P3777, DOI 10.1073/pnas.94.8.3777; Olsen GS, 2002, AM J PHYSIOL-ENDOC M, V283, pE965, DOI 10.1152/ajpendo.00118.2002; Pandini G, 2003, J BIOL CHEM, V278, P42178, DOI 10.1074/jbc.M304980200; Pillutla RC, 2002, J BIOL CHEM, V277, P22590, DOI 10.1074/jbc.M202119200; Sasaoka T, 2000, ENDOCR J, V47, P373, DOI 10.1507/endocrj.47.373; Schaffer L, 2003, P NATL ACAD SCI USA, V100, P4435, DOI 10.1073/pnas.0830026100; Sciacca L, 2002, ONCOGENE, V21, P8240, DOI 10.1038/sj.onc.1206058; Thirone ACP, 2006, TRENDS ENDOCRIN MET, V17, P70, DOI 10.1016/j.tem.2006.01.005; Thirone ACP, 1998, FEBS LETT, V421, P191, DOI 10.1016/S0014-5793(97)01560-3; Uhles S, 2007, FASEB J, V21, P1609, DOI 10.1096/fj.06-7589com; ULLRICH A, 1985, NATURE, V313, P756, DOI 10.1038/313756a0; White MF, 1997, DIABETOLOGIA, V40, pS2, DOI 10.1007/s001250051387; WILDEN PA, 1990, P NATL ACAD SCI USA, V87, P3358, DOI 10.1073/pnas.87.9.3358; WILDEN PA, 1992, J BIOL CHEM, V267, P13719; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; Yamauchi T, 1996, MOL CELL BIOL, V16, P3074	28	55	58	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					35179	35186		10.1074/jbc.M704599200	http://dx.doi.org/10.1074/jbc.M704599200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17925406	hybrid			2022-12-27	WOS:000251155200063
J	Vasanthavada, K; Hu, X; Falick, AM; La Mattina, C; Moore, AMF; Jones, PR; Yee, R; Reza, R; Tuton, T; Vierra, C				Vasanthavada, Keshav; Hu, Xiaoyi; Falick, Arnold M.; La Mattina, Coby; Moore, Anne M. F.; Jones, Patrick R.; Yee, Russell; Reza, Ryan; Tuton, Tiffany; Vierra, Craig			Aciniform spidroin, a constituent of egg case sacs and wrapping silk fibers from the black widow spider Latrodectus hesperus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONSERVED C-TERMINI; COB WEAVER; PROTEINS; DRAGLINE; FIBROIN; FLAGELLIFORM; PREDATORS; EVOLUTION; COCOONS; GENE	Spiders produce high performance fibers with diverse mechanical properties and biological functions. Molecular and biochemical studies of spider egg case silk have revealed that the main constituent of the large diameter fiber contains the fibroin TuSp1. Here we demonstrate by SDS-PAGE and protein silver staining the presence of a distinct similar to 300-kDa polypeptide that is found in solubilized egg case sacs. Combining matrix-assisted laser desorption ionization tandem time-of-flight mass spectrometry and reverse genetics, we have isolated a novel gene called AcSp1-like and demonstrate that its protein product is assembled into the small diameter fibers of egg case sacs and wrapping silks from the black widow spider, Latrodectus hesperus. BLAST searches of the NCBInr protein data base using the amino acid sequence of AcSp1-like revealed similarity to AcSp1, an inferred protein proposed to be a component of wrapping silk. However, the AcSp1-like protein was found to display more nonuniformity in its internal iterated repeat modules than the putative AcSp1 fibroin. Real time quantitative PCR analysis demonstrates that the AcSp1-like gene displays an aciniform gland-restricted pattern of expression. The amino acid composition of the fibroins extracted from the luminal contents of the aciniform glands was remarkably similar to the predicted amino acid composition of the AcSp1-like protein, which supports the assertion that AcSp1-like protein represents the major constituent stored within the aciniform gland. Collectively, our findings provide the first direct molecular evidence for the involvement of the aciniform gland in the production of a common fibroin that is assembled into the small diameter threads of egg case and wrapping silk of cob weavers.	Univ Pacific, Dept Biol Sci, Stockton, CA 95211 USA; Univ Pacific, Dept Chem, Stockton, CA 95211 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of the Pacific; University of the Pacific; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Vierra, C (corresponding author), Univ Pacific, Dept Biol Sci, 3601 Pacific Ave, Stockton, CA 95211 USA.	cvierra@pacific.edu						AUSTIN AD, 1985, J NAT HIST, V19, P359, DOI 10.1080/00222938500770261; Ayoub NA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000514; Casem ML, 1999, INT J BIOL MACROMOL, V24, P103, DOI 10.1016/S0141-8130(98)00078-6; Challis RJ, 2006, INSECT MOL BIOL, V15, P45, DOI 10.1111/j.1365-2583.2005.00606.x; FOELIX RF, 1996, BIOL SPIDERS, P1; Garb JE, 2005, P NATL ACAD SCI USA, V102, P11379, DOI 10.1073/pnas.0502473102; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Hayashi CY, 2004, MOL BIOL EVOL, V21, P1950, DOI 10.1093/molbev/msh204; Hayashi CY, 1998, J MOL BIOL, V275, P773, DOI 10.1006/jmbi.1997.1478; HIEBER CS, 1985, J THERM BIOL, V10, P171, DOI 10.1016/0306-4565(85)90023-3; HIEBER CS, 1992, OECOLOGIA, V91, P530, DOI 10.1007/BF00650327; Hu X, 2006, CELL MOL LIFE SCI, V63, P1986, DOI 10.1007/s00018-006-6090-y; Hu XY, 2007, BIOCHEMISTRY-US, V46, P3294, DOI 10.1021/bi602507e; Hu XY, 2006, BIOCHEMISTRY-US, V45, P3506, DOI 10.1021/bi052105q; Hu XY, 2005, BIOCHEMISTRY-US, V44, P10020, DOI 10.1021/bi050494i; Hu XY, 2005, J BIOL CHEM, V280, P21220, DOI 10.1074/jbc.M412316200; Huemmerich D, 2004, BIOCHEMISTRY-US, V43, P13604, DOI 10.1021/bi048983q; JIMENEZ CR, 1998, IN GEL DIGESTION PRO; Mitchell B, 2000, BBA-GENE STRUCT EXPR, V1492, P320, DOI 10.1016/S0167-4781(00)00109-3; Moon Myung-Jin, 2003, Korean Journal of Biological Sciences, V7, P35; Motriuk-Smith D, 2005, BIOMACROMOLECULES, V6, P3152, DOI 10.1021/bm050472b; Nguyen L, 2001, NUCLEIC ACIDS RES, V29, P4423, DOI 10.1093/nar/29.21.4423; Rising A, 2006, BIOMACROMOLECULES, V7, P3120, DOI 10.1021/bm060693x; SHULTZ JW, 1987, BIOL REV, V62, P89, DOI 10.1111/j.1469-185X.1987.tb01263.x; Sponner A, 2005, BIOCHEM BIOPH RES CO, V338, P897, DOI 10.1016/j.bbrc.2005.10.048; Sponner A, 2005, NAT MATER, V4, P772, DOI 10.1038/nmat1493; Sponner A, 2004, BIOMACROMOLECULES, V5, P840, DOI 10.1021/bm034378b; Tian MZ, 2005, BIOCHEMISTRY-US, V44, P8006, DOI 10.1021/bi050366u; Zhao AC, 2006, BIOCHEMISTRY-US, V45, P3348, DOI 10.1021/bi052414g	29	56	62	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					35088	35097		10.1074/jbc.M705791200	http://dx.doi.org/10.1074/jbc.M705791200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17921147	hybrid			2022-12-27	WOS:000251155200053
J	Baerson, SR; Dayan, FE; Rimando, AM; Nanayakkara, NPD; Liu, CJ; Schroerder, J; Fishbein, M; Pan, Z; Kagan, IA; Pratt, LH; Le Cordonnier-Pratt, MM; Duke, SO				Baerson, Scott R.; Dayan, Franck E.; Rimando, Agnes M.; Nanayakkara, N. P. Dhammika; Liu, Chang-Jun; Schroerder, Joachim; Fishbein, Mark; Pan, Zhiqiang; Kagan, Isabelle A.; Pratt, Lee H.; Le Cordonnier-Pratt, Marie-Miche; Duke, Stephen O.			A functional genomics investigation of allelochemical biosynthesis in Sorghum bicolor root hairs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLANT O-METHYLTRANSFERASES; EXPRESSED SEQUENCE TAGS; SUBSTRATE-SPECIFICITY; RESORCINOLIC LIPIDS; GLANDULAR TRICHOMES; INHIBITORY-ACTIVITY; NATURAL-PRODUCTS; STRUCTURAL BASIS; SORGOLEONE; METHYLATION	Sorghum is considered to be one of the more allelopathic crop species, producing phytotoxins such as the potent benzoquinone sorgoleone (2-hydroxy-5-methoxy-3-[(Z,Z)-8',11',14'-pentadecatriene]-p-benzoquinone) and its analogs. Sorgoleone likely accounts for much of the allelopathy of Sorghum spp., typically representing the predominant constituent of Sorghum bicolor root exudates. Previous and ongoing studies suggest that the biosynthetic pathway for this plant growth inhibitor occurs in root hair cells, involving a polyketide synthase activity that utilizes an atypical 16:3 fatty acyl-CoA starter unit, resulting in the formation of a pentadecatrienyl resorcinol intermediate. Subsequent modifications of this resorcinolic intermediate are likely to be mediated by S-adenosylmethionine-dependent O-methyltransferases and dihydroxylation by cytochrome P450 monooxygenases, although the precise sequence of reactions has not been determined previously. Analyses performed by gas chromatography-mass spectrometry with sorghum root extracts identified a 3-methyl ether derivative of the likely pentadecatrienyl resorcinol intermediate, indicating that dihydroxylation of the resorcinol ring is preceded by O-methylation at the 3'-position by a novel 5-n-alk(en)ylresorcinol-utilizing O-methyltransferase activity. An expressed sequence tag data set consisting of 5,468 sequences selected at random from an S. bicolor root hair-specific cDNA library was generated to identify candidate sequences potentially encoding enzymes involved in the sorgoleone biosynthetic pathway. Quantitative real time reverse transcription-PCR and recombinant enzyme studies with putative O-methyltransferase sequences obtained from the expressed sequence tag data set have led to the identification of a novel O-methyltransferase highly and predominantly expressed in root hairs (designated SbOMT3), which preferentially utilizes alk(en)ylresorcinols among a panel of benzene-derivative substrates tested. SbOMT3 is therefore proposed to be involved in the biosynthesis of the allelochemical sorgoleone.	[Baerson, Scott R.; Dayan, Franck E.; Rimando, Agnes M.; Pan, Zhiqiang; Kagan, Isabelle A.; Duke, Stephen O.] USDA ARS, Nat Prod Utilizat Res Unit, University, MS 38677 USA; [Nanayakkara, N. P. Dhammika] Univ Mississippi, Sch Pharm, Natl Ctr Nat Prod Res, University, MS 38677 USA; [Liu, Chang-Jun] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA; [Schroerder, Joachim] Univ Freiburg, Inst Biol 2, D-79104 Freiburg, Germany; [Fishbein, Mark] Portland State Univ, Dept Biol, Portland, OR 97207 USA; [Pratt, Lee H.; Le Cordonnier-Pratt, Marie-Miche] Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA	United States Department of Agriculture (USDA); University of Mississippi; United States Department of Energy (DOE); Brookhaven National Laboratory; University of Freiburg; Portland State University; University System of Georgia; University of Georgia	Baerson, SR (corresponding author), USDA ARS, Nat Prod Utilizat Res Unit, POB 8048, University, MS 38677 USA.	sbaerson@ars.usda.gov	Dayan, Franck/A-7592-2009; Dayan, Franck E/AAB-6565-2022	Dayan, Franck/0000-0001-6964-2499; Dayan, Franck E/0000-0001-6964-2499; Fishbein, Mark/0000-0003-3099-4387				Achnine L, 2004, PLANT CELL, V16, P3098, DOI 10.1105/tpc.104.024406; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Baerson SR, 2005, J BIOL CHEM, V280, P21867, DOI 10.1074/jbc.M500694200; Bais HP, 2004, TRENDS PLANT SCI, V9, P26, DOI 10.1016/j.tplants.2003.11.008; Berardini TZ, 2004, PLANT PHYSIOL, V2, P1; Bertin C, 2003, PLANT SOIL, V256, P67, DOI 10.1023/A:1026290508166; Bowers JE, 2003, GENETICS, V165, P367; Bucher M, 1997, PLANT MOL BIOL, V35, P497, DOI 10.1023/A:1005869717158; Coiner H, 2006, PLANT J, V46, P193, DOI 10.1111/J.1365-313X.2006.02680.x; Cordonnier-Pratt MM, 2004, COMP FUNCT GENOM, V5, P268, DOI 10.1002/cfg.399; Cutter E. G., 1978, PLANT ANATOMY, P94; Czarnota MA, 2003, INT J PLANT SCI, V164, P861, DOI 10.1086/378661; Czarnota MA, 2003, J CHEM ECOL, V29, P2073, DOI 10.1023/A:1025634402071; Czarnota MA, 2001, WEED TECHNOL, V15, P813, DOI 10.1614/0890-037X(2001)015[0813:MOALOP]2.0.CO;2; Dayan FE, 2003, J BIOL CHEM, V278, P28607, DOI 10.1074/jbc.M304185200; Dayan FE, 2007, J EXP BOT, V58, P3263, DOI 10.1093/jxb/erm173; Dayan FE, 2006, PLANTA, V224, P339, DOI 10.1007/s00425-005-0217-5; Dogget H., 1988, SORGHUM; Duke S. O., 2005, Outlooks on Pest Management, V16, P64, DOI 10.1564/16apl05; Duke SO, 2002, J PESTIC SCI, V27, P298; Duke SO, 2003, TRENDS BIOTECHNOL, V21, P192, DOI 10.1016/S0167-7799(03)00056-8; EINHELLIG FA, 1992, J CHEM ECOL, V18, P1, DOI 10.1007/BF00997160; ENGELS WR, 1993, TRENDS BIOCHEM SCI, V18, P448, DOI 10.1016/0968-0004(93)90148-G; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Facchini PJ, 2005, CURR OPIN PLANT BIOL, V8, P657, DOI 10.1016/j.pbi.2005.09.008; Fate GD, 1996, J AM CHEM SOC, V118, P11369, DOI 10.1021/ja961395i; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; FRANKE I, 1980, HELV CHIM ACTA, V63, P2508, DOI 10.1002/hlca.19800630845; Fridman E, 2005, PLANT CELL, V17, P1252, DOI 10.1105/tpc.104.029736; Gang DR, 2002, PLANT CELL, V14, P505, DOI 10.1105/tpc.010327; Gossett RE, 1996, LIPIDS, V31, P895, DOI 10.1007/BF02522684; Grierson Claire, 2002, Arabidopsis Book, V1, pe0060, DOI 10.1199/tab.0060; Guterman I, 2002, PLANT CELL, V14, P2325, DOI 10.1105/tpc.005207; He XZ, 1998, PLANT MOL BIOL, V36, P43, DOI 10.1023/A:1005938121453; Hejl AM, 2004, J CHEM ECOL, V30, P2181, DOI 10.1023/B:JOEC.0000048782.87862.7f; HELD BM, 1993, PLANT PHYSIOL, V102, P1001, DOI 10.1104/pp.102.3.1001; Inderjit, 2003, PLANTA, V217, P529, DOI 10.1007/s00425-003-1054-z; Kagan IA, 2003, J AGR FOOD CHEM, V51, P7589, DOI 10.1021/jf034789j; KOZUBEK A, 1995, ACTA BIOCHIM POL, V42, P241; Kozubek A, 1999, CHEM REV, V99, P1, DOI 10.1021/cr970464o; KOZUBEK A, 1989, ACTA U WRATISL, V868, P27; Lange BM, 2000, P NATL ACAD SCI USA, V97, P2934, DOI 10.1073/pnas.97.6.2934; Lavid N, 2002, PLANT PHYSIOL, V129, P1899, DOI 10.1104/pp.005330; Liang C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-115; Liu CJ, 2006, PLANT CELL, V18, P3656, DOI 10.1105/tpc.106.041376; Martinez GL, 2000, J ELECTRON MATER, V29, P325, DOI 10.1007/s11664-000-0072-x; Meazza G, 2002, PHYTOCHEMISTRY, V60, P281, DOI 10.1016/S0031-9422(02)00121-8; Menz MA, 2002, PLANT MOL BIOL, V48, P483, DOI 10.1023/A:1014831302392; NETZLY DH, 1986, CROP SCI, V26, P775, DOI 10.2135/cropsci1986.0011183X002600040031x; NETZLY DH, 1988, WEED SCI, V36, P441, DOI 10.1017/S0043174500075172; Nimbal CI, 1996, J AGR FOOD CHEM, V44, P1343, DOI 10.1021/jf950561n; Noel JP, 2003, RECENT ADV PHYTOCHEM, V37, P37; Ohlrogge J, 2000, CURR OPIN PLANT BIOL, V3, P224, DOI 10.1016/S1369-5266(00)00068-6; Ohyanagi H, 2006, NUCLEIC ACIDS RES, V34, pD741, DOI 10.1093/nar/gkj094; Pan ZQ, 2007, J BIOL CHEM, V282, P4326, DOI 10.1074/jbc.M606343200; Paramashivappa R, 2001, J AGR FOOD CHEM, V49, P2548, DOI 10.1021/jf001222j; Paterson Andrew H, 2006, Genome Biol, V7, P311, DOI 10.1186/gb-2006-7-3-311; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Pratt LH, 2005, PLANT PHYSIOL, V139, P869, DOI 10.1104/pp.105.066134; RASMUSSEN JA, 1992, J CHEM ECOL, V18, P197, DOI 10.1007/BF00993753; Rimando AM, 2003, J NAT PROD, V66, P42, DOI 10.1021/np0203842; Rimando AM, 1998, J NAT PROD, V61, P927, DOI 10.1021/np9800708; RIMANDO AM, 2005, SEMIOCHEMICALS PEST, V906, P59; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sambrook J, 1989, MOL CLONING LAB MANU, P9; Schulz M, 1999, CHEMOECOLOGY, V9, P133, DOI 10.1007/s000490050044; Swofford DL., 2001, PAUP PHYLOGENETIC AN; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wang JH, 1999, ARCH BIOCHEM BIOPHYS, V368, P172, DOI 10.1006/abbi.1999.1304; Wang JH, 1997, PLANT PHYSIOL, V114, P213, DOI 10.1104/pp.114.1.213; Weston LA, 2003, CRIT REV PLANT SCI, V22, P367, DOI 10.1080/713610861; Wu CH, 2002, NUCLEIC ACIDS RES, V30, P35, DOI 10.1093/nar/30.1.35; Yang XH, 2004, J EXP BOT, V55, P2251, DOI 10.1093/jxb/erh252; Zubieta C, 2002, PLANT CELL, V14, P1265, DOI 10.1105/tpc.001412; Zubieta C, 2001, NAT STRUCT BIOL, V8, P271, DOI 10.1038/85029	76	55	69	3	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3231	3247		10.1074/jbc.M706587200	http://dx.doi.org/10.1074/jbc.M706587200			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	17998204	hybrid			2022-12-27	WOS:000253083000027
J	Kim, YJ; Hwang, SY; Hwang, JS; Lee, JW; Oh, ES; Han, IO				Kim, Yoon-Jung; Hwang, So-Young; Hwang, Ji-Sun; Lee, Jung-Weon; Oh, Eok-Soo; Han, Inn-Oc			C6 glioma cell insoluble matrix components enhance interferon-gamma-stimulated inducible nitric-oxide synthase/nitric oxide production in BV2 microglial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR-MATRIX; INTEGRIN; ACTIVATION; ADHESION; LIPOPOLYSACCHARIDE; ASTROCYTES; EXPRESSION; MIGRATION; CYTOKINES; BRAIN	Microglia are the primary central nervous system immune effector cells. Microglial activation is linked to interactions with extracellular cytokines and the extracellular matrix (ECM). Astrocytomas are characterized by their diffuse nature, which is regulated by insoluble ECM components produced by the tumor cells that are largely absent from normal central nervous system tissue. The present study examined the influence of astrocytoma (C6 rat glioma) insoluble matrix components on interferon-gamma (IFN-gamma)- mediated inducible nitric-oxide synthase (iNOS) induction in microglial cells. We found that IFN-gamma-stimulated iNOS induction and nitric oxide release was greater in microglia cultured on C6 glioma cell-derived matrices compared with microglia cultured on primary rat astrocyte-derived matrices. Culture of microglia on C6 glioma cell-derived matrices also led to activation of STAT1, augmentation of IFN-gamma-induced STAT-3 activation, and an increase in IFN-gamma-activated site (GAS)- luciferase reporter activity. In addition, culture of microglia on C6 glioma cell-derived matrices activated NF-kappa B DNA binding activity and transcriptional activity. The results suggest that insoluble matrix components derived from malignant glioma cells can regulate microglia activation. These factors may include ECM components, such as fibronectin, collagen, laminin, vitronectin, and other nondiffusible compounds, and laminin seems to a critical regulator of this process. Microglia activation and subsequent brain inflammation may influence tumor growth, treatment, and metastasis. Better understanding of the regulation of microglial activation by astrocytoma-derived insoluble matrix components may be important in the development of immune-based treatment strategies against malignant brain tumors.	[Kim, Yoon-Jung; Hwang, So-Young; Hwang, Ji-Sun; Han, Inn-Oc] Inha Univ, Dept Physiol & Biophys, Coll Med, Inchon 402751, South Korea; [Lee, Jung-Weon] Seoul Natl Univ, Coll Med, Inst Canc Res, Dept Tumor Biol, Seoul 110799, South Korea; [Oh, Eok-Soo] Ewha Womans Univ, Dept Life Sci, Div Mol Life Sci, Seoul 120750, South Korea; [Oh, Eok-Soo] Ewha Womans Univ, Ctr Cell Signaling Res, Seoul 120750, South Korea	Inha University; Seoul National University (SNU); Ewha Womans University; Ewha Womans University	Han, IO (corresponding author), Inha Univ, Dept Physiol & Biophys, Coll Med, 253 Yonghyun Dong, Inchon 402751, South Korea.	iohan@inha.ac.kr	Lee, Jung Weon/AAC-1146-2020; Lee, Jung Weon/F-9149-2012	Lee, Jung Weon/0000-0003-2722-8200; 				Aloisi F, 1999, ADV EXP MED BIOL, V468, P123; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; DIAMOND MS, 1994, CURR BIOL, V4, P506, DOI 10.1016/S0960-9822(00)00111-1; DUSTIN ML, 1991, ANNU REV IMMUNOL, V9, P27, DOI 10.1146/annurev.iy.09.040191.000331; EGAN RA, 1991, BRAIN RES, V568, P330, DOI 10.1016/0006-8993(91)91421-V; Feuerstein GZ, 1998, NEUROIMMUNOMODULAT, V5, P143, DOI 10.1159/000026331; FRISEN J, 1995, NEUROSCIENCE, V65, P293, DOI 10.1016/0306-4522(94)00467-J; Gladson CL, 1999, J NEUROPATH EXP NEUR, V58, P1029, DOI 10.1097/00005072-199910000-00001; Guan JL, 1997, MATRIX BIOL, V16, P195, DOI 10.1016/S0945-053X(97)90008-1; Han IO, 2003, J NEUROSCI RES, V73, P659, DOI 10.1002/jnr.10706; HUTTENLOCHER A, 1995, CURR OPIN CELL BIOL, V7, P697, DOI 10.1016/0955-0674(95)80112-X; Hwang SY, 2004, BIOCHEM BIOPH RES CO, V318, P691, DOI 10.1016/j.bbrc.2004.04.082; Jack C, 2005, J NEUROSCI RES, V81, P363, DOI 10.1002/jnr.20482; Kim HS, 2004, J NEUROIMMUNOL, V151, P85, DOI 10.1016/j.jneuroim.2004.02.006; Kim WK, 2004, J IMMUNOL, V172, P7015, DOI 10.4049/jimmunol.172.11.7015; Kloss CUA, 2001, EXP NEUROL, V168, P32, DOI 10.1006/exnr.2000.7575; Labeur MS, 1999, J IMMUNOL, V162, P168; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; LAYWELL ED, 1991, ANN NY ACAD SCI, V633, P122; Mettouchi A, 2001, MOL CELL, V8, P115, DOI 10.1016/S1097-2765(01)00285-4; Milner R, 2003, J IMMUNOL, V170, P3850, DOI 10.4049/jimmunol.170.7.3850; Milner R, 2002, J NEUROSCI, V22, P1562, DOI 10.1523/JNEUROSCI.22-05-01562.2002; MORRIS CS, 1991, J NEUROL SCI, V101, P47, DOI 10.1016/0022-510X(91)90017-2; Nakagawa T, 1996, J NEURO-ONCOL, V28, P13, DOI 10.1007/BF00300442; Niquet J, 1996, GLIA, V16, P359, DOI 10.1002/(SICI)1098-1136(199604)16:4<359::AID-GLIA8>3.0.CO;2-V; Raines EW, 2000, INT J EXP PATHOL, V81, P173, DOI 10.1046/j.1365-2613.2000.00155.x; Raivich G, 1999, BRAIN RES REV, V30, P77, DOI 10.1016/S0165-0173(99)00007-7; Roggendorf W, 1996, ACTA NEUROPATHOL, V92, P288, DOI 10.1007/s004010050520; Rosales AA, 1997, BRAIN RES, V748, P195, DOI 10.1016/S0006-8993(96)01301-7; Sola C, 2002, EUR J NEUROSCI, V16, P1275, DOI 10.1046/j.1460-9568.2002.02199.x; Stoll G, 1999, PROG NEUROBIOL, V58, P233, DOI 10.1016/S0301-0082(98)00083-5; Werb Z, 1998, ANN NY ACAD SCI, V857, P110, DOI 10.1111/j.1749-6632.1998.tb10111.x	32	12	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2526	2533		10.1074/jbc.M610219200	http://dx.doi.org/10.1074/jbc.M610219200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	17981810	hybrid			2022-12-27	WOS:000252622300009
J	Sherwood, TW; Askwith, CC				Sherwood, Thomas W.; Askwith, Candice C.			Endogenous arginine-phenylalanine-amide-related peptides alter steady-state desensitization of ASIC1a	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSING ION CHANNELS; TARANTULA TOXIN PSALMOTOXIN-1; PROTON-GATED CHANNELS; DORSAL-HORN NEURONS; INTRACELLULAR PH; SENSORY NEURONS; RFAMIDE NEUROPEPTIDES; EXTRACELLULAR DOMAIN; CEREBRAL-ISCHEMIA; SODIUM-CHANNEL	The acid-sensing ion channels ( ASICs) are proton-gated, voltage-insensitive cation channels expressed throughout the nervous system. ASIC1a plays a role in learning, pain, and fear-related behaviors. In addition, activation of ASIC1a during prolonged acidosis following cerebral ischemia induces neuronal death. ASICs undergo steady-state desensitization, a characteristic that limits ASIC1a activity and may play a prominent role in the prevention of ASIC1a-evoked neuronal death. In this study, we found exogenous and endogenous arginine-phenylalanineamide ( RF-amide)-related peptides decreased the pH sensitivity of ASIC1a steady-state desensitization. During conditions that normally induced steady-state desensitization, these peptides profoundly enhanced ASIC1a activity. We also determined that human ASIC1a required more acidic pH to undergo steady-state desensitization compared with mouse ASIC1a. Surprisingly, steady-state desensitization of human ASIC1a was also affected by a greater number of peptides compared with mouse ASIC1a. Mutation of five amino acids in a region of the extracellular domain changed the characteristics of human ASIC1a to those of mouse ASIC1a, suggesting that this region plays a pivotal role in neuropeptide and pH sensitivity of steady-state desensitization. Overall, these experiments lend vital insight into steady-state desensitization of ASIC1a and expand our understanding of the structural determinants of RF-amide-related peptide modulation. Furthermore, our finding that endogenous peptides shift steady-state desensitization suggests that RF-amides could impact the role of ASIC1a in both pain and neuronal damage following stroke and ischemia.	[Sherwood, Thomas W.; Askwith, Candice C.] Ohio State Univ, Dept Neurosci, Coll Med, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Askwith, CC (corresponding author), Ohio State Univ, Dept Neurosci, Coll Med, 4197 Graves Hall,333 W 10th Ave, Columbus, OH 43210 USA.	askwith.1@osu.edu						Adams CM, 1998, J BIOL CHEM, V273, P30204, DOI 10.1074/jbc.273.46.30204; ALLEN GV, 1995, NEUROSCIENCE, V68, P1037, DOI 10.1016/0306-4522(95)00198-R; Allen NJ, 2002, J PHYSIOL-LONDON, V543, P521, DOI 10.1113/jphysiol.2002.020297; ANDREWS BT, 1988, J PHARMACOL EXP THER, V247, P1248; Askwith CC, 2000, NEURON, V26, P133, DOI 10.1016/S0896-6273(00)81144-7; Askwith CC, 2004, J BIOL CHEM, V279, P18296, DOI 10.1074/jbc.M312145200; Babini E, 2002, J BIOL CHEM, V277, P41597, DOI 10.1074/jbc.M205877200; Babinski K, 2000, J BIOL CHEM, V275, P28519, DOI 10.1074/jbc.M004114200; Benson CJ, 2002, P NATL ACAD SCI USA, V99, P2338, DOI 10.1073/pnas.032678399; Catarsi S, 2001, NEUROPHARMACOLOGY, V41, P592, DOI 10.1016/S0028-3908(01)00107-1; Chartrel N, 2006, PEPTIDES, V27, P1110, DOI 10.1016/j.peptides.2005.06.035; Chen XM, 2006, J GEN PHYSIOL, V127, P267, DOI 10.1085/jgp.200509409; Chen XM, 2005, J GEN PHYSIOL, V126, P71, DOI 10.1085/jgp.200509303; Chen XM, 2006, NEUROPHARMACOLOGY, V50, P964, DOI 10.1016/j.neuropharm.2006.01.007; CHEUNG RTF, 1995, J COMP NEUROL, V360, P101, DOI 10.1002/cne.903600108; CHEUNG RTF, 1995, J COMP NEUROL, V362, P535, DOI 10.1002/cne.903620408; Cho JH, 2007, AM J PHYSIOL-CELL PH, V292, pC2161, DOI 10.1152/ajpcell.00598.2006; Chu XP, 2006, J NEUROSCI, V26, P5329, DOI 10.1523/JNEUROSCI.0938-06.2006; Coric T, 2005, J PHYSIOL-LONDON, V568, P725, DOI 10.1113/jphysiol.2005.087734; Coric T, 2003, J BIOL CHEM, V278, P45240, DOI 10.1074/jbc.M304441200; Cottrell GA, 2001, FEBS LETT, V489, P71, DOI 10.1016/S0014-5793(01)02081-6; Cushman KA, 2007, J GEN PHYSIOL, V129, P345, DOI 10.1085/jgp.200709757; Deval E, 2003, NEUROPHARMACOLOGY, V44, P662, DOI 10.1016/S0028-3908(03)00047-9; Duan B, 2007, J NEUROSCI, V27, P11139, DOI 10.1523/JNEUROSCI.3364-07.2007; Fukusumi S, 2006, PEPTIDES, V27, P1073, DOI 10.1016/j.peptides.2005.06.031; Hesselager M, 2004, J BIOL CHEM, V279, P11006, DOI 10.1074/jbc.M313507200; Hey JG, 2007, STROKE, V38, P670, DOI 10.1161/01.STR.0000251443.68897.99; Huang BS, 2002, HYPERTENSION, V39, P557, DOI 10.1161/hy02t2.103004; Immke DC, 2003, NEURON, V37, P75, DOI 10.1016/S0896-6273(02)01130-3; Immke DC, 2001, NAT NEUROSCI, V4, P869, DOI 10.1038/nn0901-869; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Jiang Y, 2003, J BIOL CHEM, V278, P27652, DOI 10.1074/jbc.M302945200; Kagansky N, 2001, ARCH NEUROL-CHICAGO, V58, P1209, DOI 10.1001/archneur.58.8.1209; KRAIG RP, 1983, J NEUROPHYSIOL, V49, P831, DOI 10.1152/jn.1983.49.3.831; Krishtal O, 2003, TRENDS NEUROSCI, V26, P477, DOI 10.1016/S0166-2236(03)00210-8; LINGUEGLIA E, 1995, NATURE, V378, P730, DOI 10.1038/378730a0; Lingueglia E, 2006, PEPTIDES, V27, P1138, DOI 10.1016/j.peptides.2005.06.037; Mazzuca M, 2007, NAT NEUROSCI, V10, P943, DOI 10.1038/nn1940; Mercado F, 2006, J NEUROPHYSIOL, V96, P1615, DOI 10.1152/jn.00378.2006; Nishimura M, 2000, HYPERTENSION, V35, P443, DOI 10.1161/01.HYP.35.1.443; Ostrovskaya O, 2004, J NEUROCHEM, V91, P252, DOI 10.1111/j.1471-4159.2004.02688.x; Panula P, 1999, BRAIN RES, V848, P191, DOI 10.1016/S0006-8993(99)02044-2; Paukert M, 2004, J GEN PHYSIOL, V124, P383, DOI 10.1085/jgp.200308973; Pignataro G, 2007, BRAIN, V130, P151, DOI 10.1093/brain/awl325; Poirot O, 2004, J BIOL CHEM, V279, P38448, DOI 10.1074/jbc.M407381200; RAFFA RB, 1988, PEPTIDES, V9, P915, DOI 10.1016/0196-9781(88)90141-6; Salinas M, 2006, J PHYSIOL-LONDON, V570, P339, DOI 10.1113/jphysiol.2005.095810; Siesjo BK, 1996, ACT NEUR S, V66, P8; SIESJO BK, 1988, NEUROCHEM PATHOL, V9, P31; SMITH ML, 1986, J CEREBR BLOOD F MET, V6, P574, DOI 10.1038/jcbfm.1986.104; Tsutsui K, 2006, PEPTIDES, V27, P1121, DOI 10.1016/j.peptides.2005.06.036; VONHANWEHR R, 1986, J NEUROCHEM, V46, P331; Waldmann R, 2001, ADV EXP MED BIOL, V502, P293; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Wang WZ, 2006, J BIOL CHEM, V281, P29369, DOI 10.1074/jbc.M605122200; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Wemmie JA, 2006, TRENDS NEUROSCI, V29, P578, DOI 10.1016/j.tins.2006.06.014; Wu LJ, 2004, J BIOL CHEM, V279, P43716, DOI 10.1074/jbc.M403557200; Xie JH, 2003, J NEUROPHYSIOL, V89, P2459, DOI 10.1152/jn.00707.2002; Xie JH, 2002, J NEUROPHYSIOL, V87, P2835, DOI 10.1152/jn.2002.87.6.2835; Xiong ZG, 2006, J MEMBRANE BIOL, V209, P59, DOI 10.1007/s00232-005-0840-x; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; YANG HY, 2007, IN PRESS NEUROPEPTID; Yermolaieva O, 2004, P NATL ACAD SCI USA, V101, P6752, DOI 10.1073/pnas.0308636100; Yoshida H, 2003, BBA-MOL CELL RES, V1593, P151, DOI 10.1016/S0167-4889(02)00389-0	66	59	59	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					1818	1830		10.1074/jbc.M705118200	http://dx.doi.org/10.1074/jbc.M705118200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	17984098	hybrid			2022-12-27	WOS:000252501000007
J	Chandramouli, S; Yu, CY; Yusoff, P; Lao, DH; Leong, HF; Mizuno, K; Guy, GR				Chandramouli, Sumana; Yu, Chye Yun; Yusoff, Permeen; Lao, Dieu-Hung; Leong, Hwei Fen; Mizuno, Kensaku; Guy, Graeme R.			Tesk1 interacts with spry2 to abrogate its inhibition of ERK phosphorylation downstream of receptor tyrosine kinase signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; SPROUTY PROTEINS; COFILIN PHOSPHORYLATION; ACTIN REORGANIZATION; TRANSLOCATION DOMAIN; LIM KINASE; GROWTH; ACTIVATION; RAS; ANTAGONIST	The Sprouty ( Spry) proteins function as inhibitors of the Ras-ERK pathway downstream of various receptor tyrosine kinases. In this study, we have identified Tesk1 ( testicular protein kinase 1) as a novel regulator of Spry2 function. Endogenous Tesk1 and Spry2 exist in a complex in cell lines and mouse tissues. Tesk1 coexpression relocalizes Spry2 to vesicles including endosomes, inhibiting its translocation to membrane ruffles upon growth factor stimulation. Independent of its kinase activity, Tesk1 binding leads to a loss of Spry2 function as an inhibitor of ERK phosphorylation and reverses inhibition of basic fibroblast growth factor (bFGF)- and nerve growth factor-induced neurite outgrowth in PC12 cells by Spry2. Furthermore, depletion of endogenous Tesk1 in PC12 cells leads to a reduction in neurite outgrowth induced by bFGF. Tesk1 nullifies the inhibitory effect of Spry2 by abrogating its interaction with the adaptor protein Grb2 and interfering with its serine dephosphorylation upon bFGF and FGF receptor 1 stimulation by impeding its binding to the catalytic subunit of protein phosphatase 2A. A construct of Tesk1 that binds to Spry2 but does not localize to the vesicles does not interfere with its function, highlighting the importance of subcellular localization of Tesk1 in this context. Conversely, Tesk1 does not affect interaction of Spry2 with the E3 ubiquitin ligase, c-Cbl, and consequently, does not affect its inhibition of Cbl-mediated ubiquitination of the epidermal growth factor receptor. By selectively modulating the downstream effects of Spry2, Tesk1 may thus serve as a molecular determinant of the signaling outcome.	[Chandramouli, Sumana; Yu, Chye Yun; Yusoff, Permeen; Lao, Dieu-Hung; Leong, Hwei Fen; Guy, Graeme R.] Inst Mol & Cell Biol, Singapore 138673, Singapore; [Mizuno, Kensaku] Tohoku Univ, Grad Sch Life Sci, Dept Biomol Sci, Sendai, Miyagi 9808578, Japan	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Tohoku University	Guy, GR (corresponding author), Inst Mol & Cell Biol, 61 Biopolis Dr, Singapore 138673, Singapore.	mcbgg@imcb.a-star.edu.sg	Mizuno, Kensaku/G-8631-2015	Chandramouli, Sumana/0000-0001-6994-506X				Casci T, 1999, CELL, V96, P655, DOI 10.1016/S0092-8674(00)80576-0; Christofori G, 2003, NAT CELL BIOL, V5, P377, DOI 10.1038/ncb0503-377; DaSilva J, 2006, MOL CELL BIOL, V26, P1898, DOI 10.1128/MCB.26.5.1898-1907.2006; Edwin F, 2006, J BIOL CHEM, V281, P4816, DOI 10.1074/jbc.M508300200; Egan JE, 2002, P NATL ACAD SCI USA, V99, P6041, DOI 10.1073/pnas.052090899; Endo M, 2003, J NEUROSCI, V23, P2527; Endo M, 2007, J BIOL CHEM, V282, P13692, DOI 10.1074/jbc.M610873200; Fong CW, 2003, J BIOL CHEM, V278, P33456, DOI 10.1074/jbc.M301317200; Gross I, 2001, J BIOL CHEM, V276, P46460, DOI 10.1074/jbc.M108234200; Guy GR, 2003, J CELL SCI, V116, P3061, DOI 10.1242/jcs.00652; Hacohen N, 1998, CELL, V92, P253, DOI 10.1016/S0092-8674(00)80919-8; Haglund K, 2005, EMBO REP, V6, P635, DOI 10.1038/sj.embor.7400453; Hall AB, 2003, CURR BIOL, V13, P308, DOI 10.1016/S0960-9822(03)00086-1; Hanafusa H, 2002, NAT CELL BIOL, V4, P850, DOI 10.1038/ncb867; Impagnatiello MA, 2001, J CELL BIOL, V152, P1087, DOI 10.1083/jcb.152.5.1087; Kim HJ, 2007, CURR BIOL, V17, P455, DOI 10.1016/j.cub.2007.01.059; Kramer S, 1999, DEVELOPMENT, V126, P2515; LaLonde DP, 2005, J BIOL CHEM, V280, P21680, DOI 10.1074/jbc.m500752200; Lao DH, 2007, J BIOL CHEM, V282, P9117, DOI 10.1074/jbc.M607563200; Lao DH, 2006, J BIOL CHEM, V281, P29993, DOI 10.1074/jbc.M604044200; Leeksma OC, 2002, EUR J BIOCHEM, V269, P2546, DOI 10.1046/j.1432-1033.2002.02921.x; Lim J, 2000, J BIOL CHEM, V275, P32837, DOI 10.1074/jbc.M002156200; Lim J, 2002, MOL CELL BIOL, V22, P7953, DOI 10.1128/MCB.22.22.7953-7966.2002; Lo TL, 2006, CANCER LETT, V242, P141, DOI 10.1016/j.canlet.2005.12.032; Manser E, 1997, MOL CELL BIOL, V17, P1129, DOI 10.1128/MCB.17.3.1129; Mason JM, 2004, MOL BIOL CELL, V15, P2176, DOI 10.1091/mbc.E03-07-0503; Minowada G, 1999, DEVELOPMENT, V126, P4465; Nonami A, 2005, GENES CELLS, V10, P887, DOI 10.1111/j.1365-2443.2005.00886.x; Rodriguez-Viciana P, 2006, P NATL ACAD SCI USA, V103, P19290, DOI 10.1073/pnas.0609343103; Rubin C, 2003, CURR BIOL, V13, P297, DOI 10.1016/S0960-9822(03)00053-8; Sasaki A, 2003, NAT CELL BIOL, V5, P427, DOI 10.1038/ncb978; Sasaki A, 2001, J BIOL CHEM, V276, P36804, DOI 10.1074/jbc.C100386200; Shaw AT, 2007, GENE DEV, V21, P694, DOI 10.1101/gad.1526207; Tefft JD, 1999, CURR BIOL, V9, P219, DOI 10.1016/S0960-9822(99)80094-3; Toshima J, 1998, BIOCHEM BIOPH RES CO, V249, P107, DOI 10.1006/bbrc.1998.9099; Toshima J, 2001, J BIOL CHEM, V276, P31449, DOI 10.1074/jbc.M102988200; Toshima J, 2001, MOL BIOL CELL, V12, P1131, DOI 10.1091/mbc.12.4.1131; Toshima J, 1999, J BIOL CHEM, V274, P12171, DOI 10.1074/jbc.274.17.12171; Tsumura Y, 2005, BIOCHEM J, V387, P627, DOI 10.1042/BJ20041181; Wakioka T, 2001, NATURE, V412, P647, DOI 10.1038/35088082; Wong ESM, 2002, EMBO J, V21, P4796, DOI 10.1093/emboj/cdf493; Wong ESM, 2001, J BIOL CHEM, V276, P5866, DOI 10.1074/jbc.M006945200; Yigzaw Y, 2003, J BIOL CHEM, V278, P284, DOI 10.1074/jbc.M210359200; Yusoff P, 2002, J BIOL CHEM, V277, P3195, DOI 10.1074/jbc.M108368200	44	28	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1679	1691		10.1074/jbc.M705457200	http://dx.doi.org/10.1074/jbc.M705457200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	17974561	hybrid			2022-12-27	WOS:000252282700055
J	Frankel, LB; Christoffersen, NR; Jacobsen, A; Lindow, M; Krogh, A; Lund, AH				Frankel, Lisa B.; Christoffersen, Nanna R.; Jacobsen, Anders; Lindow, Morten; Krogh, Anders; Lund, Anders H.			Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR GENE; NF-KAPPA-B; TRANSFORMATION SUPPRESSOR; TRANSLATION INITIATION; SMALL RNAS; EXPRESSION; APOPTOSIS; AP-1; INVOLVEMENT; REPRESSION	MicroRNAs are emerging as important regulators of cancer-related processes. The miR-21 microRNA is overexpressed in a wide variety of cancers and has been causally linked to cellular proliferation, apoptosis, and migration. Inhibition of mir-21 in MCF-7 breast cancer cells causes reduced cell growth. Using array expression analysis of MCF-7 cells depleted of miR-21, we have identified mRNA targets of mir-21 and have shown a link between miR-21 and the p53 tumor suppressor protein. We furthermore found that the tumor suppressor protein Programmed Cell Death 4 (PDCD4) is regulated by miR-21 and demonstrated that PDCD4 is a functionally important target for miR-21 in breast cancer cells.	[Frankel, Lisa B.; Christoffersen, Nanna R.; Jacobsen, Anders; Lindow, Morten; Krogh, Anders; Lund, Anders H.] Univ Copenhagen, Biotech Res & Innovat Ctr, DK-2200 Copenhagen, Denmark; [Jacobsen, Anders; Lindow, Morten; Krogh, Anders] Univ Copenhagen, Bioinformat Ctr, DK-2200 Copenhagen, Denmark; [Lund, Anders H.] Univ Copenhagen, Ctr Epigenet, DK-2200 Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen	Lund, AH (corresponding author), Univ Copenhagen, Biotech Res & Innovat Ctr, Ole Maaloes Vej 5, DK-2200 Copenhagen, Denmark.	anders.lund@bric.dk	Skanderup, Anders Jacobsen/K-1081-2013; Lund, Anders H./F-4786-2014; Krogh, Anders/M-1541-2014	Skanderup, Anders Jacobsen/0000-0001-6847-4980; Lund, Anders H./0000-0002-7407-3398; Frankel, Lisa/0000-0001-7249-3607; Krogh, Anders/0000-0002-5147-6282				Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2007, J CLIN INVEST, V117, P2059, DOI 10.1172/JCI32577; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chen Y, 2003, J PATHOL, V200, P640, DOI 10.1002/path.1378; Chow LML, 2006, CANCER LETT, V241, P184, DOI 10.1016/j.canlet.2005.11.042; Christoffersen NR, 2007, RNA, V13, P1172, DOI 10.1261/rna.586807; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Gao F, 2007, ONCOL REP, V17, P123; Goke A, 2002, BIOCHEM BIOPH RES CO, V297, P78, DOI 10.1016/S0006-291X(02)02129-0; Goke R, 2004, AM J PHYSIOL-CELL PH, V287, pC1541, DOI 10.1152/ajpcell.00025.2004; Griffiths-Jones Sam, 2006, V342, P129, DOI 10.1385/1-59745-123-1:129; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Humphreys DT, 2005, P NATL ACAD SCI USA, V102, P16961, DOI 10.1073/pnas.0506482102; Hwang SK, 2007, GENE THER, V14, P1353, DOI 10.1038/sj.gt.3302983; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; JACKSON RJ, 2007, SCI STKE, pRE1, DOI DOI 10.1126/STKE.3672007RE1; Jansen AP, 2005, CANCER RES, V65, P6034, DOI 10.1158/0008-5472.CAN-04-2119; Jansen AP, 2004, MOL CANCER THER, V3, P103; Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Jovanovic M, 2006, ONCOGENE, V25, P6176, DOI 10.1038/sj.onc.1209912; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lankat-Buttgereit B, 2003, BIOL CELL, V95, P515, DOI 10.1016/j.biolcel.2003.09.003; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Levine AJ, 2006, GENE DEV, V20, P267, DOI 10.1101/gad.1363206; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Meng FY, 2006, GASTROENTEROLOGY, V130, P2113, DOI 10.1053/j.gastro.2006.02.057; Nilsen TW, 2007, TRENDS GENET, V23, P243, DOI 10.1016/j.tig.2007.02.011; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Roldo C, 2006, J CLIN ONCOL, V24, P4677, DOI 10.1200/JCO.2005.05.5194; Sage C Ie, 2007, EMBO J, V26, P3699; Sevignani C, 2007, P NATL ACAD SCI USA, V104, P8017, DOI 10.1073/pnas.0702177104; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Tarasov V, 2007, CELL CYCLE, V6, P1586, DOI 10.4161/cc.6.13.4436; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Welch C, 2007, ONCOGENE, V26, P5017, DOI 10.1038/sj.onc.1210293; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103; Yang HS, 2003, MOL CELL BIOL, V23, P26, DOI 10.1128/MCB.23.1.26-37.2003; Yang HS, 2003, ONCOGENE, V22, P3712, DOI 10.1038/sj.onc.1206433; Yang HS, 2001, ONCOGENE, V20, P669, DOI 10.1038/sj.onc.1204137; Young MR, 2003, TRENDS MOL MED, V9, P36, DOI 10.1016/S1471-4914(02)00009-6; Zhang H, 2006, ONCOGENE, V25, P6101, DOI 10.1038/sj.onc.1209634; Zhu SM, 2007, J BIOL CHEM, V282, P14328, DOI 10.1074/jbc.M611393200	61	915	995	0	77	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					1026	1033		10.1074/jbc.M707224200	http://dx.doi.org/10.1074/jbc.M707224200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	17991735	hybrid			2022-12-27	WOS:000252128100042
J	He, R; Drury, GE; Rotari, VI; Gordon, A; Willer, M; Farzaneh, T; Woltering, EJ; Gallois, P				He, Rui; Drury, Georgina E.; Rotari, Vitalie I.; Gordon, Anna; Willer, Martin; Farzaneh, Tabasum; Woltering, Ernst J.; Gallois, Patrick			Metacaspase-8 modulates programmed cell death induced by ultraviolet light and H2O2 in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNALING PATHWAYS; APOPTOSIS; THALIANA; YEAST; GENE; RESISTANCE; JASMONATE; ETHYLENE; PROTEIN; FAMILY	Programmed cell death (PCD) is a genetically controlled cell death that is regulated during development and activated in response to environmental stresses or pathogen infection. The degree of conservation of PCD across kingdoms and phylum is not yet clear; however, whereas caspases are proteases that act as key components of animal apoptosis, plants have no orthologous caspase sequences in their genomes. The discovery of plant and fungi metacaspases as proteases most closely related to animal caspases led to the hypothesis that metacaspases are the functional homologues of animal caspases in these organisms. Arabidopsis thaliana has nine metacaspase genes, and so far it is unknown which members of the family if any are involved in the regulation of PCD. We show here that metacaspase-8 (AtMC8) is a member of the gene family strongly up-regulated by oxidative stresses caused by UVC, H2O2, or methyl viologen. This up-regulation was dependent of RCD1, a mediator of the oxidative stress response. Recombinant metacaspase-8 cleaved after arginine, had a pH optimum of 8, and complemented the H2O2 no-death phenotype of a yeast metacaspase knock-out. Overexpressing AtMC8 up-regulated PCD induced by UVC or H2O2, and knocking out AtMC8 reduced cell death triggered by UVC and H2O2 in protoplasts. Knock-out seeds and seedlings had an increased tolerance to the herbicide methyl viologen. We suggest that metacaspase-8 is part of an evolutionary conserved PCD pathway activated by oxidative stress.	[He, Rui; Drury, Georgina E.; Rotari, Vitalie I.; Gordon, Anna; Willer, Martin; Farzaneh, Tabasum; Gallois, Patrick] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Woltering, Ernst J.] Univ Wageningen & Res Ctr, Agrotechnol & Food Sci Grp, NL-6700 AA Wageningen, Netherlands	University of Manchester; Wageningen University & Research	Gallois, P (corresponding author), Univ Manchester, Fac Life Sci, 3 614 Stopford Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	patrick.gallois@manchester.ac.uk		GALLOIS, Patrick/0000-0002-6305-2807				Ahlfors R, 2004, PLANT CELL, V16, P1925, DOI 10.1105/tpc.021832; Asai T, 2000, PLANT CELL, V12, P1823, DOI 10.1105/tpc.12.10.1823; BECHTOLD N, 1993, CR ACAD SCI III-VIE, V316, P1194; Belenghi B, 2007, J BIOL CHEM, V282, P1352, DOI 10.1074/jbc.M608931200; Belles-Boix E, 2000, FEBS LETT, V482, P19, DOI 10.1016/S0014-5793(00)02016-0; Bozhkov PV, 2004, CELL DEATH DIFFER, V11, P175, DOI 10.1038/sj.cdd.4401330; Bozhkov PV, 2005, P NATL ACAD SCI USA, V102, P14463, DOI 10.1073/pnas.0506948102; Chandra-Shekara AC, 2006, PLANT J, V45, P320, DOI 10.1111/j.1365-313X.2005.02618.x; Chen SR, 2004, J EXP BOT, V55, P2617, DOI 10.1093/jxb/erh275; Danon A, 1998, FEBS LETT, V437, P131, DOI 10.1016/S0014-5793(98)01208-3; Danon A, 2004, J BIOL CHEM, V279, P779, DOI 10.1074/jbc.M304468200; Danon A, 2006, P NATL ACAD SCI USA, V103, P17036, DOI 10.1073/pnas.0608139103; Desikan R, 1998, BIOCHEM J, V330, P115, DOI 10.1042/bj3300115; Dietrich RA, 1997, CELL, V88, P685, DOI 10.1016/S0092-8674(00)81911-X; Fujibe T, 2004, PLANT PHYSIOL, V134, P275, DOI 10.1104/pp.103.033480; Gunawardena AHLAN, 2005, PLANTA, V221, P607, DOI 10.1007/s00425-005-1545-1; HAJDUKIEWICZ P, 1994, PLANT MOL BIOL, V25, P989, DOI 10.1007/BF00014672; Hauptmann P, 2006, MOL MICROBIOL, V59, P765, DOI 10.1111/j.1365-2958.2005.04981.x; Helms MJ, 2006, J CELL SCI, V119, P1105, DOI 10.1242/jcs.02809; Hoeberichts FA, 2003, PLANTA, V217, P517, DOI 10.1007/s00425-003-1049-9; Ivanovska I, 2005, J CELL BIOL, V170, P391, DOI 10.1083/jcb.200503069; Koonin EV, 2002, CELL DEATH DIFFER, V9, P394, DOI 10.1038/sj.cdd.4400991; Los M, 1999, IMMUNITY, V10, P629, DOI 10.1016/S1074-7613(00)80062-X; Madeo F, 2002, MOL CELL, V9, P911, DOI 10.1016/S1097-2765(02)00501-4; Matsumura H, 2003, PLANT J, V33, P425, DOI 10.1046/j.1365-313X.2003.01639.x; Nawrath C, 2002, PLANT CELL, V14, P275, DOI 10.1105/tpc.010376; Overmyer K, 2000, PLANT CELL, V12, P1849, DOI 10.1105/tpc.12.10.1849; PIETRZAK M, 1986, NUCLEIC ACIDS RES, V14, P5857, DOI 10.1093/nar/14.14.5857; Richie DL, 2007, MOL MICROBIOL, V63, P591, DOI 10.1111/j.1365-2958.2006.05534.x; Rotari VI, 2005, PHYSIOL PLANTARUM, V123, P376, DOI 10.1111/j.1399-3054.2005.00465.x; SAMBROOK J, 2000, MOL CLONING LAB MANU; Silva RD, 2005, MOL MICROBIOL, V58, P824, DOI 10.1111/j.1365-2958.2005.04868.x; Suarez MF, 2004, CURR BIOL, V14, pR339, DOI 10.1016/j.cub.2004.04.019; Szallies A, 2002, FEBS LETT, V517, P144, DOI 10.1016/S0014-5793(02)02608-X; Uren AG, 2000, MOL CELL, V6, P961, DOI 10.1016/S1097-2765(05)00086-9; Vachova L, 2005, J CELL BIOL, V169, P711, DOI 10.1083/jcb.200410064; van Baarlen P, 2007, MOL PLANT PATHOL, V8, P41, DOI 10.1111/j.1364-3703.2006.00367.x; Vercammen D, 2004, J BIOL CHEM, V279, P45329, DOI 10.1074/jbc.M406329200; Vercammen D, 2006, J MOL BIOL, V364, P625, DOI 10.1016/j.jmb.2006.09.010; Watanabe N, 2005, J BIOL CHEM, V280, P14691, DOI 10.1074/jbc.M413527200; Zhang NN, 2006, MOL BIOL CELL, V17, P3409, DOI 10.1091/mbc.E06-03-0177	41	180	195	0	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					774	783		10.1074/jbc.M704185200	http://dx.doi.org/10.1074/jbc.M704185200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	17998208	hybrid			2022-12-27	WOS:000252128100016
J	Kudryashov, DS; Cordero, CL; Reisler, E; Satchell, KJF				Kudryashov, Dmitri S.; Cordero, Christina L.; Reisler, Emil; Satchell, Karla J. Fullner			Characterization of the enzymatic activity of the actin cross-linking domain from the Vibrio cholerae MARTX(Vc) toxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-AFFINITY SITES; RTX TOXIN; ATP HYDROLYSIS; F-ACTIN; DIVALENT-CATION; YEAST COFILIN; BINDING; POLYMERIZATION; FILAMENTS; ADF/COFILIN	Vibrio cholerae is a Gram-negative bacterial pathogen that exports enterotoxins, which alter host cells through a number of mechanisms resulting in diarrheal disease. Among the secreted toxins is the multifunctional, autoprocessing RTX toxin (MARTX(Vc)), which disrupts actin cytoskeleton by covalently cross-linking actin monomers into oligomers. The region of the toxin responsible for cross-linking activity is the actin cross-linking domain (ACD). In this study, we demonstrate unambiguously that ACD utilizes G-and not F-actin as a substrate for the cross-linking reaction and hydrolyzes one molecule of ATP per cross-linking event. Furthermore, major actin-binding proteins that regulate actin cytoskeleton in vivo do not block the cross-linking reaction in vitro. Cofilin inhibits the cross-linking of G- and F-actin, at a high mole ratio to actin but accelerates F-actin cross-linking at low mole ratios. DNase I completely blocks the cross-linking of actin, likely due to steric hindrance with one of the cross-linking sites on actin. In the context of the holotoxin, the inhibition of Rho by the Rho-inactivating domain of MARTX(Vc) (Sheahan, K. L., and Satchell, K. J. F. (2007) Cell. Microbiol. 9, 1324-1335) would accelerate F-actin depolymerization and provide G- actin, alone or in complex with actin-binding proteins, for cross-linking by ACD, ultimately leading to the observed rapid cell rounding.	[Cordero, Christina L.; Satchell, Karla J. Fullner] Northwestern Univ, Feinberg Sch Med, Dept Microbiol & Immunol, Chicago, IL 60611 USA; [Kudryashov, Dmitri S.; Reisler, Emil] Univ Calif Los Angeles, Inst Mol Biol, Dept Chem & Biochem, Los Angeles, CA 90095 USA	Northwestern University; Feinberg School of Medicine; University of California System; University of California Los Angeles	Satchell, KJF (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Microbiol & Immunol, 303 E Chicago Ave,Tarry 3-713, Chicago, IL 60611 USA.	k-satchell@northwestern.edu	Kudryashov, Dmitri/P-9004-2014; Satchell, Karla/GSN-3100-2022	Kudryashov, Dmitri/0000-0003-1782-3305	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051490, F31AI052490] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077190] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI051490-05, F31 AI 52490, AI 051490, R01 AI051490, F31 AI052490] Funding Source: Medline; NIGMS NIH HHS [R01 GM077190, GM 077190] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barth H, 2004, MICROBIOL MOL BIOL R, V68, P373, DOI 10.1128/MMBR.68.3.373-402.2004; Blanchoin L, 1999, J BIOL CHEM, V274, P15538, DOI 10.1074/jbc.274.22.15538; Bobkov AA, 2002, J MOL BIOL, V323, P739, DOI 10.1016/S0022-2836(02)01008-2; CARLIER MF, 1987, J BIOL CHEM, V262, P3052; CARLIER MF, 1987, BIOCHEM BIOPH RES CO, V143, P1069, DOI 10.1016/0006-291X(87)90361-5; CARLIER MF, 1986, J BIOL CHEM, V261, P778; Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; Chen H, 2004, BIOCHEMISTRY-US, V43, P7127, DOI 10.1021/bi049797n; Cordero CL, 2007, J CLIN MICROBIOL, V45, P2289, DOI 10.1128/JCM.00349-07; Cordero CL, 2006, J BIOL CHEM, V281, P32366, DOI 10.1074/jbc.M605275200; Du JY, 1998, BIOCHEMISTRY-US, V37, P13276, DOI 10.1021/bi981117r; Fullner KJ, 2000, EMBO J, V19, P5315, DOI 10.1093/emboj/19.20.5315; GERSHMAN LC, 1986, BIOCHEM BIOPH RES CO, V135, P607, DOI 10.1016/0006-291X(86)90036-7; Goldsmith SC, 2001, J BIOMOL STRUCT DYN, V19, P405, DOI 10.1080/07391102.2001.10506750; Goode BL, 1998, J CELL BIOL, V142, P723, DOI 10.1083/jcb.142.3.723; Hatanaka H, 1996, CELL, V85, P1047, DOI 10.1016/S0092-8674(00)81305-7; Huang TY, 2006, CURR OPIN CELL BIOL, V18, P26, DOI 10.1016/j.ceb.2005.11.005; KAISER DA, 1989, CELL MOTIL CYTOSKEL, V14, P251, DOI 10.1002/cm.970140211; KAPER JB, 1995, CLIN MICROBIOL REV, V8, P48, DOI 10.1128/CMR.8.1.48; Kim E, 1998, BIOCHEMISTRY-US, V37, P17793, DOI 10.1021/bi9812874; KINOSIAN HJ, 1993, J BIOL CHEM, V268, P8683; Klenchin VA, 2003, NAT STRUCT BIOL, V10, P1058, DOI 10.1038/nsb1006; KORN ED, 1987, SCIENCE, V238, P638, DOI 10.1126/science.3672117; Kudryashov DS, 2003, BIOPHYS J, V85, P2466, DOI 10.1016/S0006-3495(03)74669-4; Kudryashov DS, 2006, J MOL BIOL, V358, P785, DOI 10.1016/j.jmb.2006.02.029; KUROKAWA H, 1990, BIOCHEM BIOPH RES CO, V168, P451, DOI 10.1016/0006-291X(90)92342-W; Lappalainen P, 1997, EMBO J, V16, P5520, DOI 10.1093/emboj/16.18.5520; Morton WM, 2000, NAT CELL BIOL, V2, P376, DOI 10.1038/35014075; Olivier V, 2007, INFECT IMMUN, V75, P5043, DOI 10.1128/IAI.00508-07; Otterbein LR, 2001, SCIENCE, V293, P708, DOI 10.1126/science.1059700; Paavilainen VO, 2007, P NATL ACAD SCI USA, V104, P3113, DOI 10.1073/pnas.0608725104; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; POLLARD TD, 1992, J BIOL CHEM, V267, P20339; ROUAYRENC JF, 1981, EUR J BIOCHEM, V116, P73, DOI 10.1111/j.1432-1033.1981.tb05302.x; Saito S, 1996, CLIN EXP PHARMACOL P, V23, P743, DOI 10.1111/j.1440-1681.1996.tb01770.x; Satchell KJF, 2007, INFECT IMMUN, V75, P5079, DOI 10.1128/IAI.00525-07; Schuler H, 2001, BBA-PROTEIN STRUCT M, V1549, P137, DOI 10.1016/S0167-4838(01)00255-2; Sept D, 2001, BIOPHYS J, V81, P667, DOI 10.1016/S0006-3495(01)75731-1; Sheahan KL, 2007, EMBO J, V26, P2552, DOI 10.1038/sj.emboj.7601700; Sheahan KL, 2007, CELL MICROBIOL, V9, P1324, DOI 10.1111/j.1462-5822.2006.00876.x; Sheahan KL, 2004, P NATL ACAD SCI USA, V101, P9798, DOI 10.1073/pnas.0401104101; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Steele-Mortimer O, 2000, TRAFFIC, V1, P107, DOI 10.1034/j.1600-0854.2000.010203.x; TELLAM R, 1985, BIOCHEMISTRY-US, V24, P4455, DOI 10.1021/bi00337a029; Van Troys M, 1997, J BIOL CHEM, V272, P32750, DOI 10.1074/jbc.272.52.32750; Wriggers W, 1998, J MOL BIOL, V282, P921, DOI 10.1006/jmbi.1998.2048; ZIMMERLE CT, 1987, BIOCHEMISTRY-US, V26, P6545, DOI 10.1021/bi00394a039	47	34	38	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					445	452		10.1074/jbc.M703910200	http://dx.doi.org/10.1074/jbc.M703910200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17951576	Green Accepted, hybrid			2022-12-27	WOS:000251940300049
J	Liu, C; Zhang, Y; Cao, D; He, Y; Kuang, T; Yang, C				Liu, Cheng; Zhang, Yajie; Cao, Derong; He, Yikun; Kuang, Tingyun; Yang, Chunhong			Structural and functional analysis of the antiparallel strands in the lumenal loop of the major light-harvesting chlorophyll a/b complex of photosystem II (LHCIIb) by site-directed mutagenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FEMTOSECOND TRANSIENT ABSORPTION; NEOXANTHIN-BINDING-SITE; HIGHER-PLANTS; ENERGY-TRANSFER; IN-VITRO; ESCHERICHIA-COLI; AMINO-ACIDS; FLUORESCENCE; PROTEIN; XANTHOPHYLLS	The light-harvesting chlorophyll a/b-binding protein of photosystem II ( LHCIIb) fulfills multiple functions, such as light harvesting and energy dissipation under different illuminations. The crystal structure of LHCIIb at the near atomic resolution reveals an antiparallel strands structure in the lumenal loop between the transmembrane helices B/C. To study the structural and functional significances of this structure, three amino acids (Val-119, His-120, and Ser-123) in this region have been exchanged to Phe, Leu, and Gly, respectively, and the influence of the mutagenesis on the structure and function of LHCIIb has been investigated. The results are as follows. 1) Circular dichroism spectra of the mutations reveals that the antiparallel strands in the lumenal region are very important for adjusting pigment conformation in the neoxanthin domain of LHCIIb. Although the mutagenesis causes only a slight loss of the Neo binding in the complexes (V119F, 0.09; S123G, 0.19; and H120L, 0.27), it imparts remarkable changes to the pigment conformation. 2) Substituting Ser-123 with Gly results in a higher susceptibility to photodamage, an increased tendency to aggregate, and enhanced fluorescence quenching induced by the medium acidification. These results demonstrate that this antiparallel strands domain plays an important role in regulating the pigment conformation and in adjusting the aggregation and the fluorescence yield of LHCIIb.	[Liu, Cheng; Zhang, Yajie; Kuang, Tingyun; Yang, Chunhong] Chinese Acad Sci, Inst Bot, Key Lab Photosynthesis & Environm Mol Physiol, Beijing 100093, Peoples R China; [Cao, Derong] S China Univ Technol, Coll Chem, Guangzhou 510640, Peoples R China; [He, Yikun; Kuang, Tingyun] Capital Normal Univ, Coll Life Sci, Beijing 100037, Peoples R China; [Yang, Chunhong] Johannes Gutenberg Univ Mainz, Inst Allgemeine Bot, D-55099 Mainz, Germany; [Liu, Cheng; Zhang, Yajie] Grad Univ, Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; South China University of Technology; Capital Normal University; Johannes Gutenberg University of Mainz; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Yang, C (corresponding author), Chinese Acad Sci, Inst Bot, Key Lab Photosynthesis & Environm Mol Physiol, 20 Nanxincun, Beijing 100093, Peoples R China.	yangch@ibcas.ac.cn						ALLEN JF, 1995, PHYSIOL PLANTARUM, V93, P196, DOI 10.1034/j.1399-3054.1995.930128.x; CASHMORE AR, 1984, P NATL ACAD SCI-BIOL, V81, P2960, DOI 10.1073/pnas.81.10.2960; Cogdell RJ, 2006, TRENDS PLANT SCI, V11, P59, DOI 10.1016/j.tplants.2005.12.002; Connelly JP, 1997, BIOCHEMISTRY-US, V36, P281, DOI 10.1021/bi962467l; Croce R, 1999, FEBS LETT, V456, P1, DOI 10.1016/S0014-5793(99)00907-2; Croce R, 1999, J BIOL CHEM, V274, P29613, DOI 10.1074/jbc.274.42.29613; Croce R, 2003, BIOPHYS J, V84, P2517, DOI 10.1016/S0006-3495(03)75057-7; CROFTS AR, 1994, FEBS LETT, V352, P265, DOI 10.1016/0014-5793(94)00976-7; Formaggio E, 2001, J MOL BIOL, V314, P1157, DOI 10.1006/jmbi.2000.5179; Gilmore AM, 1998, BIOCHEMISTRY-US, V37, P13582, DOI 10.1021/bi981384x; Goss R, 2005, BIOCHEMISTRY-US, V44, P4028, DOI 10.1021/bi047464k; Gradinaru CC, 2003, J PHYS CHEM B, V107, P3938, DOI 10.1021/jp026278q; Grudzinski W, 2001, BBA-BIOENERGETICS, V1503, P291, DOI 10.1016/S0005-2728(00)00206-1; Gruszecki WI, 2006, BBA-BIOENERGETICS, V1757, P1504, DOI 10.1016/j.bbabio.2006.08.002; Hobe S, 2003, J BIOL CHEM, V278, P5912, DOI 10.1074/jbc.M211145200; HOBE S, 1994, EMBO J, V13, P3423, DOI 10.1002/j.1460-2075.1994.tb06647.x; Hobe S, 2006, J BIOL CHEM, V281, P25156, DOI 10.1074/jbc.M604828200; Holt NE, 2005, SCIENCE, V307, P433, DOI 10.1126/science.1105833; Holt NE, 2003, CHEM PHYS LETT, V379, P305, DOI 10.1016/j.cplett.2003.08.039; Horton P, 2000, PHILOS T R SOC B, V355, P1361, DOI 10.1098/rstb.2000.0698; Horton P, 2005, FEBS LETT, V579, P4201, DOI 10.1016/j.febslet.2005.07.003; Horton P, 2005, J EXP BOT, V56, P365, DOI 10.1093/jxb/eri023; Horton P, 1996, ANNU REV PLANT PHYS, V47, P655, DOI 10.1146/annurev.arplant.47.1.655; Kirchhoff H, 2003, BBA-BIOENERGETICS, V1606, P105, DOI 10.1016/S0005-2728(03)00105-1; Kleima FJ, 1999, BIOCHEMISTRY-US, V38, P6587, DOI 10.1021/bi982823v; Li XP, 2004, J BIOL CHEM, V279, P22866, DOI 10.1074/jbc.M402461200; Li XP, 2000, NATURE, V403, P391, DOI 10.1038/35000131; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; MARTINSON TA, 1995, ANAL BIOCHEM, V228, P123, DOI 10.1006/abio.1995.1323; Mick V, 2004, BIOCHEMISTRY-US, V43, P5467, DOI 10.1021/bi036198s; Niedzwiedzki D, 2005, J PHOTOCH PHOTOBIO B, V78, P109, DOI 10.1016/j.jphotobiol.2004.09.012; Palacios MA, 2004, BBA-BIOENERGETICS, V1656, P177, DOI 10.1016/j.bbabio.2004.04.002; Pascal AA, 2005, NATURE, V436, P134, DOI 10.1038/nature03795; PAULSEN H, 1990, PLANTA, V181, P204, DOI 10.1007/BF02411539; Pesaresi P, 1997, FEBS LETT, V402, P151, DOI 10.1016/S0014-5793(96)01518-9; Peterman EJG, 1997, BIOCHEMISTRY-US, V36, P12208, DOI 10.1021/bi9711689; Remelli R, 1999, J BIOL CHEM, V274, P33510, DOI 10.1074/jbc.274.47.33510; Rogl H, 1998, FEBS LETT, V432, P21, DOI 10.1016/S0014-5793(98)00825-4; Ruban AV, 1999, J BIOL CHEM, V274, P10458, DOI 10.1074/jbc.274.15.10458; Ruban AV, 2002, J BIOL CHEM, V277, P42937, DOI 10.1074/jbc.M207823200; RUBAN AV, 1994, BBA-BIOENERGETICS, V1186, P123, DOI 10.1016/0005-2728(94)90143-0; RUBAN AV, 1992, BIOCHIM BIOPHYS ACTA, V1102, P39, DOI 10.1016/0167-4838(92)90496-Z; Ruban AV, 2001, J BIOL CHEM, V276, P24862, DOI 10.1074/jbc.M103263200; Snyder AM, 2004, J BIOL CHEM, V279, P5162, DOI 10.1074/jbc.M309676200; Standfuss R, 2005, EMBO J, V24, P919, DOI 10.1038/sj.emboj.7600585; Vasilev S, 1997, BIOCHEMISTRY-US, V36, P7503, DOI 10.1021/bi9625253; Walters RG, 1996, P NATL ACAD SCI USA, V93, P14204, DOI 10.1073/pnas.93.24.14204; Wentworth M, 2004, BIOCHEMISTRY-US, V43, P501, DOI 10.1021/bi034975i; Wentworth M, 2000, FEBS LETT, V471, P71, DOI 10.1016/S0014-5793(00)01369-7; Wentworth M, 2003, J BIOL CHEM, V278, P21845, DOI 10.1074/jbc.M302586200; Yang CH, 1999, BIOCHEMISTRY-US, V38, P16205, DOI 10.1021/bi990738x	51	29	39	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					487	495		10.1074/jbc.M705736200	http://dx.doi.org/10.1074/jbc.M705736200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17959607	hybrid			2022-12-27	WOS:000251940300054
J	Snowden, T; Shim, KS; Schmutte, C; Acharya, S; Fishel, R				Snowden, Timothy; Shim, Kang-Sup; Schmutte, Christoph; Acharya, Samir; Fishel, Richard			hMSH4-hMSH5 adenosine nucleotide processing and interactions with homologous recombination machinery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA MISMATCH REPAIR; RAD51 NUCLEOPROTEIN FILAMENT; MUTS HOMOLOG; CROSSING-OVER; MEIOTIC RECOMBINATION; RECIPROCAL RECOMBINATION; SACCHAROMYCES-CEREVISIAE; CHROMOSOMAL LOCALIZATION; HOLLIDAY JUNCTION; MAMMALIAN MEIOSIS	We have previously demonstrated that the human heterodimeric meiosis-specific MutS homologs, hMSH4-hMSH5, bind uniquely to a Holliday Junction and its developmental progenitor (Snowden, T., Acharya, S., Butz, C., Berardini, M., and Fishel, R. (2004) Mol. Cell 15, 437-451). ATP binding by hMSH4-hMSH5 resulted in the formation of a sliding clamp that dissociated from the Holliday Junction crossover region embracing two duplex DNA arms. The loading of multiple hMSH4-hMSH5 sliding clamps was anticipated to stabilize the interaction between parental chromosomes during meiosis double-stranded break repair. Here we have identified the interaction region between the individual subunits of hMSH4-hMSH5 that are likely involved in clamp formation and show that each subunit of the heterodimer binds ATP. We have determined that ADP-->ATP exchange is uniquely provoked by Holliday Junction recognition. Moreover, the hydrolysis of ATP by hMSH4-hMSH5 appears to occur after the complex transits the open ends of model Holliday Junction oligonucleotides. Finally, we have identified several components of the double-stranded break repair machinery that strongly interact with hMSH4-hMSH5. These results further underline the function(s) and interactors of hMSH4-hMSH5 that ensure accurate chromosomal repair and segregation during meiosis.	[Snowden, Timothy] Kimmel Canc Ctr, Genet & Mol Biol Program, Philadelphia, PA 19107 USA; [Shim, Kang-Sup; Schmutte, Christoph; Acharya, Samir; Fishel, Richard] Ohio State Univ, Sch Med & Publ Hlth, Columbus, OH 43210 USA	Jefferson University; University System of Ohio; Ohio State University	Fishel, R (corresponding author), Wiseman 485N,400 W 12th Ave, Columbus, OH 43210 USA.	rfishel@osu.edu			NATIONAL CANCER INSTITUTE [R01CA067007, T32CA009662] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080176, R01GM062556] Funding Source: NIH RePORTER; NCI NIH HHS [CA 67007, R01 CA067007-14, R01 CA067007, T32 CA009662, T32 CA 09662] Funding Source: Medline; NIGMS NIH HHS [GM 62556, R01 GM080176-16, R01 GM062556-05, R01 GM062556-08, R01 GM080176, R01 GM080176-17, R01 GM062556] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Acharya S, 2003, MOL CELL, V12, P233, DOI 10.1016/S1097-2765(03)00219-3; Acharya S, 1996, P NATL ACAD SCI USA, V93, P13629, DOI 10.1073/pnas.93.24.13629; Allers T, 2001, MOL CELL, V8, P225, DOI 10.1016/S1097-2765(01)00280-5; Blackwell LJ, 1998, J BIOL CHEM, V273, P32049, DOI 10.1074/jbc.273.48.32049; Bocher T, 1999, CANCER RES, V59, P816; BOCKER T, 1999, BIOCHIM BIOPHYS ACTA, V31, P1; de Vries SS, 1999, GENE DEV, V13, P523, DOI 10.1101/gad.13.5.523; DUCKETT DR, 1988, CELL, V55, P79, DOI 10.1016/0092-8674(88)90011-6; Edelmann W, 1999, NAT GENET, V21, P123, DOI 10.1038/5075; Eisen JA, 1998, NUCLEIC ACIDS RES, V26, P4291, DOI 10.1093/nar/26.18.4291; Fishel R, 1999, NAT MED, V5, P1239, DOI 10.1038/15191; Fishel R, 1998, GENE DEV, V12, P2096, DOI 10.1101/gad.12.14.2096; Fishel R, 1997, CURR OPIN GENET DEV, V7, P105, DOI 10.1016/S0959-437X(97)80117-7; Franklin FCH, 2006, BIOCHEM SOC T, V34, P542, DOI 10.1042/BST0340542; Gradia S, 2000, J BIOL CHEM, V275, P3922, DOI 10.1074/jbc.275.6.3922; Gradia S, 1997, CELL, V91, P995, DOI 10.1016/S0092-8674(00)80490-0; Gradia S, 1999, MOL CELL, V3, P255, DOI 10.1016/S1097-2765(00)80316-0; Guerrette S, 1999, J BIOL CHEM, V274, P6336, DOI 10.1074/jbc.274.10.6336; Guerrette S, 1998, MOL CELL BIOL, V18, P6616, DOI 10.1128/MCB.18.11.6616; HABER LT, 1991, EMBO J, V10, P2707, DOI 10.1002/j.1460-2075.1991.tb07815.x; Hassold T, 2000, HUM MOL GENET, V9, P2409, DOI 10.1093/hmg/9.16.2409; Her C, 1998, GENOMICS, V52, P50, DOI 10.1006/geno.1998.5374; Heyer WD, 2006, NUCLEIC ACIDS RES, V34, P4115, DOI 10.1093/nar/gkl481; Higgins JD, 2004, GENE DEV, V18, P2557, DOI 10.1101/gad.317504; HOLLIDAY R, 1964, GENET RES, V5, P282, DOI 10.1017/S0016672300001233; HOLLINGSWORTH NM, 1995, GENE DEV, V9, P1728, DOI 10.1101/gad.9.14.1728; Kelly KO, 2000, GENETICS, V156, P617; Kleckner N, 1996, P NATL ACAD SCI USA, V93, P8167, DOI 10.1073/pnas.93.16.8167; Kneitz B, 2000, GENE DEV, V14, P1085; Kolas NK, 2004, CYTOGENET GENOME RES, V107, P216, DOI 10.1159/000080600; Kolas NK, 2005, J CELL BIOL, V171, P447, DOI 10.1083/jcb.200506170; Kuznetsov S, 2007, J CELL BIOL, V176, P581, DOI 10.1083/jcb.200608130; Lamers MH, 2000, NATURE, V407, P711, DOI 10.1038/35037523; Lamers MH, 2003, EMBO J, V22, P746, DOI 10.1093/emboj/cdg064; Lenzi ML, 2005, AM J HUM GENET, V76, P112, DOI 10.1086/427268; Lipkin SM, 2002, NAT GENET, V31, P385, DOI 10.1038/ng931; Liu YL, 2007, J BIOL CHEM, V282, P1973, DOI 10.1074/jbc.M609066200; Liu YL, 2004, SCIENCE, V303, P243, DOI 10.1126/science.1093037; Mazin AV, 2000, MOL CELL, V6, P583, DOI 10.1016/S1097-2765(00)00057-5; Mazin AV, 2003, J BIOL CHEM, V278, P14029, DOI 10.1074/jbc.M212779200; Mazur DJ, 2006, MOL CELL, V22, P39, DOI 10.1016/j.molcel.2006.02.010; Moens PB, 2002, J CELL SCI, V115, P1611; Muller HJ, 1916, AM NAT, V50, P193, DOI 10.1086/279534; Neyton S, 2004, MOL HUM REPROD, V10, P917, DOI 10.1093/molehr/gah123; Novak JE, 2001, GENETICS, V158, P1013; Obmolova G, 2000, NATURE, V407, P703, DOI 10.1038/35037509; Roeder GS, 1997, GENE DEV, V11, P2600, DOI 10.1101/gad.11.20.2600; ROSSMACDONALD P, 1994, CELL, V79, P1069, DOI 10.1016/0092-8674(94)90037-X; Schmutte C, 2001, J BIOL CHEM, V276, P33011, DOI 10.1074/jbc.M102670200; Snowden T, 2004, MOL CELL, V15, P437, DOI 10.1016/j.molcel.2004.06.040; Sturtevant A. H., 1915, Zs indukt Abstamm Berlin, V13, DOI 10.1007/BF01792906; SZOSTAK JW, 1983, CELL, V33, P25, DOI 10.1016/0092-8674(83)90331-8; Tran PT, 2004, DNA REPAIR, V3, P1549, DOI 10.1016/j.dnarep.2004.05.015; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Wilson T, 1999, J BIOL CHEM, V274, P21659, DOI 10.1074/jbc.274.31.21659; Zalevsky J, 1999, GENETICS, V153, P1271	56	32	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					145	154		10.1074/jbc.M704060200	http://dx.doi.org/10.1074/jbc.M704060200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17977839	Green Accepted, hybrid			2022-12-27	WOS:000251940300017
J	Lagna, G; Ku, MM; Nguyen, PH; Neuman, NA; Davis, BN; Hata, A				Lagna, Giorgio; Ku, Manching M.; Nguyen, Peter H.; Neuman, Nicole A.; Davis, Brandi N.; Hata, Akiko			Control of phenotypic plasticity of smooth muscle cells by bone morphogenetic protein signaling through the myocardin-related transcription factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; PRIMARY PULMONARY-HYPERTENSION; SERUM RESPONSE FACTOR; BMPR-II; SM22-ALPHA TRANSCRIPTION; ARTERIAL-HYPERTENSION; DEPENDENT ACTIVATION; GENE-EXPRESSION; RECEPTOR; SMAD	Vascular smooth muscle cells (VSMCs), unlike other muscle cells, do not terminally differentiate. In response to injury, VSMCs change phenotype, proliferate, and migrate as part of the repair process. Dysregulation of this plasticity program contributes to the pathogenesis of several vascular disorders, such as atherosclerosis, restenosis, and hypertension. The discovery of mutations in the gene encoding BMPRII, the type II subunit of the receptor for bone morphogenetic proteins (BMPs), in patients with pulmonary arterial hypertension (PAH) provided an indication that BMP signaling may affect the homeostasis of VSMCs and their phenotype modulation. Here we report that BMP signaling potently induces SMC-specific genes in pluripotent cells and prevents dedifferentiation of arterial SMCs. The BMP-induced phenotype switch requires intact RhoA/ROCK signaling but is not blocked by inhibitors of the TGF beta and PI3K/ Akt pathways. Furthermore, nuclear localization and recruitment of the myocardin-related transcription factors (MRTF-A and MRTF-B) to a smooth muscle alpha-actin promoter is observed in response to BMP treatment. Thus, BMP signaling modulates VSMC phenotype via cross-talk with the RhoA/MRTFs pathway, and may contribute to the development of the pathological characteristics observed in patients with PAH and other obliterative vascular diseases.	[Lagna, Giorgio; Ku, Manching M.; Nguyen, Peter H.; Neuman, Nicole A.; Davis, Brandi N.; Hata, Akiko] Tufts Univ New England Med Ctr, MCRI, Boston, MA 02111 USA; [Ku, Manching M.; Neuman, Nicole A.; Davis, Brandi N.; Hata, Akiko] Tufts Univ, Sch Med, Dept Biochem, Boston, MA 02111 USA	Tufts Medical Center; Tufts University	Lagna, G (corresponding author), Tufts Univ New England Med Ctr, MCRI, 750 Washington St,Box 8486, Boston, MA 02111 USA.	glagna@tufts-nemc.org	Davis-Dusenbery, Brandi/N-2798-2013	Davis-Dusenbery, Brandi/0000-0001-7811-8613	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL086572] Funding Source: NIH RePORTER; NHLBI NIH HHS [R21 HL086572] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abdalla SA, 2004, EUR RESPIR J, V23, P373, DOI 10.1183/09031936.04.00085504; Atkinson C, 2002, CIRCULATION, V105, P1672, DOI 10.1161/01.CIR.0000012754.72951.3D; Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Beppu H, 2004, AM J PHYSIOL-LUNG C, V287, pL1241, DOI 10.1152/ajplung.00239.2004; Bobik A, 2006, ARTERIOSCL THROM VAS, V26, P1712, DOI 10.1161/01.ATV.0000225287.20034.2c; Brown JH, 2006, CIRC RES, V98, P730, DOI 10.1161/01.RES.0000216039.75913.9e; Callis TE, 2005, CIRC RES, V97, P992, DOI 10.1161/01.RES.0000190670.92879.7d; CHAMLEYCAMPBELL J, 1979, PHYSIOL REV, V59, P1, DOI 10.1152/physrev.1979.59.1.1; David L, 2007, BLOOD, V109, P1953, DOI 10.1182/blood-2006-07-034124; Deaton RA, 2005, J BIOL CHEM, V280, P31172, DOI 10.1074/jbc.M504774200; Dorai H, 2000, J CELL PHYSIOL, V184, P37, DOI 10.1002/(SICI)1097-4652(200007)184:1<37::AID-JCP4>3.0.CO;2-M; Du Lingling, 2003, New England Journal of Medicine, V348, P500, DOI 10.1056/NEJMoa021650; Elliott CG, 2006, CIRCULATION, V113, P2509, DOI 10.1161/CIRCULATIONAHA.105.601930; Foletta VC, 2003, J CELL BIOL, V162, P1089, DOI 10.1083/jcb.200212060; Fujii M, 1999, MOL BIOL CELL, V10, P3801, DOI 10.1091/mbc.10.11.3801; Grainger DJ, 2004, ARTERIOSCL THROM VAS, V24, P399, DOI 10.1161/01.ATV.0000114567.76772.33; Guo JH, 2004, TOXICOL APPL PHARM, V194, P79, DOI 10.1016/j.taap.2003.09.002; Hata A, 2000, CELL, V100, P229, DOI 10.1016/S0092-8674(00)81561-5; Hautmann MB, 1997, J BIOL CHEM, V272, P10948; Hayashi K, 1999, J CELL BIOL, V145, P727, DOI 10.1083/jcb.145.4.727; Hayashi K, 2006, MOL CELL BIOL, V26, P9456, DOI 10.1128/MCB.00759-06; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hinson JS, 2007, AM J PHYSIOL-HEART C, V292, pH1170, DOI 10.1152/ajpheart.00864.2006; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Hollnagel A, 1999, J BIOL CHEM, V274, P19838, DOI 10.1074/jbc.274.28.19838; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Iyemere VP, 2006, J INTERN MED, V260, P192, DOI 10.1111/j.1365-2796.2006.01692.x; Johnson RC, 2006, CIRC RES, V99, P1044, DOI 10.1161/01.RES.0000249379.55535.21; King KE, 2003, J BIOL CHEM, V278, P11661, DOI 10.1074/jbc.M211337200; Ku MC, 2006, J BIOL CHEM, V281, P5277, DOI 10.1074/jbc.M510004200; Lagna G, 2006, AM J PHYSIOL-LUNG C, V291, pL1059, DOI 10.1152/ajplung.00180.2006; Lee-Hoeflich ST, 2004, EMBO J, V23, P4792, DOI 10.1038/sj.emboj.7600418; Li L, 1997, DEV BIOL, V187, P311, DOI 10.1006/dbio.1997.8621; Liu Y, 2005, J BIOL CHEM, V280, P9719, DOI 10.1074/jbc.M412862200; Long L, 2006, CIRC RES, V98, P818, DOI 10.1161/01.RES.0000215809.47923.fd; Machado RD, 2003, HUM MOL GENET, V12, P3277, DOI 10.1093/hmg/ddg365; Machado RD, 2001, AM J HUM GENET, V68, P92, DOI 10.1086/316947; Mack CP, 1999, CIRC RES, V84, P852; Madsen CS, 1998, CIRC RES, V82, P908; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Mercher T, 2001, P NATL ACAD SCI USA, V98, P5776, DOI 10.1073/pnas.101001498; Miano JM, 2003, J MOL CELL CARDIOL, V35, P577, DOI 10.1016/S0022-2828(03)00110-X; Miano JM, 2000, J BIOL CHEM, V275, P9814, DOI 10.1074/jbc.275.13.9814; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Misiakos EP, 2001, EUR SURG RES, V33, P264, DOI 10.1159/000049716; Morrell NW, 2001, CIRCULATION, V104, P790, DOI 10.1161/hc3201.094152; Morty RE, 2007, ARTERIOSCL THROM VAS, V27, P1072, DOI 10.1161/ATVBAHA.107.141200; Moser M, 2005, THROMB HAEMOSTASIS, V94, P713, DOI 10.1160/TH05-05-0312; Nagaoka T, 2006, J APPL PHYSIOL, V100, P996, DOI 10.1152/japplphysiol.01028.2005; Nakagawa O, 1999, DEV BIOL, V216, P72, DOI 10.1006/dbio.1999.9454; NAKAOKAA T, 2004, J CLIN INVEST, V43, pS33; Narumiya S, 2000, METHOD ENZYMOL, V325, P273; Newman JH, 2004, J AM COLL CARDIOL, V43, p33S, DOI 10.1016/j.jacc.2004.02.028; Nishihara A, 2002, MOL BIOL CELL, V13, P3055, DOI 10.1091/mbc.E02-02-0063; Nishimura T, 2003, CIRCULATION, V108, P1640, DOI 10.1161/01.CIR.0000087592.47401.37; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; OWENS GK, 1995, PHYSIOL REV, V75, P487; Philippar U, 2004, MOL CELL, V16, P867, DOI 10.1016/j.molcel.2004.11.039; Pipes GCT, 2006, GENE DEV, V20, P1545, DOI 10.1101/gad.1428006; Proweller A, 2005, J BIOL CHEM, V280, P8994, DOI 10.1074/jbc.M413316200; Puri A, 2007, NAT CLIN PRACT CARD, V4, P319, DOI 10.1038/ncpcardio0890; Qiu P, 2005, CIRC RES, V97, P983, DOI 10.1161/01.RES.0000190604.90049.71; Rolfe BE, 2005, ATHEROSCLEROSIS, V183, P1, DOI 10.1016/j.atherosclerosis.2005.04.023; RUBIN LJ, 1997, PRIMARY PULMONARY HY; Runo JR, 2003, LANCET, V361, P1533, DOI 10.1016/S0140-6736(03)13167-4; Takahashi H, 2006, AM J PHYSIOL-LUNG C, V290, pL450, DOI 10.1152/ajplung.00206.2005; Thomson JR, 2000, J MED GENET, V37, P741, DOI 10.1136/jmg.37.10.741; Tzima E, 2006, CIRC RES, V98, P176, DOI 10.1161/01.RES.0000200162.94463.d7; van den Driesche S, 2003, CARDIOVASC RES, V58, P20, DOI 10.1016/S0008-6363(02)00852-0; Wang DZ, 2002, P NATL ACAD SCI USA, V99, P14855, DOI 10.1073/pnas.222561499; Willette RN, 1999, J VASC RES, V36, P120, DOI 10.1159/000025634; Ying Y, 2000, BIOL REPROD, V63, P1781, DOI 10.1095/biolreprod63.6.1781; Zhang S, 2003, AM J PHYSIOL-LUNG C, V285, pL740, DOI 10.1152/ajplung.00284.2002	75	131	139	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					37244	37255		10.1074/jbc.M708137200	http://dx.doi.org/10.1074/jbc.M708137200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17947237	hybrid, Green Accepted			2022-12-27	WOS:000251646000050
J	Bodai, L; Pardi, N; Ujfaludi, Z; Bereczki, O; Komonyi, O; Balint, E; Boros, IM				Bodai, Laszlo; Pardi, Norbert; Ujfaludi, Zsuzsanna; Bereczki, Orsolya; Komonyi, Orban; Balint, Eva; Boros, Imre M.			Daxx-like protein of Drosophila interacts with Dmp53 and affects longevity and Ark mRNA level	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P53 ACTIVITY; DNA-DAMAGE; LIFE-SPAN; APOPTOSIS; MELANOGASTER; EXPRESSION; HOMOLOG; DEATH; CELL; PML	Daxx-like protein (DLP), the Drosophila homolog of Daxx, binds Drosophila melanogaster p53 (Dmp53) through its C-terminal region. We generated DLP mutants and found that although DLP expression is developmentally regulated, it is not essential for the execution of the developmental program. The effects DLP mutations show in the loss of heterozygosity assay and on phenotypes resulting from Dmp53 overexpression indicate a genetic interaction between DLP and Dmp53. In contrast to Dmp53 mutants, however, loss of DLP does not result in radiosensitivity indicating that it does not play an essential role in the activation of Dmp53-dependent response after ionizing radiation, and DLP is also not required for the irradiation-induced activation of reaper. In contrast, DLP is involved in the transcriptional regulation of Ark, because Ark mRNA level is decreased in DLP mutants and increased upon ectopic overexpression of DLP. Interestingly, DLP mutants have reduced longevity and reduced female fertility. Altogether, our data suggest complex functions for DLP, which include an anti-apoptotic effect exerted through repression of some Dmp53 functions, and activation of some proapoptotic genes.	Univ Szeged, Dept Biochem & Mol Biol, Chromatin Res Grp USZ HAS, H-6726 Szeged, Hungary; Biol Res Ctr, Inst Biochem, H-6726 Szeged, Hungary	Szeged University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center	Boros, IM (corresponding author), Univ Szeged, Dept Biochem & Mol Biol, Kozep Fasor 52, H-6726 Szeged, Hungary.	borosi@bio.u-szeged.hu	Ujfaludi, Zsuzsanna/AAC-7657-2020; Balint, Eva/B-8695-2008; Bodai, Laszlo/A-9764-2012	Balint, Eva/0000-0002-1258-6892; Bodai, Laszlo/0000-0001-8411-626X; Ujfaludi Dr., Zsuzsanna/0000-0003-4738-0963; Boros, Imre/0000-0001-8504-9687				ALTSCHUL SF, 1997, NUCLEIC ACIDS RES, V25, P3402; Bauer JH, 2005, CURR BIOL, V15, P2063, DOI 10.1016/j.cub.2005.10.051; Boehrer S, 2004, HEMATOL J, V5, P513, DOI 10.1038/sj.thj.6200547; BREEDEN L, 1985, COLD SPRING HARB SYM, V50, P643, DOI 10.1101/SQB.1985.050.01.078; Brodsky MH, 2004, MOL CELL BIOL, V24, P1219, DOI 10.1128/MCB.24.3.1219-1231.2004; Brodsky MH, 2000, CELL, V101, P103, DOI 10.1016/S0092-8674(00)80627-3; Chang HY, 1998, SCIENCE, V281, P1860, DOI 10.1126/science.281.5384.1860; Coates PJ, 2005, J PATHOL, V205, P221, DOI 10.1002/path.1701; Emelyanov AV, 2002, J BIOL CHEM, V277, P11156, DOI 10.1074/jbc.M111763200; Fogal V, 2000, EMBO J, V19, P6185, DOI 10.1093/emboj/19.22.6185; Gostissa M, 2004, J BIOL CHEM, V279, P48013, DOI 10.1074/jbc.M310801200; Hainaut P, 1998, NUCLEIC ACIDS RES, V26, P205, DOI 10.1093/nar/26.1.205; Jin SK, 2000, P NATL ACAD SCI USA, V97, P7301, DOI 10.1073/pnas.97.13.7301; Kim EJ, 2003, NUCLEIC ACIDS RES, V31, P5356, DOI 10.1093/nar/gkg741; Lee JH, 2003, FEBS LETT, V550, P5, DOI 10.1016/S0014-5793(03)00771-3; Li H, 2000, MOL CELL BIOL, V20, P1784, DOI 10.1128/MCB.20.5.1784-1796.2000; Maier B, 2004, GENE DEV, V18, P306, DOI 10.1101/gad.1162404; Michaelson JS, 1999, GENE DEV, V13, P1918, DOI 10.1101/gad.13.15.1918; Ohiro Y, 2003, MOL CELL BIOL, V23, P322, DOI 10.1128/MCB.23.1.322-334.2003; Ollmann M, 2000, CELL, V101, P91, DOI 10.1016/S0092-8674(00)80626-1; Peters M, 2002, P NATL ACAD SCI USA, V99, P11305, DOI 10.1073/pnas.172382899; Price DM, 2002, GENETICS, V161, P721; Rodriguez A, 1999, NAT CELL BIOL, V1, P272, DOI 10.1038/12984; Rong YKS, 2002, GENE DEV, V16, P1568, DOI 10.1101/gad.986602; Ryder E, 2004, GENETICS, V167, P797, DOI 10.1534/genetics.104.026658; Salomoni P, 2006, TRENDS CELL BIOL, V16, P97, DOI 10.1016/j.tcb.2005.12.002; Schuler M, 2005, TRENDS GENET, V21, P182, DOI 10.1016/j.tig.2005.01.001; Sogame N, 2003, P NATL ACAD SCI USA, V100, P4696, DOI 10.1073/pnas.0736384100; STAPLETON M, 2002, GENOME BIOL, V0003; Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a; Yang XL, 1997, CELL, V89, P1067, DOI 10.1016/S0092-8674(00)80294-9; Zhao LY, 2004, J BIOL CHEM, V279, P50566, DOI 10.1074/jbc.M406743200; Zhao LY, 2003, J VIROL, V77, P11809, DOI 10.1128/JVI.77.21.11809-11821.2003	33	11	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36386	36393		10.1074/jbc.M705547200	http://dx.doi.org/10.1074/jbc.M705547200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17933869	hybrid			2022-12-27	WOS:000251458300030
J	Li, D; Fournel-Gigleux, S; Barre, L; Mulliert, G; Netter, P; Magdalou, J; Ouzzine, M				Li, Dong; Fournel-Gigleux, Sylvie; Barre, Lydia; Mulliert, Guillermo; Netter, Patrick; Magdalou, Jacques; Ouzzine, Mohamed			Identification of aspartic acid and histidine residues mediating the reaction mechanism and the substrate specificity of the human UDP-glucuronosyltransferases 1A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHEMICAL MODIFICATION; CRYSTAL-STRUCTURES; EXPRESSION; SEQUENCE; PROTEIN; GLYCOSYLTRANSFERASES; GLUCOSYLTRANSFERASE; GLUCURONIDATION; REVEALS; RAT	The human UDP-glucuronosyltransferase UGT1A6 is the primary phenol-metabolizing UDP-glucuronosyltransferase isoform. It catalyzes the nucleophilic attack of phenolic xenobiotics on UDP-glucuronic acid, leading to the formation of water-soluble glucuronides. The catalytic mechanism proposed for this reaction is an acid-base mechanism that involves an aspartic/glutamic acid and/or histidine residue. Here, we investigated the role of 14 highly conserved aspartic/glutamic acid residues over the entire sequence of human UGT1A6 by site-directed mutagenesis. We showed that except for aspartic residues Asp-150 and Asp-488, the substitution of carboxylic residues by alanine led to active mutants but with decreased enzyme activity and lower affinity for acceptor and/or donor substrate. Further analysis including mutation of the corresponding residue in other UGT1A isoforms suggests that Asp-150 plays a major catalytic role. In this report we also identified a single active site residue important for glucuronidation of phenols and carboxylic acid substrates by UGT1A enzyme family. Replacing Pro-40 of UGT1A4 by histidine expanded the glucuronidation activity of the enzyme to phenolic and carboxylic compounds, therefore, leading to UGT1A3-type isoform in terms of substrate specificity. Conversely, when His-40 residue of UGT1A3 was replaced with proline, the substrate specificity shifted toward that of UGT1A4 with loss of glucuronidation of phenolic substrates. Furthermore, mutation of His-39 residue of UGT1A1 (His-40 in UGT1A4) to proline led to loss of glucuronidation of phenols but not of estrogens. This study provides a step forward to better understand the glucuronidation mechanism and substrate recognition, which is invaluable for a better prediction of drug metabolism and toxicity in human.	Univ Nancy 1, CNRS, UMR 7561, Fac Med, F-54505 Vandoeuvre Les Nancy, France; Univ Nancy 1, CNRS, UMR 7036, Fac Sci, F-54505 Vandoeuvre Les Nancy, France	Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Lorraine	Ouzzine, M (corresponding author), Univ Nancy 1, CNRS, UMR 7561, Fac Med, BP 184, F-54505 Vandoeuvre Les Nancy, France.	ouzzine@medecine.uhp-nancy.fr	Ouzzine, Mohamed/G-4368-2013	OUZZINE, Mohamed/0000-0003-0058-4950				BANSAL SK, 1980, ANAL BIOCHEM, V109, P321, DOI 10.1016/0003-2697(80)90655-7; BATTAGLIA E, 1994, ARCH BIOCHEM BIOPHYS, V309, P266, DOI 10.1006/abbi.1994.1112; BATTAGLIA E, 1994, FEBS LETT, V346, P146, DOI 10.1016/0014-5793(94)00453-6; BOCK KW, 1991, CRIT REV BIOCHEM MOL, V26, P129, DOI 10.3109/10409239109081125; BOCK KW, 1993, BIOCHEM PHARMACOL, V45, P1809, DOI 10.1016/0006-2952(93)90437-2; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Breton C, 2006, GLYCOBIOLOGY, V16, p29R, DOI 10.1093/glycob/cwj016; Campbell JA, 1997, BIOCHEM J, V326, P929, DOI 10.1042/bj3260929u; CLARKE DJ, 1994, HDB EXPT PHARM, V112, P3; Funhoff EG, 2005, FEBS J, V272, P2968, DOI 10.1111/j.1742-4658.2005.04686.x; Green MD, 1998, DRUG METAB DISPOS, V26, P507; Ha S., 2001, Current Drug Targets - Infectious Disorders, V1, P201, DOI 10.2174/1568005014606116; Harley CA, 1996, J BIOL CHEM, V271, P24625, DOI 10.1074/jbc.271.40.24625; Herber R, 1995, DRUG METAB DISPOS, V23, P1305; Hu YN, 2003, P NATL ACAD SCI USA, V100, P845, DOI 10.1073/pnas.0235749100; Iwano H, 1997, BIOCHEM J, V325, P587, DOI 10.1042/bj3250587; Kapitonov D, 1999, GLYCOBIOLOGY, V9, P961, DOI 10.1093/glycob/9.10.961; Kiang TKL, 2005, PHARMACOL THERAPEUT, V106, P97, DOI 10.1016/j.pharmthera.2004.10.013; King CD, 1999, ARCH BIOCHEM BIOPHYS, V365, P156, DOI 10.1006/abbi.1999.1155; Krishnaswamy S, 2004, DRUG METAB DISPOS, V32, P862, DOI 10.1124/dmd.32.8.862; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lariviere L, 2003, J MOL BIOL, V330, P1077, DOI 10.1016/S0022-2836(03)00635-1; Li Q, 1997, J BIOL CHEM, V272, P3272, DOI 10.1074/jbc.272.6.3272; LILIENBLUM W, 1982, BIOCHEM PHARMACOL, V31, P907, DOI 10.1016/0006-2952(82)90319-7; Mackenzie PI, 1997, PHARMACOGENETICS, V7, P255, DOI 10.1097/00008571-199708000-00001; Miley MJ, 2007, J MOL BIOL, V369, P498, DOI 10.1016/j.jmb.2007.03.066; Mulichak AM, 2003, P NATL ACAD SCI USA, V100, P9238, DOI 10.1073/pnas.1233577100; Mulichak AM, 2001, STRUCTURE, V9, P547, DOI 10.1016/S0969-2126(01)00616-5; Offen W, 2006, EMBO J, V25, P1396, DOI 10.1038/sj.emboj.7600970; Ouzzine M, 2000, MOL PHARMACOL, V58, P1609, DOI 10.1124/mol.58.6.1609; Ouzzine M, 2006, FEBS LETT, V580, P1953, DOI 10.1016/j.febslet.2006.02.058; Ouzzine M, 1999, J BIOL CHEM, V274, P31401, DOI 10.1074/jbc.274.44.31401; OUZZINE M, 1994, ARCH BIOCHEM BIOPHYS, V310, P196, DOI 10.1006/abbi.1994.1157; Radominska-Pandya A, 1999, DRUG METAB REV, V31, P817, DOI 10.1081/DMR-100101944; SEGEL IH, 1975, ENZYME KINETICS, P18; Shao H, 2005, PLANT CELL, V17, P3141, DOI 10.1105/tpc.105.035055; TEPHLY TR, 1990, TRENDS PHARMACOL SCI, V11, P276, DOI 10.1016/0165-6147(90)90008-V; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tukey RH, 2000, ANNU REV PHARMACOL, V40, P581, DOI 10.1146/annurev.pharmtox.40.1.581; Unligil UM, 2000, CURR OPIN STRUC BIOL, V10, P510, DOI 10.1016/S0959-440X(00)00124-X; von Heijne G, 1994, Subcell Biochem, V22, P1; Watts KT, 2006, CHEM BIOL, V13, P1317, DOI 10.1016/j.chembiol.2006.10.008	42	25	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36514	36524		10.1074/jbc.M703107200	http://dx.doi.org/10.1074/jbc.M703107200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17956868	hybrid			2022-12-27	WOS:000251458300044
J	Ren, Y; Chen, ZM; Chen, LW; Woods, NT; Reuther, GW; Cheng, JQ; Wang, HG; Wu, J				Ren, Yuan; Chen, Zhengming; Chen, Liwei; Woods, Nicholas T.; Reuther, Gary W.; Cheng, Jin Q.; Wang, Hong-Gang; Wu, Jie			Shp2(E76K) mutant confers cytokine-independent survival of TF-1 myeloid cells by up-regulating Bcl-X-L	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							JUVENILE MYELOMONOCYTIC LEUKEMIA; SIGNALING PATHWAY; CANCER-CELLS; KINASE ACTIVATION; SHP-2 PHOSPHATASE; ORGANIC-COMPOUND; PTPN11 MUTATIONS; DOWN-REGULATION; PROTEIN; APOPTOSIS	Shp2 has been known to mediate growth factor-stimulated cell proliferation, but its role in cell survival is less clear. Gain-of-function Shp2 mutants such as Shp2(E76K) are associated with myeloid leukemias. We found that Shp2(E76K) could transform cytokine-dependent human TF-1 myeloid cells into cytokine independence and further characterized the Shp2(E76K)-induced cell survival mechanism in this study. Expression of Shp2(E76K) suppressed the cytokine withdrawal-induced intrinsic/mitochondrial apoptosis pathway, which is controlled by the Bcl-2 family proteins. Analysis of Bcl-2 family proteins showed that Bcl-XL and Mcl-1 were up-regulated in Shp2(E76K)-transformed TF-1 (TF-1/Shp2(E76K)) cells. Knockdown of Bcl-X-L but not Mcl-1 with short hairpin RNAs prevented Shp2(E76K)-induced cytokine-independent survival. Roscovitine, which down-regulated Mcl-1, also did not prevent cytokine-independent survival of TF-1/Shp2(E76K) cells, whereas the Bcl-X-L inhibitor HA14-1 did. Ras and mitogen-activated protein kinases Erk1 and Erk2 (Erk1/2) were constitutively activated in TF-1/Shp2(E76K) cells, whereas little active Akt was detected under cytokine-free conditions. Shp2(E76K)-induced Bcl-X-L expression was suppressed by Mek inhibitors and by a dominant-negative Mek1 mutant but not by the phosphoinositide 3-phosphate inhibitor LY294002 and the Akt inhibitor API-2. Inhibition of Erk1/2 blocked cytokine-independent survival of TF-1/Shp2(E76K) cells, whereas inhibition of Akt had a minimal effect on cytokine-independent survival of TF-1/Shp2(E76K) cells. These results show that Shp2(E76K) can evoke constitutive Erk1/2 activation in TF-1 cells. Furthermore, Shp2(E76K) induces cytokine-independent survival of TF-1 cells by a novel mechanism involving up-regulation of Bcl-X-L through the Erk1/2 pathway.	Univ S Florida, Mol Oncol Program, Tampa, FL 33612 USA; Univ S Florida, H Lee Moffitt Canc Ctr, Res Inst, Drug Discovery Program, Tampa, FL 33612 USA; Univ S Florida, Dept Interdisciplinary Oncol, Tampa, FL 33612 USA	State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Wu, J (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Res Inst, Mol Oncol Program, 12902 Magnolia Dr, Tampa, FL 33612 USA.	jerry.wu@moffitt.org	Wang, Hong-Gang/A-3018-2015; Reuther, Gary/AFR-2892-2022; Wu, Jie/R-2404-2019	Wang, Hong-Gang/0000-0003-0551-0571; Wu, Jie/0000-0002-2864-1606; Woods, Nicholas/0000-0002-4962-9083	NCI NIH HHS [R01 CA077467, P01 CA118210, R01CA077467, R01 CA077467-09, P01CA118210] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA077467, P01CA118210] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; An J, 2007, ONCOGENE, V26, P652, DOI 10.1038/sj.onc.1209830; Arico M, 1997, BLOOD, V90, P479, DOI 10.1182/blood.V90.2.479.479_479_488; Bai JR, 2005, CANCER RES, V65, P2344, DOI 10.1158/0008-5472.CAN-04-3502; Bennett AM, 1996, MOL CELL BIOL, V16, P1189; Bentires-Alj M, 2004, CANCER RES, V64, P8816, DOI 10.1158/0008-5472.CAN-04-1923; CATLING AD, 1995, MOL CELL BIOL, V15, P5214; Chan RJ, 2007, BLOOD, V109, P862, DOI 10.1182/blood-2006-07-028829; Chan RJ, 2005, BLOOD, V105, P3737, DOI 10.1182/blood-2004-10-4002; Chen S, 2007, CANCER RES, V67, P782, DOI 10.1158/0008-5472.CAN-06-3964; Cunnick JM, 2000, J BIOL CHEM, V275, P13842, DOI 10.1074/jbc.275.18.13842; Cunnick JM, 2002, J BIOL CHEM, V277, P9498, DOI 10.1074/jbc.M110547200; Cunnick JM, 2001, J BIOL CHEM, V276, P24380, DOI 10.1074/jbc.M010275200; Deb TB, 1998, J BIOL CHEM, V273, P16643, DOI 10.1074/jbc.273.27.16643; Dorsey JF, 2002, BLOOD, V99, P1388, DOI 10.1182/blood.V99.4.1388; Doshi JM, 2006, J MED CHEM, V49, P7731, DOI 10.1021/jm060968r; Emanuel PD, 1996, MOL MED TODAY, V2, P468, DOI 10.1016/1357-4310(96)10044-7; Gelb BD, 2006, HUM MOL GENET, V15, pR220, DOI 10.1093/hmg/ddl197; Gu HH, 2003, TRENDS CELL BIOL, V13, P122, DOI 10.1016/S0962-8924(03)00002-3; Hof P, 1998, CELL, V92, P441, DOI 10.1016/S0092-8674(00)80938-1; Hsu YT, 1997, J BIOL CHEM, V272, P13829, DOI 10.1074/jbc.272.21.13829; Keilhack H, 2005, J BIOL CHEM, V280, P30984, DOI 10.1074/jbc.M504699200; Kratz CP, 2005, BLOOD, V106, P2183, DOI 10.1182/blood-2005-02-0531; Lauchle JO, 2006, PEDIATR BLOOD CANCER, V46, P579, DOI 10.1002/pbc.20644; Loh ML, 2004, BLOOD, V103, P2325, DOI 10.1182/blood-2003-09-3287; Lu XH, 2005, P NATL ACAD SCI USA, V102, P18962, DOI 10.1073/pnas.0509714102; MacCallum DE, 2005, CANCER RES, V65, P5399, DOI 10.1158/0008-5472.CAN-05-0233; Manero F, 2006, CANCER RES, V66, P2757, DOI 10.1158/0008-5472.CAN-05-2097; Mohi MG, 2007, CURR OPIN GENET DEV, V17, P23, DOI 10.1016/j.gde.2006.12.011; Mohi MG, 2005, CANCER CELL, V7, P179, DOI 10.1016/j.ccr.2005.01.010; Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4; Pear WS, 1998, BLOOD, V92, P3780, DOI 10.1182/blood.V92.10.3780.422k15_3780_3792; Pei XY, 2004, MOL CANCER THER, V3, P1513; Ren Y, 2004, J BIOL CHEM, V279, P8497, DOI 10.1074/jbc.M312575200; RIVARD N, 1995, J BIOL CHEM, V270, P11017, DOI 10.1074/jbc.270.18.11017; Schubbert S, 2005, BLOOD, V106, P311, DOI 10.1182/blood-2004-11-4207; Takahashi Y, 2005, MOL CELL BIOL, V25, P9369, DOI 10.1128/MCB.25.21.9369-9382.2005; Tartaglia M, 2001, NAT GENET, V29, P465, DOI 10.1038/ng772; Tartaglia M, 2003, NAT GENET, V34, P148, DOI 10.1038/ng1156; Wang JL, 2000, P NATL ACAD SCI USA, V97, P7124, DOI 10.1073/pnas.97.13.7124; XIAO S, 1994, J BIOL CHEM, V269, P21244; Xie HM, 2005, J IMMUNOL, V175, P7981, DOI 10.4049/jimmunol.175.12.7981; Yang L, 2004, CANCER RES, V64, P4394, DOI 10.1158/0008-5472.CAN-04-0343; Yang WT, 2006, DEV CELL, V10, P317, DOI 10.1016/j.devcel.2006.01.002; Yu M, 2006, J BIOL CHEM, V281, P28615, DOI 10.1074/jbc.M603742200; Yu WM, 2006, J BIOL CHEM, V281, P5426, DOI 10.1074/jbc.M507622200	46	12	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36463	36473		10.1074/jbc.M705789200	http://dx.doi.org/10.1074/jbc.M705789200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17942397	hybrid, Green Accepted			2022-12-27	WOS:000251458300038
J	Dall'Osto, L; Fiore, A; Cazzaniga, S; Giuliano, G; Bassi, R				Dall'Osto, Luca; Fiore, Alessia; Cazzaniga, Stefano; Giuliano, Giovanni; Bassi, Roberto			Different roles of alpha- and beta-branch xanthophylls in photosystem assembly and photoprotection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-HARVESTING COMPLEX; CHLOROPHYLL-A FLUORESCENCE; TROPICAL TREE SEEDLINGS; ANTENNA PROTEIN CP26; ARABIDOPSIS-THALIANA; ENERGY-DISSIPATION; HIGHER-PLANTS; PHOTOOXIDATIVE STRESS; SINGLET OXYGEN; DELTA-PH	Xanthophylls ( oxygenated carotenoids) are essential components of the plant photosynthetic apparatus, where they act in photosystem assembly, light harvesting, and photoprotection. Nevertheless, the specific function of individual xanthophyll species awaits complete elucidation. In this work, we analyze the photosynthetic phenotypes of two newly isolated Arabidopsis mutants in carotenoid biosynthesis containing exclusively alpha-branch (chy1chy2lut5)or beta-branch (chy1chy2lut2) xanthophylls. Both mutants show complete lack of qE, the rapidly reversible component of nonphotochemical quenching, and high levels of photoinhibition and lipid peroxidation under photooxidative stress. Both mutants are much more photosensitive than npq1lut2, which contains high levels of viola- and neoxanthin and a higher stoichiometry of light-harvesting proteins with respect to photosystem II core complexes, suggesting that the content in light-harvesting complexes plays an important role in photoprotection. In addition, chy1chy2lut5, which has lutein as the only xanthophyll, shows unprecedented photosensitivity even in low light conditions, reduced electron transport rate, enhanced photobleaching of isolated LHCII complexes, and a selective loss of CP26 with respect to chy1chy2lut2, highlighting a specific role of beta-branch xanthophylls in photoprotection and in qE mechanism. The stronger photosystem II photoinhibition of both mutants correlates with the higher rate of singlet oxygen production from thylakoids and isolated light-harvesting complexes, whereas carotenoid composition of photosystem II core complex was not influential. In depth analysis of the mutant phenotypes suggests that alpha-branch ( lutein) and beta-branch ( zeaxanthin, violaxanthin, and neoxanthin) xanthophylls have distinct and complementary roles in antenna protein assembly and in the mechanisms of photoprotection.	Univ Verona, Dipartimento Sci & Tecnol, I-37134 Verona, Italy; Ctr Ric Casaccia, Dipartimento Biotecnol, I-00100 Rome, Italy	University of Verona; Italian National Agency New Technical Energy & Sustainable Economics Development	Bassi, R (corresponding author), Univ Verona, Dipartimento Sci & Tecnol, Strada Le Grazie 15, I-37134 Verona, Italy.	bassi@sci.univr.it	Cazzaniga, Stefano/ABG-3898-2021; Dall'Osto, Luca/A-9384-2010; Giuliano, Giovanni/A-2701-2012	Cazzaniga, Stefano/0000-0002-2824-7916; Dall'Osto, Luca/0000-0001-9497-5156; bassi, roberto/0000-0002-4140-8446; Giuliano, Giovanni/0000-0002-2486-0510				Andersson J, 2001, PLANT CELL, V13, P1193, DOI 10.1105/tpc.13.5.1193; ARO EM, 1994, PLANT PHYSIOL, V104, P1033, DOI 10.1104/pp.104.3.1033; Ballottari M, 2004, EUR J BIOCHEM, V271, P4659, DOI 10.1111/j.1432-1033.2004.04426.x; Ballottari M, 2007, J BIOL CHEM, V282, P8947, DOI 10.1074/jbc.M606417200; BARBER J, 1992, TRENDS BIOCHEM SCI, V17, P61, DOI 10.1016/0968-0004(92)90503-2; Baroli I, 2003, PLANT CELL, V15, P992, DOI 10.1105/tpc.010405; Baroli I, 2004, J BIOL CHEM, V279, P6337, DOI 10.1074/jbc.M312919200; Bassi R, 1999, P NATL ACAD SCI USA, V96, P10056, DOI 10.1073/pnas.96.18.10056; BASSI R, 1993, EUR J BIOCHEM, V212, P297, DOI 10.1111/j.1432-1033.1993.tb17662.x; Bellafiore S, 2005, NATURE, V433, P892, DOI 10.1038/nature03286; Caffarri S, 2001, J BIOL CHEM, V276, P35924, DOI 10.1074/jbc.M105199200; Casazza AP, 2001, PHOTOSYNTH RES, V68, P175, DOI 10.1023/A:1011818021875; Castelletti S, 2003, BIOCHEMISTRY-US, V42, P4226, DOI 10.1021/bi027398r; Connelly JP, 1997, BIOCHEMISTRY-US, V36, P281, DOI 10.1021/bi962467l; Croce R, 1999, J BIOL CHEM, V274, P29613, DOI 10.1074/jbc.274.42.29613; Croce R, 2002, BIOCHEMISTRY-US, V41, P7334, DOI 10.1021/bi0257437; Dall'Osto L, 2005, PLANT CELL, V17, P1217, DOI 10.1105/tpc.104.030601; Dall'Osto L, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-32; Dall'Osto L, 2007, PLANT CELL, V19, P1048, DOI 10.1105/tpc.106.049114; Davison PA, 2002, NATURE, V418, P203, DOI 10.1038/nature00861; DEMMIGADAMS B, 1992, ANNU REV PLANT PHYS, V43, P599, DOI 10.1146/annurev.pp.43.060192.003123; DEMMIGADAMS B, 1990, PLANT PHYSIOL, V92, P293, DOI 10.1104/pp.92.2.293; DEMMIGADAMS B, 1995, AUST J PLANT PHYSIOL, V22, P249, DOI 10.1071/PP9950249; Espineda CE, 1999, P NATL ACAD SCI USA, V96, P10507, DOI 10.1073/pnas.96.18.10507; Evron Y, 2000, PLANT PHYSIOL, V124, P407, DOI 10.1104/pp.124.1.407; Fiore A, 2006, FEBS LETT, V580, P4718, DOI 10.1016/j.febslet.2006.07.055; Flors C, 2006, J EXP BOT, V57, P1725, DOI 10.1093/jxb/erj181; Formaggio E, 2001, J MOL BIOL, V314, P1157, DOI 10.1006/jmbi.2000.5179; GILMORE AM, 1994, FEBS LETT, V350, P271, DOI 10.1016/0014-5793(94)00784-5; GILMORE AM, 1991, PLANT PHYSIOL, V96, P635, DOI 10.1104/pp.96.2.635; Gilmore AM, 2001, PHOTOCHEM PHOTOBIOL, V74, P291, DOI 10.1562/0031-8655(2001)074<0291:TROTAA>2.0.CO;2; Gilmore AM, 2001, PHOTOSYNTH RES, V67, P89, DOI 10.1023/A:1010657000548; Havaux M, 1999, P NATL ACAD SCI USA, V96, P8762, DOI 10.1073/pnas.96.15.8762; Havaux M, 2004, J BIOL CHEM, V279, P13878, DOI 10.1074/jbc.M311154200; Havaux M, 2005, PLANT CELL, V17, P3451, DOI 10.1105/tpc.105.037036; Havaux M, 2001, PLANTA, V213, P953, DOI 10.1007/s004250100572; Holt NE, 2005, SCIENCE, V307, P433, DOI 10.1126/science.1105833; Horton P, 1996, ANNU REV PLANT PHYS, V47, P655, DOI 10.1146/annurev.arplant.47.1.655; Kim J, 2006, P NATL ACAD SCI USA, V103, P3474, DOI 10.1073/pnas.0511207103; Krause GH, 2004, FUNCT PLANT BIOL, V31, P743, DOI 10.1071/FP03239; Krause GH, 2001, PLANT CELL ENVIRON, V24, P1345, DOI 10.1046/j.0016-8025.2001.00786.x; Krieger-Liszkay A, 2005, J EXP BOT, V56, P337, DOI 10.1093/jxb/erh237; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; Lokstein H, 2002, BBA-BIOENERGETICS, V1553, P309, DOI 10.1016/S0005-2728(02)00184-6; Lundin B, 2007, PLANT J, V49, P528, DOI 10.1111/j.1365-313X.2006.02976.x; MALKIN S, 1981, PLANT PHYSIOL, V67, P570, DOI 10.1104/pp.67.3.570; Matsubara S, 2005, J EXP BOT, V56, P461, DOI 10.1093/jxb/eri012; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; Milborrow BV, 2001, J EXP BOT, V52, P1145, DOI 10.1093/jexbot/52.359.1145; Morosinotto T, 2003, PHYSIOL PLANTARUM, V119, P347, DOI 10.1034/j.1399-3054.2003.00213.x; Niyogi KK, 1997, P NATL ACAD SCI USA, V94, P14162, DOI 10.1073/pnas.94.25.14162; Niyogi KK, 1998, PLANT CELL, V10, P1121, DOI 10.1105/tpc.10.7.1121; Niyogi KK, 1999, ANNU REV PLANT PHYS, V50, P333, DOI 10.1146/annurev.arplant.50.1.333; Niyogi KK, 2001, PHOTOSYNTH RES, V67, P139, DOI 10.1023/A:1010661102365; op den Camp RGL, 2003, PLANT CELL, V15, P2320, DOI 10.1105/tpc.014662; Peterman EJG, 1997, BIOCHEMISTRY-US, V36, P12208, DOI 10.1021/bi9711689; PLUMLEY FG, 1987, P NATL ACAD SCI USA, V84, P146, DOI 10.1073/pnas.84.1.146; Pogson BJ, 1998, P NATL ACAD SCI USA, V95, P13324, DOI 10.1073/pnas.95.22.13324; Pogson BJ, 2000, PHILOS T ROY SOC B, V355, P1395, DOI 10.1098/rstb.2000.0701; Rissler HM, 2001, PHOTOSYNTH RES, V67, P127, DOI 10.1023/A:1010669404183; Sbarbati A, 2004, CHEM SENSES, V29, P683, DOI 10.1093/chemse/bjh071; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SIEFERMANNHARMS D, 1987, PHYSIOL PLANTARUM, V69, P561, DOI 10.1111/j.1399-3054.1987.tb09240.x; Sonoike K, 1996, PLANT CELL PHYSIOL, V37, P239, DOI 10.1093/oxfordjournals.pcp.a028938; Tian L, 2003, PLANT CELL, V15, P1320, DOI 10.1105/tpc.011403; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VANKOOTEN O, 1990, PHOTOSYNTH RES, V25, P147, DOI 10.1007/BF00033156; Verhoeven AS, 1999, PLANT PHYSIOL, V120, P727, DOI 10.1104/pp.120.3.727; WALTERS RG, 1995, PLANTA, V197, P306, DOI 10.1007/BF00202652; Wollman FA, 2001, EMBO J, V20, P3623, DOI 10.1093/emboj/20.14.3623; YAMAMOTO HY, 1962, ARCH BIOCHEM BIOPHYS, V97, P168, DOI 10.1016/0003-9861(62)90060-7	71	115	120	4	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					35056	35068		10.1074/jbc.M704729200	http://dx.doi.org/10.1074/jbc.M704729200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17913714	hybrid			2022-12-27	WOS:000251155200050
J	Olesen, LE; Ford, MGJ; Schmid, EM; Vallis, Y; Babu, MM; Li, PH; Mills, IG; Mcmahon, HT; Praefcke, GJK				Olesen, Lene E.; Ford, Marijn G. J.; Schmid, Eva M.; Vallis, Yvonne; Babu, M. Madan; Li, Peter H.; Mills, Ian G.; Mcmahon, Harvey T.; Praefcke, Gerrit J. K.			Solitary and repetitive binding motifs for the AP2 complex alpha-appendage in amphiphysin and other accessory proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLATHRIN-COATED PITS; SYNAPTIC VESICLE ENDOCYTOSIS; FUNCTIONAL DISSECTION; DOMAIN; AP-2; INTERACTS; MEMBRANE; DYNAMIN; MODEL; IDENTIFICATION	Adaptor protein (AP) complexes bind to transmembrane proteins destined for internalization and to membrane lipids, so linking cargo to the accessory internalization machinery. This machinery interacts with the appendage domains of APs, which have platform and beta-sandwich subdomains, forming the binding surfaces for interacting proteins. Proteins that interact with the subdomains do so via short motifs, usually found in regions of low structural complexity of the interacting proteins. So far, up to four motifs have been identified that bind to and partially compete for at least two sites on each of the appendage domains of the AP2 complex. Motifs in individual accessory proteins, their sequential arrangement into motif domains, and partial competition for binding sites on the appendage domains coordinate the formation of endocytic complexes in a temporal and spatial manner. In this work, we examine the dominant interaction sequence in amphiphysin, a synapse-enriched accessory protein, which generates membrane curvature and recruits the scission protein dynamin to the necks of coated pits, for the platform subdomain of the alpha-appendage. The motif domain of amphiphysin1 contains one copy of each of a DX(F/W) and FXDXF motif. We find that the FXDXF motif is the main determinant for the high affinity interaction with the alpha-adaptin appendage. We describe the optimal sequence of the FXDXF motif using thermodynamic and structural data and show how sequence variation controls the affinities of these motifs for the alpha-appendage.	[Olesen, Lene E.; Ford, Marijn G. J.; Schmid, Eva M.; Vallis, Yvonne; Babu, M. Madan; Li, Peter H.; Mills, Ian G.; Mcmahon, Harvey T.] MRC, Mol Biol Lab, Div Neurobiol, Cambridge CB2 2QH, England; [Praefcke, Gerrit J. K.] Ctr Mol Med Cologne, Inst Genet, D-50674 Cologne, Germany	MRC Laboratory Molecular Biology; University of Cologne	Mcmahon, HT (corresponding author), MRC, Mol Biol Lab, Div Neurobiol, Hills Rd, Cambridge CB2 2QH, England.	hmm@mrc-lmb.cam.ac.uk; gpraefck@uni-koeln.de	Mohan, Babu P./I-7362-2019; Mills, Ian/AAK-9292-2020	Mills, Ian/0000-0001-5347-5083; Praefcke, Gerrit/0000-0001-8818-1499	MRC [MC_U105178795, MC_U105185859] Funding Source: UKRI; Medical Research Council [MC_U105185859, MC_U105178795] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		AHLE S, 1986, EMBO J, V5, P3143, DOI 10.1002/j.1460-2075.1986.tb04621.x; Allaire PD, 2006, J NEUROSCI, V26, P13202, DOI 10.1523/JNEUROSCI.4608-06.2006; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bayliss R, 2002, J BIOL CHEM, V277, P50597, DOI 10.1074/jbc.M209037200; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Brett TJ, 2002, STRUCTURE, V10, P797, DOI 10.1016/S0969-2126(02)00784-0; Burman JL, 2005, FEBS LETT, V579, P2177, DOI 10.1016/j.febslet.2005.03.008; Collins BM, 2003, NAT STRUCT BIOL, V10, P607, DOI 10.1038/nsb955; Collins BM, 2002, CELL, V109, P523, DOI 10.1016/S0092-8674(02)00735-3; David C, 1996, P NATL ACAD SCI USA, V93, P331, DOI 10.1073/pnas.93.1.331; de Beer T, 1998, SCIENCE, V281, P1357, DOI 10.1126/science.281.5381.1357; Dell'Angelica EC, 2001, TRENDS CELL BIOL, V11, P315, DOI 10.1016/S0962-8924(01)02043-8; Edeling MA, 2006, DEV CELL, V10, P329, DOI 10.1016/j.devcel.2006.01.016; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ford MGJ, 2001, SCIENCE, V291, P1051, DOI 10.1126/science.291.5506.1051; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Fotin A, 2004, NATURE, V432, P573, DOI 10.1038/nature03079; Haffner C, 2000, CURR BIOL, V10, P471, DOI 10.1016/S0960-9822(00)00446-2; Hinrichsen L, 2006, P NATL ACAD SCI USA, V103, P8715, DOI 10.1073/pnas.0600312103; Iovine MK, 1995, J CELL BIOL, V131, P1699, DOI 10.1083/jcb.131.6.1699; Jha A, 2004, J BIOL CHEM, V279, P2281, DOI 10.1074/jbc.M305644200; Jockusch WJ, 2005, NEURON, V46, P869, DOI 10.1016/j.neuron.2005.05.004; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kalthoff C, 2002, J BIOL CHEM, V277, P8209, DOI 10.1074/jbc.M111587200; Lee EY, 2002, SCIENCE, V297, P1193, DOI 10.1126/science.1071362; LESLIE AGW, 1992, JOINT CCP4 ESF EACMB, V26; Lui WWY, 2003, MOL BIOL CELL, V14, P2385, DOI 10.1091/mbc.e02-11-0735; Lundmark R, 2002, BIOCHEM J, V362, P597, DOI 10.1042/0264-6021:3620597; Mattera R, 2004, J BIOL CHEM, V279, P8018, DOI 10.1074/jbc.M311873200; McMahon HT, 1997, FEBS LETT, V413, P319, DOI 10.1016/S0014-5793(97)00928-9; Meyerholz A, 2005, TRAFFIC, V6, P1225, DOI 10.1111/j.1600-0854.2005.00355.x; Miele AE, 2004, NAT STRUCT MOL BIOL, V11, P242, DOI 10.1038/nsmb736; Miller GJ, 2003, NAT STRUCT BIOL, V10, P599, DOI 10.1038/nsb953; Mills IG, 2003, J CELL BIOL, V160, P213, DOI 10.1083/jcb.200208023; Mishra SK, 2005, J BIOL CHEM, V280, P19270, DOI 10.1074/jbc.M501029200; Mishra SK, 2004, J BIOL CHEM, V279, P46191, DOI 10.1074/jbc.M408095200; Morris SM, 2001, TRAFFIC, V2, P111, DOI 10.1034/j.1600-0854.2001.020206.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Owen DJ, 2000, EMBO J, V19, P4216, DOI 10.1093/emboj/19.16.4216; Owen DJ, 1999, CELL, V97, P805, DOI 10.1016/S0092-8674(00)80791-6; PEARSE BMF, 1984, EMBO J, V3, P1951, DOI 10.1002/j.1460-2075.1984.tb02075.x; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Praefcke GJK, 2004, EMBO J, V23, P4371, DOI 10.1038/sj.emboj.7600445; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; RADU A, 1995, CELL, V81, P215, DOI 10.1016/0092-8674(95)90331-3; Razzaq A, 2001, GENE DEV, V15, P2967, DOI 10.1101/gad.207801; Ritter B, 2003, EMBO REP, V4, P1089, DOI 10.1038/sj.embor.7400004; Ritter B, 2007, EMBO J, V26, P4066, DOI 10.1038/sj.emboj.7601836; Salcini AE, 1997, GENE DEV, V11, P2239, DOI 10.1101/gad.11.17.2239; Schmid EM, 2007, NATURE, V448, P883, DOI 10.1038/nature06031; Schmid EM, 2006, PLOS BIOL, V4, P1532, DOI 10.1371/journal.pbio.0040262; Slepnev VI, 2000, J BIOL CHEM, V275, P17583, DOI 10.1074/jbc.M910430199; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; Tebar F, 1999, MOL BIOL CELL, V10, P2687, DOI 10.1091/mbc.10.8.2687; Tebar F, 1996, J BIOL CHEM, V271, P28727, DOI 10.1074/jbc.271.46.28727; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Walther K, 2004, P NATL ACAD SCI USA, V101, P964, DOI 10.1073/pnas.0307862100; Wasiak S, 2003, FEBS LETT, V555, P437, DOI 10.1016/S0014-5793(03)01299-7; Wigge P, 1997, MOL BIOL CELL, V8, P2003, DOI 10.1091/mbc.8.10.2003; Wigge P, 1997, CURR BIOL, V7, P554, DOI 10.1016/S0960-9822(06)00254-5; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3	61	21	21	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					5099	5109		10.1074/jbc.M708621200	http://dx.doi.org/10.1074/jbc.M708621200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	17986441	hybrid, Green Published			2022-12-27	WOS:000253426500067
J	Avenson, TJ; Ahn, TK; Zigmantas, D; Niyogi, KK; Li, Z; Ballottari, M; Bassi, R; Fleming, GR				Avenson, Thomas J.; Ahn, Tae Kyu; Zigmantas, Donatas; Niyogi, Krishna K.; Li, Zhirong; Ballottari, Matteo; Bassi, Roberto; Fleming, Graham R.			Zeaxanthin radical cation formation in minor light-harvesting complexes of higher plant antenna	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESOLVED FLUORESCENCE ANALYSIS; PHOTOSYSTEM-II; CHLOROPHYLL FLUORESCENCE; XANTHOPHYLL CYCLE; GREEN PLANTS; OXYGENIC PHOTOSYNTHESIS; ENERGY-DISSIPATION; EXCITED-STATES; PROTEIN CP26; IN-VIVO	Previous work on intact thylakoid membranes showed that transient formation of a zeaxanthin radical cation was correlated with regulation of photosynthetic light-harvesting via energy-dependent quenching. A molecular mechanism for such quenching was proposed to involve charge transfer within a chlorophyll-zeaxanthin heterodimer. Using near infrared (880 - 1100 nm) transient absorption spectroscopy, we demonstrate that carotenoid (mainly zeaxanthin) radical cation generation occurs solely in isolated minor light-harvesting complexes that bind zeaxanthin, consistent with the engagement of charge transfer quenching therein. We estimated that less than 0.5% of the isolated minor complexes undergo charge transfer quenching in vitro, whereas the fraction of minor complexes estimated to be engaged in charge transfer quenching in isolated thylakoids was more than 80 times higher. We conclude that minor complexes which bind zeaxanthin are sites of charge transfer quenching in vivo and that they can assume Non-quenching and Quenching conformations, the equilibrium LHC(N) reversible arrow LHC(Q) of which is modulated by the transthylakoid pH gradient, the PsbS protein, and protein-protein interactions.	[Avenson, Thomas J.; Ahn, Tae Kyu; Fleming, Graham R.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Ahn, Tae Kyu; Zigmantas, Donatas; Niyogi, Krishna K.; Li, Zhirong; Fleming, Graham R.] Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Avenson, Thomas J.; Zigmantas, Donatas; Niyogi, Krishna K.; Li, Zhirong] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Ballottari, Matteo; Bassi, Roberto] Univ Verona, Dept Sci & TEchnol, I-37134 Verona, Italy	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Verona	Fleming, GR (corresponding author), Univ Calif Berkeley, Dept Chem, Hildebrand B77, Berkeley, CA 94720 USA.	GRFleming@lbl.gov	Ahn, Tae Kyu/A-5838-2013; Ballottari, Matteo/N-1916-2019; Zigmantas, Donatas/E-5541-2014	Ahn, Tae Kyu/0000-0002-7474-6513; Ballottari, Matteo/0000-0001-8410-3397; Zigmantas, Donatas/0000-0003-2007-5256; bassi, roberto/0000-0002-4140-8446				Amarie S, 2007, J PHYS CHEM B, V111, P3481, DOI 10.1021/jp066458q; Andersson J, 2001, PLANT CELL, V13, P1193, DOI 10.1105/tpc.13.5.1193; Avenson TJ, 2004, P NATL ACAD SCI USA, V101, P5530, DOI 10.1073/pnas.0401269101; BASSI R, 1987, J BIOL CHEM, V262, P13333; BASSI R, 1992, EUR J BIOCHEM, V204, P317, DOI 10.1111/j.1432-1033.1992.tb16640.x; Crimi M, 2001, EUR J BIOCHEM, V268, P260, DOI 10.1046/j.1432-1033.2001.01874.x; Croce R, 2003, BIOPHYS J, V84, P2508, DOI 10.1016/S0006-3495(03)75056-5; Croce R, 2002, BIOCHEMISTRY-US, V41, P7334, DOI 10.1021/bi0257437; Dall'Osto L, 2005, PLANT CELL, V17, P1217, DOI 10.1105/tpc.104.030601; Dekker JP, 2005, BBA-BIOENERGETICS, V1706, P12, DOI 10.1016/j.bbabio.2004.09.009; DEMMIGADAMS B, 1990, BIOCHIM BIOPHYS ACTA, V1020, P1, DOI 10.1016/0005-2728(90)90088-L; DemmigAdams B, 1996, FASEB J, V10, P403, DOI 10.1096/fasebj.10.4.8647339; Dreuw A, 2005, BIOCHEM SOC T, V33, P858, DOI 10.1042/BST0330858; Dreuw A, 2003, PHYS CHEM CHEM PHYS, V5, P3247, DOI 10.1039/b304944b; Dreuw A, 2004, J AM CHEM SOC, V126, P4007, DOI 10.1021/ja039556n; Edge R, 1998, J AM CHEM SOC, V120, P4087, DOI 10.1021/ja974191q; FRANK HA, 1994, PHOTOSYNTH RES, V41, P389, DOI 10.1007/BF02183041; Galinato MGI, 2007, PHOTOSYNTH RES, V94, P67, DOI 10.1007/s11120-007-9218-5; GILMORE AM, 1995, P NATL ACAD SCI USA, V92, P2273, DOI 10.1073/pnas.92.6.2273; GILMORE AM, 1991, PLANT PHYSIOL, V96, P635, DOI 10.1104/pp.96.2.635; Green BR, 1996, ANNU REV PLANT PHYS, V47, P685, DOI 10.1146/annurev.arplant.47.1.685; Han RM, 2006, PHOTOCHEM PHOTOBIOL, V82, P538, DOI 10.1562/2005-09-30-RA-705; Harrer R, 1998, EUR J BIOCHEM, V255, P196, DOI 10.1046/j.1432-1327.1998.2550196.x; Hendrickson L, 2005, PHOTOSYNTH RES, V84, P43, DOI 10.1007/s11120-004-6430-4; Hendrickson L, 2004, PHOTOSYNTH RES, V82, P73, DOI 10.1023/B:PRES.0000040446.87305.f4; Holt NE, 2005, SCIENCE, V307, P433, DOI 10.1126/science.1105833; Holt NE, 2004, BIOCHEMISTRY-US, V43, P8281, DOI 10.1021/bi0494020; Horton P, 2005, FEBS LETT, V579, P4201, DOI 10.1016/j.febslet.2005.07.003; Horton P, 2005, J EXP BOT, V56, P365, DOI 10.1093/jxb/eri023; Horton P, 1996, ANNU REV PLANT PHYS, V47, P655, DOI 10.1146/annurev.arplant.47.1.655; Kovacs L, 2006, PLANT CELL, V18, P3106, DOI 10.1105/tpc.106.045641; Li XP, 2004, J BIOL CHEM, V279, P22866, DOI 10.1074/jbc.M402461200; Li XP, 2000, NATURE, V403, P391, DOI 10.1038/35000131; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; Ma YZ, 2003, P NATL ACAD SCI USA, V100, P4377, DOI 10.1073/pnas.0736959100; Morosinotto T, 2002, J BIOL CHEM, V277, P36913, DOI 10.1074/jbc.M205339200; Mortensen A, 1997, J AGR FOOD CHEM, V45, P2970, DOI 10.1021/jf970010s; Moya I, 2001, BIOCHEMISTRY-US, V40, P12552, DOI 10.1021/bi010342x; Muller P, 2001, PLANT PHYSIOL, V125, P1558, DOI 10.1104/pp.125.4.1558; Niyogi KK, 1998, PLANT CELL, V10, P1121, DOI 10.1105/tpc.10.7.1121; Pascal AA, 2005, NATURE, V436, P134, DOI 10.1038/nature03795; Polivka T, 2002, BIOCHEMISTRY-US, V41, P439, DOI 10.1021/bi011589x; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Tracewell CA, 2003, BIOCHEMISTRY-US, V42, P9127, DOI 10.1021/bi0345844; YAMAMOTO HY, 1962, ARCH BIOCHEM BIOPHYS, V97, P168, DOI 10.1016/0003-9861(62)90060-7	45	188	189	1	51	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3550	3558		10.1074/jbc.M705645200	http://dx.doi.org/10.1074/jbc.M705645200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	17991753	Green Submitted, hybrid			2022-12-27	WOS:000253083000060
J	Bedoukian, MA; Whitesell, JD; Peterson, EJ; Clay, CM; Partin, KM				Bedoukian, Matthew A.; Whitesell, Jennifer D.; Peterson, Erik J.; Clay, Colin M.; Partin, Kathryn M.			The stargazin C terminus encodes an intrinsic and transferable membrane sorting signal	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMPA RECEPTOR TRAFFICKING; 2 DISTINCT MECHANISMS; EXPRESSION; DESENSITIZATION; IDENTIFICATION; DEACTIVATION; MODULATION; PLASTICITY; TRANSPORT; DOMAINS	Activity-dependent plasticity of alpha-amino-3-hydroxy-5methylisoxazole-4-propionic acid receptors is regulated by their auxiliary subunit, stargazin. Association with stargazin enhances alpha-amino-3-hydroxy-5-methylisoxazole-4- propionic acid receptor surface expression and modifies the receptor's biophysical properties. Fusing the cytoplasmic C terminus of stargazin to the C- terminal domains of either GluR1 or the gonadotropin- releasing hormone receptor permits efficient trafficking from the endoplasmic reticulum and sorting to the basolateral membrane without altering other properties of either receptor.	[Bedoukian, Matthew A.; Whitesell, Jennifer D.; Peterson, Erik J.; Clay, Colin M.; Partin, Kathryn M.] Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA	Colorado State University	Partin, KM (corresponding author), Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA.	kathy.partin@research.colostate.edu	Partin, Kathryn/A-8706-2015; Partin, Kathryn/AAI-5412-2021	Partin, Kathryn/0000-0003-3801-3299; Partin, Kathryn/0000-0003-3801-3299; Whitesell, Jennifer/0000-0002-2961-5207	NIMH NIH HHS [R01 MH064700] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064700] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bats C, 2007, NEURON, V53, P719, DOI 10.1016/j.neuron.2007.01.030; Bedoukian MA, 2006, J BIOL CHEM, V281, P23908, DOI 10.1074/jbc.M600679200; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Deng F, 2006, J NEUROSCI, V26, P7875, DOI 10.1523/JNEUROSCI.1851-06.2006; Hall RA, 1997, J NEUROCHEM, V68, P625; Horton AC, 2003, NEURON, V40, P277, DOI 10.1016/S0896-6273(03)00629-9; Horvat RD, 2001, MOL ENDOCRINOL, V15, P695, DOI 10.1210/me.15.5.695; Knollman PE, 2005, J BIOL CHEM, V280, P24506, DOI 10.1074/jbc.M501978200; Leever JD, 2003, MOL PHARMACOL, V64, P5, DOI 10.1124/mol.64.1.5; Ma D, 2002, CURR OPIN NEUROBIOL, V12, P287, DOI 10.1016/S0959-4388(02)00319-7; Malenka RC, 2003, ANN NY ACAD SCI, V1003, P1, DOI 10.1196/annals.1300.001; Navratil AM, 2003, J BIOL CHEM, V278, P31593, DOI 10.1074/jbc.M304273200; Nicoll RA, 2003, PHILOS T R SOC B, V358, P721, DOI 10.1098/rstb.2002.1228; Priel A, 2005, J NEUROSCI, V25, P2682, DOI 10.1523/JNEUROSCI.4834-04.2005; Scannevin RH, 1996, J CELL BIOL, V135, P1619, DOI 10.1083/jcb.135.6.1619; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; Tomita S, 2005, NATURE, V435, P1052, DOI 10.1038/nature03624; Tucker TA, 2003, AM J PHYSIOL-CELL PH, V284, pC791, DOI 10.1152/ajpcell.00435.2002; Turetsky D, 2005, J NEUROSCI, V25, P7438, DOI 10.1523/JNEUROSCI.1108-05.2005; Vandenberghe W, 2005, J NEUROSCI, V25, P1095, DOI 10.1523/JNEUROSCI.3568-04.2005; Vandenberghe W, 2005, P NATL ACAD SCI USA, V102, P485, DOI 10.1073/pnas.0408269102; Ziff EB, 2007, NEURON, V53, P627, DOI 10.1016/j.neuron.2007.02.006	22	17	17	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1597	1600		10.1074/jbc.M708141200	http://dx.doi.org/10.1074/jbc.M708141200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	17986442	hybrid			2022-12-27	WOS:000252282700045
J	Abramovitz, L; Shapira, T; Ben-Dror, I; Dror, V; Granot, L; Rousso, T; Landoy, E; Blau, L; Thiel, G; Vardimon, L				Abramovitz, Lilach; Shapira, Tamar; Ben-Dror, Iris; Dror, Vardit; Granot, Limor; Rousso, Tal; Landoy, Elad; Blau, Lior; Thiel, Gerald; Vardimon, Lily			Dual role of NRSF/REST in activation and repression of the glucocorticoid response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESTRICTIVE SILENCER FACTOR; TRANSCRIPTION FACTOR REST; HISTONE DEACETYLASE INHIBITION; NEURONAL GENES; TARGET GENES; BIOLOGICAL-ACTIVITY; PROMOTER ACTIVITY; EXPRESSION; COMPLEX; ELEMENT	Restriction of glutamine synthetase to the nervous system is mainly achieved through the mutual function of the glucocorticoid receptor and the neural restrictive silencing factor, NRSF/REST. Glucocorticoids induce glutamine synthetase expression in neural tissues while NRSF/REST represses the hormonal response in non-neural cells. NRSF/REST is a modular protein that contains two independent repression domains, at the N and C termini of the molecule, and is dominantly expressed in nonneural cells. Neural tissues express however splice variants, REST4/5, which contain the repression domain at the N, but not at the C terminus of the molecule. Here we show that full-length NRSF/REST or its C-terminal domain can inhibit almost completely the induction of gene transcription by glucocorticoids. By contrast, the N-terminal domain not only fails to repress the hormonal response but rather stimulates it markedly. The inductive activity of the N-terminal domain is mediated by hBrm, which is recruited to the promoter only in the concomitant presence of GR. Importantly, a similar inductive activity is also exerted by the splice variant REST4. These findings raise the possibility that NRSF/REST exhibits a dual role in regulation of glutamine synthetase. It represses gene induction in nonneural cells and enhances the hormonal response, via its splice variant, in the nervous system.	[Abramovitz, Lilach; Shapira, Tamar; Ben-Dror, Iris; Dror, Vardit; Granot, Limor; Rousso, Tal; Landoy, Elad; Blau, Lior; Vardimon, Lily] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem, IL-69978 Tel Aviv, Israel; [Thiel, Gerald] Univ Saarland, Med Ctr, Dept Med Biochem & Mol Biol, D-66421 Homburg, Germany	Tel Aviv University; Saarland University	Vardimon, L (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem, IL-69978 Tel Aviv, Israel.	vardi@post.tau.ac.il		Abramovitz, Lilach/0000-0001-9961-9986				Armisen R, 2002, J NEUROSCI, V22, P8347; Avisar N, 1999, J BIOL CHEM, V274, P11399, DOI 10.1074/jbc.274.16.11399; Bai G, 2003, J NEUROCHEM, V86, P992, DOI 10.1046/j.1471-4159.2003.01922.x; Balasubramanian B, 1999, MOL CELL BIOL, V19, P2977; Ballas N, 2001, NEURON, V31, P353, DOI 10.1016/S0896-6273(01)00371-3; Battaglioli E, 2002, J BIOL CHEM, V277, P41038, DOI 10.1074/jbc.M205691200; BENDROR I, 1993, P NATL ACAD SCI USA, V90, P1117, DOI 10.1073/pnas.90.3.1117; Bessis A, 1997, P NATL ACAD SCI USA, V94, P5906, DOI 10.1073/pnas.94.11.5906; Brene S, 2000, EUR J NEUROSCI, V12, P1525, DOI 10.1046/j.1460-9568.2000.00040.x; Bruce AW, 2004, P NATL ACAD SCI USA, V101, P10458, DOI 10.1073/pnas.0401827101; Chen ZF, 1998, NAT GENET, V20, P136, DOI 10.1038/2431; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; DUNAIEF JL, 1994, CELL, V79, P119, DOI 10.1016/0092-8674(94)90405-7; Ferguson M, 2003, NUCLEIC ACIDS RES, V31, P3123, DOI 10.1093/nar/gkg403; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gordon S, 2006, ONCOGENE, V25, P1125, DOI 10.1038/sj.onc.1209080; Grimes JA, 2000, J BIOL CHEM, V275, P9461, DOI 10.1074/jbc.275.13.9461; Hebbar PB, 2003, MOL CELL BIOL, V23, P887, DOI 10.1128/MCB.23.3.887-898.2003; Huang YF, 1999, NAT NEUROSCI, V2, P867, DOI 10.1038/13165; Humphrey GW, 2001, J BIOL CHEM, V276, P6817, DOI 10.1074/jbc.M007372200; Kallunki P, 1998, P NATL ACAD SCI USA, V95, P3233, DOI 10.1073/pnas.95.6.3233; Krumm A, 1998, P NATL ACAD SCI USA, V95, P13501, DOI 10.1073/pnas.95.23.13501; Kuwabara T, 2004, CELL, V116, P779, DOI 10.1016/S0092-8674(04)00248-X; Laherty CD, 1997, CELL, V89, P349, DOI 10.1016/S0092-8674(00)80215-9; Laribee RN, 2001, J IMMUNOL, V167, P5160, DOI 10.4049/jimmunol.167.9.5160; Lee JH, 2000, J MOL NEUROSCI, V15, P205, DOI 10.1385/JMN:15:3:205; LEE JS, 1995, GENE DEV, V9, P1188, DOI 10.1101/gad.9.10.1188; LEE KAW, 1988, GENE ANAL TECH, V5, P22, DOI 10.1016/0735-0651(88)90023-4; Lietz M, 2001, EUR J NEUROSCI, V14, P1303, DOI 10.1046/j.0953-816x.2001.01762.x; LUCKOW B, 1987, NUCLEIC ACIDS RES, V15, P5490, DOI 10.1093/nar/15.13.5490; Lunyak VV, 2002, SCIENCE, V298, P1747, DOI 10.1126/science.1076469; Magin A, 2002, NEUROCHEM INT, V40, P195, DOI 10.1016/S0197-0186(01)00091-2; MIESFELD R, 1986, CELL, V46, P389, DOI 10.1016/0092-8674(86)90659-8; MUCHARDT C, 1993, EMBO J, V12, P4279, DOI 10.1002/j.1460-2075.1993.tb06112.x; Naruse Y, 1999, P NATL ACAD SCI USA, V96, P13691, DOI 10.1073/pnas.96.24.13691; Ooi L, 2006, J BIOL CHEM, V281, P38974, DOI 10.1074/jbc.M605370200; Palm K, 1998, J NEUROSCI, V18, P1280; Paz I, 1999, GENE, V236, P33, DOI 10.1016/S0378-1119(99)00264-4; Qiu Y, 2006, MOL CELL, V22, P669, DOI 10.1016/j.molcel.2006.04.019; Rabinovich E, 2002, MOL CELL BIOL, V22, P626, DOI 10.1128/MCB.22.2.626-634.2002; Roopra A, 2000, MOL CELL BIOL, V20, P2147, DOI 10.1128/MCB.20.6.2147-2157.2000; Roopra A, 2004, MOL CELL, V14, P727, DOI 10.1016/j.molcel.2004.05.026; SADOWSKI I, 1992, GENE, V118, P137, DOI 10.1016/0378-1119(92)90261-M; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Shimojo M, 1999, MOL CELL BIOL, V19, P6788; Shimojo M, 2001, J BIOL CHEM, V276, P13121, DOI 10.1074/jbc.M011193200; Tabuchi A, 2002, BIOCHEM BIOPH RES CO, V290, P415, DOI 10.1006/bbrc.2001.6194; TapiaRamirez J, 1997, P NATL ACAD SCI USA, V94, P1177, DOI 10.1073/pnas.94.4.1177; Thiel G, 1998, J BIOL CHEM, V273, P26891, DOI 10.1074/jbc.273.41.26891; Vardimon L, 1999, J NEUROBIOL, V40, P513, DOI 10.1002/(SICI)1097-4695(19990915)40:4<513::AID-NEU8>3.0.CO;2-D; Wang XQ, 2002, BIOCHEM BIOPH RES CO, V294, P660, DOI 10.1016/S0006-291X(02)00523-5; Watanabe H, 2006, ONCOGENE, V25, P470, DOI 10.1038/sj.onc.1209068; Yoo JY, 2001, BIOCHEM BIOPH RES CO, V283, P928, DOI 10.1006/bbrc.2001.4857; YOSHINAGA SK, 1992, SCIENCE, V258, P1598, DOI 10.1126/science.1360703; You A, 2001, P NATL ACAD SCI USA, V98, P1454, DOI 10.1073/pnas.98.4.1454	56	31	33	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					110	119		10.1074/jbc.M707366200	http://dx.doi.org/10.1074/jbc.M707366200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17984088	hybrid			2022-12-27	WOS:000251940300013
J	Lieber, MR				Lieber, Michael R.			The mechanism of human nonhomologous DNA end joining	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							DEPENDENT PROTEIN-KINASE; DOUBLE-STRAND BREAKS; XRCC4-DNA LIGASE-IV; V(D)J RECOMBINATION; BACKUP PATHWAYS; KU; REPAIR; COMPLEX; ARTEMIS; AUTOPHOSPHORYLATION	Double-strand breaks are common in all living cells, and there are two major pathways for their repair. In eukaryotes, homologous recombination is restricted to late S or G(2), whereas nonhomologous DNA end joining (NHEJ) can occur throughout the cell cycle and is the major pathway for the repair of double-strand breaks in multicellular eukaryotes. NHEJ is distinctive for the flexibility of the nuclease, polymerase, and ligase activities that are used. This flexibility permits NHEJ to function on the wide range of possible substrate configurations that can arise when double-strand breaks occur, particularly at sites of oxidative damage or ionizing radiation. NHEJ does not return the local DNA to its original sequence, thus accounting for the wide range of end results. Part of this heterogeneity arises from the diversity of the DNA ends, but much of it arises from the many alternative ways in which the nuclease, polymerases, and ligase can act during NHEJ. Physiologic double-strand break processes make use of the imprecision of NHEJ in generating antigen receptor diversity. Pathologically, the imprecision of NHEJ contributes to genome mutations that arise over time.	[Lieber, Michael R.] Univ So Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Pathol, Los Angeles, CA 90089 USA; [Lieber, Michael R.] Univ So Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Biochem, Los Angeles, CA 90089 USA; [Lieber, Michael R.] Univ So Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Biol Mol, Los Angeles, CA 90089 USA; [Lieber, Michael R.] Univ So Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Mol Microbiol, Los Angeles, CA 90089 USA; [Lieber, Michael R.] Univ So Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Immunol, Los Angeles, CA 90089 USA; [Lieber, Michael R.] Univ So Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Biol Sci, Los Angeles, CA 90089 USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California	Lieber, MR (corresponding author), Univ So Calif, Keck Sch Med, Rm 5428, 1441 Eastlake Ave, Los Angeles, CA 90089 USA.	lieber@usc.edu		Lieber, Michael/0000-0003-3700-6345; Lieber, Michael/0000-0001-8809-0909				Adachi N, 2001, P NATL ACAD SCI USA, V98, P12109, DOI 10.1073/pnas.201271098; Ahnesorg P, 2006, CELL, V124, P301, DOI 10.1016/j.cell.2005.12.031; Bertocci B, 2006, IMMUNITY, V25, P31, DOI 10.1016/j.immuni.2006.04.013; Buck D, 2006, CELL, V124, P287, DOI 10.1016/j.cell.2005.12.030; Chappell C, 2002, EMBO J, V21, P2827, DOI 10.1093/emboj/21.11.2827; Chu G, 1997, J BIOL CHEM, V272, P24097, DOI 10.1074/jbc.272.39.24097; Corneo B, 2007, NATURE, V449, P483, DOI 10.1038/nature06168; Daley JM, 2005, ANNU REV GENET, V39, P431, DOI 10.1146/annurev.genet.39.073003.113340; Daley JM, 2005, J BIOL CHEM, V280, P29030, DOI 10.1074/jbc.M505277200; Downs JA, 2004, NAT REV MOL CELL BIO, V5, P367, DOI 10.1038/nrm1367; FALZON M, 1993, J BIOL CHEM, V268, P10546; Ferguson DO, 2001, ONCOGENE, V20, P5572, DOI 10.1038/sj.onc.1204767; GILFILLAN S, 1993, SCIENCE, V261, P1175, DOI 10.1126/science.8356452; Gong CL, 2005, NAT STRUCT MOL BIOL, V12, P304, DOI 10.1038/nsmb915; Goodarzi AA, 2006, EMBO J, V25, P3880, DOI 10.1038/sj.emboj.7601255; Grawunder U, 1997, NATURE, V388, P492, DOI 10.1038/41358; Gu JF, 2007, NUCLEIC ACIDS RES, V35, P5755, DOI 10.1093/nar/gkm579; Gu JF, 2007, EMBO J, V26, P1010, DOI 10.1038/sj.emboj.7601559; Hammarsten O, 2000, J BIOL CHEM, V275, P1541, DOI 10.1074/jbc.275.3.1541; Jager U, 2000, BLOOD, V95, P3520, DOI 10.1182/blood.V95.11.3520.011k12_3520_3529; Jovanovic M, 2006, NUCLEIC ACIDS RES, V34, P1112, DOI 10.1093/nar/gkj504; KOMORI T, 1993, SCIENCE, V261, P1171, DOI 10.1126/science.8356451; Li H, 2007, MOL CELL BIOL, V27, P8205, DOI 10.1128/MCB.00785-07; Lieber MR, 2006, DNA REPAIR, V5, P1234, DOI 10.1016/j.dnarep.2006.05.013; Lieber MR, 2004, NAT REV MOL CELL BIO, V5, P69, DOI 10.1038/nrm1281; Ma JL, 2003, MOL CELL BIOL, V23, P8820, DOI 10.1128/MCB.23.23.8820-8828.2003; Ma YM, 2005, DNA REPAIR, V4, P845, DOI 10.1016/j.dnarep.2005.04.013; Ma YM, 2004, MOL CELL, V16, P701, DOI 10.1016/j.molcel.2004.11.017; Ma YM, 2002, CELL, V108, P781, DOI 10.1016/S0092-8674(02)00671-2; Mahajan KN, 2002, MOL CELL BIOL, V22, P5194, DOI 10.1128/MCB.22.14.5194-5202.2002; Meek K, 2004, IMMUNOL REV, V200, P132, DOI 10.1111/j.0105-2896.2004.00162.x; Meek K, 2007, MOL CELL BIOL, V27, P3881, DOI 10.1128/MCB.02366-06; Modesti M, 1999, EMBO J, V18, P2008, DOI 10.1093/emboj/18.7.2008; Moon AF, 2007, DNA REPAIR, V6, P1709, DOI 10.1016/j.dnarep.2007.05.009; Moore JK, 1996, MOL CELL BIOL, V16, P2164, DOI 10.1128/mcb.16.5.2164; Niewolik D, 2006, J BIOL CHEM, V281, P33900, DOI 10.1074/jbc.M606023200; Pitcher RS, 2007, ANNU REV MICROBIOL, V61, P259, DOI 10.1146/annurev.micro.61.080706.093354; Povirk LR, 2006, DNA REPAIR, V5, P1199, DOI 10.1016/j.dnarep.2006.05.016; Riballo E, 2004, MOL CELL, V16, P715, DOI 10.1016/j.molcel.2004.10.029; Sonoda E, 2006, DNA REPAIR, V5, P1021, DOI 10.1016/j.dnarep.2006.05.022; Stephanou NC, 2007, J BACTERIOL, V189, P5237, DOI 10.1128/JB.00332-07; Tsai CJ, 2007, P NATL ACAD SCI USA, V104, P7851, DOI 10.1073/pnas.0702620104; Tseng HM, 2002, J BIOL CHEM, V277, P45630, DOI 10.1074/jbc.M206861200; Uematsu N, 2007, J CELL BIOL, V177, P219, DOI 10.1083/jcb.200608077; van Heemst D, 2004, DNA REPAIR, V3, P43, DOI 10.1016/j.dnarep.2003.09.004; Walker JR, 2001, NATURE, V412, P607, DOI 10.1038/35088000; Wang HC, 2005, CANCER RES, V65, P4020, DOI 10.1158/0008-5472.CAN-04-3055; Weinstock David M, 2007, Nat Cell Biol, V9, P978; West RB, 1998, MOL CELL BIOL, V18, P5908, DOI 10.1128/MCB.18.10.5908; Wilson TE, 1999, J BIOL CHEM, V274, P23599, DOI 10.1074/jbc.274.33.23599; Windhofer F, 2007, INT J RADIAT ONCOL, V68, P1462, DOI 10.1016/j.ijrobp.2007.04.038; Yan CT, 2007, NATURE, V449, P478, DOI 10.1038/nature06020; Yaneva M, 1997, EMBO J, V16, P5098, DOI 10.1093/emboj/16.16.5098; Yoo S, 1999, NUCLEIC ACIDS RES, V27, P4679, DOI 10.1093/nar/27.24.4679	54	478	504	3	46	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					1	5		10.1074/jbc.R700039200	http://dx.doi.org/10.1074/jbc.R700039200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17999957	hybrid			2022-12-27	WOS:000251940300002
J	Hakuno, F; Kurihara, S; Watson, RT; Pessin, JE; Takahashi, SI				Hakuno, Fumihiko; Kurihara, Shigekazu; Watson, Robert T.; Pessin, Jeffrey E.; Takahashi, Shin-Ichiro			53BP2S, interacting with insulin receptor substrates, modulates insulin signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-I; PHOSPHATIDYLINOSITOL 3-KINASE ACTIVATION; DEOXYRIBONUCLEIC-ACID SYNTHESIS; STIMULATED GLUT4 TRANSLOCATION; NECROSIS-FACTOR-ALPHA; TYROSINE KINASE; PHOSPHOINOSITIDE 3-KINASE; SERINE PHOSPHORYLATION; TUMOR-SUPPRESSOR; GLUCOSE-UPTAKE	It is well known that insulin receptor substrates (IRS) act as a mediator for signal transduction of insulin, insulin-like growth factors, and several cytokines. To identify proteins that interact with IRS and modulate IRS-mediated signals, we performed yeast two-hybrid screening with IRS-1 as bait. Out of 109 cDNA-positive clones identified from a human placental cDNA library, two clones encoded 53BP2, p53-binding protein 2 (53BP2S), a short form splicing variant of the apoptosis-stimulating protein of p53 that possesses Src homology region 3 domain, and ankyrin repeats domain, and had been reported to interact with p53, Bcl-2, and NF-kappa B. Interaction of 53BP2S with IRS-1 was confirmed by glutathione S-transferase pull-down and co-immunoprecipitation assays in COS-7 cells and 3T3-L1 adipocytes. The Src homology region 3 domain and ankyrin repeats domain of 53BP2S were responsible for its interaction with IRS-1, whereas the phosphotyrosine binding domain and a central domain ( amino acid residues 750 - 861) of IRS-1 were required for its interaction with 53BP2S. In CHO-C400 cells, expression of 53BP2S reduced insulin-stimulated IRS-1 tyrosine phosphorylation with a concomitant enhancement of IRS-2 tyrosine phosphorylation. In addition, the amount of the phosphatidylinositol 3-kinase regulatory p85 subunit associated with tyrosine-phosphorylated proteins, and activation of Akt was enhanced by 53BP2S expression. Although 53BP2S also enhanced Akt activation in 3T3-L1 adipocytes, insulin-induced glucose transporter 4 translocation was markedly inhibited in accordance with reduction of insulin-induced AS160 phosphorylation. Together these data demonstrate that 53BP2S interacts and modulates the insulin signals mediated by IRSs.	[Hakuno, Fumihiko; Kurihara, Shigekazu; Takahashi, Shin-Ichiro] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Anim Sci, Bunkyo Ku, Tokyo 1138657, Japan; [Hakuno, Fumihiko; Kurihara, Shigekazu; Takahashi, Shin-Ichiro] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, Tokyo 1138657, Japan; [Watson, Robert T.; Pessin, Jeffrey E.] SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA	University of Tokyo; University of Tokyo; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Takahashi, SI (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Anim Sci, Lab Cell Regulat,Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	atkshin@mail.ecc.u-tokyo.ac.jp		Takahashi, Shin-Ichiro/0000-0002-2323-2010; Hakuno, Fumihiko/0000-0002-4447-6225				Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047; ARAKI E, 1994, NATURE, V372, P186, DOI 10.1038/372186a0; Ariga M, 2000, BIOCHEM J, V348, P409, DOI 10.1042/0264-6021:3480409; BACKER JM, 1992, J BIOL CHEM, V267, P1367; Bae SS, 2003, J BIOL CHEM, V278, P49530, DOI 10.1074/jbc.M306782200; Baumann CA, 2000, NATURE, V407, P202, DOI 10.1038/35025089; CHEATHAM B, 1994, MOL CELL BIOL, V14, P4902, DOI 10.1128/MCB.14.7.4902; Chiang SH, 2001, NATURE, V410, P944, DOI 10.1038/35073608; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Clark SF, 1998, J CELL BIOL, V140, P1211, DOI 10.1083/jcb.140.5.1211; CLARKE JF, 1994, BIOCHEM J, V300, P631, DOI 10.1042/bj3000631; Elmendorf JS, 1998, J BIOL CHEM, V273, P13289, DOI 10.1074/jbc.273.21.13289; Gao ZG, 2003, J BIOL CHEM, V278, P24944, DOI 10.1074/jbc.M300423200; GRONBORG M, 1993, J BIOL CHEM, V268, P23435; Gual P, 2003, DIABETOLOGIA, V46, P1532, DOI 10.1007/s00125-003-1223-4; Helps NR, 1995, FEBS LETT, V377, P295, DOI 10.1016/0014-5793(95)01347-4; HOTAMISLIGIL GS, 1994, DIABETES, V43, P1271, DOI 10.2337/diabetes.43.11.1271; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Huang C, 2005, J BIOL CHEM, V280, P19426, DOI 10.1074/jbc.M412317200; IWABUCHI K, 1994, P NATL ACAD SCI USA, V91, P6098, DOI 10.1073/pnas.91.13.6098; Jiang T, 1998, J BIOL CHEM, V273, P11017, DOI 10.1074/jbc.273.18.11017; Jiang ZY, 2003, P NATL ACAD SCI USA, V100, P7569, DOI 10.1073/pnas.1332633100; JULLIEN D, 1993, J BIOL CHEM, V268, P15246; Kabuta T, 2002, J BIOL CHEM, V277, P6846, DOI 10.1074/jbc.M107058200; Kanzaki M, 2002, J BIOL CHEM, V277, P25867, DOI 10.1074/jbc.C200292200; KOTANI K, 1995, BIOCHEM BIOPH RES CO, V209, P343, DOI 10.1006/bbrc.1995.1509; Le Marchand-Brustel Y, 2003, BIOCHEM SOC T, V31, P1152; Martin SS, 1996, J BIOL CHEM, V271, P17605, DOI 10.1074/jbc.271.30.17605; Mauvais-Jarvis F, 2002, J CLIN INVEST, V109, P141, DOI 10.1172/JCI200213305; Min J, 1999, MOL CELL, V3, P751, DOI 10.1016/S1097-2765(01)80007-1; MYERS MG, 1994, MOL CELL BIOL, V14, P3577, DOI 10.1128/MCB.14.6.3577; Nakaga H, 2000, CANCER RES, V60, P101; Naumovski L, 1996, MOL CELL BIOL, V16, P3884; Nedachi T, 2000, ENDOCRINOLOGY, V141, P2429, DOI 10.1210/en.141.7.2429; Nicholson KM, 2002, CELL SIGNAL, V14, P381, DOI 10.1016/S0898-6568(01)00271-6; Ogihara T, 1997, J BIOL CHEM, V272, P25267, DOI 10.1074/jbc.272.40.25267; OKADA T, 1994, J BIOL CHEM, V269, P3568; Ozes ON, 2001, P NATL ACAD SCI USA, V98, P4640, DOI 10.1073/pnas.051042298; Samuels-Lev Y, 2001, MOL CELL, V8, P781, DOI 10.1016/S1097-2765(01)00367-7; Sano H, 2003, J BIOL CHEM, V278, P14599, DOI 10.1074/jbc.C300063200; Sano H, 2007, CELL METAB, V5, P293, DOI 10.1016/j.cmet.2007.03.001; Sharma PM, 1998, J BIOL CHEM, V273, P18528, DOI 10.1074/jbc.273.29.18528; SKOLNIK EY, 1993, EMBO J, V12, P1929, DOI 10.1002/j.1460-2075.1993.tb05842.x; SKOLNIK EY, 1993, SCIENCE, V260, P1953, DOI 10.1126/science.8316835; TAKAHASHI S, 1990, ENDOCRINOLOGY, V126, P736, DOI 10.1210/endo-126-2-736; TAKAHASHI SI, 1991, J BIOL CHEM, V266, P7834; TAMEMOTO H, 1994, NATURE, V372, P182, DOI 10.1038/372182a0; TANTI JF, 1994, J BIOL CHEM, V269, P6051; Ueno H, 2000, MOL BIOL CELL, V11, P735, DOI 10.1091/mbc.11.2.735; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; White MF, 2002, AM J PHYSIOL-ENDOC M, V283, pE413, DOI 10.1152/ajpendo.00514.2001; White MF, 1997, DIABETOLOGIA, V40, pS2, DOI 10.1007/s001250051387; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; Yang JP, 1999, ONCOGENE, V18, P5177, DOI 10.1038/sj.onc.1202904	56	23	25	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37747	37758		10.1074/jbc.M702472200	http://dx.doi.org/10.1074/jbc.M702472200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17965023	hybrid			2022-12-27	WOS:000251833600051
J	Huzil, JT; Pannu, R; Ptak, C; Garen, G; Ellison, MJ				Huzil, J. Torin; Pannu, Rajeet; Ptak, Christopher; Garen, Grace; Ellison, Michael J.			Direct catalysis of lysine 48-linked polyubiquitin chains by the ubiquitin-activating enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; MULTIUBIQUITIN CHAIN; LIGASE COMPLEX; PROTEIN LIGASE; DEGRADATION; PATHWAY; CONJUGATION; SYSTEM; TAIL; E2	Within the ubiquitin degradation pathway, the canonical signal is a lysine 48-linked polyubiquitin chain that is assembled upon an internal lysine residue of a substrate protein. Once constructed, this ubiquitin chain becomes the principle signal for recognition and target degradation by the 26S proteasome. The mechanism by which polyubiquitin chains are assembled on a substrate protein, however, has yet to be clearly defined. In an in vitro model system, purified E2-ubiquitin thiolester was unable to catalyze the formation of polyubiquitin chains in the absence of the ubiquitin-activating enzyme E1. Mutagenesis of key residues within the E1 active site revealed that its conserved catalytic cysteine residue is essential for the formation of these chains. Moreover, inactivation of the E2 active site had no effect on the ability of E1 to catalyze ubiquitin chain formation. These findings strongly suggest E1 is responsible for not only the activation of ubiquitin but also for the direct catalytic extension of a lysine 48-linked polyubiquitin chain.	[Huzil, J. Torin; Pannu, Rajeet; Ptak, Christopher; Garen, Grace; Ellison, Michael J.] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada; [Ellison, Michael J.] Univ Alberta, Inst Biomol Design, Edmonton, AB T6G 2H7, Canada	University of Alberta; University of Alberta	Ellison, MJ (corresponding author), Univ Alberta, 3-67 Med Sci Bldg, Edmonton, AB T6G 2H7, Canada.	michael.ellison@ualberta.ca						ARNASON T, 1994, MOL CELL BIOL, V14, P7876, DOI 10.1128/MCB.14.12.7876; CASADABAN MJ, 1980, J MOL BIOL, V138, P179, DOI 10.1016/0022-2836(80)90283-1; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; CHEN ZJ, 1990, J BIOL CHEM, V265, P21835; DEVERAUX Q, 1994, J BIOL CHEM, V269, P7059; DOHMEN RJ, 1995, J BIOL CHEM, V270, P18099, DOI 10.1074/jbc.270.30.18099; GREGORI L, 1990, J BIOL CHEM, V265, P8354; HAAS A, 1990, J BIOL CHEM, V265, P21664; HAAS AL, 1988, J BIOL CHEM, V263, P13258; Haldeman MT, 1997, BIOCHEMISTRY-US, V36, P10526, DOI 10.1021/bi970750u; Hamilton KS, 2001, STRUCTURE, V9, P897, DOI 10.1016/S0969-2126(01)00657-8; HATFIELD PM, 1990, J BIOL CHEM, V265, P15813; HATFIELD PM, 1992, J BIOL CHEM, V267, P14799; HERSHKO A, 1983, J BIOL CHEM, V258, P8206; HERSHKO A, 1984, P NATL ACAD SCI-BIOL, V81, P1619, DOI 10.1073/pnas.81.6.1619; Hodgins R, 1996, J BIOL CHEM, V271, P28766, DOI 10.1074/jbc.271.46.28766; HODGINS RRW, 1992, J BIOL CHEM, V267, P8807; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; Huang DT, 2005, MOL CELL, V17, P341, DOI 10.1016/j.molcel.2004.12.020; Huang DT, 2004, NAT STRUCT MOL BIOL, V11, P927, DOI 10.1038/nsmb826; Johnson ES, 1997, EMBO J, V16, P5509, DOI 10.1093/emboj/16.18.5509; KLEMPERER NS, 1989, BIOCHEMISTRY-US, V28, P6035, DOI 10.1021/bi00440a047; Leimkuhler S, 2001, J BIOL CHEM, V276, P22024, DOI 10.1074/jbc.M102072200; Liakopoulos D, 1998, EMBO J, V17, P2208, DOI 10.1093/emboj/17.8.2208; Mastrandrea LD, 1998, BIOCHEMISTRY-US, V37, P9784, DOI 10.1021/bi9800911; Mastrandrea LD, 1999, J BIOL CHEM, V274, P27299, DOI 10.1074/jbc.274.38.27299; MCGRATH JP, 1991, EMBO J, V10, P227, DOI 10.1002/j.1460-2075.1991.tb07940.x; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; PAPA FR, 1993, NATURE, V366, P313, DOI 10.1038/366313a0; Petroski MD, 2005, CELL, V123, P1107, DOI 10.1016/j.cell.2005.09.033; PICKART CM, 1988, J BIOL CHEM, V263, P15076; Piotrowski J, 1997, J BIOL CHEM, V272, P23712, DOI 10.1074/jbc.272.38.23712; PTAK C, 1994, J BIOL CHEM, V269, P26539; SCHEFFNER M, 1995, NATURE, V373, P81, DOI 10.1038/373081a0; Schulman BA, 2000, NATURE, V408, P381, DOI 10.1038/35042620; SEUFERT W, 1992, EMBO J, V11, P3077, DOI 10.1002/j.1460-2075.1992.tb05379.x; Staszczak M, 2007, INT J BIOCHEM CELL B, V39, P319, DOI 10.1016/j.biocel.2006.08.013; SUNG P, 1991, EMBO J, V10, P2187, DOI 10.1002/j.1460-2075.1991.tb07754.x; Terrell J, 1998, MOL CELL, V1, P193, DOI 10.1016/S1097-2765(00)80020-9; VAN NS, 1991, P NATL ACAD SCI USA, V88, P10297; VanDemark AP, 2003, NAT STRUCT BIOL, V10, P244, DOI 10.1038/nsb0403-244; VANNOCKER S, 1993, J BIOL CHEM, V268, P24766; Walden H, 2003, NATURE, V422, P330, DOI 10.1038/nature01456; WALKER JE, 1982, BIOCHEM SOC T, V10, P203, DOI 10.1042/bst0100203; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a	45	9	10	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37454	37460		10.1074/jbc.M705242200	http://dx.doi.org/10.1074/jbc.M705242200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17951259	hybrid			2022-12-27	WOS:000251833600020
J	Xu, H; Shi, Y; Wang, JL; Jones, D; Weilrauch, D; Ying, R; Wakim, B; Pritchard, KA				Xu, Hao; Shi, Yang; Wang, Jingli; Jones, Deron; Weilrauch, Dorothee; Ying, Rong; Wakim, Basam; Pritchard, Kirkwood A., Jr.			A heat shock protein 90 binding domain in endothelial nitric-oxide synthase influences enzyme function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TAT FUSION PROTEINS; SUPEROXIDE ANION; TRANSDUCTION; PHOSPHORYLATION; ACTIVATION; GENERATION; BALANCE; HSP90; L-4F	Previous reports suggest heat shock protein 90 (hsp90) associates with endothelial nitric-oxide synthase (eNOS) to increase nitric oxide (center dot NO) generation. Ansamycin inhibition of chaperone-dependent activity increases eNOS generation of superoxide anion (O-2 radical anion) upon enzyme activation. In the present study we identify where hsp90 binds to eNOS using overlapping decoy peptides based on the amino acid (aa) sequence of eNOS (291-420). B1, B2, and B3 peptides inhibited hsp90 association with eNOS in cell lysates from proliferating bovine aortic endothelial cells. B2 (aa 301-320), common to both B1 and B3, decreased stimulated center dot NO production and hsp90 association in bovine aortic endothelial cells. The B2/ B3 peptide was redesigned to TSB2 that includes a TAT protein transduction domain and shortened to 14 aa. TSB2 impaired vasodilation of isolated facialis arteries in vitro and in vivo and increased eNOS-dependent O-2 radical anion radical anion generation in native endothelial cells on mouse aortas, whereas a control peptide, TSB(Ctr), which has the four glutamic acids in TSB2 substituted with alanine, showed no such effects. Site-directed mutagenesis of eNOS at 310, 314, 318, and 323 Glu to Ala yields an eNOS mutant that exhibited reduced hsp90 association and generated O-2 radical anion rather than center dot NO upon activation. Together, these data demonstrate that hsp90 associates with eNOS at aa 310 -323. Moreover, a decoy peptide based on this sequence is sufficient to displace hsp90 from eNOS and uncouple eNOS activity from center dot NO generation. Thus, Glu-310, Glu-314, Glu-318, and Glu-323 in eNOS, although each does not do much by itself, synergistically they increase " cooperativity" in the association step that is critical for maintaining hsp90-eNOS interactions and promoting coupled eNOS activity. Such chaperone-dependent signaling may play an important role in modulating the balance of center dot NOandO(2) radical anion generation from eNOS and, therefore, vascular function.	[Xu, Hao; Shi, Yang; Wang, Jingli; Jones, Deron; Ying, Rong; Pritchard, Kirkwood A., Jr.] Med Coll Wisconsin, Childrens Res Inst, Dept Surg, Div Pediat Surg, Milwaukee, WI 53226 USA; [Weilrauch, Dorothee] Med Coll Wisconsin, Childrens Res Inst, Dept Anesthesiol, Milwaukee, WI 53226 USA; [Wakim, Basam] Med Coll Wisconsin, Cardiovasc Res Ctr, Childrens Res Inst, Dept Biochem, Milwaukee, WI USA	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin	Shi, Y (corresponding author), Med Coll Wisconsin, Childrens Res Inst, Dept Surg, Div Pediat Surg, Milwaukee, WI 53226 USA.	yangshi@mcw.edu; kpritch@mcw.edu			NHLBI NIH HHS [HL71214, HL48251, HL080468] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080468, R01HL071214, R01HL048251] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Dolgilevich S, 2002, BIOCHEM BIOPH RES CO, V299, P505, DOI 10.1016/S0006-291X(02)02664-5; Drouin A, 2007, CARDIOVASC RES, V73, P73, DOI 10.1016/j.cardiores.2006.10.005; DUNHAM AJ, 1995, ANAL CHEM, V67, P220, DOI 10.1021/ac00097a033; Fontana J, 2002, CIRC RES, V90, P866, DOI 10.1161/01.RES.0000016837.26733.BE; Fulton D, 2004, J BIOL CHEM, V279, P30349, DOI 10.1074/jbc.M402155200; Garcia-Cardena G, 1998, NATURE, V392, P821, DOI 10.1038/33934; Guo XQ, 2004, EXP EYE RES, V78, P997, DOI 10.1016/j.exer.2003.12.010; Gustafsson AB, 2002, CIRCULATION, V106, P735, DOI 10.1161/01.CIR.0000023943.50821.F7; Jagnandan D, 2005, AM J PHYSIOL-CELL PH, V289, pC1024, DOI 10.1152/ajpcell.00162.2005; Morris MC, 2001, NAT BIOTECHNOL, V19, P1173, DOI 10.1038/nbt1201-1173; Oak JH, 2007, DIABETES, V56, P118, DOI 10.2337/db06-0288; Osuka K, 2004, STROKE, V35, P2582, DOI 10.1161/01.STR.0000143454.14159.28; Ou J, 2003, FREE RADICAL BIO MED, V34, P269, DOI 10.1016/S0891-5849(02)01299-6; Ou JS, 2004, AM J PHYSIOL-HEART C, V286, pH561, DOI 10.1152/ajpheart.00736.2003; Ou JS, 2003, CIRCULATION, V107, P2337, DOI 10.1161/01.CIR.0000070589.61860.A9; Ou ZJ, 2003, CIRCULATION, V107, P1520, DOI 10.1161/01.CIR.0000061949.17174.B6; Pritchard KA, 2001, J BIOL CHEM, V276, P17621, DOI 10.1074/jbc.C100084200; PRITCHARD KA, 1995, CIRC RES, V77, P510, DOI 10.1161/01.RES.77.3.510; Rey FE, 2001, CIRC RES, V89, P408, DOI 10.1161/hh1701.096037; Sakai H, 2006, INVEST OPHTH VIS SCI, V47, P4427, DOI 10.1167/iovs.06-0047; Salerno JC, 1997, J BIOL CHEM, V272, P29769, DOI 10.1074/jbc.272.47.29769; Stepp DW, 2002, AM J PHYSIOL-HEART C, V283, pH750, DOI 10.1152/ajpheart.00029.2002; Vasquez-Vivar J, 1998, P NATL ACAD SCI USA, V95, P9220, DOI 10.1073/pnas.95.16.9220; Zhao HT, 2003, FREE RADICAL BIO MED, V34, P1359, DOI 10.1016/S0891-5849(03)00142-4	25	54	56	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37567	37574		10.1074/jbc.M706464200	http://dx.doi.org/10.1074/jbc.M706464200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17971446	hybrid			2022-12-27	WOS:000251833600032
J	Hou, T; Ray, S; Brasier, AR				Hou, Tieying; Ray, Sutapa; Brasier, Allan R.			The functional role of an interleukin 6-inducible CDK9 center dot STAT3 complex in human gamma-fibrinogen gene expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; PERIPHERAL-BLOOD LYMPHOCYTES; PROMONOCYTIC CELL-LINES; CDK9 PHOSPHORYLATES P53; TAT-ASSOCIATED KINASE; ACUTE-PHASE RESPONSE; FACTOR P-TEFB; HIV-1 TAT; TRANSCRIPTION ELONGATION; IN-VITRO	The signal transducer and activator of transcription 3 (STAT3) is an IL-6-inducible transcription factor that mediates the hepatic acute phase response (APR). Using gamma-fibrinogen (FBG) as a model of the APR, we investigated the requirement of an IL-6-inducible complex of STAT3 with cyclin-dependent kinase 9 (CDK9) on gamma-FBG expression in HepG2 hepatocarcinoma cells. IL-6 induces rapid nuclear translocation of Tyrphosphorylated STAT3 that forms a nuclear complex with CDK9 in nondenaturing co-immunoprecipitation and confocal colocalization assays. To further understand this interaction, we found that CDK9-STAT3 binding is mediated via both STAT NH2-terminal modulatory and COOH-terminal transactivation domains. Both IL-6-inducible gamma-FBG reporter gene and endogenous mRNA expression are significantly decreased after CDK9 inhibition using the potent CDK inhibitor, flavopiridol ( FP), or specific CDK9 siRNA. Moreover, chromatin immunoprecipitation (ChIP) experiments revealed an IL-6-inducible STAT3 and CDK9 binding to the proximal gamma-FBG promoter as well as increased loading of RNA Pol II and phospho-Ser(2) CTD Pol II on the TATA box and coding regions. Finally, FP specifically and efficiently inhibits association of phospho-Ser(2) CTD RNA Pol II on the gamma-FBG promoter, indicating that CDK9 kinase activity mediates IL-6-inducible CTD phosphorylation. Our data indicate that IL-6 induces a STAT3 center dot CDK9 complex mediated by bivalent STAT3 domains and CDK9 kinase activity is necessary for licensing Pol II to enter a transcriptional elongation mode. Therefore, disruption of IL-6 signaling by CDK9 inhibitors could be a potential therapeutic strategy for inflammatory disease.	[Hou, Tieying] Univ Texas Galveston, Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Ray, Sutapa; Brasier, Allan R.] Univ Texas Galveston, Med Branch, Dept Internal Med, Galveston, TX 77555 USA; [Brasier, Allan R.] Univ Texas Galveston, Med Branch, Sealy Ctr Mol Med, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Brasier, AR (corresponding author), Univ Texas Galveston, Med Branch, Div Endocrinol, MRB 8-138,301 Univ Blvd, Galveston, TX 77555 USA.	arbrasie@utmb.edu	Ray, Sutapa/D-3272-2012	Brasier, Allan/0000-0002-5012-4090; Ray, Sutapa/0000-0003-4234-2124	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070925] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006676] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL070925] Funding Source: Medline; NIEHS NIH HHS [P30 ES06676] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Barboric M, 2001, MOL CELL, V8, P327, DOI 10.1016/S1097-2765(01)00314-8; Bieniasz PD, 1998, EMBO J, V17, P7056, DOI 10.1093/emboj/17.23.7056; BRASIER AR, 1989, BIOTECHNIQUES, V7, P1116; Chao SH, 2000, J BIOL CHEM, V275, P28345, DOI 10.1074/jbc.C000446200; Chao SH, 2001, J BIOL CHEM, V276, P31793, DOI 10.1074/jbc.M102306200; Claudio PP, 2006, J CELL PHYSIOL, V208, P602, DOI 10.1002/jcp.20698; Duan HO, 2006, J BIOL CHEM, V281, P12451, DOI 10.1074/jbc.M600294200; Duan HO, 2003, J BIOL CHEM, V278, P41270, DOI 10.1074/jbc.M304210200; Eberhardy SR, 2001, J BIOL CHEM, V276, P48562, DOI 10.1074/jbc.M109014200; Eberhardy SR, 2002, J BIOL CHEM, V277, P40156, DOI 10.1074/jbc.M207441200; FU J, 2007, MOL CELL BIOL, V27, P4661; Garriga J, 1998, ONCOGENE, V17, P3093, DOI 10.1038/sj.onc.1202548; Garriga J, 2004, GENE, V337, P15, DOI 10.1016/j.gene.2004.05.007; Ghose R, 2001, J VIROL, V75, P11336, DOI 10.1128/JVI.75.23.11336-11343.2001; Giraud S, 2004, ONCOGENE, V23, P7391, DOI 10.1038/sj.onc.1207972; Gomes NP, 2006, GENE DEV, V20, P601, DOI 10.1101/gad.1398206; GRANA X, 1994, P NATL ACAD SCI USA, V91, P3834, DOI 10.1073/pnas.91.9.3834; Haga S, 2003, J CLIN INVEST, V112, P989, DOI 10.1172/JCI200317970; Hagihara K, 2005, GENES CELLS, V10, P1051, DOI 10.1111/j.1365-2443.2005.00900.x; HAWIGER J, 1995, SEMIN HEMATOL, V32, P99; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; Herrmann CH, 1998, J VIROL, V72, P9881, DOI 10.1128/JVI.72.12.9881-9888.1998; Hirano T, 2000, ONCOGENE, V19, P2548, DOI 10.1038/sj.onc.1203551; Iankova I, 2006, MOL ENDOCRINOL, V20, P1494, DOI 10.1210/me.2005-0222; JIANG SL, 1992, FOLIA HISTOCHEM CYTO, V30, P133; Kanazawa S, 2000, IMMUNITY, V12, P61, DOI 10.1016/S1074-7613(00)80159-4; Kim JB, 2001, J BIOL CHEM, V276, P12317, DOI 10.1074/jbc.M010908200; Kouzarides T, 1999, CURR OPIN GENET DEV, V9, P40, DOI 10.1016/S0959-437X(99)80006-9; Lee DK, 2001, J BIOL CHEM, V276, P9978, DOI 10.1074/jbc.M002285200; LEUNG S, 1995, MOL CELL BIOL, V15, P1312; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; MADORE SJ, 1993, J VIROL, V67, P3703, DOI 10.1128/JVI.67.7.3703-3711.1993; Marshall RM, 2005, J IMMUNOL, V175, P6402, DOI 10.4049/jimmunol.175.10.6402; MIZUGUCHI J, 1995, J BIOL CHEM, V270, P28350; Murphy TL, 2000, MOL CELL BIOL, V20, P7121, DOI 10.1128/MCB.20.19.7121-7131.2000; Ni ZY, 2007, J IMMUNOL, V178, P345, DOI 10.4049/jimmunol.178.1.345; Nowak DE, 2005, BIOTECHNIQUES, V39, P715, DOI 10.2144/000112014; Peng JM, 1998, GENE DEV, V12, P755, DOI 10.1101/gad.12.5.755; Ping YH, 2001, J BIOL CHEM, V276, P12951, DOI 10.1074/jbc.M006130200; Price DH, 2000, MOL CELL BIOL, V20, P2629, DOI 10.1128/MCB.20.8.2629-2634.2000; Radhakrishnan SK, 2006, CELL CYCLE, V5, P519, DOI 10.4161/cc.5.5.2514; RAMJI DP, 1993, NUCLEIC ACIDS RES, V21, P289, DOI 10.1093/nar/21.2.289; Rana TM, 1999, ARCH BIOCHEM BIOPHYS, V365, P175, DOI 10.1006/abbi.1999.1206; Ray A, 2000, J IMMUNOL, V165, P3411, DOI 10.4049/jimmunol.165.6.3411; Ray S, 2005, GASTROENTEROLOGY, V129, P1616, DOI 10.1053/j.gastro.2005.07.055; Ray S, 2002, MOL ENDOCRINOL, V16, P824, DOI 10.1210/me.16.4.824; Roberts CWM, 2004, NAT REV CANCER, V4, P133, DOI 10.1038/nrc1273; Rooney MM, 1996, J BIOL CHEM, V271, P8553, DOI 10.1074/jbc.271.15.8553; Sahni A, 2000, BLOOD, V96, P3772, DOI 10.1182/blood.V96.12.3772.h8003772_3772_3778; Sahni A, 2004, BLOOD, V104, P409, DOI 10.1182/blood-2004-01-0126; Sahni A, 2003, J THROMB HAEMOST, V1, P1304, DOI 10.1046/j.1538-7836.2003.00250.x; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Sherman CT, 2001, MOL ENDOCRINOL, V15, P441, DOI 10.1210/me.15.3.441; Shore SM, 2003, GENE, V307, P175, DOI 10.1016/S0378-1119(03)00466-9; Song A, 1998, MOL CELL BIOL, V18, P4994, DOI 10.1128/MCB.18.9.4994; Strehlow I, 1998, J BIOL CHEM, V273, P28049, DOI 10.1074/jbc.273.43.28049; Ugarova TP, 2003, BIOCHEMISTRY-US, V42, P9365, DOI 10.1021/bi034057k; Vinkemeier U, 1996, EMBO J, V15, P5616, DOI 10.1002/j.1460-2075.1996.tb00946.x; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Wimmer J, 1999, VIROLOGY, V255, P182, DOI 10.1006/viro.1998.9589; Xu XA, 1996, SCIENCE, V273, P794, DOI 10.1126/science.273.5276.794; Yang XZ, 1997, P NATL ACAD SCI USA, V94, P12331, DOI 10.1073/pnas.94.23.12331; Zhang JJ, 1996, P NATL ACAD SCI USA, V93, P15092, DOI 10.1073/pnas.93.26.15092; Zhu YR, 1997, GENE DEV, V11, P2622, DOI 10.1101/gad.11.20.2622	65	61	67	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					37091	37102		10.1074/jbc.M706458200	http://dx.doi.org/10.1074/jbc.M706458200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17956865	hybrid			2022-12-27	WOS:000251646000036
J	Pulukuri, SMK; Gorantla, B; Rao, JS				Pulukuri, Sai Murali Krishna; Gorantla, Bharathi; Rao, Jasti S.			Inhibition of histone deacetylase activity promotes invasion of human cancer cells through activation of urokinase plasminogen activator	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN BREAST-CANCER; TUMOR-GROWTH; DISEASE PROGRESSION; DNA METHYLATION; UP-REGULATION; IN-VITRO; EXPRESSION; RECEPTOR; CHROMATIN; GENE	Histone acetylation plays an important role in chromatin remodeling and gene expression. The molecular mechanisms involved in differential regulation of urokinase plasminogen activator (uPA) gene expression are not fully understood. In this study, we investigated whether histone deacetylation was involved in repression of uPA expression in human cancer cells. Induction of uPA expression by histone deacetylase (HDAC) inhibitors trichostatin A (TSA), sodium butyrate, and scriptaid was observed in all three different types of human cancer cells examined. Chromatin immunoprecipitation assays showed that the induction of uPA expression by TSA was accompanied by a remarkable increase of acetylation of histones H3 and H4, which are associated with the uPA promoter region in human cancer cells. These results were further substantiated by the findings of a restriction enzyme accessibility assay and TSA-stimulated uPA promoter activity through the inhibition of HDAC activity. In vitro Matrigel invasion assays showed that induction of uPA expression by HDAC inhibitors in human cancer cells resulted in a significant increase of cancer cell invasion. Furthermore, HDAC1 knockdown by small interference RNA stimulated uPA expression and cancer cell invasion. In conclusion, this study demonstrates the important role of histone modifications in regulating uPA gene expression and raises a possibility that the use of HDAC inhibitors in patients as cancer therapy may paradoxically establish metastasis through up-regulation or reactivation of uPA.	Univ Illinois, Coll Med, Dept Canc Biol & Pharmacol, Peoria, IL 61656 USA; Univ Illinois, Coll Med, Dept Neurosurg, Peoria, IL 61656 USA	University of Illinois System; University of Illinois Peoria; University of Illinois System; University of Illinois Peoria	Rao, JS (corresponding author), Univ Illinois, Coll Med, Program Canc Biol, 1 Illini Dr, Peoria, IL 61605 USA.	jsrao@uic.edu			NCI NIH HHS [R01 CA092393, CA92393, R01 CA095058, R01 CA075557, R01 CA116708, CA75557, R01 CA092393-04, R01 CA116708-02, R01 CA095058-04, CA116708, CA95058, R01 CA075557-09] Funding Source: Medline; NINDS NIH HHS [R01 NS057529, R01 NS047699-03, NS47699, R01 NS057529-01, R01 NS047699, NS057529] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA116708, R01CA075557, R01CA092393, R01CA095058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047699, R01NS057529] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aguirre-Ghiso JA, 2003, CANCER RES, V63, P1684; AZNAVOORIAN S, 1993, CANCER-AM CANCER SOC, V71, P1368, DOI 10.1002/1097-0142(19930215)71:4<1368::AID-CNCR2820710432>3.0.CO;2-L; Blasi F, 1999, THROMB HAEMOSTASIS, V82, P298; Boire A, 2005, CELL, V120, P303, DOI 10.1016/j.cell.2004.12.018; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; Cheung WL, 2000, CURR OPIN CELL BIOL, V12, P326, DOI 10.1016/S0955-0674(00)00096-X; Collen D, 1999, THROMB HAEMOSTASIS, V82, P259; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Cong YS, 2000, J BIOL CHEM, V275, P35665, DOI 10.1074/jbc.C000637200; Davie JR, 1999, J CELL BIOCHEM, P141; Dazzi C, 2003, CANCER INVEST, V21, P208, DOI 10.1081/CNV-120016417; Degryse B, 1999, BLOOD, V94, P649, DOI 10.1182/blood.V94.2.649.414k34_649_662; Della Ragione F, 2001, FEBS LETT, V499, P199, DOI 10.1016/S0014-5793(01)02539-X; Drummond DC, 2005, CLIN CANCER RES, V11, P3392, DOI 10.1158/1078-0432.CCR-04-2445; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Geiman TM, 2002, J CELL BIOCHEM, V87, P117, DOI 10.1002/jcb.10286; Gerber AN, 1997, GENE DEV, V11, P436, DOI 10.1101/gad.11.4.436; Gondi CS, 2003, ONCOGENE, V22, P5967, DOI 10.1038/sj.onc.1206535; Guo YJ, 2002, J BIOL CHEM, V277, P41571, DOI 10.1074/jbc.M201864200; HSU DW, 1995, AM J PATHOL, V147, P114; Iizuka M, 2003, CURR OPIN GENET DEV, V13, P154, DOI 10.1016/S0959-437X(03)00020-0; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jaskelioff M, 2003, NAT CELL BIOL, V5, P395, DOI 10.1038/ncb0503-395; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kelly WK, 2002, EXPERT OPIN INV DRUG, V11, P1695, DOI 10.1517/13543784.11.12.1695; Konecny G, 2001, CLIN CANCER RES, V7, P1743; Kusch A, 2000, J BIOL CHEM, V275, P39466, DOI 10.1074/jbc.M003626200; Lakka SS, 2005, BRAIN PATHOL, V15, P327; Legrand C, 2001, EXP CELL RES, V264, P326, DOI 10.1006/excr.2000.5125; Liu LT, 2003, CANCER RES, V63, P3069; MacDougall JR, 1995, CANCER METAST REV, V14, P351, DOI 10.1007/BF00690603; Marks PA, 2001, CLIN CANCER RES, V7, P759; Marks PA, 2001, NAT REV CANCER, V1, P194, DOI 10.1038/35106079; Miyake H, 1999, INT J ONCOL, V14, P535; MOHANAM S, 1993, CANCER RES, V53, P4143; Mohanam S, 1999, INT J ONCOL, V14, P169; Mori T, 2005, CANCER RES, V65, P1800, DOI 10.1158/0008-5472.CAN-04-3531; Munster PN, 2001, CANCER RES, V61, P8492; Osada H, 2001, CANCER RES, V61, P8331; Pakneshan P, 2003, FASEB J, V17, P1081, DOI 10.1096/fj.02-0973com; Pazin MJ, 1997, CELL, V89, P325, DOI 10.1016/S0092-8674(00)80211-1; Pulukuri SMK, 2007, CANCER RES, V67, P930, DOI 10.1158/0008-5472.CAN-06-2892; Pulukuri SM, 2005, J BIOL CHEM, V280, P36529, DOI 10.1074/jbc.M503111200; Qiu P, 2002, CIRC RES, V90, P858, DOI 10.1161/01.RES.0000016504.08608.B9; Rao JS, 2003, NAT REV CANCER, V3, P489, DOI 10.1038/nrc1121; Richon VM, 2000, P NATL ACAD SCI USA, V97, P10014, DOI 10.1073/pnas.180316197; Sadri-Vakili Ghazaleh, 2006, Current Alzheimer Research, V3, P403, DOI 10.2174/156720506778249407; Salvi A, 2004, MOL CANCER THER, V3, P671; Sambucetti LC, 1999, J BIOL CHEM, V274, P34940, DOI 10.1074/jbc.274.49.34940; Sartorelli V, 2001, FRONT BIOSCI-LANDMRK, V6, pD1024, DOI 10.2741/Sartorel; Schweinitz A, 2004, J BIOL CHEM, V279, P33613, DOI 10.1074/jbc.M314151200; Sengupta N, 2004, J CELL BIOCHEM, V93, P57, DOI 10.1002/jcb.20179; Sidenius N, 2003, CANCER METAST REV, V22, P205, DOI 10.1023/A:1023099415940; Steeg PS, 2003, NAT REV CANCER, V3, P55, DOI 10.1038/nrc967; Stewart Delisha A, 2004, Reprod Biol Endocrinol, V2, P2, DOI 10.1186/1477-7827-2-2; Takada Y, 2006, J BIOL CHEM, V281, P5612, DOI 10.1074/jbc.M507213200; Uchida H, 2007, ENDOCRINOLOGY, V148, P896, DOI 10.1210/en.2006-0896; VanLint C, 1996, GENE EXPRESSION, V5, P245; VASSALLI JD, 1994, NATURE, V370, P14, DOI 10.1038/370014a0; YAMAMOTO M, 1994, CANCER RES, V54, P3656; Yang JL, 2000, INT J CANCER, V89, P431, DOI 10.1002/1097-0215(20000920)89:5<431::AID-IJC6>3.0.CO;2-V; Zhang XH, 2004, MOL CELL BIOL, V24, P5106, DOI 10.1128/MCB.24.12.5106-5118.2004; Zhao SJ, 2003, CANCER RES, V63, P2624	63	46	48	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35594	35603		10.1074/jbc.M705867200	http://dx.doi.org/10.1074/jbc.M705867200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17923479	Green Accepted, hybrid			2022-12-27	WOS:000251458100019
J	Zhang, T; Kohlhaas, M; Backs, J; Mishra, S; Phillips, W; Dybkova, N; Chang, S; Ling, H; Bers, DM; Maier, LS; Olson, EN; Brown, JH				Zhang, Tong; Kohlhaas, Michael; Backs, Johannes; Mishra, Shikha; Phillips, William; Dybkova, Nataliya; Chang, Shurong; Ling, Haiyun; Bers, Donald M.; Maier, Lars S.; Olson, Eric N.; Brown, Joan Heller			CaMKII delta isoforms differentially affect calcium handling but similarly regulate HDAC/MEF2 transcriptional responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-II; CARDIAC RYANODINE RECEPTOR; FACTOR GENE-EXPRESSION; HEART-FAILURE; SARCOPLASMIC-RETICULUM; TRANSGENIC MICE; DILATED CARDIOMYOPATHY; HISTONE DEACETYLASE-4; NUCLEAR CALCIUM; RELEASE CHANNEL	The delta(B) and delta(C) splice variants of Ca2+ /calmodulin-dependent protein kinase II (CaMKII), which differ by the presence of a nuclear localization sequence, are both expressed in cardiomyocytes. We used transgenic (TG) mice and CaMKII expression in cardiomyocytes to test the hypothesis that the CaMKII delta(C) isoform regulates cytosolic Ca2+ handling and the delta(B) isoform, which localizes to the nucleus, regulates gene transcription. Phosphorylation of CaMKII sites on the ryanodine receptor (RyR) and on phospholamban (PLB) were increased in CaMKII delta(C) TG. This was associated with markedly enhanced sarcoplasmic reticulum (SR) Ca2+ spark frequency and decreased SR Ca2+ content in cardiomyocytes. None of these parameters were altered in TG mice expressing the nuclear-targeted CaMKII delta(B). In contrast, cardiac expression of either CaMKII delta(B) or delta(C) induced transactivation of myocyte enhancer factor 2 (MEF2) gene expression and up-regulated hypertrophic marker genes. Studies using rat ventricular cardiomyocytes confirmed that CaMKII delta(B) and delta(C) both regulate MEF2-luciferase gene expression, increase histone deacetylase 4 (HDAC4) association with 14-3-3, and induce HDAC4 translocation from nucleus to cytoplasm, indicating that either isoform can stimulate HDAC4 phosphorylation. Finally, HDAC4 kinase activity was shown to be increased in cardiac homogenates from either CaMKII delta(B) or delta(C) TG mice. Thus CaMKII delta isoforms have similar effects on hypertrophic gene expression but disparate effects on Ca2+ handling, suggesting distinct roles for CaMKII delta isoform activation in the pathogenesis of cardiac hypertrophy versus heart failure.	Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA; Univ Gottingen, Abt Kardiol, D-37075 Gottingen, Germany; Univ Gottingen, Pneumol Herzzentrum, D-37075 Gottingen, Germany; Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; Loyola Univ Chicago, Dept Physiol, Maywood, IL 60153 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of Gottingen; University of Gottingen; University of Texas System; University of Texas Southwestern Medical Center Dallas; Loyola University Chicago	Brown, JH (corresponding author), Univ Calif San Diego, Dept Pharmacol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	jhbrown@ucsd.edu	Maier, Lars/AAQ-8313-2021; Bers, Donald M/C-4507-2012	Maier, Lars/0000-0001-9915-4429; Bers, Donald/0000-0002-2237-9483	NHLBI NIH HHS [HL46345, HL80101] Funding Source: Medline; NIGMS NIH HHS [GM007752, T32 GM007752] Funding Source: Medline; NINDS NIH HHS [NS047101] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL080101, P01HL046345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047101] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adams JW, 1998, P NATL ACAD SCI USA, V95, P10140, DOI 10.1073/pnas.95.17.10140; Ai X, 2005, CIRC RES, V97, P1314, DOI 10.1161/01.RES.0000194329.41863.89; Backs J, 2006, J CLIN INVEST, V116, P1853, DOI 10.1172/JCI27438; Badminton MN, 1998, CELL CALCIUM, V23, P79, DOI 10.1016/S0143-4160(98)90105-1; BALTAS LG, 1995, FEBS LETT, V373, P71, DOI 10.1016/0014-5793(95)00981-E; Bare DJ, 2005, J BIOL CHEM, V280, P15912, DOI 10.1074/jbc.M414212200; BASSANI RA, 1995, AM J PHYSIOL-HEART C, V268, pH703, DOI 10.1152/ajpheart.1995.268.2.H703; BRAUN AP, 1995, ANNU REV PHYSIOL, V57, P417, DOI 10.1146/annurev.ph.57.030195.002221; Chang SR, 2004, MOL CELL BIOL, V24, P8467, DOI 10.1128/MCB.24.19.8467-8476.2004; Colomer JM, 2000, MOL ENDOCRINOL, V14, P1125, DOI 10.1210/me.14.8.1125; Colomer JM, 2003, MOL ENDOCRINOL, V17, P183, DOI 10.1210/me.2002-0350; Davis FJ, 2003, J BIOL CHEM, V278, P20047, DOI 10.1074/jbc.M209998200; EDMAN CF, 1994, BBA-MOL CELL RES, V1221, P89, DOI 10.1016/0167-4889(94)90221-6; GRUVER CL, 1993, ENDOCRINOLOGY, V133, P376, DOI 10.1210/en.133.1.376; HAIN J, 1995, J BIOL CHEM, V270, P2074, DOI 10.1074/jbc.270.5.2074; Heist EK, 1998, CELL CALCIUM, V23, P103; KANASEKI T, 1991, J CELL BIOL, V115, P1049, DOI 10.1083/jcb.115.4.1049; Karczewski P, 1997, BASIC RES CARDIOL, V92, P37, DOI 10.1007/BF00794066; Kohlhaas M, 2006, CIRC RES, V98, P235, DOI 10.1161/01.RES.0000200739.90811.9f; Kolodziejczyk SM, 1999, CURR BIOL, V9, P1203, DOI 10.1016/S0960-9822(00)80027-5; Little GH, 2007, J BIOL CHEM, V282, P7219, DOI 10.1074/jbc.M604281200; Lu JR, 2000, P NATL ACAD SCI USA, V97, P4070, DOI 10.1073/pnas.080064097; Maier LS, 2003, CIRC RES, V92, P904, DOI 10.1161/01.RES.0000069685.20258.F1; Maier LS, 2002, J MOL CELL CARDIOL, V34, P919, DOI 10.1006/jmcc.2002.2038; Malviya AN, 1998, CELL, V92, P17, DOI 10.1016/S0092-8674(00)80895-8; Marks AR, 2001, J MOL CELL CARDIOL, V33, P615, DOI 10.1006/jmcc.2000.1343; Marx SO, 2000, CELL, V101, P365, DOI 10.1016/S0092-8674(00)80847-8; Mattiazzi A, 2005, CARDIOVASC RES, V68, P366, DOI 10.1016/j.cardiores.2005.08.010; MAYER P, 1995, BASIC RES CARDIOL, V90, P372, DOI 10.1007/BF00788498; Miska EA, 1999, EMBO J, V18, P5099, DOI 10.1093/emboj/18.18.5099; MIYANO O, 1992, J BIOL CHEM, V267, P1198; Naya FJ, 1999, DEVELOPMENT, V126, P2045; Nelson TJ, 2005, J MOL CELL CARDIOL, V39, P479, DOI 10.1016/j.yjmcc.2005.05.004; Passier R, 2000, J CLIN INVEST, V105, P1395, DOI 10.1172/JCI8551; RAMIREZ MT, 1995, J BIOL CHEM, V270, P8446, DOI 10.1074/jbc.270.15.8446; Ramirez MT, 1997, J BIOL CHEM, V272, P31203, DOI 10.1074/jbc.272.49.31203; SRINIVASAN M, 1994, J CELL BIOL, V126, P839, DOI 10.1083/jcb.126.4.839; Wehrens XHT, 2005, ANNU REV PHYSIOL, V67, P69, DOI 10.1146/annurev.physiol.67.040403.114521; Wehrens XHT, 2004, CIRC RES, V94, pE61, DOI 10.1161/01.RES.0000125626.33738.E2; WITCHER DR, 1991, J BIOL CHEM, V266, P11144; Wu X, 2006, J CLIN INVEST, V116, P675, DOI 10.1172/JCI27374; Xu J, 2006, J BIOL CHEM, V281, P9152, DOI 10.1074/jbc.M510217200; Yano M, 2000, CIRCULATION, V102, P2131, DOI 10.1161/01.CIR.102.17.2131; Yano M, 2005, PHARMACOL THERAPEUT, V107, P377, DOI 10.1016/j.pharmthera.2005.04.003; Youn HD, 2000, J BIOL CHEM, V275, P22563, DOI 10.1074/jbc.C000304200; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9; Zhang T, 2003, CIRC RES, V92, P912, DOI 10.1161/01.RES.0000069686.31472.C5; Zhang T, 2002, J BIOL CHEM, V277, P1261, DOI 10.1074/jbc.M108525200; Zhang XM, 2001, AM J PHYSIOL-HEART C, V280, pH1782, DOI 10.1152/ajpheart.2001.280.4.H1782	49	158	175	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					35078	35087		10.1074/jbc.M707083200	http://dx.doi.org/10.1074/jbc.M707083200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17923476	hybrid			2022-12-27	WOS:000251155200052
J	Chutkow, WA; Patwari, P; Yoshioka, J; Lee, RT				Chutkow, William A.; Patwari, Parth; Yoshioka, Jun; Lee, Richard T.			Thioredoxin-interacting protein (Txnip) is a critical regulator of hepatic glucose production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; ISOLATED HEPATOCYTES; INSULIN-RESISTANCE; LENTIVIRAL VECTOR; REDOX REGULATION; MICE LACKING; GLUCONEOGENESIS; GENE; HOMEOSTASIS; METABOLISM	Thioredoxin-interacting protein (Txnip) has been recently described as a possible link between cellular redox state and metabolism; Txnip binds thioredoxin and inhibits its disulfide reductase activity in vitro, while a naturally occurring strain of Txnip-deficient mice has hyperlipidemia, hypoglycemia, and ketosis exacerbated by fasting. We generated Txnip-null mice to investigate the role of Txnip in glucose homeostasis. Txnip-null mice were hypoglycemic, hypoinsulinemic, and had blunted glucose production following a glucagon challenge, consistent with a central liver glucose-handling defect. Glucose release from isolated Txnip-null hepatocytes was 2-fold lower than wild-type hepatocytes, whereas beta-hydroxybutyrate release was increased 2-fold, supporting an intrinsic defect in hepatocyte glucose metabolism. While hepatocyte-specific gene deletion of Txnip did not alter glucose clearance compared with littermate controls, Txnip expression in the liver was required for maintaining normal fasting glycemia and glucose production. In addition, hepatic overexpression of a Txnip transgene in wildtype mice resulted in elevated serum glucose levels and decreased ketone levels. Liver homogenates from Txnip-null mice had no significant differences in the glutathione oxidation state or in the amount of available thioredoxin. However, overexpression of wild-type Txnip in Txnip-null hepatocytes rescued cellular glucose production, whereas overexpression of a C247S mutant Txnip, which does not bind thioredoxin, had no effect. These data demonstrate that Txnip is required for normal glucose homeostasis in the liver. While available thioredoxin is not changed in Txnip-null mice, the effects of Txnip on glucose homeostasis are abolished by a single cysteine mutation that inhibits binding to thioredoxin.	[Chutkow, William A.; Patwari, Parth; Yoshioka, Jun; Lee, Richard T.] Brigham & Womens Hosp, Dept Med, Div Cardiovasc, Cambridge, MA 02139 USA; [Chutkow, William A.; Patwari, Parth; Yoshioka, Jun; Lee, Richard T.] Harvard Univ, Sch Med, Cambridge, MA 02139 USA	Harvard University; Brigham & Women's Hospital; Harvard University	Chutkow, WA (corresponding author), Partners Res Facil, 65 Landsdowne St,Rm 280, Cambridge, MA 02139 USA.	wchutkow@partners.org		Lee, Richard/0000-0003-4687-1381	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL048743, R01HL073809] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL048743, HL073809] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Andrews RC, 1999, CLIN SCI, V96, P513, DOI 10.1042/cs0960513; Berry MN, 1997, CELL BIOL TOXICOL, V13, P223, DOI 10.1023/A:1007402505482; Bodnar JS, 2002, NAT GENET, V30, P110, DOI 10.1038/ng811; Brown M, 2003, ADULT EDUC QUART, V54, P75, DOI 10.1177/0741713603257017; Buchanan BB, 2005, ANNU REV PLANT BIOL, V56, P187, DOI 10.1146/annurev.arplant.56.032604.144246; CONSOLI A, 1989, DIABETES, V38, P550, DOI 10.2337/diabetes.38.5.550; Emilsson V. e. a., 2005, Patent No. [2005/111239, 2005111239]; Engelgau MM, 2004, ANN INTERN MED, V140, P945, DOI 10.7326/0003-4819-140-11-200406010-00035; Evans JL, 2003, DIABETES, V52, P1, DOI 10.2337/diabetes.52.1.1; EXTON J, 1972, INTERACTION INSULIN; FELIG P, 1970, NEW ENGL J MED, V282, P166; Finkel T, 2003, CURR OPIN CELL BIOL, V15, P247, DOI 10.1016/S0955-0674(03)00002-4; GILBERT HF, 1984, METHOD ENZYMOL, V107, P330; GROOP LC, 1989, J CLIN INVEST, V84, P205, DOI 10.1172/JCI114142; Guo Y, 2004, STEM CELLS, V22, P259, DOI 10.1634/stemcells.22-3-259; Hausler N, 2006, BIOCHEM J, V394, P465, DOI 10.1042/BJ20051174; Herman MA, 2006, J CLIN INVEST, V116, P1767, DOI 10.1172/JCI29027; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; HOLMGREN A, 1995, METHOD ENZYMOL, V252, P199; Hui TY, 2004, J BIOL CHEM, V279, P24387, DOI 10.1074/jbc.M401280200; HULTMAN E, 1974, ACTA ANAESTH SCAND, P28; JAHOOR F, 1990, AM J PHYSIOL, V258, pE288, DOI 10.1152/ajpendo.1990.258.2.E288; Junn E, 2000, J IMMUNOL, V164, P6287, DOI 10.4049/jimmunol.164.12.6287; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006; Meuillet EJ, 2004, ARCH BIOCHEM BIOPHYS, V429, P123, DOI 10.1016/j.abb.2004.04.020; Minn AH, 2005, ENDOCRINOLOGY, V146, P2397, DOI 10.1210/en.2004-1378; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; Morizono K, 2005, NAT MED, V11, P346, DOI 10.1038/nm1192; NEESE RA, 1995, J BIOL CHEM, V270, P14452, DOI 10.1074/jbc.270.24.14452; Nishiyama A, 1999, J BIOL CHEM, V274, P21645, DOI 10.1074/jbc.274.31.21645; Oka S, 2006, FASEB J, V20, pA45, DOI 10.1096/fj.05-4439fje; Pan D, 2002, MOL THER, V6, P19, DOI 10.1006/mthe.2002.0630; Parikh H, 2007, PLOS MED, V4, P868, DOI 10.1371/journal.pmed.0040158; Patwari P, 2006, J BIOL CHEM, V281, P21884, DOI 10.1074/jbc.M600427200; PILKIS SJ, 1992, ANNU REV PHYSIOL, V54, P885, DOI 10.1146/annurev.ph.54.030192.004321; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; PRYOR HJ, 1987, BIOCHEM J, V247, P449, DOI 10.1042/bj2470449; QUINLAN PT, 1986, BIOCHEM J, V236, P789, DOI 10.1042/bj2360789; Schulze PC, 2004, J BIOL CHEM, V279, P30369, DOI 10.1074/jbc.M400549200; Schulze PC, 2002, CIRC RES, V91, P689, DOI 10.1161/01.RES.0000037982.55074.F6; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; Sheth SS, 2005, J LIPID RES, V46, P123, DOI 10.1194/jlr.M400341-JLR200; SISTARE FD, 1985, J BIOL CHEM, V260, P2748; SPIEGELMAN BM, 1993, CELL, V73, P625, DOI 10.1016/0092-8674(93)90243-J; TRENT DF, 1984, HORM RES, V19, P70, DOI 10.1159/000179869; Wang YL, 2002, J BIOL CHEM, V277, P26496, DOI 10.1074/jbc.M202133200; Wang Z, 2006, ONCOGENE, V25, P1903, DOI 10.1038/sj.onc.1209218; Yamanaka H, 2000, BIOCHEM BIOPH RES CO, V271, P796, DOI 10.1006/bbrc.2000.2699; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Yoshioka J, 2007, CIRC RES, V101, P1328, DOI 10.1161/CIRCRESAHA.106.160515	52	145	148	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					2397	2406		10.1074/jbc.M708169200	http://dx.doi.org/10.1074/jbc.M708169200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	17998203	hybrid			2022-12-27	WOS:000252501000066
J	Fonte, V; Kipp, DR; Yerg, J; Merin, D; Forrestal, M; Wagner, E; Roberts, CM; Link, CD				Fonte, Virginia; Kipp, D. Randal; Yerg, John, III; Merin, David; Forrestal, Margaret; Wagner, Eileen; Roberts, Christine M.; Link, Christopher D.			Suppression of in vivo beta-amyloid peptide toxicity by overexpression of the HSP-16.2 small chaperone protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-B-CRYSTALLIN; TRANSGENIC CAENORHABDITIS-ELEGANS; INCLUSION-BODY MYOSITIS; HEAT-SHOCK PROTEINS; ALZHEIMERS-DISEASE; C-ELEGANS; A-BETA; EXPRESSION; AGGREGATION; MODEL	Expression of the human beta-amyloid peptide (A beta) in a transgenic Caenorhabditis elegans Alzheimer disease model leads to the induction of HSP-16 proteins, a family of small heat shock-inducible proteins homologous to vertebrate alpha B crystallin. These proteins also co-localize and co-immunoprecipitate with A beta in this model (Fonte, V., Kapulkin, V., Taft, A., Fluet, A., Friedman, D., and Link, C. D. (2002) Proc. Natl. Acad. Sci. U. S. A. 99, 9439-9444). To investigate the molecular basis and biological function of this interaction between HSP-16 and A beta, we generated transgenic C. elegans animals with high level, constitutive expression of HSP-16.2. We find that constitutive expression of wild type, but not mutant, HSP-16.2 partially suppresses A beta toxicity. Wild type A beta-(1-42), but not A beta single chain dimer, was observed to become sequestered in HSP-16.2-containing inclusions, indicating a conformation-dependent interaction between HSP-16.2 and A beta in vivo. Constitutive expression of HSP-16.2 could reduce amyloid fibril formation, but it did not reduce the overall accumulation of A beta peptide or alter the pattern of the predominant oligomeric species. Studies with recombinant HSP-16.2 demonstrated that HSP-16.2 can bind directly to A beta in vitro, with a preferential affinity for oligomeric A beta species. This interaction between A beta and HSP-16.2 also influences the formation of A beta oligomers in in vitro assays. These studies are consistent with a model in which small chaperone proteins reduce A beta toxicity by interacting directly with the A beta peptide and altering its oligomerization pathways, thereby reducing the formation of a minor toxic species.	[Fonte, Virginia; Kipp, D. Randal; Yerg, John, III; Merin, David; Forrestal, Margaret; Wagner, Eileen; Roberts, Christine M.; Link, Christopher D.] Univ Colorado, Inst Behav Genet Integrat Physiol, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Link, CD (corresponding author), Univ Colorado, Inst Behav Genet Integrat Physiol, Boulder, CO 80309 USA.	linkc@colorado.edu		Kipp, Randy/0000-0002-4094-6250	NATIONAL INSTITUTE ON AGING [R01AG021037] Funding Source: NIH RePORTER; NIA NIH HHS [AG21037] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ASKANAS V, 1992, AM J PATHOL, V141, P31; Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Banwell BL, 2000, NEUROLOGY, V54, P1033, DOI 10.1212/WNL.54.5.1033; Barghorn S, 2005, J NEUROCHEM, V95, P834, DOI 10.1111/j.1471-4159.2005.03407.x; Bova MP, 1999, P NATL ACAD SCI USA, V96, P6137, DOI 10.1073/pnas.96.11.6137; Chan HYE, 2000, HUM MOL GENET, V9, P2811, DOI 10.1093/hmg/9.19.2811; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; Cummings CJ, 2001, HUM MOL GENET, V10, P1511, DOI 10.1093/hmg/10.14.1511; DAHL R, 1989, J ELECTRON MICR TECH, V13, P165, DOI 10.1002/jemt.1060130305; Drake J, 2003, NEUROBIOL AGING, V24, P415, DOI 10.1016/S0197-4580(02)00225-7; Fay DS, 1998, J NEUROCHEM, V71, P1616; Florez-McClure ML, 2007, AUTOPHAGY, V3, P569, DOI 10.4161/auto.4776; Fonte V, 2002, P NATL ACAD SCI USA, V99, P9439, DOI 10.1073/pnas.152313999; Gidalevitz T, 2006, SCIENCE, V311, P1471, DOI 10.1126/science.1124514; Glabe CG, 2006, NEUROLOGY, V66, pS74, DOI 10.1212/01.wnl.0000192103.24796.42; Goldstein LE, 2003, LANCET, V361, P1258, DOI 10.1016/S0140-6736(03)12981-9; Gouras GK, 2000, AM J PATHOL, V156, P15, DOI 10.1016/S0002-9440(10)64700-1; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Kapulkin V, 2005, FEBS LETT, V579, P3063, DOI 10.1016/j.febslet.2005.04.062; Katoh Y, 2004, FEBS LETT, V565, P28, DOI 10.1016/j.febslet.2003.12.085; Kazemi-Esfarjani P, 2000, SCIENCE, V287, P1837, DOI 10.1126/science.287.5459.1837; Kitazawa M, 2006, AM J PATHOL, V168, P1986, DOI 10.2353/ajpath.2006.051232; Kudva YC, 1997, FEBS LETT, V416, P117, DOI 10.1016/S0014-5793(97)01180-0; Lee S, 2005, PROTEIN SCI, V14, P593, DOI 10.1110/ps.041020705; Leroux MR, 1997, J BIOL CHEM, V272, P24646, DOI 10.1074/jbc.272.39.24646; Liang JJN, 2000, FEBS LETT, V484, P98, DOI 10.1016/S0014-5793(00)02136-0; Link CD, 1999, CELL STRESS CHAPERON, V4, P235, DOI 10.1379/1466-1268(1999)004<0235:DOOSRI>2.3.CO;2; LINK CD, 1995, P NATL ACAD SCI USA, V92, P9368, DOI 10.1073/pnas.92.20.9368; Link CD, 2001, NEUROBIOL AGING, V22, P217, DOI 10.1016/S0197-4580(00)00237-2; Link CD, 2003, NEUROBIOL AGING, V24, P397, DOI 10.1016/S0197-4580(02)00224-5; Link CD, 2006, J BIOL CHEM, V281, P1808, DOI 10.1074/jbc.M505581200; Link CD, 2006, EXP GERONTOL, V41, P1007, DOI 10.1016/j.exger.2006.06.059; Magrane J, 2004, J NEUROSCI, V24, P1700, DOI 10.1523/JNEUROSCI.4330-03.2004; Moussa CEH, 2006, FASEB J, V20, P2165, DOI 10.1096/fj.06-5763fje; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Raman B, 2005, BIOCHEM J, V392, P573, DOI 10.1042/BJ20050339; RENKAWEK K, 1994, ACTA NEUROPATHOL, V87, P155, DOI 10.1007/BF00296185; Sanbe A, 2007, J BIOL CHEM, V282, P555, DOI 10.1074/jbc.M605481200; Santhoshkumar P, 2004, MOL CELL BIOCHEM, V267, P147, DOI 10.1023/B:MCBI.0000049373.15558.b8; SHINOHARA H, 1993, J NEUROL SCI, V119, P203, DOI 10.1016/0022-510X(93)90135-L; Stege GJJ, 1999, BIOCHEM BIOPH RES CO, V262, P152, DOI 10.1006/bbrc.1999.1167; Taylor RP, 2005, J MOL CELL CARDIOL, V38, P433, DOI 10.1016/j.yjmcc.2004.12.014; Walker GA, 2003, AGING CELL, V2, P131, DOI 10.1046/j.1474-9728.2003.00045.x; Wilhelmus MMM, 2006, BRAIN RES, V1089, P67, DOI 10.1016/j.brainres.2006.03.058; Wilhelmus MMM, 2006, ACTA NEUROPATHOL, V111, P139, DOI 10.1007/s00401-005-0030-z; Yoo BC, 2001, BIOCHEM BIOPH RES CO, V280, P249, DOI 10.1006/bbrc.2000.4109; Zobel ATC, 2003, HUM MOL GENET, V12, P1609, DOI 10.1093/hmg/ddg173	47	124	130	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					784	791		10.1074/jbc.M703339200	http://dx.doi.org/10.1074/jbc.M703339200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	17993648	hybrid			2022-12-27	WOS:000252128100017
J	Kim, JH; Kim, JE; Liu, HY; Cao, WH; Chen, J				Kim, Jeong-Ho; Kim, Jae Eun; Liu, Hui-Yu; Cao, Wenhong; Chen, Jie			Regulation of interleukin-6-induced hepatic insulin resistance by mammalian target of rapamycin through the STAT3-SOCS3 pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; DIET-INDUCED OBESITY; SERINE PHOSPHORYLATION; ADIPOCYTE DIFFERENTIATION; RECEPTOR SUBSTRATE-1; MAXIMAL ACTIVATION; AMINO-ACID; MTOR; PROTEIN; 3T3-L1	The proinflammatory cytokine interleukin (IL)-6 has been proposed to be one of the mediators that link obesity-derived chronic inflammation with insulin resistance. Signaling through the mammalian target of rapamycin ( mTOR) has been found to impact insulin sensitivity under various pathological conditions, through serine phosphorylation and inhibition of insulin receptor substrate by the downstream effector of mTOR, ribosomal S6 kinase 1 (S6K1). However, an involvement of mTOR in IL-6-induced insulin resistance has not yet been reported. Here we show that rapamycin, the inhibitor of mTOR signaling, rescues insulin signaling and glycogen synthesis from IL-6 inhibition in HepG2 hepatocarcinoma cells as well as in mouse primary hepatocytes. IL-6 activates S6K1 in these cells, but unexpectedly, S6K1 is not involved in IL-6 inhibition of insulin signaling, since the effect of IL-6 persists in cells with drastically reduced S6K1 levels induced by RNA interference, suggesting that the function of mTOR signaling is through a mechanism different from the prevailing model of S6K1 phosphorylation of insulin receptor substrate-1. Interestingly, we find that the phosphorylation of STAT3 on Ser(727) and STAT3 transcriptional activity are regulated by mTOR upon IL-6 stimulation and that STAT3 is required for IL-6 inhibition of insulin signaling. Furthermore, IL-6-induced SOCS3 expression is inhibited by rapamycin, and ectopic expression of SOCS3 blocks the ability of rapamycin to enhance insulin sensitivity in the presence of IL-6. Taken together, we propose that mTOR plays a key role in IL-6-induced hepatic insulin resistance by regulating STAT3 activation and subsequent SOCS3 expression.	[Kim, Jeong-Ho; Kim, Jae Eun; Chen, Jie] Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA; [Liu, Hui-Yu; Cao, Wenhong] Hamner Inst Hlth Sci, Res Triangle Pk, NC USA	University of Illinois System; University of Illinois Urbana-Champaign; The Hamner Institutes for Health Sciences	Chen, J (corresponding author), 601 S Goodwin Ave B107, Urbana, IL 61801 USA.	jiechen@uiuc.edu		Chen, Jie/0000-0002-7887-3747	NIAMS NIH HHS [R01 AR48914] Funding Source: Medline; NIDDK NIH HHS [R01DK76039] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048914] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076039] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bell A, 2000, OBES RES, V8, P249, DOI 10.1038/oby.2000.29; Berg CE, 2002, BIOCHEM BIOPH RES CO, V293, P1021, DOI 10.1016/S0006-291X(02)00333-9; Carey AL, 2004, DIABETOLOGIA, V47, P1135, DOI 10.1007/s00125-004-1447-y; Carlson CJ, 2004, BIOCHEM BIOPH RES CO, V316, P533, DOI 10.1016/j.bbrc.2004.02.082; Carter-Su C, 1998, RECENT PROG HORM RES, V53, P61; Chen J, 2002, BIOCHEM PHARMACOL, V64, P1071, DOI 10.1016/S0006-2952(02)01263-7; Cho HJ, 2004, BIOCHEM BIOPH RES CO, V321, P942, DOI 10.1016/j.bbrc.2004.07.050; Decker T, 2000, ONCOGENE, V19, P2628, DOI 10.1038/sj.onc.1203481; Erbay E., 2005, Nutrients and cell signaling, P353; Foster DA, 2007, CANCER RES, V67, P1, DOI 10.1158/0008-5472.CAN-06-3016; Gagnon A, 2001, J CELL PHYSIOL, V189, P14, DOI 10.1002/jcp.1132; Giraud J, 2004, J BIOL CHEM, V279, P3447, DOI 10.1074/jbc.M308631200; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Howard JK, 2006, TRENDS ENDOCRIN MET, V17, P365, DOI 10.1016/j.tem.2006.09.007; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Kern PA, 2001, AM J PHYSIOL-ENDOC M, V280, pE745; Kim JE, 2004, DIABETES, V53, P2748, DOI 10.2337/diabetes.53.11.2748; KLAUNIG JE, 1981, IN VITRO CELL DEV B, V17, P913; Klover PJ, 2003, DIABETES, V52, P2784, DOI 10.2337/diabetes.52.11.2784; Klover PJ, 2005, ENDOCRINOLOGY, V146, P3417, DOI 10.1210/en.2004-1468; Krebs DL, 2000, J CELL SCI, V113, P2813; Le Bacquer O, 2007, J CLIN INVEST, V117, P387, DOI 10.1172/JCI29528; McManus EJ, 2002, NAT CELL BIOL, V4, pE214, DOI 10.1038/ncb0902-e214; Mohamed-Ali V, 1997, J CLIN ENDOCR METAB, V82, P4196, DOI 10.1210/jc.82.12.4196; Peterson RT, 2000, J BIOL CHEM, V275, P7416, DOI 10.1074/jbc.275.10.7416; Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327; Rajan P, 2003, J CELL BIOL, V161, P911, DOI 10.1083/jcb.200211021; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; Senn JJ, 2002, DIABETES, V51, P3391, DOI 10.2337/diabetes.51.12.3391; Senn JJ, 2003, J BIOL CHEM, V278, P13740, DOI 10.1074/jbc.M210689200; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; Shiba T, 1998, DIABETIC MED, V15, P435, DOI 10.1002/(SICI)1096-9136(199805)15:5<435::AID-DIA566>3.0.CO;2-N; Torisu T, 2007, GENES CELLS, V12, P143, DOI 10.1111/j.1365-2443.2007.01044.x; Tremblay F, 2005, DIABETES, V54, P2674, DOI 10.2337/diabetes.54.9.2674; Tremblay F, 2005, ENDOCRINOLOGY, V146, P1328, DOI 10.1210/en.2004-0777; Tremblay F, 2001, J BIOL CHEM, V276, P38052; Tsigos C, 1997, J CLIN ENDOCR METAB, V82, P4167, DOI 10.1210/jc.82.12.4167; Tzatsos A, 2006, MOL CELL BIOL, V26, P63, DOI 10.1128/MCB.26.1.63-76.2006; Ueki K, 2004, P NATL ACAD SCI USA, V101, P10422, DOI 10.1073/pnas.0402511101; Ueno M, 2005, DIABETOLOGIA, V48, P506, DOI 10.1007/s00125-004-1662-6; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Um SH, 2006, CELL METAB, V3, P393, DOI 10.1016/j.cmet.2006.05.003; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; Ventre J, 1997, DIABETES, V46, P1526, DOI 10.2337/diabetes.46.9.1526; Vozarova B, 2001, OBES RES, V9, P414, DOI 10.1038/oby.2001.54; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; YEH WC, 1995, P NATL ACAD SCI USA, V92, P11086, DOI 10.1073/pnas.92.24.11086; Yokogami K, 2000, CURR BIOL, V10, P47, DOI 10.1016/S0960-9822(99)00268-7; ZHANG XK, 1995, SCIENCE, V267, P1990, DOI 10.1126/science.7701321	53	108	113	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					708	715		10.1074/jbc.M708568200	http://dx.doi.org/10.1074/jbc.M708568200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	17993646	hybrid			2022-12-27	WOS:000252128100008
J	Gunawardena, SR; Ruis, BL; Meyer, JA; Kapoor, M; Conklin, KF				Gunawardena, Shanaka R.; Ruis, Brian L.; Meyer, Julia A.; Kapoor, Meenal; Conklin, Kathleen F.			NOM1 targets protein phosphatase I to the nucleolus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINOBLASTOMA TUMOR-SUPPRESSOR; MYOSIN PHOSPHATASE; CATALYTIC SUBUNIT; BINDING; TYPE-1; DEPHOSPHORYLATES; PHOSPHORYLATION; INTERPHASE; PP1-GAMMA; ISOFORM	Protein phosphatase I (PP1) is an essential eukaryotic serine/threonine phosphatase required for many cellular processes, including cell division, signaling, and metabolism. In mammalian cells there are three major isoforms of the PP1 catalytic subunit (PP1 alpha, PP1 beta, and PP1 gamma) that are over 90% identical. Despite this high degree of identity, the PP1 catalytic subunits show distinct localization patterns in interphase cells; PP1 alpha is primarily nuclear and largely excluded from nucleoli, whereas PP1 gamma and to a lesser extent PP1 beta concentrate in the nucleoli. The subcellular localization and the substrate specificity of PP1 catalytic subunits are determined by their interaction with targeting subunits, most of which bind PP1 through a so-called "RVXF" sequence. Although PP1 targeting subunits have been identified that direct PP1 to a number of subcellular locations and/or substrates, no targeting subunit has been identified that localizes PP1 to the nucleolus. Identification of nucleolar PP1 targeting subunit(s) is important because all three PP1 isoforms are included in the nucleolar proteome, enzymatically active PP1 is present in nucleoli, and PP1 gamma is highly concentrated in nucleoli of interphase cells. In this study, we identify NOM1 ( nucleolar protein with MIF4G domain 1) as a PP1-interacting protein and further identify the NOM1 RVXF motif required for its binding to PP1. We also define the NOM1 nucleolar localization sequence. Finally, we demonstrate that NOM1 can target PP1 to the nucleolus and show that a specific NOM1 RVXF motif and the NOM1 nucleolar localization sequence are required for this targeting activity. We therefore conclude that NOM1 is a PP1 nucleolar targeting subunit, the first identified in eukaryotic cells.	[Gunawardena, Shanaka R.; Ruis, Brian L.; Meyer, Julia A.; Kapoor, Meenal; Conklin, Kathleen F.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; [Conklin, Kathleen F.] Univ Minnesota, Inst Human Genet, Minneapolis, MN 55455 USA; [Conklin, Kathleen F.] Univ Minnesota, Ctr Canc, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Conklin, KF (corresponding author), 321 Church St SE,6-160 Jackson, Minneapolis, MN 55455 USA.	conkl001@umn.edu	Meyer, Julia/ABD-4452-2021					ALBERTS AS, 1993, P NATL ACAD SCI USA, V90, P388, DOI 10.1073/pnas.90.2.388; Allen PB, 1998, J BIOL CHEM, V273, P4089, DOI 10.1074/jbc.273.7.4089; Andreassen PR, 1998, J CELL BIOL, V141, P1207, DOI 10.1083/jcb.141.5.1207; Angus SP, 2003, MOL CELL BIOL, V23, P8172, DOI 10.1128/MCB.23.22.8172-8188.2003; Berndt N, 1997, CURR BIOL, V7, P375, DOI 10.1016/S0960-9822(06)00185-0; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Bollen M, 2001, TRENDS BIOCHEM SCI, V26, P426, DOI 10.1016/S0968-0004(01)01836-9; Ceulemans H, 2004, PHYSIOL REV, V84, P1, DOI 10.1152/physrev.00013.2003; Cohen PTW, 2002, J CELL SCI, V115, P241; DURFEE T, 1993, GENE DEV, V7, P555, DOI 10.1101/gad.7.4.555; Egloff MP, 1997, EMBO J, V16, P1876, DOI 10.1093/emboj/16.8.1876; Huang HS, 2005, ARCH BIOCHEM BIOPHYS, V443, P33, DOI 10.1016/j.abb.2005.08.021; Ito M, 2004, MOL CELL BIOCHEM, V259, P197, DOI 10.1023/B:MCBI.0000021373.14288.00; Jiao W, 2006, J BIOL CHEM, V281, P38098, DOI 10.1074/jbc.M605271200; KIM DW, 1990, GENE, V91, P217, DOI 10.1016/0378-1119(90)90091-5; Kotani H, 1998, BIOCHEM BIOPH RES CO, V249, P292, DOI 10.1006/bbrc.1998.9126; Lesage B, 2004, J BIOL CHEM, V279, P55978, DOI 10.1074/jbc.M411911200; Meiselbach H, 2006, CHEM BIOL, V13, P49, DOI 10.1016/j.chembiol.2005.10.009; Miyoshi H, 1998, J VIROL, V72, P8150, DOI 10.1128/JVI.72.10.8150-8157.1998; Negi SS, 2006, J CELL SCI, V119, P3676, DOI 10.1242/jcs.03090; Nelson DA, 1997, J BIOL CHEM, V272, P4528, DOI 10.1074/jbc.272.7.4528; Okada T, 2004, INT J ONCOL, V25, P1383; Parra M, 2007, GENE DEV, V21, P638, DOI 10.1101/gad.1513107; Rubin E, 2001, ONCOGENE, V20, P3776, DOI 10.1038/sj.onc.1204518; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Simmons HM, 2005, GENE, V347, P137, DOI 10.1016/j.gene.2004.12.027; Simmons HM, 2002, LEUKEMIA, V16, P2408, DOI 10.1038/sj.leu.2402773; Takemura M, 2002, EXP CELL RES, V276, P233, DOI 10.1006/excr.2002.5523; Trinkle-Mulcahy L, 2006, J CELL BIOL, V172, P679, DOI 10.1083/jcb.200508154; Trinkle-Mulcahy L, 2001, J CELL SCI, V114, P4219; Trinkle-Mulcahy L, 2003, MOL BIOL CELL, V14, P107, DOI 10.1091/mbc.E02-07-0376; Trinkle-Mulcahy Laura, 2007, V365, P133; Vagnarelli P, 2006, NAT CELL BIOL, V8, P1133, DOI 10.1038/ncb1475; Vietri M, 2006, CANCER CELL INT, V6, DOI 10.1186/1475-2867-6-3; Wakula P, 2003, J BIOL CHEM, V278, P18817, DOI 10.1074/jbc.M300175200; Wu XL, 2001, BIOCHEMISTRY-US, V40, P7410, DOI 10.1021/bi002796k	36	15	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					398	404		10.1074/jbc.M706708200	http://dx.doi.org/10.1074/jbc.M706708200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17965019	hybrid			2022-12-27	WOS:000251940300044
J	Shen, X; Koga, T; Park, BC; SundarRaj, N; Yue, BYJT				Shen, Xiang; Koga, Takahisa; Park, Bum-Chan; SundarRaj, Nirmala; Yue, Beatrice Y. J. T.			Rho GTPase and cAMP/protein kinase A signaling mediates myocilin-induced alterations in cultured human trabecular meshwork cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR-MATRIX; LYSOPHOSPHATIDIC ACID; PROTEIN-KINASE; GLAUCOMA GENE; OUTFLOW FACILITY; BINDING PROTEIN; ACTIN; ADHESION; PHOSPHORYLATION; EXPRESSION	Myocilin is a gene linked to the most common form of glaucoma, a major blinding disease. The trabecular meshwork (TM), a specialized eye tissue, is believed to be involved, at least in part, in the development of glaucoma. The myocilin expression is known to be up-regulated by glucocorticoids in TM cells, and an altered myocilin level may be the culprit in conditions such as corticosteroid glaucoma. Wild type myocilin, when transfected into cultured human TM cells, induced a dramatic loss of actin stress fibers and focal adhesions. Myocilin transfectants displayed a heightened sensitivity to trypsin. Adhesion to fibronectin, collagens, and vitronectin was compromised. The fibronectin deposition and the levels of fibronectin protein and mRNA were also reduced in myocilin transfectants. The fibronectin deposition could be restored by treatment with lysophosphatidic acid, a Rho stimulator. Assays further revealed that upon myocilin overexpression, the activity of RhoA was diminished, whereas the cAMP level and the protein kinase A (PKA) activity were augmented. Myocilin protein did not affect actin polymerization. The collapse of actin stress fibers and increased trypsin sensitivity from myocilin transfection could be reverted by co-expression of constitutively active RhoA or by treatment with PKA inhibitor H-89. The PKA activity, however, was not modified by co-expression of either constitutively active or dominant negative RhoA. These results demonstrate that myocilin has a deadhesive activity and triggers signaling events. cAMP/PKA activation and the downstream Rho inhibition are possible mechanisms by which myocilin in overabundance may lead to TM cell or tissue damage.	[Shen, Xiang; Koga, Takahisa; Park, Bum-Chan; Yue, Beatrice Y. J. T.] Univ Illinois, Coll Med, Dept Ophthalmol & Visual Sci, Chicago, IL 60612 USA; [SundarRaj, Nirmala] Univ Pittsburgh, Dept Ophthalmol, Pittsburgh, PA 15213 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Yue, BYJT (corresponding author), Univ Illinois, Coll Med, Dept Ophthalmol & Visual Sci, 1855 W Taylor St, Chicago, IL 60612 USA.	beatyue@uic.edu			NATIONAL EYE INSTITUTE [P30EY001792, R01EY003263, R01EY005628, R01EY003890] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY003263, R01 EY005628, P30 EY001792, EY 01792, R01 EY003890, EY 05628, P30 EY001792-309005, EY 03890, EY 03263, R01 EY005628-22] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALEXANDER JP, 1991, INVEST OPHTH VIS SCI, V32, P172; ANDO H, 1993, INVEST OPHTH VIS SCI, V34, P3541; BILL A, 1975, INVEST OPHTH VISUAL, V14, P1; Bornstein P, 2002, CURR OPIN CELL BIOL, V14, P608, DOI 10.1016/S0955-0674(02)00361-7; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Caballero M, 2000, BBA-MOL BASIS DIS, V1502, P447, DOI 10.1016/S0925-4439(00)00068-5; CALTHORPE CM, 1990, EXP EYE RES, V51, P39, DOI 10.1016/0014-4835(90)90168-T; CHANG IL, 1991, CURR EYE RES, V10, P1101, DOI 10.3109/02713689109024127; Clark A F, 1995, J Glaucoma, V4, P354; Dong JM, 1998, J BIOL CHEM, V273, P22554, DOI 10.1074/jbc.273.35.22554; Dormond O, 2002, J BIOL CHEM, V277, P45838, DOI 10.1074/jbc.M209213200; Forster ML, 2006, J CELL BIOL, V173, P853, DOI 10.1083/jcb.200602046; Gong G, 2004, HUM MOL GENET, V13, pR91, DOI 10.1093/hmg/ddh074; HALL A, 1994, ANNU REV CELL BIOL, V10, P31, DOI 10.1146/annurev.cb.10.110194.000335; Hardy KM, 2005, J BIOL CHEM, V280, P28917, DOI 10.1074/jbc.M504803200; Honjo M, 2001, INVEST OPHTH VIS SCI, V42, P137; Howe AK, 2004, BBA-MOL CELL RES, V1692, P159, DOI 10.1016/j.bbamcr.2004.03.005; Jacobson N, 2001, HUM MOL GENET, V10, P117, DOI 10.1093/hmg/10.2.117; Kato M, 1999, J HEPATOL, V31, P91, DOI 10.1016/S0168-8278(99)80168-8; Kreisberg JI, 1997, AM J PHYSIOL-RENAL, V273, pF283, DOI 10.1152/ajprenal.1997.273.2.F283; LAMPUGNANI MG, 1990, LAB INVEST, V63, P521; Lang P, 1996, EMBO J, V15, P510, DOI 10.1002/j.1460-2075.1996.tb00383.x; Lee CW, 2003, BIOCHEM BIOPH RES CO, V305, P455, DOI 10.1016/S0006-291X(03)00790-3; Lin YL, 2007, J CELL BIOL, V177, P829, DOI 10.1083/jcb.200608121; Liu XY, 2005, MOL VIS, V11, P1112; Mackay DJG, 1998, J BIOL CHEM, V273, P20685, DOI 10.1074/jbc.273.33.20685; Midwood KS, 2002, MOL BIOL CELL, V13, P3601, DOI 10.1091/mbc.E02-05-0292; Nguyen TD, 1998, J BIOL CHEM, V273, P6341, DOI 10.1074/jbc.273.11.6341; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; O'Connor KL, 2000, J CELL BIOL, V148, P253, DOI 10.1083/jcb.148.2.253; Park BC, 2007, GENES CELLS, V12, P969, DOI 10.1111/j.1365-2443.2007.01102.x; Park BC, 2006, AM J PATHOL, V169, P1976, DOI 10.2353/ajpath.2006.060400; Park BC, 2006, MOL VIS, V12, P832; Pereira M, 2002, J CELL SCI, V115, P609; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; RHO PV, 2001, INVEST OPHTH VIS SCI, V42, P1029; Sakai H, 2006, INVEST OPHTH VIS SCI, V47, P4427, DOI 10.1167/iovs.06-0047; Schoenwaelder SM, 1999, CURR OPIN CELL BIOL, V11, P274, DOI 10.1016/S0955-0674(99)80037-4; SMIRNOV VN, 1989, J MOL CELL CARDIOL, V21, P3, DOI 10.1016/0022-2828(89)90832-8; Srinivas SP, 2006, INVEST OPHTH VIS SCI, V47, P4011, DOI 10.1167/iovs.05-1127; Stamer WD, 1998, INVEST OPHTH VIS SCI, V39, P1804; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; Stumpff F, 2000, OPHTHALMOLOGICA, V214, P33, DOI 10.1159/000027471; Tamm ER, 2002, PROG RETIN EYE RES, V21, P395, DOI 10.1016/S1350-9462(02)00010-1; Tapon N, 1997, CURR OPIN CELL BIOL, V9, P86, DOI 10.1016/S0955-0674(97)80156-1; TAYLOR SS, 1989, J BIOL CHEM, V264, P8443; TIAN B, 2006, CURR OPIN OPHTHALMOL, V17, P168; Tian BH, 2000, INVEST OPHTH VIS SCI, V41, P619; Ueda J, 2000, J HISTOCHEM CYTOCHEM, V48, P1321, DOI 10.1177/002215540004801003; van Leeuwen FN, 2003, BIOCHEM SOC T, V31, P1209; Vittitow JL, 2002, MOL VIS, V8, P32; Vouret-Craviari V, 2002, J CELL SCI, V115, P2475; Weiner JA, 2001, J NEUROSCI, V21, P7069, DOI 10.1523/JNEUROSCI.21-18-07069.2001; Wentz-Hunter K, 2004, EXP CELL RES, V297, P39, DOI 10.1016/j.yexcr.2004.02.024; Wentz-Hunter K, 2003, MOL VIS, V9, P308; YUE BYJT, 1990, EXP CELL RES, V187, P65, DOI 10.1016/0014-4827(90)90117-S; Yue BYJT, 1996, SURV OPHTHALMOL, V40, P379; Zhou LL, 1996, INVEST OPHTH VIS SCI, V37, P104; ZHOU LL, 1995, INVEST OPHTH VIS SCI, V36, P787; Zhou LL, 2000, EXP EYE RES, V70, P457, DOI 10.1006/exer.1999.0806	60	47	50	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					603	612		10.1074/jbc.M708250200	http://dx.doi.org/10.1074/jbc.M708250200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17984096	Green Accepted, hybrid			2022-12-27	WOS:000251940300065
J	Demirel, O; Waibler, Z; Kalinke, U; Grunebach, F; Appel, S; Brossart, P; Hasilik, A; Tampe, R; Abele, R				Demirel, Oezlem; Waibler, Zoe; Kalinke, Ulrich; Gruenebach, Frank; Appel, Silke; Brossart, Peter; Hasilik, Andrej; Tampe, Robert; Abele, Rupert			Identification of a lysosomal peptide transport system induced during dendritic cell development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIGEN-PROCESSING TAP; NECROSIS-FACTOR-ALPHA; RESTRICTED T-CELLS; CLASS-I MOLECULES; CROSS-PRESENTATION; ENDOPLASMIC-RETICULUM; TUMOR-ANTIGEN; INFLAMMATORY CYTOKINES; CYTOPLASMIC ANTIGENS; STIMULATORY CAPACITY	The delivery of protein fragments to major histocompatibility complex (MHC)-loading compartments of professional antigen-presenting cells is essential in the adaptive immune response against pathogens. Apart from the crucial role of the transporter associated with antigen processing (TAP) for peptide loading of MHC class I molecules in the endoplasmic reticulum, TAP-independent translocation pathways have been proposed but not identified so far. Based on its overlapping substrate specificity with TAP, we herein investigated the ABC transporter ABCB9, also named TAP-like (TAPL). Remarkably, TAPL expression is strongly induced during differentiation of monocytes to dendritic cells and to macrophages. TAPL does not, however, restore MHC class I surface expression in TAP-deficient cells, demonstrating that TAPL alone or in combination with single TAP subunits does not form a functional transport complex required for peptide loading of MHC I in the endoplasmic reticulum. In fact, by using quantitative immunofluorescence and subcellular fractionation, TAPL was detected in the lysosomal compartment co-localizing with the lysosome-associated membrane protein LAMP-2. By in vitro assays, we demonstrate a TAPL-specific translocation of peptides into isolated lysosomes, which strictly requires ATP hydrolysis. These results suggest a mechanism by which antigenic peptides have access to the lysosomal compartment in professional antigen-presenting cells.	[Gruenebach, Frank; Appel, Silke; Brossart, Peter] Univ Tubingen, Dept Hematol Oncol & Immunol, D-72076 Tubingen, Germany; [Demirel, Oezlem; Tampe, Robert; Abele, Rupert] Univ Frankfurt, Bioctr, Inst Biochem, D-60438 Frankfurt, Germany; [Waibler, Zoe; Kalinke, Ulrich] Paul Ehrlich Inst, Div Immunol, D-63225 Langen, Germany; [Hasilik, Andrej] Univ Marburg, Inst Physiol Chem, D-35032 Marburg, Germany	Eberhard Karls University of Tubingen; Goethe University Frankfurt; Paul Ehrlich Institute; Philipps University Marburg	Appel, S (corresponding author), Univ Tubingen, Dept Hematol Oncol & Immunol, Otfried-Muller-Str 10, D-72076 Tubingen, Germany.	tampe@em.uni-frankfurt.de; abele@em.uni-frankfurt.de	Tampé, Robert/H-2953-2015	Tampé, Robert/0000-0002-0403-2160; Appel, Silke/0000-0002-2199-2315; Kalinke, Ulrich/0000-0003-0503-9564				Abele R, 2004, PHYSIOLOGY, V19, P216, DOI 10.1152/physiol.00002.2004; Ackerman AL, 2003, P NATL ACAD SCI USA, V100, P12889, DOI 10.1073/pnas.1735556100; ANDERSON K, 1991, J EXP MED, V174, P489, DOI 10.1084/jem.174.2.489; AUWERX J, 1991, EXPERIENTIA, V47, P22, DOI 10.1007/BF02041244; BACHMANN MF, 1995, EUR J IMMUNOL, V25, P1739, DOI 10.1002/eji.1830250637; BACIK I, 1994, J IMMUNOL, V152, P381; BAHRAM S, 1991, P NATL ACAD SCI USA, V88, P10094, DOI 10.1073/pnas.88.22.10094; Brossart P, 2001, CANCER RES, V61, P6846; Brossart P, 2000, CANCER RES, V60, P4485; Buelens C, 1997, EUR J IMMUNOL, V27, P756, DOI 10.1002/eji.1830270326; CHICZ RM, 1993, J EXP MED, V178, P27, DOI 10.1084/jem.178.1.27; COSTES S, 2002, P MICROSC MICROANAL, V8, P1040; Cresswell P, 2005, IMMUNOL REV, V207, P145, DOI 10.1111/j.0105-2896.2005.00316.x; Dani A, 2004, J CELL SCI, V117, P4219, DOI 10.1242/jcs.01288; Day PM, 1997, P NATL ACAD SCI USA, V94, P8064, DOI 10.1073/pnas.94.15.8064; de la Salle H, 1999, J CLIN INVEST, V103, pR9, DOI 10.1172/JCI5687; DELASALLE H, 1994, SCIENCE, V265, P237, DOI 10.1126/science.7517574; Dissanayake SK, 2005, J IMMUNOL, V174, P1811, DOI 10.4049/jimmunol.174.4.1811; Efron PA, 2005, J ENDOTOXIN RES, V11, P145, DOI 10.1179/096805105X46583; Gorbulev S, 2001, P NATL ACAD SCI USA, V98, P3732, DOI 10.1073/pnas.061467898; Granucci F, 2001, EUR J IMMUNOL, V31, P2539, DOI 10.1002/1521-4141(200109)31:9<2539::AID-IMMU2539>3.0.CO;2-9; Guermonprez P, 2003, NATURE, V425, P397, DOI 10.1038/nature01911; Heintke S, 2003, FEBS LETT, V533, P42, DOI 10.1016/S0014-5793(02)03746-8; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Houde M, 2003, NATURE, V425, P402, DOI 10.1038/nature01912; Huang Q, 2001, SCIENCE, V294, P870, DOI 10.1126/science.294.5543.870; JACOBSON S, 1989, J VIROL, V63, P1756, DOI 10.1128/JVI.63.4.1756-1762.1989; JARAQUEMADA D, 1990, J EXP MED, V172, P947, DOI 10.1084/jem.172.3.947; Jonuleit H, 1997, EUR J IMMUNOL, V27, P3135, DOI 10.1002/eji.1830271209; KLEIJMEER MJ, 1992, NATURE, V357, P342, DOI 10.1038/357342a0; Kobayashi A, 2004, BIOL PHARM BULL, V27, P1916, DOI 10.1248/bpb.27.1916; Kobayashi A, 2003, BIOCHEM BIOPH RES CO, V309, P815, DOI 10.1016/j.bbrc.2003.08.081; Kobayashi A, 2000, J BIOCHEM, V128, P711, DOI 10.1093/oxfordjournals.jbchem.a022805; Koch J, 2004, J BIOL CHEM, V279, P10142, DOI 10.1074/jbc.M312816200; Koopmann JO, 1996, EUR J IMMUNOL, V26, P1720, DOI 10.1002/eji.1830260809; Lacaille VG, 1998, J BIOL CHEM, V273, P17386, DOI 10.1074/jbc.273.28.17386; Lackman RL, 2006, J IMMUNOL, V177, P4833, DOI 10.4049/jimmunol.177.7.4833; Lapointe R, 2000, EUR J IMMUNOL, V30, P3291, DOI 10.1002/1521-4141(200011)30:11<3291::AID-IMMU3291>3.0.CO;2-2; Leveson-Gower DB, 2004, BIOCHEMISTRY-US, V43, P14257, DOI 10.1021/bi0491245; Lich JD, 2000, J EXP MED, V191, P1513, DOI 10.1084/jem.191.9.1513; Lizee G, 2003, NAT IMMUNOL, V4, P1065, DOI 10.1038/ni989; Majeski AE, 2004, INT J BIOCHEM CELL B, V36, P2435, DOI 10.1016/j.biocel.2004.02.013; MALNATI MS, 1992, NATURE, V357, P702, DOI 10.1038/357702a0; Mellman I, 2005, ADV EXP MED BIOL, V560, P63; Mizumoto N, 2005, J INVEST DERMATOL, V124, P718, DOI 10.1111/j.0022-202X.2005.23616.x; Naviaux RK, 1996, J VIROL, V70, P5701, DOI 10.1128/JVI.70.8.5701-5705.1996; Norbury CC, 2001, J IMMUNOL, V166, P4355, DOI 10.4049/jimmunol.166.7.4355; Pieters J, 1997, CURR OPIN IMMUNOL, V9, P89, DOI 10.1016/S0952-7915(97)80164-1; RADONS J, 1992, EUR J CELL BIOL, V57, P184; RUDENSKY AY, 1991, NATURE, V353, P622, DOI 10.1038/353622a0; Sharma S, 2000, J BACTERIOL, V182, P6570, DOI 10.1128/JB.182.23.6570-6576.2000; Shen LJ, 2006, CURR OPIN IMMUNOL, V18, P85, DOI 10.1016/j.coi.2005.11.003; Uinuk-ool TS, 2003, IMMUNOGENETICS, V55, P38, DOI 10.1007/s00251-003-0548-y; Wang RF, 1999, SCIENCE, V284, P1351, DOI 10.1126/science.284.5418.1351; Wilson NS, 2004, BLOOD, V103, P2187, DOI 10.1182/blood-2003-08-2729; Wirths S, 2002, CANCER RES, V62, P5065; Wolters JC, 2005, J BIOL CHEM, V280, P23631, DOI 10.1074/jbc.M503231200; Yamaguchi Y, 1999, FEBS LETT, V457, P231, DOI 10.1016/S0014-5793(99)01042-X; Zhang F, 2000, J BIOL CHEM, V275, P23287, DOI 10.1074/jbc.M001819200; Zhou DL, 2005, IMMUNITY, V22, P571, DOI 10.1016/j.immuni.2005.03.009	60	35	37	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37836	37843		10.1074/jbc.M708139200	http://dx.doi.org/10.1074/jbc.M708139200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17977821	hybrid			2022-12-27	WOS:000251833600059
J	Hanada, T; Noda, NN; Satomi, Y; Ichimura, Y; Fujioka, Y; Takao, T; Inagaki, F; Ohsumi, Y				Hanada, Takao; Noda, Nobuo N.; Satomi, Yoshinori; Ichimura, Yoshinobu; Fujioka, Yuko; Takao, Toshifumi; Inagaki, Fuyuhiko; Ohsumi, Yoshinori			The Atg12-Atg5 conjugate has a novel E3-like activity for protein lipidation in autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; YEAST; MEMBRANE; ATG8; SYSTEM; ENZYME; DISSECTION; MECHANISMS; PATHWAY; COMPLEX	Autophagy is a bulk degradation process in eukaryotic cells; autophagosomes enclose cytoplasmic components for degradation in the lysosome/vacuole. Autophagosome formation requires two ubiquitin-like conjugation systems, the Atg12 and Atg8 systems, which are tightly associated with expansion of autophagosomal membrane. Previous studies have suggested that there is a hierarchy between these systems; the Atg12 system is located upstream of the Atg8 system in the context of Atg protein organization. However, the concrete molecular relationship is unclear. Here, we show using an in vitro Atg8 conjugation system that the Atg12-Atg5 conjugate, but not unconjugated Atg12 or Atg5, strongly enhances the formation of the other conjugate, Atg8-PE. The Atg12-Atg5 conjugate promotes the transfer of Atg8 from Atg3 to the substrate, phosphatidylethanolamine ( PE), by stimulating the activity of Atg3. We also show that the Atg12-Atg5 conjugate interacts with both Atg3 and PE-containing liposomes. These results indicate that the Atg12-Atg5 conjugate is a ubiquitin-protein ligase (E3)-like enzyme for Atg8-PE conjugation reaction, distinctively promoting protein-lipid conjugation.	[Hanada, Takao; Ichimura, Yoshinobu; Ohsumi, Yoshinori] Natl Inst Basic Biol, Div Mol & Cell Biol, Okazaki, Aichi 444, Japan; [Noda, Nobuo N.; Fujioka, Yuko; Inagaki, Fuyuhiko] Hokkaido Univ, Grad Sch Pharmaceut Sci, Dept Biol Struct, Kita Ku, Sapporo, Hokkaido 001, Japan; [Satomi, Yoshinori; Takao, Toshifumi] Osaka Univ, Inst Protein Res, Suita, Osaka 5650871, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Hokkaido University; Osaka University	Ohsumi, Y (corresponding author), Natl Inst Basic Biol, Div Mol & Cell Biol, Okazaki, Aichi 444, Japan.	yohsumi@nibb.ac.jp	Ohsumi, Yoshinori/C-6449-2009; Noda, Nobuo/P-1397-2015	Ohsumi, Yoshinori/0000-0003-2384-2166; Fujioka, Yuko/0000-0002-6905-0669; Noda, Nobuo/0000-0002-6940-8069; Hanada, Takao/0000-0003-2732-4008; Satomi, Yoshinori/0000-0002-8991-1040				Cuervo AM, 2004, TRENDS CELL BIOL, V14, P70, DOI 10.1016/j.tcb.2003.12.002; Dye BT, 2007, ANNU REV BIOPH BIOM, V36, P131, DOI 10.1146/annurev.biophys.36.040306.132820; Hanada T, 2005, AUTOPHAGY, V1, P110, DOI 10.4161/auto.1.2.1858; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Ichimura Y, 2004, J BIOL CHEM, V279, P40584, DOI 10.1074/jbc.M405860200; Kirisako T, 2000, J CELL BIOL, V151, P263, DOI 10.1083/jcb.151.2.263; Kirisako T, 1999, J CELL BIOL, V147, P435, DOI 10.1083/jcb.147.2.435; Kuma A, 2002, J BIOL CHEM, V277, P18619, DOI 10.1074/jbc.M111889200; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Matsushita M, 2007, J BIOL CHEM, V282, P6763, DOI 10.1074/jbc.M609876200; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2003, J CELL SCI, V116, P1679, DOI 10.1242/jcs.00381; Mizushima N, 1999, EMBO J, V18, P3888, DOI 10.1093/emboj/18.14.3888; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Noda T, 2002, TRENDS CELL BIOL, V12, P231, DOI 10.1016/S0962-8924(02)02278-X; Ohsumi Y, 2001, NAT REV MOL CELL BIO, V2, P211, DOI 10.1038/35056522; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Shintani T, 1999, EMBO J, V18, P5234, DOI 10.1093/emboj/18.19.5234; Sou Y, 2006, J BIOL CHEM, V281, P3017, DOI 10.1074/jbc.M505888200; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; Suzuki K, 2007, GENES CELLS, V12, P209, DOI 10.1111/j.1365-2443.2007.01050.x; Suzuki NN, 2005, AUTOPHAGY, V1, P119, DOI 10.4161/auto.1.2.1859; Tanida I, 1999, MOL BIOL CELL, V10, P1367, DOI 10.1091/mbc.10.5.1367; Yamada Y, 2007, J BIOL CHEM, V282, P8036, DOI 10.1074/jbc.M611473200; Yorimitsu T, 2005, CELL DEATH DIFFER, V12, P1542, DOI 10.1038/sj.cdd.4401765; ZINSER E, 1995, YEAST, V11, P493, DOI 10.1002/yea.320110602	28	774	801	5	88	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37298	37302		10.1074/jbc.C700195200	http://dx.doi.org/10.1074/jbc.C700195200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17986448	hybrid			2022-12-27	WOS:000251833600003
J	Lin, FT; Lai, YJ; Makarova, N; Tigyi, G; Lin, WC				Lin, Fang-Tsyr; Lai, Yun-Ju; Makarova, Natalia; Tigyi, Gabor; Lin, Weei-Chin			The lysophosphatidic acid 2 receptor mediates down-regulation of Siva-1 to promote cell survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; NF-KAPPA-B; INDUCED APOPTOSIS; SIGNALING PATHWAYS; BETA-ARRESTIN; KINASE 2; UBIQUITINATION; DEATH; GENE; DEGRADATION	Lysophosphatidic acid (LPA) promotes cell survival through the activation of G protein-coupled LPA receptors. However, whether different LPA receptors activate distinct anti-apoptotic signaling pathways is not yet clear. Here we report a novel mechanism by which the LPA(2) receptor targets the proapoptotic Siva-1 protein for LPA-dependent degradation, thereby attenuating Siva-1 function in DNA damage response. The carboxylterminal tail of the LPA2 receptor, but not LPA(1) or LPA(3) receptor, specifically associates with the carboxyl cysteine-rich domain of Siva-1. Prolonged LPA stimulation promotes the association of Siva-1 with the LPA(2) receptor and targets both proteins for ubiquitination and degradation. As a result, adriamycin-induced Siva-1 protein stabilization is attenuated by LPA in an LPA(2)-dependent manner, and the function of Siva-1 in promoting DNA damage-induced apoptosis is inhibited by LPA pretreatment. Consistent with this result, inhibition of the LPA2 receptor expression increases Siva-1 protein levels and augments adriamycin-induced caspase-3 cleavage and apoptosis. Together, these findings reveal a critical and specific role for the LPA(2) receptor through which LPA directly inactivates a critical component of the death machinery to promote cell survival.	[Lin, Fang-Tsyr; Lai, Yun-Ju; Lin, Weei-Chin] Univ Alabama, Dept Cell Biol, Birmingham, AL 35294 USA; [Lin, Weei-Chin] Univ Alabama, Dept Med, Div Hematol & Oncol, Birmingham, AL 35294 USA; [Makarova, Natalia; Tigyi, Gabor] Univ Tennessee, Ctr Hlth Sci, Dept Physiol, Memphis, TN 38163 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Tennessee System; University of Tennessee Health Science Center	Lin, FT (corresponding author), Univ Alabama, Dept Cell Biol, MCLM 360A,1918 Univ Blvd, Birmingham, AL 35294 USA.	flin@uab.edu			NATIONAL CANCER INSTITUTE [R01CA092160, R01CA100848, R01CA100857] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080405] Funding Source: NIH RePORTER; NCI NIH HHS [CA100848, R01 CA092160-09, R01 CA100848, R01 CA092160, R01 CA100857] Funding Source: Medline; NIAID NIH HHS [R01 AI080405, R01 AI080405-01] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		An SZ, 1997, FEBS LETT, V417, P279, DOI 10.1016/S0014-5793(97)01301-X; Baker DL, 2001, ANAL BIOCHEM, V292, P287, DOI 10.1006/abio.2001.5063; Bandoh K, 1999, J BIOL CHEM, V274, P27776, DOI 10.1074/jbc.274.39.27776; Cao C, 2001, J BIOL CHEM, V276, P11465, DOI 10.1074/jbc.C100050200; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Contos JJA, 2002, MOL CELL BIOL, V22, P6921, DOI 10.1128/MCB.22.19.6921-6929.2002; Cook LB, 2003, MOL ENDOCRINOL, V17, P1777, DOI 10.1210/me.2003-0073; Daoud SS, 2003, CANCER RES, V63, P2782; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Deng W, 2007, GASTROENTEROLOGY, V132, P1834, DOI 10.1053/j.gastro.2007.03.038; Drake MT, 2006, CIRC RES, V99, P570, DOI 10.1161/01.RES.0000242563.47507.ce; Dupre DJ, 2003, J BIOL CHEM, V278, P48228, DOI 10.1074/jbc.M304082200; Fang XJ, 2000, BIOCHEM J, V352, P135, DOI 10.1042/0264-6021:3520135; Fortin A, 2004, J BIOL CHEM, V279, P28706, DOI 10.1074/jbc.M400376200; Fukushima N, 1998, P NATL ACAD SCI USA, V95, P6151, DOI 10.1073/pnas.95.11.6151; Gudi R, 2006, ONCOGENE, V25, P3458, DOI 10.1038/sj.onc.1209381; Hecht JH, 1996, J CELL BIOL, V135, P1071, DOI 10.1083/jcb.135.4.1071; Hu XJ, 2005, J BIOL CHEM, V280, P9498, DOI 10.1074/jbc.M410455200; Jacobs SBR, 2007, CELL DEATH DIFFER, V14, P1374, DOI 10.1038/sj.cdd.4402128; Kang YC, 2004, CELL DEATH DIFFER, V11, P1287, DOI 10.1038/sj.cdd.4401489; Lee CW, 2006, J BIOL CHEM, V281, P23589, DOI 10.1074/jbc.M603670200; Li CY, 2005, J EXP MED, V202, P975, DOI 10.1084/jem.20050421; Liu K, 2006, EMBO J, V25, P4795, DOI 10.1038/sj.emboj.7601355; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; Martin NP, 2003, J BIOL CHEM, V278, P45954, DOI 10.1074/jbc.M308285200; MARTIN SJ, 1990, J IMMUNOL, V145, P1859; Mills GB, 2003, NAT REV CANCER, V3, P582, DOI 10.1038/nrc1143; Nocentini G, 1997, P NATL ACAD SCI USA, V94, P6216, DOI 10.1073/pnas.94.12.6216; Noguchi K, 2003, J BIOL CHEM, V278, P25600, DOI 10.1074/jbc.M302648200; Penela P, 1998, J BIOL CHEM, V273, P35238, DOI 10.1074/jbc.273.52.35238; Petaja-Repo UE, 2001, J BIOL CHEM, V276, P4416, DOI 10.1074/jbc.M007151200; Prasad KVS, 1997, P NATL ACAD SCI USA, V94, P6346, DOI 10.1073/pnas.94.12.6346; Py B, 2004, J IMMUNOL, V172, P4008, DOI 10.4049/jimmunol.172.7.4008; Qin LF, 2002, LIFE SCI, V70, P1677, DOI 10.1016/S0024-3205(01)01554-5; Radeff-Huang J, 2004, J CELL BIOCHEM, V92, P949, DOI 10.1002/jcb.20094; Raj GV, 2004, PROSTATE, V61, P105, DOI 10.1002/pros.20083; Salcedo A, 2006, EMBO J, V25, P4752, DOI 10.1038/sj.emboj.7601351; Shenoy SK, 2003, J BIOL CHEM, V278, P14498, DOI 10.1074/jbc.M209626200; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Spinicelli S, 2002, CELL DEATH DIFFER, V9, P1382, DOI 10.1038/sj.cdd.4401140; Virag T, 2003, MOL PHARMACOL, V63, P1032, DOI 10.1124/mol.63.5.1032; Wang B, 2004, J BIOL CHEM, V279, P54140, DOI 10.1074/jbc.M410493200; Wojcikiewicz RJH, 2004, TRENDS PHARMACOL SCI, V25, P35, DOI 10.1016/j.tips.2003.11.008; Xiao H, 2000, EMBO J, V19, P956, DOI 10.1093/emboj/19.5.956; Xu J, 2004, J BIOL CHEM, V279, P10459, DOI 10.1074/jbc.M311891200; Xu Y, 1998, JAMA-J AM MED ASSOC, V280, P719, DOI 10.1001/jama.280.8.719; Xue L, 2002, P NATL ACAD SCI USA, V99, P6925, DOI 10.1073/pnas.102182299; Ye XQ, 2002, BBA-MOL CELL BIOL L, V1585, P108, DOI 10.1016/S1388-1981(02)00330-X; Yoon Y, 1999, ONCOGENE, V18, P7174, DOI 10.1038/sj.onc.1203144	49	55	61	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37759	37769		10.1074/jbc.M705025200	http://dx.doi.org/10.1074/jbc.M705025200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17965021	Green Accepted, hybrid			2022-12-27	WOS:000251833600052
J	Fuenzalida, K; Quintanilla, R; Ramos, P; Piderit, D; Fuentealba, RA; Martinez, G; Inestrosa, NC; Bronfman, M				Fuenzalida, Karen; Quintanilla, Rodrigo; Ramos, Patricio; Piderit, Daniela; Fuentealba, Rodrigo A.; Martinez, Gabriela; Inestrosa, Nibaldo C.; Bronfman, Miguel			Peroxisome proliferator-activated receptor gamma up-regulates the Bcl-2 anti-apoptotic protein in neurons and induces mitochondrial stabilization and protection against oxidative stress and apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; PPAR-GAMMA; CELL-DEATH; ALZHEIMERS-DISEASE; INSULIN-RESISTANCE; SIGNALING PATHWAY; SURVIVAL; AGONISTS; TROGLITAZONE; LIGAND	Peroxisome proliferator-activated receptor gamma(PPAR gamma) has been proposed as a therapeutic target for neurodegenerative diseases because of its anti-inflammatory action in glial cells. However, PPAR gamma agonists prevent beta-amyloid (A beta)-induced neurodegeneration in hippocampal neurons, and PPAR gamma is activated by the nerve growth factor (NGF) survival pathway, suggesting a neuroprotective anti-inflammatory independent action. Here we show that the PPAR gamma agonist rosiglitazone (RGZ) protects hippocampal and dorsal root ganglion neurons against A beta-induced mitochondrial damage and NGF deprivation-induced apoptosis, respectively, and promotes PC12 cell survival. In neurons and in PC12 cells RGZ protective effects are associated with increased expression of the Bcl-2 anti-apoptotic protein. NGF-differentiated PC12 neuronal cells constitutively overexpressing PPAR gamma are resistant to A beta-induced apoptosis and morphological changes and show functionally intact mitochondria and no increase in reactive oxygen species when challenged with up to 50 mu M H2O2. Conversely, cells expressing a dominant negative mutant of PPAR gamma show increased A beta-induced apoptosis and disruption of neuronal-like morphology and are highly sensitive to oxidative stress-induced impairment of mitochondrial function. Cells overexpressing PPAR gamma present a 4-to 5-fold increase in Bcl-2 protein content, whereas in dominant negative PPAR gamma-expressing cells, Bcl-2 is barely detected. Bcl-2 knockdown by small interfering RNA in cells overexpressing PPAR gamma results in increased sensitivity to A beta and oxidative stress, further suggesting that Bcl-2 up-regulation mediates PPAR gamma protective effects. PPAR gamma prosurvival action is independent of the signal-regulated MAPK or the Akt prosurvival pathways. Altogether, these data suggest that PPAR gamma supports survival in neurons in part through a mechanism involving increased expression of Bcl-2.	[Fuenzalida, Karen; Quintanilla, Rodrigo; Ramos, Patricio; Piderit, Daniela; Fuentealba, Rodrigo A.; Martinez, Gabriela; Inestrosa, Nibaldo C.; Bronfman, Miguel] Pontificia Univ Catolica Chile, Dept Cellular & Mol Biol, Joaquin V Luco & Millennium Inst Fundamental & Ap, Fac Ciencias Biol,Ctr Regulac Celular & Patol, Santiago 340, Chile	Pontificia Universidad Catolica de Chile	Bronfman, M (corresponding author), Pontificia Univ Catolica Chile, Dept Cellular & Mol Biol, Joaquin V Luco & Millennium Inst Fundamental & Ap, Fac Ciencias Biol,Ctr Regulac Celular & Patol, 114-D, Santiago 340, Chile.	mbronfman@bio.puc.cl	QUINTANILLA, RODRIGO/ABG-8829-2021; martinez, gabriela/GWV-0033-2022; Martinez, Gabriela/E-2964-2017; Ramos, Patricio/ABE-5961-2021; Ramos, Patricio/B-6665-2017; Martínez, Gabriela/GWR-1584-2022	Ramos, Patricio/0000-0001-8341-314X; Fuentealba, Rodrigo/0000-0001-8724-091X; Fuenzalida, Karen/0000-0001-8829-7336				Abramov AY, 2003, J NEUROSCI, V23, P5088; Akaike M, 2004, MOL CELL BIOL, V24, P8691, DOI 10.1128/MCB.24.19.8691-8704.2004; Aoun P, 2003, EUR J PHARMACOL, V472, P65, DOI 10.1016/S0014-2999(03)01867-3; Baek SJ, 2003, J BIOL CHEM, V278, P5845, DOI 10.1074/jbc.M208394200; Bernardo A, 2006, CURR PHARM DESIGN, V12, P93, DOI 10.2174/138161206780574579; Bishop-Bailey D, 1999, J BIOL CHEM, V274, P17042, DOI 10.1074/jbc.274.24.17042; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Butts BD, 2004, INT J ONCOL, V24, P1305; Chen F, 2003, J CELL BIOCHEM, V90, P732, DOI 10.1002/jcb.10668; Chintharlapalli S, 2005, MOL PHARMACOL, V68, P1782, DOI 10.1124/mol.105.017046; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Davies GF, 2001, BIOCHEM PHARMACOL, V62, P1071, DOI 10.1016/S0006-2952(01)00764-X; Duchen Michael R., 2004, Molecular Aspects of Medicine, V25, P365, DOI 10.1016/j.mam.2004.03.001; EICHLER ME, 1989, BRAIN RES, V482, P340, DOI 10.1016/0006-8993(89)91197-9; Feinstein Douglas L, 2003, Diabetes Technol Ther, V5, P67, DOI 10.1089/152091503763816481; Feng LF, 2006, J DRUG TARGET, V14, P21, DOI 10.1080/10611860500527947; Fuenzalida KM, 2005, J BIOL CHEM, V280, P9604, DOI 10.1074/jbc.M409447200; Futami Takashi, 2002, Nucleic Acids Res Suppl, P251; Gardner OS, 2003, J BIOL CHEM, V278, P46261, DOI 10.1074/jbc.M307827200; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Harris SG, 2001, EUR J IMMUNOL, V31, P1098, DOI 10.1002/1521-4141(200104)31:4<1098::AID-IMMU1098>3.0.CO;2-I; Hauser S, 2000, J BIOL CHEM, V275, P18527, DOI 10.1074/jbc.M001297200; Holle L, 2004, INT J ONCOL, V24, P615; Inestrosa NC, 2005, EXP CELL RES, V304, P91, DOI 10.1016/j.yexcr.2004.09.032; Jang JH, 2004, BIOCHEM BIOPH RES CO, V320, P880, DOI 10.1016/j.bbrc.2004.06.035; Jung TW, 2006, BIOCHEM BIOPH RES CO, V340, P221, DOI 10.1016/j.bbrc.2005.11.177; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549; Kersten S, 2000, NATURE, V405, P421, DOI 10.1038/35013000; Kiaei M, 2005, EXP NEUROL, V191, P331, DOI 10.1016/j.expneurol.2004.10.007; Landreth GE, 2001, NEUROBIOL AGING, V22, P937, DOI 10.1016/S0197-4580(01)00296-2; Lawlor MA, 2001, J CELL SCI, V114, P2903; Lee FS, 2001, P NATL ACAD SCI USA, V98, P3555, DOI 10.1073/pnas.061020198; Leisewitz AV, 2003, J NEUROCHEM, V85, P135, DOI 10.1046/j.1471-4159.2003.01641.x; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; LINDSAY RM, 1988, J NEUROSCI, V8, P2394; Liu YZ, 1999, NUCLEIC ACIDS RES, V27, P2086, DOI 10.1093/nar/27.10.2086; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Mattson MP, 2006, NAT REV NEUROSCI, V7, P278, DOI 10.1038/nrn1886; Michaelidis TM, 1996, NEURON, V17, P75, DOI 10.1016/S0896-6273(00)80282-2; Miranda S, 1999, BIOCHEM BIOPH RES CO, V258, P44, DOI 10.1006/bbrc.1999.0580; Moore KJ, 2001, NAT MED, V7, P41, DOI 10.1038/83328; Nemenoff RA, 2005, EUR J CANCER, V41, P2561, DOI 10.1016/j.ejca.2005.08.015; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; Padilla J, 2000, J IMMUNOL, V165, P6941, DOI 10.4049/jimmunol.165.12.6941; Ptasinska A, 2007, FASEB J, V21, P950, DOI 10.1096/fj.06-6822com; RADEKE MJ, 1987, NATURE, V325, P593, DOI 10.1038/325593a0; Riccio A, 1999, SCIENCE, V286, P2358, DOI 10.1126/science.286.5448.2358; Rossi A, 2000, NATURE, V403, P103, DOI 10.1038/47520; Roth AD, 2003, J NEUROSCI RES, V72, P425, DOI 10.1002/jnr.10596; Russell JW, 1998, J NEUROBIOL, V36, P455, DOI 10.1002/(SICI)1097-4695(19980915)36:4<455::AID-NEU1>3.0.CO;2-V; Saille C, 1999, NEUROSCIENCE, V92, P1455, DOI 10.1016/S0306-4522(99)00089-5; Scheid MP, 2003, FEBS LETT, V546, P108, DOI 10.1016/S0014-5793(03)00562-3; Segal RA, 2003, ANNU REV NEUROSCI, V26, P299, DOI 10.1146/annurev.neuro.26.041002.131421; SMEYNE RJ, 1994, NATURE, V368, P246, DOI 10.1038/368246a0; Soane L, 2005, J BIOENERG BIOMEMBR, V37, P179, DOI 10.1007/s10863-005-6590-8; Strum JC, 2007, J ALZHEIMERS DIS, V11, P45; Teng KK, 2004, CELL MOL LIFE SCI, V61, P35, DOI 10.1007/s00018-003-3099-3; Uryu S, 2002, BRAIN RES, V924, P229, DOI 10.1016/S0006-8993(01)03242-5; van der Heide LP, 2006, PROG NEUROBIOL, V79, P205, DOI 10.1016/j.pneurobio.2006.06.003; Vila M, 2003, NAT REV NEUROSCI, V4, P365, DOI 10.1038/nrn1100; Vogelbaum MA, 1998, J NEUROSCI, V18, P8928; Wacheck V, 2003, OLIGONUCLEOTIDES, V13, P393, DOI 10.1089/154545703322617078; Walsh GS, 2004, J NEUROSCI, V24, P9638, DOI 10.1523/JNEUROSCI.1299-04.2004; Wang MH, 1999, DIABETES, V48, P254, DOI 10.2337/diabetes.48.2.254; Wang YL, 2002, J BIOL CHEM, V277, P31781, DOI 10.1074/jbc.M204279200; Ward MW, 2000, J NEUROSCI, V20, P7208; Watson GS, 2006, J NEUROL SCI, V245, P21, DOI 10.1016/j.jns.2005.08.017; Watson GS, 2003, CNS DRUGS, V17, P27, DOI 10.2165/00023210-200317010-00003; Winn RA, 2006, J BIOL CHEM, V281, P26943, DOI 10.1074/jbc.M604145200; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739; Zhao XR, 2006, BRAIN RES, V1073, P460, DOI 10.1016/j.brainres.2005.12.061; Zhao Y, 2005, J NEUROCHEM, V94, P1395, DOI 10.1111/j.1471-4159.2005.03275.x; Zhao Y, 2006, FASEB J, V20, P1162, DOI 10.1096/fj.05-5007com	74	219	236	3	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					37006	37015		10.1074/jbc.M700447200	http://dx.doi.org/10.1074/jbc.M700447200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17965419	hybrid			2022-12-27	WOS:000251646000027
J	Monde, K; Maeda, Y; Tanaka, Y; Harada, S; Yusa, K				Monde, Kazuaki; Maeda, Yosuke; Tanaka, Yuetsu; Harada, Shinji; Yusa, Keisuke			Gp120 V3-dependent impairment of R5 HIV-1 infectivity due to virion-incorporated CCR5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CD4 DOWN-REGULATION; CELL-SURFACE CCR5; ENVELOPE GLYCOPROTEIN; DILEUCINE MOTIF; VIRAL INFECTIVITY; TYPE-1 ENVELOPE; TROPIC HIV-1; BINDING-SITE; NEF PROTEIN	Entry of R5 human immunodeficiency virus type 1 (HIV-1) into target cells requires sequential interactions of the envelope glycoprotein gp120 with the receptor CD4 and the coreceptor CCR5. We investigated replication of 45 R5 viral clones derived from the HIV-1(JR-FLan) library carrying 0 - 10 random amino acid substitutions in the gp120 V3 loop. It was found that 6.7% (3/45) of the viruses revealed >= 10-fold replication suppression in PM1/CCR5 cells expressing high levels of CCR5 compared with PM1 cells expressing low levels of CCR5. In HIV-1(V3L#08), suppression of replication was not associated with entry events and viral production but with a marked decrease in infectivity of nascent progeny virus. HIV-1(V3L#08), generated from infected PM1/CCR5 cells, was 98% immunoprecipitated by anti-CCR5 monoclonal antibody T21/8, whereas the other infectious viruses were only partially precipitated, suggesting that incorporation of larger amounts of CCR5 into the virions caused impairment of viral infectivity in HIV-1(V3L#08). The results demonstrate the implications of an alternative influence of CCR5 on HIV-1 replication.	[Monde, Kazuaki; Maeda, Yosuke; Harada, Shinji; Yusa, Keisuke] Kumamoto Univ, Grad Sch Med Sci, Dept Med Virol, Kumamoto 8608556, Japan; [Tanaka, Yuetsu] Univ Ryukyus, Fac Med, Dept Immunol & Infect Dis, Okinawa Asia Res Ctr Med Sci, Okinawa 9030215, Japan	Kumamoto University; University of the Ryukyus	Yusa, K (corresponding author), Kumamoto Univ, Grad Sch Med Sci, Dept Med Virol, Honjo 1-1-1, Kumamoto 8608556, Japan.	yusak@kumamoto-u.ac.jp	Monde, Kazuaki/I-6493-2019	Monde, Kazuaki/0000-0002-8314-5306				AIKEN C, 1994, CELL, V76, P853, DOI 10.1016/0092-8674(94)90360-3; Berger EA, 1998, NATURE, V391, P240, DOI 10.1038/34571; Bresnahan PA, 1998, CURR BIOL, V8, P1235, DOI 10.1016/S0960-9822(07)00517-9; Cantin R, 1997, J VIROL, V71, P1922, DOI 10.1128/JVI.71.3.1922-1930.1997; Cantin R, 1997, BLOOD, V90, P1091, DOI 10.1182/blood.V90.3.1091.1091_1091_1100; Craig HM, 1998, P NATL ACAD SCI USA, V95, P11229, DOI 10.1073/pnas.95.19.11229; DELWART EL, 1989, J VIROL, V63, P273, DOI 10.1128/JVI.63.1.273-280.1989; Doms RW, 1997, VIROLOGY, V235, P179, DOI 10.1006/viro.1997.8703; Dragic T, 1998, J VIROL, V72, P279, DOI 10.1128/JVI.72.1.279-285.1998; Esser MT, 2001, J VIROL, V75, P6173, DOI 10.1128/JVI.75.13.6173-6182.2001; Farzan M, 1998, J VIROL, V72, P1160, DOI 10.1128/JVI.72.2.1160-1164.1998; GELEZIUNAS R, 1994, FASEB J, V8, P593, DOI 10.1096/fasebj.8.9.8005387; Greenberg M, 1998, CURR BIOL, V8, P1239, DOI 10.1016/S0960-9822(07)00518-0; Hachiya A, 2001, ANTIMICROB AGENTS CH, V45, P495, DOI 10.1128/AAC.45.2.495-501.2001; HOXIE JA, 1987, HUM IMMUNOL, V18, P39, DOI 10.1016/0198-8859(87)90111-X; Inudoh M, 1998, MICROBIOL IMMUNOL, V42, P875, DOI 10.1111/j.1348-0421.1998.tb02364.x; KIMPTON J, 1992, J VIROL, V66, P2232, DOI 10.1128/JVI.66.4.2232-2239.1992; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Lallos LB, 1999, AIDS RES HUM RETROV, V15, P895, DOI 10.1089/088922299310601; Lama J, 1999, CURR BIOL, V9, P622, DOI 10.1016/S0960-9822(99)80284-X; Lee B, 1999, J BIOL CHEM, V274, P9617, DOI 10.1074/jbc.274.14.9617; Levesque K, 2003, J BIOL CHEM, V278, P28346, DOI 10.1074/jbc.M300327200; Lin YL, 2002, P NATL ACAD SCI USA, V99, P15590, DOI 10.1073/pnas.242134499; LUSSO P, 1995, J VIROL, V69, P3712, DOI 10.1128/JVI.69.6.3712-3720.1995; Maeda Y, 2000, J VIROL, V74, P1787, DOI 10.1128/JVI.74.4.1787-1793.2000; Mangasarian A, 1997, IMMUNITY, V6, P67, DOI 10.1016/S1074-7613(00)80243-5; Mariani R, 2000, J VIROL, V74, P3859, DOI 10.1128/JVI.74.8.3859-3870.2000; Michel N, 2005, CURR BIOL, V15, P714, DOI 10.1016/j.cub.2005.02.058; Moore JP, 1997, CURR OPIN IMMUNOL, V9, P551, DOI 10.1016/S0952-7915(97)80110-0; Moore JP, 1997, SCIENCE, V276, P51, DOI 10.1126/science.276.5309.51; O'Connor KH, 2005, J IMMUNOL METHODS, V299, P21, DOI 10.1016/j.jim.2004.11.025; Ott DE, 2002, REV MED VIROL, V12, P359, DOI 10.1002/rmv.367; Ott DE, 1997, REV MED VIROL, V7, P167, DOI 10.1002/(SICI)1099-1654(199709)7:3&lt;167::AID-RMV199&gt;3.0.CO;2-K; PALESE P, 1974, VIROLOGY, V61, P397, DOI 10.1016/0042-6822(74)90276-1; Peters PJ, 2004, J VIROL, V78, P6915, DOI 10.1128/JVI.78.13.6915-6926.2004; Piguet V, 1998, EMBO J, V17, P2472, DOI 10.1093/emboj/17.9.2472; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Reeves JD, 2004, J VIROL, V78, P5476, DOI 10.1128/JVI.78.10.5476-5485.2004; Reeves JD, 2002, P NATL ACAD SCI USA, V99, P16249, DOI 10.1073/pnas.252469399; Reyues J, 2003, JAIDS-J ACQ IMM DEF, V34, P114, DOI 10.1097/00126334-200309010-00018; Rizzuto C, 2000, AIDS RES HUM RETROV, V16, P741, DOI 10.1089/088922200308747; Rizzuto CD, 1998, SCIENCE, V280, P1949, DOI 10.1126/science.280.5371.1949; STECK FT, 1966, VIROLOGY, V29, P628, DOI 10.1016/0042-6822(66)90287-X; Suphaphiphat P, 2003, J VIROL, V77, P3832, DOI 10.1128/JVI.77.6.3832-3837.2003; Tremblay MJ, 1998, IMMUNOL TODAY, V19, P346, DOI 10.1016/S0167-5699(98)01286-9; Trkola A, 1996, NATURE, V384, P184, DOI 10.1038/384184a0; Walter BL, 2005, J VIROL, V79, P4828, DOI 10.1128/JVI.79.8.4828-4837.2005; WILLEY RL, 1992, J VIROL, V66, P7193, DOI 10.1128/JVI.66.12.7193-7200.1992; Wu LJ, 1997, J EXP MED, V185, P1681, DOI 10.1084/jem.185.9.1681; Wu LJ, 1996, NATURE, V384, P179, DOI 10.1038/384179a0; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Yusa K, 2005, J BIOL CHEM, V280, P30083, DOI 10.1074/jbc.M414360200; Zhang WT, 1999, BIOCHEMISTRY-US, V38, P9405, DOI 10.1021/bi990654o	54	7	7	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					36923	36932		10.1074/jbc.M705298200	http://dx.doi.org/10.1074/jbc.M705298200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17971448	hybrid			2022-12-27	WOS:000251646000018
J	Mukhopadhyay, A; Yang, CS; Wei, BX; Weiner, H				Mukhopadhyay, Abhijit; Yang, Chun-Song; Wei, Baoxian; Weiner, Henry			Precursor protein is readily degraded in mitochondrial matrix space if the leader is not processed by mitochondrial processing peptidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALDEHYDE DEHYDROGENASE; SIGNAL PEPTIDE; SACCHAROMYCES-CEREVISIAE; ASPARTATE-AMINOTRANSFERASE; 3-DIMENSIONAL STRUCTURE; CRYSTAL-STRUCTURES; ESCHERICHIA-COLI; YEAST FUMARASE; IN-VIVO; IMPORT	It is not known why leader peptides are removed by the mitochondrial processing peptidase after import into the matrix space. The leaders of yeast aldehyde dehydrogenase ( pALDH) and malate dehydrogenase were mutated so that they would not be processed after import. The recombinant nonprocessed precursor of yeast pALDH possessed a similar specific activity as the corresponding mature form but was much less stable. The nonprocessed pALDH was transformed into a yeast strain missing ALDHs. The transformed yeast grew slowly on ethanol as the sole carbon source showing that the nonprocessed precursor was functional in vivo. Western blot analysis showed that the amount of precursor was 15-20% of that found in cells transformed with the native enzyme. Pulse-chase experiments revealed that the turnover rate for the nonprocessed precursor was greater than that of the mature protein indicating that the nonprocessed precursor could have been degraded. By using carbonyl cyanide m-chlorophenylhydrazone, we showed that the nonprocessed precursor was degraded in the matrix space. The nonprocessed precursor forms of precursor yeast malate dehydrogenase and rat liver pALDH also were degraded in the matrix space of HeLa cell mitochondria faster than their corresponding mature forms. In the presence of o-phenanthroline, an inhibitor of mitochondrial processing peptidase, the wild type precursor was readily degraded in the matrix space. Collectively, this study showed that the precursor form is less stable in the matrix space than is the mature form and provides an explanation for why the leader peptide is removed from the precursors.	[Mukhopadhyay, Abhijit; Yang, Chun-Song; Wei, Baoxian; Weiner, Henry] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Weiner, H (corresponding author), Purdue Univ, Dept Biochem, 175S Univ St, W Lafayette, IN 47907 USA.	mukhopad@purdue.edu; Hweiner@purdue.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053169] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA010795, R01AA005812, R37AA005812] Funding Source: NIH RePORTER; NIAAA NIH HHS [AA05812, AA10795] Funding Source: Medline; NIGMS NIH HHS [GM53169] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Berezov A, 2005, PROTEIN J, V24, P465, DOI 10.1007/s10930-005-7642-y; Braun HP, 1997, INT J BIOCHEM CELL B, V29, P1043, DOI 10.1016/S1357-2725(97)00032-0; DIEDERICHS K, 1991, J MOL BIOL, V217, P541, DOI 10.1016/0022-2836(91)90756-V; FUJIKI M, 1993, J BIOL CHEM, V268, P1914; Gakh E, 2002, BBA-MOL CELL RES, V1592, P63, DOI 10.1016/S0167-4889(02)00265-3; Glaser E, 2006, BIOL CHEM, V387, P1441, DOI 10.1515/BC.2006.180; Glick BS, 1995, METHOD ENZYMOL, V260, P213, DOI 10.1016/0076-6879(95)60139-2; Gliubich F, 1998, ACTA CRYSTALLOGR D, V54, P481, DOI 10.1107/S090744499701216X; Hammen PK, 1996, J BIOL CHEM, V271, P21041, DOI 10.1074/jbc.271.35.21041; HAMMEN PK, 1994, BIOCHEMISTRY-US, V33, P8610, DOI 10.1021/bi00194a028; HARTL FU, 1987, CELL, V51, P1027, DOI 10.1016/0092-8674(87)90589-7; Ito A, 1999, BIOCHEM BIOPH RES CO, V265, P611, DOI 10.1006/bbrc.1999.1703; JARVIS JA, 1995, J BIOL CHEM, V270, P1323, DOI 10.1074/jbc.270.3.1323; JENG JJ, 1991, ARCH BIOCHEM BIOPHYS, V289, P214, DOI 10.1016/0003-9861(91)90464-T; KARSLAKE C, 1990, BIOCHEMISTRY-US, V29, P9872, DOI 10.1021/bi00494a017; Kaser M, 2000, SEMIN CELL DEV BIOL, V11, P181, DOI 10.1006/scdb.2000.0166; Koppen M, 2007, CRIT REV BIOCHEM MOL, V42, P221, DOI 10.1080/10409230701380452; MacKenzie JA, 2007, BBA-MOL BASIS DIS, V1772, P509, DOI 10.1016/j.bbadis.2006.12.002; MCPHALEN CA, 1992, J MOL BIOL, V227, P197, DOI 10.1016/0022-2836(92)90691-C; Mukhopadhyay A, 2005, CELL MOL LIFE SCI, V62, P1890, DOI 10.1007/s00018-005-5178-0; Mukhopadhyay A, 2004, BIOCHEM J, V382, P385, DOI 10.1042/BJ20040065; Mukhopadhyay A, 2003, J BIOL CHEM, V278, P13712, DOI 10.1074/jbc.M212743200; Mukhopadhyay A, 2002, PROTEIN SCI, V11, P1026, DOI 10.1110/ps.3760102; Nett JH, 1997, J BIOL CHEM, V272, P2212; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Ni L, 1999, PROTEIN SCI, V8, P2784; PAK YK, 1990, J BIOL CHEM, V265, P14298; Pfanner N, 2001, NAT REV MOL CELL BIO, V2, P339, DOI 10.1038/35073006; Roberts DL, 1996, P NATL ACAD SCI USA, V93, P14355, DOI 10.1073/pnas.93.25.14355; Sass E, 2001, J BIOL CHEM, V276, P46111, DOI 10.1074/jbc.M106061200; SCHMID D, 1992, EUR J BIOCHEM, V208, P699, DOI 10.1111/j.1432-1033.1992.tb17237.x; Steinmetz CG, 1997, STRUCTURE, V5, P701, DOI 10.1016/S0969-2126(97)00224-4; SZTUL ES, 1987, J CELL BIOL, V105, P2631, DOI 10.1083/jcb.105.6.2631; Taylor AB, 2001, STRUCTURE, V9, P615, DOI 10.1016/S0969-2126(01)00621-9; THORNTON K, 1993, J BIOL CHEM, V268, P19906; Trevino RJ, 1999, J BIOL CHEM, V274, P13938, DOI 10.1074/jbc.274.20.13938; VERNER K, 1993, TRENDS BIOCHEM SCI, V18, P366, DOI 10.1016/0968-0004(93)90090-A; WALTNER M, 1995, J BIOL CHEM, V270, P26311, DOI 10.1074/jbc.270.44.26311; Wang LY, 2000, BIOCHEM J, V351, P469, DOI 10.1042/0264-6021:3510469; Wang XP, 1998, J BACTERIOL, V180, P822, DOI 10.1128/JB.180.4.822-830.1998; Weaver T, 1998, J MOL BIOL, V280, P431, DOI 10.1006/jmbi.1998.1862; YAFFE MP, 1985, EMBO J, V4, P2069, DOI 10.1002/j.1460-2075.1985.tb03893.x	42	20	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					37266	37275		10.1074/jbc.M706594200	http://dx.doi.org/10.1074/jbc.M706594200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17959599	hybrid			2022-12-27	WOS:000251646000052
J	Guo, D; Sarkar, J; Suino-Powell, K; Xu, Y; Matsumoto, K; Jia, YZ; Yu, S; Khare, S; Haldar, K; Rao, MS; Foreman, JE; Monga, SPS; Peters, JM; Xu, HE; Reddy, JK				Guo, Dongsheng; Sarkar, Joy; Suino-Powell, Kelly; Xu, Yong; Matsumoto, Kojiro; Jia, Yuzhi; Yu, Songtao; Khare, Sonal; Haldar, Kasturi; Rao, M. Sambasiva; Foreman, Jennifer E.; Monga, Satdarshan P. S.; Peters, Jeffrey M.; Xu, H. Eric; Reddy, Janardan K.			Induction of nuclear translocation of constitutive androstane receptor by peroxisome proliferator-activated receptor alpha synthetic ligands in mouse liver	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COA HYDRATASE/3-HYDROXYACYL-COA DEHYDROGENASE; UNION-OF-PHARMACOLOGY; BETA-OXIDATION; PPAR-ALPHA; TRANSCRIPTIONAL REGULATION; STRUCTURAL DETERMINANTS; (PPAR)-BINDING PROTEIN; TARGETED DISRUPTION; GENE-EXPRESSION; X-RECEPTOR	Peroxisome proliferators activate nuclear receptor peroxisome proliferator-activated receptor alpha ( PPAR alpha) and enhance the transcription of several genes in liver. We report here that synthetic PPAR alpha ligands Wy-14,643, ciprofibrate, clofibrate, and others induce the nuclear translocation of constitutive androstane receptor (CAR) in mouse liver cells in vivo. Adeno-viral-enhanced green fluorescent protein-CAR expression demonstrated that PPAR alpha synthetic ligands drive CAR into the hepatocyte nucleus in a PPAR alpha- and PPAR beta-independent manner. This translocation is dependent on the transcription coactivator PPAR-binding protein but independent of coactivators PRIP and SRC-1. PPAR alpha ligand-induced nuclear translocation of CAR is not associated with induction of Cyp2b10 mRNA in mouse liver. PPAR alpha ligands interfered with coactivator recruitment to the CAR ligand binding domain and reduced the constitutive transactivation of CAR. Both Wy-14,643 and ciprofibrate occupied the ligand binding pocket of CAR and adapted a binding mode similar to that of the CAR inverse agonist androstenol. These observations, therefore, provide information for the first time to indicate that PPAR alpha ligands not only serve as PPAR alpha agonists but possibly act as CAR antagonists.	Northwestern Univ, Feinberg Sch Med, Dept Pathol, Chicago, IL 60611 USA; Van Andel Res Inst, Lab Struct Sci, Grand Rapids, MI 49503 USA; Penn State Univ, Dept Vet & Biomed Sci, Ctr Mol Toxicol & Carcinogenesis, University Pk, PA 16802 USA; Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15261 USA	Northwestern University; Feinberg School of Medicine; Van Andel Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Reddy, JK (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Pathol, 303 E Chicago Ave, Chicago, IL 60611 USA.	jkreddy@northwestern.edu	Xu, H. Eric/ABD-7487-2021; Haldar, Kasturi/C-6685-2014; Peters, Jeffrey/D-8847-2011; guo, Dongsheng/A-2196-2010	Monga, Satdarshan/0000-0002-8437-3378; Peters, Jeffrey/0000-0003-2782-2998; Xu, H. Eric/0000-0002-6829-8144; Khare, Sonal/0000-0002-4044-3581; Foreman, Jennifer/0000-0001-8480-1734	NATIONAL CANCER INSTITUTE [R01CA104578] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM023750, R37GM023750] Funding Source: NIH RePORTER; NCI NIH HHS [CA104578] Funding Source: Medline; NIGMS NIH HHS [GM23750] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bookout AL, 2006, CELL, V126, P789, DOI 10.1016/j.cell.2006.06.049; Chang TKH, 2006, DRUG METAB REV, V38, P51, DOI 10.1080/03602530600569828; CHU RY, 1995, P NATL ACAD SCI USA, V92, P11593, DOI 10.1073/pnas.92.25.11593; Columbano A, 2001, HEPATOLOGY, V34, P262, DOI 10.1053/jhep.2001.26172; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; DREYER C, 1992, CELL, V68, P879, DOI 10.1016/0092-8674(92)90031-7; Fan CY, 1996, J BIOL CHEM, V271, P24698, DOI 10.1074/jbc.271.40.24698; Fan CY, 1998, J BIOL CHEM, V273, P15639, DOI 10.1074/jbc.273.25.15639; Fondell JD, 1996, P NATL ACAD SCI USA, V93, P8329, DOI 10.1073/pnas.93.16.8329; Forman BM, 1998, NATURE, V395, P612, DOI 10.1038/26996; Guo DS, 2006, BIOCHEM BIOPH RES CO, V347, P485, DOI 10.1016/j.bbrc.2006.06.129; Halgren TA, 1999, J COMPUT CHEM, V20, P730, DOI 10.1002/(SICI)1096-987X(199905)20:7<730::AID-JCC8>3.0.CO;2-T; Hermanson O, 2002, TRENDS ENDOCRIN MET, V13, P55, DOI 10.1016/S1043-2760(01)00527-6; Honkakoski P, 1998, J BIOCHEM MOL TOXIC, V12, P3; Hosseinpour F, 2006, MOL PHARMACOL, V69, P1095, DOI 10.1124/mol.105.019505; Huang WD, 2005, MOL ENDOCRINOL, V19, P1646, DOI 10.1210/me.2004-0520; ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0; Jia YZ, 2005, P NATL ACAD SCI USA, V102, P12531, DOI 10.1073/pnas.0506000102; Jia YZ, 2004, J BIOL CHEM, V279, P24427, DOI 10.1074/jbc.M402391200; Kanno Y, 2007, BBA-MOL CELL RES, V1773, P934, DOI 10.1016/j.bbamcr.2007.03.020; Kassam A, 2000, J BIOL CHEM, V275, P4345, DOI 10.1074/jbc.275.6.4345; Kawamoto T, 1999, MOL CELL BIOL, V19, P6318; KLAYMAN DL, 1985, SCIENCE, V228, P1049, DOI 10.1126/science.3887571; KLIEWER SA, 1992, NATURE, V358, P771, DOI 10.1038/358771a0; Kobayashi K, 2003, MOL PHARMACOL, V64, P1069, DOI 10.1124/mol.64.5.1069; Koike C, 2005, FEBS LETT, V579, P6733, DOI 10.1016/j.febslet.2005.10.070; LEE SST, 1995, MOL CELL BIOL, V15, P3012; Lonard DM, 2006, CELL, V125, P411, DOI 10.1016/j.cell.2006.04.021; MANAUTOU JE, 1994, TOXICOL APPL PHARM, V129, P252, DOI 10.1006/taap.1994.1250; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; Michalik L, 2007, CELL, V129, P649, DOI 10.1016/j.cell.2007.05.001; Michalik L, 2006, PHARMACOL REV, V58, P726, DOI 10.1124/pr.58.4.5; Min GS, 2002, J BIOL CHEM, V277, P26356, DOI 10.1074/jbc.M200051200; Moore DD, 2006, PHARMACOL REV, V58, P742, DOI 10.1124/pr.58.4.6; Peters JM, 2005, J MOL MED-JMM, V83, P774, DOI 10.1007/s00109-005-0678-9; Peters JM, 2000, MOL CELL BIOL, V20, P5119, DOI 10.1128/MCB.20.14.5119-5128.2000; Qi C, 1999, P NATL ACAD SCI USA, V96, P1585, DOI 10.1073/pnas.96.4.1585; Rachez C, 1999, NATURE, V398, P824, DOI 10.1038/19783; Reddy JK, 2006, AD DEV BIOL, V16, P389, DOI 10.1016/S1574-3349(06)16012-3; REDDY JK, 1975, SCIENCE, V190, P787, DOI 10.1126/science.1198095; Reddy JK, 2004, AM J PATHOL, V164, P2305, DOI 10.1016/S0002-9440(10)63787-X; Reddy JK, 2001, ANNU REV NUTR, V21, P193, DOI 10.1146/annurev.nutr.21.1.193; REDDY JK, 1980, NATURE, V283, P397, DOI 10.1038/283397a0; REDDY JK, 1986, P NATL ACAD SCI USA, V83, P1747, DOI 10.1073/pnas.83.6.1747; Roeder RG, 2005, FEBS LETT, V579, P909, DOI 10.1016/j.febslet.2004.12.007; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; Ryu SJ, 1999, NATURE, V397, P446, DOI 10.1038/17141; Sarkar J, 2007, GENE EXPRESSION, V13, P255; Shan L, 2004, MOL CELL, V16, P907, DOI 10.1016/S1097-2765(04)00728-2; Simonsson USH, 2006, EUR J CLIN INVEST, V36, P647, DOI 10.1111/j.1365-2362.2006.01700.x; Spiegelman BM, 2004, CELL, V119, P157, DOI 10.1016/j.cell.2004.09.037; Suino K, 2004, MOL CELL, V16, P893, DOI 10.1016/j.molcel.2004.11.036; Swales K, 2004, MOL ENDOCRINOL, V18, P1589, DOI 10.1210/me.2003-0397; Thomas J, 2003, J BIOL CHEM, V278, P2403, DOI 10.1074/jbc.M209629200; Timsit YE, 2007, STEROIDS, V72, P231, DOI 10.1016/j.steroids.2006.12.006; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Tzameli I, 2000, MOL CELL BIOL, V20, P2951, DOI 10.1128/MCB.20.9.2951-2958.2000; Wei P, 2000, NATURE, V407, P920, DOI 10.1038/35038112; WRIGHT E, 2005, BIOCHEMISTRY-US, V46, P862; Xia J, 2005, J BIOL CHEM, V280, P7285, DOI 10.1074/jbc.M409696200; XIA J, 2007, IN PRESS ARCH BIOCH; Xu HE, 2001, P NATL ACAD SCI USA, V98, P13919, DOI 10.1073/pnas.241410198; Yamada H, 2000, BIOCHEM BIOPH RES CO, V277, P66, DOI 10.1006/bbrc.2000.3620; Yu ST, 2007, BBA-MOL CELL BIOL L, V1771, P936, DOI 10.1016/j.bbalip.2007.01.008; Zhang J, 2002, SCIENCE, V298, P422, DOI 10.1126/science.1073502; Zhu YJ, 1997, J BIOL CHEM, V272, P25500, DOI 10.1074/jbc.272.41.25500	66	31	33	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36766	36776		10.1074/jbc.M707183200	http://dx.doi.org/10.1074/jbc.M707183200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17962186	hybrid			2022-12-27	WOS:000251458300069
J	Choi, H; Aboulfatova, K; Pownall, HJ; Cook, R; Dong, JF				Choi, Hiuwan; Aboulfatova, Khatira; Pownall, Henry J.; Cook, Richard; Dong, Jing-fei			Shear-induced disulfide bond formation regulates adhesion activity of von Willebrand factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLATELET GLYCOPROTEIN IB; VONWILLEBRAND-FACTOR; ENDOTHELIAL-CELLS; ISOMERASE CATALYZES; VICINAL CYSTEINES; LINKED COMPLEXES; SELF-ASSOCIATION; VWF MULTIMERS; PROTEIN; VITRONECTIN	von Willebrand factor (VWF) is the largest multimeric adhesion ligand circulating in blood. Its adhesion activity is related to multimer size, with the ultra-large forms freshly released from the activated endothelial cells being most active, capable of spontaneously binding to platelets. In comparison, smaller plasma forms circulating in blood bind platelets only under high fluid shear stress or induced by modulators. The structure-function relationships that distinguish the two types of VWF multimers are not known. In this study, we demonstrate that some of the plasma VWF multimers contain surface-exposed free thiols. Physiological and pathological levels of shear stresses (50 and 100 dynes/cm(2)) promote the formation of disulfide bonds utilizing these free thiols. The shear-induced thiol-disulfide exchange increases VWF binding to platelets. The thiol-disulfide exchange involves some or all of nine cysteine residues (Cys(889), Cys(898), Cys(2448), Cys(2451), Cys(2490), Cys(2491), Cys(2453), Cys(2528), and Cys(2533)) in the D3 and C domains as determined by mass spectrometry of the tryptic VWF peptides. These results suggest that the thiol-disulfide state may serve as an important structural determinant of VWF adhesion activity and can be modified by fluid shear stress.	Baylor Coll Med, Dept Med, Thrombosis Res Sect, Houston, TX 77030 USA; Baylor Coll Med, Dept Med, Sect Atherosclerosis & Vasc Dis, Houston, TX 77030 USA; Baylor Coll Med, Dept Immunol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Dong, JF (corresponding author), Baylor Coll Med, Dept Med, Thrombosis Res Sect, BCM286,N1319,1 Baylor Plaza, Houston, TX 77030 USA.	jfdong@bcm.tmc.edu		Pownall, Henry/0000-0001-8412-506X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071895, R01HL030914] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL30914, HL71895] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Arya M, 2002, BLOOD, V99, P3971, DOI 10.1182/blood-2001-11-0060; BRAAKMAN I, 1991, J CELL BIOL, V114, P401, DOI 10.1083/jcb.114.3.401; Brouland JP, 1999, ARTERIOSCL THROM VAS, V19, P3055, DOI 10.1161/01.ATV.19.12.3055; Burgess JK, 2000, J BIOL CHEM, V275, P9758, DOI 10.1074/jbc.275.13.9758; Carugo O, 2003, PROTEIN ENG, V16, P637, DOI 10.1093/protein/gzg088; Chen VM, 2006, BIOCHEMISTRY-US, V45, P12020, DOI 10.1021/bi061271a; Chiarugi P, 2001, J BIOL CHEM, V276, P33478, DOI 10.1074/jbc.M102302200; DEBOER HC, 1993, J BIOL CHEM, V268, P1279; Dong JF, 2002, BLOOD, V100, P4033, DOI 10.1182/blood-2002-05-1401; Dong JF, 2001, BLOOD, V97, P162, DOI 10.1182/blood.V97.1.162; Essex DW, 1999, BIOCHEMISTRY-US, V38, P10398, DOI 10.1021/bi990694s; Ganderton T, 2007, J THROMB HAEMOST, V5, P204, DOI 10.1111/j.1538-7836.2006.02292.x; HESSEL B, 1984, THROMB RES, V35, P637, DOI 10.1016/0049-3848(84)90267-6; ISAACS NW, 1995, CURR OPIN STRUC BIOL, V5, P391, DOI 10.1016/0959-440X(95)80102-2; Katsumi A, 2000, J BIOL CHEM, V275, P25585, DOI 10.1074/jbc.M002654200; Keuren JFW, 2004, BLOOD, V103, P1741, DOI 10.1182/blood-2003-07-2267; LOSCALZO J, 1985, BIOCHEMISTRY-US, V24, P4468, DOI 10.1021/bi00337a031; MARTI T, 1987, BIOCHEMISTRY-US, V26, P8099, DOI 10.1021/bi00399a013; MAYADAS TN, 1992, P NATL ACAD SCI USA, V89, P3531, DOI 10.1073/pnas.89.8.3531; MAYADAS TN, 1989, J BIOL CHEM, V264, P13497; MCCRARY JK, 1995, ANN BIOMED ENG, V23, P787, DOI 10.1007/BF02584477; Milev Y, 1999, ARCH BIOCHEM BIOPHYS, V361, P120, DOI 10.1006/abbi.1998.0963; MOAKE JL, 1988, BLOOD, V71, P1366; Moake JL, 1998, J CLIN APHERESIS, V13, P126, DOI 10.1002/(SICI)1098-1101(1998)13:3<126::AID-JCA6>3.0.CO;2-U; MOAKE JL, 1986, J CLIN INVEST, V78, P1456, DOI 10.1172/JCI112736; OHMORI K, 1982, J CELL BIOL, V95, P632, DOI 10.1083/jcb.95.2.632; Purvis AR, 2007, P NATL ACAD SCI USA, V104, P15647, DOI 10.1073/pnas.0705175104; Sadler JE, 1998, ANNU REV BIOCHEM, V67, P395, DOI 10.1146/annurev.biochem.67.1.395; Savage B, 2002, P NATL ACAD SCI USA, V99, P425, DOI 10.1073/pnas.012459599; Schneppenheim R, 1996, P NATL ACAD SCI USA, V93, P3581, DOI 10.1073/pnas.93.8.3581; Shankaran H, 2003, BLOOD, V101, P2637, DOI 10.1182/blood-2002-05-1550; Siedlecki CA, 1996, BLOOD, V88, P2939, DOI 10.1182/blood.V88.8.2939.bloodjournal8882939; THORELL L, 1984, THROMB RES, V35, P431, DOI 10.1016/0049-3848(84)90235-4; TOMASINI BR, 1989, BIOCHEMISTRY-US, V28, P7617, DOI 10.1021/bi00445a017; TSAI HM, 1991, BRIT J HAEMATOL, V79, P239, DOI 10.1111/j.1365-2141.1991.tb04528.x; VERWEIJ CL, 1987, EMBO J, V6, P2885, DOI 10.1002/j.1460-2075.1987.tb02591.x; VOORBERG J, 1991, J CELL BIOL, V113, P195, DOI 10.1083/jcb.113.1.195; WAGNER DD, 1987, BLOOD, V69, P27; WAGNER DD, 1984, J CELL BIOL, V99, P2123, DOI 10.1083/jcb.99.6.2123; Wang SH, 2001, J CHROMATOGR A, V924, P345, DOI 10.1016/S0021-9673(01)00961-X; WISE RJ, 1988, CELL, V52, P229, DOI 10.1016/0092-8674(88)90511-9; Zhang JN, 2003, THROMB HAEMOSTASIS, V90, P672, DOI 10.1160/TH03-03-0145	42	88	88	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35604	35611		10.1074/jbc.M704047200	http://dx.doi.org/10.1074/jbc.M704047200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17925407	hybrid			2022-12-27	WOS:000251458100020
J	Pless, SA; Dibas, MI; Lester, HA; Lynch, JW				Pless, Stephan A.; Dibas, Mohammed I.; Lester, Henry A.; Lynch, Joseph W.			Conformational variability of the glycine receptor M2 domain in response to activation by different agonists	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; CHLORIDE CHANNEL; GATING MECHANISM; ION-CHANNEL; M2-M3 LOOP; OPEN STATE; PORE; BINDING; IDENTIFICATION; ACCESSIBILITY	Models describing the structural changes mediating Cys loop receptor activation generally give little attention to the possibility that different agonists may promote activation via distinct M2 pore-lining domain structural rearrangements. We investigated this question by comparing the effects of different ligands on the conformation of the external portion of the homomeric alpha 1 glycine receptor M2 domain. Conformational flexibility was assessed by tethering a rhodamine fluorophore to cysteines introduced at the 19' or 22' positions and monitoring fluorescence and current changes during channel activation. During glycine activation, fluorescence of the label attached to R19' C increased by similar to 20%, and the emission peak shifted to lower wavelengths, consistent with a more hydrophobic fluorophore environment. In contrast, ivermectin activated the receptors without producing a fluorescence change. Although taurine and beta-alanine were weak partial agonists at the alpha 1R19' C glycine receptor, they induced large fluorescence changes. Propofol, which drastically enhanced these currents, did not induce a glycine-like blue shift in the spectral emission peak. The inhibitors strychnine and picrotoxin elicited fluorescence and current changes as expected for a competitive antagonist and an open channel blocker, respectively. Glycine and taurine (or beta-alanine) also produced an increase and a decrease, respectively, in the fluorescence of a label attached to the nearby L22' C residue. Thus, results from two separate labeled residues support the conclusion that the glycine receptor M2 domain responds with distinct conformational changes to activation by different agonists.	Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia; CALTECH, Div Biol, Pasadena, CA 91125 USA	University of Queensland; California Institute of Technology	Lynch, JW (corresponding author), Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia.	j.lynch@uq.edu.au	Lynch, Joseph/C-8636-2009	Pless, Stephan/0000-0001-6654-114X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS011756] Funding Source: NIH RePORTER; NINDS NIH HHS [NS-11756] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AKABAS MH, 1994, NEURON, V13, P919, DOI 10.1016/0896-6273(94)90257-7; Chang YC, 2002, NAT NEUROSCI, V5, P1163, DOI 10.1038/nn926; Cymes GD, 2005, NATURE, V438, P975, DOI 10.1038/nature04293; Cymes GD, 2002, BIOCHEMISTRY-US, V41, P5548, DOI 10.1021/bi011864f; Dahan DS, 2004, P NATL ACAD SCI USA, V101, P10195, DOI 10.1073/pnas.0301885101; England PM, 1999, CELL, V96, P89, DOI 10.1016/S0092-8674(00)80962-9; Gandhi CS, 2005, TRENDS NEUROSCI, V28, P472, DOI 10.1016/j.tins.2005.07.005; Grosman C, 2000, NATURE, V403, P773, DOI 10.1038/35001586; Han NLR, 2004, J BIOL CHEM, V279, P19559, DOI 10.1074/jbc.M400548200; Hawthorne R, 2005, J BIOL CHEM, V280, P35836, DOI 10.1074/jbc.M506645200; Hawthorne R, 2006, J NEUROCHEM, V98, P395, DOI 10.1111/j.1471-4159.2006.03875.x; Hemmings HC, 2005, TRENDS PHARMACOL SCI, V26, P503, DOI 10.1016/j.tips.2005.08.006; Kondratskaya EL, 2005, NEUROPHARMACOLOGY, V49, P945, DOI 10.1016/j.neuropharm.2005.07.001; Kondratskaya EL, 2002, NEUROCHEM INT, V40, P647, DOI 10.1016/S0197-0186(01)00109-7; Law RJ, 2000, PROTEINS, V39, P47, DOI 10.1002/(SICI)1097-0134(20000401)39:1<47::AID-PROT5>3.0.CO;2-A; Lee WY, 2005, NATURE, V438, P243, DOI 10.1038/nature04156; Lewis TM, 2003, J PHYSIOL-LONDON, V549, P361, DOI 10.1113/jphysiol.2002.037796; Lobo IA, 2004, J BIOL CHEM, V279, P33919, DOI 10.1074/jbc.M313941200; Lynch JW, 1997, EMBO J, V16, P110, DOI 10.1093/emboj/16.1.110; Lynch JW, 2001, J NEUROSCI, V21, P2589, DOI 10.1523/JNEUROSCI.21-08-02589.2001; Lynch JW, 2004, PHYSIOL REV, V84, P1051, DOI 10.1152/physrev.00042.2003; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Muroi Y, 2006, BIOCHEMISTRY-US, V45, P7013, DOI 10.1021/bi060222v; O'Shea SM, 2004, J NEUROSCI, V24, P2322, DOI 10.1523/JNEUROSCI.4675-03.2004; Paas Y, 2005, P NATL ACAD SCI USA, V102, P15877, DOI 10.1073/pnas.0507599102; RAJENDRA S, 1995, NEURON, V14, P169, DOI 10.1016/0896-6273(95)90251-1; Shan Q, 2001, J BIOL CHEM, V276, P12556, DOI 10.1074/jbc.M011264200; UNWIN N, 1995, NATURE, V373, P37, DOI 10.1038/373037a0; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Webb TI, 2007, CURR PHARM DESIGN, V13, P2350; Wilson GG, 1998, NEURON, V20, P1269, DOI 10.1016/S0896-6273(00)80506-1	31	63	64	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					36057	36067		10.1074/jbc.M706468200	http://dx.doi.org/10.1074/jbc.M706468200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17911099	Green Accepted, Green Published, hybrid			2022-12-27	WOS:000251458100065
J	Tozawa, Y; Nozawa, A; Kanno, T; Narisawa, T; Masuda, S; Kasai, K; Nanamiya, H				Tozawa, Yuzuru; Nozawa, Akira; Kanno, Takuya; Narisawa, Takakuni; Masuda, Shinji; Kasai, Koji; Nanamiya, Hideaki			Calcium-activated (p)ppGpp synthetase in chloroplasts of land plants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPOT-DEPENDENT ACCUMULATION; PROTEIN-SYNTHESIS SYSTEM; STRUCTURAL BASIS; BACTERIAL; IDENTIFICATION; BINDING; PPGPP; RELA; ARABIDOPSIS; CALMODULIN	The genetic system of chloroplasts, including the machinery for transcription, translation, and DNA replication, exhibits substantial similarity to that of eubacteria. Chloroplasts are also thought to possess a system for generating guanosine 5 '-triphosphate ((p) ppGpp), which triggers the stringent response in eubacteria, with genes encoding chloroplastic (p) ppGpp synthetase having been identified. We now describe the identification and characterization of genes (OsCRSH1, OsCRSH2, and OsCRSH3) for a novel type of ( p) ppGpp synthetase in rice. The proteins encoded by these genes contain a putative chloroplast transit peptide at the NH2 terminus, a central RelA-SpoT-like domain, and two EF-hand motifs at the COOH terminus. The recombinant OsCRSH1 protein was imported into chloroplasts in vitro, and genetic complementation analysis revealed that expression of OsCRSH1 suppressed the phenotype of an Escherichia coli mutant deficient in the RelA and SpoT enzymes. Biochemical analysis showed that the OsCRSH proteins possess (p)ppGpp synthetase activity that is dependent both on Ca2+ and on the EF-hand motifs. A data base search identified a CRSH homolog in the dicotyledon Arabidopsis thaliana, indicating that such genes are conserved among both monocotyledonous and dicotyledonous land plants. CRSH proteins thus likely function as Ca2+-activated (p)ppGpp synthetases in plant chloroplasts, implicating both Ca2+ and (p)ppGpp signaling in regulation of the genetic system of these organelles.	Ehime Univ, Grad Sch Sci & Engn, Cell Free Sci & Technol Res Ctr, Matsuyama, Ehime 8908577, Japan; Ehime Univ, Grad Sch Sci & Engn, Dept Appl Chem, Matsuyama, Ehime 8908577, Japan; Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Biol Sci, Yokohama, Kanagawa 2268501, Japan; Univ Tokyo, Biotechnol Res Ctr, Tokyo 1138657, Japan	Ehime University; Ehime University; Tokyo Institute of Technology; University of Tokyo	Tozawa, Y (corresponding author), Ehime Univ, Grad Sch Sci & Engn, Cell Free Sci & Technol Res Ctr, 3 Bunkyo Cho, Matsuyama, Ehime 8908577, Japan.	tozaway@ccr.ehime-u.ac.jp	Tozawa, Yuzuru/G-2657-2013; Tozawa, Yuzuru/AAM-9620-2020; Masuda, Shinji/A-2703-2014	Tozawa, Yuzuru/0000-0002-3885-1105; Masuda, Shinji/0000-0002-5349-4927; Nozawa, Akira/0000-0003-4886-0213				Artsimovitch I, 2004, CELL, V117, P299, DOI 10.1016/S0092-8674(04)00401-5; Battesti A, 2006, MOL MICROBIOL, V62, P1048, DOI 10.1111/j.1365-2958.2006.05442.x; Braeken K, 2006, TRENDS MICROBIOL, V14, P45, DOI 10.1016/j.tim.2005.11.006; Cashel M., 1996, ESCHERICHIA COLI SAL, P1458; Day IS, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-10-research0056; Ettinger WF, 1999, PLANT PHYSIOL, V119, P1379, DOI 10.1104/pp.119.4.1379; GHANOTAKIS DF, 1984, FEBS LETT, V167, P127, DOI 10.1016/0014-5793(84)80846-7; Givens RM, 2004, J BIOL CHEM, V279, P7495, DOI 10.1074/jbc.M311573200; GOGFREY HP, 2002, TRENDS MICROBIOL, V10, P349; Grabarek Z, 2006, J MOL BIOL, V359, P509, DOI 10.1016/j.jmb.2006.03.066; Hou ZL, 1999, J BIOL CHEM, V274, P17505, DOI 10.1074/jbc.274.25.17505; HUANG LQ, 1993, P NATL ACAD SCI USA, V90, P10066, DOI 10.1073/pnas.90.21.10066; JARRETT HW, 1982, J BIOL CHEM, V257, P13795; JOHNSON CH, 1995, SCIENCE, V269, P1863, DOI 10.1126/science.7569925; Kanno T, 2005, PLANT PHYSIOL, V138, P2260, DOI 10.1104/pp.105.062885; Kanno T, 2007, PROTEIN EXPRES PURIF, V52, P59, DOI 10.1016/j.pep.2006.09.007; Kasai K, 2005, PLANTA, V222, P438, DOI 10.1007/s00425-005-1559-8; Kasai K, 2004, NUCLEIC ACIDS RES, V32, P5732, DOI 10.1093/nar/gkh916; Kasai K, 2002, NUCLEIC ACIDS RES, V30, P4985, DOI 10.1093/nar/gkf628; Madin K, 2000, P NATL ACAD SCI USA, V97, P559, DOI 10.1073/pnas.97.2.559; Magnusson LU, 2005, TRENDS MICROBIOL, V13, P236, DOI 10.1016/j.tim.2005.03.008; MANIATIS T, 1982, MOL CLONING LAB MAN; McCormack E, 2005, TRENDS PLANT SCI, V10, P383, DOI 10.1016/j.tplants.2005.07.001; Milon P, 2006, P NATL ACAD SCI USA, V103, P13962, DOI 10.1073/pnas.0606384103; Mittenhuber G, 2001, J MOL MICROB BIOTECH, V3, P585; Osawa M, 2005, J BIOL CHEM, V280, P18008, DOI 10.1074/jbc.M500338200; Reddy ASN, 2001, PLANT SCI, V160, P381, DOI 10.1016/S0168-9452(00)00386-1; Sai JQ, 2002, PLANT CELL, V14, P1279, DOI 10.1105/tpc.000653; Sanders D, 2002, PLANT CELL, V14, pS401, DOI 10.1105/tpc.002899; Sawasaki T, 2002, P NATL ACAD SCI USA, V99, P14652, DOI 10.1073/pnas.232580399; SEYFZADEH M, 1993, P NATL ACAD SCI USA, V90, P11004, DOI 10.1073/pnas.90.23.11004; Takahashi K, 2004, P NATL ACAD SCI USA, V101, P4320, DOI 10.1073/pnas.0308555101; Tozawa Y, 1998, NUCLEIC ACIDS RES, V26, P415, DOI 10.1093/nar/26.2.415; Turner WL, 2004, PLANT PHYSIOL, V135, P1243, DOI 10.1104/pp.104.040428; van der Biezen EA, 2000, P NATL ACAD SCI USA, V97, P3747, DOI 10.1073/pnas.060392397; Vinella D, 2005, MOL MICROBIOL, V56, P958, DOI 10.1111/j.1365-2958.2005.04601.x; Wang JD, 2007, CELL, V128, P865, DOI 10.1016/j.cell.2006.12.043; Wendrich TM, 2002, MOL CELL, V10, P779, DOI 10.1016/S1097-2765(02)00656-1; WOLOSIUK RA, 1993, FASEB J, V7, P622, DOI 10.1096/fasebj.7.8.8500687; XIAO H, 1991, J BIOL CHEM, V266, P5980	40	54	60	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35536	35545		10.1074/jbc.M703820200	http://dx.doi.org/10.1074/jbc.M703820200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17938177	hybrid			2022-12-27	WOS:000251458100013
J	Arokium, H; Ouerfelli, H; Velours, G; Camougrand, N; Vallette, FM; Manon, S				Arokium, Hubert; Ouerfelli, Hakim; Velours, Gisele; Camougrand, Nadine; Vallette, Francois M.; Manon, Stephen			Substitutions of potentially phosphorylatable serine residues of Bax reveal how they may regulate its interaction with mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C RELEASE; OUTER-MEMBRANE; DEPENDENT DEGRADATION; PROAPOPTOTIC FUNCTION; TERMINAL DOMAIN; ALPHA-HELIX; BCL-2; APOPTOSIS; PROTEIN; LOCALIZATION	During apoptosis, the pro-apoptotic protein Bax relocalizes from the cytosol to the mitochondrial outer membrane. This relocalization is associated to major conformational changes, namely at the N- and C- terminal ends of the protein. Substitution of residues located at critical positions within the protein potentially stimulates or inhibits this process. In the present study, we investigated the hypothesis that phosphorylation of serine residues might trigger these conformational changes, with a focus on Ser(163) and Ser(184), which have been shown to be phosphorylatable by protein kinases GSK3 beta and Akt/PKB, respectively, and on Ser(60), which is located in a consensus target sequence for PKA. Substitutions of these serine residues by alanine or aspartate were done in wild type or previously characterized Bax mutants, and the capacity of the resulting proteins to interact with mitochondria and to release cytochrome c was assayed in yeast, which provides a tool to study the function of Bax, independently of the rest of the apoptotic network. We conclude that sequential phosphorylation of these serine residues might participate in the triggering of the different conformational changes associated with Bax activation during apoptosis.	Univ Bordeaux 2, CNRS, UMR5095, F-33077 Bordeaux, France; Univ Nantes, INSERM, U601, F-44035 Nantes, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite	Manon, S (corresponding author), Univ Bordeaux 2, CNRS, UMR5095, 1 Rue Camille St Saens, F-33077 Bordeaux, France.	stephen.manon@ibgc.cnrs.fr	Manon, Stéphen/C-7088-2017; Vallette, Francois M/K-9047-2015; Vallette, Francois/N-2361-2018	Vallette, Francois M/0000-0002-3296-8572; Vallette, Francois/0000-0003-0802-0519; Manon, Stephen/0000-0002-5792-1084				Adams JM, 2001, TRENDS BIOCHEM SCI, V26, P61, DOI 10.1016/S0968-0004(00)01740-0; Annis MG, 2005, EMBO J, V24, P2096, DOI 10.1038/sj.emboj.7600675; Antonsson B, 2001, J BIOL CHEM, V276, P11615, DOI 10.1074/jbc.M010810200; Arokium H, 2004, J BIOL CHEM, V279, P52566, DOI 10.1074/jbc.M408373200; Bellot G, 2007, CELL DEATH DIFFER, V14, P785, DOI 10.1038/sj.cdd.4402055; Brichese L, 2004, CELL CYCLE, V3, P1312, DOI 10.4161/cc.3.10.1166; Brichese L, 2002, EXP CELL RES, V278, P101, DOI 10.1006/excr.2002.5563; Cartron PF, 2003, J BIOL CHEM, V278, P11633, DOI 10.1074/jbc.M208955200; Cartron PF, 2002, FEBS LETT, V512, P95, DOI 10.1016/S0014-5793(02)02227-5; Cartron PF, 2004, MOL CELL, V16, P807, DOI 10.1016/j.molcel.2004.10.028; Cartron PF, 2005, J BIOL CHEM, V280, P10587, DOI 10.1074/jbc.M409714200; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Dejean LM, 2006, CELL DEATH DIFFER, V13, P1387, DOI 10.1038/sj.cdd.4401949; Dejean LM, 2005, MOL BIOL CELL, V16, P2424, DOI 10.1091/mbc.E04-12-1111; Dimmeler S, 1999, J EXP MED, V189, P1815, DOI 10.1084/jem.189.11.1815; Garcia-Saez AJ, 2004, BIOCHEMISTRY-US, V43, P10930, DOI 10.1021/bi036044c; Gardai SJ, 2004, J BIOL CHEM, V279, P21085, DOI 10.1074/jbc.M400063200; Goping IS, 1998, J CELL BIOL, V143, P207, DOI 10.1083/jcb.143.1.207; Guihard G, 2004, J BIOL CHEM, V279, P46542, DOI 10.1074/jbc.M405153200; Heimlich G, 2004, BIOCHEM J, V378, P247, DOI 10.1042/BJ20031152; JANIAK F, 1994, J BIOL CHEM, V269, P9842; Kissova I, 2006, J BIOL CHEM, V281, P36187, DOI 10.1074/jbc.M607444200; Lalier L, 2007, APOPTOSIS, V12, P887, DOI 10.1007/s10495-007-0749-1; Linseman DA, 2004, J NEUROSCI, V24, P9993, DOI 10.1523/JNEUROSCI.2057-04.2004; Madeo F, 2004, CURR OPIN MICROBIOL, V7, P655, DOI 10.1016/j.mib.2004.10.012; Makin GWJ, 2001, EMBO J, V20, P6306, DOI 10.1093/emboj/20.22.6306; Mancinelli F, 2006, J CELL BIOCHEM, V99, P305, DOI 10.1002/jcb.20893; Martinez-Senac MD, 2001, BIOCHEMISTRY-US, V40, P9983; Martinou JC, 2001, NAT REV MOL CELL BIO, V2, P63, DOI 10.1038/35048069; Marzo I, 1998, SCIENCE, V281, P2027, DOI 10.1126/science.281.5385.2027; Motz C, 2002, J MOL BIOL, V323, P729, DOI 10.1016/S0022-2836(02)00995-6; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Nechushtan A, 1999, EMBO J, V18, P2330, DOI 10.1093/emboj/18.9.2330; NGUYEN M, 1993, J BIOL CHEM, V268, P25265; Nomura M, 2003, J BIOL CHEM, V278, P2058, DOI 10.1074/jbc.M207880200; Oliver L, 2000, FEBS LETT, V487, P161, DOI 10.1016/S0014-5793(00)02330-9; Pavlov EV, 2001, J CELL BIOL, V155, P725, DOI 10.1083/jcb.200107057; Peyerl FW, 2007, CELL DEATH DIFFER, V14, P447, DOI 10.1038/sj.cdd.4402025; Pinson B, 1996, EUR J BIOCHEM, V239, P439, DOI 10.1111/j.1432-1033.1996.0439u.x; Poruchynsky MS, 1998, CANCER RES, V58, P3331; Priault M, 1999, FEBS LETT, V443, P225, DOI 10.1016/S0014-5793(98)01661-5; Priault M, 2003, CELL DEATH DIFFER, V10, P1068, DOI 10.1038/sj.cdd.4401270; Schendel SL, 1998, CELL DEATH DIFFER, V5, P372, DOI 10.1038/sj.cdd.4400365; Schinzel A, 2004, J CELL BIOL, V164, P1021, DOI 10.1083/jcb.200309013; Setoguchi K, 2006, EMBO J, V25, P5635, DOI 10.1038/sj.emboj.7601438; Sharpe JC, 2004, BBA-MOL CELL RES, V1644, P107, DOI 10.1016/j.bbamcr.2003.10.016; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; Tremblais K, 1999, BIOCHEM BIOPH RES CO, V260, P582, DOI 10.1006/bbrc.1999.0904; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Xin MG, 2006, J BIOL CHEM, V281, P18859, DOI 10.1074/jbc.M512543200; Xin MG, 2005, J BIOL CHEM, V280, P10781, DOI 10.1074/jbc.M500084200; Yamaguchi H, 2001, ONCOGENE, V20, P7779, DOI 10.1038/sj.onc.1204984	54	49	49	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					35104	35112		10.1074/jbc.M704891200	http://dx.doi.org/10.1074/jbc.M704891200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17911107	hybrid			2022-12-27	WOS:000251155200055
J	Mallette, FA; Gaumont-Leclerc, MF; Huot, G; Ferbeyre, G				Mallette, Frederick A.; Gaumont-Leclerc, Marie-France; Huot, Genevieve; Ferbeyre, Gerardo			Myc down-regulation as a mechanism to activate the Rb pathway in STAT5A-induced senescence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ONCOGENE-INDUCED SENESCENCE; C-MYC; MAMMARY-GLAND; IN-VIVO; SIGNAL TRANSDUCER; PROTEIN STABILITY; NULL FIBROBLASTS; MESSENGER-RNA; PML; STAT5	Senescence is a general antiproliferative program that avoids the expansion of cells bearing oncogenic mutations. We found that constitutively active STAT5A (ca-STAT5A) can induce a p53- and Rb-dependent cellular senescence response. However, ca-STAT5A did not induce p21 and p16(INK4a), which are responsible for inhibiting cyclin-dependent protein kinases and engaging the Rb pathway during the senescence response to oncogenic ras. Intriguingly, ca-STAT5A led to a down-regulation of Myc and Myc targets, including CDK4, a negative regulator of Rb. The down-regulation of Myc was in part proteasome-dependent and correlated with its localization to promyelocytic leukemia bodies, which were found to be highly abundant during STAT5-induced senescence. Introduction of CDK4 or Myc bypassed STAT5A-induced senescence in cells in which p53 was also inactivated. These results uncover a novel mechanism to engage the Rb pathway in oncogene-induced senescence and indicate the existence of oncogene-specific pathways that regulate senescence.	Univ Montreal, Dept Biochim, Montreal, PQ H3C 3J7, Canada	Universite de Montreal	Ferbeyre, G (corresponding author), Univ Montreal, Dept Biochim, E-515,CP 6128,Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.	g.ferbeyre@umontreal.ca	Mallette, Frédérick A./J-6646-2019; Ferbeyre, Gerardo/A-1569-2010	Mallette, Frédérick A./0000-0001-7932-0338; 				Barash I, 2006, J CELL PHYSIOL, V209, P305, DOI 10.1002/jcp.20771; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; BENTLEY DL, 1986, NATURE, V321, P702, DOI 10.1038/321702a0; Berns K, 2000, ONCOGENE, V19, P3330, DOI 10.1038/sj.onc.1203639; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Buck A, 2006, MOL CANCER RES, V4, P861, DOI 10.1158/1541-7786.MCR-06-0081; Buschbeck M, 2007, ONCOGENE, V26, P3415, DOI 10.1038/sj.onc.1210128; Cairo S, 2005, ONCOGENE, V24, P2195, DOI 10.1038/sj.onc.1208338; Cobrinik D, 2005, ONCOGENE, V24, P2796, DOI 10.1038/sj.onc.1208619; Cotarla I, 2004, INT J CANCER, V108, P665, DOI 10.1002/ijc.11619; DANI C, 1985, P NATL ACAD SCI USA, V82, P4896, DOI 10.1073/pnas.82.15.4896; de Stanchina E, 2004, MOL CELL, V13, P523, DOI 10.1016/S1097-2765(04)00062-0; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Fabunmi RP, 2001, J CELL SCI, V114, P29; Ferbeyre G, 2000, GENE DEV, V14, P2015; Fulop T, 2006, MECH AGEING DEV, V127, P526, DOI 10.1016/j.mad.2006.01.025; Gil J, 2005, CANCER RES, V65, P2179, DOI 10.1158/0008-5472.CAN-03-4030; Guney I, 2006, P NATL ACAD SCI USA, V103, P3645, DOI 10.1073/pnas.0600069103; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hermeking H, 2000, P NATL ACAD SCI USA, V97, P2229, DOI 10.1073/pnas.050586197; HIEBERT SW, 1989, P NATL ACAD SCI USA, V86, P3594, DOI 10.1073/pnas.86.10.3594; Huot TJ, 2002, MOL CELL BIOL, V22, P8135, DOI 10.1128/MCB.22.23.8135-8143.2002; JONES TR, 1987, MOL CELL BIOL, V7, P4513, DOI 10.1128/MCB.7.12.4513; Kato Y, 2005, J EXP MED, V202, P169, DOI 10.1084/jem.20042541; LAVAU C, 1995, ONCOGENE, V11, P871; LAW JC, 1993, LEUKEMIA RES, V17, P1045, DOI 10.1016/0145-2126(93)90161-D; Lawlor ER, 2006, CANCER RES, V66, P4591, DOI 10.1158/0008-5472.CAN-05-3826; Li HZ, 2004, CANCER RES, V64, P4774, DOI 10.1158/0008-5472.CAN-03-3499; Liu XW, 1997, GENE DEV, V11, P179, DOI 10.1101/gad.11.2.179; Lord JD, 2000, J IMMUNOL, V164, P2533, DOI 10.4049/jimmunol.164.5.2533; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; Mallette FA, 2004, ONCOGENE, V23, P91, DOI 10.1038/sj.onc.1206886; Mallette FA, 2007, GENE DEV, V21, P43, DOI 10.1101/gad.1487307; Malumbres M, 2000, MOL CELL BIOL, V20, P2915, DOI 10.1128/MCB.20.8.2915-2925.2000; Moriggl R, 2005, CANCER CELL, V7, P87, DOI 10.1016/j.ccr.2004.12.010; Muller H, 2001, GENE DEV, V15, P267, DOI 10.1101/gad.864201; Nevalainen MT, 2004, J CLIN ONCOL, V22, P2053, DOI 10.1200/JCO.2004.11.046; Onishi M, 1998, MOL CELL BIOL, V18, P3871, DOI 10.1128/MCB.18.7.3871; OTSUKI T, 1995, CANCER RES, V55, P1436; Ren SX, 2002, ONCOGENE, V21, P4335, DOI 10.1038/sj.onc.1205484; RUSTGI AK, 1991, NATURE, V352, P541, DOI 10.1038/352541a0; Sarkisian CJ, 2007, NAT CELL BIOL, V9, P493, DOI 10.1038/ncb1567; SCHWAB M, 1990, Critical Reviews in Oncogenesis, V2, P35; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Sears R, 1999, MOL CELL, V3, P169, DOI 10.1016/S1097-2765(00)80308-1; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sillaber C, 2000, BLOOD, V95, P2118, DOI 10.1182/blood.V95.6.2118; Smith KP, 2004, J CELL BIOCHEM, V93, P1282, DOI 10.1002/jcb.20273; Staller P, 2001, NAT CELL BIOL, V3, P392, DOI 10.1038/35070076; WAKAO H, 1994, EMBO J, V13, P2182, DOI 10.1002/j.1460-2075.1994.tb06495.x; Weniger MA, 2006, ONCOGENE, V25, P2679, DOI 10.1038/sj.onc.1209151; Wu CH, 2007, P NATL ACAD SCI USA, V104, P13028, DOI 10.1073/pnas.0701953104; Xi SC, 2003, CANCER RES, V63, P6763; Xi SC, 2003, J BIOL CHEM, V278, P31574, DOI 10.1074/jbc.M303499200; Yamashita Hiroko, 2002, Breast Cancer, V9, P312, DOI 10.1007/BF02967610; Yang HS, 2003, MOL CELL, V11, P1163, DOI 10.1016/S1097-2765(03)00135-7	56	38	38	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					34938	34944		10.1074/jbc.M707074200	http://dx.doi.org/10.1074/jbc.M707074200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17913706	hybrid			2022-12-27	WOS:000251155200037
J	Oh, H; Ozkirimli, E; Shah, K; Harrison, ML; Geahlen, RL				Oh, Hyunju; Ozkirimli, Elif; Shah, Kavita; Harrison, Marietta L.; Geahlen, Robert L.			Generation of an analog-sensitive syk tyrosine kinase for the study of signaling dynamics from the B cell antigen receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; ACTIVATION; LYMPHOMA; CA2+; ENGAGEMENT; INHIBITORS; KINETICS; LOOP; LYN	The Syk protein-tyrosine kinase is an essential component of the signaling machinery that couples the B cell receptor for antigen to multiple downstream signal transduction pathways. Syk is phosphorylated and activated rapidly and transiently following receptor engagement, but many signaling events, such as the activation of transcription factors occur over the course of several minutes or hours. To investigate a role for the continued activation of Syk in these processes, we generated an analog-sensitive mutant with an engineered ATP-binding pocket to render the kinase uniquely sensitive to an orthogonal inhibitor. Mutation of the gatekeeper residue in Syk yielded an enzyme with very low activity. Second-site mutations, selected based on structural comparisons between Syk and Src, were introduced that restored catalytic activity to the mutant Syk. Syk-deficient DT40 B cells were prepared expressing the analog-sensitive Syk (Syk-AQL). Inhibition of the activity of Syk prior to, concomitant with or shortly following receptor engagement led to the rapid inhibition of receptor-mediated tyrosine phosphorylation and blocked the activation of extracellular signal-regulated kinase, NF-kappa B, and NFAT. The receptor-mediated activation of NF-kappa B required active Syk for a relatively short period of time, whereas the activation of NFAT required active kinase for a prolonged (> 1 h) period. Receptor cross-linking led to the recruitment of Syk to the clustered receptor. Retention of these receptor-kinase complexes on the cell surface was dependent on the continued activity of Syk. Thus, despite the apparent transient nature of the activation of Syk, the catalytic activity of the Syk was required for sustained signaling from ligated receptors.	Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA; Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA; Purdue Univ, Purdue Canc Ctr, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Geahlen, RL (corresponding author), Purdue Univ, Dept Med Chem & Mol Pharmacol, Hansen Life Sci Res Bldg,201 S Univ St, W Lafayette, IN 47907 USA.	geahlen@purdue.edu	Shah, Kavita/Y-9755-2019; Ozkirimli, Elif/Q-1586-2015	Shah, Kavita/0000-0002-0451-1305; Ozkirimli, Elif/0000-0002-3206-8427; Geahlen, Robert/0000-0001-8400-2924	NCI NIH HHS [CA37372] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA037372] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Atwell S, 2004, J BIOL CHEM, V279, P55827, DOI 10.1074/jbc.M409792200; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Bishop AC, 1998, CURR BIOL, V8, P257, DOI 10.1016/S0960-9822(98)70198-8; Bishop AC, 1999, J AM CHEM SOC, V121, P627, DOI 10.1021/ja983267v; DeLano W.L, PYMOL MOL GRAPHICS S; Dolmetsch RE, 1997, NATURE, V388, P308, DOI 10.1038/40912; Donahue AC, 2003, J IMMUNOL, V170, P5851, DOI 10.4049/jimmunol.170.12.5851; Fluckiger AC, 1998, EMBO J, V17, P1973, DOI 10.1093/emboj/17.7.1973; Gauld SB, 2005, NAT IMMUNOL, V6, P1160, DOI 10.1038/ni1256; Gururajan M, 2006, J IMMUNOL, V176, P5715, DOI 10.4049/jimmunol.176.10.5715; Hou P, 2006, PLOS BIOL, V4, P1147, DOI 10.1371/journal.pbio.0040200; Irish JM, 2006, BLOOD, V108, P3135, DOI 10.1182/blood-2006-02-003921; Irish JM, 2006, J IMMUNOL, V177, P1581, DOI 10.4049/jimmunol.177.3.1581; Ma H, 2001, J IMMUNOL, V166, P1507, DOI 10.4049/jimmunol.166.3.1507; PAGE DM, 1990, MOL CELL BIOL, V10, P3003, DOI 10.1128/MCB.10.6.3003; Rolli V, 2002, MOL CELL, V10, P1057, DOI 10.1016/S1097-2765(02)00739-6; SAOUAF SJ, 1994, P NATL ACAD SCI USA, V91, P9524, DOI 10.1073/pnas.91.20.9524; Singh DK, 2005, CELL, V121, P281, DOI 10.1016/j.cell.2005.02.036; Skaggs B.J., 2004, SIGNAL TRANSDUCT, V4, P173; TAKATA M, 1994, EMBO J, V13, P1341, DOI 10.1002/j.1460-2075.1994.tb06387.x; Yamaguchi H, 1996, NATURE, V384, P484, DOI 10.1038/384484a0; Zhang C, 2005, NAT METHODS, V2, P435, DOI 10.1038/NMETH764	22	21	23	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2007	282	46					33760	33768		10.1074/jbc.M704846200	http://dx.doi.org/10.1074/jbc.M704846200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	229XP	17913708	hybrid			2022-12-27	WOS:000250840200058
J	Jin, W; Yun, C; Jeong, J; Park, Y; Lee, HD; Kim, SJ				Jin, Wook; Yun, Chohee; Jeong, Joon; Park, Yangho; Lee, Hy-De; Kim, Seong-Jin			c-Src is required for tropomyosin receptor kinase C (TrkC)-induced activation of the phosphatidylinositol 3-kinase (PI3K)-AKT pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; SIGNAL-TRANSDUCTION; NEUROTROPHIN RECEPTORS; INSULIN-RECEPTOR; PERINEURAL INVASION; TRK RECEPTORS; EXPRESSION; CELL; FAMILY; SURVIVAL	TrkC mediates many aspects of growth and development in the central nervous system. TrkC is expressed in a variety of non-neuronal tissues as well as human cancers. TrkC overexpression may drive tumorigenesis, invasion, and metastatic capability in cancer cells. However, relatively little is known about whether TrkC activity is also essential to maintain the malignant properties in human tumors. TrkC expression leads to the constitutive activation of two major effector pathways, namely the Ras-MAP kinase ( MAPK) mitogenic pathway and the phosphatidylinositol 3-kinase (PI3K)-AKT pathway mediating cell survival. However, it remains unclear how TrkC activates Ras-Erk1/2 and/or PI3K-Akt cascades. Here we define some aspects of the molecular mechanisms regulating TrkC-dependent Ras-Erk1/2 and PI3K/Akt activation. We show that endogenous TrkC associated with c-Src in human and mouse cancer cells which express TrkC. TrkC-c-Src complexes were also detected in primary human breast cancer tissues. Suppression of c-Src by RNA interference in highly metastatic 4T1 mammary cancer cells, which express endogenous TrkC, resulted in markedly decreased expression of cyclin D1 and suppression of activation of Ras-Erk1/2 and PI3K-Akt. Moreover, inhibition of c-Src expression almost completely blocks colony formation of 4T1 cells in soft agar. Furthermore, in c-Src-deficient SYF cells, TrkC failed to activate the PI3K-Atk pathway, but not the Ras-Erk1/2 pathway. Therefore these data indicate that TrkC induces the PI3K-Akt cascade through the activation of c-Src.	[Jin, Wook; Kim, Seong-Jin] Gachon Univ Med & Sci, Lee Gil Ya Canc & Diabet Inst, Lab Cell Regulat & Carcinogenesis, Inchon 406840, South Korea; [Yun, Chohee; Kim, Seong-Jin] Case Western Reserve Univ, Ireland Canc Ctr, Dept Pediat, Cleveland, OH 44106 USA; [Jeong, Joon; Lee, Hy-De] Yonsei Univ, Yongdong Severance Hosp, Seoul 135720, South Korea; [Park, Yangho] BRM Inst, Seoul 135822, South Korea	Gachon University; Case Western Reserve University; Yonsei University	Kim, SJ (corresponding author), Gachon Univ Med & Sci, Lee Gil Ya Canc & Diabet Inst, Lab Cell Regulat & Carcinogenesis, Inchon 406840, South Korea.	jasonsjkim@gachon.ac.kr	, 정준/I-2133-2019	, 정준/0000-0003-0397-0005				ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Astolfi A, 2001, EUR J CANCER, V37, P1719, DOI 10.1016/S0959-8049(01)00190-3; BARBACID M, 1995, CURR OPIN CELL BIOL, V7, P148, DOI 10.1016/0955-0674(95)80022-0; Bates RC, 2000, CRIT REV ONCOL HEMAT, V36, P61, DOI 10.1016/S1040-8428(00)00077-9; BELLACOSA A, 1995, INT J CANCER, V64, P280, DOI 10.1002/ijc.2910640412; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Blake RA, 2000, MOL CELL BIOL, V20, P9018, DOI 10.1128/MCB.20.23.9018-9027.2000; Bonfini L, 1996, TRENDS BIOCHEM SCI, V21, P257, DOI 10.1016/S0968-0004(96)10033-5; BOTHWELL M, 1995, ANNU REV NEUROSCI, V18, P223, DOI 10.1146/annurev.neuro.18.1.223; Brodeur GM, 1997, J NEURO-ONCOL, V31, P49, DOI 10.1023/A:1005729329526; Brown MT, 1996, BBA-REV CANCER, V1287, P121, DOI 10.1016/0304-419X(96)00003-0; Chao MV, 2002, NEURON, V33, P9, DOI 10.1016/S0896-6273(01)00573-6; Chen-Tsai CP, 2004, DERMATOL SURG, V30, P1009, DOI 10.1111/j.1524-4725.2004.30306.x; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; Descamps S, 2001, J BIOL CHEM, V276, P17864, DOI 10.1074/jbc.M010499200; Dixon SJ, 2006, BBA-MOL CELL RES, V1763, P366, DOI 10.1016/j.bbamcr.2006.02.009; Downward J, 1996, CANCER SURV, V27, P87; Eggert A, 2000, MED PEDIATR ONCOL, V35, P569, DOI 10.1002/1096-911X(20001201)35:6<569::AID-MPO16>3.0.CO;2-A; Encinas M, 1999, J NEUROCHEM, V73, P1409, DOI 10.1046/j.1471-4159.1999.0731409.x; Funakoshi-Tago M, 2005, J BIOCHEM, V137, P189, DOI 10.1093/jb/mvi018; Goi T, 2000, EMBO J, V19, P623, DOI 10.1093/emboj/19.4.623; Grotzer MA, 2000, J CLIN ONCOL, V18, P1027, DOI 10.1200/JCO.2000.18.5.1027; Guate JL, 1999, BJU INT, V84, P495; Gunther S, 2007, CANCER LETT, V250, P25, DOI 10.1016/j.canlet.2006.09.014; GUITON M, 1995, J BIOL CHEM, V270, P20384, DOI 10.1074/jbc.270.35.20384; GUSTAFSON TA, 1995, MOL CELL BIOL, V15, P2500; Hallberg B, 1998, ONCOGENE, V17, P691, DOI 10.1038/sj.onc.1201980; Hisaoka M, 2002, J PATHOL, V197, P661, DOI 10.1002/path.1138; Hu XH, 2004, J NEUROCHEM, V90, P1339, DOI 10.1111/j.1471-4159.2004.02594.x; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Jimenez C, 1998, EMBO J, V17, P743, DOI 10.1093/emboj/17.3.743; JING SQ, 1992, NEURON, V9, P1067, DOI 10.1016/0896-6273(92)90066-M; Jones RJ, 2000, EUR J CANCER, V36, P1595, DOI 10.1016/S0959-8049(00)00153-2; Kaplan DR, 1997, CURR OPIN CELL BIOL, V9, P213, DOI 10.1016/S0955-0674(97)80065-8; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; Kopnin BP, 2000, BIOCHEMISTRY-MOSCOW+, V65, P2; KREMER NE, 1991, J CELL BIOL, V115, P809, DOI 10.1083/jcb.115.3.809; Lannon CL, 2004, J BIOL CHEM, V279, P6225, DOI 10.1074/jbc.M307388200; LEE SB, 1995, CURR OPIN CELL BIOL, V7, P183, DOI 10.1016/0955-0674(95)80026-3; LEMMON MA, 1994, TRENDS BIOCHEM SCI, V19, P459, DOI 10.1016/0968-0004(94)90130-9; Lentz SI, 1999, J NEUROSCI, V19, P1038; Lewin GR, 1996, ANNU REV NEUROSCI, V19, P289, DOI 10.1146/annurev.ne.19.030196.001445; LINDSAY RM, 1994, TRENDS NEUROSCI, V17, P182, DOI 10.1016/0166-2236(94)90099-X; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; MARCHETTI D, 1993, INT J CANCER, V55, P692, DOI 10.1002/ijc.2910550430; McGregor LM, 1999, P NATL ACAD SCI USA, V96, P4540, DOI 10.1073/pnas.96.8.4540; MENTER DG, 1994, INVAS METAST, V14, P372; Miknyoczki SJ, 1999, INT J CANCER, V81, P417, DOI 10.1002/(SICI)1097-0215(19990505)81:3<417::AID-IJC16>3.0.CO;2-6; Nakagawara A, 2001, CANCER LETT, V169, P107, DOI 10.1016/S0304-3835(01)00530-4; Ness JK, 2002, DEV NEUROSCI-BASEL, V24, P437, DOI 10.1159/000069050; NICHOLSON KM, BREAST CANC RES TREA, V81, P117; PAWSON T, 1992, CELL, V71, P359, DOI 10.1016/0092-8674(92)90504-6; Ricci A, 2001, AM J RESP CELL MOL, V25, P439, DOI 10.1165/ajrcmb.25.4.4470; Rickert CH, 2004, J NEUROPATH EXP NEUR, V63, P1211, DOI 10.1093/jnen/63.12.1211; Ryden M, 1996, BRIT J CANCER, V74, P773, DOI 10.1038/bjc.1996.435; Sakamoto Y, 2001, ONCOL REP, V8, P477; Satoh F, 2001, INT J UROL, V8, pS28, DOI 10.1046/j.1442-2042.2001.00331.x; Schlessinger J, 2000, CELL, V100, P293, DOI 10.1016/S0092-8674(00)80664-9; Shayesteh L, 1999, NAT GENET, V21, P99, DOI 10.1038/5042; Shibayama E, 1996, AM J PATHOL, V148, P1807; Singer HS, 1999, J NEURO-ONCOL, V45, P1, DOI 10.1023/A:1006323523437; Sun XJ, 1996, J BIOL CHEM, V271, P10583, DOI 10.1074/jbc.271.18.10583; Tessarollo L, 1998, CYTOKINE GROWTH F R, V9, P125, DOI 10.1016/S1359-6101(98)00003-3; Tognon C, 2001, CANCER RES, V61, P8909; Weeraratna AT, 2001, CLIN CANCER RES, V7, P2237; White MF, 1997, DIABETOLOGIA, V40, pS2, DOI 10.1007/s001250051387; Yamamoto M, 1996, NEUROCHEM RES, V21, P929, DOI 10.1007/BF02532343; Yan KS, 2002, FEBS LETT, V513, P67, DOI 10.1016/S0014-5793(01)03305-1; Yenush L, 1996, J BIOL CHEM, V271, P24300, DOI 10.1074/jbc.271.39.24300; Zhang SQ, 2004, MOL CELL, V13, P341, DOI 10.1016/S1097-2765(04)00050-4	70	25	28	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1391	1400		10.1074/jbc.M705052200	http://dx.doi.org/10.1074/jbc.M705052200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	17991742	hybrid			2022-12-27	WOS:000252282700022
J	Teghanemt, A; Re, F; Prohinar, P; Widstrom, R; Gioannini, TL; Weiss, JP				Teghanemt, Athmane; Re, Fabio; Prohinar, Polonca; Widstrom, Richard; Gioannini, Theresa L.; Weiss, Jerrold P.			Novel roles in human MD-2 of phenylalanines 121 and 126 and tyrosine 131 in activation of toll-like receptor 4 by endotoxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTOR-4; LIPOPOLYSACCHARIDE-BINDING; CELL ACTIVATION; LIPID-IVA; NEISSERIA-MENINGITIDIS; MONOMERIC ENDOTOXIN; SIGNAL-TRANSDUCTION; TLR4-MD-2 COMPLEX; PROTEIN COMPLEXES; TLR4	Potent mammalian cell activation by Gram-negative bacterial endotoxin requires sequential protein-endotoxin and protein-protein interactions involving lipopolysaccharide-binding protein, CD14, MD-2, and Toll-like receptor 4 (TLR4). TLR4 activation requires simultaneous binding of MD-2 to endotoxin ( E) and the ectodomain of TLR4. We now describe mutants of recombinant human MD-2 that bind TLR4 and react with E center dot CD14 but do not support cellular responsiveness to endotoxin. The mutants F121A/K122A MD-2 and Y131A/K132A MD-2 react with E center dot CD14 only when co-expressed with TLR4. Single mutants K122A and K132A each react with E center dot CD14 +/- TLR4 and promote TLR4-dependent cell activation by endotoxin suggesting that Phe(121) and Tyr(131) are needed for TLR4-independent transfer of endotoxin from CD14 to MD-2 and also needed for TLR4 activation by bound E center dot MD-2. The mutant F126A MD-2 reacts as well as wild-type MD-2 with E center dot CD14 +/- TLR4. E center dot MD-2(F126A) binds TLR4 with high affinity (K-d similar to 200 pM) but does not activate TLR4 and instead acts as a potent TLR4 antagonist, inhibiting activation of HEK/TLR4 cells by wildtype E center dot MD-2. These findings reveal roles of Phe121 and Tyr131 in TLR4-independent interactions of human MD-2 with E center dot CD14 and, together with Phe(126), in activation of TLR4 by bound E center dot MD-2. These findings strongly suggest that the structural properties of E center dot MD-2, not E alone, determine agonist or antagonist effects on TLR4.	[Teghanemt, Athmane; Prohinar, Polonca; Widstrom, Richard; Gioannini, Theresa L.; Weiss, Jerrold P.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; [Teghanemt, Athmane; Prohinar, Polonca; Widstrom, Richard; Gioannini, Theresa L.; Weiss, Jerrold P.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Inflammat Program, Iowa City, IA 52242 USA; [Weiss, Jerrold P.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Microbiol, Iowa City, IA 52242 USA; [Gioannini, Theresa L.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Biochem, Iowa City, IA 52242 USA; [Gioannini, Theresa L.] Vet Adm Med Ctr, Iowa City, IA 52246 USA; [Re, Fabio] Univ Tennessee, Hlth Sci Ctr, Dept Mol Sci, Memphis, TN 38163 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Tennessee System; University of Tennessee Health Science Center	Weiss, JP (corresponding author), Univ Iowa, Roy J & Lucille A Carver Coll Med, 2501 Crosspk Rd, Coralville, IA 52241 USA.	jerrold-weiss@uiowa.edu		Weiss, Jerrold/0000-0003-1476-4485	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI054665, R01AI059372] Funding Source: NIH RePORTER; NIAID NIH HHS [R21 AI 54665, AI 59372] Funding Source: Medline; PHS HHS [P01 44642] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Akashi S, 2001, INT IMMUNOL, V13, P1595, DOI 10.1093/intimm/13.12.1595; Beutler B, 2003, ANNU REV PHARMACOL, V43, P609, DOI 10.1146/annurev.pharmtox.43.100901.135729; Gangloff M, 2004, TRENDS BIOCHEM SCI, V29, P294, DOI 10.1016/j.tibs.2004.04.008; Giardina PC, 2001, J BIOL CHEM, V276, P5883, DOI 10.1074/jbc.M009273200; Gioannini TL, 2007, IMMUNOL RES, V39, P249, DOI 10.1007/s12026-007-0069-0; Gioannini TL, 2007, J BIOL CHEM, V282, P7877, DOI 10.1074/jbc.M605031200; Gioannini TL, 2005, J ENDOTOXIN RES, V11, P117, DOI 10.1179/096805105X35198; Gioannini TL, 2003, J ENDOTOXIN RES, V9, P401, DOI 10.1179/096805103225002773; Gioannini TL, 2002, J BIOL CHEM, V277, P47818, DOI 10.1074/jbc.M206404200; Gioannini TL, 2004, P NATL ACAD SCI USA, V101, P4186, DOI 10.1073/pnas.0306906101; Gruber A, 2004, J BIOL CHEM, V279, P28475, DOI 10.1074/jbc.M400993200; Hajjar AM, 2002, NAT IMMUNOL, V3, P354, DOI 10.1038/ni777; Hyakushima N, 2004, J IMMUNOL, V173, P6949, DOI 10.4049/jimmunol.173.11.6949; Jia HP, 2004, AM J PHYSIOL-LUNG C, V287, pL428, DOI 10.1152/ajplung.00377.2003; Jiang ZF, 2005, NAT IMMUNOL, V6, P565, DOI 10.1038/ni1207; Kawasaki K, 2003, J IMMUNOL, V170, P413, DOI 10.4049/jimmunol.170.1.413; Kawasaki K, 2001, J ENDOTOXIN RES, V7, P232, DOI 10.1177/09680519010070030701; Kennedy MN, 2004, J BIOL CHEM, V279, P34698, DOI 10.1074/jbc.M405444200; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Kitchens RL, 2001, J CLIN INVEST, V108, P485, DOI 10.1172/JCI200113139; Kobayashi M, 2006, J IMMUNOL, V176, P6211, DOI 10.4049/jimmunol.176.10.6211; Miyake K, 2003, INT IMMUNOPHARMACOL, V3, P119, DOI 10.1016/S1567-5769(02)00258-8; Montminy SW, 2006, NAT IMMUNOL, V7, P1066, DOI 10.1038/ni1386; Mullen GED, 2003, P NATL ACAD SCI USA, V100, P3919, DOI 10.1073/pnas.0630495100; Muroi M, 2006, J BIOL CHEM, V281, P5484, DOI 10.1074/jbc.M509193200; Ohto U, 2007, SCIENCE, V316, P1632, DOI 10.1126/science.1139111; Post DMB, 2005, J BIOL CHEM, V280, P38383, DOI 10.1074/jbc.M508063200; Prohinar P, 2007, J BIOL CHEM, V282, P1010, DOI 10.1074/jbc.M609400200; Re F, 2003, J IMMUNOL, V171, P5272, DOI 10.4049/jimmunol.171.10.5272; Re F, 2002, J BIOL CHEM, V277, P23427, DOI 10.1074/jbc.M202554200; Saitoh S, 2004, J ENDOTOXIN RES, V10, P257, DOI 10.1179/096805104225005904; Saitoh S, 2004, INT IMMUNOL, V16, P961, DOI 10.1093/intimm/dxh097; Teghanemt A, 2005, J IMMUNOL, V175, P4669, DOI 10.4049/jimmunol.175.7.4669; Tsuneyoshi N, 2005, J IMMUNOL, V174, P340, DOI 10.4049/jimmunol.174.1.340; Ulevitch RJ, 1999, CURR OPIN IMMUNOL, V11, P19, DOI 10.1016/S0952-7915(99)80004-1; Viriyakosol S, 2006, J BIOL CHEM, V281, P11955, DOI 10.1074/jbc.M511627200; Viriyakosol S, 2000, J ENDOTOXIN RES, V6, P489, DOI 10.1179/096805100101532379; Visintin A, 2005, J IMMUNOL, V175, P6465, DOI 10.4049/jimmunol.175.10.6465; Visintin A, 2003, J BIOL CHEM, V278, P48313, DOI 10.1074/jbc.M306802200; Yang H, 2000, J BIOL CHEM, V275, P20861, DOI 10.1074/jbc.M002896200	40	38	38	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1257	1266		10.1074/jbc.M705994200	http://dx.doi.org/10.1074/jbc.M705994200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	17977838	hybrid			2022-12-27	WOS:000252282700008
J	Kuraoka, I; Ito, S; Wada, T; Hayashida, M; Lee, L; Saijo, M; Nakatsu, Y; Matsumoto, M; Matsunaga, T; Handa, H; Qin, J; Nakatani, Y; Tanaka, K				Kuraoka, Isao; Ito, Shinsuke; Wada, Tadashi; Hayashida, Mika; Lee, Lily; Saijo, Masafumi; Nakatsu, Yoshimichi; Matsumoto, Megumi; Matsunaga, Tsukasa; Handa, Hiroshi; Qin, Jun; Nakatani, Yoshihiro; Tanaka, Kiyoji			Isolation of XAB2 complex involved in pre-mRNA splicing, transcription, and transcription-coupled repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCISION-REPAIR; CYCLOBUTANE PYRIMIDINE DIMER; DNA-REPAIR; COCKAYNE-SYNDROME; POLYMERASE-II; SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; XERODERMA-PIGMENTOSUM; NUCLEAR-MATRIX; CANCER-CELLS	Nucleotide excision repair is a versatile repair pathway that counteracts the deleterious effects of various DNA lesions. In nucleotide excision repair, there is a transcription-coupled repair (TCR) pathway that focuses on DNA damage that blocks RNA polymerase IIo in transcription elongation. XAB2 (XPA-binding protein 2), containing tetratricopeptide repeats, has been isolated by virtue of its ability to interact with xeroderma pigmentosum group A protein (XPA). Moreover, XAB2 has been shown to interact with Cockayne syndrome group A and B proteins (CSA and CSB) and RNA polymerase II, as well as XPA, and is involved in TCR and transcription. Here we purified XAB2 as a multimeric protein complex consisting of hAquarius, XAB2, hPRP19, CCDC16, hISY1, and PPIE, which are involved in pre-mRNA splicing. Knockdown of XAB2 with small interfering RNA in HeLa cells resulted in a hypersensitivity to killing by UV light and a decreased recovery of RNA synthesis after UV irradiation and regular RNA synthesis. Enhanced interaction of XAB2 with RNA polymerase IIo or XPA was observed in cells treated with DNA-damaging agents, indicating DNA damage-responsive activity of the XAB2 complex. These results indicated that the XAB2 complex is a multifunctional factor involved in pre-mRNA splicing, transcription, and TCR.	[Kuraoka, Isao; Ito, Shinsuke; Hayashida, Mika; Lee, Lily; Saijo, Masafumi; Nakatsu, Yoshimichi; Tanaka, Kiyoji] Osaka Univ, Grad Sch Frontier Biosci, Labs Organismal Biosyst, Suita, Osaka 5650871, Japan; [Kuraoka, Isao; Saijo, Masafumi; Tanaka, Kiyoji] Japan Sci & Technol Agcy, Solut Oriented Res Sci & Technol, Suita, Osaka 5650871, Japan; [Matsumoto, Megumi; Matsunaga, Tsukasa] Kanazawa Univ, Grad Sch Nat Sci & Technol, Lab Human Mol Genet, Kakuma, Kanazawa 9201192, Japan; [Wada, Tadashi; Handa, Hiroshi] Tokyo Inst Technol, Fac Biosci & Biotechnol, Yokohama, Kanagawa 2268501, Japan; [Wada, Tadashi; Handa, Hiroshi] Tokyo Inst Technol, Frontier Collaborat Res Ctr, Yokohama, Kanagawa 2268501, Japan; [Qin, Jun] Baylor Coll Med, Dept Biochem, Houston, TX 77030 USA; [Nakatani, Yoshihiro] Dana Farber Canc Inst, Boston, MA 02115 USA; [Nakatani, Yoshihiro] Harvard Univ, Sch Med, Boston, MA 02115 USA	Osaka University; Japan Science & Technology Agency (JST); Kanazawa University; Tokyo Institute of Technology; Tokyo Institute of Technology; Baylor College of Medicine; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Kuraoka, I (corresponding author), Osaka Univ, Grad Sch Frontier Biosci, Labs Organismal Biosyst, 1-3 Yamadaoka, Suita, Osaka 5650871, Japan.	ikuraoka@nk-cc.go.jp; ktanaka@fbs.osaka-u.ac.jp		Kuraoka, Isao/0000-0001-6391-3411; Nakatsu, Yoshimichi/0000-0001-7408-7071				Araujo SJ, 2000, GENE DEV, V14, P349; Bedford MT, 1998, P NATL ACAD SCI USA, V95, P10602, DOI 10.1073/pnas.95.18.10602; Ben-Yehuda S, 2000, GENETICS, V156, P1503; Bregman DB, 1996, P NATL ACAD SCI USA, V93, P11586, DOI 10.1073/pnas.93.21.11586; Brendel M, 2003, MUTAT RES-REV MUTAT, V544, P179, DOI 10.1016/j.mrrev.2003.06.018; Chan SP, 2003, SCIENCE, V302, P279, DOI 10.1126/science.1086602; Dahan O, 2002, NUCLEIC ACIDS RES, V30, P4361, DOI 10.1093/nar/gkf563; Das AK, 1998, EMBO J, V17, P1192, DOI 10.1093/emboj/17.5.1192; Dix I, 1999, RNA, V5, P360, DOI 10.1017/S1355838299981396; DONAHUE BA, 1994, P NATL ACAD SCI USA, V91, P8502, DOI 10.1073/pnas.91.18.8502; Fong YW, 2001, NATURE, V414, P929, DOI 10.1038/414929a; Fousteri M, 2006, MOL CELL, V23, P471, DOI 10.1016/j.molcel.2006.06.029; Goldstrohm AC, 2001, MOL CELL BIOL, V21, P7617, DOI 10.1128/MCB.21.22.7617-7628.2001; Grey M, 1996, NUCLEIC ACIDS RES, V24, P4009, DOI 10.1093/nar/24.20.4009; Groisman R, 2003, CELL, V113, P357, DOI 10.1016/S0092-8674(03)00316-7; Groisman R, 2006, GENE DEV, V20, P1429, DOI 10.1101/gad.378206; GUZDER SN, 1995, J BIOL CHEM, V270, P12973, DOI 10.1074/jbc.270.22.12973; Hasegawa J, 2003, J BIOCHEM, V133, P133, DOI 10.1093/jb/mvg013; Hirose T, 2006, MOL CELL, V23, P673, DOI 10.1016/j.molcel.2006.07.011; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Inukai N, 2004, J BIOL CHEM, V279, P8190, DOI 10.1074/jbc.M311412200; Ito S, 2007, MOL CELL, V26, P231, DOI 10.1016/j.molcel.2007.03.013; Kamiuchi S, 2002, P NATL ACAD SCI USA, V99, P201, DOI 10.1073/pnas.012473199; Kim JO, 1998, ONCOGENE, V17, P1019, DOI 10.1038/sj.onc.1202006; Kwei JSM, 2004, BIOCHEM BIOPH RES CO, V320, P1133, DOI 10.1016/j.bbrc.2004.06.066; LAMB JR, 1995, TRENDS BIOCHEM SCI, V20, P257, DOI 10.1016/S0968-0004(00)89037-4; Lehmann AR, 2003, BIOCHIMIE, V85, P1101, DOI 10.1016/j.biochi.2003.09.010; Lindahl T, 1999, SCIENCE, V286, P1897, DOI 10.1126/science.286.5446.1897; Mahajan KN, 2003, P NATL ACAD SCI USA, V100, P10746, DOI 10.1073/pnas.1631060100; Makarova OV, 2004, EMBO J, V23, P2381, DOI 10.1038/sj.emboj.7600241; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; Matsushima Y, 1997, BIOSCI BIOTECH BIOCH, V61, P905, DOI 10.1271/bbb.61.905; Mercatante DR, 2002, BBA-MOL BASIS DIS, V1587, P126, DOI 10.1016/S0925-4439(02)00075-3; Mercatante DR, 2001, J BIOL CHEM, V276, P16411, DOI 10.1074/jbc.M009256200; Mi HF, 1996, FEBS LETT, V398, P201, DOI 10.1016/S0014-5793(96)01248-3; NAGAI A, 1995, BIOCHEM BIOPH RES CO, V211, P960, DOI 10.1006/bbrc.1995.1905; Nagai K, 2004, BIOCHEM BIOPH RES CO, V316, P512, DOI 10.1016/j.bbrc.2004.02.077; Nakatani Y, 2003, METHOD ENZYMOL, V370, P430; Nakatsu Y, 2000, J BIOL CHEM, V275, P34931, DOI 10.1074/jbc.M004936200; NANCE MA, 1992, AM J MED GENET, V42, P68, DOI 10.1002/ajmg.1320420115; Ohnuma-Ishikawa K, 2007, CANCER RES, V67, P1019, DOI 10.1158/0008-5472.CAN-06-1638; Prakash S, 2000, MUTAT RES-FUND MOL M, V451, P13, DOI 10.1016/S0027-5107(00)00037-3; Reed R, 2003, CURR OPIN CELL BIOL, V15, P326, DOI 10.1016/S0955-0674(03)00048-6; Saijo M, 2007, MOL CELL BIOL, V27, P2538, DOI 10.1128/MCB.01288-06; Sam M, 1998, DEV DYNAM, V212, P304, DOI 10.1002/(SICI)1097-0177(199806)212:2<304::AID-AJA15>3.0.CO;2-3; Sancar A, 1996, ANNU REV BIOCHEM, V65, P43, DOI 10.1146/annurev.bi.65.070196.000355; Stein P, 2003, RNA, V9, P187, DOI 10.1261/rna.2860603; Sugasawa K, 1998, MOL CELL, V2, P223, DOI 10.1016/S1097-2765(00)80132-X; Svejstrup JQ, 2002, NAT REV MOL CELL BIO, V3, P21, DOI 10.1038/nrm703; Villa T, 2005, GENE DEV, V19, P1894, DOI 10.1101/gad.1336305; Wang Y, 2000, GENE DEV, V14, P927; Wood RD, 2001, SCIENCE, V291, P1284, DOI 10.1126/science.1056154; Yonemasu R, 2005, DNA REPAIR, V4, P479, DOI 10.1016/j.dnarep.2004.12.004; Zorio DAR, 2004, EXP CELL RES, V296, P91, DOI 10.1016/j.yexcr.2004.03.019	54	76	83	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					940	950		10.1074/jbc.M706647200	http://dx.doi.org/10.1074/jbc.M706647200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	17981804	hybrid			2022-12-27	WOS:000252128100034
J	Petrovic, V; Costa, RH; Lau, LF; Raychaudhuri, P; Tyner, AL				Petrovic, Vladimir; Costa, Robert H.; Lau, Lester F.; Raychaudhuri, Pradip; Tyner, Angela L.			FoxM1 regulates growth factor-induced expression of kinase-interacting stathmin (KIS) to promote cell cycle progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORKHEAD BOX M1; TRANSCRIPTION FACTOR; HEPATOCELLULAR-CARCINOMA; UBIQUITIN LIGASE; INHIBITOR P27; LIVER-REGENERATION; TUMOR-SUPPRESSOR; P27(KIP1); PROTEIN; GENES	The Forkhead box M1 ( FoxM1) transcription factor is essential for cell cycle progression and mitosis. FoxM1 regulates expression of Skp2 and Cks1, subunits of the SCF ubiquitin ligase complex, which ubiquitinates p27(Kip1) and targets it for degradation. Kinase-interacting stathmin (KIS) is a growth factor-dependent nuclear kinase that regulates cell cycle progression by phosphorylating p27(Kip1) to promote its nuclear export. Here we present an additional mechanism of FoxM1-mediated regulation of p27(Kip1) and provide evidence that FoxM1 regulates growth factor-induced expression of KIS. In cells harboring FoxM1 deletion or expressing FoxM1-short interfering RNA, the expression of KIS is impaired, leading to an accumulation of p27(Kip1) in the nucleus. Furthermore, we show that KIS is a direct transcriptional target of FoxM1. Thus FoxM1 promotes cell cycle progression by down-regulating p27(Kip1) through multiple mechanisms.	[Petrovic, Vladimir; Costa, Robert H.; Lau, Lester F.; Raychaudhuri, Pradip; Tyner, Angela L.] Univ Illinois, Coll Med, Dept Biochem & Mol Genet, MC 669, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Tyner, AL (corresponding author), Univ Illinois, Coll Med, Dept Biochem & Mol Genet, MC 669, 900 S Ashland Ave, Chicago, IL 60607 USA.	atyner@uic.edu		Lau, Lester/0000-0002-4364-2914; Tyner, Angela/0000-0001-7448-8625	NATIONAL CANCER INSTITUTE [R01CA124488, R01CA046565] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R55DK044525, R01DK044525, R01DK068503, R01DK054687] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021842] Funding Source: NIH RePORTER; NCI NIH HHS [CA 46565, CA 124488] Funding Source: Medline; NIA NIH HHS [R01 AG021842-05, R01 AG021842, AG 21842] Funding Source: Medline; NIDDK NIH HHS [R01 DK044525-14, R01 DK044525, DK 44525, DK 054687, R01 DK054687, R01 DK054687-09, DK 068503] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adam Taghreed, 2003, Cost Eff Resour Alloc, V1, P3, DOI 10.1186/1478-7547-1-3; Alessandrini A, 1997, LEUKEMIA, V11, P342, DOI 10.1038/sj.leu.2400581; Armengol C, 2003, J HEPATOL, V38, P591, DOI 10.1016/S0168-8278(03)00025-4; Boehm M, 2002, EMBO J, V21, P3390, DOI 10.1093/emboj/cdf343; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Costa RH, 2005, CURR OPIN GENET DEV, V15, P42, DOI 10.1016/j.gde.2004.12.007; Costa RH, 2005, NAT CELL BIOL, V7, P108, DOI 10.1038/ncb0205-108; Gusarova GA, 2007, J CLIN INVEST, V117, P99, DOI 10.1172/JCI27527; Heselmeyer K, 1997, GENE CHROMOSOME CANC, V19, P233, DOI 10.1002/(SICI)1098-2264(199708)19:4<233::AID-GCC5>3.0.CO;2-Y; HOGAN B, 1994, MANIPULATING MOUSE E, P260; Kalinichenko VV, 2004, GENE DEV, V18, P830, DOI 10.1101/gad.1200704; Kalinina OA, 2003, ONCOGENE, V22, P6266, DOI 10.1038/sj.onc.1206640; Kamura T, 2004, NAT CELL BIOL, V6, P1229, DOI 10.1038/ncb1194; Kim IM, 2006, CANCER RES, V66, P2153, DOI 10.1158/0008-5472.CAN-05-3003; Korver W, 1997, GENOMICS, V46, P435, DOI 10.1006/geno.1997.5065; Korver W, 1997, NUCLEIC ACIDS RES, V25, P1715, DOI 10.1093/nar/25.9.1715; Kotoshiba S, 2005, J BIOL CHEM, V280, P17694, DOI 10.1074/jbc.M500866200; Laoukili J, 2005, NAT CELL BIOL, V7, P126, DOI 10.1038/ncb1217; Laoukili J, 2007, BBA-REV CANCER, V1775, P92, DOI 10.1016/j.bbcan.2006.08.006; Major ML, 2004, MOL CELL BIOL, V24, P2649, DOI 10.1128/MCB.24.7.2649-2661.2004; Maucuer A, 1997, J BIOL CHEM, V272, P23151, DOI 10.1074/jbc.272.37.23151; MAUCUER A, 1995, P NATL ACAD SCI USA, V92, P3100, DOI 10.1073/pnas.92.8.3100; PAGANO M, 1995, SCIENCE, V269, P682, DOI 10.1126/science.7624798; Pilarsky C, 2004, NEOPLASIA, V6, P744, DOI 10.1593/neo.04277; Radhakrishnan SK, 2006, CANCER RES, V66, P9731, DOI 10.1158/0008-5472.CAN-06-1576; Rausa FM, 2000, MOL CELL BIOL, V20, P8264, DOI 10.1128/MCB.20.21.8264-8282.2000; Rodriguez S, 2005, CANCER GENET CYTOGEN, V157, P140, DOI 10.1016/j.cancergencyto.2004.08.017; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shiyanov P, 1997, MOL BIOL CELL, V8, P1815, DOI 10.1091/mbc.8.9.1815; Singh B, 2001, CANCER RES, V61, P4506; Spirin KS, 1996, CANCER RES, V56, P2400; Tannapfel A, 2000, INT J CANCER, V89, P350, DOI 10.1002/1097-0215(20000720)89:4<350::AID-IJC6>3.0.CO;2-3; Teh MT, 2002, CANCER RES, V62, P4773; Tsvetkov LM, 1999, CURR BIOL, V9, P661, DOI 10.1016/S0960-9822(99)80290-5; van den Boom J, 2003, AM J PATHOL, V163, P1033, DOI 10.1016/S0002-9440(10)63463-3; Wang IC, 2005, MOL CELL BIOL, V25, P10875, DOI 10.1128/MCB.25.24.10875-10894.2005; Wang XH, 2002, P NATL ACAD SCI USA, V99, P16881, DOI 10.1073/pnas.252570299; Wang XH, 2002, J BIOL CHEM, V277, P44310, DOI 10.1074/jbc.M207510200; Wang XH, 2001, P NATL ACAD SCI USA, V98, P11468, DOI 10.1073/pnas.201360898; Wells J, 2002, METHODS, V26, P48, DOI 10.1016/S1046-2023(02)00007-5; Ye HG, 1999, MOL CELL BIOL, V19, P8570; Ye HG, 1997, MOL CELL BIOL, V17, P1626, DOI 10.1128/MCB.17.3.1626; Zettl A, 2004, AM J PATHOL, V164, P1837, DOI 10.1016/S0002-9440(10)63742-X; Zindy F, 1997, ONCOGENE, V15, P203, DOI 10.1038/sj.onc.1201178	44	49	52	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					453	460		10.1074/jbc.M705792200	http://dx.doi.org/10.1074/jbc.M705792200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17984092	hybrid			2022-12-27	WOS:000251940300050
J	Sakamoto, Y; Ogita, H; Komura, H; Takai, Y				Sakamoto, Yasuhisa; Ogita, Hisakazu; Komura, Hitomi; Takai, Yoshimi			Involvement of nectin in inactivation of integrin alpha(v)beta(3) after the establishment of cell-cell adhesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL PHOSPHATE KINASE; HOMOPHILIC BINDING-SITE; INTEGRIN ACTIVATION; PTP-MU; TYROSINE PHOSPHORYLATION; ADHERENS JUNCTIONS; FOCAL ADHESIONS; RPTP-MU; IN-VIVO; C-SRC	Integrin plays an essential role in the formation of cell-matrix junctions and is also involved in the fundamental cellular functions. In the process of the formation of cell-cell junctions, an immunoglobulin-like cell-cell adhesion molecule nectin initially trans-interacts together and promotes the formation of adherens junctions (AJs) cooperatively with another cell-cell adhesion molecule cadherin. The activation of integrin alpha(v)beta(3) is critically necessary for this nectin-induced formation of AJs. However, after the establishment of AJs, integrin alpha(v)beta(3) becomes inactive and retains the association with nectin at AJs. The molecular mechanism of this dynamic regulation of integrin alpha(v)beta(3) during the formation of AJs remains unclear. We found here that the expression of phosphatidylinositol-phosphate kinase type I gamma 90 (PIPKI gamma 90), which is involved in the regulation of integrin activation, in Madin-Darby canine kidney cells, preferentially reversed the inactivation of integrin alpha(v)beta(3) at cell-cell adhesion sites and partially disrupted E-cadherin-based AJs. The activation of PIPKI gamma is correlated with its phosphorylation state. The tyrosine phosphatase protein-tyrosine phosphatase mu (PTP mu) effectively dephosphorylated PIPKI gamma and thus canceled the PIPKI gamma-dependent activation of integrin alpha(v)beta(3) by blocking the interaction of integrin alpha(v)beta(3) with talin. Moreover, PTP mu associated with nectin, and its phosphatase activity was enhanced by the trans-interaction of nectin, leading to the decrease in PIPKI gamma 90 phosphorylation. Therefore, the trans-interaction of nectin essentially functions in the inactivation of integrin at AJs through the PTP mu-induced inactivation of PIPKI gamma.	Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Kobe, Hyogo 6500017, Japan; [Sakamoto, Yasuhisa; Ogita, Hisakazu; Komura, Hitomi; Takai, Yoshimi] Osaka Univ, Grad Sch Med, Fac Med, Dept Mol Biol & Biochem, Suita, Osaka 5650871, Japan	Kobe University; Osaka University	Takai, Y (corresponding author), Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Kobe, Hyogo 6500017, Japan.	ytakai@med.kobe-u.ac.jp	Ogita, Hisakazu/AAE-4416-2020	Sakamoto, Yasuhisa/0000-0003-1833-6197; Ogita, Hisakazu/0000-0001-6750-1668				ABERCROMBIE M, 1953, EXP CELL RES, V5, P111, DOI 10.1016/0014-4827(53)90098-6; Brady-Kalnay SM, 1998, J CELL BIOL, V141, P287, DOI 10.1083/jcb.141.1.287; BRADYKALNAY SM, 1994, J BIOL CHEM, V269, P28472; BRADYKALNAY SM, 1995, J CELL BIOL, V130, P977, DOI 10.1083/jcb.130.4.977; Calderwood DA, 2004, J CELL SCI, V117, P657, DOI 10.1242/jcs.01014; Carragher NO, 1999, J CELL BIOL, V147, P619, DOI 10.1083/jcb.147.3.619; Cismasiu VB, 2004, J BIOL CHEM, V279, P26922, DOI 10.1074/jbc.M313115200; Daniel JM, 1997, BIOESSAYS, V19, P883, DOI 10.1002/bies.950191008; Del Vecchio RL, 2005, J BIOL CHEM, V280, P1603, DOI 10.1074/jbc.M410181200; Di Paolo G, 2002, NATURE, V420, P85, DOI 10.1038/nature01147; Feiken E, 2000, J BIOL CHEM, V275, P15350, DOI 10.1074/jbc.275.20.15350; FISHER HW, 1967, SCIENCE, V155, P581, DOI 10.1126/science.155.3762.581; Fujita Y, 2002, NAT CELL BIOL, V4, P222, DOI 10.1038/ncb758; Fujito T, 2005, J CELL BIOL, V171, P165, DOI 10.1083/jcb.200501090; Fukuhara T, 2004, J CELL BIOL, V166, P393, DOI 10.1083/jcb.200401093; Fukuyama T, 2005, J BIOL CHEM, V280, P815, DOI 10.1074/jbc.M411099200; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Honda T, 2003, GENES CELLS, V8, P51, DOI 10.1046/j.1365-2443.2003.00616.x; Ikeda W, 2004, J BIOL CHEM, V279, P18015, DOI 10.1074/jbc.M312969200; Ikeda W, 2003, J BIOL CHEM, V278, P28167, DOI 10.1074/jbc.M303586200; Katsumi A, 2005, J BIOL CHEM, V280, P16546, DOI 10.1074/jbc.C400455200; Kawakatsu T, 2005, J BIOL CHEM, V280, P4940, DOI 10.1074/jbc.M408710200; Kinbara K, 2003, NAT REV MOL CELL BIO, V4, P767, DOI 10.1038/nrm1229; Kiosses WB, 2001, NAT CELL BIOL, V3, P316, DOI 10.1038/35060120; Kodama A, 1999, ONCOGENE, V18, P3996, DOI 10.1038/sj.onc.1202773; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Ling K, 2003, J CELL BIOL, V163, P1339, DOI 10.1083/jcb.200310067; Ling K, 2002, NATURE, V420, P89, DOI 10.1038/nature01082; Ling K, 2007, J CELL BIOL, V176, P343, DOI 10.1083/jcb.200606023; Martel V, 2001, J BIOL CHEM, V276, P21217, DOI 10.1074/jbc.M102373200; Minami Y, 2007, J BIOL CHEM, V282, P18481, DOI 10.1074/jbc.M611330200; Ogita H, 2006, IUBMB LIFE, V58, P334, DOI 10.1080/15216540600719622; Ozaki M, 2007, GENES CELLS, V12, P651, DOI 10.1111/j.1365-2443.2007.01083.x; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Sakamoto Y, 2006, J BIOL CHEM, V281, P19631, DOI 10.1074/jbc.M600301200; Sakisaka T, 1999, ONCOGENE, V18, P1609, DOI 10.1038/sj.onc.1202451; Sui XF, 2005, AM J PATHOL, V166, P1247, DOI 10.1016/S0002-9440(10)62343-7; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Takai Y, 2003, J CELL SCI, V116, P17, DOI 10.1242/jcs.00167; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Watt FM, 2002, EMBO J, V21, P3919, DOI 10.1093/emboj/cdf399; Yamamoto Y, 2002, ONCOGENE, V21, P2545, DOI 10.1038/sj.onc.1205335; Zondag GCM, 2000, J BIOL CHEM, V275, P11264, DOI 10.1074/jbc.275.15.11264	44	26	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					496	505		10.1074/jbc.M704195200	http://dx.doi.org/10.1074/jbc.M704195200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17965016	hybrid			2022-12-27	WOS:000251940300055
J	Van Itallie, CM; Betts, L; Smedley, JG; McClane, BA; Anderson, JM				Van Itallie, Christina M.; Betts, Laurie; Smedley, James G., III; McClane, Bruce A.; Anderson, James M.			Structure of the claudin-binding domain of Clostridium perfringens enterotoxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL FRAGMENT; CRYSTAL-STRUCTURE; PROTEIN; TOXIN; CANCER; RECEPTORS; COMPLEX	Clostridium perfringens enterotoxin is a common cause of food-borne and antibiotic-associated diarrhea. The toxin's receptors on intestinal epithelial cells include claudin-3 and -4, members of a large family of tight junction proteins. Toxin-induced cytolytic pore formation requires residues in the NH2-terminal half, whereas residues near the COOH terminus are required for binding to claudins. The claudin-binding COOH-terminal domain is not toxic and is currently under investigation as a potential drug absorption enhancer. Because claudin-4 is overexpressed on some human cancers, the toxin is also being investigated for targeting chemotherapy. Our aim was to solve the structure of the claudin-binding domain to advance its therapeutic applications. The structure of a 14-kDa fragment containing residues 194 to the native COOH terminus at position 319 was solved by x-ray diffraction to a resolution of 1.75 angstrom. The structure is a nine-strand beta sandwich with previously unappreciated similarity to the receptor-binding domains of several other toxins of spore-forming bacteria, including the collagen-binding domain of ColG from Clostridium histolyticum and the large Cry family of toxins ( including Cry4Ba) of Bacillus thuringiensis. Correlations with previous studies suggest that the claudin-4 binding site is on a large surface loop between strands beta 8 and beta 9 or includes these strands. The sequence that was crystallized (residues 194-319) binds to purified human claudin-4 with a 1: 1 stoichiometry and affinity in the submicromolar range similar to that observed for binding of native toxin to cells. Our results provide a structural framework to advance therapeutic applications of the toxin and suggest a common ancestor for several receptor-binding domains of bacterial toxins.	[Van Itallie, Christina M.] Univ N Carolina, Sch Med, Dept Med, Chapel Hill, NC 27599 USA; [Betts, Laurie] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Anderson, James M.] Univ N Carolina, Sch Med, Dept Cell Mol Physiol, Chapel Hill, NC 27599 USA; [Smedley, James G., III; McClane, Bruce A.] Univ Pittsburgh, Sch Med, Dept Mol Genet & Biochem, Pittsburgh, PA 15261 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Anderson, JM (corresponding author), Univ N Carolina, Chapel Hill, NC 27599 USA.	jandersn@med.unc.edu		Anderson, James/0000-0003-2765-7996	NIAID NIH HHS [R37 AI019844, R37 AI 19844] Funding Source: Medline; NIDDK NIH HHS [R01 DK 45134, P30 DK 034987] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI019844] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045134, P30DK034987] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Boonserm P, 2005, J MOL BIOL, V348, P363, DOI 10.1016/j.jmb.2005.02.013; Burton SL, 1999, J MOL BIOL, V287, P1011, DOI 10.1006/jmbi.1999.2649; Chakrabarti G, 2005, CELL MICROBIOL, V7, P129, DOI 10.1111/j.1462-5822.2004.00442.x; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; Dauter Z, 2000, ACTA CRYSTALLOGR D, V56, P232, DOI 10.1107/S0907444999016352; Ebihara C, 2006, J PHARMACOL EXP THER, V316, P255, DOI 10.1124/jpet.105.093351; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fujita K, 2000, FEBS LETT, V476, P258, DOI 10.1016/S0014-5793(00)01744-0; Gardberg A, 2003, STRUCTURE, V11, P1265, DOI 10.1016/j.str.2003.09.003; GUERRA C, 2003, MATH METHODS PROTEIN, P109; HANNA PC, 1991, J BIOL CHEM, V266, P11037; Harada M, 2007, BIOCHEM PHARMACOL, V73, P206, DOI 10.1016/j.bcp.2006.10.002; Katahira J, 1997, J BIOL CHEM, V272, P26652, DOI 10.1074/jbc.272.42.26652; KNOWLES BH, 1994, ADV INSECT PHYSIOL, V24, P275, DOI 10.1016/S0065-2806(08)60085-5; KOKAIKUN JF, 1997, CLIN INFECT DIS   S2, V25, P165; Kominsky SL, 2007, CANCER RES, V67, P7977, DOI 10.1158/0008-5472.CAN-07-1314; Kondoh M, 2005, MOL PHARMACOL, V67, P749, DOI 10.1124/mol.104.008375; MCPHERSON A, 1987, J BIOL CHEM, V262, P1791; Michl P, 2001, GASTROENTEROLOGY, V121, P678, DOI 10.1053/gast.2001.27124; Mitic LL, 2003, PROTEIN SCI, V12, P218, DOI 10.1110/ps.0233903; Miyakawa MEF, 2005, INFECT IMMUN, V73, P8407, DOI 10.1128/IAI.73.12.8407-8410.2005; Morin PJ, 2005, CANCER RES, V65, P9603, DOI 10.1158/0008-5472.CAN-05-2782; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Pigott CR, 2007, MICROBIOL MOL BIOL R, V71, P255, DOI 10.1128/MMBR.00034-06; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Robertson SL, 2007, CELL MICROBIOL, V9, P2734, DOI 10.1111/j.1462-5822.2007.00994.x; Santin AD, 2005, CANCER RES, V65, P4334, DOI 10.1158/0008-5472.CAN-04-3472; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Singh U, 2000, J BIOL CHEM, V275, P18407, DOI 10.1074/jbc.M001530200; Smedley JG, 2005, REV PHYSIOL BIOCH P, V152, P183, DOI 10.1007/s10254-004-0036-2; Sonoda N, 1999, J CELL BIOL, V147, P195, DOI 10.1083/jcb.147.1.195; Stocker A, 2000, ANTIOXID REDOX SIGN, V2, P397, DOI 10.1089/15230860050192170; Takahashi A, 2005, J CONTROL RELEASE, V108, P56, DOI 10.1016/j.jconrel.2005.07.008; Wendt KS, 2001, NAT STRUCT BIOL, V8, P784, DOI 10.1038/nsb0901-784; Wilson JJ, 2003, EMBO J, V22, P1743, DOI 10.1093/emboj/cdg172	35	88	90	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					268	274		10.1074/jbc.M708066200	http://dx.doi.org/10.1074/jbc.M708066200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17977833	hybrid, Green Published			2022-12-27	WOS:000251940300030
J	Di Padova, M; Caretti, G; Zhao, P; Hoffman, EP; Sartorelli, V				Di Padova, Monica; Caretti, Giuseppina; Zhao, Po; Hoffman, Eric P.; Sartorelli, Vittorio			MyoD acetylation influences temporal patterns of skeletal muscle gene expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOCYTE ENHANCER FACTOR-2; MYOGENIC DIFFERENTIATION; TRANSCRIPTIONAL ACTIVATION; REGULATORY FACTORS; DISTINCT ROLES; DNA-BINDING; IN-VITRO; CHROMATIN; PROTEINS; COMPLEX	MyoD is sufficient to initiate the skeletal muscle gene expression program. Transcription of certain MyoD target genes occurs in the early phases, whereas that of others is induced only at later stages, although MyoD is present throughout the differentiation process. MyoD acetylation regulates transcriptional competency, yet whether this post-translational modification is equally relevant for activation of all the MyoD targets is unknown. Moreover, the molecular mechanisms through which acetylation ensures that MyoD achieves its optimal activity remain unexplored. To address these two outstanding issues, we have coupled genome- wide expression profiling and chromatin immunoprecipitation in a model system in which MyoD or its nonacetylatable version was inducibly activated in mouse embryonic fibroblasts derived from MyoD(-/-) /Myf5 (-/-) mice. Our results reveal that MyoD acetylation influences transcription of selected genes expressed at defined stages of the muscle program by regulating chromatin access of MyoD, histone acetylation, and RNA polymerase II recruitment.	[Di Padova, Monica; Caretti, Giuseppina; Sartorelli, Vittorio] NIH, NIAMS, Lab Muscle Stem Cells & Gene Regulat, Bethesda, MD 20892 USA; [Zhao, Po; Hoffman, Eric P.] Childrens Natl Med Ctr, Res Ctr Genet Med, Washington, DC 20010 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Children's National Health System	Sartorelli, V (corresponding author), NIH, NIAMS, Lab Muscle Stem Cells & Gene Regulat, 50 S Dr,Rm 1351, Bethesda, MD 20892 USA.	sartorev@mail.nih.gov		Hoffman, Eric/0000-0001-6470-5139; DI PADOVA, Monica/0000-0003-3808-7159; Sartorelli, Vittorio/0000-0002-9284-3675	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041126, Z01AR041126] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Bergstrom DA, 2002, MOL CELL, V9, P587, DOI 10.1016/S1097-2765(02)00481-1; Berkes CA, 2004, MOL CELL, V14, P465, DOI 10.1016/S1097-2765(04)00260-6; Brooks CL, 2003, CURR OPIN CELL BIOL, V15, P164, DOI 10.1016/S0955-0674(03)00003-6; Cao Y, 2006, EMBO J, V25, P502, DOI 10.1038/sj.emboj.7600958; Caretti G, 2006, DEV CELL, V11, P547, DOI 10.1016/j.devcel.2006.08.003; de la Serna IL, 2005, MOL CELL BIOL, V25, P3997, DOI 10.1128/MCB.25.10.3997-4009.2005; Delgado I, 2003, GENOMICS, V82, P109, DOI 10.1016/S0888-7543(03)00104-6; Dilworth FJ, 2004, P NATL ACAD SCI USA, V101, P11593, DOI 10.1073/pnas.0404192101; Duquet A, 2006, EMBO REP, V7, P1140, DOI 10.1038/sj.embor.7400820; Fulco M, 2003, MOL CELL, V12, P51, DOI 10.1016/S1097-2765(03)00226-0; Gerber AN, 1997, GENE DEV, V11, P436, DOI 10.1101/gad.11.4.436; Gregoire S, 2007, MOL CELL BIOL, V27, P1280, DOI 10.1128/MCB.00882-06; Hardin PE, 2006, CELL, V125, P424, DOI 10.1016/j.cell.2006.04.010; HOLLENBERG SM, 1993, P NATL ACAD SCI USA, V90, P8028, DOI 10.1073/pnas.90.17.8028; Iezzi S, 2004, DEV CELL, V6, P673, DOI 10.1016/S1534-5807(04)00107-8; Ishibashi J, 2005, J CELL BIOL, V171, P471, DOI 10.1083/jcb.200502101; LASSAR AB, 1991, CELL, V66, P305, DOI 10.1016/0092-8674(91)90620-E; LYONS GE, 1991, DEVELOPMENT, V113, P1017; Ma KW, 2005, MOL CELL BIOL, V25, P3575, DOI 10.1128/MCB.25.9.3575-3582.2005; MA PCM, 1994, CELL, V77, P451, DOI 10.1016/0092-8674(94)90159-7; Mal A, 2001, EMBO J, V20, P1739, DOI 10.1093/emboj/20.7.1739; Martinez-Balbas MA, 2000, EMBO J, V19, P662, DOI 10.1093/emboj/19.4.662; McKinsey TA, 2001, CURR OPIN GENET DEV, V11, P497, DOI 10.1016/S0959-437X(00)00224-0; Molkentin JD, 1995, CELL, V83, P1125, DOI 10.1016/0092-8674(95)90139-6; MURRE C, 1989, CELL, V58, P537, DOI 10.1016/0092-8674(89)90434-0; Naya FJ, 1999, CURR OPIN CELL BIOL, V11, P683, DOI 10.1016/S0955-0674(99)00036-8; Penn BH, 2004, GENE DEV, V18, P2348, DOI 10.1101/gad.1234304; Polesskaya A, 2000, J BIOL CHEM, V275, P34359, DOI 10.1074/jbc.M003815200; Polesskaya A, 2001, MOL CELL BIOL, V21, P5312, DOI 10.1128/MCB.21.16.5312-5320.2001; Polesskaya A, 2001, EMBO J, V20, P6816, DOI 10.1093/emboj/20.23.6816; Puri PL, 2000, J CELL PHYSIOL, V185, P155, DOI 10.1002/1097-4652(200011)185:2<155::AID-JCP1>3.0.CO;2-Z; Puri PL, 2001, MOL CELL, V8, P885, DOI 10.1016/S1097-2765(01)00373-2; Rosenberg MI, 2006, J CELL BIOL, V175, P77, DOI 10.1083/jcb.200603039; RUDNICKI MA, 1995, BIOESSAYS, V17, P203, DOI 10.1002/bies.950170306; Sartorelli V, 1999, MOL CELL, V4, P725, DOI 10.1016/S1097-2765(00)80383-4; Sartorelli V, 2001, FRONT BIOSCI-LANDMRK, V6, pD1024, DOI 10.2741/Sartorel; SASSOON D, 1989, NATURE, V341, P303, DOI 10.1038/341303a0; Simone C, 2004, NAT GENET, V36, P738, DOI 10.1038/ng1378; Solanes G, 2003, MOL ENDOCRINOL, V17, P1944, DOI 10.1210/me.2002-0395; Tapscott SJ, 2005, DEVELOPMENT, V132, P2685, DOI 10.1242/dev.01874; Wyzykowski JC, 2002, MOL CELL BIOL, V22, P6199, DOI 10.1128/MCB.22.17.6199-6208.2002; Yoshida N, 1998, J CELL SCI, V111, P769; Zhao P, 2002, J BIOL CHEM, V277, P30091, DOI 10.1074/jbc.M202668200; Zhao X, 2005, MOL CELL BIOL, V25, P8456, DOI 10.1128/MCB.25.19.8456-8464.2005	44	37	37	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37650	37659		10.1074/jbc.M707309200	http://dx.doi.org/10.1074/jbc.M707309200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17965412	hybrid			2022-12-27	WOS:000251833600041
J	Xu, Y; Zhang, J; Chen, XB				Xu, Yang; Zhang, Jin; Chen, Xinbin			The activity of p53 is differentially regulated by Brm-and Brg1-containing SWI/SNF chromatin remodeling complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL REGULATION; DNA-DAMAGE; CELL-LINES; IN-VIVO; RECRUITMENT; ACTIVATION; PROMOTER; BINDING; FAMILY; GENE	Brahma (Brm) and Brahma-related gene-1 (Brg1) ATPases share similarities in structure and function, but their presence in human SWI/SNF chromatin remodeling complexes is mutually exclusive. Although Brm and Brg1 can compensate for each other, it is possible that Brm and Brg1 have their unique properties to differentially regulate gene expression in vivo. To explore this, we examined the requirement of Brm and Brg1 for p53-dependent transcription, especially p53-mediated induction of p21 and MDM2, using cell lines in which Brm or Brg1 could be inducibly knocked down. We found that Brg1, but not Brm, is required for p21 induction in MCF7 cells. However, in Brg1-deficient H1299 cells, Brm is also required for p21 induction. Likewise, Brm is necessary for induction of p21 in MCF7 cells in which Brg1 is stably knocked down. In contrast, Brg1 has little, if any, effect on p53-mediated induction of MDM2 in cells that have Brm and vice versa. In addition, we demonstrated that the impaired induction of p21 upon Brg1 knockdown is at least in part due to decreased p53 binding to the p21 promoter. Taken together, we provided evidence that Brg1 is preferentially recruited by p53 for inducing a subset of target genes through chromatin remodeling. Thus, we hypothesize that the potential tumor suppressor function for Brg1 is mediated in part through the p53 pathway.	[Xu, Yang; Zhang, Jin; Chen, Xinbin] Univ Calif Davis, Ctr Comparat Oncol, Davis, CA 95616 USA; [Xu, Yang] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Hematol, Hangzhou 310009, Peoples R China	University of California System; University of California Davis; Zhejiang University	Chen, XB (corresponding author), Univ Calif Davis, Ctr Comparat Oncol, 2128 Tupper Hall, Davis, CA 95616 USA.	xbchen@ucdavis.edu			NCI NIH HHS [CA076069, CA102188, CA081237] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R29CA076069, R01CA076069, R01CA102188, R01CA081237] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Barlev NA, 2001, MOL CELL, V8, P1243, DOI 10.1016/S1097-2765(01)00414-2; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; Coisy-Quivy M, 2006, CANCER RES, V66, P5069, DOI 10.1158/0008-5472.CAN-05-0596; Cosma MP, 2002, MOL CELL, V10, P227, DOI 10.1016/S1097-2765(02)00604-4; EISEN JA, 1995, NUCLEIC ACIDS RES, V23, P2715, DOI 10.1093/nar/23.14.2715; Espinosa JM, 2003, MOL CELL, V12, P1015, DOI 10.1016/S1097-2765(03)00359-9; Espinosa JM, 2001, MOL CELL, V8, P57, DOI 10.1016/S1097-2765(01)00283-0; Gartel AL, 1999, EXP CELL RES, V246, P280, DOI 10.1006/excr.1998.4319; Harms K, 2004, CELL MOL LIFE SCI, V61, P822, DOI 10.1007/s00018-003-3304-4; Harms KL, 2005, MOL CELL BIOL, V25, P2014, DOI 10.1128/MCB.25.5.2014-2030.2005; Kadam S, 2003, MOL CELL, V11, P377, DOI 10.1016/S1097-2765(03)00034-0; Kaeser MD, 2002, P NATL ACAD SCI USA, V99, P95, DOI 10.1073/pnas.012283399; Khorasanizadeh S, 2004, CELL, V116, P259, DOI 10.1016/S0092-8674(04)00044-3; Kingston RE, 1999, GENE DEV, V13, P2339, DOI 10.1101/gad.13.18.2339; Lee D, 2002, J BIOL CHEM, V277, P22330, DOI 10.1074/jbc.M111987200; Liu G, 2006, MOL CELL BIOL, V26, P1398, DOI 10.1128/MCB.26.4.1398-1413.2006; Liu G, 2003, J BIOL CHEM, V278, P17557, DOI 10.1074/jbc.M210696200; Liu K, 2004, GENE DEV, V18, P673, DOI 10.1101/gad.1180204; Liu R, 2001, CELL, V106, P309, DOI 10.1016/S0092-8674(01)00446-9; Mellor J, 2005, MOL CELL, V19, P147, DOI 10.1016/j.molcel.2005.06.023; Mohrmann L, 2005, BBA-GENE STRUCT EXPR, V1681, P59, DOI 10.1016/j.bbaexp.2004.10.005; Nozell S, 2002, ONCOGENE, V21, P1285, DOI 10.1038/sj.onc.1205191; Reisman DN, 2005, APPL IMMUNOHISTO M M, V13, P66, DOI 10.1097/00129039-200503000-00011; Reisman DN, 2003, CANCER RES, V63, P560; Reyes JC, 1998, EMBO J, V17, P6979, DOI 10.1093/emboj/17.23.6979; Roberts CWM, 2004, NAT REV CANCER, V4, P133, DOI 10.1038/nrc1273; Simone C, 2006, J CELL PHYSIOL, V207, P309, DOI 10.1002/jcp.20514; Strobeck MW, 2002, J BIOL CHEM, V277, P4782, DOI 10.1074/jbc.M109532200; Strobeck MW, 2001, J BIOL CHEM, V276, P9273, DOI 10.1074/jbc.M009747200; Szak ST, 2001, MOL CELL BIOL, V21, P3375, DOI 10.1128/MCB.21.10.3375-3386.2001; Vassilev LT, 2004, CELL CYCLE, V3, P419; Vignali M, 2000, MOL CELL BIOL, V20, P1899, DOI 10.1128/MCB.20.6.1899-1910.2000; Wang F, 2004, J BIOL CHEM, V279, P46733, DOI 10.1074/jbc.M409002200; Wang S, 2004, EMBO J, V23, P2293, DOI 10.1038/sj.emboj.7600231; Wong AKC, 2000, CANCER RES, V60, P6171; Zhu JH, 1998, J BIOL CHEM, V273, P13030, DOI 10.1074/jbc.273.21.13030	36	46	46	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37429	37435		10.1074/jbc.M706039200	http://dx.doi.org/10.1074/jbc.M706039200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17938176	hybrid			2022-12-27	WOS:000251833600017
J	McKenzie, M; Liolitsa, D; Akinshina, N; Campanella, M; Sisodiya, S; Hargreaves, I; Nirmalananthan, N; Sweeney, MG; Abou-Sleiman, PM; Wood, NW; Hanna, MG; Duchen, MR				McKenzie, Matthew; Liolitsa, Danae; Akinshina, Natalya; Campanella, Michelangelo; Sisodiya, Sanjay; Hargreaves, Ian; Nirmalananthan, Niranjanan; Sweeney, Mary G.; Abou-Sleiman, Patrick M.; Wood, Nicholas W.; Hanna, Michael G.; Duchen, Michael R.			Mitochondrial ND5 gene variation associated with encephalomyopathy and mitochondrial ATP consumption	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEREDITARY OPTIC NEUROPATHY; STROKE-LIKE EPISODES; DNA MUTATION; LACTIC-ACIDOSIS; MELAS; DISEASE; ENCEPHALOPATHY; IDENTIFICATION; FIBROBLASTS; RESPIRATION	Mitochondrial encephalomyopathy and lactic acidosis with strokelike episodes ( MELAS) is a severe young onset stroke disorder without effective treatment. We have identified a MELAS patient harboring a 13528A -> G mitochondrial DNA ( mtDNA) mutation in the Complex I ND5 gene. This mutation was homoplasmic in mtDNA from patient muscle and nearly homoplasmic (99.9%) in blood. Fibroblasts from the patient exhibited decreased mitochondrial membrane potential (Delta psi(m)) and increased lactate production, consistent with impaired mitochondrial function. Transfer of patient mtDNA to a new nuclear background using transmitochondrial cybrid fusions confirmed the pathogenicity of the 13528A -> G mutation; Complex I-linked respiration and Delta psi(m) were both significantly reduced in patient mtDNA cybrids compared with controls. Inhibition of the adenine nucleotide translocase or the F1F0-ATPase with bongkrekic acid or oligomycin caused a loss of potential in patient mtDNA cybrid mitochondria, indicating a requirement for glycolytically generated ATP to maintain Delta psi(m). This was confirmed by inhibition of glycolysis with 2-deoxy-D-glucose, which caused depletion of ATP and mitochondrial depolarization in patient mtDNA cybrids. These data suggest that in response to impaired respiration due to the mtDNA mutation, mitochondria consume ATP to maintain Delta psi(m), representing a potential pathophysiological mechanism in human mitochondrial disease.	[Akinshina, Natalya; Campanella, Michelangelo; Duchen, Michael R.] UCL, Dept Physiol, London WC1E 6BT, England; [McKenzie, Matthew] La Trobe Univ, Dept Biochem, Melbourne, Vic 3086, Australia; [Liolitsa, Danae; Nirmalananthan, Niranjanan; Hanna, Michael G.] UCL, Inst Neurol, MRC, Ctr Neuromuscular Dis, London WC1N 3BG, England; [Liolitsa, Danae; Hargreaves, Ian; Nirmalananthan, Niranjanan; Sweeney, Mary G.; Abou-Sleiman, Patrick M.; Wood, Nicholas W.; Hanna, Michael G.] UCL, Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England; [Sisodiya, Sanjay] UCL, Inst Neurol, Dept Clin & Expt Epilepsy, London WC1N 3BG, England	University of London; University College London; La Trobe University; University of London; University College London; University of London; University College London; University of London; University College London	Duchen, MR (corresponding author), UCL, Dept Physiol, Gower St, London WC1E 6BT, England.	m.duchen@ucl.ac.uk	Nirmalananthan, Niranjanan/AAF-1115-2019; , Nataly/V-5794-2017; McKenzie, Matthew/H-4926-2019; Hanna, Michael G/B-1995-2009; Hargreaves, Iain/AAJ-6757-2020; duchen, michael/A-2116-2009; Wood, Nicholas W/C-2505-2009; Campanella, Michelangelo/K-8172-2016	, Nataly/0000-0001-5968-6172; McKenzie, Matthew/0000-0001-7508-1800; duchen, michael/0000-0003-2548-4294; Wood, Nicholas W/0000-0002-9500-3348; Hanna, Michael/0000-0003-0825-4075; Campanella, Michelangelo/0000-0002-6948-4184	Medical Research Council [G84/6699] Funding Source: Medline; Wellcome Trust Funding Source: Medline; MRC [G84/6699] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Appleby RD, 1999, EUR J BIOCHEM, V262, P108, DOI 10.1046/j.1432-1327.1999.00350.x; AVNER PR, 1973, EUR J BIOCHEM, V32, P312, DOI 10.1111/j.1432-1033.1973.tb02612.x; Batandier C, 2000, Hum Mutat, V16, P532, DOI 10.1002/1098-1004(200012)16:6<532::AID-HUMU19>3.0.CO;2-P; Bentlage HACM, 1996, HUM MOL GENET, V5, P197, DOI 10.1093/hmg/5.2.197; Brown MD, 2000, J BIOL CHEM, V275, P39831, DOI 10.1074/jbc.M006476200; Dimauro S, 2001, AM J MED GENET, V106, P18, DOI 10.1002/ajmg.1392; Dimauro S, 2005, ANN MED, V37, P222, DOI 10.1080/07853890510007368; Gajewski CD, 2003, MOL BIOL CELL, V14, P3628, DOI 10.1091/mbc.E02-12-0796; GOTO Y, 1992, NEUROLOGY, V42, P545, DOI 10.1212/WNL.42.3.545; Grover GJ, 2004, AM J PHYSIOL-HEART C, V287, pH1747, DOI 10.1152/ajpheart.01019.2003; Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933; Hofhaus G, 1996, J BIOL CHEM, V271, P13155, DOI 10.1074/jbc.271.22.13155; Hudson G, 2005, AM J HUM GENET, V77, P1086, DOI 10.1086/498176; Irwin WA, 2003, NAT GENET, V35, P367, DOI 10.1038/ng1270; James AM, 1999, EUR J BIOCHEM, V259, P462, DOI 10.1046/j.1432-1327.1999.00066.x; James AM, 1996, BIOCHEM J, V318, P401, DOI 10.1042/bj3180401; KING MP, 1992, MOL CELL BIOL, V12, P480, DOI 10.1128/MCB.12.2.480; KOGA Y, 1995, MUSCLE NERVE, pS119; Leyssens A, 1996, J PHYSIOL-LONDON, V496, P111, DOI 10.1113/jphysiol.1996.sp021669; Liolitsa D, 2003, ANN NEUROL, V53, P128, DOI 10.1002/ana.10435; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Man PYW, 2002, J MED GENET, V39, P162, DOI 10.1136/jmg.39.3.162; McFarland R, 2002, NAT GENET, V30, P145, DOI 10.1038/ng819; MOUDY AM, 1995, P NATL ACAD SCI USA, V92, P729, DOI 10.1073/pnas.92.3.729; Pulkes T, 1999, ANN NEUROL, V46, P916, DOI 10.1002/1531-8249(199912)46:6<916::AID-ANA16>3.0.CO;2-R; Santorelli FM, 1997, BIOCHEM BIOPH RES CO, V238, P326, DOI 10.1006/bbrc.1997.7167; Saraste M, 1999, SCIENCE, V283, P1488, DOI 10.1126/science.283.5407.1488; SCOTT ID, 1980, BIOCHEM J, V186, P21, DOI 10.1042/bj1860021; Simbula G, 1997, AM J PHYSIOL-CELL PH, V273, pC479, DOI 10.1152/ajpcell.1997.273.2.C479; St-Pierre J, 2000, P NATL ACAD SCI USA, V97, P8670, DOI 10.1073/pnas.140093597; Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0; Wallace DC, 2001, AM J MED GENET, V106, P71, DOI 10.1002/ajmg.1393; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482	33	55	56	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					36845	36852		10.1074/jbc.M704158200	http://dx.doi.org/10.1074/jbc.M704158200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17940288	hybrid			2022-12-27	WOS:000251646000009
J	Bhowmik, S; Horsman, GP; Bolin, JT; Eltis, LD				Bhowmik, Shiva; Horsman, Geoff P.; Bolin, Jeffrey T.; Eltis, Lindsay D.			The molecular basis for inhibition of BphD, a C-C bond hydrolase involved in polychlorinated biphenyls degradation - Large 3-substituents prevent tautomerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2-HYDROXY-6-KETO-NONA-2,4-DIENE-1,9-DIOIC ACID 5,6-HYDROLASE; MICROBIAL-DEGRADATION; CATALYTIC MECHANISM; CHLORINE SUBSTITUTION; SERINE HYDROLASE; KINETIC-ANALYSIS; X-RAY; ENZYMES; CRYSTALLOGRAPHY; IDENTIFICATION	The microbial degradation of polychlorinated biphenyls (PCBs) by the biphenyl catabolic (Bph) pathway is limited in part by the pathway's fourth enzyme, BphD. BphD catalyzes an unusual carbon-carbon bond hydrolysis of 2-hydroxy-6-oxo-6phenylhexa-2,4-dienoic acid (HOPDA), in which the substrate is subject to histidine-mediated enol-keto tautomerization prior to hydrolysis. Chlorinated HOPDAs such as 3-Cl HOPDA inhibit BphD. Here we report that BphD preferentially hydrolyzed a series of 3-substituted HOPDAs in the order H > F > Cl > Me, suggesting that catalysis is affected by steric, not electronic, determinants. Transient state kinetic studies performed using wild-type BphD and the hydrolysis-defective S112A variant indicated that large 3-substituents inhibited His-265-catalyzed tautomerization by 5 orders of magnitude. Structural analyses of S112A center dot 3-Cl HOPDA and S112A center dot 3,10-diF HOPDA complexes revealed a non-productive binding mode in which the plane defined by the carbon atoms of the dienoate moiety of HOPDA is nearly orthogonal to that of the proposed keto tautomer observed in the S112A center dot HOPDA complex. Moreover, in the 3-Cl HOPDA complex, the 2-hydroxo group is moved by 3.6 A from its position near the catalytic His-265 to hydrogen bond with Arg-190 and access of His-265 is blocked by the 3- Cl substituent. Nonproductive binding may be stabilized by interactions involving the 3-substituent with non-polar side chains. Solvent molecules have poor access to C6 in the S112A center dot 3- Cl HOPDA structure, more consistent with hydrolysis occurring via an acyl-enzyme than a gem-diol intermediate. These results provide insight into engineering BphD for PCB degradation.	Purdue Univ, Ctr Canc, Markey Ctr Struct Biol, Dept Biol Sci, W Lafayette, IN 47907 USA; Univ British Columbia, Inst Life Sci, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Inst Life Sci, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada	Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of British Columbia; University of British Columbia	Eltis, LD (corresponding author), Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	leltis@interchange.ubc.ca	Eltis, Lindsay D/J-8272-2015; Horsman, Geoff/AAQ-2349-2020	Eltis, Lindsay D/0000-0002-6774-8158; Horsman, Geoff/0000-0002-2023-2349				ALLEN FH, 1987, J CHEM SOC PERK T 2, pS1, DOI 10.1039/p298700000s1; Allred A.L, 1958, J INORG NUCL CHEM, V5, P215; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Camps P, 1999, J MED CHEM, V42, P3227, DOI 10.1021/jm980620z; Cornish-Bowden A., 1995, ANAL ENZYME KINETIC; Cruickshank DWJ, 1999, ACTA CRYSTALLOGR D, V55, P583, DOI 10.1107/S0907444998012645; Dai SD, 2002, NAT STRUCT BIOL, V9, P934, DOI 10.1038/nsb866; Dvir H, 2002, BIOCHEMISTRY-US, V41, P2970, DOI 10.1021/bi011652i; Fleming SM, 2000, BIOCHEMISTRY-US, V39, P1522, DOI 10.1021/bi9923095; Fortin PD, 2006, J BACTERIOL, V188, P4424, DOI 10.1128/JB.01849-05; FURUKAWA K, 1978, APPL ENVIRON MICROB, V35, P223, DOI 10.1128/AEM.35.2.223-227.1978; FURUKAWA K, 1979, APPL ENVIRON MICROB, V38, P301, DOI 10.1128/AEM.38.2.301-310.1979; Henderson IMJ, 1997, BIOCHEMISTRY-US, V36, P12252, DOI 10.1021/bi971116j; Holmquist M, 2000, CURR PROTEIN PEPT SC, V1, P209, DOI 10.2174/1389203003381405; Horsman GP, 2007, J BIOL CHEM, V282, P19894, DOI 10.1074/jbc.M702237200; Horsman GP, 2006, BIOCHEMISTRY-US, V45, P11071, DOI 10.1021/bi0611098; Jacobson JL, 1996, NEW ENGL J MED, V335, P783, DOI 10.1056/NEJM199609123351104; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Knerr S, 2006, CRIT REV TOXICOL, V36, P663, DOI 10.1080/10408440600845304; Lam WWY, 1997, BIOCHEMISTRY-US, V36, P12242, DOI 10.1021/bi971115r; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li C, 2005, J MOL BIOL, V346, P241, DOI 10.1016/j.jmb.2004.11.032; Li JJ, 2007, ORG BIOMOL CHEM, V5, P507, DOI 10.1039/b615605c; Li JJ, 2006, BIOCHEMISTRY-US, V45, P12461, DOI 10.1021/bi0612519; LIU H, 1992, J CHEM EDUC, V69, P783; Mozaffarian D, 2006, JAMA-J AM MED ASSOC, V296, P1885, DOI 10.1001/jama.296.15.1885; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nerdinger S, 1999, CHEM COMMUN, P2259, DOI 10.1039/a907279i; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pieper DH, 2005, APPL MICROBIOL BIOT, V67, P170, DOI 10.1007/s00253-004-1810-4; Rengarajan J, 2005, P NATL ACAD SCI USA, V102, P8327, DOI 10.1073/pnas.0503272102; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Seah SYK, 2007, J BACTERIOL, V189, P4038, DOI 10.1128/JB.01950-06; Seah SYK, 1998, J BIOL CHEM, V273, P22943, DOI 10.1074/jbc.273.36.22943; Seah SYK, 2001, J BACTERIOL, V183, P1511, DOI 10.1128/JB.183.5.1511-1516.2001; Seah SYK, 2000, J BIOL CHEM, V275, P15701, DOI 10.1074/jbc.275.21.15701; SEEGER M, 1995, APPL ENVIRON MICROB, V61, P2654, DOI 10.1128/AEM.61.7.2654-2658.1995; SETO M, 1995, APPL ENVIRON MICROB, V61, P3353, DOI 10.1128/AEM.61.9.3353-3358.1995; Speare DM, 2004, ORG BIOMOL CHEM, V2, P2942, DOI 10.1039/b410322j; Speare DM, 2002, CHEM COMMUN, P2304, DOI 10.1039/b208168g; Toft G, 2004, REPROD TOXICOL, V19, P5, DOI 10.1016/j.reprotox.2004.05.006; Vaillancourt FH, 2002, J BIOL CHEM, V277, P2019, DOI 10.1074/jbc.M106890200; Van der Geize R, 2007, P NATL ACAD SCI USA, V104, P1947, DOI 10.1073/pnas.0605728104; Word JM, 1999, J MOL BIOL, V285, P1735, DOI 10.1006/jmbi.1998.2401; Zhao YH, 2003, J ORG CHEM, V68, P7368, DOI 10.1021/jo034808o	46	18	28	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36377	36385		10.1074/jbc.M707035200	http://dx.doi.org/10.1074/jbc.M707035200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17932031	hybrid			2022-12-27	WOS:000251458300029
J	Okada, M; Jang, SW; Ye, KQ				Okada, Masashi; Jang, Sung-Wuk; Ye, Keqiang			Ebp1 association with nucleophosmin/B23 is essential for regulating cell proliferation and suppressing apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ERBB-3 BINDING-PROTEIN; NUCLEAR MATRIX PROTEIN; RIBONUCLEOPROTEIN COMPLEXES; CENTROSOME DUPLICATION; MEDIATED TRANSCRIPTION; RIBOSOME BIOGENESIS; TUMOR-SUPPRESSOR; 3T3 FIBROBLASTS; GROWTH-FACTOR; EXPRESSION	Ebp1 and NPM/B23 are essential for cell proliferation and survival. Ebp1 possesses p42 and p48 isoforms. Whereas p42 exclusively resides in the cytoplasm, p48 localizes in both the cytoplasm and the nucleolus. Here, we show that Ebp1 forms a complex with B23, and this complex plays a critical role in cell proliferation and survival. p42 specifically associates with B23 upon epidermal growth factor stimulation, while p48 constantly binds B23. Moreover, Ser(360) phosphorylation in p42, but not p48, is critical for the interaction. p48 constitutively binds B23 in the nucleolus, for which B23 Lys(263) sumoylation is indispensable. By contrast, p42 selectively binds unsumoylated B23 mutants. Interestingly, B23 K263R, an unsumoylated mutant, triggers p42 nuclear translocation and interacts with it in the nucleus even in the absence of epidermal growth factor. In contrast, the nucleolar residency of p48 is abolished in B23 K263R cells. During the cell cycle, p42 selectively colocalizes with B23 in the mitotic cells, correlating with its phosphorylation status in mitosis. Knocking down of B23 or Ebp1 substantially decreases ribosome biogenesis and cell survival. Thus, B23 distinctively binds Ebp1 isoforms and regulates cell proliferation and survival through p42 and p48, respectively.	Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA	Emory University	Ye, KQ (corresponding author), Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA.	kye@emory.edu	Okada, Masashi/AAC-2171-2021		NINDS NIH HHS [R01,NS045627] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045627] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ahn JY, 2006, EMBO J, V25, P2083, DOI 10.1038/sj.emboj.7601111; Ahn JY, 2005, MOL CELL, V18, P435, DOI 10.1016/j.molcel.2005.04.010; Colombo E, 2005, MOL CELL BIOL, V25, P8874, DOI 10.1128/MCB.25.20.8874-8886.2005; Colombo E, 2002, NAT CELL BIOL, V4, P529, DOI 10.1038/ncb814; FEUERSTEIN N, 1988, J CELL BIOL, V107, P1629, DOI 10.1083/jcb.107.5.1629; FEUERSTEIN N, 1987, J BIOL CHEM, V262, P11389; Grisendi S, 2005, NATURE, V437, P147, DOI 10.1038/nature03915; HADJIOLOVA KV, 1994, MOL CELL BIOL, V14, P4044, DOI 10.1128/MCB.14.6.4044; HERRERA JE, 1995, NUCLEIC ACIDS RES, V23, P3974, DOI 10.1093/nar/23.19.3974; Higuchi Y, 1998, BIOCHEM BIOPH RES CO, V248, P597, DOI 10.1006/bbrc.1998.8978; Huang N, 2005, J BIOL CHEM, V280, P5496, DOI 10.1074/jbc.M407856200; Itahana K, 2003, MOL CELL, V12, P1151, DOI 10.1016/S1097-2765(03)00431-3; Jiang PS, 2000, CANCER LETT, V153, P151, DOI 10.1016/S0304-3835(00)00362-1; Kondo T, 1997, ONCOGENE, V15, P1275, DOI 10.1038/sj.onc.1201286; Kowalinski E, 2007, ACTA CRYSTALLOGR F, V63, P768, DOI 10.1107/S1744309107038985; Kurki S, 2004, CELL CYCLE, V3, P976; Lessor TJ, 2000, J CELL PHYSIOL, V183, P321, DOI 10.1002/(SICI)1097-4652(200006)183:3<321::AID-JCP4>3.0.CO;2-O; Liu X, 2007, P NATL ACAD SCI USA, V104, P9679, DOI 10.1073/pnas.0701806104; Liu ZX, 2006, P NATL ACAD SCI USA, V103, P10917, DOI 10.1073/pnas.0602923103; Monie TP, 2007, EMBO J, V26, P3936, DOI 10.1038/sj.emboj.7601817; Nozawa Y, 1996, J PATHOL, V178, P48; Okuda M, 2000, CELL, V103, P127, DOI 10.1016/S0092-8674(00)00093-3; Ou K, 2006, J PROTEOME RES, V5, P2194, DOI 10.1021/pr060115n; Pinol-Roma S, 1999, MOL BIOL CELL, V10, P77, DOI 10.1091/mbc.10.1.77; RADOMSKI N, 1995, EXP CELL RES, V220, P434, DOI 10.1006/excr.1995.1335; Savkur RS, 1998, NUCLEIC ACIDS RES, V26, P4508, DOI 10.1093/nar/26.19.4508; SCHMIDTZACHMANN MS, 1988, CHROMOSOMA, V96, P417, DOI 10.1007/BF00303035; SCHMIDTZACHMANN MS, 1987, EMBO J, V6, P1881, DOI 10.1002/j.1460-2075.1987.tb02447.x; Squatrito M, 2006, BIOCHEM BIOPH RES CO, V344, P859, DOI 10.1016/j.bbrc.2006.03.205; Squatrito M, 2004, ONCOGENE, V23, P4454, DOI 10.1038/sj.onc.1207579; Tago K, 2005, P NATL ACAD SCI USA, V102, P7689, DOI 10.1073/pnas.0502978102; Takemura M, 2002, EXP CELL RES, V276, P233, DOI 10.1006/excr.2002.5523; Tokuyama Y, 2001, J BIOL CHEM, V276, P21529, DOI 10.1074/jbc.M100014200; Wu MH, 2002, CARCINOGENESIS, V23, P93, DOI 10.1093/carcin/23.1.93; Wu MH, 2002, J BIOL CHEM, V277, P48234, DOI 10.1074/jbc.M206550200; Xia XM, 2001, J CELL PHYSIOL, V187, P209, DOI 10.1002/jcp.1075; Ye KQ, 1998, P NATL ACAD SCI USA, V95, P1601, DOI 10.1073/pnas.95.4.1601; Ye KQ, 1999, J NEUROSCI, V19, P10747, DOI 10.1523/JNEUROSCI.19-24-10747.1999; Yoo JY, 2000, BRIT J CANCER, V82, P683; Zhang YX, 2005, NUCLEIC ACIDS RES, V33, P6024, DOI 10.1093/nar/gki903; Zhang YX, 2005, P NATL ACAD SCI USA, V102, P9890, DOI 10.1073/pnas.0503829102; Zhang YX, 2004, J BIOL CHEM, V279, P26126, DOI 10.1074/jbc.M314305200; Zhang YX, 2003, NUCLEIC ACIDS RES, V31, P2168, DOI 10.1093/nar/gkg318; Zhang YX, 2002, ONCOGENE, V21, P5609, DOI 10.1038/sj.onc.1205638; Zirwes RF, 1997, MOL BIOL CELL, V8, P231, DOI 10.1091/mbc.8.2.231	45	45	50	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36744	36754		10.1074/jbc.M706169200	http://dx.doi.org/10.1074/jbc.M706169200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17951246	hybrid			2022-12-27	WOS:000251458300067
J	Choi, SJ; Gustafson-Wagner, EA; Wang, QC; Harlan, SM; Sinn, HW; Lin, JLC; Lin, JJC				Choi, Sunju; Gustafson-Wagner, Elisabeth A.; Wang, Qinchuan; Harlan, Shannon M.; Sinn, Haley W.; Lin, Jenny L. -C.; Lin, Jim J. -C.			Loss of mXin alpha, an intercalated disk protein, results in cardiac hypertrophy and cardiomyopathy with conduction defects	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CATENIN; XIN-REPEATS; N-CADHERIN; ACTIN; COMPLEX; GENE; ASSOCIATION; ISOFORMS; WNT	Targeted deletion of mXin alpha results in cardiac hypertrophy and cardiomyopathy with conduction defects (Gustafson-Wagner, E., Sinn, H. W., Chen, Y.-L., Wang, D.-Z., Reiter, R. S., Lin, J.L.-C., Yang, B., Williamson, R. A., Chen, J.N., Lin, C.-I., and Lin, J.J.-C. ( 2007) Am. J. Physiol. 293, H2680 - H2692). To understand the underlying mechanisms leading to such cardiac defects, the functional domains of mXin alpha and its interacting proteins were investigated. Interaction studies using co-immunoprecipitation, pull-down, and yeast two-hybrid assays revealed that mXin alpha directly interacts with beta-catenin. The beta-catenin-binding site on mXin alpha was mapped to amino acids 535 - 636, which overlaps with the known actin-binding domains composed of the Xin repeats. The overlapping nature of these domains provides insight into the molecular mechanism for mXin alpha localization and function. Purified recombinant glutathione S-transferase- or His-tagged mXin alpha proteins are capable of binding and bundling actin filaments, as determined by co-sedimentation and electron microscopic studies. The binding to actin was saturated at an approximate stoichiometry of nine actin monomers to one mXin alpha. A stronger interaction was observed between mXin alpha C-terminal deletion and actin as compared with the interaction between full-length mXin alpha and actin. Furthermore, force expression of green fluorescent protein fused to an mXin alpha C-terminal deletion in cultured cells showed greater stress fiber localization compared with force-expressed GFP-mXin alpha. These results suggest a model whereby the C terminus of mXin alpha may prevent the full-length molecule from binding to actin, until the beta-catenin- binding domain is occupied by beta-catenin. The binding of mXin alpha to beta-catenin at the adherens junction would then facilitate actin binding. In support of this model, we found that the actin binding and bundling activity of mXin alpha was enhanced in the presence of beta-catenin.	Univ Iowa, Dept Biol Sci, Iowa City, IA 52242 USA	University of Iowa	Lin, JJC (corresponding author), Univ Iowa, Dept Biol Sci, 340 Biol Bldg E,210 E Iowa Ave, Iowa City, IA 52242 USA.	jim-lin@uiowa.edu	Wang, Qinchuan/AAH-5614-2021	Wang, Qinchuan/0000-0002-2359-3262	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075015] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL075015-04, HL075015, R01 HL075015] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Cherepanova O, 2006, J MOL BIOL, V356, P714, DOI 10.1016/j.jmb.2005.11.082; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; CHOU PY, 1990, PREDICTION PROTEIN S, P549; CLONTECH, 1999, MATCHMAKER 2 HYBRID; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Gates J, 2005, CELL, V123, P769, DOI 10.1016/j.cell.2005.11.009; Gonsior SM, 1998, J MUSCLE RES CELL M, V19, P225, DOI 10.1023/A:1005372915268; Gustafson-Wagner EA, 2007, AM J PHYSIOL-HEART C, V293, pH2680, DOI 10.1152/ajpheart.00806.2007; Hertig CM, 1996, J CELL SCI, V109, P11; Huang HT, 2006, J BIOL CHEM, V281, P39370, DOI 10.1074/jbc.M603244200; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; JI XH, 1992, BIOCHEMISTRY-US, V31, P10169, DOI 10.1021/bi00157a004; Jung-Ching Lin Jim, 2005, J Med Sci, V25, P215; Li Y, 2004, J CELL SCI, V117, P3593, DOI 10.1242/jcs.01216; Lin JJC, 2001, CARDIOVAS MOL MORPH, P75; Lukoyanova N, 2002, CURR BIOL, V12, P383, DOI 10.1016/S0960-9822(02)00678-4; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; NOVY RE, 1993, CELL MOTIL CYTOSKEL, V26, P248, DOI 10.1002/cm.970260308; Ong LL, 1998, DEV BIOL, V193, P1, DOI 10.1006/dbio.1997.8775; Pacholsky D, 2004, J CELL SCI, V117, P5257, DOI 10.1242/jcs.01406; Pokutta S, 2000, MOL CELL, V5, P533, DOI 10.1016/S1097-2765(00)80447-5; Pokutta S, 2002, CURR OPIN STRUC BIOL, V12, P255, DOI 10.1016/S0959-440X(02)00318-4; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; Reynolds AB, 2004, ONCOGENE, V23, P7947, DOI 10.1038/sj.onc.1208161; RUBINFELD B, 1993, SCIENCE, V262, P1731, DOI 10.1126/science.8259518; Sadot E, 1998, P NATL ACAD SCI USA, V95, P15339, DOI 10.1073/pnas.95.26.15339; Shih IM, 2000, CANCER RES, V60, P1671; Sinn HW, 2002, DEV DYNAM, V225, P1, DOI 10.1002/dvdy.10131; Soll DR, 1998, TECH MOD B, P25; SOLL DR, 1995, INT REV CYTOL, V8, P439; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; SU LK, 1993, SCIENCE, V262, P1734, DOI 10.1126/science.8259519; van der Flier A, 2002, J CELL BIOL, V156, P361, DOI 10.1083/jcb.200103037; van der Ven PFM, 2006, EXP CELL RES, V312, P2154, DOI 10.1016/j.yexcr.2006.03.015; Wang DZ, 1999, DEVELOPMENT, V126, P1281; Xing Y, 2003, GENE DEV, V17, P2753, DOI 10.1101/gad.1142603; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020	40	35	38	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					36024	36036		10.1074/jbc.M707639200	http://dx.doi.org/10.1074/jbc.M707639200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17925400	Green Accepted, hybrid			2022-12-27	WOS:000251458100062
J	Rampazzo, C; Fabris, S; Franzolin, E; Crovatto, K; Frangini, M; Bianchi, V				Rampazzo, Chiara; Fabris, Sonia; Franzolin, Elisa; Crovatto, Katia; Frangini, Miriam; Bianchi, Vera			Mitochondrial thymidine kinase and the enzymatic network regulating thymidine triphosphate pools in cultured human cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBONUCLEOTIDE REDUCTASE GENE; NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY; DNA DEPLETION; EXPRESSION; P53; SUBSTRATE; TARGET; DEOXYRIBONUCLEOTIDES; 5'-NUCLEOTIDASES; IDENTIFICATION	In non-proliferating cells mitochondrial (mt) thymidine kinase (TK2) salvages thymidine derived from the extracellular milieu for the synthesis of mt dTTP. TK2 is a synthetic enzyme in a network of cytosolic and mt proteins with either synthetic or catabolic functions regulating the dTTP pool. In proliferating cultured cells the canonical cytosolic ribonucleotide reductase (R1-R2) is the prominent synthetic enzyme that by de novo synthesis provides most of dTTP for mt DNA replication. In non-proliferating cells p53R2 substitutes for R2. Catabolic enzymes safeguard the size of the dTTP pool: thymidine phosphorylase by degradation of thymidine and deoxyribonucleotidases by degradation of dTMP. Genetic deficiencies in three of the participants in the network, TK2, p53R2, or thymidine phosphorylase, result in severe mt DNA pathologies. Here we demonstrate the interdependence of the different enzymes of the network. We quantify changes in the size and turnover of the dTTP pool after inhibition of TK2 by RNA interference, of p53R2 with hydroxyurea, and of thymidine phosphorylase with 5-bromouracil. In proliferating cells the de novo pathway dominates, supporting large cytosolic and mt dTTP pools, whereas TK2 is dispensable, even in cells lacking the cytosolic thymidine kinase. In non-proliferating cells the small dTTP pools depend on the activities of both R1-p53R2 and TK2. The activity of TK2 is curbed by thymidine phosphorylase, which degrades thymidine in the cytoplasm, thus limiting the availability of thymidine for phosphorylation by TK2 in mitochondria. The dTTP pool shows an exquisite sensitivity to variations of thymidine concentrations at the nanomolar level.	Univ Padua, Dept Biol, I-35131 Padua, Italy	University of Padua	Bianchi, V (corresponding author), Univ Padua, Dept Biol, Via Ugo Bassi 58B, I-35131 Padua, Italy.	vbianchi@bio.unipd.it	Frangini, Miriam/I-3532-2013		Fondazione Telethon Funding Source: Custom; Telethon [GGP05001] Funding Source: Medline	Fondazione Telethon(Fondazione Telethon); Telethon(Fondazione Telethon)		ARNER ESJ, 1995, PHARMACOL THERAPEUT, V67, P155, DOI 10.1016/0163-7258(95)00015-9; BERK AJ, 1973, J BIOL CHEM, V248, P2722; BIANCHI V, 1986, J BIOL CHEM, V261, P6037; Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bridges EG, 1999, J BIOL CHEM, V274, P4620, DOI 10.1074/jbc.274.8.4620; Byun DS, 2002, INT J CANCER, V98, P718, DOI 10.1002/ijc.10253; Chabes AL, 2003, P NATL ACAD SCI USA, V100, P3925, DOI 10.1073/pnas.0330774100; Coller HA, 2006, PLOS BIOL, V4, P329, DOI 10.1371/journal.pbio.0040083; Ferraro P, 2005, J BIOL CHEM, V280, P24472, DOI 10.1074/jbc.M502869200; Ferraro P, 2006, P NATL ACAD SCI USA, V103, P18586, DOI 10.1073/pnas.0609020103; Franzolin E, 2006, BIOCHEM BIOPH RES CO, V344, P30, DOI 10.1016/j.bbrc.2006.03.147; Gazziola C, 2001, J BIOL CHEM, V276, P6185, DOI 10.1074/jbc.M007623200; Hakansson P, 2006, J BIOL CHEM, V281, P7834, DOI 10.1074/jbc.M512894200; Itahana K, 2002, J BIOL CHEM, V277, P18206, DOI 10.1074/jbc.M201028200; Johansson M, 1997, J BIOL CHEM, V272, P8454, DOI 10.1074/jbc.272.13.8454; Johansson M, 1996, P NATL ACAD SCI USA, V93, P7258, DOI 10.1073/pnas.93.14.7258; Jordheim LP, 2005, MOL CANCER THER, V4, P1268, DOI 10.1158/1535-7163.MCT-05-0121; Ke PY, 2004, MOL CELL BIOL, V24, P514, DOI 10.1128/MCB.24.2.514-526.2004; Magnusson J, 2003, EXP CELL RES, V289, P133, DOI 10.1016/S0014-4827(03)00249-0; Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746; Marobbio CMT, 2006, BIOCHEM J, V393, P441, DOI 10.1042/BJ20051284; Marti R, 2004, CLIN CHEM, V50, P120, DOI 10.1373/clinchem.2003.026179; Matsukawa K, 1996, BBA-MOL CELL RES, V1314, P71, DOI 10.1016/S0167-4889(96)00078-X; Mrass P, 2004, CANCER RES, V64, P6542, DOI 10.1158/0008-5472.CAN-04-1129; MUNCHPETERSEN B, 1991, J BIOL CHEM, V266, P9032; Nakano K, 2000, ONCOGENE, V19, P4283, DOI 10.1038/sj.onc.1203774; Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pontarin G, 2007, J BIOL CHEM, V282, P16820, DOI 10.1074/jbc.M701310200; Pontarin G, 2006, J BIOL CHEM, V281, P22720, DOI 10.1074/jbc.M604498200; Rampazzo C, 2004, J BIOL CHEM, V279, P17019, DOI 10.1074/jbc.M313957200; Rampazzo C, 2002, BIOCHEM BIOPH RES CO, V293, P258, DOI 10.1016/S0006-291X(02)00206-1; Rylova SN, 2007, BIOCHEM PHARMACOL, V74, P169, DOI 10.1016/j.bcp.2007.03.029; Saada A, 2003, MOL GENET METAB, V79, P1, DOI 10.1016/S1096-7192(03)00063-5; Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751; SHERMAN PA, 1989, ANAL BIOCHEM, V180, P222, DOI 10.1016/0003-2697(89)90420-X; Tanaka H, 2000, NATURE, V404, P42, DOI 10.1038/35003506; van de Wetering M, 2003, EMBO REP, V4, P609, DOI 10.1038/sj.embor.embor865; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vozza A, 2004, J BIOL CHEM, V279, P20850, DOI 10.1074/jbc.M313610200	41	38	38	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					34758	34769		10.1074/jbc.M705923200	http://dx.doi.org/10.1074/jbc.M705923200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17913703	hybrid			2022-12-27	WOS:000251155200018
J	Sundermeier, TR; Karzai, AW				Sundermeier, Thomas R.; Karzai, A. Wali			Functional SmpB-ribosome interactions require tmRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-MESSENGER-RNA; SMALL PROTEIN-B; MEDIATED TRANS-TRANSLATION; ESCHERICHIA-COLI; STALLED RIBOSOME; TAGGING ACTIVITY; DEGRADATION; BINDING; RESCUE; SYSTEM	Small protein B (SmpB) is a requisite component of the transfer messenger RNA (tmRNA)-mediated bacterial translational quality control system known as trans-translation. The initial binding of tmRNA and its subsequent accommodation into the ribosomal A-site are activities intimately linked to SmpB protein function. From a mechanistic perspective, two key unanswered questions that require further investigation are: 1) what constitutes a stalled ribosome recognition complex and 2) does SmpB pre-bind ribosomes to recruit tmRNA. We have assessed, both in vivo and in vitro, the nature and stability of free SmpB interactions with stalled ribosomes and examined whether these interactions are functionally relevant. We present evidence to demonstrate that interaction of free SmpB with ribosomes is salt sensitive and significantly more labile than interaction of the SmpB center dot tmRNA complex with ribosomes. Upon dissociation of 70 S ribosomes SmpB partitions primarily with tmRNA rather than ribosomal subunits. This finding is consistent with biochemical and structural data demonstrating that tmRNA is the high-affinity binding partner of SmpB. Moreover, we show that under normal physiological conditions roughly similar numbers of SmpB and tmRNA molecules are present in cells. Our investigations also reveal that upon induction of a nonstop mRNA, SmpB is enriched in stalled ribosome fractions only in the presence of tmRNA. Based on these findings, we conclude that SmpB does not pre-bind stalled ribosome and that functional SmpB-stalled ribosome interactions require tmRNA. We propose that a 1:1:1 complex of SmpB center dot tmRNA center dot EF-Tu(GTP) recognizes and binds a stalled ribosome to initiate trans-translation.	SUNY Stony Brook, Ctr Infect Dis, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Karzai, AW (corresponding author), SUNY Stony Brook, Ctr Infect Dis, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA.	akarzai@ms.cc.sunysb.edu			NIAID NIH HHS [AI055621, P01 AI055621-050003, P01 AI055621] Funding Source: Medline; NIGMS NIH HHS [R01 GM065319, R56 GM065319, GM65319, R01 GM065319-05] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI055621] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM065319, R01GM065319] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barends S, 2000, BIOCHEMISTRY-US, V39, P2652, DOI 10.1021/bi992439d; Barends S, 2002, FEBS LETT, V514, P78, DOI 10.1016/S0014-5793(02)02306-2; Barends S, 2001, J MOL BIOL, V314, P9, DOI 10.1006/jmbi.2001.5114; Bessho Y, 2007, P NATL ACAD SCI USA, V104, P8293, DOI 10.1073/pnas.0700402104; BOREL F, 1993, FEBS LETT, V324, P162, DOI 10.1016/0014-5793(93)81385-D; Choy JS, 2007, J BACTERIOL, V189, P6564, DOI 10.1128/JB.00860-07; Culver GM, 1999, RNA, V5, P832, DOI 10.1017/S1355838299990714; Dulebohn D, 2007, BIOCHEMISTRY-US, V46, P4681, DOI 10.1021/bi6026055; Dulebohn DP, 2006, J BIOL CHEM, V281, P28536, DOI 10.1074/jbc.M605137200; Gillet R, 2007, J BIOL CHEM, V282, P6356, DOI 10.1074/jbc.M609658200; Gottesman S, 1998, GENE DEV, V12, P1338, DOI 10.1101/gad.12.9.1338; Gutmann S, 2003, NATURE, V424, P699, DOI 10.1038/nature01831; Haebel PW, 2004, CURR OPIN STRUC BIOL, V14, P58, DOI 10.1016/j.sbi.2004.01.010; Hallier M, 2006, NUCLEIC ACIDS RES, V34, P1935, DOI 10.1093/nar/gkl097; Hallier M, 2004, J BIOL CHEM, V279, P25978, DOI 10.1074/jbc.M314086200; Hanawa-Suetsugu K, 2002, NUCLEIC ACIDS RES, V30, P1620, DOI 10.1093/nar/30.7.1620; Herman C, 1998, GENE DEV, V12, P1348, DOI 10.1101/gad.12.9.1348; Hong SJ, 2005, MOL MICROBIOL, V57, P565, DOI 10.1111/j.1365-2958.2005.04709.x; Ivanova N, 2005, NUCLEIC ACIDS RES, V33, P3529, DOI 10.1093/nar/gki666; Jacob Y, 2005, J BIOL CHEM, V280, P5503, DOI 10.1074/jbc.M409277200; Karzai AW, 2000, NAT STRUCT BIOL, V7, P449; Karzai AW, 1999, EMBO J, V18, P3793, DOI 10.1093/emboj/18.13.3793; Kaur S, 2006, P NATL ACAD SCI USA, V103, P16484, DOI 10.1073/pnas.0607438103; Keiler KC, 2003, J BACTERIOL, V185, P1825, DOI 10.1128/JB.185.6.1825-1830.2003; Keiler KC, 1996, SCIENCE, V271, P990, DOI 10.1126/science.271.5251.990; LEARN B, 1993, COLD SPRING HARB SYM, V58, P389, DOI 10.1101/SQB.1993.058.01.046; Mehta P, 2006, RNA, V12, P2187, DOI 10.1261/rna.247706; Metzinger L, 2005, NUCLEIC ACIDS RES, V33, P2384, DOI 10.1093/nar/gki534; Moore SD, 2005, MOL MICROBIOL, V58, P456, DOI 10.1111/j.1365-2958.2005.04832.x; Moore SD, 2007, ANNU REV BIOCHEM, V76, P101, DOI 10.1146/annurev.biochem.75.103004.142733; Nameki N, 2005, J BIOCHEM, V138, P729, DOI 10.1093/jb/mvi180; Okan Nihal A., 2006, PLoS Pathogens, V2, P50; Richards J, 2006, MOL MICROBIOL, V62, P1700, DOI 10.1111/j.1365-2958.2006.05472.x; RICHEY B, 1987, J BIOL CHEM, V262, P7157; Shimizu Y, 2002, FEBS LETT, V514, P74, DOI 10.1016/S0014-5793(02)02333-5; Shpanchenko OV, 2005, J BIOL CHEM, V280, P18368, DOI 10.1074/jbc.M409094200; Sundermeier TR, 2005, P NATL ACAD SCI USA, V102, P2316, DOI 10.1073/pnas.0409694102; TU GF, 1995, J BIOL CHEM, V270, P9322, DOI 10.1074/jbc.270.16.9322; Valle M, 2003, SCIENCE, V300, P127, DOI 10.1126/science.1081798; Withey JH, 2003, ANNU REV MICROBIOL, V57, P101, DOI 10.1146/annurev.micro.57.030502.090945; Wower IK, 2004, J BIOL CHEM, V279, P54202, DOI 10.1074/jbc.M410488200; Wower J, 2002, BIOCHEMISTRY-US, V41, P8826, DOI 10.1021/bi0201365; Yamamoto Y, 2003, RNA, V9, P408, DOI 10.1261/rna.2174803	43	25	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					34779	34786		10.1074/jbc.M707256200	http://dx.doi.org/10.1074/jbc.M707256200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17911096	hybrid, Green Accepted			2022-12-27	WOS:000251155200020
J	Domaoal, RA; McMahon, M; Thio, CL; Bailey, CM; Tirado-Rives, J; Obikhod, A; Detorio, M; Rapp, KL; Siliciano, RF; Schinazi, RF; Anderson, KS				Domaoal, Robert A.; McMahon, Moira; Thio, Chloe L.; Bailey, Christopher M.; Tirado-Rives, Julian; Obikhod, Aleksander; Detorio, Mervi; Rapp, Kimberly L.; Siliciano, Robert F.; Schinazi, Raymond F.; Anderson, Karen S.			Pre-steady-state kinetic studies establish entecavir 5 '-triphosphate as a substrate for HIV-1 reverse transcriptase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HEPATITIS-B-VIRUS; DRUG-RESISTANCE; DNA-POLYMERASES; INHIBITION; MECHANISM; TYPE-1; REPLICATION; NUCLEOTIDE; 4'-AZIDOTHYMIDINE	The novel 2 '-deoxyguanosine analog Entecavir (ETV) is a potent inhibitor of hepatitis B virus (HBV) replication and is recommended for treatment in human immunodeficiency virus type 1 (HIV-1) and HBV-co-infected patients because it had been reported that ETV is HBV-specific. Recent clinical observations, however, have suggested that ETV may indeed demonstrate anti-HIV-1 activity. To investigate this question at a molecular level, kinetic studies were used to examine the interaction of 5'-triphosphate form of ETV with wild type (WT) HIV-1 reverse transcriptase (RT) and the nucleoside reverse transcriptase inhibitor-resistant mutation M184V. Using single turnover kinetic assays, we found that HIV-1 WT RT and M184V RT could use the activated ETV triphosphate metabolite as a substrate for incorporation. The mutant displayed a slower incorporation rate, a lower binding affinity, and a lower incorporation efficiency with the 5'-triphosphate form of ETV compared with WTRT, suggesting a kinetic basis for resistance. Our results are supported by cell-based assays in primary human lymphocytes that show inhibition of WT HIV-1 replication by ETV and decreased susceptibility of the HIV-1 containing the M184V mutation. This study has important therapeutic implications as it establishes ETV as an inhibitor for HIV-1 RT and illustrates the mechanism of resistance by the M184V mutant.	[Domaoal, Robert A.; Bailey, Christopher M.; Anderson, Karen S.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; [McMahon, Moira; Thio, Chloe L.; Siliciano, Robert F.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Med, Baltimore, MD 21205 USA; [Obikhod, Aleksander; Detorio, Mervi; Rapp, Kimberly L.; Schinazi, Raymond F.] Emory Univ, Sch Med, Vet Affairs Med Ctr, Decatur, GA 30033 USA; [Tirado-Rives, Julian] Yale Univ, Dept Chem, New Haven, CT 06510 USA	Yale University; Howard Hughes Medical Institute; Johns Hopkins University; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Yale University	Anderson, KS (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, 333 Cedar St, New Haven, CT 06520 USA.	karen.anderson@yale.edu	Tirado-Rives, Julian/A-4992-2012	Tirado-Rives, Julian/0000-0001-7330-189X; Bailey, Chris/0000-0002-5962-9511; McMahon, Moira/0000-0001-9810-8623	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051178, R37AI041980, R37AI051178, R01AI044616, R01AI043222, P30AI050409] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049551] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIAID NIH HHS [5R37-AI-041980, R37 AI051178, R37 AI041980, R01 AI043222, R01 AI051178, 5P30-AI-50409, AI-51178, P30 AI050409, R01 AI044616, AI-44616, AI-43222] Funding Source: Medline; NIGMS NIH HHS [GM-49551, R01 GM049551] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Benson Constance A., 2004, Morbidity and Mortality Weekly Report, V53, P1; Boyer PL, 2005, J MOL BIOL, V345, P441, DOI 10.1016/j.jmb.2004.10.021; CHEN MS, 1992, J BIOL CHEM, V267, P257; CHEN MS, 1993, BIOCHEMISTRY-US, V32, P6002, DOI 10.1021/bi00074a011; Frisch M. J., 2019, GAUSSIAN 16 REVISION; GANEM D, 1994, INFECT AGENT DIS, V3, P85; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; Innaimo SF, 1997, ANTIMICROB AGENTS CH, V41, P1444, DOI 10.1128/AAC.41.7.1444; KATI WM, 1992, J BIOL CHEM, V267, P25988; Kerr SG, 1997, BIOCHEMISTRY-US, V36, P14064, DOI 10.1021/bi9713862; Langley DR, 2007, J VIROL, V81, P3992, DOI 10.1128/JVI.02395-06; Locarnini SA, 1996, ANTIVIR CHEM CHEMOTH, V7, P53, DOI 10.1177/095632029600700201; McMahon MA, 2007, NEW ENGL J MED, V356, P2614, DOI 10.1056/NEJMoa067710; Murakami E, 2005, ANTIVIR RES, V67, P10, DOI 10.1016/j.antiviral.2004.12.004; Nakata H, 2007, ANTIMICROB AGENTS CH, V51, P2701, DOI 10.1128/AAC.00277-07; Ono SK, 2001, J CLIN INVEST, V107, P449, DOI 10.1172/JCI11100; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ray AS, 2002, BIOCHEMISTRY-US, V41, P5150, DOI 10.1021/bi0121858; Rivkin A, 2007, DRUG TODAY, V43, P201, DOI 10.1358/dot.2007.43.4.1037479; SCHINAZI RF, 1990, ANTIMICROB AGENTS CH, V34, P1061, DOI 10.1128/AAC.34.6.1061; SCHINAZI RF, 1992, ANTIMICROB AGENTS CH, V36, P2423, DOI 10.1128/AAC.36.11.2423; SEEGER C, 1991, CURR TOP MICROBIOL, V168, P41; Seifer M, 1998, ANTIMICROB AGENTS CH, V42, P3200, DOI 10.1128/AAC.42.12.3200; Skoog D.A., 1992, PRINCIPLES INSTRUMEN; Soriano V, 2004, J VIRAL HEPATITIS, V11, P2, DOI 10.1046/j.1365-2893.2003.00491.x; 2006, VERSION 7 5; 2006, VERSION 4 0	27	32	33	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5452	5459		10.1074/jbc.M707834200	http://dx.doi.org/10.1074/jbc.M707834200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	17962184	hybrid, Green Accepted			2022-12-27	WOS:000253426700025
J	Venteclef, N; Haroniti, A; Tousaint, JJ; Talianidis, I; Delerive, P				Venteclef, Nicolas; Haroniti, Anna; Tousaint, Jean-Jacques; Talianidis, Iannis; Delerive, Philippe			Regulation of anti-atherogenic apolipoprotein m gene expression by the orphan nuclear receptor LRH-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BILE-ACID BIOSYNTHESIS; STEROIDOGENIC FACTOR-I; ACUTE-PHASE RESPONSE; LIVER-X RECEPTOR; FEEDBACK-REGULATION; HOMOLOG-1 CONTROLS; TRANSCRIPTION; METABOLISM; SHP; INDUCTION	The orphan nuclear receptor liver receptor homolog-1 (LRH-1, NR5A2) has been reported to play a crucial role in early development, in the control of the hepatic inflammatory response, in intestinal cell crypt renewal as well as in bile acid biosynthesis and reverse cholesterol transport (RCT). Here, we report the identification of apolipoprotein M(APOM) as a novel target gene for LRH-1. Using gene-silencing experiments, adenovirus-mediated overexpression, transient transfection, and chromatin immunoprecipitation (ChIP) assays, it is shown that LRH-1 directly regulates human and mouse APOM transcription by binding to an LRH-1 response element located in the proximal APOM promoter region. In addition, we demonstrate that bile acids suppress APOM expression in a SHP-dependent manner in vitro and in vivo by inhibiting LRH-1 transcriptional activity on the APOM promoter as demonstrated by in vivo ChIP assay. Taken together, our results demonstrate that LRH-1 is a novel regulator of APOM transcription and further extend the role of this orphan nuclear receptor in lipoprotein metabolism and cholesterol homeostasis.	[Venteclef, Nicolas; Tousaint, Jean-Jacques; Delerive, Philippe] GlaxoSmithKline R&D, CVU CEDD, F-91951 Les Ulis, France; [Haroniti, Anna; Talianidis, Iannis] Biomed Sci Res Ctr Alexander Fleming, GR-16672 Athens, Greece	GlaxoSmithKline; Alexander Fleming Biomedical Sciences Research Center	Delerive, P (corresponding author), GlaxoSmithKline R&D, CVU CEDD, 25 Ave Quebec, F-91951 Les Ulis, France.	delerive@hotmail.com	Talianidis, Iannis/F-7556-2016; Venteclef, Nicolas/K-8484-2017	Talianidis, Iannis/0000-0002-1209-3609; Venteclef, Nicolas/0000-0002-6313-1214				BARD JM, 1990, METABOLISM, V39, P269, DOI 10.1016/0026-0495(90)90046-F; Botrugno OA, 2004, MOL CELL, V15, P499, DOI 10.1016/j.molcel.2004.07.009; Boulias K, 2005, EMBO J, V24, P2624, DOI 10.1038/sj.emboj.7600728; CASTILLOOLIVARE.A, 2000, J BIOL CHEM, V275, P17793; CASTILLOOLIVARE.A, 2004, J BIOL CHEM, V279, P16813; Chalkiadaki A, 2005, MOL CELL BIOL, V25, P5095, DOI 10.1128/MCB.25.12.5095-5105.2005; Chen F, 2003, J BIOL CHEM, V278, P19909, DOI 10.1074/jbc.M207903200; Christoffersen C, 2006, J LIPID RES, V47, P1833, DOI 10.1194/jlr.M600055-JLR200; Claudel T, 2002, J CLIN INVEST, V109, P961; Clyne CD, 2002, J BIOL CHEM, V277, P20591, DOI 10.1074/jbc.M201117200; Dahlback B, 2006, CURR OPIN LIPIDOL, V17, P291, DOI 10.1097/01.mol.0000226122.10005.88; Delerive P, 2004, MOL ENDOCRINOL, V18, P2378, DOI 10.1210/me.2004-0132; Fayard E, 2003, J BIOL CHEM, V278, P35725, DOI 10.1074/jbc.M302370200; Fayard E, 2004, TRENDS CELL BIOL, V14, P250, DOI 10.1016/j.tcb.2004.03.008; Freeman LA, 2004, J LIPID RES, V45, P1197, DOI 10.1194/jlr.C400002-JLR200; Galarneau L, 1996, MOL CELL BIOL, V16, P3853; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Gu PL, 2005, MOL CELL BIOL, V25, P3492, DOI 10.1128/MCB.25.9.3492-3505.2005; Holt JA, 2003, GENE DEV, V17, P1581, DOI 10.1101/gad.1083503; Huang JS, 2007, HEPATOLOGY, V46, P147, DOI 10.1002/hep.21632; Insull W, 2006, SOUTH MED J, V99, P257, DOI 10.1097/01.smj.0000208120.73327.db; Iwaki M, 2003, DIABETES, V52, P1655, DOI 10.2337/diabetes.52.7.1655; Kouskouti A, 2005, EMBO J, V24, P347, DOI 10.1038/sj.emboj.7600516; Krylova IN, 2005, CELL, V120, P343, DOI 10.1016/j.cell.2005.01.024; Ktistaki E, 1997, SCIENCE, V277, P109, DOI 10.1126/science.277.5322.109; Kyrmizi I, 2006, GENE DEV, V20, P2293, DOI 10.1101/gad.390906; Lee YK, 2006, J BIOL CHEM, V281, P7850, DOI 10.1074/jbc.M509115200; Lee YK, 1999, J BIOL CHEM, V274, P20869, DOI 10.1074/jbc.274.30.20869; Li Y, 2005, MOL CELL, V17, P491, DOI 10.1016/j.molcel.2005.02.002; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; Luo Y, 2001, J BIOL CHEM, V276, P24767, DOI 10.1074/jbc.M100912200; Malerod L, 2005, BIOCHEM BIOPH RES CO, V336, P1096, DOI 10.1016/j.bbrc.2005.08.237; Matsukuma KE, 2007, J BIOL CHEM, V282, P20164, DOI 10.1074/jbc.M702895200; Melter M, 2000, AM J GASTROENTEROL, V95, P3522; Mueller M, 2006, J EXP MED, V203, P2057, DOI 10.1084/jem.20060357; Nitta M, 1999, P NATL ACAD SCI USA, V96, P6660, DOI 10.1073/pnas.96.12.6660; Ortlund EA, 2005, NAT STRUCT MOL BIOL, V12, P357, DOI 10.1038/nsmb910; Pare JF, 2004, J BIOL CHEM, V279, P21206, DOI 10.1074/jbc.M401523200; Rader DJ, 2006, J CLIN INVEST, V116, P3090, DOI 10.1172/JCI30163; Richter S, 2003, DIABETES, V52, P2989, DOI 10.2337/diabetes.52.12.2989; Schoonjans K, 2002, EMBO REP, V3, P1181, DOI 10.1093/embo-reports/kvf238; Shih DQ, 2001, NAT GENET, V27, P375, DOI 10.1038/86871; Srivastava RAK, 2000, EUR J BIOCHEM, V267, P4272, DOI 10.1046/j.1432-1327.2000.01473.x; Suzuki T, 2002, ENDOCR RES, V28, P537, DOI 10.1081/ERC-120016835; Tallet F, 1996, CLIN CHIM ACTA, V244, P1, DOI 10.1016/0009-8981(95)06161-4; Venteclef N, 2007, J BIOL CHEM, V282, P4393, DOI 10.1074/jbc.M608993200; Venteclef N, 2006, MOL CELL BIOL, V26, P6799, DOI 10.1128/MCB.00579-06; Wang W, 2005, P NATL ACAD SCI USA, V102, P7505, DOI 10.1073/pnas.0409482102; Wolfrum C, 2005, NAT MED, V11, P418, DOI 10.1038/nm1211; Xu N, 2004, BIOCHEM BIOPH RES CO, V321, P916, DOI 10.1016/j.bbrc.2004.06.180; Xu N, 1999, J BIOL CHEM, V274, P31286, DOI 10.1074/jbc.274.44.31286	51	50	60	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					3694	3701		10.1074/jbc.M706382200	http://dx.doi.org/10.1074/jbc.M706382200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	17977826	hybrid			2022-12-27	WOS:000253083500002
J	Shankaran, SS; Capell, A; Hruscha, AT; Fellerer, K; Neumann, M; Schmid, B; Haass, C				Shankaran, Sunita S.; Capell, Anja; Hruscha, Alexander T.; Fellerer, Katrin; Neumann, Manuela; Schmid, Bettina; Haass, Christian			Missense mutations in the progranulin gene linked to frontotemporal lobar degeneration with ubiquitin-immunoreactive inclusions reduce progranulin production and secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; GRANULIN-EPITHELIN PRECURSOR; GROWTH-FACTOR PCDGF; CELL-LINE; POSITIVE INCLUSIONS; DEMENTIA; TDP-43; ZEBRAFISH; PROTEIN; TAU	Loss of function mutations in progranulin cause tau-negative frontotemporal lobar degeneration with ubiquitin-positive inclusions. A major protein component of these inclusions is TDP-43, which becomes hyperphosphorylated, ubiquitinated, and cleaved to generate C-terminal fragments, which apparently translocate from nuclei to the cytoplasm. Most progranulin mutations are nonsense mutations resulting in nonsense-mediated mRNA decay and consequently reduced progranulin protein levels. However, some missense mutations are described that occur within the signal sequence and mature progranulin. We now demonstrate that a progranulin mutation located within the signal sequence (PGRN A9D) results in cytoplasmic missorting with extremely low expression. In contrast, two other progranulin mutations (PGRN P248L and R432C) are expressed as immature proteins but are inefficiently transported through and partially degraded within the secretory pathway, resulting in a significantly reduced secretion. Thus apparently all progranulin mutations cause reduced protein expression or secretion, although by different cellular mechanisms. To investigate a putative relationship between reduced expression of progranulin and TDP-43 relocalization and deposition, we down-regulated progranulin in human cell lines and in zebrafish. Upon reduction of progranulin, neither a major redistribution of TDP-43 nor proteolytic processing to disease-characterizing C-terminal fragments could be observed.	[Shankaran, Sunita S.; Capell, Anja; Hruscha, Alexander T.; Fellerer, Katrin; Schmid, Bettina; Haass, Christian] Univ Munich, Dept Biochem, Adolf Butenandt Inst, Lab Neurodegenerat Dis Res, D-80336 Munich, Germany; [Shankaran, Sunita S.; Capell, Anja; Hruscha, Alexander T.; Fellerer, Katrin; Schmid, Bettina; Haass, Christian] Univ Munich, Munich Ctr Integrated Prot Sci, D-80336 Munich, Germany; [Neumann, Manuela] Univ Munich, Ctr Neuropathol & Pr Res, D-80336 Munich, Germany	University of Munich; University of Munich; University of Munich	Haass, C (corresponding author), Univ Munich, Dept Biochem, Adolf Butenandt Inst, Lab Neurodegenerat Dis Res, Schillerstr 44, D-80336 Munich, Germany.	chaass@med.uni-muenchen.de	Neumann, Manuela/F-6558-2011	Neumann, Manuela/0000-0002-6232-4057				Ahmed Z, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-7; Ayala YM, 2006, FEBS LETT, V580, P1339, DOI 10.1016/j.febslet.2006.01.052; Ayala YM, 2005, J MOL BIOL, V348, P575, DOI 10.1016/j.jmb.2005.02.038; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Benussi L, 2008, NEUROBIOL AGING, V29, P427, DOI 10.1016/j.neurobiolaging.2006.10.028; Boeve BF, 2006, BRAIN, V129, P3103, DOI 10.1093/brain/awl268; Buratti E, 2001, EMBO J, V20, P1774, DOI 10.1093/emboj/20.7.1774; Cadieux B, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-156; Cairns NJ, 2007, AM J PATHOL, V171, P227, DOI 10.2353/ajpath.2007.070182; Capell A, 2000, NAT CELL BIOL, V2, P205, DOI 10.1038/35008626; Chiba S, 2007, J REPROD DEVELOP, V53, P297, DOI 10.1262/jrd.18108; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; Daniel R, 2000, J HISTOCHEM CYTOCHEM, V48, P999, DOI 10.1177/002215540004800713; Davidson Y, 2007, ACTA NEUROPATHOL, V113, P521, DOI 10.1007/s00401-006-0189-y; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; He ZH, 2003, J MOL MED-JMM, V81, P600, DOI 10.1007/s00109-003-0474-3; He ZH, 2003, NAT MED, V9, P225, DOI 10.1038/nm816; He ZH, 2002, CANCER RES, V62, P5590; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; IGNATIUS SH, 1995, J VIROL, V69, P3584, DOI 10.1128/JVI.69.6.3584-3596.1995; Josephs KA, 2007, J NEUROPATH EXP NEUR, V66, P142, DOI 10.1097/nen.0b013e31803020cf; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Lu RQ, 2000, P NATL ACAD SCI USA, V97, P3993, DOI 10.1073/pnas.97.8.3993; Mackenzie IRA, 2006, BRAIN, V129, P3081, DOI 10.1093/brain/awl271; Masellis M, 2006, BRAIN, V129, P3115, DOI 10.1093/brain/awl276; Mukherjee O, 2006, ANN NEUROL, V60, P314, DOI 10.1002/ana.20963; MULLINS MC, 1994, CURR BIOL, V4, P189, DOI 10.1016/S0960-9822(00)00048-8; Neary D, 2000, ANN NY ACAD SCI, V920, P46; Neumann M, 2007, J NEUROPATH EXP NEUR, V66, P152, DOI 10.1097/nen.0b013e31803020b9; Neumann M, 2007, J NEUROPATH EXP NEUR, V66, P177, DOI 10.1097/01.jnen.0000248554.45456.58; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Pizarro GO, 2007, INT J CANCER, V120, P2339, DOI 10.1002/ijc.22559; Rademakers R, 2002, MOL PSYCHIATR, V7, P1064, DOI 10.1038/sj.mp.4001198; SCHULTEMERKER S, 1992, DEVELOPMENT, V116, P1021; Schymick JC, 2007, J NEUROL NEUROSUR PS, V78, P754, DOI 10.1136/jnnp.2006.109553; Seelaar H, 2007, BRAIN, V130, P1375, DOI 10.1093/brain/awm024; van der Zee J, 2007, HUM MUTAT, V28, P416, DOI 10.1002/humu.9484; Wang HY, 2004, GENOMICS, V83, P130, DOI 10.1016/S0888-7543(03)00214-3; Zanocco-Marani T, 1999, CANCER RES, V59, P5331; Zhang HD, 1998, P NATL ACAD SCI USA, V95, P14202, DOI 10.1073/pnas.95.24.14202; Zhang YJ, 2007, J NEUROSCI, V27, P10530, DOI 10.1523/JNEUROSCI.3421-07.2007; ZHOU J, 1993, J BIOL CHEM, V268, P10863; Zuccato E, 2004, J BIOL CHEM, V279, P16980, DOI 10.1074/jbc.M313439200	43	139	143	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1744	1753		10.1074/jbc.M705115200	http://dx.doi.org/10.1074/jbc.M705115200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	17984093	hybrid			2022-12-27	WOS:000252282700061
J	Strop, P; Kaiser, SE; Vrljic, M; Brunger, AT				Strop, Pavel; Kaiser, Stephen E.; Vrljic, Marija; Brunger, Axel T.			The structure of the yeast plasma membrane SNARE complex reveals destabilizing water-filled cavities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; SYNAPTOTAGMIN; FUSION; CRYSTALLOGRAPHY; MECHANISMS; SOFTWARE	SNARE proteins form a complex that leads to membrane fusion between vesicles, organelles, and plasma membrane in all eukaryotic cells. We report the 1.7 angstrom resolution structure of the SNARE complex that mediates exocytosis at the plasma membrane in the yeast Saccharomyces cerevisiae. Similar to its neuronal and endosomal homologues, the S. cerevisiae SNARE complex forms a parallel four-helix bundle in the center of which is an ionic layer. The S. cerevisiae SNARE complex exhibits increased helix bending near the ionic layer, contains water-filled cavities in the complex core, and exhibits reduced thermal stability relative to mammalian SNARE complexes. Mutagenesis experiments suggest that the water-filled cavities contribute to the lower stability of the S. cerevisiae complex.	Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; Stanford Univ, Dept Struct Biol & Photon Sci, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; Stanford University	Brunger, AT (corresponding author), Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA.	brunger@stanford.edu		Brunger, Axel/0000-0001-5121-2036				Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Antonin W, 2002, NAT STRUCT BIOL, V9, P107, DOI 10.1038/nsb746; Antonin W, 2000, EMBO J, V19, P6453, DOI 10.1093/emboj/19.23.6453; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Brunger AT, 2005, Q REV BIOPHYS, V38, P1, DOI 10.1017/S0033583505004051; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ernst JA, 2003, J BIOL CHEM, V278, P8630, DOI 10.1074/jbc.M211889200; Fasshauer D, 1997, J BIOL CHEM, V272, P28036, DOI 10.1074/jbc.272.44.28036; Fenn TD, 2003, J APPL CRYSTALLOGR, V36, P944, DOI 10.1107/S0021889803006721; Gerber SH, 2002, DIABETES, V51, pS3, DOI 10.2337/diabetes.51.2007.S3; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Lagow RD, 2007, PLOS BIOL, V5, P800, DOI 10.1371/journal.pbio.0050072; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Mayer A, 2002, ANNU REV CELL DEV BI, V18, P289, DOI 10.1146/annurev.cellbio.18.032202.114809; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peters C, 1998, NATURE, V396, P575, DOI 10.1038/25133; Rice LM, 1997, FEBS LETT, V415, P49, DOI 10.1016/S0014-5793(97)01091-0; Rizo J, 2002, NAT REV NEUROSCI, V3, P641, DOI 10.1038/nrn898; Rizo J, 2006, TRENDS CELL BIOL, V16, P339, DOI 10.1016/j.tcb.2006.04.006; Shao XG, 1997, NEURON, V18, P133, DOI 10.1016/S0896-6273(01)80052-0; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Tang J, 2006, CELL, V126, P1175, DOI 10.1016/j.cell.2006.08.030; Zwilling D, 2007, EMBO J, V26, P9, DOI 10.1038/sj.emboj.7601467	27	36	38	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					1113	1119		10.1074/jbc.M707912200	http://dx.doi.org/10.1074/jbc.M707912200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	17956869	hybrid			2022-12-27	WOS:000252128100051
J	Tew, GW; Lorimer, EL; Berg, TJ; Zhi, HY; Li, RS; Williams, CL				Tew, Gaik Wei; Lorimer, Ellen L.; Berg, Tracy J.; Zhi, Huiying; Li, Rongshan; Williams, Carol L.			SmgGDS regulates cell proliferation, migration, and NF-kappa B transcriptional activity in non-small cell lung carcinoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GDP/GTP EXCHANGE PROTEIN; RHO-FAMILY; SUPEROXIDE DISMUTASES; NUCLEAR-LOCALIZATION; POLYBASIC REGION; BINDING PROTEIN; CANCER-CELLS; RAP1 GTPASE; STEM-CELLS; EXPRESSION	Non-small cell lung carcinoma (NSCLC) is promoted by the increased activities of several small GTPases, including K-Ras4B, Rap1A, Rap1B, RhoC, and Rac1. SmgGDS is an unusual guanine nucleotide exchange factor that activates many of these small GTPases, and thus may promote NSCLC development or progression. We report here that SmgGDS protein levels are elevated in NSCLC tumors, compared with normal lung tissue from the same patients or from individuals without cancer. To characterize SmgGDS functions in NSCLC, we tested the effects of silencing SmgGDS expression by transfecting cultured NSCLC cells with SmgGDS small interfering RNA (siRNA). Cells with silenced SmgGDS expression form fewer colonies in soft agar, do not proliferate in culture due to an arrest in G(1) phase, and exhibit disrupted myosin organization and reduced cell migration. The transcriptional activity of NF-kappa B in NSCLC cells is diminished by transfecting the cells with SmgGDS siRNA, and enhanced by transfecting the cells with a cDNA encoding SmgGDS. Because RhoA is a major substrate for SmgGDS, we investigated whether diminished RhoA expression mimics the effects of diminished SmgGDS expression. Silencing RhoA expression with RhoA siRNA disrupts myosin organization, but only moderately decreases cell proliferation and does not inhibit migration. Our finding that the aggressive NSCLC phenotype is more effectively suppressed by silencing SmgGDS than by silencing RhoA is consistent with the ability of SmgGDS to regulate multiple small GTPases in addition to RhoA. These results demonstrate that SmgGDS promotes the malignant NSCLC phenotype and is an intriguing therapeutic target in NSCLC.	[Tew, Gaik Wei; Lorimer, Ellen L.; Berg, Tracy J.; Williams, Carol L.] Med Coll Wisconsin, Dept Pharmacol & Toxicol, Ctr Cardiovasc, Milwaukee, WI 53226 USA; [Zhi, Huiying; Li, Rongshan] Med Coll Wisconsin, Dept Pathol, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin	Williams, CL (corresponding author), 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	Williams@mcw.edu			NIGMS NIH HHS [GM069700, R01 GM069700] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069700] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; Aznar S, 2001, CANCER LETT, V165, P1, DOI 10.1016/S0304-3835(01)00412-8; Babbar N, 2006, CANCER RES, V66, P11125, DOI 10.1158/0008-5472.CAN-06-3174; Berman KS, 2002, CLIN CANCER RES, V8, P354; Berns A, 2005, CELL, V121, P811, DOI 10.1016/j.cell.2005.06.004; Bolick DT, 2005, ARTERIOSCL THROM VAS, V25, P2301, DOI 10.1161/01.ATV.0000186181.19909.a6; Bommer GT, 2007, CURR BIOL, V17, P1298, DOI 10.1016/j.cub.2007.06.068; Bubici C, 2006, ONCOGENE, V25, P6731, DOI 10.1038/sj.onc.1209936; Campbell KJ, 2004, CELL CYCLE, V3, P869; Castanotto D, 2007, NUCLEIC ACIDS RES, V35, P5154, DOI 10.1093/nar/gkm543; Castranova V, 2004, FREE RADICAL BIO MED, V37, P916, DOI 10.1016/j.freeradbiomed.2004.05.032; CHUANG TH, 1994, BIOCHEM J, V303, P761, DOI 10.1042/bj3030761; Denlinger Chadrick E, 2004, Semin Thorac Cardiovasc Surg, V16, P28, DOI 10.1053/j.semtcvs.2003.12.004; Frost JA, 2000, J BIOL CHEM, V275, P19693, DOI 10.1074/jbc.M909860199; FUJIOKA H, 1992, J BIOL CHEM, V267, P926; Fujita H, 2005, J BIOL CHEM, V280, P5022, DOI 10.1074/jbc.M409701200; Grimes KR, 2006, ONCOL REP, V16, P771; HATA Y, 1991, J BIOL CHEM, V266, P6571; Hattori M, 2003, J BIOCHEM, V134, P479, DOI 10.1093/jb/mvg180; Hirata T, 2004, J HUM GENET, V49, P290, DOI 10.1007/s10038-004-0148-1; Ho WC, 2005, CANCER RES, V65, P4273, DOI 10.1158/0008-5472.CAN-04-3494; Hogan C, 2004, MOL CELL BIOL, V24, P6690, DOI 10.1128/mcb.24.15.6690-6700.2004; Hutchinson JP, 2000, BIOCHEMISTRY-US, V39, P11348, DOI 10.1021/bi0007573; Ikoma T, 2004, CLIN CANCER RES, V10, P1192, DOI 10.1158/1078-0432.CCR-03-0275; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Johnson BE, 2004, CLIN CANCER RES, V10, p4254S, DOI 10.1158/1078-0432.CCR-040016; Jones DR, 2000, ANN THORAC SURG, V70, P930, DOI 10.1016/S0003-4975(00)01635-0; Joyce D, 2001, CYTOKINE GROWTH F R, V12, P73, DOI 10.1016/S1359-6101(00)00018-6; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kim CFB, 2005, COLD SH Q B, V70, P241, DOI 10.1101/sqb.2005.70.037; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Kinnula VL, 2003, AM J RESP CRIT CARE, V167, P1600, DOI 10.1164/rccm.200212-1479SO; Kinnula VL, 2004, FREE RADICAL BIO MED, V36, P718, DOI 10.1016/j.freeradbiomed.2003.12.010; Lang WH, 2004, CELL SIGNAL, V16, P457, DOI 10.1016/j.cellsig.2003.09.002; Lanning CC, 2004, J BIOL CHEM, V279, P44197, DOI 10.1074/jbc.M404977200; Lanning CC, 2003, J BIOL CHEM, V278, P12495, DOI 10.1074/jbc.M211286200; Li RS, 2005, APPL IMMUNOHISTO M M, V13, P85, DOI 10.1097/00129039-200503000-00014; Luo JL, 2004, CANCER CELL, V6, P297, DOI 10.1016/j.ccr.2004.08.012; Luo JL, 2005, J CLIN INVEST, V115, P2625, DOI 10.1172/JCI26322; Maehara K, 2000, J CELL BIOCHEM, V77, P474, DOI 10.1002/(SICI)1097-4644(20000601)77:3<474::AID-JCB12>3.0.CO;2-H; Maeno K, 2006, ONCOGENE, V25, P271, DOI 10.1038/sj.onc.1209018; Mascaux C, 2005, BRIT J CANCER, V92, P131, DOI 10.1038/sj.bjc.6602258; Mazieres J, 2004, CLIN CANCER RES, V10, P2742, DOI 10.1158/1078-0432.CCR-03-0149; Mijatovic T, 2006, MOL CANCER THER, V5, P391, DOI 10.1158/1535-7163.MCT-05-0367; MIZUNO T, 1991, P NATL ACAD SCI USA, V88, P6442, DOI 10.1073/pnas.88.15.6442; Montaner S, 1998, J BIOL CHEM, V273, P12779, DOI 10.1074/jbc.273.21.12779; Park GY, 2006, CURR DRUG TARGETS, V7, P661, DOI 10.2174/138945006777435317; Perona R, 1997, GENE DEV, V11, P463, DOI 10.1101/gad.11.4.463; Piekny A, 2005, TRENDS CELL BIOL, V15, P651, DOI 10.1016/j.tcb.2005.10.006; Pourazar J, 2005, AM J PHYSIOL-LUNG C, V289, pL724, DOI 10.1152/ajplung.00055.2005; Qanungo S, 2004, J BIOL CHEM, V279, P50455, DOI 10.1074/jbc.M406749200; Rahman I, 2004, BIOCHEM PHARMACOL, V68, P1255, DOI 10.1016/j.bcp.2004.05.042; Rebhun JF, 2000, J BIOL CHEM, V275, P34901, DOI 10.1074/jbc.M005327200; Regala RP, 2005, J BIOL CHEM, V280, P31109, DOI 10.1074/jbc.M505402200; Ridley AJ, 2004, BREAST CANCER RES TR, V84, P13, DOI 10.1023/B:BREA.0000018423.47497.c6; Schrump DS, 2005, SEMIN ONCOL, V32, P488, DOI 10.1053/j.seminoncol.2005.07.007; Shafer SH, 2003, INT J ONCOL, V23, P389; Shikada Y, 2003, CLIN CANCER RES, V9, P5282; Shumilla JA, 1999, J BIOL CHEM, V274, P36207, DOI 10.1074/jbc.274.51.36207; Sordella R, 2004, SCIENCE, V305, P1163, DOI 10.1126/science.1101637; Strassheim D, 1999, J BIOL CHEM, V274, P18675, DOI 10.1074/jbc.274.26.18675; Strassheim D, 2000, CANCER RES, V60, P2730; Sun WY, 2004, CANCER LETT, V212, P83, DOI 10.1016/j.canlet.2004.03.023; Tichelaar JW, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-155; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Varker KA, 2002, BIOCHEM PHARMACOL, V63, P597, DOI 10.1016/S0006-2952(01)00901-7; Vermeulen L, 2006, CANC TREAT, V130, P89; Wang SW, 2003, ONCOGENE, V22, P6204, DOI 10.1038/sj.onc.1206653; Wang X, 2006, CANCER RES, V66, P1089, DOI 10.1158/0008-5472.CAN-05-2698; Wei CY, 2006, MOL PHARMACOL, V69, P960, DOI 10.1124/mol.105.017368; Weidauer E, 2004, TOXICOL LETT, V151, P69, DOI 10.1016/j.toxlet.2004.02.014; Williams CL, 2003, CELL SIGNAL, V15, P1071, DOI 10.1016/S0898-6568(03)00098-6; Wittchen ES, 2005, CURR OPIN HEMATOL, V12, P14, DOI 10.1097/01.moh.0000147892.83713.a7; YAKU H, 1994, BIOCHEM BIOPH RES CO, V198, P811, DOI 10.1006/bbrc.1994.1116; Yao PL, 2005, AM J RESP CELL MOL, V32, P540, DOI 10.1165/rcmb.2004-0223OC; YOSHIDA Y, 1992, MOL CELL BIOL, V12, P3407, DOI 10.1128/MCB.12.8.3407; Zhang ZF, 2006, ANN THORAC SURG, V82, P243, DOI 10.1016/j.athoracsur.2006.01.049	77	53	54	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					963	976		10.1074/jbc.M707526200	http://dx.doi.org/10.1074/jbc.M707526200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	17951244	hybrid			2022-12-27	WOS:000252128100036
J	Bansode, RR; Huang, W; Roy, SK; Mehta, M; Mehta, KD				Bansode, Rishipal R.; Huang, Wei; Roy, Sanjit K.; Mehta, Madhu; Mehta, Kamal D.			Protein kinase C beta deficiency increases fatty acid oxidation and reduces fat storage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE; RECEPTOR TRANSCRIPTION; OBESITY RESISTANCE; INSULIN-RESISTANCE; GLUCOSE-TRANSPORT; MICE; CELLS; GENE; PHOSPHORYLATION; DYSFUNCTION	Metabolic syndrome is common in the general population, but there is little information available on the underlying signaling mechanisms regulating triglyceride (TG) content in the body. In the current study, we have uncovered a role for protein kinase C beta (PKC beta) in TG homeostasis by studying the consequences of a targeted disruption of this kinase. PKC beta(-/-) mutant mice were considerably leaner and the size of white fat depots was markedly decreased compared with wild-type littermates. TG content in the liver and skeletal muscle of PKC beta(-/-) mice was also significantly low. Interestingly, mutant animals were hyperphagic and exhibited higher food intake and reduced feed efficiency versus wild type. The protection from obesity involves elevated oxygen consumption/ energy expenditure and increased fatty acid oxidation in adipose tissue with concurrent increased mitochondria genesis, up-regulation of PGC-1 alpha and UCP-2, and down-regulation of perilipin. The ability of PKC beta deficiency to promote fat burning in adipocytes may suggest novel therapeutic strategies for obesity and obesity-related disorders.	[Bansode, Rishipal R.; Huang, Wei; Roy, Sanjit K.; Mehta, Kamal D.] Ohio State Univ, Coll Med, Dorothy M Davis Heart & Lung Res Inst, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; [Mehta, Madhu] Ohio State Univ, Coll Med, Dorothy M Davis Heart & Lung Res Inst, Dept Med, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Mehta, KD (corresponding author), Ohio State Univ, Coll Med, Dorothy M Davis Heart & Lung Res Inst, Dept Mol & Cellular Biochem, 464 Hamilton Hall,1645 Neil Ave, Columbus, OH 43210 USA.	Mehta.80@osu.edu	Bansode, Rishipal/E-9293-2010; Huang, Wei/E-3270-2011	Bansode, Rishipal/0000-0001-7826-2711; 	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079091] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL079091, HL 079091] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abu-Elheiga L, 2001, SCIENCE, V291, P2613, DOI 10.1126/science.1056843; Benton CR, 2006, J APPL PHYSIOL, V100, P377, DOI 10.1152/japplphysiol.00781.2005; Cline GW, 2001, J BIOL CHEM, V276, P20240, DOI 10.1074/jbc.M102540200; DEKKER LV, 1994, TRENDS BIOCHEM SCI, V19, P73, DOI 10.1016/0968-0004(94)90038-8; Farese RV, 2002, AM J PHYSIOL-ENDOC M, V283, pE1, DOI 10.1152/ajpendo.00045.2002; Gaidhu MP, 2006, J BIOL CHEM, V281, P25956, DOI 10.1074/jbc.M602992200; GAO Z, 2006, AM J PHYSIOL-ENDOC M, V292, pE84; Gavrilova O, 2000, J CLIN INVEST, V105, P271, DOI 10.1172/JCI7901; Ginsberg HN, 2006, OBESITY, V14, p41S, DOI 10.1038/oby.2006.281; Huang W, 2005, J CELL PHYSIOL, V205, P37, DOI 10.1002/jcp.20372; Huang W, 2004, J LIPID RES, V45, P1519, DOI 10.1194/jlr.M400088-JLR200; Ishii H, 1996, SCIENCE, V272, P728, DOI 10.1126/science.272.5262.728; Itani SI, 2000, DIABETES, V49, P1353, DOI 10.2337/diabetes.49.8.1353; Kapoor GS, 2003, J LIPID RES, V44, P584, DOI 10.1194/jlr.M200302-JLR200; Lee Y, 2002, P NATL ACAD SCI USA, V99, P11848, DOI 10.1073/pnas.182420899; Leitges M, 1996, SCIENCE, V273, P788, DOI 10.1126/science.273.5276.788; Letiges M, 2002, MOL ENDOCRINOL, V16, P847, DOI 10.1210/me.16.4.847; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Martinez-Botas J, 2000, NAT GENET, V26, P474, DOI 10.1038/82630; Matsumoto M, 2003, J CLIN INVEST, V112, P935, DOI 10.1172/JCI200318816; Mehta KD, 2002, MOL CELL BIOL, V22, P3783, DOI 10.1128/MCB.22.11.3783-3793.2002; Meier M, 2000, VASC MED, V5, P173, DOI 10.1177/1358836X0000500307; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699; Oberkofler H, 2006, ENDOCRINOLOGY, V147, P966, DOI 10.1210/en.2005-0817; Pinton P, 2007, SCIENCE, V315, P659, DOI 10.1126/science.1135380; Reitman ML, 2002, ANNU REV NUTR, V22, P459, DOI 10.1146/annurev.nutr.22.010402.102849; Schmitz-Peiffer C, 2002, ANN NY ACAD SCI, V967, P146; Smith SJ, 2000, NAT GENET, V25, P87, DOI 10.1038/75651; Standaert ML, 1999, ENDOCRINOLOGY, V140, P4470, DOI 10.1210/en.140.10.4470; Surwit RS, 1998, P NATL ACAD SCI USA, V95, P4061, DOI 10.1073/pnas.95.7.4061; Tiraby C, 2003, J BIOL CHEM, V278, P33370, DOI 10.1074/jbc.M305235200; Wang YX, 2003, CELL, V113, P159, DOI 10.1016/S0092-8674(03)00269-1; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Xia Z, 2002, J BIOL CHEM, V277, P45874, DOI 10.1074/jbc.M207281200	35	44	47	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					231	236		10.1074/jbc.M707268200	http://dx.doi.org/10.1074/jbc.M707268200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17962198	hybrid			2022-12-27	WOS:000251940300026
J	Bao, Y; Lopez, JA; James, DE; Hunziker, W				Bao, Yiqun; Lopez, Jamie A.; James, David E.; Hunziker, Walter			Snapin interacts with the exo70 subunit of the exocyst and modulates GLUT4 trafficking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-INDUCED TRANSLOCATION; VESICULAR TRANSPORT; SACCHAROMYCES-CEREVISIAE; 3T3-L1 ADIPOCYTES; MEMBRANE-PROTEIN; SEC6/8 COMPLEX; GOLGI-COMPLEX; EXOCYTOSIS; CELLS; YEAST	The exocyst is a multisubunit complex that has been implicated in the transport of vesicles from the Golgi complex to the plasma membrane, possibly acting as a vesicle tether and contributing to the specificity of membrane fusion. Here we characterize a novel interaction between the Exo70 subunit of the exocyst and Snapin, a ubiquitous protein known to associate with at least two t-SNAREs, SNAP23 and SNAP25. The interaction between Exo70 and Snapin is mediated via an N-terminal coil-coil domain in Exo70 and a C-terminal helical region in Snapin. Exo70 competes with SNAP23 for Snapin binding, suggesting that Snapin does not provide a direct link between the exocyst and the SNARE complex but, rather, mediates cross-talk between the two complexes by sequential interactions. The insulin-regulated trafficking of GLUT4 to the plasma membrane serves to facilitate glucose uptake in adipocytes, and both SNAP23 and the exocyst have been implicated in this process. In this study, depletion of Snapin in adipocytes using RNA interference inhibits insulin-stimulated glucose uptake. Thus, Snapin interacts with the exocyst and plays a modulatory role in GLUT4 vesicle trafficking.	[Bao, Yiqun; Hunziker, Walter] Inst Cell & Mol Biol, Epithelial Cell Biol Lab, Singapore 138673, Singapore; [Lopez, Jamie A.; James, David E.] Garvan Inst Med Res, Diabetes Obes Res Program, Sydney, NSW 2010, Australia	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Garvan Institute of Medical Research	Hunziker, W (corresponding author), Inst Cell & Mol Biol, Epithelial Cell Biol Lab, 61 Biopolis Dr, Singapore 138673, Singapore.	hunziker@imcb.a-star.edu.sg	Hunziker, Walter/B-3140-2010; Hunziker, Walter/GSM-8190-2022	Hunziker, Walter/0000-0002-5265-4933; Lopez Bernal, Jamie/0000-0002-1301-5653; James, David/0000-0001-5946-5257				AALTO MK, 1993, EMBO J, V12, P4095, DOI 10.1002/j.1460-2075.1993.tb06093.x; Buxton P, 2003, BIOCHEM J, V375, P433, DOI 10.1042/BJ20030427; Carlotti F, 2004, MOL THER, V9, P209, DOI 10.1016/j.ymthe.2003.11.021; Chheda MG, 2001, NAT CELL BIOL, V3, P331, DOI 10.1038/35070000; Conibear E, 2003, MOL BIOL CELL, V14, P1610, DOI 10.1091/mbc.E02-10-0654; Grindstaff KK, 1998, CELL, V93, P731, DOI 10.1016/S0092-8674(00)81435-X; Guo W, 1999, J BIOL CHEM, V274, P23558, DOI 10.1074/jbc.274.33.23558; Guo W, 1999, EMBO J, V18, P1071, DOI 10.1093/emboj/18.4.1071; Hamburger ZA, 2006, J MOL BIOL, V356, P9, DOI 10.1016/j.jmb.2005.09.099; HARDWICK KG, 1992, J CELL BIOL, V119, P513, DOI 10.1083/jcb.119.3.513; Ilardi JM, 1999, NAT NEUROSCI, V2, P119, DOI 10.1038/5673; Inoue M, 2006, MOL BIOL CELL, V17, P2303, DOI 10.1091/mbc.E06-01-0030; Inoue M, 2003, NATURE, V422, P629, DOI 10.1038/nature01533; Kawanishi M, 2000, J BIOL CHEM, V275, P8240, DOI 10.1074/jbc.275.11.8240; Li MJ, 2005, METHOD ENZYMOL, V392, P218, DOI 10.1016/S0076-6879(04)92013-7; Malide D, 2000, J CELL SCI, V113, P4203; Matern HT, 2001, P NATL ACAD SCI USA, V98, P9648, DOI 10.1073/pnas.171317898; Munson M, 2006, NAT STRUCT MOL BIOL, V13, P577, DOI 10.1038/nsmb1097; Novick P, 2006, BIOCHEM SOC T, V34, P683, DOI 10.1042/BST0340683; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; Rea S, 1998, J BIOL CHEM, V273, P18784, DOI 10.1074/jbc.273.30.18784; SHIM J, 1991, J CELL BIOL, V113, P55, DOI 10.1083/jcb.113.1.55; Sivaram MVS, 2005, BIOCHEMISTRY-US, V44, P6302, DOI 10.1021/bi048008z; Stroupe C, 2006, EMBO J, V25, P1579, DOI 10.1038/sj.emboj.7601051; TerBush DR, 1996, EMBO J, V15, P6483, DOI 10.1002/j.1460-2075.1996.tb01039.x; Thurmond DC, 1998, J BIOL CHEM, V273, P33876, DOI 10.1074/jbc.273.50.33876; Tian JH, 2005, J NEUROSCI, V25, P10546, DOI 10.1523/JNEUROSCI.3275-05.2005; Tsuboi T, 2005, J BIOL CHEM, V280, P25565, DOI 10.1074/jbc.M501674200; Vega IE, 2001, J NEUROSCI, V21, P3839, DOI 10.1523/JNEUROSCI.21-11-03839.2001; Vites O, 2004, J BIOL CHEM, V279, P26251, DOI 10.1074/jbc.M404079200; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Wiederkehr A, 2004, J CELL BIOL, V167, P875, DOI 10.1083/jcb.200408001; Zuo XF, 2006, NAT CELL BIOL, V8, P1383, DOI 10.1038/ncb1505	33	40	41	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					324	331		10.1074/jbc.M706873200	http://dx.doi.org/10.1074/jbc.M706873200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17947242	hybrid			2022-12-27	WOS:000251940300036
J	Nagaraj, VA; Arumugam, R; Gopalakrishnan, B; Jyothsna, YS; Rangarajan, PN; Padmanaban, G				Nagaraj, Viswanathan Arun; Arumugam, Rajavel; Gopalakrishnan, Bulusu; Jyothsna, Yeleswarapu Sri; Rangarajan, Pundi N.; Padmanaban, Govindarajan			Unique properties of Plasmodium falciparum porphobilinogen deaminase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UROPORPHYRINOGEN-III SYNTHASE; AMINOLEVULINIC-ACID DEHYDRATASE; HUMAN MALARIAL PARASITE; HYDROXYMETHYLBILANE SYNTHASE; HUMAN-ERYTHROCYTES; HEME-BIOSYNTHESIS; RECOMBINANT STRAIN; CATALYTIC SITE; METABOLIC MAPS; PURIFICATION	The hybrid pathway for heme biosynthesis in the malarial parasite proposes the involvement of parasite genome-coded enzymes of the pathway localized in different compartments such as apicoplast, mitochondria, and cytosol. However, knowledge on the functionality and localization of many of these enzymes is not available. In this study, we demonstrate that porphobilinogen deaminase encoded by the Plasmodium falciparum genome (PfPBGD) has several unique biochemical properties. Studies carried out with PfPBGD partially purified from parasite membrane fraction, as well as recombinant PfPBGD lacking N-terminal 64 amino acids expressed and purified from Escherichia coli cells ( Delta PfPBGD), indicate that both the proteins are catalytically active. Surprisingly, PfPBGD catalyzes the conversion of porphobilinogen to uroporphyrinogen III (UROGEN III), indicating that it also possesses uroporphyrinogen III synthase (UROS) activity, catalyzing the next step. This obviates the necessity to have a separate gene for UROS that has not been so far annotated in the parasite genome. Interestingly, Delta PfPBGD gives rise to UROGEN III even after heat treatment, although UROS from other sources is known to be heat-sensitive. Based on the analysis of active site residues, a Delta PfPBGDL116K mutant enzyme was created and the specific activity of this recombinant mutant enzyme is 5-fold higher than Delta PfPBGD. More interestingly, Delta PfPBGDL116K catalyzes the formation of uroporphyrinogen I ( UROGEN I) in addition to UROGEN III, indicating that with increased PBGD activity the UROS activity of PBGD may perhaps become rate-limiting, thus leading to non-enzymatic cyclization of preuroporphyrinogen to UROGEN I. PfPBGD is localized to the apicoplast and is catalytically very inefficient compared with the host red cell enzyme.	[Nagaraj, Viswanathan Arun; Arumugam, Rajavel; Rangarajan, Pundi N.; Padmanaban, Govindarajan] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India; [Gopalakrishnan, Bulusu; Jyothsna, Yeleswarapu Sri] Innovat Labs Hyderabad, Div Life Sci, Tata Consult Serv, Hyderabad 500081, Andhra Pradesh, India	Indian Institute of Science (IISC) - Bangalore	Padmanaban, G (corresponding author), Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India.	geepee@biochem.iisc.ernet.in	Rangarajan, Pundi/A-7365-2009; Bulusu, Gopalakrishnan/R-3053-2019; Rajavelu, Arumugam/B-7832-2013	Rangarajan, Pundi/0000-0002-6536-9891; Rajavelu, Arumugam/0000-0001-6666-8925; Bulusu, Gopalakrishnan/0000-0002-4958-7573				ALWAN AF, 1989, BIOCHEM J, V264, P397, DOI 10.1042/bj2640397; AMILLET JM, 1995, YEAST, V11, P419, DOI 10.1002/yea.320110504; Beale SI, 1999, PHOTOSYNTH RES, V60, P43, DOI 10.1023/A:1006297731456; Bonday ZQ, 1997, J BIOL CHEM, V272, P21839, DOI 10.1074/jbc.272.35.21839; Bonday ZQ, 2000, NAT MED, V6, P898, DOI 10.1038/78659; CHARTRAND P, 1979, J GEN MICROBIOL, V110, P61, DOI 10.1099/00221287-110-1-61; Dhanasekaran S, 2004, J BIOL CHEM, V279, P6934, DOI 10.1074/jbc.M311409200; Erlandsen EJ, 2000, SCAND J CLIN LAB INV, V60, P627; Fidock DA, 2004, NAT REV DRUG DISCOV, V3, P509, DOI 10.1038/nrd1416; FITCH CD, 1982, ANTIMICROB AGENTS CH, V21, P819, DOI 10.1128/AAC.21.5.819; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Guegan R, 2003, MOL MICROBIOL, V49, P745, DOI 10.1046/j.1365-2958.2003.03589.x; JORDAN PM, 1987, FEBS LETT, V225, P87, DOI 10.1016/0014-5793(87)81136-5; JORDAN PM, 1979, J CHEM SOC CHEM COMM, P204, DOI 10.1039/c39790000204; JORDAN PM, 1988, BIOCHEM J, V254, P427, DOI 10.1042/bj2540427; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; LANDER M, 1991, BIOCHEM J, V275, P447, DOI 10.1042/bj2750447; LANNFELT L, 1989, SCAND J CLIN LAB INV, V49, P677, DOI 10.3109/00365518909091544; LIM CK, 1983, BIOCHEM J, V211, P435, DOI 10.1042/bj2110435; LOUIE GV, 1992, NATURE, V359, P33, DOI 10.1038/359033a0; Mathews MAA, 2001, EMBO J, V20, P5832, DOI 10.1093/emboj/20.21.5832; MILLER AD, 1989, BIOCHEM J, V262, P119, DOI 10.1042/bj2620119; Padmanaban G, 2007, TRENDS BIOCHEM SCI, V32, P443, DOI 10.1016/j.tibs.2007.09.005; Padmanaban G, 2007, CURR SCI INDIA, V92, P1545; Ralph SA, 2004, NAT REV MICROBIOL, V2, P203, DOI 10.1038/nrmicro843; Sato S, 2004, PROTIST, V155, P117, DOI 10.1078/1434461000169; Sato S, 2002, CURR GENET, V40, P391, DOI 10.1007/s00294-002-0273-3; Sharma A, 2005, INDIAN J BIOCHEM BIO, V42, P145; SMYTHE E, 1988, BIOCHEM J, V251, P237, DOI 10.1042/bj2510237; SUROLIA N, 1992, BIOCHEM BIOPH RES CO, V187, P744, DOI 10.1016/0006-291X(92)91258-R; Tonkin CJ, 2004, MOL BIOCHEM PARASIT, V137, P13, DOI 10.1016/j.molbiopara.2004.05.009; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; TSAI SF, 1988, P NATL ACAD SCI USA, V85, P7049, DOI 10.1073/pnas.85.19.7049; van Dooren GG, 2006, FEMS MICROBIOL REV, V30, P596, DOI 10.1111/j.1574-6976.2006.00027.x; Varadharajan S, 2004, BIOCHEM J, V384, P429, DOI 10.1042/BJ20040952; Varadharajan S, 2002, BIOCHEM J, V367, P321, DOI 10.1042/BJ20020834; WEINER MP, 1994, GENE, V151, P119, DOI 10.1016/0378-1119(94)90641-6; Wilson RJM, 2005, BIOL REV, V80, P129, DOI 10.1017/S1464793104006591	38	36	36	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					437	444		10.1074/jbc.M706861200	http://dx.doi.org/10.1074/jbc.M706861200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17962188	hybrid			2022-12-27	WOS:000251940300048
J	Paukert, M; Chen, XM; Polleichtner, G; Schindelin, H; Grunder, S				Paukert, Martin; Chen, Xuanmao; Polleichtner, Georg; Schindelin, Hermann; Gruender, Stefan			Candidate amino acids involved in H+ gating of acid-sensing ion channel 1a	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL SODIUM-CHANNEL; NA+ CHANNEL; EXTRACELLULAR DOMAIN; IDENTIFICATION; ION-CHANNEL-1; EXPRESSION; SUBUNIT; FAMILY; DESENSITIZATION; PERMEATION	Acid-sensing ion channels are ligand-gated cation channels, gated by extracellular H+. H+ is the simplest ligand possible, and whereas for larger ligands that gate ion channels complex binding sites in the three-dimensional structure of the proteins have to be assumed, H+ could in principle gate a channel by titration of a single amino acid. Experimental evidence suggests a more complex situation, however. For example, it has been shown that extracellular Ca2+ ions compete with H+; probably Ca2+ ions bound to the extracellular loop of ASICs stabilize the closed state of the channel and have to be displaced before the channel can open. In such a scheme, amino acids contributing to Ca2+ binding would also be candidates contributing to H+ gating. In this study we systematically screened more than 40 conserved, charged amino acids in the extracellular region of ASIC1a for a possible contribution to H+ gating. We identified four amino acids where substitution strongly affects H+ gating: Glu(63), His(72)/His(73), and Asp(78). These amino acids are highly conserved among H+-sensitive ASICs and are candidates for the "H+ sensor" of ASICs.	Johns Hopkins Univ, Dept Neurosci, Baltimore, MD 21205 USA; [Chen, Xuanmao; Polleichtner, Georg; Gruender, Stefan] Univ Wurzburg, Dept Physiol 2, D-97070 Wurzburg, Germany; [Paukert, Martin; Chen, Xuanmao; Gruender, Stefan] Univ Tubingen, Dept Physiol 2, D-72076 Tubingen, Germany; [Schindelin, Hermann] Univ Wurzburg, Rudolf Virchow Ctr Expt Biomed, Inst Biol Struct, D-97078 Wurzburg, Germany	Johns Hopkins University; University of Wurzburg; Eberhard Karls University of Tubingen; University of Wurzburg	Paukert, M (corresponding author), Johns Hopkins Univ, Dept Neurosci, 725 N Wolfe St,WBSB 1001, Baltimore, MD 21205 USA.	mpauker1@jhmi.edu; stefan.gruender@uni-wuerzburg.de	Schindelin, Hermann/Q-2697-2019; Gründer, Stefan/I-2495-2019; chen, xuanmao/I-7576-2013	Gründer, Stefan/0000-0002-7635-9883; Chen, Xuanmao/0000-0002-0057-8510				Babini E, 2002, J BIOL CHEM, V277, P41597, DOI 10.1074/jbc.M205877200; Baron A, 2001, J BIOL CHEM, V276, P35361, DOI 10.1074/jbc.M105208200; Bassilana F, 1997, J BIOL CHEM, V272, P28819, DOI 10.1074/jbc.272.46.28819; Bassler EL, 2001, J BIOL CHEM, V276, P33782, DOI 10.1074/jbc.M104030200; Benson CJ, 1999, CIRC RES, V84, P921; Chen XM, 2007, J BIOL CHEM, V282, P30406, DOI 10.1074/jbc.M702229200; Chen XM, 2007, J PHYSIOL-LONDON, V579, P657, DOI 10.1113/jphysiol.2006.120733; Coric T, 2003, J BIOL CHEM, V278, P45240, DOI 10.1074/jbc.M304441200; Coscoy S, 1999, J BIOL CHEM, V274, P10129, DOI 10.1074/jbc.274.15.10129; Cushman KA, 2007, J GEN PHYSIOL, V129, P345, DOI 10.1085/jgp.200709757; Firsov D, 1999, J BIOL CHEM, V274, P2743, DOI 10.1074/jbc.274.5.2743; Grunder S, 2000, NEUROREPORT, V11, P1607; Immke DC, 2003, NEURON, V37, P75, DOI 10.1016/S0896-6273(02)01130-3; Immke DC, 2001, NAT NEUROSCI, V4, P869, DOI 10.1038/nn0901-869; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Kellenberger S, 1999, J GEN PHYSIOL, V114, P13, DOI 10.1085/jgp.114.1.13; Lingueglia E, 1997, J BIOL CHEM, V272, P29778, DOI 10.1074/jbc.272.47.29778; Paukert M, 2004, J BIOL CHEM, V279, P18783, DOI 10.1074/jbc.M401477200; Paukert M, 2004, J GEN PHYSIOL, V124, P383, DOI 10.1085/jgp.200308973; Sakai H, 1999, J PHYSIOL-LONDON, V519, P323, DOI 10.1111/j.1469-7793.1999.0323m.x; Saugstad JA, 2004, J BIOL CHEM, V279, P55514, DOI 10.1074/jbc.M411849200; Schild L, 1997, J GEN PHYSIOL, V109, P15, DOI 10.1085/jgp.109.1.15; Sheng SH, 2000, J BIOL CHEM, V275, P8572, DOI 10.1074/jbc.275.12.8572; Smith ESJ, 2007, NEUROSCI LETT, V426, P12, DOI 10.1016/j.neulet.2007.07.047; Sutherland SP, 2001, P NATL ACAD SCI USA, V98, P711, DOI 10.1073/pnas.011404498; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Waldmann R, 1998, CURR OPIN NEUROBIOL, V8, P418, DOI 10.1016/S0959-4388(98)80070-6; Zhang P, 2006, J GEN PHYSIOL, V127, P109, DOI 10.1085/jgp.200509396	30	87	89	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					572	581		10.1074/jbc.M706811200	http://dx.doi.org/10.1074/jbc.M706811200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17981796	hybrid, Green Published			2022-12-27	WOS:000251940300062
J	Rubenstein, EM; McCartney, RR; Zhang, C; Shokat, KM; Shirra, MK; Arndt, KM; Schmidt, MC				Rubenstein, Eric M.; McCartney, Rhonda R.; Zhang, Chao; Shokat, Kevan M.; Shirra, Margaret K.; Arndt, Karen M.; Schmidt, Martin C.			Access denied: Snf1 activation loop phosphorylation is controlled by availability of the phosphorylated threonine 210 to the PP1 phosphatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE KINASE; YEAST SNF1; GLUCOSE REPRESSION; UPSTREAM KINASE; BETA-SUBUNITS; SNF1-ACTIVATING KINASES; TYPE-1; LKB1; LOCALIZATION; MUTATIONS	Phosphorylation of the Saccharomyces cerevisiae Snf1 kinase activation loop is determined by the integration of two reaction rates: the rate of phosphorylation by upstream kinases and the rate of dephosphorylation by Glc7. The activities of the Snf1-activating kinases do not appear to be glucose-regulated, since immune complex kinase assays with each of the three Snf1-activating kinases show similar levels of activity when prepared from cells grown in either high or low glucose. In contrast, the dephosphorylation of the Snf1 activation loop was strongly regulated by glucose. When de novo phosphorylation of Snf1 was inhibited, phosphorylation of the Snf1 activation loop was found to be stable in low glucose but rapidly lost upon the addition of glucose. A greater than 10-fold difference in the rates of Snf1 activation loop dephosphorylation was detected. However, the activity of the Glc7-Reg1 phosphatase may not itself be directly regulated by glucose, since the Glc7-Reg1 enzyme was active in low glucose toward another substrate, the transcription factor Mig1. Glucose-mediated regulation of Snf1 activation loop dephosphorylation is controlled by changes in the ability of the Snf1 activation loop to act as a substrate for Glc7.	[Rubenstein, Eric M.; McCartney, Rhonda R.; Schmidt, Martin C.] Univ Pittsburgh, Sch Med, Dept Mol Genet & Biochem, Pittsburgh, PA 15261 USA; [Zhang, Chao; Shokat, Kevan M.] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; [Shirra, Margaret K.; Arndt, Karen M.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Schmidt, MC (corresponding author), Univ Pittsburgh, Sch Med, Dept Mol Genet & Biochem, Pittsburgh, PA 15261 USA.	mcs2@pitt.edu		Rubenstein, Eric/0000-0003-4983-1430	NIAID NIH HHS [R01 AI044009, AI 44009] Funding Source: Medline; NIDDK NIH HHS [R21 DK074654-01, DK 74654, R21 DK074654-02, R21 DK074654] Funding Source: Medline; NIGMS NIH HHS [R01 GM052593-11, R01 GM046443, R01 GM052593, GM 52593, GM 46443, R01 GM046443-20] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK074654] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052593, R01GM046443, R29GM046443] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bishop AC, 1998, CURR BIOL, V8, P257, DOI 10.1016/S0960-9822(98)70198-8; Bouquin N, 2000, J CELL SCI, V113, P1435; Crute BE, 1998, J BIOL CHEM, V273, P35347, DOI 10.1074/jbc.273.52.35347; De Wever V, 2005, EMBO J, V24, P4115, DOI 10.1038/sj.emboj.7600871; Dombek KM, 2004, J BIOL CHEM, V279, P39165, DOI 10.1074/jbc.M400433200; Dombek KM, 1999, MOL CELL BIOL, V19, P6029; Elbing K, 2006, BIOCHEM J, V393, P797, DOI 10.1042/BJ20051213; Elbing K, 2006, J BIOL CHEM, V281, P26170, DOI 10.1074/jbc.M603811200; ESTRUCH F, 1992, GENETICS, V132, P639; Goldstein A, 1975, Methods Enzymol, V42, P504; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; Hawley SA, 2002, DIABETES, V51, P2420, DOI 10.2337/diabetes.51.8.2420; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hedbacker K, 2004, MOL CELL BIOL, V24, P8255, DOI 10.1128/MCB.24.18.8255-8263.2004; Hedbacker K, 2006, EUKARYOT CELL, V5, P1950, DOI 10.1128/EC.00256-06; Hong SP, 2005, J BIOL CHEM, V280, P21804, DOI 10.1074/jbc.M501887200; Hong SP, 2003, P NATL ACAD SCI USA, V100, P8839, DOI 10.1073/pnas.1533136100; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Jiang R, 1996, GENE DEV, V10, P3105, DOI 10.1101/gad.10.24.3105; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Ludin K, 1998, P NATL ACAD SCI USA, V95, P6245, DOI 10.1073/pnas.95.11.6245; McCartney R, 2005, CURR GENET, V47, P335, DOI 10.1007/s00294-005-0576-2; McCartney RR, 2001, J BIOL CHEM, V276, P36460, DOI 10.1074/jbc.M104418200; Momcilovic M, 2006, J BIOL CHEM, V281, P25336, DOI 10.1074/jbc.M604399200; Nath N, 2003, MOL CELL BIOL, V23, P3909, DOI 10.1128/MCB.23.11.3909-3917.2003; Nayak V, 2006, STRUCTURE, V14, P477, DOI 10.1016/j.str.2005.12.008; Sanders MJ, 2007, BIOCHEM J, V403, P139, DOI 10.1042/BJ20061520; Sanz P, 2000, MOL CELL BIOL, V20, P1321, DOI 10.1128/MCB.20.4.1321-1328.2000; Schmidt MC, 2000, EMBO J, V19, P4936, DOI 10.1093/emboj/19.18.4936; Scott JW, 2007, EMBO J, V26, P806, DOI 10.1038/sj.emboj.7601542; Scott JW, 2004, J CLIN INVEST, V113, P274, DOI 10.1172/JCI200419874; SIKORSKI RS, 1989, GENETICS, V122, P19; Sreenivasan A, 2003, MOL CELL BIOL, V23, P6327, DOI 10.1128/MCB.23.17.6327-6337.2003; Sreenivasan A, 1999, MOL CELL BIOL, V19, P7983; Suter M, 2006, J BIOL CHEM, V281, P32207, DOI 10.1074/jbc.M606357200; Sutherland CM, 2003, CURR BIOL, V13, P1299, DOI 10.1016/S0960-9822(03)00459-7; TREITEL MA, 1995, P NATL ACAD SCI USA, V92, P3132, DOI 10.1073/pnas.92.8.3132; TU JL, 1994, MOL CELL BIOL, V14, P6789, DOI 10.1128/MCB.14.10.6789; TU JL, 1995, EMBO J, V14, P5939, DOI 10.1002/j.1460-2075.1995.tb00282.x; Vincent O, 2001, GENE DEV, V15, P1104, DOI 10.1101/gad.879301; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Wu XL, 2001, BIOCHEMISTRY-US, V40, P7410, DOI 10.1021/bi002796k; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788	46	86	87	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					222	230		10.1074/jbc.M707957200	http://dx.doi.org/10.1074/jbc.M707957200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17991748	Green Accepted, hybrid			2022-12-27	WOS:000251940300025
J	Song, WL; Lawson, JA; Reilly, D; Rokach, J; Chang, CT; Giasson, B; FitzGerald, GA				Song, Wen-Liang; Lawson, John A.; Reilly, Dermot; Rokach, Joshua; Chang, Chih-Tsung; Giasson, Benoit; FitzGerald, Garret A.			Neurofurans, novel indices of oxidant stress derived from docosahexaenoic acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-3 FATTY-ACIDS; LIPID-PEROXIDATION; FISH-OIL; IN-VIVO; EICOSAPENTAENOIC ACID; ALZHEIMERS-DISEASE; DOUBLE-BLIND; F-2-ISOPROSTANES; BRAIN; ISOPROSTANES	Isoeicosanoids are free radical-catalyzed isomers of the enzymatic products of arachidonic acid. They are formed in situ in cell membranes, are cleaved, circulate, and are excreted in urine. Isomers of prostaglandin F-2 alpha, the F-2-isoprostanes, have emerged as sensitive indices of lipid peroxidation in vivo. Analogous compounds formed from docosahexaenoic acid (DHA) are termed neuroprostanes and are more abundant than isoprostanes (iPs) in brain. Isofurans are another class of isoeicosanoids characterized by a substituted tetrahydrofuran ring. They are preferentially formed, relative to iPs, under conditions of elevated oxygen tension. Here, we report the discovery of neurofurans (nFs), the analogous family of compounds formed from DHA. Formation of nFs is characterized by mass spectrometry and confirmed by oxidation of DHA in vitro and following CCl4 administration in liver in vivo. It is demonstrated that the levels of nFs are elevated in the brain cortex of a mouse model of Alzheimer disease and are depressed in mouse brain cortex by deletion of p47(phox), an essential component of the phagocyte NADPH oxidase. Measurement of the nFs may ultimately prove useful in diagnosis, timing, and selection of dose in the treatment and chemoprevention of neurodegenerative disease.	[Song, Wen-Liang; Lawson, John A.; Reilly, Dermot; FitzGerald, Garret A.] Univ Penn, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA; [Song, Wen-Liang; Lawson, John A.; Reilly, Dermot; Giasson, Benoit; FitzGerald, Garret A.] Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA; [Rokach, Joshua; Chang, Chih-Tsung] Florida Inst Technol, Claude Pepper Inst, Dept Chem, Melbourne, FL 32901 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Florida Institute of Technology	FitzGerald, GA (corresponding author), Univ Penn, Sch Med, 153 Johnson Pavilion, Philadelphia, PA 19104 USA.	garret@spirit.gcrc.upenn.edu	FitzGerald, Garret A/A-4222-2010	Song, Wenliang/0000-0002-1866-0635; Rokach, Joshu/0000-0003-1814-7505	NHLBI NIH HHS [HL 81873, HL 62250] Funding Source: Medline; NINDS NIH HHS [P50 NS053488, P50 NS053488-01A20004] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL062250, R01HL081873] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS053488] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Appleton KM, 2006, AM J CLIN NUTR, V84, P1308, DOI 10.1093/ajcn/84.6.1308; Birch EE, 2007, EARLY HUM DEV, V83, P279, DOI 10.1016/j.earlhumdev.2006.11.003; Brouwer IA, 2006, JAMA-J AM MED ASSOC, V295, P2613, DOI 10.1001/jama.295.22.2613; Brunton S, 2007, CURR MED RES OPIN, V23, P1139, DOI 10.1185/030079907X188017; Erkkila AT, 2006, J LIPID RES, V47, P2814, DOI 10.1194/jlr.P600005-JLR200; Fessel JP, 2003, J NEUROCHEM, V85, P645, DOI 10.1046/j.1471-4159.2003.01709.x; Fessel JP, 2002, P NATL ACAD SCI USA, V99, P16713, DOI 10.1073/pnas.252649099; Flood DG, 2002, NEUROBIOL AGING, V23, P335, DOI 10.1016/S0197-4580(01)00330-X; Freund-Levi Y, 2006, ARCH NEUROL-CHICAGO, V63, P1402, DOI 10.1001/archneur.63.10.1402; Hogyes E, 2003, NEUROSCIENCE, V119, P999, DOI 10.1016/S0306-4522(03)00198-2; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Kadiiska MB, 2005, FREE RADICAL BIO MED, V38, P711, DOI 10.1016/j.freeradbiomed.2004.10.024; KNAPP HR, 1986, NEW ENGL J MED, V314, P937, DOI 10.1056/NEJM198604103141501; KNAPP HR, 1989, NEW ENGL J MED, V320, P1037, DOI 10.1056/NEJM198904203201603; Lavigne MC, 2001, FASEB J, V15, P285; Lawson JA, 1999, J BIOL CHEM, V274, P24441, DOI 10.1074/jbc.274.35.24441; Makrides M, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003402.pub2; Montine KS, 2004, CHEM PHYS LIPIDS, V128, P117, DOI 10.1016/j.chemphyslip.2003.10.010; Montine TJ, 2002, ANN NEUROL, V52, P175, DOI 10.1002/ana.10272; Montine TJ, 1999, NEUROLOGY, V52, P562, DOI 10.1212/WNL.52.3.562; MOORE SA, 1991, J NEUROCHEM, V56, P518, DOI 10.1111/j.1471-4159.1991.tb08180.x; Mori Trevor A, 2004, Curr Atheroscler Rep, V6, P461, DOI 10.1007/s11883-004-0087-5; MORROW JD, 1992, P NATL ACAD SCI USA, V89, P10721, DOI 10.1073/pnas.89.22.10721; Murphy KJ, 2007, BRIT J NUTR, V97, P749, DOI 10.1017/S000711450747252X; Nourooz-Zadeh J, 1999, J NEUROCHEM, V72, P734, DOI 10.1046/j.1471-4159.1999.0720734.x; PHILLIPSON BE, 1985, NEW ENGL J MED, V312, P1210, DOI 10.1056/NEJM198505093121902; Pratico D, 1997, J CLIN INVEST, V100, P2028, DOI 10.1172/JCI119735; Pratico D, 1997, J CLIN INVEST, V100, P2637; Pratico D, 1998, FASEB J, V12, P1777, DOI 10.1096/fasebj.12.15.1777; Reich EE, 2001, AM J PATHOL, V158, P293, DOI 10.1016/S0002-9440(10)63968-5; Roberts LJ, 1998, J BIOL CHEM, V273, P13605, DOI 10.1074/jbc.273.22.13605; Schmidt EB, 2000, PUBLIC HEALTH NUTR, V3, P91, DOI 10.1017/S1368980000000112; Shaw LM, 2007, NAT REV DRUG DISCOV, V6, P295, DOI 10.1038/nrd2176; SKINNER ER, 1993, BRAIN, V116, P717, DOI 10.1093/brain/116.3.717; SODERBERG M, 1991, LIPIDS, V26, P421, DOI 10.1007/BF02536067; Wada M, 2007, J BIOL CHEM, V282, P22254, DOI 10.1074/jbc.M703169200; Wang CC, 2006, AM J CLIN NUTR, V84, P5, DOI 10.1093/ajcn/84.1.5; Xiao Y, 2006, BIOMED ENVIRON SCI, V19, P474; Yokoyama M, 2007, LANCET, V369, P1090, DOI 10.1016/S0140-6736(07)60527-3	39	67	68	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					6	16		10.1074/jbc.M706124200	http://dx.doi.org/10.1074/jbc.M706124200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17921521	hybrid			2022-12-27	WOS:000251940300003
J	Zhang, YQ; Rao, R				Zhang, Yong-Qiang; Rao, Rajini			Global disruption of cell cycle progression and nutrient response by the antifungal agent amiodarone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; NITROGEN; GLUCOSE; CALCINEURIN; METABOLISM; PATHWAYS; CALCIUM; STRESS	The antiarrhythmic drug amiodarone has fungicidal activity against a broad range of fungi. In Saccharomyces cerevisiae, it elicits an immediate influx of Ca2+ followed by mitochondrial fragmentation and eventual cell death. To dissect the mechanism of its toxicity, we assessed the transcriptional response of S. cerevisiae to amiodarone by DNA microarray. Consistent with the drug-induced calcium burst, more than half of the differentially transcribed genes were induced by high levels of CaCl2. Amiodarone also caused rapid nuclear accumulation of the calcineurin-regulated Crz1. The majority of genes induced by amiodarone within 10 min were involved in utilization of alternative carbon and nitrogen sources and in mobilizing energy reserves. The similarity to nutrient starvation responses seen in stationary phase cells, rapamycin treatment, and late stages of shift to diauxic conditions and nitrogen depletion suggests that amiodarone may interfere with nutrient sensing and regulatory networks. Transcription of a set of nutrient-responsive genes was affected by amiodarone but not CaCl2, indicating that activation of the starvation response was independent of Ca2+. Genes down-regulated by amiodarone were involved in all stages of cell cycle control. A moderate dose of amiodarone temporarily delayed cell cycle progression at G(1), S, and G(2)/M phases, with the Swe1-mediated delay in G(2)/Mphase being most prominent in a calcineurin-dependent manner. Overall, the transcriptional responses to amiodarone revealed by this study were found to be distinct from other classes of antifungals, including the azole drugs, pointing toward a novel target pathway in combating fungal pathogenesis.	[Zhang, Yong-Qiang; Rao, Rajini] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA	Johns Hopkins University	Rao, R (corresponding author), Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA.	rrao@jhmi.edu			NIAID NIH HHS [R01 AI065983] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065983] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agarwal AK, 2003, J BIOL CHEM, V278, P34998, DOI 10.1074/jbc.M306291200; Alexander MR, 2001, MOL BIOL CELL, V12, P53, DOI 10.1091/mbc.12.1.53; ANTUNESMADEIRA MD, 1995, INT J CARDIOL, V48, P211; Begley TJ, 2002, MOL CANCER RES, V1, P103; Benaim G, 2006, J MED CHEM, V49, P892, DOI 10.1021/jm050691f; Birrell GW, 2002, P NATL ACAD SCI USA, V99, P8778, DOI 10.1073/pnas.132275199; Boer VM, 2003, J BIOL CHEM, V278, P3265, DOI 10.1074/jbc.M209759200; Bonilla M, 2003, MOL BIOL CELL, V14, P4296, DOI 10.1091/mbc.E03-02-0113; Brauer MJ, 2005, MOL BIOL CELL, V16, P2503, DOI 10.1091/mbc.E04-11-0968; Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323; Cooper TG, 2002, FEMS MICROBIOL REV, V26, P223, DOI 10.1111/j.1574-6976.2002.tb00612.x; Courchesne WE, 2003, MOL MICROBIOL, V47, P223, DOI 10.1046/j.1365-2958.2003.03291.x; Courchesne WE, 2002, J PHARMACOL EXP THER, V300, P195, DOI 10.1124/jpet.300.1.195; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Hardwick JS, 1999, P NATL ACAD SCI USA, V96, P14866, DOI 10.1073/pnas.96.26.14866; Haugen AC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r95; Kafadar KA, 2004, EUKARYOT CELL, V3, P1147, DOI 10.1128/EC.3.5.1147-1153.2004; Magasanik B, 2002, GENE, V290, P1, DOI 10.1016/S0378-1119(02)00558-9; Marzluf GA, 1997, MICROBIOL MOL BIOL R, V61, P17, DOI 10.1128/.61.1.17-32.1997; Millard PJ, 1997, APPL ENVIRON MICROB, V63, P2897, DOI 10.1128/AEM.63.7.2897-2905.1997; Mizunuma M, 1998, NATURE, V392, P303, DOI 10.1038/32695; Onyewu C, 2007, ANTIMICROB AGENTS CH, V51, P3743, DOI 10.1128/AAC.00492-07; Pozniakovsky AI, 2005, J CELL BIOL, V168, P257, DOI 10.1083/jcb.200408145; Rolland F, 2002, FEMS YEAST RES, V2, P183, DOI 10.1111/j.1567-1364.2002.tb00084.x; Rosa SMLJ, 2000, BBA-MOL CELL BIOL L, V1487, P286, DOI 10.1016/S1388-1981(00)00122-0; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Santangelo GM, 2006, MICROBIOL MOL BIOL R, V70, P253, DOI 10.1128/MMBR.70.1.253-282.2006; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; Schuller HJ, 2003, CURR GENET, V43, P139, DOI 10.1007/s00294-003-0381-8; Sen Gupta S, 2003, J BIOL CHEM, V278, P28831, DOI 10.1074/jbc.M303300200; Steinbach WJ, 2007, NAT REV MICROBIOL, V5, P418, DOI 10.1038/nrmicro1680; Wu J, 2004, P NATL ACAD SCI USA, V101, P3148, DOI 10.1073/pnas.0308321100; Yadav J, 2007, MOL BIOL CELL, V18, P1480, DOI 10.1091/mbc.E06-11-1049; Yoshimoto H, 2002, J BIOL CHEM, V277, P31079, DOI 10.1074/jbc.M202718200	36	28	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37844	37853		10.1074/jbc.M707593200	http://dx.doi.org/10.1074/jbc.M707593200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17974566	hybrid			2022-12-27	WOS:000251833600060
J	Teghanemt, A; Prohinar, P; Gioannini, TL; Weiss, JP				Teghanemt, Athmane; Prohinar, Polonca; Gioannini, Theresa L.; Weiss, Jerrold P.			Transfer of monomeric endotoxin from MD-2 to CD14	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPOPOLYSACCHARIDE-BINDING PROTEIN; GRAM-NEGATIVE BACTERIA; NEISSERIA-MENINGITIDIS; CELL ACTIVATION; ENDOTHELIAL-CELLS; RECEPTOR; LBP; LPS; RECOGNITION; EXPRESSION	Potent Toll-like receptor 4 (TLR4)-dependent cell activation by endotoxin depends on sequential transfer of monomers of endotoxin from an aggregated form to CD14 via the lipopolysaccharide-binding protein and then to MD-2. We now show that monomeric endotoxin can be transferred in reverse from MD-2 to CD14 but not to lipopolysaccharide-binding protein. Reverse transfer requires a similar to 1000-fold molar excess of CD14 to endotoxin-MD-2. Transfer of endotoxin from MD-2 to extracellular soluble CD14 reduces activation of cells expressing TLR4 without MD-2. However, transfer of endotoxin from MD-2 to membrane CD14 (mCD14) makes cells expressing MD-2 center dot TLR4 sensitive to activation by the endotoxin-MD-2 complex. An endotoxin-mutant (F126A) MD-2 complex that does not activate cells expressing TLR4 alone potently activates cells expressing mCD14, MD-2, and TLR4 by transferring endotoxin to mCD14, which then transfers endotoxin to endogenous wildtype MD-2 center dot TLR4. These findings describe a novel pathway of endotoxin transfer that provides an additional layer of regulation of cell activation by endotoxin.	Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; Univ Iowa, Roy J & Lucille A Carver Coll Med, Inflammat Program, Iowa City, IA 52242 USA; Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Microbiol, Iowa City, IA 52242 USA; Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Biochem, Iowa City, IA 52242 USA; Vet Affairs Med Ctr, Iowa City, IA 52246 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Weiss, JP (corresponding author), Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA.	jerrold-weiss@uiowa.edu		Weiss, Jerrold/0000-0003-1476-4485	NIAID NIH HHS [AI59372] Funding Source: Medline; PHS HHS [P0144642] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059372] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552; Dunzendorfer S, 2004, FASEB J, V18, P1117, DOI 10.1096/fj.03-1263fje; Gangloff M, 2004, TRENDS BIOCHEM SCI, V29, P294, DOI 10.1016/j.tibs.2004.04.008; Giardina PC, 2001, J BIOL CHEM, V276, P5883, DOI 10.1074/jbc.M009273200; Gioannini TL, 2007, IMMUNOL RES, V39, P249, DOI 10.1007/s12026-007-0069-0; Gioannini TL, 2007, J BIOL CHEM, V282, P7877, DOI 10.1074/jbc.M605031200; Gioannini TL, 2005, J ENDOTOXIN RES, V11, P117, DOI 10.1179/096805105X35198; Gioannini TL, 2003, J ENDOTOXIN RES, V9, P401, DOI 10.1179/096805103225002773; Gioannini TL, 2002, J BIOL CHEM, V277, P47818, DOI 10.1074/jbc.M206404200; Gioannini TL, 2004, P NATL ACAD SCI USA, V101, P4186, DOI 10.1073/pnas.0306906101; Gruber A, 2004, J BIOL CHEM, V279, P28475, DOI 10.1074/jbc.M400993200; Hamann L, 2002, BIOCHEM BIOPH RES CO, V295, P553, DOI 10.1016/S0006-291X(02)00710-6; Heumann D, 2003, J ENDOTOXIN RES, V9, P381, DOI 10.1179/0963805103225003312; Iovine N, 2002, J BIOL CHEM, V277, P7970, DOI 10.1074/jbc.M109622200; Jersmann HPA, 2001, INFECT IMMUN, V69, P479, DOI 10.1128/IAI.69.1.479-485.2001; Jia HP, 2004, AM J PHYSIOL-LUNG C, V287, pL428, DOI 10.1152/ajplung.00377.2003; Kim JI, 2005, J BIOL CHEM, V280, P11347, DOI 10.1074/jbc.M414607200; Kitchens RL, 2005, J ENDOTOXIN RES, V11, P225, DOI 10.1179/096805105X46565; Kitchens RL, 2003, J ENDOTOXIN RES, V9, P113, DOI 10.1179/096805103125001504; Kobayashi Y, 2000, J PATHOL, V192, P263; Miller SI, 2005, NAT REV MICROBIOL, V3, P36, DOI 10.1038/nrmicro1068; Miyake K, 2003, INT IMMUNOPHARMACOL, V3, P119, DOI 10.1016/S1567-5769(02)00258-8; Ohto U, 2007, SCIENCE, V316, P1632, DOI 10.1126/science.1139111; Post DMB, 2006, J ENDOTOXIN RES, V12, P93, DOI 10.1177/09680519060120020501; Post DMB, 2005, J BIOL CHEM, V280, P38383, DOI 10.1074/jbc.M508063200; Post DMB, 2003, INFECT IMMUN, V71, P647, DOI 10.1128/IAI.71.2.647-655.2003; Prohinar P, 2007, J BIOL CHEM, V282, P1010, DOI 10.1074/jbc.M609400200; Pugin J, 2004, BLOOD, V104, P4071, DOI 10.1182/blood-2003-04-1290; Re F, 2003, J IMMUNOL, V171, P5272, DOI 10.4049/jimmunol.171.10.5272; Teghanemt A, 2005, J IMMUNOL, V175, P4669, DOI 10.4049/jimmunol.175.7.4669; TEGHANEMT A, 2007, J BIOL CHEM     1030; Ulevitch RJ, 1999, CURR OPIN IMMUNOL, V11, P19, DOI 10.1016/S0952-7915(99)80004-1; Weiss J, 2003, BIOCHEM SOC T, V31, P785, DOI 10.1042/BST0310785; Yang H, 2000, J BIOL CHEM, V275, P20861, DOI 10.1074/jbc.M002896200; Zarember KA, 2002, J IMMUNOL, V168, P554, DOI 10.4049/jimmunol.168.2.554; Zweigner J, 2006, MICROBES INFECT, V8, P946, DOI 10.1016/j.micinf.2005.10.006	37	24	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36250	36256		10.1074/jbc.M705995200	http://dx.doi.org/10.1074/jbc.M705995200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17934216	hybrid			2022-12-27	WOS:000251458300015
J	Gunzburg, MJ; Perugini, MA; Howlett, GJ				Gunzburg, Menachem J.; Perugini, Matthew A.; Howlett, Geoffrey J.			Structural basis for the recognition and cross-linking of amyloid fibrils by human apolipoprotein E	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEDIMENTATION-VELOCITY ANALYSIS; RECEPTOR-BINDING DOMAIN; PROTEIN-PROTEIN DOCKING; ALZHEIMERS-DISEASE; SELF-ASSOCIATION; TERMINAL DOMAIN; AQUEOUS-SOLUTION; BETA-PEPTIDE; MOUSE MODEL; C-II	Apolipoprotein (apo) E is a well characterized lipid-binding protein in plasma that also exists as a common nonfibrillar component of both cerebral and systemic amyloid deposits. A genetic link between a common isoform of apoE, apoE4, and the incidence of late onset Alzheimer disease has drawn considerable attention to the potential roles of apoE in amyloid-related disease. We examined the interactions of apoE with amyloid fibrils composed of apoC-II and the amyloid-beta (A beta) peptide. Aggregates of apoE with A beta and apoC-II are found in Alzheimer and atherosclerotic plaques, respectively. Sedimentation velocity and fibril size distribution analysis showed that apoE3 and E4 isoforms bind and noncovalently cross-link apoC-II fibrils in a similar manner. This ability to cross-link apoC-II fibrils was abolished by the dissociation of the apoE tetramer to monomers or by thrombin cleavage to yield separate N- and C-terminal domains. Preparative ultracentrifuge binding studies indicated that apoE and the isolated N- and C-terminal domains of apoE bind with submicromolar affinities to both apoC-II and A beta fibrils. Fluorescence quenching and resonance energy transfer experiments confirmed that both domains of apoE interact with apoC-II fibrils and demonstrated that the binding of the isolated N-terminal domain of apoE to apoC-II or A beta fibrils is accompanied by a significant conformational change with helix three of the domain moving relative to helix one. We propose a model involving the interaction of apoE with patterns of aligned residues that could explain the general ability of apoE to bind to a diverse range of amyloid fibrils.	Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3010, Australia; Univ Melbourne, Bio Mol Sci & Biotechnol Inst 21, Parkville, Vic 3010, Australia	University of Melbourne; University of Melbourne	Howlett, GJ (corresponding author), Univ Melbourne, Dept Biochem & Mol Biol, 30 Flemington Rd, Parkville, Vic 3010, Australia.	ghowlett@unimelb.edu.au		Perugini, Matthew/0000-0001-8052-5584				AGGERBECK LP, 1988, J BIOL CHEM, V263, P6249; Breslow JL, 1996, SCIENCE, V272, P685, DOI 10.1126/science.272.5262.685; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Chen R, 2003, PROTEINS, V51, P397, DOI 10.1002/prot.10334; Chou CY, 2006, J BIOL CHEM, V281, P13333, DOI 10.1074/jbc.M511077200; Comeau SR, 2005, PROTEINS, V60, P239, DOI 10.1002/prot.20564; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Comeau SR, 2004, NUCLEIC ACIDS RES, V32, pW96, DOI 10.1093/nar/gkh354; CORDER EH, 1993, SCIENCE, V261, P9921; De Meyer GRY, 2002, CIRC RES, V90, P1197, DOI 10.1161/01.RES.0000020017.84398.61; DELANO WL, 2002, PYMOL USERS MANUAL V; Fadika GO, 2002, AMYLOID, V9, P75, DOI 10.3109/13506120208995239; Findeis MA, 1999, BIOCHEMISTRY-US, V38, P6791, DOI 10.1021/bi982824n; Fisher CA, 1999, J LIPID RES, V40, P93; Harris FM, 2003, P NATL ACAD SCI USA, V100, P10966, DOI 10.1073/pnas.1434398100; Hatters DM, 2006, J MOL BIOL, V361, P932, DOI 10.1016/j.jmb.2006.06.080; Hatters DM, 2005, J BIOL CHEM, V280, P26477, DOI 10.1074/jbc.M503910200; Hatters DM, 2003, BIOPHYS J, V85, P3979, DOI 10.1016/S0006-3495(03)74812-7; Hatters DM, 2002, EUR BIOPHYS J BIOPHY, V31, P2, DOI 10.1007/s002490100172; Hatters DM, 2000, BIOCHEMISTRY-US, V39, P8276, DOI 10.1021/bi000002w; Hatters DM, 2005, J BIOL CHEM, V280, P34288, DOI 10.1074/jbc.M506044200; Holtzman DM, 1999, J CLIN INVEST, V103, pR15, DOI 10.1172/JCI6179; Holtzman DM, 2000, P NATL ACAD SCI USA, V97, P2892, DOI 10.1073/pnas.050004797; Howlett GJ, 2006, CURR OPIN LIPIDOL, V17, P541, DOI 10.1097/01.mol.0000245260.63505.4f; Hrncic R, 2000, AM J PATHOL, V157, P1239, DOI 10.1016/S0002-9440(10)64639-1; Huang YD, 2004, J MOL NEUROSCI, V23, P189, DOI 10.1385/JMN:23:3:189; HUDSON EN, 1973, BIOCHEMISTRY-US, V12, P4154, DOI 10.1021/bi00745a019; INNERARITY TL, 1983, J BIOL CHEM, V258, P2341; Kisilevsky R, 2000, AMYLOID, V7, P23, DOI 10.3109/13506120009146820; Lakowicz J R, 1999, PRINCIPLES FLUORESCE, P367, DOI 10.1007/978-1-4757-3061-6; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; LeVine H, 2000, AMYLOID, V7, P83, DOI 10.3109/13506120009146243; Lu B, 2000, J BIOL CHEM, V275, P20775, DOI 10.1074/jbc.M003508200; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; MacRaild CA, 2004, J BIOL CHEM, V279, P21038, DOI 10.1074/jbc.M314008200; MacRaild CA, 2003, BIOPHYS J, V84, P2562, DOI 10.1016/S0006-3495(03)75061-9; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; MCGHEE JD, 1974, J MOL BIOL, V86, P469, DOI 10.1016/0022-2836(74)90031-X; Medeiros LA, 2004, J BIOL CHEM, V279, P10643, DOI 10.1074/jbc.M311735200; Mok YF, 2006, METHOD ENZYMOL, V413, P199, DOI 10.1016/S0076-6879(06)13011-6; Morrow JA, 1999, PROTEIN EXPRES PURIF, V16, P224, DOI 10.1006/prep.1999.1069; Mucchiano GI, 2001, J PATHOL, V193, P270, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH753>3.0.CO;2-S; Mucchiano GI, 2001, AM J CLIN PATHOL, V115, P298; NAMBA Y, 1991, BRAIN RES, V541, P163, DOI 10.1016/0006-8993(91)91092-F; Narayanaswami V, 2001, J BIOL CHEM, V276, P37853; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; O'Nuallain B, 2002, P NATL ACAD SCI USA, V99, P1485, DOI 10.1073/pnas.022662599; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Pepys MB, 1997, AMYLOID, V4, P274, DOI 10.3109/13506129709003838; Perugini MA, 2000, J BIOL CHEM, V275, P36758, DOI 10.1074/jbc.M005565200; Peters-Libeu CA, 2006, J BIOL CHEM, V281, P1073, DOI 10.1074/jbc.M510851200; Peters-Libeu CA, 2007, J LIPID RES, V48, P1035, DOI 10.1194/jlr.M600545-JLR200; Ritter C, 2005, NATURE, V435, P844, DOI 10.1038/nature03793; Rocken C, 2006, ARTERIOSCL THROM VAS, V26, P676, DOI 10.1161/01.ATV.0000201930.10103.be; Saito H, 2001, J BIOL CHEM, V276, P40949, DOI 10.1074/jbc.M106337200; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sipe JD, 2000, J STRUCT BIOL, V130, P88, DOI 10.1006/jsbi.2000.4221; Stewart CR, 2007, J LIPID RES, V48, P2162, DOI 10.1194/jlr.M700098-JLR200; Stratman NC, 2005, CHEM PHYS LIPIDS, V137, P52, DOI 10.1016/j.chemphyslip.2005.06.005; Tedgui A, 2002, CIRC RES, V90, P1145, DOI 10.1161/01.RES.0000023048.87638.92; VOLLMER E, 1991, VIRCHOWS ARCH A, V419, P79, DOI 10.1007/BF01600220; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; WESTERLUND JA, 1993, J BIOL CHEM, V268, P15745; WETTERAU JR, 1988, J BIOL CHEM, V263, P6240; WILSON C, 1991, SCIENCE, V252, P1817, DOI 10.1126/science.2063194; WISNIEWSKI T, 1992, NEUROSCI LETT, V135, P235, DOI 10.1016/0304-3940(92)90444-C; Yamaguchi I, 2001, BIOCHEMISTRY-US, V40, P8499, DOI 10.1021/bi0027128	68	20	20	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35831	35841		10.1074/jbc.M706425200	http://dx.doi.org/10.1074/jbc.M706425200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17916554	hybrid			2022-12-27	WOS:000251458100045
J	Lu, BB; Xu, CC; Awai, K; Jones, AD; Benning, C				Lu, Binbin; Xu, Changcheng; Awai, Koichiro; Jones, A. Daniel; Benning, Christoph			A small ATPase protein of Arabidopsis, TGD3, involved in chloroplast lipid import	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENVELOPE MEMBRANE; TRAFFICKING; MUTANT; GALACTOLIPIDS; BIOSYNTHESIS; ACCUMULATION; TRANSPORTERS; METABOLISM; DEFICIENT; PHOSPHATE	Polar lipid trafficking is essential in eukaryotic cells as membranes of lipid assembly are often distinct from final destination membranes. A striking example is the biogenesis of the photosynthetic membranes (thylakoids) in plastids of plants. Lipid biosynthetic enzymes at the endoplasmic reticulum and the inner and outer plastid envelope membranes are involved. This compartmentalization requires extensive lipid trafficking. Mutants of Arabidopsis are available that are disrupted in the incorporation of endoplasmic reticulum-derived lipid precursors into thylakoid lipids. Two proteins affected in two of these mutants, trigalactosyldiacylglycerol 1 (TGD1) and TGD2, encode the permease and substrate binding component, respectively, of a proposed lipid translocator at the inner chloroplast envelope membrane. Here we describe a third protein of Arabidopsis, TGD3, a small ATPase proposed to be part of this translocator. As in the tgd1 and tgd2 mutants, triacylglycerols and trigalactolipids accumulate in a tgd3 mutant carrying a T-DNA insertion just 5' of the TGD3 coding region. The TGD3 protein shows basal ATPase activity and is localized inside the chloroplast beyond the inner chloroplast envelope membrane. Proteins orthologous to TGD1, -2, and -3 are predicted to be present in Gram - bacteria, and the respective genes are organized in operons suggesting a common biochemical role for the gene products. Based on the current analysis, it is hypothesized that TGD3 is the missing ATPase component of a lipid transporter involving TGD1 and TGD2 required for the biosynthesis of ER-derived thylakoid lipids in Arabidopsis.	Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA; Michigan State Univ, Dept Energy, Plant Res Lab, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Michigan State University	Benning, C (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, Biochem 215, E Lansing, MI 48824 USA.	benning@msu.edu	Jones, Arthur D/C-2670-2013; Awai, Koichiro/B-5119-2010; Benning, Christoph/Y-2528-2019	Awai, Koichiro/0000-0002-1731-7499; Benning, Christoph/0000-0001-8585-3667; Jones, A. Daniel/0000-0002-7408-6690				Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ambudkar SV, 2006, FEBS LETT, V580, P1049, DOI 10.1016/j.febslet.2005.12.051; Awai K, 2006, P NATL ACAD SCI USA, V103, P10817, DOI 10.1073/pnas.0602754103; Benning C, 2006, CURR OPIN PLANT BIOL, V9, P241, DOI 10.1016/j.pbi.2006.03.012; Benning C, 2005, J BIOL CHEM, V280, P2397, DOI 10.1074/jbc.R400032200; BENNING C, 1995, ARCH BIOCHEM BIOPHYS, V317, P103, DOI 10.1006/abbi.1995.1141; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHIFFLET S, 1988, ANAL BIOCHEM, V168, P1, DOI 10.1016/0003-2697(88)90002-4; CLINE K, 1984, PLANT PHYSIOL, V75, P675, DOI 10.1104/pp.75.3.675; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Davidson AL, 2004, ANNU REV BIOCHEM, V73, P241, DOI 10.1146/annurev.biochem.73.011303.073626; Doerrler WT, 2006, MOL MICROBIOL, V60, P542, DOI 10.1111/j.1365-2958.2006.05130.x; Doerrler WT, 2002, J BIOL CHEM, V277, P36697, DOI 10.1074/jbc.M205857200; Doerrler WT, 2001, J BIOL CHEM, V276, P11461, DOI 10.1074/jbc.C100091200; Dormann P, 1999, SCIENCE, V284, P2181, DOI 10.1126/science.284.5423.2181; DORMANN P, 1995, PLANT CELL, V7, P1801, DOI 10.1105/tpc.7.11.1801; Dormann P, 2002, TRENDS PLANT SCI, V7, P112, DOI 10.1016/S1360-1385(01)02216-6; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Froehlich JE, 2001, J BIOL CHEM, V276, P31806, DOI 10.1074/jbc.M104652200; HEINZ E, 1983, PLANT PHYSIOL, V72, P273, DOI 10.1104/pp.72.2.273; Houjou T, 2005, RAPID COMMUN MASS SP, V19, P654, DOI 10.1002/rcm.1836; Jackson DT, 1998, J BIOL CHEM, V273, P16583, DOI 10.1074/jbc.273.26.16583; Jarvis P, 2000, P NATL ACAD SCI USA, V97, P8175, DOI 10.1073/pnas.100132197; Miquel M, 1998, PLANT PHYSIOL, V117, P923, DOI 10.1104/pp.117.3.923; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Osterman A, 2003, CURR OPIN CHEM BIOL, V7, P238, DOI 10.1016/S1367-5931(03)00027-9; Rossak M, 1997, ARCH BIOCHEM BIOPHYS, V340, P219, DOI 10.1006/abbi.1997.9931; ROUGHAN PG, 1982, ANNU REV PLANT PHYS, V33, P97, DOI 10.1146/annurev.pp.33.060182.000525; Sanchez-Fernandez R, 2001, J BIOL CHEM, V276, P30231, DOI 10.1074/jbc.M103104200; SIEBERTZ HP, 1977, Z NATURFORSCH C, V32, P193; Tefsen B, 2005, J BIOL CHEM, V280, P35961, DOI 10.1074/jbc.M509026200; Xu CC, 2005, PLANT CELL, V17, P3094, DOI 10.1105/tpc.105.035592; Xu CC, 2003, EMBO J, V22, P2370, DOI 10.1093/emboj/cdg234; Zhao Q, 2004, J BIOL CHEM, V279, P48505, DOI 10.1074/jbc.M408343200	35	95	103	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35945	35953		10.1074/jbc.M704063200	http://dx.doi.org/10.1074/jbc.M704063200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17938172	hybrid			2022-12-27	WOS:000251458100055
J	Muff, TJ; Ordal, GW				Muff, Travis J.; Ordal, George W.			The CheC phosphatase regulates chemotactic adaptation through CheD	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-SUBTILIS; CRYSTAL-STRUCTURE; BACTERIAL CHEMOTAXIS; PROMOTES ADAPTATION; SIGNAL-TRANSDUCTION; METHYLATION; RECEPTOR; PROTEINS; REVEALS; MCPB	The bacterial chemotaxis system is one of the most extensively studied signal transduction systems in biology. The response regulator CheY controls flagellar rotation and is phosphorylated by the CheA histidine kinase to its active form. CheC is a CheY- P phosphatase, and this activity is enhanced in a CheC-CheD heterodimer. CheC is also critical for chemotactic adaptation, the return to the prestimulus system state despite persistent attractant concentrations. Here, CheC point mutants were examined in Bacillus subtilis for in vivo complementation and in vitro activity. The mutants were identified separating the three known abilities of CheC: CheD binding, CheY-P binding, and CheY-P phosphatase activity. Remarkably, the phosphatase ability was not as critical to the in vivo function of CheC as the ability to bind both CheY- P and CheD. Additionally, it was confirmed that CheY-P increases the affinity of CheC for CheD, the later of which is known to be necessary for receptor activation of CheA. These data suggest a model of CheC as a CheY-P-induced regulator of CheD. Here, CheY-P would cause CheC to sequester CheD from the chemoreceptors, inducing adaptation of the chemotaxis system. This model represents the first plausible means for feedback from the output of the system, CheY-P, to the receptors.	Univ Illinois, Coll Med, Dept Biochem, Urbana, IL 61801 USA; Univ Illinois, Coll Liberal Arts & Sci, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Ordal, GW (corresponding author), Univ Illinois, Coll Med, Dept Biochem, 506 S Matthews,190 MSB, Urbana, IL 61801 USA.	ordal@uiuc.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054365] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM 54365] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADLER J, 1973, J GEN MICROBIOL, V74, P77, DOI 10.1099/00221287-74-1-77; Boesch KC, 2000, J BACTERIOL, V182, P3544, DOI 10.1128/JB.182.12.3544-3552.2000; BORKOVICH KA, 1989, P NATL ACAD SCI USA, V86, P1208, DOI 10.1073/pnas.86.4.1208; Chao XJ, 2006, CELL, V124, P561, DOI 10.1016/j.cell.2005.11.046; Djordjevic S, 1997, STRUCTURE, V5, P545, DOI 10.1016/S0969-2126(97)00210-4; Garrity LF, 1997, MICROBIOL-UK, V143, P2945, DOI 10.1099/00221287-143-9-2945; IRETON K, 1993, GENE DEV, V7, P283, DOI 10.1101/gad.7.2.283; Jasuja R, 1999, P NATL ACAD SCI USA, V96, P11346, DOI 10.1073/pnas.96.20.11346; Karatan E, 2001, J BIOL CHEM, V276, P43618, DOI 10.1074/jbc.M104955200; Kirby JR, 1999, J BIOL CHEM, V274, P11092, DOI 10.1074/jbc.274.16.11092; Kirby JR, 2001, MOL MICROBIOL, V42, P573, DOI 10.1046/j.1365-2958.2001.02581.x; KIRSCH ML, 1993, J BIOL CHEM, V268, P18610; KIRSCH ML, 1993, J BIOL CHEM, V268, P25350; Kristich CJ, 2004, J BACTERIOL, V186, P5950, DOI 10.1128/JB.186.17.5950-5955.2004; Kristich CJ, 2002, J BIOL CHEM, V277, P25356, DOI 10.1074/jbc.M201334200; Muff TJ, 2007, J BACTERIOL, V189, P7007, DOI 10.1128/JB.00896-07; Muff TJ, 2007, METHOD ENZYMOL, V423, P336, DOI 10.1016/S0076-6879(07)23015-0; Ordal Geroge W., 1993, P765; Park SY, 2004, MOL CELL, V16, P563, DOI 10.1016/j.molcel.2004.10.018; PARKINSON JS, 1992, ANNU REV GENET, V26, P71, DOI 10.1146/annurev.ge.26.120192.000443; Rosario MML, 1996, MOL MICROBIOL, V21, P511, DOI 10.1111/j.1365-2958.1996.tb02560.x; ROSARIO MML, 1995, BIOCHEMISTRY-US, V34, P3823, DOI 10.1021/bi00011a040; Scharf BE, 1998, P NATL ACAD SCI USA, V95, P201, DOI 10.1073/pnas.95.1.201; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Szurmant H, 2004, J BIOL CHEM, V279, P21787, DOI 10.1074/jbc.M311497200; Szurmant H, 2003, J BIOL CHEM, V278, P48611, DOI 10.1074/jbc.M306180200; Szurmant L, 2004, MICROBIOL MOL BIOL R, V68, P301, DOI 10.1128/MMBR.68.2.301-319.2004; Terry K, 2006, MOL MICROBIOL, V61, P871, DOI 10.1111/j.1365-2958.2006.05283.x; Toker AS, 1997, J MOL BIOL, V273, P623, DOI 10.1006/jmbi.1997.1335; ULLAH AHJ, 1981, J BACTERIOL, V145, P958, DOI 10.1128/JB.145.2.958-965.1981; Varughese KI, 2006, J BACTERIOL, V188, P4970, DOI 10.1128/JB.00160-06; WEST AH, 1995, J MOL BIOL, V250, P276, DOI 10.1006/jmbi.1995.0376; Zhao R, 2002, NAT STRUCT BIOL, V9, P570; Zimmer MA, 2002, MOL MICROBIOL, V45, P555, DOI 10.1046/j.1365-2958.2002.03035.x; Zimmer MA, 2000, J BIOL CHEM, V275, P24264, DOI 10.1074/jbc.M004001200	35	32	33	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					34120	34128		10.1074/jbc.M706432200	http://dx.doi.org/10.1074/jbc.M706432200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17908686	hybrid			2022-12-27	WOS:000251145700026
J	Marri, L; Trost, P; Trivelli, X; Gonnelli, L; Pupillo, P; Sparla, F				Marri, Lucia; Trost, Paolo; Trivelli, Xavier; Gonnelli, Leonardo; Pupillo, Paolo; Sparla, Francesca			Spontaneous assembly of photosynthetic supramolecular complexes as mediated by the intrinsically unstructured protein CP12	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLOROPLAST GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; CALVIN CYCLE ACTIVITY; C-TERMINAL EXTENSION; SPINACH-CHLOROPLASTS; LIGHT REGULATION; B-SUBUNIT; PHOSPHORIBULOKINASE; ARABIDOPSIS; DISORDER; ISOFORM	CP12 is a protein of 8.7 kDa that contributes to Calvin cycle regulation by acting as a scaffold element in the formation of a supramolecular complex with glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and phosphoribulokinase (PRK) in photosynthetic organisms. NMR studies of recombinant CP12 (isoform 2) of Arabidopsis thaliana show that CP12-2 is poorly structured. CP12-2 is monomeric in solution and contains four cysteines, which can form two intramolecular disulfides with midpoint redox potentials of -326 and -352 mV, respectively, at pH 7.9. Site-specific mutants indicate that the C-terminal disulfide is involved in the interaction between CP12-2 and GAPDH (isoform A(4)), whereas the N-terminal disulfide is involved in the interaction between this binary complex and PRK. In the presence of NAD, oxidized CP12-2 interacts with A(4)-GAPDH(K-D (=) 0.18 mu M) to form a binary complex of 170 kDa with (A(4)-GAPDH)-(CP12-2)(2) stoichiometry, as determined by isothermal titration calorimetry and multiangle light scattering analysis. PRK is a dimer and by interacting with this binary complex (K-D = 0.17 mu M) leads to a 498-kDa ternary complex constituted by two binary complexes and two PRK dimers, i.e. ((A(4)-GAPDH)-(CP12-2)(2)-(PRK))(2). Thermodynamic parameters indicate that assembly of both binary and ternary complexes is exoergonic although penalized by a decrease in entropy that suggests an induced folding of CP12-2 upon binding to partner proteins. The redox dependence of events leading to supramolecular complexes is consistent with a role of CP12 in coordinating the reversible inactivation of chloroplast enzymes A(4)-GAPDH and PRK during darkness in photosynthetic tissues.	[Marri, Lucia; Trost, Paolo; Pupillo, Paolo; Sparla, Francesca] Univ Bologna, Dept Expt Evolut Biol, Lab Mol Plant Physiol, I-40126 Bologna, Italy; [Trivelli, Xavier] Univ Lille, UMR 8576, CNRS, IFR 147 Sci & Technol, F-59655 Villeneuve Dascq, France; [Gonnelli, Leonardo] Univ Florence, Magnet Resonance Ctr, I-50019 Florence, Italy	University of Bologna; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; University of Florence	Trost, P (corresponding author), Univ Bologna, Dept Expt Evolut Biol, Lab Mol Plant Physiol, I-40126 Bologna, Italy.	trost@alma.unibo.it	Trost, Paolo/F-2425-2011	Sparla, Francesca/0000-0002-2103-4870; Trost, Paolo/0000-0002-6347-8701; Trivelli, Xavier/0000-0001-6775-9650				Baalmann E, 1996, PLANT MOL BIOL, V32, P505, DOI 10.1007/BF00019102; BAALMANN E, 1994, BOT ACTA, V107, P313, DOI 10.1111/j.1438-8677.1994.tb00801.x; Baalmann E, 1995, ARCH BIOCHEM BIOPHYS, V324, P201, DOI 10.1006/abbi.1995.0031; BODENHAUSEN G, 1980, CHEM PHYS LETT, V69, P185, DOI 10.1016/0009-2614(80)80041-8; CERFF R, 1979, J BIOL CHEM, V254, P6094; Collin V, 2003, J BIOL CHEM, V278, P23747, DOI 10.1074/jbc.M302077200; Conway ME, 2004, BIOCHEMISTRY-US, V43, P7356, DOI 10.1021/bi0498050; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; Fermani S, 2007, P NATL ACAD SCI USA, V104, P11109, DOI 10.1073/pnas.0611636104; Fermani S, 2001, J MOL BIOL, V314, P527, DOI 10.1006/jmbi.2001.5172; Figge RM, 1999, MOL BIOL EVOL, V16, P429, DOI 10.1093/oxfordjournals.molbev.a026125; Gardebien F, 2006, J MOL GRAPH MODEL, V25, P186, DOI 10.1016/j.jmgm.2005.12.003; Graciet E, 2004, J EXP BOT, V55, P1245, DOI 10.1093/jxb/erh107; Graciet E, 2003, BIOCHEMISTRY-US, V42, P8163, DOI 10.1021/bi034474x; Graciet E, 2003, EUR J BIOCHEM, V270, P129, DOI 10.1046/j.1432-1033.2003.03372.x; Haynes C, 2006, PLOS COMPUT BIOL, V2, P890, DOI 10.1371/journal.pcbi.0020100; Lebreton S, 2003, J BIOL CHEM, V278, P12078, DOI 10.1074/jbc.M213096200; Lebreton S, 2006, FEBS J, V273, P3358, DOI 10.1111/j.1742-4658.2006.05342.x; Li AD, 1997, PLANT PHYSIOL, V115, P1201, DOI 10.1104/pp.115.3.1201; Marri L, 2005, J EXP BOT, V56, P73, DOI 10.1093/jxb/eri020; Marri L, 2005, PLANT PHYSIOL, V139, P1433, DOI 10.1104/pp.105.068445; Michels J, 2002, PROTEIN SCI, V11, P1565, DOI 10.1110/ps.2760102; Petersen J, 2006, MOL BIOL EVOL, V23, P1109, DOI 10.1093/molbev/msj123; Pohlmeyer K, 1996, PLANT MOL BIOL, V32, P969, DOI 10.1007/BF00020493; PORTER MA, 1990, PLANTA, V181, P349, DOI 10.1007/BF00195887; PORTER MA, 1988, J BIOL CHEM, V263, P123; PUPILLO P, 1975, EUR J BIOCHEM, V51, P475, DOI 10.1111/j.1432-1033.1975.tb03947.x; Qi JF, 2001, J BIOL CHEM, V276, P35247, DOI 10.1074/jbc.M103855200; Radivojac P, 2007, BIOPHYS J, V92, P1439, DOI 10.1529/biophysj.106.094045; Raines CA, 2006, J EXP BOT, V57, P1857, DOI 10.1093/jxb/erl011; Scagliarini S, 1998, J EXP BOT, V49, P1307, DOI 10.1093/jexbot/49.325.1307; Scheibe R, 2002, EUR J BIOCHEM, V269, P5617, DOI 10.1046/j.1432-1033.2002.03269.x; Sparla F, 2002, J BIOL CHEM, V277, P44946, DOI 10.1074/jbc.M206873200; Tamoi M, 2005, PLANT J, V42, P504, DOI 10.1111/j.1365-313X.2005.02391.x; Tompa P, 2005, TRENDS BIOCHEM SCI, V30, P484, DOI 10.1016/j.tibs.2005.07.008; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Trost P, 2006, PHOTOSYNTH RES, V89, P263, DOI 10.1007/s11120-006-9099-z; TROST P, 1993, PLANTA, V190, P320, DOI 10.1007/BF00196960; Wedel N, 1997, P NATL ACAD SCI USA, V94, P10479, DOI 10.1073/pnas.94.19.10479; Wedel N, 1998, P NATL ACAD SCI USA, V95, P9699, DOI 10.1073/pnas.95.16.9699; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; WOLOSIUK RA, 1993, FASEB J, V7, P622, DOI 10.1096/fasebj.7.8.8500687; Yao J, 1997, FEBS LETT, V419, P285, DOI 10.1016/S0014-5793(97)01474-9; Zaffagnini M, 2007, FEBS J, V274, P212, DOI 10.1111/j.1742-4658.2006.05577.x	45	59	61	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					1831	1838		10.1074/jbc.M705650200	http://dx.doi.org/10.1074/jbc.M705650200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	17947231	hybrid			2022-12-27	WOS:000252501000008
J	Cooper, SE; Murawsky, CM; Lowe, N; Travers, AA				Cooper, Sarah E.; Murawsky, Christopher M.; Lowe, Nicholas; Travers, Andrew A.			Two modes of degradation of the tramtrack transcription factors by Siah homologues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL FATE; DROSOPHILA EYE; UBIQUITIN LIGASE; FINGER PROTEIN; R7 CELL; GENE; STABILITY; REPRESSOR; PHYLLOPOD; ACTS	The Siah proteins, mammalian homologues of the Drosophila Sina protein, function as ubiquitin-protein isopeptide ligase enzymes to target a wide range of cellular proteins for degradation. We report here a novel Drosophila protein that is homologous to Sina, named Sina-Homologue (SinaH). We show that it can direct the degradation of the transcriptional repressor Tramtrack (Ttk) using two different mechanisms. One is similar to Sina and requires the adaptor Phyllopod, and the other is a novel mechanism of recognition. This novel mode of targeting for degradation is specific for the 69-kDa Ttk isoform, Ttk69. Ttk69 contains a region that is required for binding of SinaH and for SinaH-directed degradation. This region contains an AXVXP motif, which is the consensus sequence found in Siah substrate proteins. These results suggest that degradation directed by SinaH differs from that directed by Sina and is more similar to that found in vertebrates. We speculate that SinaH may be involved in regulating the levels of developmentally important transcription factors.	[Cooper, Sarah E.; Murawsky, Christopher M.; Lowe, Nicholas; Travers, Andrew A.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Cooper, SE (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 0QH, England.	scooper@mrc-lmb.cam.ac.uk		Murawsky, Christopher/0000-0002-9698-052X	Medical Research Council [U.1051.01.011(78785), MC_U105184288] Funding Source: Medline; MRC [MC_U105184288] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Badenhorst P, 2002, MECH DEVELOP, V117, P87, DOI 10.1016/S0925-4773(02)00183-1; Badenhorst P, 2001, DEVELOPMENT, V128, P4093; Baonza A, 2002, NAT CELL BIOL, V4, P976, DOI 10.1038/ncb887; Boehm J, 2001, EMBO J, V20, P4153, DOI 10.1093/emboj/20.15.4153; Boulton SJ, 2000, EMBO J, V19, P5376, DOI 10.1093/emboj/19.20.5376; CARTHEW RW, 1990, CELL, V63, P561, DOI 10.1016/0092-8674(90)90452-K; CHANG HC, 1995, CELL, V80, P463, DOI 10.1016/0092-8674(95)90497-2; Cooper SE, 2007, MECH DEVELOP, V124, P584, DOI 10.1016/j.mod.2007.04.007; Dallman JE, 2004, J NEUROSCI, V24, P7186, DOI 10.1523/JNEUROSCI.0238-04.2004; Dong XZ, 1999, GENE DEV, V13, P954, DOI 10.1101/gad.13.8.954; Galan JM, 1999, P NATL ACAD SCI USA, V96, P9124, DOI 10.1073/pnas.96.16.9124; Giesen K, 1997, DEVELOPMENT, V124, P2307; GUO M, 1995, NEURON, V14, P913, DOI 10.1016/0896-6273(95)90330-5; HARRISON SD, 1990, EMBO J, V9, P207, DOI 10.1002/j.1460-2075.1990.tb08097.x; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; House CM, 2003, P NATL ACAD SCI USA, V100, P3101, DOI 10.1073/pnas.0534783100; Hu G, 1997, GENOMICS, V46, P103, DOI 10.1006/geno.1997.4997; Kauffmann RC, 1996, GENE DEV, V10, P2167, DOI 10.1101/gad.10.17.2167; Li SH, 2002, MOL CELL BIOL, V22, P6854, DOI 10.1128/MCB.22.19.6854-6865.2002; Li SH, 1997, CELL, V90, P469, DOI 10.1016/S0092-8674(00)80507-3; Matsuzawa S, 2001, MOL CELL, V7, P915, DOI 10.1016/S1097-2765(01)00242-8; Matsuzawa S, 1998, EMBO J, V17, P2736, DOI 10.1093/emboj/17.10.2736; Murawsky CM, 2001, EMBO REP, V2, P1089, DOI 10.1093/embo-reports/kve252; Nakayama K, 2004, CELL, V117, P941, DOI 10.1016/j.cell.2004.06.001; Pi HW, 2001, DEVELOPMENT, V128, P2699; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; READ D, 1992, EMBO J, V11, P1035, DOI 10.1002/j.1460-2075.1992.tb05142.x; Santelli E, 2005, J BIOL CHEM, V280, P34278, DOI 10.1074/jbc.M506707200; Sourisseau T, 2001, J CELL SCI, V114, P1409; Tang AH, 1997, CELL, V90, P459, DOI 10.1016/S0092-8674(00)80506-1; Tiedt R, 2001, EMBO J, V20, P4143, DOI 10.1093/emboj/20.15.4143; Wen Y, 2000, GENETICS, V156, P195; XIONG WC, 1993, GENE DEV, V7, P1085, DOI 10.1101/gad.7.6.1085; Zhang X, 1998, MOL ENDOCRINOL, V12, P513, DOI 10.1210/me.12.4.513	34	5	8	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					1076	1083		10.1074/jbc.M707765200	http://dx.doi.org/10.1074/jbc.M707765200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	17962185	hybrid, Green Accepted			2022-12-27	WOS:000252128100047
J	Ploskon, E; Arthur, CJ; Evans, SE; Williams, C; Crosby, J; Simpson, TJ; Crump, MP				Ploskon, Eliza; Arthur, Christopher J.; Evans, Simon E.; Williams, Christopher; Crosby, John; Simpson, Thomas J.; Crump, Matthew P.			A mammalian type I fatty acid synthase acyl carrier protein domain does not sequester acyl chains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; BACKBONE DYNAMICS; SURFACE-TOPOGRAPHY; NMR-SPECTROSCOPY; EXCHANGE-RATES; COMPUTED ATLAS; EGLIN-C; IDENTIFICATION; RESTRAINTS; ASSIGNMENT	The synthases that produce fatty acids in mammals (FASs) are arranged as large multidomain polypeptides. The growing fatty acid chain is bound covalently during chain elongation and reduction to the acyl carrier protein (ACP) domain that is then able to access each catalytic site. In this work we report the high-resolution nuclear magnetic resonance (NMR) solution structure of the isolated rat fatty acid synthase apoACP domain. The final ensemble of NMR structures and backbone N-15 relaxation studies show that apoACP adopts a single, well defined fold. On conversion to the holo form, several small chemical shift changes are observed on the ACP for residues surrounding the phosphopantetheine attachment site ( as monitored by backbone H-1-N-15 correlation experiments). However, there are negligible chemical shift changes when the holo form is modified to either the hexanoyl or palmitoyl forms. For further NMR analysis, a C-13,N-15-labeled hexanoyl-ACP sample was prepared and full chemical shift assignments completed. Analysis of two-dimensional F-2-filtered and three-dimensional C-13-edited nuclear Overhauser effect spectroscopy experiments revealed no detectable NOEs to the acyl chain. These experiments demonstrate that unlike other FAS ACPs studied, this Type I ACP does not sequester a covalently linked acyl moiety, although transient interactions cannot be ruled out. This is an important mechanistic difference between the ACPs from Type I and Type II FASs and may be significant for the modulation and regulation of these important mega-synthases.	Univ Bristol, Sch Chem, Bristol BS8 1TS, Avon, England	University of Bristol	Crump, MP (corresponding author), Univ Bristol, Sch Chem, Bristol BS8 1TS, Avon, England.	matt.crump@bristol.ac.uk	Simpson, Thomas J/P-5058-2015; Arthur, Christopher J/F-9710-2011; Wiliams, Christopher/P-4904-2015	Wiliams, Christopher/0000-0001-5806-9842; Arthur, Christopher/0000-0001-7577-8472; Crump, Matthew/0000-0002-7868-5818	Biotechnology and Biological Sciences Research Council [BB/F014570/1, B20055] Funding Source: Medline; Wellcome Trust Funding Source: Medline; BBSRC [BB/F014570/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		ANDREC M, 1995, PROTEIN SCI, V4, P983; Arthur C, 2002, CHEMBIOCHEM, V3, P253, DOI 10.1002/1439-7633(20020301)3:2/3<253::AID-CBIC253>3.0.CO;2-7; Binkowski TA, 2003, NUCLEIC ACIDS RES, V31, P3352, DOI 10.1093/nar/gkg512; Bonvin AMJJ, 2001, J BIOMOL NMR, V21, P221, DOI 10.1023/A:1012935005256; Breeze AL, 2000, PROG NUCL MAG RES SP, V36, P323, DOI 10.1016/S0079-6565(00)00020-0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CONSTANTINIDES PP, 1986, ARCH BIOCHEM BIOPHYS, V250, P267, DOI 10.1016/0003-9861(86)90726-5; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Crump MP, 1997, BIOCHEMISTRY-US, V36, P6000, DOI 10.1021/bi970006+; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; FARROW NA, 1994, J BIOMOL NMR, V4, P727, DOI 10.1007/BF00404280; Findlow SC, 2003, BIOCHEMISTRY-US, V42, P8423, DOI 10.1021/bi0342259; Fogh Rasmus, 2002, Nature Structural Biology, V9, P416, DOI 10.1038/nsb0602-416; Habeck Michael, 2004, Methods Mol Biol, V278, P379; HOLAK TA, 1986, BIOCHEMISTRY-US, V25, P5766, DOI 10.1021/bi00367a063; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; ISHIMA R, 1995, BIOCHEMISTRY-US, V34, P3162, DOI 10.1021/bi00010a005; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Kay LE, 1995, PROG BIOPHYS MOL BIO, V63, P277, DOI 10.1016/0079-6107(95)00007-0; Keating MM, 2002, BBA-PROTEINS PROTEOM, V1601, P208, DOI 10.1016/S1570-9639(02)00470-3; KIM Y, 1989, BIOCHEMISTRY-US, V28, P8792, DOI 10.1021/bi00448a017; Kim Y, 2006, BIOCHEM BIOPH RES CO, V341, P776, DOI 10.1016/j.bbrc.2006.01.025; KIM YM, 1990, PROTEINS, V8, P377, DOI 10.1002/prot.340080411; Koglin A, 2006, SCIENCE, V312, P273, DOI 10.1126/science.1122928; Kuhajda FP, 2006, CANCER RES, V66, P5977, DOI 10.1158/0008-5472.CAN-05-4673; Kuhajda FP, 2005, TRENDS PHARMACOL SCI, V26, P541, DOI 10.1016/j.tips.2005.09.002; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Leibundgut M, 2007, SCIENCE, V316, P288, DOI 10.1126/science.1138249; Li Q, 2003, BIOCHEMISTRY-US, V42, P4648, DOI 10.1021/bi0274120; Linge JP, 2003, BIOINFORMATICS, V19, P315, DOI 10.1093/bioinformatics/19.2.315; Lomakin IB, 2007, CELL, V129, P319, DOI 10.1016/j.cell.2007.03.013; Maier T, 2006, SCIENCE, V311, P1258, DOI 10.1126/science.1123248; MAYO KH, 1985, BIOCHEMISTRY-US, V24, P7834, DOI 10.1021/bi00347a049; Nederveen AJ, 2005, PROTEINS, V59, P662, DOI 10.1002/prot.20408; Pellecchia M, 1999, NAT STRUCT BIOL, V6, P336; Peng JW, 1995, BIOCHEMISTRY-US, V34, P16733, DOI 10.1021/bi00051a023; PENG JW, 1992, BIOCHEMISTRY-US, V31, P8571, DOI 10.1021/bi00151a027; PENG JW, 1992, J MAGN RESON, V98, P308, DOI 10.1016/0022-2364(92)90135-T; Peterson RD, 2004, J BIOMOL NMR, V28, P59, DOI 10.1023/B:JNMR.0000012861.95939.05; Qiu XY, 2004, ACTA CRYSTALLOGR D, V60, P1545, DOI 10.1107/S0907444904015422; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; Reed MAC, 2003, ORG BIOMOL CHEM, V1, P463, DOI 10.1039/b208941f; ROCK CO, 1979, J BIOL CHEM, V254, P7123; Roujeinikova A, 2002, STRUCTURE, V10, P825, DOI 10.1016/S0969-2126(02)00775-X; Roujeinikova A, 2007, J MOL BIOL, V365, P135, DOI 10.1016/j.jmb.2006.09.049; Sharma AK, 2006, BIOCHEMISTRY-US, V45, P6904, DOI 10.1021/bi060368u; Tropf S, 1998, CHEM BIOL, V5, P135, DOI 10.1016/S1074-5521(98)90058-8; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; White SW, 2005, ANNU REV BIOCHEM, V74, P791, DOI 10.1146/annurev.biochem.74.082803.133524; Winston RL, 1998, ANAL BIOCHEM, V262, P83, DOI 10.1006/abio.1998.2754; Wong HC, 2002, J BIOL CHEM, V277, P15874, DOI 10.1074/jbc.M112300200; Xu GY, 2001, STRUCTURE, V9, P277, DOI 10.1016/S0969-2126(01)00586-X; ZHANG OW, 1994, J BIOMOL NMR, V4, P845, DOI 10.1007/BF00398413; Zhang YM, 2001, J BIOL CHEM, V276, P8231, DOI 10.1074/jbc.M008042200; Zhang YQ, 2003, J BIOL CHEM, V278, P10417, DOI 10.1074/jbc.M211044200; Zornetzer GA, 2006, BIOCHEMISTRY-US, V45, P5217, DOI 10.1021/bi052062d	57	59	59	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					518	528		10.1074/jbc.M703454200	http://dx.doi.org/10.1074/jbc.M703454200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17971456	hybrid			2022-12-27	WOS:000251940300057
J	Su, Q; Wang, S; Gao, HQ; Kazemi, S; Harding, HP; Ron, D; Koromilas, AE				Su, Qiaozhu; Wang, Shuo; Gao, Hong Qing; Kazemi, Shirin; Harding, Heather P.; Ron, David; Koromilas, Antonis E.			Modulation of the eukaryotic initiation factor 2 alpha-subunit kinase PERK by tyrosine phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; NF-KAPPA-B; TRANSLATIONAL CONTROL; EIF2-ALPHA KINASE; PKR; ACTIVATION; SUBSTRATE; STRESS; ELF2-ALPHA; INTERACT	The endoplasmic reticulum (ER)-resident protein kinase PERK attenuates protein synthesis in response to ER stress through the phosphorylation of translation initiation factor eIF2 alpha at serine 51. ER stress induces PERK autophosphorylation at several serine/threonine residues, a process that is required for kinase activation and phosphorylation of eIF2 alpha. Herein, we demonstrate that PERK also possesses tyrosine kinase activity. Specifically, we show that PERK is capable of autophosphorylating on tyrosine residues in vitro and in vivo. We further show that tyrosine 615, which is embedded in a highly conserved region of the kinase domain of PERK, is essential for autocatalytic activity. That is, mutation of Tyr-615 to phenylalanine compromises the autophosphorylation capacity of PERK and the phosphorylation of eIF2 alpha in vitro and in vivo. The Y615F mutation also impairs the ability of PERK to induce translation of ATF4. Immunoblot analyses with a phospho-specific antibody confirm the phosphorylation of PERK at Tyr- 615 both in vitro and in vivo. Thus, our data classify PERK as a dual specificity kinase whose regulation by tyrosine phosphorylation contributes to its optimal activation in response to ER stress.	[Su, Qiaozhu; Wang, Shuo; Gao, Hong Qing; Kazemi, Shirin; Koromilas, Antonis E.] Sir Mortimer B Davis Jewish Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada; [Harding, Heather P.; Ron, David] NYU, Sch Med, Skirball Inst, New York, NY 10016 USA	Lady Davis Institute; McGill University; New York University	Koromilas, AE (corresponding author), Sir Mortimer B Davis Jewish Hosp, Lady Davis Inst Med Res, 3999 Cote-Ste-Catherine St, Montreal, PQ H3T 1E2, Canada.	antonis.koromilas@mcgill.ca		Ron, David/0000-0002-3014-5636; Harding, Heather P/0000-0002-7359-7974				Abbott CM, 2004, TRENDS BIOCHEM SCI, V29, P25, DOI 10.1016/j.tibs.2003.11.006; Baltzis D, 2004, J VIROL, V78, P12747, DOI 10.1128/JVI.78.23.12747-12761.2004; Baltzis D, 2002, J BIOL CHEM, V277, P38364, DOI 10.1074/jbc.M203564200; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Brand SR, 1997, J BIOL CHEM, V272, P8388, DOI 10.1074/jbc.272.13.8388; Chen JJ, 2007, BLOOD, V109, P2693, DOI 10.1182/blood-2006-08-041830; Chen JJ, 2000, COLD SPRING HARBOR M, V39, P529; Clemens MJ, 1997, J INTERF CYTOK RES, V17, P503, DOI 10.1089/jir.1997.17.503; Cuddihy AR, 1999, ONCOGENE, V18, P2690, DOI 10.1038/sj.onc.1202620; Cullinan SB, 2003, MOL CELL BIOL, V23, P7198, DOI 10.1128/MCB.23.20.7198-7209.2003; Dar AC, 2005, CELL, V122, P887, DOI 10.1016/j.cell.2005.06.044; Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6; Dey M, 2005, CELL, V122, P901, DOI 10.1016/j.cell.2005.06.041; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Ibarra-Sanchez MD, 2000, SEMIN IMMUNOL, V12, P379, DOI 10.1006/smim.2000.0220; Ibarra-Sanchez MD, 2001, ONCOGENE, V20, P4728, DOI 10.1038/sj.onc.1204648; Kaufman RJ, 2000, COLD SPRING HARBOR M, V39, P503; Kazemi S, 2004, MOL CELL BIOL, V24, P3415, DOI 10.1128/MCB.24.8.3415-3429.2004; Kimball S R, 2001, Prog Mol Subcell Biol, V26, P155; Kimball Sr, 2000, COLD SPRING HARBOR M, V39, P561; KUMAR A, 1994, P NATL ACAD SCI USA, V91, P6288, DOI 10.1073/pnas.91.14.6288; Li SY, 2001, J BIOL CHEM, V276, P13881, DOI 10.1074/jbc.M008140200; Lochhead PA, 2006, MOL CELL, V24, P627, DOI 10.1016/j.molcel.2006.10.009; Ma YL, 2001, RAPID COMMUN MASS SP, V15, P1693, DOI 10.1002/rcm.426; MCMILLAN NAJ, 1995, VIROLOGY, V213, P413, DOI 10.1006/viro.1995.0014; Proud C G, 2001, Prog Mol Subcell Biol, V26, P95; Proud CG, 2005, SEMIN CELL DEV BIOL, V16, P3, DOI 10.1016/j.semcdb.2004.11.004; Ron D, 2000, COLD SPRING HARBOR M, V39, P547; Ron D, 2002, J CLIN INVEST, V110, P1383, DOI 10.1172/JCI200216784; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; Saunders LR, 2001, J BIOL CHEM, V276, P32300, DOI 10.1074/jbc.M104207200; Su QZ, 2007, EMBO REP, V8, P265, DOI 10.1038/sj.embor.7400891; Su QZ, 2006, P NATL ACAD SCI USA, V103, P63, DOI 10.1073/pnas.0508207103; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Wang S, 2006, J BIOL CHEM, V281, P9439, DOI 10.1074/jbc.M504977200; Wong AHT, 2001, J BIOL CHEM, V276, P13727, DOI 10.1074/jbc.M011240200; Zhu SH, 1996, J BIOL CHEM, V271, P24989, DOI 10.1074/jbc.271.40.24989	40	56	61	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					469	475		10.1074/jbc.M704612200	http://dx.doi.org/10.1074/jbc.M704612200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17998206	hybrid			2022-12-27	WOS:000251940300052
J	Yeh, LK; Liu, CY; Chien, CL; Converse, RL; Kao, WWY; Chen, MS; Hu, FR; Hsieh, FJ; Wang, IJ				Yeh, Lung-Kun; Liu, Chia-Yang; Chien, Chung-Liang; Converse, Richard L.; Kao, Winston W. -Y.; Chen, Muh-Shy; Hu, Fung-Rong; Hsieh, Fon-Jou; Wang, I-Jong			Molecular analysis and characterization of zebrafish keratocan (zKera) gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KERATAN SULFATE PROTEOGLYCAN; LEUCINE-RICH PROTEOGLYCANS; PROTEIN; PERSPECTIVES; EVOLUTION; SEQUENCE; CLONING; EYE	Corneal small leucine-rich proteoglycans play a pivotal role in maintaining corneal transparency and function. In this study, we isolated and characterized the zebrafish ( Danio rerio) keratocan (zKera) gene. The human keratocan sequence was used to search zebrafish homologues. The zKera full-length genomic DNA and cDNA were generated via PCR of zebrafish genomic DNA and reverse transcription-PCR of total zebrafish eye RNA, respectively. The zKera spanning 3.5 kilobase pairs consists of two exons and one intron and a TATA-less promoter. The zKera encodes 341 amino acids with 59% identity to its human counterpart and 57% identity to that of mouse keratocan. Like mouse and chick keratocan, zKera mRNA is selectively expressed in the adult cornea; however, during embryonic development, zKera mRNA is expressed in both the brain and the cornea. Interestingly, it is expressed mainly in corneal epithelium but also in the stroma. A pseudogene was proved by introducing a zKera promoter-driven enhanced green fluorescence protein reporter gene into fertilized zebrafish eggs. Using morpholino-antisense against zKera to knock down zKera resulted in a lethal phenotype due to massive caspase-dependent apoptosis, which was noted by a significant increase of active caspase-3 and caspase-8 in the developing forebrain area, including the eyes. This is different from mouse, for which keratocan-deficient mice are viable. Taken together, our data indicate that mammalian keratocan is conserved in zebrafish in terms of gene structure, expression pattern, and promoter function.	[Chen, Muh-Shy; Hu, Fung-Rong; Wang, I-Jong] Natl Taiwan Univ Hosp, Dept Ophthalmol, Taipei 100, Taiwan; [Yeh, Lung-Kun; Chien, Chung-Liang] Natl Taiwan Univ, Coll Med, Dept Anat & Cell Biol, Taipei 100, Taiwan; [Yeh, Lung-Kun] Chang Gung Univ, Chang Gung Mem Hosp, Coll Med, Dept Ophthalmol, Tao Yuan 333, Taiwan; [Liu, Chia-Yang; Converse, Richard L.; Kao, Winston W. -Y.] Univ Cincinnati, Coll Med, Dept Ophthalmol, Cincinnati, OH 45267 USA; [Kao, Winston W. -Y.] Univ Cincinnati, Coll Med, Dept Cell Biol Neurosci & Anat, Cincinnati, OH 45267 USA	National Taiwan University; National Taiwan University Hospital; National Taiwan University; Chang Gung Memorial Hospital; Chang Gung University; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Wang, IJ (corresponding author), Natl Taiwan Univ Hosp, Dept Ophthalmol, 7 Chug-Shan S Rd, Taipei 100, Taiwan.	ijong@ha.mc.ntu.edu.tw		Liu, Chia-yang/0000-0002-8398-5516; CHIEN, CHUNG-LIANG/0000-0001-9806-486X; HU, FUNG-RONG/0000-0002-2102-5317; Wang, I-Jong/0000-0002-3045-0614	NEI NIH HHS [R01 EY 12486, EY 11845] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY011845, R01EY012486] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ANTONSSON P, 1991, J BIOL CHEM, V266, P16859; Braat AK, 2001, GENESIS, V30, P183, DOI 10.1002/gene.1060; BRITTEN RJ, 1971, Q REV BIOL, V46, P111, DOI 10.1086/406830; Chang HY, 2000, SCIENCE, V290, P1978, DOI 10.1126/science.290.5498.1978; Chen T T, 1996, Biotechnol Annu Rev, V2, P205, DOI 10.1016/S1387-2656(08)70011-5; Conrad AH, 2003, MATRIX BIOL, V22, P323, DOI 10.1016/S0945-053X(03)00039-8; Corpuz LM, 1996, J BIOL CHEM, V271, P9759, DOI 10.1074/jbc.271.16.9759; ERNST B, 2000, CARBOHYDRATES CHEM B, P717; FUNDERBURGH JL, 1993, J BIOL CHEM, V268, P11874; Funderburgh JL, 1997, J BIOL CHEM, V272, P28089, DOI 10.1074/jbc.272.44.28089; FUNDERBURGH JL, 1995, INVEST OPHTH VIS SCI, V36, P2296; Hackett P.B, 2000, RECENT ADV MARINE BI, V4, P77; Iozzo RV, 1999, J BIOL CHEM, V274, P18843, DOI 10.1074/jbc.274.27.18843; Iozzo RV, 1997, CRIT REV BIOCHEM MOL, V32, P141, DOI 10.3109/10409239709108551; Karlen S, 2001, GENESIS, V30, P126, DOI 10.1002/gene.1046; Kennedy BN, 2001, J BIOL CHEM, V276, P14037, DOI 10.1074/jbc.M010490200; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Lele Z, 2001, GENESIS, V30, P190, DOI 10.1002/gene.1063; LIU CY, 1994, J BIOL CHEM, V269, P24627; Liu CY, 2003, J BIOL CHEM, V278, P21672, DOI 10.1074/jbc.M301169200; Liu CY, 1998, J BIOL CHEM, V273, P22584, DOI 10.1074/jbc.273.35.22584; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Negron JF, 2004, DEV DYNAM, V231, P161, DOI 10.1002/dvdy.20124; Pellegata NS, 2000, NAT GENET, V25, P91, DOI 10.1038/75664; Piatigorsky J, 2003, INTEGR COMP BIOL, V43, P492, DOI 10.1093/icb/43.4.492; PIATIGORSKY J, 1988, PROG RETIN EYE RES, V17, P145; Soules KA, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-12; STELLER H, 1995, SCIENCE, V267, P1445, DOI 10.1126/science.7878463; Udvadia AJ, 2003, DEV BIOL, V256, P1, DOI 10.1016/S0012-1606(02)00083-0; Vorbach C, 2002, GENE DEV, V16, P3223, DOI 10.1101/gad.1032702; WEINHEIM W, 2001, EXP EYE RES, V73, P411; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; WILSON AC, 1977, ANNU REV BIOCHEM, V46, P573, DOI 10.1146/annurev.bi.46.070177.003041; WILSON AC, 1987, TRENDS GENET, V3, P241, DOI 10.1016/0168-9525(87)90257-5; Xu YS, 2000, J BIOL CHEM, V275, P24645, DOI 10.1074/jbc.M001159200; ZUCKERKANDL E, 1994, J MOL EVOL, V39, P661, DOI 10.1007/BF00160412	37	18	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					506	517		10.1074/jbc.M707656200	http://dx.doi.org/10.1074/jbc.M707656200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17965408	hybrid			2022-12-27	WOS:000251940300056
J	Fanning, AS; Lye, MF; Anderson, JM; Lavie, A				Fanning, Alan S.; Lye, Ming F.; Anderson, James M.; Lavie, Arnon			Domain swapping within PDZ2 is responsible for dimerization of ZO proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TIGHT-JUNCTION; ZONULA OCCLUDENS-1; CRYSTAL-STRUCTURE; COMPLEX REVEALS; BINDING; RECOGNITION; MEMBRANE; ADHESION; MOTIFS; LOCALIZATION	ZO-1 is a multidomain protein involved in cell- cell junctions and contains three PDZ domains, which are necessary for its function in vivo. PDZ domains play a central role in assembling diverse protein complexes through their ability to recognize short peptide motifs on other proteins. We determined the structure of the second of the three PDZ domains of ZO-1, which is known to promote dimerization as well as bind to C-terminal sequences on connexins. The dimer is stabilized by extensive symmetrical domain swapping of beta-strands, which is unlike any other known mechanism of PDZ dimerization. The canonical peptide-binding groove remains intact in both subunits of the PDZ2 dimer and is created by elements contributed from both monomers. This unique structure reveals an additional example of how PDZ domains dimerize and has multiple implications for both peptide binding and oligomerization in vivo.	[Lye, Ming F.; Lavie, Arnon] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA; [Fanning, Alan S.; Anderson, James M.] Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC 27599 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of North Carolina; University of North Carolina Chapel Hill	Lavie, A (corresponding author), Univ Illinois, Dept Biochem & Mol Genet, 900 S Ashland Ave,Mol Biol Res Bldg,Rm 1108, Chicago, IL 60607 USA.	Lavie@uic.edu	Lavie, Arnon/H-4927-2012	Lavie, Arnon/0000-0001-5591-8722; Anderson, James/0000-0003-2765-7996	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK061397, T32DK007739, R01DK061397] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK061397, R56 DK061397, R01 DK061397-05, T32 DK007739, DK61397] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Anderson JM, 2004, CURR OPIN CELL BIOL, V16, P140, DOI 10.1016/j.ceb.2004.01.005; Appleton BA, 2006, J BIOL CHEM, V281, P22312, DOI 10.1074/jbc.M602901200; Bazzoni G, 2000, J BIOL CHEM, V275, P20520, DOI 10.1074/jbc.M905251199; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cuppen E, 1998, MOL BIOL CELL, V9, P671, DOI 10.1091/mbc.9.3.671; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Fanning AS, 2007, MOL BIOL CELL, V18, P721, DOI 10.1091/mbc.E06-08-0764; Fanning AS, 1998, CURR TOP MICROBIOL, V228, P209; Fanning AS, 1999, J CLIN INVEST, V103, P767, DOI 10.1172/JCI6509; Funke L, 2005, ANNU REV BIOCHEM, V74, P219, DOI 10.1146/annurev.biochem.74.082803.133339; Giepmans BNG, 2004, CARDIOVASC RES, V62, P233, DOI 10.1016/j.cardiores.2003.12.009; Hillier BJ, 1999, SCIENCE, V284, P812, DOI 10.1126/science.284.5415.812; Hunter AW, 2005, MOL BIOL CELL, V16, P5686, DOI 10.1091/mbc.E05-08-0737; Im YJ, 2003, J BIOL CHEM, V278, P48099, DOI 10.1074/jbc.M306919200; Im YJ, 2003, J BIOL CHEM, V278, P8501, DOI 10.1074/jbc.M212263200; Itoh M, 1999, J CELL BIOL, V147, P1351, DOI 10.1083/jcb.147.6.1351; Itoh M, 1999, J BIOL CHEM, V274, P5981, DOI 10.1074/jbc.274.9.5981; Jemth P, 2007, BIOCHEMISTRY-US, V46, P8701, DOI 10.1021/bi7008618; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kang BS, 2003, STRUCTURE, V11, P845, DOI 10.1016/S0969-2126(03)00125-4; Kausalya PJ, 2004, MOL BIOL CELL, V15, P5503, DOI 10.1091/mbc.E04-04-0350; Kausalya PJ, 2001, FEBS LETT, V505, P92, DOI 10.1016/S0014-5793(01)02786-7; Lamzin V. S., 2001, INT TABLES CRYSTALLO, VF, P720; Li X, 2004, NEUROSCIENCE, V126, P611, DOI 10.1016/j.neuroscience.2004.03.063; Long JF, 2005, NAT STRUCT MOL BIOL, V12, P722, DOI 10.1038/nsmb958; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Polette M, 2005, CANCER RES, V65, P7691, DOI 10.1158/0008-5472.CAN-04-4230; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Reichert M, 2000, J BIOL CHEM, V275, P9492, DOI 10.1074/jbc.275.13.9492; Shieh BH, 1996, NEURON, V16, P991, DOI 10.1016/S0896-6273(00)80122-1; Singh D, 2005, J BIOL CHEM, V280, P30416, DOI 10.1074/jbc.M506799200; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Sorgen PL, 2004, J BIOL CHEM, V279, P54695, DOI 10.1074/jbc.M409552200; Stiffler MA, 2007, SCIENCE, V317, P364, DOI 10.1126/science.1144592; Umeda K, 2006, CELL, V126, P741, DOI 10.1016/j.cell.2006.06.043; Utepbergenov DI, 2006, J BIOL CHEM, V281, P24671, DOI 10.1074/jbc.M512820200; van Zeijl L, 2007, J CELL BIOL, V177, P881, DOI 10.1083/jcb.200610144; Wittchen ES, 1999, J BIOL CHEM, V274, P35179, DOI 10.1074/jbc.274.49.35179; Zimmermann P, 2005, DEV CELL, V9, P377, DOI 10.1016/j.devcel.2005.07.011	41	43	45	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37710	37716		10.1074/jbc.M707255200	http://dx.doi.org/10.1074/jbc.M707255200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17928286	Green Submitted, Green Accepted, hybrid			2022-12-27	WOS:000251833600047
J	Takaki, E; Fujimoto, M; Nakahari, T; Yonemura, S; Miyata, Y; Hayashida, N; Yamamoto, K; Vallee, RB; Mikuriya, T; Sugahara, K; Yamashita, H; Inouye, S; Nakai, A				Takaki, Eiichi; Fujimoto, Mitsuaki; Nakahari, Takashi; Yonemura, Shigenobu; Miyata, Yoshihiko; Hayashida, Naoki; Yamamoto, Kaoru; Vallee, Richard B.; Mikuriya, Tsuyoshi; Sugahara, Kazuma; Yamashita, Hiroshi; Inouye, Sachiye; Nakai, Akira			Heat shock transcription factor 1 is required for maintenance of ciliary beating in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR CHAPERONES; MALE-INFERTILITY; LENS DEVELOPMENT; SITUS-INVERSUS; BETA-TUBULIN; RAT TRACHEAL; MOUSE; HSF1; GENE; HYDROCEPHALUS	Heat shock transcription factors (HSFs) maintain protein homeostasis through regulating expression of heat shock proteins, especially in stressed conditions. In addition, HSFs are involved in cellular differentiation and development by regulating development-related genes, as well as heat shock genes. Here, we showed chronic sinusitis and mild hydrocephalus in postnatal HSF1-null mice, which are associated with impaired mucociliary clearance and cerebrospinal flow, respectively. Analysis of ciliary beating revealed that the amplitude of the beating was significantly reduced, and ciliary beat frequencies were lower in the respiratory epithelium, ependymal cells, oviduct, and trachea of HSF1-null mice than those of wild-type mice. Cilia possess a common axonema structure composed of microtubules of alpha- and beta-tubulin. We found a marked reduction in alpha- and ciliary beta(iv)-tubulin in the HSF1-null cilia, which is developmentally associated with reduced Hsp90 expression in HSF1-null mice. Treatment of the respiratory epithelium with geldanamycin resulted in rapid reduction of ciliary beating in a dose-dependent manner. Furthermore, Hsp90 was physically associated with ciliary beta(iv)-tubulin, and Hsp90 stabilizes tubulin polymerization in vitro. These results indicate that HSF1 is required to maintain ciliary beating in postnatal mice, probably by regulating constitutive expression of Hsp90 that is important for tubulin polymerization.	[Takaki, Eiichi; Fujimoto, Mitsuaki; Hayashida, Naoki; Yamamoto, Kaoru; Inouye, Sachiye; Nakai, Akira] Yamaguchi Univ, Sch Med, Dept Biochem, Ube, Yamaguchi 7558505, Japan; [Yamashita, Hiroshi] Yamaguchi Univ, Sch Med, Dept Otolaryngol, Ube, Yamaguchi 7558505, Japan; [Nakahari, Takashi] Osaka Med Coll, Dept Physiol, Osaka 5698686, Japan; [Yonemura, Shigenobu] RIKEN Ctr Dev Biol, Lab Cellular Morphogenesis, Kobe, Hyogo 6500047, Japan; [Miyata, Yoshihiko] Kyoto Univ, Grad Sch Biostudies, Dept Cell & Dev Biol, Kyoto 6068502, Japan; [Vallee, Richard B.] Columbia Univ, Dept Pathol, Coll Phys & Surg, New York, NY 10032 USA	Yamaguchi University; Yamaguchi University; Osaka Medical College; RIKEN; Kyoto University; Columbia University	Nakai, A (corresponding author), Yamaguchi Univ, Sch Med, Dept Biochem, Ube, Yamaguchi 7558505, Japan.	anakai@yamaguchi-u.ac.jp	Hayashida, Naoki/HGA-3453-2022; Miyata, Y/X-7111-2019	Mikuriya, Takefumi/0000-0001-7389-5421; Hayashida, Naoki/0000-0002-8785-8012				AFZELIUS BA, 1994, METABOLIC MOL BASES, P3943; Bartoloni L, 2002, P NATL ACAD SCI USA, V99, P10282, DOI 10.1073/pnas.152337699; BLOCH MA, 1995, J CELL SCI, V108, P3541; Bu L, 2002, NAT GENET, V31, P276, DOI 10.1038/ng921; Casano C, 2003, J HISTOCHEM CYTOCHEM, V51, P1581, DOI 10.1177/002215540305101202; Chang YH, 2006, GENE DEV, V20, P836, DOI 10.1101/gad.366906; Christians E, 2000, NATURE, V407, P693, DOI 10.1038/35037669; Dale EC, 1997, CELL STRESS CHAPERON, V2, P87, DOI 10.1379/1466-1268(1997)002<0087:MKHSPG>2.3.CO;2; Duriez B, 2007, P NATL ACAD SCI USA, V104, P3336, DOI 10.1073/pnas.0611405104; Foster WM, 2001, J APPL PHYSIOL, V90, P1111, DOI 10.1152/jappl.2001.90.3.1111; Fujimoto M, 2004, EMBO J, V23, P4297, DOI 10.1038/sj.emboj.7600435; Fujimoto M, 2005, J BIOL CHEM, V280, P34908, DOI 10.1074/jbc.M506288200; Hayashi T, 2005, EXP PHYSIOL, V90, P535, DOI 10.1113/expphysiol.2004.028746; Hayashida N, 2006, EMBO J, V25, P4773, DOI 10.1038/sj.emboj.7601370; Ibanez-Tallon I, 2004, HUM MOL GENET, V13, P2133, DOI 10.1093/hmg/ddh219; Ibanez-Tallon I, 2003, HUM MOL GENET, V12, pR27, DOI 10.1093/hmg/ddg061; Ibanez-Tallon I, 2002, HUM MOL GENET, V11, P715, DOI 10.1093/hmg/11.6.715; Inouye S, 2004, J BIOL CHEM, V279, P38701, DOI 10.1074/jbc.M405986200; Inouye S, 2003, MOL CELL BIOL, V23, P5882, DOI 10.1128/MCB.23.16.5882-5895.2003; Izu H, 2004, BIOL REPROD, V70, P18, DOI 10.1095/biolreprod.103.020065; Jedlicka P, 1997, EMBO J, V16, P2452, DOI 10.1093/emboj/16.9.2452; Jensen-Smith HC, 2003, CELL MOTIL CYTOSKEL, V55, P213, DOI 10.1002/cm.10122; Kallio M, 2002, EMBO J, V21, P2591, DOI 10.1093/emboj/21.11.2591; Kawakami M, 2004, EXP PHYSIOL, V89, P739, DOI 10.1113/expphysiol.2004.028670; Kobayashi Y, 2002, MOL CELL BIOL, V22, P2769, DOI 10.1128/MCB.22.8.2769-2776.2002; Liang P, 1997, J CELL SCI, V110, P1431; McMillan DR, 1998, J BIOL CHEM, V273, P7523, DOI 10.1074/jbc.273.13.7523; Mikami A, 2002, J CELL SCI, V115, P4801, DOI 10.1242/jcs.00168; Min JN, 2004, GENESIS, V40, P205, DOI 10.1002/gene.20087; MIYATA Y, 1995, BIOCHEMISTRY-US, V34, P8123, DOI 10.1021/bi00025a019; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Nakai A, 1999, CELL STRESS CHAPERON, V4, P86, DOI 10.1054/csac.1998.0002; Nakai A, 2000, EMBO J, V19, P1545, DOI 10.1093/emboj/19.7.1545; Nakai A, 2001, EMBO J, V20, P2885, DOI 10.1093/emboj/20.11.2885; Neesen J, 2001, HUM MOL GENET, V10, P1117, DOI 10.1093/hmg/10.11.1117; Pazour GJ, 2005, J CELL BIOL, V170, P103, DOI 10.1083/jcb.200504008; Pirkkala L, 2001, FASEB J, V15, P1118, DOI 10.1096/fj00-0294rev; RENTHAL R, 1993, CELL MOTIL CYTOSKEL, V25, P19, DOI 10.1002/cm.970250104; Sakamoto M, 2006, CIRC RES, V99, P1411, DOI 10.1161/01.RES.0000252345.80198.97; Santos SD, 2004, NEUROSCIENCE, V126, P657, DOI 10.1016/j.neuroscience.2004.03.023; Sapiro R, 2002, MOL CELL BIOL, V22, P6298, DOI 10.1128/MCB.22.17.6298-6305.2002; Satouh Y, 2005, MOL BIOL CELL, V16, P626, DOI 10.1091/mbc.e04-09-0784; Sawamoto K, 2006, SCIENCE, V311, P629, DOI 10.1126/science.1119133; SCHIFF PB, 1979, NATURE, V277, P665, DOI 10.1038/277665a0; Stephens RE, 1999, CELL MOTIL CYTOSKEL, V44, P274, DOI 10.1002/(SICI)1097-0169(199912)44:4<274::AID-CM5>3.0.CO;2-O; STURGESS JM, 1980, NEW ENGL J MED, V303, P318, DOI 10.1056/NEJM198008073030606; Takaki E, 2006, J BIOL CHEM, V281, P4931, DOI 10.1074/jbc.M506911200; Tanabe M, 1998, EMBO J, V17, P1750, DOI 10.1093/emboj/17.6.1750; Tanabe M, 1999, J BIOL CHEM, V274, P27845, DOI 10.1074/jbc.274.39.27845; Tanaka KI, 2007, MOL PHARMACOL, V71, P985, DOI 10.1124/mol.106.033282; Vent J, 2005, J CELL SCI, V118, P4333, DOI 10.1242/jcs.02550; Wang GH, 2004, GENESIS, V38, P66, DOI 10.1002/gene.20005; Williams NE, 1997, J CELL SCI, V110, P1665; Wirth D, 2003, TOXICOL APPL PHARM, V192, P12, DOI 10.1016/S0041-008X(03)00256-4; Wu C, 1995, ANNU REV CELL DEV BI, V11, P441, DOI 10.1146/annurev.cellbio.11.1.441; Yan LJ, 2002, EMBO J, V21, P5164, DOI 10.1093/emboj/cdf528; Yang C, 2005, MOL BIOL CELL, V16, P637, DOI 10.1091/mbc.E04-09-0787; Yue L, 1999, GENETICS, V151, P1065; Zheng H, 2004, J IMMUNOL, V173, P5929, DOI 10.4049/jimmunol.173.10.5929; Zou YZ, 2003, CIRCULATION, V108, P3024, DOI 10.1161/01.CIR.0000101923.54751.77	60	48	50	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					37285	37292		10.1074/jbc.M704562200	http://dx.doi.org/10.1074/jbc.M704562200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17965413	hybrid			2022-12-27	WOS:000251646000054
J	Deng, YZ; Chen, PP; Wang, Y; Yin, D; Koeffler, HP; Li, BJ; Tong, XJ; Xie, D				Deng, Yue-Zhen; Chen, Ping-Ping; Wang, Yan; Yin, Dong; Koeffler, H. Phillip; Li, Baojie; Tong, Xiang-Jun; Xie, Dong			Connective tissue growth factor is overexpressed in esophageal squamous cell carcinoma and promotes tumorigenicity through beta-catenin-T-cell factor/Lef signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR GENE-EXPRESSION; PROGNOSTIC MARKER; FACTOR CTGF; CANCER; PROGRESSION; ACTIVATION; BINDING; KINASE; CYR61; WNT	Connective tissue growth factor (CTGF or CCN2), a member of the CCN family, is involved in diverse biological processes such as cell adhesion, proliferation, and angiogenesis. In this study, we show that overexpression of CTGF occurred in a significant proportion of esophageal squamous cell carcinoma (ESCC) samples that were of a high tumor grade and metastatic. Forced expression of CTGF in Eca109 ESCC cells accelerated their growth in culture and significantly increased tumor formation in nude mice, whereas RNA interference-mediated knockdown of CTGF in ESCC cells significantly inhibited cell growth and colony formation, as well as tumorigenicity in vivo. Moreover, overexpression of CTGF in ESCC cells resulted in the accumulation and nuclear translocation of beta-catenin, leading to activation of beta-catenin-T-cell factor (TCF)/Lef signaling. Up-regulation of c-Myc and cyclin D1, two target genes of beta-catenin-TCF/Lef signaling, was also observed in the CTGF-overexpressing cells. These effects of CTGF in ESCC cells were abolished by transfection with either dominant negative beta-catenin or dominant negative TCF4. Furthermore, we identified a beta-cateninTCF/Lef-binding site (TBE) in the promoter region of CTGF and found that CTGF is a transcriptional target of beta-cateninTCF/Lef signaling. Taken together, these results revealed that the interaction of CTGF and beta-catenin-TCF/Lef forms a positive feedback loop, which could contribute to the tumorigenicity of ESCC.	Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Mol Oncol Lab, Shanghai 200031, Peoples R China; Chinese Acad Sci, Grad Sch, Shanghai 200031, Peoples R China; Zhengzhou Univ, Coll Publ Hlth, Zhengzhou 450052, Peoples R China; Univ Calif Los Angeles, Sch Med, Div Hematol Oncol, Los Angeles, CA 90048 USA; Inst Mol & Cell Biol, Singapore 138673, Singapore; Beijing Univ, Coll Life Sci, Beijing 100083, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Zhengzhou University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Peking University	Xie, D (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Mol Oncol Lab, 294 Tai-Yuan Rd, Shanghai 200031, Peoples R China.	dxie@sibs.ac.cn	Wang, Yan/G-1213-2012	Xie, Dong/0000-0002-1150-8657				BORK P, 1993, FEBS LETT, V327, P125, DOI 10.1016/0014-5793(93)80155-N; BRADHAM DM, 1991, J CELL BIOL, V114, P1285, DOI 10.1083/jcb.114.6.1285; Brigstock DR, 1999, ENDOCR REV, V20, P189, DOI 10.1210/er.20.2.189; Chang CC, 2004, JNCI-J NATL CANCER I, V96, P364, DOI 10.1093/jnci/djh059; Chapman ML, 1997, BIOPHYS J, V72, P708, DOI 10.1016/S0006-3495(97)78707-1; Clement G, 2006, ONCOGENE, V25, P3084, DOI 10.1038/sj.onc.1209338; Delcommenne M, 1998, P NATL ACAD SCI USA, V95, P11211, DOI 10.1073/pnas.95.19.11211; Dornhofer N, 2006, CANCER RES, V66, P5816, DOI 10.1158/0008-5472.CAN-06-0081; Goss KJH, 1998, INT J CANCER, V78, P629; Grabowski P, 2003, BRIT J CANCER, V88, P115, DOI 10.1038/sj.bjc.6600696; Hishikawa K, 1999, J BIOL CHEM, V274, P37461, DOI 10.1074/jbc.274.52.37461; IGARASHI A, 1995, J INVEST DERMATOL, V105, P280, DOI 10.1111/1523-1747.ep12318465; Igarashi A, 1996, J INVEST DERMATOL, V106, P729, DOI 10.1111/1523-1747.ep12345771; IGARASHI A, 1993, MOL BIOL CELL, V4, P637, DOI 10.1091/mbc.4.6.637; Ishitani T, 1999, NATURE, V399, P798, DOI 10.1038/21674; Ito Y, 1998, KIDNEY INT, V53, P853, DOI 10.1046/j.1523-1755.1998.00820.x; KATO J, 1993, GENE DEV, V7, P331; Kihara C, 2000, JPN J CANCER RES, V91, P190, DOI 10.1111/j.1349-7006.2000.tb00931.x; Kothapalli D, 1998, FASEB J, V12, P1151, DOI 10.1096/fasebj.12.12.1151; Leu SJ, 2003, J BIOL CHEM, V278, P33801, DOI 10.1074/jbc.M305862200; Levy L, 2002, J BIOL CHEM, V277, P42386, DOI 10.1074/jbc.M207418200; Li GM, 2006, J GENE MED, V8, P889, DOI 10.1002/jgm.894; Lin BR, 2005, GASTROENTEROLOGY, V128, P9, DOI 10.1053/j.gastro.2004.10.007; Lu SH, 2000, MUTAT RES-REV MUTAT, V462, P343, DOI 10.1016/S1383-5742(00)00023-5; Luo Q, 2004, J BIOL CHEM, V279, P55958, DOI 10.1074/jbc.M407810200; McCabe ML, 2005, INT IMMUNOPHARMACOL, V5, P1113, DOI 10.1016/j.intimp.2004.11.017; Morales CP, 2002, LANCET, V360, P1587, DOI 10.1016/S0140-6736(02)11569-8; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; MUNOZ N, 1993, ENDOSCOPY, V25, P609, DOI 10.1055/s-2007-1010415; Oemar BS, 1997, CIRCULATION, V95, P831; Perbal B, 2001, J CLIN PATHOL-MOL PA, V54, P57, DOI 10.1136/mp.54.2.57; Polakis P, 2000, GENE DEV, V14, P1837; Qin XF, 2003, P NATL ACAD SCI USA, V100, P183, DOI 10.1073/pnas.232688199; Rimerman RA, 2000, J BIOL CHEM, V275, P14736, DOI 10.1074/jbc.M910241199; Shakunaga T, 2000, CANCER, V89, P1466, DOI 10.1002/1097-0142(20001001)89:7<1466::AID-CNCR8>3.0.CO;2-G; Stoner GD, 2001, CARCINOGENESIS, V22, P1737, DOI 10.1093/carcin/22.11.1737; Suzuma K, 2000, J BIOL CHEM, V275, P40725, DOI 10.1074/jbc.M006509200; Tamatani T, 1998, BIOCHEM BIOPH RES CO, V251, P748, DOI 10.1006/bbrc.1998.9543; Wang LD, 2003, WORLD J GASTROENTERO, V9, P1156, DOI 10.3748/wjg.v9.i6.1156; Xie D, 2004, CANCER RES, V64, P1987, DOI 10.1158/0008-5472.CAN-03-0666; Xie D, 2004, CLIN CANCER RES, V10, P2072, DOI 10.1158/1078-0432.CCR-0659-03; Xie D, 2001, CANCER RES, V61, P8917; Xing EP, 1999, CARCINOGENESIS, V20, P77, DOI 10.1093/carcin/20.1.77; Xing EP, 1999, CLIN CANCER RES, V5, P1231; Xu LF, 2000, GENE DEV, V14, P585; Yang F, 2005, CANCER RES, V65, P8887, DOI 10.1158/0008-5472.CAN-05-1702	46	108	119	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36571	36581		10.1074/jbc.M704141200	http://dx.doi.org/10.1074/jbc.M704141200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17951630	hybrid			2022-12-27	WOS:000251458300050
J	Funasaka, T; Hu, H; Hogan, V; Raz, A				Funasaka, Tatsuyoshi; Hu, Huankai; Hogan, Victor; Raz, Avraham			Down-regulation of phosphoglucose isomerase/autocrine motility factor expression sensitizes human fibrosarcoma cells to oxidative stress leading to cellular senescence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR SUPPRESSION; CANCER; RECEPTOR; OVEREXPRESSION; NEUROLEUKIN; DEFICIENCY; LOCOMOTION; MECHANISM; EVOLUTION; ENZYMES	Phosphoglucose isomerase/autocrine motility factor (PGI/AMF) is a housekeeping gene product present in all cells, is an essential enzyme of catabolic glycolysis and anabolic gluconeogenesis, and regulates tumor cell growth and metastasis. Because glycolytic enzyme up-regulation of expression contributes to glycolytic flux, leading to increased of cell growth and a resistance to cellular stress of normal fibroblasts whereas down-regulation of PGI/AMF leads to mesenchymal-to-epithelial transition in tumor cells, we examined the involvement of PGI/AMF in overcoming cellular senescence in cancer cells. PGI/AMF cellular expression in HT1080 human fibrosarcoma was down-regulated by small interfering RNA methodology, which resulted in an increased sensitivity to oxidative stress and oxidative stress-induced cellular senescence. Signaling analysis revealed that the senescence pathway involving p21 cyclin-dependent kinase inhibitor was up-regulated in PGI/AMF knockdown cells and that superoxide dismutase is the upstream regulator protein of p21-mediated cellular senescence. A specific inhibitor of PGI/AMF induced cellular senescence and p21 expression in tumor cells exposed to an oxidative stress environment. Taken together, the results presented here suggest that PGI/AMF is involved in oxidative stress-induced cellular senescence and should bring novel insights into the control of cellular growth leading to a new methodology for cancer treatment.	Wayne State Univ, Sch Med, Karmanos Canc Inst, Tumor Progress & Metastasis Program, Detroit, MI 48201 USA	Barbara Ann Karmanos Cancer Institute; Wayne State University	Raz, A (corresponding author), 110 E Warren Ave, Detroit, MI 48201 USA.	raza@karmanos.org			NATIONAL CANCER INSTITUTE [R01CA051714] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA51714] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BAUMANN M, 1990, CANCER INVEST, V8, P351, DOI 10.3109/07357909009012053; Behrend L, 2003, BIOCHEM SOC T, V31, P1441; Benhar M, 2002, EMBO REP, V3, P420, DOI 10.1093/embo-reports/kvf094; Beutler E, 1997, BLOOD CELL MOL DIS, V23, P402, DOI 10.1006/bcmd.1997.0157; Brown JP, 1997, SCIENCE, V277, P831, DOI 10.1126/science.277.5327.831; Campisi J, 2003, NAT REV CANCER, V3, P339, DOI 10.1038/nrc1073; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Cao MJ, 2000, BIOCHEM BIOPH RES CO, V272, P485, DOI 10.1006/bbrc.2000.2803; CHEN Q, 1994, P NATL ACAD SCI USA, V91, P4130, DOI 10.1073/pnas.91.10.4130; Dawson PJ, 1996, AM J PATHOL, V148, P313; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; FILELLA X, 1991, TUMOR BIOL, V12, P360, DOI 10.1159/000217737; Funasaka T, 2007, CANCER RES, V67, P4236, DOI 10.1158/0008-5472.CAN-06-3935; GOMM SA, 1988, BRIT J CANCER, V58, P797, DOI 10.1038/bjc.1988.312; Gottlieb TM, 2002, ONCOGENE, V21, P1299, DOI 10.1038/sj.onc.1205181; GURNEY ME, 1986, SCIENCE, V234, P574, DOI 10.1126/science.3020690; Haga A, 2003, INT J CANCER, V107, P707, DOI 10.1002/ijc.11449; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Kim JW, 2005, TRENDS BIOCHEM SCI, V30, P142, DOI 10.1016/j.tibs.2005.01.005; Kondoh H, 2005, CANCER RES, V65, P177; Landis GN, 2005, MECH AGEING DEV, V126, P365, DOI 10.1016/j.mad.2004.08.012; Leonard SS, 2004, FREE RADICAL BIO MED, V37, P1921, DOI 10.1016/j.freeradbiomed.2004.09.010; Martindale JL, 2002, J CELL PHYSIOL, V192, P1, DOI 10.1002/jcp.10119; Matsumoto I, 1999, SCIENCE, V286, P1732, DOI 10.1126/science.286.5445.1732; Miller FR, 2000, J NATL CANCER I, V92, P1185, DOI 10.1093/jnci/92.14.1185A; NABI IR, 1992, CANCER METAST REV, V11, P5, DOI 10.1007/BF00047599; Niinaka Y, 1998, CANCER RES, V58, P2667; OBERLEY LW, 1988, MOL CELL BIOCHEM, V84, P147, DOI 10.1007/BF00421049; Oberley LW, 2001, ANTIOXID REDOX SIGN, V3, P461, DOI 10.1089/15230860152409095; Plymate SR, 2003, ONCOGENE, V22, P1024, DOI 10.1038/sj.onc.1206210; RAVINDRANATH Y, 1987, NEW ENGL J MED, V316, P258, DOI 10.1056/NEJM198701293160506; Roninson IB, 2003, CANCER RES, V63, P2705; SAFFORD SE, 1994, CANCER RES, V54, P4261; Serrano M, 2001, CURR OPIN CELL BIOL, V13, P748, DOI 10.1016/S0955-0674(00)00278-7; Shay JW, 2004, ONCOGENE, V23, P2919, DOI 10.1038/sj.onc.1207518; Shimizu K, 1999, FEBS LETT, V456, P295, DOI 10.1016/S0014-5793(99)00966-7; Silletti S, 1996, CURR TOP MICROBIOL, V213, P137; SOULE HD, 1990, CANCER RES, V50, P6075; Tanaka N, 2002, J MOL BIOL, V318, P985, DOI 10.1016/S0022-2836(02)00186-9; TARUNINA M, 1993, ONCOGENE, V8, P3165; Tsutsumi S, 2003, CANCER RES, V63, P242; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Watanabe H, 1996, CANCER RES, V56, P2960; Xu W, 1996, BLOOD, V87, P4502, DOI 10.1182/blood.V87.11.4502.bloodjournal87114502; Yakirevich E, 2000, BIOL REPROD, V62, P1016, DOI 10.1095/biolreprod62.4.1016; Zhou BHP, 2002, SEMIN ONCOL, V29, P62, DOI 10.1053/sonc.2002.34057	46	27	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36362	36369		10.1074/jbc.M706301200	http://dx.doi.org/10.1074/jbc.M706301200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17925402	hybrid			2022-12-27	WOS:000251458300027
J	Ravindranath, RMH; Devarajan, A; Uchida, T				Ravindranath, Rajeswari M. H.; Devarajan, Asokan; Uchida, Takashi			Spatiotemporal expression of ameloblastin isoforms during murine tooth development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYL-D-GLUCOSAMINE; ENAMEL PROTEIN; GENE-EXPRESSION; SIALIC ACIDS; AMELOGENIN; ANTIBODIES; MATRIX; BINDS; IMMUNOCYTOCHEMISTRY; LOCALIZATION	Ameloblasts synthesize and secrete the enamel matrix proteins (amelogenin, ameloblastin, and enamelin). This investigation examined the profiles of ameloblastin in the ameloblasts and in the enamel matrix during different postnatal (PN) days (days 0-9) of development of mouse molar, using an antibody specific for C-terminal sequence of ameloblastin (Ct; GNKVHQPQVHNAWRF). Ameloblastin is found in three different molecular sizes (37, 55, and 66 kDa) in both ameloblasts and enamel matrix during PN development. In the ameloblasts, the sequence of expression of these fractions varied. The 37-kDa fraction was observed (even before the appearances of mRNA of the proteases, enamelysin and kallikrein-4) on days 0 and 1, persisted until day 3, and was not found thereafter. Other isoforms (55 and 66 kDa) distinctly appeared in ameloblasts after day 1, reached a peak on day 5, and remained thereafter. The Ct-positive granules appeared beaded in the ameloblasts on day 3. In the extracellular matrix, a 37-kDa (but not 66- or 55-kDa) fraction was detected on days 0 and 1 and remained in the matrix throughout the PN days. The larger isoforms (55 and 66 kDa) appeared in the enamel matrix from day 3 onward. On days 0-3, but not later, the 37-kDa isoform co-localizes with amelogenin in Tomes' process and formative enamel, as revealed by laser scan confocal microscopy. Autoradiography confirmed accumulation of H-3-labeled amelogenin trityrosyl motif peptide in the region of Tomes' process and formative enamel from day 0 to 3. These observations suggest that the 37-kDa isoform interacts with amelogenin during early tooth development.	Univ So Calif, Sch Dent, Ctr Craniofacial Mol Biol, Los Angeles, CA 90033 USA; Hiroshima Univ, Grad Sch Biomed Sci, Dept Oral Biol, Div Mol Med Sci, Hiroshima 734, Japan	University of Southern California; Hiroshima University	Ravindranath, RMH (corresponding author), Univ So Calif, Sch Dent, Ctr Craniofacial Mol Biol, 2250 Alcazar St, Los Angeles, CA 90033 USA.	rravindr@usc.edu			NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE013204] Funding Source: NIH RePORTER; NIDCR NIH HHS [R01-DE-13204-05] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		CARL SAL, 1993, J HISTOCHEM CYTOCHEM, V41, P1273; DEUTSCH D, 1991, J BIOL CHEM, V266, P16021; Fincham AG, 1999, J STRUCT BIOL, V126, P270, DOI 10.1006/jsbi.1999.4130; FINCHAM AG, 1994, CALCIFIED TISSUE INT, V55, P398, DOI 10.1007/BF00299322; Fong C D, 1996, Adv Dent Res, V10, P195; Fukumoto S, 2004, J CELL BIOL, V167, P973, DOI 10.1083/jcb.200409077; Gibson CW, 2001, J BIOL CHEM, V276, P31871, DOI 10.1074/jbc.M104624200; Hu JCC, 2002, EUR J ORAL SCI, V110, P307, DOI 10.1034/j.1600-0722.2002.21301.x; Iacob S, 2006, EUR J ORAL SCI, V114, P194, DOI 10.1111/j.1600-0722.2006.00287.x; Krebsbach PH, 1996, J BIOL CHEM, V271, P4431; Lee SK, 2003, MOL CELLS, V15, P216; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Nagano T, 2003, J DENT RES, V82, P982, DOI 10.1177/154405910308201209; NANCI A, 1985, J HISTOCHEM CYTOCHEM, V33, P1153, DOI 10.1177/33.11.4056379; NEGOESCU A, 1994, J HISTOCHEM CYTOCHEM, V42, P433, DOI 10.1177/42.3.7508473; Oida S, 2002, J DENT RES, V81, P103, DOI 10.1177/154405910208100204; RAVIDRANATH RMH, 2003, J BIOL CHEM, V276, P20293; RAVIDRANATH RMH, 2005, J GLYCOCONJ J, V22, P129; Ravindranath HH, 2004, BIOCHEM BIOPH RES CO, V323, P1075, DOI 10.1016/j.bbrc.2004.08.207; Ravindranath RMH, 2005, ACTA HISTOCHEM, V107, P43, DOI 10.1016/j.acthis.2004.11.004; Ravindranath RMH, 1999, J BIOL CHEM, V274, P2464, DOI 10.1074/jbc.274.4.2464; Ravindranath RMH, 2000, J BIOL CHEM, V275, P39654, DOI 10.1074/jbc.M006471200; RAVINDRANATH RMH, 1990, J VIROL, V64, P5430, DOI 10.1128/JVI.64.11.5430-5440.1990; Ravindranath RMH, 2001, J BIOL CHEM, V276, P36586, DOI 10.1074/jbc.M104656200; Uchida T, 1997, J HISTOCHEM CYTOCHEM, V45, P1329, DOI 10.1177/002215549704501002; Xiao GZ, 1998, J BIOL CHEM, V273, P32988, DOI 10.1074/jbc.273.49.32988; Yamakoshi Y, 2001, ARCH ORAL BIOL, V46, P1005, DOI 10.1016/S0003-9969(01)00070-X	27	10	12	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36370	36376		10.1074/jbc.M704731200	http://dx.doi.org/10.1074/jbc.M704731200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17921454	hybrid			2022-12-27	WOS:000251458300028
J	Young, KA; Chen, XJS; Holers, VM; Hannan, JP				Young, Kendra A.; Chen, Xiaojiang S.; Holers, V. Michael; Hannan, Jonathan P.			Isolating the Epstein-Barr virus gp350/220 binding site on complement receptor type 2 (CR2/CD21)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN LYMPHOCYTES-B; SYSTEMIC-LUPUS-ERYTHEMATOSUS; COMPLEMENT RECEPTOR TYPE-2; CD21 LIGAND-BINDING; C3D RECEPTOR; MONOCLONAL-ANTIBODY; IFN-ALPHA; CR-2; GLYCOPROTEIN; EBV	Complement receptor type 2 (CR2/CD21) is essential for the attachment of Epstein-Barr virus (EBV) to the surface of B-lymphocytes in an interaction mediated by the viral envelope glycoprotein gp350. The heavily glycosylated structure of EBV gp350 has recently been elucidated by x-ray crystallography, and the CR2 binding site on this protein has been characterized. To identify the corresponding gp350 binding site on CR2, we have undertaken a site-directed mutagenesis study targeting regions of CR2 that have previously been implicated in the binding of CR2 to the C3d/C3dg fragments of complement component C3. Wild-type or mutant forms of CR2 were expressed on K562 cells, and the ability of these CR2-expressing cells to bind gp350 was measured using flow cytometry. Mutations directed toward the two N-terminal extracellular domains of CR2 (SCR1-2) reveal that a large contiguous surface of CR2 SCR1-2 is involved in gp350 binding, including a number of positively charged residues (Arg-13, (Arg-28, (Arg-36, Lys-41, Lys-57, Lys-67, and Arg-83). These data appear to complement the CR2 binding site on gp350, which is characterized by a preponderance of negative charge. In addition to identifying the importance of charge in the formation of a CR2-gp350 complex, we also provide evidence that both SCR1 and SCR2 make contact with gp350. Specifically, two anti-CR2 monoclonal antibodies, designated as monoclonal antibodies 171 and 1048 whose primary epitopes are located within SCR2, inhibit binding of wild-type CR2 to EBV gp350; with regard to SCR1, both K562 cells expressing an S15P mutation and recombinant S15P CR2 proteins exhibit diminished gp350 binding.	Hlth Sci Ctr, Aurora, CO 80045 USA; Univ So Calif, Dept Mol & Computat Biol, Los Angeles, CA 90089 USA	University of Southern California	Hannan, JP (corresponding author), Univ Colorado Denver, Dept Med & Immunol, Div Rheumatol, Barbara Davis Ctr Childhood Diabet, POB 6511,Mail Stop B-115,1775 N Ursula St, Aurora, CO 80045 USA.	Jonathan.Hannan@UCHSC.edu		Hannan, Jonathan/0000-0003-3318-2341	NATIONAL CANCER INSTITUTE [R01CA053615] Funding Source: NIH RePORTER; NCI NIH HHS [R0-1 R01CA053615] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AHEARN JM, 1989, ADV IMMUNOL, V46, P183, DOI 10.1016/S0065-2776(08)60654-9; Ascherio A, 2000, EPIDEMIOLOGY, V11, P220, DOI 10.1097/00001648-200003000-00023; Asokan R, 2006, J IMMUNOL, V177, P383, DOI 10.4049/jimmunol.177.1.383; AUBRY JP, 1994, J IMMUNOL, V152, P5806; AUBRY JP, 1992, NATURE, V358, P505, DOI 10.1038/358505a0; BEISEL C, 1985, J VIROL, V54, P665, DOI 10.1128/JVI.54.3.665-674.1985; CAREL JC, 1990, J BIOL CHEM, V265, P12293; Carroll MC, 1997, CURR OPIN IMMUNOL, V9, P64, DOI 10.1016/S0952-7915(97)80160-4; Costenbader KH, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1893; DELCAYRE AX, 1991, EMBO J, V10, P919, DOI 10.1002/j.1460-2075.1991.tb08025.x; Dempsey PW, 1996, SCIENCE, V271, P348, DOI 10.1126/science.271.5247.348; Fearon DT, 1998, SEMIN IMMUNOL, V10, P355, DOI 10.1006/smim.1998.0137; FINGEROTH JD, 1988, J VIROL, V62, P1442, DOI 10.1128/JVI.62.4.1442-1447.1988; FINGEROTH JD, 1984, P NATL ACAD SCI-BIOL, V81, P4510, DOI 10.1073/pnas.81.14.4510; FRADE R, 1985, P NATL ACAD SCI USA, V82, P1490, DOI 10.1073/pnas.82.5.1490; Griffin BE, 2005, EPSTEIN-BARR VIRUS, P113; Gross AJ, 2005, J IMMUNOL, V174, P6599, DOI 10.4049/jimmunol.174.11.6599; Guthridge JM, 2001, J IMMUNOL, V167, P5758, DOI 10.4049/jimmunol.167.10.5758; Guthridge JM, 2001, BIOCHEMISTRY-US, V40, P5931, DOI 10.1021/bi0101749; Haan KM, 2001, VIROLOGY, V290, P106, DOI 10.1006/viro.2001.1141; HADDAD RS, 1989, J VIROL, V63, P4998, DOI 10.1128/JVI.63.12.4998-5005.1989; Hannan JP, 2005, J MOL BIOL, V346, P845, DOI 10.1016/j.jmb.2004.12.007; HEDRICK JA, 1994, J IMMUNOL, V153, P4418; HOFFMAN GJ, 1980, P NATL ACAD SCI-BIOL, V77, P2979, DOI 10.1073/pnas.77.5.2979; Iwakiri D, 2005, EPSTEIN-BARR VIRUS, P157; Jackman WT, 1999, VACCINE, V17, P660, DOI 10.1016/S0264-410X(98)00248-5; Janz A, 2000, J VIROL, V74, P10142, DOI 10.1128/JVI.74.21.10142-10152.2000; Johannsen E, 2004, P NATL ACAD SCI USA, V101, P16286, DOI 10.1073/pnas.0407320101; KALLI KR, 1991, J IMMUNOL, V147, P590; LOWELL CA, 1989, J EXP MED, V170, P1931, DOI 10.1084/jem.170.6.1931; Mackett M, 1996, J MED VIROL, V50, P263, DOI 10.1002/(SICI)1096-9071(199611)50:3<263::AID-JMV9>3.0.CO;2-7; MARTIN DR, 1991, J EXP MED, V174, P1299, DOI 10.1084/jem.174.6.1299; Molesworth SJ, 2000, J VIROL, V74, P6324, DOI 10.1128/JVI.74.14.6324-6332.2000; MOLINA H, 1995, J IMMUNOL, V154, P5426; MOLINA H, 1991, J BIOL CHEM, V266, P12173; MOORE MD, 1989, J BIOL CHEM, V264, P20576; Morikis D, 2004, J IMMUNOL, V172, P7537, DOI 10.4049/jimmunol.172.12.7537; Mullen MM, 2002, MOL CELL, V9, P375, DOI 10.1016/S1097-2765(02)00465-3; Murray PG, 2005, EPSTEIN-BARR VIRUS, P93; NEMEROW GR, 1987, J VIROL, V61, P1416, DOI 10.1128/JVI.61.5.1416-1420.1987; NEMEROW GR, 1985, J VIROL, V55, P347, DOI 10.1128/JVI.55.2.347-351.1985; PEPYS MB, 1974, J EXP MED, V140, P126, DOI 10.1084/jem.140.1.126; Prota AE, 2002, P NATL ACAD SCI USA, V99, P10641, DOI 10.1073/pnas.162360499; Raab-Traub N, 2005, EPSTEIN-BARR VIRUS, P71; Roberge CJ, 1996, J IMMUNOL, V156, P4884; Salek-Ardakani S, 2004, J IMMUNOL, V173, P321, DOI 10.4049/jimmunol.173.1.321; Sarrias MR, 2001, J IMMUNOL, V167, P1490, DOI 10.4049/jimmunol.167.3.1490; Spriggs MK, 1996, J VIROL, V70, P5557, DOI 10.1128/JVI.70.8.5557-5563.1996; Szakonyi G, 2001, SCIENCE, V292, P1725, DOI 10.1126/science.1059118; Szakonyi G, 2006, NAT STRUCT MOL BIOL, V13, P996, DOI 10.1038/nsmb1161; TANNER J, 1988, J VIROL, V62, P4452, DOI 10.1128/JVI.62.12.4452-4464.1988; TANNER J, 1987, CELL, V50, P203, DOI 10.1016/0092-8674(87)90216-9; THORLEYLAWSON DA, 1980, P NATL ACAD SCI-BIOL, V77, P5307, DOI 10.1073/pnas.77.9.5307; Urquiza M, 2005, J BIOL CHEM, V280, P35598, DOI 10.1074/jbc.M504544200; WEIS JJ, 1984, P NATL ACAD SCI-BIOL, V81, P881, DOI 10.1073/pnas.81.3.881	55	25	32	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36614	36625		10.1074/jbc.M706324200	http://dx.doi.org/10.1074/jbc.M706324200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17925391	hybrid			2022-12-27	WOS:000251458300054
J	Mellgren, RL; Huang, XH				Mellgren, Ronald L.; Huang, Xinhua			Fetuin A stabilizes m-calpain and facilitates plasma membrane repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THROMBOTIC THROMBOCYTOPENIC PURPURA; CALCIUM-DEPENDENT PROTEASE; GIRDLE MUSCULAR-DYSTROPHY; MEDIATES PROGRESSION; CRYSTAL-STRUCTURE; LIVER-INJURY; C2 DOMAINS; SERUM; CELLS; VESICLES	Yeast two-hybrid experiments identified alpha(2)-Heremans-Schmid glycoprotein (human fetuin A) as a binding partner for calpain domain III (DIII). The tandem DIIIs of calpain-10 interacted under the most selective culture conditions, but DIIIs of m-calpain, calpain-3, and calpain-5 also interacted under less stringent selection. DIIIs of mu-calpain, calpain-6, and the tandem DIII-like domains of the Dictyostelium Cpl protein did not interact with alpha(2)-Heremans-Schmid glycoprotein in the yeast two-hybrid system. Bovine fetuin A stabilized proteolytic activity of purified m-calpain incubated in the presence of mM calcium chloride and prevented calcium-dependent m-calpain aggregation. Consistent with the yeast two-hybrid studies, fetuin A neither stabilized mu-calpain nor prevented its aggregation. Confocal immunofluorescence microscopy of scratch-damaged L6 myotubes demonstrated accumulation of m-calpain at the wound site in association with the membrane repair protein, dysferlin. m-Calpain also co-localized with fluorescein-labeled fetuin A at the wound site. The effect of fetuin A on calpain-mediated plasma membrane resealing was investigated using fibroblasts from Capns1(-/-) and Capns1(+/+) mouse embryos. Capns1 encodes the small noncatalytic subunit that is required for the proteolytic function of m- and mu-calpains. Thus, Capns1(-/-) fibroblasts do not express these calpains in active form. Fetuin A increased resealing of scrape-damaged wild-type fibroblasts but not Capns1(-/-) fibroblasts. These studies identify fetuin A as a potential extracellular regulator of m-calpain at nascent sites of plasma membrane wounding.	Univ Toledo, Coll Med, Dept Physiol & Pharmacol, Toledo, OH 43614 USA	University System of Ohio; University of Toledo	Mellgren, RL (corresponding author), Univ Toledo, Coll Med, Dept Physiol & Pharmacol, 3000 Arlington Ave, Toledo, OH 43614 USA.	ronald.mellgren@utoledo.edu						Ardoin SP, 2007, SCAND J IMMUNOL, V66, P159, DOI 10.1111/j.1365-3083.2007.01984.x; Bai JH, 2004, TRENDS BIOCHEM SCI, V29, P143, DOI 10.1016/j.tibs.2004.01.008; Bansal D, 2003, NATURE, V423, P168, DOI 10.1038/nature01573; BRADFORD HN, 1993, J BIOL CHEM, V268, P26546; BROWN WM, 1992, BIOESSAYS, V14, P749, DOI 10.1002/bies.950141105; Cartellieri S, 2002, BIOTECHNOL APPL BIOC, V35, P83, DOI 10.1042/BA20010067; COOLICAN SA, 1986, J BIOL CHEM, V261, P4170; CRESSIE NAC, 1981, BIOMETRICS, V37, P235, DOI 10.2307/2530414; Dourdin N, 1999, EXP CELL RES, V246, P433, DOI 10.1006/excr.1998.4325; Franco SJ, 2005, J CELL SCI, V118, P3829, DOI 10.1242/jcs.02562; Frangie C, 2006, J BIOL CHEM, V281, P26624, DOI 10.1074/jbc.M603007200; Furlan M, 2001, BEST PRACT RES CL HA, V14, P437, DOI 10.1053/beha.2001.0142; Galvez AS, 2007, CIRC RES, V100, P1071, DOI 10.1161/01.RES.0000261938.28365.11; Ginestra A, 1998, ANTICANCER RES, V18, P3433; Glading A, 2004, MOL CELL BIOL, V24, P2499, DOI 10.1128/MCB.24.6.2499-2512.2004; Godell CM, 1997, P NATL ACAD SCI USA, V94, P4751, DOI 10.1073/pnas.94.9.4751; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; HARLOW E, 1999, USING ANTIBODIES LAB, P85; Hosfield CM, 1999, EMBO J, V18, P6880, DOI 10.1093/emboj/18.24.6880; Huang XH, 2003, BIOCHEMISTRY-US, V42, P1789, DOI 10.1021/bi026461+; Jia ZC, 2001, BIOPHYS J, V80, P2590, DOI 10.1016/S0006-3495(01)76229-7; Kazi JA, 1998, J BIOCHEM-TOKYO, V124, P179, DOI 10.1093/oxfordjournals.jbchem.a022077; Klinge L, 2007, FASEB J, V21, P1768, DOI 10.1096/fj.06-7659com; LEE TL, 1993, J CELL SCI, V105, P167; Lennon NJ, 2003, J BIOL CHEM, V278, P50466, DOI 10.1074/jbc.M307247200; Limaye PB, 2003, TOXICOL APPL PHARM, V191, P211, DOI 10.1016/S0041-008X(03)00250-3; Liu XL, 2004, ANNU REV PHARMACOL, V44, P349, DOI 10.1146/annurev.pharmtox.44.101802.121804; MAKI M, 1987, FEBS LETT, V223, P174, DOI 10.1016/0014-5793(87)80531-8; Mathews ST, 1997, LIFE SCI, V61, P1583, DOI 10.1016/S0024-3205(97)00737-6; Matsumura Y, 2001, J MOL CELL CARDIOL, V33, P1133, DOI 10.1006/jmcc.2001.1373; Mehendale HM, 2005, TRENDS PHARMACOL SCI, V26, P232, DOI 10.1016/j.tips.2005.03.008; MELLGREN RL, 1982, J BIOL CHEM, V257, P7203; MELLGREN RL, 1989, RBC-CELL BIOL REV, V20, P139; MELLGREN RL, 1987, FASEB J, V1, P110, DOI 10.1096/fasebj.1.2.2886390; MELLGREN RL, 1991, J BIOL CHEM, V266, P13920; MELLGREN RL, 1986, ARCH BIOCHEM BIOPHYS, V246, P233, DOI 10.1016/0003-9861(86)90468-6; Mellgren RL, 2007, J BIOL CHEM, V282, P2567, DOI 10.1074/jbc.M604560200; Moldoveanu T, 2003, NAT STRUCT BIOL, V10, P371, DOI 10.1038/nsb917; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nalefski EA, 2001, BIOCHEMISTRY-US, V40, P3089, DOI 10.1021/bi001968a; Niapour M, 2007, CYTOM PART A, V71A, P475, DOI 10.1002/cyto.a.20399; Ono Y, 1999, CALPAIN PHARM TOXICO, P1; Osawa M, 2005, HUM GENET, V116, P146, DOI 10.1007/s00439-004-1222-7; Pal GP, 2003, STRUCTURE, V11, P1521, DOI 10.1016/j.str.2003.11.007; Pal GP, 2001, J BIOL CHEM, V276, P47233, DOI 10.1074/jbc.M105149200; Patchell BJ, 2006, CLIN EXP ALLERGY, V36, P585, DOI 10.1111/j.1365-2222.2006.02394.x; Pavord S, 1997, BRIT J HAEMATOL, V97, P762, DOI 10.1046/j.1365-2141.1997.1282947.x; Ray S, 2003, BBA-PROTEINS PROTEOM, V1652, P91, DOI 10.1016/j.bbapap.2003.08.004; RICHARD I, 1995, CELL, V81, P27, DOI 10.1016/0092-8674(95)90368-2; SANDBERG H, 1985, THROMB RES, V39, P63, DOI 10.1016/0049-3848(85)90122-7; Schafer C, 2003, J CLIN INVEST, V112, P357, DOI 10.1172/JCI17202; Schinke T, 1996, J BIOL CHEM, V271, P20789, DOI 10.1074/jbc.271.34.20789; Schote U, 1998, BBA-BIOMEMBRANES, V1415, P135, DOI 10.1016/S0005-2736(98)00188-6; Taverna S, 2003, J BIOL CHEM, V278, P51911, DOI 10.1074/jbc.M304192200; Townsend DeWayne, 2007, Expert Rev Cardiovasc Ther, V5, P99, DOI 10.1586/14779072.5.1.99; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; Xiao Z, 2007, J CELL PHYSIOL, V210, P325, DOI 10.1002/jcp.20826; XIE XY, 1991, J NEUROSCI, V11, P3257; YAMAMOTO S, 1992, ARTHRITIS RHEUM-US, V35, P1309, DOI 10.1002/art.1780351111	59	25	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35868	35877		10.1074/jbc.M706929200	http://dx.doi.org/10.1074/jbc.M706929200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17942392	hybrid			2022-12-27	WOS:000251458100048
J	Millard, CJ; Ellis, IR; Pickford, AR; Schor, AM; Schor, SL; Campbell, ID				Millard, Christopher J.; Ellis, Ian R.; Pickford, Andrew R.; Schor, Ana M.; Schor, Seth L.; Campbell, Iain D.			The role of the fibronectin IGD motif in stimulating fibroblast migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-SITE; MODULE PAIR; PLASMA FIBRONECTIN; GELATIN-BINDING; CELL-ADHESION; MATRIX; RGD; IDENTIFICATION; FIBRILLOGENESIS; SEQUENCE	The motogenic activity of migration-stimulating factor, a truncated isoform of fibronectin (FN), has been attributed to the IGD motifs present in its FN type 1 modules. The structure-function relationship of various recombinant IGD-containing FN fragments is now investigated. Their structure is assessed by solution state NMR and their motogenic ability tested on fibroblasts. Even conservative mutations in the IGD motif are inactive or have severely reduced potency, while the structure remains essentially the same. A fragment with two IGD motifs is 100 times more active than a fragment with one and up to 106 times more than synthetic tetrapeptides. The wide range of potency in different contexts is discussed in terms of cryptic FN sites and cooperativity. These results give new insight into the stimulation of fibroblast migration by IGD motifs in FN.	Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; Univ Dundee, Unit Cell & Mol Biol, Dundee DD1 4HR, Scotland; Univ Portsmouth, Sch Biol Sci, Portsmouth PO1 2DY, Hants, England	University of Oxford; University of Dundee; University of Portsmouth	Campbell, ID (corresponding author), Univ Oxford, Dept Biochem, S Parks Rd, Oxford OX1 3QU, England.	iain.campbell@bioch.ox.ac.uk	Ellis, Ian/AAM-9833-2021; Pickford, Andy/AGB-6901-2022	Ellis, Ian/0000-0001-8035-6012; Pickford, Andy/0000-0002-7237-0030; Millard, Chris/0000-0002-1012-0829	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Bright Jr, 2000, METH MOL B, V139, P59; Curnis F, 2006, J BIOL CHEM, V281, P36466, DOI 10.1074/jbc.M604812200; Ellis IR, 2007, EXP CELL RES, V313, P732, DOI 10.1016/j.yexcr.2006.11.016; FUKAI F, 1991, J BIOL CHEM, V266, P8807; Homandberg Gene A., 1999, Frontiers in Bioscience, V4, pd713, DOI 10.2741/Homandberg; Houard X, 2005, INT J CANCER, V116, P378, DOI 10.1002/ijc.21053; HUMPHRIES MJ, 1986, J CELL BIOL, V103, P2637, DOI 10.1083/jcb.103.6.2637; HYNES RO, 1990, FIBRONECTINS, P1; Ingham KC, 2004, J BIOL CHEM, V279, P28132, DOI 10.1074/jbc.M312785200; KUMAGAI H, 1991, BIOCHEM BIOPH RES CO, V177, P74, DOI 10.1016/0006-291X(91)91950-H; MAIN AL, 1992, CELL, V71, P671, DOI 10.1016/0092-8674(92)90600-H; Mao Y, 2005, MATRIX BIOL, V24, P389, DOI 10.1016/j.matbio.2005.06.008; Millard CJ, 2005, FEBS LETT, V579, P4529, DOI 10.1016/j.febslet.2005.05.082; MOULD AP, 1991, EMBO J, V10, P4089, DOI 10.1002/j.1460-2075.1991.tb04985.x; Oberhauser AF, 2002, J MOL BIOL, V319, P433, DOI 10.1016/S0022-2836(02)00306-6; Potts JR, 1996, MATRIX BIOL, V15, P313, DOI 10.1016/S0945-053X(96)90133-X; POTTS JR, 1994, CURR OPIN CELL BIOL, V6, P648, DOI 10.1016/0955-0674(94)90090-6; Potts JR, 1999, BIOCHEMISTRY-US, V38, P8304, DOI 10.1021/bi990202b; Rudino-Pinera E, 2007, J MOL BIOL, V368, P833, DOI 10.1016/j.jmb.2007.02.061; RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619; Schor SL, 2003, CANCER RES, V63, P8827; Schor SL, 1999, J CELL SCI, V112, P3879; SCHOR SL, 1988, J CELL SCI, V90, P391; SCHOR SL, 1980, J CELL SCI, V41, P159; Schor SL, 1996, J CELL SCI, V109, P2581; SCHWARZBAUER JE, 1991, J CELL BIOL, V113, P1463, DOI 10.1083/jcb.113.6.1463; Sechler JL, 2001, J CELL BIOL, V154, P1081, DOI 10.1083/jcb.200102034; Takahashi S, 2007, J CELL BIOL, V178, P167, DOI 10.1083/jcb.200703021; Tomasini-Johansson BR, 2006, MATRIX BIOL, V25, P282, DOI 10.1016/j.matbio.2006.02.002; Vakonakis I, 2007, EMBO J, V26, P2575, DOI 10.1038/sj.emboj.7601694; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; YAMADA T, 1994, BIOCHEMISTRY-US, V33, P11678, DOI 10.1021/bi00205a002	32	30	30	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35530	35535		10.1074/jbc.M707532200	http://dx.doi.org/10.1074/jbc.M707532200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17921136	hybrid			2022-12-27	WOS:000251458100012
J	Wu, SW; Chen, HR; Alexeyev, MF; King, JAC; Moore, TM; Stevens, T; Balczon, RD				Wu, Songwei; Chen, Hairu; Alexeyev, Mikhail F.; King, Judy A. C.; Moore, Timothy M.; Stevens, Troy; Balczon, Ronald D.			Microtubule motors regulate I-SOC activation necessary to increase endothelial cell permeability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAMSTER OVARY CELLS; OPERATED CA2+ ENTRY; ENDOPLASMIC-RETICULUM; CYTOPLASMIC DYNEIN; CALCIUM-CHANNELS; BARRIER FUNCTION; MEMBRANE; OVEREXPRESSION; DYNACTIN; PIGMENTATION	Calcium store depletion activates multiple ion channels, including calcium-selective and nonselective channels. Endothelial cells express TRPC1 and TRPC4 proteins that contribute to a calcium-selective store-operated current, I-SOC. Whereas thapsigargin activates the I-SOC in pulmonary artery endothelial cells (PAECs), it does not activate I-SOC in pulmonary microvascular endothelial cells (PMVECs), despite inducing a significant rise in global cytosolic calcium. Endoplasmic reticulum exhibits retrograde distribution in PMVECs when compared with PAECs. We therefore sought to determine whether endoplasmic reticulum-to-plasma membrane coupling represents an important determinant of I-SOC activation in PAECs and PMVECs. Endoplasmic reticulum organization is controlled by microtubules, because nocodozole induced microtubule disassembly and caused retrograde endoplasmic reticulum collapse in PMVECs. In PMVECs, rolipram treatment produced anterograde endoplasmic reticulum distribution and revealed a thapsigarin-activated I-SOC that was abolished by nocodozole and taxol. Microtubule motors control organelle distribution along microtubule tracks, with the dynein motor causing retrograde movement and the kinesin motor causing anterograde movement. Dynamitin expression reduces dynein motor function inducing anterograde endoplasmic reticulum transport, which allows for direct activation of I-SOC by thapsigargin in PMVECs. In contrast, expression of dominant negative kinesin light chain reduces kinesin motor function and induces retrograde endoplasmic reticulum transport; dominant negative kinesin light chain expression prevented the direct activation of I-SOC by thapsigargin in PAECs. I-SOC activation is an important step leading to disruption of cell-cell adhesion and increased macromolecular permeability. Thus, microtubule motor function plays an essential role in activating cytosolic calcium transitions through the membrane I-SOC channel leading to endothelial barrier disruption.	Univ S Alabama, Coll Med, Ctr Lung Biol, Dept Mol & Cellular Pharmacol, Mobile, AL 36688 USA; Univ S Alabama, Coll Med, Ctr Lung Biol, Dept Cell Biol & Neurosci, Mobile, AL 36688 USA; Univ S Alabama, Coll Med, Ctr Lung Biol, Dept Pathol, Mobile, AL 36688 USA; Univ S Alabama, Coll Med, Ctr Lung Biol, Dept Med, Mobile, AL 36688 USA	University of South Alabama; University of South Alabama; University of South Alabama; University of South Alabama	Wu, SW (corresponding author), Univ S Alabama, Coll Med, Ctr Lung Biol, Dept Mol & Cellular Pharmacol, Mobile, AL 36688 USA.	swu@jaguar1.usouthal.edu; rbalczon@usouthal.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060024, P01HL066299, R37HL060024] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-60024, HL-66299] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Balczon R, 2001, CHROMOSOMA, V110, P381, DOI 10.1007/s004120100157; BALCZON R, 1995, J CELL BIOL, V130, P105, DOI 10.1083/jcb.130.1.105; Barral DC, 2004, PIGM CELL RES, V17, P111, DOI 10.1111/j.1600-0749.2004.00138.x; Brough GH, 2001, FASEB J, V15, P1727, DOI 10.1096/fj.01-0108com; Burkhardt JK, 1997, J CELL BIOL, V139, P469, DOI 10.1083/jcb.139.2.469; Byers HR, 2003, J INVEST DERMATOL, V121, P813; Chetham PM, 1997, AM J PHYSIOL-LUNG C, V273, pL22, DOI 10.1152/ajplung.1997.273.1.L22; Chetham PM, 1999, AM J PHYSIOL-LUNG C, V276, pL41, DOI 10.1152/ajplung.1999.276.1.L41; Cioffi DL, 2005, CIRC RES, V97, P1164, DOI 10.1161/01.RES.0000193597.65217.00; Cioffi DL, 2003, CELL CALCIUM, V33, P323, DOI 10.1016/S0143-4160(03)00046-0; Creighton JR, 2003, AM J PHYSIOL-LUNG C, V284, pL100, DOI 10.1152/ajplung.00083.2002; Dudek SM, 2001, J APPL PHYSIOL, V91, P1487, DOI 10.1152/jappl.2001.91.4.1487; Hirose H, 2004, EMBO J, V23, P1267, DOI 10.1038/sj.emboj.7600135; Kelly JJ, 1998, AM J PHYSIOL-LUNG C, V274, pL810, DOI 10.1152/ajplung.1998.274.5.L810; King J, 2004, MICROVASC RES, V67, P139, DOI 10.1016/j.mvr.2003.11.006; Lambert J, 1999, CELL MOL BIOL, V45, P905; Liu QQ, 2001, J CELL SCI, V114, P797; Logan DW, 2006, PIGM CELL RES, V19, P206, DOI 10.1111/j.1600-0749.2006.00307.x; Marklund U, 1996, EMBO J, V15, P5290, DOI 10.1002/j.1460-2075.1996.tb00914.x; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; Metge B, 2004, J BIOL CHEM, V279, P41801, DOI 10.1074/jbc.M407094200; MINOTTI AM, 1991, J BIOL CHEM, V266, P3987; Moore TM, 1998, AM J PHYSIOL-LUNG C, V275, pL203, DOI 10.1152/ajplung.1998.275.2.L203; Nilius B, 2003, ENDOTHELIUM-J ENDOTH, V10, P5, DOI 10.1080/10623320303356; Oka T, 2005, J IMMUNOL, V174, P4584, DOI 10.4049/jimmunol.174.8.4584; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Quintana A, 2006, J BIOL CHEM, V281, P40302, DOI 10.1074/jbc.M607896200; Skold HN, 2002, PIGM CELL RES, V15, P357, DOI 10.1034/j.1600-0749.2002.02048.x; Stevens T, 2000, AM J PHYSIOL-LUNG C, V279, pL419, DOI 10.1152/ajplung.2000.279.3.L419; Stevens T, 1999, AM J PHYSIOL-LUNG C, V277, pL119, DOI 10.1152/ajplung.1999.277.1.L119; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Upadhyaya A, 2004, BIOPHYS J, V86, P2923, DOI 10.1016/S0006-3495(04)74343-X; Valetti C, 1999, MOL BIOL CELL, V10, P4107, DOI 10.1091/mbc.10.12.4107; Varadi A, 2004, J CELL SCI, V117, P4389, DOI 10.1242/jcs.01299; Vedrenne C, 2006, TRAFFIC, V7, P639, DOI 10.1111/j.1600-0854.2006.00419.x; Vedrenne C, 2005, MOL BIOL CELL, V16, P1928, DOI 10.1091/mbc.E04-07-0554; Verhey KJ, 1998, J CELL BIOL, V143, P1053, DOI 10.1083/jcb.143.4.1053; Watson P, 2005, NAT CELL BIOL, V7, P48, DOI 10.1038/ncb1206; Wedlich-Soldner R, 2002, MOL BIOL CELL, V13, P965, DOI 10.1091/mbc.01-10-0475; Wu SW, 2005, CIRC RES, V96, P856, DOI 10.1161/01.RES.0000163632.67282.1f	40	26	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					34801	34808		10.1074/jbc.M704522200	http://dx.doi.org/10.1074/jbc.M704522200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17921144	hybrid			2022-12-27	WOS:000251155200022
J	Wang, YQ; Zhu, M; Ayalew, M; Ruff, JA				Wang, Yuqi; Zhu, Ming; Ayalew, Mihretu; Ruff, Jack A.			Down-regulation of Pkc1-mediated signaling by the deubiquitinating enzyme Ubp3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; MAP KINASE; G-PROTEIN; HISTONE H2B; UBIQUITINATION; YEAST; DEGRADATION; ACTIVATION; SPECIFICITY; PROTEASOME	Regulated ubiquitination and degradation of signaling proteins have emerged as key mechanisms for modulating the strength and duration of signaling pathways. The reversible nature of the ubiquitination process as well as the large number and diversity of the deubiquitinating enzymes raise the possibility that signaling pathways might be modulated by specific deubiquitinating enzyme(s). Here we provide evidence that in the yeast Saccharomyces cerevisiae, the Pkc1-mediated signaling pathway that controls the cell wall integrity is negatively regulated by the deubiquitinating enzyme Ubp3. Disruption of the UBP3 gene leads to an enhanced activation of the cell wall integrity pathway MAPK Slt2 when cells are challenged with a variety of pathway activation agents such as pheromone and Congo red. The ubp3 deletion mutants accumulate high levels of Pkc1, suggesting potential regulation of Pkc1 by Ubp3. Consistent with this, Pkc1 and Ubp3 interact in vivo, and the stability of Pkc1 is markedly increased in the ubp3 deletion mutants. Moreover, disruption of the PKC1 gene, but not the genes that encode components downstream of Pkc1, completely suppresses other phenotypes displayed by the ubp3 deletion mutants such as hyperactivation of the pheromone-responsive MAPK Fus3 (Wang, Y., and Dohlman, H. G. ( 2002) J. Biol. Chem. 277, 15766-15772). These findings demonstrate that Ubp3 can regulate Pkc1 by facilitating its destruction and provide the initial evidence that Pkc1 plays a positive role in modulating the parallel pheromone-signaling pathway.	[Wang, Yuqi; Zhu, Ming; Ayalew, Mihretu; Ruff, Jack A.] St Louis Univ, Dept Biol, St Louis, MO 63103 USA	Saint Louis University	Wang, YQ (corresponding author), St Louis Univ, Dept Biol, 128 Macelwane Hall,3507 Laclede Ave, St Louis, MO 63103 USA.	ywang8@slu.edu						Amerik AY, 2000, BIOL CHEM, V381, P981, DOI 10.1515/BC.2000.121; Amerik AY, 2004, BBA-MOL CELL RES, V1695, P189, DOI 10.1016/j.bbamcr.2004.10.003; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Buehrer BM, 1997, MOL CELL BIOL, V17, P6517, DOI 10.1128/MCB.17.11.6517; Daniel JA, 2004, J BIOL CHEM, V279, P1867, DOI 10.1074/jbc.C300494200; Dohlman HG, 2002, ANNU REV PHYSIOL, V64, P129, DOI 10.1146/annurev.physiol.64.081701.133448; Dohlman HG, 2001, ANNU REV BIOCHEM, V70, P703, DOI 10.1146/annurev.biochem.70.1.703; ERREDE B, 1995, MOL REPROD DEV, V42, P477, DOI 10.1002/mrd.1080420416; Esch RK, 2002, P NATL ACAD SCI USA, V99, P9160, DOI 10.1073/pnas.142034399; Flandez M, 2004, J BIOL CHEM, V279, P11027, DOI 10.1074/jbc.M306412200; Henry KW, 2003, GENE DEV, V17, P2648, DOI 10.1101/gad.1144003; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Lee HW, 1996, J BIOL CHEM, V271, P20973, DOI 10.1074/jbc.271.35.20973; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; Lu ZM, 1998, MOL CELL BIOL, V18, P839, DOI 10.1128/MCB.18.2.839; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; RONCERO C, 1985, J BACTERIOL, V163, P1180, DOI 10.1128/JB.163.3.1180-1185.1985; Sabbagh W, 2001, MOL CELL, V8, P683, DOI 10.1016/S1097-2765(01)00322-7; Slessareva JE, 2006, CELL, V126, P191, DOI 10.1016/j.cell.2006.04.045; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Verma R, 2004, CELL, V118, P99, DOI 10.1016/j.cell.2004.06.014; Wang YQ, 2004, SCIENCE, V306, P1508, DOI 10.1126/science.1104568; Wang YQ, 2003, J BIOL CHEM, V278, P22284, DOI 10.1074/jbc.M301272200; Wang YQ, 2002, J BIOL CHEM, V277, P15766, DOI 10.1074/jbc.M111733200; Wang YQ, 2006, CIRC RES, V99, P1305, DOI 10.1161/01.RES.0000251641.57410.81; WATANABE M, 1994, J BIOL CHEM, V269, P16829; Zarzov P, 1996, EMBO J, V15, P83, DOI 10.1002/j.1460-2075.1996.tb00336.x	30	15	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					1954	1961		10.1074/jbc.M705682200	http://dx.doi.org/10.1074/jbc.M705682200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	17986446	hybrid			2022-12-27	WOS:000252501000022
J	Fujiwara, K; Daido, S; Yamamoto, A; Kobayashi, R; Yokoyama, T; Aoki, H; Iwado, E; Shinojima, N; Kondo, Y; Kondo, S				Fujiwara, Keishi; Daido, Shigeru; Yamamoto, Akitsugu; Kobayashi, Ryuji; Yokoyama, Tomohisa; Aoki, Hiroshi; Iwado, Eiji; Shinojima, Naoki; Kondo, Yasuko; Kondo, Seiji			Pivotal role of the cyclin-dependent kinase inhibitor p21(WAF1/CIP1) in apoptosis and autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRAMMED CELL-DEATH; MALIGNANT GLIOMA-CELLS; HUMAN COLON-CANCER; CARCINOMA CELLS; P21 WAF1/CIP1; CERAMIDE; P53; BCL-2; MACROAUTOPHAGY; CAMPTOTHECIN	Programmed cell death (PCD) is involved in a variety of biologic events. Based on the morphologic appearance of the cells, there are two types of PCD as follows: apoptotic(type I) and autophagic(type II). However, the molecular machinery that determines the type of PCD is poorly defined. The purpose of this study was to show whether the presence of the cyclin-dependent kinase (CDK) inhibitor p21(WAF1/CIP1), a modulator of apoptosis, determines which type of PCD the cell undergoes. Treatment with C-2-ceramide was associated with both the cleavage of caspase-3 and poly(ADP- ribose) polymerase and the degradation of autophagy-related Beclin 1 and Atg5 proteins, without a change in the cyclin-CDK activity, which culminated in apoptosis in p21(+/+) mouse embryonic fibroblasts (MEFs). On the other hand, C-2-ceramide did not cleave caspase-3 or poly(ADP- ribose) polymerase and kept Beclin 1 and Atg5 proteins stable in p21(+/+) MEFs, events that this time culminated in autophagy. When expression of the p21 protein was inhibited by small interfering RNA or when the overexpression of Beclin 1 or Atg5 was induced, autophagy rather than apoptosis was initiated in the p21(+/+) MEFs treated with C-2-ceramide. In contrast, the exogenous expression of p21 or the silencing of Beclin 1 and Atg5 with small interfering RNA increased the number of apoptotic cells and decreased the number of autophagic cells among C-2-ceramide-treated p21(+/+) MEFs. gamma-Irradiation, which endogenously generates ceramide, induced a similar tendency in these MEFs. These results suggest that p21 plays an essential role in determining the type of cell death, positively for apoptosis and negatively for autophagy.	[Fujiwara, Keishi; Daido, Shigeru; Yokoyama, Tomohisa; Aoki, Hiroshi; Iwado, Eiji; Shinojima, Naoki; Kondo, Yasuko; Kondo, Seiji] Univ Texas, MD Anderson Canc Ctr, Dept Neurosurg, Houston, TX 77030 USA; [Yamamoto, Akitsugu] Nagahama Inst Biosci & Technol, Dept Cell Biol & Biosci, Shiga 5260829, Japan; [Kobayashi, Ryuji] Univ Texas, MD Anderson Canc Ctr, Dept Mol Pathol, Houston, TX 77030 USA; [Kondo, Seiji] Univ Texas, Grad Sch Biomed Sci, Houston, TX 77030 USA; [Kondo, Seiji] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; Baylor College of Medicine	Kondo, S (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Neurosurg, 1515 Holcombe Blvd,Unit BSRB 1004, Houston, TX 77030 USA.	seikondo@mdanderson.org	Shinojima, Naoki/GSI-6790-2022; Shinojima, Naoki/AAW-3038-2021	Shinojima, Naoki/0000-0003-3352-7936	NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NCI NIH HHS [CA 16672] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bursch W, 2000, ANN NY ACAD SCI, V926, P1, DOI 10.1111/j.1749-6632.2000.tb05594.x; Cheng MG, 1999, EMBO J, V18, P1571, DOI 10.1093/emboj/18.6.1571; Chopin V, 2004, EXP CELL RES, V298, P560, DOI 10.1016/j.yexcr.2004.04.038; CIFONE MG, 1994, J EXP MED, V180, P1547, DOI 10.1084/jem.180.4.1547; Coqueret O, 2003, TRENDS CELL BIOL, V13, P65, DOI 10.1016/S0962-8924(02)00043-0; Cuervo AM, 2004, TRENDS CELL BIOL, V14, P70, DOI 10.1016/j.tcb.2003.12.002; Daido S, 2004, CANCER RES, V64, P4286, DOI 10.1158/0008-5472.CAN-03-3084; Daido S, 2005, CANCER RES, V65, P4368, DOI 10.1158/0008-5472.CAN-04-4202; Detjen KM, 2003, EXP CELL RES, V282, P78, DOI 10.1016/S0014-4827(02)00011-3; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Gartel AL, 2002, MOL CANCER THER, V1, P639; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Ha HC, 1999, P NATL ACAD SCI USA, V96, P13978, DOI 10.1073/pnas.96.24.13978; Han ZY, 2002, J BIOL CHEM, V277, P17154, DOI 10.1074/jbc.M112401200; HARPER JW, 1993, CELL, V75, P805; Ito H, 2005, HUM GENE THER, V16, P685, DOI 10.1089/hum.2005.16.685; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kang KH, 1999, EXP CELL RES, V253, P403, DOI 10.1006/excr.1999.4644; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Klionsky DJ, 2003, DEV CELL, V5, P539, DOI 10.1016/S1534-5807(03)00296-X; Kondo S, 1996, ONCOGENE, V13, P1279; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Lockshin RA, 2002, CURR OPIN CELL BIOL, V14, P727, DOI 10.1016/S0955-0674(02)00383-6; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Mahyar-Roemer M, 2001, ONCOGENE, V20, P3387, DOI 10.1038/sj.onc.1204440; Mengubas K, 1999, ONCOGENE, V18, P2499, DOI 10.1038/sj.onc.1202622; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Noda T, 2002, TRENDS CELL BIOL, V12, P231, DOI 10.1016/S0962-8924(02)02278-X; OBEID LM, 1993, SCIENCE, V259, P1769, DOI 10.1126/science.8456305; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; Pettus BJ, 2002, BBA-MOL CELL BIOL L, V1585, P114, DOI 10.1016/S1388-1981(02)00331-1; Pua HH, 2007, J EXP MED, V204, P25, DOI 10.1084/jem.20061303; Qiao L, 2002, HEPATOLOGY, V36, P39, DOI 10.1053/jhep.2002.33899; Scarlatti F, 2004, J BIOL CHEM, V279, P18384, DOI 10.1074/jbc.M313561200; Scovassi AI, 2004, BIOCHEM PHARMACOL, V68, P1041, DOI 10.1016/j.bcp.2004.04.023; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Shibata MA, 2001, CANCER GENE THER, V8, P23, DOI 10.1038/sj.cgt.7700275; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Talloczy Z, 2002, P NATL ACAD SCI USA, V99, P190, DOI 10.1073/pnas.012485299; Tian H, 2000, CANCER RES, V60, P679; Tsao YP, 1999, J VIROL, V73, P4983, DOI 10.1128/JVI.73.6.4983-4990.1999; Tsujimoto Y, 2005, CELL DEATH DIFFER, V12, P1528, DOI 10.1038/sj.cdd.4401777; Verheij M, 1996, NATURE, V380, P75, DOI 10.1038/380075a0; WAGA S, 1994, NATURE, V369, P574, DOI 10.1038/369574a0; Weiss RH, 2003, CANCER CELL, V4, P425, DOI 10.1016/S1535-6108(03)00308-8; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Xu Y, 2006, J BIOL CHEM, V281, P19179, DOI 10.1074/jbc.M513377200; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Zeng XH, 2006, J CELL SCI, V119, P259, DOI 10.1242/jcs.02735; Zhang YK, 1999, INT J CANCER, V83, P790, DOI 10.1002/(SICI)1097-0215(19991210)83:6<790::AID-IJC15>3.0.CO;2-6	55	90	97	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					388	397		10.1074/jbc.M611043200	http://dx.doi.org/10.1074/jbc.M611043200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17959603	hybrid			2022-12-27	WOS:000251940300043
J	Baggaley, E; McLarnon, S; Demeter, I; Varga, G; Bruce, JIE				Baggaley, Erin; McLarnon, Stuart; Demeter, Irma; Varga, Gabor; Bruce, Jason I. E.			Differential regulation of the apical plasma membrane Ca2+-ATPase by protein kinase a in parotid acinar cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; CALCIUM-PUMP; SALIVARY-GLANDS; CA2+ PUMP; ENDOPLASMIC-RETICULUM; SIGNALING DYNAMICS; PANCREATIC ACINAR; CYTOSOLIC CA2+; ISOFORMS 2B; RAT	Cross-talk between intracellular calcium ([Ca2+](i)) signaling and cAMP defines the specificity of stimulus-response coupling in a variety of cells. Previous studies showed that protein kinase A (PKA) potentiates and phosphorylates the plasma membrane Ca2+-ATPase (PMCA) in a Ca2+-dependent manner in parotid acinar cells (Bruce, J. I. E., Yule, D. I., and Shuttleworth, T. J. (2002) J. Biol. Chem. 277, 48172 -48181). The aim of this study was to further investigate the spatial regulation of [Ca2+](i) clearance in parotid acinar cells. Par-C10 cells were used to functionally isolate the apical and basolateral PMCA activity by applying La3+ to the opposite side to inhibit the PMCA. Activation of PKA (using forskolin) differentially potentiated apical [Ca2+](i) clearance in mouse parotid acinar cells and apical PMCA activity in Par-C10 cells. Immunofluorescence of parotid tissue slices revealed that PMCA1 was distributed throughout the plasma membrane, PMCA2 was localized to the basolateral membrane, and PMCA4 was localized to the apical membrane of parotid acinar cells. However, in situ phosphorylation assays demonstrated that PMCA1 was the only isoform phosphorylated by PKA following stimulation. Similarly, immunofluorescence of acutely isolated parotid acinar cells showed that the regulatory subunit of PKA (RII beta) translocated to the apical region following stimulation. These data suggest that PKA-mediated phosphorylation of PMCA1 differentially regulates [Ca2+](i) clearance in the apical region of parotid acinar cells because of a dynamic translocation of PKA. Such tight spatial regulation of Ca2+ efflux is likely important for the fine-tuning of Ca2+-dependent effectors close to the apical membrane important for the regulation of fluid secretion and exocytosis.	[Baggaley, Erin; McLarnon, Stuart; Bruce, Jason I. E.] Univ Manchester, Fac Life Sci, Manchester M13 9NT, Lancs, England; [Demeter, Irma; Varga, Gabor] Semmelweis Univ, Dept Oral Biol, H-1089 Budapest, Hungary	University of Manchester; Semmelweis University	Bruce, JIE (corresponding author), Univ Manchester, Fac Life Sci, 2nd Floor Core Technol Facil,46 Grafton St, Manchester M13 9NT, Lancs, England.	jason.bruce@manchester.ac.uk	Varga, Gábor/O-8858-2017	Varga, Gabor/0000-0002-5506-8198	Biotechnology and Biological Sciences Research Council [BB/C514607/1] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Ankorina-Stark I, 2002, J MEMBRANE BIOL, V186, P43, DOI 10.1007/s00232-001-0134-x; Bautista DM, 2002, J PHYSIOL-LONDON, V541, P877, DOI 10.1113/jphysiol.2001.016154; Belan PV, 1996, J BIOL CHEM, V271, P7615, DOI 10.1074/jbc.271.13.7615; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; BEZPROZVANNY I, 1991, NATURE, V351, P751, DOI 10.1038/351751a0; Bretscher A, 2000, ANNU REV CELL DEV BI, V16, P113, DOI 10.1146/annurev.cellbio.16.1.113; Bretscher A, 1997, J CELL SCI, V110, P3011; Bruce JIE, 2004, J BIOL CHEM, V279, P12909, DOI 10.1074/jbc.M309070200; Bruce JIE, 2002, J BIOL CHEM, V277, P48172, DOI 10.1074/jbc.M208393200; Bruce JIE, 2002, J BIOL CHEM, V277, P1340, DOI 10.1074/jbc.M106609200; Carafoli E, 2002, P NATL ACAD SCI USA, V99, P1115, DOI 10.1073/pnas.032427999; CARAFOLI E, 1991, PHYSIOL REV, V71, P129, DOI 10.1152/physrev.1991.71.1.129; Caride AJ, 2001, J BIOL CHEM, V276, P39797, DOI 10.1074/jbc.M104380200; Castle AM, 2002, J CELL SCI, V115, P2963; Collins TJ, 2001, J BIOL CHEM, V276, P26411, DOI 10.1074/jbc.M101101200; Dell'Acqua ML, 1998, EMBO J, V17, P2246, DOI 10.1093/emboj/17.8.2246; DeMarco SJ, 2002, J BIOL CHEM, V277, P10506, DOI 10.1074/jbc.M111616200; DeMarco SJ, 2001, J BIOL CHEM, V276, P21594, DOI 10.1074/jbc.M101448200; Giovannucci DR, 2002, J PHYSIOL-LONDON, V540, P469, DOI 10.1113/jphysiol.2001.013453; GREEB J, 1989, J BIOL CHEM, V264, P18569; Gromadzinska E, 2001, BBA-PROTEIN STRUCT M, V1549, P19, DOI 10.1016/S0167-4838(01)00244-8; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Guerini D, 2003, J BIOL CHEM, V278, P38141, DOI 10.1074/jbc.M302400200; Hall RA, 1998, NATURE, V392, P626, DOI 10.1038/33458; Henn V, 2004, J BIOL CHEM, V279, P26654, DOI 10.1074/jbc.M312835200; HERSCHER CJ, 1994, J BIOL CHEM, V269, P10400; Hillman DE, 1996, NEUROSCIENCE, V72, P315, DOI 10.1016/0306-4522(95)00518-8; Ishikawa Y, 2006, J PHARMACOL SCI, V100, P495, DOI 10.1254/jphs.CRJ06007X; JAMES PH, 1989, BIOCHEMISTRY-US, V28, P4253, DOI 10.1021/bi00436a020; KASAI H, 1993, CELL, V74, P669, DOI 10.1016/0092-8674(93)90514-Q; Kurihara K, 2003, BIOCHEM PHARMACOL, V66, P239, DOI 10.1016/S0006-2952(03)00259-4; LARSSON O, 1989, ACTA PHYSIOL SCAND, V137, P231, DOI 10.1111/j.1748-1716.1989.tb08743.x; Lee MG, 1997, J BIOL CHEM, V272, P15771, DOI 10.1074/jbc.272.25.15771; MASON MJ, 1991, J BIOL CHEM, V266, P20856; Maudsley S, 2000, MOL CELL BIOL, V20, P8352, DOI 10.1128/MCB.20.22.8352-8363.2000; Monteith GR, 1998, J PHARMACOL TOXICOL, V40, P183, DOI 10.1016/S1056-8719(99)00004-0; Penniston JT, 1998, J MEMBRANE BIOL, V165, P101, DOI 10.1007/s002329900424; Perez-Cornejo P, 2004, BIOCHEM BIOPH RES CO, V316, P612, DOI 10.1016/j.bbrc.2004.02.097; Reuter H, 2005, CARDIOVASC RES, V67, P198, DOI 10.1016/j.cardiores.2005.04.031; Schuh K, 2004, J BIOL CHEM, V279, P28220, DOI 10.1074/jbc.M312599200; Schuh K, 2003, J BIOL CHEM, V278, P9778, DOI 10.1074/jbc.M212507200; Schuh K, 2001, J CELL BIOL, V155, P201, DOI 10.1083/jcb.200104131; Segawa A, 1998, CELL TISSUE RES, V291, P325, DOI 10.1007/s004410051002; Shmigol A, 1998, PFLUG ARCH EUR J PHY, V437, P158, DOI 10.1007/s004240050761; Strehler EE, 2001, PHYSIOL REV, V81, P21, DOI 10.1152/physrev.2001.81.1.21; Takemura H, 1999, BIOCHEM BIOPH RES CO, V259, P656, DOI 10.1006/bbrc.1999.0818; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Tojyo Y, 1997, CELL CALCIUM, V22, P455, DOI 10.1016/S0143-4160(97)90073-7; Trotter KW, 1999, J CELL BIOL, V147, P1481, DOI 10.1083/jcb.147.7.1481; Turner JT, 1998, AM J PHYSIOL-CELL PH, V275, pC367, DOI 10.1152/ajpcell.1998.275.2.C367; Westphal RS, 2000, EMBO J, V19, P4589, DOI 10.1093/emboj/19.17.4589; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Yonemura S, 1999, J CELL BIOL, V145, P1497, DOI 10.1083/jcb.145.7.1497; Yule DI, 2001, J GEN PHYSIOL, V117, P431, DOI 10.1085/jgp.117.5.431; Zabe M, 2001, J BIOL CHEM, V276, P14704, DOI 10.1074/jbc.M009850200; Zeng WZ, 1997, AM J PHYSIOL-CELL PH, V273, pC442, DOI 10.1152/ajpcell.1997.273.2.C442; Zhang XJ, 1999, BIOCHEM J, V340, P519, DOI 10.1042/0264-6021:3400519	57	20	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37678	37693		10.1074/jbc.M703416200	http://dx.doi.org/10.1074/jbc.M703416200			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17938178	hybrid			2022-12-27	WOS:000251833600044
J	Jha, SK; Udgaonkar, JB				Jha, Santosh Kumar; Udgaonkar, Jayant B.			Exploring the cooperativity of the fast folding reaction of a small protein using pulsed thiol labeling and mass spectrometry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIDE-CHAIN PACKING; HYDROGEN-EXCHANGE; TRANSITION-STATES; COLD DENATURATION; HYDROPHOBIC CORE; BARSTAR; INTERMEDIATE; KINETICS; PATHWAYS; DYNAMICS	It has been difficult to obtain directly residue-specific information on side chain packing during a fast (ms) protein folding reaction. Such information is necessary to determine the extent to which structural changes in different parts of the protein molecule are coupled together in defining the cooperativity of the overall folding transition. In this study, structural changes occurring during the major fast folding reaction of the small protein barstar have been characterized at the level of individual residue side chains. A pulsed cysteine labeling methodology has been employed in conjunction with mass spectrometry. This provides, with ms temporal resolution, direct information on structure formation at 10 different locations in barstar during its folding. Cysteine residues located on the surface of native barstar, at four different positions, remain fully solvent-accessible throughout the folding process, indicating the absence of any ephemeral nonnative structure in which these four cysteine residues get transiently buried. For buried cysteine residues, the rates of the change in cysteine-thiol accessibility to rapid chemical labeling by the thiol reagent methyl methanethiosulfonate appear to be dependent upon the location of the cysteine residue in the protein and are different from the rate measured by the change in tryptophan fluorescence. But the rates vary over only a 3-fold range. Nevertheless, a comparison of the kinetics of the change in accessibility of the cysteine 3 thiol with those of the change in the fluorescence of tryptophan 53, as well as of their denaturant dependences, indicates that the major folding reaction comprises more than one step.	[Jha, Santosh Kumar; Udgaonkar, Jayant B.] Tata Inst Fundamental Res, Natl Ctr & Biol Sci, Bangalore 560065, Karnataka, India	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS)	Udgaonkar, JB (corresponding author), Tata Inst Fundamental Res, Natl Ctr & Biol Sci, Bangalore 560065, Karnataka, India.	jayant@ncbs.res.in						AGASHE VR, 1995, BIOCHEMISTRY-US, V34, P3286, DOI 10.1021/bi00010a019; AGASHE VR, 1995, NATURE, V377, P754, DOI 10.1038/377754a0; Ahmed Z, 2005, J AM CHEM SOC, V127, P10943, DOI 10.1021/ja050664e; Anil B, 2006, BIOCHEMISTRY-US, V45, P10110, DOI 10.1021/bi060636o; BALDWIN RL, 1995, J BIOMOL NMR, V5, P103; BALLERY N, 1993, BIOCHEMISTRY-US, V32, P708, DOI 10.1021/bi00053a040; Bhuyan AK, 1999, BIOCHEMISTRY-US, V38, P9158, DOI 10.1021/bi990285w; Booth DR, 1997, NATURE, V385, P787, DOI 10.1038/385787a0; BOWIE JU, 1989, BIOCHEMISTRY-US, V28, P7139, DOI 10.1021/bi00444a001; Chan HS, 2004, METHOD ENZYMOL, V380, P350; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cho JH, 2006, J MOL BIOL, V359, P1437, DOI 10.1016/j.jmb.2006.04.038; Cho JH, 2004, J MOL BIOL, V338, P827, DOI 10.1016/j.jmb.2004.02.073; DeLano W.L, PYMOL MOL GRAPHICS S; DILL KA, 1993, P NATL ACAD SCI USA, V90, P1942, DOI 10.1073/pnas.90.5.1942; Eaton WA, 1999, P NATL ACAD SCI USA, V96, P5897, DOI 10.1073/pnas.96.11.5897; ENGLANDER SW, 1992, ANNU REV BIOPH BIOM, V21, P243, DOI 10.1146/annurev.biophys.21.1.243; Fersht AR, 2004, P NATL ACAD SCI USA, V101, P7976, DOI 10.1073/pnas.0402684101; Fink AL, 1998, FOLD DES, V3, pR9, DOI 10.1016/S1359-0278(98)00002-9; FINKELSTEIN AV, 2002, PROTEIN PHYS, P205; Frieden C, 2003, BIOCHEMISTRY-US, V42, P12439, DOI 10.1021/bi030192l; Goldenberg DP, 1999, NAT STRUCT BIOL, V6, P987, DOI 10.1038/14866; Ha JH, 1998, NAT STRUCT BIOL, V5, P730, DOI 10.1038/1436; Holtzer ME, 1997, BIOPHYS J, V73, P1031, DOI 10.1016/S0006-3495(97)78136-0; Huang F, 2007, P NATL ACAD SCI USA, V104, P123, DOI 10.1073/pnas.0609717104; JACOBS MD, 1994, P NATL ACAD SCI USA, V91, P449, DOI 10.1073/pnas.91.2.449; Juneja J, 2003, CURR SCI INDIA, V84, P157; Juneja J, 2002, BIOCHEMISTRY-US, V41, P2641, DOI 10.1021/bi011480p; KHURANA R, 1995, PROTEIN SCI, V4, P1133, DOI 10.1002/pro.5560040612; Klimov DK, 1998, FOLD DES, V3, P127, DOI 10.1016/S1359-0278(98)00018-2; Krishna MMG, 2007, PROTEIN SCI, V16, P449, DOI 10.1110/ps.062655907; Kussell E, 2003, PROTEINS, V52, P303, DOI 10.1002/prot.10426; Lakshmikanth GS, 2001, NAT STRUCT BIOL, V8, P799, DOI 10.1038/nsb0901-799; Levitt M, 1997, ANNU REV BIOCHEM, V66, P549, DOI 10.1146/annurev.biochem.66.1.549; Li H, 2007, BIOCHEMISTRY-US, V46, P4337, DOI 10.1021/bi6026083; LIM WA, 1989, NATURE, V339, P31, DOI 10.1038/339031a0; Ma HR, 2005, P NATL ACAD SCI USA, V102, P2283, DOI 10.1073/pnas.0409270102; Nolting B, 1997, P NATL ACAD SCI USA, V94, P826, DOI 10.1073/pnas.94.3.826; Nolting B, 1997, BIOCHEMISTRY-US, V36, P9899, DOI 10.1021/bi962879u; Northey JGB, 2002, NAT STRUCT BIOL, V9, P126, DOI 10.1038/nsb748; Osvath S, 2003, J MOL BIOL, V333, P187, DOI 10.1016/j.jmb.2003.08.011; Pradeep L, 2004, BIOCHEMISTRY-US, V43, P11393, DOI 10.1021/bi049320b; Pradeep L, 2004, J BIOL CHEM, V279, P40303, DOI 10.1074/jbc.M406323200; Pradeep L, 2002, J MOL BIOL, V324, P331, DOI 10.1016/S0022-2836(02)01068-9; RADFORD SE, 1992, NATURE, V358, P302, DOI 10.1038/358302a0; Ramachandran S, 2000, J MOL BIOL, V297, P733, DOI 10.1006/jmbi.2000.3605; Rami BR, 2003, BIOCHEMISTRY-US, V42, P7986, DOI 10.1021/bi030006b; Rami BR, 2001, BIOCHEMISTRY-US, V40, P15267, DOI 10.1021/bi011701r; Reich L, 2006, PROTEINS, V63, P1052, DOI 10.1002/prot.20966; ROBERTS DD, 1986, BIOCHEMISTRY-US, V25, P5595, DOI 10.1021/bi00367a038; RODER H, 1988, NATURE, V335, P700, DOI 10.1038/335700a0; Roy M, 2003, J MOL BIOL, V328, P693, DOI 10.1016/S0022-2836(03)00340-1; Sabelko J, 1999, P NATL ACAD SCI USA, V96, P6031, DOI 10.1073/pnas.96.11.6031; Sadqi M, 2006, NATURE, V442, P317, DOI 10.1038/nature04859; Sanchez IE, 2003, J MOL BIOL, V325, P367, DOI 10.1016/S0022-2836(02)01230-5; Schanda P, 2007, P NATL ACAD SCI USA, V104, P11257, DOI 10.1073/pnas.0702069104; SCHREIBER G, 1993, BIOCHEMISTRY-US, V32, P11195, DOI 10.1021/bi00092a032; SHASTRY MCR, 1995, J MOL BIOL, V247, P1013, DOI 10.1006/jmbi.1994.0196; SHASTRY MCR, 1994, PROTEIN SCI, V3, P1409, DOI 10.1002/pro.5560030907; Shortle D, 2002, ADV PROTEIN CHEM, V62, P1; Silverman JA, 2002, J BIOL CHEM, V277, P30968, DOI 10.1074/jbc.M203172200; Sinha KK, 2007, J MOL BIOL, V370, P385, DOI 10.1016/j.jmb.2007.04.061; Sinha KK, 2005, J MOL BIOL, V353, P704, DOI 10.1016/j.jmb.2005.08.056; Song JX, 1999, NAT STRUCT BIOL, V6, P129, DOI 10.1038/5815; Sridevi K, 2004, J MOL BIOL, V337, P699, DOI 10.1016/j.jmb.2003.12.083; Sridevi K, 2002, BIOCHEMISTRY-US, V41, P1568, DOI 10.1021/bi011494v; Sridevi K, 2000, J MOL BIOL, V302, P479, DOI 10.1006/jmbi.2000.4060; SRIDEVI K, 2003, THESIS, P62; Swaminathan R, 1996, BIOCHEMISTRY-US, V35, P9150, DOI 10.1021/bi9603478; UDGAONKAR JB, 1990, P NATL ACAD SCI USA, V87, P8197, DOI 10.1073/pnas.87.21.8197; Wani AH, 2006, BIOCHEMISTRY-US, V45, P11226, DOI 10.1021/bi060647h; Weikl TR, 2007, J MOL BIOL, V365, P1578, DOI 10.1016/j.jmb.2006.10.082; Wong KB, 1996, J MOL BIOL, V259, P805, DOI 10.1006/jmbi.1996.0359; Zaidi FN, 1997, NAT STRUCT BIOL, V4, P1016, DOI 10.1038/nsb1297-1016	74	42	42	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37479	37491		10.1074/jbc.M706714200	http://dx.doi.org/10.1074/jbc.M706714200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17959598	hybrid			2022-12-27	WOS:000251833600023
J	Katsuyama, Y; Matsuzawa, M; Funa, N; Horinouchi, S				Katsuyama, Yohei; Matsuzawa, Miku; Funa, Nobutaka; Horinouchi, Sueharu			In vitro synthesis of curcuminoids by type III polyketide synthase from Oryza sativa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BENZALACETONE SYNTHASE; CHALCONE SYNTHASE; BIOSYNTHESIS; PHENYLPHENALENONES	Curcuminoids, major components of the spice turmeric, are used as a traditional Asian medicine and a food additive. Curcumin, a representative curcuminoid, has received a great deal of attention because of its anti-inflammatory, anticarcinogenic, and antitumor activities. Here we report a novel type III polyketide synthase named curcuminoid synthase from Oryza sativa, which synthesizes bisdemethoxycurcumin via a unique mechanism from two 4-coumaroyl-CoAs and one malonyl-CoA. The reaction begins with the thioesterification of the thiol moiety of Cys-174 by a starter molecule, 4-coumaroyl-CoA. Decarboxylative condensation of the first extender substrate, malonyl-CoA, onto the thioester of 4-coumarate results in the formation of a diketide-CoA intermediate. Subsequent hydrolysis of the intermediate yields a beta-keto acid, which in turn acts as the second extender substrate. The beta-keto acid is then joined to the Cys-174-bound 4-coumarate by decarboxylative condensation to form bisdemethoxycurcumin. This reaction violates the traditional head-to-tail model of polyketide assembly; the growing diketide intermediate is hydrolyzed to a beta-keto acid that subsequently serves as the second extender to form curcuminoids. Curcuminoid synthase appears to be capable of the synthesis of not only diarylheptanoids but also gingerol analogues, because it synthesized cinnamoyl(hexanoyl) methane, a putative intermediate of gingerol, from cinnamoyl-CoA and 3-oxo-octanoic acid.	[Katsuyama, Yohei; Matsuzawa, Miku; Funa, Nobutaka; Horinouchi, Sueharu] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan	University of Tokyo	Horinouchi, S (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan.	asuhori@mail.ecc.u-tokyo.ac.jp						Abe I, 2001, EUR J BIOCHEM, V268, P3354, DOI 10.1046/j.1432-1327.2001.02255.x; Abe I, 2003, J BIOL CHEM, V278, P25218, DOI 10.1074/jbc.M303276200; Austin MB, 2004, CHEM BIOL, V11, P1179, DOI 10.1016/j.chembiol.2004.05.024; Austin MB, 2003, NAT PROD REP, V20, P79, DOI 10.1039/b100917f; Blecher M, 1981, Methods Enzymol, V72, P404; Brand S, 2006, PLANTA, V224, P413, DOI 10.1007/s00425-006-0228-x; DENNIFF P, 1980, J CHEM SOC PERK T 1, P2637, DOI 10.1039/p19800002637; Duvoix A, 2005, CANCER LETT, V223, P181, DOI 10.1016/j.canlet.2004.09.041; Ferrer JL, 1999, NAT STRUCT BIOL, V6, P775, DOI 10.1038/11553; GILBERT IH, 1995, BIOORG MED CHEM LETT, V5, P1587, DOI 10.1016/0960-894X(95)00276-Y; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; HIRAI N, 1994, PHYTOCHEMISTRY, V37, P383, DOI 10.1016/0031-9422(94)85064-X; HOLSCHER D, 1995, NAT PROD LETT, V7, P177, DOI 10.1080/10575639508043208; HOLSCHER D, 1995, J CHEM SOC CHEM COMM, P525, DOI 10.1039/c39950000525; Katsuyama Y, 2007, CHEM BIOL, V14, P613, DOI 10.1016/j.chembiol.2007.05.004; Kress WJ, 2001, SYST BIOL, V50, P926, DOI 10.1080/106351501753462885; Kuchitsu K, 1997, PLANT CELL PHYSIOL, V38, P1012, DOI 10.1093/oxfordjournals.pcp.a029265; Lokot IP, 1999, TETRAHEDRON, V55, P4783, DOI 10.1016/S0040-4020(99)00150-7; Maheshwari RK, 2006, LIFE SCI, V78, P2081, DOI 10.1016/j.lfs.2005.12.007; MATSUMURA S, 1985, B CHEM SOC JPN, V3, P310; Ramirez-Ahumada MD, 2006, PHYTOCHEMISTRY, V67, P2017, DOI 10.1016/j.phytochem.2006.06.028; Ricke DO, 2006, CURR OPIN CHEM BIOL, V10, P303, DOI 10.1016/j.cbpa.2006.06.024; ROUGHLEY PJ, 1973, J CHEM SOC PERK T 1, P2379, DOI 10.1039/p19730002379; Schroder J, 1997, TRENDS PLANT SCI, V2, P373, DOI 10.1016/S1360-1385(97)01104-7; Sharma RA, 2005, EUR J CANCER, V41, P1955, DOI 10.1016/j.ejca.2005.05.009	25	73	79	4	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37702	37709		10.1074/jbc.M707569200	http://dx.doi.org/10.1074/jbc.M707569200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17932040	hybrid			2022-12-27	WOS:000251833600046
J	Alvarez-Rodiguez, R; Barzi, M; Berenguer, J; Pons, S				Alvarez-Rodiguez, Ruben; Barzi, Mercedes; Berenguer, Jordi; Pons, Sebastian			Bone morphogenetic protein 2 opposes Shh-mediated proliferation in cerebellar granule cells through a TIEG-1-based regulation of Nmyc	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-MYC ONCOGENE; C-MYC; HEDGEHOG; GENE; EXPRESSION; AMPLIFICATION; GROWTH; TIEG; PROGRESSION; MUTATIONS	Nmyc is a potent regulator of cell cycle in cerebellar granular neuron precursors (CGNPs) and has been proposed to be the main effector of Shh ( Sonic hedgehog) proliferative activity. Nmyc ectopic expression is sufficient to promote cell autonomous proliferation and can lead to tumorigenesis. Bone morphogenetic protein 2 (BMP2) antagonizes Shh proliferative effect by promoting cell cycle exit and differentiation in CGNPs. Here we report that BMP2 opposes Shh mitogenic activity by blocking Nmyc expression. We have identified TIEG-1 (KLF10) as the intermediary factor that blocks Nmyc expression through the occupancy of the Sp1 sites present in its promoter. We also demonstrate that TIEG-1 ectopic expression in CGNPs induces cell cycle arrest that can lead to apoptosis but fails to promote differentiation. Moreover, TIEG-1 synergizes with BMP2 activity to terminally differentiate CGNPs and independent differentiator signals such as dibutyryl cAMP and prevents apoptosis in TIEG-1 arrested cells. All together, these data strongly suggest that the BMP2 pathway triggers cell cycle exit and differentiation as two separated but coordinated processes, where TIEG-1 acts as a mediator of the cell cycle arrest.	[Alvarez-Rodiguez, Ruben; Barzi, Mercedes; Berenguer, Jordi; Pons, Sebastian] Biomed Res Inst, CSIC, Dept Cell Death & Proliferat, IDIBAPS, Barcelona 08036, Spain	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Pons, S (corresponding author), Biomed Res Inst, CSIC, Dept Cell Death & Proliferat, IDIBAPS, Rosello 161,6th Fl, Barcelona 08036, Spain.	spfnqi@iibb.csic.es	Pons, Sebastian/K-7794-2014; Berenguer, Jordi/AAK-5540-2020	Pons, Sebastian/0000-0003-1027-0621; Berenguer de Felipe, Jordi/0000-0003-4007-1631				Aldosari N, 2002, ARCH PATHOL LAB MED, V126, P540; Altman J, 1997, DEV CEREBELLAR SYSTE; Bonvini P, 1998, ONCOGENE, V16, P1131, DOI 10.1038/sj.onc.1201625; BRODEUR GM, 1984, SCIENCE, V224, P1121, DOI 10.1126/science.6719137; Cajal S. R., 1911, HISTOLOGIE SYSTEME N; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Cook T, 1999, J BIOL CHEM, V274, P29500, DOI 10.1074/jbc.274.41.29500; Cook T, 1998, J BIOL CHEM, V273, P25929, DOI 10.1074/jbc.273.40.25929; Dahmane N, 1999, DEVELOPMENT, V126, P3089; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Dyer BW, 2000, ANAL BIOCHEM, V282, P158, DOI 10.1006/abio.2000.4605; Ellenrieder V, 2002, EMBO J, V21, P2451, DOI 10.1093/emboj/21.10.2451; Epstein DJ, 1996, DEVELOPMENT, V122, P2885; Feng XH, 2002, MOL CELL, V9, P133, DOI 10.1016/S1097-2765(01)00430-0; GARSON JA, 1985, LANCET, V2, P718; HATTEN ME, 1995, ANNU REV NEUROSCI, V18, P385, DOI 10.1146/annurev.ne.18.030195.002125; Hefferan TE, 2000, J BIOL CHEM, V275, P20255, DOI 10.1074/jbc.C000135200; Hefferan TE, 2000, J CELL BIOCHEM, V78, P380, DOI 10.1002/1097-4644(20000901)78:3<380::AID-JCB4>3.0.CO;2-L; HENIKOFF S, 1984, GENE, V28, P351, DOI 10.1016/0378-1119(84)90153-7; HIRNING U, 1991, MECH DEVELOP, V33, P119, DOI 10.1016/0925-4773(91)90078-K; Hollnagel A, 1999, J BIOL CHEM, V274, P19838, DOI 10.1074/jbc.274.28.19838; Hynes M, 2000, NAT NEUROSCI, V3, P41, DOI 10.1038/71114; Johnsen SA, 2004, SIGNAL TRANSDUCT, V4, P29; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; Kenney AM, 2004, DEVELOPMENT, V131, P217, DOI 10.1242/dev.00891; Kenney AM, 2003, DEVELOPMENT, V130, P15, DOI 10.1242/dev.00182; KINZLER KW, 1987, SCIENCE, V236, P70, DOI 10.1126/science.3563490; Kramps C, 2004, J BIOL CHEM, V279, P5110, DOI 10.1074/jbc.M304758200; Lewis PM, 2004, DEV BIOL, V270, P393, DOI 10.1016/j.ydbio.2004.03.007; LITTLE MH, 1992, P NATL ACAD SCI USA, V89, P4791, DOI 10.1073/pnas.89.11.4791; Lomberk G, 2005, BIOCHEM J, V392, P1, DOI 10.1042/BJ20051234; Lum L, 2004, SCIENCE, V304, P1755, DOI 10.1126/science.1098020; Malynn BA, 2000, GENE DEV, V14, P1390; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 2000, GENE DEV, V14, P627; McMahon AP, 2003, CURR TOP DEV BIOL, V53, P1, DOI 10.1016/S0070-2153(03)53002-2; MUGRAUER G, 1988, J CELL BIOL, V107, P1325, DOI 10.1083/jcb.107.4.1325; Nicot A, 2002, J NEUROSCI, V22, P9244; Noti JD, 2004, J BIOL CHEM, V279, P26948, DOI 10.1074/jbc.M310634200; Noveen A, 1996, BIOCHEM BIOPH RES CO, V219, P180, DOI 10.1006/bbrc.1996.0202; Oliver TG, 2003, P NATL ACAD SCI USA, V100, P7331, DOI 10.1073/pnas.0832317100; Pons S, 2001, DEVELOPMENT, V128, P1481; Rios I, 2004, DEVELOPMENT, V131, P3159, DOI 10.1242/dev.01188; SCHWAB M, 1984, P NATL ACAD SCI-BIOL, V81, P4940, DOI 10.1073/pnas.81.15.4940; SEEGER RC, 1985, NEW ENGL J MED, V313, P1111, DOI 10.1056/NEJM198510313131802; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Strieder V, 2003, J BIOL CHEM, V278, P2983, DOI 10.1074/jbc.M207596200; Tachibana I, 1997, J CLIN INVEST, V99, P2365, DOI 10.1172/JCI119418; Taylor MD, 2002, NAT GENET, V31, P306, DOI 10.1038/ng916; Tuthill MC, 2003, MOL GENET METAB, V80, P272, DOI 10.1016/S1096-7192(03)00133-1; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; WONG AJ, 1986, SCIENCE, V233, P461, DOI 10.1126/science.3014659; Xie JW, 1997, CANCER RES, V57, P2369; Yagi K, 2002, J BIOL CHEM, V277, P854, DOI 10.1074/jbc.M104170200	54	52	55	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					37170	37180		10.1074/jbc.M705414200	http://dx.doi.org/10.1074/jbc.M705414200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17951258	hybrid			2022-12-27	WOS:000251646000043
J	Chen, JX; Chloupkova, M; Gao, JW; Chapman-Arvedson, TL; Enns, CA				Chen, Juxing; Chloupkova, Maja; Gao, Junwei; Chapman-Arvedson, Tara L.; Enns, Caroline A.			HFE modulates transferrin receptor 2 levels in hepatoma cells via interactions that differ from transferrin receptor 1-HFE interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEREDITARY HEMOCHROMATOSIS PROTEIN; NEONATAL FC-RECEPTOR; CRYSTAL-STRUCTURE; IRON-METABOLISM; MESSENGER-RNAS; BINDING; GENE; EXPRESSION; PHENOTYPE; COMPLEX	Mutations in the transmembrane glycoproteins transferrin receptor 2 (TfR2) and HFE are associated with hereditary hemochromatosis. Interactions between HFE and transferrin receptor 1 (TfR1) have been mapped to the alpha 1- and alpha 2-helices in HFE and to the helical domain of TfR1. Recently, TfR2 was also reported to interact with HFE in transfected mammalian cells. To test whether similar HFE residues are important for both TfR1 and TfR2 binding, a mutant form of HFE (W81AHFE) that has a similar to 5,000-fold lower affinity for TfR1 than HFE was employed. As expected, W81AHFE does not interact with TfR1. However, we found that the same mutation in HFE does not affect the TfR2/HFE interaction. This finding indicates that the TfR2/HFE and TfR1/HFE interactions are distinct. We further observed that, unlike TfR1/HFE, Tf does not compete with HFE for binding to TfR2 and that binding is independent of pH ( pH 6 - 7.5). TfR2-TfR1 and HFE-HLA-B7 chimeras were generated to map the domains of the TfR2/HFE interaction. TfR1 and HLA-B7 were chosen because of their similar overall structures with TfR2 and HFE, respectively. We mapped the interacting domains to the putative stalk and protease-like domains of TfR2 located between residues 104 and 250 and to the alpha 3 domain of HFE, both of which differ from the TfR1/HFE interacting domains. Furthermore, we found that HFE increases TfR2 levels in hepatic cells independent of holo-Tf.	[Chen, Juxing; Chloupkova, Maja; Gao, Junwei; Enns, Caroline A.] Oregon Hlth & Sci Univ, Dept Cell & Dev Biol, Portland, OR 97239 USA; [Chapman-Arvedson, Tara L.] Amgen Inc, Thousand Oaks, CA 91320 USA	Oregon Health & Science University; Amgen	Enns, CA (corresponding author), 3181 SW Sam Jackson Pk Rd,L215, Portland, OR 97239 USA.	ennsca@ohsu.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072166] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01-DK072166] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Andrews NC, 1999, NEW ENGL J MED, V341, P1986, DOI 10.1056/NEJM199912233412607; Bennett MJ, 2000, NATURE, V403, P46, DOI 10.1038/47417; Bomford A, 2002, LANCET, V360, P1673, DOI 10.1016/S0140-6736(02)11607-2; Bothwell TH, 1998, SEMIN HEMATOL, V35, P55; BURMEISTER WP, 1994, NATURE, V372, P379, DOI 10.1038/372379a0; Camaschella C, 2000, NAT GENET, V25, P14, DOI 10.1038/75534; Carlson H, 2005, BLOOD, V105, P2564, DOI 10.1182/blood-2004-03-1204; Chapman TL, 1999, IMMUNITY, V11, P603, DOI 10.1016/S1074-7613(00)80135-1; Chen JX, 2007, J BIOL CHEM, V282, P6201, DOI 10.1074/jbc.M610127200; Corsi B, 1999, FEBS LETT, V460, P149, DOI 10.1016/S0014-5793(99)01330-7; Cullen LM, 1999, ANNU REV MED, V50, P87; Davies PS, 2003, BIOCHEM J, V373, P145, DOI 10.1042/BJ20030202; Dupic F, 2002, GASTROENTEROLOGY, V122, P745, DOI 10.1053/gast.2002.31877; ENNS CA, 1981, J BIOL CHEM, V256, P2620; Enns CA, 2001, TRAFFIC, V2, P167, DOI 10.1034/j.1600-0854.2001.020303.x; Feder JN, 1998, P NATL ACAD SCI USA, V95, P1472, DOI 10.1073/pnas.95.4.1472; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Feder JN, 1997, J BIOL CHEM, V272, P14025, DOI 10.1074/jbc.272.22.14025; Fleming RE, 2000, P NATL ACAD SCI USA, V97, P2214, DOI 10.1073/pnas.040548097; Fleming RE, 2001, P NATL ACAD SCI USA, V98, P2707, DOI 10.1073/pnas.051630898; Gao GF, 1997, NATURE, V387, P630, DOI 10.1038/42523; Goswami T, 2006, J BIOL CHEM, V281, P28494, DOI 10.1074/jbc.C600197200; Gross CN, 1998, J BIOL CHEM, V273, P22068, DOI 10.1074/jbc.273.34.22068; Johnson MB, 2007, MOL BIOL CELL, V18, P743, DOI 10.1091/mbc.E06-09-0798; Johnson MB, 2004, BLOOD, V104, P4287, DOI 10.1182/blood-2004-06-2477; Kawabata H, 2000, J BIOL CHEM, V275, P16618, DOI 10.1074/jbc.M908846199; Kawabata H, 2004, BRIT J HAEMATOL, V127, P464, DOI 10.1111/j.1365-2141.2004.05224.x; KLAUSNER RD, 1993, CELL, V72, P19, DOI 10.1016/0092-8674(93)90046-S; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lebron JA, 1998, CELL, V93, P111, DOI 10.1016/S0092-8674(00)81151-4; Lebron JA, 1999, J MOL BIOL, V294, P239, DOI 10.1006/jmbi.1999.3252; Lebron JA, 1999, J MOL BIOL, V289, P1109, DOI 10.1006/jmbi.1999.2842; Levy JE, 1999, NAT GENET, V21, P396, DOI 10.1038/7727; Levy JE, 2000, J CLIN INVEST, V105, P1209, DOI 10.1172/JCI9635; MADDEN DR, 1995, ANNU REV IMMUNOL, V13, P587, DOI 10.1146/annurev.iy.13.040195.003103; Nicolas G, 2004, BLOOD, V103, P2841, DOI 10.1182/blood-2003-09-3358; Riedel HD, 1999, BLOOD, V94, P3915, DOI 10.1182/blood.V94.11.3915.423k27_3915_3921; Robb A, 2004, BLOOD, V104, P4294, DOI 10.1182/blood-2004-06-2481; Roetto A, 2002, BLOOD CELL MOL DIS, V29, P465, DOI 10.1006/bcmd.2002.0585; TSUNOO H, 1983, ARCH BIOCHEM BIOPHYS, V225, P42, DOI 10.1016/0003-9861(83)90005-X; Vaughn DE, 1997, J MOL BIOL, V274, P597, DOI 10.1006/jmbi.1997.1388; VERLAND S, 1989, J IMMUNOL, V143, P945; Vogt TM, 2003, BLOOD, V101, P2008, DOI 10.1182/blood-2002-09-2742; Waheed A, 1999, P NATL ACAD SCI USA, V96, P1579, DOI 10.1073/pnas.96.4.1579; Warren RA, 1997, J BIOL CHEM, V272, P2116; West AP, 2001, J MOL BIOL, V313, P385, DOI 10.1006/jmbi.2001.5048; West AP, 2000, J BIOL CHEM, V275, P38135, DOI 10.1074/jbc.C000664200; Zhang AS, 2004, BLOOD, V103, P1509, DOI 10.1182/blood-2003-07-2378; Zhang AS, 2003, P NATL ACAD SCI USA, V100, P9500, DOI 10.1073/pnas.1233675100	49	68	70	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					36862	36870		10.1074/jbc.M706720200	http://dx.doi.org/10.1074/jbc.M706720200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17956864	hybrid			2022-12-27	WOS:000251646000011
J	Kadyrov, FA; Holmes, SF; Arana, ME; Lukianova, OA; O'Donnell, M; Kunkel, TA; Modrich, P				Kadyrov, Farid A.; Holmes, Shannon F.; Arana, Mercedes E.; Lukianova, Olga A.; O'Donnell, Mike; Kunkel, Thomas A.; Modrich, Paul			Saccharomyces cerevisiae MutL alpha is a mismatch repair endonuclease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; MUTATOR PHENOTYPES; ATP BINDING; DNA-BINDING; YEAST; REPLICATION; SYSTEM; EXCISION; CLAMP; GENE	MutL homologs are crucial for mismatch repair and genetic stability, but their function is not well understood. Human MutL alpha (MLH1-PMS2 heterodimer) harbors a latent endonuclease that is dependent on the integrity of a PMS2 DQHA(X)(2)E(X)(4)E motif (Kadyrov, F. A., Dzantiev, L., Constantin, N., and Modrich, P. (2006) Cell 126, 297-308). This sequence element is conserved in many MutL homologs, including the PMS1 subunit of Saccharomyces cerevisiae MutL alpha, but is absent in MutL proteins from bacteria like Escherichia coli that rely on d(GATC) methylation for strand directionality. We show that yeast MutL alpha is a strand-directed endonuclease that incises DNA in a reaction that depends on a mismatch, yMutS alpha, yRFC, yPCNA, ATP, and a pre-existing strand break, whereas E. coli MutL is not. Amino acid substitution within the PMS1 DQHA(X)(2)E(X)(4)E motif abolishes yMutL alpha endonuclease activity in vitro and confers strong genetic instability in vivo, but does not affect yMutL alpha ATPase activity or the ability of the protein to support assembly of the yMutL alpha center dot yMutS alpha center dot heteroduplex ternary complex. The loaded form of yPCNA may play an important effector role in directing yMutL alpha incision to the discontinuous strand of a nicked heteroduplex.	[Kadyrov, Farid A.; Lukianova, Olga A.; Modrich, Paul] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Modrich, Paul] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; [Holmes, Shannon F.; Arana, Mercedes E.; Kunkel, Thomas A.] Natl Inst Hlth, Struct Biol Lab, Res Triangle Pk, NC 27709 USA; [Holmes, Shannon F.; Arana, Mercedes E.; Kunkel, Thomas A.] Natl Inst Hlth, Genet Mol Lab, NIEHS, Res Triangle Pk, NC 27709 USA; [O'Donnell, Mike] Rockefeller Univ, Lab DNA Replicat, New York, NY 10021 USA; [O'Donnell, Mike] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA	Duke University; Duke University; Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Rockefeller University; Howard Hughes Medical Institute; Rockefeller University	Modrich, P (corresponding author), Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA.	modrich@biochem.duke.edu	Kunkel, Thomas A./D-5088-2019	Kunkel, Thomas A./0000-0002-9900-1788; O'Donnell, Michael/0000-0001-9002-4214; Modrich, Paul/0000-0001-8708-9885	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES065089] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045190, R37GM038839, R01GM038839] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; Intramural NIH HHS [Z01 ES065089-11] Funding Source: Medline; NIGMS NIH HHS [GM 38839, R01 GM045190-17, R01 GM045190, R01 GM038839, R37 GM038839, GM45190] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AU KG, 1992, J BIOL CHEM, V267, P12142; AYYAGARI R, 1995, MOL CELL BIOL, V15, P4420; Blackwell LJ, 2001, J BIOL CHEM, V276, P33233, DOI 10.1074/jbc.M105076200; Blackwell LJ, 2001, J BIOL CHEM, V276, P34339, DOI 10.1074/jbc.M104256200; Burdett V, 2001, P NATL ACAD SCI USA, V98, P6765, DOI 10.1073/pnas.121183298; Constantin N, 2005, J BIOL CHEM, V280, P39752, DOI 10.1074/jbc.M509701200; COOPER DL, 1993, J BIOL CHEM, V268, P11823; Deschenes SM, 2007, CANCER LETT, V249, P148, DOI 10.1016/j.canlet.2006.08.008; Drotschmann K, 1999, P NATL ACAD SCI USA, V96, P2970, DOI 10.1073/pnas.96.6.2970; Dzantiev L, 2004, MOL CELL, V15, P31, DOI 10.1016/j.molcel.2004.06.016; ERDENIZ N, 2007, DNA REPAIR AMST, P1463; FANG WH, 1993, J BIOL CHEM, V268, P11838; Finkelstein J, 2003, ANAL BIOCHEM, V319, P78, DOI 10.1016/S0003-2697(03)00273-2; Genschel J, 2003, MOL CELL, V12, P1077, DOI 10.1016/S1097-2765(03)00428-3; Goldstein AL, 1999, YEAST, V15, P507, DOI 10.1002/(SICI)1097-0061(199904)15:6<507::AID-YEA369>3.0.CO;2-P; Hall MC, 2001, PROTEIN EXPRES PURIF, V21, P333, DOI 10.1006/prep.2000.1379; Hall MC, 2002, J BIOL CHEM, V277, P3673, DOI 10.1074/jbc.M106120200; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; Kadyrov FA, 2006, CELL, V126, P297, DOI 10.1016/j.cell.2006.05.039; KONG XP, 1992, CELL, V69, P425, DOI 10.1016/0092-8674(92)90445-I; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; LAHUE RS, 1989, SCIENCE, V245, P160, DOI 10.1126/science.2665076; LANGLEROUAULT F, 1987, EMBO J, V6, P1121, DOI 10.1002/j.1460-2075.1987.tb04867.x; Lee SD, 2006, J MOL BIOL, V355, P175, DOI 10.1016/j.jmb.2005.10.059; Miyaki M, 1997, ONCOGENE, V15, P2877, DOI 10.1038/sj.onc.1201668; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; Modrich P, 2006, J BIOL CHEM, V281, P30305, DOI 10.1074/jbc.R600022200; Nielsen FC, 2004, ONCOGENE, V23, P1457, DOI 10.1038/sj.onc.1207265; ONRUST R, 1995, J BIOL CHEM, V270, P13366, DOI 10.1074/jbc.270.22.13366; Reardon JT, 2003, GENE DEV, V17, P2539, DOI 10.1101/gad.1131003; RUNYON GT, 1993, BIOCHEMISTRY-US, V32, P602, DOI 10.1021/bi00053a028; Shcherbakova PV, 1999, MOL CELL BIOL, V19, P3177; Spampinato C, 2000, J BIOL CHEM, V275, P9863, DOI 10.1074/jbc.275.13.9863; Storici F, 2001, NAT BIOTECHNOL, V19, P773, DOI 10.1038/90837; Storici F, 2006, METHOD ENZYMOL, V409, P329, DOI 10.1016/S0076-6879(05)09019-1; SU SS, 1988, J BIOL CHEM, V263, P6829; Tran HT, 1997, MOL CELL BIOL, V17, P2859, DOI 10.1128/MCB.17.5.2859; Turner J, 1999, EMBO J, V18, P771, DOI 10.1093/emboj/18.3.771; Umar A, 1996, CELL, V87, P65, DOI 10.1016/S0092-8674(00)81323-9; Viswanathan M, 2001, J BIOL CHEM, V276, P31053, DOI 10.1074/jbc.M105481200; Zhang YB, 2005, CELL, V122, P693, DOI 10.1016/j.cell.2005.06.027	42	173	176	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					37181	37190		10.1074/jbc.M707617200	http://dx.doi.org/10.1074/jbc.M707617200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17951253	hybrid, Green Accepted			2022-12-27	WOS:000251646000044
J	Riekhof, WR; Wu, J; Gijon, MA; Zarini, S; Murphy, RC; Voelker, DR				Riekhof, Wayne R.; Wu, James; Gijon, Miguel A.; Zarini, Simona; Murphy, Robert C.; Voelker, Dennis R.			Lysophosphatidylcholine metabolism in Saccharomyces cerevisiae - The role of P-type ATPases in transport and a broad specificity acyltransferase in acylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNSATURATED FATTY-ACIDS; YEAST PLASMA-MEMBRANE; ARACHIDONIC-ACID; HUMAN NEUTROPHIL; GENE; PHOSPHATIDYLETHANOLAMINE; IDENTIFICATION; BIOSYNTHESIS; RESPIRATION; ENCODES	We recently described a new route for the synthesis of phosphatidylethanolamine (PtdEtn) from exogenous lyso-PtdEtn, which we have termed the exogenous lysolipid metabolism ( ELM) pathway. The ELM pathway for lyso-PtdEtn requires the action of plasma membrane P-type ATPases Dnf1p and Dnf2p and their requisite beta-subunit, Lem3p, for the active uptake of lyso-PtdEtn. In addition, the acyl-CoA-dependent acyltransferase, Ale1p, mediates the acylation of the imported lysolipid to form PtdEtn. We now report that these components of the lyso-PtdEtn ELM pathway are also active with lyso-1-acyl-2-hydroxyl-sn-glycero-3-phosphocholine (PtdCho) as a substrate. Lyso-PtdCho supports the growth of a choline auxotrophic pem1 Delta pem2 Delta strain. Uptake of radiolabeled lyso- PtdCho was impaired by the dnf2 Delta and lem3 Delta mutations. Introduction of a lem3 Delta mutation into a pem1 Delta pem2 Delta background impaired the ability of the resulting strain to grow with lyso- PtdCho as the sole precursor of PtdCho. After import of lyso- PtdCho, the recently characterized lyso- PtdEtn acyltransferase, Ale1p, functioned as the sole lyso- PtdCho acyltransferase in yeast. A pem1 Delta pem2 Delta ale1 Delta strain grew with lyso- PtdCho as a substrate but showed a profound reduction in PtdCho content when lysoPtdCho was the only precursor of PtdCho. Ale1p acylates lyso- PtdCho with a preference for monounsaturated acyl-CoA species, and the specific LPCAT activity of Ale1p in yeast membranes is >50-fold higher than the basal rate of de novo aminoglycerophospholipid biosynthesis from phosphatidylserine synthase activity. In addition to lyso- PtdCho, lyso- PtdEtn, and lyso- phosphatidic acid, Ale1p was also active with lysophosphatidylserine, lysophosphatidylglycerol, and lysophosphatidylinositol as substrates. These results establish a new pathway for the net synthesis of PtdCho in yeast and provide new tools for the study of PtdCho synthesis, transport, and remodeling.	[Riekhof, Wayne R.; Wu, James; Voelker, Dennis R.] Natl Jewish Med & Res Ctr, Dept Med, Cell Biol Program, Denver, CO 80206 USA; [Gijon, Miguel A.; Zarini, Simona; Murphy, Robert C.] Univ Colorado, Dept Pharmacol, Aurora, CO 80045 USA; [Gijon, Miguel A.; Zarini, Simona; Murphy, Robert C.] Hlth Sci Ctr, Aurora, CO 80045 USA	National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus	Voelker, DR (corresponding author), Natl Jewish Med & Res Ctr, Dept Med, Cell Biol Program, 1400 Jackson St, Denver, CO 80206 USA.	voelkerd@njc.org	Murphy, Robert/AAO-5349-2020	Murphy, Robert/0000-0002-9430-6515; Zarini, Simona/0000-0002-7460-3299	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL025785, R37HL025785] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032453, R01GM081461, F32GM076798, R37GM032453] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL25785] Funding Source: Medline; NIGMS NIH HHS [5R37 GM32453, R01 GM081461, GM076798, R01 GM032453] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Athenstaedt K, 1997, J BACTERIOL, V179, P7611, DOI 10.1128/jb.179.24.7611-7616.1997; Benghezal M, 2007, J BIOL CHEM, V282, P30845, DOI 10.1074/jbc.M702719200; BENNING C, 1995, ARCH BIOCHEM BIOPHYS, V317, P103, DOI 10.1006/abbi.1995.1141; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; CHILTON FH, 1986, J BIOL CHEM, V261, P7771; CHILTON FH, 1987, BIOCHIM BIOPHYS ACTA, V917, P48, DOI 10.1016/0005-2760(87)90282-7; FERNANDEZMURRAY JP, 2006, BIOCHIM BIOPHYS ACTA, V1771, P331; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Glick BS, 1995, METHOD ENZYMOL, V260, P213, DOI 10.1016/0076-6879(95)60139-2; Hanson PK, 2003, J BIOL CHEM, V278, P36041, DOI 10.1074/jbc.M305263200; Iwamoto K, 2004, GENES CELLS, V9, P891, DOI 10.1111/j.1365-2443.2004.00782.x; Jain S, 2007, J BIOL CHEM, V282, P30562, DOI 10.1074/jbc.M706326200; Merkel O, 2005, BIOCHEM J, V387, P489, DOI 10.1042/BJ20041272; NAGIEC MM, 1993, J BIOL CHEM, V268, P22156; Pomorski T, 2003, MOL BIOL CELL, V14, P1240, DOI 10.1091/mbc.E02-08-0501; Riekhof WR, 2007, J BIOL CHEM, V282, P28344, DOI 10.1074/jbc.M705256200; Riekhof WR, 2006, J BIOL CHEM, V281, P36588, DOI 10.1074/jbc.M608851200; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Sohlenkamp C, 2000, J BIOL CHEM, V275, P18919, DOI 10.1074/jbc.M000844200; STEIN O., 1965, LIFE SCI, V4, P203, DOI 10.1016/0024-3205(65)90120-7; STEIN Y, 1966, BIOCHIM BIOPHYS ACTA, V116, P95, DOI 10.1016/0005-2760(66)90095-6; Tamaki H, 2007, J BIOL CHEM, V282, P34288, DOI 10.1074/jbc.M704509200; TROTTER PJ, 1995, J BIOL CHEM, V270, P6071, DOI 10.1074/jbc.270.11.6071; WALENGA RW, 1975, J BIOL CHEM, V250, P9121; WALENGA RW, 1975, J BIOL CHEM, V250, P9130; Zarini S, 2006, J BIOL CHEM, V281, P10134, DOI 10.1074/jbc.M510783200	26	90	95	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					36853	36861		10.1074/jbc.M706718200	http://dx.doi.org/10.1074/jbc.M706718200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17951629	hybrid			2022-12-27	WOS:000251646000010
J	Ananthanarayanan, B; Fosbrink, M; Rahdar, M; Zhang, J				Ananthanarayanan, Bharath; Fosbrink, Matthew; Rahdar, Meghdad; Zhang, Jin			Live-cell molecular analysis of Akt activation reveals roles for activation loop phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-B; PLECKSTRIN HOMOLOGY DOMAIN; CONFORMATIONAL-CHANGES; DYNAMICS; REPORTERS; PATHWAY; COMPLEX; BINDING; SYSTEM; FAMILY	Activation of the serine/threonine protein kinase Akt/PKB is a multi-step process involving membrane recruitment, phosphorylation, and membrane detachment. To investigate this process in the cellular context, we employed a live-cell fluorescence imaging approach to examine conformational changes of Akt and its membrane association. A fluorescence resonance energy transfer-based reporter of Akt action (ReAktion) reveals a conformational change that is critically dependent on the existence of a phosphorylatable threonine 308 in the activation loop, because mutations to either aspartate or alanine abolished the change. Furthermore, a mutant carrying a phosphorylation mimic at this position showed diminished membrane association, suggesting that this phosphorylation plays an important role of promoting the dissociation of activated Akt from the membrane. In addition, the membrane-associating pleckstrin homology domain was found to associate with the catalytic domain when Thr(308) is phosphorylated, suggesting such an interdomain interaction as a mechanism by which phosphorylation within the catalytic domain can affect membrane association. These studies uncover new regulatory roles of this critical phosphorylation event of Akt for ensuring its proper activation and function.	Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Solomon H Synder Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Zhang, J (corresponding author), 725 N Wolfe St,Hunterian 307, Baltimore, MD 21205 USA.	jzhang32@jhmi.edu			NCI NIH HHS [CA122673] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R21CA122673] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Allen MD, 2006, BIOCHEM BIOPH RES CO, V348, P716, DOI 10.1016/j.bbrc.2006.07.136; Ananthanarayanan B, 2005, P NATL ACAD SCI USA, V102, P15081, DOI 10.1073/pnas.0502889102; Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; Aoki M, 1998, P NATL ACAD SCI USA, V95, P14950, DOI 10.1073/pnas.95.25.14950; Astoul E, 1999, J CELL BIOL, V145, P1511, DOI 10.1083/jcb.145.7.1511; Bellacosa A, 1998, ONCOGENE, V17, P313, DOI 10.1038/sj.onc.1201947; Bellacosa A, 2005, ADV CANCER RES, V94, P29, DOI 10.1016/S0065-230X(05)94002-5; Brazil DP, 2004, TRENDS BIOCHEM SCI, V29, P233, DOI 10.1016/j.tibs.2004.03.006; Calleja V, 2003, BIOCHEM J, V372, P33, DOI 10.1042/BJ20030358; Calleja V, 2007, PLOS BIOL, V5, P780, DOI 10.1371/journal.pbio.0050095; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Frech M, 1997, J BIOL CHEM, V272, P8474, DOI 10.1074/jbc.272.13.8474; Hajduch E, 1998, DIABETES, V47, P1006, DOI 10.2337/diabetes.47.7.1006; Huang BX, 2006, MOL CELL PROTEOMICS, V5, P1045, DOI 10.1074/mcp.M600026-MCP200; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Kunkel MT, 2005, J BIOL CHEM, V280, P5581, DOI 10.1074/jbc.M411534200; Kunstle G, 2002, MOL CELL BIOL, V22, P1513, DOI 10.1128/MCB.22.5.1513-1525.2002; Miyawaki A, 2003, DEV CELL, V4, P295, DOI 10.1016/S1534-5807(03)00060-1; Mora A, 2004, SEMIN CELL DEV BIOL, V15, P161, DOI 10.1016/j.semcdb.2003.12.022; Neri LM, 2002, BBA-MOL CELL BIOL L, V1584, P73, DOI 10.1016/S1388-1981(02)00300-1; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Peterson RT, 1999, CURR BIOL, V9, pR521, DOI 10.1016/S0960-9822(99)80326-1; Scheid MP, 2002, MOL CELL BIOL, V22, P6247, DOI 10.1128/MCB.22.17.6247-6260.2002; Teitell MA, 2005, NAT REV CANCER, V5, P640, DOI 10.1038/nrc1672; Thomas CC, 2002, CURR BIOL, V12, P1256, DOI 10.1016/S0960-9822(02)00972-7; Varnai P, 2005, J CELL SCI, V118, P4879, DOI 10.1242/jcs.02606; Woodgett JR, 2005, CURR OPIN CELL BIOL, V17, P150, DOI 10.1016/j.ceb.2005.02.010; Yang J, 2002, NAT STRUCT BIOL, V9, P940, DOI 10.1038/nsb870; Zhang J, 2002, NAT REV MOL CELL BIO, V3, P906, DOI 10.1038/nrm976	31	43	46	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36634	36641		10.1074/jbc.M706227200	http://dx.doi.org/10.1074/jbc.M706227200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17928291	hybrid			2022-12-27	WOS:000251458300056
J	Craven, RJ; Mallory, JC; Hand, RA				Craven, Rolf J.; Mallory, Julia C.; Hand, Randal A.			Regulation of iron homeostasis mediated by the heme-binding protein Dap1 (damage resistance protein 1) via the p450 protein Erg11/Cyp51	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNER ZONE ANTIGEN; SACCHAROMYCES-CEREVISIAE; PROGESTERONE-RECEPTOR; YEAST; GENE; IDENTIFICATION; BIOSYNTHESIS; TRANSPORT; ENDOCYTOSIS; EXPRESSION	Fungal infections arise frequently in immunocompromised patients, and sterol synthesis is a primary pathway targeted by antifungal drugs. In particular, the P450 protein Erg11/Cyp51 catalyzes a critical step in ergosterol synthesis, and the azole class of antifungal drugs inhibits Erg11. Dap1 is a heme-binding protein related to cytochrome b(5) that activates Erg11, so that cells lacking Dap1 accumulate the Erg11 substrate and are hypersensitive to Erg11 inhibitors. Heme binding by Dap1 is crucial for its function, and point mutants in its heme-binding domain render Dap1 inactive for sterol biosynthesis and DNA damage resistance. Like Dap1, the human homologue, PGRMC1/Hpr6, also regulates sterol synthesis and DNA damage resistance. In the present study, we demonstrate that the Dap1 heme-1 domain is required for growth under conditions of low iron availability. Loss of Dap1 is suppressed by elevated levels of Erg11 but not by increased heme biosynthesis. Dap1 localizes to punctate cytoplasmic structures that co-fractionate with endosomes, and Dap1 contributes to the integrity of the vacuole. The results suggest that Saccharomyces cerevisiae Dap1 stimulates a P450-catalyzed step in sterol synthesis via a distinct localization from its homologues in Schizosaccharomyces pombe and mammals and that this function regulates iron metabolism.	Univ Kentucky, Dept Mol & Biomed Pharmacol, Lexington, KY 40536 USA; Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA	University of Kentucky; University of North Carolina; University of North Carolina Chapel Hill	Craven, RJ (corresponding author), Univ Kentucky, Dept Mol & Biomed Pharmacol, Lexington, KY 40536 USA.	rolf.craven@uky.edu			NCRR NIH HHS [P20 RR 15592] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015592] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		ARTHINGTON BA, 1991, GENE, V102, P39, DOI 10.1016/0378-1119(91)90535-J; Athenstaedt K, 1999, J BACTERIOL, V181, P6441, DOI 10.1128/JB.181.20.6441-6448.1999; BAYNES RD, 1990, ANNU REV NUTR, V10, P133, DOI [10.1146/annurev.nutr.10.1.133, 10.1146/annurev.nu.10.070190.001025]; Bowers K, 2005, BBA-MOL CELL RES, V1744, P438, DOI 10.1016/j.bbamcr.2005.04.004; Chen OS, 2000, J BIOL CHEM, V275, P7626, DOI 10.1074/jbc.275.11.7626; Craven RJ, 2002, GENETICS, V161, P493; Craven RJ, 2001, GENETICS, V158, P145; Crisp RJ, 2003, J BIOL CHEM, V278, P45499, DOI 10.1074/jbc.M307229200; Crudden G, 2006, J PHARMACOL EXP THER, V316, P448, DOI 10.1124/jpet.105.094631; Crudden G, 2005, TUMOR BIOL, V26, P142, DOI 10.1159/000086485; DANCIS A, 1990, MOL CELL BIOL, V10, P2294, DOI 10.1128/MCB.10.5.2294; Daum G, 1998, YEAST, V14, P1471, DOI 10.1002/(SICI)1097-0061(199812)14:16<1471::AID-YEA353>3.0.CO;2-Y; Falkenstein E, 1996, BIOCHEM BIOPH RES CO, V229, P86, DOI 10.1006/bbrc.1996.1761; Felice MR, 2005, J BIOL CHEM, V280, P22181, DOI 10.1074/jbc.M414663200; Fratti RA, 2004, J CELL BIOL, V167, P1087, DOI 10.1083/jcb.200409068; GABER RF, 1989, MOL CELL BIOL, V9, P3447, DOI 10.1128/MCB.9.8.3447; Gaspar ML, 2007, BBA-MOL CELL BIOL L, V1771, P241, DOI 10.1016/j.bbalip.2006.06.011; Gerdes D, 1998, BIOL CHEM, V379, P907; Ghosh K, 2005, BIOCHEMISTRY-US, V44, P16729, DOI 10.1021/bi0511585; GUARENTE L, 1984, CELL, V36, P503, DOI 10.1016/0092-8674(84)90243-5; Hand RA, 2003, EUKARYOT CELL, V2, P306, DOI 10.1128/EC.2.2.306-317.2003; Hannemann F, 2007, BBA-GEN SUBJECTS, V1770, P330, DOI 10.1016/j.bbagen.2006.07.017; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hughes AL, 2007, CELL METAB, V5, P143, DOI 10.1016/j.cmet.2006.12.009; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Kagiwada S, 1998, J BACTERIOL, V180, P1700, DOI 10.1128/JB.180.7.1700-1708.1998; Kato M, 2001, EMBO J, V20, P4035, DOI 10.1093/emboj/20.15.4035; Krebs CJ, 2000, P NATL ACAD SCI USA, V97, P12816, DOI 10.1073/pnas.97.23.12816; Labombarda F, 2003, J NEUROCHEM, V87, P902, DOI 10.1046/j.1471-4159.2003.02055.x; Lepesheva GI, 2007, BBA-GEN SUBJECTS, V1770, P467, DOI 10.1016/j.bbagen.2006.07.018; Li LT, 1996, J BIOL CHEM, V271, P16927, DOI 10.1074/jbc.271.28.16927; Li LT, 2001, J BIOL CHEM, V276, P29515, DOI 10.1074/jbc.M103944200; Li LT, 2001, J BIOL CHEM, V276, P5036, DOI 10.1074/jbc.M008969200; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lum PY, 2004, CELL, V116, P121, DOI 10.1016/S0092-8674(03)01035-3; Mallory JC, 2005, MOL CELL BIOL, V25, P1669, DOI 10.1128/MCB.25.5.1669-1679.2005; Mense SM, 2006, CELL RES, V16, P681, DOI 10.1038/sj.cr.7310086; Mifsud W, 2002, GENOME BIOL, V3; Min L, 2004, MOL CELL ENDOCRINOL, V215, P143, DOI 10.1016/j.mce.2003.11.025; Natter K, 2005, MOL CELL PROTEOMICS, V4, P662, DOI 10.1074/mcp.M400123-MCP200; Nolte I, 2000, BBA-PROTEIN STRUCT M, V1543, P123, DOI 10.1016/S0167-4838(00)00188-6; Prasad T, 2006, ANTIMICROB AGENTS CH, V50, P3597, DOI 10.1128/AAC.00653-06; Puig S, 2005, CELL, V120, P99, DOI 10.1016/j.cell.2004.11.032; Rahier A, 2000, BIOCHEM SOC T, V28, P799, DOI 10.1042/BST0280799; Raza FS, 2001, EUR J BIOCHEM, V268, P2141, DOI 10.1046/j.1432-1327.2001.02096.x; REDDY VVR, 1977, J BIOL CHEM, V252, P2797; Roy CN, 2001, HUM MOL GENET, V10, P2181, DOI 10.1093/hmg/10.20.2181; Schenkman JB, 2003, PHARMACOL THERAPEUT, V97, P139, DOI 10.1016/S0163-7258(02)00327-3; Seeley ES, 2002, MOL BIOL CELL, V13, P782, DOI 10.1091/mbc.01-10-0512; Selmin O, 1996, CARCINOGENESIS, V17, P2609, DOI 10.1093/carcin/17.12.2609; Shakoury-Elizeh M, 2004, MOL BIOL CELL, V15, P1233, DOI 10.1091/mbc.E03-09-0642; Souza CM, 2007, BBA-MOL CELL BIOL L, V1771, P442, DOI 10.1016/j.bbalip.2006.08.006; Suchanek M, 2005, NAT METHODS, V2, P261, DOI 10.1038/NMETH752; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Van Ho A, 2002, ANNU REV MICROBIOL, V56, P237, DOI 10.1146/annurev.micro.56.012302.160847; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; WEINSTEIN JD, 1986, ARCH BIOCHEM BIOPHYS, V245, P44, DOI 10.1016/0003-9861(86)90188-8; WICHMANN H, 1992, CELL, V71, P1131, DOI 10.1016/S0092-8674(05)80062-5; Wiwatwattana N, 2007, NUCLEIC ACIDS RES, V35, pD810, DOI 10.1093/nar/gkl1000; Zhang L, 1999, CELL MOL LIFE SCI, V56, P415, DOI 10.1007/s000180050442; ZINSER E, 1991, J BACTERIOL, V173, P2026, DOI 10.1128/jb.173.6.2026-2034.1991; ZINSER E, 1993, J BACTERIOL, V175, P2853, DOI 10.1128/JB.175.10.2853-2858.1993; Zweytick D, 2000, BBA-REV BIOMEMBRANES, V1469, P101, DOI 10.1016/S0005-2736(00)00294-7	64	46	49	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36543	36551		10.1074/jbc.M706770200	http://dx.doi.org/10.1074/jbc.M706770200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17954932	Green Published, hybrid			2022-12-27	WOS:000251458300047
J	Moreland, JG; Davis, AP; Matsuda, JJ; Hook, JS; Bailey, G; Nauseef, WM; Lamb, FS				Moreland, Jessica G.; Davis, A. Paige; Matsuda, James J.; Hook, Jessica S.; Bailey, Gail; Nauseef, William M.; Lamb, Fred S.			Endotoxin priming of neutrophils requires NADPH oxidase-generated oxidants and is regulated by the anion transporter ClC-3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPOPOLYSACCHARIDE-BINDING-PROTEIN; RESPIRATORY BURST; CYTOSOLIC COMPONENTS; REDOX REGULATION; PLASMA-MEMBRANE; KAPPA-B; ACTIVATION; SUPEROXIDE; P38; PHOSPHORYLATION	Several soluble mediators, including endotoxin, prime neutrophils for an enhanced respiratory burst in response to subsequent stimulation. Priming of neutrophils occurs in vitro, and primed neutrophils are found in vivo. We previously localized the anion transporter ClC-3 to polymorphonuclear leukocytes (PMN) secretory vesicles and demonstrated that it is required for normal NADPH oxidase activation in response to both particulate and soluble stimuli. We now explore the contribution of the NADPH oxidase and ClC-3 to endotoxin-mediated priming. Lipooligosaccharide (LOS) from Neisseria meningitidis enhances the respiratory burst in response to formyl-Met-Leu-Phe, an effect that was impaired in PMNs lacking functional ClC-3 and under anaerobic conditions. Mobilization of receptors to the cell surface and phosphorylation of p38 MAPK by LOS were both impaired in PMN with the NADPH oxidase chemically inhibited or genetically absent and in cells lacking functional ClC-3. Furthermore, inhibition of the NADPH oxidase or ClC-3 in otherwise unstimulated cells elicited a phenotype similar to that seen after endotoxin priming, suggesting that basal oxidant production helps to maintain cellular quiescence. In summary, NADPH oxidase activation was required for LOS-mediated priming, but basal oxidants kept unstimulated cells from becoming primed. ClC-3 contributes to both of these processes.	Univ Iowa, Dept Pediat, Div Crit Care, Iowa City, IA 52242 USA; Univ Iowa, Inflammat Program, Iowa City, IA 52242 USA; Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; Vet Affairs Med Ctr, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Moreland, JG (corresponding author), Univ Iowa, Dept Pediat, Div Pediat Crit Care, 200 Hawkins Dr, Iowa City, IA 52242 USA.	jessica-moreland@uiowa.edu		Nauseef, William/0000-0003-4032-757X; Lamb, Fred/0000-0003-2955-5133	NHLBI NIH HHS [HL 62483-06] Funding Source: Medline; NIAID NIH HHS [AI 067533, AI 34879-19, P01 AI 4462] Funding Source: Medline; NICHD NIH HHS [5K12 HD 047349] Funding Source: Medline; NIDDK NIH HHS [DK 07690-15] Funding Source: Medline; BLRD VA [I01 BX000513] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD047349] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062483, R56HL062483] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034879, R56AI034879, R21AI067533] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007690] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000513] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); BLRD VA; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)		AIDA Y, 1990, J IMMUNOL, V145, P3017; Ambruso DR, 2004, MOL GENET METAB, V81, P313, DOI 10.1016/j.ymgme.2004.01.009; [Anonymous], 2000, SCI STKE, V2000, P2000, DOI [10.1126/stke.2000.62.tw8, DOI 10.1126/STKE.2000.62.TW8]; Babior BM, 1999, BLOOD, V93, P1464, DOI 10.1182/blood.V93.5.1464.405a32_1464_1476; BASS DA, 1986, J IMMUNOL, V136, P860; Blouin E, 1999, EUR J IMMUNOL, V29, P3419, DOI 10.1002/(SICI)1521-4141(199911)29:11<3419::AID-IMMU3419>3.3.CO;2-T; Bouaouina M, 2004, J IMMUNOL, V173, P1313, DOI 10.4049/jimmunol.173.2.1313; BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77; Brown GE, 2003, MOL CELL, V11, P35, DOI 10.1016/S1097-2765(03)00005-4; Chamseddine AH, 2003, AM J PHYSIOL-HEART C, V285, pH2284, DOI 10.1152/ajpheart.00459.2003; CHOLLETMARTIN S, 1992, AM REV RESPIR DIS, V146, P990, DOI 10.1164/ajrccm/146.4.990; CLARK RA, 1990, J CLIN INVEST, V85, P714, DOI 10.1172/JCI114496; Condliffe AM, 1996, IMMUNOLOGY, V89, P105, DOI 10.1046/j.1365-2567.1996.d01-711.x; Condliffe AM, 1998, CLIN SCI, V94, P461, DOI 10.1042/cs0940461; CROSS AR, 1986, BIOCHEM J, V237, P111, DOI 10.1042/bj2370111; Dang PMC, 2006, J CLIN INVEST, V116, P2033, DOI 10.1172/JCI27544; Dang PMC, 2003, BIOCHEMISTRY-US, V42, P4520, DOI 10.1021/bi0205754; DeLeo FR, 1998, J CLIN INVEST, V101, P455, DOI 10.1172/JCI949; Dickerson LW, 2002, BRAIN RES, V958, P227, DOI 10.1016/S0006-8993(02)03519-9; Duan D, 1997, NATURE, V390, P417, DOI 10.1038/37151; ElBenna J, 1996, ARCH BIOCHEM BIOPHYS, V334, P395; Filali M, 2006, FASEB J, V20, pA1163; FITTSCHEN C, 1988, J LEUKOCYTE BIOL, V43, P547, DOI 10.1002/jlb.43.6.547; FOLLIN P, 1992, INFLAMMATION, V16, P83, DOI 10.1007/BF00918949; FOREHAND JR, 1991, ADV EXP MED BIOL, V297, P65; Friedrich T, 1999, J BIOL CHEM, V274, P896, DOI 10.1074/jbc.274.2.896; GABIG TG, 1979, BLOOD, V53, P1133; Geiszt M, 1997, J BIOL CHEM, V272, P26471, DOI 10.1074/jbc.272.42.26471; Giardina PC, 2001, J BIOL CHEM, V276, P5883, DOI 10.1074/jbc.M009273200; Harfouche R, 2005, FASEB J, V19, P1728, DOI 10.1096/fj.04-3621fje; Huang P, 2001, J BIOL CHEM, V276, P20093, DOI 10.1074/jbc.M009376200; Jankowski A, 1999, J BIOL CHEM, V274, P26098, DOI 10.1074/jbc.274.37.26098; Kobayashi T, 1998, J CELL SCI, V111, P81; Li JM, 2004, CIRCULATION, V109, P1307, DOI 10.1161/01.CIR.0000118463.23388.B9; Li JM, 2002, J BIOL CHEM, V277, P19952, DOI 10.1074/jbc.M110073200; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Miller FJ, 2007, CIRC RES, V101, P663, DOI 10.1161/CIRCRESAHA.107.151076; Moreland JG, 2006, J BIOL CHEM, V281, P12277, DOI 10.1074/jbc.M511030200; Nauseef WM, 2001, J CLIN INVEST, V107, P401, DOI 10.1172/JCI11713; Ogura H, 1999, J TRAUMA, V46, P774, DOI 10.1097/00005373-199905000-00004; Ogura T, 2002, FASEB J, V16, P863, DOI 10.1096/fj.01-0845fje; PARK JW, 1992, J BIOL CHEM, V267, P17327; Picollo A, 2005, NATURE, V436, P420, DOI 10.1038/nature03720; Scheel O, 2005, NATURE, V436, P424, DOI [10.1038/nature03860, 10.1038/nature0386O]; Segal BH, 2000, MEDICINE, V79, P170, DOI 10.1097/00005792-200005000-00004; Venet C, 2000, INTENS CARE MED, V26, P538, DOI 10.1007/s001340051201; VOSBECK K, 1990, J LEUKOCYTE BIOL, V47, P97, DOI 10.1002/jlb.47.2.97; Watson RWG, 2002, ANTIOXID REDOX SIGN, V4, P97, DOI 10.1089/152308602753625898; Yaffe MB, 1999, SURGERY, V126, P248, DOI 10.1016/S0039-6060(99)70162-5; Yamamoto A, 2002, CLIN EXP IMMUNOL, V129, P479, DOI 10.1046/j.1365-2249.2002.01930.x; Yan SR, 2002, INFECT IMMUN, V70, P4068, DOI 10.1128/IAI.70.8.4068-4074.2002	51	43	44	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					33958	33967		10.1074/jbc.M705289200	http://dx.doi.org/10.1074/jbc.M705289200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17908687	hybrid			2022-12-27	WOS:000251145700009
J	Xu, Y; Harton, JA; Smith, BD				Xu, Yong; Harton, Jonathan A.; Smith, Barbara D.			CIITA mediates interferon-gamma repression of collagen transcription through phosphorylation-dependent interactions with co-repressor molecules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLASS-II TRANSACTIVATOR; BARE LYMPHOCYTE SYNDROME; CREB BINDING-PROTEIN; IL-4 GENE-TRANSCRIPTION; NOD-LIKE RECEPTORS; HISTONE DEACETYLASES; BETA-CATENIN; MICE LACKING; IFN-GAMMA; SACCHAROMYCES-CEREVISIAE	Previously, we have demonstrated that major histocompatibility class II trans-activator ( CIITA) is crucial in mediating interferon-gamma(IFN-gamma)-induced repression of collagen type I gene transcription. Here we report that CIITA represses collagen transcription through a phosphorylation-dependent interaction between its proline/serine/threonine domain and co-repressor molecules such as histone deacetylase (HDAC2) and Sin3B. Mutation of a serine (S373A) in CIITA, within a glycogen synthase kinase 3 (GSK3) consensus site, decreases repression of collagen transcription by blocking interaction with Sin3B. In vitro phosphorylation of CIITA by GSK3 relies on a casein kinase I site three amino acids C-terminal to the GSK3 site in CIITA. Both GSK3 and casein kinase I inhibitors alleviate collagen repression and disrupt IFN-gamma-mediated recruitment of Sin3B and HDAC2 to the collagen start site. Therefore, we have identified the region within CIITA responsible for mediating IFN-gamma-induced inhibition of collagen synthesis.	[Xu, Yong; Smith, Barbara D.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Harton, Jonathan A.] Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA	Boston University; Albany Medical College	Smith, BD (corresponding author), Boston Univ, Sch Med, Dept Biochem, 715 Albany St, Boston, MA 02118 USA.	smith@biochem.bumc.bu.edu	Harton, Jonathan/F-2848-2010; Harton, Jonathan A/AAW-5283-2021	Harton, Jonathan/0000-0002-0350-1877; Harton, Jonathan A/0000-0002-0350-1877; Smith, Barbara/0000-0002-5375-7627	NATIONAL CANCER INSTITUTE [K01CA095582] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068094, P01HL013262] Funding Source: NIH RePORTER; NCI NIH HHS [K01 CA095582] Funding Source: Medline; NHLBI NIH HHS [HL 68094, HL 013262-31] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Al-Khouri AM, 2005, J BIOL CHEM, V280, P35195, DOI 10.1074/jbc.M503045200; Aparicio JG, 2004, MOL CELL BIOL, V24, P4769, DOI 10.1128/MCB.24.11.4769-4780.2004; Armstrong TD, 1997, P NATL ACAD SCI USA, V94, P6886, DOI 10.1073/pnas.94.13.6886; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Bontron S, 1997, MOL CELL BIOL, V17, P4249, DOI 10.1128/MCB.17.8.4249; Bontron S, 1997, HUM GENET, V99, P541, DOI 10.1007/s004390050403; Boss JM, 1997, CURR OPIN IMMUNOL, V9, P107, DOI 10.1016/S0952-7915(97)80166-5; Boucher MJ, 2006, J BIOL CHEM, V281, P6395, DOI 10.1074/jbc.M511597200; Bradley MB, 1997, J IMMUNOL, V159, P1086; Bustos VH, 2006, P NATL ACAD SCI USA, V103, P19725, DOI 10.1073/pnas.0609424104; Buttice G, 2006, CIRC RES, V98, P472, DOI 10.1161/01.RES.0000204725.46332.97; Chang CH, 1996, IMMUNITY, V4, P167, DOI 10.1016/S1074-7613(00)80681-0; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; Creagh EM, 2006, TRENDS IMMUNOL, V27, P352, DOI 10.1016/j.it.2006.06.003; Ellenrieder V, 2002, EMBO J, V21, P2451, DOI 10.1093/emboj/21.10.2451; Fontes JD, 1997, NUCLEIC ACIDS RES, V25, P2522, DOI 10.1093/nar/25.12.2522; Fontes JD, 1999, MOL CELL BIOL, V19, P941; Fritz JH, 2005, J ENDOTOXIN RES, V11, P390, DOI 10.1179/096805105X76850; GOLDBERG H, 1992, J BIOL CHEM, V267, P19622; Gourley T, 1999, IMMUNITY, V10, P377, DOI 10.1016/S1074-7613(00)80037-0; Gourley TS, 2001, J IMMUNOL, V166, P2917, DOI 10.4049/jimmunol.166.5.2917; Greer SF, 2003, NAT IMMUNOL, V4, P1074, DOI 10.1038/ni985; Greer SF, 2004, J IMMUNOL, V173, P376, DOI 10.4049/jimmunol.173.1.376; HALLECK MS, 1995, GENOMICS, V26, P403, DOI 10.1016/0888-7543(95)80229-F; Harte D, 1998, J NONLINEAR SCI, V8, P581, DOI 10.1007/s003329900060; Hassig CA, 1997, CELL, V89, P341, DOI 10.1016/S0092-8674(00)80214-7; Hergovich A, 2006, MOL CELL BIOL, V26, P5784, DOI 10.1128/MCB.00232-06; Hu XY, 2006, IMMUNITY, V24, P563, DOI 10.1016/j.immuni.2006.02.014; Itoh-Lindstrom Y, 1999, J IMMUNOL, V163, P2425; Jabrane-Ferrat N, 2003, INT IMMUNOL, V15, P467, DOI 10.1093/intimm/dxg048; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kretsovali A, 1998, MOL CELL BIOL, V18, P6777, DOI 10.1128/MCB.18.11.6777; Laherty CD, 1997, CELL, V89, P349, DOI 10.1016/S0092-8674(00)80215-9; Lee E, 2001, J CELL BIOL, V154, P983, DOI 10.1083/jcb.200102074; Li GX, 2001, MOL CELL BIOL, V21, P4626, DOI 10.1128/MCB.21.14.4626-4635.2001; Linhoff MW, 2001, MOL CELL BIOL, V21, P3001, DOI 10.1128/MCB.21.9.3001-3011.2001; Mach B, 1996, ANNU REV IMMUNOL, V14, P301, DOI 10.1146/annurev.immunol.14.1.301; Mahanta SK, 1997, P NATL ACAD SCI USA, V94, P6324, DOI 10.1073/pnas.94.12.6324; Masternak K, 2000, GENE DEV, V14, P1156; Masternak K, 2000, Rev Immunogenet, V2, P267; Mori-Aoki A, 2000, BIOCHEM BIOPH RES CO, V278, P58, DOI 10.1006/bbrc.2000.3769; Mudhasani R, 2002, MOL CELL BIOL, V22, P5019, DOI 10.1128/MCB.22.14.5019-5026.2002; Nozell S, 2004, J BIOL CHEM, V279, P38577, DOI 10.1074/jbc.M403738200; Okamura H, 2004, MOL CELL BIOL, V24, P4184, DOI 10.1128/MCB.24.10.4184-4195.2004; Otten LA, 2006, EUR J IMMUNOL, V36, P1548, DOI 10.1002/eji.200535687; Reith W, 2001, ANNU REV IMMUNOL, V19, P331, DOI 10.1146/annurev.immunol.19.1.331; RILEY JL, 1995, IMMUNITY, V2, P533, DOI 10.1016/1074-7613(95)90033-0; Rosenstiel P, 2007, MICROBES INFECT, V9, P648, DOI 10.1016/j.micinf.2007.01.015; Sartoris S, 1996, EUR J IMMUNOL, V26, P2456, DOI 10.1002/eji.1830261028; SASAKI A, 1990, J NEUROIMMUNOL, V29, P213, DOI 10.1016/0165-5728(90)90164-I; Scholl T, 1997, P NATL ACAD SCI USA, V94, P6330, DOI 10.1073/pnas.94.12.6330; Scott KL, 2003, MOL CELL BIOL, V23, P4522, DOI 10.1128/MCB.23.13.4522-4531.2003; Sengupta P, 2005, J BIOL CHEM, V280, P21004, DOI 10.1074/jbc.M413191200; Sengupta PK, 2003, CANCER RES, V63, P1789; Sengupta PK, 2002, J BIOL CHEM, V277, P24926, DOI 10.1074/jbc.M111712200; Sif S, 2001, GENE DEV, V15, P603, DOI 10.1101/gad.872801; Sisk TJ, 2000, J IMMUNOL, V165, P2511, DOI 10.4049/jimmunol.165.5.2511; Sisk TJ, 2003, INT IMMUNOL, V15, P1195, DOI 10.1093/intimm/dxg116; Spilianakis C, 2003, EMBO J, V22, P5125, DOI 10.1093/emboj/cdg496; Spilianakis C, 2000, MOL CELL BIOL, V20, P8489, DOI 10.1128/MCB.20.22.8489-8498.2000; STEIMLE V, 1993, CELL, V75, P135, DOI 10.1016/0092-8674(93)90685-J; STEIMLE V, 1994, SCIENCE, V265, P106, DOI 10.1126/science.8016643; STERNBERG PW, 1987, CELL, V48, P567, DOI 10.1016/0092-8674(87)90235-2; Tosi G, 2002, EMBO J, V21, P5467, DOI 10.1093/emboj/cdf557; Turenne GA, 2001, BMC CELL BIOL, V2, DOI 10.1186/1471-2121-2-12; Um JH, 2007, J BIOL CHEM, V282, P20794, DOI 10.1074/jbc.C700070200; Williams GS, 1998, INT IMMUNOL, V10, P1957, DOI 10.1093/intimm/10.12.1957; Wong AW, 2003, NAT IMMUNOL, V4, P891, DOI 10.1038/ni960; Wu G, 2006, BIOCHEMISTRY-US, V45, P5319, DOI 10.1021/bi0601149; Xu Y, 2006, J BIOL CHEM, V281, P9260, DOI 10.1074/jbc.M511724200; Xu Y, 2004, J BIOL CHEM, V279, P41319, DOI 10.1074/jbc.M404174200; Xu Y, 2003, J BIOL CHEM, V278, P49134, DOI 10.1074/jbc.M309003200; Xu Y, 2007, MOL IMMUNOL, V44, P1709, DOI 10.1016/j.molimm.2006.07.294; Yang L, 2003, BIOCHEM J, V369, P651, DOI 10.1042/BJ20020854; Yang XY, 2002, CELL, V110, P69, DOI 10.1016/S0092-8674(02)00810-3; Yee CSK, 2005, J IMMUNOL, V174, P1222, DOI 10.4049/jimmunol.174.3.1222; Yee CSK, 2004, J IMMUNOL, V172, P5528, DOI 10.4049/jimmunol.172.9.5528; Zhang XH, 2004, MOL CELL BIOL, V24, P5106, DOI 10.1128/MCB.24.12.5106-5118.2004; Zhang Y, 1997, CELL, V89, P357, DOI 10.1016/S0092-8674(00)80216-0; Zhou XR, 2007, IMMUNOLOGY, V122, P476, DOI 10.1111/j.1365-2567.2007.02674.x; Zhu XS, 2001, MOL CELL BIOL, V21, P7078, DOI 10.1128/MCB.21.20.7078-7088.2001; Zika E, 2003, MOL CELL BIOL, V23, P3091, DOI 10.1128/MCB.23.9.3091-3102.2003; Zilfou JT, 2001, MOL CELL BIOL, V21, P3974, DOI 10.1128/MCB.21.12.3974-3985.2001	83	25	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1243	1256		10.1074/jbc.M707180200	http://dx.doi.org/10.1074/jbc.M707180200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	17991736	hybrid			2022-12-27	WOS:000252282700007
J	Lee, CM; Kim, BY; Li, LA; Morgan, ET				Lee, Choon-Myung; Kim, Bong-Yoon; Li, Lian; Morgan, Edward T.			Nitric oxide-dependent proteasomal degradation of cytochrome P4502B proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOWN-REGULATION; RAT-LIVER; GENE-EXPRESSION; PRIMARY CULTURES; MESSENGER-RNAS; KAPPA-B; INHIBITION; INDUCTION; ENDOTOXIN; HEPATOCYTES	Exposure to inflammatory agents or cytokines causes the suppression of cytochrome P450 (CYP) enzyme activities and expression in liver and primary hepatocyte cultures. We showed previously that phenobarbital-induced CYP2B protein is down-regulated in primary cultures of rat hepatocytes after exposure to bacterial endotoxin ( lipopolysaccharide) in a nitric oxide (NO)-dependent manner. In this study, we found that CYP2B proteins in primary rat hepatocyte cultures were suppressed > 60% after 6 h of treatment with interleukin-1 beta (IL-1). This effect was NO-dependent, and treatment of cells with the NO donors (Z)-1-[2-(2-aminoethyl)-N-(2-ammonioethyl) aminodiazen-1-ium-1,2-diolate (NOC-18), S-nitrosoglutathione, and S-nitroso-N-acetylpenicillamine also suppressed CYP2B proteins. However, the down-regulation by IL-1 was insensitive to inhibition of cGMP-dependent protein kinases. The down-regulation by IL-1 or NO donors was abolished by treatments with the proteasome inhibitors MG132 and lactacystin that did not affect NO production. The calpain inhibitor E64-d or the lysosomal protease inhibitors NH4Cl and chloroquine did not attenuate the down-regulation of CYP2B by IL-1. Treatment of HeLa cells expressing c-Myc-tagged CYP2B1 with NOC-18 down-regulated its expression and enhanced its ubiquitination. Treatment of rat liver microsomes with S-nitrosoglutathione caused S-nitrosylation of CYP2B protein and enhanced the ubiquitination pattern of CYP2B compared with unmodified CYP2B in an in vitro ubiquitination assay. These data are consistent with the hypothesis that NO-dependent CYP2B ubiquitination and proteasomal degradation are dependent on protein modification by reactive nitrogen species.	[Lee, Choon-Myung; Kim, Bong-Yoon; Li, Lian; Morgan, Edward T.] Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA	Emory University	Morgan, ET (corresponding author), Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA.	edward.morgan@emory.edu		Li, Lian/0000-0003-4700-1134; Morgan, Edward/0000-0003-4273-2261	NIEHS NIH HHS [T32 ES012870, T32 ES012870-03, T32ES01287, T32 ES012870-04] Funding Source: Medline; NIGMS NIH HHS [R01 GM069971-03, R01 GM069971-01, R01 GM069971-04, R01 GM069971-02, GM066971, R01 GM069971] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES012870] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069971] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agrawal AK, 1996, MOL PHARMACOL, V49, P523; Aitken AE, 2006, ANNU REV PHARMACOL, V46, P123, DOI 10.1146/annurev.pharmtox.46.120604.141059; Baldwin SJ, 2006, DRUG METAB DISPOS, V34, P1063, DOI 10.1124/dmd.105.008185; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; BREDT DS, 1994, ANNU REV BIOCHEM, V63, P175, DOI 10.1146/annurev.bi.63.070194.001135; Carlson TJ, 1996, MOL PHARMACOL, V49, P796; CHEN JQ, 1995, MOL PHARMACOL, V47, P940; Correia MA, 2005, ANNU REV PHARMACOL, V45, P439, DOI 10.1146/annurev.pharmtox.45.120403.100127; Dedon PC, 2004, ARCH BIOCHEM BIOPHYS, V423, P12, DOI 10.1016/j.abb.2003.12.017; Eum HA, 2006, NITRIC OXIDE-BIOL CH, V15, P423, DOI 10.1016/j.niox.2006.06.004; Ferrari L, 2001, MOL PHARMACOL, V60, P209, DOI 10.1124/mol.60.1.209; GELLER DA, 1994, ARCH SURG-CHICAGO, V129, P165; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Guengerich FP, 2004, DRUG METAB REV, V36, P159, DOI 10.1081/DMR-120033996; Hara H, 2000, FREE RADICAL RES, V33, P279, DOI 10.1080/10715760000301441; Hara H, 2002, MOL PHARMACOL, V61, P194, DOI 10.1124/mol.61.1.194; HONKAKOSKI P, 1992, BIOCHEM J, V285, P979, DOI 10.1042/bj2850979; Huan JY, 2004, TOXICOL APPL PHARM, V199, P332, DOI 10.1016/j.taap.2003.12.019; Ingelman-Sundberg M, 2004, TRENDS PHARMACOL SCI, V25, P193, DOI 10.1016/j.tips.2004.02.007; Jaffrey S R, 2001, Sci STKE, V2001, ppl1, DOI 10.1126/stke.2001.86.pl1; Khatsenko OG, 1997, TOXICOL LETT, V90, P207, DOI 10.1016/S0378-4274(96)03857-X; Khatsenko OG, 1998, BIOCHEM PHARMACOL, V55, P1835, DOI 10.1016/S0006-2952(98)00066-5; Kim S, 2004, MOL CELL BIOL, V24, P330, DOI 10.1128/MCB.24.1.330-337.2004; KIM YM, 1995, J BIOL CHEM, V270, P5710, DOI 10.1074/jbc.270.11.5710; Korsmeyer KK, 1999, ARCH BIOCHEM BIOPHYS, V365, P31, DOI 10.1006/abbi.1999.1138; Kotamraju S, 2003, P NATL ACAD SCI USA, V100, P10653, DOI 10.1073/pnas.1933581100; Li HC, 1998, J BIOCHEM MOL TOXIC, V12, P315; Li-Masters T, 2002, BIOCHEM PHARMACOL, V64, P1703, DOI 10.1016/S0006-2952(02)01423-5; Liao MX, 2005, MOL PHARMACOL, V67, P1460, DOI 10.1124/mol.104.009654; Lin HL, 2003, CHEM RES TOXICOL, V16, P129, DOI 10.1021/tx020040b; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mannick JB, 2004, FREE RADICAL RES, V38, P1, DOI 10.1080/10715760310001629065; MASAKI R, 1987, J CELL BIOL, V104, P1207, DOI 10.1083/jcb.104.5.1207; MCGOWAN EB, 1989, BIOCHEM BIOPH RES CO, V158, P432, DOI 10.1016/S0006-291X(89)80065-8; Milligan SA, 1996, ARCH BIOCHEM BIOPHYS, V335, P388, DOI 10.1006/abbi.1996.9998; Minamiyama Y, 1997, J PHARMACOL EXP THER, V283, P1479; MISKO TP, 1993, EUR J PHARMACOL, V233, P119, DOI 10.1016/0014-2999(93)90357-N; Morgan ET, 1997, DRUG METAB REV, V29, P1129, DOI 10.3109/03602539709002246; MORGAN ET, 1985, MOL PHARMACOL, V27, P471; Mosesson Y, 2003, J BIOL CHEM, V278, P21323, DOI 10.1074/jbc.C300096200; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Radi R, 2004, P NATL ACAD SCI USA, V101, P4003, DOI 10.1073/pnas.0307446101; Roberts BJ, 1997, J BIOL CHEM, V272, P9771; Roberts ES, 1998, CHEM RES TOXICOL, V11, P1067, DOI 10.1021/tx980099b; RONIS MJJ, 1991, EUR J BIOCHEM, V198, P383, DOI 10.1111/j.1432-1033.1991.tb16026.x; Sewer MB, 1998, J PHARMACOL EXP THER, V287, P352; Sewer MB, 1997, BIOCHEM PHARMACOL, V54, P729, DOI 10.1016/S0006-2952(97)00226-8; Sewer MB, 1998, MOL PHARMACOL, V54, P273, DOI 10.1124/mol.54.2.273; SHIRAKI H, 1984, ARCH BIOCHEM BIOPHYS, V235, P86, DOI 10.1016/0003-9861(84)90257-1; Song BL, 2004, J BIOL CHEM, V279, P28798, DOI 10.1074/jbc.M402442200; Spencer NY, 2000, J BIOL CHEM, V275, P36562, DOI 10.1074/jbc.M005347200; STADLER J, 1994, P NATL ACAD SCI USA, V91, P3559, DOI 10.1073/pnas.91.9.3559; Takemura S, 1999, J HEPATOL, V30, P1035, DOI 10.1016/S0168-8278(99)80257-8; Tong LM, 2001, DRUG METAB DISPOS, V29, P252; Tunctan B, 2006, NITRIC OXIDE-BIOL CH, V14, P51, DOI 10.1016/j.niox.2005.09.006; VILLA P, 1995, CLIN DIAGN LAB IMMUN, V2, P549, DOI 10.1128/CDLI.2.5.549-553.1995; Vuppugalla R, 2004, J PHARMACOL EXP THER, V310, P718, DOI 10.1124/jpet.104.065557; Willmott N, 1996, J BIOL CHEM, V271, P3699; WINK DA, 1993, ARCH BIOCHEM BIOPHYS, V300, P115, DOI 10.1006/abbi.1993.1016; Zhang YH, 2005, FREE RADICAL BIO MED, V38, P874, DOI 10.1016/j.freeradbiomed.2004.12.012; Zou MH, 2000, ARCH BIOCHEM BIOPHYS, V376, P149, DOI 10.1006/abbi.2000.1699	61	57	59	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					889	898		10.1074/jbc.M708821200	http://dx.doi.org/10.1074/jbc.M708821200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	17993647	hybrid, Green Accepted			2022-12-27	WOS:000252128100029
J	Yan, D; Mayranpaa, MI; Wong, J; Perttila, J; Lehto, M; Jauhiainen, M; Kovanen, PT; Ehnholm, C; Brown, AJ; Olkkonen, VM				Yan, Daoguang; Mayranpaa, Mikko I.; Wong, Jenny; Perttila, Julia; Lehto, Markku; Jauhiainen, Matti; Kovanen, Petri T.; Ehnholm, Christian; Brown, Andrew J.; Olkkonen, Vesa M.			OSBP-related protein 8 (ORP8) suppresses ABCA1 expression and cholesterol efflux from macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXYSTEROL-BINDING-PROTEIN; LIVER-X-RECEPTOR; CELLULAR LIPID-METABOLISM; ABCG1(-/-) BONE-MARROW; OSBP-RELATED PROTEINS; CARDIOVASCULAR-DISEASE; DENSITY-LIPOPROTEIN; GENE-EXPRESSION; KNOCKOUT MICE; ATHEROSCLEROSIS	ORP8 is a previously unexplored member of the family of oxysterol-binding protein- related proteins (ORP). We now report the expression pattern, the subcellular distribution, and data on the ligand binding properties and the physiological function of ORP8. ORP8 is localized in the endoplasmic reticulum ( ER) via its C-terminal transmembrane span and binds 25-hydroxycholesterol, identifying it as a new ER oxysterol-binding protein. ORP8 is expressed at highest levels in macrophages, liver, spleen, kidney, and brain. Immunohistochemical analysis revealed ORP8 in the shoulder regions of human coronary atherosclerotic lesions, where it is present in CD68(+) macrophages. In advanced lesions the ORP8 mRNA was up-regulated 2.7-fold as compared with healthy coronary artery wall. Silencing of ORP8 by RNA interference in THP-1 macrophages increased the expression of ATP binding cassette transporter A1 (ABCA1) and concomitantly cholesterol efflux to lipid-free apolipoprotein A-I but had no significant effect on ABCG1 expression or cholesterol efflux to spherical high density lipoprotein HDL2. Experiments employing an ABCA1 promoter-luciferase reporter confirmed that ORP8 silencing enhances ABCA1 transcription. The silencing effect was partially attenuated by mutation of the DR4 element in the ABCA1 promoter and synergized with that of the liver X receptor agonist T0901317. Furthermore, inactivation of the E-box in the promoter synergized with ORP8 silencing, suggesting that the suppressive effect of ORP8 involves both the liver X receptor and the E-box functions. Our data identify ORP8 as a negative regulator of ABCA1 expression and macrophage cholesterol efflux. ORP8 may, thus, modulate the development of atherosclerosis.	[Yan, Daoguang; Perttila, Julia; Lehto, Markku; Jauhiainen, Matti; Ehnholm, Christian; Olkkonen, Vesa M.] Natl Publ Hlth Inst, Dept Mol Med, FI-00251 Helsinki, Finland; [Mayranpaa, Mikko I.; Kovanen, Petri T.] Wihuri Res Inst, FI-00140 Helsinki, Finland; [Mayranpaa, Mikko I.] Univ Helsinki, Dept Forens Med, FI-00014 Helsinki, Finland; [Wong, Jenny; Brown, Andrew J.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia	Finland National Institute for Health & Welfare; Wihuri Research Institute; University of Helsinki; University of New South Wales Sydney	Olkkonen, VM (corresponding author), Natl Publ Hlth Inst, Dept Mol Med, Biomedicum,P Box 104, FI-00251 Helsinki, Finland.	vesa.olkkonen@ktl.fi		Olkkonen, Vesa/0000-0001-5553-7997; Mayranpaa, Mikko/0000-0002-0877-9640				Aiello RJ, 2002, ARTERIOSCL THROM VAS, V22, P630, DOI 10.1161/01.ATV.0000014804.35824.DA; Baldan A, 2006, ARTERIOSCL THROM VAS, V26, P2301, DOI 10.1161/01.ATV.0000240051.22944.dc; Beyea MM, 2007, J BIOL CHEM, V282, P5207, DOI 10.1074/jbc.M611063200; Bjorkhem I, 2002, J CLIN INVEST, V110, P725, DOI 10.1172/JCI200216388; Bjorkhem I, 2002, ARTERIOSCL THROM VAS, V22, P734, DOI 10.1161/01.ATV.0000013312.32196.49; Brown AJ, 1999, ATHEROSCLEROSIS, V142, P1, DOI 10.1016/S0021-9150(98)00196-8; Chen WL, 2007, CELL METAB, V5, P73, DOI 10.1016/j.cmet.2006.11.012; Colles SM, 2001, TRENDS CARDIOVAS MED, V11, P131, DOI 10.1016/S1050-1738(01)00106-2; Costet P, 2000, J BIOL CHEM, V275, P28240; Costet P, 2003, MOL CELL BIOL, V23, P7756, DOI 10.1128/MCB.23.21.7756-7766.2003; DAWSON PA, 1989, J BIOL CHEM, V264, P16798; DAWSON PA, 1989, J BIOL CHEM, V264, P9046; Eberle D, 2004, BIOCHIMIE, V86, P839, DOI 10.1016/j.biochi.2004.09.018; Frikke-Schmidt R, 2005, J AM COLL CARDIOL, V46, P1516, DOI 10.1016/j.jacc.2005.06.066; Fu X, 2001, J BIOL CHEM, V276, P38378, DOI 10.1074/jbc.M105805200; Fujiyoshi M, 2007, J NEUROCHEM, V100, P968, DOI 10.1111/j.1471-4159.2006.04240.x; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; Hu X, 2003, MOL ENDOCRINOL, V17, P1019, DOI 10.1210/me.2002-0399; Jakobsson T, 2007, BIOCHEM J, V405, P31, DOI 10.1042/BJ20070004; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Jaworski CJ, 2001, GENOMICS, V78, P185, DOI 10.1006/geno.2001.6663; Kaplan R, 2002, J LIPID RES, V43, P952; Khovidhunkit W, 2003, J LIPID RES, V44, P1728, DOI 10.1194/jlr.M300100-JLR200; Lehmann JM, 1997, J BIOL CHEM, V272, P3137, DOI 10.1074/jbc.272.6.3137; Lehto M, 2003, BBA-MOL CELL BIOL L, V1631, P1, DOI 10.1016/S1388-1981(02)00364-5; Lehto M, 2001, J LIPID RES, V42, P1203; Li AC, 2004, J LIPID RES, V45, P2161, DOI 10.1194/jlr.R400010-JLR200; Libby P, 2005, CIRCULATION, V111, P3481, DOI 10.1161/CIRCULATIONAHA.105.537878; Lindstedt KA, 2004, ARTERIOSCL THROM VAS, V24, P2205, DOI 10.1161/01.ATV.0000149753.74793.88; Mayranpaa MI, 2006, CORONARY ARTERY DIS, V17, P611; Moreira EF, 2001, J BIOL CHEM, V276, P18570, DOI 10.1074/jbc.M011259200; Olkkonen VM, 2006, BIOCHEM SOC T, V34, P389, DOI 10.1042/BST0340389; Olkkonen VM, 2004, ANN MED, V36, P562, DOI 10.1080/07853890410018907; Olkkonen VM, 2004, CURR OPIN LIPIDOL, V15, P321, DOI 10.1097/00041433-200406000-00013; Oram JF, 2006, CIRC RES, V99, P1031, DOI 10.1161/01.RES.0000250171.54048.5c; Out R, 2006, ARTERIOSCL THROM VAS, V26, P2295, DOI 10.1161/01.ATV.0000237629.29842.4c; Perry RJ, 2006, MOL BIOL CELL, V17, P2604, DOI 10.1091/mbc.E06-01-0060; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Radhakrishnan A, 2007, P NATL ACAD SCI USA, V104, P6511, DOI 10.1073/pnas.0700899104; Ranalletta M, 2006, ARTERIOSCL THROM VAS, V26, P2308, DOI 10.1161/01.ATV.0000242275.92915.43; Rowe AH, 2003, CIRC RES, V93, P717, DOI 10.1161/01.RES.0000097606.43659.F4; Schmitz G, 2005, BBA-MOL CELL BIOL L, V1735, P1, DOI 10.1016/j.bbalip.2005.04.004; SERFATYLACROSNIERE C, 1994, ATHEROSCLEROSIS, V107, P85, DOI 10.1016/0021-9150(94)90144-9; Singaraja RR, 2003, ARTERIOSCL THROM VAS, V23, P1322, DOI 10.1161/01.ATV.0000078520.89539.77; Suchanek M, 2007, BIOCHEM J, V405, P473, DOI 10.1042/BJ20070176; Szanto A, 2004, MOL CELL BIOL, V24, P8154, DOI 10.1128/MCB.24.18.8154-8166.2004; TAYLOR FR, 1985, METHOD ENZYMOL, V110, P9; TAYLOR FR, 1984, J BIOL CHEM, V259, P2382; Tontonoz P, 2003, MOL ENDOCRINOL, V17, P985, DOI 10.1210/me.2003-0061; Van Eck M, 2006, ARTERIOSCL THROM VAS, V26, P929, DOI 10.1161/01.ATV.0000208364.22732.16; Van Eck M, 2002, P NATL ACAD SCI USA, V99, P6298, DOI 10.1073/pnas.092327399; Wagner BL, 2003, MOL CELL BIOL, V23, P5780, DOI 10.1128/MCB.23.16.5780-5789.2003; Wang C, 2002, BIOCHEM J, V361, P461, DOI 10.1042/0264-6021:3610461; Wang PY, 2005, SCIENCE, V307, P1472, DOI 10.1126/science.1107710; Wong J, 2004, ARTERIOSCL THROM VAS, V24, P2365, DOI 10.1161/01.ATV.0000148707.93054.7d; Wong J, 2006, BIOCHEM J, V400, P485, DOI 10.1042/BJ20060914; Yang XP, 2002, J LIPID RES, V43, P297; Yokoyama S, 2005, CURR OPIN LIPIDOL, V16, P269, DOI 10.1097/01.mol.0000169346.15450.90; Zelcer N, 2006, J CLIN INVEST, V116, P607, DOI 10.1172/JCI27883	61	101	109	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					332	340		10.1074/jbc.M705313200	http://dx.doi.org/10.1074/jbc.M705313200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17991739	hybrid			2022-12-27	WOS:000251940300037
J	Huang, JH; Gabrielsen, JS; Cooksey, RC; Luo, B; Boros, LG; Jones, DL; Jouihan, HA; Soesanto, Y; Knecht, L; Hazel, MW; Kushner, JP; McClain, DA				Huang, Jingyu; Gabrielsen, J. Scott; Cooksey, Robert C.; Luo, Bai; Boros, Laszlo G.; Jones, Deborah L.; Jouihan, Hani A.; Soesanto, Yudi; Knecht, Lauren; Hazel, Mark W.; Kushner, James P.; McClain, Donald A.			Increased glucose disposal and AMP-dependent kinase signaling in a mouse model of hemochromatosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; INSULIN SECRETORY CAPACITY; HEREDITARY HEMOCHROMATOSIS; OXIDATIVE STRESS; SERUM FERRITIN; IRON; RESISTANCE; ADIPOCYTES; SENSITIVITY; DYSFUNCTION	Hereditary hemochromatosis is an inherited disorder of increased iron absorption that can result in cirrhosis, diabetes, and other morbidities. We have investigated the mechanisms underlying supranormal glucose tolerance despite decreased insulin secretion in a mouse model of hemochromatosis with deletion of the hemochromatosis gene (Hfe(-/-)). Hfe(-/-) mice on 129Sv or C57BL/6J backgrounds have decreased glucose excursions after challenge compared with controls. In the C57BL/6J/Hfe(-/-), for example, incremental area under the glucose curve is reduced 52% (p < 0.001) despite decreased serum insulin, and homeostasis model assessment insulin resistance is decreased 50% (p < 0.05). When studied by the euglycemic clamp technique 129Sv/Hfe(-/-) mice exhibit a 20% increase in glucose disposal (p < 0.05) at submaximal insulin but no increase at maximal insulin compared with wild types. [1,2-C-13]D-glucose clearance from plasma is significantly increased in Hfe(-/-) mice (19%, p < 0.05), and lactate derived from glycolysis is elevated 5.1-fold in Hfe(-/-) mice (p < 0.0001). Basal but not insulin-stimulated glucose uptake is elevated in isolated soleus muscle from Hfe(-/-) mice (p < 0.03). Compared with controls Hfe(-/-) mice exhibit no differences in serum lipid, insulin, glucagon, or thyroid hormone levels; adiponectin levels are elevated 41% (p < 0.05), and the adiponectin message in adipocytes is increased 83% (p = 0.04). Insulin action measured by phosphorylation of Akt is not enhanced in muscle, but phosphorylation of AMP-dependent kinase is increased. We conclude that supranormal glucose tolerance in iron overload is characterized by increased glucose disposal that does not result from increased insulin action. Instead, the Hfe(-/-) mice demonstrate increased adiponectin levels and activation of AMP-dependent kinase.	[Huang, Jingyu; Gabrielsen, J. Scott; Cooksey, Robert C.; Luo, Bai; Jones, Deborah L.; Jouihan, Hani A.; McClain, Donald A.] Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84132 USA; [Huang, Jingyu; Gabrielsen, J. Scott; Cooksey, Robert C.; Luo, Bai; Jones, Deborah L.; Jouihan, Hani A.; Soesanto, Yudi; Knecht, Lauren; Hazel, Mark W.; Kushner, James P.; McClain, Donald A.] Univ Utah, Sch Med, Dept Med, Salt Lake City, UT 84132 USA; [Cooksey, Robert C.; McClain, Donald A.] VA Affairs Med Ctr, Res Serv, Salt Lake City, UT 84132 USA; [Boros, Laszlo G.] SIDMAP, Los Angeles, CA 90064 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	McClain, DA (corresponding author), Univ Utah, Sch Med, Div Endocrinol, 30 N 2030 E, Salt Lake City, UT 84132 USA.	donald.mcclain@hsc.utah.edu		McClain, Don/0000-0002-3310-2359	NCATS NIH HHS [UL1 TR001420] Funding Source: Medline; NIDDK NIH HHS [DK59512, R01 DK081842] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081842, R56DK059512, R01DK059512] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abraham D, 2006, DIABETOLOGIA, V49, P2546, DOI 10.1007/s00125-006-0445-7; Bahceci M, 2007, J ENDOCRINOL INVEST, V30, P210, DOI 10.1007/BF03347427; BARON AD, 1988, AM J PHYSIOL, V255, P769; BOTHWELL TH, 1995, METABOLIC MOL BASES, P2237; Cooksey RC, 2004, ENDOCRINOLOGY, V145, P5305, DOI 10.1210/en.2004-0392; Cooksey RC, 2002, ANN NY ACAD SCI, V967, P102; CUSHMAN SW, 1978, J LIPID RES, V19, P269; Edwards C, 1999, WINTROBES CLIN HEMAT, P1056; Feder JN, 1997, J BIOL CHEM, V272, P14025, DOI 10.1074/jbc.272.22.14025; Fujii N, 2006, AM J PHYSIOL-ENDOC M, V291, pE867, DOI 10.1152/ajpendo.00207.2006; Gillum RF, 2001, INT J OBESITY, V25, P639, DOI 10.1038/sj.ijo.0801561; Haurie V, 2003, J BIOL CHEM, V278, P45391, DOI 10.1074/jbc.M307447200; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Hue L, 2002, J MOL CELL CARDIOL, V34, P1091, DOI 10.1006/jmcc.2002.2063; Iwasaki T, 2005, DIABETES CARE, V28, P2486, DOI 10.2337/diacare.28.10.2486; Jehn M, 2004, DIABETES CARE, V27, P2422, DOI 10.2337/diacare.27.10.2422; Kamigaki M, 2006, BIOCHEM BIOPH RES CO, V339, P624, DOI 10.1016/j.bbrc.2005.11.059; LEE WNP, 1991, BIOL MASS SPECTROM, V20, P451, DOI 10.1002/bms.1200200804; LEE WNP, 1995, ANAL BIOCHEM, V226, P100, DOI 10.1006/abio.1995.1197; Levy JE, 1999, BLOOD, V94, P9, DOI 10.1182/blood.V94.1.9.413a43_9_11; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Marsin AS, 2000, CURR BIOL, V10, P1247, DOI 10.1016/S0960-9822(00)00742-9; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McClain DA, 2006, DIABETOLOGIA, V49, P1661, DOI 10.1007/s00125-006-0200-0; Morrison TB, 1998, BIOTECHNIQUES, V24, P954; Nemeth E, 2005, BLOOD, V105, P1803, DOI 10.1182/blood-2004-08-3042; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Qi L, 2007, DIABETES CARE, V30, P101, DOI 10.2337/dc06-1686; Rebouche CJ, 2004, J BIOCHEM BIOPH METH, V58, P239, DOI 10.1016/j.jbbm.2003.11.003; Rumberger JM, 2004, DIABETES, V53, P2535, DOI 10.2337/diabetes.53.10.2535; Russell RR, 2004, J CLIN INVEST, V114, P495, DOI 10.1172/JCI200419297; Subauste AR, 2007, AM J PHYSIOL-ENDOC M, V293, pE159, DOI 10.1152/ajpendo.00629.2006; Tomas E, 2002, P NATL ACAD SCI USA, V99, P16309, DOI 10.1073/pnas.222657499; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984	36	30	30	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37501	37507		10.1074/jbc.M703625200	http://dx.doi.org/10.1074/jbc.M703625200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17971451	hybrid			2022-12-27	WOS:000251833600025
J	Ropolo, A; Grasso, D; Pardo, R; Sacchetti, ML; Archange, C; Lo Re, A; Seux, M; Nowak, J; Gonzalez, CD; Iovanna, JL; Vaccaro, MI				Ropolo, Alejandro; Grasso, Daniel; Pardo, Romina; Sacchetti, Maria L.; Archange, Cendrine; Lo Re, Andrea; Seux, Mylene; Nowak, Jonathan; Gonzalez, Claudio D.; Iovanna, Juan L.; Vaccaro, Maria I.			The pancreatitis-induced vacuole membrane protein 1 triggers autophagy in mammalian cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; DEATH; YEAST; ATG9; EXPRESSION; MARKER; VMP1; RAT; LC3; AUTOPHAGOCYTOSIS	Autophagy is a degradation process of cytoplasmic cellular constituents, which serves as a survival mechanism in starving cells, and it is characterized by sequestration of bulk cytoplasm and organelles in double-membrane vesicles called autophagosomes. Autophagy has been linked to a variety of pathological processes such as neurodegenerative diseases and tumorigenesis, which highlights its biological and medical importance. We have previously characterized the vacuole membrane protein 1 (VMP1) gene, which is highly activated in acute pancreatitis, a disease associated with morphological changes resembling autophagy. Here we show that VMP1 expression triggers autophagy in mammalian cells. VMP1 expression induces the formation of ultrastructural features of autophagy and recruitment of the microtubule-associated protein 1 light-chain 3 (LC3), which is inhibited after treatment with the autophagy inhibitor 3-methiladenine. VMP1 is induced by starvation and rapamycin treatments. Its expression is necessary for autophagy, because VMP1 small interfering RNA inhibits autophagosome formation under both autophagic stimuli. VMP1 is a transmembrane protein that co-localizes with LC3, a marker of the autophagosomes. It interacts with Beclin 1, a mammalian autophagy initiator, through the VMP1-Atg domain, which is essential for autophagosome formation. VMP1 endogenous expression co-localizes with LC3 in pancreas tissue undergoing pancreatitis-induced autophagy. Finally, VMP1 stable expression targeted to pancreas acinar cell in transgenic mice induces autophagosome formation. Our results identify VMP1 as a novel autophagy-related membrane protein involved in the initial steps of the mammalian cell autophagic process.	[Archange, Cendrine; Seux, Mylene; Nowak, Jonathan; Iovanna, Juan L.] INSERM, Unit 624, F-13288 Marseille, France; [Ropolo, Alejandro; Grasso, Daniel; Pardo, Romina; Sacchetti, Maria L.; Vaccaro, Maria I.] Univ Buenos Aires, Sch Med, Dept Physiol, Buenos Aires, DF, Argentina; [Gonzalez, Claudio D.] CEMIC Univ Hosp, Buenos Aires, DF, Argentina	Institut National de la Sante et de la Recherche Medicale (Inserm); University of Buenos Aires; Centro de Educacion Medica e Investigaciones Clinicas (CEMIC); University of Buenos Aires	Iovanna, JL (corresponding author), INSERM, Unit 624, 163 Ave Luminy,Case 915, F-13288 Marseille, France.	iovanna@marseille.inserm.fr; mvaccaro@fmed.uba.ar	Iovanna, Juan/M-9805-2017; Vaccaro, Maria I./L-8348-2017	Iovanna, Juan/0000-0003-1822-2237; Vaccaro, Maria/0000-0002-2456-747X; Gonzalez, Claudio/0000-0002-3772-8850; GRASSO, DANIEL/0000-0002-8932-716X				ADLER G, 1985, DIGESTION, V32, P10, DOI 10.1159/000199210; AHO HJ, 1980, SCAND J GASTROENTERO, V15, P417, DOI 10.3109/00365528009181494; Codogno P, 2005, CELL DEATH DIFFER, V12, P1509, DOI 10.1038/sj.cdd.4401751; Dusetti NJ, 2002, BIOCHEM BIOPH RES CO, V290, P641, DOI 10.1006/bbrc.2001.6244; Fernandez-Zapico ME, 2003, EMBO J, V22, P4748, DOI 10.1093/emboj/cdg470; Gozuacik D, 2004, ONCOGENE, V23, P2891, DOI 10.1038/sj.onc.1207521; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; HELIN H, 1980, VIRCHOWS ARCH A, V387, P259, DOI 10.1007/BF00454829; Jacinto E, 2003, NAT REV MOL CELL BIO, V4, P117, DOI 10.1038/nrm1018; Jiang PH, 2004, PANCREAS, V29, P225, DOI 10.1097/00006676-200410000-00008; Juhasz G, 2006, PLOS BIOL, V4, P161, DOI 10.1371/journal.pbio.0040036; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; Kihara A, 2001, J CELL BIOL, V152, P519, DOI 10.1083/jcb.152.3.519; Klionsky DJ, 2007, AUTOPHAGY, V3, P181, DOI 10.4161/auto.3678; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Klionsky DJ, 2004, NATURE, V431, P31, DOI 10.1038/431031a; Klionsky DJ, 2003, DEV CELL, V5, P539, DOI 10.1016/S1534-5807(03)00296-X; Klionsky DJ, 2005, J CELL SCI, V118, P7, DOI 10.1242/jcs.01620; Komatsu M, 2007, CELL DEATH DIFFER, V14, P887, DOI 10.1038/sj.cdd.4402120; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; Kuma A, 2007, AUTOPHAGY, V3, P323, DOI 10.4161/auto.4012; Legakis JE, 2007, AUTOPHAGY, V3, P422, DOI 10.4161/auto.4129; Levine B, 2005, CELL, V120, P159, DOI 10.1016/j.cell.2005.01.005; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Liang C, 2006, NAT CELL BIOL, V8, P688, DOI 10.1038/ncb1426; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Mari M, 2007, AUTOPHAGY, V3, P145, DOI 10.4161/auto.3608; MITCHENER JS, 1976, AM J PATHOL, V83, P485; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2005, CELL DEATH DIFFER, V12, P1535, DOI 10.1038/sj.cdd.4401728; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Pattingre S, 2006, CANCER RES, V66, P2885, DOI 10.1158/0008-5472.CAN-05-4412; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; Qu XP, 2007, CELL, V128, P931, DOI 10.1016/j.cell.2006.12.044; Reggiori F, 2005, AUTOPHAGY, V1, P101, DOI 10.4161/auto.1.2.1840; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Vaccaro MI, 2003, PANCREATOLOGY, V3, P69, DOI 10.1159/000069150; Wagner S, 2006, TRENDS BIOTECHNOL, V24, P364, DOI 10.1016/j.tibtech.2006.06.008; WATANABE O, 1984, AM J PHYSIOL, V246, P457; WEBBER JL, 2007, AUTOHAGY, V3, P145; WILLEMER S, 1989, VIRCHOWS ARCH A, V415, P115, DOI 10.1007/BF00784348; Yen WL, 2007, MOL BIOL CELL, V18, P581, DOI 10.1091/mbc.E06-07-0612; Yoshimori T, 2004, BIOCHEM BIOPH RES CO, V313, P453, DOI 10.1016/j.bbrc.2003.07.023; Young ARJ, 2006, J CELL SCI, V119, P3888, DOI 10.1242/jcs.03172	49	148	161	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					37124	37133		10.1074/jbc.M706956200	http://dx.doi.org/10.1074/jbc.M706956200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17940279	hybrid			2022-12-27	WOS:000251646000039
J	Zhao, DH; Curatti, L; Rubio, LM				Zhao, Dehua; Curatti, Leonardo; Rubio, Luis M.			Evidence for nifU and nifS participation in the biosynthesis of the iron-molybdenum cofactor of nitrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO SYNTHESIS; AZOTOBACTER-VINELANDII; FEMO-COFACTOR; CRYSTALLOGRAPHIC STRUCTURE; KLEBSIELLA-PNEUMONIAE; FIXATION GENES; MOFE-PROTEIN; CLUSTER; SULFUR; MATURATION	The nifU and nifS genes encode the components of a cellular machinery dedicated to the assembly of [2Fe-2S] and [4Fe-4S] clusters required for growth under nitrogen-fixing conditions. The NifU and NifS proteins are involved in the production of active forms of the nitrogenase component proteins, NifH and NifDK. Although NifH contains a [4Fe-4S] cluster, the NifDK component carries two complex metalloclusters, the iron-molybdenum cofactor (FeMo-co) and the [8Fe-7S] P-cluster. FeMo-co, located at the active site of NifDK, is composed of 7 iron, 9 sulfur, 1 molybdenum, 1 homocitrate, and 1 unidentified light atom. To investigate whether NifUS are required for FeMo-co biosynthesis and to understand at what level(s) they might participate in this process, we analyzed the effect of nifU and nifS mutations on the formation of active NifB protein and on the accumulation of NifB-co, an isolatable intermediate of the FeMo-co biosynthetic pathway synthesized by the product of the nifB gene. The nifU and nifS genes were required to accumulate NifB-co in a nifN mutant background. This result clearly demonstrates the participation of NifUS in NifB-co synthesis and suggests a specific role of NifUS as the major provider of [Fe-S] clusters that serve as metabolic substrates for the biosynthesis of FeMo-co. Surprisingly, although nifB expression was attenuated in nifUS mutants, the assembly of the [Fe-S] clusters of NifB was compensated by other non-nif machinery for the assembly of [Fe-S] clusters, indicating that NifUS are not essential to synthesize active NifB.	[Zhao, Dehua; Curatti, Leonardo; Rubio, Luis M.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Rubio, LM (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, 111 Koshland Hall, Berkeley, CA 94720 USA.	lrubio@nature.berkeley.edu	Rubio, Luis M./B-5827-2009	Rubio, Luis M./0000-0003-1596-2475	PHS HHS [35332] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ALLEN RM, 1995, J BIOL CHEM, V270, P26890, DOI 10.1074/jbc.270.45.26890; BRANDNER JP, 1989, J BACTERIOL, V171, P360, DOI 10.1128/jb.171.1.360-368.1989; BULEN WA, 1966, P NATL ACAD SCI USA, V56, P979, DOI 10.1073/pnas.56.3.979; CHAN MK, 1993, SCIENCE, V260, P792, DOI 10.1126/science.8484118; Christiansen J, 1998, BIOCHEMISTRY-US, V37, P12611, DOI 10.1021/bi981165b; Curatti L, 2006, P NATL ACAD SCI USA, V103, P5297, DOI 10.1073/pnas.0601115103; Curatti L, 2005, P NATL ACAD SCI USA, V102, P6291, DOI 10.1073/pnas.0501216102; Curatti L, 2007, P NATL ACAD SCI USA, V104, P17626, DOI 10.1073/pnas.0703050104; Dos Santos PC, 2007, J BACTERIOL, V189, P2854, DOI 10.1128/JB.01734-06; Dos Santos PC, 2004, CHEM REV, V104, P1159, DOI 10.1021/cr020608l; Einsle O, 2002, SCIENCE, V297, P1696, DOI 10.1126/science.1073877; FISH WW, 1988, METHOD ENZYMOL, V158, P357, DOI 10.1016/0076-6879(88)58067-9; GEORGIADIS MM, 1992, SCIENCE, V257, P1653, DOI 10.1126/science.1529353; Hernandez JA, 2007, MOL MICROBIOL, V63, P177, DOI 10.1111/j.1365-2958.2006.05514.x; JACOBSON MR, 1989, MOL GEN GENET, V219, P49, DOI 10.1007/BF00261156; Johnson DC, 2005, BIOCHEM SOC T, V33, P90, DOI 10.1042/BST0330090; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; KIM JS, 1992, NATURE, V360, P553, DOI 10.1038/360553a0; KUO CF, 1988, ANAL BIOCHEM, V170, P183, DOI 10.1016/0003-2697(88)90106-6; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Ludden PW, 2004, CATALYSTS FOR NITROGEN FIXATION: NITROGENASES, RELEVANT CHEMICAL MODELS AND COMMERCIAL PROCESSES, P219; MACNEIL T, 1978, J BACTERIOL, V136, P253, DOI 10.1128/JB.136.1.253-266.1978; NAGATANI HH, 1974, J BACTERIOL, V120, P697, DOI 10.1128/JB.120.2.697-701.1974; Philippe N, 2004, PLASMID, V51, P246, DOI 10.1016/j.plasmid.2004.02.003; Rangaraj P, 1997, P NATL ACAD SCI USA, V94, P11250, DOI 10.1073/pnas.94.21.11250; Rangaraj P, 2001, J BIOL CHEM, V276, P15968, DOI 10.1074/jbc.M100907200; ROBERTS GP, 1978, J BACTERIOL, V136, P267, DOI 10.1128/JB.136.1.267-279.1978; Rubio LM, 2002, J BIOL CHEM, V277, P14299, DOI 10.1074/jbc.M107289200; Rubio LM, 2005, J BACTERIOL, V187, P405, DOI 10.1128/JB.187.2.405-414.2005; Sambrook J., 2001, MOL CLONING LAB MANU; SHAH VK, 1972, BIOCHIM BIOPHYS ACTA, V256, P498, DOI 10.1016/0005-2728(72)90078-3; SHAH VK, 1994, J BIOL CHEM, V269, P1154; SHAH VK, 1973, BIOCHIM BIOPHYS ACTA, V305, P445, DOI 10.1016/0005-2728(73)90190-4; SHAH VK, 1977, P NATL ACAD SCI USA, V74, P3249, DOI 10.1073/pnas.74.8.3249; SHOKOLENKO IN, 1995, BIOTECHNIQUES, V18, P596; Smith AD, 2005, BIOCHEMISTRY-US, V44, P12955, DOI 10.1021/bi051257i; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; STEWART WDP, 1967, P NATL ACAD SCI USA, V58, P2071, DOI 10.1073/pnas.58.5.2071; Walker KA, 2004, J BACTERIOL, V186, P4056, DOI 10.1128/JB.186.13.4056-4066.2004; Yang TC, 2005, J AM CHEM SOC, V127, P12804, DOI 10.1021/ja0552489; Yuvaniyama P, 2000, P NATL ACAD SCI USA, V97, P599, DOI 10.1073/pnas.97.2.599; ZHENG LM, 1993, P NATL ACAD SCI USA, V90, P2754, DOI 10.1073/pnas.90.7.2754; ZHENG LM, 1994, J BIOL CHEM, V269, P18723; ZHENG LM, 1994, BIOCHEMISTRY-US, V33, P4714, DOI 10.1021/bi00181a031	44	40	42	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					37016	37025		10.1074/jbc.M708097200	http://dx.doi.org/10.1074/jbc.M708097200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17959596	hybrid			2022-12-27	WOS:000251646000028
J	Harrigan, JA; Piotrowski, J; Di Noto, L; Levine, RL; Bohr, VA				Harrigan, Jeanine A.; Piotrowski, Jason; Di Noto, Luca; Levine, Rodney L.; Bohr, Vilhelm A.			Metal-catalyzed oxidation of the Werner syndrome protein causes loss of catalytic activities and impaired protein-protein interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MIXED-FUNCTION OXIDATION; DNA-DAMAGE; BINDING-SITE; WRN PROTEIN; MECHANISM; HELICASE; COMPLEX; IRON; AGE; KU	Metal-catalyzed oxidation reactions target amino acids in the metal binding pocket of proteins. Such oxidation reactions generally result in either preferential degradation of the protein or accumulation of a catalytically inactive pool of protein with age. Consistently, levels of oxidized proteins have been shown to increase with age. The segmental, progeroid disorder Werner syndrome results from loss of the Werner syndrome protein (WRN). WRN is a member of the RecQ family of DNA helicases and possesses exonuclease and ATP-dependent helicase activities. Furthermore, each of the helicase and exonuclease domains of WRN contains a metal binding pocket. In this report we examined for metal-catalyzed oxidation of WRN in the presence of iron or copper. We found that WRN was oxidized in vitro by iron but not by copper. Iron-mediated oxidation resulted in the inhibition of both WRN helicase and exonuclease activities. Oxidation of WRN also inhibited binding to several known protein partners. In addition, we did not observe degradation of oxidized WRN by the 20 S proteasome in vitro. Finally, exposure of cells to hydrogen peroxide resulted in oxidation of WRN in vivo. Therefore, our results demonstrate that WRN undergoes metal-catalyzed oxidation in the presence of iron, and iron-mediated oxidation of WRN likely results in the accumulation of a catalytically inactive form of the protein, which may contribute to age-related phenotypes.	NIH, NIA, Lab Mol Gerontol, Baltimore, MD 21224 USA; NIH, NHLBI, Biochem Lab, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Bohr, VA (corresponding author), NIH, NIA, Lab Mol Gerontol, 5600 Nathan Shock Dr, Baltimore, MD 21224 USA.	vbohr@nih.gov	Bohr, Vilhelm/AAP-5931-2020; Levine, Rodney L/D-9885-2011		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL000225, Z01HL000225] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [Z01AG000726, ZIAAG000726] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Aguilaniu H, 2003, SCIENCE, V299, P1751, DOI 10.1126/science.1080418; Barlow C, 1999, P NATL ACAD SCI USA, V96, P9915, DOI 10.1073/pnas.96.17.9915; Bernstein DA, 2003, EMBO J, V22, P4910, DOI 10.1093/emboj/cdg500; Caruthers JM, 2002, CURR OPIN STRUC BIOL, V12, P123, DOI 10.1016/S0959-440X(02)00298-1; Choudhary S, 2004, J BIOL CHEM, V279, P34603, DOI 10.1074/jbc.M401901200; Cooper MP, 2000, GENE DEV, V14, P907; Di Noto L, 2005, J BIOL CHEM, V280, P39907, DOI 10.1074/jbc.M506247200; EPSTEIN CJ, 1966, MEDICINE, V45, P177, DOI 10.1097/00005792-196605000-00001; FARBER JM, 1986, J BIOL CHEM, V261, P4574; Featherstone C, 1999, MUTAT RES-DNA REPAIR, V434, P3, DOI 10.1016/S0921-8777(99)00006-3; FRY DC, 1986, P NATL ACAD SCI USA, V83, P907, DOI 10.1073/pnas.83.4.907; FUCCI L, 1983, P NATL ACAD SCI-BIOL, V80, P1521, DOI 10.1073/pnas.80.6.1521; Gray MD, 1997, NAT GENET, V17, P100, DOI 10.1038/ng0997-100; Graziewicz MA, 2002, NUCLEIC ACIDS RES, V30, P2817, DOI 10.1093/nar/gkf392; Grune T, 2003, BIOCHEM BIOPH RES CO, V305, P709, DOI 10.1016/S0006-291X(03)00809-X; Karmakar P, 2002, NUCLEIC ACIDS RES, V30, P3583, DOI 10.1093/nar/gkf482; Levine RL, 2001, EXP GERONTOL, V36, P1495, DOI 10.1016/S0531-5565(01)00135-8; Li BM, 2001, J BIOL CHEM, V276, P9896, DOI 10.1074/jbc.M008575200; Luo S, 2006, ANAL BIOCHEM, V350, P233, DOI 10.1016/j.ab.2005.10.048; Machwe A, 2000, NUCLEIC ACIDS RES, V28, P2762, DOI 10.1093/nar/28.14.2762; McMurray MA, 2003, SCIENCE, V301, P1908, DOI 10.1126/science.1087706; MELLO AC, 1991, MUTAT RES, V251, P109, DOI 10.1016/0027-5107(91)90220-I; Meneghini R, 1997, FREE RADICAL BIO MED, V23, P783, DOI 10.1016/S0891-5849(97)00016-6; Mian IS, 1997, NUCLEIC ACIDS RES, V25, P3187, DOI 10.1093/nar/25.16.3187; Mushegian AR, 1997, P NATL ACAD SCI USA, V94, P5831, DOI 10.1073/pnas.94.11.5831; OLIVER CN, 1987, J BIOL CHEM, V262, P5488; Opresko PL, 2002, J BIOL CHEM, V277, P41110, DOI 10.1074/jbc.M205396200; Orren DK, 1999, NUCLEIC ACIDS RES, V27, P3557, DOI 10.1093/nar/27.17.3557; Pagano G, 2005, FREE RADICAL RES, V39, P529, DOI 10.1080/10715760500092683; Perry JJP, 2006, NAT STRUCT MOL BIOL, V13, P414, DOI 10.1038/nsmb1088; SANDSTROM BE, 1994, FREE RADICAL BIO MED, V16, P177, DOI 10.1016/0891-5849(94)90141-4; SHACTER E, 1995, FREE RADICAL BIO MED, V18, P815, DOI 10.1016/0891-5849(95)93872-4; Shen JC, 1998, J BIOL CHEM, V273, P34139, DOI 10.1074/jbc.273.51.34139; Sinclair DA, 2003, SCIENCE, V301, P1859, DOI 10.1126/science.1090465; Stadtman ER, 2000, ANN NY ACAD SCI, V899, P191; Stadtman ER, 1998, DRUG METAB REV, V30, P225, DOI 10.3109/03602539808996310; STADTMAN ER, 1990, FREE RADICAL BIO MED, V9, P315, DOI 10.1016/0891-5849(90)90006-5; Tuteja N, 2004, EUR J BIOCHEM, V271, P1849, DOI 10.1111/j.1432-1033.2004.04094.x; von Kobbe C, 2003, MOL CELL BIOL, V23, P8601, DOI 10.1128/MCB.23.23.8601-8613.2003; Williams AB, 1999, FASEB J, V13, P1435, DOI 10.1096/fasebj.13.11.1435	40	12	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36403	36411		10.1074/jbc.M706107200	http://dx.doi.org/10.1074/jbc.M706107200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17911100	hybrid			2022-12-27	WOS:000251458300032
J	Irimia, A; Eoff, RL; Pallan, PS; Guengerich, FP; Egli, M				Irimia, Adriana; Eoff, Robert L.; Pallan, Pradeep S.; Guengerich, F. Peter; Egli, Martin			Structure and activity of Y-class DNA polymerase DPO4 from Sulfolobus solfataricus with templates containing the hydrophobic thymine analog 2,4-difluorotoluene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIPHOSPHATE INCORPORATION; SUBANGSTROM INCREMENTS; CRYSTAL-STRUCTURES; DIFFRACTION DATA; SITE TIGHTNESS; STEADY-STATE; DUPLEX DNA; FIDELITY; REPLICATION; BYPASS	The 2,4-difluorotoluene (DFT) analog of thymine has been used extensively to probe the relative importance of shape an dhydrogen bonding for correct nucleotide insertion by DNA polymerases. As far as high fidelity (A-class) polymerases are concerned, shape is considered by some as key to incorporation of A(T) opposite T(A) and G(C) opposite C(G). We have carried out a detailed kinetic analysis of invitro primer extension opposite DFT-containingtemplates by the trans-lesion (Y-class) DNA polymerase Dpo4 from Sulfolobus solfataricus. Although full-length product formation was observed, steady-state kinetic data show that dATP insertion opposite DFT is greatly inhibited relative to insertion opposite T (similar to 5,000-fold). No products were observed in the pre-steady-state. Furthermore, it is noteworthy that Dpo4 strongly prefers dATP opposite DFT over dGTP (similar to 200-fold) and that the polymerase is able to extend an A: DFT but not a G: DFT pair. We present crystal structures of Dpo4 in complex with DNA duplexes containing the DFT analog, the first for any DNA polymerase. In the structures, template-DFT is either positioned opposite primer-A or -G at the -1 site or is unopposed by a primer base and followed by adGTP:A mismatch pair at the active site, representative of a -1 frameshift. The three structures provide insight into the discrimination by Dpo4 between dATP and dGTP opposite DFT and its inability to extend beyond aG: DFT pair. Although hydrogen bonding is clearly important for error-free replication by this Y-class DNA polymerase, our work demonstrates that Dpo4 also relies on shape and electrostatics to distinguish between correct and incorrect incoming nucleotide.	Vanderbilt Univ, Sch Med, Ctr Mol Toxicol, Dept Biochem, Nashville, TN 37232 USA	Vanderbilt University	Egli, M (corresponding author), Vanderbilt Univ, Sch Med, Ctr Mol Toxicol, Dept Biochem, 607 Light Hall, Nashville, TN 37232 USA.	martin.egli@vanderbilt.edu			NCI NIH HHS [F32 CA119776] Funding Source: Medline; NIEHS NIH HHS [P30 ES000267, P01 ES05355, R01 ES010375] Funding Source: Medline; NIGMS NIH HHS [GM055237] Funding Source: Medline; NATIONAL CANCER INSTITUTE [F32CA119776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES010375, P30ES000267, P01ES005355] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055237] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BEESE LS, 1993, SCIENCE, V260, P352, DOI 10.1126/science.8469987; Boudsocq F, 2001, NUCLEIC ACIDS RES, V29, P4607, DOI 10.1093/nar/29.22.4607; Brieba LG, 2004, EMBO J, V23, P3452, DOI 10.1038/sj.emboj.7600354; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CAMBILLAU C, 1997, TURBO FRODO; Christian NP, 2001, J AM SOC MASS SPECTR, V12, P744, DOI 10.1016/S1044-0305(01)00228-8; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; DeLano W.L, PYMOL MOL GRAPHICS S; Einolf HJ, 1998, BIOCHEMISTRY-US, V37, P13300, DOI 10.1021/bi981346d; Eoff RL, 2007, J BIOL CHEM, V282, P19831, DOI 10.1074/jbc.M702290200; Eoff RL, 2007, J BIOL CHEM, V282, P13573, DOI 10.1074/jbc.M700656200; Eoff RL, 2007, J BIOL CHEM, V282, P1456, DOI 10.1074/jbc.M609661200; Fiala KA, 2004, BIOCHEMISTRY-US, V43, P2116, DOI 10.1021/bi035746z; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; Guckian KM, 1998, NAT STRUCT BIOL, V5, P954, DOI 10.1038/2930; Guckian KM, 1996, J AM CHEM SOC, V118, P8182, DOI 10.1021/ja961733f; Guengerich FP, 2006, CHEM REV, V106, P420, DOI 10.1021/cr0404693; Irimia A, 2006, BIOCHEMISTRY-US, V45, P5949, DOI 10.1021/bi052511+; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kim TW, 2006, J BIOL CHEM, V281, P2289, DOI 10.1074/jbc.M510744200; Kim TW, 2005, P NATL ACAD SCI USA, V102, P15803, DOI 10.1073/pnas.0505113102; Kool ET, 2006, CHEM COMMUN, P3665, DOI 10.1039/b605414e; Kool ET, 2002, ANNU REV BIOCHEM, V71, P191, DOI 10.1146/annurev.biochem.71.110601.135453; LI F, 2007, IN PRESS NUCL ACIDS, V35; Ling H, 2001, CELL, V107, P91, DOI 10.1016/S0092-8674(01)00515-3; Ling H, 2004, MOL CELL, V13, P751, DOI 10.1016/S1097-2765(04)00101-7; Ling H, 2004, P NATL ACAD SCI USA, V101, P2265, DOI 10.1073/pnas.0308332100; Ling H, 2003, NATURE, V424, P1083, DOI 10.1038/nature01919; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mizukami S, 2006, BIOCHEMISTRY-US, V45, P2772, DOI 10.1021/bi051961z; Morales JC, 1998, NAT STRUCT BIOL, V5, P950, DOI 10.1038/2925; Moran S, 1997, P NATL ACAD SCI USA, V94, P10506, DOI 10.1073/pnas.94.20.10506; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Potapova O, 2006, BIOCHEMISTRY-US, V45, P890, DOI 10.1021/bi051792i; Trincao J, 2004, NAT STRUCT MOL BIOL, V11, P457, DOI 10.1038/nsmb755; Vaisman A, 2005, EMBO J, V24, P2957, DOI 10.1038/sj.emboj.7600786; Warren JJ, 2006, P NATL ACAD SCI USA, V103, P19701, DOI 10.1073/pnas.0609580103; Washington MT, 2003, MOL CELL BIOL, V23, P5107, DOI 10.1128/MCB.23.14.5107-5112.2003; Wolfle WT, 2005, MOL CELL BIOL, V25, P7137, DOI 10.1128/MCB.25.16.7137-7143.2005; Xia J, 2006, ACS CHEM BIOL, V1, P176, DOI 10.1021/cb600063p; Zang H, 2006, J BIOL CHEM, V281, P2358, DOI 10.1074/jbc.M510889200; Zang H, 2005, J BIOL CHEM, V280, P29750, DOI 10.1074/jbc.M504756200	43	24	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36421	36433		10.1074/jbc.M707267200	http://dx.doi.org/10.1074/jbc.M707267200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17951245	hybrid			2022-12-27	WOS:000251458300034
J	Li, X; Lee, YK; Jeng, JC; Yen, Y; Schultz, DC; Shih, HM; Ann, DK				Li, Xu; Lee, Yung-Kang; Jeng, Jen-Chong; Yen, Yun; Schultz, David C.; Shih, Hsiu-Ming; Ann, David K.			Role for KAP1 serine 824 phosphorylation and sumoylation/desumoylation switch in regulating KAP1-mediated transcriptional repression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC-FINGER PROTEINS; DNA-DAMAGE; DEPENDENT TRANSCRIPTION; SUMO MODIFICATION; MDM2 INTERACTION; G(2) CHECKPOINT; C-JUN; P53; CANCER; CELLS	As a multifunctional protein, KRAB domain-associated protein 1 (KAP1) is reportedly subjected to multiple protein post-translational modifications, including phosphorylation and sumoylation. However, gaps exist in our knowledge of how KAP1 phosphorylation cross-talks with KAP1 sumoylation and what the biological consequence is. Here, we show that doxorubicin (Dox) treatment induces KAP1 phosphorylation at Ser-824 via an ataxia telangiectasia mutated (ATM)-dependent manner, correlating with the transcriptional de-repression of p21(WAF1/CIP1) and Gadd45 alpha. A S824A substitution of KAP1, which ablates the ATM-induced phosphorylation, results in an increase of KAP1 sumoylation and repression of p21 transcription in Dox-treated cells. By contrast, a S824D mutation of KAP1, which mimics constitutive phosphorylation of KAP1, leads to a decrease of KAP1 sumoylation and stimulation of p21 transcription before the exposure of Dox. We further provide evidence that SENP1 deSUMOylase is involved in activating basal, but not Dox-induced, KAP1 Ser-824 phosphorylation, rendering a stimulation of p21 and Gadd45 alpha transcription. Moreover, KAP1 and differential sumoylation of KAP1 were also demonstrated to fine-tune the transcription of three additional KAP1-targeted genes, including Bax, Puma, and Noxa. Taken together, our results suggest a novel role for ATM that selectively stimulates KAP1 Ser-824 phosphorylation to repress its sumoylation, leading to the de-repression of expression of a subset of genes involved in promoting cell cycle control and apoptosis in response to genotoxic stresses.	City Hope Natl Med Ctr, Dep Clin & Mol Pharmacol, Duarte, CA 91010 USA; Univ So Calif, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA 90033 USA; Acad Sinica, Inst Biomed Sci, Taipei 11529, Taiwan; Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA	City of Hope; University of Southern California; Academia Sinica - Taiwan; The Wistar Institute	Ann, DK (corresponding author), City Hope Natl Med Ctr, Dep Clin & Mol Pharmacol, 1500 E Duarte Rd, Duarte, CA 91010 USA.	dann@coh.org	Yen, Yun/H-9591-2016; Shih, Hsiu-Ming/S-7023-2018; Li, Xu/A-7108-2013		NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE010742] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE014183] Funding Source: NIH RePORTER; NIDCR NIH HHS [R01 DE 10742, DE 14183] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Bossis G, 2005, MOL CELL BIOL, V25, P6964, DOI 10.1128/MCB.25.16.6964-6979.2005; Bossis G, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-13; Broude EV, 2007, ONCOGENE, V26, P6954, DOI 10.1038/sj.onc.1210516; Cheng JK, 2005, J BIOL CHEM, V280, P14492, DOI 10.1074/jbc.M412185200; Cheng JK, 2004, MOL CELL BIOL, V24, P6021, DOI 10.1128/MCB.24.13.6021-6028.2004; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Gregoire S, 2006, J BIOL CHEM, V281, P4423, DOI 10.1074/jbc.M509471200; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hietakangas V, 2003, MOL CELL BIOL, V23, P2953, DOI 10.1128/MCB.23.8.2953-2968.2003; Hietakangas V, 2006, P NATL ACAD SCI USA, V103, P45, DOI 10.1073/pnas.0503698102; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Lechner MS, 2000, MOL CELL BIOL, V20, P6449, DOI 10.1128/MCB.20.17.6449-6465.2000; Lee YK, 2007, J BIOL CHEM, V282, P1595, DOI 10.1074/jbc.M606306200; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Lin JY, 2004, FEBS LETT, V573, P15, DOI 10.1016/j.febslet.2004.07.059; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Muller S, 2000, J BIOL CHEM, V275, P13321, DOI 10.1074/jbc.275.18.13321; Nefkens I, 2003, J CELL SCI, V116, P513, DOI 10.1242/jcs.00253; Nghiem P, 2001, P NATL ACAD SCI USA, V98, P9092, DOI 10.1073/pnas.161281798; O'Geen H, 2007, PLOS GENET, V3, P916, DOI 10.1371/journal.pgen.0030089; Okamoto K, 2006, BIOCHEM BIOPH RES CO, V351, P216, DOI 10.1016/j.bbrc.2006.10.022; Oren M, 2003, CELL DEATH DIFFER, V10, P431, DOI 10.1038/sj.cdd.4401183; Passalaris TM, 1999, MOL CELL BIOL, V19, P5872, DOI 10.1128/mcb.19.9.5872; Riballo E, 2004, MOL CELL, V16, P715, DOI 10.1016/j.molcel.2004.10.029; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Schultz DC, 2001, GENE DEV, V15, P428, DOI 10.1101/gad.869501; Shiloh Y, 1997, ANNU REV GENET, V31, P635, DOI 10.1146/annurev.genet.31.1.635; Shiloh Y, 2006, TRENDS BIOCHEM SCI, V31, P402, DOI 10.1016/j.tibs.2006.05.004; Sripathy SP, 2006, MOL CELL BIOL, V26, P8623, DOI 10.1128/MCB.00487-06; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; Underhill C, 2000, J BIOL CHEM, V275, P40463, DOI 10.1074/jbc.M007864200; Urrutia R, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-231; van de Wetering M, 2003, EMBO REP, V4, P609, DOI 10.1038/sj.embor.embor865; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wang CG, 2005, EMBO J, V24, P3279, DOI 10.1038/sj.emboj.7600791; Wang QZ, 1996, J NATL CANCER I, V88, P956, DOI 10.1093/jnci/88.14.956; White DE, 2006, CANCER RES, V66, P11594, DOI 10.1158/0008-5472.CAN-06-4138; Yun JH, 2003, MOL CELL BIOL, V23, P7305, DOI 10.1128/MCB.23.20.7305-7314.2003; Zhao LY, 2003, J VIROL, V77, P11809, DOI 10.1128/JVI.77.21.11809-11821.2003; Zheng L, 2000, MOL CELL, V6, P757, DOI 10.1016/S1097-2765(00)00075-7; Ziv Y, 1997, ONCOGENE, V15, P159, DOI 10.1038/sj.onc.1201319; Ziv Y, 2006, NAT CELL BIOL, V8, P870, DOI 10.1038/ncb1446	45	128	132	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36177	36189		10.1074/jbc.M706912200	http://dx.doi.org/10.1074/jbc.M706912200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17942393	hybrid			2022-12-27	WOS:000251458300007
J	Mirsaliotis, A; Nurkiyanova, K; Lamb, D; Kuo, CWS; Brighty, DW				Mirsaliotis, Antonis; Nurkiyanova, Kulpash; Lamb, Daniel; Kuo, Chien-Wen S.; Brighty, David W.			Resistance to neutralization by antibodies targeting the coiled coil of fusion-active envelope is a common feature of retroviruses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HUMAN MONOCLONAL-ANTIBODIES; HEPARAN-SULFATE PROTEOGLYCANS; MALTOSE-BINDING PROTEIN; CELL-CELL FUSION; CONFORMATIONAL EPITOPES; SURFACE GLYCOPROTEIN; MEMBRANE-FUSION; HIV-1 GP41; HTLV-I	The human T-cell leukemia virus transmembrane glycoprotein (TM) is a typical class 1 membrane fusion protein and a subunit of the viral envelope glycoprotein complex. Following activation, the TM undergoes conformational transitions from a native nonfusogenic state to a fusion-active pre-hairpin intermediate that subsequently resolves to a compact trimer-of-hairpins or six-helix bundle. Disruption of these structural transitions inhibits membrane fusion and viral entry and validates TM as an anti-viral and vaccine target. To investigate the immunological properties of fusion-active TM, we have generated a panel of monoclonal antibodies that recognize the coiled-coil domain of the pre-hairpin intermediate. Antibody reactivity is highly sensitive to the conformation of the coiled coil as binding is dramatically reduced or lost on denatured antigen. Moreover, a unique group of antibodies are 100-1000-fold more reactive with the coiled coil than the trimer-of-hairpins form of TM. The antibodies recognize virally expressed envelope, and significantly, some selectively bind to envelope only under conditions that promote membrane fusion. Most importantly, many of the antibodies potently block six-helix bundle formation in vitro. Nevertheless, viral envelope was remarkably resistant to neutralization by antibodies directed to the coiled coil. The data imply that the coiled coil of viral envelope is poorly exposed to antibody during membrane fusion. We suggest that resistance to neutralization by antibodies directed to fusion-associated structures is a common property of retroviral TM and perhaps of other viral class I fusion proteins. These observations have significant implications for vaccine design.	Univ Dundee, Ninewells Hosp & Med Sch, Biomed Res Ctr, Dundee DD1 9SY, Scotland	University of Dundee	Brighty, DW (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Biomed Res Ctr, Dundee DD1 9SY, Scotland.	brighty@cancer.org.uk						AstierGin T, 1997, J INFECT DIS, V175, P716, DOI 10.1093/infdis/175.3.716; Brighty DW, 2001, J VIROL, V75, P10472, DOI 10.1128/JVI.75.21.10472-10478.2001; CARR CM, 1993, CELL, V73, P823, DOI 10.1016/0092-8674(93)90260-W; Center RJ, 1998, PROTEIN SCI, V7, P1612, DOI 10.1002/pro.5560070715; De Rosny E, 2001, J VIROL, V75, P8859, DOI 10.1128/JVI.75.18.8859-8863.2001; DOKHELAR MC, 1989, J ACQ IMMUN DEF SYND, V2, P431; Eckert DM, 1999, CELL, V99, P103, DOI 10.1016/S0092-8674(00)80066-5; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; FREY S, 1995, J VIROL, V69, P1462, DOI 10.1128/JVI.69.3.1462-1472.1995; Golding H, 2002, J VIROL, V76, P6780, DOI 10.1128/JVI.76.13.6780-6790.2002; Gorny MK, 2000, J VIROL, V74, P6186, DOI 10.1128/JVI.74.13.6186-6192.2000; Grange MP, 1997, DNA CELL BIOL, V16, P1439, DOI 10.1089/dna.1997.16.1439; Hadlock KG, 1997, J VIROL, V71, P5828, DOI 10.1128/JVI.71.8.5828-5840.1997; Hadlock KG, 2002, AIDS RES HUM RETROV, V18, P57, DOI 10.1089/088922202753394727; Hadlock KG, 1999, J VIROL, V73, P1205, DOI 10.1128/JVI.73.2.1205-1212.1999; Hunter E., 1997, P71; Igakura T, 2003, SCIENCE, V299, P1713, DOI 10.1126/science.1080115; Jassal SR, 2001, J VIROL, V75, P8317, DOI 10.1128/JVI.75.17.8317-8328.2001; Jassal SR, 2001, VIRUS RES, V78, P17, DOI 10.1016/S0168-1702(01)00279-9; Jiang S, 1998, J VIROL, V72, P10213, DOI 10.1128/JVI.72.12.10213-10217.1998; JIANG SB, 1993, NATURE, V365, P113, DOI 10.1038/365113a0; Jones KS, 2005, J VIROL, V79, P12692, DOI 10.1128/JVI.79.20.12692-12702.2005; Kilby JM, 1998, NAT MED, V4, P1302, DOI 10.1038/3293; Kobe B, 1999, P NATL ACAD SCI USA, V96, P4319, DOI 10.1073/pnas.96.8.4319; Manel N, 2003, CELL, V115, P449, DOI 10.1016/S0092-8674(03)00881-X; Melikyan GB, 2000, J CELL BIOL, V151, P413, DOI 10.1083/jcb.151.2.413; Miller MD, 2005, P NATL ACAD SCI USA, V102, P14759, DOI 10.1073/pnas.0506927102; Mirsaliotis A, 2007, J VIROL, V81, P6019, DOI 10.1128/JVI.02544-06; Mirsaliotis A, 2007, J GEN VIROL, V88, P660, DOI 10.1099/vir.0.82390-0; MOORE JP, 1993, J VIROL, V67, P863, DOI 10.1128/JVI.67.2.863-875.1993; Pinon JD, 2003, J VIROL, V77, P9922, DOI 10.1128/JVI.77.18.9922-9930.2003; Pinon JD, 2003, J VIROL, V77, P3281, DOI 10.1128/JVI.77.5.3281-3290.2003; Sagara Y, 1996, J VIROL, V70, P1564, DOI 10.1128/JVI.70.3.1564-1569.1996; SATTENTAU QJ, 1995, VIROLOGY, V206, P713, DOI 10.1016/S0042-6822(95)80094-8; SATTENTAU QJ, 1993, J VIROL, V67, P7383, DOI 10.1128/JVI.67.12.7383-7393.1993; SATTENTAU QJ, 1995, J EXP MED, V182, P185, DOI 10.1084/jem.182.1.185; Sodroski JG, 1999, CELL, V99, P243, DOI 10.1016/S0092-8674(00)81655-4; Sundaram R, 2004, J BIOL CHEM, V279, P24141, DOI 10.1074/jbc.M313210200; THIRIART C, 1989, J IMMUNOL, V143, P1832; Weissenhorn W, 1999, MOL MEMBR BIOL, V16, P3, DOI 10.1080/096876899294706; WILD C, 1993, AIDS RES HUM RETROV, V9, P1051, DOI 10.1089/aid.1993.9.1051; WILD C, 1995, AIDS RES HUM RETROV, V11, P323, DOI 10.1089/aid.1995.11.323; Zwick MB, 2004, NAT MED, V10, P133, DOI 10.1038/nm0204-133; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	44	7	7	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36724	36735		10.1074/jbc.M706827200	http://dx.doi.org/10.1074/jbc.M706827200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17940280	hybrid			2022-12-27	WOS:000251458300065
J	Li, Y; Wang, Y; Kim, EJ; Beemiller, P; Wang, CY; Swanson, J; You, M; Guan, KL				Li, Yong; Wang, Yian; Kim, Eunjung; Beemiller, Peter; Wang, Cun-Yu; Swanson, Joel; You, Ming; Guan, Kun-Liang			Bnip3 mediates the hypoxia-induced inhibition on mammalian target of rapamycin by interacting with rheb	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL PERMEABILITY TRANSITION; TUMOR-SUPPRESSOR COMPLEX; S6 KINASE ACTIVATION; RICTOR-MTOR COMPLEX; CELL-GROWTH CONTROL; SMALL GTPASE RHEB; TSC2 GAP ACTIVITY; TUBEROUS-SCLEROSIS; PANCREATIC-CANCER; TRANSMEMBRANE DOMAIN	The mammalian target of rapamycin (mTOR) is a central controller of cell growth, and it regulates translation, cell size, cell viability, and cell morphology. mTOR integrates a wide range of extracellular and intracellular signals, including growth factors, nutrients, energy levels, and stress conditions. Rheb, a Ras-related small GTPase, is a key upstream activator of mTOR. In this study, we found that Bnip3, a hypoxia-inducible Bcl-2 homology 3 domain-containing protein, directly binds Rheb and inhibits the mTOR pathway. Bnip3 decreases Rheb GTP levels in a manner depending on the binding to Rheb and the presence of the N-terminal domain. Both knockdown and overexpression experiments show that Bnip3 plays an important role in mTOR inactivation in response to hypoxia. Moreover, Bnip3 inhibits cell growth in vivo by suppressing the mTOR pathway. These observations demonstrate that Bnip3 mediates the inhibition of the mTOR pathway in response to hypoxia.	Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA; Univ Michigan, Inst Gerontol, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA; Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA; Washington Univ, Sch Med, Alvin J Siteman Canc Ctr, St Louis, MO 63110 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL)	Guan, KL (corresponding author), Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA.	kunliang@umich.edu	Swanson, Joel A/P-4362-2014; Guan, Kun-Liang/ADK-7088-2022	Swanson, Joel A/0000-0003-0900-8212; Beemiller, Peter/0000-0002-2736-3405	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI035950, R01AI064668] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI035950, R01 AI035950-14, R01 AI064668-03, R01 AI064668] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abe T, 2005, J GASTROENTEROL, V40, P504, DOI 10.1007/s00535-005-1576-1; Arsham AM, 2003, J BIOL CHEM, V278, P29655, DOI 10.1074/jbc.M212770200; Aspuria PJ, 2004, CELL SIGNAL, V16, P1105, DOI 10.1016/j.cellsig.2004.03.019; Beemiller P, 2006, PLOS BIOL, V4, P987, DOI 10.1371/journal.pbio.0040162; BOYD JM, 1994, CELL, V79, P341, DOI 10.1016/0092-8674(94)90202-X; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Bruick RK, 2000, P NATL ACAD SCI USA, V97, P9082, DOI 10.1073/pnas.97.16.9082; Castro AF, 2003, J BIOL CHEM, V278, P32493, DOI 10.1074/jbc.C300226200; Chen G, 1997, J EXP MED, V186, P1975, DOI 10.1084/jem.186.12.1975; Chen G, 1999, J BIOL CHEM, V274, P7, DOI 10.1074/jbc.274.1.7; Clark GJ, 1997, J BIOL CHEM, V272, P10608; Corradetti MN, 2005, J BIOL CHEM, V280, P9769, DOI 10.1074/jbc.C400557200; Daido S, 2004, CANCER RES, V64, P4286, DOI 10.1158/0008-5472.CAN-03-3084; Dan HC, 2002, J BIOL CHEM, V277, P35364, DOI 10.1074/jbc.M205838200; Erkan M, 2005, ONCOGENE, V24, P4421, DOI 10.1038/sj.onc.1208642; Eshleman JS, 2002, CANCER RES, V62, P7291; Figueroa C, 2001, J BIOL CHEM, V276, P28219, DOI 10.1074/jbc.M101763200; Frias MA, 2006, CURR BIOL, V16, P1865, DOI 10.1016/j.cub.2006.08.001; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; Giatromanolaki A, 2004, CLIN CANCER RES, V10, P5566, DOI 10.1158/1078-0432.CCR-04-0076; Goncharova EA, 2002, J BIOL CHEM, V277, P30958, DOI 10.1074/jbc.M202678200; Guo K, 2001, CELL DEATH DIFFER, V8, P367, DOI 10.1038/sj.cdd.4400810; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hoppe A, 2002, BIOPHYS J, V83, P3652, DOI 10.1016/S0006-3495(02)75365-4; Inoki K, 2006, TRENDS CELL BIOL, V16, P206, DOI 10.1016/j.tcb.2006.02.002; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2005, MICROBIOL MOL BIOL R, V69, P79, DOI 10.1128/MMBR.69.1.79-100.2005; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kim JY, 2002, ARCH BIOCHEM BIOPHYS, V398, P147, DOI 10.1006/abbi.2001.2673; Kwiatkowski DJ, 2003, ANN HUM GENET, V67, P87, DOI 10.1046/j.1469-1809.2003.00012.x; Lee H, 2006, MOL CELLS, V21, P1; Li Y, 2004, MOL CELL BIOL, V24, P7965, DOI 10.1128/MCB.24.18.7965-7975.2004; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Long XM, 2005, J BIOL CHEM, V280, P23433, DOI 10.1074/jbc.C500169200; Manka D, 2005, CANCER RES, V65, P11689, DOI 10.1158/0008-5472.CAN-05-3091; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Manning BD, 2003, TRENDS BIOCHEM SCI, V28, P573, DOI 10.1016/j.tibs.2003.09.003; Matsushima M, 1998, GENE CHROMOSOME CANC, V21, P230, DOI 10.1002/(SICI)1098-2264(199803)21:3<230::AID-GCC7>3.0.CO;2-0; Murai M, 2005, BRIT J CANCER, V92, P1165, DOI 10.1038/sj.bjc.6602422; Murai M, 2005, CLIN CANCER RES, V11, P1021; Nobukuni T, 2005, P NATL ACAD SCI USA, V102, P14238, DOI 10.1073/pnas.0506925102; Okami J, 2004, CANCER RES, V64, P5338, DOI 10.1158/0008-5472.CAN-04-0089; Ray R, 2000, J BIOL CHEM, V275, P1439, DOI 10.1074/jbc.275.2.1439; Reiling JH, 2004, GENE DEV, V18, P2879, DOI 10.1101/gad.322704; Roccio M, 2006, ONCOGENE, V25, P657, DOI 10.1038/sj.onc.1209106; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Saucedo LJ, 2003, NAT CELL BIOL, V5, P566, DOI 10.1038/ncb996; Sowter HM, 2001, CANCER RES, V61, P6669; Stocker H, 2003, NAT CELL BIOL, V5, P559, DOI 10.1038/ncb995; Sulistijo ES, 2006, J MOL BIOL, V364, P974, DOI 10.1016/j.jmb.2006.09.065; Sulistijo ES, 2003, J BIOL CHEM, V278, P51950, DOI 10.1074/jbc.M308429200; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Urano J, 2005, MOL MICROBIOL, V58, P1074, DOI 10.1111/j.1365-2958.2005.04877.x; Vande Velde C, 2000, MOL CELL BIOL, V20, P5454, DOI 10.1128/MCB.20.15.5454-5468.2000; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Webster KA, 2005, J MOL CELL CARDIOL, V38, P35, DOI 10.1016/j.yjmcc.2004.11.007; WENG QP, 1995, MOL CELL BIOL, V15, P2333; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yang Q, 2006, P NATL ACAD SCI USA, V103, P6811, DOI 10.1073/pnas.0602282103; Yang Q, 2006, GENE DEV, V20, P2820, DOI 10.1101/gad.1461206; Yasuda M, 1998, ONCOGENE, V17, P2525, DOI 10.1038/sj.onc.1202467; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999	71	201	207	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35803	35813		10.1074/jbc.M705231200	http://dx.doi.org/10.1074/jbc.M705231200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17928295	hybrid			2022-12-27	WOS:000251458100042
J	Martin, KA; Merenick, BL; Ding, M; Fetalvero, KM; Rzucidlo, EM; Kozul, CD; Brown, DJ; Chiu, HY; Shyu, M; Drapeau, BL; Wagner, RJ; Powell, RJ				Martin, Kathleen A.; Merenick, Bethany L.; Ding, Min; Fetalvero, Kristina M.; Rzucidlo, Eva M.; Kozul, Courtney D.; Brown, David J.; Chiu, Helen Y.; Shyu, Maureen; Drapeau, Bethany L.; Wagner, Robert J.; Powell, Richard J.			Rapamycin promotes vascular smooth muscle cell differentiation through insulin receptor substrate-1/phosphatidylinositol 3-kinase/Akt2 feedback signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELUTING STENTS; AMINO-ACID; RESISTANCE; PHENOTYPE; PATHWAY; GROWTH; SIROLIMUS; ROLES; AKT2; PROLIFERATION	The phenotypic plasticity of mature vascular smooth muscle cells (VSMCs) facilitates angiogenesis and wound healing, but VSCM dedifferentiation also contributes to vascular pathologies such as intimal hyperplasia. Insulin/insulin-like growth factor I(IGF-I) is unique among growth factors in promoting VSMC differentiation via preferential activation of phosphatidylinositol 3-kinase (PI3K) and Akt. We have previously reported that rapamycin promotes VSMC differentiation by inhibiting the mammalian target of rapamycin (mTOR) target S6K1. Here, we show that rapamycin activates Akt and induces contractile protein expression in human VSMC in an insulin-like growth factor I-dependent manner, by relieving S6K1-dependent negative regulation of insulin receptor substrate-1 (IRS-1). In skeletal muscle and adipocytes, rapamycin relieves mTOR/S6K1-dependent inhibitory phosphorylation of IRS-1, thus preventing IRS-1 degradation and enhancing PI3K activation. We report that this mechanism is functional in VSMCs and crucial for rapamycin-induced differentiation. Rapamycin inhibits S6K1-dependent IRS-1 serine phosphorylation, increases IRS-1 protein levels, and promotes association of tyrosine-phosphorylated IRS-1 with PI3K. A rapamycin-resistant S6K1 mutant prevents rapamycin-induced Akt activation and VSMC differentiation. Notably, we find that rapamycin selectively activates only the Akt2 isoform and that Akt2, but not Akt1, is sufficient to induce contractile protein expression. Akt2 is required for rapamycin-induced VSMC differentiation, whereas Akt1 appears to oppose contractile protein expression. The anti-restenotic effect of rapamycin in patients may be attributable to this unique pattern of PI3K effector regulation wherein anti-differentiation signals from S6K1 are inhibited, but pro-differentiation Akt2 activity is promoted through an IRS-1 feedback signaling mechanism.	Dartmouth Med Sch, Div Vasc Surg, Lebanon, NH 03756 USA; Dartmouth Med Sch, Dept Pharmacol & Toxicol, Lebanon, NH 03756 USA	Dartmouth College; Dartmouth College	Martin, KA (corresponding author), Dartmouth Hitchcock Med Ctr, Div Vasc Surg, 1 Med Ctr Dr, Lebanon, NH 03756 USA.	Kathleen.A.Martin@Dartmouth.edu		Martin, Kathleen/0000-0002-1748-0034	NATIONAL CANCER INSTITUTE [T32CA009658] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL071905, R01HL076612] Funding Source: NIH RePORTER; NCI NIH HHS [CA09658] Funding Source: Medline; NHLBI NIH HHS [5K08HL71905-3, R01 HL76612] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bae SS, 2003, J BIOL CHEM, V278, P49530, DOI 10.1074/jbc.M306782200; Brown DJ, 2005, J VASC SURG, V41, P509, DOI 10.1016/j.jvs.2004.12.024; Calera MR, 1998, J BIOL CHEM, V273, P7201, DOI 10.1074/jbc.273.13.7201; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Dibra A, 2005, NEW ENGL J MED, V353, P663, DOI 10.1056/NEJMoa044372; Duan C, 2000, CIRC RES, V86, P15, DOI 10.1161/01.RES.86.1.15; Eisenberg MJ, 2006, AM J CARDIOL, V98, P375, DOI 10.1016/j.amjcard.2006.02.042; Fetalvero KM, 2006, AM J PHYSIOL-HEART C, V290, pH1337, DOI 10.1152/ajpheart.00936.2005; Greene MW, 2002, BIOCHEMISTRY-US, V41, P7082, DOI 10.1021/bi015992f; Harrington LS, 2005, TRENDS BIOCHEM SCI, V30, P35, DOI 10.1016/j.tibs.2004.11.003; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Hayashi K, 2004, J BIOL CHEM, V279, P40807, DOI 10.1074/jbc.M405100200; Hayashi K, 1998, J BIOL CHEM, V273, P28860, DOI 10.1074/jbc.273.44.28860; Hayashi K, 1999, J CELL BIOL, V145, P727, DOI 10.1083/jcb.145.4.727; Hixon ML, 2000, J CLIN INVEST, V106, P1011, DOI 10.1172/JCI8252; Irie HY, 2005, J CELL BIOL, V171, P1023, DOI 10.1083/jcb.200505087; Liu L, 2006, ONCOGENE, V25, P7029, DOI 10.1038/sj.onc.1209691; Liu ZP, 2005, DEV CELL, V9, P261, DOI 10.1016/j.devcel.2005.05.017; Martin KA, 2004, AM J PHYSIOL-CELL PH, V286, pC507, DOI 10.1152/ajpcell.00201.2003; Martin KA, 2002, ADV CANCER RES, V86, P1, DOI 10.1016/S0065-230X(02)86001-8; MARX SO, 1995, CIRC RES, V76, P412, DOI 10.1161/01.RES.76.3.412; Moliterno DJ, 2005, NEW ENGL J MED, V353, P724, DOI 10.1056/NEJMe058140; Ohkawa Y, 2003, BIOCHEM BIOPH RES CO, V301, P78, DOI 10.1016/S0006-291X(02)02965-0; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Ozes ON, 2001, P NATL ACAD SCI USA, V98, P4640, DOI 10.1073/pnas.051042298; Poon M, 1996, J CLIN INVEST, V98, P2277, DOI 10.1172/JCI119038; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Stone GW, 2007, NEW ENGL J MED, V356, P998, DOI 10.1056/NEJMoa067193; Tremblay F, 2005, DIABETES, V54, P2674, DOI 10.2337/diabetes.54.9.2674; Tremblay F, 2001, J BIOL CHEM, V276, P38052; Tzatsos A, 2006, MOL CELL BIOL, V26, P63, DOI 10.1128/MCB.26.1.63-76.2006; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Um SH, 2006, CELL METAB, V3, P393, DOI 10.1016/j.cmet.2006.05.003; Yang ZZ, 2003, J BIOL CHEM, V278, P32124, DOI 10.1074/jbc.M302847200; Zhang HB, 2007, J CLIN INVEST, V117, P730, DOI 10.1172/JCI28984; Zhou GL, 2006, J BIOL CHEM, V281, P36443, DOI 10.1074/jbc.M600788200	39	109	117	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					36112	36120		10.1074/jbc.M703914200	http://dx.doi.org/10.1074/jbc.M703914200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17908691	hybrid			2022-12-27	WOS:000251458100070
J	Neimanis, S; Albig, W; Doenecke, D; Kahle, J				Neimanis, Sonja; Albig, Werner; Doenecke, Detlef; Kahle, Joerg			Sequence elements in both subunits of the DNA fragmentation factor are essential for its nuclear transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CASPASE-ACTIVATED DNASE; MAMMALIAN IMPORTIN-ALPHA; AMINO-ACID MOTIF; LARGE-T-ANTIGEN; LOCALIZATION SIGNAL; PROTEIN IMPORT; KARYOPHERIN-ALPHA; CRYSTALLOGRAPHIC ANALYSIS; MULTIPLE PATHWAYS; CRYSTAL-STRUCTURE	DNA cleavage is a biochemical hallmark of apoptosis. In humans, apoptotic DNA cleavage is executed by DNA fragmentation factor (DFF) 40. In proliferating cells DFF40 is expressed in the presence of its chaperone and inhibitor DFF45, which results in the formation of the DFF complex. Here, we present a systematic analysis of the nuclear import of the DFF complex. Our in vitro experiments demonstrate that the importin alpha/beta-heterodimer mediates the translocation of the DFF complex from the cytoplasm to the nucleus. Both DFF subunits interact directly with the importin alpha/beta-heterodimer. However, importin alpha/beta binds more tightly to the DFF complex compared with the individual subunits. Additionally, the isolated C-terminal regions of both DFF subunits together bind importin alpha/beta more strongly than the individual C termini. Our results from in vivo studies reveal that the C-terminal regions of both DFF subunits harbor nuclear localization signals. Furthermore, nuclear import of the DFF complex requires the C-terminal regions of both subunits. In more detail, one basic cluster in the C-terminal region of each subunit, DFF40 (RLKRK) and DFF45 (KRAR), is essential for nuclear accumulation of the DFF complex. Based on these findings two alternative models for the interaction of importin alpha/beta with the DFF complex are presented.	Univ Gottingen, Mol Biol Abt, Inst Biochem & Mol Zellbiol, D-37073 Gottingen, Germany	University of Gottingen	Doenecke, D (corresponding author), Univ Gottingen, Mol Biol Abt, Inst Biochem & Mol Zellbiol, Humboldtallee 23, D-37073 Gottingen, Germany.	ddoenec@gwdg.de						ADAM SA, 1990, J CELL BIOL, V111, P807, DOI 10.1083/jcb.111.3.807; ANDRADE MA, 1995, NAT GENET, V11, P115, DOI 10.1038/ng1095-115; CHARNEAU P, 1994, J MOL BIOL, V241, P651, DOI 10.1006/jmbi.1994.1542; CHELSKY D, 1989, MOL CELL BIOL, V9, P2487, DOI 10.1128/MCB.9.6.2487; Cingolani G, 2002, MOL CELL, V10, P1345, DOI 10.1016/S1097-2765(02)00727-X; Cingolani G, 1999, NATURE, V399, P221, DOI 10.1038/20367; Conti E, 1998, CELL, V94, P193, DOI 10.1016/S0092-8674(00)81419-1; Conti E, 2000, STRUCTURE, V8, P329, DOI 10.1016/S0969-2126(00)00107-6; Conti Elena, 2002, Results Probl Cell Differ, V35, P93; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; DINGWALL C, 1988, J CELL BIOL, V107, P841, DOI 10.1083/jcb.107.3.841; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Fanara P, 2000, J BIOL CHEM, V275, P21218, DOI 10.1074/jbc.M002217200; Fontes MRM, 2000, J MOL BIOL, V297, P1183, DOI 10.1006/jmbi.2000.3642; GLOVER JNM, 1995, NATURE, V373, P257, DOI 10.1038/373257a0; Goebel W, 2007, BIOL CHEM, V388, P197, DOI 10.1515/BC.2007.022; GORLICH D, 1994, CELL, V79, P767, DOI 10.1016/0092-8674(94)90067-1; GORLICH D, 1995, CURR BIOL, V5, P383, DOI 10.1016/S0960-9822(95)00079-0; Gorlich D, 1996, EMBO J, V15, P1810, DOI 10.1002/j.1460-2075.1996.tb00530.x; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Gorlich D, 1996, EMBO J, V15, P5584, DOI 10.1002/j.1460-2075.1996.tb00943.x; Inohara N, 1999, J BIOL CHEM, V274, P270, DOI 10.1074/jbc.274.1.270; Izaurralde E, 1997, EMBO J, V16, P6535, DOI 10.1093/emboj/16.21.6535; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; Jakel S, 1998, EMBO J, V17, P4491, DOI 10.1093/emboj/17.15.4491; KALDERON D, 1984, NATURE, V311, P33, DOI 10.1038/311033a0; Kobe B, 1999, NAT STRUCT BIOL, V6, P388, DOI 10.1038/7625; Kohler M, 1997, FEBS LETT, V417, P104, DOI 10.1016/S0014-5793(97)01265-9; Kutay U, 1997, EMBO J, V16, P1153, DOI 10.1093/emboj/16.6.1153; Lechardeur D, 2005, J BIOL CHEM, V280, P40216, DOI 10.1074/jbc.M502220200; Lechardeur D, 2000, J CELL BIOL, V150, P321, DOI 10.1083/jcb.150.2.321; Leung SW, 2003, J BIOL CHEM, V278, P41947, DOI 10.1074/jbc.M307162200; Liku ME, 2005, MOL BIOL CELL, V16, P5026, DOI 10.1091/mbc.E05-05-0412; Liu XS, 1999, J BIOL CHEM, V274, P13836, DOI 10.1074/jbc.274.20.13836; Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001; Madrid AS, 2006, CHROMOSOMA, V115, P98, DOI 10.1007/s00412-005-0043-3; Mingot JM, 2001, EMBO J, V20, P3685, DOI 10.1093/emboj/20.14.3685; Miyamoto Y, 1997, J BIOL CHEM, V272, P26375, DOI 10.1074/jbc.272.42.26375; Muhlhausser P, 2001, EMBO REP, V2, P690, DOI 10.1093/embo-reports/kve168; Nagata S, 2000, EXP CELL RES, V256, P12, DOI 10.1006/excr.2000.4834; Otomo T, 2000, NAT STRUCT BIOL, V7, P658, DOI 10.1038/77957; PEIFER M, 1994, CELL, V76, P789, DOI 10.1016/0092-8674(94)90353-0; Ribbeck K, 2002, EMBO J, V21, P2664, DOI 10.1093/emboj/21.11.2664; Ribbeck K, 1998, EMBO J, V17, P6587, DOI 10.1093/emboj/17.22.6587; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; Romanelli MG, 2002, EUR J BIOCHEM, V269, P2727, DOI 10.1046/j.1432-1033.2002.02942.x; Sakahira H, 2000, J BIOL CHEM, V275, P8091, DOI 10.1074/jbc.275.11.8091; Sakahira H, 1998, NATURE, V391, P96, DOI 10.1038/34214; Samejima K, 2000, EXP CELL RES, V255, P314, DOI 10.1006/excr.2000.4801; Strom AC, 2001, GENOME BIOL, V2; Weis K, 1996, EMBO J, V15, P1818, DOI 10.1002/j.1460-2075.1996.tb00531.x; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0; YONEDA Y, 1987, EXP CELL RES, V173, P586, DOI 10.1016/0014-4827(87)90297-7; Zhou P, 2001, P NATL ACAD SCI USA, V98, P6051, DOI 10.1073/pnas.111145098	55	11	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35821	35830		10.1074/jbc.M703110200	http://dx.doi.org/10.1074/jbc.M703110200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17938174	hybrid			2022-12-27	WOS:000251458100044
J	Woloszynek, JC; Coleman, T; Semenkovich, CF; Sands, MS				Woloszynek, Josh C.; Coleman, Trey; Semenkovich, Clay F.; Sands, Mark S.			Lysosomal dysfunction results in altered energy balance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUCOPOLYSACCHARIDOSIS TYPE-VII; NEURONAL CEROID-LIPOFUSCINOSIS; MOUSE MODEL; MICE; FAT; DEFICIENCY; AUTOPHAGY; STORAGE; GENE	The mucopolysaccharidosis (MPS) type VII mouse was originally described as the adipose storage deficiency mouse because of its extreme lean phenotype of unknown etiology. Here, we show that adipose storage deficiency and lower leptin levels are common to five different lysosomal storage diseases (LSDs): MPSI, MPSIIIB, MPSVII, Niemann-Pick type A/B, and infantile neuronal ceroid lipofuscinosis. Elevated circulating pro-inflammatory proteins (VCAM1 and MCP1) were found in multiple LSDs. Multiple anti-inflammatory strategies (dexamethasone, MCP1 deficiency, M3 expression) failed to alter adiposity in LSD animals. All of the models had normal or greater caloric intake and lower to normal metabolic rate, fasting plasma glucose, non-esterified fatty acids, cholesterol, and triglycerides. Triglycerides were lower in the livers of MPSI mice, and the trend was lower in the muscle. Lipid absorption and processing in MPSI mice were indistinguishable from those in normal mice following oral gavage of olive oil. The increased lean mass of MPSI and MPSIIIB mice suggests a shift in adipose triglycerides to lysosomal storage. In agreement, MPSI livers had a similar total caloric content but reduced caloric density, indicating a shift in energy from lipids to proteins/carbohydrates (lysosomal storage). Enzyme replacement therapy normalized the caloric density within 48 h without reducing total caloric content. This was due to an increase in lipids. Recycling of stored material is likely reduced or nonexistent. Therefore, to maintain homeostasis, energy is likely diverted to synthesis at the expense of typical energy storage depots. Thus, these diseases will serve as important tools in studying the role of lysosome function in metabolism and obesity.	Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Sands, MS (corresponding author), Washington Univ, Sch Med, Dept Med, 660 S Euclid Ave, St Louis, MO 63110 USA.	msands@im.wustl.edu		Sands, Mark/0000-0002-5559-0832; Semenkovich, Clay/0000-0003-1163-1871	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL083762] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057586, P30DK056341] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043205, R56NS043205] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL083762] Funding Source: Medline; NIDDK NIH HHS [DK56341, P30 DK056341, DK57586, P30 DK056341-06, P30 DK056341-07] Funding Source: Medline; NINDS NIH HHS [NS043205] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BEAMER WG, 1982, MOUSE NEWSLETT, V67, P21; Bernal-Mizrachi C, 2002, ARTERIOSCL THROM VAS, V22, P961, DOI 10.1161/01.ATV.0000019404.65403.71; Bijvelds MJC, 2005, AM J PHYSIOL-GASTR L, V288, pG646, DOI 10.1152/ajpgi.00295.2004; BIRKENMEIER EH, 1989, J CLIN INVEST, V83, P1258, DOI 10.1172/JCI114010; Cao Y, 2006, J BIOL CHEM, V281, P20483, DOI 10.1074/jbc.M602180200; Cuervo AM, 2004, MOL CELL BIOCHEM, V263, P55, DOI 10.1023/B:MCBI.0000041848.57020.57; Du H, 1998, HUM MOL GENET, V7, P1347, DOI 10.1093/hmg/7.9.1347; Du H, 2005, AM J ROENTGENOL, V184, P658, DOI 10.2214/ajr.184.2.01840658; Du H, 2001, J LIPID RES, V42, P489; Frisella WA, 2001, MOL THER, V3, P351, DOI 10.1006/mthe.2001.0274; Gerhardt CC, 2001, MOL CELL ENDOCRINOL, V175, P81, DOI 10.1016/S0303-7207(01)00394-X; Hofmann SL, 1997, NEUROPEDIATRICS, V28, P27, DOI 10.1055/s-2007-973661; Reitman ML, 2002, ANNU REV NUTR, V22, P459, DOI 10.1146/annurev.nutr.22.010402.102849; SANDS MS, 1993, P NATL ACAD SCI USA, V90, P6567, DOI 10.1073/pnas.90.14.6567; SANDS MS, 1994, J CLIN INVEST, V93, P2324, DOI 10.1172/JCI117237; Sartipy P, 2003, P NATL ACAD SCI USA, V100, P7265, DOI 10.1073/pnas.1133870100; Scriver CR, 2001, METABOLIC MOL BASES, V8, P3371; Vellodi A, 2005, BRIT J HAEMATOL, V128, P413, DOI 10.1111/j.1365-2141.2004.05293.x; [No title captured]	19	57	58	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35765	35771		10.1074/jbc.M705124200	http://dx.doi.org/10.1074/jbc.M705124200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17911106	hybrid			2022-12-27	WOS:000251458100038
J	Fan, X; Liu, YH; Smith, D; Konermann, L; Siu, KWM; Golemi-Kotra, D				Fan, Xin; Liu, Yuhong; Smith, Daryl; Konermann, Lars; Siu, K. W. Michael; Golemi-Kotra, Dasantila			Diversity of penicillin-binding proteins - Resistance factor FmtA of Staphylococcus aureus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-LACTAM ANTIBIOTICS; LEVEL METHICILLIN RESISTANCE; BACTERIAL-CELL WALL; DRUG-RESISTANCE; SIGNALING PATHWAY; DD-PEPTIDASES; SWISS-MODEL; GENE; MECHANISM; CLONING	Antibiotic-resistant Staphylococcus aureus is a major concern to public health. Methicillin-resistant S. aureus strains are completely resistant to all beta-lactams antibiotics. One of the main factors involved in methicillin resistance in S. aureus is the penicillin-binding protein, PBP2a. This protein is insensitive to inactivation by beta-lactam antibiotics such as methicillin. Although other proteins are implicated in high and homogeneous levels of methicillin resistance, the functions of these other proteins remain elusive. Herein, we report for the first time on the putative function of one of these proteins, FmtA. This protein specifically interacts with beta-lactam antibiotics forming covalently bound complexes. The serine residue present in the sequence motif Ser-X-X-Lys (which is conserved among penicillin-binding proteins and beta-lactamases) is the active-site nucleophile during the formation of acyl-enzyme species. FmtA has a low binding affinity for beta-lactams, and it experiences a slow acylation rate, suggesting that this protein is intrinsically resistant to beta-lactam inactivation. We found that FmtA undergoes conformational changes in presence of beta-lactams that may be essential to the beta-lactam resistance mechanism. FmtA binds to peptidoglycan in vitro. Our findings suggest that FmtA is a penicillin-binding protein, and as such, it may compensate for suppressed peptidoglycan biosynthesis under beta-lactam induced cell wall stress conditions.	York Univ, Dept Chem, Toronto, ON M3J 1P3, Canada; York Univ, Ctr Res Mass Spectrometry, Toronto, ON M3J 1P3, Canada; Univ Western Ontario, Dept Chem, London, ON N6A 5B7, Canada	York University - Canada; York University - Canada; Western University (University of Western Ontario)	Golemi-Kotra, D (corresponding author), York Univ, Dept Chem, Toronto, ON M3J 1P3, Canada.	dgkotra@yorku.ca	/N-6611-2013	/0000-0003-1299-6987				ALTSCHUL SF, 1997, NUCLEIC ACIDS RES, V25, P3402; Amyes SGB, 2005, BRIT MED J, V330, P976, DOI 10.1136/bmj.330.7498.976; Barrett D, 2005, J BACTERIOL, V187, P2215, DOI 10.1128/JB.187.6.2215-2217.2005; Berger-Bachi B, 1999, CELL MOL LIFE SCI, V56, P764, DOI 10.1007/s000180050023; Berger-Bachi B, 1998, DRUG RESIST UPDATE, V1, P325, DOI 10.1016/S1368-7646(98)80048-4; Berger-Bachi B, 2002, ARCH MICROBIOL, V178, P165, DOI 10.1007/s00203-002-0436-0; BERGERBACHI B, 1992, ANTIMICROB AGENTS CH, V36, P1367, DOI 10.1128/AAC.36.7.1367; Chambers HF, 2001, EMERG INFECT DIS, V7, P178, DOI 10.3201/eid0702.010204; Chambers HF, 1997, CLIN MICROBIOL REV, V10, P781, DOI 10.1128/CMR.10.4.781; COX RA, 1995, J HOSP INFECT, V29, P107, DOI 10.1016/0195-6701(95)90192-2; CROSSLEY K, 1979, J INFECT DIS, V139, P280, DOI 10.1093/infdis/139.3.280; DEJONGE BLM, 1992, J BIOL CHEM, V267, P11248; DELENCASTRE H, 1994, J ANTIMICROB CHEMOTH, V33, P7, DOI 10.1093/jac/33.1.7; DELENCASTRE H, 1994, ANTIMICROB AGENTS CH, V38, P2590, DOI 10.1128/AAC.38.11.2590; DUBUS A, 1994, BIOCHEM J, V301, P485, DOI 10.1042/bj3010485; EFTINK MR, 1976, BIOCHEMISTRY-US, V15, P672, DOI 10.1021/bi00648a035; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Fitzgerald JR, 2001, P NATL ACAD SCI USA, V98, P8821, DOI 10.1073/pnas.161098098; Fuda C, 2004, J BIOL CHEM, V279, P40802, DOI 10.1074/jbc.M403589200; Fuda CCS, 2005, CELL MOL LIFE SCI, V62, P2617, DOI 10.1007/s00018-005-5148-6; Gee KR, 2001, ELECTROPHORESIS, V22, P960, DOI 10.1002/1522-2683()22:5<960::AID-ELPS960>3.0.CO;2-9; GEORGOPAPADAKOU NH, 1980, ANTIMICROB AGENTS CH, V18, P834, DOI 10.1128/AAC.18.5.834; Goffin C, 2002, MICROBIOL MOL BIOL R, V66, P702, DOI 10.1128/MMBR.66.4.702-738.2002; Goffin C, 1998, MICROBIOL MOL BIOL R, V62, P1079, DOI 10.1128/MMBR.62.4.1079-1093.1998; Golemi-Kotra D, 2003, J BIOL CHEM, V278, P18419, DOI 10.1074/jbc.M300611200; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P9786, DOI 10.1073/pnas.0402521101; Howe RA, 2004, LANCET, V364, P500, DOI 10.1016/S0140-6736(04)16803-7; Howe RA, 2004, EMERG INFECT DIS, V10, P855, DOI 10.3201/eid1005.030556; Hujer AM, 2005, ANTIMICROB AGENTS CH, V49, P612, DOI 10.1128/AAC.49.2.612-618.2005; JACOB F, 1990, PROTEIN ENG, V4, P79, DOI 10.1093/protein/4.1.79; JACOB F, 1990, BIOCHEM J, V271, P399, DOI 10.1042/bj2710399; Komatsuzawa H, 1999, ANTIMICROB AGENTS CH, V43, P2121, DOI 10.1128/AAC.43.9.2121; Komatsuzawa H, 2000, FEMS MICROBIOL LETT, V188, P35, DOI 10.1016/S0378-1097(00)00194-4; Komatsuzawa H, 2000, J ANTIMICROB CHEMOTH, V45, P421, DOI 10.1093/jac/45.4.421; Komatsuzawa H, 1997, ANTIMICROB AGENTS CH, V41, P2355, DOI 10.1128/AAC.41.11.2355; Komatsuzawa H, 2001, FEMS MICROBIOL LETT, V203, P49, DOI 10.1111/j.1574-6968.2001.tb10819.x; KRAULIS PJ, 1991, SCIENCE, V254, P581, DOI 10.1126/science.1658931; Kuroda M, 2003, MOL MICROBIOL, V49, P807, DOI 10.1046/j.1365-2958.2003.03599.x; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lakowicz J. R., 1991, TOPICS FLUORESCENCE; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Lamotte-Brasseur J, 2000, PROTEINS, V40, P23, DOI 10.1002/(SICI)1097-0134(20000701)40:1<23::AID-PROT40>3.0.CO;2-7; Lee M, 2003, J AM CHEM SOC, V125, P16322, DOI 10.1021/ja038445l; Leski TA, 2005, J BACTERIOL, V187, P1815, DOI 10.1128/JB.187.5.1815-1824.2005; Lim D, 2002, NAT STRUCT BIOL, V9, P870, DOI 10.1038/nsb858; Lim SM, 2005, ANAESTHESIA, V60, P887, DOI 10.1111/j.1365-2044.2005.04220.x; Lowy FD, 2003, J CLIN INVEST, V111, P1265, DOI 10.1172/JC1200318535; Macheboeuf P, 2006, FEMS MICROBIOL REV, V30, P673, DOI 10.1111/j.1574-6976.2006.00024.x; MAKI H, 1994, J BACTERIOL, V176, P4993, DOI 10.1128/jb.176.16.4993-5000.1994; McAleese F, 2006, J BACTERIOL, V188, P1120, DOI 10.1128/JB.188.3.1120-1133.2006; McCallum N, 2006, BBA-GEN SUBJECTS, V1760, P1475, DOI 10.1016/j.bbagen.2006.06.008; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; MONNAIE D, 1994, BIOCHEMISTRY-US, V33, P5193, DOI 10.1021/bi00183a024; MORENO F, 1995, CLIN INFECT DIS, V21, P1308, DOI 10.1093/clinids/21.5.1308; MURAKAMI K, 1989, J BACTERIOL, V171, P874, DOI 10.1128/jb.171.2.874-879.1989; Mwangi MM, 2007, P NATL ACAD SCI USA, V104, P9451, DOI 10.1073/pnas.0609839104; *NOV, 2006, PET SYST MAN, P63; Pagliero E, 2004, ANTIMICROB AGENTS CH, V48, P1848, DOI 10.1128/AAC.48.5.1848-1855.2004; Pinho MG, 2001, P NATL ACAD SCI USA, V98, P10886, DOI 10.1073/pnas.191260798; Pinho MG, 2001, J BACTERIOL, V183, P6525, DOI 10.1128/JB.183.22.6525-6531.2001; REYNOLDS P, 1988, ANTIBIOTICS INHIBITI; Said-Salim B, 2003, INFECT CONT HOSP EP, V24, P451, DOI 10.1086/502231; SARAVOLATZ LD, 1982, ANN INTERN MED, V97, P325, DOI 10.7326/0003-4819-97-3-325; Schaffer AA, 2001, NUCLEIC ACIDS RES, V29, P2994, DOI 10.1093/nar/29.14.2994; Scheffers DJ, 2005, MICROBIOL MOL BIOL R, V69, P585, DOI 10.1128/MMBR.69.4.585-607.2005; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shin I, 2002, PROTEIN SCI, V11, P2022, DOI 10.1110/ps.0205102; Silvaggi NR, 2003, BIOCHEMISTRY-US, V42, P1199, DOI 10.1021/bi0268955; Ursinus A, 2004, J BACTERIOL, V186, P6728, DOI 10.1128/JB.186.20.6728-6737.2004; Utaida S, 2003, MICROBIOL-SGM, V149, P2719, DOI 10.1099/mic.0.26426-0; Wada A, 1998, J BACTERIOL, V180, P2759, DOI 10.1128/JB.180.10.2759-2765.1998; WILKIN JM, 1994, BIOCHEM J, V301, P477, DOI 10.1042/bj3010477; WILKIN JM, 1993, BIOCHEM J, V293, P195, DOI 10.1042/bj2930195; Wu SW, 1996, MICROB DRUG RESIST, V2, P277, DOI 10.1089/mdr.1996.2.277; Zhang HZ, 2001, SCIENCE, V291, P1962, DOI 10.1126/science.1055144; Zhao GS, 1999, ANTIMICROB AGENTS CH, V43, P1124, DOI 10.1128/AAC.43.5.1124	78	30	31	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					35143	35152		10.1074/jbc.M706296200	http://dx.doi.org/10.1074/jbc.M706296200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17925392	hybrid			2022-12-27	WOS:000251155200059
J	Golubovic, A; Kuhn, A; Williamson, M; Kalbacher, H; Holstein, TW; Grimmelikhuijzen, CJP; Grunder, S				Golubovic, Andjelko; Kuhn, Anne; Williamson, Michael; Kalbacher, Hubert; Holstein, Thomas W.; Grimmelikhuijzen, Cornelis J. P.; Gruender, Stefan			A peptide-gated ion channel from the freshwater polyp Hydra	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL SODIUM-CHANNEL; NA+ CHANNEL; NERVOUS SYSTEMS; FMRFAMIDE; NEUROPEPTIDES; MAGNIPAPILLATA; LOCALIZATION; SELECTIVITY; EXPRESSION; MUTATION	Chemical transmitters are either low molecular weight molecules or neuropeptides. As a general rule, neuropeptides activate only slow metabotropic receptors. To date, only one exception to this rule is known, the FMRFamide-activated Na+ channel (FaNaC) from snails. Until now FaNaC has been regarded as a curiosity, and it was not known whether peptide-gated ionotropic receptors are also present in other animal groups. Nervous systems first evolved in cnidarians, which extensively use neuropeptides. Here we report cloning from the freshwater cnidarian Hydra of a novel ion channel (Hydra sodium channel, HyNaC) that is directly gated by the neuropeptides Hydra-RFamides I and II and is related to FaNaC. The cells expressing HyNaC localize to the base of the tentacles, adjacent to the neurons producing the Hydra-RFamides, suggesting that the peptides are the natural ligands for this channel. Our results suggest that neuropeptides were already used for fast transmission in ancient nervous systems.	Univ Wurzburg, Dept Physiol 2, D-97070 Wurzburg, Germany; Heidelberg Inst Zool, D-69120 Heidelberg, Germany; Univ Copenhagen, Inst Biol, Dept Cell Biol & Comparat Zool, DK-2100 Copenhagen, Denmark; Univ Tubingen, Interfak Inst Biochem, D-72074 Tubingen, Germany	University of Wurzburg; University of Copenhagen; Eberhard Karls University of Tubingen	Grunder, S (corresponding author), Univ Wurzburg, Dept Physiol 2, Rontgenring 9, D-97070 Wurzburg, Germany.	stefan.gruender@uni-wuerzburg.de	Gründer, Stefan/I-2495-2019	Gründer, Stefan/0000-0002-7635-9883; Grimmelikhuijzen, Cornelis Johannes Pieter/0000-0001-6486-2046; Holstein, Thomas/0000-0003-0480-4674				Askwith CC, 2000, NEURON, V26, P133, DOI 10.1016/S0896-6273(00)81144-7; Chen XM, 2007, J PHYSIOL-LONDON, V579, P657, DOI 10.1113/jphysiol.2006.120733; Coscoy S, 1998, J BIOL CHEM, V273, P8317, DOI 10.1074/jbc.273.14.8317; COTTRELL GA, 1990, PFLUG ARCH EUR J PHY, V416, P612, DOI 10.1007/BF00382698; Cottrell GA, 2001, FEBS LETT, V489, P71, DOI 10.1016/S0014-5793(01)02081-6; Darmer D, 1998, BIOCHEM J, V332, P403, DOI 10.1042/bj3320403; Grimmelikhuijzen CJP, 1996, INT REV CYTOL, V167, P37, DOI 10.1016/S0074-7696(08)61345-5; GRIMMELIKHUIJZEN CJP, 1985, CELL TISSUE RES, V241, P171, DOI 10.1007/BF00214639; GRIMMELIKHUIJZEN CJP, 1983, NEUROSCIENCE, V9, P837, DOI 10.1016/0306-4522(83)90272-5; Grunder S, 2000, NEUROREPORT, V11, P1607; Grunder S, 1997, EMBO J, V16, P899, DOI 10.1093/emboj/16.5.899; Guder C, 2006, DEVELOPMENT, V133, P901, DOI 10.1242/dev.02265; Hansen GN, 2000, CELL TISSUE RES, V301, P245; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Kellenberger S, 1999, P NATL ACAD SCI USA, V96, P4170, DOI 10.1073/pnas.96.7.4170; Kellenberger S, 1999, J GEN PHYSIOL, V114, P13, DOI 10.1085/jgp.114.1.13; KOIZUMI O, 1989, J EXP ZOOL, V249, P17, DOI 10.1002/jez.1402490105; LINGUEGLIA E, 1995, NATURE, V378, P730, DOI 10.1038/378730a0; Mano I, 1999, BIOESSAYS, V21, P568, DOI 10.1002/(SICI)1521-1878(199907)21:7&lt;568::AID-BIES5&gt;3.0.CO;2-L; Moosler A, 1996, BIOCHEM BIOPH RES CO, V229, P596, DOI 10.1006/bbrc.1996.1849; Paukert M, 2004, J BIOL CHEM, V279, P18783, DOI 10.1074/jbc.M401477200; Raible F, 2004, CURR BIOL, V14, pR106, DOI 10.1016/j.cub.2004.01.015; Schaefer L, 2000, FEBS LETT, V471, P205, DOI 10.1016/S0014-5793(00)01403-4; Schultheiss M, 1997, CELL MOL LIFE SCI, V53, P842, DOI 10.1007/s000180050104; Sheng SH, 2000, J BIOL CHEM, V275, P8572, DOI 10.1074/jbc.275.12.8572; Snyder PM, 1999, J BIOL CHEM, V274, P28484, DOI 10.1074/jbc.274.40.28484; Westfall JA, 1996, J NEUROCYTOL, V25, P735, DOI 10.1007/BF02284838	27	69	70	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					35098	35103		10.1074/jbc.M706849200	http://dx.doi.org/10.1074/jbc.M706849200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17911098	hybrid			2022-12-27	WOS:000251155200054
J	Schwamborn, JC; Khazaei, MR; Puschel, AW				Schwamborn, Jens C.; Khazaei, Mohammad R.; Pueschel, Andreas W.			The interaction of mPar3 with the ubiquitin ligase Smurf2 is required for the establishment of neuronal polarity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-POLARITY; MAMMALIAN-CELLS; PROTEIN PAR6; PHOSPHORYLATION; ACTIVATION; COMPLEX; CDC42; TIAM1; APKC; DEGRADATION	The Par polarity complex consisting of the evolutionarily conserved proteins mPar3, mPar6, and aPKC regulates cell polarity in many cell types including neurons. Here we show that mPar3 is required for the establishment of neuronal polarity and links the Smurf2 to Kinesin-2. The HECT domain E3 ubiquitin ligase Smurf2 ensures that neurons extend only a single axon by initiating the degradation of inactive Rap1B through the ubiquitin/proteasome system. Its interaction with mPar3 is required to localize Smurf2 to growth cones and restrict Rap1B to the axon. Interfering with the binding of mPar3 to Kinesin-2 or Smurf2 to mPar3 and knockdown of mPar3 by RNAi disrupt the establishment of neuronal polarity through the failure to restrict Rap1B to a single neurite.	Univ Munster, Mol Biol Abt, Inst Allgemeine Zool & Genet, D-48149 Munster, Germany	University of Munster	Puschel, AW (corresponding author), Univ Munster, Mol Biol Abt, Inst Allgemeine Zool & Genet, Schlosspl 5, D-48149 Munster, Germany.	apuschel@uni-muenster.de						Arimura N, 2007, NAT REV NEUROSCI, V8, P194, DOI 10.1038/nrn2056; Chen XY, 2006, J CELL BIOL, V172, P671, DOI 10.1083/jcb.200510061; Chen XY, 2005, NAT CELL BIOL, V7, P262, DOI 10.1038/ncb1226; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Endo M, 2003, J NEUROSCI, V23, P2527; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Furrer MP, 2003, NAT NEUROSCI, V6, P223, DOI 10.1038/nn1017; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Huppi K, 2005, MOL CELL, V17, P1, DOI 10.1016/j.molcel.2004.12.017; Jiang H, 2005, CELL, V120, P123, DOI 10.1016/j.cell.2004.12.033; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Lee T, 1999, DEVELOPMENT, V126, P4065; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Macara IG, 2004, NAT REV MOL CELL BIO, V5, P220, DOI 10.1038/nrm1332; Mandell JW, 1996, J NEUROSCI, V16, P5727; Mertens AEE, 2005, J CELL BIOL, V170, P1029, DOI 10.1083/jcb.200502129; Nakahira E, 2005, J COMP NEUROL, V483, P329, DOI 10.1002/cne.20441; Nishimura T, 2005, NAT CELL BIOL, V7, P270, DOI 10.1038/ncb1227; Nishimura T, 2004, NAT CELL BIOL, V6, P328, DOI 10.1038/ncb1118; Ozdamar B, 2005, SCIENCE, V307, P1603, DOI 10.1126/science.1105718; Paddison PJ, 2002, GENE DEV, V16, P948, DOI 10.1101/gad.981002; Rolls MM, 2004, NAT NEUROSCI, V7, P1293, DOI 10.1038/nn1346; Schwamborn JC, 2004, NAT NEUROSCI, V7, P923, DOI 10.1038/nn1295; Schwamborn JC, 2007, EMBO J, V26, P1410, DOI 10.1038/sj.emboj.7601580; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Wang HR, 2003, SCIENCE, V302, P1775, DOI 10.1126/science.1090772; Yamanaka T, 2001, GENES CELLS, V6, P721, DOI 10.1046/j.1365-2443.2001.00453.x; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Zhang HY, 2006, NAT CELL BIOL, V8, P227, DOI 10.1038/ncb1368; Zhu HT, 1999, NATURE, V400, P687, DOI 10.1038/23293	31	30	34	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					35259	35268		10.1074/jbc.M703438200	http://dx.doi.org/10.1074/jbc.M703438200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17906294	hybrid			2022-12-27	WOS:000251155200070
J	Kapoor, M; Zhou, Q; Otero, F; Myers, CA; Bates, A; Belani, R; Liu, J; Luo, JK; Tzima, E; Zhang, DE; Yang, XL; Schimmel, P				Kapoor, Mili; Zhou, Quansheng; Otero, Francella; Myers, Christopher A.; Bates, Alison; Belani, Rajesh; Liu, Jianming; Luo, Jiann-Kae; Tzima, Eleni; Zhang, Dong-Er; Yang, Xiang-Lei; Schimmel, Paul			Evidence for annexin II-S100A10 complex and plasmin in mobilization of cytokine activity of human TrpRS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA-SYNTHETASE; ENDOTHELIAL-CELLS; ANGIOGENESIS; FRAGMENT; LOCALIZATION; SECRETION; RETENTION; PROTEINS; SUBUNIT; CANCER	In mammalian cells, specific aminoacyl-transfer RNA (tRNA) synthetases have cytokine functions that require interactions with partners outside of the translation apparatus. Little is known about these interactions and how they facilitate expanded functions that link protein translation to other cellular pathways. For example, an alternative splice fragment of tryptophanyl-tRNA synthetase (TrpRS) and a similar natural proteolytic fragment are potent angiostatic factors that act through the vascular endothelial-cadherin receptor and Akt signaling pathway. Here we demonstrate mobilization of TrpRS for exocytosis from endothelial cells and the potential for plasmin to activate the cytokine function of the extracellular synthetase. Direct physical evidence showed that the annexin II-S100A10 complex, which regulates exocytosis, forms a ternary complex with TrpRS. Functional studies demonstrate that both annexin II and S100A10 regulate trafficking of TrpRS. Thus, complexes of mammalian tRNA synthetases with seemingly disparate proteins may in general be relevant to understanding how their expanded functions are implemented.	[Luo, Jiann-Kae; Zhang, Dong-Er] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Kapoor, Mili; Zhou, Quansheng; Otero, Francella; Myers, Christopher A.; Bates, Alison; Belani, Rajesh; Liu, Jianming; Yang, Xiang-Lei; Schimmel, Paul] Skaggs Inst Chem Biol, Dept Mol Biol, La Jolla, CA 92037 USA; [Tzima, Eleni] Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC 27599 USA	Scripps Research Institute; Scripps Research Institute; University of North Carolina; University of North Carolina Chapel Hill	Schimmel, P (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	schimmel@scripps.edu	Yang, Xiang-Lei/AAR-7107-2020; Tzima, Ellie/L-9256-2017	Tzima, Ellie/0000-0002-3437-0902; Zhou, Quansheng/0000-0003-4712-0731; Yang, Xiang-Lei/0000-0003-2554-084X	NATIONAL CANCER INSTITUTE [R01CA092577] Funding Source: NIH RePORTER; NCI NIH HHS [CA092577] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Andreasen PA, 1997, INT J CANCER, V72, P1, DOI 10.1002/(SICI)1097-0215(19970703)72:1<1::AID-IJC1>3.0.CO;2-Z; Chang SY, 2002, J BIOL CHEM, V277, P8388, DOI 10.1074/jbc.M108792200; Dorrell MI, 2007, P NATL ACAD SCI USA, V104, P967, DOI 10.1073/pnas.0607542104; FARBER JM, 1993, BIOCHEM BIOPH RES CO, V192, P223, DOI 10.1006/bbrc.1993.1403; FAVOROVA OO, 1989, EUR J BIOCHEM, V184, P583, DOI 10.1111/j.1432-1033.1989.tb15053.x; FLECKNER J, 1991, P NATL ACAD SCI USA, V88, P11520, DOI 10.1073/pnas.88.24.11520; Gromov P, 2003, MOL CELL PROTEOMICS, V2, P70, DOI 10.1074/mcp.M200051-MCP200; Halwani R, 2004, J VIROL, V78, P7553, DOI 10.1128/JVI.78.14.7553-7564.2004; Han JM, 2007, AM J PATHOL, V170, P2042, DOI 10.2353/ajpath.2007.061266; Jeffery CJ, 1999, TRENDS BIOCHEM SCI, V24, P8, DOI 10.1016/S0968-0004(98)01335-8; Kim MJ, 2003, NAT GENET, V34, P330, DOI 10.1038/ng1182; Kise Y, 2004, NAT STRUCT MOL BIOL, V11, P149, DOI 10.1038/nsmb722; Knop M, 2004, EMBO J, V23, P2982, DOI 10.1038/sj.emboj.7600319; Ko HS, 2005, J NEUROSCI, V25, P7968, DOI 10.1523/JNEUROSCI.2172-05.2005; Ko YG, 2001, J BIOL CHEM, V276, P6030, DOI 10.1074/jbc.M006189200; Ko YG, 2000, J CELL BIOL, V149, P567, DOI 10.1083/jcb.149.3.567; Konig J, 1998, J BIOL CHEM, V273, P19679, DOI 10.1074/jbc.273.31.19679; Kwon MJ, 2005, FRONT BIOSCI-LANDMRK, V10, P300, DOI 10.2741/1529; Liu JM, 2004, NUCLEIC ACIDS RES, V32, P719, DOI 10.1093/nar/gkh240; Martinis Susan A., 1999, EMBO (European Molecular Biology Organization) Journal, V18, P4591, DOI 10.1093/emboj/18.17.4591; MIGNATTI P, 1993, PHYSIOL REV, V73, P161, DOI 10.1152/physrev.1993.73.1.161; Nickel W, 2003, EUR J BIOCHEM, V270, P2109, DOI 10.1046/j.1432-1033.2003.03577.x; Otani A, 2002, P NATL ACAD SCI USA, V99, P178, DOI 10.1073/pnas.012601899; Otani A, 2002, NAT MED, V8, P1004, DOI 10.1038/nm744; Park BJ, 2005, CELL, V120, P209, DOI 10.1016/j.cell.2004.11.054; Park SG, 2005, TRENDS BIOCHEM SCI, V30, P569, DOI 10.1016/j.tibs.2005.08.004; Park SG, 2005, P NATL ACAD SCI USA, V102, P6356, DOI 10.1073/pnas.0500226102; Renigunta V, 2006, TRAFFIC, V7, P168, DOI 10.1111/j.1600-0854.2005.00375.x; Sampath P, 2004, CELL, V119, P195, DOI 10.1016/j.cell.2004.09.030; Seshaiah P, 1999, MOL BIOL CELL, V10, P1595, DOI 10.1091/mbc.10.5.1595; Sottile J, 2004, BBA-REV CANCER, V1654, P13, DOI 10.1016/j.bbcan.2003.07.002; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; STRIETER RM, 1995, J LEUKOCYTE BIOL, V57, P752, DOI 10.1002/jlb.57.5.752; TOLSTRUP AB, 1995, J BIOL CHEM, V270, P397, DOI 10.1074/jbc.270.1.397; Turpaev KT, 1996, EUR J BIOCHEM, V240, P732, DOI 10.1111/j.1432-1033.1996.0732h.x; Tzima E, 2005, J BIOL CHEM, V280, P2405, DOI 10.1074/jbc.C400431200; Tzima E, 2003, P NATL ACAD SCI USA, V100, P14903, DOI 10.1073/pnas.2436330100; Van de Graaf SFJ, 2003, EMBO J, V22, P1478, DOI 10.1093/emboj/cdg162; Wakasugi K, 2002, J BIOL CHEM, V277, P20124, DOI 10.1074/jbc.C200126200; Wakasugi K, 2002, P NATL ACAD SCI USA, V99, P173, DOI 10.1073/pnas.012602099; Wakasugi K, 1999, SCIENCE, V284, P147, DOI 10.1126/science.284.5411.147; Yang D, 2001, J BIOCHEM-TOKYO, V129, P561, DOI 10.1093/oxfordjournals.jbchem.a002891	43	31	34	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					2070	2077		10.1074/jbc.M706028200	http://dx.doi.org/10.1074/jbc.M706028200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	17999956	Green Published, hybrid			2022-12-27	WOS:000252501000034
J	Osusky, M; Teschke, L; Wang, XY; Wong, K; Buckley, JT				Osusky, Milan; Teschke, Lisa; Wang, Xiaoying; Wong, Kevin; Buckley, J. Thomas			A chimera of interleukin 2 and a binding variant of aerolysin is selectively toxic to cells displaying the interleukin 2 receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHANNEL-FORMING TOXIN; SEPTICUM ALPHA-TOXIN; AEROMONAS-SALMONICIDA; RECEPTOR-BINDING; MEMBRANE-CHANNEL; BETA-SUBUNIT; PROTEIN; PROAEROLYSIN; EXPRESSION; DOMAIN	Aerolysin is a bacterial toxin that binds to glycosylphosphatidylinositol-anchored proteins (GPI-AP) on mammalian cells and oligomerizes, inserting into the target membranes and forming channels that cause cell death. We have made a variant of aerolysin, R336A, that has greatly reduced the ability to bind to GPI-AP, and as a result it is only very weakly active. Fusion of interleukin 2 (IL2) to the N terminus of R336A-aerolysin results in a hybrid that has little or no activity against cells that do not have an IL2 receptor because it cannot bind to the GPI-AP on the cells. Strikingly, the presence of the IL2 moiety allows this hybrid to bind to cells displaying high affinity IL2 receptors. Once bound, the hybrid molecules form insertion-competent oligomers. Cell death occurs at picomolar concentrations of the hybrid, whereas the same cells are insensitive to much higher concentrations of R336A-aerolysin lacking the IL2 domain. The targeted channel-forming hybrid protein may have important advantages as a therapeutic agent.	[Osusky, Milan; Teschke, Lisa; Wang, Xiaoying; Wong, Kevin; Buckley, J. Thomas] Protox Therapeut Inc, Vancouver, BC V6C 3E8, Canada		Buckley, JT (corresponding author), Protox Therapeut Inc, 1210-885 W Georgia St, Vancouver, BC V6C 3E8, Canada.	tbuckley@protoxtherapeutics.com						Abrami L, 1998, J BIOL CHEM, V273, P32656, DOI 10.1074/jbc.273.49.32656; BUCKLEY JT, 1990, BIOCHEM CELL BIOL, V68, P221, DOI 10.1139/o90-029; BUCKLEY JT, 1999, COMPREHENSIVE SOURCE, P362; Cabiaux V, 1997, BIOCHEMISTRY-US, V36, P15224, DOI 10.1021/bi971216p; Cowell S, 1997, MOL MICROBIOL, V25, P343, DOI 10.1046/j.1365-2958.1997.4691828.x; Diep DB, 1998, J BIOL CHEM, V273, P2355, DOI 10.1074/jbc.273.4.2355; Diep DB, 1998, MOL MICROBIOL, V30, P341, DOI 10.1046/j.1365-2958.1998.01068.x; DUPREZ V, 1985, P NATL ACAD SCI USA, V82, P6932, DOI 10.1073/pnas.82.20.6932; FURSTE JP, 1986, GENE, V48, P119, DOI 10.1016/0378-1119(86)90358-6; HARAYAMA S, 1980, MOL GEN GENET, V180, P47, DOI 10.1007/BF00267351; HOWARD SP, 1985, J BACTERIOL, V161, P1118, DOI 10.1128/JB.161.3.1118-1124.1985; HOWARD SP, 1985, J BACTERIOL, V163, P336, DOI 10.1128/JB.163.1.336-340.1985; HULI J, 1987, J EXP MED, V165, P157, DOI 10.1084/jem.165.1.157; Li Z, 2005, CELL MOL IMMUNOL, V2, P106; LORBERBOUMGALSKI H, 1990, J BIOL CHEM, V265, P16311; MacKenzie CR, 1999, J BIOL CHEM, V274, P22604, DOI 10.1074/jbc.274.32.22604; Melton JA, 2004, J BIOL CHEM, V279, P14315, DOI 10.1074/jbc.M313758200; Miller J. H., 1972, EXPT MOL GENETICS, P431; MINAMI Y, 1993, ANNU REV IMMUNOL, V11, P245, DOI 10.1146/annurev.immunol.11.1.245; Nelson KL, 1997, J BIOL CHEM, V272, P12170, DOI 10.1074/jbc.272.18.12170; PARKER MW, 1994, NATURE, V367, P292, DOI 10.1038/367292a0; ROSOLEN A, 1989, BLOOD, V73, P1968; Rossjohn J, 1998, J STRUCT BIOL, V121, P92, DOI 10.1006/jsbi.1997.3947; Rossjohn J, 1998, BIOCHEMISTRY-US, V37, P741, DOI 10.1021/bi9721039; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sellman BR, 1997, MOL MICROBIOL, V25, P429, DOI 10.1046/j.1365-2958.1997.4541820.x; Steinberger I, 1997, SCAND J IMMUNOL, V46, P129, DOI 10.1046/j.1365-3083.1997.d01-101.x; UCHIYAMA T, 1981, J IMMUNOL, V126, P1393; VANDERGOOT FG, 1993, BIOCHEMISTRY-US, V32, P2636, DOI 10.1021/bi00061a023; WILLIAMS DP, 1987, PROTEIN ENG, V1, P493, DOI 10.1093/protein/1.6.493; Williams SA, 2007, JNCI-J NATL CANCER I, V99, P376, DOI 10.1093/jnci/djk065; WONG KR, 1989, J BACTERIOL, V171, P2523, DOI 10.1128/jb.171.5.2523-2527.1989; Wong L, 2005, SEMIN ONCOL, V32, P591, DOI 10.1053/j.seminoncol.2005.08.002	33	4	5	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1572	1579		10.1074/jbc.M706424200	http://dx.doi.org/10.1074/jbc.M706424200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	17981806	hybrid			2022-12-27	WOS:000252282700042
J	Panka, DJ; Cho, DC; Atkins, MB; Mier, JW				Panka, David J.; Cho, Daniel C.; Atkins, Michael B.; Mier, James W.			GSK-3 beta inhibition enhances sorafenib-induced apoptosis in melanoma cell lines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; CASPASE-INDEPENDENT APOPTOSIS; CASEIN KINASE-II; MULTISITE PHOSPHORYLATION; MEMBRANE PERMEABILIZATION; MCL-1; ACTIVATION; P53; INACTIVATION; SPECIFICITY	Glycogen synthase kinase-3 beta(GSK-3 beta) can participate in the induction of apoptosis or, alternatively, provide a survival signal that minimizes cellular injury. We previously demonstrated that the multikinase inhibitor sorafenib induces apoptosis in melanoma cell lines. In this report, we show that sorafenib activates GSK-3 beta in multiple subcellular compartments and that this activation undermines the lethality of the drug. Pharmacologic inhibition and/or down-modulation of the kinase enhances sorafenib-induced apoptosis as determined by propidium iodide staining and by assessing the mitochondrial release of apoptosis-inducing factor and Smac/DIABLO. Conversely, the forced expression of a constitutively active form of the enzyme (GSK-3 beta(S9A)) protects the cells from the apoptotic effects of the drug. This protective effect is associated with a marked increase in basal levels of Bcl-2, Bcl-x(L), and survivin and a diminution in the degree to which these anti-apoptotic proteins are down-modulated by sorafenib exposure. Sorafenib down-modulates the pro-apoptotic Bcl-2 family member Noxa in cells with high constitutive GSK-3 beta activity. Pharmacologic inhibition of GSK-3 beta prevents the disappearance of Noxa induced by sorafenib and enhances the down-modulation of Mcl-1. Down-modulation of Noxa largely eliminates the enhancing effect of GSK-3 inhibition on sorafenib-induced apoptosis. These data provide a strong rationale for the use of GSK-3 beta inhibitors as adjuncts to sorafenib treatment and suggest that preservation of Noxa may contribute to their efficacy.	[Panka, David J.; Cho, Daniel C.; Atkins, Michael B.; Mier, James W.] Beth Israel Deaconess Med Ctr, Div Oncol, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center	Mier, JW (corresponding author), Beth Israel Deaconess Med Ctr, Div Oncol, Boston, MA 02215 USA.	jmier@bidmc.harvard.edu			NATIONAL CANCER INSTITUTE [P50CA093683] Funding Source: NIH RePORTER; NCI NIH HHS [P50CA93683] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ali A, 2001, CHEM REV, V101, P2527, DOI 10.1021/cr000110o; Bijur GN, 2003, NEUROREPORT, V14, P2415, DOI 10.1097/00001756-200312190-00025; Bijur GN, 2001, J BIOL CHEM, V276, P37436, DOI 10.1074/jbc.M105725200; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Czabotar PE, 2007, P NATL ACAD SCI USA, V104, P6217, DOI 10.1073/pnas.0701297104; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dong JJ, 2005, CANCER RES, V65, P1961, DOI 10.1158/0008-5472.CAN-04-2501; Ghosh JC, 2005, CLIN CANCER RES, V11, P4580, DOI 10.1158/1078-0432.CCR-04-2624; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Liu T, 2004, ONCOGENE, V23, P39, DOI 10.1038/sj.onc.1206978; LOMAX MI, 1992, P NATL ACAD SCI USA, V89, P5266, DOI 10.1073/pnas.89.12.5266; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; NEVINS JR, 1987, METHOD ENZYMOL, V152, P234; Panka DJ, 2006, CANCER RES, V66, P1611, DOI 10.1158/0008-5472.CAN-05-0808; PICTON C, 1982, FEBS LETT, V150, P191, DOI 10.1016/0014-5793(82)81332-X; Rottmann S, 2005, P NATL ACAD SCI USA, V102, P15195, DOI 10.1073/pnas.0505114102; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; SKURAT AV, 1995, J BIOL CHEM, V270, P12491, DOI 10.1074/jbc.270.21.12491; Smalley KSM, 2007, CANCER RES, V67, P209, DOI 10.1158/0008-5472.CAN-06-1538; STAMBOLIC V, 1994, BIOCHEM J, V303, P701, DOI 10.1042/bj3030701; Summers SA, 1999, J BIOL CHEM, V274, P17934, DOI 10.1074/jbc.274.25.17934; SUTHERLAND C, 1993, BIOCHEM J, V296, P15, DOI 10.1042/bj2960015; Turenne GA, 2001, BMC CELL BIOL, V2, DOI 10.1186/1471-2121-2-12; Vong QP, 2005, SCIENCE, V310, P1499, DOI 10.1126/science.1120160; Williams DD, 1999, FEBS LETT, V448, P86, DOI 10.1016/S0014-5793(99)00342-7; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; WOODGETT JR, 1984, BIOCHIM BIOPHYS ACTA, V788, P339, DOI 10.1016/0167-4838(84)90047-5; WOODGETT JR, 2001, SCI STKE, V100, P1; Yu CR, 2005, ONCOGENE, V24, P6861, DOI 10.1038/sj.onc.1208841	30	50	53	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					726	732		10.1074/jbc.M705343200	http://dx.doi.org/10.1074/jbc.M705343200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	17991738	hybrid			2022-12-27	WOS:000252128100010
J	Buxade, M; Morrice, N; Krebs, DL; Proud, CG				Buxade, Maria; Morrice, Nick; Krebs, Danielle L.; Proud, Christopher G.			The PSF.p54(nrb) complex is a novel Mnk substrate that binds the mRNA for tumor necrosis factor alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; INITIATION-FACTOR 4E; PHOSPHORYLATION; PSF; TRANSLATION; IDENTIFICATION; ELEMENTS; CLONING	To identify new potential substrates for the MAP kinase signal-integrating kinases (Mnks), we employed a proteomic approach. The Mnks are targeted to the translational machinery through their interaction with the cap-binding initiation factor complex. Wetested whether proteins retained on cap resin were substrates for the Mnks in vitro, and identified one such protein as PSF (the PTB (polypyrimidine tract-binding protein)-associated splicing factor). Mnks phosphorylate PSF at two sites in vitro, and our data show that PSF is an Mnk substrate in vivo. We also demonstrate that PSF, together with its partner, p54(nrb), binds RNAs that contain AU-rich elements (AREs), such as those for proinflammatory cytokines (e. g. tumor necrosis factor alpha (TNF alpha)). Indeed, PSF associates specifically with the TNF alpha mRNA in living cells. PSF is phosphorylated at two sites by the Mnks. Our data show that Mnk-mediated phosphorylation increases the binding of PSF to the TNF alpha mRNA in living cells. These findings identify a novel Mnk substrate. They also suggest that the Mnk-catalyzed phosphorylation of PSF may regulate the fate of specific mRNAs by modulating their binding to PSF.p54nrb.	[Buxade, Maria; Proud, Christopher G.] Univ Dundee, Coll Life Sci, Div Mol Physiol, Dundee DD1 5EH, Scotland; [Morrice, Nick] Univ Dundee, Coll Life Sci, Med Res Council Protein Phosphorylat Unit, Dundee DD1 5EH, Scotland; [Buxade, Maria; Krebs, Danielle L.; Proud, Christopher G.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada	University of Dundee; University of Dundee; University of British Columbia	Proud, CG (corresponding author), Univ Dundee, Coll Life Sci, Div Mol Physiol, Dundee DD1 5EH, Scotland.	cgpr@interchange.ubc.ca	Buxade, Maria/F-7870-2014	Buxade, Maria/0000-0002-3020-8393; Proud, Christopher/0000-0003-0704-6442; Krebs, Danielle/0000-0002-6522-7308				Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; Buxade M, 2005, IMMUNITY, V23, P177, DOI 10.1016/j.immuni.2005.06.009; Fukunaga R, 1997, EMBO J, V16, P1921, DOI 10.1093/emboj/16.8.1921; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Herbert TP, 2000, J BIOL CHEM, V275, P11249, DOI 10.1074/jbc.275.15.11249; Hershey JWB, 2000, COLD SPRING HARBOR M, V39, P33; IZAURRALDE E, 1994, CELL, V78, P657, DOI 10.1016/0092-8674(94)90530-4; Karin Michael, 2005, Proc Am Thorac Soc, V2, P386, DOI 10.1513/pats.200504-034SR; Knauf U, 2001, MOL CELL BIOL, V21, P5500, DOI 10.1128/MCB.21.16.5500-5511.2001; Knebel A, 2001, EMBO J, V20, P4360, DOI 10.1093/emboj/20.16.4360; MADER S, 1995, MOL CELL BIOL, V15, P4990; Mathur M, 2001, MOL CELL BIOL, V21, P2298, DOI 10.1128/MCB.21.7.2298-2311.2001; Niranjanakumari S, 2002, METHODS, V26, P182, DOI 10.1016/S1046-2023(02)00021-X; O'Loghlen A, 2004, EXP CELL RES, V299, P343, DOI 10.1016/j.yexcr.2004.06.006; PATTON JG, 1993, GENE DEV, V7, P393, DOI 10.1101/gad.7.3.393; Proteau A, 2005, J MOL BIOL, V346, P1163, DOI 10.1016/j.jmb.2004.12.034; Pyronnet S, 1999, EMBO J, V18, P270, DOI 10.1093/emboj/18.1.270; Raught B, 2000, COLD SPRING HARBOR M, V39, P245; Rom E, 1998, J BIOL CHEM, V273, P13104, DOI 10.1074/jbc.273.21.13104; Rousseau S, 2002, EMBO J, V21, P6505, DOI 10.1093/emboj/cdf639; Sachs A, 2000, COLD SPRING HARBOR M, V39, P447; Scheper GC, 2003, MOL CELL BIOL, V23, P5692, DOI 10.1128/MCB.23.16.5692-5705.2003; Scheper GC, 2001, MOL CELL BIOL, V21, P743, DOI 10.1128/MCB.21.3.743-754.2001; Shav-Tal Y, 2002, FEBS LETT, V531, P109, DOI 10.1016/S0014-5793(02)03447-6; Shav-Tal Y, 2001, MOL BIOL CELL, V12, P2328, DOI 10.1091/mbc.12.8.2328; STERN BD, 1993, PROTEIN EXPRES PURIF, V4, P320, DOI 10.1006/prep.1993.1041; Ueda T, 2004, MOL CELL BIOL, V24, P6539, DOI 10.1128/MCB.24.15.6539-6549.2004; Urban RJ, 2002, AM J PHYSIOL-ENDOC M, V283, pE423, DOI 10.1152/ajpendo.00057.2002; Wang XM, 2001, EMBO J, V20, P4370, DOI 10.1093/emboj/20.16.4370; Wang XM, 1998, J BIOL CHEM, V273, P9373, DOI 10.1074/jbc.273.16.9373; Waskiewicz AJ, 1999, MOL CELL BIOL, V19, P1871; Waskiewicz AJ, 1997, EMBO J, V16, P1909, DOI 10.1093/emboj/16.8.1909; Williamson BL, 2006, MOL CELL PROTEOMICS, V5, P337, DOI 10.1074/mcp.M500210-MCP200; Zhang T, 2002, BIOCHEM SOC T, V30, P952, DOI 10.1042/BST0300952; Zolotukhin AS, 2003, MOL CELL BIOL, V23, P6618, DOI 10.1128/MCB.23.18.6618-6630.2003	36	59	63	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					57	65		10.1074/jbc.M705286200	http://dx.doi.org/10.1074/jbc.M705286200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17965020	Green Accepted, hybrid			2022-12-27	WOS:000251940300008
J	Kim, JY; Omori, E; Matsumoto, K; Nunez, G; Ninomiya-Tsuji, J				Kim, Jae-Young; Omori, Emily; Matsumoto, Kunihiro; Nunez, Gabriel; Ninomiya-Tsuji, Jun			TAK1 is a central mediator of NOD2 signaling in epidermal cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; INTESTINAL EPITHELIAL-CELLS; TOLL-LIKE RECEPTORS; CROHNS-DISEASE; MURAMYL DIPEPTIDE; INNATE IMMUNITY; PROTEIN-KINASE; ACTIVATION; PATHWAYS; RECOGNITION	Muramyl dipeptide (MDP) is a peptidoglycan moiety derived from commensal and pathogenic bacteria, and a ligand of its intracellular sensor NOD2. Mutations in NOD2 are highly associated with Crohn disease, which is characterized by dysregulated inflammation in the intestine. However, the mechanism linking abnormality of NOD2 signaling and inflammation has yet to be elucidated. Here we show that transforming growth factor beta-activated kinase 1 (TAK1) is an essential intermediate of NOD2 signaling. We found that TAK1 deletion completely abolished MDP-NOD2 signaling, activation of NF-kappa B and MAPKs, and subsequent induction of cytokines/chemokines in keratinocytes. NOD2 and its downstream effector RICK associated with and activated TAK1. TAK1 deficiency also abolished MDP-induced NOD2 expression. Because mice with epidermis-specific deletion of TAK1 develop severe inflammatory conditions, we propose that TAK1 and NOD2 signaling are important for maintaining normal homeostasis of the skin, and its ablation may impair the skin barrier function leading to inflammation.	[Kim, Jae-Young; Omori, Emily; Ninomiya-Tsuji, Jun] N Carolina State Univ, Dept Environm & Mol Toxicol, Raleigh, NC 27695 USA; [Matsumoto, Kunihiro] Nagoya Univ, Grad Sch Sci, Dept Mol Biol, Nagoya, Aichi 4648602, Japan; [Nunez, Gabriel] Univ Michigan, Ctr Comprehens Canc, Dept Pathol, Ann Arbor, MI 48109 USA; [Matsumoto, Kunihiro] Japan Sci & Technol, Solut Oriented Res Sci & Technol, Tokyo, Japan	University of North Carolina; North Carolina State University; Nagoya University; University of Michigan System; University of Michigan; Japan Science & Technology Agency (JST)	Ninomiya-Tsuji, J (corresponding author), N Carolina State Univ, Dept Environm & Mol Toxicol, Campus Box 7633, Raleigh, NC 27695 USA.	Jun_Tsuji@ncsu.edu	Nuñez, Gabriel/A-7160-2014	Kim, Jae-Young/0000-0001-6700-1372; Ninomiya-Tsuji, Jun/0000-0002-5584-0176	NIGMS NIH HHS [R01 GM068812, R01 GM068812-04, GM 068812] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068812] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abbott DW, 2004, CURR BIOL, V14, P2217, DOI 10.1016/j.cub.2004.12.032; ABBOTT DW, 2007, MOL CELL BIOL; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Bouma G, 2003, NAT REV IMMUNOL, V3, P521, DOI 10.1038/nri1132; Chen CM, 2004, J BIOL CHEM, V279, P25876, DOI 10.1074/jbc.M400682200; Chen ZJ, 2006, CELL DEATH DIFFER, V13, P687, DOI 10.1038/sj.cdd.4401869; Eckmann L, 2005, IMMUNITY, V22, P661, DOI 10.1016/j.immuni.2005.06.004; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Gutierrez O, 2002, J BIOL CHEM, V277, P41701, DOI 10.1074/jbc.M206473200; Hugot JP, 2006, ANN NY ACAD SCI, V1072, P9, DOI 10.1196/annals.1326.011; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Inohara N, 2000, J BIOL CHEM, V275, P27823; Inohara N, 2005, ANNU REV BIOCHEM, V74, P355, DOI 10.1146/annurev.biochem.74.082803.133347; Inohara N, 1998, J BIOL CHEM, V273, P12296, DOI 10.1074/jbc.273.20.12296; Kajino T, 2006, J BIOL CHEM, V281, P39891, DOI 10.1074/jbc.M608155200; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Kelsall B, 2005, NAT MED, V11, P383, DOI 10.1038/nm0405-383; Kishida S, 2005, GENES CELLS, V10, P447, DOI 10.1111/j.1365-2443.2005.00852.x; Kishimoto K, 2000, J BIOL CHEM, V275, P7359, DOI 10.1074/jbc.275.10.7359; Kitamura T, 1998, INT J HEMATOL, V67, P351; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Kobayashi KS, 2003, NAT IMMUNOL, V4, P652, DOI 10.1038/ni0703-652; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Lotz M, 2006, J EXP MED, V203, P973, DOI 10.1084/jem.20050625; Lu CF, 2005, J BIOL CHEM, V280, P16278, DOI 10.1074/jbc.M410114200; McCarthy JV, 1998, J BIOL CHEM, V273, P16968, DOI 10.1074/jbc.273.27.16968; Medzhitov R, 2000, IMMUNOL REV, V173, P89, DOI 10.1034/j.1600-065X.2000.917309.x; Nenci A, 2006, HUM MOL GENET, V15, P531, DOI 10.1093/hmg/ddi470; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Omori E, 2006, J BIOL CHEM, V281, P19610, DOI 10.1074/jbc.M603384200; Park JH, 2007, J IMMUNOL, V178, P2380, DOI 10.4049/jimmunol.178.4.2380; Pauleau AL, 2003, MOL CELL BIOL, V23, P7531, DOI 10.1128/MCB.23.21.7531-7539.2003; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rosenstiel P, 2003, GASTROENTEROLOGY, V124, P1001, DOI 10.1053/gast.2003.50157; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Strober W, 2006, NAT REV IMMUNOL, V6, P9, DOI 10.1038/nri1747; Takaesu G, 2003, J MOL BIOL, V326, P105, DOI 10.1016/S0022-2836(02)01404-3; Thome M, 1998, CURR BIOL, V8, P885, DOI 10.1016/S0960-9822(07)00352-1; Voss E, 2006, J BIOL CHEM, V281, P2005, DOI 10.1074/jbc.M511044200; Watanabe T, 2004, NAT IMMUNOL, V5, P800, DOI 10.1038/ni1092; Wehkamp J, 2004, GUT, V53, P1658, DOI 10.1136/gut.2003.032805; Windheim M, 2007, BIOCHEM J, V404, P179, DOI 10.1042/BJ20061704	46	75	81	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					137	144		10.1074/jbc.M704746200	http://dx.doi.org/10.1074/jbc.M704746200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17965022	Green Accepted, hybrid			2022-12-27	WOS:000251940300016
J	Supekova, L; Supek, F; Lee, J; Chen, S; Gray, N; Pezacki, JP; Schlapbach, A; Schultz, PG				Supekova, Lubica; Supek, Frantisek; Lee, Jongkook; Chen, Shawn; Gray, Nathanael; Pezacki, John P.; Schlapbach, Achim; Schultz, Peter G.			Identification of human kinases involved in hepatitis C virus replication by small interference RNA library screening	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VACCINIA-RELATED KINASE-1; SRC FAMILY KINASES; TYROSINE KINASES; DISRUPTION; ACTIVATION; GENE; PHOSPHORYLATION; MATURATION; INHIBITORS; REPORTER	The propagation of the hepatitis C virus (HCV) is a complex process that requires both host and viral proteins. To facilitate identification of host cell factors that are required for HCV replication, we screened a panel of small interference RNAs that preferentially target human protein kinases using an HCV replicon expressing the firefly luciferase gene as a genetic reporter. Small interference RNAs specific for three human kinases, Csk, Jak1, and Vrk1, were identified that reproducibly reduce viral RNA and viral protein levels in HCV replicon-bearing cells. Treatment of replicon cells with a small molecule inhibitor of Csk also resulted in a significant reduction in HCV RNA and proteins, further supporting a role for Csk in HCV replication. The effects of siRNAs targeting eight kinases known to be negatively regulated by Csk were then examined; knock down of one of these kinases, Fyn, resulted in up-regulation of the HCV replicon, suggesting that Csk mediates its effect on HCV replication through Fyn. This conclusion was further corroborated by demonstration that replicon cells treated with Csk inhibitor contained lower levels of the phosphorylated form of Fyn than control cells.	[Supekova, Lubica; Lee, Jongkook; Schultz, Peter G.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Supek, Frantisek; Schultz, Peter G.] Genom Inst Novartis Res Fdn, Dept Drug Discovery, San Diego, CA 92121 USA; [Gray, Nathanael] Harvard Med Sch, Dana Farber Canc Inst, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Pezacki, John P.] Steacie Inst Mol Sci, Ottawa, ON K1A 0R6, Canada; [Schlapbach, Achim] Novartis Inst Biomed Res, CH-4002 Basel, Switzerland	Scripps Research Institute; Novartis; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; National Research Council Canada; Novartis	Schultz, PG (corresponding author), 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	schultz@scripps.edu	Chen, Shawn/K-3585-2012	Chen, Shawn/0000-0002-6678-3293; Schlapbach, Achim/0000-0001-8137-8889; Lee, Jongkook/0000-0003-0739-7963				Aza-Blanc P, 2003, MOL CELL, V12, P627, DOI 10.1016/S1097-2765(03)00348-4; Barcia R, 2002, ARCH BIOCHEM BIOPHYS, V399, P1, DOI 10.1006/abbi.2001.2746; Blanco S, 2006, FEBS J, V273, P2487, DOI 10.1111/j.1742-4658.2006.05256.x; Bouchard MJ, 2004, J VIROL, V78, P12725, DOI 10.1128/JVI.78.23.12725-12734.2004; Chan L, 2004, BIOORG MED CHEM LETT, V14, P797, DOI 10.1016/j.bmcl.2003.10.068; Chu JJH, 2007, P NATL ACAD SCI USA, V104, P3520, DOI 10.1073/pnas.0611681104; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Gao L, 2004, J VIROL, V78, P3480, DOI 10.1128/JVI.78.7.3480-3488.2004; Gosert R, 2003, J VIROL, V77, P5487, DOI 10.1128/JVI.77.9.5487-5492.2003; Hirsch AJ, 2005, J VIROL, V79, P11943, DOI 10.1128/JVI.79.18.11943-11951.2005; Ihle JN, 1995, ADV IMMUNOL, V60, P1, DOI 10.1016/S0065-2776(08)60582-9; IMAMOTO A, 1993, CELL, V73, P1117, DOI 10.1016/0092-8674(93)90641-3; Ishii N, 2006, J VIROL, V80, P4510, DOI 10.1128/JVI.80.9.4510-4520.2006; Klein NP, 1999, EMBO J, V18, P5019, DOI 10.1093/emboj/18.18.5019; Liang Y, 2006, J VIROL, V80, P3349, DOI 10.1128/JVI.80.7.3349-3359.2006; Lin K, 2006, ANTIMICROB AGENTS CH, V50, P1813, DOI 10.1128/AAC.50.5.1813-1822.2006; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Lopez-Borges S, 2000, ONCOGENE, V19, P3656, DOI 10.1038/sj.onc.1203709; Lund TC, 1997, J VIROL, V71, P6677, DOI 10.1128/JVI.71.9.6677-6682.1997; Lundin M, 2003, J VIROL, V77, P5428, DOI 10.1128/JVI.77.9.5428-5438.2003; Macdonald A, 2005, J GEN VIROL, V86, P1035, DOI 10.1099/vir.0.80734-0; Macdonald A, 2004, J GEN VIROL, V85, P721, DOI 10.1099/vir.0.19691-0; MIGONE TS, 1995, SCIENCE, V269, P79, DOI 10.1126/science.7604283; MULLER M, 1993, NATURE, V366, P129, DOI 10.1038/366129a0; Murray EM, 2003, J VIROL, V77, P2928, DOI 10.1128/JVI.77.5.2928-2935.2003; NADA S, 1993, CELL, V73, P1125, DOI 10.1016/0092-8674(93)90642-4; Rakic B, 2006, CHEM BIOL, V13, P23, DOI 10.1016/j.chembiol.2005.10.006; Rodig SJ, 1998, CELL, V93, P373, DOI 10.1016/S0092-8674(00)81166-6; Sarcar B, 2004, VIROLOGY, V322, P51, DOI 10.1016/j.virol.2004.01.008; Sevilla A, 2004, J BIOL CHEM, V279, P27458, DOI 10.1074/jbc.M401009200; Thomas RM, 2004, IMMUNITY, V20, P181, DOI 10.1016/S1074-7613(04)00023-8; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Valbuena A, 2006, MOL CELL BIOL, V26, P4782, DOI 10.1128/MCB.00069-06; Vrolijk JM, 2003, J VIROL METHODS, V110, P201, DOI 10.1016/S0166-0934(03)00134-4; Wasley A, 2000, SEMIN LIVER DIS, V20, P1, DOI 10.1055/s-2000-9506; Ye J, 2003, P NATL ACAD SCI USA, V100, P15865, DOI 10.1073/pnas.2237238100; Yi MK, 2002, VIROLOGY, V304, P197, DOI 10.1006/viro.2002.1652	38	83	88	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					29	36		10.1074/jbc.M703988200	http://dx.doi.org/10.1074/jbc.M703988200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17951261	hybrid			2022-12-27	WOS:000251940300005
J	Morgan, AJ; Galione, A				Morgan, Anthony J.; Galione, Antony			Fertilization and nicotinic acid adenine dinucleotide phosphate induce pH changes in acidic Ca2+ stores in sea urchin eggs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORTICAL GRANULE EXOCYTOSIS; ENDOPLASMIC-RETICULUM; CONFOCAL MICROSCOPY; RESPIRATORY BURST; YOLK PLATELETS; CALCIUM; NAADP; ACTIVATION; MEMBRANE; ACIDIFICATION	The second messenger nicotinic acid adenine dinucleotide phosphate (NAADP) releases Ca2+ from the acidic Ca2+ stores of many organisms, including those of the sea urchin egg. We investigated whether the pH within the lumen of these acidic organelles changes in response to stimuli. Fertilization activates the egg by Ca2+ release dependent upon NAADP, and accordingly, we report that fertilization also alters organellar pH in a spatio-temporally complex manner. Upon sperm fusion, vesicles deep in the egg center slowly acidify, whereas cortical vesicles undergo a rapid alkalinization. The cortical vesicle alkalinization is independent of exocytosis and cytosolic pH but coincides with the NAADP-dependent fertilization Ca2+ wave. Microinjection of NAADP mimicked the fertilization cortical response, suggesting that it occurred within NAADP-sensitive acidic Ca2+ stores. Our data show that NAADP and physiological stimuli alter the pH within intracellular organelles and suggest that NAADP signals through pH as well as Ca2+.	[Morgan, Anthony J.; Galione, Antony] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England	University of Oxford	Morgan, AJ (corresponding author), Univ Oxford, Dept Pharmacol, Mansfield Rd, Oxford OX1 3QT, England.	Anthony.morgan@pharm.ox.ac.uk	Galione, Antony/E-5884-2011	Galione, Antony/0000-0002-4132-7646	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Busch GL, 1996, PFLUG ARCH EUR J PHY, V431, P690, DOI 10.1007/BF02253831; Churchill GC, 2000, J BIOL CHEM, V275, P38687, DOI 10.1074/jbc.M005827200; Churchill GC, 2003, CURR BIOL, V13, P125, DOI 10.1016/S0960-9822(03)00002-2; Churchill GC, 2001, J BIOL CHEM, V276, P11223, DOI 10.1074/jbc.M009335200; Churchill GC, 2002, CELL, V111, P703, DOI 10.1016/S0092-8674(02)01082-6; DEITS T, 1985, J BIOL CHEM, V260, P7882; FAGOTTO F, 1994, J CELL BIOL, V125, P1047, DOI 10.1083/jcb.125.5.1047; FAGOTTO F, 1994, J CELL SCI, V107, P3325; FISHKIND DJ, 1990, DEV BIOL, V142, P439, DOI 10.1016/0012-1606(90)90366-Q; FOERDER CA, 1978, P NATL ACAD SCI USA, V75, P3183, DOI 10.1073/pnas.75.7.3183; Galione A, 2005, CELL CALCIUM, V38, P273, DOI 10.1016/j.ceca.2005.06.031; Haley SA, 2004, MOL BIOL CELL, V15, P2084, DOI 10.1091/mbc.E03-11-0843; HEINECKE JW, 1992, J BIOL CHEM, V267, P7959; Kawai A, 2007, AUTOPHAGY, V3, P154, DOI 10.4161/auto.3634; Leckie C, 2003, J BIOL CHEM, V278, P12247, DOI 10.1074/jbc.M210770200; LEE HC, 1983, DEV BIOL, V98, P446, DOI 10.1016/0012-1606(83)90374-3; Lim D, 2001, FASEB J, V15, P2257, DOI 10.1096/fj.01-0157com; Lopez-Godinez J, 2003, BIOCHEM BIOPH RES CO, V301, P13, DOI 10.1016/S0006-291X(02)02979-0; MALLYA SK, 1992, J CELL BIOL, V117, P1211, DOI 10.1083/jcb.117.6.1211; Matese JC, 1997, DEV BIOL, V186, P16, DOI 10.1016/S0012-1606(97)98585-7; Matese JC, 1998, ZYGOTE, V6, P55, DOI 10.1017/S0967199400005086; MCPHERSON SM, 1992, J CELL BIOL, V116, P1111, DOI 10.1083/jcb.116.5.1111; MOHRI T, 1990, CELL STRUCT FUNCT, V15, P309, DOI 10.1247/csf.15.309; MORGAN AJ, 2006, METHODS CALCIUM SIGN, P265; Morgan AJ, 2007, BIOCHEM J, V402, P301, DOI 10.1042/BJ20060759; Papp S, 2003, J CELL BIOL, V160, P475, DOI 10.1083/jcb.200207136; Renstrom E, 2002, J BIOL CHEM, V277, P26717, DOI 10.1074/jbc.C200314200; SAITO K, 1995, BIOCHEM BIOPH RES CO, V215, P828, DOI 10.1006/bbrc.1995.2538; Sardet C, 2002, DEV BIOL, V241, P1, DOI 10.1006/dbio.2001.0474; Schomer B, 1998, DEV BIOL, V203, P1, DOI 10.1006/dbio.1998.9044; SHAPIRO BM, 1991, SCIENCE, V252, P533, DOI 10.1126/science.1850548; Smith RM, 2002, TRAFFIC, V3, P397, DOI 10.1034/j.1600-0854.2002.30603.x; Song JL, 2006, DEV BIOL, V300, P385, DOI 10.1016/j.ydbio.2006.07.041; Stricker SA, 1999, DEV BIOL, V211, P157, DOI 10.1006/dbio.1999.9340; SWANN K, 1986, J CELL BIOL, V103, P2333, DOI 10.1083/jcb.103.6.2333; TERASAKI M, 1995, J CELL SCI, V108, P2293; TERASAKI M, 1991, J CELL BIOL, V114, P929, DOI 10.1083/jcb.114.5.929; Wessel GM, 2000, DEV GROWTH DIFFER, V42, P507; WHALLEY T, 1995, J CELL BIOL, V131, P1183, DOI 10.1083/jcb.131.5.1183; Whitaker M, 2006, PHYSIOL REV, V86, P25, DOI 10.1152/physrev.00023.2005; Wong JL, 2004, DEV CELL, V7, P801, DOI 10.1016/j.devcel.2004.10.014	41	36	37	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37730	37737		10.1074/jbc.M704630200	http://dx.doi.org/10.1074/jbc.M704630200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17959608	hybrid			2022-12-27	WOS:000251833600049
J	Coddou, C; Acuna-Castillo, C; Bull, P; Huidobro-Toro, JP				Coddou, Claudio; Acuna-Castillo, Claudio; Bull, Paulina; Huidobro-Toro, J. Pablo			Dissecting the facilitator and inhibitor allosteric metal sites of the P2X(4) receptor channel - Critical roles of Cys(132) for zinc potentiation and Asp(138) for copper inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENTIAL MODULATION; BINDING SITE; NEURONAL EXCITABILITY; HISTIDINE-RESIDUES; CELL-SURFACE; RAT-BRAIN; SUBUNITS; ZN2+; IDENTIFICATION; DETERMINANTS	Zinc and copper are atypical modulators of ligand-gated ionic channels in the central nervous system. We sought to identify the amino acids of the rat P2X(4) receptor involved in trace metal interaction, specifically in the immediate linear vicinity of His(140), a residue previously identified as being critical for copper-induced inhibition of the ATP-evoked currents. Site-directed mutagenesis replaced conspicuous amino acids located within the extracellular domain region between Thr(123) and Thr(146) for alanines. cDNAs for the wild-type and the receptor mutants were expressed in Xenopus laevis oocytes and examined by the two-electrode technique. Cys(132), but not Cys(126), proved crucial for zinc-induced potentiation of the receptor activity, but not for copper-induced inhibition. Zinc inhibited in a concentration-dependent manner the ATP-gated currents of the C132A mutant. Likewise, Asp(138), but not Asp(131) was critical for copper and zinc inhibition; moreover, mutant D138A was 20-fold more reactive to zinc potentiation than wild-type receptors. Asp(129), Asp131, and Thr(133) had minor roles in metal modulation. We conclude that this region of the P2X4 receptor has a pocket for trace metal coordination with two distinct and separate facilitator and inhibitor metal allosteric sites. In addition, Cys132 does not seem to participate exclusively as a structural receptor channel folding motif but plays a role as a ligand for zinc modulation highlighting the role of trace metals in neuronal excitability.	[Coddou, Claudio; Bull, Paulina; Huidobro-Toro, J. Pablo] Pontificia Univ Catolica Chile, Ctr Regulac Celular & Patol JV Luco, Inst Milenio Biol Fundamental & Aplicada MIFAB, Lab Nucleotidos,Dept Fisiol, Santiago 6513677, Chile; [Bull, Paulina] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Santiago 6513677, Chile; [Acuna-Castillo, Claudio] Univ Santiago Chile, Fac Quim & Biol, Dept Biol, Santiago 9170019, Chile	Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Universidad de Santiago de Chile	Huidobro-Toro, JP (corresponding author), Pontificia Univ Catolica Chile, Fac Biol Sci, Dept Physiol, Nucleotide Res Lab, Casilla 114-D, Santiago, Chile.	jphuid@bio.puc.cl	Acuña-Castillo, Claudio/AAI-7090-2021	Acuña-Castillo, Claudio/0000-0003-3607-6077				Acuna-Castillo C, 2000, J NEUROCHEM, V74, P1529, DOI 10.1046/j.1471-4159.2000.0741529.x; Acuna-Castillo C, 2007, J NEUROCHEM, V101, P17, DOI 10.1111/j.1471-4159.2006.04343.x; Aitken A, 1999, MOL BIOTECHNOL, V12, P241, DOI 10.1385/MB:12:3:241; ASSAF S, 1984, NATURE, V208, P734; Baranano DE, 2001, TRENDS NEUROSCI, V24, P99, DOI 10.1016/S0166-2236(00)01716-1; Barrera NP, 2005, J BIOL CHEM, V280, P10759, DOI 10.1074/jbc.M412265200; BLOOMENTHAL AB, 1994, MOL PHARMACOL, V46, P1156; Clyne JD, 2002, J PHYSIOL-LONDON, V539, P347, DOI 10.1113/jphysiol.2001.013244; Clyne JD, 2002, J NEUROSCI, V22, P3873, DOI 10.1523/JNEUROSCI.22-10-03873.2002; Coddou C, 2003, J BIOL CHEM, V278, P36777, DOI 10.1074/jbc.M305177200; Coddou C, 2003, EUR J PHARMACOL, V472, P49, DOI 10.1016/S0014-2999(03)01864-8; Coddou C, 2002, J NEUROCHEM, V80, P626, DOI 10.1046/j.0022-3042.2001.00732.x; Ennion S, 2000, J BIOL CHEM, V275, P29361, DOI 10.1074/jbc.M003637200; Ennion SJ, 2002, MOL PHARMACOL, V61, P303, DOI 10.1124/mol.61.2.303; Fountain SJ, 2007, NATURE, V448, P200, DOI 10.1038/nature05926; Hershfinkel M, 2001, P NATL ACAD SCI USA, V98, P11749, DOI 10.1073/pnas.201193398; Hirzel K, 2006, NEURON, V52, P679, DOI 10.1016/j.neuron.2006.09.035; Jiang LH, 2000, J BIOL CHEM, V275, P34190, DOI 10.1074/jbc.M005481200; KARDOS J, 1989, NEUROSCI LETT, V103, P139, DOI 10.1016/0304-3940(89)90565-X; Khakh BS, 2006, NATURE, V442, P527, DOI 10.1038/nature04886; Khakh BS, 1999, J NEUROSCI, V19, P7289, DOI 10.1523/JNEUROSCI.19-17-07289.1999; Lorca RA, 2005, J NEUROCHEM, V95, P499, DOI 10.1111/j.1471-4159.2005.03387.x; MA JY, 1993, BRAIN RES, V607, P222; Mathie A, 2006, PHARMACOL THERAPEUT, V111, P567, DOI 10.1016/j.pharmthera.2005.11.004; Nagaya N, 2005, J BIOL CHEM, V280, P25982, DOI 10.1074/jbc.M504545200; Nicke A, 2005, J NEUROCHEM, V92, P925, DOI 10.1111/j.1471-4159.2004.02939.x; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Palma E, 1998, P NATL ACAD SCI USA, V95, P10246, DOI 10.1073/pnas.95.17.10246; Ralevic V, 1998, PHARMACOL REV, V50, P413; Rassendren F, 1997, EMBO J, V16, P3446, DOI 10.1093/emboj/16.12.3446; Silberberg SD, 2007, NEURON, V54, P263, DOI 10.1016/j.neuron.2007.03.020; Soto F, 1996, P NATL ACAD SCI USA, V93, P3684, DOI 10.1073/pnas.93.8.3684; Tittle RK, 2007, J BIOL CHEM, V282, P19526, DOI 10.1074/jbc.M701604200; Torres GE, 1999, J BIOL CHEM, V274, P6653, DOI 10.1074/jbc.274.10.6653; Trombley PQ, 1996, J NEUROPHYSIOL, V76, P2536, DOI 10.1152/jn.1996.76.4.2536; VALLEE BL, 1990, BIOCHEMISTRY-US, V29, P5647, DOI 10.1021/bi00476a001; Vial C, 2004, TRENDS PHARMACOL SCI, V25, P487, DOI 10.1016/j.tips.2004.07.008; Xiong KM, 1999, J NEUROPHYSIOL, V81, P2088, DOI 10.1152/jn.1999.81.5.2088; Yamasaki S, 2007, J CELL BIOL, V177, P637, DOI 10.1083/jcb.200702081; Yan ZH, 2005, MOL PHARMACOL, V67, P1078, DOI 10.1124/mol.104.010108	40	38	41	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					36879	36886		10.1074/jbc.M706925200	http://dx.doi.org/10.1074/jbc.M706925200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17962187	hybrid			2022-12-27	WOS:000251646000013
J	Gerits, N; Mikalsen, T; Kostenko, S; Shiryaev, A; Johannessen, M; Moens, U				Gerits, Nancy; Mikalsen, Theresa; Kostenko, Sergiy; Shiryaev, Alexey; Johannessen, Mona; Moens, Ugo			Modulation of F-actin rearrangement by the cyclic AMP/cAMP-dependent protein kinase (PKA) pathway is mediated by MAPK-activated protein kinase 5 and requires PKA-induced nuclear export of MK5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-MIGRATION; SUBCELLULAR-LOCALIZATION; SIGNALING PATHWAYS; GENE-TRANSCRIPTION; NEURITE OUTGROWTH; ENDOTHELIAL-CELLS; BINDING-PROTEIN; P38; CAMP; AMP	The MAPK-activated protein kinases belong to the Ca2+/ calmodulin-dependent protein kinases. Within this group, MK2, MK3, and MK5 constitute three structurally related enzymes with distinct functions. Few genuine substrates for MK5 have been identified, and the only known biological role is in ras-induced senescence and in tumor suppression. Here we demonstrate that activation of cAMP-dependent protein kinase (PKA) or ectopic expression of the catalytic subunit C alpha in PC12 cells results in transient nuclear export of MK5, which requires the kinase activity of both C alpha and MK5 and the ability of C alpha to enter the nucleus. C alpha and MK5, but not MK2, interact in vivo, and C alpha increases the kinase activity of MK5. Moreover, C alpha augments MK5 phosphorylation, but not MK2, whereas MK5 does not seem to phosphorylate C alpha. Activation of PKA can induce actin filament accumulation at the plasma membrane and formation of actin-based filopodia. We demonstrate that small interfering RNA-triggered depletion of MK5 interferes with PKA-induced F-actin rearrangement. Moreover, cytoplasmic expression of an activated MK5 variant is sufficient to mimic PKA-provoked F-actin remodeling. Our results describe a novel interaction between the PKA pathway and MAPK signaling cascades and suggest that MK5, but not MK2, is implicated in PKA-induced microfilament rearrangement.	[Gerits, Nancy; Mikalsen, Theresa; Kostenko, Sergiy; Shiryaev, Alexey; Johannessen, Mona; Moens, Ugo] Univ Tromso, Fac Med, Dept Microbiol & Virol, N-9037 Tromso, Norway	UiT The Arctic University of Tromso	Moens, U (corresponding author), Univ Tromso, Fac Med, Dept Microbiol & Virol, N-9037 Tromso, Norway.	ugom@fagmed.uit.no	Kostenko, Sergiy/Q-6251-2017	Kostenko, Sergiy/0000-0002-3677-9859				Aberg E, 2006, J BIOL CHEM, V281, P35499, DOI 10.1074/jbc.M606225200; Azuma N, 2001, AM J PHYSIOL-HEART C, V280, pH189, DOI 10.1152/ajpheart.2001.280.1.H189; Bok J, 2003, J NEUROSCI, V23, P777; Chaturvedi D, 2006, MOL CELL BIOL, V26, P4586, DOI 10.1128/MCB.01422-05; Culbert AA, 2006, J BIOL CHEM, V281, P23658, DOI 10.1074/jbc.M513646200; Dalton GD, 2006, NEUROPEPTIDES, V40, P23, DOI 10.1016/j.npep.2005.10.002; DAY RN, 1989, J BIOL CHEM, V264, P431; Delghandi MP, 2005, CELL SIGNAL, V17, P1343, DOI 10.1016/j.cellsig.2005.02.003; Dumaz N, 2005, FEBS J, V272, P3491, DOI 10.1111/j.1742-4658.2005.04763.x; Gaestel M, 2006, NAT REV MOL CELL BIO, V7, P120, DOI 10.1038/nrm1834; Gerits N, 2007, TRANSGENIC RES, V16, P281, DOI 10.1007/s11248-006-9052-0; Han J, 1999, NAT CELL BIOL, V1, pE39, DOI 10.1038/10032; Hedges JC, 1999, J BIOL CHEM, V274, P24211, DOI 10.1074/jbc.274.34.24211; HOUBEN R, 2005, J CARCINOGEGEN, V20, P23; Houslay M.D., 2006, SCI STKE, V2006, ppe32; Howe AK, 2004, BBA-MOL CELL RES, V1692, P159, DOI 10.1016/j.bbamcr.2004.03.005; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Huot J, 1998, J CELL BIOL, V143, P1361, DOI 10.1083/jcb.143.5.1361; Huot J, 1997, CIRC RES, V80, P383, DOI 10.1161/01.RES.80.3.383; Imajo M, 2006, IUBMB LIFE, V58, P312, DOI 10.1080/15216540600746393; Johannessen M, 2004, CELL SIGNAL, V16, P1187, DOI 10.1016/j.cellsig.2004.03.009; JOHANNESSEN M, 2005, TRENDS CELLULAR SIGN, P41; Johannessen M, 2007, J BIOL CHEM, V282, P14777, DOI 10.1074/jbc.M610669200; Kant S, 2006, J BIOL CHEM, V281, P35511, DOI 10.1074/jbc.M606693200; Kayyali US, 2002, J BIOL CHEM, V277, P42596, DOI 10.1074/jbc.M205863200; Kim HS, 2006, EXP MOL MED, V38, P85, DOI 10.1038/emm.2006.10; Kobayashi M, 2006, EMBO J, V25, P713, DOI 10.1038/sj.emboj.7600973; Kotlyarov A, 1999, NAT CELL BIOL, V1, P94, DOI 10.1038/10061; Kotlyarov A, 2002, MOL CELL BIOL, V22, P4827, DOI 10.1128/MCB.22.13.4827-4835.2002; Krens SFG, 2006, FEBS LETT, V580, P4984, DOI 10.1016/j.febslet.2006.08.025; Larsen JK, 1997, AM J PHYSIOL-LUNG C, V273, pL930, DOI 10.1152/ajplung.1997.273.5.L930; Ma SM, 2007, BBA-MOL CELL RES, V1773, P912, DOI 10.1016/j.bbamcr.2007.02.006; Manke IA, 2005, MOL CELL, V17, P37, DOI 10.1016/j.molcel.2004.11.021; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Moens MJU, 2007, FRONT BIOSCI-LANDMRK, V12, P1814; Montminy M, 1997, ANNU REV BIOCHEM, V66, P807, DOI 10.1146/annurev.biochem.66.1.807; Neufeld B, 2000, J BIOL CHEM, V275, P20239, DOI 10.1074/jbc.C901040199; New L, 2003, MOL BIOL CELL, V14, P2603, DOI 10.1091/mbc.E02-08-0538; New L, 1998, EMBO J, V17, P3372, DOI 10.1093/emboj/17.12.3372; Ni H, 1998, BIOCHEM BIOPH RES CO, V243, P492, DOI 10.1006/bbrc.1998.8135; Paliga AJM, 2005, BIOL CELL, V97, P629, DOI 10.1042/BC20040146; Pearson GW, 2006, MOL CELL BIOL, V26, P3039, DOI 10.1128/MCB.26.8.3039-3047.2006; Pichon S, 2004, J CELL SCI, V117, P2569, DOI 10.1242/jcs.01110; Rousseau S, 2006, CELL SIGNAL, V18, P1897, DOI 10.1016/j.cellsig.2006.02.006; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Saxena M, 1999, NAT CELL BIOL, V1, P305, DOI 10.1038/13024; Schafer C, 1998, J BIOL CHEM, V273, P24173, DOI 10.1074/jbc.273.37.24173; Schumacher S, 2004, EMBO J, V23, P4770, DOI 10.1038/sj.emboj.7600467; Seternes OM, 2004, EMBO J, V23, P4780, DOI 10.1038/sj.emboj.7600489; Seternes OM, 2002, MOL CELL BIOL, V22, P6931, DOI 10.1128/MCB.22.20.6931-6945.2002; Shi Y, 2003, MOL CELL BIOL, V23, P7732, DOI 10.1128/MCB.23.21.7732-7741.2003; Shimomura A, 1998, J NEUROCHEM, V70, P1029; Sithanandam G, 1996, MOL CELL BIOL, V16, P868; Skalhegg BS, 2000, FRONT BIOSCI-LANDMRK, V5, pD678, DOI 10.2741/Skalhegg; STOKOE D, 1992, EMBO J, V11, P3985, DOI 10.1002/j.1460-2075.1992.tb05492.x; Stork PJS, 2002, TRENDS CELL BIOL, V12, P258, DOI 10.1016/S0962-8924(02)02294-8; Sun PQ, 2007, CELL, V128, P295, DOI 10.1016/j.cell.2006.11.050; Thiel G, 2005, J NEUROCHEM, V92, P321, DOI 10.1111/j.1471-4159.2004.02882.x; Thyssen G, 2006, MOL CELL BIOL, V26, P8857, DOI 10.1128/MCB.01031-06; Voncken JW, 2005, J BIOL CHEM, V280, P5178, DOI 10.1074/jbc.M407155200; Whitmarsh AJ, 2007, BBA-MOL CELL RES, V1773, P1285, DOI 10.1016/j.bbamcr.2006.11.011; Wu R, 2007, J BIOL CHEM, V282, P21598, DOI 10.1074/jbc.M611316200; Yao J, 2004, TRAFFIC, V5, P1006, DOI 10.1111/j.1600-0854.2004.00240.x; Zheng CL, 2006, J BIOL CHEM, V281, P37215, DOI 10.1074/jbc.M603622200	64	48	51	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					37232	37243		10.1074/jbc.M704873200	http://dx.doi.org/10.1074/jbc.M704873200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17947239	hybrid			2022-12-27	WOS:000251646000049
J	Geoghegan, JC; Valdes, PA; Orem, NR; Deleault, NR; Williamson, RA; Harris, BT; Supattapone, S				Geoghegan, James C.; Valdes, Pablo A.; Orem, Nicholas R.; Deleault, Nathan R.; Williamson, R. Anthony; Harris, Brent T.; Supattapone, Surachai			Selective incorporation of polyanionic molecules into hamster prions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CREUTZFELDT-JAKOB-DISEASE; HIGHLY STRUCTURED RNAS; IN-VITRO CONVERSION; NUCLEIC-ACID; NUCLEOCAPSID PROTEIN; ACRIDINE-ORANGE; LIPID-MEMBRANES; CYCLIC AMPLIFICATION; SEEDING SPECIFICITY; INCUBATION PERIOD	The central pathogenic event of prion disease is the conformational conversion of a host protein, PrPC, into a pathogenic isoform, PrPSc. We previously showed that the protein misfolding cyclic amplification (PMCA) technique can be used to form infectious prion molecules de novo from purified native PrPC molecules in an autocatalytic process requiring accessory polyanions (Deleault, N. R., Harris, B. T., Rees, J. R., and Supattapone, S. (2007) Proc. Natl. Acad. Sci. U. S. A. 104, 9741-9746). Here we investigated the molecular mechanism by which polyanionic molecules facilitate infectious prion formation in vitro. In a PMCA reaction lacking PrPSc template seed, synthetic poly(A) RNA molecules induce hamster (Ha) PrPC to adopt a protease-sensitive, detergent-insoluble conformation reactive against antibodies specific for PrPSc. During PMCA, labeled nucleic acids form nuclease-resistant complexes with HaPrP molecules. Strikingly, purified HaPrP(C) molecules subjected to PMCA selectively incorporate an similar to 1 -2.5-kb subset of [P-32] poly(A) RNA molecules from a heterogeneous mixture ranging in size from similar to 0.1 to > 6 kb. Neuropathological analysis of scrapie-infected hamsters using the fluorescent dye acridine orange revealed that RNA molecules co-localize with large extracellular HaPrP aggregates. These findings suggest that polyanionic molecules such as RNA may become selectively incorporated into stable complexes with PrP molecules during the formation of native hamster prions.	Dartmouth Med Sch, Dept Biochem, Hanover, NH 03755 USA; Dartmouth Med Sch, Dept Pathol, Hanover, NH 03755 USA; Dartmouth Med Sch, Dept Med, Hanover, NH 03755 USA; Scripps Res Inst, La Jolla, CA 92037 USA	Dartmouth College; Dartmouth College; Dartmouth College; Scripps Research Institute	Supattapone, S (corresponding author), Dartmouth Med Sch, Dept Biochem, 7200 Vail Bldg, Hanover, NH 03755 USA.	supattapone@dartmouth.edu			NINDS NIH HHS [R01 NS055875-03, R01 NS046478-06, R01 NS055875, R01 NS046478] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055875, R01NS046478] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adler V, 2003, J MOL BIOL, V332, P47, DOI 10.1016/S0022-2836(03)00919-7; AKOWITZ A, 1994, NUCLEIC ACIDS RES, V22, P1101, DOI 10.1093/nar/22.6.1101; AKOWITZ A, 1993, ARCH VIROL, V130, P301, DOI 10.1007/BF01309662; Apetri AC, 2002, J BIOL CHEM, V277, P44589, DOI 10.1074/jbc.C200507200; Apetri AC, 2006, J AM CHEM SOC, V128, P11673, DOI 10.1021/ja063880b; Bell JE, 1997, NEUROPATH APPL NEURO, V23, P26, DOI 10.1111/j.1365-2990.1997.tb01182.x; Ben-Zaken O, 2003, J BIOL CHEM, V278, P40041, DOI 10.1074/jbc.M301152200; Bera A, 2007, BIOCHEMISTRY-US, V46, P1320, DOI 10.1021/bi0620050; Bocharova OV, 2005, J MOL BIOL, V346, P645, DOI 10.1016/j.jmb.2004.11.068; Bosque PJ, 2000, J VIROL, V74, P4377, DOI 10.1128/JVI.74.9.4377-4386.2000; BRANDES G, 1990, HISTOCHEM J, V22, P106, DOI 10.1007/BF01885789; BRUCE ME, 1993, BRIT MED BULL, V49, P822, DOI 10.1093/oxfordjournals.bmb.a072649; Carlson GA, 1996, CURR TOP MICROBIOL, V207, P35; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Castilla J, 2005, NAT MED, V11, P982, DOI 10.1038/nm1286; CAUGHEY B, 1994, J VIROL, V68, P2135, DOI 10.1128/JVI.68.4.2135-2141.1994; Caughey B, 2006, NATURE, V443, P803, DOI 10.1038/nature05294; Chien P, 2001, NATURE, V410, P223, DOI 10.1038/35065632; Cordeiro Y, 2001, J BIOL CHEM, V276, P49400, DOI 10.1074/jbc.M106707200; Critchley P, 2004, BIOCHEM BIOPH RES CO, V313, P559, DOI 10.1016/j.bbrc.2003.12.004; DebBurman SK, 1997, P NATL ACAD SCI USA, V94, P13938, DOI 10.1073/pnas.94.25.13938; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Deleault NR, 2005, J BIOL CHEM, V280, P26873, DOI 10.1074/jbc.M503973200; Deleault NR, 2003, NATURE, V425, P717, DOI 10.1038/nature01979; Derrington E, 2002, CR BIOL, V325, P17, DOI 10.1016/S1631-0691(02)01388-4; Enari M, 2001, P NATL ACAD SCI USA, V98, P9295, DOI 10.1073/pnas.151242598; GABIZON R, 1987, P NATL ACAD SCI USA, V84, P4017, DOI 10.1073/pnas.84.12.4017; Gabus C, 2001, J BIOL CHEM, V276, P19301, DOI 10.1074/jbc.M009754200; Gabus C, 2001, J MOL BIOL, V307, P1011, DOI 10.1006/jmbi.2001.4544; Ginsberg SD, 1999, ANN NEUROL, V45, P174, DOI 10.1002/1531-8249(199902)45:2<174::AID-ANA7>3.0.CO;2-E; Ginsberg SD, 1998, ACTA NEUROPATHOL, V96, P487, DOI 10.1007/s004010050923; Ginsberg SD, 1997, ANN NEUROL, V41, P200, DOI 10.1002/ana.410410211; Glatzel M, 2005, ARCH NEUROL-CHICAGO, V62, P545, DOI 10.1001/archneur.62.4.545; Hetz C, 2007, J BIOL CHEM, V282, P12725, DOI 10.1074/jbc.M611909200; Hornemann S, 1998, P NATL ACAD SCI USA, V95, P6010, DOI 10.1073/pnas.95.11.6010; Horwich A, 2002, J CLIN INVEST, V110, P1221, DOI 10.1172/JCI200216781; Jackson GS, 1999, BBA-PROTEIN STRUCT M, V1431, P1, DOI 10.1016/S0167-4838(99)00038-2; Jones EM, 2005, CELL, V121, P63, DOI 10.1016/j.cell.2005.01.034; Kazlauskaite J, 2005, BIOCHEM SOC SYMP, V72, P211, DOI 10.1042/bss0720211; Kazlauskaite J, 2003, BIOCHEMISTRY-US, V42, P3295, DOI 10.1021/bi026872q; King CY, 2001, J MOL BIOL, V307, P1247, DOI 10.1006/jmbi.2001.4542; Korth C, 1997, NATURE, V390, P74, DOI 10.1038/36337; Kuwata K, 2002, BIOCHEMISTRY-US, V41, P12277, DOI 10.1021/bi026129y; Leblanc P, 2004, J MOL BIOL, V337, P1035, DOI 10.1016/j.jmb.2004.02.007; Liu ML, 2007, MOL CELL BIOCHEM, V294, P197, DOI 10.1007/s11010-006-9260-1; Lloyd SE, 2001, P NATL ACAD SCI USA, V98, P6279, DOI 10.1073/pnas.101130398; MAI JK, 1984, J HISTOCHEM CYTOCHEM, V32, P97, DOI 10.1177/32.1.6197440; Manolakou K, 2001, P NATL ACAD SCI USA, V98, P7402, DOI 10.1073/pnas.121172098; Moroncini G, 2004, P NATL ACAD SCI USA, V101, P10404, DOI 10.1073/pnas.0403522101; Moscardini M, 2002, J MOL BIOL, V318, P149, DOI 10.1016/S0022-2836(02)00092-X; Nandi PK, 2004, J MOL BIOL, V344, P827, DOI 10.1016/j.jmb.2004.09.080; Nandi PK, 2001, ARCH VIROL, V146, P327, DOI 10.1007/s007050170178; Nandi PK, 1999, ARCH VIROL, V144, P1751, DOI 10.1007/s007050050702; Nandi PK, 2002, J MOL BIOL, V322, P153, DOI 10.1016/S0022-2836(02)00750-7; Novitskaya V, 2006, J BIOL CHEM, V281, P15536, DOI 10.1074/jbc.M601349200; Pergami P, 1999, BIOCHEM BIOPH RES CO, V264, P972, DOI 10.1006/bbrc.1999.1430; PINTO A, 1990, ARCH PATHOL LAB MED, V114, P585; Proske D, 2002, CHEMBIOCHEM, V3, P717, DOI 10.1002/1439-7633(20020802)3:8<717::AID-CBIC717>3.0.CO;2-C; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Raeber AJ, 1999, P NATL ACAD SCI USA, V96, P3987, DOI 10.1073/pnas.96.7.3987; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Saborio GP, 1999, BIOCHEM BIOPH RES CO, V258, P470, DOI 10.1006/bbrc.1999.0660; Sanghera N, 2002, J MOL BIOL, V315, P1241, DOI 10.1006/jmbi.2001.5322; Shaked GM, 2001, J BIOL CHEM, V276, P14324, DOI 10.1074/jbc.M007815200; Smith SB, 1996, SCIENCE, V271, P795, DOI 10.1126/science.271.5250.795; SNOW AD, 1990, LAB INVEST, V63, P601; Soto C, 2005, FEBS LETT, V579, P638, DOI 10.1016/j.febslet.2004.12.035; Stephenson DA, 2000, GENOMICS, V69, P47, DOI 10.1006/geno.2000.6320; Swietnicki W, 1997, J BIOL CHEM, V272, P27517, DOI 10.1074/jbc.272.44.27517; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; TELLING GC, 1995, CELL, V83, P79, DOI 10.1016/0092-8674(95)90236-8; TOPALOGLU H, 1989, ANAT REC, V224, P88, DOI 10.1002/ar.1092240111; Lima LMTR, 2006, BIOCHEMISTRY-US, V45, P9180, DOI 10.1021/bi060532d; Van Everbroeck B, 1999, J HISTOCHEM CYTOCHEM, V47, P1465; Vasan S, 2006, NEUROCHEM RES, V31, P629, DOI 10.1007/s11064-006-9063-5; Warner RG, 2002, J BIOL CHEM, V277, P18421, DOI 10.1074/jbc.M110406200; WEISSMANN C, 1991, NATURE, V352, P679, DOI 10.1038/352679a0; Wong C, 2001, EMBO J, V20, P377, DOI 10.1093/emboj/20.3.377; Yuan J, 2006, J BIOL CHEM, V281, P34848, DOI 10.1074/jbc.M602238200; Zahn R, 2000, P NATL ACAD SCI USA, V97, P145, DOI 10.1073/pnas.97.1.145; Zeiler B, 2003, BIOTECHNOL APPL BIOC, V37, P173, DOI 10.1042/BA20020087; Zou WQ, 2002, J BIOL CHEM, V277, P43942, DOI 10.1074/jbc.M203611200	82	78	79	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36341	36353		10.1074/jbc.M704447200	http://dx.doi.org/10.1074/jbc.M704447200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17940287	Green Accepted, hybrid			2022-12-27	WOS:000251458300025
J	L'Hoste, S; Poet, M; Duranton, C; Belfodil, R; Barriere, HE; Rubera, I; Tauc, M; Poujeol, C; Barhanin, J; Poujeol, P				L'Hoste, Sebastien; Poet, Mallorie; Duranton, Christophe; Belfodil, Radia; Barriere, Herv e; Rubera, Isabelle; Tauc, Michel; Poujeol, Chantal; Barhanin, Jacques; Poujeol, Phillipe			Role of TASK2 in the control of apoptotic volume decrease in proximal kidney cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUBULAR EPITHELIAL-CELLS; SMOOTH-MUSCLE CELLS; K+ CHANNELS; CHLORIDE CHANNELS; PRIMARY CULTURES; CYCLOSPORINE-A; POTASSIUM CHANNELS; NITRIC-OXIDE; HIGH GLUCOSE; TUMOR-CELLS	Apoptotic volume decrease (AVD) is prerequisite to apoptotic events that lead to cell death. In a previous study, we demonstrated in kidney proximal cells that the TASK2 channel was involved in the K+ efflux that occurred during regulatory volume decrease. The aim of the present study was to determine the role of the TASK2 channel in the regulation of AVD and apoptosis phenomenon. For this purpose renal cells were immortalized from primary cultures of proximal convoluted tubules (PCT) from wild type and TASK2 knock-out mice (task2(-/-)). Apoptosis was induced by staurosporine, cyclosporin A, or tumor necrosis factor alpha. Cell volume, K+ conductance, caspase-3, and intracellular reactive oxygen species (ROS) levels were monitored during AVD. In wild type PCT cells the K+ conductance activated during AVD exhibited characteristics of TASK2 currents. In task2(-/-) PCT cells, AVD and caspase activation were reduced by 59%. Whole cell recordings indicated that large conductance calcium-activated K+ currents inhibited by iberiotoxin (BK channels) partially compensated for the deletion of TASK2 K+ currents in the task2(-/-) PCT cells. This result explained the residual AVD measured in these cells. In both cell lines, apoptosis was mediated via intracellular ROS increase. Moreover AVD, K+ conductances, and caspase-3 were strongly impaired by ROS scavenger N-acetylcysteine. In conclusion, the main K+ channels involved in staurosporine, cyclosporin A, and tumor necrosis factor-alpha-induced AVD are TASK2 K+ channels in proximal wild type cells and iberiotoxin-sensitive BK channels in proximal task2(-/-) cells. Both K+ channels could be activated by ROS production.	Univ Nice Sophia Antipolis, CNRS, UMR 6548, F-06108 Nice 2, France; CNRS, Inst Pharmacol, F-06560 Valbonne Sophia Antipoli, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS)	Poujeol, P (corresponding author), Univ Nice Sophia Antipolis, CNRS, UMR 6548, F-06108 Nice 2, France.	Philippe.POUJEOL@unice.fr	DURANTON, CHRISTOPHE/E-9582-2019; Tauc, Michel/F-1530-2013	DURANTON, CHRISTOPHE/0000-0003-1127-2346; Tauc, Michel/0000-0002-8383-9818; RUBERA, Isabelle/0000-0002-4267-6207				Allen DA, 2003, FASEB J, V17, P908, DOI 10.1096/fj.02-0130fje; Alonso MM, 2003, ONCOGENE, V22, P3759, DOI 10.1038/sj.onc.1206435; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Baek SM, 2003, J LAB CLIN MED, V142, P178, DOI 10.1016/S0022-2143(03)00111-2; Bailey MA, 2006, KIDNEY INT, V70, P51, DOI 10.1038/sj.ki.5000388; Bakker RC, 2002, NEPHROL DIAL TRANSPL, V17, P1181, DOI 10.1093/ndt/17.7.1181; Barlow RS, 2000, AM J PHYSIOL-HEART C, V279, pH475, DOI 10.1152/ajpheart.2000.279.2.H475; Barriere H, 2003, J GEN PHYSIOL, V122, P177, DOI 10.1085/jgp.200308820; Barriere H, 2003, J MEMBRANE BIOL, V193, P153, DOI 10.1007/s00232-003-2014-z; BEAUVAIS F, 1995, J LEUKOCYTE BIOL, V57, P851, DOI 10.1002/jlb.57.6.851; Belfodil R, 2003, AM J PHYSIOL-RENAL, V284, pF812, DOI 10.1152/ajprenal.00238.2002; Bock J, 2002, BIOCHEM BIOPH RES CO, V295, P526, DOI 10.1016/S0006-291X(02)00695-2; Bortner CD, 1998, BIOCHEM PHARMACOL, V56, P1549, DOI 10.1016/S0006-2952(98)00225-1; Burg ED, 2006, J MEMBRANE BIOL, V209, P3, DOI 10.1007/s00232-005-0838-4; Chien CT, 2001, J AM SOC NEPHROL, V12, P973, DOI 10.1681/ASN.V125973; COCAPRADOS M, 1995, AM J PHYSIOL-CELL PH, V268, pC572, DOI 10.1152/ajpcell.1995.268.3.C572; DESMET P, 1995, PFLUG ARCH EUR J PHY, V430, P936, DOI 10.1007/BF01837407; Duprat F, 2005, J PHYSIOL-LONDON, V562, P235, DOI 10.1113/jphysiol.2004.071266; DUPRAT F, 1995, P NATL ACAD SCI USA, V92, P11796, DOI 10.1073/pnas.92.25.11796; Erkan E, 2007, J AM SOC NEPHROL, V18, P1199, DOI 10.1681/ASN.2006040407; Gil J, 2003, FREE RADICAL BIO MED, V35, P1500, DOI 10.1016/j.freeradbiomed.2003.08.022; Gomez-Angelats M, 2000, CELL TISSUE RES, V301, P33, DOI 10.1007/s004410000216; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HALLIWELL B, 1999, FREE RADICALS BIOL; Healy E, 1998, KIDNEY INT, V54, P1955, DOI 10.1046/j.1523-1755.1998.00202.x; Hughes FM, 1997, J BIOL CHEM, V272, P30567, DOI 10.1074/jbc.272.48.30567; Ichikawa D, 2006, BIOCHEM BIOPH RES CO, V351, P93, DOI 10.1016/j.bbrc.2006.10.010; Justo P, 2003, J AM SOC NEPHROL, V14, P3072, DOI 10.1097/01.ASN.0000099383.57934.0E; KNOBLAUCH C, 1989, AM J PHYSIOL, V256, pC252, DOI 10.1152/ajpcell.1989.256.2.C252; Krick S, 2002, AM J PHYSIOL-HEART C, V282, pH184, DOI 10.1152/ajpheart.2002.282.1.H184; Krick S, 2001, AM J PHYSIOL-LUNG C, V281, pL887, DOI 10.1152/ajplung.2001.281.4.L887; Krick S, 2001, AM J PHYSIOL-CELL PH, V280, pC970, DOI 10.1152/ajpcell.2001.280.4.C970; Kruidering M, 1997, J PHARMACOL EXP THER, V280, P638; L'Hoste S, 2007, AM J PHYSIOL-RENAL, V292, pF628, DOI 10.1152/ajprenal.00132.2006; LOPES AG, 1988, P NATL ACAD SCI USA, V85, P2873, DOI 10.1073/pnas.85.8.2873; Lu L, 2006, PROG RETIN EYE RES, V25, P515, DOI 10.1016/j.preteyeres.2006.07.004; Lu SP, 2007, FREE RADICAL BIO MED, V42, P936, DOI 10.1016/j.freeradbiomed.2006.11.027; Lu T, 2006, CIRC RES, V99, P607, DOI 10.1161/01.RES.0000243147.41792.93; Maeno E, 2000, P NATL ACAD SCI USA, V97, P9487, DOI 10.1073/pnas.140216197; Montague JW, 1999, STEROIDS, V64, P563, DOI 10.1016/S0039-128X(99)00034-3; Nietsch HH, 2000, J BIOL CHEM, V275, P20556, DOI 10.1074/jbc.M002535200; Okada Y, 2006, J MEMBRANE BIOL, V209, P21, DOI 10.1007/s00232-005-0836-6; Okada Y, 2001, COMP BIOCHEM PHYS A, V130, P377, DOI 10.1016/S1095-6433(01)00424-X; Okada Y, 2001, J PHYSIOL-LONDON, V532, P3, DOI 10.1111/j.1469-7793.2001.0003g.x; Pedersen SF, 1999, EXP CELL RES, V252, P63, DOI 10.1006/excr.1999.4615; Remillard CV, 2004, AM J PHYSIOL-LUNG C, V286, pL49, DOI 10.1152/ajplung.00041.2003; Sato T, 2004, J IMMUNOL, V173, P285, DOI 10.4049/jimmunol.173.1.285; Shen HM, 2006, FASEB J, V20, P1589, DOI 10.1096/fj.05-5603rev; Shimizu T, 2004, P NATL ACAD SCI USA, V101, P6770, DOI 10.1073/pnas.0401604101; Tang XD, 2004, NAT STRUCT MOL BIOL, V11, P171, DOI 10.1038/nsmb725; TAUC M, 1990, BIOCHIM BIOPHYS ACTA, V1052, P278, DOI 10.1016/0167-4889(90)90222-Y; Thevenod F, 2003, NEPHRON PHYSIOL, V93, P87, DOI DOI 10.1159/000070241; Trimarchi JR, 2002, AM J PHYSIOL-CELL PH, V282, pC588, DOI 10.1152/ajpcell.00365.2001; Warth R, 2004, P NATL ACAD SCI USA, V101, P8215, DOI 10.1073/pnas.0400081101; Yu SP, 1997, SCIENCE, V278, P114, DOI 10.1126/science.278.5335.114	55	34	34	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36692	36703		10.1074/jbc.M703933200	http://dx.doi.org/10.1074/jbc.M703933200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17947235	hybrid			2022-12-27	WOS:000251458300062
J	Lee, KS; Raymond, LD; Schoen, B; Raymond, GJ; Kett, L; Moore, RA; Johnson, LM; Taubner, L; Speare, JO; Onwubiko, HA; Baron, GS; Caughey, WS; Caughey, B				Lee, Kil S.; Raymond, Lynne D.; Schoen, Brianna; Raymond, Gregory J.; Kett, Lauren; Moore, Roger A.; Johnson, Lisa M.; Taubner, Lara; Speare, Jonathan O.; Onwubiko, Henry A.; Baron, Gerald S.; Caughey, Winslow S.; Caughey, Byron			Hemin interactions and alterations of the subcellular localization of prion protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELLULAR PRION; CASPASE-3 ACTIVATION; NEUROBLASTOMA-CELLS; OCTAREPEAT REGION; SULFATED GLYCANS; OXIDATIVE STRESS; PLASMA-MEMBRANE; CULTURED-CELLS; ENDOCYTOSIS; DISEASE	Hemin (iron protoporphyrin IX) is a crucial component of many physiological processes acting either as a prosthetic group or as an intracellular messenger. Some unnatural, synthetic porphyrins have potent anti-scrapie activity and can interact with normal prion protein (PrPC). These observations raised the possibility that hemin, as a natural porphyrin, is a physiological ligand for PrPC. Accordingly, we evaluated PrPC interactions with hemin. When hemin (3-10 mu M) was added to the medium of cultured cells, clusters of PrPC formed on the cell surface, and the detergent solubility of PrPC decreased. The addition of hemin also induced PrPC internalization and turnover. The ability of hemin to bind directly to PrPC was demonstrated by hemin-agarose affinity chromatography and UV-visible spectroscopy. Multiple hemin molecules bound primarily to the N-terminal third of PrPC, with reduced binding to PrPC lacking residues 34-94. These hemin-PrPC interactions suggest that PrPC may participate in hemin homeostasis, sensing, and/or uptake and that hemin might affect PrPC functions.	NIAID, NIH, Rocky Mt Labs, Persistent Viral Dis Lab, Hamilton, MT 59840 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Caughey, B (corresponding author), Rocky Mt Labs, 903 S 4th St, Hamilton, MT 59840 USA.	bcaughey@nih.gov	Lee, Kil S/D-3678-2012; Lee, Kil Sun/AAL-8564-2020	Lee, Kil S/0000-0002-2390-2774; 	Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000580, Z01AI000580] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Atamna H, 2006, P NATL ACAD SCI USA, V103, P3381, DOI 10.1073/pnas.0600134103; Basu S, 2007, MOL BIOL CELL, V18, P3302, DOI 10.1091/mbc.E07-04-0317; BORCHELT DR, 1990, J CELL BIOL, V110, P743, DOI 10.1083/jcb.110.3.743; Brazier MW, 2006, BRAIN RES BULL, V68, P346, DOI 10.1016/j.brainresbull.2005.09.010; Brown LR, 2003, J NEUROCHEM, V87, P353, DOI 10.1046/j.1471-4159.2003.01996.x; CAUGHEY B, 1991, J BIOL CHEM, V266, P18217; Caughey B, 2006, ACCOUNTS CHEM RES, V39, P646, DOI 10.1021/ar050068p; CAUGHEY B, 1989, J VIROL, V63, P175, DOI 10.1128/JVI.63.1.175-181.1989; Caughey WS, 1998, P NATL ACAD SCI USA, V95, P12117, DOI 10.1073/pnas.95.21.12117; Cheng F, 2006, J NEUROCHEM, V98, P1445, DOI 10.1111/j.1471-4159.2006.03981.x; Choi KH, 2005, GLYCOCONJUGATE J, V22, P63, DOI 10.1007/s10719-005-0326-1; Everse J, 2005, FREE RADICAL BIO MED, V38, P1296, DOI 10.1016/j.freeradbiomed.2005.01.018; Faller M, 2007, NAT STRUCT MOL BIOL, V14, P23, DOI 10.1038/nsmb1182; Galzigna L, 2000, CLIN CHIM ACTA, V300, P131, DOI 10.1016/S0009-8981(00)00313-2; Graner E, 2000, MOL BRAIN RES, V76, P85, DOI 10.1016/S0169-328X(99)00334-4; Hou SW, 2006, ACCOUNTS CHEM RES, V39, P918, DOI 10.1021/ar040020w; Hvidberg V, 2005, BLOOD, V106, P2572, DOI 10.1182/blood-2005-03-1185; Kiachopoulos S, 2004, TRAFFIC, V5, P426, DOI 10.1111/j.1398-9219.2004.00185.x; Klamt F, 2001, FREE RADICAL BIO MED, V30, P1137; Kocisko DA, 2006, ANTIMICROB AGENTS CH, V50, P1034, DOI 10.1128/AAC.50.3.1034-1044.2006; Kocisko DA, 2006, ANTIMICROB AGENTS CH, V50, P759, DOI 10.1128/AAC.50.2.759-761.2006; Kocisko DA, 2007, ANAL BIOCHEM, V363, P154, DOI 10.1016/j.ab.2006.11.007; Krishnamurthy P, 2007, PHARMACOL THERAPEUT, V114, P345, DOI 10.1016/j.pharmthera.2007.02.001; Kuczius T, 2004, BIOL CHEM, V385, P739, DOI 10.1515/BC.2004.090; Kumar S, 2005, TOXICOL LETT, V157, P175, DOI 10.1016/j.toxlet.2005.03.004; Lawson VA, 2001, J BIOL CHEM, V276, P35265, DOI 10.1074/jbc.M103799200; LIN H, 1987, ANAL BIOCHEM, V161, P323, DOI 10.1016/0003-2697(87)90458-1; Lopes MH, 2005, J NEUROSCI, V25, P11330, DOI 10.1523/JNEUROSCI.2313-05.2005; Maxson L, 2003, ANAL BIOCHEM, V323, P54, DOI 10.1016/j.ab.2003.07.028; Millhauser GL, 2007, ANNU REV PHYS CHEM, V58, P299, DOI 10.1146/annurev.physchem.58.032806.104657; Minana R, 2001, EUR J NEUROSCI, V13, P749, DOI 10.1046/j.0953-816x.2000.01439.x; Mitteregger G, 2007, BRAIN PATHOL, V17, P174, DOI 10.1111/j.1750-3639.2007.00061.x; Monzani E, 2001, BBA-PROTEIN STRUCT M, V1547, P302, DOI 10.1016/S0167-4838(01)00192-3; Morris RJ, 2006, FEBS LETT, V580, P5565, DOI 10.1016/j.febslet.2006.07.053; Nadal RC, 2007, FREE RADICAL BIO MED, V42, P79, DOI 10.1016/j.freeradbiomed.2006.09.019; Nichols BJ, 2001, J CELL BIOL, V153, P529, DOI 10.1083/jcb.153.3.529; Nunziante M, 2005, J CELL SCI, V118, P4959, DOI 10.1242/jcs.02609; Pauly PC, 1998, J BIOL CHEM, V273, P33107, DOI 10.1074/jbc.273.50.33107; Petersen RB, 2005, ACTA NEUROPATHOL, V110, P232, DOI 10.1007/s00401-005-1034-4; Priola SA, 2003, J INFECT DIS, V188, P699, DOI 10.1086/377310; Priola SA, 2000, SCIENCE, V287, P1503, DOI 10.1126/science.287.5457.1503; Quaglio E, 2001, J BIOL CHEM, V276, P11432, DOI 10.1074/jbc.M009666200; Santuccione A, 2005, J CELL BIOL, V169, P341, DOI 10.1083/jcb.200409127; SCHMITT TH, 1993, ARCH BIOCHEM BIOPHYS, V307, P96, DOI 10.1006/abbi.1993.1566; Schmitt-Ulms G, 2001, J MOL BIOL, V314, P1209, DOI 10.1006/jmbi.2000.5183; Scibior Dorota, 2006, Postepy Hig Med Dosw (Online), V60, P170; SHYNG SL, 1993, J BIOL CHEM, V268, P15922; SHYNG SL, 1995, J BIOL CHEM, V270, P30221; STAHL N, 1991, FASEB J, V5, P2799, DOI 10.1096/fasebj.5.13.1916104; Sumudhu W, 2001, CURR BIOL, V11, P519, DOI 10.1016/S0960-9822(01)00147-6; Sun JY, 2004, P NATL ACAD SCI USA, V101, P1461, DOI 10.1073/pnas.0308083100; Sunyach C, 2003, EMBO J, V22, P3591, DOI 10.1093/emboj/cdg344; Sunyach C, 2005, J NEUROCHEM, V92, P1399, DOI 10.1111/j.1471-4159.2004.02989.x; Sunyach C, 2007, J BIOL CHEM, V282, P1956, DOI 10.1074/jbc.M609663200; Takemura K, 2006, EXP BIOL MED, V231, P204; Taylor DR, 2007, BIOCHEM J, V402, P17, DOI 10.1042/BJ20061736; Warner RG, 2002, J BIOL CHEM, V277, P18421, DOI 10.1074/jbc.M110406200; Watt NT, 2005, J BIOL CHEM, V280, P35914, DOI 10.1074/jbc.M507327200; White AR, 1999, AM J PATHOL, V155, P1723, DOI 10.1016/S0002-9440(10)65487-9; Wong C, 2001, EMBO J, V20, P377, DOI 10.1093/emboj/20.3.377; Zahn R, 1997, FEBS LETT, V417, P400, DOI 10.1016/S0014-5793(97)01330-6; Zeng FN, 2003, J NEUROCHEM, V84, P480, DOI 10.1046/j.1471-4159.2003.01529.x; Zhu YH, 2002, DNA CELL BIOL, V21, P333, DOI 10.1089/104454902753759744	63	40	43	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36525	36533		10.1074/jbc.M705620200	http://dx.doi.org/10.1074/jbc.M705620200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17925394	hybrid			2022-12-27	WOS:000251458300045
J	Mans, BJ; Calvo, E; Ribeiro, JMC; Andersen, JF				Mans, Ben J.; Calvo, Eric; Ribeiro, Jose M. C.; Andersen, John F.			The crystal structure of D7r4, a salivary biogenic amine-binding protein from the malaria mosquito anopheles gambiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADULT FEMALE MOSQUITO; HISTAMINE-BINDING; PHEROMONE-BINDING; AEDES-AEGYPTI; DENSITY MODIFICATION; RHODNIUS-PROLIXUS; NMR STRUCTURE; GLAND; SIALOME; CLONING	The D7-related (D7r) proteins of the malaria vector Anopheles gambiae have been shown to bind the biogenic amines serotonin, norepinephrine, and histamine with high affinity. One member of the group (D7r1 or hamadarin) has also been shown to have an anticoagulant/antikinin activity. To understand the mechanistic details of its antihemostatic/anti-inflammatory effects, we have determined the crystal structure of one member of this group, D7r4, along with the structures of ligand complexes with serotonin, tryptamine, histamine, and norepinephrine. The D7 fold consists of an arrangement of eight alpha-helices stabilized by three disulfide bonds. The structure is similar to those of the arthropod odorant-binding proteins, a relationship that had been predicted based on sequence comparisons. Although odorant-binding proteins commonly have six alpha-helices, D7r4 has eight, resulting in significantly different positioning and structure of the ligand binding pocket. The pocket itself is lined by hydrophobic side chains along with polar and charged groups oriented to form hydrogen bonds with the aliphatic amino group and with groups on the aromatic portions of the ligands. These structures, along with accompanying mutagenesis studies, have allowed us to identify critical residues for biogenic amine binding and to predict which members of the large D7 protein family found in blood-feeding nematocerous Diptera will function as biogenic amine-binding proteins.	NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD 20852 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Andersen, JF (corresponding author), NIAID, Lab Malaria & Vector Res, NIH, Rm 2E32B,Twinbrook 3 Bldg,12735 Twinbrook Pkwy, Rockville, MD 20852 USA.	jandersen@niaid.nih.gov	Calvo, Eric/ABB-4935-2021; Mans, Ben J./M-2427-2017	Calvo, Eric/0000-0001-7880-2730; Mans, Ben J./0000-0002-0177-0029; Ribeiro, Jose/0000-0002-9107-0818	Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI001012, ZIAAI001012, ZIAAI000810, Z01AI000810] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Andersen JF, 2003, J BIOL CHEM, V278, P4611, DOI 10.1074/jbc.M211438200; Anderson JM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-52; Arca B, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P483; Calvo E, 2006, J BIOL CHEM, V281, P1935, DOI 10.1074/jbc.M510359200; Calvo E, 2004, INSECT MOL BIOL, V13, P73, DOI 10.1111/j.1365-2583.2004.00463.x; Calvo E, 2002, INSECT BIOCHEM MOLEC, V32, P1419, DOI 10.1016/S0965-1748(02)00062-0; Calvo E, 2007, INSECT BIOCHEM MOLEC, V37, P164, DOI 10.1016/j.ibmb.2006.11.005; Campbell CL, 2005, INSECT MOL BIOL, V14, P121, DOI 10.1111/j.1365-2583.2004.00537.x; *CCPA, 1994, ACTA CRYSTALLOGR D, V50, P760; Cowtan K, 1998, ACTA CRYSTALLOGR D, V54, P487, DOI 10.1107/S0907444997011980; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Francischetti IMB, 2002, J EXP BIOL, V205, P2429; Hekmat-Scafe DS, 2000, GENETICS, V155, P117; Horst R, 2001, P NATL ACAD SCI USA, V98, P14374, DOI 10.1073/pnas.251532998; Isawa H, 2007, INSECT BIOCHEM MOLEC, V37, P466, DOI 10.1016/j.ibmb.2007.02.002; JAMES AA, 1991, MOL BIOCHEM PARASIT, V44, P245, DOI 10.1016/0166-6851(91)90010-4; KLEYWEGT GJ, 1995, STRUCTURE, V3, P535, DOI 10.1016/S0969-2126(01)00187-3; Lee D, 2002, FEBS LETT, V531, P314, DOI 10.1016/S0014-5793(02)03548-2; Looger LL, 2003, NATURE, V423, P185, DOI 10.1038/nature01556; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Montfort WR, 2000, BBA-PROTEIN STRUCT M, V1482, P110, DOI 10.1016/S0167-4838(00)00165-5; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; OTWINOWSKI Z, 1991, P CCP4 STUD WEEK 25, P60; Paesen GC, 1999, MOL CELL, V3, P661, DOI 10.1016/S1097-2765(00)80359-7; RIBEIRO JMC, 1994, J EXP MED, V180, P2251, DOI 10.1084/jem.180.6.2251; RIBEIRO JMC, 1994, J MED ENTOMOL, V31, P747, DOI 10.1093/jmedent/31.5.747; Ribeiro JMC, 1999, J EXP BIOL, V202, P809; Ribeiro JMC, 2004, INSECT BIOCHEM MOLEC, V34, P543, DOI 10.1016/j.ibmb.2004.02.008; RIBEIRO JMC, 1995, INFECT AGENT DIS, V4, P143; Ribeiro JMC, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-6; Rothemund S, 1999, STRUCT FOLD DES, V7, P1325, DOI 10.1016/S0969-2126(00)80022-2; Sandler BH, 2000, CHEM BIOL, V7, P143, DOI 10.1016/S1074-5521(00)00078-8; Sangamnatdej S, 2002, INSECT MOL BIOL, V11, P79, DOI 10.1046/j.0962-1075.2001.00311.x; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Sheldrick GM, 2002, Z KRISTALLOGR, V217, P644, DOI 10.1524/zkri.217.12.644.20662; Tegoni M, 2000, BBA-PROTEIN STRUCT M, V1482, P229, DOI 10.1016/S0167-4838(00)00167-9; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Valenzuela JG, 1999, BIOCHEMISTRY-US, V38, P11209, DOI 10.1021/bi990761i; Valenzuela JG, 2002, INSECT BIOCHEM MOLEC, V32, P1101, DOI 10.1016/S0965-1748(02)00047-4; Weston-Davies W, 2002, LANCET, V359, P1067, DOI 10.1016/S0140-6736(02)08075-3	42	63	64	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36626	36633		10.1074/jbc.M706410200	http://dx.doi.org/10.1074/jbc.M706410200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17928288	hybrid			2022-12-27	WOS:000251458300055
J	Beran, RKF; Serebrov, V; Pyle, AM				Beran, Rudolf K. F.; Serebrov, Victor; Pyle, Anna Marie			The serine protease domain of hepatitis C viral NS3 activates RNA helicase activity by promoting the binding of RNA substrate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUTATIONAL ANALYSIS; VIRUS; REQUIRES; NS4A; TRANSLOCATION; INHIBITORS; SEPARATION; MECHANISM; MOTOR	Nonstructural (NS) protein 3 is a DEXH/D-box motor protein that is an essential component of the hepatitis C viral (HCV) replicative complex. The full-length NS3 protein contains two functional modules, both of which are essential in the life cycle of HCV: a serine protease domain at the N terminus and an ATPase/helicase domain (NS3hel) at the C terminus. Truncated NS3hel constructs have been studied extensively; the ATPase, nucleic acid binding, and helicase activities have been examined and NS3hel has been used as a target in the development of antivirals. However, a comprehensive comparison of NS3 and NS3hel activities has not been performed, so it remains unclear whether the protease domain plays a vital role in NS3 helicase function. Given that many DEXH/D-box proteins are activated upon interaction with cofactor proteins, it is important to establish if the protease domain acts as the cofactor for stimulating NS3 helicase function. Here we show that the protease domain greatly enhances both the direct and functional binding of RNA to NS3. Whereas electrostatics plays an important role in this process, there is a specific allosteric contribution from the interaction interface between NS3hel and the protease domain. Most importantly, we establish that the protease domain is required for RNA unwinding by NS3. Our results suggest that, in addition to its role in cleavage of host and viral proteins, the NS3 protease domain is essential for the process of viral RNA replication and, given its electrostatic contribution to RNA binding, it may also assist in packaging of the viral RNA.	Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Yale University; Howard Hughes Medical Institute	Pyle, AM (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, 266 Whitney Ave,Bass Bldg,Rm 334, New Haven, CT 06520 USA.	anna.pyle@yale.edu		Serebrov, Victor/0000-0002-5800-3103	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM071120, R01GM060620] Funding Source: NIH RePORTER; NIGMS NIH HHS [F32 GM071120-01A1, GM60620] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Beran RKF, 2006, J MOL BIOL, V358, P974, DOI 10.1016/j.jmb.2006.02.078; Binder M, 2007, J VIROL, V81, P5270, DOI 10.1128/JVI.00032-07; Borowski P, 2003, EUR J BIOCHEM, V270, P1645, DOI 10.1046/j.1432-1033.2003.03540.x; Buttner K, 2007, NAT STRUCT MOL BIOL, V14, P647, DOI 10.1038/nsmb1246; Coburn GA, 1999, GENE DEV, V13, P2594, DOI 10.1101/gad.13.19.2594; Diges CM, 2001, EMBO J, V20, P5503, DOI 10.1093/emboj/20.19.5503; FAILLA C, 1994, J VIROL, V68, P3753, DOI 10.1128/JVI.68.6.3753-3760.1994; Foy E, 2003, SCIENCE, V300, P1145, DOI 10.1126/science.1082604; Frick DN, 2007, CURR ISSUES MOL BIOL, V9, P1; Frick DN, 2007, J MOL BIOL, V365, P1017, DOI 10.1016/j.jmb.2006.10.023; Frick DN, 2004, J BIOL CHEM, V279, P1269, DOI 10.1074/jbc.M310630200; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Granneman S, 2006, NUCLEIC ACIDS RES, V34, P3189, DOI 10.1093/nar/gkl419; Hwang B, 2004, RNA, V10, P1277, DOI 10.1261/rna.7100904; Ishido S, 1998, BIOCHEM BIOPH RES CO, V244, P35, DOI 10.1006/bbrc.1998.8202; Jankowsky E, 2000, NATURE, V403, P447, DOI 10.1038/35000239; Kawaoka J, 2004, NAT STRUCT MOL BIOL, V11, P526, DOI 10.1038/nsmb771; Lam AMI, 2006, J VIROL, V80, P404, DOI 10.1128/JVI.80.1.404-411.2006; Lam AMI, 2003, J VIROL, V77, P3950, DOI 10.1128/JVI.77.7.3950-3961.2003; Levin MK, 2005, NAT STRUCT MOL BIOL, V12, P429, DOI 10.1038/nsmb920; Lin C, 2005, J BIOL CHEM, V280, P36784, DOI 10.1074/jbc.M506462200; Lindenbach BD, 2007, J VIROL, V81, P8905, DOI 10.1128/JVI.00937-07; Merrick WC, 1997, METHODS, V11, P333, DOI 10.1006/meth.1996.0431; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Myong S, 2007, SCIENCE, V317, P513, DOI 10.1126/science.1144130; Pang PS, 2002, EMBO J, V21, P1168, DOI 10.1093/emboj/21.5.1168; PAOLETTI E, 1974, J BIOL CHEM, V249, P3281; Piccininni S, 2002, J BIOL CHEM, V277, P45670, DOI 10.1074/jbc.M204124200; Py B, 1996, NATURE, V381, P169, DOI 10.1038/381169a0; Serebrov V, 2004, NATURE, V430, P476, DOI 10.1038/nature02704; SUZICH JA, 1993, J VIROL, V67, P6152, DOI 10.1128/JVI.67.10.6152-6158.1993; Tackett AJ, 2005, J BIOL CHEM, V280, P10797, DOI 10.1074/jbc.M407971200; Tai CL, 2001, J VIROL, V75, P8289, DOI 10.1128/JVI.75.17.8289-8297.2001; Tanaka N, 2007, GENE DEV, V21, P2312, DOI 10.1101/gad.1580507; Turner AMW, 2007, J BACTERIOL, V189, P2769, DOI 10.1128/JB.01509-06; Vanzo NF, 1998, GENE DEV, V12, P2770, DOI 10.1101/gad.12.17.2770; Voet D., 1995, BIOCHEMISTRY; Weirich CS, 2006, NAT CELL BIOL, V8, P668, DOI 10.1038/ncb1424; WONG I, 1993, P NATL ACAD SCI USA, V90, P5428, DOI 10.1073/pnas.90.12.5428; Yao NH, 1999, STRUCTURE, V7, P1353, DOI 10.1016/S0969-2126(00)80025-8; Yao NH, 1997, NAT STRUCT BIOL, V4, P463, DOI 10.1038/nsb0697-463; Yi MK, 2007, J VIROL, V81, P629, DOI 10.1128/JVI.01890-06; Zhang C, 2005, J VIROL, V79, P8687, DOI 10.1128/JVI.79.14.8687-8697.2005	43	89	92	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					34913	34920		10.1074/jbc.M707165200	http://dx.doi.org/10.1074/jbc.M707165200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17921146	hybrid			2022-12-27	WOS:000251155200034
J	Dunn-Siegrist, I; Leger, O; Daubeuf, B; Poitevin, Y; Depis, F; Herren, S; Kosco-Vilbois, M; Dean, Y; Pugin, J; Elson, G				Dunn-Siegrist, Irene; Leger, Olivier; Daubeuf, Bruno; Poitevin, Yves; Depis, Fabien; Herren, Suzanne; Kosco-Vilbois, Marie; Dean, Yann; Pugin, Jerome; Elson, Greg			Pivotal involvement of Fc gamma receptor IIA in the neutralization of lipopolysaccharide signaling via a potent novel anti-TLR4 monoclonal antibody 15C1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DROSOPHILA TOLL; HUMAN MONOCYTES; CUTTING EDGE; IN-VIVO; TLR4; BINDING; ACTIVATION; CELLS; MD-2; LPS	The mammalian Toll-like receptor (TLR) family has evolved to sense pathogens in the environment and protect the host against infection. TLR4 recognizes lipopolysaccharide (LPS) from Gram-negative bacteria and induces a signaling cascade that, when exaggerated, has been associated with severe sepsis. Wehave generated a TLR4-specific monoclonal antibody, 15C1, which neutralizes LPS-induced TLR4 activation in a dose-dependent manner. 15C1 potently blocks the effects of LPS on a panel of primary cells and cell lines in vitro. The binding of 15C1 was mapped to an epitope in the second portion of the extracellular region of TLR4, which has been shown previously to be functionally important in the recognition of LPS. Furthermore, we demonstrate a novel mechanism of inhibition, as the effects of 15C1 are partially Fc-dependent, involving the regulatory Fc gamma receptor IIA (CD32A). In addition to introducing 15C1 as a potent clinical candidate for use in the treatment of LPS-mediated indications, our work demonstrates a newly discovered pathway whose manipulation is pivotal in achieving optimal neutralizing benefit.	NovImmune SA, CH-1228 Geneva, Switzerland; Univ Med Ctr, CH-1211 Geneva, Switzerland	NovImmune SA; University of Geneva	Elson, G (corresponding author), NovImmune SA, Plan-les-Ouates, CH-1228 Geneva, Switzerland.	gelson@novimmune.com						Akashi S, 2000, J IMMUNOL, V164, P3471, DOI 10.4049/jimmunol.164.7.3471; Akashi-Takamura S, 2006, J IMMUNOL, V176, P4244, DOI 10.4049/jimmunol.176.7.4244; Annane D, 2005, LANCET, V365, P63, DOI 10.1016/S0140-6736(04)17667-8; Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; BAUMGARTNER JD, 1985, LANCET, V2, P59; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Carlsson LE, 1998, BLOOD, V92, P1526, DOI 10.1182/blood.V92.5.1526.417k26_1526_1531; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; Clynes RA, 2000, NAT MED, V6, P443, DOI 10.1038/74704; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Cohen SB, 2005, HYBRIDOMA, V24, P27, DOI 10.1089/hyb.2005.24.27; Correia JD, 2001, J BIOL CHEM, V276, P21129, DOI 10.1074/jbc.M009164200; Dijstelbloem HM, 2001, TRENDS IMMUNOL, V22, P510, DOI 10.1016/S1471-4906(01)02014-2; Elson G, 2007, BLOOD, V109, P1574, DOI 10.1182/blood-2006-06-032961; Flo TH, 2002, J BIOL CHEM, V277, P35489, DOI 10.1074/jbc.M201366200; Gamberale R, 2003, BLOOD, V102, P2698, DOI 10.1182/blood-2003-05-1416; Gay NJ, 2007, ANNU REV BIOCHEM, V76, P141, DOI 10.1146/annurev.biochem.76.060305.151318; GAY NJ, 1991, NATURE, V351, P355, DOI 10.1038/351355b0; GOLDIE AS, 1995, JAMA-J AM MED ASSOC, V274, P172, DOI 10.1001/jama.274.2.172; Groger M, 1996, J IMMUNOL, V156, P1549; Hajjar AM, 2002, NAT IMMUNOL, V3, P354, DOI 10.1038/ni777; Hamerman JA, 2005, NAT IMMUNOL, V6, P579, DOI 10.1038/ni1204; HAMERMAN JA, 2006, SCI STKE, pRE1, DOI DOI 10.1126/STKE.3202006RE1; Hamerman JA, 2006, J IMMUNOL, V177, P2051, DOI 10.4049/jimmunol.177.4.2051; Hawkins LD, 2004, CURR TOP MED CHEM, V4, P1147, DOI 10.2174/1568026043388123; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; JONES ST, 1991, BIO-TECHNOL, V9, P88, DOI 10.1038/nbt0191-88; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Lanier LL, 2000, IMMUNOL TODAY, V21, P611, DOI 10.1016/S0167-5699(00)01745-X; Maresco DL, 1999, J IMMUNOL, V162, P6458; Marshall JC, 2003, NAT REV DRUG DISCOV, V2, P391, DOI 10.1038/nrd1084; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Meng GX, 2004, J CLIN INVEST, V113, P1473, DOI 10.1172/JCI200420762; Merck E, 2006, J IMMUNOL, V176, P3149, DOI 10.4049/jimmunol.176.5.3149; Merck E, 2005, BLOOD, V105, P3623, DOI 10.1182/blood-2004-07-2809; MOST J, 1992, IMMUNOL LETT, V32, P159, DOI 10.1016/0165-2478(92)90109-2; Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809; Nattermann J, 2000, J ENDOTOXIN RES, V6, P257, DOI 10.1179/096805100101532126; Nimmerjahn F, 2005, IMMUNITY, V23, P41, DOI 10.1016/j.immuni.2005.05.010; Ohta S, 2006, CLIN VACCINE IMMUNOL, V13, P1131, DOI 10.1128/CVI.00173-06; Palsson-McDermott EM, 2004, IMMUNOLOGY, V113, P153, DOI 10.1111/j.1365-2567.2004.01976.x; PARREN PWHI, 1992, J CLIN INVEST, V90, P1537, DOI 10.1172/JCI116022; Pfeiffer A, 2001, EUR J IMMUNOL, V31, P3153, DOI 10.1002/1521-4141(200111)31:11<3153::AID-IMMU3153>3.0.CO;2-0; POLLACK M, 1983, J CLIN INVEST, V72, P1874, DOI 10.1172/JCI111150; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Pugin J, 2004, BLOOD, V104, P4071, DOI 10.1182/blood-2003-04-1290; PUGIN J, 1993, P NATL ACAD SCI USA, V90, P2744, DOI 10.1073/pnas.90.7.2744; Qureshi ST, 1999, J EXP MED, V189, P615, DOI 10.1084/jem.189.4.615; Rallabhandi P, 2006, J IMMUNOL, V177, P322, DOI 10.4049/jimmunol.177.1.322; SCHUMANN RR, 1990, SCIENCE, V249, P1429, DOI 10.1126/science.2402637; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Siberil S, 2007, CRIT REV ONCOL HEMAT, V62, P26, DOI 10.1016/j.critrevonc.2006.12.003; VANDEWINKEL JGJ, 1991, J LEUKOCYTE BIOL, V49, P511, DOI 10.1002/jlb.49.5.511; Visintin A, 2003, J BIOL CHEM, V278, P48313, DOI 10.1074/jbc.M306802200; WEINGARTEN R, 1993, J LEUKOCYTE BIOL, V53, P518, DOI 10.1002/jlb.53.5.518; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311	57	45	48	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					34817	34827		10.1074/jbc.M706440200	http://dx.doi.org/10.1074/jbc.M706440200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17921137	hybrid			2022-12-27	WOS:000251155200024
J	Yi, HQ; Friedman, JL; Ferreira, PA				Yi, Haiqing; Friedman, Julie L.; Ferreira, Paulo A.			The cyclophilin-like domain of Ran-binding protein-2 modulates selectively the activity of the ubiquitin-proteasome system and protein biogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-PORE COMPLEX; MULTIUBIQUITIN-CHAIN-BINDING; LINKED MENTAL-RETARDATION; 26S PROTEASOME; SUMO-1 MODIFICATION; REGULATORY SUBUNIT; SACCHAROMYCES-CEREVISIAE; FUNCTIONAL-ANALYSIS; HUMAN-DISEASES; CDNA CLONING	The ubiquitin-proteasome system (UPS) plays a critical role in protein degradation. The 19S regulatory particle (RP) of the 26S proteasome mediates the recognition, deubiquitylation, unfolding, and channeling of ubiquitylated substrates to the 20S proteasome. Several subunits of the 19S RP interact with a growing number of factors. The cyclophilin-like domain (CLD) of Ran-binding protein-2 (RanBP2/Nup358) associates specifically with at least one subunit, S1, of the base subcomplex of the 19S RP, but the functional implications of this interaction on the UPS activity are elusive. This study shows the CLD of RanBP2 promotes selectively the accumulation of a subset of reporter substrates of the UPS, such as the ubiquitin (Ub)-fusion yellow fluorescent protein (YFP) degradation substrate, UbG76V-YFP, and the N-end rule substrate, Ub-R-YFP. Conversely, the degradation of endoplasmic reticulum and misfolded proteins, and of those linked to UPS-independent degradation, is not affected by CLD. The selective effect of CLD on the UPS in vivo is independent of, and synergistic with, proteasome inhibitors, and CLD does not affect the intrinsic proteolytic activity of the 20S proteasome. The inhibitory activity of CLD on the UPS resides in a purported SUMO binding motif. We also found two RanBP2 substrates, RanGTPase-activating protein and retinitis pigmentosa GTPase regulator interacting protein-1 alpha 1, whose steady-state levels are selectively modulated by CLD. Hence, the CLD of RanBP2 acts as a novel auxiliary modulator of the UPS activity; it may contribute to the molecular and subcellular compartmentation of the turnover of properly folded proteins and modulation of the expressivity of several neurological diseases.	Duke Univ, Ctr Med, Dept Ophthalmol, Durham, NC 27710 USA; Duke Univ, Ctr Med, Dept Mol Genet & Microbiol, Durham, NC 27710 USA	Duke University; Duke University	Ferreira, PA (corresponding author), Duke Univ, Ctr Med, Dept Ophthalmol, Durham, NC 27710 USA.	ferre044@mc.duke.edu	Ferreira, Paulo/A-3893-2008; Ferreira, Paulo A/S-4209-2016	Ferreira, Paulo A/0000-0003-4585-1717; Yi, Haiqing/0000-0003-2254-6226	NATIONAL EYE INSTITUTE [R01EY011993, P30EY005722] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY011993, 2P30-EY005722-21, EY011993] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Aslanukov A, 2006, PLOS GENET, V2, P1653, DOI 10.1371/journal.pgen.0020177; Baumer M, 2000, J BIOL CHEM, V275, P38929, DOI 10.1074/jbc.M007925200; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bennett EJ, 2007, NATURE, V448, P704, DOI 10.1038/nature06022; Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; Braslavsky CIV, 2000, BIOCHEMISTRY-US, V39, P11629, DOI 10.1021/bi001010f; Buschmann T, 2000, CELL, V101, P753, DOI 10.1016/S0092-8674(00)80887-9; Cai YF, 2001, J BIOL CHEM, V276, P41594, DOI 10.1074/jbc.M104514200; Castagnet P, 2003, HUM MOL GENET, V12, P1847, DOI 10.1093/hmg/ddg202; Cho KI, 2007, TRAFFIC, V8, P1722, DOI 10.1111/j.1600-0854.2007.00647.x; Ciechanover A, 2005, NAT REV MOL CELL BIO, V6, P79, DOI 10.1038/nrm1552; Ciechanover A, 2005, CELL DEATH DIFFER, V12, P1178, DOI 10.1038/sj.cdd.4401692; Cummings CJ, 1998, NAT GENET, V19, P148, DOI 10.1038/502; Delphin C, 1997, MOL BIOL CELL, V8, P2379, DOI 10.1091/mbc.8.12.2379; DEMARINI DJ, 1995, MOL CELL BIOL, V15, P6311; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; DEVERAUX Q, 1994, J BIOL CHEM, V269, P7059; Elsasser S, 2005, NAT CELL BIOL, V7, P742, DOI 10.1038/ncb0805-742; Elsasser S, 2004, J BIOL CHEM, V279, P26817, DOI 10.1074/jbc.M404020200; Ethen CM, 2007, FEBS LETT, V581, P885, DOI 10.1016/j.febslet.2007.01.061; Fauser S, 2001, MAMM GENOME, V12, P406, DOI 10.1007/s003350010291; FERREIRA PA, 1995, J BIOL CHEM, V270, P23179, DOI 10.1074/jbc.270.39.23179; Ferreira PA, 1996, NATURE, V383, P637, DOI 10.1038/383637a0; Ferreira PA, 1998, J BIOL CHEM, V273, P24676, DOI 10.1074/jbc.273.38.24676; Ferreira PA, 1997, P NATL ACAD SCI USA, V94, P1556, DOI 10.1073/pnas.94.4.1556; Ferreira PA, 2000, METHOD ENZYMOL, V315, P455; Ferrell K, 2000, TRENDS BIOCHEM SCI, V25, P83, DOI 10.1016/S0968-0004(99)01529-7; Fu HY, 1998, J BIOL CHEM, V273, P1970, DOI 10.1074/jbc.273.4.1970; Glickman MH, 1998, MOL CELL BIOL, V18, P3149, DOI 10.1128/MCB.18.6.3149; GOUW LG, 1994, NEUROLOGY, V44, P1441, DOI 10.1212/WNL.44.8.1441; Hirsch C, 2000, TRENDS CELL BIOL, V10, P268, DOI 10.1016/S0962-8924(00)01768-2; Hofmann K, 2001, TRENDS BIOCHEM SCI, V26, P347, DOI 10.1016/S0968-0004(01)01835-7; Jiang YH, 2004, CURR OPIN PEDIATR, V16, P419, DOI 10.1097/01.mop.0000133634.79661.cd; Kapphahn RJ, 2007, EXP EYE RES, V84, P646, DOI 10.1016/j.exer.2006.12.002; Kisselev AF, 2005, METHOD ENZYMOL, V398, P364, DOI 10.1016/S0076-6879(05)98030-0; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kleijnen MF, 2000, MOL CELL, V6, P409, DOI 10.1016/S1097-2765(00)00040-X; Kristiansen M, 2007, MOL CELL, V26, P175, DOI 10.1016/j.molcel.2007.04.001; Kurtzman AL, 2001, P NATL ACAD SCI USA, V98, P5602, DOI 10.1073/pnas.101129698; LARRIVEE DC, 1981, J GEN PHYSIOL, V78, P521, DOI 10.1085/jgp.78.5.521; Lee GW, 1998, J BIOL CHEM, V273, P6503, DOI 10.1074/jbc.273.11.6503; Li XQ, 1998, J BIOL CHEM, V273, P34970, DOI 10.1074/jbc.273.52.34970; Lin L, 1998, CELL, V92, P819, DOI 10.1016/S0092-8674(00)81409-9; Lindsten K, 2003, NAT BIOTECHNOL, V21, P897, DOI 10.1038/nbt851; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Mahajan R, 1998, J CELL BIOL, V140, P259, DOI 10.1083/jcb.140.2.259; MARTIN JJ, 1994, ACTA NEUROPATHOL, V88, P277; Matilla A, 2001, HUM MOL GENET, V10, P2821, DOI 10.1093/hmg/10.24.2821; McNaught KS, 2003, EXP NEUROL, V179, P38, DOI 10.1006/exnr.2002.8050; Menendez-Benito V, 2005, HUM MOL GENET, V14, P2787, DOI 10.1093/hmg/ddi312; Ortolan TG, 2000, NAT CELL BIOL, V2, P601, DOI 10.1038/35023547; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; Roepman R, 2000, HUM MOL GENET, V9, P2095, DOI 10.1093/hmg/9.14.2095; Saeki Y, 2002, BIOCHEM BIOPH RES CO, V293, P986, DOI 10.1016/S0006-291X(02)00340-6; Saitoh H, 2002, J BIOL CHEM, V277, P4755, DOI 10.1074/jbc.M104453200; Sakata E, 2003, EMBO REP, V4, P301, DOI 10.1038/sj.embor.embor764; Schmidt M, 2005, BIOL CHEM, V386, P725, DOI 10.1515/BC.2005.085; SCHNEUWLY S, 1989, P NATL ACAD SCI USA, V86, P5390, DOI 10.1073/pnas.86.14.5390; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; Schwartz AL, 1999, ANNU REV MED, V50, P57; Sheaff RJ, 2000, MOL CELL, V5, P403, DOI 10.1016/S1097-2765(00)80435-9; SHIEH BH, 1989, NATURE, V338, P67, DOI 10.1038/338067a0; Singh BB, 1999, J BIOL CHEM, V274, P37370, DOI 10.1074/jbc.274.52.37370; Song J, 2004, P NATL ACAD SCI USA, V101, P14373, DOI 10.1073/pnas.0403498101; STAMNES MA, 1991, CELL, V65, P219, DOI 10.1016/0092-8674(91)90156-S; Tarpey PS, 2007, AM J HUM GENET, V80, P345, DOI 10.1086/511134; Tsurumi C, 1996, EUR J BIOCHEM, V239, P912, DOI 10.1111/j.1432-1033.1996.0912u.x; vanNocker S, 1996, MOL CELL BIOL, V16, P6020; WILKEN N, 1995, EUR J CELL BIOL, V68, P211; Witkovsky P, 2004, DOC OPHTHALMOL, V108, P17, DOI 10.1023/B:DOOP.0000019487.88486.0a; WU J, 1995, J BIOL CHEM, V270, P14209, DOI 10.1074/jbc.270.23.14209; Yeh ETH, 2000, GENE, V248, P1, DOI 10.1016/S0378-1119(00)00139-6; Yokota K, 1996, MOL BIOL CELL, V7, P853, DOI 10.1091/mbc.7.6.853; YOKOYAMA N, 1995, NATURE, V376, P184, DOI 10.1038/376184a0; Young P, 1998, J BIOL CHEM, V273, P5461, DOI 10.1074/jbc.273.10.5461; Zou YX, 2007, AM J HUM GENET, V80, P561, DOI 10.1086/512489	77	14	14	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					34770	34778		10.1074/jbc.M706903200	http://dx.doi.org/10.1074/jbc.M706903200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17911097	hybrid			2022-12-27	WOS:000251155200019
J	Sibilio, L; Martayan, A; Setini, A; Lo Monaco, E; Tremante, E; Butler, RH; Giacomini, P				Sibilio, Leonardo; Martayan, Aline; Setini, Andrea; Lo Monaco, Elisa; Tremante, Elisa; Butler, Richard H.; Giacomini, Patrizio			A single bottleneck in HLA-C assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLASS-I MOLECULES; CELL-SURFACE EXPRESSION; HEAVY-CHAINS FREE; PEPTIDE BINDING; CRYSTAL-STRUCTURE; OPEN CONFORMERS; MHC; TAP; POLYMORPHISM; RECEPTOR	Poor assembly of class I major histocompatibility HLA-C heavy chains results in their intracellular accumulation in two forms: free of and associated with their light chain subunit (beta(2)-microglobulin). Both intermediates are retained in the endoplasmic reticulum by promiscuous and HLA-dedicated chaperones and are poorly associated with peptide antigens. In this study, the eight serologically defined HLA-C alleles and the interlocus recombinant HLA-B46 allele ( sharing the HLA-C-specific motif KYRV at residues 66-76 of the alpha 1-domain alpha-helix) were compared with a large series of HLA-B and HLA-A alleles. Pulse-labeling experiments with HLA-C transfectants and HLA homozygous cell lines demonstrated that KYRV alleles accumulate as free heavy chains because of both poor assembly and post-assembly instability. Reactivity with antibodies to mapped linear epitopes, co-immunoprecipitation experiments, and molecular dynamics simulation studies additionally showed that the KYRV motif confers association to the HLA-dedicated chaperones TAP and tapasin as well as reduced plasticity and unfolding in the peptide-binding groove. Finally, in vitro assembly experiments in cell extracts of the T2 and 721.220 mutant cell lines demonstrated that HLA-Cw1 retains the ability to form a peptide-receptive interface despite a lack of TAP and functional tapasin, respectively. In the context of the available literature, these results indicate that a single locus-specific biosynthetic bottleneck renders HLA-C peptide-selective ( rather than peptide-unreceptive) and a preferential natural killer cell ligand.	[Sibilio, Leonardo; Martayan, Aline; Setini, Andrea; Lo Monaco, Elisa; Tremante, Elisa; Giacomini, Patrizio] Ctr Ric Sperimentale, Regina Elena Natl Canc Res Inst, Immunol Lab, I-00158 Rome, Italy; [Butler, Richard H.] CNR, Inst Cell Biol, I-00016 Monterotondo Scalo Rome, Italy	Consiglio Nazionale delle Ricerche (CNR)	Giacomini, P (corresponding author), Ctr Ric Sperimentale, Regina Elena Natl Canc Res Inst, Immunol Lab, Via Messi Oro 156, I-00158 Rome, Italy.	giacomini@ifo.it	Giacomini, Patrizio/K-5217-2016; Tremante, Elisa/K-5288-2018	Giacomini, Patrizio/0000-0001-6109-1709; Tremante, Elisa/0000-0002-8584-9913; SETINI, Andrea/0000-0001-8098-6671				Andersen MH, 1999, TISSUE ANTIGENS, V54, P185, DOI 10.1034/j.1399-0039.1999.540210.x; ANDERSON KS, 1993, J IMMUNOL, V151, P3407; Arosa FA, 2007, TRENDS IMMUNOL, V28, P115, DOI 10.1016/j.it.2007.01.002; BAAS EJ, 1992, J EXP MED, V176, P147, DOI 10.1084/jem.176.1.147; Barber LD, 1996, J EXP MED, V184, P735, DOI 10.1084/jem.184.2.735; BENJAMIN RJ, 1992, IMMUNOGENETICS, V37, P73; Boyington JC, 2000, NATURE, V405, P537, DOI 10.1038/35014520; BRODSKY FM, 1979, IMMUNOL REV, V47, P3, DOI 10.1111/j.1600-065X.1979.tb00288.x; Caley RRP, 1999, HUM IMMUNOL, V60, P743, DOI 10.1016/S0198-8859(99)00022-1; Colonna M, 2000, IMMUNOL TODAY, V21, P428, DOI 10.1016/S0167-5699(00)01697-2; Falk CS, 1997, IMMUNOL RES, V16, P203, DOI 10.1007/BF02786363; FALK K, 1993, P NATL ACAD SCI USA, V90, P12005, DOI 10.1073/pnas.90.24.12005; Fan QR, 2001, NAT IMMUNOL, V2, P452, DOI 10.1038/87766; Giacomini P, 1997, TISSUE ANTIGENS, V50, P555, DOI 10.1111/j.1399-0039.1997.tb02913.x; GILLET AC, 1990, EUR J IMMUNOL, V20, P759, DOI 10.1002/eji.1830200408; Giorda E, 2003, CANCER RES, V63, P4119; Grandea AG, 1997, IMMUNOGENETICS, V46, P477, DOI 10.1007/s002510050308; GRANDEA AG, 1995, SCIENCE, V270, P105, DOI 10.1126/science.270.5233.105; GREENWOOD R, 1994, J IMMUNOL, V153, P5525; Groothuis TAM, 2005, IMMUNOL REV, V207, P60, DOI 10.1111/j.0105-2896.2005.00305.x; Hansen TH, 2005, IMMUNOL REV, V207, P100, DOI 10.1111/j.0105-2896.2005.00315.x; HENDERSON RA, 1992, SCIENCE, V255, P1264, DOI 10.1126/science.1546329; Hiby SE, 2004, J EXP MED, V200, P957, DOI 10.1084/jem.20041214; HILL A, 1993, IMMUNOGENETICS, V37, P95; Hulsmeyer M, 2002, J BIOL CHEM, V277, P47844, DOI 10.1074/jbc.M206392200; Lee N, 1998, J IMMUNOL, V160, P4951; Lewis JW, 1998, EUR J IMMUNOL, V28, P3214, DOI 10.1002/(SICI)1521-4141(199810)28:10<3214::AID-IMMU3214>3.3.CO;2-3; Lewis JW, 1998, CURR BIOL, V8, P717, DOI 10.1016/S0960-9822(98)70280-5; MCCUTCHEON JA, 1995, J EXP MED, V181, P2085, DOI 10.1084/jem.181.6.2085; MIZUNO S, 1989, IMMUNOGENETICS, V29, P323, DOI 10.1007/BF00352842; NEEFJES JJ, 1988, EUR J IMMUNOL, V18, P801, DOI 10.1002/eji.1830180522; Neisig A, 1998, J IMMUNOL, V160, P171; Paquet ME, 2002, INT IMMUNOL, V14, P347, DOI 10.1093/intimm/14.4.347; PeaceBrewer AL, 1996, IMMUNITY, V4, P505, DOI 10.1016/S1074-7613(00)80416-1; Peh CA, 1998, IMMUNITY, V8, P531, DOI 10.1016/S1074-7613(00)80558-0; Roder G, 2006, ACTA CRYSTALLOGR D, V62, P1300, DOI 10.1107/S0907444906027636; Sernee MF, 1998, MOL IMMUNOL, V35, P177, DOI 10.1016/S0161-5890(98)00026-1; Setini A, 1996, HUM IMMUNOL, V46, P69, DOI 10.1016/0198-8859(96)00011-0; SHIMIZU Y, 1988, P NATL ACAD SCI USA, V85, P227, DOI 10.1073/pnas.85.1.227; Sibilio L, 2005, J IMMUNOL, V175, P6651, DOI 10.4049/jimmunol.175.10.6651; Smith KD, 1997, IMMUNOL RES, V16, P243, DOI 10.1007/BF02786393; STEINLE A, 1994, TISSUE ANTIGENS, V44, P268, DOI 10.1111/j.1399-0039.1994.tb02394.x; TOWNSEND A, 1990, CELL, V62, P285, DOI 10.1016/0092-8674(90)90366-M; Turnquist HR, 2000, EUR J IMMUNOL, V30, P3021, DOI 10.1002/1521-4141(200010)30:10<3021::AID-IMMU3021>3.0.CO;2-U; Yu YYL, 1999, J IMMUNOL, V163, P4427; Zacharias M, 2004, BIOPHYS J, V87, P2203, DOI 10.1529/biophysj.104.044743; ZEMMOUR J, 1992, J EXP MED, V176, P937, DOI 10.1084/jem.176.4.937	47	31	31	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1267	1274		10.1074/jbc.M708068200	http://dx.doi.org/10.1074/jbc.M708068200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	17956861	hybrid			2022-12-27	WOS:000252282700009
J	Boos, D; Kuffer, C; Lenobel, R; Korner, R; Stemmann, O				Boos, Dominik; Kuffer, Christian; Lenobel, Rene; Koerner, Roman; Stemmann, Olaf			Phosphorylation-dependent binding of cyclin B1 to a Cdc6-like domain of human separase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SISTER-CHROMATID COHESION; ESCHERICHIA-COLI; XENOPUS-OOCYTES; MEIOSIS-I; COMPLEX; SECURIN; PROTEIN; PROGRESSION; INHIBITION; ANAPHASE	Sister chromatids are held together by the ring-shaped cohesin complex, which likely entraps both DNA- double strands in its middle. This tie is resolved in anaphase when separase, a giant protease, becomes active and cleaves the kleisin subunit of cohesin. Premature activation of separase and, hence, chromosome missegregation are prevented by at least two inhibitory mechanisms. Although securin has long been appreciated as a direct inhibitor of separase, surprisingly its loss has basically no phenotype in mammals. Phosphorylation-dependent binding of Cdk1 constitutes an alternative way to inhibit vertebrate separase. Its importance is illustrated by the premature loss of cohesion when Cdk1-resistant separase is expressed in mammalian cells without or with limiting amounts of securin. Here, we demonstrate that crucial inhibitory phosphorylations occur within a region of human separase that is also shown to make direct contact with the cyclin B1 subunit of Cdk1. This region exhibits a weak homology to Saccharomyces cerevisiae Cdc6 of similar Cdk1 binding behavior, thereby establishing phosphoserine/threonine- mediated binding of partners as a conserved characteristic of B-type cyclins. In contrast to the Cdc6-like domain, the previously identified serine 1126 phosphorylation is fully dispensable for Cdk1 binding to separase fragments. This suggests that despite its in vivo relevance, it promotes complex formation indirectly, possibly by inducing a conformational change in full-length separase.	[Boos, Dominik; Kuffer, Christian; Stemmann, Olaf] Max Planck Inst Biochem, Dept Mol Cell Biol, D-82152 Martinsried, Germany; [Lenobel, Rene; Koerner, Roman] Max Planck Inst Biochem, Dept Cell Biol, D-82152 Martinsried, Germany	Max Planck Society; Max Planck Society	Stemmann, O (corresponding author), Max Planck Inst Biochem, Dept Mol Cell Biol, Am Klopferspitz 18, D-82152 Martinsried, Germany.	stemmann@biochem.mpg.de	LENOBEL, René/AAD-5606-2020; Kuffer, Christian CK/D-9314-2015; Körner, Roman/G-8565-2011	Kuffer, Christian CK/0000-0003-3798-8959; Körner, Roman/0000-0001-9285-9290; Stemmann, Olaf/0000-0003-3044-2515; Lenobel, Rene/0000-0001-7387-0056; Boos, Dominik/0000-0003-0018-4375				Archambault V, 2003, MOL BIOL CELL, V14, P4592, DOI 10.1091/mbc.E03-06-0384; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Bourne Y, 2000, STRUCT FOLD DES, V8, P841, DOI 10.1016/S0969-2126(00)00175-1; Chin JW, 2002, P NATL ACAD SCI USA, V99, P11020, DOI 10.1073/pnas.172226299; DORMAN G, 1994, BIOCHEMISTRY-US, V33, P5661, DOI 10.1021/bi00185a001; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Elsasser S, 1996, MOL BIOL CELL, V7, P1723, DOI 10.1091/mbc.7.11.1723; Gorr IH, 2005, MOL CELL, V19, P135, DOI 10.1016/j.molcel.2005.05.022; Gorr IH, 2006, NAT CELL BIOL, V8, P1035, DOI 10.1038/ncb1467; Holland AJ, 2007, J BIOL CHEM, V282, P24623, DOI 10.1074/jbc.M702545200; Holland AJ, 2006, J CELL SCI, V119, P3325, DOI 10.1242/jcs.03083; Huang XX, 2005, MOL BIOL CELL, V16, P4725, DOI 10.1091/mbc.E05-03-0190; Ivanov D, 2005, CELL, V122, P849, DOI 10.1016/j.cell.2005.07.018; Ivanov D, 2007, MOL CELL, V27, P300, DOI 10.1016/j.molcel.2007.07.002; Jallepalli PV, 2001, CELL, V105, P445, DOI 10.1016/S0092-8674(01)00340-3; Ji JY, 2005, DEVELOPMENT, V132, P1875, DOI 10.1242/dev.01780; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; Kudo NR, 2006, CELL, V126, P135, DOI 10.1016/j.cell.2006.05.033; Kumada K, 2006, J CELL BIOL, V172, P835, DOI 10.1083/jcb.200511126; Li M, 2007, MOL CELL BIOL, V27, P3481, DOI 10.1128/MCB.02088-06; Lin DI, 2006, MOL CELL, V24, P355, DOI 10.1016/j.molcel.2006.09.007; Lu KP, 1996, NATURE, V380, P544; Mei JJ, 2001, CURR BIOL, V11, P1197, DOI 10.1016/S0960-9822(01)00325-6; Mimura S, 2004, NATURE, V431, P1118, DOI 10.1038/nature03024; Mirgorodskaya OA, 2000, RAPID COMMUN MASS SP, V14, P1226, DOI 10.1002/1097-0231(20000730)14:14<1226::AID-RCM14>3.0.CO;2-V; Papi M, 2005, NAT CELL BIOL, V7, P1029, DOI 10.1038/ncb1303; Patra D, 1999, J BIOL CHEM, V274, P36839, DOI 10.1074/jbc.274.52.36839; Peter M, 2001, NAT CELL BIOL, V3, P83, DOI 10.1038/35050607; Pfleghaar K, 2005, PLOS BIOL, V3, P2127, DOI 10.1371/journal.pbio.0030416; Ryu YH, 2006, NAT METHODS, V3, P263, DOI 10.1038/NMETH864; Shen MH, 1998, GENE DEV, V12, P706, DOI 10.1101/gad.12.5.706; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Stemmann O, 2001, CELL, V107, P715, DOI 10.1016/S0092-8674(01)00603-1; Taieb FE, 2001, CURR BIOL, V11, P508, DOI 10.1016/S0960-9822(01)00145-2; Thingholm TE, 2006, NAT PROTOC, V1, P1929, DOI 10.1038/nprot.2006.185; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Wang ZY, 2001, MOL ENDOCRINOL, V15, P1870, DOI 10.1210/me.15.11.1870; Wirth KG, 2006, J CELL BIOL, V172, P847, DOI 10.1083/jcb.200506119	39	26	26	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					816	823		10.1074/jbc.M706748200	http://dx.doi.org/10.1074/jbc.M706748200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	17974570	hybrid			2022-12-27	WOS:000252128100021
J	Bowden, MG; Heuck, AP; Ponnuraj, K; Kolosova, E; Choe, D; Gurusiddappa, S; Narayana, SVL; Johnson, AE; Hook, M				Bowden, M. Gabriela; Heuck, Alejandro P.; Ponnuraj, Karthe; Kolosova, Elena; Choe, Damon; Gurusiddappa, Sivashankarappa; Narayana, Sthanam V. L.; Johnson, Arthur E.; Hook, Magnus			Evidence for the "Dock, Lock, and Latch" ligand binding mechanism of the staphylococcal microbial surface component recognizing adhesive matrix molecules (MSCRAMM) SdrG	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLUMPING FACTOR; FIBRINOGEN; AUREUS; PROTEIN; COLLAGEN; EPIDERMIDIS; ARTHRITIS; FAMILY; REGION; DOMAIN	Staphylococcus epidermidis is an opportunistic pathogen and a major cause of foreign body infections. The S. epidermidis fibrinogen (Fg)-binding adhesin SdrG is necessary and sufficient for the attachment of this pathogen to Fg-coated materials. Based largely on structural analyses of the ligand binding domain of SdrG as an apo-protein and in complex with a Fg-like peptide, we proposed that SdrG follows a "dock, lock, and latch" mechanism to bind to Fg. This binding mechanism involves the docking of the ligand in a pocket formed between two SdrG subdomains followed by the movement of a C-terminal extension of one subdomain to cover the ligand and to insert and complement a beta-sheet in a neighboring subdomain. These proposed events result in a greatly stabilized closed conformation of the MSCRAMM-ligand complex. In this report, we describe a biochemical analysis of the proposed conformational changes that SdrG undergoes upon binding to its ligand. We have introduced disulfide bonds into SdrG to stabilize the open and closed forms of the apo-form of the MSCRAMM. We show that the stabilized closed form does not bind to the ligand and that binding can be restored in the presence of reducing agents such as dithiothreitol. We have also used Forster resonance energy transfer to dynamically show the conformational changes of SdrG upon binding to its ligand. Finally, we have used isothermic calorimetry to determine that hydrophobic interactions between the ligand and the protein are responsible for re-directing the C-terminal extension of the second subdomain required for triggering the beta-strand complementation event.	[Bowden, M. Gabriela; Kolosova, Elena; Choe, Damon; Gurusiddappa, Sivashankarappa; Hook, Magnus] Texas A&M Univ, Syst Hlth Sci Ctr, Ctr Extracellular Matrix Biol, Inst Biosci & Technol, Houston, TX 77030 USA; [Heuck, Alejandro P.] Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA; [Heuck, Alejandro P.; Johnson, Arthur E.] Texas A&M Univ, Syst Hlth Sci Ctr, Sch Med, Dept Mol & Cellular Med, College Stn, TX 77843 USA; [Ponnuraj, Karthe; Narayana, Sthanam V. L.] Univ Alabama Birmingham, Ctr Biophys Sci & Engn, Birmingham, AL 35294 USA; [Ponnuraj, Karthe] Univ Madras, Ctr Adv Study Crystallog & Biophys, Madras 600025, Tamil Nadu, India	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Massachusetts System; University of Massachusetts Amherst; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Alabama System; University of Alabama Birmingham; University of Madras	Bowden, MG (corresponding author), Texas A&M Univ, Syst Hlth Sci Ctr, Ctr Extracellular Matrix Biol, Inst Biosci & Technol, 2121 W Holcombe Blvd, Houston, TX 77030 USA.	gbowden@ibt.tamhsc.edu	Johnson, Arthur E/G-3457-2012		NIAID NIH HHS [AI 020624, AI 61426] Funding Source: Medline; NIGMS NIH HHS [GM26494] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020624, R21AI061426] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026494] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen Y, 1998, BIOCHEMISTRY-US, V37, P9976, DOI 10.1021/bi980274n; Davis SL, 2001, J BIOL CHEM, V276, P27799, DOI 10.1074/jbc.M103873200; Deivanayagam CCS, 2000, STRUCTURE, V8, P67, DOI 10.1016/S0969-2126(00)00081-2; Deivanayagam CCS, 2002, EMBO J, V21, P6660, DOI 10.1093/emboj/cdf619; Eidhin DN, 1998, MOL MICROBIOL, V30, P245; Fisher CA, 1999, J LIPID RES, V40, P93; Hartford O, 2001, MICROBIOL-SGM, V147, P2545, DOI 10.1099/00221287-147-9-2545; Josefsson E, 2001, J INFECT DIS, V184, P1572, DOI 10.1086/324430; Josefsson E, 1998, J BIOL CHEM, V273, P31145, DOI 10.1074/jbc.273.47.31145; Liu Q, 2007, J BIOL CHEM, V282, P19629, DOI 10.1074/jbc.M611137200; McCrea KW, 2000, MICROBIOL-SGM, V146, P1535, DOI 10.1099/00221287-146-7-1535; MCDEVITT D, 1995, MOL MICROBIOL, V16, P895, DOI 10.1111/j.1365-2958.1995.tb02316.x; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Palmqvist N, 2005, J INFECT DIS, V191, P791, DOI 10.1086/427663; Perkins S, 2001, J BIOL CHEM, V276, P44721, DOI 10.1074/jbc.M106741200; Ponnuraj K, 2003, CELL, V115, P217, DOI 10.1016/S0092-8674(03)00809-2; Que YA, 2005, J EXP MED, V201, P1627, DOI 10.1084/jem.20050125; Sillanpaa J, 2004, MICROBIOL-SGM, V150, P2069, DOI 10.1099/mic.0.27074-0; Wann ER, 2000, J BIOL CHEM, V275, P13863, DOI 10.1074/jbc.275.18.13863; WU PG, 1994, ANAL BIOCHEM, V218, P1, DOI 10.1006/abio.1994.1134; Zong YN, 2005, EMBO J, V24, P4224, DOI 10.1038/sj.emboj.7600888	24	73	79	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					638	647		10.1074/jbc.M706252200	http://dx.doi.org/10.1074/jbc.M706252200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17991749	hybrid			2022-12-27	WOS:000251940300068
J	Bai, P; Houten, SM; Huber, A; Schreiber, V; Watanabe, M; Kiss, B; de Murcia, G; Auwerx, J; Menissier-de Murcia, J				Bai, Peter; Houten, Sander M.; Huber, Aline; Schreiber, Valerie; Watanabe, Mitsuhiro; Kiss, Borbala; de Murcia, Gilbert; Auwerx, Johan; Menissier-de Murcia, Josiane			Peroxisome proliferator-activated receptor (PPAR)-2 controls adipocyte differentiation and adipose tissue function through the regulation of the activity of the retinoid x receptor/PPAR gamma heterodimer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLY(ADP-RIBOSE) POLYMERASE-2 PARP-2; PPAR-GAMMA; GENE-EXPRESSION; INHIBITORS; CELLS; PROTEIN; ALPHA; BETA; PREADIPOCYTES; TRANSCRIPTION	The peroxisome proliferator-activated receptor-gamma (PPAR gamma, NR1C3) in complex with the retinoid X receptor (RXR) plays a central role in white adipose tissue (WAT) differentiation and function, regulating the expression of key WAT proteins. In this report we show that poly(ADP-ribose) polymerase-2 (PARP-2), also known as an enzyme participating in the surveillance of the genome integrity, is a member of the PPAR gamma/ RXR transcription machinery. PARP-2(-/)-mice accumulate less WAT, characterized by smaller adipocytes. In the WAT of PARP-2(-/-)mice the expression of a number of PPAR target genes is reduced despite the fact that PPAR gamma 1 and -gamma 2 are expressed at normal levels. Consistent with this, PARP-2(-/)-mouse embryonic fibroblasts fail to differentiate to adipocytes. In transient transfection assays, PARP-2 small interference RNA decreases basal activity and ligand-dependent activation of PPAR gamma, whereas PARP-2 overexpression enhances the basal activity of PPAR gamma, although it does not change the maximal ligand-dependent activation. In addition, we show a DNA-dependent interaction of PARP-2 and PPAR gamma/RXR heterodimer by chromatin immunoprecipitation. In combination, our results suggest that PARP-2 is a novel cofactor of PPAR gamma activity.	[Bai, Peter; Huber, Aline; Schreiber, Valerie; Kiss, Borbala; de Murcia, Gilbert; Menissier-de Murcia, Josiane] CNRS, Ecole Super Biotechnol Strasbourg, Dept Integrite Genom, UMR 7175, F-67412 Illkirch Graffenstaden, France; [Houten, Sander M.; Watanabe, Mitsuhiro; Auwerx, Johan] Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France; [Bai, Peter] Univ Debrecen, Med & Hlth Sci Ctr, Dept Med Chem, H-4032 Debrecen, Hungary; [Houten, Sander M.] Acad Med Ctr, Lab Genet Metab Dis, NL-1105 AZ Amsterdam, Netherlands; [Auwerx, Johan] Inst Clin Souris, F-67404 Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Debrecen; University of Amsterdam; Academic Medical Center Amsterdam	Bai, P (corresponding author), CNRS, Ecole Super Biotechnol Strasbourg, Dept Integrite Genom, UMR 7175, BP 10413, F-67412 Illkirch Graffenstaden, France.	baip@dote.hu	Bai, Peter/C-8005-2014; Houten, Sander/Y-3599-2019; Auwerx, Johan/ABE-9307-2021; Schreiber, Valérie/M-5007-2016	Houten, Sander/0000-0002-6167-9147; Schreiber, Valérie/0000-0003-0507-639X; Auwerx, Johan/0000-0002-5065-5393	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067320] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK067320] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ame JC, 1999, J BIOL CHEM, V274, P17860, DOI 10.1074/jbc.274.25.17860; AMRI EZ, 1995, J BIOL CHEM, V270, P2367, DOI 10.1074/jbc.270.5.2367; Balint BL, 2005, MOL CELL BIOL, V25, P5648, DOI 10.1128/MCB.25.13.5648-5663.2005; Boulias K, 2005, EMBO J, V24, P2624, DOI 10.1038/sj.emboj.7600728; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Cock TA, 2004, EMBO REP, V5, P142, DOI 10.1038/sj.embor.7400082; Dantzer F, 2004, MOL CELL BIOL, V24, P1595, DOI 10.1128/MCB.24.4.1595-1607.2004; Dantzer F, 2006, P NATL ACAD SCI USA, V103, P14854, DOI 10.1073/pnas.0604252103; de Murcia JMN, 2003, EMBO J, V22, P2255, DOI 10.1093/emboj/cdg206; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Fajas L, 1997, J BIOL CHEM, V272, P18779, DOI 10.1074/jbc.272.30.18779; Feige JN, 2007, TRENDS CELL BIOL, V17, P292, DOI 10.1016/j.tcb.2007.04.001; Gurnell M, 2005, BEST PRACT RES CL EN, V19, P501, DOI 10.1016/j.beem.2005.10.001; Huber A, 2004, DNA REPAIR, V3, P1103, DOI 10.1016/j.dnarep.2004.06.002; ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0; Jagtap P, 2005, NAT REV DRUG DISCOV, V4, P421, DOI 10.1038/nrd1718; JANSSEN OE, 1989, EUR J BIOCHEM, V180, P595, DOI 10.1111/j.1432-1033.1989.tb14686.x; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Knouff C, 2004, ENDOCR REV, V25, P899, DOI 10.1210/er.2003-0036; Kofler J, 2006, J CEREBR BLOOD F MET, V26, P135, DOI 10.1038/sj.jcbfm.9600173; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; Maeda Y, 2006, J BIOL CHEM, V281, P9600, DOI 10.1074/jbc.M510435200; Maquoi E, 2002, DIABETES, V51, P1093, DOI 10.2337/diabetes.51.4.1093; Mayeur GL, 2005, J BIOL CHEM, V280, P10827, DOI 10.1074/jbc.M413336200; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; Meder VS, 2005, J CELL SCI, V118, P211, DOI 10.1242/jcs.01606; Miyamoto T, 1999, MOL CELL BIOL, V19, P2644; Mota RA, 2005, LAB INVEST, V85, P1250, DOI 10.1038/labinvest.3700326; Motojima K, 1998, J BIOL CHEM, V273, P16710, DOI 10.1074/jbc.273.27.16710; Nirodi C, 2001, J BIOL CHEM, V276, P9366, DOI 10.1074/jbc.M009897200; Oliver AW, 2004, NUCLEIC ACIDS RES, V32, P456, DOI 10.1093/nar/gkh215; Oliver FJ, 1999, EMBO J, V18, P4446, DOI 10.1093/emboj/18.16.4446; Pavri R, 2005, MOL CELL, V18, P83, DOI 10.1016/j.molcel.2005.02.034; Popoff I, 2002, J PHARMACOL EXP THER, V303, P1145, DOI 10.1124/jpet.102.039768; Prins JB, 1997, DIABETES, V46, P1939, DOI 10.2337/diabetes.46.12.1939; Rosen ED, 2001, J BIOL CHEM, V276, P37731, DOI 10.1074/jbc.R100034200; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; Saladin R, 1999, CELL GROWTH DIFFER, V10, P43; Sarruf DA, 2005, MOL CELL BIOL, V25, P9985, DOI 10.1128/MCB.25.22.9985-9995.2005; Sartorius CA, 2000, J MOL ENDOCRINOL, V24, P165, DOI 10.1677/jme.0.0240165; Saxena A, 2002, HUM MOL GENET, V11, P2319, DOI 10.1093/hmg/11.19.2319; Schreiber V, 2002, J BIOL CHEM, V277, P23028, DOI 10.1074/jbc.M202390200; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; SMULSON ME, 1995, J BIOL CHEM, V270, P119, DOI 10.1074/jbc.270.1.119; Tee MK, 2004, MOL BIOL CELL, V15, P1262, DOI 10.1091/mbc.E03-06-0360; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; Tramontano F, 2005, J CELL BIOCHEM, V94, P58, DOI 10.1002/jcb.20295; Tremblay GB, 1997, MOL ENDOCRINOL, V11, P353, DOI 10.1210/me.11.3.353; Virag L, 2002, PHARMACOL REV, V54, P375, DOI 10.1124/pr.54.3.375; VUDAC N, 1995, J CLIN INVEST, V96, P741, DOI 10.1172/JCI118118; Yelamos J, 2006, EMBO J, V25, P4350, DOI 10.1038/sj.emboj.7601301	52	86	90	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37738	37746		10.1074/jbc.M701021200	http://dx.doi.org/10.1074/jbc.M701021200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17951580	Green Published, hybrid			2022-12-27	WOS:000251833600050
J	Broere, N; Hillesheim, J; Tuo, B; Jorna, H; Houtsmuller, AB; Shenolikar, S; Weinman, EJ; Donowitz, M; Seidler, U; de Jonge, HR; Hogema, BM				Broere, Nellie; Hillesheim, Jutta; Tuo, Biguang; Jorna, Huub; Houtsmuller, Adriaan B.; Shenolikar, Shirish; Weinman, Edward J.; Donowitz, Mark; Seidler, Ursula; de Jonge, Hugo R.; Hogema, Boris M.			Cystic fibrosis transmembrane conductance regulator activation is reduced in the small intestine of Na+/H+ exchanger 3 regulatory factor 1 (NHERF-1)-but not NHERF-2-deficient mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PDZ DOMAIN INTERACTIONS; APICAL MEMBRANE; ION-TRANSPORT; ANCHORING PROTEIN; CHLORIDE CHANNEL; PLASMA-MEMBRANE; BINDING MOTIF; C-TERMINUS; IN-VIVO; CFTR	Binding of the cystic fibrosis transmembrane conductance regulator (CFTR) chloride channel to the Na+/H+ exchanger 3 regulatory factor 1 (NHERF-1) and NHERF-2 scaffolding proteins has been shown to affect its localization and activation. We have for the first time studied the physiological role of these proteins in CFTR regulation in native tissue by determining CFTR-dependent chloride current in NHERF-1-and NHERF-2-deficient mice. The cAMP-and cGMP-activated chloride current and the basal chloride current in basolaterally permeabilized jejunum were reduced by similar to 30% in NHERF-1-deficient mice but not in NHERF-2-deficient mice. The duodenal bicarbonate secretion was affected in a similar way, whereas no significant differences in CFTR activity were observed in ileum. CFTR abundance as determined by Western blotting was unaltered in jejunal epithelial cells and brush border membranes of NHERF-1 and NHERF-2 mutant mice. However, semi-quantitative detection of CFTR by confocal microscopy showed that the level of apically localized CFTR in jejunal crypts was reduced by similar to 35% in NHERF-1-deficient and NHERF-1/ 2 double deficient mice but not in NHERF-2 null mice. Together our results indicate that NHERF-1 is required for full activation of CFTR in murine duodenal and jejunal mucosa and that NHERF-1 affects the local distribution of CFTR in or near the plasma membrane. These studies provide the first evidence in native intestinal epithelium that NHERF-1 but not NHERF-2 is involved in the formation of CFTR-containing functional complexes that serve to position CFTR in the crypt apical membrane and/ or to optimize its function as a cAMP-and cGMP-regulated anion channel.	[Broere, Nellie; Jorna, Huub; Donowitz, Mark; de Jonge, Hugo R.; Hogema, Boris M.] Erasmus Univ, Med Ctr, Dept Biochem, NL-3015 GE Rotterdam, Netherlands; [Hillesheim, Jutta; Tuo, Biguang; Seidler, Ursula] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-30625 Hannover, Germany; [Houtsmuller, Adriaan B.] Erasmus Univ, Med Ctr, Opt Image Ctr, Josephine Nefkens Inst, Rotterdam, Netherlands; [Shenolikar, Shirish] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Weinman, Edward J.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Weinman, Edward J.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Weinman, Edward J.] Univ Maryland, Sch Med, Dept Vet Affairs Med Ctr, Med Serv, Baltimore, MD 21201 USA; [Broere, Nellie; Jorna, Huub; Donowitz, Mark; de Jonge, Hugo R.; Hogema, Boris M.] Johns Hopkins Univ, Sch Med, Dept Physiol & Med, Div Gastroenterol, Baltimore, MD 21205 USA	Erasmus University Rotterdam; Erasmus MC; Hannover Medical School; Erasmus University Rotterdam; Erasmus MC; Duke University; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Johns Hopkins University	Hogema, BM (corresponding author), Erasmus Univ, Med Ctr, Dept Biochem, Dr Molewaterplein 50,Ee634b, NL-3015 GE Rotterdam, Netherlands.	B.Hogema@ErasmusMC.nl	Seidler, Ursula/HII-8049-2022	Seidler, Ursula/0000-0002-9600-2769	NIDDK NIH HHS [R24 DK64388, R01 DK61765, R01 DK26523, P01 DK072084, DK55881] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061765, R01DK026523, P01DK072084, R24DK064388, R01DK055881] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Barrett KE, 2000, ANNU REV PHYSIOL, V62, P535, DOI 10.1146/annurev.physiol.62.1.535; Bates IR, 2006, BIOPHYS J, V91, P1046, DOI 10.1529/biophysj.106.084830; Benharouga M, 2003, J BIOL CHEM, V278, P22079, DOI 10.1074/jbc.M301030200; Bijvelds MJC, 2005, AM J PHYSIOL-GASTR L, V289, pG870, DOI 10.1152/ajpgi.00226.2005; Capuano P, 2005, PFLUG ARCH EUR J PHY, V449, P392, DOI 10.1007/s00424-004-1351-9; Cha B, 2005, J BIOL CHEM, V280, P16642, DOI 10.1074/jbc.M500505200; Cheng J, 2002, J BIOL CHEM, V277, P3520, DOI 10.1074/jbc.M110177200; Claass A, 2000, J HISTOCHEM CYTOCHEM, V48, P831, DOI 10.1177/002215540004800611; COLLINS FS, 1992, SCIENCE, V256, P774, DOI 10.1126/science.1375392; Donowitz M, 2005, J PHYSIOL-LONDON, V567, P3, DOI 10.1113/jphysiol.2005.090399; Dransfield DT, 1997, EMBO J, V16, P35, DOI 10.1093/emboj/16.1.35; Field M, 2003, J CLIN INVEST, V111, P931, DOI 10.1172/JCI200318326; French PJ, 1996, J CLIN INVEST, V98, P1304, DOI 10.1172/JCI118917; Fujii N, 2007, BIOORG MED CHEM LETT, V17, P549, DOI 10.1016/j.bmcl.2006.10.006; Gisler SM, 2003, KIDNEY INT, V64, P1733, DOI 10.1046/j.1523-1755.2003.00266.x; Guggino WB, 2006, NAT REV MOL CELL BIO, V7, P426, DOI 10.1038/nrm1949; Haggie PM, 2006, MOL BIOL CELL, V17, P4937, DOI 10.1091/mbc.E06-08-0670; Haggie PM, 2004, J BIOL CHEM, V279, P5494, DOI 10.1074/jbc.M312445200; Hillesheim J, 2007, PFLUG ARCH EUR J PHY, V454, P575, DOI 10.1007/s00424-007-0239-x; Hwang JI, 2000, J BIOL CHEM, V275, P16632, DOI 10.1074/jbc.M001410200; Karthikeyan S, 2001, J BIOL CHEM, V276, P19683, DOI 10.1074/jbc.C100154200; KNOWLES MR, 1995, HUM GENE THER, V6, P445, DOI 10.1089/hum.1995.6.4-445; Lee JH, 2007, J BIOL CHEM, V282, P10414, DOI 10.1074/jbc.M610857200; Li CY, 2005, J EXP MED, V202, P975, DOI 10.1084/jem.20050421; MARKERT T, 1995, J CLIN INVEST, V96, P822, DOI 10.1172/JCI118128; Milewski MI, 2001, J CELL SCI, V114, P719; Morales FC, 2004, P NATL ACAD SCI USA, V101, P17705, DOI 10.1073/pnas.0407974101; Moyer BD, 1999, J CLIN INVEST, V104, P1353, DOI 10.1172/JCI7453; Ostedgaard LS, 2003, P NATL ACAD SCI USA, V100, P1937, DOI 10.1073/pnas.2627982100; PRINCE LS, 1994, P NATL ACAD SCI USA, V91, P5192, DOI 10.1073/pnas.91.11.5192; Raghuram V, 2001, P NATL ACAD SCI USA, V98, P1300, DOI 10.1073/pnas.031538898; Raghuram V, 2003, P NATL ACAD SCI USA, V100, P9620, DOI 10.1073/pnas.1633250100; RATCLIFF R, 1993, NAT GENET, V4, P35, DOI 10.1038/ng0593-35; REDDY MM, 1994, J MEMBRANE BIOL, V140, P57; Schreiber R, 2004, J MEMBRANE BIOL, V199, P85, DOI 10.1007/s00232-004-0679-6; Seidler U, 2001, JOP, V2, P247; Shenolikar S, 2002, P NATL ACAD SCI USA, V99, P11470, DOI 10.1073/pnas.162232699; Short DB, 1998, J BIOL CHEM, V273, P19797, DOI 10.1074/jbc.273.31.19797; Sun F, 2000, J BIOL CHEM, V275, P14360, DOI 10.1074/jbc.275.19.14360; Swiatecka-Urban A, 2002, J BIOL CHEM, V277, P40099, DOI 10.1074/jbc.M206964200; Thelin WR, 2005, J PHYSIOL-LONDON, V567, P13, DOI 10.1113/jphysiol.2005.091041; Thiagarajah JR, 2003, CURR OPIN PHARMACOL, V3, P594, DOI 10.1016/j.coph.2003.06.012; VAANDRAGER AB, 1991, AM J PHYSIOL, V261, pG958, DOI 10.1152/ajpgi.1991.261.6.G958; VANDOMMELEN FS, 1986, BIOCHEM J, V236, P771, DOI 10.1042/bj2360771; Wang SS, 1998, FEBS LETT, V427, P103, DOI 10.1016/S0014-5793(98)00402-5; Wang SS, 2000, CELL, V103, P169, DOI 10.1016/S0092-8674(00)00096-9; Weinman EJ, 2003, FEBS LETT, V536, P141, DOI 10.1016/S0014-5793(03)00043-7; Weinman EJ, 1998, J CLIN INVEST, V101, P2199, DOI 10.1172/JCI204; Yun CC, 2002, J BIOL CHEM, V277, P7676, DOI 10.1074/jbc.M107768200; Yun CHC, 1997, P NATL ACAD SCI USA, V94, P3010, DOI 10.1073/pnas.94.7.3010; Zambrowicz BP, 1998, NATURE, V392, P608, DOI 10.1038/33423	51	41	41	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37575	37584		10.1074/jbc.M704878200	http://dx.doi.org/10.1074/jbc.M704878200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17947234	hybrid			2022-12-27	WOS:000251833600033
J	Montalbano, J; Jin, WX; Sheikh, MS; Huang, Y				Montalbano, JoAnne; Jin, Weixin; Sheikh, M. Saeed; Huang, Ying			RBEL1 is a novel gene that encodes a nucleocytoplasmic ras superfamily GTP-binding protein and is overexpressed in breast cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAN/TC4 GTPASE; NUCLEAR; P53; FAMILY; IDENTIFICATION; STABILIZES; EXPRESSION; TRANSPORT; PROLINE; PATHWAY	Rab family proteins are generally known as regulators of protein transport and trafficking. A number of Rab proteins have been implicated in cancer development and/ or progression. Here we report the identification of a novel Rab- like protein, which we have named RBEL1 ((R) under bara (b) under bar- (l) under bar ike protein 1) for its higher similarity to the Rab subfamily members. We have characterized two isoforms of RBEL1 including the predominant RBEL1A and the less abundant RBEL1B that results from alternative splicing. Both isoforms harbor conserved N-terminal guanine trinucleotide phosphate (GTP) binding domains and, accordingly, are capable of binding to GTP. Both isoforms contain variable C termini and exhibit differential subcellular localization patterns. Unlike known Rabs that are mostly cytosolic, RBEL1B predominantly resides in the nucleus, whereas RBEL1A is localized primarily to the cytosol. Interestingly, a point mutation affecting RBEL1B GTP binding also alters the ability of mutant protein to accumulate in the nucleus, suggesting GTP binding potential to be important for RBEL1B nuclear localization. Our results also indicate that RBEL1A is overexpressed in about 67% of primary breast tumors. Thus, RBEL1A and RBEL1B are novel Rab- like proteins that localize in the nucleus and cytosol and may play an important role in breast tumorigenesis.	[Montalbano, JoAnne; Jin, Weixin; Sheikh, M. Saeed; Huang, Ying] SUNY Syracuse, Upstate Med Univ, Dept Pharmacol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Huang, Y (corresponding author), SUNY Syracuse, Upstate Med Univ, Dept Pharmacol, Syracuse, NY 13210 USA.	huangy@upstate.edu			NATIONAL CANCER INSTITUTE [R21CA113868] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK062136, R21DK067271] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES014489] Funding Source: NIH RePORTER; NCI NIH HHS [CA113868] Funding Source: Medline; NIDDK NIH HHS [DK062136, DK067271] Funding Source: Medline; NIEHS NIH HHS [ES014489] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; Cheng KW, 2005, CANCER RES, V65, P2516, DOI 10.1158/0008-5472.CAN-05-0573; Cheng KW, 2004, NAT MED, V10, P1251, DOI 10.1038/nm1125; Colicelli John, 2004, Sci STKE, V2004, pRE13, DOI 10.1126/stke.2502004re13; Corcoran CA, 2005, ONCOGENE, V24, P1634, DOI 10.1038/sj.onc.1208353; Darchen F, 2000, BIOCHIMIE, V82, P375, DOI 10.1016/S0300-9084(00)00219-4; Dumas JJ, 1999, STRUCTURE, V7, P413, DOI 10.1016/S0969-2126(99)80054-9; Erdman RA, 2000, J BIOL CHEM, V275, P3848, DOI 10.1074/jbc.275.6.3848; Fahrenkrog B, 2003, NAT REV MOL CELL BIO, V4, P757, DOI 10.1038/nrm1230; He H, 2002, GENE EXPRESSION, V10, P231, DOI 10.3727/000000002783992406; Huang Y, 2001, CANCER RES, V61, P6918; HUANG Y, 1995, ONCOGENE, V11, P1255; JORCYK C, 2002, CANCER RES, V62, P5325; KAPLAN JB, 1994, ONCOL RES, V6, P611; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Lanning CC, 2004, J BIOL CHEM, V279, P44197, DOI 10.1074/jbc.M404977200; Lounsbury KM, 1996, J BIOL CHEM, V271, P32834, DOI 10.1074/jbc.271.51.32834; Lowe SW, 2003, CURR OPIN GENET DEV, V13, P77, DOI 10.1016/S0959-437X(02)00013-8; Luo XQ, 2005, CANCER RES, V65, P10725, DOI 10.1158/0008-5472.CAN-05-1132; Luo XQ, 2003, ONCOGENE, V22, P7247, DOI 10.1038/sj.onc.1207010; Macias MJ, 2002, FEBS LETT, V513, P30, DOI 10.1016/S0014-5793(01)03290-2; Melen K, 1996, J BIOL CHEM, V271, P23478, DOI 10.1074/jbc.271.38.23478; Mitra RS, 2003, ONCOGENE, V22, P6243, DOI 10.1038/sj.onc.1206534; Ossareh-Nazari B, 2001, TRAFFIC, V2, P684, DOI 10.1034/j.1600-0854.2001.21002.x; Pereira-Leal JB, 2000, J MOL BIOL, V301, P1077, DOI 10.1006/jmbi.2000.4010; Pfeffer SR, 2001, TRENDS CELL BIOL, V11, P487, DOI 10.1016/S0962-8924(01)02147-X; Quimby BB, 2003, CURR OPIN CELL BIOL, V15, P338, DOI 10.1016/S0955-0674(03)00046-2; Quimby BB, 2001, CELL MOL LIFE SCI, V58, P1766, DOI 10.1007/PL00000816; RICHARDS SA, 1995, J BIOL CHEM, V270, P14405, DOI 10.1074/jbc.270.24.14405; Rong R, 2004, ONCOGENE, V23, P8216, DOI 10.1038/sj.onc.1207901; Seabra MC, 2002, TRENDS MOL MED, V8, P23, DOI 10.1016/S1471-4914(01)02227-4; Tompkins V, 2006, CELL CYCLE, V5, P641; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Yao RS, 2003, NEOPLASIA, V5, P41, DOI 10.1016/S1476-5586(03)80016-7; Ye KQ, 2000, CELL, V103, P919, DOI 10.1016/S0092-8674(00)00195-1; Zhang YP, 2001, CELL GROWTH DIFFER, V12, P175; Zhu WJ, 2001, EMBO J, V20, P5999, DOI 10.1093/emboj/20.21.5999	37	26	27	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37640	37649		10.1074/jbc.M704760200	http://dx.doi.org/10.1074/jbc.M704760200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17962191	hybrid			2022-12-27	WOS:000251833600040
J	Devlin, AM; Singh, R; Wade, RE; Innis, SM; Bottiglieri, T; Lentz, SR				Devlin, Angela M.; Singh, Ranji; Wade, Rachel E.; Innis, Sheila M.; Bottiglieri, Teodoro; Lentz, Steven R.			Hypermethylation of Fads2 and altered hepatic fatty acid and phospholipid metabolism in mice with hyperhomocysteinemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTATHIONINE BETA-SYNTHASE; DENSITY LIPOPROTEIN SECRETION; PLASMA HIGH-DENSITY; S-ADENOSYLHOMOCYSTEINE; ENDOTHELIAL DYSFUNCTION; VASCULAR DYSFUNCTION; N-METHYLTRANSFERASE; HOMOCYSTEINE; METHYLATION; DEFICIENT	Alterations in lipid metabolism may play a role in the vascular pathology associated with hyperhomocysteinemia (HHcy). Homocysteine is linked to lipid metabolism through the methionine cycle and the synthesis of phosphatidylcholine ( PC) by phosphatidylethanolamine (PE) methyltransferase, which is responsible for the synthesis of 20-40% of liver PC. The goal of the present study was to determine if the reduced methylation capacity in HHcy is associated with alterations in liver phospholipid and fatty acid metabolism. Mice heterozygous for disruption of cystathionine beta-synthase (Cbs(+/-)) fed a diet to induce HHcy (HH diet) had higher (p < 0.001) plasma total homocysteine (30.8 +/- 4.4 mu M, mean +/- S.E.) than C57BL/6 mice (Cbs(+/+)) fed the HH diet (7.0 +/- 1.1 mu M) or Cbs(+/+)mice fed a control diet (2.3 +/- 0.3 mu M). Mild and moderate HHcy was accompanied by lower adenosylmethionine/adenosylhomocysteine ratios (p < 0.05), higher PE ( p < 0.05) and PE/PC ratios (p < 0.01), lower PE methyltransferase activity ( p < 0.001), and higher linoleic acid ( p < 0.05) and lower arachidonic acid ( p < 0.05) in PE. Mice with moderate HHcy also had higher linoleic acid and alpha-linolenic acid (p < 0.05) and lower arachidonic acid and docosahexaenoic acid ( p < 0.05) in liver PC. The first step in the desaturation and elongation of linoleic acid and linolenic acid to arachidonic acid and docosahexaenoic acid, respectively, is catalyzed by Delta(6)-desaturase (encoded by Fads2). We found hypermethylation of the Fads2 promoter (p < 0.01), lower Fads2 mRNA ( p < 0.05), and lower Delta(6)-desaturase activity ( p < 0.001) in liver from mice with HHcy. These findings suggest that methylation silencing of liver Fads2 expression and changes in liver fatty acids may contribute to the pathology of HHcy.	[Devlin, Angela M.; Singh, Ranji; Wade, Rachel E.; Innis, Sheila M.] Univ British Columbia, Dept Pediat, Nutr Res Program, Child & Family Res Inst, Vancouver, BC V6H 3N1, Canada; [Bottiglieri, Teodoro] Baylor Inst Metab Dis, Dallas, TX 75226 USA; [Lentz, Steven R.] Univ Iowa, Carver Coll Med, Dept Internal Med, Iowa City, IA 52246 USA; [Lentz, Steven R.] Vet Affairs Med Ctr, Iowa City, IA 52246 USA	Child & Family Research Institute; University of British Columbia; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Devlin, AM (corresponding author), Univ British Columbia, Dept Paediat, Nutr Res Program, 4500 Oak St,Mailbox 65, Vancouver, BC V6H 3N1, Canada.	angela.devlin@ubc.ca		Devlin, Angela/0000-0002-1390-6587; Lentz, Steven/0000-0002-8885-4718	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063943, P01HL062984] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL063943, HL 62984, HL63943] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bellamy MF, 1998, CIRCULATION, V98, P1848, DOI 10.1161/01.CIR.98.18.1848; BOTTIGLIERI T, 1990, BIOMED CHROMATOGR, V4, P239, DOI 10.1002/bmc.1130040606; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Calvisi DF, 2007, J CLIN INVEST, V117, P2713, DOI 10.1172/JCI31457; Castro R, 2003, CLIN CHEM, V49, P1292, DOI 10.1373/49.8.1292; Chen ZT, 2001, HUM MOL GENET, V10, P433, DOI 10.1093/hmg/10.5.433; Clarke R, 2002, JAMA-J AM MED ASSOC, V288, P2015, DOI 10.1001/jama.288.16.2015; Dayal S, 2005, CIRCULATION, V112, P737, DOI 10.1161/CIRCULATIONAHA.104.529248; Dayal S, 2001, CIRC RES, V88, P1203, DOI 10.1161/hh1101.092180; De Vriese AS, 2004, CIRCULATION, V109, P2331, DOI 10.1161/01.CIR.0000129138.08493.4D; DeLong CJ, 1999, J BIOL CHEM, V274, P29683, DOI 10.1074/jbc.274.42.29683; Devlin AM, 2004, BLOOD, V103, P2624, DOI 10.1182/blood-2003-09-3078; Devlin AM, 2005, J BIOL CHEM, V280, P25506, DOI 10.1074/jbc.M504815200; Dupont JM, 2004, ANAL BIOCHEM, V333, P119, DOI 10.1016/j.ab.2004.05.007; Eberhardt RT, 2000, J CLIN INVEST, V106, P483, DOI 10.1172/JCI8342; FINKELSTEIN JD, 1990, J NUTR BIOCHEM, V1, P228, DOI 10.1016/0955-2863(90)90070-2; Fleming I, 2006, HYPERTENSION, V47, P629, DOI 10.1161/01.HYP.0000208597.87957.89; FOLCH J, 1957, J BIOL CHEM, V226, P497; GARG ML, 1988, BIOCHEM J, V249, P351, DOI 10.1042/bj2490351; Herrmann W, 2001, CLIN CHEM LAB MED, V39, P739, DOI 10.1515/CCLM.2001.123; Innis SM, 2002, J LIPID RES, V43, P1529, DOI 10.1194/jlr.M200120-JLR200; Issa JPJ, 2007, CLIN CANCER RES, V13, P1634, DOI 10.1158/1078-0432.CCR-06-2076; Jacobs RL, 2004, J BIOL CHEM, V279, P47402, DOI 10.1074/jbc.M404027200; Lentz SR, 1996, J CLIN INVEST, V98, P24, DOI 10.1172/JCI118771; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Liao D, 2006, CIRC RES, V99, P598, DOI 10.1161/01.RES.0000242559.42077.22; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mallamaci F, 2002, KIDNEY INT, V61, P609, DOI 10.1046/j.1523-1755.2002.00144.x; Mikael LG, 2006, CIRC RES, V98, P564, DOI 10.1161/01.RES.0000204825.66410.0b; Nakamura MT, 2004, ANNU REV NUTR, V24, P345, DOI 10.1146/annurev.nutr.24.121803.063211; Namekata K, 2004, J BIOL CHEM, V279, P52961, DOI 10.1074/jbc.M406820200; Node K, 1999, SCIENCE, V285, P1276, DOI 10.1126/science.285.5431.1276; Noga AA, 2003, J BIOL CHEM, V278, P21851, DOI 10.1074/jbc.M301982200; RIDGWAY ND, 1992, METHOD ENZYMOL, V209, P366; RIDGWAY ND, 1988, J BIOL CHEM, V263, P16856; STAMPFER MJ, 1992, JAMA-J AM MED ASSOC, V268, P877, DOI 10.1001/jama.268.7.877; UBBINK JB, 1991, J CHROMATOGR-BIOMED, V565, P441, DOI 10.1016/0378-4347(91)80407-4; Vance JE, 2004, BIOCHEM CELL BIOL, V82, P113, DOI 10.1139/o03-073; Wang H, 2003, BLOOD, V101, P3901, DOI 10.1182/blood-2002-08-2606; WATANABE M, 1995, P NATL ACAD SCI USA, V92, P1585, DOI 10.1073/pnas.92.5.1585; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Werstuck GH, 2001, J CLIN INVEST, V107, P1263, DOI 10.1172/JCI11596; Woo CWH, 2005, AM J PHYSIOL-ENDOC M, V288, pE1002, DOI 10.1152/ajpendo.00518.2004; YAO ZM, 1988, J BIOL CHEM, V263, P2998; YAO ZM, 1989, J BIOL CHEM, V264, P11373; Yi P, 2000, J BIOL CHEM, V275, P29318, DOI 10.1074/jbc.M002725200	46	61	63	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					37082	37090		10.1074/jbc.M704256200	http://dx.doi.org/10.1074/jbc.M704256200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17971455	hybrid			2022-12-27	WOS:000251646000035
J	Maruyama, Y; Ogura, T; Mio, K; Kiyonaka, S; Kato, K; Mori, Y; Sato, C				Maruyama, Yuusuke; Ogura, Toshihiko; Mio, Kazuhiro; Kiyonaka, Shigeki; Kato, Kenta; Mori, Yasuo; Sato, Chikara			Three-dimensional reconstruction using transmission electron microscopy reveals a swollen, bell-shaped structure of transient receptor potential melastatin type 2 cation channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOMATIC PARTICLE PICKUP; ADP-RIBOSE; HYDROGEN-PEROXIDE; SODIUM-CHANNEL; CALCIUM INFLUX; NEURAL-NETWORK; TRPM2; ACTIVATION; LTRPC2; FAMILY	Transient receptor potential melastatin type 2 (TRPM2) is a redox-sensitive, calcium-permeable cation channel activated by various signals, such as adenosine diphosphate ribose ( ADPR) acting on the ADPR pyrophosphatase (ADPRase) domain, and cyclic ADPR. Here, we purified the FLAG-tagged tetrameric TRPM2 channel, analyzed it using negatively stained electron microscopy, and reconstructed the three-dimensional structure at 2.8-nm resolution. This multimodal sensor molecule has a bell-like shape of 18 nm in width and 25 nm in height. The overall structure is similar to another multimodal sensor channel, TRP canonical type 3 (TRPC3). In both structures, the small extracellular domain is a dense half-dome, whereas the large cytoplasmic domain has a sparse, double-layered structure with multiple internal cavities. However, a unique square prism protuberance was observed under the cytoplasmic domain of TRPM2. The FLAG epitope, fused at the C terminus of the ADPRase domain, was assigned by the antibody to a position close to the protuberance. This indicates that the agonist-binding ADPRase domain and the ion gate in the transmembrane region are separately located in the molecule.	[Maruyama, Yuusuke; Ogura, Toshihiko; Mio, Kazuhiro; Sato, Chikara] Natl Inst Adv Ind Sci & Technol, Neurosci Res Inst, Tsukuba, Ibaraki 3058568, Japan; [Maruyama, Yuusuke; Sato, Chikara] Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 3058577, Japan; [Ogura, Toshihiko] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama, Japan; [Kiyonaka, Shigeki; Kato, Kenta; Mori, Yasuo] Kyoto Univ, Grad Sch Engn, Dept Synth Chem & Biol Chem, Kyoto 6158510, Japan	National Institute of Advanced Industrial Science & Technology (AIST); University of Tsukuba; Japan Science & Technology Agency (JST); Kyoto University	Sato, C (corresponding author), Natl Inst Adv Ind Sci & Technol, Neurosci Res Inst, Umezono 1-1-4, Tsukuba, Ibaraki 3058568, Japan.	ti-sato@aist.go.jp	Mio, Kazuhiro/L-7488-2018; Kiyonaka, Shigeki/AAM-7303-2021; Ogura, Toshihiko/M-4089-2018; Sato, Chikara/M-7183-2016	Mio, Kazuhiro/0000-0002-1655-8231; Sato, Chikara/0000-0001-5543-4496				Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; DAVIS BJ, 1964, ANN NY ACAD SCI, V121, P404, DOI 10.1111/j.1749-6632.1964.tb14213.x; FRANK J, 2006, 3 DIMENSTIONAL ELECT; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Grubisha O, 2006, J BIOL CHEM, V281, P14057, DOI 10.1074/jbc.M513741200; Hara Y, 2002, MOL CELL, V9, P163, DOI 10.1016/S1097-2765(01)00438-5; HARAUZ G, 1986, OPTIK, V73, P146; Harteneck C, 2000, TRENDS NEUROSCI, V23, P159, DOI 10.1016/S0166-2236(99)01532-5; Heiner I, 2003, BIOCHEM J, V371, P1045, DOI 10.1042/BJ20021975; Hoenderop JGJ, 2003, EMBO J, V22, P776, DOI 10.1093/emboj/cdg080; Inamura K, 2003, J MEMBRANE BIOL, V191, P201, DOI 10.1007/s00232-002-1057-x; Inoue R, 2001, CIRC RES, V88, P325, DOI 10.1161/01.RES.88.3.325; Kolisek M, 2005, MOL CELL, V18, P61, DOI 10.1016/j.molcel.2005.02.033; Kraft R, 2004, AM J PHYSIOL-CELL PH, V286, pC129, DOI 10.1152/ajpcell.00331.2003; Kuhn FJP, 2004, J BIOL CHEM, V279, P46431, DOI 10.1074/jbc.M407263200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; McHugh D, 2003, J BIOL CHEM, V278, P11002, DOI 10.1074/jbc.M210810200; Mei ZZ, 2006, J BIOL CHEM, V281, P38748, DOI 10.1074/jbc.M607591200; Minke B, 2002, PHYSIOL REV, V82, P429, DOI 10.1152/physrev.00001.2002; Mio K, 2005, BIOCHEM BIOPH RES CO, V333, P768, DOI 10.1016/j.bbrc.2005.05.181; Mio K, 2007, J MOL BIOL, V367, P373, DOI 10.1016/j.jmb.2006.12.043; Miyazawa A, 1999, J MOL BIOL, V288, P765, DOI 10.1006/jmbi.1999.2721; MONTELL C, 1989, NEURON, V2, P1313, DOI 10.1016/0896-6273(89)90069-X; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; Nagamine K, 1998, GENOMICS, V54, P124, DOI 10.1006/geno.1998.5551; Nishida M, 2003, EMBO J, V22, P4677, DOI 10.1093/emboj/cdg457; Ogura T, 2003, J STRUCT BIOL, V143, P185, DOI 10.1016/j.jsb.2003.08.005; Ogura T, 2004, J STRUCT BIOL, V145, P63, DOI 10.1016/S1047-8477(03)00139-4; Ogura T, 2004, J STRUCT BIOL, V146, P344, DOI 10.1016/j.jsb.2004.01.007; Ogura T, 2001, J STRUCT BIOL, V136, P227, DOI 10.1006/jsbi.2002.4442; Ogura T, 2006, J STRUCT BIOL, V156, P371, DOI 10.1016/j.jsb.2006.05.016; PENCZEK P, 1992, ULTRAMICROSCOPY, V40, P33, DOI 10.1016/0304-3991(92)90233-A; PENCZEK PA, 1994, ULTRAMICROSCOPY, V53, P251, DOI 10.1016/0304-3991(94)90038-8; Perraud AL, 2005, J BIOL CHEM, V280, P6138, DOI 10.1074/jbc.M411446200; Perraud AL, 2003, J BIOL CHEM, V278, P1794, DOI 10.1074/jbc.M205601200; Perraud AL, 2001, NATURE, V411, P595, DOI 10.1038/35079100; Sano Y, 2001, SCIENCE, V293, P1327, DOI 10.1126/science.1062473; Sato C, 2004, J MOL BIOL, V336, P155, DOI 10.1016/j.jmb.2003.11.024; Sato C, 1998, J STRUCT BIOL, V121, P314, DOI 10.1006/jsbi.1998.3990; Sato C, 2001, NATURE, V409, P1047, DOI 10.1038/35059098; Shen BW, 2003, J MOL BIOL, V332, P385, DOI 10.1016/S0022-2836(03)00954-9; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Togashi K, 2006, EMBO J, V25, P1804, DOI 10.1038/sj.emboj.7601083; Tong Q, 2006, J BIOL CHEM, V281, P9076, DOI 10.1074/jbc.M510422200; Tsuruda PR, 2006, NEURON, V51, P201, DOI 10.1016/j.neuron.2006.06.023; Uemura T, 2005, BIOCHEM BIOPH RES CO, V328, P1232, DOI 10.1016/j.bbrc.2005.01.086; van Heel M, 2000, Q REV BIOPHYS, V33, P307, DOI 10.1017/S0033583500003644; van Rossum DB, 2005, NATURE, V434, P99, DOI 10.1038/nature03340; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Vazquez G, 2001, P NATL ACAD SCI USA, V98, P11777, DOI 10.1073/pnas.201238198; Wehage E, 2002, J BIOL CHEM, V277, P23150, DOI 10.1074/jbc.M112096200; Yazawa M, 2007, NATURE, V448, P78, DOI 10.1038/nature05928; Zhang W, 2003, J BIOL CHEM, V278, P16222, DOI 10.1074/jbc.M300298200; Zhu X, 1996, CELL, V85, P661, DOI 10.1016/S0092-8674(00)81233-7	54	56	60	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					36961	36970		10.1074/jbc.M705694200	http://dx.doi.org/10.1074/jbc.M705694200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17940282	hybrid			2022-12-27	WOS:000251646000022
J	Nechifor, R; Murataliev, M; Wilson, KS				Nechifor, Roxana; Murataliev, Marat; Wilson, Kevin S.			Functional interactions between the G ' subdomain of bacterial translation factor EF-G and ribosomal protein L7/L12	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELONGATION-FACTOR-G; MESSENGER-RNA TRANSLOCATION; C-TERMINAL DOMAIN; ESCHERICHIA-COLI; FACTOR TU; STRUCTURAL BASIS; GUANOSINE TRIPHOSPHATE; CONFORMATIONAL-CHANGES; GTPASE ACTIVATION; CRYSTAL-STRUCTURE	Protein L7/L12 of the bacterial ribosome plays an important role in activating the GTP hydrolytic activity of elongation factor G (EF-G), which promotes ribosomal translocation during protein synthesis. Previously, we cross-linked L7/L12 from two residues (209 and 231) flanking alpha-helixA(G ') in theG ' subdomain of Escherichia coli EF-G. Here we report kinetic studies on the functional effects of mutating three neighboring glutamic acid residues ( 224, 228, and 231) to lysine, either singly or in combination. Two single mutations ( E224K and E228K), both within helix A(G '), caused large defects in GTP hydrolysis and smaller defects in ribosomal translocation. Removal of L7/L12 from the ribosome strongly reduced the activities of wild type EF-G but had no effect on the activities of the E224K and E228K mutants. Together, these results provide evidence for functionally important interactions between helix A(G ') of EF-G and L7/L12 of the ribosome.	[Nechifor, Roxana; Murataliev, Marat; Wilson, Kevin S.] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada	University of Alberta	Wilson, KS (corresponding author), Univ Alberta, Dept Biochem, 3-31 Med Sci Bldg, Edmonton, AB T6G 2H7, Canada.	s.wilson@ualberta.ca						Andersen GR, 2000, MOL CELL, V6, P1261, DOI 10.1016/S1097-2765(00)00122-2; Bargis-Surgey P, 1999, EUR J BIOCHEM, V262, P606, DOI 10.1046/j.1432-1327.1999.00434.x; BERCHTOLD H, 1993, NATURE, V365, P126, DOI 10.1038/365126a0; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BROT N, 1974, P NATL ACAD SCI USA, V71, P89, DOI 10.1073/pnas.71.1.89; Connell SR, 2007, MOL CELL, V25, P751, DOI 10.1016/j.molcel.2007.01.027; CUNDLIFFE E, 1989, RIBOSOME STRUCTURE F, P479; CZWORKOWSKI J, 1994, EMBO J, V13, P3661, DOI 10.1002/j.1460-2075.1994.tb06675.x; Datta PP, 2005, MOL CELL, V20, P723, DOI 10.1016/j.molcel.2005.10.028; Daviter T, 2003, J MOL BIOL, V332, P689, DOI 10.1016/S0022-2836(03)00947-1; Diaconu M, 2005, CELL, V121, P991, DOI 10.1016/j.cell.2005.04.015; ECCLESTON JF, 1982, J BIOL CHEM, V257, P5046; Feinberg JS, 2006, RNA, V12, P580, DOI 10.1261/rna.2290706; Gao HX, 2007, CELL, V129, P929, DOI 10.1016/j.cell.2007.03.050; HAMEL E, 1972, J BIOL CHEM, V247, P805; HARTZ D, 1988, METHOD ENZYMOL, V164, P419; Helgstrand M, 2007, J MOL BIOL, V365, P468, DOI 10.1016/j.jmb.2006.10.025; Jorgensen R, 2003, NAT STRUCT BIOL, V10, P379, DOI 10.1038/nsb923; Katunin VI, 2002, BIOCHEMISTRY-US, V41, P12806, DOI 10.1021/bi0264871; KIRSEBOM LA, 1986, EUR J BIOCHEM, V156, P669, DOI 10.1111/j.1432-1033.1986.tb09630.x; KISCHA K, 1971, NATURE-NEW BIOL, V233, P62, DOI 10.1038/newbio233062a0; Kothe U, 2004, J MOL BIOL, V336, P1011, DOI 10.1016/j.jmb.2003.12.080; LOCKWOOD AH, 1974, J BIOL CHEM, V249, P1213; Mohr D, 2002, BIOCHEMISTRY-US, V41, P12520, DOI 10.1021/bi026301y; Nechifor R, 2007, J MOL BIOL, V368, P1412, DOI 10.1016/j.jmb.2007.03.009; Pan DL, 2007, MOL CELL, V25, P519, DOI 10.1016/j.molcel.2007.01.014; PARISI B, 1967, J MOL BIOL, V28, P295, DOI 10.1016/S0022-2836(67)80011-1; Rodnina MV, 1997, NATURE, V385, P37, DOI 10.1038/385037a0; ROHRBACH MS, 1976, BIOCHEMISTRY-US, V15, P4565, DOI 10.1021/bi00666a003; Savelsbergh A, 2005, EMBO J, V24, P4316, DOI 10.1038/sj.emboj.7600884; Savelsbergh A, 2000, J BIOL CHEM, V275, P890, DOI 10.1074/jbc.275.2.890; Savelsbergh A, 2003, MOL CELL, V11, P1517, DOI 10.1016/S1097-2765(03)00230-2; Sergiev PV, 2005, FEBS LETT, V579, P5439, DOI 10.1016/j.febslet.2005.09.010; Studer SM, 2003, J MOL BIOL, V327, P369, DOI 10.1016/S0022-2836(03)00146-3; Uchiumi T, 2002, J BIOL CHEM, V277, P3857, DOI 10.1074/jbc.M107730200; Valle M, 2003, CELL, V114, P123, DOI 10.1016/S0092-8674(03)00476-8; Wilden B, 2006, P NATL ACAD SCI USA, V103, P13670, DOI 10.1073/pnas.0606099103; Wilson KS, 2004, J MOL BIOL, V337, P15, DOI 10.1016/j.jmb.2004.01.013	39	26	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					36998	37005		10.1074/jbc.M707179200	http://dx.doi.org/10.1074/jbc.M707179200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17932030	hybrid			2022-12-27	WOS:000251646000026
J	Holbert, MA; Sikorski, T; Carten, J; Snowflack, D; Hodawadekar, S; Marmorstein, R				Holbert, Marc A.; Sikorski, Timothy; Carten, Juliana; Snowflack, Danielle; Hodawadekar, Santosh; Marmorstein, Ronen			The human monocytic leukemia zinc finger histone acetyltransferase domain contains DNA-binding activity implicated in chromatin targeting	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE MYELOID-LEUKEMIA; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; NUCLEOSOME RECOGNITION; IN-VITRO; PROTEIN; ACETYLATION; GCN5; TRANSCRIPTION; MECHANISM	The human monocytic leukemia zinc finger (MOZ) protein is an essential transcriptional coactivator and histone acetyltransferase ( HAT) that plays a primary role in the differentiation of erythroid and myeloid cells and is required to maintain hematopoietic stem cells. Chromosomal translocations involving the HAT-encoded region are also associated with acute myeloid leukemia. Here we present the x-ray crystal structure of the MOZ HAT domain and related biochemical studies. We find that the HAT domain contains a central region that is structurally and functionally conserved with the yeast MYST HAT protein Esa1, but contains more divergent N- and C-terminal regions harboring a TFIIIA-type zinc finger and helix-turn-helix DNA-binding motifs. Solution DNA-binding and acetyltransferase activity assays, in concert with mutagenesis, confirm that the MOZ HAT domain binds strongly to DNA through the zinc finger and helix-turn-helix motifs and that DNA binding and catalysis are not mutually exclusive. Consistent with the DNA-binding properties of MOZ, we also show that MOZ is able to acetylate nucleosomes and free histones equally well, whereas other HATs prefer free histones. Our results reveal, for the first time, that enzymatic and DNA-targeting activities can be contained within the same chromatin regulatory domain.	Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA; Univ Penn, Dept Chem, Philadelphia, PA 19104 USA	The Wistar Institute; University of Pennsylvania	Marmorstein, R (corresponding author), Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA.	marmor@wistar.org			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060293] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM60293, R01 GM060293] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahn SH, 2005, CELL, V120, P25, DOI 10.1016/j.cell.2004.11.016; Akhtar A, 2000, NATURE, V407, P405, DOI 10.1038/35030169; Akhtar A, 2001, EMBO REP, V2, P113, DOI 10.1093/embo-reports/kve022; Alekshun MN, 2001, NAT STRUCT BIOL, V8, P710, DOI 10.1038/90429; ALLFREY VG, 1964, P NATL ACAD SCI USA, V51, P786, DOI 10.1073/pnas.51.5.786; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Berndsen CE, 2007, BIOCHEMISTRY-US, V46, P2091, DOI 10.1021/bi602366n; BIANCHI ME, 1989, SCIENCE, V243, P1056, DOI 10.1126/science.2922595; Borrow J, 1996, NAT GENET, V14, P33, DOI 10.1038/ng0996-33; BRADBURY EM, 1992, BIOESSAYS, V14, P9; BRIDGES D, 2005, SCI STKE, pRE10, DOI DOI 10.1126/STKE.2962005RE10; Brownell JE, 1996, CELL, V84, P843, DOI 10.1016/S0092-8674(00)81063-6; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Clements A, 2003, MOL CELL, V12, P461, DOI 10.1016/S1097-2765(03)00288-0; Clements A, 1999, EMBO J, V18, P3521, DOI 10.1093/emboj/18.13.3521; Da GP, 2006, P NATL ACAD SCI USA, V103, P2057, DOI 10.1073/pnas.0510949103; de la Cruz X, 2005, BIOESSAYS, V27, P164, DOI 10.1002/bies.20176; Deguchi K, 2003, CANCER CELL, V3, P259, DOI 10.1016/S1535-6108(03)00051-5; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; GEHRING WJ, 1994, CELL, V78, P211, DOI 10.1016/0092-8674(94)90292-5; Grant PA, 1999, J BIOL CHEM, V274, P5895, DOI 10.1074/jbc.274.9.5895; Grune T, 2003, MOL CELL, V12, P449, DOI 10.1016/S1097-2765(03)00273-9; HARRISON SC, 1990, ANNU REV BIOCHEM, V59, P933, DOI 10.1146/annurev.bi.59.070190.004441; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; JONES TA, 1978, J APPL CRYSTALLOGR, V11, P268, DOI 10.1107/S0021889878013308; Kamine J, 1996, VIROLOGY, V216, P357, DOI 10.1006/viro.1996.0071; Katsumoto T, 2006, GENE DEV, V20, P1321, DOI 10.1101/gad.1393106; Kitabayashi I, 2001, EMBO J, V20, P7184, DOI 10.1093/emboj/20.24.7184; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LILLEY DMJ, 1992, NATURE, V357, P282, DOI 10.1038/357282a0; Lo WS, 2000, MOL CELL, V5, P917, DOI 10.1016/S1097-2765(00)80257-9; Luger K, 1999, METHOD ENZYMOL, V304, P3; Min JR, 2003, GENE DEV, V17, P1823, DOI 10.1101/gad.269603; Neuwald AF, 1997, TRENDS BIOCHEM SCI, V22, P154, DOI 10.1016/S0968-0004(97)01034-7; Nolte RT, 1998, P NATL ACAD SCI USA, V95, P2938, DOI 10.1073/pnas.95.6.2938; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Owen DJ, 2000, EMBO J, V19, P6141, DOI 10.1093/emboj/19.22.6141; Pardo PS, 2002, J BIOL CHEM, V277, P50860, DOI 10.1074/jbc.M203839200; PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256; Poux AN, 2003, BIOCHEMISTRY-US, V42, P14366, DOI 10.1021/bi035632n; Poux AN, 2002, P NATL ACAD SCI USA, V99, P14065, DOI 10.1073/pnas.222373899; Qian CM, 2005, NAT STRUCT MOL BIOL, V12, P1078, DOI 10.1038/nsmb1022; Reifsnyder C, 1996, NAT GENET, V14, P42, DOI 10.1038/ng0996-42; Rojas JR, 1999, NATURE, V401, P93, DOI 10.1038/43487; Rozman M, 2004, GENE CHROMOSOME CANC, V40, P140, DOI 10.1002/gcc.20022; SCHULTZ SC, 1991, SCIENCE, V253, P1001, DOI 10.1126/science.1653449; Schwartz T, 1999, SCIENCE, V284, P1841, DOI 10.1126/science.284.5421.1841; Sharma M, 2000, J BIOL CHEM, V275, P35200, DOI 10.1074/jbc.M004838200; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Smith ER, 1998, P NATL ACAD SCI USA, V95, P3561, DOI 10.1073/pnas.95.7.3561; Steiner T, 2002, EMBO J, V21, P4641, DOI 10.1093/emboj/cdf455; Takechi S, 1999, BIOCHEM BIOPH RES CO, V266, P405, DOI 10.1006/bbrc.1999.1836; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P1863, DOI 10.1107/S0907444999010033; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Thomas T, 2006, GENE DEV, V20, P1175, DOI 10.1101/gad.1382606; Trievel RC, 1999, P NATL ACAD SCI USA, V96, P8931, DOI 10.1073/pnas.96.16.8931; Utley RT, 1996, METHOD ENZYMOL, V274, P276; VIPOND IB, 1993, MOL MICROBIOL, V9, P225, DOI 10.1111/j.1365-2958.1993.tb01685.x; Wang WD, 1998, P NATL ACAD SCI USA, V95, P492, DOI 10.1073/pnas.95.2.492; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yan Y, 2000, MOL CELL, V6, P1195, DOI 10.1016/S1097-2765(00)00116-7; Yan Y, 2002, NAT STRUCT BIOL, V9, P862, DOI 10.1038/nsb849	62	39	41	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36603	36613		10.1074/jbc.M705812200	http://dx.doi.org/10.1074/jbc.M705812200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17925393	hybrid			2022-12-27	WOS:000251458300053
J	Cohen, O; Kronman, C; Lazar, A; Velan, B; Shafferman, A				Cohen, Ofer; Kronman, Chanoch; Lazar, Arie; Velan, Baruch; Shafferman, Avigdor			Controlled concealment of exposed clearance and immunogenic domains by site-specific polyethylene glycol attachment to acetylcholinesterase hypolysine mutants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECOMBINANT HUMAN ACETYLCHOLINESTERASE; CIRCULATORY RESIDENCE TIME; HUMAN BUTYRYLCHOLINESTERASE; BOVINE ACETYLCHOLINESTERASE; CHEMICAL-MODIFICATION; N-GLYCOSYLATION; SIALYLATION; EXPRESSION; PEGYLATION; SUBUNIT	Cholinesterases are efficient scavengers of organophosphates and are currently being developed as drugs for treatment against poisoning by such compounds. Recombinant ChE bioscavengers have very short circular longevity, a limitation that can be overcome by complex post-translation manipulations or by chemical modification such as polyethylene glycol conjugation. Series of multiple Lys-Ala mutants of human acetylcholinesterase were prepared allowing the generation of homogenous and well defined polyethylene-glycol conjugated AChEs with either one, two, three, four, or five appended polyethylene glycol ( PEG) moieties/molecule. The rank order of circulatory longevity of these molecules was dependent on the number of PEG appendages up to a certain threshold: 5 = 4 > 3 > 2 > 1 > 0. Hypolysine acetylcholinesterases ( AChEs) carrying the same number of PEGs, and therefore with identical masses, allowed us to demonstrate that circulatory longevity correlates with the predicted extent of concealment of the AChE surface. Furthermore, circulatory profiles of high number and low number PEG-AChEs differing in their sialic acid contents demonstrate a direct relationship between PEG loading and the effective seclusion of AChE from the hepatic asialoglycoprotein receptor clearance system. Finally, an inverse relationship is found between the extent of PEG loading and the ability of the human acetylcholinesterase to elicit specific anti-HuAChE antibodies. In conclusion, these findings suggest that for the extension of circulatory longevity, protein surface domain concealment exerted by polyethylene glycol attachment is at least as important as its effect on size enlargement and highlights the role of PEG attachment in masking interactions between biomolecules and their cognate receptors.	Israel Inst Biol Res, Dept Biochem & Mol Genet, IL-74100 Ness Ziona, Israel; Israel Inst Biol Res, Dept Biotechnol, IL-74100 Ness Ziona, Israel		Shafferman, A (corresponding author), Israel Inst Biol Res, Dept Biochem & Mol Genet, IL-74100 Ness Ziona, Israel.	avigdors@iibr.gov.il						Chilukuri N, 2005, CHEM-BIOL INTERACT, V157, P115, DOI 10.1016/j.cbi.2005.10.013; Chitlaru T, 2002, BIOCHEM J, V363, P619, DOI 10.1042/0264-6021:3630619; Chitlaru T, 2001, BIOCHEM J, V354, P613, DOI 10.1042/0264-6021:3540613; Chitlaru T, 1998, BIOCHEM J, V336, P647, DOI 10.1042/bj3360647; Cohen O, 2004, BIOCHEM J, V378, P117, DOI 10.1042/BJ20031305; Cohen O, 2001, BIOCHEM J, V357, P795, DOI 10.1042/0264-6021:3570795; COHEN O, 2004, Patent No. 0147002; Cohen O, 2006, MOL PHARMACOL, V70, P1121, DOI 10.1124/mol.106.026179; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; FISCHER M, 1993, CELL MOL NEUROBIOL, V13, P25, DOI 10.1007/BF00712987; KRONMAN C, 1992, GENE, V121, P295, DOI 10.1016/0378-1119(92)90134-B; KRONMAN C, 1995, BIOCHEM J, V311, P959, DOI 10.1042/bj3110959; Kronman C, 2000, J BIOL CHEM, V275, P29488, DOI 10.1074/jbc.M004298200; Kronman C, 2007, TOXICOLOGY, V233, P40, DOI 10.1016/j.tox.2006.08.036; Kryger G, 2000, ACTA CRYSTALLOGR D, V56, P1385, DOI 10.1107/S0907444900010659; Laub PB, 1996, J PHARM SCI, V85, P393, DOI 10.1021/js9503744; Lee H, 2003, PHARMACEUT RES, V20, P818, DOI 10.1023/A:1023402123119; Lenz DE, 2005, CHEM-BIOL INTERACT, V157, P205, DOI 10.1016/j.cbi.2005.10.025; Long DL, 2006, EXP HEMATOL, V34, P697, DOI 10.1016/j.exphem.2006.02.011; Mendelson I, 1998, BIOCHEM J, V334, P251, DOI 10.1042/bj3340251; Natarajan A, 2005, BIOCONJUGATE CHEM, V16, P113, DOI 10.1021/bc0498121; Onda M, 2003, BIOCONJUGATE CHEM, V14, P480, DOI 10.1021/bc020069r; Raveh L, 1997, TOXICOL APPL PHARM, V145, P43, DOI 10.1006/taap.1997.8160; RAVEH L, 1993, BIOCHEM PHARMACOL, V45, P37; Saxena A, 1998, MOL PHARMACOL, V53, P112, DOI 10.1124/mol.53.1.112; SHAFFERMAN A, 1992, J BIOL CHEM, V267, P17640; VELAN B, 1991, J BIOL CHEM, V266, P23977; Yamamoto Y, 2003, NAT BIOTECHNOL, V21, P546, DOI 10.1038/nbt812	28	14	14	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35491	35501		10.1074/jbc.M704785200	http://dx.doi.org/10.1074/jbc.M704785200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17932038	hybrid			2022-12-27	WOS:000251458100008
J	Fiaschi, M; Rozell, B; Bergstrom, A; Toftgard, R; Kleman, MI				Fiaschi, Marie; Rozell, Bjorn; Bergstrom, Asa; Toftgard, Rune; Kleman, Marika I.			Targeted expression of GLI1 in the mammary gland disrupts pregnancy-induced maturation and causes lactation failure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR SNAIL; E-CADHERIN; INDIAN HEDGEHOG; GENE-EXPRESSION; SONIC HEDGEHOG; HAIR FOLLICLE; KNOCKOUT MICE; MOUSE UTERUS; ACTIVATION; TISSUE	The Hedgehog signaling pathway regulates the development and function of numerous tissues and when mis-regulated causes tumorigenesis. To assess the role of a deregulated Hedgehog signaling pathway in the mammary gland we targeted the expression of the Hedgehog effector protein, GLI1, to mammary epithelial cells using a bigenic inducible system. A constitutively active Hedgehog signaling pathway resulted with 100% penetrance in an undifferentiated mammary lobuloalveolar network during pregnancy. GLI1-expressing transgenic females were unable to lactate and milk protein gene expression was essentially absent. The inability to lactate was permanent and independent of continued GLI1 transgene expression. An increased expression of the GLI1 response gene Snail coupled to reduced expression of E-cadherin and STAT5 in the transgenic mammary gland provides a likely molecular explanation, underlying the observed phenotypic changes. In addition, remodeling of the mammary gland after parturition was impaired and expression of GLI1 was associated with accumulation of cellular debris in the mammary ducts during involution, indicating a defect in the clearance of dead cells. Areas with highly proliferative epithelial cells were observed in mammary glands with induced expression of GLI1. Within such areas an increased frequency of cells expressing nuclear Cyclin D1 was observed. Taken together the data support the notion that correct regulation of Hedgehog signaling within the epithelial cell compartment is critical for pregnancy-induced mammary gland development and remodeling.	Karolinska Inst, Dept Biosci & Nutr, SE-14157 Huddinge, Sweden; Karolinska Inst, Unit Morphol Phenotype Anal, Clin Res Ctr, SE-14157 Huddinge, Sweden; Karolinska Inst, Dept Lab Med, Div Pathol, SE-14157 Huddinge, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet	Toftgard, R (corresponding author), Karolinska Inst, Dept Biosci & Nutr, SE-14157 Huddinge, Sweden.	rune.toftgard@biosci.ki.se			NATIONAL CANCER INSTITUTE [U01CA105491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR047898] Funding Source: NIH RePORTER; NCI NIH HHS [U01 CA105491] Funding Source: Medline; NIAMS NIH HHS [AR47898] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Abrahams VM, 2004, AM J REPROD IMMUNOL, V51, P275, DOI 10.1111/j.1600-0897.2004.00156.x; Agren M, 2004, GENE, V330, P101, DOI 10.1016/j.gene.2004.01.010; Altaba ARI, 1998, DEVELOPMENT, V125, P2203; Aza-Blanc P, 2000, DEVELOPMENT, V127, P4293; Bai CB, 2004, DEV CELL, V6, P103, DOI 10.1016/S1534-5807(03)00394-0; Bai CB, 2002, DEVELOPMENT, V129, P4753; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Bitgood MJ, 1996, CURR BIOL, V6, P298, DOI 10.1016/S0960-9822(02)00480-3; Boussadia O, 2002, MECH DEVELOP, V115, P53, DOI 10.1016/S0925-4773(02)00090-4; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Cohen MM, 2003, AM J MED GENET A, V123A, P5, DOI 10.1002/ajmg.a.20495; Come C, 2004, J MAMMARY GLAND BIOL, V9, P183, DOI 10.1023/B:JOMG.0000037161.91969.de; Dai P, 1999, J BIOL CHEM, V274, P8143, DOI 10.1074/jbc.274.12.8143; DANIEL CW, 1995, DEV BIOL, V169, P511, DOI 10.1006/dbio.1995.1165; Duman-Scheel M, 2002, NATURE, V417, P299, DOI 10.1038/417299a; Gallego MI, 2002, DEV BIOL, V249, P131, DOI 10.1006/dbio.2002.0761; Gunther EJ, 2002, FASEB J, V16, DOI 10.1096/fj.01-0551com; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; Hanayama R, 2005, P NATL ACAD SCI USA, V102, P16886, DOI 10.1073/pnas.0508599102; Hatsell SJ, 2006, DEVELOPMENT, V133, P3661, DOI 10.1242/dev.02542; Hennighausen L, 2001, DEV CELL, V1, P467, DOI 10.1016/S1534-5807(01)00064-8; Hooper JE, 2005, NAT REV MOL CELL BIO, V6, P306, DOI 10.1038/nrm1622; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Kouros-Mehr H, 2006, DEV DYNAM, V235, P3404, DOI 10.1002/dvdy.20978; Lee J, 1997, DEVELOPMENT, V124, P2537; Lee K, 2006, NAT GENET, V38, P1204, DOI 10.1038/ng1874; Lewis MT, 1999, DEVELOPMENT, V126, P5181; Lewis MT, 2001, DEV BIOL, V238, P133, DOI 10.1006/dbio.2001.0410; Li N, 2005, EMBO J, V24, P1942, DOI 10.1038/sj.emboj.7600674; Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054; Liu XW, 1998, CELL GROWTH DIFFER, V9, P795; Louro ID, 2002, CANCER RES, V62, P5867; Matsumoto H, 2002, DEV BIOL, V245, P280, DOI 10.1006/dbio.2002.0645; Michno K, 2003, DEV BIOL, V264, P153, DOI 10.1016/S0012-1606(03)00401-9; Monks J, 2002, J MAMMARY GLAND BIOL, V7, P163, DOI 10.1023/A:1020351919634; Moraes RC, 2007, DEVELOPMENT, V134, P1231, DOI 10.1242/dev.02797; Ormandy CJ, 1997, GENE DEV, V11, P167, DOI 10.1101/gad.11.2.167; Park HL, 2000, DEVELOPMENT, V127, P1593; RAMIREZ A, 1994, DIFFERENTIATION, V58, P53, DOI 10.1007/s002580050065; Shillingford JM, 2003, J HISTOCHEM CYTOCHEM, V51, P555, DOI 10.1177/002215540305100501; Takamoto N, 2002, MOL ENDOCRINOL, V16, P2338, DOI 10.1210/me.2001-0154; Teglund S, 1998, CELL, V93, P841, DOI 10.1016/S0092-8674(00)81444-0; Veltmaat JM, 2006, DEVELOPMENT, V133, P2325, DOI 10.1242/dev.02394; Wagner KU, 2002, DEVELOPMENT, V129, P1377; Wagner KU, 2004, MOL CELL BIOL, V24, P5510, DOI 10.1128/MCB.24.12.5510-5520.2004; Wang QT, 2000, DEVELOPMENT, V127, P3131	46	38	39	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					36090	36101		10.1074/jbc.M704280200	http://dx.doi.org/10.1074/jbc.M704280200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17928300	hybrid			2022-12-27	WOS:000251458100068
J	Nichols, RA; Dengler, AF; Nakagawa, EM; Bashkin, M; Paul, BT; Wu, JL; Khan, GM				Nichols, Robert A.; Dengler, Andrew F.; Nakagawa, Emily M.; Bashkin, Marisa; Paul, Brian T.; Wu, Jianlin; Khan, Ghous M.			A constitutive, transient receptor potential-like Ca2+ influx pathway in presynaptic nerve endings independent of voltage-gated Ca2+ channels and Na+/Ca2+ exchange	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							GLIOMA HYBRID-CELLS; SODIUM-CALCIUM EXCHANGE; RAT-BRAIN SYNAPTOSOMES; ENDOPLASMIC-RETICULUM; EXTRACELLULAR CALCIUM; TRANSMITTER RELEASE; SYNAPTIC-TRANSMISSION; NEUROBLASTOMA-CELLS; INTACT SYNAPTOSOMES; RYANODINE RECEPTORS	Calcium levels in the presynaptic nerve terminal are altered by several pathways, including voltage-gated Ca2+ channels, the Na+/Ca2+ exchanger, Ca2+-ATPase, and the mitochondria. The influx pathway for homeostatic control of [Ca2+](i) in the nerve terminal has been unclear. One approach to detecting the pathway that maintains internal Ca2+ is to test for activation of Ca2+ influx following Ca2+ depletion. Here, we demonstrate that a constitutive influx pathway for Ca2+ exists in presynaptic terminals to maintain internal Ca2+ independent of voltage-gated Ca2+ channels and Na+/Ca2+ exchange, as measured in intact isolated nerve endings from mouse cortex and in intact varicosities in a neuronal cell line using fluorescence spectroscopy and confocal imaging. The Mg2+ and lanthanide sensitivity of the influx pathway, in addition to its pharmacological and short hairpin RNA sensitivity, and the results of immunostaining for transient receptor potential (TRP) channels indicate the involvement of TRPC channels, possibly TRPC5 and TRPC1. This constitutive Ca2+ influx pathway likely serves to maintain synaptic function under widely varying levels of synaptic activity.	Drexel Univ, Dept Physiol & Pharmacol, Coll Med, Philadelphia, PA 19102 USA	Drexel University	Nichols, RA (corresponding author), 245 N 15th St, Philadelphia, PA 19102 USA.	robert.nichols@drexel.edu			NATIONAL INSTITUTE ON AGING [R01AG021586] Funding Source: NIH RePORTER; NIA NIH HHS [AG21586] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Ahmmed GU, 2004, J BIOL CHEM, V279, P20941, DOI 10.1074/jbc.M313975200; AKERMAN KEO, 1981, EUR J BIOCHEM, V117, P491; Arnaudeau S, 2001, J BIOL CHEM, V276, P29430, DOI 10.1074/jbc.M103274200; Bardo S, 2006, TRENDS PHARMACOL SCI, V27, P78, DOI 10.1016/j.tips.2005.12.008; BENNINGER C, 1980, BRAIN RES, V187, P165, DOI 10.1016/0006-8993(80)90502-8; Bergsman JB, 2000, J NEUROSCI, V20, P4368, DOI 10.1523/JNEUROSCI.20-12-04368.2000; Berridge MJ, 2002, CELL CALCIUM, V32, P235, DOI 10.1016/S0143416002001823; BLAUSTEIN MP, 1975, J PHYSIOL-LONDON, V247, P657, DOI 10.1113/jphysiol.1975.sp010951; Borst JGG, 1999, J PHYSIOL-LONDON, V521, P123, DOI 10.1111/j.1469-7793.1999.00123.x; Bouchard R, 2003, PROG NEUROBIOL, V69, P391, DOI 10.1016/S0301-0082(03)00053-4; Brain KL, 2001, NEUROSCIENCE, V106, P395, DOI 10.1016/S0306-4522(01)00280-9; Budd SL, 1996, J NEUROCHEM, V66, P403, DOI 10.1046/j.1471-4159.1996.66010403.x; Carter AG, 2002, J NEUROSCI, V22, P21, DOI 10.1523/JNEUROSCI.22-01-00021.2002; Castelli L, 2003, J MEMBRANE BIOL, V195, P121, DOI 10.1007/s00232-003-0614-2; Chang DTW, 2006, J NEUROSCI, V26, P7035, DOI 10.1523/JNEUROSCI.1012-06.2006; Chernaya G, 1996, J BIOL CHEM, V271, P5378, DOI 10.1074/jbc.271.10.5378; Cohen JE, 2004, NEUROSCIENTIST, V10, P12, DOI 10.1177/1073858403259440; Collin T, 2005, CURR OPIN NEUROBIOL, V15, P275, DOI 10.1016/j.conb.2005.05.003; Demeuse P, 2006, J GEN PHYSIOL, V127, P421, DOI 10.1085/jgp.200509410; DRAPEAU P, 1984, J PHYSIOL-LONDON, V348, P493, DOI 10.1113/jphysiol.1984.sp015121; DUNKLEY PR, 1986, BRAIN RES, V372, P115, DOI 10.1016/0006-8993(86)91464-2; EBERHARD M, 1989, BIOCHEM BIOPH RES CO, V163, P309, DOI 10.1016/0006-291X(89)92136-0; Egelman DM, 1999, BIOPHYS J, V76, P1856, DOI 10.1016/S0006-3495(99)77345-5; Emptage NJ, 2001, NEURON, V29, P197, DOI 10.1016/S0896-6273(01)00190-8; Flemming PK, 2006, J BIOL CHEM, V281, P4977, DOI 10.1074/jbc.M510301200; FONTANA G, 1993, J NEUROCHEM, V60, P843, DOI 10.1111/j.1471-4159.1993.tb03228.x; Goel M, 2002, J BIOL CHEM, V277, P48303, DOI 10.1074/jbc.M207882200; Greka A, 2003, NAT NEUROSCI, V6, P837, DOI 10.1038/nn1092; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; GUNTER TE, 1990, AM J PHYSIOL, V258, pC755, DOI 10.1152/ajpcell.1990.258.5.C755; Halaszovich CR, 2000, J BIOL CHEM, V275, P37423, DOI 10.1074/jbc.M007010200; HAN HQ, 1991, NATURE, V349, P697, DOI 10.1038/349697a0; He LP, 2005, J BIOL CHEM, V280, P10997, DOI 10.1074/jbc.M411797200; HEINEMANN U, 1990, PROG BRAIN RES, V83, P197; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; Hui H, 2006, J PHYSIOL-LONDON, V572, P165, DOI 10.1113/jphysiol.2005.102889; Jiang XP, 2003, J BIOL CHEM, V278, P42867, DOI 10.1074/jbc.M304487200; Jinno S, 2002, NEUROSCIENCE, V113, P449, DOI 10.1016/S0306-4522(02)00172-0; Juhaszova M, 2000, EUR J NEUROSCI, V12, P839, DOI 10.1046/j.1460-9568.2000.00974.x; KOMULAINEN H, 1987, NEUROCHEM INT, V10, P55, DOI 10.1016/0197-0186(87)90172-0; Korge P, 1999, EUR J BIOCHEM, V265, P273, DOI 10.1046/j.1432-1327.1999.00724.x; Kozak JA, 2003, BIOPHYS J, V84, P922, DOI 10.1016/S0006-3495(03)74909-1; Kozak JA, 2002, J GEN PHYSIOL, V120, P221, DOI 10.1085/jgp.20028601; Langeslag M, 2007, J BIOL CHEM, V282, P232, DOI 10.1074/jbc.M605300200; Li NZ, 2003, J NEUROSCI, V23, P10302; Liang Y, 2002, J NEUROPHYSIOL, V87, P1132, DOI 10.1152/jn.00661.2001; Lievremont JP, 2005, MOL PHARMACOL, V68, P758, DOI 10.1124/mol.105.012856; Lukyanetz EA, 1998, J PHYSIOL-LONDON, V510, P371, DOI 10.1111/j.1469-7793.1998.371bk.x; Ma HT, 2000, SCIENCE, V287, P1647, DOI 10.1126/science.287.5458.1647; MARTINEZSERRANO A, 1992, MOL BIOL CELL, V3, P235, DOI 10.1091/mbc.3.2.235; Martone ME, 1999, CELL TISSUE RES, V295, P395, DOI 10.1007/s004410051246; MCGEE R, 1978, P NATL ACAD SCI USA, V75, P1314, DOI 10.1073/pnas.75.3.1314; MCGRAW CF, 1980, J CELL BIOL, V85, P228, DOI 10.1083/jcb.85.2.228; MEIRI U, 1972, SCIENCE, V176, P308, DOI 10.1126/science.176.4032.308; Millan C, 2002, J BIOL CHEM, V277, P14092, DOI 10.1074/jbc.M109044200; Mori Y, 1998, NEUROREPORT, V9, P507; Muschol M, 1999, BIOPHYS J, V77, P577, DOI 10.1016/S0006-3495(99)76914-6; NACHSHEN DA, 1985, J PHYSIOL-LONDON, V363, P87, DOI 10.1113/jphysiol.1985.sp015697; Narita K, 2000, J GEN PHYSIOL, V115, P519, DOI 10.1085/jgp.115.4.519; NAVONE F, 1986, J CELL BIOL, V103, P2511, DOI 10.1083/jcb.103.6.2511; Nayak SV, 1999, NEUROSCIENCE, V91, P107, DOI 10.1016/S0306-4522(98)00520-X; Nayak SV, 2001, J NEUROCHEM, V76, P1860, DOI 10.1046/j.1471-4159.2001.00197.x; NELSON P, 1976, P NATL ACAD SCI USA, V73, P123, DOI 10.1073/pnas.73.1.123; Nicholls DG, 2003, NEUROCHEM RES, V28, P1433, DOI 10.1023/A:1025653805029; NICHOLLS DG, 1981, PHILOS T ROY SOC B, V296, P115, DOI 10.1098/rstb.1981.0176; Nichols RA, 1996, J NEUROCHEM, V67, P581; NICHOLSON C, 1980, FED PROC, V39, P1519; NICHOLSON C, 1977, P NATL ACAD SCI USA, V74, P1287, DOI 10.1073/pnas.74.3.1287; Obukhov AG, 2005, J NEUROSCI, V25, P1234, DOI 10.1523/JNEUROSCI.4451-04.2005; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Partridge LD, 2000, BRAIN RES, V867, P143, DOI 10.1016/S0006-8993(00)02275-7; Raiteri L, 2002, J NEUROCHEM, V80, P706, DOI 10.1046/j.0022-3042.2001.00750.x; Reid CA, 2003, TRENDS NEUROSCI, V26, P683, DOI 10.1016/j.tins.2003.10.003; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; Ronde P, 1998, J NEUROCHEM, V70, P1094; Ronde P, 2001, NEUROSCIENCE, V102, P979, DOI 10.1016/S0306-4522(00)00512-1; Ronde P, 2000, J PHYSIOL-LONDON, V529, P307, DOI 10.1111/j.1469-7793.2000.00307.x; RUAT M, 1995, P NATL ACAD SCI USA, V92, P3161, DOI 10.1073/pnas.92.8.3161; Runnels LW, 2002, NAT CELL BIOL, V4, P329, DOI 10.1038/ncb781; Runnels LW, 2001, SCIENCE, V291, P1043, DOI 10.1126/science.1058519; Rusakov DA, 2003, NEURON, V37, P287, DOI 10.1016/S0896-6273(03)00025-4; Rusakov DA, 2006, NEUROSCIENTIST, V12, P317, DOI 10.1177/1073858405284672; Schmitz C, 2003, CELL, V114, P191, DOI 10.1016/S0092-8674(03)00556-7; SCOTT ID, 1980, BIOCHEM J, V192, P873, DOI 10.1042/bj1920873; Scotti AL, 1999, PHILOS T ROY SOC B, V354, P357, DOI 10.1098/rstb.1999.0387; Sharma G, 2003, NEURON, V38, P929, DOI 10.1016/S0896-6273(03)00322-2; Shepherd GMG, 1998, J NEUROSCI, V18, P8300; Smith RM, 1974, CRITICAL STABILITY C, V1-6; Smith SM, 2004, NEURON, V41, P243, DOI 10.1016/S0896-6273(03)00837-7; Strubing C, 2001, NEURON, V29, P645, DOI 10.1016/S0896-6273(01)00240-9; TAREILUS E, 1993, NEUROCHEM INT, V23, P331, DOI 10.1016/0197-0186(93)90077-I; Tozzi A, 2003, EUR J NEUROSCI, V18, P2133, DOI 10.1046/j.1460-9568.2003.02936.x; Trebak M, 2002, J BIOL CHEM, V277, P21617, DOI 10.1074/jbc.M202549200; Unni VK, 2004, J NEUROSCI, V24, P9612, DOI 10.1523/JNEUROSCI.5583-03.2004; Vassilev PM, 1997, BIOPHYS J, V72, P2103, DOI 10.1016/S0006-3495(97)78853-2; Venkatachalam K, 2002, NAT CELL BIOL, V4, pE263, DOI 10.1038/ncb1102-e263; von Bohlen und Halbach O, 2005, CELL TISSUE RES, V322, P201, DOI 10.1007/s00441-005-0004-4; Wu JL, 2006, J NEUROCHEM, V98, P481, DOI 10.1111/j.1471-4159.2006.03901.x; Xu F, 1998, ANESTH ANALG, V87, P701, DOI 10.1097/00000539-199809000-00040; YEAGER RE, 1987, J NEUROSCI, V7, P2390; Zeng FN, 2004, J PHYSIOL-LONDON, V559, P739, DOI 10.1113/jphysiol.2004.065391	103	17	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					36102	36111		10.1074/jbc.M706002200	http://dx.doi.org/10.1074/jbc.M706002200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17928293	hybrid			2022-12-27	WOS:000251458100069
J	Reyes-Juarez, JL; Juarez-Rubi, R; Rodriguez, G; Zarain-Herzberg, A				Reyes-Juarez, Jose Luis; Juarez-Rubi, Raul; Rodriguez, Gabriela; Zarain-Herzberg, Angel			Transcriptional analysis of the human cardiac calsequestrin gene in cardiac and skeletal myocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM RESPONSE FACTOR; CALCIUM-RELEASE CHANNEL; MUSCLE DEVELOPMENT; MYOCARDIN FAMILY; EXPRESSION; ENHANCER; ACTIVATION; MEF2; PROTEINS; TARGET	Calsequestrin is the main calcium-binding protein inside the sarcoplasmic reticulum of striated muscle. In mammals, the cardiac calsequestrin gene (casq2) mainly expresses in cardiac muscle and to a minor extent in slow-twitch skeletal muscle and it is not expressed in non-muscle tissues. This work is the first study on the transcriptional regulation of the casq2 gene in cardiac and skeletal muscle cells. The sequence of the casq2 genes proximal promoter ( 180 bp) of mammals and avians is highly conserved and contains one TATA box, one CArG box, one E-box, and one myocyte enhancer factor 2 (MEF-2) site. We cloned the human casq2 gene 5 '-regulatory region into aluciferase reporter expression vector. By functional assays we showed that a construct containing the first 288 bp of promoter was up-regulated during myogenic differentiation of Sol8 cells and had higher transcriptional activity compared with longer constructs. In neonatal rat cardiac myocytes, the larger construct containing 3.2 kb showed the highest transcriptional activity, demonstrating that the first 288 bp are sufficient to confer muscle specificity, whereas distal sequences may act as a cardiac-specific enhancer. Electrophoretic mobility shift assay studies demonstrated that the proximal MEF-2 and CArG box sequences were capable of binding MEF-2 and serum response factor, respectively, whereas the E-box did not show binding properties. Functional studies demonstrated that site-directed mutagenesis of the proximal MEF-2 and CArG box sites significantly decreased the transcription of the gene in cardiac and skeletal muscle cells, indicating that they are important to drive cardiac and skeletal muscle-specific transcription of the casq2 gene.	Univ Nacl Autonoma Mexico, Fac Med, Dept Bioquim & Biol Mol, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico	Zarain-Herzberg, A (corresponding author), Apartado Postal 70-159, Mexico City 04510, DF, Mexico.	zarain@servidor.unam.mx		Reyes Juarez, Jose L/0000-0002-0524-9257				ARAI M, 1991, GENE, V109, P275, DOI 10.1016/0378-1119(91)90621-H; Azakie A, 2005, AM J PHYSIOL-CELL PH, V289, pC1522, DOI 10.1152/ajpcell.00126.2005; Balza RO, 2006, J BIOL CHEM, V281, P6498, DOI 10.1074/jbc.M509487200; Beard NA, 2004, PROG BIOPHYS MOL BIO, V85, P33, DOI 10.1016/j.pbiomolbio.2003.07.001; Beard NA, 2002, BIOPHYS J, V82, P310, DOI 10.1016/S0006-3495(02)75396-4; Belaguli NS, 2000, MOL CELL BIOL, V20, P7550, DOI 10.1128/MCB.20.20.7550-7558.2000; Berkes CA, 2005, SEMIN CELL DEV BIOL, V16, P585, DOI 10.1016/j.semcdb.2005.07.006; Beylkin DH, 2006, DEV BIOL, V294, P541, DOI 10.1016/j.ydbio.2006.02.049; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Blais A, 2005, GENE DEV, V19, P553, DOI 10.1101/gad.1281105; Bodmer R, 1998, DEV GENET, V22, P181, DOI 10.1002/(SICI)1520-6408(1998)22:3<181::AID-DVG1>3.0.CO;2-2; Chen CY, 1996, DEV GENET, V19, P119, DOI 10.1002/(SICI)1520-6408(1996)19:2<119::AID-DVG3>3.0.CO;2-C; Creemers EE, 2006, DEVELOPMENT, V133, P4245, DOI 10.1242/dev.02610; Cripps RM, 2002, DEV BIOL, V246, P14, DOI 10.1006/dbio.2002.0666; Dai YS, 2002, J BIOL CHEM, V277, P24390, DOI 10.1074/jbc.M202490200; Dhar M, 1997, J BIOL CHEM, V272, P18490, DOI 10.1074/jbc.272.29.18490; di Barletta MR, 2006, CIRCULATION, V114, P1012, DOI 10.1161/CIRCULATIONAHA.106.623793; Durocher D, 1997, EMBO J, V16, P5687, DOI 10.1093/emboj/16.18.5687; Frank KF, 2001, BASIC RES CARDIOL, V96, P636, DOI 10.1007/s003950170016; Franzini-Armstrong C, 1999, BIOPHYS J, V77, P1528, DOI 10.1016/S0006-3495(99)77000-1; Gregoire S, 2007, MOL CELL BIOL, V27, P1280, DOI 10.1128/MCB.00882-06; Kontula K, 2005, CARDIOVASC RES, V67, P379, DOI 10.1016/j.cardiores.2005.04.027; LaPointe MC, 2005, PEPTIDES, V26, P944, DOI 10.1016/j.peptides.2004.08.028; Lehnart SE, 1998, ANN NY ACAD SCI, V853, P220, DOI 10.1111/j.1749-6632.1998.tb08270.x; Lemonnier M, 2004, J BIOL CHEM, V279, P55651, DOI 10.1074/jbc.M411082200; MacLennan DH, 2000, EUR J BIOCHEM, V267, P5291, DOI 10.1046/j.1432-1327.2000.01566.x; Meissner JD, 2007, J CELL PHYSIOL, V211, P138, DOI 10.1002/jcp.20916; Molkentin JD, 1996, J MOL CELL CARDIOL, V28, P1211, DOI 10.1006/jmcc.1996.0112; Morin S, 2000, EMBO J, V19, P2046, DOI 10.1093/emboj/19.9.2046; Morin S, 2005, J BIOL CHEM, V280, P32272, DOI 10.1074/jbc.M507640200; Nelson TJ, 2005, J MOL CELL CARDIOL, V39, P479, DOI 10.1016/j.yjmcc.2005.05.004; Park HJ, 2003, J BIOL CHEM, V278, P16176, DOI 10.1074/jbc.M300120200; Park HJ, 2004, J BIOL CHEM, V279, P18026, DOI 10.1074/jbc.M311553200; Park KW, 1998, GENE, V217, P25, DOI 10.1016/S0378-1119(98)00372-2; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pipes GCT, 2006, GENE DEV, V20, P1545, DOI 10.1101/gad.1428006; Postma AV, 2002, CIRC RES, V91, pE21, DOI 10.1161/01.RES.0000038886.18992.6B; Sato Y, 1998, J BIOL CHEM, V273, P28470, DOI 10.1074/jbc.273.43.28470; Terentyev D, 2006, CIRC RES, V98, P1151, DOI 10.1161/01.RES.0000220647.93982.08; vonHarsdorf R, 1997, J CLIN INVEST, V100, P1294, DOI 10.1172/JCI119643; Wamhoff BR, 2004, CIRC RES, V95, P406, DOI 10.1161/01.RES.0000138582.36921.9e; Wang DZ, 2004, CURR OPIN GENET DEV, V14, P558, DOI 10.1016/j.gde.2004.08.003; WANG GS, 1994, J BIOL CHEM, V269, P30595; Wang SR, 1998, NAT STRUCT BIOL, V5, P476, DOI 10.1038/nsb0698-476; Wu H, 2001, EMBO J, V20, P6414, DOI 10.1093/emboj/20.22.6414; Yang A, 2004, AM J PHYSIOL-HEART C, V287, pH1096, DOI 10.1152/ajpheart.00079.2004; YANO K, 1994, MOL CELL BIOCHEM, V135, P61, DOI 10.1007/BF00925961; Zhang XM, 2004, J BIOL CHEM, V279, P55626, DOI 10.1074/jbc.M405945200	48	13	16	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35554	35563		10.1074/jbc.M707788200	http://dx.doi.org/10.1074/jbc.M707788200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17938175	hybrid			2022-12-27	WOS:000251458100015
J	Watanabe, K; Hamada, S; Bianco, C; Mancino, M; Nagaoka, T; Gonzales, M; Bailly, V; Strizzi, L; Salomon, DS				Watanabe, Kazuhide; Hamada, Shin; Bianco, Caterina; Mancino, Mario; Nagaoka, Tadahiro; Gonzales, Monica; Bailly, Veronique; Strizzi, Luigi; Salomon, David S.			Requirement of Glycosylphosphatidylinositol anchor of cripto-1 for trans activity as a nodal co-receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIGHT ASYMMETRIC EXPRESSION; ONE-EYED-PINHEAD; EGF-CFC FAMILY; INTERCELLULAR TRANSFER; SIGNALING PATHWAY; PRION PROTEIN; MOUSE; CELLS; IDENTIFICATION; CANCER	Cripto-1 (CR-1) has an indispensable role as a Nodal coreceptor for patterning of body axis in embryonic development. CR-1 is reported to have a paracrine activity as a Nodal co-receptor, although CR-1 is primarily produced as a glycosylphosphatidylinositol (GPI)-anchored membrane protein. Regulation of cis and trans function of CR-1 should be important to establish the precise body patterning. However, the mechanism by which GPI-anchored CR-1 can act in trans is not well known. Here we confirmed the paracrine activity of CR-1 by fluorescent cell-labeling and immunofluorescent staining. We generated COOH-terminal-truncated soluble forms of CR-1 based on the attachment site for the GPI moiety (omega-site), which we identified in the present study. GPI-anchored CR-1 has a significantly higher activity than COOH-terminal-truncated soluble forms to induce Nodal signal in trans as well as in cis. Moreover, transmembrane forms of CR-1 partially retained their ability to induce Nodal signaling only when type I receptor Activin-like kinase 4 was overexpressed. NTERA2/D1 cells, which express endogenous CR-1, lost the cell-surface expression of CR-1 after phosphatidylinositol-phospholipase C treatment and became refractory to stimulation of Nodal. These observations suggest that GPI attachment of CR-1 is required for the paracrine activity as a Nodal co-receptor.	NCI, Tumor Growth Factor Sect, Mammary Biol & Tumorigenesis Lab, Ctr Canc Res,NIH, Bethesda, MD 20892 USA; Biogen Idec Inc, Cambridge, MA 02142 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Biogen	Salomon, DS (corresponding author), Bldg 37,Rm 1118B,37 Convent Dr, Bethesda, MD 20892 USA.	salomond@mail.nih.gov	Nagaoka, Tadahiro/ABI-3842-2022; Hamada, Shin/Z-3023-2019; Watanabe, Kazuhide/C-9667-2017	Nagaoka, Tadahiro/0000-0002-9391-0243; Watanabe, Kazuhide/0000-0002-5331-0593; Mancino, Mario/0000-0003-1957-3119	Intramural NIH HHS Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Adachi H, 1999, GENE DEV, V13, P1589, DOI 10.1101/gad.13.12.1589; Adkins HB, 2003, J CLIN INVEST, V112, P575, DOI 10.1172/JCI200317788; Anderson SM, 1996, P NATL ACAD SCI USA, V93, P5894, DOI 10.1073/pnas.93.12.5894; Bamford RN, 2000, NAT GENET, V26, P365, DOI 10.1038/81695; Bianco C, 2002, MOL CELL BIOL, V22, P2586, DOI 10.1128/MCB.22.8.2586-2597.2002; Bianco C, 2006, CLIN CANCER RES, V12, P5158, DOI 10.1158/1078-0432.CCR-06-0274; Bottcher RT, 2005, ENDOCR REV, V26, P63, DOI 10.1210/er.2003-0040; Chea HK, 2005, DEV DYNAM, V234, P269, DOI 10.1002/dvdy.20549; Chen CH, 2004, CURR BIOL, V14, P618, DOI 10.1016/j.cub.2004.02.042; Chu GC, 2004, DEVELOPMENT, V131, P3501, DOI 10.1242/dev.01248; Chu JH, 2005, DEVELOPMENT, V132, P5539, DOI 10.1242/dev.02157; Davis DM, 2007, NAT REV IMMUNOL, V7, P238, DOI 10.1038/nri2020; FURUKAWA Y, 1994, BBA-BIOMEMBRANES, V1190, P273, DOI 10.1016/0005-2736(94)90084-1; Gritsman K, 1999, CELL, V97, P121, DOI 10.1016/S0092-8674(00)80720-5; Hirokawa N, 2006, CELL, V125, P33, DOI 10.1016/j.cell.2006.03.002; Lauc G, 2006, BBA-GEN SUBJECTS, V1760, P584, DOI 10.1016/j.bbagen.2005.11.014; Le Good JA, 2005, CURR BIOL, V15, P31, DOI 10.1016/j.cub.2004.12.062; Liu T, 2002, J BIOL CHEM, V277, P47671, DOI 10.1074/jbc.M207458200; Marikawa Y, 2006, SEMIN CELL DEV BIOL, V17, P175, DOI 10.1016/j.semcdb.2006.04.003; Minchiotti G, 2000, MECH DEVELOP, V90, P133, DOI 10.1016/S0925-4773(99)00235-X; Minchiotti G, 2001, DEVELOPMENT, V128, P4501; MORAN P, 1992, J CELL BIOL, V119, P763, DOI 10.1083/jcb.119.4.763; Nicholson TB, 2007, J CELL BIOL, V177, P211, DOI 10.1083/jcb.200701158; Nicholson TB, 2006, J CELL BIOL, V175, P647, DOI 10.1083/jcb.200605001; Norris DP, 1999, GENE DEV, V13, P1575, DOI 10.1101/gad.13.12.1575; Okada Y, 2005, CELL, V121, P633, DOI 10.1016/j.cell.2005.04.008; Parisi S, 2003, J CELL BIOL, V163, P303, DOI 10.1083/jcb.200303010; Saijoh Y, 2000, MOL CELL, V5, P35, DOI 10.1016/S1097-2765(00)80401-3; Sakuma R, 2002, GENES CELLS, V7, P401, DOI 10.1046/j.1365-2443.2002.00528.x; Salomon DS, 2000, ENDOCR-RELAT CANCER, V7, P199, DOI 10.1677/erc.0.0070199; Schiffer SG, 2001, J BIOL CHEM, V276, P37769; Shen MM, 2007, DEVELOPMENT, V134, P1023, DOI 10.1242/dev.000166; Shi SL, 2007, J BIOL CHEM, V282, P20133, DOI 10.1074/jbc.M702593200; Tabata T, 2004, DEVELOPMENT, V131, P703, DOI 10.1242/dev.01043; Walmsley AR, 2001, EMBO J, V20, P703, DOI 10.1093/emboj/20.4.703; Watanabe K, 2007, J BIOL CHEM, V282, P31643, DOI 10.1074/jbc.M702713200; Wheeler SF, 2002, GLYCOBIOLOGY, V12, P261, DOI 10.1093/glycob/12.4.261; Xing PX, 2004, CANCER RES, V64, P4018, DOI 10.1158/0008-5472.CAN-03-3888; Xu CH, 1999, DEVELOPMENT, V126, P483; Yamamoto M, 2001, GENE DEV, V15, P1242, DOI 10.1101/gad.883901; Yan YT, 2002, MOL CELL BIOL, V22, P4439, DOI 10.1128/MCB.22.13.4439-4449.2002; Yeo CY, 2001, MOL CELL, V7, P949, DOI 10.1016/S1097-2765(01)00249-0; Zhang JJ, 1998, CELL, V92, P241, DOI 10.1016/S0092-8674(00)80918-6	43	45	45	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35772	35786		10.1074/jbc.M707351200	http://dx.doi.org/10.1074/jbc.M707351200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17925387	hybrid			2022-12-27	WOS:000251458100039
J	Garscha, U; Jerneren, F; Chung, D; Keller, NP; Hamberg, M; Oliw, EH				Garscha, Ulrike; Jerneren, Fredrik; Chung, DaWoon; Keller, Nancy P.; Hamberg, Mats; Oliw, Ernst H.			Identification of dioxygenases required for aspergillus development - Studies of products, stereochemistry, and the reaction mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNGUS GAEUMANNOMYCES-GRAMINIS; LINOLEATE DIOL SYNTHASE; HYDROPEROXIDE ISOMERASE; ACID 8R-DIOXYGENASE; MASS-SPECTROMETRY; NIDULANS; BIOSYNTHESIS; OXYGENATION; METABOLITES; OXYLIPINS	Aspergillus sp. contain ppoA, ppoB, and ppoC genes, which code for fatty acid oxygenases with homology to fungal linoleate 7,8-diol synthases (7,8-LDS) and cyclooxygenases. Our objective was to identify these enzymes, as ppo gene replacements show critical developmental aberrancies in sporulation and pathogenicity in the human pathogen Aspergillus fumigatus and the genetic model Aspergillus nidulans. The PpoAs of A. fumigatus and A. nidulans were identified as (8R)-dioxygenases with hydroperoxide isomerase activity, designated 5,8-LDS. 5,8-LDS transformed 18:2n-6 to (8R)-hydroperoxyoctadecadienoic acid ((8R)- HPODE) and (5S,8R)-dihydroxy-9Z,12Z-octadecadienoic acid ((5S,8R)-DiHODE). We also detected 8,11-LDS in A. fumigatus and (10R)-dioxygenases in both Aspergilli. The diol synthases oxidized [(8R)-2H] 18: 2n-6 to (8R)-HPODE with retention of the deuterium label, suggesting antarafacial hydrogen abstraction and insertion of molecular oxygen. Experiments with stereospecifically deuterated 18: 2n-6 showed that (8R)HPODE was isomerized by 5,8- and 8,11-LDS to (5S, 8R)DiHODE and to (8R,11S)-dihydroxy-9Z, 12Z-octadecadienoic acid, respectively, by suprafacial hydrogen abstraction and oxygen insertion at C-5 and C-11. PpoCs were identified as (10R)-dioxygenases, which catalyzed abstraction of the pro-S hydrogen at C-8 of 18: 2n-6, double bond migration, and antafacial insertion of molecular oxygen with formation of (10R)-hydroxy8E, 12Z-hydroperoxyoctadecadienoic acid ((10R)-HPODE). Deletion of ppoA led to prominent reduction of (8R)- H(P) ODE and complete loss of (5S,8R)-DiHODE biosynthesis, whereas biosynthesis of (10R)-HPODE was unaffected. Deletion of ppoC caused biosynthesis of traces of racemic 10-HODE but did not affect the biosynthesis of other oxylipins. We conclude that ppoA of Aspergillus sp. may code for 5,8-LDS with catalytic similarities to 7,8-LDS and ppoC for linoleate (10R)-dioxygenases. Identification of these oxygenases and their products will provide tools for analyzing the biological impact of oxylipin biosynthesis in Aspergilli.	Uppsala Biomed Ctr, Dept Pharmaceut Biosci, SE-75124 Uppsala, Sweden; Univ Wisconsin, Dept Med & Microbiol Immunobiol, Madison, WI 53706 USA; Univ Wisconsin, Dept Plant Pathol, Madison, WI 53706 USA; Karolinska Inst, Dept Med Biochem & Biophys, SE-17177 Stockholm, Sweden	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Karolinska Institutet	Oliw, EH (corresponding author), Uppsala Biomed Ctr, Dept Pharmaceut Biosci, SE-75124 Uppsala, Sweden.	Ernst.Oliw@farmbio.uu.se	Keller, Nancy P./ABC-5911-2021; Garscha, Ulrike/G-3559-2018	Oliw, Ernst/0000-0002-7986-8130; Hamberg, Mats/0000-0002-8910-7810; Garscha, Ulrike/0000-0002-3645-7833; Jerneren, Fredrik/0000-0003-0897-7177				Akakabe Y, 2005, BIOSCI BIOTECH BIOCH, V69, P1539, DOI 10.1271/bbb.69.1539; BOWERS WS, 1986, SCIENCE, V232, P105, DOI 10.1126/science.232.4746.105; BRODOWSKY ID, 1994, ANN NY ACAD SCI, V744, P314, DOI 10.1111/j.1749-6632.1994.tb52750.x; BRODOWSKY ID, 1992, BIOCHIM BIOPHYS ACTA, V1124, P59, DOI 10.1016/0005-2760(92)90126-G; BRODOWSKY ID, 1992, J BIOL CHEM, V267, P14738; BRODOWSKY ID, 1993, BIOCHIM BIOPHYS ACTA, V1168, P68, DOI 10.1016/0005-2760(93)90267-D; BRODOWSKY ID, 1994, EUR J PHARMACOL, V254, P43, DOI 10.1016/0014-2999(94)90368-9; CHAMPE SP, 1989, J BACTERIOL, V171, P3982, DOI 10.1128/jb.171.7.3982-3988.1989; Coffa G, 2005, BIOCHEM BIOPH RES CO, V338, P87, DOI 10.1016/j.bbrc.2005.07.185; Cristea M, 2003, LIPIDS, V38, P1275, DOI 10.1007/s11745-003-1189-3; Daiyasu H, 2000, J MOL EVOL, V51, P433, DOI 10.1007/s002390010106; de Boer HJ, 2005, J ETHNOPHARMACOL, V96, P461, DOI 10.1016/j.jep.2004.09.035; DOONAN JH, 1992, J CELL SCI, V103, P599; Fox SR, 2000, LIPIDS, V35, P23, DOI 10.1007/s11745-000-0490-5; Galagan JE, 2005, NATURE, V438, P1105, DOI 10.1038/nature04341; Garscha U, 2007, ANAL BIOCHEM, V367, P238, DOI 10.1016/j.ab.2007.04.045; Hamberg M, 2005, BIOCHEM BIOPH RES CO, V338, P169, DOI 10.1016/j.bbrc.2005.08.117; Hamberg M, 1998, J BIOL CHEM, V273, P13080, DOI 10.1074/jbc.273.21.13080; HAMBERG M, 1994, ARCH BIOCHEM BIOPHYS, V309, P77, DOI 10.1006/abbi.1994.1087; HAMBERG M, 1992, LIPIDS, V27, P487, DOI 10.1007/BF02536128; Hornsten L, 1999, J BIOL CHEM, V274, P28219, DOI 10.1074/jbc.274.40.28219; Jones MG, 2007, MICROBIOL-SGM, V153, P1, DOI 10.1099/mic.0.2006/001479-0; KOSHINO H, 1987, TETRAHEDRON LETT, V28, P73, DOI 10.1016/S0040-4039(00)95652-1; LABEQUE R, 1987, J AM CHEM SOC, V109, P2828, DOI 10.1021/ja00243a048; MAZUR P, 1990, TETRAHEDRON LETT, V31, P3837, DOI 10.1016/S0040-4039(00)97482-3; Murphy RC, 2005, ANAL BIOCHEM, V346, P1, DOI 10.1016/j.ab.2005.04.042; Nierman WC, 2005, NATURE, V438, P1151, DOI 10.1038/nature04332; Oliw EH, 1998, LIPIDS, V33, P843, DOI 10.1007/s11745-998-0280-0; Schneider C, 2007, CHEM BIOL, V14, P473, DOI 10.1016/j.chembiol.2007.04.007; Su C, 1998, J BIOL CHEM, V273, P20744, DOI 10.1074/jbc.273.33.20744; Su C, 1996, J BIOL CHEM, V271, P14112, DOI 10.1074/jbc.271.24.14112; Thuresson ED, 2001, J BIOL CHEM, V276, P10347, DOI 10.1074/jbc.M009377200; Tsitsigiannis D, 2004, EUKARYOT CELL, V3, P1398, DOI 10.1128/EC.3.6.1398-1411.2004; Tsitsigiannis DI, 2006, MOL MICROBIOL, V59, P882, DOI 10.1111/j.1365-2958.2005.05000.x; Tsitsigiannis DI, 2005, INFECT IMMUN, V73, P4548, DOI 10.1128/IAI.73.8.4548-4559.2005; Tsitsigiannis DI, 2005, MICROBIOL-SGM, V151, P1809, DOI 10.1099/mic.0.27880-0; Tsitsigiannis DI, 2004, J BIOL CHEM, V279, P11344, DOI 10.1074/jbc.M310840200; Wadman MW, 2005, LIPIDS, V40, P1163, DOI 10.1007/s11745-005-1481-2; Wilson DM, 2002, ADV EXP MED BIOL, V504, P3; WURZENBERGER M, 1984, BIOCHIM BIOPHYS ACTA, V794, P25, DOI 10.1016/0005-2760(84)90293-5; Xue T, 2004, ARCH MICROBIOL, V182, P346, DOI 10.1007/s00203-004-0707-z	41	77	84	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					34707	34718		10.1074/jbc.M705366200	http://dx.doi.org/10.1074/jbc.M705366200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17906293	hybrid			2022-12-27	WOS:000251155200013
J	Hervas-Aguilar, A; Rodriguez, JM; Tilburn, J; Arst, HN; Penalva, MA				Hervas-Aguilar, America; Rodriguez, Jose M.; Tilburn, Joan; Arst, Herbert N., Jr.; Penalva, Miguel A.			Evidence for the direct involvement of the proteasome in the proteolytic processing of the Aspergillus nidulans zinc finger transcription factor PacC	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B P105; GLYCINE-RICH REGION; CUBITUS-INTERRUPTUS; AMBIENT PH; 20S PROTEASOME; REQUIRES PHOSPHORYLATION; NUCLEAR-LOCALIZATION; BETA-TRCP; HEDGEHOG; PROTEIN	The 72-kDa zinc finger transcription factor PacC, distantly related to Ci/Gli developmental regulators, undergoes two-step proteolytic processing in response to alkaline ambient pH. "Signaling protease" cleavage of PacC(72) removes a processing-inhibitory C-terminal domain, making its truncated PacC(53) product accessible to a second "processing" protease, yielding PacC(27). Features of the processing proteolysis suggested the proteasome as a candidate protease. We constructed, using gene replacements, two missense active site mutations in preB, the Aspergillus nidulans orthologue of Saccharomyces cerevisiae PRE2 encoding the proteasome beta 5 subunit. preB1(K101A) is lethal. Viable preB2(K101R) impairs growth and, like its equivalent pre2(K108R) in yeast, impairs chymotryptic activity. pre2(K108R) and preB2(K101R) active site mutations consistently shift position of the scissile bonds when PacC is processed in S. cerevisiae and A. nidulans, respectively, indicating that PacC must be a direct substrate of the proteasome. preB2K101R leads to a 2-3-fold elevation in NimE mitotic cyclin levels but appears to result in PacC instability, suggesting an altered balance between processing and degradation. preB2(K101R) compensates the marked impairment in PacC(27) formation resulting from deletion of the processing efficiency determinant in PacC, further indicating direct proteasomal involvement in the formation of PacC(27). Deletion of a Gly-Pro- Ala-rich region within this processing efficiency determinant markedly destabilizes PacC. Arg substitutions of Lys residues within this efficiency determinant and nearby show that they cooperate to promote PacC processing. A quadruple Lys-to-Arg substitution (4K -> R) impairs formation of PacC(27) and leads to persistence of PacC(53). Wild-type PacC(53) becomes multiply phosphorylated upon alkaline pH exposure. Processing-impaired 4K -> R PacC(53) becomes excessively phosphorylated.	CSIC, Ctr Invest Biol, Dept Mol Microbiol, E-28040 Madrid, Spain; Imperial Coll London, Dept Microbiol, London SW7 2AZ, England	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Imperial College London	Penalva, MA (corresponding author), CSIC, Ctr Invest Biol, Dept Mol Microbiol, E-28040 Madrid, Spain.	penalva@cib.csic.es	Penalva, Miguel A/G-2295-2015	Penalva, Miguel A/0000-0002-3102-2806	Wellcome Trust [067878] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ALVARO J, 2003, THESIS U AUTONOMA MA; ARST HN, 1994, MOL GEN GENET, V245, P787, DOI 10.1007/BF00297286; Arst HN, 2003, TRENDS GENET, V19, P224, DOI 10.1016/S0168-9525(03)00052-0; AzaBlanc P, 1997, CELL, V89, P1043, DOI 10.1016/S0092-8674(00)80292-5; Chen P, 1996, CELL, V86, P961, DOI 10.1016/S0092-8674(00)80171-3; Chen Y, 1998, P NATL ACAD SCI USA, V95, P2349, DOI 10.1073/pnas.95.5.2349; Chen Y, 1999, DEVELOPMENT, V126, P3607; COVE DJ, 1966, BIOCHIM BIOPHYS ACTA, V113, P51, DOI 10.1016/S0926-6593(66)80120-0; DENISON SH, 1995, J BIOL CHEM, V270, P28519, DOI 10.1074/jbc.270.48.28519; Diez E, 2002, EMBO J, V21, P1350, DOI 10.1093/emboj/21.6.1350; Espeso EA, 2000, EMBO J, V19, P719, DOI 10.1093/emboj/19.4.719; Espeso EA, 1997, J MOL BIOL, V274, P466, DOI 10.1006/jmbi.1997.1428; Fernandez-Martinez J, 2003, J MOL BIOL, V334, P667, DOI 10.1016/j.jmb.2003.09.072; Groll M, 1999, P NATL ACAD SCI USA, V96, P10976, DOI 10.1073/pnas.96.20.10976; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Heinemeyer W, 1997, J BIOL CHEM, V272, P25200, DOI 10.1074/jbc.272.40.25200; Heissmeyer V, 1999, EMBO J, V18, P4766, DOI 10.1093/emboj/18.17.4766; Hoyt MA, 2006, EMBO J, V25, P1720, DOI 10.1038/sj.emboj.7601058; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Jiang J, 1998, NATURE, V391, P493, DOI 10.1038/35154; Kisselev AF, 2000, J BIOL CHEM, V275, P14831, DOI 10.1074/jbc.275.20.14831; Lee C, 2001, MOL CELL, V7, P627, DOI 10.1016/S1097-2765(01)00209-X; Lee DH, 1996, J BIOL CHEM, V271, P27280, DOI 10.1074/jbc.271.44.27280; Lee SC, 2007, MOL MICROBIOL, V63, P1039, DOI 10.1111/j.1365-2958.2006.05575.x; Li WS, 1997, GENETICS, V145, P63; Lin L, 1996, MOL CELL BIOL, V16, P2248; Lin L, 1998, CELL, V92, P819, DOI 10.1016/S0092-8674(00)81409-9; Methot N, 1999, CELL, V96, P819, DOI 10.1016/S0092-8674(00)80592-9; MIMS CW, 1988, PROTOPLASMA, V144, P132, DOI 10.1007/BF01637246; Mingot JM, 1999, MOL CELL BIOL, V19, P1390; Moorthy AK, 2006, EMBO J, V25, P1945, DOI 10.1038/sj.emboj.7601081; Nayak T, 2006, GENETICS, V172, P1557, DOI 10.1534/genetics.105.052563; Ohlmeyer JT, 1998, NATURE, V396, P749, DOI 10.1038/25533; OREJAS M, 1995, GENE DEV, V9, P1622, DOI 10.1101/gad.9.13.1622; Orian A, 2000, EMBO J, V19, P2580, DOI 10.1093/emboj/19.11.2580; Orian A, 1999, MOL CELL BIOL, V19, P3664; Osmani AH, 2006, NAT PROTOC, V1, P2517, DOI 10.1038/nprot.2006.406; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Penalva MA, 2004, ANNU REV MICROBIOL, V58, P425, DOI 10.1146/annurev.micro.58.030603.123715; PERIAS MM, 2007, EUKARYOT CELL, V6, P960; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; Prakash S, 2004, NAT STRUCT MOL BIOL, V11, P830, DOI 10.1038/nsmb814; Price MA, 2002, CELL, V108, P823, DOI 10.1016/S0092-8674(02)00664-5; Rodgers KJ, 2003, INT J BIOCHEM CELL B, V35, P716, DOI 10.1016/S1357-2725(02)00391-6; Sears C, 1998, J BIOL CHEM, V273, P1409, DOI 10.1074/jbc.273.3.1409; Smelkinson MG, 2006, CURR BIOL, V16, P110, DOI 10.1016/j.cub.2005.12.012; Staszczak M, 2005, BIOCHIMIE, V87, P755, DOI 10.1016/j.biochi.2005.03.002; Stimpson HEM, 2006, EMBO J, V25, P662, DOI 10.1038/sj.emboj.7600984; Takeuchi J, 2007, EMBO J, V26, P123, DOI 10.1038/sj.emboj.7601476; Tempe D, 2006, MOL CELL BIOL, V26, P4316, DOI 10.1128/MCB.02183-05; Tian L, 2005, NAT STRUCT MOL BIOL, V12, P1045, DOI 10.1038/nsmb1018; Tilburn J, 2005, GENETICS, V171, P393, DOI 10.1534/genetics.105.044644; TILBURN J, 1983, GENE, V26, P205, DOI 10.1016/0378-1119(83)90191-9; TILBURN J, 1995, EMBO J, V14, P779, DOI 10.1002/j.1460-2075.1995.tb07056.x; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Wang BW, 2006, P NATL ACAD SCI USA, V103, P33, DOI 10.1073/pnas.0509927103; Wu L, 1998, J CELL BIOL, V141, P1575, DOI 10.1083/jcb.141.7.1575; Xu WJ, 2001, J BACTERIOL, V183, P6917, DOI 10.1128/JB.183.23.6917-6923.2001; Zhang MS, 2003, EMBO J, V22, P1488, DOI 10.1093/emboj/cdg158; Zhang MS, 2004, J BIOL CHEM, V279, P8635, DOI 10.1074/jbc.M310449200	60	64	71	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					34735	34747		10.1074/jbc.M706723200	http://dx.doi.org/10.1074/jbc.M706723200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17911112	Green Published, hybrid			2022-12-27	WOS:000251155200016
J	Ju, ZL; Volpi, SA; Hassan, R; Martinez, N; Giannini, SL; Gold, T; Birshtein, BK				Ju, Zhongliang; Volpi, Sabrina A.; Hassan, Rabih; Martinez, Nancy; Giannini, Sandra L.; Gold, Tamar; Birshtein, Barbara K.			Evidence for physical interaction between the immunoglobulin heavy chain variable region and the 3 ' regulatory region	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GLOBIN LOCUS; B-CELLS; DNA REARRANGEMENTS; GENE-EXPRESSION; IGH LOCUS; IN-VIVO; 3' END; TRANSCRIPTION; ENHANCER; VARIANTS	B cell-specific expression of immunoglobulin heavy chain (IgH) genes utilizes two cis regulatory regions, the intronic enhancer (E mu), located in the J(H)-C mu intron, and a complex regulatory region that lies 3 ' to the IgH gene cluster, 3 ' RR. We hypothesized that the 3 ' RR is involved in IgH gene transcription in plasma cells via physical interaction between distal 3 ' RR enhancers and target V-H sequences, with loop formation by intervening DNA. In support of this hypothesis we report sequence data at DNA recombination breakpoints as evidence for loop formation preceding DNA inversion in a plasma cell line. In addition, using the chromosome conformation capture technique, physical interactions between VH and 3 ' RR were analyzed directly and detected in MPC11 plasma cells and variants and normal splenic B cells but not detected in splenic T cells or in non-B cells. V-H-3 ' RR interactions were present in the absence of E mu, but when the hs1,2 enhancer was replaced by a Neo(R) gene in a variant cell line lacking E mu, H chain expression was lost, and interactions between VH and 3 ' RR and among the 3 ' RR regulators themselves were severely disrupted. In addition, the chromosome conformation capture technique detected interactions between the myc promoter and 3 ' RR elements in MPC11, which like other plasmacytomas contains a reciprocal translocation between the c-myc and the IgH locus. In sum, our data support a hypothesis that cis V-H-3 ' RR and myc-3 ' RR interactions involve physical interactions between these DNA elements.	Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Birshtein, BK (corresponding author), Albert Einstein Coll Med, Dept Cell Biol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	birshtei@aecom.yu.edu			NCI NIH HHS [P30 CA13330, 5T32 CA09173] Funding Source: Medline; NIAID NIH HHS [AI13509, R01 AI013509] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA013330, T32CA009173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI013509, R37AI013509] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Arulampalam V, 1997, IMMUNOL TODAY, V18, P549, DOI 10.1016/S0167-5699(97)01154-7; CALVO CF, 1991, J IMMUNOL, V146, P1353; Dekker J, 2006, NAT METHODS, V3, P17, DOI 10.1038/NMETH823; Dunnick WA, 2005, J EXP MED, V201, P1459, DOI 10.1084/jem.20041988; ECKHARDT LA, 1982, P NATL ACAD SCI-BIOL, V79, P3006, DOI 10.1073/pnas.79.9.3006; ECKHARDT LA, 1985, MOL CELL BIOL, V5, P856, DOI 10.1128/MCB.5.4.856; Garrett FE, 2005, MOL CELL BIOL, V25, P1511, DOI 10.1128/MCB.25.4.1511-1525.2005; GILMORE GL, 1988, J IMMUNOL, V141, P1754; GILMORE GL, 1987, J IMMUNOL, V139, P619; GREGOR PD, 1986, MOL CELL BIOL, V6, P1903, DOI 10.1128/MCB.6.6.1903; KOSKIMIES S, 1976, NATURE, V264, P480, DOI 10.1038/264480a0; Lieberson R, 1995, EMBO J, V14, P6229, DOI 10.1002/j.1460-2075.1995.tb00313.x; Liu Z, 2005, MOL CELL BIOL, V25, P3220, DOI 10.1128/MCB.25.8.3220-3231.2005; Madisen L, 1998, MOL CELL BIOL, V18, P6281, DOI 10.1128/MCB.18.11.6281; Majumder P, 2006, J BIOL CHEM, V281, P18435, DOI 10.1074/jbc.M601298200; Manis JP, 1998, J EXP MED, V188, P1421, DOI 10.1084/jem.188.8.1421; Max E E., 2003, FUNDAMENTAL IMMUNOLO, P107; MICHAELSON JS, 1995, NUCLEIC ACIDS RES, V23, P975, DOI 10.1093/nar/23.6.975; Pinaud E, 2001, IMMUNITY, V15, P187, DOI 10.1016/S1074-7613(01)00181-9; Ragoczy T, 2006, GENE DEV, V20, P1447, DOI 10.1101/gad.1419506; Rogozin IB, 2004, J IMMUNOL, V172, P3382, DOI 10.4049/jimmunol.172.6.3382; Roldan E, 2005, NAT IMMUNOL, V6, P31, DOI 10.1038/ni1150; Saleque S, 1997, J IMMUNOL, V158, P4780; Saleque S, 1999, J IMMUNOL, V162, P2791; Sayegh C, 2005, GENE DEV, V19, P322, DOI 10.1101/gad.1254305; SCHLISSEL MS, 1991, J EXP MED, V173, P711, DOI 10.1084/jem.173.3.711; Sepulveda MA, 2005, MOL IMMUNOL, V42, P605, DOI 10.1016/j.molimm.2004.09.006; Shi XR, 2001, INT IMMUNOL, V13, P1003, DOI 10.1093/intimm/13.8.1003; Spilianakis CG, 2004, NAT IMMUNOL, V5, P1017, DOI 10.1038/ni1115; Splinter E, 2004, METHOD ENZYMOL, V375, P493; STANTON LW, 1984, P NATL ACAD SCI-BIOL, V81, P829, DOI 10.1073/pnas.81.3.829; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Vakoc CR, 2005, MOL CELL, V17, P453, DOI 10.1016/j.molcel.2004.12.028; Yang QX, 2005, MOL CELL BIOL, V25, P6021, DOI 10.1128/MCB.25.14.6021-6030.2005; ZALLER DM, 1985, P NATL ACAD SCI USA, V82, P5088, DOI 10.1073/pnas.82.15.5088; Zhang BY, 2007, J IMMUNOL, V178, P6297, DOI 10.4049/jimmunol.178.10.6297; Zhou J, 2002, P NATL ACAD SCI USA, V99, P13693, DOI 10.1073/pnas.212392399	37	40	41	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					35169	35178		10.1074/jbc.M705719200	http://dx.doi.org/10.1074/jbc.M705719200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17921139	hybrid			2022-12-27	WOS:000251155200062
J	Marques, AJ; Glanemann, C; Ramos, PC; Dohmen, J				Marques, Antonio J.; Glanemann, Christoph; Ramos, Paula C.; Dohmen, Juergen			The C-terminal extension of the beta 7 subunit and activator complexes stabilize nascent 20 S proteasomes and promote their maturation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							26S PROTEASOME; SITE FORMATION; YEAST; UBIQUITIN; DEGRADATION; COMPLETION; BIOGENESIS; CHAPERONES; EXPRESSION; RESOLUTION	The eukaryotic 20 S proteasome is formed by dimerization of two precursor complexes containing the maturation factor Ump1. beta 7/Pre4 is the only one of the 14 subunits forming the 20 S proteasome that is absent from these precursor complexes in Saccharomyces cerevisiae. Increased expression of Pre4 leads to a reduction in the level of precursor complex, indicating that Pre4 incorporation into these complexes is rate-limiting for their dimerization. When we purified these precursor complexes, we observed co-purification of Blm10, a large protein known to attach to the alpha ring surface of proteasomes. In contrast to single mutants lacking either Blm10 or the C-terminal extension of Pre4, a mutant lacking both grew extremely poorly, accumulated very high levels of precursor complexes, and was impaired in beta subunit maturation. The effect of blm10 Delta on proteasome biogenesis is modest, apparently because the 19 S regulatory particle is capable of substituting for Blm10, as long as precursor complex dimers are stabilized by the Pre4Cterminus. We found that a mutation (sen3/rpn2) affecting the Rpn2 subunit inhibits attachment of the 19 S activator to the 20 S particle or its precursors. Although the sen3 mutation alone had no apparent effect on precursor complex dimerization and active site maturation, the sen3 blm10 double mutant was impaired in these processes. Together these data demonstrate that Blm10 and the 19 S activator have a partially redundant function in stabilizing nascent 20 S proteasomes and in promoting their activation.	Univ Cologne, Inst Genet, D-50674 Cologne, Germany; Univ Algarve, Fac Ciencias & Tecnol, Dept Quim Bioquim & Farm, P-8000117 Faro, Portugal	University of Cologne; Universidade do Algarve	Dohmen, J (corresponding author), Univ Cologne, Inst Genet, Zulpicher Str 47, D-50674 Cologne, Germany.	j.dohmen@uni-koeln.de		Dohmen, R. Jurgen/0000-0002-5756-6780				Adams J, 2004, NAT REV CANCER, V4, P349, DOI 10.1038/nrc1361; Arendt CS, 1997, P NATL ACAD SCI USA, V94, P7156, DOI 10.1073/pnas.94.14.7156; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Chen P, 1996, CELL, V86, P961, DOI 10.1016/S0092-8674(00)80171-3; DEMARINI DJ, 1995, MOL CELL BIOL, V15, P6311; DeMartino GN, 2007, CELL, V129, P659, DOI 10.1016/j.cell.2007.05.007; Dohmen RJ, 2007, BBA-MOL CELL RES, V1773, P1599, DOI 10.1016/j.bbamcr.2007.05.015; Dohmen R. Jurgen, 2005, V301, P243; Fehlker M, 2003, EMBO REP, V4, P959, DOI 10.1038/sj.embor.embor938; Glickman MH, 1998, CELL, V94, P615, DOI 10.1016/S0092-8674(00)81603-7; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Hanna J, 2007, FEBS LETT, V581, P2854, DOI 10.1016/j.febslet.2007.03.053; Heinemeyer W, 2004, CELL MOL LIFE SCI, V61, P1562, DOI 10.1007/s00018-004-4130-z; Heinemeyer W, 1997, J BIOL CHEM, V272, P25200, DOI 10.1074/jbc.272.40.25200; Hirano Y, 2006, MOL CELL, V24, P977, DOI 10.1016/j.molcel.2006.11.015; Hughes TR, 2000, NAT GENET, V25, P333, DOI 10.1038/77116; Iwanczyk J, 2006, J MOL BIOL, V363, P648, DOI 10.1016/j.jmb.2006.08.010; Kruger E, 2001, BIOCHIMIE, V83, P289, DOI 10.1016/S0300-9084(01)01241-X; Le Tallec B, 2007, MOL CELL, V27, P660, DOI 10.1016/j.molcel.2007.06.025; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Lehmann A, 2002, J MOL BIOL, V317, P401, DOI 10.1006/jmbi.2002.5443; Li X, 2007, EMBO J, V26, P2339, DOI 10.1038/sj.emboj.7601681; London MK, 2004, FEBS LETT, V567, P259, DOI 10.1016/j.febslet.2004.04.078; Mannhaupt G, 1999, FEBS LETT, V450, P27, DOI 10.1016/S0014-5793(99)00467-6; Mullapudi S, 2004, BIOPHYS J, V87, P4098, DOI 10.1529/biophysj.104.051144; Nandi D, 1997, EMBO J, V16, P5363, DOI 10.1093/emboj/16.17.5363; NEUHOFF V, 1990, ELECTROPHORESIS, V11, P101, DOI 10.1002/elps.1150110202; Palanimurugan R, 2004, EMBO J, V23, P4857, DOI 10.1038/sj.emboj.7600473; Ramos PC, 2004, J BIOL CHEM, V279, P14323, DOI 10.1074/jbc.M308757200; Ramos PC, 1998, CELL, V92, P489, DOI 10.1016/S0092-8674(00)80942-3; Realini C, 1997, J BIOL CHEM, V272, P25483, DOI 10.1074/jbc.272.41.25483; Reed SH, 2007, DNA REPAIR, V6, P149, DOI 10.1016/j.dnarep.2006.10.026; Schmidt M, 2005, NAT STRUCT MOL BIOL, V12, P294, DOI 10.1038/nsmb914; Unno M, 2002, STRUCTURE, V10, P609, DOI 10.1016/S0969-2126(02)00748-7; Ustrell V, 2002, EMBO J, V21, P3516, DOI 10.1093/emboj/cdf333; Whitby FG, 2000, NATURE, V408, P115, DOI 10.1038/35040607; Witt S, 2006, STRUCTURE, V14, P1179, DOI 10.1016/j.str.2006.05.019; Xie YM, 2001, P NATL ACAD SCI USA, V98, P3056, DOI 10.1073/pnas.071022298	38	71	77	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					34869	34876		10.1074/jbc.M705836200	http://dx.doi.org/10.1074/jbc.M705836200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17911101	Green Published, hybrid			2022-12-27	WOS:000251155200029
J	Merino, E; Sanjuan, MA; Moraga, I; Cipres, A; Merida, I				Merino, Ernesto; Sanjuan, Miguel A.; Moraga, Ignacio; Cipres, Angel; Merida, Isabel			Role of the diacylglycerol kinase alpha-conserved domains in membrane targeting in intact T cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-CLONING; INDUCED TRANSLOCATION; BINDING DOMAIN; C-DELTA; ACTIVATION; PROTEIN; SPHINGOSINE; HOMOLOGY; CALCIUM; ENZYME	Diacylglycerol kinase (DGK) phosphorylates diacylglycerol to phosphatidic acid, modifying the cellular levels of these two lipid mediators. Ten DGK isoforms, grouped into five subtypes, are found in higher organisms. All contain a conserved C-terminal domain and at least two cysteine-rich motifs of unknown function. DGK alpha is a type I enzyme that acts as a negative modulator of diacylglycerol-based signals during T cell activation. Here we studied the functional role of the DGK alpha domains using mutation alanalysis to investigate membrane binding in intact cells. We show that the two atypical C1domains are essential for plasma membrane targeting of the protein in intact cells but unnecessary for catalytic activity. We also identify the C-terminal sequence of the protein as essential for membrane binding in a phosphatidic acid-dependent manner. Finally we demonstrate that, in the absence of the calcium binding domain, receptor-dependent translocation of the truncated protein is regulated by phosphorylation of Tyr(335). This functional study provides new insight into the role of the so-called conserved domains of this lipid kinase family and demonstrates the existence of additional domains that confer specific plasma membrane localization to this particular isoform.	Ctr Nacl Biotecnol, Dept Immunol & Oncol, Consejo Super Invest Cient, E-28049 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Merida, I (corresponding author), Ctr Nacl Biotecnol, Dept Immunol & Oncol, Consejo Super Invest Cient, E-28049 Madrid, Spain.	imerida@cnb.uam.es	Sanjuán, Miguel Ángel/I-6896-2019; Ciprés, Ángel/ABH-6863-2020; Merida, Isabel/A-9713-2014	Sanjuán, Miguel Ángel/0000-0001-6694-0634; Merida, Isabel/0000-0003-2762-6241; Cipres, Angel/0000-0001-7086-2704; Moraga, Ignacio/0000-0001-9909-0701				Abe T, 2003, BIOCHEM J, V375, P673, DOI 10.1042/BJ20031052; BESTERMAN JM, 1986, P NATL ACAD SCI USA, V83, P9378, DOI 10.1073/pnas.83.24.9378; Caricasole A, 2002, J BIOL CHEM, V277, P4790, DOI 10.1074/jbc.M110249200; Cipres A, 2003, J BIOL CHEM, V278, P35629, DOI 10.1074/jbc.M305635200; Delon C, 2004, J BIOL CHEM, V279, P44763, DOI 10.1074/jbc.M405771200; DESAI DM, 1990, NATURE, V348, P66, DOI 10.1038/348066a0; Drugan JK, 1996, J BIOL CHEM, V271, P233, DOI 10.1074/jbc.271.1.233; Flores I, 1996, J BIOL CHEM, V271, P10334, DOI 10.1074/jbc.271.17.10334; Fukunaga-Takenaka R, 2005, GENES CELLS, V10, P311, DOI 10.1111/j.1365-2443.2005.00842.x; Ghosh S, 2003, J BIOL CHEM, V278, P45690, DOI 10.1074/jbc.M302933200; Goto K, 1996, P NATL ACAD SCI USA, V93, P11196, DOI 10.1073/pnas.93.20.11196; Houssa B, 1999, J BIOL CHEM, V274, P6820, DOI 10.1074/jbc.274.11.6820; Houssa B, 1997, J BIOL CHEM, V272, P10422; Hurley JH, 2000, ANNU REV BIOPH BIOM, V29, P49, DOI 10.1146/annurev.biophys.29.1.49; Hurley JH, 1997, PROTEIN SCI, V6, P477; Jiang Y, 2000, J BIOL CHEM, V275, P34092, DOI 10.1074/jbc.M004914200; Jones DR, 2002, FASEB J, V16, P595, DOI 10.1096/fj.01-0762fje; Kohama T, 1998, J BIOL CHEM, V273, P23722, DOI 10.1074/jbc.273.37.23722; Los AP, 2007, BBA-MOL CELL RES, V1773, P352, DOI 10.1016/j.bbamcr.2006.12.004; MARONEY AC, 1989, J BIOL CHEM, V264, P2537; Nelson CD, 2007, SCIENCE, V315, P663, DOI 10.1126/science.1134562; Olenchock BA, 2006, NAT IMMUNOL, V7, P1174, DOI 10.1038/ni1400; Pitson SM, 2000, J BIOL CHEM, V275, P33945, DOI 10.1074/jbc.M006176200; SAKANE F, 1991, J BIOL CHEM, V266, P7096; Sakane F, 1996, BIOCHEM J, V318, P583, DOI 10.1042/bj3180583; Sanders CR, 1996, BIOCHEMISTRY-US, V35, P8610, DOI 10.1021/bi9604892; Sanjuan MA, 2003, J IMMUNOL, V170, P2877, DOI 10.4049/jimmunol.170.6.2877; Sanjuan MA, 2001, J CELL BIOL, V153, P207, DOI 10.1083/jcb.153.1.207; Santos T, 2002, J BIOL CHEM, V277, P30300, DOI 10.1074/jbc.M200999200; Shirai Y, 2000, J BIOL CHEM, V275, P24760, DOI 10.1074/jbc.M003151200; Stahelin RV, 2005, J BIOL CHEM, V280, P43030, DOI 10.1074/jbc.M507574200; Stahelin RV, 2005, J BIOL CHEM, V280, P19784, DOI 10.1074/jbc.M411285200; Sugiura M, 2002, J BIOL CHEM, V277, P23294, DOI 10.1074/jbc.M201535200; Topham MK, 2006, J CELL BIOCHEM, V97, P474, DOI 10.1002/jcb.20704; Topham MK, 1998, NATURE, V394, P697, DOI 10.1038/29337; van Baal J, 2005, J BIOL CHEM, V280, P9870, DOI 10.1074/jbc.M409301200; Wattenberg BW, 2006, J LIPID RES, V47, P1128, DOI 10.1194/jlr.R600003-JLR200; Yakubchyk Y, 2005, MOL CELL BIOL, V25, P7289, DOI 10.1128/MCB.25.16.7289-7302.2005; Yasuda S, 2007, FEBS LETT, V581, P551, DOI 10.1016/j.febslet.2007.01.022; ZHANG GG, 1995, CELL, V81, P917, DOI 10.1016/0092-8674(95)90011-X	40	33	36	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					35396	35404		10.1074/jbc.M702085200	http://dx.doi.org/10.1074/jbc.M702085200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17911109	hybrid			2022-12-27	WOS:000251155200082
J	Ryoo, SR; Jeong, HK; Radnaabazar, C; Yoo, JJ; Cho, HJ; Lee, HW; Kim, IS; Cheon, YH; Ahn, YS; Chung, SH; Song, WJ				Ryoo, Soo-Ryoon; Jeong, Hey Kyeong; Radnaabazar, Chinzorig; Yoo, Jin-Ju; Cho, Hyun-Jeong; Lee, Hye-Won; Kim, In-Sook; Cheon, Young-Hee; Ahn, Young Soo; Chung, Sul-Hee; Song, Woo-Joo			DYRK1A-mediated hyperphosphorylation of Tau - A functional link between Down syndrome and Alzheimer disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNDROME CRITICAL REGION; PROTEIN-TAU; HUMAN HOMOLOG; MOUSE MODEL; ABNORMAL PHOSPHORYLATION; KINASE; MINIBRAIN; DYRK1A; EXPRESSION; MICE	Most individuals with Down syndrome show early onset of Alzheimer disease (AD), resulting from the extra copy of chromosome 21. Located on this chromosome is a gene that encodes the dual specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A). One of the pathological hallmarks in AD is the presence of neurofibrillary tangles (NFTs), which are insoluble deposits that consist of abnormally hyperphosphorylated Tau. Previously it was reported that Tau at the Thr-212 residue was phosphorylated by Dyrk1A in vitro. To determine the physiological significance of this phosphorylation, an analysis was made of the amount of phospho-Thr-212- Tau (pT212) in the brains of transgenic mice that over-express the human DYRK1A protein ( DYRK1A TG mice) that we recently generated. A significant increase in the amount of pT212 was found in the brains of DYRK1A transgenic mice when compared with age-matched littermate controls. We further examined whether Dyrk1A phosphorylates other Tau residues that are implicated in NFTs. We found that Dyrk1A also phosphorylates Tau at Ser-202 and Ser-404 in vitro. Phosphorylation by Dyrk1A strongly inhibited the ability of Tau to promote microtubule assembly. Following this, using mammalian cells and DYRK1A TG mouse brains, it was demonstrated that the amounts of phospho-Ser-202-Tau and phospho-Ser-404-Tau are enhanced when DYRK1A amounts are high. These results provide the first in vivo evidence for a physiological role of DYRK1A in the hyperphosphorylation of Tau and suggest that the extra copy of the DYRK1A gene contributes to the early onset of AD.	Inje Univ, Grad Program Neurosci, Inst Brain Sci & Technol, Pusan 614735, South Korea; Yonsei Univ, Coll Med, Brain Korea 21 Project Med Sci, Brain Res Inst, Seoul 120749, South Korea; Yonsei Univ, Coll Med, Dept Pharmacol, Seoul 120749, South Korea; Eulji Univ, Sch Med, Dept Anat & Neurosci, Taejon 301832, South Korea	Inje University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Eulji University	Chung, SH (corresponding author), Inje Univ, Grad Program Neurosci, Inst Brain Sci & Technol, 633-146 Gaegeum 2 Dong, Pusan 614735, South Korea.	sulchung@inje.ac.kr; wjsong@inje.ac.kr		Ryoo, Soo-Ryoon/0000-0003-2798-0443				Abraha A, 2000, J CELL SCI, V113, P3737; Ahn KJ, 2006, NEUROBIOL DIS, V22, P463, DOI 10.1016/j.nbd.2005.12.006; Alonso AD, 2006, P NATL ACAD SCI USA, V103, P8864, DOI 10.1073/pnas.0603214103; Altafaj X, 2001, HUM MOL GENET, V10, P1915, DOI 10.1093/hmg/10.18.1915; Augustinack JC, 2002, ACTA NEUROPATHOL, V103, P26, DOI 10.1007/s004010100423; Bielska AA, 2006, BIOCHEMISTRY-US, V45, P5527, DOI 10.1021/bi052662c; BRAAK E, 1994, ACTA NEUROPATHOL, V87, P554, DOI 10.1007/s004010050124; BURGER PC, 1973, AM J PATHOL, V73, P457; CAMPBELL S K, 1987, Society for Neuroscience Abstracts, V13, P678; Cataldo AM, 2003, J NEUROSCI, V23, P6788; Ding HP, 2006, J BIOL CHEM, V281, P19107, DOI 10.1074/jbc.M511697200; Duff K, 2005, NAT MED, V11, P826, DOI 10.1038/nm0805-826; Ferrer I, 2005, NEUROBIOL DIS, V20, P392, DOI 10.1016/j.nbd.2005.03.020; Fotaki V, 2002, MOL CELL BIOL, V22, P6636, DOI 10.1128/MCB.22.18.6636-6647.2002; Galceran J, 2003, J NEURAL TRANSM-SUPP, P139; GALLYAS F, 1971, ACTA MORPHOL HUNG, V19, P1; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Guimera J, 1999, GENOMICS, V57, P407, DOI 10.1006/geno.1999.5775; Guimera J, 1996, HUM MOL GENET, V5, P1305, DOI 10.1093/hmg/5.9.1305; Hammerle B, 2003, EUR J NEUROSCI, V17, P2277, DOI 10.1046/j.1460-9568.2003.02665.x; Himpel S, 2000, J BIOL CHEM, V275, P2431, DOI 10.1074/jbc.275.4.2431; JACOBS PA, 1959, LANCET, V1, P710; Johnson GVW, 2004, J CELL SCI, V117, P5721, DOI 10.1242/jcs.01558; Kentrup H, 1996, J BIOL CHEM, V271, P3488; KOPKE E, 1993, J BIOL CHEM, V268, P24374; KORENBERG JR, 1994, P NATL ACAD SCI USA, V91, P4997, DOI 10.1073/pnas.91.11.4997; KSIEZAKREDING H, 1992, BRAIN RES, V597, P209, DOI 10.1016/0006-8993(92)91476-U; LEJEUNE J, 1959, CR HEBD ACAD SCI, V248, P1721; Lochhead PA, 2005, CELL, V121, P925, DOI 10.1016/j.cell.2005.03.034; Marti E, 2003, BRAIN RES, V964, P250, DOI 10.1016/S0006-8993(02)04069-6; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Necula M, 2005, FEBS LETT, V579, P1453, DOI 10.1016/j.febslet.2005.01.047; Rahmani Z, 1998, BIOCHEM BIOPH RES CO, V253, P514, DOI 10.1006/bbrc.1998.9803; Rankin CA, 2005, MOL BRAIN RES, V138, P84, DOI 10.1016/j.molbrainres.2005.04.012; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; Shindoh N, 1996, BIOCHEM BIOPH RES CO, V225, P92, DOI 10.1006/bbrc.1996.1135; Smith DJ, 1997, NAT GENET, V16, P28, DOI 10.1038/ng0597-28; Song WJ, 1996, GENOMICS, V38, P331, DOI 10.1006/geno.1996.0636; Spires TL, 2006, AM J PATHOL, V168, P1598, DOI 10.2353/ajpath.2006.050840; Walsh DM, 2004, NEURON, V44, P181, DOI 10.1016/j.neuron.2004.09.010; Woods YL, 2001, BIOCHEM J, V355, P609, DOI 10.1042/bj3550609; Yoshida H, 2004, J NEUROCHEM, V90, P352, DOI 10.1111/j.1471-4159.2004.02479.x	43	172	178	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					34850	34857		10.1074/jbc.M707358200	http://dx.doi.org/10.1074/jbc.M707358200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17906291	hybrid			2022-12-27	WOS:000251155200027
J	Youn, MY; Yoo, HS; Kim, MJ; Hwang, SY; Choi, Y; Desiderio, SV; Yoo, JY				Youn, Min-Young; Yoo, Hyun-Seok; Kim, Min-Jung; Hwang, Sun-Young; Choi, Yongwook; Desiderio, Stephen V.; Yoo, Joo-Yeon			hCTR9, a component of Paf1 complex, participates in the transcription of interleukin 6-responsive genes through regulation of STAT3-DNA interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; ACUTE-PHASE RESPONSE; HISTONE METHYLATION; IN-VIVO; SACCHAROMYCES-CEREVISIAE; ELONGATION COMPLEX; EXPRESSION; YEAST; PROTEIN; PROMOTER	PAF, which is composed of Paf1, Cdc73, Ctr9, Leo1, and Rtf1, is a novel complex with multiple functions in transcription-related activities. The PAF complex interacts with histone-modifying enzymes and RNA polymerase II to regulate transcription. With general transcription regulatory potential in yeast, Hyrax/ Cdc73 has been reported to associate with beta-catenin to control Wnt/Wg signal-specific transcription in Drosophila. Here, we present the first evidence of IL-6 signal-specific transcriptional regulation by SH2BP1/CTR9 in mammals. Upon LPS injection of mice, we observed transient induction of the mammalian PAF complex in the liver. Inhibition of CTR9 specifically abrogated expression of IL-6-responsive genes, but had no effect on genes constitutively expressed or induced by interferon-beta, TNF alpha, or IL-1 beta. The PAF complex was found in the promoter regions of IL-6-responsive HP and FGG gamma, but not in the promoter region of constitutively active GAPDH. Transcriptional activation by STAT3 was inhibited when CTR9 siRNA was introduced, whereas transcriptional activation was enhanced by mCtr9 overexpression. IL-6-activated Stat3 was found to co-localize and interact with CTR9. In CTR9-depleted cells, decreased STAT3 association with the promoter regions, as well as impaired K4-trimethylation of histone H3 in the coding regions, of target genes was observed. These data suggest that CTR9 participates in the transcription of IL-6-responsive genes through the regulation of DNA association of STAT3 and modification of histone methylation.	Pohang Univ Sci & Technol, Dept Life Sci, Pohang 790784, South Korea; Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA	Pohang University of Science & Technology (POSTECH); Johns Hopkins University	Yoo, JY (corresponding author), Pohang Univ Sci & Technol, Dept Life Sci, Pohang 790784, South Korea.	jyoo@postech.ac.kr			NHLBI NIH HHS [R01HL07391] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adelman K, 2006, MOL CELL BIOL, V26, P250, DOI 10.1128/MCB.26.1.250-260.2006; AKIRA S, 1994, CELL, V77, P63, DOI 10.1016/0092-8674(94)90235-6; Betz JL, 2002, MOL GENET GENOMICS, V268, P272, DOI 10.1007/s00438-002-0752-8; He YH, 2004, GENE DEV, V18, P2774, DOI 10.1101/gad.1244504; Kamimura D, 2004, REV PHYSIOL BIOCH P, V149, P1, DOI 10.1007/s10254-003-0012-2; Koch C, 1999, NUCLEIC ACIDS RES, V27, P2126, DOI 10.1093/nar/27.10.2126; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; Laribee RN, 2005, CURR BIOL, V15, P1487, DOI 10.1016/j.cub.2005.07.028; MACKIEWICZ A, 1992, J IMMUNOL, V149, P2021; Malek SN, 1996, J BIOL CHEM, V271, P6952, DOI 10.1074/jbc.271.12.6952; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Mosimann C, 2006, CELL, V125, P327, DOI 10.1016/j.cell.2006.01.053; Mueller CL, 2004, MOL CELL, V14, P447, DOI 10.1016/S1097-2765(04)00257-6; Mueller CL, 2002, MOL CELL BIOL, V22, P1971, DOI 10.1128/MCB.22.7.1971-1980.2002; Ng HH, 2003, J BIOL CHEM, V278, P33625, DOI 10.1074/jbc.C300270200; Penheiter KL, 2005, MOL CELL, V20, P213, DOI 10.1016/j.molcel.2005.08.023; Pokholok DK, 2002, MOL CELL, V9, P799, DOI 10.1016/S1097-2765(02)00502-6; Porter SE, 2002, EUKARYOT CELL, V1, P830, DOI 10.1128/EC.1.5.830-842.2002; Ramadori G, 1999, SEMIN LIVER DIS, V19, P141, DOI 10.1055/s-2007-1007106; Rozenblatt-Rosen O, 2005, MOL CELL BIOL, V25, P612, DOI 10.1128/MCB.25.2.612-620.2005; SCHINDLER C, 1995, ANNU REV BIOCHEM, V64, P621, DOI 10.1146/annurev.bi.64.070195.003201; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Sheldon KE, 2005, MOL CELL, V20, P225, DOI 10.1016/j.molcel.2005.08.026; Shi XM, 1996, MOL CELL BIOL, V16, P669; Shi XM, 1997, MOL CELL BIOL, V17, P1160, DOI 10.1128/MCB.17.3.1160; Squazzo SL, 2002, EMBO J, V21, P1764, DOI 10.1093/emboj/21.7.1764; Szak ST, 2001, MOL CELL BIOL, V21, P3375, DOI 10.1128/MCB.21.10.3375-3386.2001; Wade PA, 1996, PROTEIN EXPRES PURIF, V8, P85, DOI 10.1006/prep.1996.0077; Wood A, 2003, J BIOL CHEM, V278, P34739, DOI 10.1074/jbc.C300269200; Yart A, 2005, MOL CELL BIOL, V25, P5052, DOI 10.1128/MCB.25.12.5052-5060.2005; Yoo JY, 2003, P NATL ACAD SCI USA, V100, P1157, DOI 10.1073/pnas.0336385100; Zauberman A, 2001, J BIOL CHEM, V276, P24719, DOI 10.1074/jbc.M005813200; Zhang ZX, 2000, BLOOD, V96, P3466, DOI 10.1182/blood.V96.10.3466.h8003466_3466_3472; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422; Zhu B, 2005, GENE DEV, V19, P1668, DOI 10.1101/gad.1292105	35	25	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					34727	34734		10.1074/jbc.M705411200	http://dx.doi.org/10.1074/jbc.M705411200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17911113	hybrid			2022-12-27	WOS:000251155200015
J	Evans, PM; Zhang, W; Chen, X; Yang, J; Bhakat, KK; Liu, CM				Evans, Paul M.; Zhang, Wen; Chen, Xi; Yang, Jun; Bhakat, Kishor K.; Liu, Chunming			Krurppel-like factor 4 is acetylated by p300 and regulates gene transcription via modulation of histone acetylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KRUPPEL-LIKE FACTOR; TUMOR-SUPPRESSOR GENE; CHAIN FATTY-ACIDS; CANCER CELL-LINE; BETA-CATENIN; COLON-CANCER; DNA-BINDING; ENTEROCYTE DIFFERENTIATION; COACTIVATORS P300; EPITHELIAL-CELLS	Colon cancer is the second leading cause of cancer death in the United States. Kruppel-like factor 4 (KLF4) is a transcription factor involved in both proliferation and differentiation in the colon. It is down-regulated in both mouse and human colonic adenomas and has been implicated as a tumor suppressor in the gut, whereas in breast cancer, KLF4 is an oncogene. KLF4 is also involved in reprogramming differentiated cells into pluripotent stem cells. KLF4 can act as a transcriptional activator or repressor, but the underlying mechanisms are poorly understood. We found that p300, a CREB-binding protein-related protein, interacts with KLF4 both in vitro and in vivo and activates transcription. We further made the novel observation that endogenous KLF4 is acetylated by p300/CBP in vivo and that mutations of the acetylated lysines resulted in a decreased ability of KLF4 to activate target genes, suggesting that acetylation is important for KLF4-mediated transactivation. Furthermore, we found that KLF4 differentially modulates histone H4 acetylation at the promoters of target genes. Co-transfection of KLF4 and HDAC3 resulted in a synergistic repression of a cyclin B-1 reporter construct. Our results suggest that KLF4 might function as an activator or repressor of transcription depending on whether it interacts with co-activators such as p300 and CREB-binding protein or co-repressors such as HDAC3.	Univ Texas Galveston, Med Branch, Dept Biochem & Mol Biol, Sealy Ctr Canc Cell Biol, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston	Liu, CM (corresponding author), Univ Texas Galveston, Med Branch, Dept Biochem & Mol Biol, Sealy Ctr Canc Cell Biol, Galveston, TX 77555 USA.	chliu@utmb.edu	Bhakat, Kishor/C-8072-2012	Evans, Paul/0000-0002-5981-7117	NATIONAL CANCER INSTITUTE [R21CA112007, T32CA117834] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071976] Funding Source: NIH RePORTER; NCI NIH HHS [R21 CA 112007, T32 CA 117834] Funding Source: Medline; NIDDK NIH HHS [R01 DK071976, R01 DK 071976, R01 DK071976-01A2] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALLFREY VG, 1964, P NATL ACAD SCI USA, V51, P786, DOI 10.1073/pnas.51.5.786; An W, 2004, CELL, V117, P735, DOI 10.1016/j.cell.2004.05.009; Barlev NA, 2001, MOL CELL, V8, P1243, DOI 10.1016/S1097-2765(01)00414-2; Basson MD, 1998, P SOC EXP BIOL MED, V217, P476, DOI 10.3181/00379727-217-44261; Bhakat KK, 2004, NUCLEIC ACIDS RES, V32, P3033, DOI 10.1093/nar/gkh632; Chan HM, 2001, J CELL SCI, V114, P2363; Daly K, 2006, DNA CELL BIOL, V25, P49, DOI 10.1089/dna.2006.25.49; Dang DT, 2000, FEBS LETT, V476, P203, DOI 10.1016/S0014-5793(00)01727-0; Daniels DL, 2002, MOL CELL, V10, P573, DOI 10.1016/S1097-2765(02)00631-7; Dormeyer W, 2005, METHODS, V36, P376, DOI 10.1016/j.ymeth.2005.03.006; ECKNER R, 1994, GENE DEV, V8, P869, DOI 10.1101/gad.8.8.869; Evans PM, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-22; Foster KW, 1999, CELL GROWTH DIFFER, V10, P423; Foster KW, 2000, CANCER RES, V60, P6488; GarrettSinha LA, 1996, J BIOL CHEM, V271, P31384, DOI 10.1074/jbc.271.49.31384; Geiman DE, 2000, NUCLEIC ACIDS RES, V28, P1106, DOI 10.1093/nar/28.5.1106; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; HEERDT BG, 1994, CANCER RES, V54, P3288; Hinnebusch BF, 2004, AM J PHYSIOL-GASTR L, V286, pG23, DOI 10.1152/ajpgi.00203.2003; Katz JP, 2005, GASTROENTEROLOGY, V128, P935, DOI 10.1053/j.gastro.2005.02.022; Katz JP, 2002, DEVELOPMENT, V129, P2619; Lee CH, 1999, P NATL ACAD SCI USA, V96, P12311, DOI 10.1073/pnas.96.22.12311; Levy L, 2004, MOL CELL BIOL, V24, P3404, DOI 10.1128/MCB.24.8.3404-3414.2004; Li D, 2005, CANCER RES, V65, P9216, DOI 10.1158/0008-5472.CAN-05-1040; LUNDBLAD JR, 1995, NATURE, V374, P85, DOI 10.1038/374085a0; Luo JY, 2004, P NATL ACAD SCI USA, V101, P2259, DOI 10.1073/pnas.0308762101; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Nakano K, 1997, J BIOL CHEM, V272, P22199, DOI 10.1074/jbc.272.35.22199; Nowak DE, 2005, BIOTECHNIQUES, V39, P715, DOI 10.2144/000112014; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Pandya AY, 2004, CLIN CANCER RES, V10, P2709, DOI 10.1158/1078-0432.CCR-03-0484; Rowland BD, 2006, NAT REV CANCER, V6, P11, DOI 10.1038/nrc1780; Rowland BD, 2005, NAT CELL BIOL, V7, P1074, DOI 10.1038/ncb1314; Schiltz RL, 1999, J BIOL CHEM, V274, P1189, DOI 10.1074/jbc.274.3.1189; Segre JA, 1999, NAT GENET, V22, P356, DOI 10.1038/11926; Shields JM, 1996, J BIOL CHEM, V271, P20009, DOI 10.1074/jbc.271.33.20009; Siddique A, 2003, J GASTROINTEST SURG, V7, P1053, DOI 10.1016/j.gassur.2003.09.006; Sowa Y, 1997, BIOCHEM BIOPH RES CO, V241, P142, DOI 10.1006/bbrc.1997.7786; Sui GC, 2004, CELL, V117, P859, DOI 10.1016/j.cell.2004.06.004; Swamynathan SK, 2007, MOL CELL BIOL, V27, P182, DOI 10.1128/MCB.00846-06; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; VAN LC, 1996, GENE EXPRESSION, V5, P245; Wang QD, 2001, GASTROENTEROLOGY, V120, P1381, DOI 10.1053/gast.2001.24044; Wang R, 2005, J BIOL CHEM, V280, P11528, DOI 10.1074/jbc.M413930200; Wei DY, 2006, CARCINOGENESIS, V27, P23, DOI 10.1093/carcin/bgi243; Wei XL, 2007, CANCER RES, V67, P1853, DOI 10.1158/0008-5472.CAN-06-3063; Yoon HS, 2004, J BIOL CHEM, V279, P5035, DOI 10.1074/jbc.M307631200; Yuan ZL, 2005, SCIENCE, V307, P269, DOI 10.1126/science.1105166; Zhang W, 2006, MOL CELL BIOL, V26, P2055, DOI 10.1128/MCB.26.6.2055-2064.2006; Zhang WJ, 1998, P NATL ACAD SCI USA, V95, P9855, DOI 10.1073/pnas.95.17.9855; Zhang WJ, 2001, MOL CELL BIOL, V21, P2413, DOI 10.1128/MCB.21.7.2413-2422.2001; Zhang WQ, 2000, J BIOL CHEM, V275, P18391, DOI 10.1074/jbc.C000062200; Zhao WD, 2004, ONCOGENE, V23, P395, DOI 10.1038/sj.onc.1207067	53	159	173	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2007	282	47					33994	34002		10.1074/jbc.M701847200	http://dx.doi.org/10.1074/jbc.M701847200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234FI	17908689	hybrid			2022-12-27	WOS:000251145700013
J	Shieh, HS; Mathis, KJ; Williams, JM; Hills, RL; Wiese, JF; Benson, TE; Kiefer, JR; Marino, MH; Carroll, JN; Leone, JW; Malfait, AM; Arner, EC; Tortorella, MD; Tomasselli, A				Shieh, Huey-Sheng; Mathis, Karl J.; Williams, Jennifer M.; Hills, Robert L.; Wiese, Joe F.; Benson, Timothy E.; Kiefer, James R.; Marino, Margaret H.; Carroll, Jeffery N.; Leone, Joseph W.; Malfait, Anne-Marie; Arner, Elizabeth C.; Tortorella, Micky D.; Tomasselli, Alfredo			High resolution crystal structure of the catalytic domain of ADAMTS-5 (aggrecanase-2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VENOM METALLOPROTEINASE; SNAKE-VENOM; OSTEOARTHRITIS; INHIBITOR; SUBSTRATE; CLEAVAGE; CLONING; FAMILY	Aggrecanase-2 (a disintegrin and metalloproteinase with thrombospondin motifs- 5 (ADAMTS-5)), a member of the ADAMTS protein family, is critically involved in arthritic diseases because of its direct role in cleaving the cartilage component aggrecan. The catalytic domain of aggrecanase-2 has been refolded, purified, and crystallized, and its three-dimensional structure determined to 1.4 angstrom resolution in the presence of an inhibitor. A high resolution structure of an ADAMTS/aggrecanase protein provides an opportunity for the development of therapeutics to treat osteoarthritis.	[Shieh, Huey-Sheng; Mathis, Karl J.; Williams, Jennifer M.; Hills, Robert L.; Wiese, Joe F.; Benson, Timothy E.; Kiefer, James R.; Marino, Margaret H.; Carroll, Jeffery N.; Leone, Joseph W.; Malfait, Anne-Marie; Arner, Elizabeth C.; Tomasselli, Alfredo] Pfizer Global Res & Dev, St Louis, MO 63017 USA	Pfizer	Tortorella, MD (corresponding author), Pfizer Global Res & Dev, 700 Chesterfield Pkwy, Chesterfield, MO 63017 USA.	micky.d.tortorella@pfizer.com		Malfait, Anne-Marie/0000-0003-1428-0384; Benson, Timothy/0000-0001-8633-2142; Kiefer, James/0000-0001-6317-0902				Abbaszade I, 1999, J BIOL CHEM, V274, P23443, DOI 10.1074/jbc.274.33.23443; BRUNGER AT, 1987, SCIENCE, V235, P458, DOI 10.1126/science.235.4787.458; Cirilli M, 1997, FEBS LETT, V418, P319, DOI 10.1016/S0014-5793(97)01401-4; COPELAND RA, ENZYMES, P310; GERHARDT S, 2007, T 53 ANN M ORTH RES, V32; Glasson SS, 2004, ARTHRITIS RHEUM-US, V50, P2547, DOI 10.1002/art.20558; Glasson SS, 2005, NATURE, V434, P644, DOI 10.1038/nature03369; Gomis-Ruth FX, 2003, MOL BIOTECHNOL, V24, P157, DOI 10.1385/MB:24:2:157; GOMISRUTH FX, 1993, EMBO J, V12, P4151, DOI 10.1002/j.1460-2075.1993.tb06099.x; Gong WM, 1998, J MOL BIOL, V283, P657, DOI 10.1006/jmbi.1998.2110; Hills R, 2007, J BIOL CHEM, V282, P11101, DOI 10.1074/jbc.M611588200; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kashiwagi M, 2001, J BIOL CHEM, V276, P12501, DOI 10.1074/jbc.C000848200; Lovejoy B, 1999, NAT STRUCT BIOL, V6, P217; Maskos K, 1998, P NATL ACAD SCI USA, V95, P3408, DOI 10.1073/pnas.95.7.3408; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Orth P, 2004, J MOL BIOL, V335, P129, DOI 10.1016/j.jmb.2003.10.037; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; St John RJ, 1999, P NATL ACAD SCI USA, V96, P13029, DOI 10.1073/pnas.96.23.13029; Stanton H, 2005, NATURE, V434, P648, DOI 10.1038/nature03417; Tortorella MD, 2000, J BIOL CHEM, V275, P18566, DOI 10.1074/jbc.M909383199; Tortorella MD, 2002, MATRIX BIOL, V21, P499, DOI 10.1016/S0945-053X(02)00069-0; Tortorella MD, 1999, SCIENCE, V284, P1664, DOI 10.1126/science.284.5420.1664; ZHANG DC, 1994, P NATL ACAD SCI USA, V91, P8447, DOI 10.1073/pnas.91.18.8447; 1994, ACTA CRYSTALLOGR A, V50, P760	26	60	61	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1501	1507		10.1074/jbc.M705879200	http://dx.doi.org/10.1074/jbc.M705879200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	17991750	hybrid			2022-12-27	WOS:000252282700034
J	Xu, YJ; Johansson, M; Karlsson, A				Xu, Yunjian; Johansson, Magnus; Karlsson, Anna			Human UMP-CMP kinase 2, a novel nucleoside monophosphate kinase localized in mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEOXYCYTIDINE ANALOG MONOPHOSPHATES; DNA DEPLETION SYNDROME; HUMAN UMP/CMP KINASE; DEOXYGUANOSINE KINASE; THYMIDINE KINASE; ADENYLATE KINASE; GENE-EXPRESSION; RIBONUCLEOTIDE REDUCTASE; DIPHOSPHATE KINASE; HERPES-SIMPLEX	Enzyme deficiency in the salvage pathway of deoxyribonucleotide synthesis in mitochondria can cause mtDNA depletion syndromes. We have identified a human mitochondrial UMP-CMP kinase (UMP-CMPK, cytidylate kinase; EC 2.7.4.14), designated as UMP-CMP kinase 2 (UMP-CMPK2). The C-terminal domain of this 449-amino acid protein contains all consensus motifs of a nucleoside monophosphate kinase. Phylogenetic analysis showed that UMP- CMPK2 belonged to a novel nucleoside monophosphate kinase family, which was closer to thymidylate kinase than to cytosolic UMP- CMP kinase. Subcellular localization with green fluorescent protein fusion proteins illustrated that UMP- CMPK2 was localized in the mitochondria of HeLa cells and that the mitochondrial targeting signal was included in the N- terminal 22 amino acids. The enzyme was able to phosphorylate dUMP, dCMP, CMP, and UMP with ATP as phosphate donor, but the kinetic properties were different compared with the cytosolic UMP- CMPK. Its efficacy to convert dUMP was highest, followed by dCMP, whereas CMP and UMP were the poorest substrates. It also phosphorylated the monophosphate forms of the nucleoside analogs ddC, dFdC, araC, BVDU, and FdUrd, which suggests that UMP-CMPK2 may be involved in mtDNA depletion caused by long term treatment with ddC or other pyrimidine analogs. UMP-CMPK2 mRNA expression was exclusively detected in chronic myelogenous leukemia K-562 and lymphoblastic leukemia MOLT-4 among eight studied cancer cell lines. Particular high expression in leukemia cells, dominant expression in bone marrow, and tight correlation with macrophage activation and inflammatory response suggest that UMP-CMPK2 may have other functions in addition to the supply of substrates for mtDNA synthesis.	[Xu, Yunjian; Johansson, Magnus; Karlsson, Anna] Karolinska Inst, Novum, Mitochondrial Med Ctr, Dept Lab Med, S-14186 Stockholm, Sweden	Karolinska Institutet	Xu, YJ (corresponding author), Karolinska Inst, Novum, Mitochondrial Med Ctr, Dept Lab Med, S-14186 Stockholm, Sweden.	Yunjian.Xu@ki.se	Karlsson, Anna/E-7945-2018	Karlsson, Anna/0000-0001-6843-6685				Abad MFC, 2004, J BIOL CHEM, V279, P11521, DOI 10.1074/jbc.M306766200; ARIMA T, 1977, CANCER RES, V37, P1593; Balzarini J, 2003, MOL PHARMACOL, V63, P263, DOI 10.1124/mol.63.2.263; BIANCHI V, 1994, P NATL ACAD SCI USA, V91, P8403, DOI 10.1073/pnas.91.18.8403; Bianchi V, 2003, J BIOL CHEM, V278, P46195, DOI 10.1074/jbc.R300032200; Bjorkbacka H, 2004, PHYSIOL GENOMICS, V19, P319, DOI 10.1152/physiolgenomics.00128.2004; Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040; Cheng Yung-Chi, 2001, Cancer Letters, V162, pS33, DOI 10.1016/S0304-3835(00)00650-9; Collins CA, 2007, FISH SHELLFISH IMMUN, V23, P793, DOI 10.1016/j.fsi.2007.03.001; Cote HCF, 2002, NEW ENGL J MED, V346, P811, DOI 10.1056/NEJMoa012035; Curbo S, 2003, BIOCHEM BIOPH RES CO, V311, P440, DOI 10.1016/j.bbrc.2003.10.018; DANENBERG PV, 1977, BIOCHIM BIOPHYS ACTA, V473, P73, DOI 10.1016/0304-419X(77)90001-4; Falsig J, 2006, J NEUROCHEM, V96, P893, DOI 10.1111/j.1471-4159.2005.03622.x; Ferraro P, 2006, P NATL ACAD SCI USA, V103, P18586, DOI 10.1073/pnas.0609020103; Floyd S, 2007, MOL BIOL CELL, V18, P3545, DOI 10.1091/mbc.e06-12-1109; Freisinger P, 2006, ARCH NEUROL-CHICAGO, V63, P1129, DOI 10.1001/archneur.63.8.1129; Gallinaro L, 2002, J BIOL CHEM, V277, P35080, DOI 10.1074/jbc.M203755200; GAVEL Y, 1990, PROTEIN ENG, V4, P33, DOI 10.1093/protein/4.1.33; Hsu CH, 2005, MOL PHARMACOL, V67, P806, DOI 10.1124/mol.104.006098; HUANG SH, 1994, DNA CELL BIOL, V13, P461, DOI 10.1089/dna.1994.13.461; Johansson M, 1996, GENOMICS, V38, P450, DOI 10.1006/geno.1996.0654; Johansson M, 1997, J BIOL CHEM, V272, P8454, DOI 10.1074/jbc.272.13.8454; Johansson M, 1996, P NATL ACAD SCI USA, V93, P7258, DOI 10.1073/pnas.93.14.7258; Korhonen JA, 2003, J BIOL CHEM, V278, P48627, DOI 10.1074/jbc.M306981200; LEE CG, 1995, J IMMUNOL, V154, P6094; LEE CGL, 1994, MAMM GENOME, V5, P742, DOI 10.1007/BF00426089; Lee H, 2003, BIOCHEMISTRY-US, V42, P14711, DOI 10.1021/bi035596s; Liou JY, 2002, CANCER RES, V62, P1624; Llopis J, 1998, P NATL ACAD SCI USA, V95, P6803, DOI 10.1073/pnas.95.12.6803; LUND S, 2005, J IMMUNOL, V175, P4735; LUST J, 1972, J CHROMATOGR, V71, P127, DOI 10.1016/S0021-9673(01)85696-X; Milon L, 2000, J BIOL CHEM, V275, P14264, DOI 10.1074/jbc.275.19.14264; Milon L, 1997, HUM GENET, V99, P550, DOI 10.1007/s004390050405; MUNCHPETERSEN B, 1991, J BIOL CHEM, V266, P9032; Naesens L, 2001, Herpes, V8, P12; Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689; Noble S, 1997, DRUGS, V54, P447, DOI 10.2165/00003495-199754030-00009; Noma T, 1998, BBA-GENE STRUCT EXPR, V1395, P34, DOI 10.1016/S0167-4781(97)00193-0; Noma T, 2001, BIOCHEM J, V358, P225, DOI 10.1042/0264-6021:3580225; Paglinawan R, 2003, GLIA, V44, P219, DOI 10.1002/glia.10286; Pan-Zhou XR, 2000, ANTIMICROB AGENTS CH, V44, P496, DOI 10.1128/AAC.44.3.496-503.2000; Rampazzo C, 2004, J BIOL CHEM, V279, P17019, DOI 10.1074/jbc.M313957200; Rampazzo C, 2000, P NATL ACAD SCI USA, V97, P8239, DOI 10.1073/pnas.97.15.8239; Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751; Salviati L, 2002, ANN NEUROL, V52, P311, DOI 10.1002/ana.10284; SUGINO Y, 1966, J BIOL CHEM, V241, P961; Tulinius M, 2005, NEUROMUSCULAR DISORD, V15, P412, DOI 10.1016/j.nmd.2005.03.010; Van Rompay AR, 1999, MOL PHARMACOL, V56, P562, DOI 10.1124/mol.56.3.562; Van Rompay AR, 2000, PHARMACOL THERAPEUT, V87, P189, DOI 10.1016/S0163-7258(00)00048-6; Wang JP, 2005, J VIROL, V79, P8295, DOI 10.1128/JVI.79.13.8295-8302.2005; Wang LY, 2005, MOL GENET METAB, V84, P75, DOI 10.1016/j.ymgme.2004.09.005; Wang LY, 2003, J BIOL CHEM, V278, P6963, DOI 10.1074/jbc.M206143200; Wang LY, 1996, FEBS LETT, V390, P39, DOI 10.1016/0014-5793(96)00623-0; Wutzler P, 1997, INTERVIROLOGY, V40, P343, DOI 10.1159/000150567; Yoneda T, 1998, MOL BRAIN RES, V62, P187, DOI 10.1016/S0169-328X(98)00249-6; Zhu CY, 1998, J BIOL CHEM, V273, P14707, DOI 10.1074/jbc.273.24.14707	56	59	61	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1563	1571		10.1074/jbc.M707997200	http://dx.doi.org/10.1074/jbc.M707997200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	17999954	hybrid			2022-12-27	WOS:000252282700041
J	Oganesyan, G; Saha, SK; Pietras, EM; Guo, B; Miyahira, AK; Zarnegar, B; Cheng, G				Oganesyan, Gagik; Saha, Supriya K.; Pietras, Eric M.; Guo, Beichu; Miyahira, Andrea K.; Zarnegar, Brian; Cheng, Genhong			IRF3-dependent type I interferon response in B cells regulates CpG-mediated antibody production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; TOLL-LIKE RECEPTORS; INDEPENDENT ANTIVIRAL RESPONSE; BACTERIAL-DNA; T-BET; IMMUNE-RESPONSES; GENE-EXPRESSION; ACTIVATION; MICE; LYMPHOCYTES	Hypomethylated CpG oligonucleotides (CpG) are not only potent adjuvants for enhancing adaptive immune responses but may also play a critical role in the development of autoimmune diseases such as Rheumatoid Arthritis (RA) and Systemic Lupus Erythematosus (SLE). Here we provide evidence that, in addition to dendritic cells, murine B lymphocytes also exhibit a type I IFN response to CpG-B. Unlike dendritic cells, B cell-mediated type I IFN induction depended on the transcription factor IRF3, but similar to dendritic cells this pathway was independent of the IRF3 kinase TBK1. Utilizing type I IFN receptor-deficient mice, we were able to demonstrate that this IFN pathway enhanced Syndecan-1 expression and IgM production and was required for IgG2a production following CpG-B stimulation. Overall, our findings identify a unique IFN pathway in B cells that may play a central role in mediating B cell biology in response to CpG, potentially implicating this pathway in autoantibody production and the pathogenesis of certain autoimmune diseases.	[Oganesyan, Gagik; Saha, Supriya K.; Pietras, Eric M.; Guo, Beichu; Miyahira, Andrea K.; Zarnegar, Brian; Cheng, Genhong] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Oganesyan, Gagik; Saha, Supriya K.] Univ Calif Los Angeles, Med Scientist Training Program, Los Angeles, CA 90095 USA; [Cheng, Genhong] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Cheng, Genhong] Univ Calif Los Angeles, Johnsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles	Cheng, G (corresponding author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, 8-240 Factor Bldg,10833 Conte Ave, Los Angeles, CA 90095 USA.	gcheng@mednet.ucla.edu	Saha, Supriya/AAC-5365-2019	Miyahira, Andrea/0000-0003-4976-002X	NCI NIH HHS [R01 CA87924] Funding Source: Medline; NIAID NIH HHS [R01 AI056154] Funding Source: Medline; NIGMS NIH HHS [R01 GM57559, GM08042] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA087924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056154] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057559, T32GM008042] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARNOLD LW, 1988, J IMMUNOL, V140, P4355; ARNOLD LW, 1983, J IMMUNOL, V131, P2064; Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Bas A, 2004, SCAND J IMMUNOL, V59, P566, DOI 10.1111/j.0300-9475.2004.01440.x; Behar S M, 1989, Int Rev Immunol, V5, P23, DOI 10.3109/08830188909086988; Braun D, 2003, J AUTOIMMUN, V20, P15, DOI 10.1016/S0896-8411(02)00109-9; Chu RS, 1997, J EXP MED, V186, P1623, DOI 10.1084/jem.186.10.1623; Coro ES, 2006, J IMMUNOL, V176, P4343, DOI 10.4049/jimmunol.176.7.4343; Dalpke A, 2002, BIODRUGS, V16, P419, DOI 10.2165/00063030-200216060-00003; Decker T, 2002, J CLIN INVEST, V109, P1271, DOI 10.1172/JCI200215770; Doyle SE, 2003, J IMMUNOL, V170, P3565, DOI 10.4049/jimmunol.170.7.3565; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; EHLERS M, 2006, J EXP MED; EMLEN W, 1994, J IMMUNOL, V152, P3685; Fields ML, 2003, IMMUNOL RES, V27, P219, DOI 10.1385/IR:27:2-3:219; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Gongora R, 2001, IMMUNITY, V14, P727, DOI 10.1016/S1074-7613(01)00152-2; Hacker H, 2000, J EXP MED, V192, P595, DOI 10.1084/jem.192.4.595; Hemmi H, 2003, J IMMUNOL, V170, P3059, DOI 10.4049/jimmunol.170.6.3059; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Jego G, 2003, IMMUNITY, V19, P225, DOI 10.1016/S1074-7613(03)00208-5; Jung J, 2002, J IMMUNOL, V169, P2368, DOI 10.4049/jimmunol.169.5.2368; Kadowaki N, 2001, J EXP MED, V194, P863, DOI 10.1084/jem.194.6.863; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; KRIEG AM, 1995, J CLIN IMMUNOL, V15, P284, DOI 10.1007/BF01541318; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Krieg AM, 2002, NAT IMMUNOL, V3, P423, DOI 10.1038/ni0502-423; Le Bon A, 2006, J IMMUNOL, V176, P2074, DOI 10.4049/jimmunol.176.4.2074; Le Page C, 2000, Rev Immunogenet, V2, P374; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Liu NS, 2003, NAT IMMUNOL, V4, P687, DOI 10.1038/ni941; Millan CLB, 1998, P NATL ACAD SCI USA, V95, P15553, DOI 10.1073/pnas.95.26.15553; O'Connell RM, 2004, J EXP MED, V200, P437, DOI 10.1084/jem.20040712; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Peng SL, 2003, NAT IMMUNOL, V4, P1041, DOI 10.1038/ni1103-1041a; Perry AK, 2004, J EXP MED, V199, P1651, DOI 10.1084/jem.20040528; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Qureshi ST, 1999, J EXP MED, V189, P615, DOI 10.1084/jem.189.4.615; Ronnblom L, 2002, HUM IMMUNOL, V63, P1181, DOI 10.1016/S0198-8859(02)00757-7; Ronnblom L, 2001, TRENDS IMMUNOL, V22, P427, DOI 10.1016/S1471-4906(01)01955-X; RONNBLOM LE, 1991, ANN INTERN MED, V115, P178, DOI 10.7326/0003-4819-115-3-178; Rui LX, 2003, NAT IMMUNOL, V4, P594, DOI 10.1038/ni924; STEWARD MW, 1976, CLIN EXP IMMUNOL, V26, P363; Suzuki N, 2002, NATURE, V416, P750, DOI 10.1038/nature736; Tran TT, 2003, CLIN IMMUNOL, V109, P278, DOI 10.1016/j.clim.2003.08.012; Viglianti GA, 2003, IMMUNITY, V19, P837, DOI 10.1016/S1074-7613(03)00323-6; Wang ZH, 1997, CELL IMMUNOL, V180, P162, DOI 10.1006/cimm.1997.1156; Weiner GJ, 2000, J LEUKOCYTE BIOL, V68, P455; Xu WF, 2005, J IMMUNOL, V175, P7419, DOI 10.4049/jimmunol.175.11.7419	53	28	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					802	808		10.1074/jbc.M704755200	http://dx.doi.org/10.1074/jbc.M704755200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	17925397	hybrid			2022-12-27	WOS:000252128100019
J	Maiti, A; Hait, NC; Beckman, MJ				Maiti, Aparna; Hait, Nitai C.; Beckman, Matthew J.			Extracellular calcium-sensing receptor activation induces vitamin D receptor levels in proximal kidney HK-2G cells by a mechanism that requires phosphorylation of p38 alpha MAPK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-A; 25-HYDROXYVITAMIN D-3-1-ALPHA-HYDROXYLASE; 1-ALPHA,25-DIHYDROXYVITAMIN D-3; 1,25-DIHYDROXYVITAMIN D-3; 1-ALPHA-HYDROXYLASE GENE; PARATHYROID-GLANDS; ALPHA-HYDROXYLASE; EXPRESSION; P38; HYPERCALCEMIA	In hypocalcaemia, elevated parathyroid hormone transitorily down-regulates the kidney vitamin D receptor, which returns to normal levels with the rise in serum extracellular calcium [Ca2+](e). In this study, we investigated the mechanism that underlies VDR increase in kidney in association with elevated [Ca2+](e). Examination of MAP kinase signals in a proximal tubule human kidney (HK-2G) epithelial cell line showed that treatment of [Ca2+](e) in the culture medium elevated phosphorylation of both ERK and p38 MAPKs. Blockade of p38 phosphorylation with SB203580 or SB202190 in turn abolished [Ca2+](e)-mediated VDR protein increase, while treatment with PD98059 and U0126, specifically blocked ERK phosphorylation, but had no effect on VDR stimulation by [Ca2+](e). Furthermore, SB203580 treatment potently repressed [Ca2+](e)-mediated activation of VDR promoter. We also demonstrate that si-RNA knock down of p38 alpha completely diminished high [Ca2+](e)-mediated VDR induction. Direct CaSR involvement was demonstrated by using an si-RNA of CaSR that impeded [Ca2+](e)-mediated induction of VDR. In conclusion, a high extracellular [Ca2+](e) concentration in the physiological range is capable of directly increasing renal proximal VDR expression, and the induction mechanism requires activation of the CaSR and signal mediation by the p38 alpha MAP kinase pathway.	[Maiti, Aparna; Beckman, Matthew J.] Virginia Commonwealth Univ, Dept Orthopaed Surg, Richmond, VA 23298 USA; [Hait, Nitai C.; Beckman, Matthew J.] Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Richmond, VA 23298 USA	Virginia Commonwealth University; Virginia Commonwealth University	Beckman, MJ (corresponding author), Virginia Commonwealth Univ, Dept Biochem, 1112 E Clay St, Richmond, VA 23298 USA.	mjbeckma@vcu.edu						Anderson PH, 2004, J STEROID BIOCHEM, V89-90, P111, DOI 10.1016/j.jsbmb.2004.03.089; Armbrecht HJ, 2003, AM J PHYSIOL-RENAL, V284, pF1032, DOI 10.1152/ajprenal.00306.2002; Bajwa A, 2005, ARCH BIOCHEM BIOPHYS, V438, P182, DOI 10.1016/j.abb.2005.04.016; Barletta F, 2004, AM J PHYSIOL-ENDOC M, V286, pE598, DOI 10.1152/ajpendo.00214.2003; Beckman MJ, 2002, ARCH BIOCHEM BIOPHYS, V401, P44, DOI 10.1016/S0003-9861(02)00010-3; Berndt TJ, 2005, AM J PHYSIOL-RENAL, V289, pF1170, DOI 10.1152/ajprenal.00072.2005; Bland R, 1999, ENDOCRINOLOGY, V140, P2027, DOI 10.1210/en.140.5.2027; BRENT GA, 1988, J CLIN ENDOCR METAB, V67, P944, DOI 10.1210/jcem-67-5-944; Brenza HL, 1998, P NATL ACAD SCI USA, V95, P1387, DOI 10.1073/pnas.95.4.1387; BRINGHURST FR, 1993, ENDOCRINOLOGY, V132, P2090, DOI 10.1210/en.132.5.2090; Bronner F, 2001, ScientificWorldJournal, V1, P919; Brown AJ, 2007, NAT CLIN PRACT ENDOC, V3, P134, DOI 10.1038/ncpendmet0394; Brown EM, 2007, NAT CLIN PRACT ENDOC, V3, P122, DOI 10.1038/ncpendmet0388; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; Chattopadhyay N, 1996, ENDOCR REV, V17, P289, DOI 10.1210/er.17.4.289; CHEN TH, 1994, J BONE MINER RES, V9, P293; Daniel C, 2004, BIOCHEM BIOPH RES CO, V324, P1220, DOI 10.1016/j.bbrc.2004.09.191; Dvorak MM, 2004, P NATL ACAD SCI USA, V101, P5140, DOI 10.1073/pnas.0306141101; Eyers PA, 1998, CHEM BIOL, V5, P321, DOI 10.1016/S1074-5521(98)90170-3; Friedman PA, 1996, ENDOCRINOLOGY, V137, P13, DOI 10.1210/en.137.1.13; Fukagawa M, 2002, NEPHRON, V92, P41, DOI 10.1159/000065376; FUKASE M, 1984, ENDOCRINOLOGY, V114, P1203, DOI 10.1210/endo-114-4-1203; Gao XH, 2002, INT J BIOCHEM CELL B, V34, P921, DOI 10.1016/S1357-2725(01)00165-0; Garfia B, 2002, J AM SOC NEPHROL, V13, P2945, DOI 10.1097/01.ASN.0000037676.54018.CB; HANLEY DA, 1978, J CLIN INVEST, V62, P1247, DOI 10.1172/JCI109245; Healy KD, 2005, P NATL ACAD SCI USA, V102, P4724, DOI 10.1073/pnas.0501312102; Healy KD, 2003, P NATL ACAD SCI USA, V100, P9733, DOI 10.1073/pnas.1633774100; Hendrix I, 2005, J MOL ENDOCRINOL, V34, P237, DOI 10.1677/jme.1.01654; HENRY HL, 1985, ENDOCRINOLOGY, V116, P503, DOI 10.1210/endo-116-2-503; HORIUCHI N, 1977, ENDOCRINOLOGY, V101, P969, DOI 10.1210/endo-101-3-969; Huening M, 2002, MOL ENDOCRINOL, V16, P2052, DOI 10.1210/me.2001-0260; IIDA K, 1995, P NATL ACAD SCI USA, V92, P6112, DOI 10.1073/pnas.92.13.6112; Kifor O, 2001, AM J PHYSIOL-RENAL, V280, pF291, DOI 10.1152/ajprenal.2001.280.2.F291; Kim MS, 2007, MOL CELL ENDOCRINOL, V265, P168, DOI 10.1016/j.mce.2006.12.014; Kim YH, 2003, BIOCHEM BIOPH RES CO, V304, P729, DOI 10.1016/S0006-291X(03)00661-2; Langman CB, 2000, CURR OPIN PEDIATR, V12, P135, DOI 10.1097/00008480-200004000-00009; Locatelli F, 2007, MINI-REV MED CHEM, V7, P591; Mackey SL, 1996, MOL ENDOCRINOL, V10, P298, DOI 10.1210/me.10.3.298; MacLeod RJ, 2003, AM J PHYSIOL-ENDOC M, V284, pE435, DOI 10.1152/ajpendo.00143.2002; MATSUMOTO T, 1987, AM J PHYSIOL, V253, pE503, DOI 10.1152/ajpendo.1987.253.5.E503; Murayama A, 2004, EMBO J, V23, P1598, DOI 10.1038/sj.emboj.7600157; NAVEHMANY T, 1990, J CLIN INVEST, V86, P1313, DOI 10.1172/JCI114840; Nemoto S, 1998, J BIOL CHEM, V273, P16415, DOI 10.1074/jbc.273.26.16415; Omdahl JL, 2002, ANNU REV NUTR, V22, P139, DOI 10.1146/annurev.nutr.22.120501.150216; Qi XM, 2002, J BIOL CHEM, V277, P25884, DOI 10.1074/jbc.M203039200; Rodriguez ME, 2007, AM J PHYSIOL-RENAL, V292, pF1390, DOI 10.1152/ajprenal.00262.2006; ROGERS KV, 1995, ENDOCRINOLOGY, V136, P499, DOI 10.1210/en.136.2.499; RYAN MJ, 1994, KIDNEY INT, V45, P48, DOI 10.1038/ki.1994.6; Saito H, 2005, J BIOL CHEM, V280, P2543, DOI 10.1074/jbc.M408903200; Shinki T, 1997, P NATL ACAD SCI USA, V94, P12920, DOI 10.1073/pnas.94.24.12920; Suda T, 1994, Curr Opin Nephrol Hypertens, V3, P59, DOI 10.1097/00041552-199401000-00008; Sugden PH, 1997, CELL SIGNAL, V9, P337, DOI 10.1016/S0898-6568(96)00191-X; Tfelt-Hansen J, 2005, CRIT REV CL LAB SCI, V42, P35, DOI 10.1080/10408360590886606; Tfelt-Hansen J, 2004, ENDOCRINOLOGY, V145, P1211, DOI 10.1210/en.2003-0749; Tourian L, 2004, J CELL SCI, V117, P6459, DOI 10.1242/jcs.01573; TTELHANSEN J, 2003, AM J PHYSIOL-ENDOC M, V285, pE329; WEISINGER JR, 1989, J BONE MINER RES, V4, P929; Yamaguchi T, 2000, BIOCHEM BIOPH RES CO, V279, P363, DOI 10.1006/bbrc.2000.3955; Yanagisawa J, 1999, SCIENCE, V283, P1317, DOI 10.1126/science.283.5406.1317; Yano S, 2004, CELL CALCIUM, V35, P257, DOI 10.1016/j.ceca.2003.10.008; Ye CP, 2004, J NEUROSCI RES, V75, P491, DOI 10.1002/jnr.10875; Zehnder D, 1999, J AM SOC NEPHROL, V10, P2465	62	32	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					175	183		10.1074/jbc.M707269200	http://dx.doi.org/10.1074/jbc.M707269200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17974568	hybrid			2022-12-27	WOS:000251940300020
J	Hill, WG; Butterworth, MB; Wang, H; Edinger, RS; Lebowitz, J; Peters, KW; Frizzell, RA; Johnson, JP				Hill, Warren G.; Butterworth, Michael B.; Wang, Huamin; Edinger, Robert S.; Lebowitz, Jonathan; Peters, Kathryn W.; Frizzell, Raymond A.; Johnson, John P.			The epithelial sodium channel (ENaC) traffics to apical membrane in lipid rafts in mouse cortical collecting duct cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; CANINE KIDNEY-CELLS; 1A REGULATES ENAC; PLASMA-MEMBRANE; SYNTAXIN 1A; CHOLESTEROL CONTENT; NA+ TRANSPORT; MICRODOMAINS; CAVEOLIN; LOCALIZATION	We previously showed that ENaC is present in lipid rafts in A6 cells, a Xenopus kidney cell line. We now demonstrate that ENaC can be detected in lipid rafts in mouse cortical collecting duct (MPKCCD14) cells by detergent insolubility, buoyancy on density gradients using two distinct approaches, and colocalization with caveolin 1. Less than 30% of ENaC subunits were found in raft fractions. The channel subunits also colocalized on sucrose gradients with known vesicle targeting and fusion proteins syntaxin 1A, Vamp 2, and SNAP23. Hormonal stimulation of ENaC activity by either forskolin or aldosterone, short or long term, did not alter the lipid raft distribution of ENaC. Methyl-beta-cyclodextrin added apically to MPKCCD14 cells resulted in a slow decline in amiloride-sensitive sodium transport with short circuit current reductions of 38.1 +/- 9.6% after 60 min. The slow decline in ENaC activity in response to apical cyclodextrin was identical to the rate of decline seen when protein synthesis was inhibited by cycloheximide. Apical biotinylation of MPKCCD14 cells confirmed the loss of ENaC at the cell surface following cyclodextrin treatment. Acute stimulation of the recycling pool of ENaC was unaffected by apical cyclodextrin application. Expression of dominant negative caveolin isoforms (CAV1-eGFP and CAV3-DGV) which disrupt caveolae, reduced basal ENaC currents by 72.3 and 78.2%, respectively; but, as with cyclodextrin, the acute response to forskolin was unaffected. We conclude that ENaC is present in and regulated by lipid rafts. The data are consistent with a model in which rafts mediate the constitutive apical delivery of ENaC.	[Hill, Warren G.] Beth Israel Deaconess Med Ctr, Harvard Med Sch, Dept Med, Div Matrix Biol, Boston, MA 02215 USA; [Butterworth, Michael B.; Peters, Kathryn W.; Frizzell, Raymond A.; Johnson, John P.] Univ Pittsburgh, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA; [Wang, Huamin; Edinger, Robert S.; Lebowitz, Jonathan; Johnson, John P.] Univ Pittsburgh, Dept Med, Div Renal & Electrolyte, Lab Epithelial Cell Biol, Pittsburgh, PA 15261 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Johnson, JP (corresponding author), Univ Pittsburgh, Div Renal & Electrolyte, 935 Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA.	Johnson@dom.pitt.edu	Hill, Warren/AAM-1917-2020	Hill, Warren/0000-0002-2772-7264; Butterworth, Michael/0000-0002-2173-8333	NIDDK NIH HHS [DK43955, DK48217, DK47874, DK57718, DK54814] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047874, R01DK048217, R37DK048217, R01DK057718, R01DK043955, R01DK054814] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bacia K, 2004, BIOPHYS J, V87, P1034, DOI 10.1529/biophysj.104.040519; Balut C, 2006, AM J PHYSIOL-CELL PH, V290, pC87, DOI 10.1152/ajpcell.00184.2005; Butterworth MB, 2005, AM J PHYSIOL-RENAL, V289, pF969, DOI 10.1152/ajprenal.00390.2003; Butterworth MB, 2005, J GEN PHYSIOL, V125, P81, DOI 10.1085/jgp.2004.09124; Butterworth MB, 2001, AM J PHYSIOL-CELL PH, V280, pC752, DOI 10.1152/ajpcell.2001.280.4.C752; Chamberlain LH, 2002, J BIOL CHEM, V277, P49750, DOI 10.1074/jbc.M206936200; Condliffe SB, 2004, J BIOL CHEM, V279, P10085, DOI 10.1074/jbc.M313592200; Condliffe SB, 2003, J BIOL CHEM, V278, P12796, DOI 10.1074/jbc.M210772200; CORNELIUS F, 1995, BBA-BIOMEMBRANES, V1235, P205, DOI 10.1016/0005-2736(95)80006-2; Cornelius F, 2001, BIOCHEMISTRY-US, V40, P8842, DOI 10.1021/bi010541g; Edinger RS, 2006, J BIOL CHEM, V281, P9110, DOI 10.1074/jbc.M509232200; Frindt G, 2007, AM J PHYSIOL-RENAL, V292, pF1190, DOI 10.1152/ajprenal.00399.2006; Hansen GH, 2000, J BIOL CHEM, V275, P5136, DOI 10.1074/jbc.275.7.5136; Hanwell D, 2002, J BIOL CHEM, V277, P9772, DOI 10.1074/jbc.M110904200; Hardy S, 1997, J VIROL, V71, P1842, DOI 10.1128/JVI.71.3.1842-1849.1997; Hill WG, 2005, AM J PHYSIOL-CELL PH, V289, pC33, DOI 10.1152/ajpcell.00046.2005; Hill WG, 2002, J BIOL CHEM, V277, P33541, DOI 10.1074/jbc.C200309200; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Ikonen E, 2001, CURR OPIN CELL BIOL, V13, P470, DOI 10.1016/S0955-0674(00)00238-6; Ishikawa Y, 2005, AM J PHYSIOL-CELL PH, V289, pC1303, DOI 10.1152/ajpcell.00211.2005; Kowalski MP, 2004, J IMMUNOL, V172, P418, DOI 10.4049/jimmunol.172.1.418; Lafont F, 1999, P NATL ACAD SCI USA, V96, P3734, DOI 10.1073/pnas.96.7.3734; Laude AJ, 2004, MOL MEMBR BIOL, V21, P193, DOI 10.1080/09687680410001700517; Li XH, 2001, J PHYSIOL-LONDON, V537, P537, DOI 10.1111/j.1469-7793.2001.00537.x; Lu C, 2007, TRAFFIC, V8, P1246, DOI 10.1111/j.1600-0854.2007.00602.x; Martens JR, 2004, TRENDS PHARMACOL SCI, V25, P16, DOI 10.1016/j.tips.2003.11.007; Parton RG, 2003, TRAFFIC, V4, P724, DOI 10.1034/j.1600-0854.2003.00128.x; Pearce D, 2003, CELL PHYSIOL BIOCHEM, V13, P13, DOI 10.1159/000070245; Pelkmans L, 2005, NATURE, V436, P128, DOI 10.1038/nature03866; Pelkmans L, 2001, NAT CELL BIOL, V3, P473, DOI 10.1038/35074539; Pol A, 2001, J CELL BIOL, V152, P1057, DOI 10.1083/jcb.152.5.1057; Pottosin II, 2007, PFLUG ARCH EUR J PHY, V454, P235, DOI 10.1007/s00424-007-0208-4; Prince LS, 1999, AM J PHYSIOL-CELL PH, V276, pC1346, DOI 10.1152/ajpcell.1999.276.6.C1346; Qi JJ, 1999, J BIOL CHEM, V274, P30345, DOI 10.1074/jbc.274.43.30345; Roper K, 2000, NAT CELL BIOL, V2, P582, DOI 10.1038/35023524; Ros-Baro A, 2001, P NATL ACAD SCI USA, V98, P12050, DOI 10.1073/pnas.211341698; Roy S, 1999, NAT CELL BIOL, V1, P98, DOI 10.1038/10067; Salaun C, 2004, TRAFFIC, V5, P255, DOI 10.1111/j.1600-0854.2004.0162.x; Saxena SK, 2006, BIOCHEM BIOPH RES CO, V343, P1279, DOI 10.1016/j.bbrc.2006.03.093; Shibata Erwin F, 2006, J Cardiovasc Electrophysiol, V17 Suppl 1, pS34, DOI 10.1111/j.1540-8167.2006.00387.x; Shimkets RA, 1997, J BIOL CHEM, V272, P25537, DOI 10.1074/jbc.272.41.25537; Shlyonsky VG, 2003, AM J PHYSIOL-RENAL, V284, pF182, DOI 10.1152/ajprenal.00216.2002; Slimane TA, 2003, MOL BIOL CELL, V14, P611, DOI 10.1091/mbc.E02-08-0528; SMART EJ, 1995, P NATL ACAD SCI USA, V92, P10104, DOI 10.1073/pnas.92.22.10104; Snyder PM, 2005, ENDOCRINOLOGY, V146, P5079, DOI 10.1210/en.2005-0894; Song KS, 1996, J BIOL CHEM, V271, P9690, DOI 10.1074/jbc.271.16.9690; Tillman TS, 2003, CELL BIOCHEM BIOPHYS, V38, P161, DOI 10.1385/CBB:38:2:161; Toselli M, 2005, BIOPHYS J, V89, P2443, DOI 10.1529/biophysj.105.065623; Valentijn JA, 1998, J BIOL CHEM, V273, P30344, DOI 10.1074/jbc.273.46.30344; Wang H, 2006, J BIOL CHEM, V281, P14129, DOI 10.1074/jbc.M512511200; Watson RT, 2001, J CELL BIOL, V154, P829, DOI 10.1083/jcb.200102078; West TA, 2005, CELL PHYSIOL BIOCHEM, V16, P263, DOI 10.1159/000089852; Yang N, 2004, J BIOL CHEM, V279, P20898, DOI 10.1074/jbc.M400625200; Yarbrough TL, 2002, CIRC RES, V90, P443, DOI 10.1161/hh0402.105177; YEAGLE PL, 1988, BIOCHEMISTRY-US, V27, P6449, DOI 10.1021/bi00417a037; Zheng XJ, 2003, J INVEST DERMATOL, V121, P1487, DOI 10.1111/j.1523-1747.2003.12614.x	56	49	51	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37402	37411		10.1074/jbc.M704084200	http://dx.doi.org/10.1074/jbc.M704084200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17932048	hybrid			2022-12-27	WOS:000251833600014
J	Kato, S; Yoshida, M; Kato-Yamada, Y				Kato, Shigeyuki; Yoshida, Masasuke; Kato-Yamada, Yasuyuki			Role of the epsilon subunit of thermophilic F-1-ATPase as a sensor for ATP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; POLYMERASE CHAIN-REACTION; ESCHERICHIA-COLI; ALPHA(3)BETA(3)GAMMA COMPLEX; ENDOGENOUS INHIBITOR; GENERAL-METHOD; BINDS ATP; SYNTHASE; GAMMA; F1-ATPASE	The epsilon subunit of F-1-ATPase from the thermophilic Bacillus PS3 (TF1) has been shown to bind ATP. The precise nature of the regulatory role of ATP binding to the epsilon subunit remains to be determined. To address this question, 11 mutants of the epsilon subunit were prepared, in which one of the basic or acidic residues was substituted with alanine. ATP binding to these mutants was tested by gel- filtration chromatography. Among them, four mutants that showed no ATP binding were selected and reconstituted with the alpha(3) beta(3) gamma complex of TF1. The ATPase activity of the resulting alpha(3)beta(3)gamma epsilon complexes was measured, and the extent of inhibition by the mutant epsilon subunits was compared in each case. With one exception, weaker binding of ATP correlated with greater inhibition of ATPase activity. These results clearly indicate that ATP binding to the epsilon subunit plays a regulatory role and that ATP binding may stabilize the ATPase- active form of TF1 by fixing the epsilon subunit into the folded conformation.	[Kato, Shigeyuki; Kato-Yamada, Yasuyuki] St Paul Univ, Coll Sci, Dept Life Sci, Tokyo 1718501, Japan; [Kato-Yamada, Yasuyuki] St Paul Univ, Coll Sci, Dept Frontier Project Adaptat & Evolut Extremophi, Tokyo 1718501, Japan; [Yoshida, Masasuke] Tokyo Inst Technol, Chem Resource Lab, Yokohama, Kanagawa 2268503, Japan	Rikkyo University; Rikkyo University; Tokyo Institute of Technology	Kato, S (corresponding author), St Paul Univ, Coll Sci, Dept Life Sci, 3-34-1 Nishi Ikebukuro, Tokyo 1718501, Japan.	katoyama@rikkyo.ac.jp						Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Gibbons C, 2000, NAT STRUCT BIOL, V7, P1055; Hara KY, 2001, J BIOL CHEM, V276, P23969, DOI 10.1074/jbc.M009303200; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Hisabori T, 1997, EUR J BIOCHEM, V247, P1158, DOI 10.1111/j.1432-1033.1997.01158.x; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Iino R, 2005, J BIOL CHEM, V280, P40130, DOI 10.1074/jbc.M506160200; Iizuka S, 2006, BIOCHEM BIOPH RES CO, V349, P1368, DOI 10.1016/j.bbrc.2006.09.001; Kato Y, 1997, J BIOL CHEM, V272, P24906, DOI 10.1074/jbc.272.40.24906; Kato-Yamada Y, 1999, J BIOL CHEM, V274, P33991, DOI 10.1074/jbc.274.48.33991; Kato-Yamada Y, 2005, FEBS LETT, V579, P6875, DOI 10.1016/j.febslet.2005.11.036; Kato-Yamada Y, 2003, J BIOL CHEM, V278, P36013, DOI 10.1074/jbc.M306140200; Kato-Yamada Y, 2000, J BIOL CHEM, V275, P35746, DOI 10.1074/jbc.M006575200; Kinosita K Jr, 2000, Essays Biochem, V35, P3; LAGET PP, 1979, ARCH BIOCHEM BIOPHYS, V197, P83, DOI 10.1016/0003-9861(79)90222-4; LANDT O, 1990, GENE, V96, P125, DOI 10.1016/0378-1119(90)90351-Q; MATSUI T, 1995, BBA-BIOENERGETICS, V1231, P139, DOI 10.1016/0005-2728(95)00070-Y; Matsui T, 1997, J BIOL CHEM, V272, P8215, DOI 10.1074/jbc.272.13.8215; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Ono S, 2003, BBA-BIOENERGETICS, V1607, P35, DOI 10.1016/j.bbabio.2003.08.006; ORT DR, 1992, ANNU REV PLANT PHYS, V43, P269, DOI 10.1146/annurev.pp.43.060192.001413; RICHTER ML, 1987, J BIOL CHEM, V262, P15037; Rodgers AJW, 2000, NAT STRUCT BIOL, V7, P1051; Senior AE, 2002, BBA-BIOENERGETICS, V1553, P188, DOI 10.1016/S0005-2728(02)00185-8; SMITH JB, 1975, J SUPRAMOL STR CELL, V3, P248, DOI 10.1002/jss.400030307; Stiggall D L, 1979, Methods Enzymol, V55, P308; Suzuki T, 2003, J BIOL CHEM, V278, P46840, DOI 10.1074/jbc.M307165200; Tsunoda SP, 2001, P NATL ACAD SCI USA, V98, P6560, DOI 10.1073/pnas.111128098; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Watanabe YH, 2002, J BIOL CHEM, V277, P5804, DOI 10.1074/jbc.M109349200; Yagi H, 2007, P NATL ACAD SCI USA, V104, P11233, DOI 10.1073/pnas.0701045104; Yasuda R, 1998, CELL, V93, P1117, DOI 10.1016/S0092-8674(00)81456-7; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509	35	35	37	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37618	37623		10.1074/jbc.M707509200	http://dx.doi.org/10.1074/jbc.M707509200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17933866	hybrid			2022-12-27	WOS:000251833600037
J	Poltermann, S; Kunert, A; von der Heide, M; Eck, R; Hartmann, A; Zipfel, PF				Poltermann, Sophia; Kunert, Anja; von der Heide, Monika; Eck, Raimund; Hartmann, Andrea; Zipfel, Peter F.			Gpm1p is a factor H-, FHL-1-, and plasminogen-binding surface protein of Candida albicans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-WALL; COMPLEMENT ACTIVATION; BORRELIA-BURGDORFERI; VIRULENCE FACTORS; SERUM RESISTANCE; IMMUNE EVASION; IDENTIFICATION; MORPHOGENESIS; CONSTRUCTION; ACQUISITION	The human pathogenic yeast Candida albicans utilizes host complement regulators for immune evasion. Here we identify the first fungal protein that binds Factor H and FHL-1. By screening a protein array of 4088 proteins of Saccharomyces cerevisiae, phosphoglycerate mutase (ScGpm1p) was identified as a Factor H-and FHL-1-binding protein. The homologous C. albicans Gpm1p (CaGpm1p) was cloned and recombinantly expressed as a 36-kDa His-tagged protein. Purified CaGpm1p binds the host complement regulators Factor H and FHL-1, but not C4BP. The CaGpm1p binding regions in the host proteins were localized; FHL-1 binds via short consensus repeats (SCRs) 6 and 7, and Factor H utilizes two contact regions that are located in SCRs 6 and 7 and in SCRs 19 and 20. In addition, recombinant CaGpm1p binds plasminogen via lysine residues. CaGpm1p is a surface protein as demonstrated by immunostaining and flow cytometry. A C. albicans gpm1(-/)-mutant strain was generated that did not grow on glucose-supplemented but on ethanol-and glycerol-supplemented medium. Reduced binding of Factor H and plasminogen to the null mutant strain is in agreement with the presence of additional binding proteins. Attached to CaGpm1p, each of the three host plasma proteins is functionally active. Factor H and FHL-1 show cofactor activity for cleavage of C3b, and bound plasminogen is converted by urokinase-type plasminogen activator to proteolytically active plasmin. Thus, the surface-expressed CaGpm1p is a virulence factor that utilizes the host Factor H, FHL-1, and plasminogen for immune evasion and degradation of extracellular matrices.	[Poltermann, Sophia; Kunert, Anja; von der Heide, Monika; Eck, Raimund; Hartmann, Andrea; Zipfel, Peter F.] Leibniz Inst Nat Prod Res & Infect Biol, Dept Infect Biol, D-07745 Jena, Germany; [Zipfel, Peter F.] Univ Jena, D-07743 Jena, Germany	Hans Knoll Institute (HKI); Friedrich Schiller University of Jena	Zipfel, PF (corresponding author), Leibniz Inst Nat Prod Res & Infect Biol, Dept Infect Biol, Beutenbergstr 11a, D-07745 Jena, Germany.	peter.zipfel@hki-jena.de						Alitalo A, 2001, INFECT IMMUN, V69, P3685, DOI 10.1128/IAI.69.6.3685-3691.2001; BECKSAGUE C, 1993, AM J PUBLIC HEALTH, V83, P1739, DOI 10.2105/AJPH.83.12.1739; Bergmann S, 2005, THROMB HAEMOSTASIS, V94, P304, DOI 10.1160/TH05-05-0369; Calderone RA, 2001, TRENDS MICROBIOL, V9, P327, DOI 10.1016/S0966-842X(01)02094-7; Crowe JD, 2003, MOL MICROBIOL, V47, P1637, DOI 10.1046/j.1365-2958.2003.03390.x; Diaz A, 1997, J IMMUNOL, V158, P3779; EDWARDS JE, 1991, NEW ENGL J MED, V324, P1060, DOI 10.1056/NEJM199104113241511; Fernandez-Arenas E, 2004, PROTEOMICS, V4, P3007, DOI 10.1002/pmic.200400929; FISHERHOCH SP, 1995, CLIN INFECT DIS, V21, P897, DOI 10.1093/clinids/21.4.897; FONZI WA, 1993, GENETICS, V134, P717; Huber-Lang M, 2006, NAT MED, V12, P682, DOI 10.1038/nm1419; Johnsson E, 1998, J IMMUNOL, V161, P4894; Kotarsky H, 1998, J IMMUNOL, V160, P3349; Kozel TR, 1996, INFECT IMMUN, V64, P3360, DOI 10.1128/IAI.64.8.3360-3368.1996; Kraiczy P, 2006, MOL IMMUNOL, V43, P31, DOI 10.1016/j.molimm.2005.06.016; Kraiczy P, 2001, EUR J IMMUNOL, V31, P1674, DOI 10.1002/1521-4141(200106)31:6&lt;1674::AID-IMMU1674&gt;3.0.CO;2-2; KUHN S, 1995, GENE, V162, P225, DOI 10.1016/0378-1119(95)00360-I; Kunert A, 2007, J IMMUNOL, V179, P2979, DOI 10.4049/jimmunol.179.5.2979; Lahteenmaki K, 2001, FEMS MICROBIOL REV, V25, P531, DOI 10.1111/j.1574-6976.2001.tb00590.x; Meri T, 2004, INFECT IMMUN, V72, P6633, DOI 10.1128/IAI.72.11.6633-6641.2004; Meri T, 2002, INFECT IMMUN, V70, P5185, DOI 10.1128/IAI.70.9.5185-5192.2002; Motshwene P, 2003, BIOCHEM J, V369, P357, DOI 10.1042/BJ20021352; Neeleman C, 1999, INFECT IMMUN, V67, P4517, DOI 10.1128/IAI.67.9.4517-4524.1999; Nombela C, 2006, TRENDS MICROBIOL, V14, P15, DOI 10.1016/j.tim.2005.11.009; Oppermann M, 2006, CLIN EXP IMMUNOL, V144, P342, DOI 10.1111/j.1365-2249.2006.03071.x; Pardo M, 2000, ELECTROPHORESIS, V21, P2651, DOI 10.1002/1522-2683(20000701)21:13&lt;2651::AID-ELPS2651&gt;3.0.CO;2-3; Pardo M, 2000, ELECTROPHORESIS, V21, P3396, DOI 10.1002/1522-2683(20001001)21:16<3396::AID-ELPS3396>3.0.CO;2-J; PFALLER M, 1992, EUR J CLIN MICROBIOL, V11, P287, DOI 10.1007/BF01962067; Pitarch A, 2002, MOL CELL PROTEOMICS, V1, P967, DOI 10.1074/mcp.M200062-MCP200; Ram S, 1998, J EXP MED, V188, P671, DOI 10.1084/jem.188.4.671; Ram S, 1999, MOL IMMUNOL, V36, P915, DOI 10.1016/S0161-5890(99)00114-5; RODICIO R, 1987, MOL GEN GENET, V206, P133, DOI 10.1007/BF00326548; Romani L, 2004, NAT REV IMMUNOL, V4, P11, DOI 10.1038/nri1255; Rooney PJ, 2002, CELL MICROBIOL, V4, P127, DOI 10.1046/j.1462-5822.2002.00179.x; Schaller M, 2005, MYCOSES, V48, P365, DOI 10.1111/j.1439-0507.2005.01165.x; Stoiber H, 1997, ANNU REV IMMUNOL, V15, P649, DOI 10.1146/annurev.immunol.15.1.649; SWOBODA RK, 1994, MOL MICROBIOL, V13, P663, DOI 10.1111/j.1365-2958.1994.tb00460.x; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Zhang MX, 1998, INFECT IMMUN, V66, P4845, DOI 10.1128/IAI.66.10.4845-4850.1998; Zipfel PF, 2002, BIOCHEM SOC T, V30, P971, DOI 10.1042/bst0300971	40	101	102	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37537	37544		10.1074/jbc.M707280200	http://dx.doi.org/10.1074/jbc.M707280200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17959597	hybrid			2022-12-27	WOS:000251833600029
J	Goto, Y; Hattori, A; Mizutani, S; Tsujimoto, M				Goto, Yoshikuni; Hattori, Akira; Mizutani, Shigehiko; Tsujimoto, Masafumi			Asparatic acid 221 is critical in the calcium-induced modulation of the enzymatic activity of human aminopeptidase A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PUROMYCIN-SENSITIVE AMINOPEPTIDASE; C-TERMINAL DOMAIN; MOLECULAR-CLONING; CDNA CLONING; EXOPEPTIDASE SPECIFICITY; METALLOPEPTIDASE FAMILY; OXYTOCINASE SUBFAMILY; CATALYTIC-ACTIVITY; GENOMIC STRUCTURE; ANGIOTENSIN-IV	Aminopeptidase A (APA) plays an important role in the regulation of blood pressure by mediating angiotensin II degradation in the renin-angiotensin system. The Ca2+-induced modulation of enzymatic activity is the most characteristic feature of APA among the M1 family of aminopeptidases. In this study, we used site-directed mutagenesis for any residues responsible for the Ca2+ modulation of human APA. Alignment of sequences of the M1 family members led to the identification of Asp-221 as a significant residue of APA among the family members. Replacement of Asp-221 with Asn or Gln resulted in a loss of Ca2+ responsiveness toward synthetic substrates. These enzymes were also unresponsive to Ca2+ when peptide hormones, such as angiotensin II, cholecystokinin-8, neurokinin B, and kallidin, were employed as substrates. These results suggest that the negative charge of Asp-221 is essential for Ca2+ modulation of the enzymatic activity of APA and causes preferential cleavage of acidic amino acid at the N-terminal end of substrate peptides.	[Goto, Yoshikuni; Hattori, Akira; Tsujimoto, Masafumi] RIKEN, Lab Cellular Biochem, Wako, Saitama 3510198, Japan; [Mizutani, Shigehiko] Nagoya Univ, Sch Med, Dept Med Sci Proteases, Nagoya, Aichi 4668550, Japan	RIKEN; Nagoya University	Tsujimoto, M (corresponding author), RIKEN, Lab Cellular Biochem, Wako, Saitama 3510198, Japan.	tsujimot@riken.jp						Albiston AL, 2001, J BIOL CHEM, V276, P48623, DOI 10.1074/jbc.C100512200; CONSTAM DB, 1995, J BIOL CHEM, V270, P26931, DOI 10.1074/jbc.270.45.26931; DANIELSEN EM, 1980, BIOCHEM J, V189, P591, DOI 10.1042/bj1890591; Diaz-Perales A, 2005, J BIOL CHEM, V280, P14310, DOI 10.1074/jbc.M413222200; Fujiwara H, 2004, BIOCHEM BIOPH RES CO, V313, P962, DOI 10.1016/j.bbrc.2003.12.024; FUNK CD, 1987, P NATL ACAD SCI USA, V84, P667; Goto Y, 2006, FEBS LETT, V580, P1833, DOI 10.1016/j.febslet.2006.02.041; Goto Y, 2006, J BIOL CHEM, V281, P23503, DOI 10.1074/jbc.M603191200; Hattori A, 1999, J BIOCHEM-TOKYO, V125, P931, DOI 10.1093/oxfordjournals.jbchem.a022371; Hesp JR, 1997, BIOCHEMISTRY-US, V36, P3000, DOI 10.1021/bi962401q; HOOPER NM, 1994, FEBS LETT, V354, P1, DOI 10.1016/0014-5793(94)01079-X; Huber G, 1999, J NEUROCHEM, V72, P1215, DOI 10.1046/j.1471-4159.1999.0721215.x; Iturrioz X, 2000, BIOCHEMISTRY-US, V39, P3061, DOI 10.1021/bi9925726; Iturrioz X, 2001, BIOCHEMISTRY-US, V40, P14440, DOI 10.1021/bi011409j; Kyrieleis OJP, 2005, J MOL BIOL, V349, P787, DOI 10.1016/j.jmb.2005.03.070; LI L, 1993, GENOMICS, V17, P657, DOI 10.1006/geno.1993.1386; Maruyama M, 2007, J BIOL CHEM, V282, P20088, DOI 10.1074/jbc.M702650200; Migaud M, 1996, PEPTIDES, V17, P601, DOI 10.1016/0196-9781(96)00036-8; NANUS DM, 1993, P NATL ACAD SCI USA, V90, P7069, DOI 10.1073/pnas.90.15.7069; Ofner LD, 2002, BIOCHEM J, V362, P191, DOI 10.1042/0264-6021:3620191; OLSEN J, 1988, FEBS LETT, V238, P307, DOI 10.1016/0014-5793(88)80502-7; Osada T, 2001, MOL ENDOCRINOL, V15, P960, DOI 10.1210/me.15.6.960; Osada T, 2001, MOL ENDOCRINOL, V15, P882, DOI 10.1210/me.15.6.882; Piesse C, 2002, GENE, V292, P129, DOI 10.1016/S0378-1119(02)00650-9; Reaux A, 1999, P NATL ACAD SCI USA, V96, P13415, DOI 10.1073/pnas.96.23.13415; Rogi T, 1996, J BIOL CHEM, V271, P56, DOI 10.1074/jbc.271.1.56; Rozenfeld R, 2004, J BIOL CHEM, V279, P43285, DOI 10.1074/jbc.M404369200; Saric T, 2002, NAT IMMUNOL, V3, P1169, DOI 10.1038/ni859; Sato Y, 2004, BIOL PHARM BULL, V27, P772, DOI 10.1248/bpb.27.772; Schomburg L, 1999, EUR J BIOCHEM, V265, P415, DOI 10.1046/j.1432-1327.1999.00753.x; Serwold T, 2002, NATURE, V419, P480, DOI 10.1038/nature01074; SHIPP MA, 1993, BLOOD, V82, P1052, DOI 10.1182/blood.V82.4.1052.bloodjournal8241052; Tanioka T, 2003, J BIOL CHEM, V278, P32275, DOI 10.1074/jbc.M305076200; TAYLOR A, 1993, FASEB J, V7, P290, DOI 10.1096/fasebj.7.2.8440407; Thunnissen MMGM, 2001, NAT STRUCT BIOL, V8, P131, DOI 10.1038/84117; Tsujimoto M, 2005, BBA-PROTEINS PROTEOM, V1751, P9, DOI 10.1016/j.bbapap.2004.09.011; Vazeux G, 1996, J BIOL CHEM, V271, P9069, DOI 10.1074/jbc.271.15.9069; Vazeux G, 1998, BIOCHEM J, V334, P407, DOI 10.1042/bj3340407; Vazeux G, 1997, BIOCHEM J, V327, P883, DOI 10.1042/bj3270883; WANG J, 1998, HDB PROTEOLYTIC ENZY, P1002; WANG JY, 1993, P NATL ACAD SCI USA, V90, P1222, DOI 10.1073/pnas.90.4.1222; WRIGHT JW, 1990, J HYPERTENS, V8, P969, DOI 10.1097/00004872-199010000-00013; WU Q, 1990, P NATL ACAD SCI USA, V87, P993, DOI 10.1073/pnas.87.3.993	43	21	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					37074	37081		10.1074/jbc.M707251200	http://dx.doi.org/10.1074/jbc.M707251200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17932029	hybrid			2022-12-27	WOS:000251646000034
J	Hisatsune, C; Yasumatsu, K; Takahashi-Iwanaga, H; Ogawa, N; Kuroda, Y; Yoshida, R; Ninomiya, Y; Mikoshiba, K				Hisatsune, Chihiro; Yasumatsu, Keiko; Takahashi-Iwanaga, Hiromi; Ogawa, Naoko; Kuroda, Yukiko; Yoshida, Ryusuke; Ninomiya, Yuzo; Mikoshiba, Katsuhiko			Abnormal taste perception in mice lacking the type 3 inositol 1,4,5-trisphosphate receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UMAMI TASTE; SWEET TASTE; MAMMALIAN SWEET; CATION CHANNEL; CELLS; BITTER; TRPM5; TRANSDUCTION; EXPRESSION; RESPONSES	Inositol 1,4,5-trisphosphate receptor (IP3R) is one of the important calcium channels expressed in the endoplasmic reticulum and has been shown to play crucial roles in various physiological phenomena. Type 3 IP3R is expressed in taste cells, but the physiological relevance of this receptor in taste perception in vivo is still unknown. Here, we show that mice lacking IP(3)R3 show abnormal behavioral and electrophysiological responses to sweet, umami, and bitter substances that trigger G-protein-coupled receptor activation. In contrast, responses to salty and acid tastes are largely normal in the mutant mice. We conclude that IP3R3 is a principal mediator of sweet, bitter, and umami taste perception and would be a missing molecule linking phospholipase C beta 2 to TRPM5 activation.	[Hisatsune, Chihiro; Ogawa, Naoko; Kuroda, Yukiko; Mikoshiba, Katsuhiko] RIKEN, Dev Neurobiol Lab, Brain Res Inst, Wako, Saitama 3510198, Japan; [Hisatsune, Chihiro; Mikoshiba, Katsuhiko] Univ Tokyo, Div Mol Neurobiol, Inst Med Sci, Minato Ku, Tokyo 1088639, Japan; [Yasumatsu, Keiko; Yoshida, Ryusuke; Ninomiya, Yuzo] Kyushu Univ, Grad Sch Dent Sci, Sect Oral Neurosci, Higashi Ku, Fukuoka 8128582, Japan; [Takahashi-Iwanaga, Hiromi] Hokkaido Univ, Sch Med, Dept Anat, Sapporo, Hokkaido 0608638, Japan; [Mikoshiba, Katsuhiko] Japan Sci & Technol Agcy, ICORP, Calcium Oscillat Project, Chiyoda Ku, Tokyo 1020084, Japan	RIKEN; University of Tokyo; Kyushu University; Hokkaido University; Japan Science & Technology Agency (JST)	Hisatsune, C (corresponding author), RIKEN, Dev Neurobiol Lab, Brain Res Inst, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	chihiro@brain.riken.go.jp; mikosiba@brain.riken.go.jp	Takahashi-Iwanaga, Hiromi/A-4294-2012; Hisatsune, Chihiro/C-6661-2017; Mikoshiba, Katsuhiko/N-7943-2015; Kuroda, Yukiko/L-6332-2013; Kuroda, Yukiko/L-6332-2013	Hisatsune, Chihiro/0000-0001-7811-7784; Kuroda, Yukiko/0000-0002-5335-4238; Kuroda, Yukiko/0000-0001-7713-9471				Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Asano-Miyoshi M, 2001, CHEM SENSES, V26, P259, DOI 10.1093/chemse/26.3.259; AVENET P, 1988, NATURE, V331, P351, DOI 10.1038/331351a0; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Clapp TR, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-6; CUMMINGS TA, 1992, J GEN PHYSIOL, V99, P591, DOI 10.1085/jgp.99.4.591; Damak S, 2006, CHEM SENSES, V31, P253, DOI 10.1093/chemse/bjj027; Damak S, 2003, SCIENCE, V301, P850, DOI 10.1126/science.1087155; Dotson CD, 2005, CHEM SENSES, V30, P593, DOI 10.1093/chemse/bji053; Futatsugi A, 2005, SCIENCE, V309, P2232, DOI 10.1126/science.1114110; Hattori M, 2004, J BIOL CHEM, V279, P11967, DOI 10.1074/jbc.M311456200; He W, 2004, J NEUROSCI, V24, P7674, DOI 10.1523/JNEUROSCI.2441-04.2004; Hofmann T, 2003, CURR BIOL, V13, P1153, DOI 10.1016/S0960-9822(03)00431-7; Kawai K, 2000, P NATL ACAD SCI USA, V97, P11044, DOI 10.1073/pnas.190066697; KOLESNIKOV SS, 1995, NATURE, V376, P85, DOI 10.1038/376085a0; Matsumoto M, 1996, NATURE, V379, P168, DOI 10.1038/379168a0; Misaka T, 1998, ANN NY ACAD SCI, V855, P150, DOI 10.1111/j.1749-6632.1998.tb10558.x; Nelson G, 2002, NATURE, V416, P199, DOI 10.1038/nature726; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Ninomiya Y, 2000, J NUTR, V130, p950S, DOI 10.1093/jn/130.4.950S; Perez CA, 2003, CELL CALCIUM, V33, P541, DOI 10.1016/S0143-4160(03)00059-9; Perez CA, 2002, NAT NEUROSCI, V5, P1169, DOI 10.1038/nn952; Prawitt D, 2003, P NATL ACAD SCI USA, V100, P15166, DOI 10.1073/pnas.2334624100; ROYER SM, 1988, J COMP NEUROL, V270, P11, DOI 10.1002/cne.902700103; Scott K, 2005, NEURON, V48, P455, DOI 10.1016/j.neuron.2005.10.015; Scott K, 2004, CURR OPIN NEUROBIOL, V14, P423, DOI 10.1016/j.conb.2004.06.003; SUGIYAMA T, 1994, FEBS LETT, V349, P191, DOI 10.1016/0014-5793(94)00662-8; TAKEDA M, 1976, ARCH HISTOL JAPON, V39, P257, DOI 10.1679/aohc1950.39.257; Ullrich ND, 2005, CELL CALCIUM, V37, P267, DOI 10.1016/j.ceca.2004.11.001; Wong GT, 1996, NATURE, V381, P796, DOI 10.1038/381796a0; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0; Zhang Z, 2007, J NEUROSCI, V27, P5777, DOI 10.1523/JNEUROSCI.4973-06.2007; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4	33	113	117	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					37225	37231		10.1074/jbc.M705641200	http://dx.doi.org/10.1074/jbc.M705641200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17925404	hybrid			2022-12-27	WOS:000251646000048
J	Koski, MK; Hieta, R; Bollner, C; Kivirikko, KI; Myllyharju, J; Wierenga, RK				Koski, M. Kristian; Hieta, Reija; Bollner, Claudia; Kivirikko, Kari I.; Myllyharju, Johanna; Wierenga, Rik K.			The active site of an algal prolyl 4-hydroxylase has a large structural plasticity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE-BINDING DOMAIN; CRYSTAL-STRUCTURE; PROTEIN; HYDROXYLASE; FAMILY; HIF; IDENTIFICATION; DIOXYGENASES; INHIBITION; REVEALS	Prolyl 4-hydroxylases (P4Hs) are 2-oxoglutarate dioxygenases that catalyze the hydroxylation of peptidyl prolines. They play an important role in collagen synthesis, oxygen homeostasis, and plant cell wall formation. We describe four structures of a P4H from the green alga Chlamydomonas reinhardtii, two of the apoenzyme at 1.93 and 2.90 angstrom resolution, one complexed with the competitive inhibitor Zn2+, and one with Zn2+ and pyridine 2,4-dicarboxylate (which is an analogue of 2-oxoglutarate) at 1.85 angstrom resolution. The structures reveal the double-stranded beta-helix core fold (jellyroll motif), typical for 2-oxoglutarate dioxygenases. The catalytic site is at the center of an extended shallow groove lined by two flexible loops. Mutagenesis studies together with the crystal-lographic data indicate that this groove participates in the binding of the proline-rich peptide-substrates. It is discussed that the algal P4H and the catalytic domain of collagen P4Hs have notable structural similarities, suggesting that these enzymes form a separate structural subgroup of P4Hs different from the hypoxia-inducible factor P4Hs. Key structural differences between these two subgroups are described. These studies provide first insight into the structure-function relationships of the collagen P4Hs, which unlike the hypoxia-inducible factor P4Hs use proline-rich peptides as their substrates.	[Koski, M. Kristian; Hieta, Reija; Bollner, Claudia; Kivirikko, Kari I.; Myllyharju, Johanna; Wierenga, Rik K.] Univ Oulu, Bioctr Oulu, Collagen Res Unit, FIN-90014 Oulu, Finland; [Koski, M. Kristian; Wierenga, Rik K.] Univ Oulu, Dept Biochem, FIN-90014 Oulu, Finland; [Hieta, Reija; Bollner, Claudia; Kivirikko, Kari I.; Myllyharju, Johanna] Univ Oulu, Dept Med Biochem & Mol Biol, FIN-90014 Oulu, Finland	University of Oulu; Finland National Institute for Health & Welfare; University of Oulu; University of Oulu	Wierenga, RK (corresponding author), Univ Oulu, Bioctr Oulu, Collagen Res Unit, POB 3000, FIN-90014 Oulu, Finland.	rik.wierenga@oulu.fi		Hieta, Reija/0000-0001-5724-6253				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Blasiak LC, 2006, NATURE, V440, P368, DOI 10.1038/nature04544; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Choi KO, 2005, MOL PHARMACOL, V68, P1803, DOI 10.1124/mol.105.015271; Clifton IJ, 2003, J BIOL CHEM, V278, P20843, DOI 10.1074/jbc.M213054200; Clifton IJ, 2001, EUR J BIOCHEM, V268, P6625, DOI 10.1046/j.0014-2956.2001.02617.x; CLITTON IJ, 2006, J INORG BIOCHEM, V100, P644; Dann CE, 2002, P NATL ACAD SCI USA, V99, P15351, DOI 10.1073/pnas.202614999; Elkins JM, 2003, J BIOL CHEM, V278, P1802, DOI 10.1074/jbc.C200644200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Eriksson M, 1999, J BIOL CHEM, V274, P22131, DOI 10.1074/jbc.274.32.22131; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hieta R, 2003, J BIOL CHEM, V278, P34966, DOI 10.1074/jbc.M303624200; Hieta R, 2002, J BIOL CHEM, V277, P23965, DOI 10.1074/jbc.M201865200; Hirsila M, 2005, FASEB J, V19, P1308, DOI 10.1096/fj.04-3399fje; Hirsila M, 2003, J BIOL CHEM, V278, P30772, DOI 10.1074/jbc.M304982200; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; Ivan M, 2002, P NATL ACAD SCI USA, V99, P13459, DOI 10.1073/pnas.192342099; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kaelin WG, 2005, BIOCHEM BIOPH RES CO, V338, P627, DOI 10.1016/j.bbrc.2005.08.165; Keskiaho K, 2007, PLANT CELL, V19, P256, DOI 10.1105/tpc.106.042739; Kivirikko K. I., 1992, POSTTRANSLATIONAL MO, P1; Kivirikko KI, 1998, ADV ENZYMOL RAMB, V72, P325; Kukkola L, 2003, J BIOL CHEM, V278, P47685, DOI 10.1074/jbc.M306806200; Lee C, 2003, J BIOL CHEM, V278, P7558, DOI 10.1074/jbc.M210385200; Lloyd MD, 1999, J MOL BIOL, V287, P943, DOI 10.1006/jmbi.1999.2594; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; McDonough MA, 2006, P NATL ACAD SCI USA, V103, P9814, DOI 10.1073/pnas.0601283103; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Myllyharju J, 1999, EMBO J, V18, P306, DOI 10.1093/emboj/18.2.306; Myllyharju J, 2003, MATRIX BIOL, V22, P15, DOI 10.1016/S0945-053X(03)00006-4; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Myllyharju J, 1997, EMBO J, V16, P1173, DOI 10.1093/emboj/16.6.1173; Ozer A, 2007, NAT CHEM BIOL, V3, P144, DOI 10.1038/nchembio863; Pekkala M, 2004, J BIOL CHEM, V279, P52255, DOI 10.1074/jbc.M410007200; Ratcliffe PJ, 2006, CLIN MED, V6, P573, DOI 10.7861/clinmedicine.6-6-573; Taylor MS, 2001, GENE, V275, P125, DOI 10.1016/S0378-1119(01)00633-3; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Tiainen P, 2005, J BIOL CHEM, V280, P1142, DOI 10.1074/jbc.M411109200; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Yu B, 2006, NATURE, V439, P879, DOI 10.1038/nature04561; Yuasa K, 2005, PLANT J, V41, P81, DOI 10.1111/j.1365-313X.2004.02279.x; Zhang ZH, 2002, FEBS LETT, V517, P7, DOI 10.1016/S0014-5793(02)02520-6; Zhang ZH, 2000, NAT STRUCT BIOL, V7, P127	48	48	49	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					37112	37123		10.1074/jbc.M706554200	http://dx.doi.org/10.1074/jbc.M706554200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17940281	hybrid			2022-12-27	WOS:000251646000038
J	Kumasaka, T; Yamamoto, M; Furuichi, M; Nakasako, M; Teh, AH; Kimura, M; Yamaguchi, I; Ueki, T				Kumasaka, Takashi; Yamamoto, Masaki; Furuichi, Makio; Nakasako, Masayoshi; Teh, Aik-Hong; Kimura, Makoto; Yamaguchi, Isamu; Ueki, Tatzuo			Crystal structures of blasticidin S deaminase (BSD) - Implications for dynamic properties of catalytic zinc	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTIDINE DEAMINASE; ASPERGILLUS-TERREUS; TRICHROMATIC CONCEPT; BINDING; ENZYME; PURIFICATION; GENE	The set of blasticidin S (BS) and blasticidin S deaminase (BSD) is a widely used selectable marker for gene transfer experiments. BSD is a member of the cytidine deaminase (CDA) family; it is a zinc-dependent enzyme with three cysteines and one water molecule as zinc ligands. The crystal structures of BSD were determined in six states (i.e. native, substrate-bound, product-bound, cacodylate-bound, substrate-bound E56Q mutant, and R90K mutant). In the structures, the zinc position and coordination structures vary. The substrate-bound structure shows a large positional and geometrical shift of zinc with a double-headed electron density of the substrate that seems to be assigned to the amino and hydroxyl groups of the substrate and product, respectively. In this intermediate-like structure, the steric hindrance of the hydroxyl group pushes the zinc into the triangular plane consisting of three cysteines with a positional shift of similar to 0.6 A, and the fifth ligand water approaches the opposite direction of the substrate with a shift of 0.4 angstrom. Accordingly, the zinc coordination is changed from tetrahedral to trigonal bipyramidal, and its coordination distance is extended between zinc and its intermediate. The shift of zinc and the recruited water is also observed in the structure of the inactivated E56Q mutant. This novel observation is different in two-cysteine cytidine deaminase Escherichia coli CDA and might be essential for the reaction mechanism in BSD, since it is useful for the easy release of the product by charge compensation and for the structural change of the substrate.	[Kumasaka, Takashi; Teh, Aik-Hong; Ueki, Tatzuo] Japan Synchrotron Radiat Res Inst, Sayo, Hyogo 6795198, Japan; [Kumasaka, Takashi; Teh, Aik-Hong; Kimura, Makoto; Yamaguchi, Isamu] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Life Sci, Kanagawa 2268501, Japan; [Kumasaka, Takashi; Yamamoto, Masaki; Furuichi, Makio] RIKEN SPring8 Ctr, Sayo, Hyogo 6795148, Japan; [Nakasako, Masayoshi] Keio Univ, Fac Sci & Technol, Dept Phys, Kanagawa 2238522, Japan; [Kimura, Makoto; Yamaguchi, Isamu] RIKEN Wako Inst, Wako, Saitama 3510198, Japan	Japan Synchrotron Radiation Research Institute; Tokyo Institute of Technology; RIKEN; Keio University; RIKEN	Kumasaka, T (corresponding author), Japan Synchrotron Radiat Res Inst, SPring 8, Sayo, Hyogo 6795198, Japan.	kumasaka@spring8.or.jp	Teh, Aik Hong/D-3075-2013; Nakasako, Masayoshi/C-5673-2014; Yamamoto, Masaki/B-7844-2015; Kumasaka, Takashi/D-7428-2018; Kimura, Makoto/I-6906-2014	Teh, Aik Hong/0000-0001-6365-574X; Yamamoto, Masaki/0000-0002-1311-1768; Kumasaka, Takashi/0000-0001-9289-1557; Kimura, Makoto/0000-0001-5310-2893				Alberts IL, 1998, PROTEIN SCI, V7, P1700, DOI 10.1002/pro.5560070805; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BETTS L, 1994, J MOL BIOL, V235, P635, DOI 10.1006/jmbi.1994.1018; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CARLOW DC, 1999, BIOCHEMISTRY-US, V38, P1335; CHAKRABARTI P, 1989, BIOCHEMISTRY-US, V28, P6081, DOI 10.1021/bi00440a052; Christianson DW, 1999, ANNU REV BIOCHEM, V68, P33, DOI 10.1146/annurev.biochem.68.1.33; Chung SJ, 2005, J MED CHEM, V48, P658, DOI 10.1021/jm0496279; Coleman JE, 1998, CURR OPIN CHEM BIOL, V2, P222, DOI 10.1016/S1367-5931(98)80064-1; DeLano W.L, PYMOL MOL GRAPHICS S; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; Fabris D, 1999, INORG CHEM, V38, P1322, DOI 10.1021/ic9809963; Hansen JL, 2003, J MOL BIOL, V330, P1061, DOI 10.1016/S0022-2836(03)00668-5; Johansson E, 2002, BIOCHEMISTRY-US, V41, P2563, DOI 10.1021/bi011849a; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kimura M, 2000, J BIOCHEM, V127, P955, DOI 10.1093/oxfordjournals.jbchem.a022711; KIMURA M, 1994, BBA-GENE STRUCT EXPR, V1219, P653, DOI 10.1016/0167-4781(94)90224-0; Kimura M, 2002, BIOCHEM BIOPH RES CO, V290, P421, DOI 10.1006/bbrc.2001.6184; KIMURA M, 1994, MOL GEN GENET, V242, P121, DOI 10.1007/BF00391004; Kleifeld O, 2003, NAT STRUCT BIOL, V10, P98, DOI 10.1038/nsb889; Korkhin Y, 1998, J MOL BIOL, V278, P967, DOI 10.1006/jmbi.1998.1750; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kumasaka T, 2002, STRUCTURE, V10, P1205, DOI 10.1016/S0969-2126(02)00830-4; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; McCall KA, 2000, J NUTR, V130, p1437S, DOI 10.1093/jn/130.5.1437S; MERRIT EA, 1991, ACTA CRYSTALLOGR D, V50, P869; MULLER WEG, 1979, CANCER RES, V39, P1102; Nakasako M, 1999, ACTA CRYSTALLOGR D, V55, P547, DOI 10.1107/S0907444998011809; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perutz MF, 1998, ANNU REV BIOPH BIOM, V27, P1, DOI 10.1146/annurev.biophys.27.1.1; REIZER J, 1994, PROTEIN SCI, V3, P853; Sanghani PC, 2002, BIOCHEMISTRY-US, V41, P15189, DOI 10.1021/bi026705q; Shih P, 1996, BIOCHEMISTRY-US, V35, P4697, DOI 10.1021/bi952357z; Snider MJ, 2000, BIOCHEMISTRY-US, V39, P9746, DOI 10.1021/bi000914y; STEUART CD, 1971, NATURE-NEW BIOL, V233, P109, DOI 10.1038/newbio233109a0; STEWART JJP, 1990, J COMPUT AID MOL DES, V4, P1, DOI 10.1007/BF00128336; TAKEUCHI S, 1958, J ANTIBIOT, V11, P1; Teh AH, 2006, BIOCHEMISTRY-US, V45, P7825, DOI 10.1021/bi060345f; WILSON DK, 1994, NAT STRUCT BIOL, V1, P691, DOI 10.1038/nsb1094-691; Xiang SB, 1996, BIOCHEMISTRY-US, V35, P1335, DOI 10.1021/bi9525583; Xiang SB, 1997, BIOCHEMISTRY-US, V36, P4768, DOI 10.1021/bi963091e; Xie KF, 2004, P NATL ACAD SCI USA, V101, P8114, DOI 10.1073/pnas.0400493101; YAMAGUCHI I, 1986, PESTIC BIOCHEM PHYS, V25, P54, DOI 10.1016/0048-3575(86)90031-3; YAMAGUCHI I, 1975, J ANTIBIOT, V28, P7, DOI 10.7164/antibiotics.28.7; Yamamoto M, 1998, J SYNCHROTRON RADIAT, V5, P222, DOI 10.1107/S0909049597014738; Yoshida H., 1997, J CHEM SOFTWARE, V3, P147	46	15	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					37103	37111		10.1074/jbc.M704476200	http://dx.doi.org/10.1074/jbc.M704476200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17959604	hybrid			2022-12-27	WOS:000251646000037
J	Seki, A; Hanaoka, M; Akimoto, Y; Masuda, S; Iwasaki, H; Tanaka, K				Seki, Asako; Hanaoka, Mitsumasa; Akimoto, Yuki; Masuda, Susumu; Iwasaki, Hideo; Tanaka, Kan			Induction of a group 2 sigma factor, RPOD3, by high light and the underlying mechanism in Synechococcus elongatus PCC 7942	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; STRAIN PCC 7002; RNA-POLYMERASE; POSITIVE REGULATION; ESCHERICHIA-COLI; GENES; EXPRESSION; IDENTIFICATION; CYANOBACTERIA; TRANSCRIPTION	Among the sigma(70) family bacterial sigma factors, group 2 sigma factors have similar promoter recognition specificity to group 1 (principal) sigma factors and express and function under specific environmental and physiological conditions. In general, the cyanobacterial genome encodes more than four group 2 sigma factors, and the unicellular Synechococcus elongatus PCC 7942 (Synechococcus) has five group 2 sigma factors (RpoD2 - 6). In this study, we analyzed expression of group 2 sigma factors of Synechococcus at both mRNA and protein levels, and we showed that the rpoD3 expression was activated only by high light (1,500 mu mol photons m(-2) s(-1)) among the various stress conditions examined. After high light shift, rpoD3 mRNA accumulated transiently within the first 5 min and diminished subsequently, whereas RpoD3 protein increased gradually during the first several hours. We also found that the rpoD3 deletion mutant rapidly lost viability under the same conditions. Analysis of the rpoD3 promoter structure revealed the presence of an HLR1 (high light-responsive element 1) sequence, which was suggested to be responsible for the high light-induced transcription under the control of the Nb1S (histidine kinase)-RpaB ( response regulator) two-component system (Kappell, A. D., and van Waasbergen, L. G. (2007) Arch. Microbiol. 187, 337 - 342), at +6 to +23 with respect to the transcriptional start site. Here we demonstrated that recombinant RpaB protein specifically bound to HLR1 of the rpoD3 and hliA genes in vitro, and overexpression of a truncated RpaB variant harboring only the phosphoreceiver domain derepressed the transcription in vivo. Thus, we have concluded that phosphorylated RpaB are repressing the rpoD3 and hliA transcription under normal growth conditions, and the RpaB dephosphorylation induced by high light stress results in transcriptional derepression.	[Seki, Asako; Hanaoka, Mitsumasa; Masuda, Susumu; Tanaka, Kan] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; [Akimoto, Yuki; Iwasaki, Hideo] Waseda Univ, Grad Sch Sci & Engn, Shinjuku Ku, Dept Elect Engn & Biosci, Tokyo 1698555, Japan	University of Tokyo; Waseda University	Tanaka, K (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan.	kntanaka@iam.u-tokyo.ac.jp	Hanaoka, Mitsumasa/M-9904-2015; Tanaka, Kan/E-3724-2015	Tanaka, Kan/0000-0001-7560-7884; Goto, Asako/0000-0002-0002-2619; Iwasaki, Hideo/0000-0002-3754-4955				Ashby MK, 2006, MICROBIOL MOL BIOL R, V70, P472, DOI 10.1128/MMBR.00046-05; Ashby MK, 2002, FEMS MICROBIOL LETT, V214, P25; Ashby MK, 1999, FEMS MICROBIOL LETT, V181, P253, DOI 10.1016/S0378-1097(99)00547-9; BlondeletRouault MH, 1997, GENE, V190, P315, DOI 10.1016/S0378-1119(97)00014-0; BRAHAMSHA B, 1992, J BACTERIOL, V174, P7273, DOI 10.1128/jb.174.22.7273-7282.1992; Buck M, 2006, BIOCHEM SOC T, V34, P1067, DOI 10.1042/BST0341067; Caslake LF, 1997, MICROBIOL-SGM, V143, P3807, DOI 10.1099/00221287-143-12-3807; Goto-Seki A, 1999, MOL MICROBIOL, V34, P473, DOI 10.1046/j.1365-2958.1999.01608.x; Gruber TM, 1998, ARCH MICROBIOL, V169, P211, DOI 10.1007/s002030050563; Gruber TM, 2003, ANNU REV MICROBIOL, V57, P441, DOI 10.1146/annurev.micro.57.030502.090913; Gusa AA, 2006, J BACTERIOL, V188, P4620, DOI 10.1128/JB.00198-06; Head CG, 1998, J MOL BIOL, V281, P857, DOI 10.1006/jmbi.1998.1985; Hsiao HY, 2004, J BACTERIOL, V186, P3882, DOI 10.1128/JB.186.12.3882-3888.2004; Imamura S, 2006, J BIOL CHEM, V281, P2668, DOI 10.1074/jbc.M509639200; Imamura S, 2003, FEBS LETT, V554, P357, DOI 10.1016/S0014-5793(03)01188-8; Kaneko T, 1997, PLANT CELL PHYSIOL, V38, P1171, DOI 10.1093/oxfordjournals.pcp.a029103; Kaneko T, 2001, DNA RES, V8, P205, DOI 10.1093/dnares/8.5.205; Kanesaki Y, 2002, BIOCHEM BIOPH RES CO, V290, P339, DOI 10.1006/bbrc.2001.6201; Kappell AD, 2007, ARCH MICROBIOL, V187, P337, DOI 10.1007/s00203-007-0213-1; Kappell AD, 2006, ARCH MICROBIOL, V186, P403, DOI 10.1007/s00203-006-0154-0; Khudyakov IY, 2001, J BACTERIOL, V183, P6667, DOI 10.1128/JB.183.22.6667-6675.2001; Kutsuna S, 1998, J BACTERIOL, V180, P2167, DOI 10.1128/JB.180.8.2167-2174.1998; Li W, 2007, J BACTERIOL, V189, P5413, DOI 10.1128/JB.00432-07; Los DA, 1997, MOL MICROBIOL, V25, P1167, DOI 10.1046/j.1365-2958.1997.5641912.x; Murata N, 2006, J EXP BOT, V57, P235, DOI 10.1093/jxb/erj005; Muro-Pastor AM, 2001, J BACTERIOL, V183, P1090, DOI 10.1128/JB.183.3.1090-1095.2001; Nair U, 2002, J BACTERIOL, V184, P3530, DOI 10.1128/JB.184.13.3530-3538.2002; Osanai T, 2005, J BIOL CHEM, V280, P30653, DOI 10.1074/jbc.M505043200; Paget MSB, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-203; RIPPKA R, 1988, METHOD ENZYMOL, V167, P3; Sugita C, 2007, PHOTOSYNTH RES, V93, P55, DOI 10.1007/s11120-006-9122-4; Suzuki I, 2000, EMBO J, V19, P1327, DOI 10.1093/emboj/19.6.1327; TANAKA K, 1992, BIOSCI BIOTECH BIOCH, V56, P1113, DOI 10.1271/bbb.56.1113; TANAKA K, 1992, BIOCHIM BIOPHYS ACTA, V1132, P94, DOI 10.1016/0167-4781(92)90060-D; TANAKA K, 1993, P NATL ACAD SCI USA, V90, P3511, DOI 10.1073/pnas.90.8.3511; Tsinoremas NF, 1996, EMBO J, V15, P2488, DOI 10.1002/j.1460-2075.1996.tb00606.x; Tu CJ, 2004, J BACTERIOL, V186, P3889, DOI 10.1128/JB.186.12.3889-3902.2004; Tuominen I, 2006, FEBS LETT, V580, P319, DOI 10.1016/j.febslet.2005.11.082; Zhou YN, 1998, J BACTERIOL, V180, P1154, DOI 10.1128/JB.180.5.1154-1158.1998	39	44	45	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					36887	36894		10.1074/jbc.M707582200	http://dx.doi.org/10.1074/jbc.M707582200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17977831	hybrid			2022-12-27	WOS:000251646000014
J	Pichiule, P; Chavez, JC; Schmidt, AM; Vannucci, SJ				Pichiule, Paola; Chavez, Juan Carlos; Schmidt, Ann Marie; Vannucci, Susan J.			Hypoxia-inducible factor-1 mediates neuronal expression of the receptor for advanced glycation end products following hypoxia/ischemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SURFACE RECEPTOR; NEURITE OUTGROWTH; ALZHEIMERS-DISEASE; FOCAL ISCHEMIA; BRAIN-INJURY; RAGE; ACTIVATION; S100B; MOUSE; AMPHOTERIN	Activation of the receptor for advanced glycation endproducts (RAGE) by its multiple ligands can trigger diverse signaling pathways with injurious or pro-survival consequences. In this study, we show that Rage mRNA and protein levels were stimulated in the mouse brain after experimental stroke and systemic hypoxia. In both cases, RAGE expression was primarily associated with neurons. Activation of RAGE-dependent pathway(s) post-ischemia appears to have a neuroprotective role because mice genetically deficient for RAGE exhibited increased infarct size 24 h after injury. Up-regulation of RAGE expression was also observed in primary neurons subjected to hypoxia or oxygen-glucose deprivation, an in vitro model of ischemia. Treatment of neurons with low concentrations of S100B decreased neuronal death after oxygen-glucose deprivation, and this effect was abolished by a neutralizing antibody against RAGE. Conversely, high concentrations of exogenous S100B had a cytotoxic effect that seems to be RAGE-independent. As an important novel finding, we demonstrate that hypoxic stimulation of RAGE expression is mediated by the transcription factor hypoxia-inducible factor-1. This conclusion is supported by the finding that HIF-1 alpha down-regulation by Cre-mediated excision drastically decreased RAGE induction by hypoxia or desferrioxamine. In addition, we showed that the mouse RAGE promoter region contains at least one functional HIF-1 binding site, located upstream of the proposed transcription start site. A luciferase reporter construct containing this RAGE promoter fragment was activated by hypoxia, and mutation at the potential HIF-1 binding site decreased hypoxia-dependent promoter activation. Specific binding of HIF-1 to this putative HRE in hypoxic cells was detected by chromatin immunoprecipitation assay.	Columbia Univ, Dept Pediat, New York, NY 10032 USA; Columbia Univ, Dept Surg, New York, NY 10032 USA; Cornell Univ, Coll Med, Burke Med Res Inst, White Plains, NY 10605 USA; Cornell Univ, Weill Med Coll, Dept Neurol & Neurosci, New York, NY 10021 USA	Columbia University; Columbia University; Cornell University; Cornell University	Vannucci, SJ (corresponding author), Columbia Univ, Morgan Stanley Childrens Hosp New York, Dept Pediat, 3959 Broadway,CHN 10-24, New York, NY 10032 USA.	sv2020@columbia.edu						Ahlemeyer B, 2000, BRAIN RES, V858, P121, DOI 10.1016/S0006-8993(99)02438-5; Baranova O, 2007, J NEUROSCI, V27, P6320, DOI 10.1523/JNEUROSCI.0449-07.2007; Bergeron M, 1999, EUR J NEUROSCI, V11, P4159, DOI 10.1046/j.1460-9568.1999.00845.x; Bianchi R, 2007, J LEUKOCYTE BIOL, V81, P108, DOI 10.1189/jlb.0306198; Bierhaus A, 2004, J CLIN INVEST, V114, P1741, DOI 10.1172/JCI200418058; BRETT J, 1993, AM J PATHOL, V143, P1699; Bucciarelli LG, 2006, CIRCULATION, V113, P1226, DOI 10.1161/CIRCULATIONAHA.105.575993; Businaro R, 2006, J NEUROSCI RES, V83, P897, DOI 10.1002/jnr.20785; Chavakis T, 2003, J EXP MED, V198, P1507, DOI 10.1084/jem.20030800; Chavez JC, 2000, J APPL PHYSIOL, V89, P1937, DOI 10.1152/jappl.2000.89.5.1937; Chavez JC, 2002, J NEUROSCI, V22, P8922; Chavez JC, 2006, J NEUROSCI, V26, P9471, DOI 10.1523/JNEUROSCI.2838-06.2006; Constien R, 2001, GENESIS, V30, P36, DOI 10.1002/gene.1030; Ding KH, 2006, BIOCHEM BIOPH RES CO, V340, P1091, DOI 10.1016/j.bbrc.2005.12.107; Elvidge GP, 2006, J BIOL CHEM, V281, P15215, DOI 10.1074/jbc.M511408200; Hanford LE, 2004, J BIOL CHEM, V279, P50019, DOI 10.1074/jbc.M409782200; Harashima A, 2006, BIOCHEM J, V396, P109, DOI 10.1042/BJ20051573; Hirsila M, 2005, FASEB J, V19, P1308, DOI 10.1096/fj.04-3399fje; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; HORI O, 1995, J BIOL CHEM, V270, P25752, DOI 10.1074/jbc.270.43.25752; Huttunen HJ, 1999, J BIOL CHEM, V274, P19919, DOI 10.1074/jbc.274.28.19919; Huttunen HJ, 2002, J BIOL CHEM, V277, P38635, DOI 10.1074/jbc.M202515200; Huttunen HJ, 2000, J BIOL CHEM, V275, P40096, DOI 10.1074/jbc.M006993200; Kogel D, 2004, NEUROSCIENCE, V127, P913, DOI 10.1016/j.neuroscience.2004.06.013; Leclerc E, 2007, J BIOL CHEM, V282, P31317, DOI 10.1074/jbc.M703951200; Li JF, 1997, J BIOL CHEM, V272, P16498, DOI 10.1074/jbc.272.26.16498; Liliensiek B, 2004, J CLIN INVEST, V113, P1641, DOI 10.1172/JCI200418704; Lue LF, 2001, EXP NEUROL, V171, P29, DOI 10.1006/exnr.2001.7732; Luth HJ, 2005, CEREB CORTEX, V15, P211, DOI 10.1093/cercor/bhh123; Ma L, 2003, BRAIN RES, V966, P167, DOI 10.1016/S0006-8993(02)04149-5; Matsui T, 2002, J CEREBR BLOOD F MET, V22, P711, DOI 10.1097/00004647-200206000-00010; NEEPER M, 1992, J BIOL CHEM, V267, P14998; Ostendorp T, 2007, EMBO J, V26, P3868, DOI 10.1038/sj.emboj.7601805; Park JS, 2004, J BIOL CHEM, V279, P7370, DOI 10.1074/jbc.M306793200; Ponath G, 2007, J NEUROIMMUNOL, V184, P214, DOI 10.1016/j.jneuroim.2006.12.011; Ratcliffe PJ, 2006, CLIN MED, V6, P573, DOI 10.7861/clinmedicine.6-6-573; Rong LL, 2005, RESTOR NEUROL NEUROS, V23, P355; Rong LL, 2004, FASEB J, V18, P1818, DOI 10.1096/fj.04-1900com; Rong LL, 2004, FASEB J, V18, P1812, DOI 10.1096/fj.04-1899com; Ryan HE, 2000, CANCER RES, V60, P4010; Semenza GL, 2000, J APPL PHYSIOL, V88, P1474, DOI 10.1152/jappl.2000.88.4.1474; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Shanmugam N, 2003, J BIOL CHEM, V278, P34834, DOI 10.1074/jbc.M302828200; Sorci G, 2003, MOL CELL BIOL, V23, P4870, DOI 10.1128/MCB.23.14.4870-4881.2003; Tadin D, 2006, J NEUROSCI, V26, P11403, DOI 10.1523/JNEUROSCI.2592-06.2006; Taguchi A, 2000, NATURE, V405, P354, DOI 10.1038/35012626; Toth C, 2006, NEUROBIOL DIS, V23, P445, DOI 10.1016/j.nbd.2006.03.015; Vannucci SJ, 2001, J CEREBR BLOOD F MET, V21, P52, DOI 10.1097/00004647-200101000-00007; Vincent AM, 2007, ENDOCRINOLOGY, V148, P548, DOI 10.1210/en.2006-0073; Wenger Roland H, 2005, Sci STKE, V2005, pre12, DOI 10.1126/stke.3062005re12; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0; Yan SF, 2003, CIRC RES, V93, P1159, DOI 10.1161/01.RES.0000103862.26506.3D; Yasuda Y, 2004, BRAIN RES, V1021, P20, DOI 10.1016/j.brainres.2004.06.015; Zhang LQ, 2004, J CLIN INVEST, V113, P85, DOI 10.1172/JCI200418336	54	81	83	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36330	36340		10.1074/jbc.M706407200	http://dx.doi.org/10.1074/jbc.M706407200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17942394	hybrid			2022-12-27	WOS:000251458300024
J	Sayegh, J; Webb, K; Cheng, DH; Bedford, MT; Clarke, SG				Sayegh, Joyce; Webb, Kristofor; Cheng, Donghang; Bedford, Mark T.; Clarke, Steven G.			Regulation of protein arginine methyltransferase 8 (PRMT8) activity by its N-terminal domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN ARGININE METHYLTRANSFERASE; SUBSTRATE-SPECIFICITY; S-ADENOSYLMETHIONINE; METHYLATION; BINDING; TRANSCRIPTION; RESIDUES; RNA; IDENTIFICATION; FAMILY	Human protein arginine methyltransferase PRMT8 has been recently described as a type I enzyme in brain that is localized to the plasma membrane by N-terminal myristoylation. The amino acid sequence of human PRMT8 is almost 80% identical to human PRMT1, the major protein arginine methyltransferase activity in mammalian cells. However, the activity of a recombinant PRMT8 GST fusion protein toward methyl-accepting substrates is much lower than that of a GST fusion of PRMT1. We show here that both His-tagged and GST fusion species lacking the initial 60 amino acid residues of PRMT8 have enhanced enzymatic activity, suggesting that the N-terminal domain may regulate PRMT8 activity. This conclusion is supported by limited proteolysis experiments showing an increase in the activity of the digested full-length protein, consistent with the loss of the N-terminal domain. In contrast, the activity of the N-terminal truncated protein was slightly diminished by limited proteolysis. Significantly, we detect automethylation at two sites in the N-terminal domain, as well as binding sites for SH3 domain-containing proteins. We suggest that the N-terminal domain may function as an autoregulator that may be displaced by interaction with one or more physiological inducers.	Univ Calif Los Angeles, Inst Mol Biol, Dept Chem & Biochem, Los Angeles, CA 90095 USA; Univ Texas MD Anderson Canc Ctr, Sci Pk Res Div, Smithville, TX 78957 USA	University of California System; University of California Los Angeles; University of Texas System; UTMD Anderson Cancer Center	Clarke, SG (corresponding author), Univ Calif Los Angeles, Inst Mol Biol, Dept Chem & Biochem, 607 Charles E Young Dr E, Los Angeles, CA 90095 USA.	clarke@mbi.ucla.edu	Bedford, Mark T/E-7856-2011	Webb, Kristofor/0000-0001-8111-9756	NIGMS NIH HHS [GM026020] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026020, R37GM026020] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Araya N, 2005, BIOCHEM BIOPH RES CO, V329, P653, DOI 10.1016/j.bbrc.2005.02.018; Bachand F, 2004, EMBO J, V23, P2641, DOI 10.1038/sj.emboj.7600265; Bachand F, 2007, EUKARYOT CELL, V6, P889, DOI 10.1128/EC.00099-07; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Bedford MT, 2000, J BIOL CHEM, V275, P16030, DOI 10.1074/jbc.M909368199; Branscombe TL, 2001, J BIOL CHEM, V276, P32971, DOI 10.1074/jbc.M105412200; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; Cheng DH, 2007, MOL CELL, V25, P71, DOI 10.1016/j.molcel.2006.11.019; Cook JR, 2006, BIOCHEM BIOPH RES CO, V342, P472, DOI 10.1016/j.bbrc.2006.01.167; Covic M, 2005, EMBO J, V24, P85, DOI 10.1038/sj.emboj.7600500; El Messaoudi S, 2006, P NATL ACAD SCI USA, V103, P13351, DOI 10.1073/pnas.0605692103; Espejo A, 2002, BIOCHEM J, V367, P697, DOI 10.1042/BJ20020860; Fabbrizio E, 2002, EMBO REP, V3, P641, DOI 10.1093/embo-reports/kvf136; Fackelmayer FO, 2005, TRENDS BIOCHEM SCI, V30, P666, DOI 10.1016/j.tibs.2005.10.002; Farrar C, 2002, J BIOL CHEM, V277, P27856, DOI 10.1074/jbc.M203911200; Frankel A, 2002, J BIOL CHEM, V277, P3537, DOI 10.1074/jbc.M108786200; Gary JD, 1998, PROG NUCLEIC ACID RE, V61, P65, DOI 10.1016/S0079-6603(08)60825-9; Gehrig PM, 2004, J AM SOC MASS SPECTR, V15, P142, DOI 10.1016/j.jasms.2003.10.002; Goulet I, 2007, J BIOL CHEM, V282, P33009, DOI 10.1074/jbc.M704349200; Herrmann F, 2005, J BIOL CHEM, V280, P38005, DOI 10.1074/jbc.M502458200; Hung CM, 2004, GENE, V340, P179, DOI 10.1016/j.gene.2004.07.039; INARNITSU M, 2006, FEBS LETT, V580, P6603; Kim J, 2006, EMBO REP, V7, P397, DOI 10.1038/sj.embor.7400625; Krause CD, 2007, PHARMACOL THERAPEUT, V113, P50, DOI 10.1016/j.pharmthera.2006.06.007; Krones-Herzig A, 2006, J BIOL CHEM, V281, P3025, DOI 10.1074/jbc.M509770200; Lee J, 2005, J BIOL CHEM, V280, P32890, DOI 10.1074/jbc.M506944200; Lee JH, 2005, J BIOL CHEM, V280, P3656, DOI 10.1074/jbc.M405295200; Lin WJ, 1996, J BIOL CHEM, V271, P15034, DOI 10.1074/jbc.271.25.15034; LIU Q, 1995, MOL CELL BIOL, V15, P2800; Miranda TB, 2004, J BIOL CHEM, V279, P22902, DOI 10.1074/jbc.M312904200; Naeem H, 2007, MOL CELL BIOL, V27, P120, DOI 10.1128/MCB.00815-06; Nagar B, 2006, MOL CELL, V21, P787, DOI 10.1016/j.molcel.2006.01.035; Niewmierzycka A, 1999, J BIOL CHEM, V274, P814, DOI 10.1074/jbc.274.2.814; Pahlich S, 2006, BBA-PROTEINS PROTEOM, V1764, P1890, DOI 10.1016/j.bbapap.2006.08.008; Rowe DC, 2006, P NATL ACAD SCI USA, V103, P6299, DOI 10.1073/pnas.0510041103; Swiercz R, 2005, BIOCHEM J, V386, P85, DOI 10.1042/BJ20041466; Taneda T, 2007, BRAIN RES, V1155, P1, DOI 10.1016/j.brainres.2007.03.086; Tang J, 1998, J BIOL CHEM, V273, P16935, DOI 10.1074/jbc.273.27.16935; Tang J, 2000, J BIOL CHEM, V275, P7723, DOI 10.1074/jbc.275.11.7723; Tanner S, 2005, ANAL CHEM, V77, P4626, DOI 10.1021/ac050102d; Yadav N, 2003, P NATL ACAD SCI USA, V100, P6464, DOI 10.1073/pnas.1232272100; Yaffe MB, 2001, NAT BIOTECHNOL, V19, P348, DOI 10.1038/86737; Yun CY, 2000, J CELL BIOL, V150, P707, DOI 10.1083/jcb.150.4.707; Zhang X, 2003, STRUCTURE, V11, P509, DOI 10.1016/S0969-2126(03)00071-6; Zobel-Thropp P, 1998, J BIOL CHEM, V273, P29283, DOI 10.1074/jbc.273.45.29283	45	80	85	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36444	36453		10.1074/jbc.M704650200	http://dx.doi.org/10.1074/jbc.M704650200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17925405	hybrid			2022-12-27	WOS:000251458300036
J	Wang, Y; Fu, X; Gaiser, S; Kottgen, M; Kramer-Zucker, A; Walz, G; Wegierski, T				Wang, Yan; Fu, Xiao; Gaiser, Stephanie; Koettgen, Michael; Kramer-Zucker, Albrecht; Walz, Gerd; Wegierski, Tomasz			OS-9 regulates the transit and polyubiquitination of TRPV4 in the endoplasmic reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; SHAKER POTASSIUM CHANNEL; MICE LACKING TRPV4; QUALITY-CONTROL; VANILLOID RECEPTOR; ION-CHANNEL; VR-OAC; DOMAIN; PROTEIN; GENE	Transient receptor potential (TRP) proteins constitute a family of cation-permeable channels that are formed by homo- or heteromeric assembly of four subunits. Despite recent progress in the identification of protein domains required for the formation of tetramers, the mechanisms governing TRP channel assembly, and biogenesis in general, remain largely elusive. In particular, little is known about the involvement of regulatory proteins in these processes. Here we report that OS-9, a ubiquitously expressed endoplasmic reticulum (ER)-associated protein, interacts with the cytosolic N-terminal tail of TRPV4. Using a combination of co-expression and knockdown approaches we have found that OS-9 impedes the release of TRPV4 from the ER and reduces its amount at the plasma membrane. Consistent with these in vitro findings, OS-9 protected zebrafish embryos against the detrimental effects of TRPV4 expression in vivo. A detailed analysis of the underlying mechanisms revealed that OS-9 preferably binds TRPV4 monomers and other ER-localized, immature variants of TRPV4 and attenuates their polyubiquitination. Thus, OS-9 regulates the secretory transport of TRPV4 and appears to protect TRPV4 subunits from the precocious ubiquitination and ER-associated degradation. Our data suggest that OS-9 functions as an auxiliary protein for TRPV4 maturation.	Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Univ Hosp, Div Renal, D-79106 Freiburg, Germany	Johns Hopkins University; Johns Hopkins University; University of Freiburg	Wegierski, T (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA.	wegierski@med1.ukl.uni-freiburg.de	Wegierski, Tomasz/AAG-3284-2020	Wegierski, Tomasz/0000-0003-2635-8580; Kottgen, Michael/0000-0003-2406-5039				Arniges M, 2006, J BIOL CHEM, V281, P1580, DOI 10.1074/jbc.M511456200; Baek JH, 2005, MOL CELL, V17, P503, DOI 10.1016/j.molcel.2005.01.011; Chang Q, 2004, J BIOL CHEM, V279, P54304, DOI 10.1074/jbc.M406222200; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Cormier JH, 2005, MOL CELL, V19, P717, DOI 10.1016/j.molcel.2005.08.029; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Engelke M, 2002, FEBS LETT, V523, P193, DOI 10.1016/S0014-5793(02)02971-X; Erler I, 2004, J BIOL CHEM, V279, P34456, DOI 10.1074/jbc.M404778200; Erler I, 2006, J BIOL CHEM, V281, P38396, DOI 10.1074/jbc.M607756200; Friedmann E, 2002, J BIOL CHEM, V277, P35274, DOI 10.1074/jbc.M201044200; Gao X, 2003, J BIOL CHEM, V278, P27129, DOI 10.1074/jbc.M302517200; Garcia-Sanz N, 2004, J NEUROSCI, V24, P5307, DOI 10.1523/JNEUROSCI.0202-04.2004; GREEN WN, 1995, TRENDS NEUROSCI, V18, P280, DOI 10.1016/0166-2236(95)93915-K; Guler AD, 2002, J NEUROSCI, V22, P6408; Hellwig N, 2005, J CELL SCI, V118, P917, DOI 10.1242/jcs.01675; Kimura Y, 1998, J BIOCHEM-TOKYO, V123, P876; KOPITO RR, 1999, PHYSIOL REV, V79, P167; LI M, 1992, SCIENCE, V257, P1225, DOI 10.1126/science.1519059; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P13698, DOI 10.1073/pnas.1735416100; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P14531, DOI 10.1073/pnas.2235619100; Litovchick L, 2002, J BIOL CHEM, V277, P34413, DOI 10.1074/jbc.M203986200; Mei ZZ, 2006, J BIOL CHEM, V281, P38748, DOI 10.1074/jbc.M607591200; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Mizuno A, 2003, AM J PHYSIOL-CELL PH, V285, pC96, DOI 10.1152/ajpcell.00559.2002; Montell C, 2002, CELL, V108, P595, DOI 10.1016/S0092-8674(02)00670-0; Nakayama T, 1999, FEBS LETT, V453, P77, DOI 10.1016/S0014-5793(99)00700-0; Sato S, 1998, J BIOL CHEM, V273, P7189, DOI 10.1074/jbc.273.13.7189; Schaefer M, 2005, PFLUG ARCH EUR J PHY, V451, P35, DOI 10.1007/s00424-005-1467-6; Schulteis CT, 1998, J BIOL CHEM, V273, P26210, DOI 10.1074/jbc.273.40.26210; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Su YA, 1996, MOL CARCINOGEN, V15, P270, DOI 10.1002/(SICI)1098-2744(199604)15:4<270::AID-MC4>3.0.CO;2-K; Suzuki M, 2003, J BIOL CHEM, V278, P22664, DOI 10.1074/jbc.M302561200; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; Tsuruda PR, 2006, NEURON, V51, P201, DOI 10.1016/j.neuron.2006.06.023; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; Watanabe H, 2003, NATURE, V424, P434, DOI 10.1038/nature01807; Watanabe H, 2002, J BIOL CHEM, V277, P13569, DOI 10.1074/jbc.M200062200; Wegierski T, 2006, EMBO J, V25, P5659, DOI 10.1038/sj.emboj.7601429; WESTERFIELD M, 1995, ZABRAFISH BOOK GUIDE; Wissenbach U, 2000, FEBS LETT, V485, P127, DOI 10.1016/S0014-5793(00)02212-2; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4	45	48	52	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36561	36570		10.1074/jbc.M703903200	http://dx.doi.org/10.1074/jbc.M703903200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17932042	hybrid			2022-12-27	WOS:000251458300049
J	McNevin, DB; Badger, MR; Whitney, SM; von Caemmerer, S; Tcherkez, GGB; Farquhar, GD				McNevin, Dennis B.; Badger, Murray R.; Whitney, Spencer M.; von Caemmerer, Susanne; Tcherkez, Guillaume G. B.; Farquhar, Graham D.			Differences in carbon isotope discrimination of three variants of d-ribulose-1,5-bisphosphate carboxylase/oxygenase reflect differences in their catalytic mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBULOSE-BISPHOSPHATE CARBOXYLASE; WATER-USE EFFICIENCY; RIBULOSEBISPHOSPHATE CARBOXYLASE; RIBULOSE-1,5-BISPHOSPHATE CARBOXYLASE; PHOSPHOENOLPYRUVATE CARBOXYLASE; LARGE SUBUNITS; SIDE REACTIONS; FRACTIONATION; RUBISCO; OXYGEN	The carboxylation kinetic (stable carbon) isotope effect was measured for purified D-ribulose-1,5-bisphosphate carboxylases/oxygenases (Rubiscos) with aqueous CO2 as substrate by monitoring Rayleigh fractionation using membrane inlet mass spectrometry. This resulted in discriminations (Delta) of 27.4 +/- 0.9 parts per thousand for wild-type tobacco Rubisco, 22.2 +/- 2.1 parts per thousand for Rhodospirillum rubrum Rubisco, and 11.2 +/- 1.6 parts per thousand for a large subunit mutant of tobacco Rubisco in which Leu(335) is mutated to valine (L335V). These Delta values are consistent with the photosynthetic discrimination determined for wild-type tobacco and transplastomic tobacco lines that exclusively produce R. rubrum or L335V Rubisco. The Delta values are indicative of the potential evolutionary variability of Delta values for a range of Rubiscos from different species: Form I Rubisco from higher plants; prokaryotic Rubiscos, including Form II; and the L335V mutant. We explore the implications of these Delta values for the Rubisco catalytic mechanism and suggest that Rubiscos that are associated with a lower Delta value have a less product-like carboxylation transition state and/or allow a decarboxylation step that evolution has excluded in higher plants.	Australian Natl Univ, Res Sch Biol Sci, Canberra, ACT 2601, Australia; Univ Canberra, Sch Hlth Sci, Bruce, ACT 2601, Australia; Univ Paris 11, Lab Ecophysiol Vegetale, F-91405 Orsay, France	Australian National University; University of Canberra; UDICE-French Research Universities; Universite Paris Saclay	Farquhar, GD (corresponding author), Australian Natl Univ, Res Sch Biol Sci, GPO Box 475, Canberra, ACT 2601, Australia.	graham.farquhar@anu.edu.au	von Caemmerer, Susanne/C-9317-2009; Whitney, Spencer M/C-9266-2009; FARQUHAR, GRAHAM D/A-3722-2008; McNevin, Dennis/H-3351-2019; Tcherkez, Guillaume/L-1300-2015	Whitney, Spencer M/0000-0003-2954-2359; McNevin, Dennis/0000-0003-1665-3367; Farquhar, Graham/0000-0002-7065-1971; Badger, Murray/0000-0001-9428-2579				Andersson I, 2003, ARCH BIOCHEM BIOPHYS, V414, P130, DOI 10.1016/S0003-9861(03)00164-4; Andrews T.J., 1987, BIOCH PLANTS, P131, DOI 10.1016/B978-0-12-675410-0.50009-9; ANDREWS TJ, 1991, J BIOL CHEM, V266, P9447; ANDREWS TJ, 1985, J BIOL CHEM, V260, P4632; ANDREWS TJ, 1988, J BIOL CHEM, V263, P12213; Badger MR, 1998, CAN J BOT, V76, P1052, DOI 10.1139/b98-074; BADGER MR, 2008, IN PRESS J EXP BOT; Badger MR, 1978, CARNEGIE I WASHINGTO, P355; Berti PJ, 1999, METHOD ENZYMOL, V308, P355; BIGELEISEN J, 1949, J CHEM PHYS, V17, P675, DOI 10.1063/1.1747368; Brugnoli Enrico, 2000, VVolume 9, P399; BUNCEL E, 1977, CARBON 13 ORGANIC CH; BUTZ ND, 1989, PLANT PHYSIOL, V89, P735, DOI 10.1104/pp.89.3.735; CHRISTELLER JT, 1976, PLANT PHYSIOL, V57, P580, DOI 10.1104/pp.57.4.580; Cooper A, 1999, CURR OPIN CHEM BIOL, V3, P557, DOI 10.1016/S1367-5931(99)00008-3; CRAIG H, 1957, GEOCHIM COSMOCHIM AC, V12, P133, DOI 10.1016/0016-7037(57)90024-8; EDMONDSON DL, 1990, PLANT PHYSIOL, V93, P1376, DOI 10.1104/pp.93.4.1376; FARQUHAR GD, 1989, ANNU REV PLANT PHYS, V40, P503, DOI 10.1146/annurev.pp.40.060189.002443; FARQUHAR GD, 1982, AUST J PLANT PHYSIOL, V9, P121, DOI 10.1071/PP9820121; FARQUHAR GD, 1983, AUST J PLANT PHYSIOL, V10, P205, DOI 10.1071/PP9830205; FARQUHAR GD, 1984, AUST J PLANT PHYSIOL, V11, P539, DOI 10.1071/PP9840539; FARQUHAR GD, 1979, ARCH BIOCHEM BIOPHYS, V193, P456, DOI 10.1016/0003-9861(79)90052-3; GRIFFITHS H, 1990, PLANTA, V181, P604, DOI 10.1007/BF00193017; GRIFFITHS H, 1992, PLANT CELL ENVIRON, V15, P1051, DOI 10.1111/j.1365-3040.1992.tb01655.x; Griffiths H, 2007, PLANT PHYSIOL, V143, P1055, DOI 10.1104/pp.106.088302; GUTTERIDGE S, 1995, PLANT CELL, V7, P809, DOI 10.1105/tpc.7.7.809; GUY RD, 1993, PLANT PHYSIOL, V101, P37, DOI 10.1104/pp.101.1.37; JAWOROWSKI A, 1985, J BIOL CHEM, V260, P944; Kane HJ, 1998, PLANT PHYSIOL, V117, P1059, DOI 10.1104/pp.117.3.1059; KROOPNICK P, 1976, EARTH PLANET SC LETT, V32, P375, DOI 10.1016/0012-821X(76)90078-9; LAING WA, 1976, BIOCHEM J, V159, P563, DOI 10.1042/bj1590563; LANE GA, 1956, SCIENCE, V123, P574, DOI 10.1126/science.123.3197.574; LORIMER GH, 1986, PHILOS T ROY SOC B, V313, P397, DOI 10.1098/rstb.1986.0046; McNevin DB, 2006, FUNCT PLANT BIOL, V33, P1115, DOI 10.1071/FP06201; Melander L.C.S., 1960, ISOTOPE EFFECTS REAC; MOOK WG, 1974, EARTH PLANET SC LETT, V22, P169, DOI 10.1016/0012-821X(74)90078-8; Moore W.J., 1983, BASIC PHYS CHEM; MORELL MK, 1994, J BIOL CHEM, V269, P8091; MORELL MK, 1990, FEBS LETT, V265, P41, DOI 10.1016/0014-5793(90)80879-N; OLEARY MH, 1992, PLANT CELL ENVIRON, V15, P1099, DOI 10.1111/j.1365-3040.1992.tb01660.x; OLEARY MH, 1981, BIOCHEMISTRY-US, V20, P7308, DOI 10.1021/bi00528a040; OLEARY MH, 1981, PHYTOCHEMISTRY, V20, P553, DOI 10.1016/0031-9422(81)85134-5; OLEARY MH, 1988, ACCOUNTS CHEM RES, V21, P450, DOI 10.1021/ar00156a003; PANETH P, 1985, BIOCHEMISTRY-US, V24, P5143, DOI 10.1021/bi00340a028; Pearce FG, 2003, J BIOL CHEM, V278, P32526, DOI 10.1074/jbc.M305493200; PIERCE J, 1980, BIOCHEMISTRY-US, V19, P934, DOI 10.1021/bi00546a018; PIERCE J, 1986, J BIOL CHEM, V261, P248; REIBACH PH, 1977, PLANT PHYSIOL, V59, P564, DOI 10.1104/pp.59.4.564; Robinson JJ, 2003, LIMNOL OCEANOGR, V48, P48, DOI 10.4319/lo.2003.48.1.0048; ROESKE CA, 1984, BIOCHEMISTRY-US, V23, P6275, DOI 10.1021/bi00320a058; ROESKE CA, 1985, BIOCHEMISTRY-US, V24, P1603, DOI 10.1021/bi00328a005; Ruuska S, 1998, AUST J PLANT PHYSIOL, V25, P859, DOI 10.1071/PP98079; SCHLOSS JV, 1982, J BIOL CHEM, V257, P4691; Scott KM, 2004, ENVIRON MICROBIOL, V6, P1210, DOI 10.1111/j.1462-2920.2004.00642.x; SERVAITES JC, 1985, ARCH BIOCHEM BIOPHYS, V238, P154, DOI 10.1016/0003-9861(85)90151-1; Spreitzer RJ, 1999, PHOTOSYNTH RES, V60, P29, DOI 10.1023/A:1006240202051; Taylor TC, 1996, NAT STRUCT BIOL, V3, P95, DOI 10.1038/nsb0196-95; Tcherkez G, 2005, FUNCT PLANT BIOL, V32, P277, DOI 10.1071/FP04211; Tcherkez GGB, 2006, P NATL ACAD SCI USA, V103, P7246, DOI 10.1073/pnas.0600605103; von Caemmerer S., 2000, BIOCH MODELS LEAF PH; VONCAEMMERER S, 1989, PLANTA, V178, P463, DOI 10.1007/BF00963816; Whitney SM, 1999, PLANT PHYSIOL, V121, P579, DOI 10.1104/pp.121.2.579; Whitney SM, 2001, P NATL ACAD SCI USA, V98, P14738, DOI 10.1073/pnas.261417298; WONG WW, 1979, PLANT PHYSIOL, V63, P852, DOI 10.1104/pp.63.5.852; WRIGHT GC, 1988, AUST J PLANT PHYSIOL, V15, P815, DOI 10.1071/PP9880815	65	71	74	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					36068	36076		10.1074/jbc.M706274200	http://dx.doi.org/10.1074/jbc.M706274200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17925403	Green Published, hybrid			2022-12-27	WOS:000251458100066
J	Forgacs, E; Cartwright, S; Sakamoto, T; Sellers, JR; Corrie, JET; Webb, MR; White, HD				Forgacs, Eva; Cartwright, Suzanne; Sakamoto, Takeshi; Sellers, James R.; Corrie, John E. T.; Webb, Martin R.; White, Howard D.			Kinetics of ADP dissociation from the trail and lead heads of actomyosin V following the power stroke	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOSIN-V; PROCESSIVE MYOSIN; WORKING STROKE; NECK LENGTH; MECHANISM; BINDING; ACTIN; MOTOR; ANALOGS; MUSCLE	Myosin V is a cellular motor protein, which transports cargos along actin filaments. It moves processively by 36-nm steps that require at least one of the two heads to be tightly bound to actin throughout the catalytic cycle. To elucidate the kinetic mechanism of processivity, we measured the rate of product release from the double-headed myosin V-HMM using a new ATP analogue, 3'-(7-diethylaminocoumarin-3-carbonylamino)-3'-deoxy-ATP (deac-aminoATP), which undergoes a 20-fold increase in fluorescence emission intensity when bound to the active site of myosin V (Forgacs, E., Cartwright, S., Kovacs, M., Sakamoto, T., Sellers, J. R., Corrie, J. E. T., Webb, M. R., and White, H. D. ( 2006) Biochemistry 45, 13035-13045). The kinetics of ADP and deac-aminoADP dissociation from actomyosin V-HMM, following the power stroke, were determined using double-mixing stopped-flow fluorescence. These used either deac-aminoATP as the substrate with ADP or ATP chase or alternatively ATP as the substrate with either a deac-aminoADP or deac-aminoATP chase. Both sets of experiments show that the observed rate of ADP or deac-aminoADP dissociation from the trail head of actomyosin V-HMM is the same as from actomyosin V-S1. The dissociation of ADP from the lead head is decreased by up to 250-fold.	[Forgacs, Eva; Cartwright, Suzanne; White, Howard D.] Eastern Virginia Med Sch, Dept Physiol Sci, Norfolk, VA 23507 USA; [Corrie, John E. T.; Webb, Martin R.] Natl Inst Med Res, MRC, London NW7 1AA, England; [Sakamoto, Takeshi; Sellers, James R.] NHLBI, Natl Inst Hlth, Lab Mol Physiol, Bethesda, MD 20892 USA	Eastern Virginia Medical School; MRC National Institute for Medical Research; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	White, HD (corresponding author), Eastern Virginia Med Sch, Dept Physiol Sci, Norfolk, VA 23507 USA.	whitehd@evms.edu		Webb, Martin/0000-0002-0134-9621	MRC [MC_U117512742, MC_U117532185] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL004229, ZIAHL001786] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000209] Funding Source: NIH RePORTER; Medical Research Council [MC_U117512742, MC_U117532185] Funding Source: Medline; NIBIB NIH HHS [EB00209] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		Baker JE, 2004, P NATL ACAD SCI USA, V101, P5542, DOI 10.1073/pnas.0307247101; Burgess SA, 2002, BIOPHYS J, V82, p15A; Cremo CR, 2001, J BIOL CHEM, V276, P41465, DOI 10.1074/jbc.M107103200; De La Cruz EM, 1999, P NATL ACAD SCI USA, V96, P13726, DOI 10.1073/pnas.96.24.13726; De La Cruz EM, 2004, CURR OPIN CELL BIOL, V16, P61, DOI 10.1016/j.ceb.2003.11.011; Dunn AR, 2007, NAT STRUCT MOL BIOL, V14, P246, DOI 10.1038/nsmb1206; Eccleston JF, 2001, PRACT APPROACH SER, P201; Forgacs E, 2006, BIOCHEMISTRY-US, V45, P13035, DOI 10.1021/bi060712n; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; HIRATSUKA T, 1983, BIOCHIM BIOPHYS ACTA, V742, P496, DOI 10.1016/0167-4838(83)90267-4; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; Olivares AO, 2006, J BIOL CHEM, V281, P31326, DOI 10.1074/jbc.M603898200; Purcell TJ, 2005, P NATL ACAD SCI USA, V102, P13873, DOI 10.1073/pnas.0506441102; Purcell TJ, 2002, P NATL ACAD SCI USA, V99, P14159, DOI 10.1073/pnas.182539599; Rief M, 2000, P NATL ACAD SCI USA, V97, P9482, DOI 10.1073/pnas.97.17.9482; Rosenfeld SS, 2004, J BIOL CHEM, V279, P40100, DOI 10.1074/jbc.M402583200; Sakamoto T, 2005, BIOCHEMISTRY-US, V44, P16203, DOI 10.1021/bi0512086; Sakamoto T, 2003, J BIOL CHEM, V278, P29201, DOI 10.1074/jbc.M303662200; Smith DA, 2004, BIOPHYS J, V87, P442, DOI 10.1529/biophysj.103.037788; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Steffen W, 2003, P NATL ACAD SCI USA, V100, P6434, DOI 10.1073/pnas.1231998100; Trybus KM, 1999, J BIOL CHEM, V274, P27448, DOI 10.1074/jbc.274.39.27448; Vale RD, 2003, J CELL BIOL, V163, P445, DOI 10.1083/jcb.200308093; Veigel C, 2005, NAT CELL BIOL, V7, P861, DOI 10.1038/ncb1287; Veigel C, 2002, NAT CELL BIOL, V4, P59, DOI 10.1038/ncb732; Walker ML, 2000, NATURE, V405, P804, DOI 10.1038/35015592; Wang F, 2000, J BIOL CHEM, V275, P4329, DOI 10.1074/jbc.275.6.4329; Webb MR, 2004, BIOCHEMISTRY-US, V43, P14463, DOI 10.1021/bi0486334; White HD, 2003, BIOPHYS J, V84, p116A; Wu XF, 1997, J CELL SCI, V110, P847	30	38	39	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					766	773		10.1074/jbc.M704313200	http://dx.doi.org/10.1074/jbc.M704313200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	17965414	hybrid			2022-12-27	WOS:000252128100015
J	Gilmour, DS; Fan, R				Gilmour, David S.; Fan, Ruopeng			Derailing the locomotive: Transcription termination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							RNA-POLYMERASE-II; ELONGATION COMPLEX; SACCHAROMYCES-CEREVISIAE; SITE RECOGNITION; GENE-EXPRESSION; NASCENT RNA; DNA HYBRID; YEAST; MECHANISM; RELEASE		[Gilmour, David S.; Fan, Ruopeng] Penn State Univ, Dept Biochem & Mol Biol, Ctr Gene Regulat, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Gilmour, DS (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, Ctr Gene Regulat, University Pk, PA 16802 USA.	dsg11@psu.edu	Fan, Ruopeng/A-9489-2011					Arigo JT, 2006, MOL CELL, V21, P641, DOI 10.1016/j.molcel.2006.02.005; ASHFIELD R, 1994, EMBO J, V13, P5656, DOI 10.1002/j.1460-2075.1994.tb06904.x; Birse CE, 1998, SCIENCE, V280, P298, DOI 10.1126/science.280.5361.298; Braglia P, 2005, J BIOL CHEM, V280, P19551, DOI 10.1074/jbc.M412238200; Buratowski S, 2003, NAT STRUCT BIOL, V10, P679, DOI 10.1038/nsb0903-679; Ciampi MS, 2006, MICROBIOL-SGM, V152, P2515, DOI 10.1099/mic.0.28982-0; CONNELLY S, 1989, MOL CELL BIOL, V9, P5254, DOI 10.1128/MCB.9.11.5254; CULLEN BR, 1991, FASEB J, V5, P2361, DOI 10.1096/fasebj.5.10.1712325; Deaconescu AM, 2007, CURR OPIN STRUC BIOL, V17, P96, DOI 10.1016/j.sbi.2007.01.005; Fernandez-Tornero C, 2007, MOL CELL, V25, P813, DOI 10.1016/j.molcel.2007.02.016; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Gollnick P, 2002, BBA-GENE STRUCT EXPR, V1577, P240, DOI 10.1016/S0167-4781(02)00455-4; Greger IH, 2000, P NATL ACAD SCI USA, V97, P8415, DOI 10.1073/pnas.140217697; Gross S, 2001, P NATL ACAD SCI USA, V98, P6080, DOI 10.1073/pnas.101046598; Gu WG, 1996, P NATL ACAD SCI USA, V93, P6935, DOI 10.1073/pnas.93.14.6935; Hara R, 1999, J BIOL CHEM, V274, P24779, DOI 10.1074/jbc.274.35.24779; Jansa P, 1999, MOL GEN GENET, V262, P508, DOI 10.1007/s004380051112; JEONG SW, 1995, MOL CELL BIOL, V15, P5929; Jiang Y, 2004, MOL CELL, V14, P375, DOI 10.1016/S1097-2765(04)00234-5; KERPPOLA TK, 1990, BIOCHEMISTRY-US, V29, P269, DOI 10.1021/bi00453a037; Kim M, 2004, EMBO J, V23, P354, DOI 10.1038/sj.emboj.7600053; Kim M, 2004, NATURE, V432, P517, DOI 10.1038/nature03041; Kim M, 2006, MOL CELL, V24, P723, DOI 10.1016/j.molcel.2006.11.011; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Kireeva ML, 2000, J BIOL CHEM, V275, P6530, DOI 10.1074/jbc.275.9.6530; Komissarova N, 2002, MOL CELL, V10, P1151, DOI 10.1016/S1097-2765(02)00738-4; Korzheva N, 2000, SCIENCE, V289, P619, DOI 10.1126/science.289.5479.619; Landick R, 1997, CELL, V88, P741, DOI 10.1016/S0092-8674(00)81919-4; Landrieux E, 2006, EMBO J, V25, P118, DOI 10.1038/sj.emboj.7600915; LANG WH, 1995, P NATL ACAD SCI USA, V92, P9781, DOI 10.1073/pnas.92.21.9781; Luo WF, 2006, GENE DEV, V20, P954, DOI 10.1101/gad.1409106; Luo WF, 2004, CELL, V119, P911, DOI 10.1016/j.cell.2004.11.041; MARAIA RJ, 1994, MOL CELL BIOL, V14, P2147, DOI 10.1128/MCB.14.3.2147; Maraia RJ, 2001, MOL CELL BIOL, V21, P367, DOI 10.1128/MCB.21.2.367-379.2001; McCracken S, 1997, NATURE, V385, P357, DOI 10.1038/385357a0; Nag A, 2007, NAT STRUCT MOL BIOL, V14, P662, DOI 10.1038/nsmb1253; Park JS, 2006, P NATL ACAD SCI USA, V103, P4870, DOI 10.1073/pnas.0600145103; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Rosonina E, 2006, GENE DEV, V20, P1050, DOI 10.1101/gad.1431606; Sadowski M, 2003, EMBO J, V22, P2167, DOI 10.1093/emboj/cdg200; Santangelo TJ, 2004, MOL CELL, V14, P117, DOI 10.1016/S1097-2765(04)00154-6; Steinmetz EJ, 2001, NATURE, V413, P327, DOI 10.1038/35095090; Tadigotla VR, 2006, P NATL ACAD SCI USA, V103, P4439, DOI 10.1073/pnas.0600508103; TENNYSON CN, 1995, NAT GENET, V9, P184, DOI 10.1038/ng0295-184; Toulokhonov I, 2003, MOL CELL, V12, P1125, DOI 10.1016/S1097-2765(03)00439-8; Venkataraman K, 2005, GENE DEV, V19, P1315, DOI 10.1101/gad.1298605; von Hippel PH, 1998, SCIENCE, V281, P660, DOI 10.1126/science.281.5377.660; West S, 2004, NATURE, V432, P522, DOI 10.1038/nature03035; Yarnell WS, 1999, SCIENCE, V284, P611, DOI 10.1126/science.284.5414.611; Zhang ZQ, 2007, J BIOL CHEM, V282, P16981, DOI 10.1074/jbc.M610688200; Zhang ZQ, 2007, GENE DEV, V21, P1609, DOI 10.1101/gad.1542707; Zhang ZQ, 2006, MOL CELL, V21, P65, DOI 10.1016/j.molcel.2005.11.002; Zhang ZQ, 2005, GENE DEV, V19, P1572, DOI 10.1101/gad.1296305; Zhou Y, 2007, P NATL ACAD SCI USA, V104, P10352, DOI 10.1073/pnas.0606306104	54	18	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					661	664		10.1074/jbc.R700032200	http://dx.doi.org/10.1074/jbc.R700032200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	17998201	hybrid			2022-12-27	WOS:000252128100002
J	Inesi, G; Lewis, D; Toyoshima, C; Hirata, A; de Meis, L				Inesi, Giuseppe; Lewis, David; Toyoshima, Chikashi; Hirata, Ayami; de Meis, Leopoldo			Conformational fluctuations of the Ca2+-ATPase in the native membrane environment - Effects of pH, temperature, catalytic substrates, and thapsigargin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOPLASMIC-RETICULUM CA2+-ATPASE; CA2+ ATPASE SERCA; CALCIUM-PUMP; CRYSTAL-STRUCTURE; BINDING SITES; ACTIVATION; PHOSPHORYLATION; MECHANISM; OCCLUSION; DOMAINS	Digestion with proteinase K or trypsin yields complementary information on conformational transitions of the Ca2+-ATPase (SERCA) in the native membrane environment. Distinct digestion patterns are obtained with proteinase K, revealing inter-conversion of E1 and E2 or E1-P and E2-P states. The pH dependence of digestion patterns shows that, in the presence of Mg2+, conversion of E2 to E1 pattern occurs ( even when Ca2+ is absent) asH(+) dissociates from acidic residues. Mutational analysis demonstrates that the Glu(309) and Glu(771) acidic residues ( empty Ca2+-binding sites I and II) are required for stabilization of E2. Glu309 ionization is most important to yield E1. However, a further transition produced by Ca2+-binding to E1 (i. e. E1 center dot 2Ca(2+)) is still needed for catalytic activation. Following ATP utilization, H (+)/Ca2+ exchange is involved in the transition from the E1 similar to P center dot 2Ca(2+) to the E2-P pattern, whereby alkaline pH will limit this conformational transition. Complementary experiments on digestion with trypsin exhibit high temperature dependence, indicating that, in the E1 and E2 ground states, the ATPase conformation undergoes strong fluctuations related to internal protein dynamics. The fluctuations are tightly constrained by ATP binding and phosphoenzyme formation, and this constraint must be overcome by thermal activation and substrate-free energy to allow enzyme turnover. In fact, a substantial portion of ATP free energy is utilized for conformational work related to the E1 similar to P center dot 2Ca(2+) to E2-P transition, thereby disrupting high affinity binding and allowing luminal diffusion of Ca2+. The E2 state and luminal path closure follow removal of conformational constraint by phosphate.	[Inesi, Giuseppe; Lewis, David] Calif Pacific Med Ctr, Res Inst, San Francisco, CA 94107 USA; [Toyoshima, Chikashi; Hirata, Ayami] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; [de Meis, Leopoldo] Univ Fed Rio de Janeiro, Inst Bioquim Med, BR-21941590 Rio De Janeiro, Brazil	California Pacific Medical Center; California Pacific Medical Center Research Institute; University of Tokyo; Universidade Federal do Rio de Janeiro	Inesi, G (corresponding author), Calif Pacific Med Ctr, Res Inst, 475 Brannan St, San Francisco, CA 94107 USA.	ginesi@cpmcri.com	Toyoshima, Chikashi/R-4153-2019	Toyoshima, Chikashi/0000-0001-9640-0778	PHS HHS [R01-69830] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ANDERSEN JP, 1992, J BIOL CHEM, V267, P19383; BIGELOW DJ, 1992, BIOCHIM BIOPHYS ACTA, V1113, P323, DOI 10.1016/0304-4157(92)90005-U; Champeil P, 1998, J BIOL CHEM, V273, P6619, DOI 10.1074/jbc.273.12.6619; Chen BW, 2004, BIOCHEMISTRY-US, V43, P4366, DOI 10.1021/bi0356350; Clausen JD, 2007, J BIOL CHEM, V282, P20686, DOI 10.1074/jbc.M702365200; Danko S, 2001, FEBS LETT, V505, P129, DOI 10.1016/S0014-5793(01)02801-0; de Meis L, 2001, J BIOL CHEM, V276, P25078, DOI 10.1074/jbc.M103318200; de Meis L, 1977, Biochemistry, V16, P4455, DOI 10.1021/bi00639a020; DEMEIS L, 1979, ANNU REV BIOCHEM, V48, P275; ELETR S, 1972, BIOCHIM BIOPHYS ACTA, V282, P174, DOI 10.1016/0005-2736(72)90321-5; GUILLAIN F, 1982, J BIOL CHEM, V257, P7366; INESI G, 1967, ARCH BIOCHEM BIOPHYS, V121, P665, DOI 10.1016/0003-9861(67)90051-3; Inesi G, 2004, J BIOL CHEM, V279, P31629, DOI 10.1074/jbc.M403211200; Inesi G, 2002, BIOPHYS J, V83, P2327, DOI 10.1016/S0006-3495(02)75247-8; INESI G, 1985, ANNU REV PHYSIOL, V47, P573, DOI 10.1146/annurev.ph.47.030185.003041; INESI G, 1980, J BIOL CHEM, V255, P3025; Inesi G, 2006, BIOCHEMISTRY-US, V45, P13769, DOI 10.1021/bi061255d; Jensen AML, 2006, EMBO J, V25, P2305, DOI 10.1038/sj.emboj.7601135; JUUL B, 1995, J BIOL CHEM, V270, P20123, DOI 10.1074/jbc.270.34.20123; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Ma HL, 2003, J BIOL CHEM, V278, P28938, DOI 10.1074/jbc.M304120200; MACLENNAN DH, 1985, NATURE, V316, P696, DOI 10.1038/316696a0; MASUDA H, 1973, BIOCHEMISTRY-US, V12, P4581, DOI 10.1021/bi00747a006; MOLLER M, 1986, ADV PINEAL RES, V1, P51; Mueller B, 2004, BIOCHEMISTRY-US, V43, P12846, DOI 10.1021/bi0489457; Obara K, 2005, P NATL ACAD SCI USA, V102, P14489, DOI 10.1073/pnas.0506222102; Olesen C, 2004, SCIENCE, V306, P2251, DOI 10.1126/science.1106289; Peinelt C, 2002, BIOPHYS J, V82, P170, DOI 10.1016/S0006-3495(02)75384-8; PICK U, 1982, J BIOL CHEM, V257, P6120; SCALES D, 1976, BIOPHYS J, V16, P735, DOI 10.1016/S0006-3495(76)85725-6; Sorensen TLM, 2004, SCIENCE, V304, P1672, DOI 10.1126/science.1099366; Tadini-Buoninsegni F, 2006, J BIOL CHEM, V281, P37720, DOI 10.1074/jbc.M606040200; Toyoshima C, 2004, NATURE, V430, P529, DOI 10.1038/nature02680; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; TOYOSHIMA C, 1993, NATURE, V362, P469, DOI 10.1038/362469a0; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; ZHANG Z, 1995, J BIOL CHEM, V270, P16283; Zhang ZS, 2000, BIOCHEMISTRY-US, V39, P8758, DOI 10.1021/bi000185m	40	53	53	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					1189	1196		10.1074/jbc.M707189200	http://dx.doi.org/10.1074/jbc.M707189200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	17993458	hybrid			2022-12-27	WOS:000252128100059
J	Becker, T; Pfannschmidt, S; Guiard, B; Stojanovski, D; Milenkovic, D; Kutik, S; Pfanner, N; Meisinger, C; Wiedemann, N				Becker, Thomas; Pfannschmidt, Sylvia; Guiard, Bernard; Stojanovski, Diana; Milenkovic, Dusanka; Kutik, Stephan; Pfanner, Nikolaus; Meisinger, Chris; Wiedemann, Nils			Biogenesis of the mitochondrial TOM complex - Mim1 promotes insertion and assembly of signal-anchored receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN IMPORT CHANNEL; TRANSLOCATION CONTACT SITES; OUTER-MEMBRANE; PREPROTEIN TRANSLOCASE; PRESEQUENCE TRANSLOCASE; INTERMEMBRANE SPACE; ADP/ATP CARRIER; CORE COMPLEX; YEAST; MORPHOLOGY	The translocase of the outer membrane (TOM complex) is the central entry gate for nuclear-encoded mitochondrial precursor proteins. All Tom proteins are also encoded by nuclear genes and synthesized as precursors in the cytosol. The channel-forming beta-barrel protein Tom40 is targeted to mitochondria via Tom receptors and inserted into the outer membrane by the sorting and assembly machinery (SAM complex). A further outer membrane protein, Mim1, plays a less defined role in assembly of Tom40 into the TOM complex. The three receptors Tom20, Tom22, and Tom70 are anchored in the outermembrane by a single transmembrane alpha-helix, located at the N terminus in the case of Tom20 and Tom70 (signal-anchored) or in the C-terminal portion in the case of Tom22(tail-anchored). Insertion of the precursor of Tom22 into the outermembrane requires pre-existing Tom receptors while the import pathway of the precursors of Tom20 and Tom70 is only poorly understood. We report that Mim1 is required for efficient membrane insertion and assembly of Tom20 and Tom70, but not Tom22. We show that Mim1 associates with SAM core components to a large SAM complex, explaining its role in late steps of the assembly pathway of Tom40. We conclude that Mim1 is not only required for biogenesis of the beta-barrel protein Tom40 but also for membrane insertion and assembly of signal-anchored Tom receptors. Thus, Mim1 plays an important role in the efficient assembly of the mitochondrial TOM complex.	[Becker, Thomas; Pfannschmidt, Sylvia; Stojanovski, Diana; Milenkovic, Dusanka; Kutik, Stephan; Pfanner, Nikolaus; Meisinger, Chris; Wiedemann, Nils] Univ Freiburg, Zentrum Biochem & Mol Zellforschung, Inst Biochem & Mol Biol, D-79104 Freiburg, Germany; [Guiard, Bernard] CNRS, Ctr Mol Genet, F-91190 Gif Sur Yvette, France; [Kutik, Stephan] Univ Freiburg, Fak Biol, D-79104 Freiburg, Germany	University of Freiburg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of Freiburg	Pfanner, N (corresponding author), Univ Freiburg, Zentrum Biochem & Mol Zellforschung, Inst Biochem & Mol Biol, Hermann Herder Strasse 7, D-79104 Freiburg, Germany.	nikolaus.pfanner@biochemie.uni-freiburg.de	Pfanner, Nikolaus/AAV-7878-2021; Becker, Thomas/AAS-9404-2020; Meisinger, Chris/J-1110-2014	Meisinger, Chris/0000-0002-8326-3548; Wiedemann, Nils/0000-0001-8305-6728; Stojanovski, Diana/0000-0002-0199-3222				Ahting U, 2005, J BIOL CHEM, V280, P48, DOI 10.1074/jbc.M410905200; Becker L, 2005, J MOL BIOL, V353, P1011, DOI 10.1016/j.jmb.2005.09.019; Beilharz T, 2003, J BIOL CHEM, V278, P8219, DOI 10.1074/jbc.M212725200; Berger KH, 1997, J CELL BIOL, V136, P545, DOI 10.1083/jcb.136.3.545; Boldogh IR, 2003, MOL BIOL CELL, V14, P4618, DOI 10.1091/mbc.E03-04-0225; Borgese N, 2003, J CELL BIOL, V161, P1013, DOI 10.1083/jcb.200303069; BURGESS SM, 1994, J CELL BIOL, V126, P1375, DOI 10.1083/jcb.126.6.1375; Burri L, 2006, FEBS J, V273, P1507, DOI 10.1111/j.1742-4658.2006.05171.x; Chacinska A, 2003, EMBO J, V22, P5370, DOI 10.1093/emboj/cdg532; Chacinska A, 2005, CELL, V120, P817, DOI 10.1016/j.cell.2005.01.011; Cherry JM, 1998, NUCLEIC ACIDS RES, V26, P73, DOI 10.1093/nar/26.1.73; Contamine V, 2000, MICROBIOL MOL BIOL R, V64, P281, DOI 10.1128/MMBR.64.2.281-315.2000; Coonrod EM, 2007, TRAFFIC, V8, P500, DOI 10.1111/j.1600-0854.2007.00550.x; Cruciat CM, 2000, J BIOL CHEM, V275, P18093, DOI 10.1074/jbc.M001901200; Dekker PJT, 1997, EMBO J, V16, P5408, DOI 10.1093/emboj/16.17.5408; Dekker PJT, 1998, MOL CELL BIOL, V18, P6515, DOI 10.1128/MCB.18.11.6515; Dembowski M, 2001, J BIOL CHEM, V276, P17679, DOI 10.1074/jbc.M009653200; Dolezal P, 2006, SCIENCE, V313, P314, DOI 10.1126/science.1127895; Endo T, 2003, J CELL SCI, V116, P3259, DOI 10.1242/jcs.00667; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Geissler A, 2002, CELL, V111, P507, DOI 10.1016/S0092-8674(02)01073-5; Gentle I, 2004, J CELL BIOL, V164, P19, DOI 10.1083/jcb.200310092; Hill K, 1998, NATURE, V395, P516, DOI 10.1038/26780; Hoogenraad NJ, 2002, BBA-MOL CELL RES, V1592, P97, DOI 10.1016/S0167-4889(02)00268-9; Hoppins SC, 2004, J BIOL CHEM, V279, P12396, DOI 10.1074/jbc.M313037200; Humphries AD, 2005, J BIOL CHEM, V280, P11535, DOI 10.1074/jbc.M413816200; Ishikawa D, 2004, J CELL BIOL, V166, P621, DOI 10.1083/jcb.200405138; Johnson AE, 2004, NAT STRUCT MOL BIOL, V11, P113, DOI 10.1038/nsmb0204-113; Kanaji S, 2000, J CELL BIOL, V151, P277, DOI 10.1083/jcb.151.2.277; KEIL P, 1993, FEBS LETT, V321, P197, DOI 10.1016/0014-5793(93)80107-6; Koehler CM, 2004, ANNU REV CELL DEV BI, V20, P309, DOI 10.1146/annurev.cellbio.20.010403.105057; Kondo-Okamoto N, 2003, J BIOL CHEM, V278, P48997, DOI 10.1074/jbc.M308436200; Kozjak V, 2003, J BIOL CHEM, V278, P48520, DOI 10.1074/jbc.C300442200; Krimmer T, 2001, J CELL BIOL, V152, P289, DOI 10.1083/jcb.152.2.289; Meisinger C, 2004, DEV CELL, V7, P61, DOI 10.1016/j.devcel.2004.06.003; Meisinger C, 2001, MOL CELL BIOL, V21, P2337, DOI 10.1128/MCB.21.7.2337-2348.2001; Meisinger C, 2007, EMBO J, V26, P2229, DOI 10.1038/sj.emboj.7601673; Meisinger C, 2006, J BIOL CHEM, V281, P22819, DOI 10.1074/jbc.M602679200; Meisinger Chris, 2006, Methods Mol Biol, V313, P33; Milenkovic D, 2004, J BIOL CHEM, V279, P22781, DOI 10.1074/jbc.C400120200; MILLAR DG, 1993, J BIOL CHEM, V268, P18403; Mnaimneh S, 2004, CELL, V118, P31, DOI 10.1016/j.cell.2004.06.013; Model K, 2001, NAT STRUCT BIOL, V8, P361, DOI 10.1038/86253; Motz C, 2002, J MOL BIOL, V323, P729, DOI 10.1016/S0022-2836(02)00995-6; Nakamura Y, 2004, J BIOL CHEM, V279, P21223, DOI 10.1074/jbc.M314156200; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Paschen SA, 2003, NATURE, V426, P862, DOI 10.1038/nature02208; Pfanner N, 2004, NAT STRUCT MOL BIOL, V11, P1044, DOI 10.1038/nsmb852; Prokisch H, 2000, MOL BIOL CELL, V11, P2961, DOI 10.1091/mbc.11.9.2961; Rapaport D, 2003, EMBO REP, V4, P948, DOI 10.1038/sj.embor.embor937; Ryan MT, 1999, J BIOL CHEM, V274, P20619, DOI 10.1074/jbc.274.29.20619; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; SCHLOSSMANN J, 1995, J BIOL CHEM, V270, P27116, DOI 10.1074/jbc.270.45.27116; SCHNEIDER H, 1991, SCIENCE, V254, P1659, DOI 10.1126/science.1661031; Sesaki H, 2004, J BIOL CHEM, V279, P28298, DOI 10.1074/jbc.M401363200; Setoguchi K, 2006, EMBO J, V25, P5635, DOI 10.1038/sj.emboj.7601438; Sherman EL, 2005, MOL BIOL CELL, V16, P4172, DOI 10.1091/mbc.E05-03-0187; SHORE GC, 1995, EUR J BIOCHEM, V227, P9, DOI 10.1111/j.1432-1033.1995.tb20354.x; SIKORSKI RS, 1989, GENETICS, V122, P19; Stojanovski D, 2007, METHOD CELL BIOL, V80, P783, DOI 10.1016/S0091-679X(06)80036-1; Suzuki H, 2002, J CELL SCI, V115, P1895; Suzuki H, 2004, J BIOL CHEM, V279, P50619, DOI 10.1074/jbc.M408604200; Szklarz LKS, 2005, J MOL BIOL, V351, P206, DOI 10.1016/j.jmb.2005.05.068; Truscott KN, 2002, MOL CELL BIOL, V22, P7780, DOI 10.1128/MCB.22.22.7780-7789.2002; van der Laan M, 2006, CURR BIOL, V16, P2271, DOI 10.1016/j.cub.2006.10.025; van Wilpe S, 1999, NATURE, V401, P485, DOI 10.1038/46802; Waizenegger T, 2004, EMBO REP, V5, P704, DOI 10.1038/sj.embor.7400183; Waizenegger T, 2003, J BIOL CHEM, V278, P42064, DOI 10.1074/jbc.M305736200; Waizengger T, 2005, EMBO REP, V6, P57, DOI 10.1038/sj.embor.7400318; Wiedemann N, 2004, J BIOL CHEM, V279, P14473, DOI 10.1074/jbc.R400003200; Wiedemann N, 2003, NATURE, V424, P565, DOI 10.1038/nature01753; Wiedemann N, 2001, EMBO J, V20, P951, DOI 10.1093/emboj/20.5.951; Wiedemann N, 2004, J BIOL CHEM, V279, P18188, DOI 10.1074/jbc.M400050200; YAFFE MP, 1989, J BIOL CHEM, V264, P21091	75	112	113	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					120	127		10.1074/jbc.M706997200	http://dx.doi.org/10.1074/jbc.M706997200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17974559	hybrid			2022-12-27	WOS:000251940300014
J	Tan, AHM; Goh, SYP; Wong, SC; Lam, KP				Tan, Andy Hee-Meng; Goh, Sharon Yun-Pei; Wong, Siew-Cheng; Lam, Kong-Peng			T helper cell-specific regulation of inducible costimulator expression via distinct mechanisms mediated by T-bet and GATA-3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR GATA-3; ICOS EXPRESSION; MOLECULE ICOS; TH2 DIFFERENTIATION; IMMUNE-RESPONSES; GENE-EXPRESSION; FAMILY-MEMBER; LINEAGE; PROTEIN; IL-4	Inducible costimulator (ICOS) expression is critical for T cell mediated immunity. We showed previously that T cell receptor and CD28 coengagement up-regulate ICOS expression in activated T cells via the induction of NFATc2. Here, we examined the regulation of ICOS expression by Th-specific transcription factors T-bet and GATA-3. Overexpression of T-bet or GATA-3 alone could enhance, and NFATc2 could further synergize with either of them to increase, icos transcription. Although T-bet acted on the icos promoter, GATA-3 operated via an icos 3'-untranslated region element. Interestingly, NFATc2 was found to bind promiscuously the icos promoter in developing Th0, Th1, and Th2 cells but became selectively associated with T-bet at the promoter and with GATA-3 at the 3'-untranslated region in fully differentiated Th1 and Th2 cells, respectively. Collectively, our results reveal a temporally evolving circuit in which the non-selectively expressed NFATc2 cooperates with Th-restricted T-bet or GATA-3 to direct transcription of a costimulatory gene via distinct regulatory elements in different Th cells undergoing differentiation.	[Tan, Andy Hee-Meng; Goh, Sharon Yun-Pei; Wong, Siew-Cheng; Lam, Kong-Peng] Agcy Sci Technol & Res, Singapore Immunol Network Lab Immune Reg, Singapore 138648, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN)	Lam, KP (corresponding author), Agcy Sci Technol & Res, Singapore Immunol Network Lab Immune Reg, 8A Biomed Grove, Immunos Level 3, Singapore 138648, Singapore.	lam_kong_peng@immunol.a-star.edu.sg	Lam, Kong-Peng/G-5374-2012	Lam, Kong-Peng/0000-0002-1316-4333				Agarwal S, 2000, IMMUNITY, V12, P643, DOI 10.1016/S1074-7613(00)80215-0; Avni O, 2002, NAT IMMUNOL, V3, P643, DOI 10.1038/ni808; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Coyle AJ, 2000, IMMUNITY, V13, P95, DOI 10.1016/S1074-7613(00)00011-X; Dong C, 2000, ARTHRITIS RES, V2, P179, DOI 10.1186/ar85; Dong C, 2001, NATURE, V409, P97, DOI 10.1038/35051100; Glimcher LH, 2000, GENE DEV, V14, P1693; Gonzalo JA, 2001, NAT IMMUNOL, V2, P597, DOI 10.1038/89739; HECHT TT, 1983, J IMMUNOL, V131, P1049; Ho IC, 2002, CELL, V109, pS109, DOI 10.1016/S0092-8674(02)00705-5; Ho IC, 1996, CELL, V85, P973, DOI 10.1016/S0092-8674(00)81299-4; HO SN, 1995, J BIOL CHEM, V270, P19898, DOI 10.1074/jbc.270.34.19898; Hofmann A, 1996, P NATL ACAD SCI USA, V93, P5185, DOI 10.1073/pnas.93.11.5185; Hutloff A, 1999, NATURE, V397, P263, DOI 10.1038/16717; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Iwai H, 2002, J IMMUNOL, V169, P4332, DOI 10.4049/jimmunol.169.8.4332; Kopf M, 2000, J EXP MED, V192, P53, DOI 10.1084/jem.192.1.53; Lee DU, 2004, J BIOL CHEM, V279, P4802, DOI 10.1074/jbc.M307904200; Lee GR, 2001, IMMUNITY, V14, P447, DOI 10.1016/S1074-7613(01)00125-X; Lee HJ, 2000, J EXP MED, V192, P105, DOI 10.1084/jem.192.1.105; Lohning M, 2003, J EXP MED, V197, P181, DOI 10.1084/jem.20020632; Mak TW, 2003, NAT IMMUNOL, V4, P765, DOI 10.1038/ni947; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; McAdam AJ, 2000, J IMMUNOL, V165, P5035, DOI 10.4049/jimmunol.165.9.5035; McAdam AJ, 2001, NATURE, V409, P102, DOI 10.1038/35051107; Mullen AC, 2001, SCIENCE, V292, P1907, DOI 10.1126/science.1059835; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Nurieva RI, 2003, IMMUNITY, V18, P801, DOI 10.1016/S1074-7613(03)00144-4; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; Ozkaynak E, 2001, NAT IMMUNOL, V2, P591, DOI 10.1038/89731; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Rao A, 2000, BRIT MED BULL, V56, P969, DOI 10.1258/0007142001903634; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Rottman JB, 2001, NAT IMMUNOL, V2, P605, DOI 10.1038/89750; Scales HE, 2004, EUR J IMMUNOL, V34, P2854, DOI 10.1002/eji.200324364; Scott BG, 2004, J NEUROIMMUNOL, V153, P16, DOI 10.1016/j.jneuroim.2004.04.019; Shnyreva M, 2004, P NATL ACAD SCI USA, V101, P12622, DOI 10.1073/pnas.0400849101; SIEGEL MD, 1995, J BIOL CHEM, V270, P24548, DOI 10.1074/jbc.270.41.24548; Sperling AI, 2001, NAT IMMUNOL, V2, P573, DOI 10.1038/89709; Swallow MM, 1999, IMMUNITY, V11, P423, DOI 10.1016/S1074-7613(00)80117-X; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Tafuri A, 2001, NATURE, V409, P105, DOI 10.1038/35051113; Tan AHM, 2006, J BIOL CHEM, V281, P28666, DOI 10.1074/jbc.M604081200; Taylor PA, 2005, BLOOD, V105, P3372, DOI 10.1182/blood-2004-10-3869; Tesciuba AG, 2001, J IMMUNOL, V167, P1996, DOI 10.4049/jimmunol.167.4.1996; TONY HP, 1985, J EXP MED, V162, P1695, DOI 10.1084/jem.162.5.1695; Usui Y, 2006, EUR J IMMUNOL, V36, P3071, DOI 10.1002/eji.200636138; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Villegas EN, 2002, J IMMUNOL, V169, P937, DOI 10.4049/jimmunol.169.2.937; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Wassink L, 2004, J IMMUNOL, V173, P1779, DOI 10.4049/jimmunol.173.3.1779; Wong SC, 2003, BLOOD, V102, P1381, DOI 10.1182/blood-2002-08-2416; Yagi J, 2003, J IMMUNOL, V171, P783, DOI 10.4049/jimmunol.171.2.783; Yoshinaga SK, 1999, NATURE, V402, P827, DOI 10.1038/45582; Zhang DH, 1997, J BIOL CHEM, V272, P21597, DOI 10.1074/jbc.272.34.21597; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zhou M, 2003, IMMUNOL RES, V28, P25, DOI 10.1385/IR:28:1:25	57	29	33	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					128	136		10.1074/jbc.M707693200	http://dx.doi.org/10.1074/jbc.M707693200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17986443	hybrid			2022-12-27	WOS:000251940300015
J	Ilic, MZ; East, CJ; Rogerson, FM; Fosang, AJ; Handley, CJ				Ilic, Mirna Z.; East, Charlotte J.; Rogerson, Fraser M.; Fosang, Amanda J.; Handley, Christopher J.			Distinguishing aggrecan loss from aggrecan proteolysis in ADAMTS-4 and ADAMTS-5 single and double deficient mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ARTICULAR-CARTILAGE; HUMAN SYNOVIAL-FLUID; CHONDROITIN SULFATE; EXTRACELLULAR-MATRIX; IN-VIVO; CLEAVAGE; DEGRADATION; CATABOLISM; PROTEOGLYCAN; ACTIVATION	Aggrecan loss from mouse cartilage is predominantly because of ADAMTS-5 activity; however, the relative contribution of other proteolytic and nonproteolytic processes to this loss is not clear. This is the first study to compare aggrecan loss with aggrecan processing in mice with single and double deletions of ADAMTS-4 and -5 activity (Delta cat). Cartilage explants harvested from single and double ADAMTS-4 and -5 Delta cat mice were cultured with or without interleukin (IL)-1 alpha or retinoic acid and analyzed for (i) the kinetics of 35S-labeled aggrecan loss, (ii) the pattern of S-35-labeled aggrecan fragments released into the media and retained in the matrix, (iii) the pattern of total aggrecan fragments released into the media and retained in the matrix, and (iv) specific cleavage sites within the interglobular and chondroitin sulfate-2 domains. The loss of radiolabeled aggrecan from ADAMTS-4/-5 Delta cat cartilage was less than that from ADAMTS-4, ADAMTS-5, or wild-type cartilage under nonstimulated conditions. IL-1 alpha and retinoic acid stimulated radiolabeled aggrecan loss from wild-type and ADAMTS-4 Delta cat cartilage, but there was little effect on ADAMTS-5 cartilage. Proteolysis of aggrecan contributed most to its loss in wild-type, ADAMTS-4, and ADAMTS-5 Delta cat cartilage explants. The pattern of proteolytic processing of aggrecan in these cultures was consistent with that occurring in cartilage pathologies. Retinoic acid, but not IL-1 alpha, stimulated radiolabeled aggrecan loss from ADAMTS-4/-5 Delta cat cartilage explants. Even though there was a 300% increase in aggrecan loss from ADAMTS-4/-5 Delta cat cartilage stimulated with retinoic acid, the loss was not associated with aggrecanase cleavage but with the release of predominantly intact aggrecan consistent with the phenotype of the ADAMTS4/-5 Delta cat mouse. Our results show that chondrocytes have additional mechanism for the turnover of aggrecan and that when proteolytic mechanisms are blocked by ablation of aggrecanase activity, nonproteolytic mechanisms compensate to maintain cartilage homeostasis.	[Ilic, Mirna Z.; Handley, Christopher J.] La Trobe Univ, Sch Human Biosci & Muscuoskeletal Res Ctr, Melbourne, Vic 3086, Australia; [East, Charlotte J.; Rogerson, Fraser M.; Fosang, Amanda J.] Univ Melbourne, Royal Melbourne Hosp, Murdoch Childrens Res Inst, Dept Paediat,Arthritis Res Grp, Parkville, Vic 3052, Australia	La Trobe University; Murdoch Children's Research Institute; Royal Melbourne Hospital; University of Melbourne	Ilic, MZ (corresponding author), La Trobe Univ, Sch Human Biosci, Melbourne, Vic 3086, Australia.	m.ilic@latrobe.edu.au		Fosang, Amanda/0000-0002-5523-5427				Abbaszade I, 1999, J BIOL CHEM, V274, P23443, DOI 10.1074/jbc.274.33.23443; CAMPBELL MA, 1984, ARCH BIOCHEM BIOPHYS, V234, P275, DOI 10.1016/0003-9861(84)90350-3; Collins-Racie LA, 2004, MATRIX BIOL, V23, P219, DOI 10.1016/j.matbio.2004.05.004; COUCHMAN JR, 1984, NATURE, V307, P650, DOI 10.1038/307650a0; East CJ, 2007, J BIOL CHEM, V282, P8632, DOI 10.1074/jbc.M605750200; Flannery CR, 2002, J BIOL CHEM, V277, P42775, DOI 10.1074/jbc.M205309200; Gao G, 2004, J BIOL CHEM, V279, P10042, DOI 10.1074/jbc.M312100200; Gao G, 2002, J BIOL CHEM, V277, P11034, DOI 10.1074/jbc.M107443200; Gendron C, 2007, J BIOL CHEM, V282, P18294, DOI 10.1074/jbc.M701523200; Glasson SS, 2004, ARTHRITIS RHEUM-US, V50, P2547, DOI 10.1002/art.20558; Glasson SS, 2005, NATURE, V434, P644, DOI 10.1038/nature03369; HANDLEY CJ, 1979, BIOCHIM BIOPHYS ACTA, V582, P234, DOI 10.1016/0304-4165(79)90387-8; ILIC MZ, 1995, ARCH BIOCHEM BIOPHYS, V322, P22, DOI 10.1006/abbi.1995.1431; Ilic MZ, 1998, J BIOL CHEM, V273, P17451, DOI 10.1074/jbc.273.28.17451; Ilic MZ, 2000, MATRIX BIOL, V19, P257, DOI 10.1016/S0945-053X(00)00069-X; ILIC MZ, 1992, ARCH BIOCHEM BIOPHYS, V294, P115, DOI 10.1016/0003-9861(92)90144-L; Kashiwagi M, 2004, J BIOL CHEM, V279, P10109, DOI 10.1074/jbc.M312123200; Kuno K, 2000, FEBS LETT, V478, P241, DOI 10.1016/S0014-5793(00)01854-8; Little CB, 2005, ARTHRITIS RHEUM-US, V52, P1461, DOI 10.1002/art.21022; Little CB, 2005, OSTEOARTHR CARTILAGE, V13, P162, DOI 10.1016/j.joca.2004.10.014; LOHMANDER LS, 1993, ARTHRITIS RHEUM, V36, P1214; LOULAKIS P, 1992, BIOCHEM J, V284, P589, DOI 10.1042/bj2840589; Malfait AM, 2002, J BIOL CHEM, V277, P22201, DOI 10.1074/jbc.M200431200; Miwa HE, 2006, MATRIX BIOL, V25, P534, DOI 10.1016/j.matbio.2006.07.004; NG CK, 1992, ARCH BIOCHEM BIOPHYS, V298, P70, DOI 10.1016/0003-9861(92)90095-E; OEGEMA TR, 1979, J BIOL CHEM, V254, P1312; Patwari P, 2005, OSTEOARTHR CARTILAGE, V13, P269, DOI 10.1016/j.joca.2004.10.023; Poon CJ, 2005, J BIOL CHEM, V280, P23615, DOI 10.1074/jbc.M412145200; Pratta MA, 2003, ARTHRITIS RHEUM, V48, P119, DOI 10.1002/art.10726; Pratta MA, 2000, J BIOL CHEM, V275, P39096, DOI 10.1074/jbc.M006201200; ROGERSON F, 2007, T ORTHOP RES SOC SAN, V32, P82; Roughley PJ, 2003, BIOCHEM J, V375, P183, DOI 10.1042/BJ20030609; SANDY JD, 1992, J CLIN INVEST, V89, P1512, DOI 10.1172/JCI115742; SANDY JD, 1991, J BIOL CHEM, V266, P8683; Sandy JD, 2001, BIOCHEM J, V358, P615, DOI 10.1042/0264-6021:3580615; SANDY JD, 1989, BIOCHEM J, V258, P875, DOI 10.1042/bj2580875; Somerville RPT, 2003, J BIOL CHEM, V278, P9503, DOI 10.1074/jbc.M211009200; Song RH, 2007, ARTHRITIS RHEUM-US, V56, P575, DOI 10.1002/art.22334; Stanton H, 2005, NATURE, V434, P648, DOI 10.1038/nature03417; Struglics A, 2006, OSTEOARTHR CARTILAGE, V14, P898, DOI 10.1016/j.joca.2006.02.016; Struglics A, 2006, OSTEOARTHR CARTILAGE, V14, P101, DOI 10.1016/j.joca.2005.07.018; Sztrolovics R, 2002, BIOCHEM J, V362, P473, DOI 10.1042/0264-6021:3620473; Tchetina EV, 2005, J RHEUMATOL, V32, P876; Tester AM, 1999, MATRIX BIOL, V18, P65, DOI 10.1016/S0945-053X(99)00004-9; Tortorella M, 2000, J BIOL CHEM, V275, P25791, DOI 10.1074/jbc.M001065200; Tortorella MD, 2000, J BIOL CHEM, V275, P18566, DOI 10.1074/jbc.M909383199; Tortorella MD, 2005, ARCH BIOCHEM BIOPHYS, V444, P34, DOI 10.1016/j.abb.2005.09.018; Tortorella MD, 2002, MATRIX BIOL, V21, P499, DOI 10.1016/S0945-053X(02)00069-0; Tortorella MD, 1999, SCIENCE, V284, P1664, DOI 10.1126/science.284.5420.1664; Tortorella MD, 2001, OSTEOARTHR CARTILAGE, V9, P539, DOI 10.1053/joca.2001.0427; Vankemmelbeke MN, 2003, EUR J BIOCHEM, V270, P2394, DOI 10.1046/j.1432-1033.2003.03607.x; Vankemmelbeke MN, 2001, EUR J BIOCHEM, V268, P1259, DOI 10.1046/j.1432-1327.2001.01990.x; WALCZ E, 1994, GENOMICS, V22, P364, DOI 10.1006/geno.1994.1396; Wang P, 2004, J BIOL CHEM, V279, P15434, DOI 10.1074/jbc.M312797200; Wiberg C, 2003, J BIOL CHEM, V278, P37698, DOI 10.1074/jbc.M304638200; Zeng WL, 2006, BBA-GEN SUBJECTS, V1760, P517, DOI 10.1016/j.bbagen.2006.01.013	56	23	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37420	37428		10.1074/jbc.M703184200	http://dx.doi.org/10.1074/jbc.M703184200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17938173	hybrid			2022-12-27	WOS:000251833600016
J	Li, YP; Zhang, ZL; Robinson, GE; Palli, SR				Li, Yiping; Zhang, Zhaolin; Robinson, Gene E.; Palli, Subba R.			Identification and characterization of a juvenile hormone response element and its binding proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL ECDYSONE RECEPTOR; METHOPRENE-TOLERANT GENE; DROSOPHILA-MELANOGASTER; KINASE-C; LOCUSTA-MIGRATORIA; FOLLICLE CELLS; ESTERASE GENE; CHORISTONEURA-FUMIFERANA; INSECTICIDE RESISTANCE; RHODNIUS-PROLIXUS	Juvenile hormones (JH) regulate a wide variety of developmental and physiological processes in insects. Comparison of microarray data on JH-induced genes in the fruit fly, Drosophila melanogaster, L57 cells and in the honey bee, Apis mellifera, identified 16 genes that are induced in both species. Analysis of promoter regions of these 16 D. melanogaster genes identified DmJHRE1 (D. melanogaster JH response element 1). In L57 cells, the reporter gene regulated by DmJHRE1 was induced by JH III. Two proteins (FKBP39 and Chd64) that bind to DmJHRE1 were identified. FKBP39 and Chd64 double-stranded RNA inhibited JH III induction of a reporter gene regulated by DmJHRE1. FKBP39 and Chd64 proteins expressed in yeast bound to DmJHRE1. Two-hybrid and pulldown assays showed that these two proteins interact with each other as well as with ecdysone receptor, ultraspiracle, and methoprene- tolerant protein. Developmental expression profiles and JH induction of mRNA for FKBP39 and Chd64 proteins and their interaction with proteins known to be involved in both JH (methoprene-tolerant protein) and ecdysteroid action (ecdysone receptor and ultraspiracle) suggest that these proteins probably play important roles in cross- talk between JH and ecdysteroids.	[Li, Yiping; Zhang, Zhaolin; Palli, Subba R.] Univ Kentucky, Dept Entomol, Lexington, KY 40546 USA; [Robinson, Gene E.] Univ Illinois, Dept Entomol, Program Neurosci, Urbana, IL 61801 USA	University of Kentucky; University of Illinois System; University of Illinois Urbana-Champaign	Palli, SR (corresponding author), Univ Kentucky, Dept Entomol, Lexington, KY 40546 USA.	rpalli@uky.edu	Zhang, Zhaolin/E-6183-2012; PALLI, SUBBA REDDY/AAU-8289-2020	PALLI, SUBBA REDDY/0000-0002-0873-3247	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070559] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM070559-02, R01 GM070559] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALNEMRI ES, 1994, J BIOL CHEM, V269, P30828; Ashok M, 1998, P NATL ACAD SCI USA, V95, P2761, DOI 10.1073/pnas.95.6.2761; BAILEY TL, 1994, P 2 INT C INT SYST M, P28; Berger EM, 2005, VITAM HORM, V73, P175, DOI 10.1016/S0083-6729(05)73006-5; BERGER EM, 1992, DEV BIOL, V151, P410, DOI 10.1016/0012-1606(92)90181-F; BOWNES M, 1987, EUR J BIOCHEM, V164, P709, DOI 10.1111/j.1432-1033.1987.tb11184.x; BOWNES M, 1989, J INSECT PHYSIOL, V35, P409, DOI 10.1016/0022-1910(89)90115-7; CHERBAS L, 1991, GENE DEV, V5, P120, DOI 10.1101/gad.5.1.120; Cherbas L, 1997, GENETICS, V145, P349; DasGupta R, 2005, SCIENCE, V308, P826, DOI 10.1126/science.1109374; Davidson B, 2001, DEV GENES EVOL, V211, P190, DOI 10.1007/s004270100143; DOBENS L, 1991, MOL CELL BIOL, V11, P1846, DOI 10.1128/MCB.11.4.1846; Dubrovsky EB, 2002, INSECT BIOCHEM MOLEC, V32, P1555, DOI 10.1016/S0965-1748(02)00076-0; Dubrovsky EB, 2000, DEV BIOL, V224, P486, DOI 10.1006/dbio.2000.9800; Feng QL, 1999, MOL CELL ENDOCRINOL, V148, P95, DOI 10.1016/S0303-7207(98)00228-7; GLINKA AV, 1995, BIOCHEM MOL BIOL INT, V35, P323; Godlewski J, 2006, BIOCHEM BIOPH RES CO, V342, P1305, DOI 10.1016/j.bbrc.2006.02.097; HENRICH VC, 2005, COMPREHENSIVE MOL IN, V3, P243; Hirai M, 1998, INSECT BIOCHEM MOLEC, V28, P181, DOI 10.1016/S0965-1748(97)00116-1; Hu X, 2003, MOL ENDOCRINOL, V17, P716, DOI 10.1210/me.2002-0287; IYENGAR AR, 1995, DEV BIOL, V170, P314, DOI 10.1006/dbio.1995.1217; Jones G, 1997, P NATL ACAD SCI USA, V94, P13499, DOI 10.1073/pnas.94.25.13499; KADONAGA JT, 1986, P NATL ACAD SCI USA, V83, P5889, DOI 10.1073/pnas.83.16.5889; Kethidi DR, 2006, MOL CELL ENDOCRINOL, V247, P127, DOI 10.1016/j.mce.2005.12.016; Kethidi DR, 2005, J INSECT PHYSIOL, V51, P393, DOI 10.1016/j.jinsphys.2004.12.007; Kethidi DR, 2004, J BIOL CHEM, V279, P19634, DOI 10.1074/jbc.M311647200; KOELLE MR, 1991, CELL, V67, P59, DOI 10.1016/0092-8674(91)90572-G; Maki A, 2004, BIOCHEM BIOPH RES CO, V320, P262, DOI 10.1016/j.bbrc.2004.05.156; Miura K, 2005, FEBS J, V272, P1169, DOI 10.1111/j.1742-4658.2005.04552.x; Palli SR, 2005, VITAM HORM, V73, P59, DOI 10.1016/S0083-6729(05)73003-X; Panguluri SK, 2006, FEBS J, V273, P5550, DOI 10.1111/j.1742-4658.2006.05545.x; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pursley S, 2000, INSECT BIOCHEM MOLEC, V30, P839, DOI 10.1016/S0965-1748(00)00056-4; RIDDIFORD LM, 1994, ADV INSECT PHYSIOL, V24, P213, DOI 10.1016/S0065-2806(08)60084-3; Riddiford LM, 1996, ARCH INSECT BIOCHEM, V32, P271, DOI 10.1002/(SICI)1520-6327(1996)32:3/4&lt;271::AID-ARCH2&gt;3.0.CO;2-W; SEVALA VL, 1993, INVERTEBR REPROD DEV, V23, P189, DOI 10.1080/07924259.1993.9672314; SEVALA VL, 1989, EXPERIENTIA, V45, P355, DOI 10.1007/BF01957476; SEVALA VL, 1995, INSECT BIOCHEM MOLEC, V25, P267, DOI 10.1016/0965-1748(94)00065-P; Sinha S, 2006, P NATL ACAD SCI USA, V103, P16352, DOI 10.1073/pnas.0607448103; Song QS, 1997, INSECT BIOCHEM MOLEC, V27, P973, DOI 10.1016/S0965-1748(97)00080-5; Swevers L, 1996, INSECT BIOCHEM MOLEC, V26, P217, DOI 10.1016/0965-1748(95)00097-6; THOMAS HE, 1993, NATURE, V362, P471, DOI 10.1038/362471a0; Truman JW, 2006, SCIENCE, V312, P1385, DOI 10.1126/science.1123652; VENKATARAMAN V, 1994, DEV GENET, V15, P391, DOI 10.1002/dvg.1020150502; Whitfield CW, 2006, P NATL ACAD SCI USA, V103, P16068, DOI 10.1073/pnas.0606909103; Wilson TG, 1998, P NATL ACAD SCI USA, V95, P14040, DOI 10.1073/pnas.95.24.14040; Wilson TG, 2006, GENETICS, V172, P253, DOI 10.1534/genetics.105.046631; WILSON TG, 1986, DEV BIOL, V118, P190, DOI 10.1016/0012-1606(86)90087-4; Wilson TG, 1996, ARCH INSECT BIOCHEM, V32, P641, DOI 10.1002/(SICI)1520-6327(1996)32:3/4&lt;641::AID-ARCH35&gt;3.0.CO;2-A; Wilson TG, 2006, MOL GENET GENOMICS, V276, P294, DOI 10.1007/s00438-006-0138-4; Wu Y, 2006, MECH DEVELOP, V123, P530, DOI 10.1016/j.mod.2006.05.005; Xu Y, 2002, EUR J BIOCHEM, V269, P6026, DOI 10.1046/j.1432-1033.2002.03293.x; YAMAMOTO K, 1988, SCIENCE, V239, P916, DOI 10.1126/science.3124270; YAO TP, 1993, NATURE, V366, P476, DOI 10.1038/366476a0; YAO TP, 1992, CELL, V71, P63, DOI 10.1016/0092-8674(92)90266-F; Zhang JZ, 1996, GENE, V175, P193, DOI 10.1016/0378-1119(96)00147-3; Zhang JZ, 1996, MOL CELL ENDOCRINOL, V122, P15, DOI 10.1016/0303-7207(96)03884-1; Zhou S, 2006, INSECT BIOCHEM MOLEC, V36, P726, DOI 10.1016/j.ibmb.2006.06.004; Zhou S, 2002, MOL CELL ENDOCRINOL, V190, P177, DOI 10.1016/S0303-7207(01)00602-5; Zhu HN, 2002, ANAL CHEM, V74, P1687, DOI 10.1021/ac010853p	60	80	87	0	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37605	37617		10.1074/jbc.M704595200	http://dx.doi.org/10.1074/jbc.M704595200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17956872	hybrid, Green Accepted			2022-12-27	WOS:000251833600036
J	Liu, YV; Hubbi, ME; Pan, F; McDonald, KR; Mansharamani, M; Cole, RN; Liu, JO; Semenza, GL				Liu, Ye V.; Hubbi, Maimon E.; Pan, Fan; McDonald, Karin R.; Mansharamani, Malini; Cole, Robert N.; Liu, Jun O.; Semenza, Gregg L.			Calcineurin promotes hypoxia-inducible factor 1 alpha expression by dephosphorylating RACK1 and blocking RACK1 dimerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR PROTEIN; FACTOR 1-ALPHA; TRANSCRIPTIONAL ACTIVITY; CYCLOSPORINE-A; SCAFFOLD PROTEIN; BINDING-PROTEIN; HIF-ALPHA; HIF-1-ALPHA; DEGRADATION; INHIBITION	Oxygen homeostasis represents an essential organizing principle of metazoan evolution and biology. Hypoxia-inducible factor 1 (HIF-1) is a master regulator of transcriptional responses to changes in O-2 concentration. HIF-1 is a heterodimer of HIF-1 alpha and HIF-1 beta subunits. O-2-dependent degradation of the HIF- 1 alpha subunit is mediated by prolyl hydroxylase, von Hippel-Lindau protein (VHL)/Elongin-C E3 ubiquitin ligase, and the proteasome. O-2-independent degradation of HIF- 1 alpha is regulated by the competition of RACK1 and HSP90 for binding to HIF- 1 alpha. RACK1 binding results in the recruitment of the Elongin-C E3 ubiquitin ligase, leading to VHL-independent ubiquitination and degradation of HIF- 1 alpha. In this report, we show that calcineurin inhibits the ubiquitination and proteasomal degradation of HIF- 1 alpha. Calcineurin is a serine/threonine phosphatase that is activated by calcium and calmodulin. The phosphatase activity of calcineurin is required for its regulation of HIF- 1 alpha. RACK1 binds to the catalytic domain of calcineurin and is required for HIF- 1 alpha degradation induced by the calcineurin inhibitor cyclosporine A. Elongin-C and HIF- 1 alpha each bind to RACK1 and dimerization of RACK1 is required to recruit Elongin-C to HIF-1 alpha. Phosphorylation of RACK1 promotes its dimerization and dephosphorylation by calcineurin inhibits dimerization. Serine 146 within the dimerization domain is phosphorylated and mutation of serine 146 impairs RACK1 dimerization and HIF- 1 alpha degradation. These results indicate that intracellular calcium levels can regulate HIF- 1 alpha expression by modulating calcineurin activity and RACK1 dimerization.	[Liu, Ye V.; Hubbi, Maimon E.; McDonald, Karin R.; Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Vasc Program, Inst Cell Engn, Baltimore, MD 21205 USA; [Liu, Ye V.; McDonald, Karin R.; Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [Hubbi, Maimon E.] Johns Hopkins Univ, Sch Med, Grad Training Program Cellular & Mol Med, Baltimore, MD 21205 USA; [Pan, Fan; Liu, Jun O.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Mass Spectrometry Proteom Facil, Baltimore, MD 21205 USA; [Mansharamani, Malini; Cole, Robert N.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Radiat Oncol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Semenza, GL (corresponding author), Broadway Res Bldg,Suite 671,733 N Broadway, Baltimore, MD 21205 USA.	gsemenza@jhmi.edu		Hubbi, Maimon/0000-0001-9763-287X	NHLBI NIH HHS [N01-HV28180, N01HV28180, N01 HV028180] Funding Source: Medline; DIVISION OF HEART AND VASCULAR DISEASES [N01HV028180] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Baek JH, 2005, MOL CELL, V17, P503, DOI 10.1016/j.molcel.2005.01.011; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Ceci M, 2003, NATURE, V426, P579, DOI 10.1038/nature02160; D'Angelo G, 2003, J BIOL CHEM, V278, P15406, DOI 10.1074/jbc.M211293200; Ebert BL, 1998, MOL CELL BIOL, V18, P4089, DOI 10.1128/MCB.18.7.4089; Elvidge GP, 2006, J BIOL CHEM, V281, P15215, DOI 10.1074/jbc.M511408200; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Huai Q, 2002, P NATL ACAD SCI USA, V99, P12037, DOI 10.1073/pnas.192206699; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Hui AS, 2006, FASEB J, V20, P466, DOI 10.1096/fj.05-5086com; Isaacs JS, 2002, J BIOL CHEM, V277, P29936, DOI 10.1074/jbc.M204733200; Ivan M, 2001, CURR OPIN GENET DEV, V11, P27, DOI 10.1016/S0959-437X(00)00152-0; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jiang BH, 1996, J BIOL CHEM, V271, P17771, DOI 10.1074/jbc.271.30.17771; Jiang BH, 1996, AM J PHYSIOL-CELL PH, V271, pC1172, DOI 10.1152/ajpcell.1996.271.4.C1172; Kamura T, 2000, P NATL ACAD SCI USA, V97, P10430, DOI 10.1073/pnas.190332597; Kiely PA, 2006, MOL CELL BIOL, V26, P4041, DOI 10.1128/MCB.01868-05; KLEE CB, 1979, P NATL ACAD SCI USA, V76, P6270, DOI 10.1073/pnas.76.12.6270; Klee CB, 1998, J BIOL CHEM, V273, P13367, DOI 10.1074/jbc.273.22.13367; Kong XG, 2006, FEBS LETT, V580, P6182, DOI 10.1016/j.febslet.2006.10.019; Koulmann N, 2006, AM J RESP CRIT CARE, V174, P699, DOI 10.1164/rccm.200512-1976OC; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Licht AH, 2006, BLOOD, V107, P584, DOI 10.1182/blood-2005-07-3033; Lin X, 1999, J BIOL CHEM, V274, P36125, DOI 10.1074/jbc.274.51.36125; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Liu YV, 2007, CELL CYCLE, V6, P656, DOI 10.4161/cc.6.6.3981; Liu YV, 2007, MOL CELL, V25, P207, DOI 10.1016/j.molcel.2007.01.001; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; Manalo DJ, 2005, BLOOD, V105, P659, DOI 10.1182/blood-2004-07-2958; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; McCahill A, 2002, MOL PHARMACOL, V62, P1261, DOI 10.1124/mol.62.6.1261; Patterson RL, 2004, P NATL ACAD SCI USA, V101, P2328, DOI 10.1073/pnas.0308567100; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; RON D, 1994, P NATL ACAD SCI USA, V91, P839, DOI 10.1073/pnas.91.3.839; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; Sano M, 2007, NATURE, V446, P444, DOI 10.1038/nature05602; Semenza GL, 2006, EXPERT OPIN THER TAR, V10, P267, DOI 10.1517/14728222.10.2.267; Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529; Sengupta J, 2004, NAT STRUCT MOL BIOL, V11, P957, DOI 10.1038/nsmb822; Sun L, 1998, IMMUNITY, V8, P703, DOI 10.1016/S1074-7613(00)80575-0; Thornton C, 2004, J BIOL CHEM, V279, P31357, DOI 10.1074/jbc.M402316200; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wang J, 2006, CIRC RES, V98, P1528, DOI 10.1161/01.RES.0000227551.68124.98; Yu AY, 1999, J CLIN INVEST, V103, P691, DOI 10.1172/JCI5912; Yuan GX, 2005, J BIOL CHEM, V280, P4321, DOI 10.1074/jbc.M407706200	51	120	131	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					37064	37073		10.1074/jbc.M705015200	http://dx.doi.org/10.1074/jbc.M705015200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17965024	hybrid, Green Accepted			2022-12-27	WOS:000251646000033
J	Puca, A; Fiume, G; Palmieri, C; Trimboli, F; Olimpico, F; Scala, G; Quinto, I				Puca, Antimina; Fiume, Giuseppe; Palmieri, Camillo; Trimboli, Francesca; Olimpico, Francesco; Scala, Giuseppe; Quinto, Ileana			I kappa B-alpha represses the transcriptional activity of the HIV-1 Tat transactivator by promoting its nuclear export	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PROTEOLYSIS-RESISTANT INHIBITOR; LONG TERMINAL REPEAT; TYPE-1 TAT; EXPRESSION; BINDING; PROTEIN; SIGNAL; ACTIVATION; GENE	The long terminal repeat of human immunodeficiency virus, type 1 (HIV-1) contains an NF-kappa B enhancer and is potently inhibited by I kappa B-alpha S32/36A, a proteolysis-resistant inhibitor of NF-kappa B transacting factors. The evidence that NF-kappa B is dispensable for HIV-1 expression raises the question of whether I kappa B-alpha represses the HIV-1 transcription by mechanisms distinct from NF-kappa B inhibition. Here, we report that I kappa B-alpha negatively regulates the HIV-1 expression and replication in an NF-kappa B-independent manner by directly binding to Tat, which results in the nuclear export and cytoplasmic sequestration of the viral transactivator. The sequence of I kappa B-alpha required for Tat inhibition spans from amino acids 72 to 287 and includes the nuclear localization signal, the carboxyl-terminal nuclear export signal, and the binding site for the arginine-rich domain of Tat. This novel mechanism of cross-talk between Tat and I kappa B-alpha provides further insights into the mechanisms of HIV-1 regulation and could assist in the development of novel strategies for AIDS therapy.	[Palmieri, Camillo; Trimboli, Francesca; Scala, Giuseppe; Quinto, Ileana] Univ Catanzaro Magna Graecia, Dept Expt & Clin Med, I-88100 Catanzaro, Italy; [Puca, Antimina; Fiume, Giuseppe; Olimpico, Francesco; Scala, Giuseppe; Quinto, Ileana] Univ Naples Federico II, Dept Biochem & Med Biotechnol, I-80131 Naples, Italy	Magna Graecia University of Catanzaro; University of Naples Federico II	Quinto, I (corresponding author), Univ Catanzaro Magna Graecia, Dept Expt & Clin Med, Biosci Bldg,Viale Europa Germaneto, I-88100 Catanzaro, Italy.	quinto@unicz.it	SCALA, GIUSEPPE/A-3280-2009; Trimboli, Francesca/Y-1143-2019; Palmieri, Camillo/A-3195-2009	Trimboli, Francesca/0000-0002-1766-9179; Palmieri, Camillo/0000-0001-6707-4723; FIUME, Giuseppe/0000-0002-5414-6190; QUINTO, Ileana/0000-0001-8212-8515				Ambrosino C, 1997, J BIOL CHEM, V272, P14883, DOI 10.1074/jbc.272.23.14883; ARENZANASEISDEDOS F, 1995, MOL CELL BIOL, V15, P2689; ArenzanaSeisdedos F, 1997, J CELL SCI, V110, P369; Asin S, 1999, J VIROL, V73, P3893, DOI 10.1128/JVI.73.5.3893-3903.1999; Bachelerie F, 1997, J CELL SCI, V110, P2883; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Benkirane M, 1998, J BIOL CHEM, V273, P24898, DOI 10.1074/jbc.273.38.24898; BERKHOUT B, 1989, CELL, V59, P273, DOI 10.1016/0092-8674(89)90289-4; BERKHOUT B, 1992, J VIROL, V66, P139, DOI 10.1128/JVI.66.1.139-149.1992; Bossis G, 2002, FEBS LETT, V516, P257, DOI 10.1016/S0014-5793(02)02566-8; Brady J, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-69; BROCKMAN JA, 1995, MOL CELL BIOL, V15, P2809; BROWN K, 1995, SCIENCE, V267, P1485, DOI 10.1126/science.7878466; Brussel A, 2003, J VIROL, V77, P10119, DOI 10.1128/JVI.77.18.10119-10124.2003; BUONAGURO L, 1992, J VIROL, V66, P7159, DOI 10.1128/JVI.66.12.7159-7167.1992; Carlotti F, 1999, J BIOL CHEM, V274, P37941, DOI 10.1074/jbc.274.53.37941; Chen BK, 1997, J VIROL, V71, P5495, DOI 10.1128/JVI.71.7.5495-5504.1997; Coiras M, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-56; DAYTON AI, 1986, CELL, V44, P941, DOI 10.1016/0092-8674(86)90017-6; DeLuca C, 1996, J VIROL, V70, P5183, DOI 10.1128/JVI.70.8.5183-5193.1996; Demarchi F, 1996, J VIROL, V70, P4427, DOI 10.1128/JVI.70.7.4427-4437.1996; FISHER AG, 1986, NATURE, V320, P367, DOI 10.1038/320367a0; Garber ME, 1998, GENE DEV, V12, P3512, DOI 10.1101/gad.12.22.3512; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Harhaj E, 1996, VIROLOGY, V216, P284, DOI 10.1006/viro.1996.0062; HASKILL S, 1991, CELL, V65, P1281, DOI 10.1016/0092-8674(91)90022-Q; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; HERRMANN CH, 1995, J VIROL, V69, P1612, DOI 10.1128/JVI.69.3.1612-1620.1995; Hiscott J, 2001, J CLIN INVEST, V107, P143, DOI 10.1172/JCI11918; Hoffmann A, 2003, EMBO J, V22, P5530, DOI 10.1093/emboj/cdg534; Hotttiger MO, 1998, J VIROL, V72, P8252, DOI 10.1128/JVI.72.10.8252-8256.1998; Huang TT, 2000, P NATL ACAD SCI USA, V97, P1014, DOI 10.1073/pnas.97.3.1014; JEANG KT, 1993, J VIROL, V67, P6224, DOI 10.1128/JVI.67.10.6224-6233.1993; Johnson C, 1999, EMBO J, V18, P6682, DOI 10.1093/emboj/18.23.6682; KASHANCHI F, 1994, NATURE, V367, P295, DOI 10.1038/367295a0; Kwon H, 1998, J BIOL CHEM, V273, P7431, DOI 10.1074/jbc.273.13.7431; LEONARD J, 1989, J VIROL, V63, P4919, DOI 10.1128/JVI.63.11.4919-4924.1989; Li XG, 2001, BIOCHEM BIOPH RES CO, V286, P587, DOI 10.1006/bbrc.2001.5442; LIU JS, 1992, J VIROL, V66, P3883, DOI 10.1128/JVI.66.6.3883-3887.1992; Liu WM, 2001, NAT IMMUNOL, V2, P939, DOI 10.1038/ni1001-939; Mallardo M, 1996, J BIOL CHEM, V271, P20820, DOI 10.1074/jbc.271.34.20820; Mancebo HSY, 1997, GENE DEV, V11, P2633, DOI 10.1101/gad.11.20.2633; Marzio G, 1998, P NATL ACAD SCI USA, V95, P13519, DOI 10.1073/pnas.95.23.13519; MCELHINNY JA, 1995, J VIROL, V69, P1500, DOI 10.1128/JVI.69.3.1500-1509.1995; NABEL G, 1987, NATURE, V326, P711, DOI 10.1038/326711a0; O'Doherty U, 2000, J VIROL, V74, P10074, DOI 10.1128/JVI.74.21.10074-10080.2000; Pereira LA, 2000, NUCLEIC ACIDS RES, V28, P663, DOI 10.1093/nar/28.3.663; Perkins ND, 2006, CELL DEATH DIFFER, V13, P759, DOI 10.1038/sj.cdd.4401838; Prigent M, 2000, J BIOL CHEM, V275, P36441, DOI 10.1074/jbc.M004751200; Quinto I, 1999, J BIOL CHEM, V274, P17567, DOI 10.1074/jbc.274.25.17567; Quinto I, 2004, J BIOL CHEM, V279, P1720, DOI 10.1074/jbc.M309375200; Raha T, 2005, PLOS BIOL, V3, P221, DOI 10.1371/journal.pbio.0030044; Rodriguez MS, 1999, J BIOL CHEM, V274, P9108, DOI 10.1074/jbc.274.13.9108; Sachdev S, 2000, MOL CELL BIOL, V20, P1571, DOI 10.1128/MCB.20.5.1571-1582.2000; Sachdev S, 1998, MOL CELL BIOL, V18, P2524, DOI 10.1128/MCB.18.5.2524; SCALA G, 1994, J EXP MED, V179, P961, DOI 10.1084/jem.179.3.961; SHA WC, 1995, CELL, V80, P321, DOI 10.1016/0092-8674(95)90415-8; Tam WF, 2000, MOL CELL BIOL, V20, P2269, DOI 10.1128/MCB.20.6.2269-2284.2000; Turpin P, 1999, J BIOL CHEM, V274, P6804, DOI 10.1074/jbc.274.10.6804; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; WESTENDORP MO, 1994, J VIROL, V68, P4177, DOI 10.1128/JVI.68.7.4177-4185.1994; Wu Yuntao, 2004, Retrovirology, V1, P13, DOI 10.1186/1742-4690-1-13; Zhu YR, 1997, GENE DEV, V11, P2622, DOI 10.1101/gad.11.20.2622	63	22	22	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					37146	37157		10.1074/jbc.M705815200	http://dx.doi.org/10.1074/jbc.M705815200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17942396	hybrid			2022-12-27	WOS:000251646000041
J	Pang, PC; Tissot, B; Drobnis, EZ; Sutovsky, P; Morris, HR; Clark, GF; Dell, A				Pang, Poh-Choo; Tissot, Berangere; Drobnis, Erma Z.; Sutovsky, Peter; Morris, Howard R.; Clark, Gary F.; Dell, Anne			Expression of bisecting type and Lewis(x)/Lewis(y) terminated N-Glycans on human sperm	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN SEMINAL PLASMA; NATURAL-KILLER-CELLS; TESTICULAR GERM-CELLS; HUMAN UTERINE CERVIX; TUMOR-MARKER CA125; CLASS-I MOLECULES; DC-SIGN; SEMINIFEROUS TUBULES; LOTUS-TETRAGONOLOBUS; FUCOSYL TRANSFERASE	Human sperm lack major histocompatibility class I molecules, making them susceptible to lysis by natural killer (NK) cells. Major histocompatibility class I negative tumor cells block NK cellysis by expressing sufficient amounts of bisecting type N-glycans on their surfaces. Therefore, sperm could employ the same strategy to evade NK cell lysis. The total N-glycans derived from sperm were sequenced using ultrasensitive mass spectrometric and conventional approaches. Three major classes of N-glycans were detected, (i) high mannose, (ii) biantennary bisecting type, and (iii) biantennary, triantennary, and tetraantennary oligosaccharides terminated with Lewis(x) and Lewis(y) sequences. Immunostaining of normal sperm showed that glycoproteins bearing Lewis(y) sequences are localized to the acrosome and not the plasma membrane. In contrast, defective sperm showed distinct surface labeling with anti-Lewis(y) antibody. The substantial expression of high mannose and complex type N-glycans terminated with Lewis(x) and Lewis(y) sequences suggests that sperm glycoproteins are highly decorated with ligands for DC-SIGN. Based on previous studies, the addition of such carbohydrate signals should inhibit antigen-specific responses directed against sperm glycoproteins in both the male and female reproductive systems. Thus, the major N-glycans of human sperm are associated with the inhibition of both innate and adaptive immune responses. These results provide more support for the eutherian fetoembryonic defense system hypothesis that links the expression of carbohydrate functional groups to the protection of gametes and the developing human in utero. This study also highlights the usefulness of glycomic profiling for revealing potential physiological functions of glycans expressed in specific cell types.	Univ Missouri, Sch Med, Dept Obstet Gynecol & Womens Hlth, Div Reprod & Perinatal Res, Columbia, MO 65212 USA; Univ Missouri, Sch Med, Dept Obstet Gynecol & Womens Hlth, Div Reprod Endocrinol & Infertil, Columbia, MO 65212 USA; Univ Missouri, Div Anim Sci, Columbia, MO 65202 USA; M SCAN Ltd, Wokingham RG41 2TZ, Berks, England; Univ London Imperial Coll Sci Technol & Med, Fac Nat Sci, Div Mol Biosci, London SW7 2AZ, England	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Imperial College London	Clark, GF (corresponding author), Univ Missouri, Sch Med, Dept Obstet Gynecol & Womens Hlth, Div Reprod & Perinatal Res, Columbia, MO 65212 USA.	clarkgf@health.missouri.edu; a.dell@imperial.ac.uk	Drobnis, Erna Z./M-2706-2016	Drobnis, Erna Z./0000-0001-5495-3489; Sutovsky, Peter/0000-0002-9231-2823	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI060397] Funding Source: NIH RePORTER; NIAID NIH HHS [AI060397-03] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Wellcome Trust(Wellcome TrustEuropean Commission)		ADACHI M, 1988, J EXP MED, V167, P323, DOI 10.1084/jem.167.2.323; Algarra I, 2004, CANCER IMMUNOL IMMUN, V53, P904, DOI 10.1007/s00262-004-0517-9; Avril T, 2006, J LEUKOCYTE BIOL, V80, P787, DOI 10.1189/jlb.1005559; Baldus SE, 2006, HISTOL HISTOPATHOL, V21, P503, DOI 10.14670/HH-21.503; Barber LD, 1996, J IMMUNOL, V156, P3275; Bergman M, 2006, NAT REV MICROBIOL, V4, P151, DOI 10.1038/nrmicro1344; Bergman MP, 2004, J EXP MED, V200, P979, DOI 10.1084/jem.20041061; BILLINGHAM RE, 1953, NATURE, V172, P603, DOI 10.1038/172603a0; Chalabi S, 2002, J BIOL CHEM, V277, P32562, DOI 10.1074/jbc.M205152200; Clark GF, 1997, MOL HUM REPROD, V3, P5, DOI 10.1093/molehr/3.1.5; Clarke K, 2000, CANCER RES, V60, P4804; CROSS NL, 1987, GAMETE RES, V16, P23, DOI 10.1002/mrd.1120160104; DCruz OJ, 1996, FERTIL STERIL, V65, P843, DOI 10.1016/S0015-0282(16)58224-7; DCruz OJ, 1997, AM J REPROD IMMUNOL, V37, P172; DIXON FJ, 1955, J EXP MED, V101, P245, DOI 10.1084/jem.101.3.245; Drobnis E Z, 1992, Oxf Rev Reprod Biol, V14, P1; Dym M, 1970, Biology Reprod., V3, P308; ELOUAGARI K, 1995, J BIOL CHEM, V270, P26970; Falco M, 1999, J EXP MED, V190, P793, DOI 10.1084/jem.190.6.793; Feinberg H, 2001, SCIENCE, V294, P2163, DOI 10.1126/science.1066371; Fijak M, 2006, IMMUNOL REV, V213, P66, DOI 10.1111/j.1600-065X.2006.00438.x; HANISCH FG, 1986, EUR J BIOCHEM, V155, P239, DOI 10.1111/j.1432-1033.1986.tb09482.x; Haslam SM, 2000, GLYCOBIOLOGY, V10, P223, DOI 10.1093/glycob/10.2.223; HEAD JR, 1985, PERSPECT BIOL MED, V29, P115; Hutter H, 1998, J REPROD IMMUNOL, V38, P101, DOI 10.1016/S0165-0378(98)00032-1; ITOH M, 1995, ARCH ANDROLOGY, V35, P93, DOI 10.3109/01485019508987859; Itoh M, 2005, J REPROD IMMUNOL, V67, P57, DOI 10.1016/j.jri.2005.06.007; Itoh M, 1995, J ANAT, V187, P671; Jang-Lee J, 2006, METHOD ENZYMOL, V415, P59, DOI 10.1016/S0076-6879(06)15005-3; Karre K, 2002, SCAND J IMMUNOL, V55, P221, DOI 10.1046/j.1365-3083.2002.01053.x; KASHIWAGI N, 1994, TOHOKU J EXP MED, V173, P115, DOI 10.1620/tjem.173.115; LEE MC, 1985, ANAT REC, V212, P282, DOI 10.1002/ar.1092120310; Lombardo F, 2001, HUM REPROD UPDATE, V7, P450, DOI 10.1093/humupd/7.5.450; MEDAWAR PB, 1953, SYM SOC EXP BIOL, V7, P320; Meyer S, 2005, J BIOL CHEM, V280, P37349, DOI 10.1074/jbc.M507100200; Morris HR, 1996, J BIOL CHEM, V271, P32159, DOI 10.1074/jbc.271.50.32159; MYERS RB, 1995, J UROLOGY, V153, P1572, DOI 10.1016/S0022-5347(01)67464-0; NARASIMHAN S, 1985, BIOCHEMISTRY-US, V24, P1694, DOI 10.1021/bi00328a019; Nicoll G, 1999, J BIOL CHEM, V274, P34089, DOI 10.1074/jbc.274.48.34089; Ozanon C, 2005, HUM REPROD, V20, P2271, DOI 10.1093/humrep/dei013; PANDYA IJ, 1985, FERTIL STERIL, V43, P417; Patankar MS, 1997, MOL HUM REPROD, V3, P501, DOI 10.1093/molehr/3.6.501; Patankar MS, 2005, GYNECOL ONCOL, V99, P704, DOI 10.1016/j.ygyno.2005.07.030; PEREIRA MEA, 1974, BIOCHEMISTRY-US, V13, P3184, DOI 10.1021/bi00712a029; PIKE BL, 1980, J EXP MED, V152, P1407, DOI 10.1084/jem.152.5.1407; Pilch B, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r40; Poland DCW, 2002, PROSTATE, V52, P34, DOI 10.1002/pros.10085; RONQUIST G, 1984, UROL RES, V12, P243; RONQUIST G, 1983, INT J FERTIL, V28, P239; RUMKE P, 1959, AM J CLIN PATHOL, V32, P357; Saari T, 1996, J REPROD IMMUNOL, V31, P65, DOI 10.1016/0165-0378(96)00962-X; Schroter S, 1999, J BIOL CHEM, V274, P29862, DOI 10.1074/jbc.274.42.29862; SETCHELL BP, 1967, J PHYSIOL-LONDON, V189, P63; Sutovsky Peter, 2004, Methods Mol Biol, V253, P59; Sutton-Smith M, 2007, GLYCOBIOLOGY, V17, P553, DOI 10.1093/glycob/cwm025; THOMPSON LA, 1992, AM J REPROD IMMUNOL, V28, P85, DOI 10.1111/j.1600-0897.1992.tb00765.x; TSUJI Y, 1988, J EXP MED, V168, P343, DOI 10.1084/jem.168.1.343; TUNG KSK, 1981, IMMUNOL REV, V55, P217, DOI 10.1111/j.1600-065X.1981.tb00344.x; van Die I, 2003, GLYCOBIOLOGY, V13, P471, DOI 10.1093/glycob/cwg052; van Liempt E, 2006, FEBS LETT, V580, P6123, DOI 10.1016/j.febslet.2006.10.009; VANHALBEEK H, 1985, BIOCHEM BIOPH RES CO, V131, P507, DOI 10.1016/0006-291X(85)91831-5; Wong NK, 2003, J BIOL CHEM, V278, P28619, DOI 10.1074/jbc.M302741200; World Health Organization (WHO), 1999, WHO LAB MANUAL EXAMI, V4th; Yan LY, 1997, GLYCOCONJUGATE J, V14, P45, DOI 10.1023/A:1018508914551; Yoshimura M, 1996, CANCER RES, V56, P412; YULE TD, 1988, J IMMUNOL, V141, P1161; ZINKERNA.RM, 1974, NATURE, V248, P701, DOI 10.1038/248701a0	67	49	53	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36593	36602		10.1074/jbc.M705134200	http://dx.doi.org/10.1074/jbc.M705134200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17913713	hybrid			2022-12-27	WOS:000251458300052
J	Shao, W; Yeretssian, G; Doiron, K; Hussain, SN; Saleh, M				Shao, Wei; Yeretssian, Garabet; Doiron, Karine; Hussain, Sabah N.; Saleh, Maya			The caspase-1 digestome identifies the glycolysis pathway as a target during infection and septic shock	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAS-INDUCED APOPTOSIS; INTERLEUKIN-1-BETA CONVERTING-ENZYME; INFLAMMATORY CELL-DEATH; ENERGY-METABOLISM; HUMAN-NEUTROPHILS; PROTEOME ANALYSIS; MICE DEFICIENT; CLEAVAGE; ACTIVATION; SEPSIS	Caspase-1 is an essential effector of inflammation, pyroptosis, and septic shock. Few caspase-1 substrates have been identified to date, and these substrates do not account for its wide range of actions. To understand the function of caspase-1, we initiated the systematic identification of its cellular substrates. Using the diagonal gel proteomic approach, we identified 41 proteins that are directly cleaved by caspase-1. Among these were chaperones, cytoskeletal and translation machinery proteins, and proteins involved in immunity. A series of unexpected proteins along the glycolysis pathway were also identified, including aldolase, triose-phosphate isomerase, glyceraldehyde-3-phosphate dehydrogenase, alpha-enolase, and pyruvate kinase. With the exception of the latter, the identified glycolysis enzymes were specifically cleaved in vitro by recombinant caspase-1, but not caspase-3. The enzymatic activity of wild-type glyceraldehyde-3-phosphate dehydrogenase, but not a non-cleavable mutant, was dampened by caspase-1 processing. In vivo, stimuli that fully activated caspase-1, including Salmonella typhimurium infection and septic shock, caused a pronounced processing of these proteins in the macrophage and diaphragm muscle, respectively. Notably, these stimuli inhibited glycolysis in wildtype cells compared with caspase-1-deficient cells. The systematic characterization of caspase-1 substrates identifies the glycolysis pathway as a caspase-1 target and provides new insights into its function during pyroptosis and septic shock.	McGill Univ, Ctr Hlth, Dept Biochem, Montreal, PQ H3A 1A1, Canada; McGill Univ, Dept Med, Div Crit Care, Montreal, PQ H3A 1A1, Canada; McGill Univ, Ctr Study Host Resistance, Montreal, PQ H3A 1A1, Canada	McGill University; McGill University; McGill University	Saleh, M (corresponding author), McGill Univ, Ctr Hlth, Dept Biochem, Rm M11-41,687 Pine Ave W, Montreal, PQ H3A 1A1, Canada.	maya.saleh@mcgill.ca	Hussain, Sabah/ABC-5315-2021	Saleh, Maya/0000-0003-1538-9146				BORREGAARD N, 1982, J CLIN INVEST, V70, P550, DOI 10.1172/JCI110647; Brockstedt E, 1998, J BIOL CHEM, V273, P28057, DOI 10.1074/jbc.273.43.28057; Browne KA, 2000, J BIOL CHEM, V275, P39262, DOI 10.1074/jbc.C000622200; Byun Y, 2001, CELL DEATH DIFFER, V8, P443, DOI 10.1038/sj.cdd.4400840; Colell A, 2007, CELL, V129, P983, DOI 10.1016/j.cell.2007.03.045; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Demontis S, 2006, CELL DEATH DIFFER, V13, P335, DOI 10.1038/sj.cdd.4401744; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Fink SL, 2005, INFECT IMMUN, V73, P1907, DOI 10.1128/IAI.73.4.1907-1916.2005; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Gerner C, 2000, J BIOL CHEM, V275, P39018, DOI 10.1074/jbc.M006495200; GU Y, 1995, J BIOL CHEM, V270, P18715, DOI 10.1074/jbc.270.32.18715; Haji-Michael PG, 1999, METABOLISM, V48, P779, DOI 10.1016/S0026-0495(99)90179-8; Hussain SNA, 1998, MOL CELL BIOCHEM, V179, P125, DOI 10.1023/A:1006864021783; Kawaguchi T, 2001, J BIOL CHEM, V276, P28554, DOI 10.1074/jbc.M101396200; KELLETT DN, 1966, J PHARM PHARMACOL, V18, P199, DOI 10.1111/j.2042-7158.1966.tb07853.x; Kothakota S, 1997, SCIENCE, V278, P294, DOI 10.1126/science.278.5336.294; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Lewis JS, 1999, J LEUKOCYTE BIOL, V66, P889, DOI 10.1002/jlb.66.6.889; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Mariathasan S, 2007, NAT REV IMMUNOL, V7, P31, DOI 10.1038/nri1997; Mashima T, 1997, ONCOGENE, V14, P1007, DOI 10.1038/sj.onc.1200919; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Monack DM, 2001, MICROBES INFECT, V3, P1201, DOI 10.1016/S1286-4579(01)01480-0; Nicholson DW, 1999, CELL DEATH DIFFER, V6, P1028, DOI 10.1038/sj.cdd.4400598; Prasad S, 1998, INT J ONCOL, V13, P757; Ricci JE, 2004, CELL, V117, P773, DOI 10.1016/j.cell.2004.05.008; Saleh M, 2007, CELL DEATH DIFFER, V14, P1559, DOI 10.1038/sj.cdd.4402203; Sarkar A, 2006, AM J RESP CRIT CARE, V174, P1003, DOI 10.1164/rccm.200604-546OC; Scott AM, 2007, CELL DEATH DIFFER, V14, P23, DOI 10.1038/sj.cdd.4402026; SIMCHOWITZ L, 1979, ARTHRITIS RHEUM, V22, P755, DOI 10.1002/art.1780220711; Swanson MS, 2005, AUTOPHAGY, V1, P174, DOI 10.4161/auto.1.3.2067; Thiede B, 2001, J BIOL CHEM, V276, P26044, DOI 10.1074/jbc.M101062200; Tschopp J, 2003, NAT REV MOL CELL BIO, V4, P95, DOI 10.1038/nrm1019; Van Damme P, 2005, NAT METHODS, V2, P771, DOI 10.1038/NMETH792; van de Water B, 2000, J BIOL CHEM, V275, P25805, DOI 10.1074/jbc.M001680200; WEISDORF DJ, 1982, BLOOD, V60, P888; WEISDORF DJ, 1982, INFLAMMATION, V6, P245, DOI 10.1007/BF00916406	40	250	255	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36321	36329		10.1074/jbc.M708182200	http://dx.doi.org/10.1074/jbc.M708182200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17959595	hybrid			2022-12-27	WOS:000251458300023
J	Yang, YB; Yin, C; Pandey, A; Abbott, D; Sassetti, C; Kelliher, MA				Yang, Yibin; Yin, Catherine; Pandey, Amit; Abbott, Derek; Sassetti, Christopher; Kelliher, Michelle A.			NOD2 pathway activation by MDP or Mycobacterium tuberculosis infection involves the stable polyubiquitination of Rip2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTOR; INNATE IMMUNE-RESPONSES; NF-KAPPA-B; HOST RECOGNITION; PEPTIDOGLYCAN; MACROPHAGES; SYSTEMS; PROTEIN; MYD88; TLR4	The Rip2 kinase contains a caspase recruitment domain and has been implicated in the activation of the transcriptional factor NF-kappa B downstream of Toll-like receptors, Nod-like receptors, and the T cell receptor. Although Rip2 has been linked to Nod signaling, how Nod-Rip2 proteins mediate NF-kappa B activation has remained unclear. We find Rip2 required for Nod2-mediated NF-kappa B activation and to a lesser extent mitogen-activated protein kinase activation. We demonstrate that Rip2 and I kappa B kinase-gamma become stably polyubiquitinated upon treatment of cells with the NOD2 ligand, muramyl dipeptide. We also demonstrate a requirement for the E2-conjugating enzyme Ubc13, the E3 ubiquitin ligase Traf6, and the ubiquitin-activated kinase Tak1 in Nod2-mediated NF-kappa B activation. Rip2 polyubiquitination is also stimulated when macrophages are infected with live Mycobacterium tuberculosis but not when infected with heat-killed bacteria. Consistent with our data linking Rip2 to NOD and not Toll-like receptor signaling, M. tuberculosis-induced Rip2 polyubiquitination appears MyD88-independent. Collectively, these data reveal that the NOD2 pathway is ubiquitin-regulated and that Rip2 employs a ubiquitin-dependent mechanism to achieve NF-kappa B activation.	Univ Massachusetts, Sch Med, Dept Mol Genet & Microbiol, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA 01605 USA; Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Case Western Reserve University	Kelliher, MA (corresponding author), Univ Massachusetts, Sch Med, Dept Mol Genet & Microbiol, 364 Plantat St, Worcester, MA 01605 USA.	michelle.kelliher@umassmed.edu		Abbott, Derek/0000-0003-4387-8094	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064282] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abbott DW, 2007, MOL CELL BIOL, V27, P6012, DOI 10.1128/MCB.00270-07; Abbott DW, 2004, CURR BIOL, V14, P2217, DOI 10.1016/j.cub.2004.12.032; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Boneca IG, 2007, P NATL ACAD SCI USA, V104, P997, DOI 10.1073/pnas.0609672104; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; Chin AI, 2002, NATURE, V416, P190, DOI 10.1038/416190a; Ferwerda G, 2005, PLOS PATHOG, V1, P279, DOI 10.1371/journal.ppat.0010034; Fremond CM, 2004, J CLIN INVEST, V114, P1790, DOI 10.1172/JCI200421027; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; Hise AG, 2007, J IMMUNOL, V178, P1068, DOI 10.4049/jimmunol.178.2.1068; Hsu YMS, 2007, NAT IMMUNOL, V8, P198, DOI 10.1038/ni1426; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Mazzaccaro RJ, 1996, P NATL ACAD SCI USA, V93, P11786, DOI 10.1073/pnas.93.21.11786; McCarthy JV, 1998, J BIOL CHEM, V273, P16968, DOI 10.1074/jbc.273.27.16968; Means TK, 2001, J IMMUNOL, V166, P4074, DOI 10.4049/jimmunol.166.6.4074; Meylan E, 2005, TRENDS BIOCHEM SCI, V30, P151, DOI 10.1016/j.tibs.2005.01.003; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Opitz B, 2004, J BIOL CHEM, V279, P36426, DOI 10.1074/jbc.M403861200; Park JH, 2007, J IMMUNOL, V178, P2380, DOI 10.4049/jimmunol.178.4.2380; Shi SP, 2005, J IMMUNOL, V175, P3318, DOI 10.4049/jimmunol.175.5.3318; Stanley SA, 2007, J IMMUNOL, V178, P3143, DOI 10.4049/jimmunol.178.5.3143; Teitelbaum R, 1999, P NATL ACAD SCI USA, V96, P15190, DOI 10.1073/pnas.96.26.15190	25	180	191	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36223	36229		10.1074/jbc.M703079200	http://dx.doi.org/10.1074/jbc.M703079200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17947236	hybrid			2022-12-27	WOS:000251458300012
J	Mora, L; Heurgue-Hamard, V; de Zamaroczy, M; Kervestin, S; Buckingham, RH				Mora, Liliana; Heurgue-Hamard, Valerie; de Zamaroczy, Miklos; Kervestin, Stephanie; Buckingham, Richard H.			Methylation of bacterial release factors RF1 and RF2 is required for normal translation termination in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONSERVED GGQ MOTIF; ESCHERICHIA-COLI; FACTOR-II; NUCLEOTIDE-SEQUENCE; MESSENGER-RNA; STOP CODONS; AMINO-ACID; GENE; EXPRESSION; MUTATIONS	Bacterial release factors RF1 and RF2 are methylated on the Gln residue of a universally conserved tripeptide motif GGQ, which interacts with the peptidyl transferase center of the large ribosomal subunit, triggering hydrolysis of the ester bond in peptidyl-tRNA and releasing the newly synthesized polypeptide from the ribosome. In vitro experiments have shown that the activity of RF2 is stimulated by Gln methylation. The viability of Escherichia coli K12 strains depends on the integrity of the release factor methyltransferase PrmC, because K12 strains are partially deficient in RF2 activity due to the presence of a Thr residue at position 246 instead of Ala. Here, we study in vivo RF1 and RF2 activity at termination codons in competition with programmed frameshifting and the effect of the Ala-246 -> Thr mutation. PrmC inactivation reduces the specific termination activity of RF1 and RF2(Ala-246) by similar to 3- to 4-fold. The mutation Ala-246 -> Thr in RF2 reduces the termination activity in cells similar to 5-fold. After correction for the decrease in level of RF2 due to the autocontrol of RF2 synthesis, the mutation Ala-246 -> Thr reduced RF2 termination activity by similar to 10-fold at UGA codons and UAA codons. PrmC inactivation had no effect on cell growth in rich media but reduced growth considerably on poor carbon sources. This suggests that the expression of some genes needed for optimal growth under such conditions can become growth limiting as a result of inefficient translation termination.	Inst Biol Physicochim, CNRS, UPR 9073, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS)	Buckingham, RH (corresponding author), Inst Biol Physicochim, CNRS, UPR 9073, 13 Rue Pierre & Marie Curie, F-75005 Paris, France.	richard.buckingham@ibpc.fr		Buckingham, Richard/0000-0002-8567-4500; HEURGUE-HAMARD, VALERIE/0000-0003-1576-7231				ADAMSKI FM, 1994, J MOL BIOL, V238, P302, DOI 10.1006/jmbi.1994.1293; Arkov AL, 1998, J BACTERIOL, V180, P2744, DOI 10.1128/JB.180.10.2744-2748.1998; Bachmann B.J., 1987, ESCHERICHIA COLI SAL, P1190; Collier J, 2002, MOL MICROBIOL, V45, P745, DOI 10.1046/j.1365-2958.2002.03045.x; COULONDRE C, 1977, J MOL BIOL, V117, P525, DOI 10.1016/0022-2836(77)90056-0; CRAIGEN WJ, 1986, NATURE, V322, P273, DOI 10.1038/322273a0; CRAIGEN WJ, 1985, P NATL ACAD SCI USA, V82, P3616, DOI 10.1073/pnas.82.11.3616; CURRAN JF, 1988, J MOL BIOL, V203, P75, DOI 10.1016/0022-2836(88)90092-7; CURRAN JF, 1989, J MOL BIOL, V209, P65, DOI 10.1016/0022-2836(89)90170-8; Dahlgren A, 2004, BIOCHIMIE, V86, P431, DOI 10.1016/j.biochi.2004.06.009; Dincbas-Renqvist V, 2000, EMBO J, V19, P6900, DOI 10.1093/emboj/19.24.6900; ELLIOTT T, 1989, J BACTERIOL, V171, P3948, DOI 10.1128/jb.171.7.3948-3960.1989; Frolova LY, 1999, RNA, V5, P1014, DOI 10.1017/S135583829999043X; Gerdes SY, 2003, J BACTERIOL, V185, P5673, DOI 10.1128/JB.185.19.5673-5684.2003; GOUY M, 1982, NUCLEIC ACIDS RES, V10, P7055, DOI 10.1093/nar/10.22.7055; Graille M, 2005, MOL CELL, V20, P917, DOI 10.1016/j.molcel.2005.10.025; HAMILTON CM, 1989, J BACTERIOL, V171, P4617, DOI 10.1128/jb.171.9.4617-4622.1989; Heurgue-Hamard V, 2005, J BIOL CHEM, V280, P2439, DOI 10.1074/jbc.M407252200; Heurgue-Hamard V, 2002, EMBO J, V21, P769, DOI 10.1093/emboj/21.4.769; IKEMURA T, 1981, J MOL BIOL, V151, P389, DOI 10.1016/0022-2836(81)90003-6; Jin HN, 2002, EMBO J, V21, P4357, DOI 10.1093/emboj/cdf424; Kaczanowska M, 2004, J BACTERIOL, V186, P3046, DOI 10.1128/JB.186.10.3046-3055.2004; KAWAKAMI K, 1990, P NATL ACAD SCI USA, V87, P8432, DOI 10.1073/pnas.87.21.8432; KAWAKAMI K, 1988, J BACTERIOL, V170, P5378, DOI 10.1128/jb.170.11.5378-5381.1988; Kisselev L, 2003, EMBO J, V22, P175, DOI 10.1093/emboj/cdg017; Kisselev LL, 2000, TRENDS BIOCHEM SCI, V25, P561, DOI 10.1016/S0968-0004(00)01669-8; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li X, 2007, MOL MICROBIOL, V63, P116, DOI 10.1111/j.1365-2958.2006.05498.x; Liu MZ, 2005, J BIOL CHEM, V280, P15921, DOI 10.1074/jbc.M414050200; Miller J.H., 1972, EXPT MOL GENETICS; Mora L, 2003, MOL MICROBIOL, V47, P267, DOI 10.1046/j.1365-2958.2003.03301.x; Mushegian AR, 1996, P NATL ACAD SCI USA, V93, P10268, DOI 10.1073/pnas.93.19.10268; Nakahigashi K, 2002, P NATL ACAD SCI USA, V99, P1473, DOI 10.1073/pnas.032488499; NEIDHARDT FC, 1977, J BACTERIOL, V129, P378, DOI 10.1128/JB.129.1.378-387.1977; Petry S, 2005, CELL, V123, P1255, DOI 10.1016/j.cell.2005.09.039; Polevoda B, 2006, J BIOL CHEM, V281, P2562, DOI 10.1074/jbc.M507651200; POOLE ES, 1995, EMBO J, V14, P151, DOI 10.1002/j.1460-2075.1995.tb06985.x; RYDEN SM, 1984, MOL GEN GENET, V193, P38, DOI 10.1007/BF00327411; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SINGER M, 1989, MICROBIOL REV, V53, P1; STORMO GD, 1986, NUCLEIC ACIDS RES, V14, P6661, DOI 10.1093/nar/14.16.6661; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Trobro S, 2007, MOL CELL, V27, P758, DOI 10.1016/j.molcel.2007.06.032; Uno M, 1996, BIOCHIMIE, V78, P935, DOI 10.1016/S0300-9084(97)86715-6; VOGEL HJ, 1956, J BIOL CHEM, V218, P97; WEISS RB, 1984, J BACTERIOL, V158, P362, DOI 10.1128/JB.158.1.362-364.1984	46	45	47	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35638	35645		10.1074/jbc.M706076200	http://dx.doi.org/10.1074/jbc.M706076200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17932046	hybrid			2022-12-27	WOS:000251458100024
J	Morimoto, H; Kondoh, K; Nishimoto, S; Terasawa, K; Nishida, E				Morimoto, Hiroko; Kondoh, Kunio; Nishimoto, Satoko; Terasawa, Kazuya; Nishida, Eisuke			Activation of a C-terminal transcriptional activation domain of ERK5 by autophosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION PATHWAYS; PROTEIN-KINASE PATHWAYS; MAMMALIAN MAP KINASE; REGULATED KINASE-5; MEK5-ERK5 PATHWAY; TARGETED DELETION; GROWTH-FACTOR; BMK1/ERK5; ERK5/BMK1; CASCADES	ERK5 plays a crucial role in many biological processes by regulating transcription. ERK5 has a large C-terminal-half that contains a transcriptional activation domain. However, it has remained unclear how its transcriptional activation activity is regulated. Here, we show that the activated kinase activity of ERK5 is required for the C-terminal-half to enhance the AP-1 activity, and that the activated ERK5 undergoes autophosphorylation on its most C-terminal region. Changing these phosphorylatable threonine and serine residues to unphosphorylatable alanines significantly reduces the transcriptional activation activity of ERK5. Moreover, phosphomimetic mutants of the C-terminal-half of ERK5 without an N-terminal kinase domain are shown to be able to enhance the AP-1 activity in fibroblastic cells. These results reveal the role of the stimulus-induced ERK5 autophosphorylation in regulation of gene expression.	Kyoto Univ, Grad Sch Biostudies, Dept Cell & Dev Biol, Sakyo Ku, Kyoto 6068502, Japan	Kyoto University	Nishida, E (corresponding author), Kyoto Univ, Grad Sch Biostudies, Dept Cell & Dev Biol, Sakyo Ku, Kyoto 6068502, Japan.	L50174@sakura.kudpc.kyoto-u.ac.jp		Kondoh, Kunio/0000-0002-1139-328X				Abe J, 1996, J BIOL CHEM, V271, P16586, DOI 10.1074/jbc.271.28.16586; Ahn Natalie G., 1992, Current Opinion in Cell Biology, V4, P992, DOI 10.1016/0955-0674(92)90131-U; Akaike M, 2004, MOL CELL BIOL, V24, P8691, DOI 10.1128/MCB.24.19.8691-8704.2004; Buschbeck M, 2005, J BIOL CHEM, V280, P2659, DOI 10.1074/jbc.M412599200; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chen Z, 2001, CHEM REV, V101, P2449, DOI 10.1021/cr000241p; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; English JM, 1998, J BIOL CHEM, V273, P3854, DOI 10.1074/jbc.273.7.3854; Fukuhara S, 2000, J BIOL CHEM, V275, P21730, DOI 10.1074/jbc.M002410200; Hayashi M, 2004, J CLIN INVEST, V113, P1138, DOI 10.1172/JCI200419890; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kamakura S, 1999, J BIOL CHEM, V274, P26563, DOI 10.1074/jbc.274.37.26563; Kasler HG, 2000, MOL CELL BIOL, V20, P8382, DOI 10.1128/MCB.20.22.8382-8389.2000; Kato Y, 1997, EMBO J, V16, P7054, DOI 10.1093/emboj/16.23.7054; Kato Y, 1998, NATURE, V395, P713, DOI 10.1038/27234; Kondoh K, 2006, MOL CELL BIOL, V26, P1679, DOI 10.1128/MCB.26.5.1679-1690.2006; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; LEE JD, 1995, BIOCHEM BIOPH RES CO, V213, P715, DOI 10.1006/bbrc.1995.2189; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Mody N, 2003, BIOCHEM J, V372, P567, DOI 10.1042/BJ20030193; NISHIDA E, 1993, TRENDS BIOCHEM SCI, V18, P128, DOI 10.1016/0968-0004(93)90019-J; Nishimoto S, 2005, EMBO REP, V6, P1064, DOI 10.1038/sj.embor.7400515; Pouyssegur J, 2002, BIOCHEM PHARMACOL, V64, P755, DOI 10.1016/S0006-2952(02)01135-8; Regan CP, 2002, P NATL ACAD SCI USA, V99, P9248, DOI 10.1073/pnas.142293999; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; Schaeffer HJ, 1999, MOL CELL BIOL, V19, P2435; Sohn SJ, 2002, J BIOL CHEM, V277, P43344, DOI 10.1074/jbc.M207573200; STURGILL TW, 1991, BIOCHIM BIOPHYS ACTA, V1092, P350, DOI 10.1016/S0167-4889(97)90012-4; Terasawa K, 2003, GENES CELLS, V8, P263, DOI 10.1046/j.1365-2443.2003.00631.x; Treisman R, 1996, CURR OPIN CELL BIOL, V8, P205, DOI 10.1016/S0955-0674(96)80067-6; Wang X, 2005, MOL CELL BIOL, V25, P336, DOI 10.1128/MCB.25.1.336-345.2005; WORONICZ JD, 1995, MOL CELL BIOL, V15, P6364; Yan C, 2001, J BIOL CHEM, V276, P10870, DOI 10.1074/jbc.M009286200; Yan Lijun, 2003, BMC Dev Biol, V3, P11, DOI 10.1186/1471-213X-3-11; Yang CC, 1998, NUCLEIC ACIDS RES, V26, P4771, DOI 10.1093/nar/26.20.4771; ZHOU GC, 1995, J BIOL CHEM, V270, P12665, DOI 10.1074/jbc.270.21.12665	36	73	79	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35449	35456		10.1074/jbc.M704079200	http://dx.doi.org/10.1074/jbc.M704079200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17928297	hybrid			2022-12-27	WOS:000251458100004
J	Villagra, A; Ulloa, N; Zhang, XH; Yuan, ZG; Sotomayor, E; Seto, E				Villagra, Alejandro; Ulloa, Natalia; Zhang, Xiaohong; Yuan, Zhigang; Sotomayor, Eduardo; Seto, Edward			Histone deacetylase 3 down-regulates cholesterol synthesis through repression of lanosterol synthase gene expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR YY1; ELEMENT-BINDING PROTEIN; LOW-DENSITY-LIPOPROTEIN; HISTONE DEACETYLASE; REDUCTASE-ACTIVITY; IN-VIVO; INHIBITORS; PROMOTER; CYCLASE; 2,3-OXIDOSQUALENE	In vertebrates, a key step in the biosynthesis of cholesterol and steroid hormones is the conversion of (S)-2,3-oxidosqualene to lanosterol. The enzyme that catalyzes this complex cyclization/rearrangement step via the protosteryl cation intermediate is lanosterol synthase ((S)-2,3-epoxysqualene mutase ( cyclizing, lanosterol forming), EC 5.4.99.7). Because of the crucial role that lanosterol synthase plays in cholesterol biosynthesis, there is great interest in the identification of drugs that target this enzyme for anticholesteremic purposes. Although most studies on lanosterol synthase in the past have focused on the structural and biochemical functions of this enzyme, almost nothing is known concerning how the synthesis of lanosterol synthase is regulated. Here, we report that histone deacetylase 3 (HDAC3) represses transcription from the lanosterol synthase promoter. Overexpression of HDAC3 decreases, whereas knockdown of HDAC3 by small interfering RNA increases, endogenous lanosterol synthase mRNA in cells. Similarly, in transient transfection assays, overexpression of HDAC3 decreases, whereas depletion of HDAC3 increases, expression of a reporter gene under the control of the lanosterol synthase promoter. Stable cell lines that overexpress HDAC3 show a decrease in lanosterol synthase mRNA and have lower cholesterol concentrations compared with parental cells. Extensive promoter analyses coupled with chromatin immunoprecipitation assays reveal that the transcription factor YY1 binds to and recruits HDAC3 to the lanosterol synthase promoter. Together, our results demonstrate that HDAC3 represses the synthesis of a key regulatory enzyme and reveal a novel mechanism by which the cholesterol biosynthetic pathway can be regulated.	H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA; Univ Concepcion, Sch Pharm, Dept Clin Biochem & Immunol, Concepcion, Chile	H Lee Moffitt Cancer Center & Research Institute; Universidad de Concepcion	Seto, E (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, SRB 23011,12902 Magnolia Dr, Tampa, FL 33612 USA.	ed.seto@moffitt.org		Villagra, Alejandro/0000-0001-9346-8355	NCI NIH HHS [CA109699] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA109699] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Atchison L, 2003, EMBO J, V22, P1347, DOI 10.1093/emboj/cdg124; BAKER CH, 1995, BIOCHEM BIOPH RES CO, V213, P154, DOI 10.1006/bbrc.1995.2110; Bennett MK, 1999, J BIOL CHEM, V274, P13025, DOI 10.1074/jbc.274.19.13025; Brown AJ, 2002, MOL CELL, V10, P237, DOI 10.1016/S1097-2765(02)00591-9; Brown AJ, 1996, J LIPID RES, V37, P320; Brown JL, 2003, DEVELOPMENT, V130, P285, DOI 10.1242/dev.00204; BROWN MS, 1978, J BIOL CHEM, V253, P1121; Chouinard RA, 1998, J BIOL CHEM, V273, P22409, DOI 10.1074/jbc.273.35.22409; Christenson LK, 2001, ENDOCRINOLOGY, V142, P28, DOI 10.1210/endo.142.1.7867; Duncan RE, 2005, CANCER EPIDEM BIOMAR, V14, P1897, DOI 10.1158/1055-9965.EPI-05-0027; Duncan RE, 2004, J BIOL CHEM, V279, P33079, DOI 10.1074/jbc.M400732200; Ericsson J, 1999, J BIOL CHEM, V274, P14508, DOI 10.1074/jbc.274.20.14508; Evert BO, 2006, J NEUROSCI, V26, P11474, DOI 10.1523/JNEUROSCI.2053-06.2006; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Hampton RY, 2000, CURR BIOL, V10, pR298, DOI 10.1016/S0960-9822(00)00434-6; HARIHARAN N, 1991, P NATL ACAD SCI USA, V88, P9799, DOI 10.1073/pnas.88.21.9799; Herman GE, 2003, HUM MOL GENET, V12, pR75, DOI 10.1093/hmg/ddg072; Ishizuka T, 2003, MOL CELL BIOL, V23, P5122, DOI 10.1128/MCB.23.15.5122-5131.2003; Kelley RI, 2001, ANNU REV GENOM HUM G, V2, P299, DOI 10.1146/annurev.genom.2.1.299; Klampfer L, 2004, J BIOL CHEM, V279, P30358, DOI 10.1074/jbc.M401359200; Li D, 2005, J BIOL CHEM, V280, P26941, DOI 10.1074/jbc.M500463200; Mahlknecht U, 2004, J IMMUNOL, V173, P3979, DOI 10.4049/jimmunol.173.6.3979; Maron DJ, 2000, CIRCULATION, V101, P207, DOI 10.1161/01.CIR.101.2.207; Miida Takashi, 2004, J Atheroscler Thromb, V11, P253; Morand OH, 1997, J LIPID RES, V38, P373; Mori M, 2006, J CLIN INVEST, V116, P395, DOI 10.1172/JCI20797; NESS GC, 1991, J BIOL CHEM, V266, P14854; Osborne TF, 1997, CURR BIOL, V7, pR172, DOI 10.1016/S0960-9822(97)70081-2; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PISANESCHI G, 1994, BIOCHEM BIOPH RES CO, V205, P1236, DOI 10.1006/bbrc.1994.2797; Rawson RB, 1999, J BIOL CHEM, V274, P28549, DOI 10.1074/jbc.274.40.28549; Rowe AH, 2003, CIRC RES, V93, P717, DOI 10.1161/01.RES.0000097606.43659.F4; Sakano Y, 2004, J ANTIBIOT, V57, P564, DOI 10.7164/antibiotics.57.564; Schroeder TM, 2004, J BIOL CHEM, V279, P41998, DOI 10.1074/jbc.M403702200; SETO E, 2006, BIOL HDAC3, P61; Sever N, 2003, MOL CELL, V11, P25, DOI 10.1016/S1097-2765(02)00822-5; Shenoy SD, 2004, MOL PHARMACOL, V65, P1302, DOI 10.1124/mol.65.5.1302; Shi Y, 1997, BBA-REV CANCER, V1332, pF49, DOI 10.1016/S0304-419X(96)00044-3; Simons K, 2002, J CLIN INVEST, V110, P597, DOI 10.1172/JCI200216390; Tabas I, 2002, J CLIN INVEST, V110, P583, DOI 10.1172/JCI200216381; Thoma R, 2004, NATURE, V432, P118, DOI 10.1038/nature02993; Thomas MJ, 1999, GENE, V236, P197, DOI 10.1016/S0378-1119(99)00261-9; Villagra A, 2006, J BIOL CHEM, V281, P22695, DOI 10.1074/jbc.M511640200; Wen YD, 2000, P NATL ACAD SCI USA, V97, P7202, DOI 10.1073/pnas.97.13.7202; Yang T, 2002, CELL, V110, P489, DOI 10.1016/S0092-8674(02)00872-3; Yang WM, 1996, P NATL ACAD SCI USA, V93, P12845, DOI 10.1073/pnas.93.23.12845; Yang WM, 1997, J BIOL CHEM, V272, P28001, DOI 10.1074/jbc.272.44.28001; Yang WM, 2002, J BIOL CHEM, V277, P9447, DOI 10.1074/jbc.M105993200; Yang Y, 2003, NOVON, V13, P153, DOI 10.2307/3393581; Yao YL, 2001, MOL CELL BIOL, V21, P5979, DOI 10.1128/MCB.21.17.5979-5991.2001; Yin L, 2005, MOL ENDOCRINOL, V19, P1452, DOI 10.1210/me.2005-0057; Young M, 1996, HUM GENET, V97, P620, DOI 10.1007/s004390050105; Zhang XH, 2004, MOL CELL BIOL, V24, P5106, DOI 10.1128/MCB.24.12.5106-5118.2004	54	26	26	4	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35457	35470		10.1074/jbc.M701719200	http://dx.doi.org/10.1074/jbc.M701719200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17925399	hybrid			2022-12-27	WOS:000251458100005
J	Ye, SX; Kohrer, C; Huber, T; Kazmi, M; Sachdev, P; Yan, ECY; Bhagat, A; RajBhandary, UL; Sakmar, TP				Ye, Shixin; Kohrer, Caroline; Huber, Thomas; Kazmi, Manija; Sachdev, Pallavi; Yan, Elsa C. Y.; Bhagat, Aditi; RajBhandary, Uttam L.; Sakmar, Thomas P.			Site-specific incorporation of keto amino acids into functional G protein-coupled receptors using unnatural amino acid mutagenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA-SYNTHETASE; LARGE RIBOSOMAL-SUBUNIT; HIGH-LEVEL EXPRESSION; CELL-FREE SYSTEM; MAMMALIAN-CELLS; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; GENETIC-CODE; 7-TRANSMEMBRANE RECEPTORS; CONFORMATIONAL-CHANGES	G protein-coupled receptors (GPCRs) are ubiquitous heptahelical transmembrane proteins involved in a wide variety of signaling pathways. The work described here on application of unnatural amino acid mutagenesis to two GPCRs, the chemokine receptor CCR5 (a major co-receptor for the human immunodeficiency virus) and rhodopsin (the visual photoreceptor), adds a new dimension to studies of GPCRs. We incorporated the unnatural amino acids p-acetyl-L-phenylalanine (Acp) and p-benzoyl-L-phenylalanine (Bzp) into CCR5 at high efficiency in mammalian cells to produce functional receptors harboring reactive keto groups at three specific positions. We obtained functional mutant CCR5, at levels up to similar to 50% of wild type as judged by immunoblotting, cell surface expression, and ligand- dependent calcium flux. Rhodopsin containing Acp at three different sites was also purified in high yield (0.5-2 mu g/107 cells) and reacted with fluorescein hydrazide in vitro to produce fluorescently labeled rhodopsin. The incorporation of reactive keto groups such as Acp or Bzp into GPCRs allows their reaction with different reagents to introduce a variety of spectroscopic and other probes. Bzp also provides the possibility of photo-cross-linking to identify precise sites of protein-protein interactions, including GPCR binding to G proteins and arrestins, and for understanding the molecular basis of ligand recognition by chemokine receptors.	[Kohrer, Caroline; RajBhandary, Uttam L.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Ye, Shixin; Huber, Thomas; Kazmi, Manija; Sachdev, Pallavi; Yan, Elsa C. Y.; Bhagat, Aditi; Sakmar, Thomas P.] Rockefeller Univ, Biochem & Mol Biol Lab, New York, NY 10065 USA	Massachusetts Institute of Technology (MIT); Rockefeller University	RajBhandary, UL (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	bhandary@mit.edu; sakmar@rockefeller.edu	Huber, Thomas/A-8016-2008; Sakmar, Thomas P/D-1833-2015	Huber, Thomas/0000-0002-1844-262X; Sakmar, Thomas P/0000-0002-2836-8953; Yan, Elsa/0000-0002-3583-1627; Ye, Shixin/0000-0002-9254-9409	NIGMS NIH HHS [GM 67741] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067741] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAIN JD, 1989, J AM CHEM SOC, V111, P8013, DOI 10.1021/ja00202a052; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; BAYER EA, 1988, ANAL BIOCHEM, V170, P271, DOI 10.1016/0003-2697(88)90631-8; Beene DL, 2003, CURR OPIN NEUROBIOL, V13, P264, DOI 10.1016/S0959-4388(03)00068-0; Chang PV, 2007, J AM CHEM SOC, V129, P8400, DOI 10.1021/ja070238o; Chen I, 2005, NAT METHODS, V2, P99, DOI 10.1038/NMETH735; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Chin JW, 2003, SCIENCE, V301, P964, DOI 10.1126/science.1084772; Combadiere C, 1996, J LEUKOCYTE BIOL, V60, P147, DOI 10.1002/jlb.60.1.147; CORNISH VW, 1994, P NATL ACAD SCI USA, V91, P2910, DOI 10.1073/pnas.91.8.2910; Cornish VW, 1996, J AM CHEM SOC, V118, P8150, DOI 10.1021/ja961216x; Cypess AM, 1999, J BIOL CHEM, V274, P19455, DOI 10.1074/jbc.274.27.19455; Drabkin HJ, 1996, MOL CELL BIOL, V16, P907; DRABKIN HJ, 1985, J BIOL CHEM, V260, P5588; EDWARDS H, 1990, MOL CELL BIOL, V10, P1633, DOI 10.1128/MCB.10.4.1633; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; Gether U, 1997, EMBO J, V16, P6737, DOI 10.1093/emboj/16.22.6737; Harms J, 2001, CELL, V107, P679, DOI 10.1016/S0092-8674(01)00546-3; HECKLER TG, 1984, BIOCHEMISTRY-US, V23, P1468, DOI 10.1021/bi00302a020; Hino N, 2005, NAT METHODS, V2, P201, DOI 10.1038/NMETH739; Huber T, 2004, BIOPHYS J, V86, P2078, DOI 10.1016/S0006-3495(04)74268-X; Imamoto Y, 2000, BIOCHEMISTRY-US, V39, P15225, DOI 10.1021/bi0018685; KARNIK SS, 1988, P NATL ACAD SCI USA, V85, P8459, DOI 10.1073/pnas.85.22.8459; Kazmi MA, 2000, BIOCHEMISTRY-US, V39, P3734, DOI 10.1021/bi992354c; Kiga D, 2002, P NATL ACAD SCI USA, V99, P9715, DOI 10.1073/pnas.142220099; Kohrer C, 2004, NUCLEIC ACIDS RES, V32, P6200, DOI 10.1093/nar/gkh959; Kohrer C, 2003, CHEM BIOL, V10, P1095, DOI 10.1016/j.chembiol.2003.10.013; Kowal AK, 2001, P NATL ACAD SCI USA, V98, P2268, DOI 10.1073/pnas.031488298; Lefkowitz RJ, 2004, TRENDS PHARMACOL SCI, V25, P413, DOI 10.1016/j.tips.2004.06.006; LETKOWITZ RJ, 2007, BIOCHIM BIOPHYS ACTA, V1768, P748; Liu WS, 2007, NAT METHODS, V4, P239, DOI 10.1038/NMETH1016; Lummis SCR, 2005, CHEM BIOL, V12, P993, DOI 10.1016/j.chembiol.2005.06.012; Mahal LK, 1997, SCIENCE, V276, P1125, DOI 10.1126/science.276.5315.1125; MIN KC, 1993, J BIOL CHEM, V268, P9400; NOREN CJ, 1989, SCIENCE, V244, P182, DOI 10.1126/science.2649980; NOWAK MW, 1995, SCIENCE, V268, P439, DOI 10.1126/science.7716551; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; OPRIAN DD, 1987, P NATL ACAD SCI USA, V84, P8874, DOI 10.1073/pnas.84.24.8874; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; PAYNE RC, 1987, BIOCHEMISTRY-US, V26, P3197, DOI 10.1021/bi00385a039; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13413, DOI 10.1073/pnas.212519199; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Sakamoto K, 2002, NUCLEIC ACIDS RES, V30, P4692, DOI 10.1093/nar/gkf589; Sakmar TP, 2002, ANNU REV BIOPH BIOM, V31, P443, DOI 10.1146/annurev.biophys.31.082901.134348; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Seibert C, 2006, VIROLOGY, V349, P41, DOI 10.1016/j.virol.2006.01.018; Turcatti G, 1996, J BIOL CHEM, V271, P19991, DOI 10.1074/jbc.271.33.19991; VARSHNEY U, 1991, J BIOL CHEM, V266, P24712; Wang L, 2001, SCIENCE, V292, P498, DOI 10.1126/science.1060077; Wang L, 2003, P NATL ACAD SCI USA, V100, P56, DOI 10.1073/pnas.0234824100; Wang WY, 2007, NAT NEUROSCI, V10, P1063, DOI 10.1038/nn1932; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; Zhang ZW, 2003, BIOCHEMISTRY-US, V42, P6735, DOI 10.1021/bi0300231; Zhang ZW, 2004, P NATL ACAD SCI USA, V101, P8882, DOI 10.1073/pnas.0307029101	58	123	127	0	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1525	1533		10.1074/jbc.M707355200	http://dx.doi.org/10.1074/jbc.M707355200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	17993461	hybrid			2022-12-27	WOS:000252282700037
J	Jadeski, L; Mataraza, JM; Jeong, HW; Li, ZG; Sacks, DB				Jadeski, Lorraine; Mataraza, Jennifer M.; Jeong, Ha-Won; Li, Zhigang; Sacks, David B.			IQGAP1 stimulates proliferation and enhances tumorigenesis of human breast epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E-CADHERIN; RHO-GTPASES; CANCER METASTASIS; BINDING PROTEIN; INVASION FRONTS; RAS ACTIVATION; CDC42; CALMODULIN; EXPRESSION; LINES	The scaffold protein IQGAP1 integrates signaling pathways and participates in diverse cellular activities. IQGAP1 is overexpressed in a number of human solid neoplasms, but its functional role in tumorigenesis has not been previously evaluated. Here we report that IQGAP1 contributes to neoplastic transformation of human breast epithelial cells. The amount of IQGAP1 in breast carcinoma is greater than that in normal tissue, with highly metastatic breast epithelial cells expressing the highest levels. Overexpression of IQGAP1 enhances proliferation of MCF-7 breast epithelial cells. Reduction of endogenous IQGAP1 by RNA interference impairs both serum-dependent and anchorage-independent growth of MCF-7 cells. Consistent with these in vitro observations, immortalized MCF-7 cells overexpressing IQGAP1 form invasive tumors in immunocompromised mice, whereas tumors derived from MCF-7 cells with stable knockdown of IQGAP1 are smaller and less invasive. In vitro analysis with selected IQGAP1 mutant constructs and a chemical inhibitor suggests that actin, Cdc42/Rac1, and the mitogen-activated protein kinase pathway contribute to the mechanism by which IQGAP1 increases cell invasion. Collectively, our data reveal that IQGAP1 enhances mammary tumorigenesis, suggesting that it may be a target for therapeutic intervention.	[Jadeski, Lorraine; Mataraza, Jennifer M.; Jeong, Ha-Won; Li, Zhigang; Sacks, David B.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Jadeski, Lorraine] Univ Guelph, Dept Human Biol & Nutr Sci, Guelph, ON N1G 2W1, Canada	Harvard University; Brigham & Women's Hospital; University of Guelph	Sacks, DB (corresponding author), Brigham & Womens Hosp, Dept Pathol, Thorn 530,75 Francis St, Boston, MA 02115 USA.	dsacks@rics.bwh.harvard.edu		Sacks, David/0000-0003-3100-0735				BAGULEY BC, 1989, EUR J CANCER CLIN ON, V25, P263, DOI 10.1016/0277-5379(89)90018-7; Balenci L, 2006, CANCER RES, V66, P9074, DOI 10.1158/0008-5472.CAN-06-0761; Bar-Sagi D, 2000, CELL, V103, P227, DOI 10.1016/S0092-8674(00)00115-X; Bertucci F, 2004, ONCOGENE, V23, P1377, DOI 10.1038/sj.onc.1207262; Bourguignon LYW, 2005, J BIOL CHEM, V280, P11961, DOI 10.1074/jbc.M411985200; Briggs MW, 2003, EMBO REP, V4, P571, DOI 10.1038/sj.embor.embor867; Briggs MW, 2003, FEBS LETT, V542, P7, DOI 10.1016/S0014-5793(03)00333-8; Briggs MW, 2002, J BIOL CHEM, V277, P7453, DOI 10.1074/jbc.M104315200; Brown MD, 2007, J BIOL CHEM, V282, P30265, DOI 10.1074/jbc.M702537200; Brown MD, 2006, TRENDS CELL BIOL, V16, P242, DOI 10.1016/j.tcb.2006.03.002; Campbell SL, 1998, ONCOGENE, V17, P1395, DOI 10.1038/sj.onc.1202174; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; COX AD, 1994, METHOD ENZYMOL, V238, P277; Dong PX, 2006, CANCER LETT, V243, P120, DOI 10.1016/j.canlet.2005.11.024; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Eckert LB, 2004, CANCER RES, V64, P4585, DOI 10.1158/0008-5472.CAN-04-0396; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Fidler IJ, 2002, SEMIN CANCER BIOL, V12, P89, DOI 10.1006/scbi.2001.0416; Fritz G, 1999, INT J CANCER, V81, P682, DOI 10.1002/(SICI)1097-0215(19990531)81:5<682::AID-IJC2>3.0.CO;2-B; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hart MJ, 1996, EMBO J, V15, P2997, DOI 10.1002/j.1460-2075.1996.tb00663.x; Ho YD, 1999, J BIOL CHEM, V274, P464, DOI 10.1074/jbc.274.1.464; Jadeski LC, 1999, AM J PATHOL, V155, P1381, DOI 10.1016/S0002-9440(10)65240-6; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jeong HW, 2007, J BIOL CHEM, V282, P20752, DOI 10.1074/jbc.M700487200; Jiang WG, 1996, BRIT J SURG, V83, P437, DOI 10.1002/bjs.1800830404; JOYAL JL, 1994, J BIOL CHEM, V269, P30039; Joyal JL, 1997, J BIOL CHEM, V272, P15419, DOI 10.1074/jbc.272.24.15419; Kholmanskikh SS, 2006, NAT NEUROSCI, V9, P50, DOI 10.1038/nn1619; Kim SH, 2000, J BIOL CHEM, V275, P36999, DOI 10.1074/jbc.M003430200; Kulasingam V, 2007, MOL CELL PROTEOMICS, V6, P1997, DOI 10.1074/mcp.M600465-MCP200; Kuroda S, 1998, SCIENCE, V281, P832, DOI 10.1126/science.281.5378.832; Lacroix M, 2004, BREAST CANCER RES TR, V83, P249, DOI 10.1023/B:BREA.0000014042.54925.cc; Li ZG, 1999, J BIOL CHEM, V274, P37885, DOI 10.1074/jbc.274.53.37885; Lin M, 2004, BREAST CANCER RES TR, V84, P49, DOI 10.1023/B:BREA.0000018424.43445.f3; Marshall CJ, 1996, CURR OPIN CELL BIOL, V8, P197, DOI 10.1016/S0955-0674(96)80066-4; Mataraza JM, 2007, CELL SIGNAL, V19, P1857, DOI 10.1016/j.cellsig.2007.04.011; Mataraza JM, 2003, J BIOL CHEM, V278, P41237, DOI 10.1074/jbc.M304838200; Mataraza JM, 2003, BIOCHEM BIOPH RES CO, V305, P315, DOI 10.1016/S0006-291X(03)00759-9; Mateer SC, 2003, CELL MOTIL CYTOSKEL, V55, P147, DOI 10.1002/cm.10118; Miyoshi T, 2005, PATHOL INT, V55, P419, DOI 10.1111/j.1440-1827.2005.01847.x; Nabeshima K, 2002, CANCER LETT, V176, P101, DOI 10.1016/S0304-3835(01)00742-X; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; PAGES G, 1993, P NATL ACAD SCI USA, V90, P8319, DOI 10.1073/pnas.90.18.8319; Pantel K, 2004, NAT REV CANCER, V4, P448, DOI 10.1038/nrc1370; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; QIU RG, 1995, NATURE, V374, P457, DOI 10.1038/374457a0; Ren JG, 2007, P NATL ACAD SCI USA, V104, P10465, DOI 10.1073/pnas.0611308104; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Roy M, 2005, MOL CELL BIOL, V25, P7940, DOI 10.1128/MCB.25.18.7940-7952.2005; Roy M, 2004, J BIOL CHEM, V279, P17329, DOI 10.1074/jbc.M308405200; SACKS DB, 1992, ARCH BIOCHEM BIOPHYS, V299, P275, DOI 10.1016/0003-9861(92)90275-2; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Sebolt-Leopold JS, 2004, NAT REV CANCER, V4, P937, DOI 10.1038/nrc1503; Sokol SY, 2001, J BIOL CHEM, V276, P48425, DOI 10.1074/jbc.M107975200; Sugimoto N, 2001, J HUM GENET, V46, P21, DOI 10.1007/s100380170119; Sun WY, 2004, CANCER LETT, V212, P83, DOI 10.1016/j.canlet.2004.03.023; Swart-Mataraza JM, 2002, J BIOL CHEM, V277, P24753, DOI 10.1074/jbc.M111165200; Takemoto H, 2001, INT J CANCER, V91, P783, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1121>3.0.CO;2-Z; Vadlamudi RK, 2000, J BIOL CHEM, V275, P36238, DOI 10.1074/jbc.M002138200; von Lintig FC, 2000, BREAST CANCER RES TR, V62, P51, DOI 10.1023/A:1006491619920; Watanabe T, 2004, DEV CELL, V7, P871, DOI 10.1016/j.devcel.2004.10.017; Yamaoka-Tojo M, 2004, CIRC RES, V95, P276, DOI 10.1161/01.RES.0000136522.58649.60	65	113	130	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					1008	1017		10.1074/jbc.M708466200	http://dx.doi.org/10.1074/jbc.M708466200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	17981797	hybrid			2022-12-27	WOS:000252128100040
J	Carter, JM; Demizieux, L; Campenot, RB; Vance, DE; Vance, JE				Carter, Jodi M.; Demizieux, Laurent; Campenot, Robert B.; Vance, Dennis E.; Vance, Jean E.			Phosphatidylcholine biosynthesis via CTP: Phosphocholine cytidylyltransferase beta 2 facilitates neurite outgrowth and branching	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; CYCLIN-DEPENDENT KINASE-5; MEMBRANE PHOSPHOLIPID-SYNTHESIS; RAT SYMPATHETIC NEURONS; PC12 CELLS; PHEOCHROMOCYTOMA CELLS; AXONAL REGENERATION; ACTIVATION; SYSTEM; CONE	Hallmarks of neuronal differentiation are neurite sprouting, extension, and branching. We previously showed that increased expression of CTP: phosphocholine cytidylyltransferase beta 2 (CT beta 2), an isoform of a key phosphatidylcholine ( PC) biosynthetic enzyme, accompanies neurite outgrowth ( Carter, J. M., Waite, K. A., Campenot, R. B., Vance, J. E., and Vance, D. E. (2003) J. Biol. Chem. 278, 44988 - 44994). CT beta 2 mRNA is highly expressed in the brain. We show that CT beta 2 is abundant in axons of rat sympathetic neurons and retinal ganglion cells. We used RNA silencing to decrease CT beta 2 expression in PC12 cells differentiated by nerve growth factor. In CT beta 2-silenced cells, numbers of primary and secondary neurites were markedly reduced, suggesting that CT beta 2 facilitates neurite outgrowth and branching. However, the length of individual neurites was significantly increased, and the total amount of neuronal membrane was unchanged. Neurite branching of PC12 cells is known to be inhibited by activation of Akt and promoted by the Akt inhibitor LY294002. Our experiments showed that LY294002 increases neurite sprouting and branching in control PC12 cells but not in CT beta 2-deficient cells. CT beta 2 was not phosphorylated in vitro by Akt. However, inhibition of Cdk5 by roscovitine blocked CT beta 2 phosphorylation and reduced neurite outgrowth and branching. These results highlight the importance of CT beta 2 in neurons for promoting neurite outgrowth and branching and represent the first identification of a lipid biosynthetic enzyme that facilitates these functions.	[Carter, Jodi M.; Demizieux, Laurent; Vance, Dennis E.; Vance, Jean E.] Univ Alberta, Canadian Inst Hlth Res Grp Mol Cell Biol Lipids, Edmonton, AB T6G 2S2, Canada; [Carter, Jodi M.; Vance, Dennis E.; Vance, Jean E.] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2S2, Canada; [Campenot, Robert B.] Univ Alberta, Dept Cell Biol, Edmonton, AB T6G 2S2, Canada; [Demizieux, Laurent; Vance, Jean E.] Univ Alberta, Dept Med, Edmonton, AB T6G 2S2, Canada	University of Alberta; University of Alberta; University of Alberta; University of Alberta	Vance, JE (corresponding author), Univ Alberta, Canadian Inst Hlth Res Grp Mol Cell Biol Lipids, Edmonton, AB T6G 2S2, Canada.	jean.vance@ualberta.ca		Carter, Jodi/0000-0002-5973-0732				Acebes A, 2000, TRENDS NEUROSCI, V23, P557, DOI 10.1016/S0166-2236(00)01646-5; Araki W, 1997, P NATL ACAD SCI USA, V94, P11946, DOI 10.1073/pnas.94.22.11946; Ashery U, 1996, NEURON, V16, P641, DOI 10.1016/S0896-6273(00)80083-5; CAMPENOT RB, 1982, DEV BIOL, V93, P1, DOI 10.1016/0012-1606(82)90232-9; Carter JM, 2003, J BIOL CHEM, V278, P44988, DOI 10.1074/jbc.M307336200; COVIELLA ILG, 1992, J NEUROCHEM, V59, P338, DOI 10.1111/j.1471-4159.1992.tb08909.x; de Chaves EP, 2001, J BIOL CHEM, V276, P36207, DOI 10.1074/jbc.M104282200; DECHAVES EP, 1995, J CELL BIOL, V128, P913, DOI 10.1083/jcb.128.5.913; DEVRIES GH, 1983, J NEUROCHEM, V40, P1189, DOI 10.1111/j.1471-4159.1983.tb08114.x; Dietschy JM, 2004, J LIPID RES, V45, P1375, DOI 10.1194/jlr.R400004-JLR200; Fu AKY, 2005, P NATL ACAD SCI USA, V102, P15224, DOI 10.1073/pnas.0507678102; Fujita H, 2002, J BIOL CHEM, V277, P45428, DOI 10.1074/jbc.M208090200; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Hahn CM, 2005, NEUROSCIENCE, V134, P449, DOI 10.1016/j.neuroscience.2005.04.020; Harada T, 2001, NAT CELL BIOL, V3, P453, DOI 10.1038/35074516; Hayashi H, 2004, J BIOL CHEM, V279, P14009, DOI 10.1074/jbc.M313828200; Higuchi M, 2003, GENES CELLS, V8, P657, DOI 10.1046/j.1365-2443.2003.00663.x; HORWITZ J, 1991, J NEUROCHEM, V56, P509, DOI 10.1111/j.1471-4159.1991.tb08179.x; Jackowski S, 2004, MOL CELL BIOL, V24, P4720, DOI 10.1128/MCB.24.11.4720-4733.2004; Jackson TR, 1996, J CELL SCI, V109, P289; Kalil K, 2000, J NEUROBIOL, V44, P145, DOI 10.1002/1097-4695(200008)44:2<145::AID-NEU5>3.0.CO;2-X; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; Ledesma MD, 1999, EMBO J, V18, P1761, DOI 10.1093/emboj/18.7.1761; Lykidis A, 1998, J BIOL CHEM, V273, P14022, DOI 10.1074/jbc.273.22.14022; Lykidis A, 1999, J BIOL CHEM, V274, P26992, DOI 10.1074/jbc.274.38.26992; Markus A, 2002, NEURON, V35, P65, DOI 10.1016/S0896-6273(02)00752-3; Marszalek JR, 2004, J BIOL CHEM, V279, P23882, DOI 10.1074/jbc.M313460200; Namgung U, 2004, MOL CELL NEUROSCI, V25, P422, DOI 10.1016/j.mcn.2003.11.005; Namikawa K, 2000, J NEUROSCI, V20, P2875; Nikolic M, 1996, GENE DEV, V10, P816, DOI 10.1101/gad.10.7.816; PELECH SL, 1981, J BIOL CHEM, V256, P8283; Pooler AM, 2005, NEUROSCIENCE, V134, P207, DOI 10.1016/j.neuroscience.2005.03.050; Ridsdale R, 2001, J BIOL CHEM, V276, P49148, DOI 10.1074/jbc.M103566200; SAVCI V, 1995, J NEUROCHEM, V64, P378; Smith DS, 2001, CELL GROWTH DIFFER, V12, P277; Stern CA, 2001, J NEUROSCI, V21, P1434, DOI 10.1523/JNEUROSCI.21-05-01434.2001; STROSZNAJDER J, 1979, BIOCHIM BIOPHYS ACTA, V574, P48, DOI 10.1016/0005-2760(79)90083-3; Szebenyi G, 1998, J NEUROSCI, V18, P7930; TANAKA T, 1987, BIOCHIM BIOPHYS ACTA, V922, P85, DOI 10.1016/0005-2760(87)90248-7; VANCE DE, 1984, TRENDS BIOCHEM SCI, V9, P17, DOI 10.1016/0968-0004(84)90041-0; VANCE JE, 1994, J NEUROCHEM, V62, P329; VANCE JE, 1991, J CELL BIOL, V115, P1061, DOI 10.1083/jcb.115.4.1061; WANG YL, 1993, J BIOL CHEM, V268, P5899; Watanabe H, 2004, J BIOL CHEM, V279, P37870, DOI 10.1074/jbc.M402610200; WIEPRECHT M, 1994, FEBS LETT, V353, P221, DOI 10.1016/0014-5793(94)01040-4; Yang J, 1999, TRENDS CELL BIOL, V9, P207, DOI 10.1016/S0962-8924(99)01577-9; ZHOU X, 1992, J LIPID RES, V33, P1233	47	32	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					202	212		10.1074/jbc.M706531200	http://dx.doi.org/10.1074/jbc.M706531200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17981805	hybrid			2022-12-27	WOS:000251940300023
J	McColl, G; Killilea, DW; Hubbard, AE; Vantipalli, MC; Melov, S; Lithgow, GJ				McColl, Gawain; Killilea, David W.; Hubbard, Alan E.; Vantipalli, Maithili C.; Melov, Simon; Lithgow, Gordon J.			Pharmacogenetic analysis of lithium-induced delayed aging in Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUPEROXIDE DISMUTASE/CATALASE MIMETICS; GLYCOGEN-SYNTHASE KINASE-3; PROGRAMMED CELL-DEATH; LIFE-SPAN; C-ELEGANS; CALORIC RESTRICTION; HUNTINGTONS-DISEASE; ABC TRANSPORTERS; OXIDATIVE STRESS; BODY-SIZE	Lithium (Li+) has been used to treat mood affect disorders, including bipolar, for decades. This drug is neuroprotective and has several identified molecular targets. However, it has a narrow therapeutic range and the one or more underlying mechanisms of its therapeutic action are not understood. Here we describe a pharmacogenetic study of Li+ in the nematode Caenorhabditis elegans. Exposure to Li+ at clinically relevant concentrations throughout adulthood increases survival during normal aging (up to 46% median increase). Longevity is extended via a novel mechanism with altered expression of genes encoding nucleosome-associated functions. Li+ treatment results in reduced expression of the worm ortholog of LSD-1 (T08D10.2), a histone demethylase; knockdown by RNA interference of T08D10.2 is sufficient to extend longevity (similar to 25% median increase), suggesting Li+ regulates survival by modulating histone methylation and chromatin structure.	[McColl, Gawain; Vantipalli, Maithili C.; Melov, Simon; Lithgow, Gordon J.] Buck Inst Age Res, Novato, CA 94945 USA; [Killilea, David W.] Childrens Hosp Oakland, Res Inst, Ctr Nutr & Metabol, Oakland, CA 94609 USA; [Hubbard, Alan E.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA	Buck Institute for Research on Aging; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; University of California System; University of California Berkeley	McColl, G (corresponding author), Mental Hlth Res Inst Victoria, 155 Oak St, Parkville, Vic 3052, Australia.	gmccoll@mhri.edu.au	Melov, Simon/AAC-9469-2020; McColl, Gawain/Y-8959-2018	McColl, Gawain/0000-0002-6347-6722; Melov, Simon/0000-0001-8554-2834; Killilea, David/0000-0002-8929-6527	NIA NIH HHS [R01 AG022868-03, R01 AG022868-05, R01 AG021069-03, R01 AG022868, P30 AG 025708, R01 AG021069-02, R01 AG018679, AG 21069, R01 AG024385, R01 AG021069-05, R01 AG022868-01, R01 AG022868-02, R01 AG021069, R01 AG022868-04, R01 AG021069-04, P30 AG025708, AG 22868, R01 AG021069-01] Funding Source: Medline; NINDS NIH HHS [NS 050789-01, R03 NS050789] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R03NS050789] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024385, P30AG025708, R01AG018679, R01AG021069, R01AG022868] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		An JH, 2005, P NATL ACAD SCI USA, V102, P16275, DOI 10.1073/pnas.0508105102; BEANAN MJ, 1992, DEVELOPMENT, V116, P755; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berdichevsky A, 2006, CELL, V125, P1165, DOI 10.1016/j.cell.2006.04.036; Berger Z, 2005, HUM MOL GENET, V14, P3003, DOI 10.1093/hmg/ddi331; Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616; CADE JFJ, 1949, MED J AUSTRALIA, V2, P349, DOI 10.5694/j.1326-5377.1949.tb36912.x; Carmichael J, 2002, J BIOL CHEM, V277, P33791, DOI 10.1074/jbc.m204861200; Chen G, 1999, J NEUROCHEM, V72, P879, DOI 10.1046/j.1471-4159.1999.720879.x; Chen RW, 1999, J BIOL CHEM, V274, P6039, DOI 10.1074/jbc.274.10.6039; De Sarno P, 2002, NEUROPHARMACOLOGY, V43, P1158, DOI 10.1016/S0028-3908(02)00215-0; Evason K, 2005, SCIENCE, V307, P258, DOI 10.1126/science.1105299; Flemming AJ, 2000, P NATL ACAD SCI USA, V97, P5285, DOI 10.1073/pnas.97.10.5285; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; HENGARTNER MO, 1994, CELL, V76, P665, DOI 10.1016/0092-8674(94)90506-1; HENGARTNER MO, 1992, NATURE, V356, P494, DOI 10.1038/356494a0; Herndon LA, 2002, NATURE, V419, P808, DOI 10.1038/nature01135; Hirose T, 2003, DEVELOPMENT, V130, P1089, DOI 10.1242/dev.00330; HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0; HOLM S, 1979, SCAND J STAT, V6, P65; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694; Inoue K, 2003, BIOCHEM J, V374, P21, DOI 10.1042/BJ20030827; Jope RS, 2003, TRENDS PHARMACOL SCI, V24, P441, DOI 10.1016/S0165-6147(03)00206-2; Keaney M, 2003, FREE RADICAL BIO MED, V34, P277, DOI 10.1016/S0891-5849(02)01290-X; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Killilea DW, 2003, ANTIOXID REDOX SIGN, V5, P507, DOI 10.1089/152308603770310158; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Masuda CA, 2001, J BIOL CHEM, V276, P37794; McColl G, 2005, FASEB J, V19, P1716, DOI 10.1096/fj.04-2447fje; McKay JP, 2004, GENETICS, V166, P161, DOI 10.1534/genetics.166.1.161; Mellor J, 2006, TRENDS GENET, V22, P320, DOI 10.1016/j.tig.2006.03.008; Melov S, 2000, SCIENCE, V289, P1567, DOI 10.1126/science.289.5484.1567; Mudher A, 2004, MOL PSYCHIATR, V9, P522, DOI 10.1038/sj.mp.4001483; Noble W, 2005, P NATL ACAD SCI USA, V102, P6990, DOI 10.1073/pnas.0500466102; Nonaka S, 1998, J PHARMACOL EXP THER, V286, P539; Perez M, 2003, J ALZHEIMERS DIS, V5, P301, DOI 10.3233/JAD-2003-5405; Peterson CL, 2004, CURR BIOL, V14, pR546, DOI 10.1016/j.cub.2004.07.007; Pettitt J, 2002, J CELL SCI, V115, P857; Phiel CJ, 2001, ANNU REV PHARMACOL, V41, P789, DOI 10.1146/annurev.pharmtox.41.1.789; Phiel CJ, 2003, NATURE, V423, P435, DOI 10.1038/nature01640; Pletcher SD, 1999, J EVOLUTION BIOL, V12, P430, DOI 10.1046/j.1420-9101.1999.00058.x; PRICE LH, 1994, NEW ENGL J MED, V331, P591; Ryves WJ, 2001, BIOCHEM BIOPH RES CO, V280, P720, DOI 10.1006/bbrc.2000.4169; Sadri-Vakili G, 2006, NAT CLIN PRACT NEURO, V2, P330, DOI 10.1038/ncpneuro0199; Sampayo JN, 2003, AGING CELL, V2, P319, DOI 10.1046/j.1474-9728.2003.00063.x; Sheps JA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r15; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; van der Laan MJ, 2003, J STAT PLAN INFER, V117, P275, DOI 10.1016/S0378-3758(02)00388-9; Voisine C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000504; WARD S, 1973, P NATL ACAD SCI USA, V70, P817, DOI 10.1073/pnas.70.3.817; Watase K, 2007, PLOS MED, V4, P836, DOI 10.1371/journal.pmed.0040182; WONG A, 1995, GENETICS, V139, P1247; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789; Wu YC, 1998, CELL, V93, P951, DOI 10.1016/S0092-8674(00)81201-5; Zhao ZY, 2004, J MOL BIOL, V344, P409, DOI 10.1016/j.jmb.2004.09.052	61	143	164	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					350	357		10.1074/jbc.M705028200	http://dx.doi.org/10.1074/jbc.M705028200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17959600	hybrid, Green Accepted			2022-12-27	WOS:000251940300039
J	Palkowitsch, L; Leidner, J; Ghosh, S; Marienfeld, RB				Palkowitsch, Lysann; Leidner, Julia; Ghosh, Sankar; Marienfeld, Ralf B.			Phosphorylation of serine 68 in the I kappa B kinase (IKK)-binding domain of NEMO interferes with the structure of the IKK complex and tumor necrosis factor-alpha-induced NF-kappa B activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING DOMAIN; PHOSPHATASE 2A; ACTIVATION; BETA; GAMMA; OLIGOMERIZATION; CELLS; UBIQUITINATION; SUBUNIT; TAX	The I kappa B-Kinase (IKK) complex is a multisubunit protein complex crucial for signal-induced phosphorylation of the I kappa B proteins and thus controls the activity of the transcription factor NF-kappa B. Besides the two kinases IKK alpha and IKK beta, the IKK complex contains NEMO/IKK gamma, an additional subunit with regulatory and adaptor functions. NEMO not only confers structural stability to the IKK complex but also participates in the activation process of the IKK complex by linking the IKK subunits to upstream activators. In this study we analyze the IKK beta-mediated phosphorylation of the IKK-binding domain of NEMO. In vitro, IKK beta phosphorylates three serine residues in the domain of NEMO at positions 43, 68, and 85. However, mutational analysis revealed that only the phosphorylation of serine 68 in the center of the IKK-binding domain plays an essential role for the formation and the function of the IKK complex. Thus, Ser(68) phosphorylation attenuates the amino-terminal dimerization of NEMO as well as the IKK beta-NEMO interaction. In contrast, the NEMO-IKK alpha interaction was only mildly affected by the phosphorylation of Ser68. However, functional analysis revealed that Ser68 phosphorylation primarily affects the activity of IKK alpha. Furthermore, in complementation experiments of NEMO-deficient murine embryonic fibroblasts, a S68A-NEMO mutant enhanced, whereas a S68E mutant decreased, TNF-alpha-induced NF-kappa B activity, thus emphasizing the inhibitory role of the Ser68 phosphorylation on the signal-induced NF-kappa B activity. Finally, we provide evidence that the protein phosphatase PP2A is involved in the regulation of the Ser(68)-based mechanism. In summary, we provide evidence for a signal-induced phosphorylation-dependent alteration of the IKK complex emphasizing the dynamic nature of this multisubunit kinase complex.	[Palkowitsch, Lysann; Leidner, Julia; Marienfeld, Ralf B.] Univ Ulm, Inst Physiol Chem, D-89081 Ulm, Germany; [Ghosh, Sankar] Yale Univ, Sch Med, Dept Immunobiol, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Ulm University; Yale University	Marienfeld, RB (corresponding author), Univ Ulm, Inst Physiol Chem, Albert Einstein Allee 11, D-89081 Ulm, Germany.	ralf.marienfeld@uni-ulm.de						Agou F, 2004, J BIOL CHEM, V279, P54248, DOI 10.1074/jbc.M406423200; Agou F, 2002, J BIOL CHEM, V277, P17464, DOI 10.1074/jbc.M201964200; Carter RS, 2003, J BIOL CHEM, V278, P19642, DOI 10.1074/jbc.M301705200; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Fontan E, 2007, FEBS J, V274, P2540, DOI 10.1111/j.1742-4658.2007.05788.x; Fu DX, 2003, J BIOL CHEM, V278, P1487, DOI 10.1074/jbc.M210631200; Hayden MS, 2006, ONCOGENE, V25, P6758, DOI 10.1038/sj.onc.1209943; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hu YL, 1999, SCIENCE, V284, P316, DOI 10.1126/science.284.5412.316; Huang GJ, 2002, FEBS LETT, V531, P494, DOI 10.1016/S0014-5793(02)03590-1; Huang TT, 2002, MOL CELL BIOL, V22, P5813, DOI 10.1128/MCB.22.16.5813-5825.2002; Huang TT, 2003, CELL, V115, P565, DOI 10.1016/S0092-8674(03)00895-X; Kray AE, 2005, J BIOL CHEM, V280, P35974, DOI 10.1074/jbc.M506093200; Lamsoul I, 2005, MOL CELL BIOL, V25, P10391, DOI 10.1128/MCB.25.23.10391-10406.2005; Li ZW, 1999, J EXP MED, V189, P1839, DOI 10.1084/jem.189.11.1839; Luedde T, 2005, J CLIN INVEST, V115, P849, DOI 10.1172/JCI200523493; Marienfeld R, 2003, J BIOL CHEM, V278, P19852, DOI 10.1074/jbc.M301945200; Marienfeld RB, 2006, MOL CELL BIOL, V26, P9209, DOI 10.1128/MCB.00478-06; May MJ, 2002, J BIOL CHEM, V277, P45992, DOI 10.1074/jbc.M206494200; O'Mahony A, 2000, MOL CELL BIOL, V20, P1170, DOI 10.1128/MCB.20.4.1170-1178.2000; Poyet JL, 2000, J BIOL CHEM, V275, P37966, DOI 10.1074/jbc.M006643200; Prajapati S, 2002, J BIOL CHEM, V277, P24331, DOI 10.1074/jbc.M201393200; Quirling M, 2004, J BIOL CHEM, V279, P37452, DOI 10.1074/jbc.M312119200; Schmidt-Supprian M, 2004, J IMMUNOL, V173, P1612, DOI 10.4049/jimmunol.173.3.1612; Schmidt-Supprian M, 2003, IMMUNITY, V19, P377, DOI 10.1016/S1074-7613(03)00237-1; Schomer-Miller B, 2006, J BIOL CHEM, V281, P15268, DOI 10.1074/jbc.M513793200; Schulze-Luehrmann J, 2006, IMMUNITY, V25, P701, DOI 10.1016/j.immuni.2006.10.010; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Solt LA, 2007, J BIOL CHEM, V282, P8724, DOI 10.1074/jbc.M609613200; Tarassishin L, 2001, BIOCHEM BIOPH RES CO, V285, P555, DOI 10.1006/bbrc.2001.5197; Tegethoff S, 2003, MOL CELL BIOL, V23, P2029, DOI 10.1128/MCB.23.6.2029-2041.2003; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Wu ZH, 2006, SCIENCE, V311, P1141, DOI 10.1126/science.1121513; Yamamoto Y, 2000, MOL CELL BIOL, V20, P3655, DOI 10.1128/MCB.20.10.3655-3666.2000; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7; Zhou HL, 2004, NATURE, V427, P167, DOI 10.1038/nature02273	37	59	62	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					76	86		10.1074/jbc.M708856200	http://dx.doi.org/10.1074/jbc.M708856200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17977820	hybrid			2022-12-27	WOS:000251940300010
J	Landau, M; Herz, K; Padan, E; Ben-Tal, N				Landau, Meytal; Herz, Katia; Padan, Etana; Ben-Tal, Nir			Model structure of the Na+/H+ exchanger 1 (NHE1) - Functional and clinical implications	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; ESCHERICHIA-COLI; TRANSMEMBRANE SEGMENT; MEMBRANE-PROTEINS; STRUCTURE PREDICTION; SEQUENCE ALIGNMENT; TOPOLOGY MODEL; ACID-RESIDUES; ANTIPORTER; NHAA	Eukaryotic Na+/H+ exchangers are transmembrane proteins that are vital for cellular homeostasis and play key roles in pathological conditions such as cancer and heart diseases. Using the crystal structure of the Na+/H+ antiporter from Escherichia coli (EcNhaA) as a template, we predicted the three-dimensional structure of human Na+/H+ exchanger 1 (NHE1). Modeling was particularly challenging because of the extremely low sequence identity between these proteins, but the model structure is supported by evolutionary conservation analysis and empirical data. It also revealed the location of the binding site of NHE inhibitors; which we validated by conducting mutagenesis studies with EcNhaA and its specific inhibitor 2-aminoperimidine. The model structure features a cluster of titratable residues that are evolutionarily conserved and are located in a conserved region in the center of the membrane; we suggest that they are involved in the cation binding and translocation. We also suggest a hypothetical alternating-access mechanism that involves conformational changes.	[Landau, Meytal; Ben-Tal, Nir] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem, IL-69978 Tel Aviv, Israel; [Herz, Katia; Padan, Etana] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Biochem, IL-91904 Jerusalem, Israel	Tel Aviv University; Hebrew University of Jerusalem	Ben-Tal, N (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem, IL-69978 Tel Aviv, Israel.	bental@ashtoret.tau.ac.il	Landau, Meytal/AAF-3479-2021; Landau, Meytal/J-3075-2012	Landau, Meytal/0000-0002-1743-3430; Landau, Meytal/0000-0002-1743-3430; Ben-Tal, Nir/0000-0001-6901-832X				Adamian L, 2006, BMC STRUCT BIOL, V6, DOI 10.1186/1472-6807-6-13; Baldwin JM, 1997, J MOL BIOL, V272, P144, DOI 10.1006/jmbi.1997.1240; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bowie JU, 2005, NATURE, V438, P581, DOI 10.1038/nature04395; Brett CL, 2005, AM J PHYSIOL-CELL PH, V288, pC223, DOI 10.1152/ajpcell.00360.2004; Briggs JAG, 2001, PROTEINS, V44, P370, DOI 10.1002/prot.1102; Counillon L, 1997, BIOCHEMISTRY-US, V36, P2951, DOI 10.1021/bi9615405; DeLano W.L, PYMOL MOL GRAPHICS S; Dibrov P, 2005, FEBS LETT, V579, P373, DOI 10.1016/j.febslet.2004.11.098; Ding J, 2006, J BIOL CHEM, V281, P29817, DOI 10.1074/jbc.M606152200; Fleishman SJ, 2006, CURR OPIN STRUC BIOL, V16, P496, DOI 10.1016/j.sbi.2006.06.003; Fleishman SJ, 2004, MOL CELL, V15, P879, DOI 10.1016/j.molcel.2004.08.016; Forrest LR, 2006, BIOPHYS J, V91, P508, DOI 10.1529/biophysj.106.082313; Galili L, 2004, J BIOL CHEM, V279, P23104, DOI 10.1074/jbc.M400288200; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; Hurwitz N, 2006, PHILOS T R SOC B, V361, P465, DOI 10.1098/rstb.2005.1804; INOUE H, 1995, FEBS LETT, V363, P264, DOI 10.1016/0014-5793(95)00331-3; Jaroszewski L, 2005, NUCLEIC ACIDS RES, V33, pW284, DOI 10.1093/nar/gki418; Kaim G, 1997, BIOCHEMISTRY-US, V36, P9185, DOI 10.1021/bi970831q; Kozachkov L, 2007, BIOCHEMISTRY-US, V46, P2419, DOI 10.1021/bi602393s; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Mayrose I, 2005, J MOL EVOL, V60, P345, DOI 10.1007/s00239-004-0183-8; Murtazina R, 2001, EUR J BIOCHEM, V268, P4674, DOI 10.1046/j.1432-1327.2001.02391.x; Olami Y, 1997, J BIOL CHEM, V272, P1761, DOI 10.1074/jbc.272.3.1761; Orlowski J, 2004, PFLUG ARCH EUR J PHY, V447, P549, DOI 10.1007/s00424-003-1110-3; Padan E, 2005, BBA-BIOMEMBRANES, V1717, P67, DOI 10.1016/j.bbamem.2005.09.010; Petrey D, 2003, PROTEINS, V53, P430, DOI 10.1002/prot.10550; RIMON A, 1995, J BIOL CHEM, V270, P26813, DOI 10.1074/jbc.270.45.26813; Sato Y, 2005, J BIOCHEM, V138, P425, DOI 10.1093/jb/mvi132; Shrode LD, 1998, AM J PHYSIOL-CELL PH, V275, pC431, DOI 10.1152/ajpcell.1998.275.2.C431; Slepkov ER, 2007, BIOCHEM J, V401, P623, DOI 10.1042/BJ20061062; Slepkov ER, 2005, J BIOL CHEM, V280, P17863, DOI 10.1074/jbc.M409608200; Tang CL, 2003, J MOL BIOL, V334, P1043, DOI 10.1016/j.jmb.2003.10.025; von Heijne G, 2006, NAT REV MOL CELL BIO, V7, P909, DOI 10.1038/nrm2063; Wakabayashi S, 2000, J BIOL CHEM, V275, P7942, DOI 10.1074/jbc.275.11.7942; WAKABAYASHI S, 1992, P NATL ACAD SCI USA, V89, P2424, DOI 10.1073/pnas.89.6.2424; Yohannan S, 2004, P NATL ACAD SCI USA, V101, P959, DOI 10.1073/pnas.0306077101	38	106	109	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37854	37863		10.1074/jbc.M705460200	http://dx.doi.org/10.1074/jbc.M705460200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17981808	hybrid			2022-12-27	WOS:000251833600061
J	Ochiai, A; Itoh, T; Maruyama, Y; Kawamata, A; Mikami, B; Hashimoto, W; Murata, K				Ochiai, Akihito; Itoh, Takafumi; Maruyama, Yukie; Kawamata, Akiko; Mikami, Bunzo; Hashimoto, Wataru; Murata, Kousaku			A novel structural fold in polysaccharide lyases - Bacillus subtilis family 11 rhamnogalacturonan lyase YesW with an eight-bladed beta-propeller	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SP GL1 XANTHAN; REFINED 3-DIMENSIONAL STRUCTURE; CHONDROITIN AC LYASE; PRIMARY-CELL WALLS; CRYSTAL-STRUCTURE; PECTATE LYASE; PLANT-CELL; ERWINIA-CHRYSANTHEMI; ANGSTROM RESOLUTION; PECTIC POLYSACCHARIDE	Rhamnogalacturonan (RG) lyase produced by plant pathogenic and saprophytic microbes plays an important role in degrading plant cell walls. An extracellular RG lyase YesW from saprophytic Bacillus subtilis is a member of polysaccharide lyase family 11 and cleaves glycoside bonds in polygalacturonan as well as RG type-I through a beta-elimination reaction. Crystal structures of YesW and its complex with galacturonan disaccharide, a reaction product analogue, were determined at 1.4 and 2.5 angstrom resolutions with final R-factors of 16.4% and 16.6%, respectively. The enzyme is composed of an eight-bladed beta-propeller with a deep cleft in the center as a basic scaffold, and its structural fold has not been seen in polysaccharide lyases analyzed thus far. Structural analysis of the disaccharide-bound YesW and a site-directed mutagenesis study suggested that Arg-452 and Lys-535 stabilize the carboxyl group of the acidic polysaccharide molecule and Tyr-595 makes a stack interaction with the sugar pyranose ring. In addition to amino acid residues binding to the disaccharide, one calcium ion, which is coordinated by Asp-401, Glu-422, His-363, and His-399, may mediate the enzyme activity. This is, to our knowledge, the first report of a new structural category with a beta-propeller fold in polysaccharide lyases and provides structural insights into substrate binding by RG lyase.	[Ochiai, Akihito; Itoh, Takafumi; Maruyama, Yukie; Kawamata, Akiko; Hashimoto, Wataru; Murata, Kousaku] Kyoto Univ, Lab Basic & Appl Mol Biotechnol, Kyoto 6110011, Japan; [Mikami, Bunzo] Kyoto Univ, Lab Appl Struct Biol, Grad Sch Agr, Kyoto 6110011, Japan	Kyoto University; Kyoto University	Murata, K (corresponding author), Kyoto Univ, Lab Basic & Appl Mol Biotechnol, Kyoto 6110011, Japan.	kmurata@kais.kyoto-u.ac.jp						Akita M, 2001, ACTA CRYSTALLOGR D, V57, P1786, DOI 10.1107/S0907444901014482; BAUMANN U, 1993, EMBO J, V12, P3357, DOI 10.1002/j.1460-2075.1993.tb06009.x; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CARPITA NC, 1993, PLANT J, V3, P1, DOI 10.1111/j.1365-313X.1993.tb00007.x; Charnock SJ, 2002, P NATL ACAD SCI USA, V99, P12067, DOI 10.1073/pnas.182431199; Coutinho PM, 1999, ROY SOC CH, P3; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; DARVILL AG, 1978, PLANT PHYSIOL, V62, P418, DOI 10.1104/pp.62.3.418; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; de Vries RP, 2003, APPL MICROBIOL BIOT, V61, P10, DOI 10.1007/s00253-002-1171-9; de Vries RP, 2001, MICROBIOL MOL BIOL R, V65, P497, DOI 10.1128/MMBR.65.4.497-522.2001; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fethiere J, 1999, J MOL BIOL, V288, P635, DOI 10.1006/jmbi.1999.2698; Hasegawa H, 2005, APPL ENVIRON MICROB, V71, P4655, DOI 10.1128/AEM.71.8.4655-4663.2005; Hashimoto W, 2003, J BIOL CHEM, V278, P7663, DOI 10.1074/jbc.M208100200; Herron SR, 2003, J BIOL CHEM, V278, P12271, DOI 10.1074/jbc.M209306200; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Huang WJ, 2003, J MOL BIOL, V328, P623, DOI 10.1016/S0022-2836(03)00345-0; Huang WJ, 1999, J MOL BIOL, V294, P1257, DOI 10.1006/jmbi.1999.3292; Hugouvieux-Cotte-Pattat N, 2004, MOL MICROBIOL, V51, P1361, DOI 10.1046/j.1365-2958.2003.03908.x; HugouvieuxCottePattat N, 1996, ANNU REV MICROBIOL, V50, P213, DOI 10.1146/annurev.micro.50.1.213; Itoh T, 2006, J MOL BIOL, V360, P573, DOI 10.1016/j.jmb.2006.04.047; Jenkins J, 2004, J BIOL CHEM, V279, P9139, DOI 10.1074/jbc.M311390200; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Kazemi-Pour N, 2004, PROTEOMICS, V4, P3177, DOI 10.1002/pmic.200300814; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li SL, 2000, EMBO J, V19, P1228, DOI 10.1093/emboj/19.6.1228; Li SL, 2001, J BIOL CHEM, V276, P41407, DOI 10.1074/jbc.M106634200; Lietzke SE, 1996, PLANT PHYSIOL, V111, P73, DOI 10.1104/pp.111.1.73; LINHARDT RJ, 1986, APPL BIOCHEM BIOTECH, V12, P135; Lunin VV, 2004, J MOL BIOL, V337, P367, DOI 10.1016/j.jmb.2003.12.071; LUZZATI V, 1952, ACTA CRYSTALLOGR, V5, P802, DOI 10.1107/S0365110X52002161; Maruyama Y, 2005, J MOL BIOL, V350, P974, DOI 10.1016/j.jmb.2005.05.055; Maruyama Y, 2007, BIOCHEMISTRY-US, V46, P781, DOI 10.1021/bi0619775; Mayans O, 1997, STRUCTURE, V5, P677, DOI 10.1016/S0969-2126(97)00222-0; McDonough MA, 2004, FEBS LETT, V565, P188, DOI 10.1016/j.febslet.2004.03.094; McKie VA, 2001, BIOCHEM J, V355, P167, DOI 10.1042/0264-6021:3550167; MCNEIL M, 1980, PLANT PHYSIOL, V66, P1128, DOI 10.1104/pp.66.6.1128; MCNEIL M, 1984, ANNU REV BIOCHEM, V53, P625, DOI 10.1146/annurev.bi.53.070184.003205; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NOVOA D, 2004, ACTA CRYSTALLOGR D, V0060; Ochiai A, 2006, ACTA CRYSTALLOGR F, V62, P438, DOI 10.1107/S1744309106011894; Ochiai A, 2007, APPL ENVIRON MICROB, V73, P3803, DOI 10.1128/AEM.00147-07; ONeill MA, 1996, J BIOL CHEM, V271, P22923, DOI 10.1074/jbc.271.37.22923; Osawa T, 2005, J MOL BIOL, V345, P1111, DOI 10.1016/j.jmb.2004.10.081; Pages S, 2003, J BACTERIOL, V185, P4727, DOI 10.1128/JB.185.16.4727-4733.2003; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; PICKERSGILL R, 1994, NAT STRUCT BIOL, V1, P717, DOI 10.1038/nsb1094-717; Pickersgill R, 1998, J BIOL CHEM, V273, P24660, DOI 10.1074/jbc.273.38.24660; Ramachandran G N, 1968, Adv Protein Chem, V23, P283, DOI 10.1016/S0065-3233(08)60402-7; Shaya D, 2006, J BIOL CHEM, V281, P15525, DOI 10.1074/jbc.M512055200; SIBANDA BL, 1985, NATURE, V316, P170, DOI 10.1038/316170a0; Smith NL, 2005, P NATL ACAD SCI USA, V102, P17652, DOI 10.1073/pnas.0504782102; Soriano M, 2005, CURR MICROBIOL, V50, P114, DOI 10.1007/s00284-004-4382-8; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Thakur BR, 1997, CRIT REV FOOD SCI, V37, P47, DOI 10.1080/10408399709527767; Thomas LM, 2002, ACTA CRYSTALLOGR D, V58, P1008, DOI 10.1107/S0907444902005851; van Santen Y, 1999, J BIOL CHEM, V274, P30474, DOI 10.1074/jbc.274.43.30474; Vitali J, 1998, PLANT PHYSIOL, V116, P69, DOI 10.1104/pp.116.1.69; Xiong JP, 2004, J BIOL CHEM, V279, P40252, DOI 10.1074/jbc.C400362200; Yamasaki M, 2005, J MOL BIOL, V352, P11, DOI 10.1016/j.jmb.2005.06.075; Yamasaki M, 2004, J BIOL CHEM, V279, P31863, DOI 10.1074/jbc.M402466200; YODER MD, 1995, PLANT PHYSIOL, V107, P349, DOI 10.1104/pp.107.2.349; YODER MD, 1993, STRUCTURE, V1, P241, DOI 10.1016/0969-2126(93)90013-7; Yoon HJ, 1999, J MOL BIOL, V290, P505, DOI 10.1006/jmbi.1999.2883; Yoon HJ, 2001, J MOL BIOL, V307, P9, DOI 10.1006/jmbi.2000.4509; Zhou Y, 2006, PROTEINS, V65, P643, DOI 10.1002/prot.21139	70	23	24	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					37134	37145		10.1074/jbc.M704663200	http://dx.doi.org/10.1074/jbc.M704663200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17947240	hybrid			2022-12-27	WOS:000251646000040
J	Abhyankar, MM; Urekar, C; Reddi, PP				Abhyankar, Mayuresh M.; Urekar, Craig; Reddi, Prabhakara P.			A novel CpG-free vertebrate insulator silences the testis-specific SP-10 gene in somatic tissues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPERMATID-SPECIFIC TRANSCRIPTION; TRANSGENIC MICE DEMONSTRATE; ENHANCER-BLOCKING ACTIVITY; BETA-GLOBIN DOMAIN; CHROMATIN INSULATOR; NUCLEAR-MATRIX; CTCF; MOUSE; PROMOTER; ELEMENT	Regulation of cell type-specific gene transcription is central to cellular differentiation and development. During spermatogenesis, a number of testis- specific genes are expressed in a precise spatiotemporal order. How these genes remain silent in the somatic tissues is not well understood. Our previous studies using the round spermatid-specific mouse SP-10 gene, which codes for an acrosomal protein, revealed that its proximal promoter acts as an insulator and prevents expression in the somatic tissues. Here we report that the insulator tethers the SP-10 gene to the nuclear matrix in somatic tissues, sequestering the core promoter in the process, thus preventing transcription. In round spermatids where the SP-10 gene is expressed, this tethering is released. TAR DNA-binding protein of 43 kDa (TDP-43), previously shown to interact with the SP-10 insulator, was found to be in the 2 M NaCl- insoluble nuclear matrix fraction. TDP-43 prevented enhancer-promoter interactions when artificially recruited between the two by Gal4 strategy. Knockdown of TDP-43 using small interfering RNA released the enhancer- blocking effect of the SP-10 insulator in a stable cell culture model. Mutation of TDP-43 binding sites abolished this effect. Finally, a 50-bp subfragment of the SP-10 insulator, which includes TDP-43 binding sites, functioned as a minimal insulator in transgenic mice and silenced an otherwise ectopically expressed transgene in somatic tissues. The SP-10 insulator lacks CpG dinucleotides or CTCF binding sites. Thus, the present study characterized a novel vertebrate insulator in a physiological context and showed for the first time how a testis-specific gene is silenced in the somatic tissues by an insulator.	Univ Virginia, Sch Med, Dept Pathol, Charlottesville, VA 22908 USA	University of Virginia	Reddi, PP (corresponding author), Univ Virginia, Sch Med, Dept Pathol, POB 800904, Charlottesville, VA 22908 USA.	ppr5s@virginia.edu	Reddi, Prabhakara/AAY-8092-2020	Reddi, Prabhakara/0000-0003-4891-8964	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD036239, R29HD036239] Funding Source: NIH RePORTER; NICHD NIH HHS [HD 36239] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Acharya KK, 2006, DEV BIOL, V295, P781, DOI 10.1016/j.ydbio.2006.04.443; Antes TJ, 2001, BIOCHEMISTRY-US, V40, P6731, DOI 10.1021/bi0100743; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; BELLVE AR, 1977, J CELL BIOL, V74, P68, DOI 10.1083/jcb.74.1.68; BOSHART M, 1985, CELL, V41, P521, DOI 10.1016/S0092-8674(85)80025-8; Buratti E, 2001, J BIOL CHEM, V276, P36337, DOI 10.1074/jbc.M104236200; Chao W, 2002, SCIENCE, V295, P345, DOI 10.1126/science.1065982; CHUNG JH, 1993, CELL, V74, P505, DOI 10.1016/0092-8674(93)80052-G; Dix DJ, 1996, DEV BIOL, V174, P310, DOI 10.1006/dbio.1996.0076; Filippova GN, 2001, NAT GENET, V28, P335, DOI 10.1038/ng570; Gaszner M, 2006, NAT REV GENET, V7, P703, DOI 10.1038/nrg1925; Gerasimova TI, 2000, MOL CELL, V6, P1025, DOI 10.1016/S1097-2765(00)00101-5; Geusz ME, 1997, CURR BIOL, V7, P758, DOI 10.1016/S0960-9822(06)00334-4; Geyer CB, 2004, BIOL REPROD, V71, P837, DOI 10.1095/biolreprod.104.028969; Gilbert N, 2005, INT REV CYTOL, V242, P283; Hancock R, 2000, CHROMOSOMA, V109, P219, DOI 10.1007/s004120000077; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; HOGAN B, 1994, MANIPULATING MOUSE E, P226; IGNATIUS SH, 1995, J VIROL, V69, P3584, DOI 10.1128/JVI.69.6.3584-3596.1995; IKAWA M, 1995, DEV GROWTH DIFFER, V37, P455, DOI 10.1046/j.1440-169X.1995.t01-2-00012.x; Istrail S, 2005, P NATL ACAD SCI USA, V102, P4954, DOI 10.1073/pnas.0409624102; KELLUM R, 1991, CELL, V64, P941, DOI 10.1016/0092-8674(91)90318-S; Kim M, 2006, J BIOL CHEM, V281, P34288, DOI 10.1074/jbc.M607168200; LANGFORD KG, 1991, J BIOL CHEM, V266, P15559; Levine M, 2005, P NATL ACAD SCI USA, V102, P4936, DOI 10.1073/pnas.0408031102; LI QL, 1994, BLOOD, V84, P1399; Li SH, 2006, REPRODUCTION, V132, P493, DOI 10.1530/rep.1.01183; Li SM, 1998, J BIOL CHEM, V273, P31191, DOI 10.1074/jbc.273.47.31191; MARBER MS, 1995, J CLIN INVEST, V95, P1446, DOI 10.1172/JCI117815; MIRKOVITCH J, 1984, CELL, V39, P223, DOI 10.1016/0092-8674(84)90208-3; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Pikaart MI, 1998, GENE DEV, V12, P2852, DOI 10.1101/gad.12.18.2852; Reddi PP, 1999, BIOL REPROD, V61, P1256, DOI 10.1095/biolreprod61.5.1256; Reddi PP, 2003, DEV BIOL, V262, P173, DOI 10.1016/S0012-1606(03)00349-X; Robinett CC, 1997, MOL CELL BIOL, V17, P2866, DOI 10.1128/MCB.17.5.2866; ROBINSON MO, 1989, P NATL ACAD SCI USA, V86, P8437, DOI 10.1073/pnas.86.21.8437; Saitoh N, 2000, EMBO J, V19, P2315, DOI 10.1093/emboj/19.10.2315; Sanchez Y, 1997, SCIENCE, V277, P1497, DOI 10.1126/science.277.5331.1497; SCHMIDT EV, 1990, MOL CELL BIOL, V10, P4406, DOI 10.1128/MCB.10.8.4406; Smith AD, 2006, P NATL ACAD SCI USA, V103, P6275, DOI 10.1073/pnas.0508169103; West AG, 2004, MOL CELL, V16, P453, DOI 10.1016/j.molcel.2004.10.005; West AG, 2002, GENE DEV, V16, P271, DOI 10.1101/gad.954702; Yusufzai TM, 2004, P NATL ACAD SCI USA, V101, P8620, DOI 10.1073/pnas.0402938101; Yusufzai TM, 2004, MOL CELL, V13, P291, DOI 10.1016/S1097-2765(04)00029-2; ZAMBROWICZ BP, 1993, P NATL ACAD SCI USA, V90, P5071, DOI 10.1073/pnas.90.11.5071	46	89	93	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36143	36154		10.1074/jbc.M705811200	http://dx.doi.org/10.1074/jbc.M705811200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17932037	hybrid			2022-12-27	WOS:000251458300004
J	Ignatova, Z; Thakur, AK; Wetzel, R; Gierasch, LM				Ignatova, Zoya; Thakur, Ashwani K.; Wetzel, Ronald; Gierasch, Lila M.			In-cell aggregation of a polyglutamine-containing chimera is a multistep process initiated by the flanking sequence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN AGGREGATION; FIBRIL FORMATION; HUNTINGTIN; TOXICITY; DISEASE; BINDING; VITRO; NEURODEGENERATION; FIBRILLOGENESIS; PROTOFIBRILS	Toxicity in amyloid diseases is intimately linked to the nature of aggregates, with early oligomeric species believed to be more cytotoxic than later fibrillar aggregates. Yet mechanistic understanding of how aggregating species evolve with time is currently lacking. We have explored the aggregation process of a chimera composed of a globular protein (cellular retinoic acid-binding protein, CRABP) and huntingtin exon 1 with polyglutamine tracts either above (Q53) or below (Q20) the pathological threshold using Escherichia coli cells as a model intracellular environment. Previously we showed that fusion of the huntingtin exon 1 sequence with > 40Q led to structural perturbation and decreased stability of CRABP (Ignatova, Z., and Gierasch, L. M. (2006) J. Biol. Chem. 281, 12959-12967). Here we report that the Q53 chimera aggregates in cells via a multistep process: early stage aggregates are spherical and detergent-soluble, characteristics of prefibrillar aggregates, and appear to be dominated structurally by CRABP, in that they can promote aggregation of a CRABP variant but not oligoglutamine aggregation, and the CRABP domain is relatively sequestered based on its protection from proteolysis. Late stage aggregates appear to be dominated by polyGln; they are fibrillar, detergent-resistant, capable of seeding aggregation of oligoglutamine but not the CRABP variant, and show relative protection of the polyglutamine-exon1 domain from proteolysis. These results point to an evolution of the dominant sequences in intracellular aggregates and may provide molecular insight into origins of toxic prefibrillar aggregates.	Max Planck Inst Biochem, D-82152 Martinsried, Germany; Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA; Univ Massachusetts, Dept Chem, Amherst, MA 01003 USA; Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15206 USA	Max Planck Society; University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Ignatova, Z (corresponding author), Max Planck Inst Biochem, Am Klopferspitz 18, D-82152 Martinsried, Germany.	ignatova@biochem.mpg.de; gierasch@biochem.umass.edu	Wetzel, Ronald/G-7453-2011; Thakur, Ashwani Kumar/AAL-5784-2021; Gierasch, Lila M/D-1494-2009	Ignatova, Zoya/0000-0002-9478-8825	NIA NIH HHS [R01 AG019322] Funding Source: Medline; NIGMS NIH HHS [R01 GM027616] Funding Source: Medline; NIH HHS [DP1 OD000945-02, DP1 OD000945] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027616] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019322] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000945] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Baglioni S, 2006, J NEUROSCI, V26, P8160, DOI 10.1523/JNEUROSCI.4809-05.2006; Bennett MJ, 2002, P NATL ACAD SCI USA, V99, P11634, DOI 10.1073/pnas.182393899; Berthelier V, 2006, METHOD ENZYMOL, V413, P313, DOI 10.1016/S0076-6879(06)13016-5; Bhattacharyya AM, 2005, P NATL ACAD SCI USA, V102, P15400, DOI 10.1073/pnas.0501651102; Bucciantini M, 2004, J BIOL CHEM, V279, P31374, DOI 10.1074/jbc.M400348200; Bulone D, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000111; Carrio M, 2005, J MOL BIOL, V347, P1025, DOI 10.1016/j.jmb.2005.02.030; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Chen S, 2001, J MOL BIOL, V311, P173, DOI 10.1006/jmbi.2001.4850; Chen SM, 2002, P NATL ACAD SCI USA, V99, P11884, DOI 10.1073/pnas.182276099; Chien P, 2001, NATURE, V410, P223, DOI 10.1038/35065632; Crick SL, 2006, P NATL ACAD SCI USA, V103, P16764, DOI 10.1073/pnas.0608175103; de Chiara C, 2005, J MOL BIOL, V354, P883, DOI 10.1016/j.jmb.2005.09.083; DELEEUW AM, 1990, J NEUROCYTOL, V19, P253, DOI 10.1007/BF01217303; Ding TT, 2002, BIOCHEMISTRY-US, V41, P10209, DOI 10.1021/bi020139h; Duennwald ML, 2006, P NATL ACAD SCI USA, V103, P11045, DOI 10.1073/pnas.0604547103; Ellisdon AM, 2007, J MOL BIOL, V368, P595, DOI 10.1016/j.jmb.2007.02.058; Ellisdon AM, 2006, J BIOL CHEM, V281, P16888, DOI 10.1074/jbc.M601470200; Gonzalez-Montalban N, 2007, BIOCHEM BIOPH RES CO, V355, P637, DOI 10.1016/j.bbrc.2007.01.192; Griffin BA, 2000, METHOD ENZYMOL, V327, P565; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Ignatova Z, 2006, J BIOL CHEM, V281, P12959, DOI 10.1074/jbc.M511523200; Ignatova Z, 2005, BIOCHEMISTRY-US, V44, P7266, DOI 10.1021/bi047404e; Ignatova Z, 2004, P NATL ACAD SCI USA, V101, P523, DOI 10.1073/pnas.0304533101; Ignatova Z, 2006, P NATL ACAD SCI USA, V103, P13357, DOI 10.1073/pnas.0603772103; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kheterpal I, 2001, BIOCHEMISTRY-US, V40, P11757, DOI 10.1021/bi010805z; Ko J, 2001, BRAIN RES BULL, V56, P319, DOI 10.1016/S0361-9230(01)00599-8; Kodali R, 2007, CURR OPIN STRUC BIOL, V17, P48, DOI 10.1016/j.sbi.2007.01.007; Kuemmerle S, 1999, ANN NEUROL, V46, P842; Lansbury PT, 2006, NATURE, V443, P774, DOI 10.1038/nature05290; Lee HJ, 2002, J BIOL CHEM, V277, P48976, DOI 10.1074/jbc.M208192200; Li PW, 2007, NAT STRUCT MOL BIOL, V14, P381, DOI 10.1038/nsmb1234; Masino L, 2004, J MOL BIOL, V344, P1021, DOI 10.1016/j.jmb.2004.09.065; Masino L, 2002, FEBS LETT, V513, P267, DOI 10.1016/S0014-5793(02)02335-9; Myers SL, 2006, RAPID COMMUN MASS SP, V20, P1628, DOI 10.1002/rcm.2482; Nagai Y, 2007, NAT STRUCT MOL BIOL, V14, P332, DOI 10.1038/nsmb1215; O'Nuallain B, 2004, J BIOL CHEM, V279, P17490, DOI 10.1074/jbc.M311300200; OBERG K, 1994, BIOCHEMISTRY-US, V33, P2628, DOI 10.1021/bi00175a035; Poirier MA, 2002, J BIOL CHEM, V277, P41032, DOI 10.1074/jbc.M205809200; Rockabrand E, 2007, HUM MOL GENET, V16, P61, DOI 10.1093/hmg/ddl440; Ross CA, 2005, NAT REV MOL CELL BIO, V6, P891, DOI 10.1038/nrm1742; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Tanaka M, 2003, J BIOL CHEM, V278, P34717, DOI 10.1074/jbc.M209852200; Vitalis A, 2007, BIOPHYS J, V93, P1923, DOI 10.1529/biophysj.107.110080; von Bergen M, 2006, BIOCHEMISTRY-US, V45, P6446, DOI 10.1021/bi052530j; Wacker JL, 2004, NAT STRUCT MOL BIOL, V11, P1215, DOI 10.1038/nsmb860; Walsh DM, 1997, J BIOL CHEM, V272, P22364, DOI 10.1074/jbc.272.35.22364; Wang XL, 2006, PROTEINS, V63, P297, DOI 10.1002/prot.20761; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	53	56	56	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36736	36743		10.1074/jbc.M703682200	http://dx.doi.org/10.1074/jbc.M703682200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17942400	hybrid, Green Accepted			2022-12-27	WOS:000251458300066
J	Jung, HY; Seong, HA; Ha, HJ				Jung, Haiyoung; Seong, Hyun-A.; Ha, Hyunjung			NM23-H1 tumor suppressor and its interacting partner STRAP activate p53 function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-ASSOCIATED PROTEIN; GROWTH-FACTOR; PHYSICAL INTERACTION; DIPHOSPHATE KINASE; CANCER-CELLS; DNA-BINDING; WILD-TYPE; MDM2; STABILITY; ONCOPROTEIN	p53 plays a critical role in a variety of growth inhibitory responses, including cell cycle arrest, differentiation, and apoptosis, and contributes to tumor suppression. Here we show that NM23-H1 and its binding partner STRAP (serine-threonine kinase receptor-associated protein) interact with p53 and potentiate p53 activity. Both NM23-H1 and STRAP directly interact with the central DNA binding domain within residues 113-290. The use of NM23-H1 and STRAP mutants revealed that Cys(145) of NM23-H1 and Cys(152) (or Cys(270)) of STRAP were responsible for p53 binding. Furthermore, Cys(176) and Cys(135) of p53 were required to bind NM23-H1 and STRAP, respectively. Ectopic expression of wild-type NM23-H1 and STRAP, but not NM23-H1(C145S) and STRAP(C152S/C270S), positively regulated p53-mediated transcription in a dose-dependent manner. Knockdown of endogenous NM23-H1 or STRAP produced an opposite trend and inhibited the p53-mediated transcription. Similarly, NM23-H1 and STRAP stimulated p53-induced apoptosis and growth inhibition, whereas the NM23-H1(C145S) and STRAP(C152S/C270S) mutants had no effect. We also demonstrated that p53 activation by NM23-H1 and STRAP was mediated by removing Mdm2, a negative regulator of p53, from the p53-Mdm2 complex. These results suggest that NM23-H1 and its interacting partner STRAP physically interact with p53 and positively regulate its functions, including p53-induced apoptosis and cell cycle arrest.	Chungbuk Natl Univ, Dept Biochem, Sch Life Sci, Biotechnol Res Inst, Cheongju 361763, South Korea	Chungbuk National University	Ha, HJ (corresponding author), Chungbuk Natl Univ, Dept Biochem, Sch Life Sci, Biotechnol Res Inst, Cheongju 361763, South Korea.	hyunha@chungbuk.ac.kr						ANDERSON CW, 2003, HDB CELL SIGNALING, V3, P237; Anumanthan G, 2006, CANCER RES, V66, P10824, DOI 10.1158/0008-5472.CAN-06-1599; Asher G, 2002, P NATL ACAD SCI USA, V99, P3099, DOI 10.1073/pnas.052706799; Asher G, 2001, P NATL ACAD SCI USA, V98, P1188, DOI 10.1073/pnas.021558898; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; Buschmann T, 2001, MOL CELL BIOL, V21, P2743, DOI 10.1128/MCB.21.8.2743-2754.2001; Buzek J, 2002, NUCLEIC ACIDS RES, V30, P2340, DOI 10.1093/nar/30.11.2340; Caspari T, 2000, CURR BIOL, V10, pR315, DOI 10.1016/S0960-9822(00)00439-5; Cordenonsi M, 2003, CELL, V113, P301, DOI 10.1016/S0092-8674(03)00308-8; Damalas A, 2001, EMBO J, V20, P4912, DOI 10.1093/emboj/20.17.4912; Gervasi F, 1996, CELL GROWTH DIFFER, V7, P1689; Giaccia AJ, 1998, GENE DEV, V12, P2973, DOI 10.1101/gad.12.19.2973; Gorina S, 1996, SCIENCE, V274, P1001, DOI 10.1126/science.274.5289.1001; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Haider SK, 2006, CANCER RES, V66, P6156, DOI 10.1158/0008-5472.CAN-05-3261; Hofseth LJ, 2004, TRENDS PHARMACOL SCI, V25, P177, DOI 10.1016/j.tips.2004.02.009; Hollstein M, 1996, NUCLEIC ACIDS RES, V24, P141, DOI 10.1093/nar/24.1.141; Honda R, 1999, EMBO J, V18, P22, DOI 10.1093/emboj/18.1.22; Hsieh JK, 1999, MOL CELL, V3, P181, DOI 10.1016/S1097-2765(00)80309-3; Ishikawa N, 2003, J BIOENERG BIOMEMBR, V35, P7, DOI 10.1023/A:1023433504713; IWABUCHI K, 1994, P NATL ACAD SCI USA, V91, P6098, DOI 10.1073/pnas.91.13.6098; JENKINS JR, 1988, J VIROL, V62, P3903, DOI 10.1128/JVI.62.10.3903-3906.1988; Jung H, 2001, J BIOL CHEM, V276, P15504, DOI 10.1074/jbc.M009620200; Kaeser MD, 2004, J BIOL CHEM, V279, P7598, DOI 10.1074/jbc.M311732200; Kamijo T, 1998, P NATL ACAD SCI USA, V95, P8292, DOI 10.1073/pnas.95.14.8292; KANTOR JD, 1993, CANCER RES, V53, P1971; Kimura N, 2000, J BIOENERG BIOMEMBR, V32, P309, DOI 10.1023/A:1005549315846; Koivusalo R, 2006, CANCER RES, V66, P11817, DOI 10.1158/0008-5472.CAN-06-2185; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Leung KM, 2002, CANCER RES, V62, P4890; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; May P, 1999, ONCOGENE, V18, P7621, DOI 10.1038/sj.onc.1203285; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Oh W, 2006, J BIOL CHEM, V281, P17457, DOI 10.1074/jbc.M601857200; Otero AD, 2000, J BIOENERG BIOMEMBR, V32, P269, DOI 10.1023/A:1005589029959; Park K, 2005, CANCER RES, V65, P749; Prives C, 1999, J PATHOL, V187, P112; RAINWATER R, 1995, MOL CELL BIOL, V15, P3892; RUPPERT JM, 1993, MOL CELL BIOL, V13, P3811, DOI 10.1128/MCB.13.6.3811; Ryan KM, 2001, CURR OPIN CELL BIOL, V13, P332, DOI 10.1016/S0955-0674(00)00216-7; SCHEFFNER M, 1992, J VIROL, V66, P5100, DOI 10.1128/JVI.66.8.5100-5105.1992; Seong HA, 2005, J BIOL CHEM, V280, P42897, DOI 10.1074/jbc.M507539200; Seong HA, 2007, J BIOL CHEM, V282, P12272, DOI 10.1074/jbc.M609279200; Seong HA, 2007, J BIOL CHEM, V282, P12075, DOI 10.1074/jbc.M609832200; Sharp DA, 1999, J BIOL CHEM, V274, P38189, DOI 10.1074/jbc.274.53.38189; STEEG PS, 1988, J NATL CANCER I, V80, P200, DOI 10.1093/jnci/80.3.200; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wise-Draper TM, 2006, MOL CELL BIOL, V26, P7506, DOI 10.1128/MCB.00430-06; Zilfou JT, 2001, MOL CELL BIOL, V21, P3974, DOI 10.1128/MCB.21.12.3974-3985.2001	50	79	82	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					35293	35307		10.1074/jbc.M705181200	http://dx.doi.org/10.1074/jbc.M705181200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17916563	hybrid			2022-12-27	WOS:000251155200073
J	Kim, JS; Diebold, BA; Babior, BM; Knaus, UG; Bokoch, GM				Kim, Jun-Sub; Diebold, Becky A.; Babior, Bernard M.; Knaus, Ulla G.; Bokoch, Gary M.			Regulation of Nox1 activity via protein kinase A-mediated phosphorylation of NoxA1 and 14-3-3 binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUTROPHIL NADPH OXIDASE; SMOOTH-MUSCLE-CELLS; EPITHELIAL-CELLS; INDUCED ACTIVATION; RESPIRATORY BURST; ENDOTHELIAL-CELLS; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; SH3 DOMAIN; CYCLIC-AMP	Nox activator 1 (NoxA1) is a homologue of p67(phox) that acts in conjunction with Nox organizer 1 (NoxO1) to regulate reactive oxygen species (ROS) production by the NADPH oxidase Nox1. The phosphorylation of cytosolic regulatory components by multiple kinases plays important roles in assembly and activity of the phagocyte NADPH oxidase (Nox2) system, but little is known about regulation by phosphorylation in the Nox1 system. Here we identify Ser(172) and Ser(461) of NoxA1 as phosphorylation sites for protein kinase A (PKA). A consequence of this phosphorylation was the enhancement of NoxA1 complex formation with 14-3-3 proteins. Using both a transfected human embryonic kidney 293 cell Nox1 model system and endogenous Nox1 in colon cell lines, we showed that the elevation of cAMP inhibits, whereas the inhibition of PKA enhances, Nox1-dependent ROS production through effects on NoxA1. Inhibition of Nox1 activity was intensified by the availability of 14-3-3 zeta protein, and this regulatory interaction was dependent on PKA-phosphorylatable sites at Ser172 and Ser461 in NoxA1. We showed that phosphorylation and 14-3-3 binding induce the dissociation of NoxA1 from the Nox1 complex at the plasma membrane, suggesting a mechanism for the inhibitory effect on Nox1 activity. Our data establish that PKA-phosphorylated NoxA1 is a new binding partner of 14-3-3 protein (s) and that this forms the basis of a novel mechanism regulating the formation of ROS by Nox1 and, potentially, other NoxA1-regulated Nox family members.	Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; Emory Univ, Dept Pathol, Atlanta, GA 30322 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Emory University	Diebold, BA (corresponding author), Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA.	bdiebol@emory.edu; bokoch@scripps.edu			NATIONAL CANCER INSTITUTE [R01CA068376] Funding Source: NIH RePORTER; NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID) [P01CI000095] Funding Source: NIH RePORTER; NCI NIH HHS [CA068376] Funding Source: Medline; NCPDCID CDC HHS [CI000095] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCPDCID CDC HHS		Ago T, 1999, J BIOL CHEM, V274, P33644, DOI 10.1074/jbc.274.47.33644; Ago T, 2003, P NATL ACAD SCI USA, V100, P4474, DOI 10.1073/pnas.0735712100; Ambasta RK, 2004, J BIOL CHEM, V279, P45935, DOI 10.1074/jbc.M406486200; Banfi B, 2003, J BIOL CHEM, V278, P3510, DOI 10.1074/jbc.C200613200; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; BengisGarber C, 1996, CELL SIGNAL, V8, P291, DOI 10.1016/0898-6568(96)00052-6; Bokoch GM, 2003, TRENDS BIOCHEM SCI, V28, P502, DOI 10.1016/S0968-0004(03)00194-4; BRIDGES D, 2005, SCI STKE, pRE10, DOI DOI 10.1126/STKE.2962005RE10; Brown GE, 2004, J BIOL CHEM, V279, P27059, DOI 10.1074/jbc.M314258200; Cheng GJ, 2004, J BIOL CHEM, V279, P4737, DOI 10.1074/jbc.M305968200; Cheng G, 2006, J BIOL CHEM, V281, P17718, DOI 10.1074/jbc.M512751200; CLARK RA, 1990, J CLIN INVEST, V85, P714, DOI 10.1172/JCI114496; Crawford MA, 2006, J IMMUNOL, V176, P7557, DOI 10.4049/jimmunol.176.12.7557; Dikalova A, 2005, CIRCULATION, V112, P2668, DOI 10.1161/CIRCULATIONAHA.105.538934; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Geiszt M, 2003, J BIOL CHEM, V278, P20006, DOI 10.1074/jbc.M301289200; Groemping Y, 2005, BIOCHEM J, V386, P401, DOI 10.1042/BJ20041835; Groemping Y, 2003, CELL, V113, P343, DOI 10.1016/S0092-8674(03)00314-3; Hanna IR, 2004, FREE RADICAL BIO MED, V37, P1542, DOI 10.1016/j.freeradbiomed.2004.08.011; Humphries KM, 2007, J BIOL CHEM, V282, P22072, DOI 10.1074/jbc.M702582200; KAPER JB, 1995, CLIN MICROBIOL REV, V8, P48, DOI 10.1128/CMR.8.1.48; Kawahara T, 2005, AM J PHYSIOL-CELL PH, V288, pC450, DOI 10.1152/ajpcell.00319.2004; KNAUS UG, 1995, SCIENCE, V269, P221, DOI 10.1126/science.7618083; Kuwano Y, 2006, AM J PHYSIOL-CELL PH, V290, pC433, DOI 10.1152/ajpcell.00135.2005; Lambeth JD, 2007, FREE RADICAL BIO MED, V43, P319, DOI 10.1016/j.freeradbiomed.2007.03.028; Lassegue B, 2001, CIRC RES, V88, P888, DOI 10.1161/hh0901.090299; Lin P, 2005, J IMMUNOL, V174, P2981, DOI 10.4049/jimmunol.174.5.2981; LIU D, 1995, NATURE, V376, P191, DOI 10.1038/376191a0; LUBRAN MM, 1988, ANN CLIN LAB SCI, V18, P58; Matsuno K, 2005, CIRCULATION, V112, P2677, DOI 10.1161/CIRCULATIONAHA.105.573709; Miyano K, 2006, J BIOL CHEM, V281, P21857, DOI 10.1074/jbc.M513665200; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Obsil T, 2001, CELL, V105, P257, DOI 10.1016/S0092-8674(01)00316-6; Ouedraogo R, 2006, DIABETES, V55, P1840, DOI 10.2337/db05-1174; Porter GW, 2006, SEMIN CANCER BIOL, V16, P193, DOI 10.1016/j.semcancer.2006.03.003; Ranjan P, 2006, ANTIOXID REDOX SIGN, V8, P1447, DOI 10.1089/ars.2006.8.1447; Rittinger K, 1999, MOL CELL, V4, P153, DOI 10.1016/S1097-2765(00)80363-9; Rokutan K, 2006, ANTIOXID REDOX SIGN, V8, P1573, DOI 10.1089/ars.2006.8.1573; Sheppard FR, 2005, J LEUKOCYTE BIOL, V78, P1025, DOI 10.1189/jlb.0804442; SIMCHOWITZ L, 1980, J IMMUNOL, V124, P1482; Sorescu GP, 2004, CIRC RES, V95, P773, DOI 10.1161/01.RES.0000145728.22878.45; Spisani S, 1996, CELL SIGNAL, V8, P269, DOI 10.1016/0898-6568(96)00049-6; Suh YA, 1999, NATURE, V401, P79, DOI 10.1038/43459; Sumimoto H, 2005, BIOCHEM BIOPH RES CO, V338, P677, DOI 10.1016/j.bbrc.2005.08.210; Szanto I, 2005, J PATHOL, V207, P164, DOI 10.1002/path.1824; Takeya R, 2003, J BIOL CHEM, V278, P25234, DOI 10.1074/jbc.M212856200; Ueyama T, 2006, MOL CELL BIOL, V26, P2160, DOI 10.1128/MCB.26.6.2160-2174.2006; Vojtova J, 2006, CURR OPIN MICROBIOL, V9, P69, DOI 10.1016/j.mib.2005.12.011; Wilker EW, 2005, J BIOL CHEM, V280, P18891, DOI 10.1074/jbc.M500982200; Yaffe MB, 2002, FEBS LETT, V513, P53, DOI 10.1016/S0014-5793(01)03288-4; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yasunari K, 2000, CIRCULATION, V101, P2302, DOI 10.1161/01.CIR.101.19.2302; Zhang LX, 1997, J BIOL CHEM, V272, P13717, DOI 10.1074/jbc.272.21.13717; ZHANG SJ, 1995, J BIOL CHEM, V270, P23934, DOI 10.1074/jbc.270.41.23934	55	78	81	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					34787	34800		10.1074/jbc.M704754200	http://dx.doi.org/10.1074/jbc.M704754200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17913709	hybrid			2022-12-27	WOS:000251155200021
J	Le, GT; Abbenante, G; Fairlie, DP				Le, Giang Thanh; Abbenante, Giovanni; Fairlie, David P.			Profiling the enzymatic properties and inhibition of human complement factor B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLOMERULONEPHRITIS TYPE-II; VIRUS NS3 PROTEASE; ALTERNATIVE PATHWAY; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; RENAL-DISEASE; MRL/LPR MICE; ANTIPHOSPHOLIPID SYNDROME; C3 ACTIVATION; FACTOR-H; INFLAMMATION	Human complement factor B is the crucial catalytic component of the C3 convertase enzyme that activates the alternative pathway of complement-mediated immunity. Although a serine protease in its own right, factor B circulates in human serum as an inactive zymogen and there is a crystal structure only for the inactive state of factor B and various fragments. To provide greater insight to the catalytic function and properties of factor B, we have used short para-nitroanilide derivatives of 4-to 15-residue peptides as substrates to profile the catalytic properties of factor B. Among factors found to influence catalytic activity of factor B was an unusual dependence on pH. Non-physiological alkaline conditions strongly promoted substrate cleavage by factor B, consistent with a pH-accessible conformation of the enzyme that may be critical for catalytic function. Small N-terminal extensions to conventional hexapeptide para-nitroanilide substrates significantly increased catalytic activity of factor B, which was more selective for its cleavage site than trypsin. The new chromogenic assay enabled optimization of catalysis conditions, the profiling of different substrate sequences, and the development of the first reversible and competitive substrate-based inhibitor of factor B. The inhibitor was also shown to prevent in vitro formation of C3a from C3 by factor B, by synthetic and by natural C3 convertase of the alternative complement activation pathway, and to block formation of membrane attack complex. The availability of a reversible substrate-based inhibitor that could stabilize the active conformation of factor B, in conjunction with a pH-promoted higher processing activity, may offer a new avenue to obtain crystal structures of factor B and C3 convertase in an active conformation.	Univ Queensland, Ctr Drug Design & Dev, Inst Mol Biosci, Brisbane, Qld 4072, Australia	University of Queensland	Fairlie, DP (corresponding author), Univ Queensland, Ctr Drug Design & Dev, Inst Mol Biosci, Brisbane, Qld 4072, Australia.	d.fairlie@imb.uq.edu.au	Le, Giang/I-3178-2016; Fairlie, David P/F-8865-2014	Le, Giang/0000-0002-2591-9190; Fairlie, David P/0000-0002-7856-8566				Abbenante G, 2000, LETT PEPT SCI, V7, P347, DOI 10.1023/A:1013016323676; Abbenante Giovanni, 2005, Med Chem, V1, P71, DOI 10.2174/1573406053402569; Angelo PF, 2006, J BIOL CHEM, V281, P3116, DOI 10.1074/jbc.M510096200; Appel GB, 2005, J AM SOC NEPHROL, V16, P1392, DOI 10.1681/ASN.2005010078; Arumugam TV, 2007, P NATL ACAD SCI USA, V104, P14104, DOI 10.1073/pnas.0700506104; Bao LH, 2002, J IMMUNOL, V168, P3601, DOI 10.4049/jimmunol.168.7.3601; Bessaud M, 2005, VIRUS RES, V107, P57, DOI 10.1016/j.virusres.2004.06.015; Bessaud M, 2006, VIRUS RES, V120, P79, DOI 10.1016/j.virusres.2006.01.021; Bhattacharya AA, 2004, STRUCTURE, V12, P371, DOI 10.1016/j.str.2004.02.012; Elliott MK, 2004, KIDNEY INT, V65, P129, DOI 10.1111/j.1523-1755.2004.00371.x; Fairlie DP, 2000, J MED CHEM, V43, P1271, DOI 10.1021/jm990315t; FISHELSON Z, 1984, J IMMUNOL, V132, P1425; Furlong ST, 2000, IMMUNOPHARMACOLOGY, V48, P199, DOI 10.1016/S0162-3109(00)00205-8; Hinshelwood J, 2000, J MOL BIOL, V301, P1267, DOI 10.1006/jmbi.2000.4044; HOGASEN K, 1995, J CLIN INVEST, V95, P1054, DOI 10.1172/JCI117751; INAGI R, 1991, IMMUNOL LETT, V27, P49, DOI 10.1016/0165-2478(91)90243-4; Ji H, 2002, IMMUNITY, V16, P157, DOI 10.1016/S1074-7613(02)00275-3; Jing H, 2000, EMBO J, V19, P164, DOI 10.1093/emboj/19.2.164; KAM CM, 1987, J BIOL CHEM, V262, P3444; Katschke KJ, 2007, J EXP MED, V204, P1319, DOI 10.1084/jem.20070432; Lenderink AM, 2007, AM J PHYSIOL-RENAL, V293, pF555, DOI 10.1152/ajprenal.00403.2006; Leung D, 2000, J MED CHEM, V43, P305, DOI 10.1021/jm990412m; Leung D, 2001, J BIOL CHEM, V276, P45762, DOI 10.1074/jbc.M107360200; Li J, 2005, J BIOL CHEM, V280, P28766, DOI 10.1074/jbc.M500588200; MERI S, 1992, J EXP MED, V175, P939, DOI 10.1084/jem.175.4.939; Milder FJ, 2007, NAT STRUCT MOL BIOL, V14, P224, DOI 10.1038/nsmb1210; Milder FJ, 2006, STRUCTURE, V14, P1587, DOI 10.1016/j.str.2006.08.008; Mollnes TE, 2006, MOL IMMUNOL, V43, P107, DOI 10.1016/j.molimm.2005.06.014; Nall TA, 2004, J BIOL CHEM, V279, P48535, DOI 10.1074/jbc.M406810200; PANGBURN MK, 1986, BIOCHEM J, V235, P723, DOI 10.1042/bj2350723; Park P, 2002, AM J PHYSIOL-RENAL, V282, pF352, DOI 10.1152/ajprenal.00160.2001; Peyrefitte CN, 2007, VIRUS GENES, V34, P185, DOI 10.1007/s11262-006-0052-1; Pickering MC, 2002, NAT GENET, V31, P424, DOI 10.1038/ng912; Ponnuraj K, 2004, MOL CELL, V14, P17, DOI 10.1016/S1097-2765(04)00160-1; Puente XS, 2003, NAT REV GENET, V4, P544, DOI 10.1038/nrg1111; Sahu A, 1996, J IMMUNOL, V157, P884; Salmon JE, 2007, NAT CLIN PRACT RHEUM, V3, P140, DOI 10.1038/ncprheum0432; Sim RB, 2004, BIOCHEM SOC T, V32, P21, DOI 10.1042/BST0320021; Taube C, 2006, P NATL ACAD SCI USA, V103, P8084, DOI 10.1073/pnas.0602357103; Thurman JM, 2006, J IMMUNOL, V176, P1305, DOI 10.4049/jimmunol.176.3.1305; Thurman JM, 2004, MOL IMMUNOL, V41, P318; Thurman JM, 2003, J IMMUNOL, V170, P1517, DOI 10.4049/jimmunol.170.3.1517; Tyndall JDA, 2005, CHEM REV, V105, P973, DOI 10.1021/cr040669e; Wang Y, 1996, P NATL ACAD SCI USA, V93, P8563, DOI 10.1073/pnas.93.16.8563; Watanabe H, 2000, J IMMUNOL, V164, P786, DOI 10.4049/jimmunol.164.2.786; Xu YY, 2001, IMMUNOL REV, V180, P123, DOI 10.1034/j.1600-065X.2001.1800111.x; Zhou WD, 2000, J CLIN INVEST, V105, P1363, DOI 10.1172/JCI8621	47	20	24	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					34809	34816		10.1074/jbc.M705646200	http://dx.doi.org/10.1074/jbc.M705646200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17921140	hybrid			2022-12-27	WOS:000251155200023
J	Ye, JQ; Cho, SH; Fuselier, J; Li, WK; Beckwith, J; Rapoport, TA				Ye, Jiqing; Cho, Seung-Hyun; Fuselier, Jessica; Li, Weikai; Beckwith, Jon; Rapoport, Tom A.			Crystal structure of an unusual thioredoxin protein with a zinc finger domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; ESCRT-II; EXPRESSION; COMPLEX; MODEL; MECHANISM; FORMS	Many Gram- negative bacteria have two cytoplasmic thioredoxins, thioredoxin-1 and -2, encoded by the trxA and trxC genes, respectively. Both thioredoxins have the highly conserved WCGPC motif and function as disulfide-bond reductases. However, thioredoxin-2 has unique features: it has an N-terminal motif that binds a zinc ion, and its transcription is under the control of OxyR, which allows it to be up-regulated under oxidative stress. Here, we report the crystal structure of thioredoxin-2 from Rhodobacter capsulatus. The C-terminal region of thioredoxin-2 forms a canonical thioredoxin fold with a central beta-sheet consisting of five strands and four flanking alpha-helices on either side. The N-terminal zinc finger is composed of four short beta-strands (S1-S4) connected by three short loops (L1-L3). The four cysteines are at loops L1 and L3 and form a tetragonal binding site for a zinc ion. The zinc finger is close to the first beta-strand and first alpha-helix of the thioredoxin fold. Nevertheless, the zinc finger may not directly affect the oxidoreductase activity of thioredoxin-2 because the zinc finger is not near the active site of a protomer and because thioredoxin-2 is a monomer in solution. On the basis of structural similarity to the zinc fingers in Npl4 and Vps36, we propose that the N-terminal zinc finger of thioredoxin-2 mediates protein-protein interactions, possibly with its substrates or chaperones.	Harvard Univ, Howard Hughes Med Inst, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Harvard Univ, Dept Microbiol & Mol Genet, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Rapoport, TA (corresponding author), Harvard Univ, Howard Hughes Med Inst, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.	tom_rapoport@hms.harvard.edu		cho, seung-hyun/0000-0002-5548-4239	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL097083, K99HL097083] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052586] Funding Source: NIH RePORTER; NHLBI NIH HHS [K99 HL097083, R00 HL097083] Funding Source: Medline; NIGMS NIH HHS [GM052586] Funding Source: Medline; PHS HHS [GMO41883] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Amorim GC, 2007, J BIOMOL NMR, V38, P99, DOI 10.1007/s10858-007-9144-z; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bao R, 2007, PROTEINS, V66, P246, DOI 10.1002/prot.21194; BOYD D, 1987, P NATL ACAD SCI USA, V84, P8525, DOI 10.1073/pnas.84.23.8525; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Capitani G, 2000, J MOL BIOL, V302, P135, DOI 10.1006/jmbi.2000.4006; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; Collet JF, 2003, J BIOL CHEM, V278, P45325, DOI 10.1074/jbc.M307818200; Donaldson LW, 2003, J BIOL CHEM, V278, P48991, DOI 10.1074/jbc.M307826200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GAN ZR, 1991, J BIOL CHEM, V266, P1692; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; HOLMGREN A, 1995, STRUCTURE, V3, P239, DOI 10.1016/S0969-2126(01)00153-8; Inaba K, 2006, CELL, V127, P789, DOI 10.1016/j.cell.2006.10.034; JENG MF, 1994, STRUCTURE, V2, P853, DOI 10.1016/S0969-2126(94)00086-7; KATTI SK, 1990, J MOL BIOL, V212, P167, DOI 10.1016/0022-2836(90)90313-B; Laity JH, 2001, CURR OPIN STRUC BIOL, V11, P39, DOI 10.1016/S0959-440X(00)00167-6; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; Li K, 2003, MICROBIOL-SGM, V149, P419, DOI 10.1099/mic.0.25978-0; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Miranda-Vizuete A, 1997, J BIOL CHEM, V272, P30841, DOI 10.1074/jbc.272.49.30841; Oktyabrsky ON, 2007, BIOCHEMISTRY-MOSCOW+, V72, P132, DOI 10.1134/S0006297907020022; Perederina A, 2004, CELL, V118, P297, DOI 10.1016/j.cell.2004.06.030; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; QIN J, 1995, STRUCTURE, V3, P289, DOI 10.1016/S0969-2126(01)00159-9; Ritz D, 2000, J BIOL CHEM, V275, P2505, DOI 10.1074/jbc.275.4.2505; Ritz D, 2001, ANNU REV MICROBIOL, V55, P21, DOI 10.1146/annurev.micro.55.1.21; Rozhkova A, 2004, EMBO J, V23, P1709, DOI 10.1038/sj.emboj.7600178; RUSSEL M, 1985, P NATL ACAD SCI USA, V82, P29, DOI 10.1073/pnas.82.1.29; Smeets A, 2005, PROTEIN SCI, V14, P2610, DOI 10.1110/ps.051632905; Takahashi N, 1996, BIOCHEMISTRY-US, V35, P8342, DOI 10.1021/bi960465v; Teo H, 2004, DEV CELL, V7, P559, DOI 10.1016/j.devcel.2004.09.003; Teo HL, 2006, CELL, V125, P99, DOI 10.1016/j.cell.2006.01.047; Uson I, 1999, CURR OPIN STRUC BIOL, V9, P643, DOI 10.1016/S0959-440X(99)00020-2; Wang B, 2003, J BIOL CHEM, V278, P20225, DOI 10.1074/jbc.M300459200; Zeller T, 2006, J BACTERIOL, V188, P7689, DOI 10.1128/JB.00660-06; Zhu WL, 1996, NAT STRUCT BIOL, V3, P122, DOI 10.1038/nsb0296-122	39	13	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					34945	34951		10.1074/jbc.M704044200	http://dx.doi.org/10.1074/jbc.M704044200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17913712	hybrid			2022-12-27	WOS:000251155200038
J	Harper, DC; Theos, AC; Herman, KE; Tenza, D; Raposo, G; Marks, MS				Harper, Dawn C.; Theos, Alexander C.; Herman, Kathryn E.; Tenza, Daniele; Raposo, Graca; Marks, Michael S.			Premelanosome amyloid-like fibrils are composed of only Golgi-processed forms of Pmel17 that have been proteolytically processed in Endosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							O-LINKED GLYCOSYLATION; SILVER COAT COLOR; MONOCLONAL-ANTIBODY; MELANOSOME BIOGENESIS; MELANOCYTE LINEAGE; ENDOPLASMIC-RETICULUM; GENOMIC ORGANIZATION; ME20 ANTIGEN; CELLS; LOCALIZATION	Melanin pigments are synthesized within specialized organelles called melanosomes and polymerize on intraluminal fibrils that form within melanosome precursors. The fibrils consist of proteolytic fragments derived from Pmel17, a pigment cell-specific integral membrane protein. The intracellular pathways by which Pmel17 accesses melanosome precursors and the identity of the Pmel17 derivatives within fibrillar melanosomes have been a matter of debate. Weshow here that antibodies that detect Pmel17 within fibrillar melanosomes recognize only the luminal products of proprotein convertase cleavage and not the remaining products linked to the transmembrane domain. Moreover, antibodies to the N and C termini detect only Pmel17 isoforms present in early biosynthetic compartments, which constitute a large fraction of detectable steady state Pmel17 in cell lysates because of slow early biosynthetic transport and rapid consumption by fibril formation. Using an antibody to a luminal epitope that is destroyed upon modification by O-linked oligosaccharides, we show that all post-endoplasmic reticulum Pmel17 isoforms are modified by Golgi-associated oligosaccharide transferases, and that only processed forms contribute to melanosome biogenesis. These data indicate that Pmel17 follows a single biosynthetic route from the endoplasmic reticulum through the Golgi complex and endosomes to melanosomes, and that only fragments encompassing previously described functional luminal determinants are present within the fibrils. These data have important implications for the site and mechanism of fibril formation.	[Harper, Dawn C.; Theos, Alexander C.; Herman, Kathryn E.; Marks, Michael S.] Univ Penn, Dept Pathol & Lab Med, Sch Med, Philadelphia, PA 19104 USA; [Theos, Alexander C.] Georgetown Univ, Sch Nursing & Hlth Studies, Dept Human Sci, Washington, DC 20057 USA; [Tenza, Daniele; Raposo, Graca] Inst Curie, UMR CNRS 144, Sect Rech, F-75248 Paris, France	University of Pennsylvania; Georgetown University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite	Marks, MS (corresponding author), Univ Penn, Dept Pathol & Lab Med, Sch Med, 513 Stellar Chance Labs,422 Curie Blvd, Philadelphia, PA 19104 USA.	marksm@mail.med.upenn.edu	Marks, Michael S/Q-7223-2019	Marks, Michael S/0000-0001-7435-7262; Raposo, graca/0000-0001-9590-1298; Theos, Alexander/0000-0002-1826-8705	NATIONAL CANCER INSTITUTE [T32CA009140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048155] Funding Source: NIH RePORTER; NCI NIH HHS [T32 CA009140, T32-CA-009140] Funding Source: Medline; NIAMS NIH HHS [R01 AR048155, R01 AR048155-05A1] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ADEMA GJ, 1993, AM J PATHOL, V143, P1579; ADEMA GJ, 1994, J BIOL CHEM, V269, P20126; Bailin T, 1996, J INVEST DERMATOL, V106, P24, DOI 10.1111/1523-1747.ep12326976; Basrur V, 2003, J PROTEOME RES, V2, P69, DOI 10.1021/pr025562r; Berson JF, 2000, J BIOL CHEM, V275, P12281, DOI 10.1074/jbc.275.16.12281; Berson JF, 2003, J CELL BIOL, V161, P521, DOI 10.1083/jcb.200302072; Berson JF, 2001, MOL BIOL CELL, V12, P3451, DOI 10.1091/mbc.12.11.3451; Brunberg E, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-46; CARLSSON SR, 1993, ARCH BIOCHEM BIOPHYS, V304, P65, DOI 10.1006/abbi.1993.1322; Chiamenti AM, 1996, MELANOMA RES, V6, P291, DOI 10.1097/00008390-199608000-00003; Clark LA, 2006, P NATL ACAD SCI USA, V103, P1376, DOI 10.1073/pnas.0506940103; CUOMO M, 1991, J INVEST DERMATOL, V96, P446, DOI 10.1111/1523-1747.ep12470092; DONATIEN PD, 1995, EUR J BIOCHEM, V232, P159, DOI 10.1111/j.1432-1033.1995.tb20794.x; ESCLAMADO RM, 1986, AM J SURG, V152, P376, DOI 10.1016/0002-9610(86)90308-9; Fowler DM, 2006, PLOS BIOL, V4, P100, DOI 10.1371/journal.pbio.0040006; Fowler DM, 2007, TRENDS BIOCHEM SCI, V32, P217, DOI 10.1016/j.tibs.2007.03.003; GOWN AM, 1986, AM J PATHOL, V123, P195; Hearing VJ, 2000, PIGM CELL RES, V13, P23, DOI 10.1034/j.1600-0749.13.s8.7.x; Hoashi T, 2006, J BIOL CHEM, V281, P21198, DOI 10.1074/jbc.M601643200; KAPUR RP, 1992, J HISTOCHEM CYTOCHEM, V40, P207, DOI 10.1177/40.2.1552165; Kerje S, 2004, GENETICS, V168, P1507, DOI 10.1534/genetics.104.027995; Kim KK, 1996, PIGM CELL RES, V9, P42, DOI 10.1111/j.1600-0749.1996.tb00085.x; KINGSLEY DM, 1986, CELL, V44, P749, DOI 10.1016/0092-8674(86)90841-X; Kushimoto T, 2001, P NATL ACAD SCI USA, V98, P10698, DOI 10.1073/pnas.191184798; KWON BS, 1987, MOL BIOL MED, V4, P339; Lee ZH, 1996, J INVEST DERMATOL, V106, P605, DOI 10.1111/1523-1747.ep12345163; MARESH GA, 1994, ARCH BIOCHEM BIOPHYS, V311, P95, DOI 10.1006/abbi.1994.1213; MARESH GA, 1994, DNA CELL BIOL, V13, P87, DOI 10.1089/dna.1994.13.87; Marks MS, 2006, PIGM CELL RES, V19, P253, DOI 10.1111/j.1600-0749.2006.00309.x; MARKS MS, 1995, J CELL BIOL, V131, P351, DOI 10.1083/jcb.131.2.351; Marks MS, 2001, NAT REV MOL CELL BIO, V2, P738, DOI 10.1038/35096009; Martinez-Esparza MM, 1999, MAMM GENOME, V10, P1168, DOI 10.1007/s003359901184; MAUL GG, 1969, J ULTRA MOL STRUCT R, V26, P163, DOI 10.1016/S0022-5320(69)90042-2; Nichols SE, 2003, J INVEST DERMATOL, V121, P821, DOI 10.1046/j.1523-1747.2003.12474.x; ORLOW SJ, 1995, J INVEST DERMATOL, V105, P3, DOI 10.1111/1523-1747.ep12312291; PILLER V, 1990, J BIOL CHEM, V265, P9264; RADKA SF, 1984, HUM IMMUNOL, V10, P177, DOI 10.1016/0198-8859(84)90038-7; Raposo G, 2001, J CELL BIOL, V152, P809, DOI 10.1083/jcb.152.4.809; Reissmann M, 2007, ANIM GENET, V38, P1, DOI 10.1111/j.1365-2052.2006.01553.x; Robinson MS, 2001, CURR OPIN CELL BIOL, V13, P444, DOI 10.1016/S0955-0674(00)00235-0; Rottger S, 1998, J CELL SCI, V111, P45; Santini F, 1998, MOL BIOL CELL, V9, P1177, DOI 10.1091/mbc.9.5.1177; Schonthaler HB, 2005, DEV BIOL, V284, P421, DOI 10.1016/j.ydbio.2005.06.001; SCHWEIZER A, 1988, J CELL BIOL, V107, P1643, DOI 10.1083/jcb.107.5.1643; Setty SRG, 2007, MOL BIOL CELL, V18, P768, DOI 10.1091/mbc.E06-12-1066; Theos AC, 2006, DEV CELL, V10, P343, DOI 10.1016/j.devcel.2006.01.012; Theos AC, 2005, MOL BIOL CELL, V16, P5356, DOI 10.1091/mbc.E05-07-0626; Theos AC, 2005, PIGM CELL RES, V18, P322, DOI 10.1111/j.1600-0749.2005.00269.x; Theos AC, 2006, MOL BIOL CELL, V17, P3598, DOI 10.1091/mbc.E06-01-0081; THOMSON TM, 1985, J INVEST DERMATOL, V85, P169, DOI 10.1111/1523-1747.ep12276608; THOMSON W, 1989, J AM ACAD DERMATOL, V21, P1280, DOI 10.1016/S0190-9622(89)70344-3; Tsuboi S, 2001, BIOESSAYS, V23, P46, DOI 10.1002/1521-1878(200101)23:1<46::AID-BIES1006>3.3.CO;2-V; Valencia JC, 2006, J CELL SCI, V119, P1080, DOI 10.1242/jcs.02804; Valencia JC, 2007, J BIOL CHEM, V282, P11266, DOI 10.1074/jbc.M608449200; Valencia JC, 2006, PIGM CELL RES, V19, P250, DOI 10.1111/j.1600-0749.2006.00308.x; Van den Steen P, 1998, CRIT REV BIOCHEM MOL, V33, P151; VENNEGOOR C, 1988, AM J PATHOL, V130, P179; Wopereis S, 2006, CLIN CHEM, V52, P574, DOI 10.1373/clinchem.2005.063040; Yasumoto K, 2004, J BIOL CHEM, V279, P28330, DOI 10.1074/jbc.M401269200	59	62	65	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					2307	2322		10.1074/jbc.M708007200	http://dx.doi.org/10.1074/jbc.M708007200			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	17991747	Green Accepted, hybrid			2022-12-27	WOS:000252501000058
J	Acebron, SP; Fernandez-Saiz, V; Taneva, SG; Moro, F; Muga, A				Acebron, Sergio P.; Fernandez-Saiz, Vanesa; Taneva, Stefka G.; Moro, Fernando; Muga, Arturo			DnaJ recruits DnaK to protein aggregates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR CHAPERONE DNAK; ESCHERICHIA-COLI DNAK; FINGER-LIKE DOMAIN; SUBSTRATE-BINDING; HSP70 CHAPERONES; INTERDOMAIN COMMUNICATION; MITOCHONDRIAL HSP70; PEPTIDE BINDING; MECHANISM; SPECIFICITY	Thermal stress might lead to protein aggregation in the cell. Reactivation of protein aggregates depends on Hsp100 and Hsp70 chaperones. We focus in this study on the ability of DnaK, the bacterial representative of the Hsp70 family, to interact with different aggregated model substrates. Our data indicate that DnaK binding to large protein aggregates is mediated by DnaJ, and therefore it depends on its affinity for the cochaperone. Mutations in the structural region of DnaK known as the "latch" decrease the affinity of the chaperone for DnaJ, resulting in a defective activity as protein aggregate-removing agent. As expected, the chaperone activity is recovered when DnaJ concentration is raised to overcome the lower affinity of the mutant for the cochaperone, suggesting that a minimum number of aggregate-bound DnaK molecules is necessary for its efficient reactivation. Our results provide the first experimental evidence of DnaJ-mediated recruiting of ATP-DnaK molecules to the aggregate surface.	[Acebron, Sergio P.; Fernandez-Saiz, Vanesa; Taneva, Stefka G.; Moro, Fernando; Muga, Arturo] Univ Basque Country, Fac Ciencia & Tecnol, Dept Bioquim & Biol Mol, Unidad Biofis,CSIC,Euskal Henriko Unibertsitatea, E-48080 Bilbao, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika	Muga, A (corresponding author), Univ Basque Country, Fac Ciencia & Tecnol, Dept Bioquim & Biol Mol, Unidad Biofis,CSIC,Euskal Henriko Unibertsitatea, POB 644, E-48080 Bilbao, Spain.	arturo.muga@ehu.es	Moro Pérez, Fernando/P-3891-2015; Muga, Arturo/N-1174-2014; Fernandez, Vanesa/ABD-6688-2021	Moro Pérez, Fernando/0000-0002-3568-3388; Muga, Arturo/0000-0003-0345-6882; Fernandez-Saiz, Vanesa/0000-0002-7139-8680				ANG D, 1989, J BACTERIOL, V171, P2748, DOI 10.1128/jb.171.5.2748-2755.1989; Ben-Zvi A, 2004, J BIOL CHEM, V279, P37298, DOI 10.1074/jbc.M405627200; Ben-Zvi AP, 2001, J STRUCT BIOL, V135, P84, DOI 10.1006/jsbi.2001.4352; BUCHBERGER A, 1995, J BIOL CHEM, V270, P16903, DOI 10.1074/jbc.270.28.16903; Bukau B, 2000, CELL, V101, P119, DOI 10.1016/S0092-8674(00)80806-5; BUKAU B, 1990, EMBO J, V9, P4027, DOI 10.1002/j.1460-2075.1990.tb07624.x; Craig EA, 2006, REV PHYSIOL BIOCH P, V156, P1, DOI 10.1007/s10254-005-0001-8; De los Rios P, 2006, P NATL ACAD SCI USA, V103, P6166, DOI 10.1073/pnas.0510496103; Fan CY, 2003, CELL STRESS CHAPERON, V8, P309, DOI 10.1379/1466-1268(2003)008<0309:MFROHF>2.0.CO;2; Feifel B, 1998, J BIOL CHEM, V273, P11999, DOI 10.1074/jbc.273.20.11999; Fernandez-Saiz V, 2006, J BIOL CHEM, V281, P7479, DOI 10.1074/jbc.M512744200; Gamer J, 1996, EMBO J, V15, P607, DOI 10.1002/j.1460-2075.1996.tb00393.x; Greene MK, 1998, P NATL ACAD SCI USA, V95, P6108, DOI 10.1073/pnas.95.11.6108; Ha JH, 1997, J BIOL CHEM, V272, P27796, DOI 10.1074/jbc.272.44.27796; Han WJ, 2004, FEBS LETT, V563, P146, DOI 10.1016/S0014-5793(04)00290-X; Han WJ, 2003, J BIOL CHEM, V278, P19038, DOI 10.1074/jbc.M300756200; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hennessy F, 2005, PROTEIN SCI, V14, P1697, DOI 10.1110/ps.051406805; Horst M, 1996, PROTEIN SCI, V5, P759; Hu SM, 2002, ARCH BIOCHEM BIOPHYS, V407, P135, DOI 10.1016/S0003-9861(02)00515-5; Jiang JW, 2003, BIOCHEMISTRY-US, V42, P5748, DOI 10.1021/bi034270g; Jiang JW, 2005, MOL CELL, V20, P513, DOI 10.1016/j.molcel.2005.09.028; Karzai AW, 1996, J BIOL CHEM, V271, P11236, DOI 10.1074/jbc.271.19.11236; Kelley WL, 1999, CURR BIOL, V9, pR305, DOI 10.1016/S0960-9822(99)80185-7; Kelley WL, 1998, TRENDS BIOCHEM SCI, V23, P222, DOI 10.1016/S0968-0004(98)01215-8; Landry SJ, 2003, STRUCTURE, V11, P1465, DOI 10.1016/j.str.2003.11.012; LANGER T, 1992, NATURE, V356, P683, DOI 10.1038/356683a0; Laufen T, 1999, P NATL ACAD SCI USA, V96, P5452, DOI 10.1073/pnas.96.10.5452; Laufen T., 1998, MOL CHAPERONES PROTE, P241; Lewandowska A, 2007, J MOL BIOL, V371, P800, DOI 10.1016/j.jmb.2007.05.057; LIBEREK K, 1988, P NATL ACAD SCI USA, V85, P6632, DOI 10.1073/pnas.85.18.6632; Liu QL, 2003, SCIENCE, V300, P139, DOI 10.1126/science.1083379; Lu Z, 1998, J BIOL CHEM, V273, P5970, DOI 10.1074/jbc.273.10.5970; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Mayer MP, 1999, J MOL BIOL, V289, P1131, DOI 10.1006/jmbi.1999.2844; Mehl AF, 2001, BIOCHEM BIOPH RES CO, V282, P562, DOI 10.1006/bbrc.2001.4567; Misselwitz B, 1998, MOL CELL, V2, P593, DOI 10.1016/S1097-2765(00)80158-6; Moro F, 2006, PROTEIN SCI, V15, P223, DOI 10.1110/ps.051732706; Moro F, 2004, J BIOL CHEM, V279, P19600, DOI 10.1074/jbc.M400921200; Moro F, 2003, FEBS LETT, V533, P119, DOI 10.1016/S0014-5793(02)03752-3; Pierpaoli EV, 1998, J BIOL CHEM, V273, P6643, DOI 10.1074/jbc.273.12.6643; Qiu XB, 2006, CELL MOL LIFE SCI, V63, P2560, DOI 10.1007/s00018-006-6192-6; Rudiger S, 1997, EMBO J, V16, P1501, DOI 10.1093/emboj/16.7.1501; Rudiger S, 2001, EMBO J, V20, P1042, DOI 10.1093/emboj/20.5.1042; Schlieker C, 2004, FEBS LETT, V578, P351, DOI 10.1016/j.febslet.2004.11.051; SCHRODER H, 1993, EMBO J, V12, P4137, DOI 10.1002/j.1460-2075.1993.tb06097.x; Slepenkov SV, 2002, BIOCHEMISTRY-US, V41, P12224, DOI 10.1021/bi0263208; Suh WC, 1999, J BIOL CHEM, V274, P30534, DOI 10.1074/jbc.274.43.30534; Szabo A, 1996, EMBO J, V15, P408, DOI 10.1002/j.1460-2075.1996.tb00371.x; Tomoyasu T, 1998, MOL MICROBIOL, V30, P567, DOI 10.1046/j.1365-2958.1998.01090.x; WALL D, 1995, J BIOL CHEM, V270, P2139, DOI 10.1074/jbc.270.5.2139; WAWRZYNOW A, 1995, J BIOL CHEM, V270, P19307, DOI 10.1074/jbc.270.33.19307; Weibezahn J, 2005, BIOL CHEM, V386, P739, DOI 10.1515/BC.2005.086; Weibezahn J, 2004, CELL, V119, P653, DOI 10.1016/j.cell.2004.11.027; WOOS KM, 1992, J BIOL CHEM, V267, P20429; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606; Zietkiewicz S, 2006, J BIOL CHEM, V281, P7022, DOI 10.1074/jbc.M507893200; Zietkiewicz S, 2004, J BIOL CHEM, V279, P44376, DOI 10.1074/jbc.M402405200; ZYLICZ M, 1985, J BIOL CHEM, V260, P7591	60	39	39	3	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1381	1390		10.1074/jbc.M706189200	http://dx.doi.org/10.1074/jbc.M706189200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	17984091	hybrid			2022-12-27	WOS:000252282700021
J	Kim, SY; Seo, M; Kim, Y; Lee, YI; Oh, JM; Cho, EA; Kang, JS; Juhnn, YS				Kim, So-Young; Seo, MiRan; Kim, Yeni; Lee, Yun-Il; Oh, Jung-Min; Cho, Eun-Ah; Kang, Jae-Seung; Juhnn, Yong-Sung			Stimulatory heterotrimeric GTP-binding protein inhibits hydrogen peroxide-induced apoptosis by repressing Bak induction in SH-SY5Y human neuroblastoma cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; FENRETINIDE-INDUCED APOPTOSIS; ACTIVATED T-LYMPHOCYTES; NECROSIS-FACTOR-ALPHA; TRANSCRIPTION FACTORS; PROSTAGLANDIN E-2; OXIDATIVE STRESS; NUCLEAR-FACTOR; FAS LIGAND; EXPRESSION	Heterotrimeric stimulatory GTP-binding protein (Gs) stimulates adenylate cyclases to activate the cAMP signaling pathway. Although the cAMP pathway has been reported to be involved in apoptosis, the role of the G(s)-cAMP signaling pathway during reactive oxygen species (ROS)-mediated apoptosis, which is involved in the resistance of cancer cells to chemotherapy and radiation, is not clearly understood. Thus, in this study we aimed to investigate the role of the alpha subunit of G(s) (G alpha(s)) in the ROS-induced apoptosis of cancer cells. The stable expression of constitutively active G alpha(s)(G alpha(s)QL) inhibited the hydrogen peroxide-induced apoptosis of SH-SY5Y human neuroblastoma cells and reduced the hydrogen peroxide-induced increase in Bak and the decrease in Bcl-xL protein expression. Exogenous Bak expression abolished these inhibitory effects of G alpha(s)QL, but Bak small interfering RNA decreased hydrogen peroxide-induced apoptosis. G alpha(s) repressed hydrogen peroxide-induced Bak expression by inhibiting the transcription of Bak mRNA, which resulted from the inhibition of the hydrogen peroxide-induced activation of transcription factors such as AP1, NF-kappa B, and NFAT. Moreover, G alpha(s) also inhibited the hydrogen peroxide-induced binding of AP1, NF-kappa B, and NFAT to the Bak promoter. Furthermore, hydrogen peroxide-induced apoptosis was reduced by treating cells with prostaglandin E-2, which activates G alpha(s), but this was augmented by CCPA, which activates G alpha(i) causing a decrease in cAMP levels. From the results, we conclude that G alpha(s) protects neuroblastoma cells from hydrogen peroxide-induced apoptosis by repressing Bak induction, which is mediated by the inhibition of the hydrogen peroxide-induced activations of AP1, NF-kappa B, and NFAT through cAMP-PKA-CREB signaling system.	[Kim, So-Young; Seo, MiRan; Kim, Yeni; Lee, Yun-Il; Oh, Jung-Min; Cho, Eun-Ah; Juhnn, Yong-Sung] Seoul Natl Univ, Coll Med, Dept Biochem & Mol Biol, Canc Res Inst, Seoul 110799, South Korea; [Kang, Jae-Seung] Inha Univ, Coll Med, Dept Microbiol, Inchon 402751, South Korea	Seoul National University (SNU); Inha University	Juhnn, YS (corresponding author), Seoul Natl Univ, Coll Med, Dept Biochem & Mol Biol, Canc Res Inst, 28 Yongon Dong, Seoul 110799, South Korea.	juhnn@snu.ac.kr	Juhnn, Yong-Sung/J-2790-2012; Oh, Jung-Min/ABF-5370-2021; Kang, Jae Seung/J-5363-2012	Oh, Jung-Min/0000-0003-0385-7168; 				Adams JW, 2001, ONCOGENE, V20, P1626, DOI 10.1038/sj.onc.1204275; Ahn YH, 2000, J NEUROSCI RES, V61, P508, DOI 10.1002/1097-4547(20000901)61:5<508::AID-JNR5>3.0.CO;2-V; Ballare E, 1998, J CLIN ENDOCR METAB, V83, P4386, DOI 10.1210/jc.83.12.4386; Bourne HR, 1997, CURR OPIN CELL BIOL, V9, P134, DOI 10.1016/S0955-0674(97)80054-3; BURDON RH, 1990, FREE RADICAL RES COM, V11, P65, DOI 10.3109/10715769009109669; CHITTENDEN T, 1995, NATURE, V374, P733, DOI 10.1038/374733a0; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Chow CW, 2000, MOL CELL BIOL, V20, P702, DOI 10.1128/MCB.20.2.702-712.2000; COLLART FR, 1995, RADIAT RES, V142, P188, DOI 10.2307/3579028; COLLART MA, 1990, MOL CELL BIOL, V10, P1498, DOI 10.1128/MCB.10.4.1498; Crabtree GR, 1999, CELL, V96, P611, DOI 10.1016/S0092-8674(00)80571-1; Delgado M, 2001, J IMMUNOL, V166, P1028, DOI 10.4049/jimmunol.166.2.1028; Eliseev RA, 2004, J BIOL CHEM, V279, P46748, DOI 10.1074/jbc.M406217200; Farmer P, 2000, AM J PHYSIOL-LUNG C, V279, pL675, DOI 10.1152/ajplung.2000.279.4.L675; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Gorman A, 1997, FEBS LETT, V404, P27, DOI 10.1016/S0014-5793(97)00069-0; Hata AN, 2004, PHARMACOL THERAPEUT, V103, P147, DOI 10.1016/j.pharmthera.2004.06.003; Hewson QDC, 2005, APOPTOSIS, V10, P493, DOI 10.1007/s10495-005-1878-z; Holla VR, 2006, J BIOL CHEM, V281, P2676, DOI 10.1074/jbc.M507752200; Hongisto V, 2003, MOL CELL BIOL, V23, P6027, DOI 10.1128/MCB.23.17.6027-6036.2003; Hull MA, 2004, MOL CANCER THER, V3, P1031; HYRIEN O, 1989, NUCLEIC ACIDS RES, V17, P9557, DOI 10.1093/nar/17.23.9557; Jacobson KA, 2006, NAT REV DRUG DISCOV, V5, P247, DOI 10.1038/nrd1983; Jang IS, 2001, EXP MOL MED, V33, P37, DOI 10.1038/emm.2001.8; Jin HO, 2006, J CELL PHYSIOL, V206, P477, DOI 10.1002/jcp.20488; Kamata H, 1996, NEUROSCI LETT, V212, P179, DOI 10.1016/0304-3940(96)12806-8; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Lewerenz J, 2003, J NEUROCHEM, V87, P522, DOI 10.1046/j.1471-4159.2003.02019.x; Li MT, 2000, MOL CELL BIOL, V20, P9356, DOI 10.1128/MCB.20.24.9356-9363.2000; Li XH, 1996, J NEUROSCI, V16, P5914; Lizcano JM, 2000, BIOCHEM J, V349, P547, DOI 10.1042/bj3490547; Lovat PE, 2003, CANCER RES, V63, P7310; McCudden CR, 2005, CELL MOL LIFE SCI, V62, P551, DOI 10.1007/s00018-004-4462-3; Mills GB, 2003, NAT REV CANCER, V3, P582, DOI 10.1038/nrc1143; Nicco C, 2005, BIOMED PHARMACOTHER, V59, P169, DOI 10.1016/j.biopha.2005.03.009; Parry GCN, 1997, J IMMUNOL, V159, P5450; Pelicano H, 2004, DRUG RESIST UPDATE, V7, P97, DOI 10.1016/j.drup.2004.01.004; Pohland T, 2006, ANTI-CANCER DRUG, V17, P471; Radhika V, 2001, ONCOGENE, V20, P1607, DOI 10.1038/sj.onc.1204274; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; RAO GN, 1993, NUCLEIC ACIDS RES, V21, P1259, DOI 10.1093/nar/21.5.1259; RICHTER C, 1995, BBA-MOL BASIS DIS, V1271, P67, DOI 10.1016/0925-4439(95)00012-S; Ryan KM, 2000, NATURE, V404, P892, DOI 10.1038/35009130; SATRIANO J, 1994, J CLIN INVEST, V94, P1629, DOI 10.1172/JCI117505; Schoemaker MH, 2002, J HEPATOL, V36, P742, DOI 10.1016/S0168-8278(02)00063-6; Seo MR, 2004, J BIOL CHEM, V279, P17366, DOI 10.1074/jbc.M312442200; Sheng HM, 1998, CANCER RES, V58, P362; Srivastava RK, 1999, J EXP MED, V190, P253, DOI 10.1084/jem.190.2.253; Suzuki Y, 1998, FEBS LETT, V425, P209, DOI 10.1016/S0014-5793(98)00228-2; Vollgraf U, 1999, J NEUROCHEM, V73, P2501, DOI 10.1046/j.1471-4159.1999.0732501.x; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; WU HY, 1994, J BIOL CHEM, V269, P20067; Yano T, 2005, AM J PATHOL, V166, P1333, DOI 10.1016/S0002-9440(10)62352-8; ZAMZAMI N, 1995, J EXP MED, V182, P367, DOI 10.1084/jem.182.2.367	55	25	26	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1350	1361		10.1074/jbc.M702344200	http://dx.doi.org/10.1074/jbc.M702344200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	17991745	hybrid			2022-12-27	WOS:000252282700018
J	Infante, RE; Radhakrishnan, A; Abi-Mosleh, L; Kinch, LN; Wang, ML; Grishin, NV; Goldstein, JL; Brown, MS				Infante, Rodney E.; Radhakrishnan, Arun; Abi-Mosleh, Lina; Kinch, Lisa N.; Wang, Michael L.; Grishin, Nick V.; Goldstein, Joseph L.; Brown, Michael S.			Purified NPC1 protein - II. Localization of sterol binding to a 240-amino acid soluble luminal loop	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; CLEAVAGE-ACTIVATING PROTEIN; HAMSTER OVARY CELLS; PICK C1 PROTEIN; SENSING DOMAIN; CHOLESTEROL HOMEOSTASIS; C2 DISEASE; ENDOPLASMIC-RETICULUM; DEFICIENT; MEMBRANE	Defects in Niemann-Pick, Type C-1 protein (NPC1) cause cholesterol, sphingolipids, phospholipids, and glycolipids to accumulate in lysosomes of liver, spleen, and brain. In cultured fibroblasts, NPC1 deficiency causes lysosomal retention of lipoprotein-derived cholesterol after uptake by receptor-mediated endocytosis. NPC1 contains 1278 amino acids that form 13 membrane-spanning helices and three large loops that project into the lumen of lysosomes. We showed earlier that NPC1 binds cholesterol and oxysterols. Here we localize the binding site to luminal loop-1, a 240-amino acid domain with 18 cysteines. When produced in cultured cells, luminal loop-1 was secreted as a soluble dimer. This loop bound [H-3] cholesterol (K-d, 130 nM) and [H-3] 25-hydroxycholesterol (25- HC, K-d, 10 nM) with one sterol binding site per dimer. Binding of both sterols was competed by oxysterols (24-, 25-, and 27-HC). Unlabeled cholesterol competed strongly for binding of [H-3] cholesterol, but weakly for [H-3] 25- HC binding. Binding of [ 3H] cholesterol but not [H-3] 25- HC was inhibited by detergents. We also studied NPC2, a soluble protein whose deficiency causes a similar disease phenotype. NPC2 bound cholesterol, but not oxysterols. Epicholesterol and cholesteryl sulfate competed for [H-3] cholesterol binding to NPC2, but not NPC1. Glutamine 79 in luminal loop-1 of NPC-1 is important for sterol binding; a Q79A mutation abolished binding of [H-3] cholesterol and [H-3] 25- HC to full-length NPC1. Nevertheless, the Q79A mutant restored cholesterol transport to NPC1-deficient Chinese hamster ovary cells. Thus, the sterol binding site on luminal loop-1 is not essential for NPC1 function in fibroblasts, but it may function in other cells where NPC1 deficiency produces more complicated lipid abnormalities.	[Infante, Rodney E.; Radhakrishnan, Arun; Abi-Mosleh, Lina; Wang, Michael L.; Goldstein, Joseph L.; Brown, Michael S.] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Grishin, Nick V.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Kinch, Lisa N.; Grishin, Nick V.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Goldstein, JL (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Genet, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	joe.goldstein@utsouthwestern.edu; mike.brown@utsouthwestern.edu	Radhakrishnan, Arun/Q-7437-2019; Radhakrishnan, Arun/R-8440-2019; Infante, Rodney/ABG-7756-2020	Radhakrishnan, Arun/0000-0002-7266-7336; Radhakrishnan, Arun/0000-0001-8972-7086; Infante, Rodney/0000-0003-2605-822X; Kinch, Lisa/0000-0003-3041-2615	NHLBI NIH HHS [HL20948] Funding Source: Medline; NIGMS NIH HHS [5T32 GM08014, GM67165] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067165, T32GM008014] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams CM, 2004, J BIOL CHEM, V279, P52772, DOI 10.1074/jbc.M410302200; BRADY RO, 1978, ANNU REV BIOCHEM, V47, P687, DOI 10.1146/annurev.bi.47.070178.003351; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; CADIGAN KM, 1988, J BIOL CHEM, V263, P274; Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228; CHANG CCY, 1993, J BIOL CHEM, V268, P20747; CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027; Cheruku SR, 2006, J BIOL CHEM, V281, P31594, DOI 10.1074/jbc.M602765200; Chikh K, 2004, MOL GENET METAB, V83, P220, DOI 10.1016/j.ymgme.2004.06.013; DAHL NK, 1992, J BIOL CHEM, V267, P4889; Davies JP, 2000, J BIOL CHEM, V275, P24367, DOI 10.1074/jbc.M002184200; Fisher LE, 2003, BIOPHYS J, V85, P3097, DOI 10.1016/S0006-3495(03)74728-6; Friedland N, 2003, P NATL ACAD SCI USA, V100, P2512, DOI 10.1073/pnas.0437840100; Frolov A, 2003, J BIOL CHEM, V278, P25517, DOI 10.1074/jbc.M302588200; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; Goldstein JL, 2001, SCIENCE, V292, P1310, DOI 10.1126/science.1061815; Hua XX, 1996, J BIOL CHEM, V271, P10379, DOI 10.1074/jbc.271.17.10379; Infante RE, 2008, J BIOL CHEM, V283, P1052, DOI 10.1074/jbc.M707943200; Ko DC, 2003, P NATL ACAD SCI USA, V100, P2518, DOI 10.1073/pnas.0530027100; Kolter T, 2006, BBA-BIOMEMBRANES, V1758, P2057, DOI 10.1016/j.bbamem.2006.05.027; Liou HL, 2006, J BIOL CHEM, V281, P36710, DOI 10.1074/jbc.M608743200; LISCUM L, 1987, J BIOL CHEM, V262, P17002; Loftus SK, 1997, SCIENCE, V277, P232, DOI 10.1126/science.277.5323.232; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Millard EE, 2005, J BIOL CHEM, V280, P28581, DOI 10.1074/jbc.M414024200; Naureckiene S, 2000, SCIENCE, V290, P2298, DOI 10.1126/science.290.5500.2298; Nohturfft A, 1998, P NATL ACAD SCI USA, V95, P12848, DOI 10.1073/pnas.95.22.12848; Ohgami N, 2004, P NATL ACAD SCI USA, V101, P12473, DOI 10.1073/pnas.0405255101; Okamura N, 1999, BBA-MOL CELL BIOL L, V1438, P377, DOI 10.1016/S1388-1981(99)00070-0; Pentchev P. G., 1995, METABOLIC MOL BASES, P2625; Pentchev PG, 2004, BBA-MOL CELL BIOL L, V1685, P3, DOI 10.1016/j.bbalip.2004.08.005; Radhakrishnan A, 2004, MOL CELL, V15, P259, DOI 10.1016/j.molcel.2004.06.019; Radhakrishnan A, 2007, P NATL ACAD SCI USA, V104, P6511, DOI 10.1073/pnas.0700899104; Scott C, 2004, BBA-MOL CELL BIOL L, V1685, P8, DOI 10.1016/j.bbalip.2004.08.006; Sleat DE, 2004, P NATL ACAD SCI USA, V101, P5886, DOI 10.1073/pnas.0308456101; TINOCO I, 1963, J CHEM PHYS, V38, P1117; VANDRIEL IR, 1987, J BIOL CHEM, V262, P17443; Vanier MT, 2003, CLIN GENET, V64, P269, DOI 10.1034/j.1399-0004.2003.00147.x; Watari H, 1999, J BIOL CHEM, V274, P21861, DOI 10.1074/jbc.274.31.21861; Xie CL, 2000, J NEUROPATH EXP NEUR, V59, P1106, DOI 10.1093/jnen/59.12.1106; Xu S, 2007, J BIOL CHEM, V282, P23525, DOI 10.1074/jbc.M703848200	42	179	180	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					1064	1075		10.1074/jbc.M707944200	http://dx.doi.org/10.1074/jbc.M707944200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	17989072	hybrid			2022-12-27	WOS:000252128100046
J	Kennedy, EJ; Ghosh, G; Pillus, L				Kennedy, Eileen J.; Ghosh, Gourisankar; Pillus, Lorraine			Identification of functionally distinct regions that mediate biological activity of the protein kinase a homolog Tpk2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; CATALYTIC SUBUNITS; CRYSTAL-STRUCTURE; TYROSINE KINASE; BCR-ABL; SUBSTRATE; YEAST; MECHANISMS; RESISTANCE; INHIBITION	Kinases regulate key signaling processes that are increasingly implicated in development and disease. Kinase modulators have become important therapeutic tools and often target catalytic domains that are among the most structurally and functionally conserved regions of these enzymes. Such therapies lose efficacy as mutations conferring resistance arise. Because interactions between distinct and often distant regions of kinases can be critical, we took an unbiased genetic approach to identify sites within the protein kinase A homolog Tpk2 that contribute to its biological activity. Because many of these map outside the conserved core, this approach should be broadly useful in identifying new, more kinase-specific therapeutic targets.	[Kennedy, Eileen J.; Ghosh, Gourisankar] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Pillus, Lorraine] Univ Calif San Diego, Div Biol Sci, Mol Biol Sect, La Jolla, CA 92093 USA; [Pillus, Lorraine] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Ghosh, G (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, 9500 Gilman dr,MC 0375, La Jolla, CA 92093 USA.	gghosh@ucsd.edu; lpillus@ucsd.edu		Kennedy, Eileen/0000-0001-5610-1677				Adams JA, 2001, CHEM REV, V101, P2271, DOI 10.1021/cr000230w; Akamine P, 2003, J MOL BIOL, V327, P159, DOI 10.1016/S0022-2836(02)01446-8; Amberg DC., 2005, METHODS YEAST GENETI; Arena S, 2005, CELL MOL LIFE SCI, V62, P2092, DOI 10.1007/s00018-005-5205-1; Bockmuhl DP, 2001, MOL MICROBIOL, V42, P1243, DOI 10.1046/j.1365-2958.2001.02688.x; Bode AM, 2005, PROG NUCLEIC ACID RE, V79, P237, DOI 10.1016/S0079-6603(04)79005-4; Bolte M, 2003, MICROBIOL-SGM, V149, P1205, DOI 10.1099/mic.0.26062-0; Budovskaya YV, 2005, P NATL ACAD SCI USA, V102, P13933, DOI 10.1073/pnas.0501046102; CAMERON S, 1988, CELL, V53, P555, DOI 10.1016/0092-8674(88)90572-7; Carter TA, 2005, P NATL ACAD SCI USA, V102, P11011, DOI 10.1073/pnas.0504952102; Conlan RS, 2001, J MOL BIOL, V309, P1007, DOI 10.1006/jmbi.2001.4742; Deininger Michael, 2005, J Natl Compr Canc Netw, V3, P757; Deminoff SJ, 2006, GENETICS, V173, P1909, DOI 10.1534/genetics.106.059238; DENIS CL, 1991, J BIOL CHEM, V266, P17932; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; GIBBS CS, 1991, J BIOL CHEM, V266, P8923; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Hampsey M, 1997, YEAST, V13, P1099, DOI 10.1002/(SICI)1097-0061(19970930)13:12<1099::AID-YEA177>3.3.CO;2-Z; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; HANKS SK, 1991, METHOD ENZYMOL A, V200, P38, DOI 10.1016/0076-6879(91)00126-H; Herberg FW, 1999, BIOCHEMISTRY-US, V38, P6352, DOI 10.1021/bi982672w; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hubbard SR, 1997, EMBO J, V16, P5572, DOI 10.1093/emboj/16.18.5572; Iyer GH, 2005, J MOL BIOL, V351, P1110, DOI 10.1016/j.jmb.2005.06.011; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; JOHNSON KE, 1987, J BIOL CHEM, V262, P8636; Kannan N, 2007, P NATL ACAD SCI USA, V104, P1272, DOI 10.1073/pnas.0610251104; KEMP BE, 1977, J BIOL CHEM, V252, P4888; Kim C, 2005, SCIENCE, V307, P690, DOI 10.1126/science.1104607; KNIGHTON DR, 1991, SCIENCE, V253, P414, DOI 10.1126/science.1862343; Madhusudan, 2002, NAT STRUCT BIOL, V9, P273, DOI 10.1038/nsb780; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Morris HR, 2005, ANN MED, V37, P86, DOI 10.1080/07853890510007269; Niswender CM, 2002, J BIOL CHEM, V277, P28916, DOI 10.1074/jbc.M203327200; Pan XW, 2002, MOL CELL BIOL, V22, P3981, DOI 10.1128/MCB.22.12.3981-3993.2002; Pan XW, 1999, MOL CELL BIOL, V19, P4874; Pricl S, 2005, MOL CANCER THER, V4, P1167, DOI 10.1158/1535-7163.MCT-05-0101; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Robertson LS, 2000, P NATL ACAD SCI USA, V97, P5984, DOI 10.1073/pnas.100113397; Robertson LS, 1998, P NATL ACAD SCI USA, V95, P13783, DOI 10.1073/pnas.95.23.13783; Rosati S, 2005, CURR TOP MICROBIOL, V294, P91; Rubenstein EM, 2007, EUKARYOT CELL, V6, P571, DOI 10.1128/EC.00026-07; Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X; Shaltiel S, 1998, P NATL ACAD SCI USA, V95, P484, DOI 10.1073/pnas.95.2.484; SIKORSKI RS, 1995, GENE, V155, P51, DOI 10.1016/0378-1119(94)00915-F; Smith CM, 1999, PROG BIOPHYS MOL BIO, V71, P313, DOI 10.1016/S0079-6107(98)00059-5; Suel GM, 2003, NAT STRUCT BIOL, V10, P59, DOI 10.1038/nsb881; Taylor SS, 2005, BBA-PROTEINS PROTEOM, V1754, P25, DOI 10.1016/j.bbapap.2005.08.024; Taylor SS, 2004, BBA-PROTEINS PROTEOM, V1697, P259, DOI 10.1016/j.bbapap.2003.11.029; TODA T, 1987, CELL, V50, P277, DOI 10.1016/0092-8674(87)90223-6; VERON M, 1993, P NATL ACAD SCI USA, V90, P10618, DOI 10.1073/pnas.90.22.10618; WICHERT VG, 2005, Z GASTROENTEROL, V43, P1329; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wrobleski ST, 2005, CURR TOP MED CHEM, V5, P1005, DOI 10.2174/1568026054985894; Zahringer H, 1998, EUR J BIOCHEM, V255, P544, DOI 10.1046/j.1432-1327.1998.2550544.x; ZHENG JH, 1993, BIOCHEMISTRY-US, V32, P2154, DOI 10.1021/bi00060a005; ZOLLER MJ, 1991, GENE, V99, P171, DOI 10.1016/0378-1119(91)90124-T	58	5	5	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					1084	1093		10.1074/jbc.M704028200	http://dx.doi.org/10.1074/jbc.M704028200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	17971450	hybrid			2022-12-27	WOS:000252128100048
J	Page, RM; Baumann, K; Tomioka, M; Perez-Revuelta, BI; Fukumori, A; Jacobsen, H; Flohr, A; Luebbers, T; Ozmen, L; Steiner, H; Haass, C				Page, Richard M.; Baumann, Karlheinz; Tomioka, Masanori; Perez-Revuelta, Blanca I.; Fukumori, Akio; Jacobsen, Helmut; Flohr, Alexander; Luebbers, Thomas; Ozmen, Laurence; Steiner, Harald; Haass, Christian			Generation of A beta(38) and A beta(42) is independently and differentially affected by familial Alzheimer disease-associated presenilin mutations and gamma-secretase modulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; AMYLOID PRECURSOR PROTEIN; IN-VIVO; BETA-PEPTIDE; A-BETA-42; INHIBITOR; DEPOSITION; ENDOPROTEOLYSIS; CONFORMATION; MRK-560	Alzheimer disease amyloid beta-peptide ( A beta) is generated via proteolytic processing of the beta-amyloid precursor protein by beta-and gamma-secretase. gamma-Secretase can be blocked by selective inhibitors but can also be modulated by a subset of non-steroidal anti-inflammatory drugs, including sulindac sulfide. These drugs selectively reduce the generation of the aggregation-prone 42-amino acid A beta(42) and concomitantly increase the levels of the rather benign A beta(38). Here we show that A beta(42) and A beta(38) generation occur independently from each other. The amount of A beta(42) produced by cells expressing 10 different familial Alzheimer disease (FAD)-associated mutations in presenilin (PS) 1, the catalytic subunit of gamma-secretase, appeared to correlate with the respective age of onset in patients. However, A beta(38) levels did not show a negative correlation with the age of onset. Modulation of gamma-secretase activity by sulindac sulfide reduced A beta(42) in the case of wild type PS1 and two FAD-associated PS1 mutations (M146L and A285V). The remaining eight PS1 FAD mutants showed either no reduction of A beta(42) or only rather subtle effects. Strikingly, even the mutations that showed no effect on A beta(42) levels allowed a robust increase of A beta(38) upon treatment with sulindac sulfide. Similar observations were made for fenofibrate, a compound known to increase A beta(42) and to decrease A beta(38). For mutants that predominantly produce A beta(42), the ability of fenofibrate to further increase A beta(42) levels became diminished, whereas A beta(38) levels were altered to varying extents for all mutants analyzed. Thus, we conclude that A beta(38) and A beta(42) production do not depend on each other. Using an independent non-steroidal anti-inflammatory drug derivative, we obtained similar results for PS1 as well as for PS2. These in vitro results were confirmed by in vivo experiments in transgenic mice expressing the PS2 N141I FAD mutant. Our findings therefore have strong implications on the selection of transgenic mouse models used for screening of the A beta(42)-lowering capacity of gamma-secretase modulators. Furthermore, human patients with certain PS mutations may not respond to gamma-secretase modulators.	[Baumann, Karlheinz; Jacobsen, Helmut; Flohr, Alexander; Luebbers, Thomas; Ozmen, Laurence] F Hoffmann La Roche & Co Ltd, Div Pharmaceut, Preclin CNS Res, CH-4070 Basel, Switzerland; [Page, Richard M.; Tomioka, Masanori; Perez-Revuelta, Blanca I.; Fukumori, Akio; Steiner, Harald; Haass, Christian] Univ Munich, Lab Neurodegenerat Dis Res, Dept Biochem,Munich & Adolf Butenandt Inst, Ctr Integrated Protein Sci, D-80336 Munich, Germany	Roche Holding; University of Munich	Baumann, K (corresponding author), F Hoffmann La Roche & Co Ltd, Div Pharmaceut, Preclin CNS Res, CH-4070 Basel, Switzerland.	karlheinz.baumann@roche.com; hsteiner@med.uni-muenchen.de; chaass@med.uni-muenchen.de		Flohr, Alexander/0000-0001-6847-5780				Beher D, 2004, J BIOL CHEM, V279, P43419, DOI 10.1074/jbc.M404937200; Berezovska O, 2005, J NEUROSCI, V25, P3009, DOI 10.1523/JNEUROSCI.0364-05.2005; Best JD, 2006, J PHARMACOL EXP THER, V317, P786, DOI 10.1124/jpet.105.100271; Best JD, 2007, J PHARMACOL EXP THER, V320, P552, DOI 10.1124/jpet.106.114330; Churcher I, 2006, BIOORG MED CHEM LETT, V16, P280, DOI 10.1016/j.bmcl.2005.10.009; CHURCHER J, 2004, Patent No. 0121995; Citron M, 2004, NAT REV NEUROSCI, V5, P677, DOI 10.1038/nrn1495; Czirr E, 2007, J BIOL CHEM, V282, P24504, DOI 10.1074/jbc.M700618200; Duering M, 2005, NEUROBIOL AGING, V26, P785, DOI 10.1016/j.neurobiolaging.2004.08.002; Eriksen JL, 2003, J CLIN INVEST, V112, P440, DOI 10.1172/JCI200318162; Fraering PC, 2004, BIOCHEMISTRY-US, V43, P9774, DOI 10.1021/bi0494976; Fukumori A, 2006, BIOCHEMISTRY-US, V45, P4907, DOI 10.1021/bi052412w; Haass C, 2004, EMBO J, V23, P483, DOI 10.1038/sj.emboj.7600061; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hannam J. C., 2006, Piperidines and related compounds for treatment of Alzheimer ' s disease, Patent No. [WO2006/043064A1, 2006043064]; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hyde LA, 2005, BEHAV BRAIN RES, V160, P344, DOI 10.1016/j.bbr.2004.12.017; Kukar T, 2005, NAT MED, V11, P545, DOI 10.1038/nm1235; Lleo A, 2004, NAT MED, V10, P1065, DOI 10.1038/nm1112; Moehlmann T, 2002, P NATL ACAD SCI USA, V99, P8025, DOI 10.1073/pnas.112686799; Munter LM, 2007, EMBO J, V26, P1702, DOI 10.1038/sj.emboj.7601616; Narlawar R, 2006, J MED CHEM, V49, P7588, DOI 10.1021/jm0610200; Ozmen L, 2005, NEURODEGENER DIS, V2, P284, DOI 10.1159/000092314; PINEIRO JLC, 2004, Patent No. 0116404; Richards JG, 2003, J NEUROSCI, V23, P8989; Shirotani K, 2007, NEUROBIOL DIS, V27, P102, DOI 10.1016/j.nbd.2007.04.011; Steiner H, 2000, NAT CELL BIOL, V2, P848, DOI 10.1038/35041097; Takahashi Y, 2003, J BIOL CHEM, V278, P18664, DOI 10.1074/jbc.M301619200; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Weggen S, 2003, J BIOL CHEM, V278, P30748, DOI 10.1074/jbc.M304824200; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; Weggen S, 2003, J BIOL CHEM, V278, P31831, DOI 10.1074/jbc.M303592200; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Yan Q, 2003, J NEUROSCI, V23, P7504	34	139	147	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					677	683		10.1074/jbc.M708754200	http://dx.doi.org/10.1074/jbc.M708754200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	17962197	hybrid			2022-12-27	WOS:000252128100004
J	Zaru, R; Mollahan, P; Watts, C				Zaru, Rossana; Mollahan, Pamela; Watts, Colin			3-phosphoinositide-dependent kinase 1 deficiency perturbs toll-like receptor signaling events and actin cytoskeleton dynamics in dendritic cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VIVO ROLE; DOCKING SITE; PHOSPHOINOSITIDE 3-KINASE; GLYCOGEN-SYNTHASE; C-EPSILON; PDK1; PHOSPHORYLATION; PHAGOCYTOSIS; MACROPINOCYTOSIS; COMPLEX	The adaptive immune response depends on dendritic cell (DC) activation by microbial products that signal via pattern recognition receptors and activate mitogen-activated protein kinases, NF kappa B and PI3K. The contribution of the AGC kinase family, including protein kinase B, protein kinase C, p90kDa ribosomal S6 kinase, and S6 kinase, has been little investigated because the probable redundancy among their isoforms makes their study difficult. We took advantage of the fact that all these kinases are regulated by the upstream master kinase 3-phosphoinositide-dependent kinase 1 (PDK1). Here we analyze various properties of DC from mice expressing similar to 10% of normal PDK1 (PDK1(fl/-)). DC populations in lymphoid and nonlymphoid tissues appeared normal in PDK1(fl/-) mice, and some in vitro responses to lipopolysaccharide (LPS) such as cytokine production were normal in cultured bone marrow DC. However, LPS-induced expression of class II major histocompatibility complex and CD86 were elevated in PDK1(fl/-) BMDC and PDK1(fl/-) spleen DC produced more interleukin-10 and-12, implying an attenuating role for PDK1. Unexpectedly, PDK1(fl/-) DC had a significantly reduced capacity for LPS-stimulated macropinocytosis and phagocytosis that correlated with a lowered F-actin/G-actin ratio, apparently because of increased actin depolymerization. Several PDK1-regulated kinases, some of which feed into actin regulators, showed reduced activation in PDK1(fl/-) DC. Reintroduction of PDK1 restored S6 kinase activity, increased levels of F-actin, and boosted macropinocytosis thus linking PDK1 and its downstream effectors to the unusual phenotype of PDK1(fl/-) DC.	[Zaru, Rossana; Mollahan, Pamela; Watts, Colin] Univ Dundee, Wellcome Trust Bioctr, Div Cell Biol & Immunol, Dundee DD1 5EH, Scotland	University of Dundee	Watts, C (corresponding author), Univ Dundee, Wellcome Trust Bioctr, Div Cell Biol & Immunol, Dundee DD1 5EH, Scotland.	c.watts@dundee.ac.uk		Zaru, Rossana/0000-0002-3358-4423; Watts, Colin/0000-0001-6183-2087	Medical Research Council [G0100536] Funding Source: Medline; MRC [G0100536] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Aksoy E, 2004, INT J BIOCHEM CELL B, V36, P183, DOI 10.1016/S1357-2725(03)00210-3; Aksoy E, 2002, EUR J IMMUNOL, V32, P3040, DOI 10.1002/1521-4141(200211)32:11<3040::AID-IMMU3040>3.0.CO;2-M; Araki N, 1996, J CELL BIOL, V135, P1249, DOI 10.1083/jcb.135.5.1249; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Balendran A, 2000, FEBS LETT, V484, P217, DOI 10.1016/S0014-5793(00)02162-1; Balendran A, 2000, J BIOL CHEM, V275, P20806, DOI 10.1074/jbc.M000421200; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Biondi RM, 2002, EMBO J, V21, P4219, DOI 10.1093/emboj/cdf437; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Burns S, 2004, CELL MOTIL CYTOSKEL, V57, P118, DOI 10.1002/cm.10163; Cantrell D, 2002, SEMIN IMMUNOL, V14, P19, DOI 10.1006/smim.2001.0338; Collins BJ, 2003, EMBO J, V22, P4202, DOI 10.1093/emboj/cdg407; Dormann D, 2004, J CELL SCI, V117, P6497, DOI 10.1242/jcs.01579; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; Fairchild PJ, 2000, CURR BIOL, V10, P1515, DOI 10.1016/S0960-9822(00)00824-1; Frodin M, 2000, EMBO J, V19, P2924, DOI 10.1093/emboj/19.12.2924; Fukao T, 2002, NAT IMMUNOL, V3, P875, DOI 10.1038/ni825; Ganesan LP, 2004, J BIOL CHEM, V279, P54416, DOI 10.1074/jbc.M408188200; Goley ED, 2006, NAT REV MOL CELL BIO, V7, P713, DOI 10.1038/nrm2026; Hinton HJ, 2004, NAT IMMUNOL, V5, P539, DOI 10.1038/ni1062; King CC, 2000, J BIOL CHEM, V275, P41201, DOI 10.1074/jbc.M006553200; Komander D, 2004, EMBO J, V23, P3918, DOI 10.1038/sj.emboj.7600379; Larsen EC, 2000, J IMMUNOL, V165, P2809, DOI 10.4049/jimmunol.165.5.2809; Larsson C, 2006, CELL SIGNAL, V18, P276, DOI 10.1016/j.cellsig.2005.07.010; Lawlor MA, 2002, EMBO J, V21, P3728, DOI 10.1093/emboj/cdf387; Marshall JG, 2001, J CELL BIOL, V153, P1369, DOI 10.1083/jcb.153.7.1369; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; McManus EJ, 2004, EMBO J, V23, P2071, DOI 10.1038/sj.emboj.7600218; Mora A, 2004, SEMIN CELL DEV BIOL, V15, P161, DOI 10.1016/j.semcdb.2003.12.022; Mora A, 2005, FEBS LETT, V579, P3632, DOI 10.1016/j.febslet.2005.05.040; Mora A, 2005, BIOCHEM J, V385, P639, DOI 10.1042/BJ20041782; Moss CX, 2005, J BIOL CHEM, V280, P18498, DOI 10.1074/jbc.M501241200; Newton AC, 2003, BIOCHEM J, V370, P361, DOI 10.1042/BJ20021626; Nirula A, 2006, J EXP MED, V203, P1733, DOI 10.1084/jem.20051715; O'Neill LAJ, 2006, CURR OPIN IMMUNOL, V18, P3, DOI 10.1016/j.coi.2005.11.012; Ono S, 2007, INT REV CYTOL, V258, P1, DOI 10.1016/S0074-7696(07)58001-0; Putney LK, 2002, ANNU REV PHARMACOL, V42, P527, DOI 10.1146/annurev.pharmtox.42.092001.143801; Sousa CR, 2006, NAT REV IMMUNOL, V6, P476, DOI 10.1038/nri1845; Rodionova E, 2007, BLOOD, V109, P1584, DOI 10.1182/blood-2006-06-028951; Rupper A, 2001, MOL BIOL CELL, V12, P2813, DOI 10.1091/mbc.12.9.2813; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; Sandu C, 2006, AM J PHYSIOL-GASTR L, V291, pG868, DOI 10.1152/ajpgi.00023.2006; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Swanson JA, 2004, J LEUKOCYTE BIOL, V76, P1093, DOI 10.1189/jlb.0804439; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Tan SL, 2003, BIOCHEM J, V376, P545, DOI 10.1042/BJ20031406; Tigges U, 2003, J BIOL CHEM, V278, P23561, DOI 10.1074/jbc.M302302200; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; Vanhaesebroeck B, 2000, BIOCHEM J, V346, P561, DOI 10.1042/0264-6021:3460561; West MA, 2004, SCIENCE, V305, P1153, DOI 10.1126/science.1099153; WEST MA, 1989, J CELL BIOL, V109, P2731, DOI 10.1083/jcb.109.6.2731; West MA, 2000, CURR BIOL, V10, P839, DOI 10.1016/S0960-9822(00)00595-9; Woo MS, 2004, MOL CELL BIOL, V24, P3025, DOI 10.1128/MCB.24.7.3025-3035.2004; Zaru R, 2007, NAT IMMUNOL, V8, P1227, DOI 10.1038/ni1517	58	19	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					929	939		10.1074/jbc.M708069200	http://dx.doi.org/10.1074/jbc.M708069200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	17991746	hybrid			2022-12-27	WOS:000252128100033
J	Matsumura, T; Okamoto, K; Iwahara, SI; Hori, H; Takahashi, Y; Nishino, T; Abe, Y				Matsumura, Tomohiro; Okamoto, Ken; Iwahara, Shin-Ichiro; Hori, Hiroyuki; Takahashi, Yuriko; Nishino, Takeshi; Abe, Yasuko			Dimer-oligomer interconversion of wild-type and mutant rat 2-Cys peroxiredoxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; TRYPAREDOXIN PEROXIDASE; SUPEROXIDE-DISMUTASE; ANTIOXIDANT PROTEIN; ESCHERICHIA-COLI; UP-REGULATION; C-MYC; THIOREDOXIN; EXPRESSION; AHPC	Rat heme-binding protein 23 (HBP23)/peroxiredoxin (Prx I) belongs to the 2-Cys peroxiredoxin type I family and exhibits peroxidase activity coupled with reduced thioredoxin (Trx) as an electron donor. We analyzed the dimer-oligomer interconversion of wild-type and mutant HBP23/Prx I by gel filtration and found that the C52S and C173S mutants existed mostly as decamers, whereas the wild type was a mixture of various forms, favoring the decamer at higher protein concentration and lower ionic salt concentration and in the presence of dithiothreitol. The C83S mutant was predominantly dimeric, in agreement with a previous crystallographic analysis (Hirotsu, S., Abe, Y., Okada, K., Nagahara, N., Hori, H., Nishino, T., and Hakoshima, T.(1999) Proc. Natl. Acad. Sci. U. S. A. 96, 12333-12338). X-ray diffraction analysis of the decameric C52S mutant revealed a toroidal structure (diameter, similar to 130 angstrom; inside diameter, similar to 55 angstrom; thickness, similar to 45 angstrom). In contrast to human Prx I, which was recently reported to exist predominantly as the decamer with Cys(83)-Cys(83) disulfide bonds at all dimer-dimer interfaces, rat HBP23/Prx I has a Cys(83)-Cys(83) disulfide bond at only one dimer-dimer interface (S-S separation of similar to 2.1 angstrom), whereas the interactions at the other interfaces (mean S-S separation of 3.6 angstrom) appear to involve hydrophobic and van der Waals forces. This finding is consistent with gel filtration analyses showing that the protein readily interconverts between dimer and oligomeric forms. The C83S mutant exhibited similar peroxidase activity to the wild type, which is exclusively dimeric, in the Trx/Trx reductase system. Athigher concentrations, where the protein was mostly decameric, less efficient attack of reduced Trx was observed in a [C-14] iodoacetamide incorporation experiment. We suggest that the dimer-decamer interconversion may have a regulatory role.	[Matsumura, Tomohiro; Okamoto, Ken; Iwahara, Shin-Ichiro; Hori, Hiroyuki; Takahashi, Yuriko; Nishino, Takeshi; Abe, Yasuko] Nippon Med Sch, Dept Biochem & Mol Biol, Bunkyo Ku, Tokyo 1138602, Japan	Nippon Medical School	Abe, Y (corresponding author), Nippon Med Sch, Dept Biochem & Mol Biol, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138602, Japan.	y.abe@nms.ac.jp	Okamoto, Ken/AAC-8604-2020; Hori, Hiroyuki/AAB-3911-2021					ABE Y, 1987, ARCH BIOCHEM BIOPHYS, V253, P241, DOI 10.1016/0003-9861(87)90657-6; Alphey MS, 2000, J MOL BIOL, V300, P903, DOI 10.1006/jmbi.2000.3881; Andoh T, 2003, J BIOL CHEM, V278, P885, DOI 10.1074/jbc.M209914200; Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHAE HZ, 1994, J BIOL CHEM, V269, P27670; Chauhan R, 2001, BIOCHEM J, V354, P209, DOI 10.1042/0264-6021:3540209; Choi MH, 2005, NATURE, V435, P347, DOI 10.1038/nature03587; Egler RA, 2005, ONCOGENE, V24, P8038, DOI 10.1038/sj.onc.1208821; Georgiou G, 2003, SCIENCE, V300, P592, DOI 10.1126/science.1084976; Hirotsu S, 1999, P NATL ACAD SCI USA, V96, P12333, DOI 10.1073/pnas.96.22.12333; Hirotsu S, 1999, J STRUCT BIOL, V126, P80, DOI 10.1006/jsbi.1999.4088; Hofmann B, 2002, BIOL CHEM, V383, P347, DOI 10.1515/BC.2002.040; HOLMGREN A, 1975, P NATL ACAD SCI USA, V72, P2305, DOI 10.1073/pnas.72.6.2305; Immenschuh S, 2003, J HISTOCHEM CYTOCHEM, V51, P1621, DOI 10.1177/002215540305101206; Immenschuh S, 1999, HEPATOLOGY, V30, P118, DOI 10.1002/hep.510300142; IWAHARA S, 1995, BIOCHEMISTRY-US, V34, P13398, DOI 10.1021/bi00041a017; IYER KS, 1973, J BIOL CHEM, V248, P707; Jang HH, 2006, FEBS LETT, V580, P351, DOI 10.1016/j.febslet.2005.12.030; Jeong W, 2006, J BIOL CHEM, V281, P14400, DOI 10.1074/jbc.M511082200; Jung H, 2001, J BIOL CHEM, V276, P15504, DOI 10.1074/jbc.M009620200; KALEBIC T, 1991, P NATL ACAD SCI USA, V88, P986, DOI 10.1073/pnas.88.3.986; KALLIS GB, 1980, J BIOL CHEM, V255, P261; Kato M, 2006, HISTOL HISTOPATHOL, V21, P729, DOI 10.14670/HH-21.729; Kato S, 2005, ACTA NEUROPATHOL, V110, P101, DOI 10.1007/s00401-005-1019-3; KATTI SK, 1990, J MOL BIOL, V212, P167, DOI 10.1016/0022-2836(90)90313-B; Kissinger CR, 1999, ACTA CRYSTALLOGR D, V55, P484, DOI 10.1107/S0907444998012517; Kitano K, 1999, J BIOCHEM, V126, P313, DOI 10.1093/oxfordjournals.jbchem.a022451; Kitano K, 2005, PROTEINS, V59, P644, DOI 10.1002/prot.20412; Konig J, 2003, J BIOL CHEM, V278, P24409, DOI 10.1074/jbc.M301145200; Koo KH, 2002, ARCH BIOCHEM BIOPHYS, V397, P312, DOI 10.1006/abbi.2001.2700; Kristensen P, 1999, BIOCHEM BIOPH RES CO, V262, P127, DOI 10.1006/bbrc.1999.1107; LAEMMLI UK, 1973, J MOL BIOL, V80, P575, DOI 10.1016/0022-2836(73)90198-8; Lee WS, 2007, J BIOL CHEM, V282, P22011, DOI 10.1074/jbc.M610330200; Lillig CH, 2007, ANTIOXID REDOX SIGN, V9, P25, DOI 10.1089/ars.2007.9.25; Matsumoto A, 1999, FEBS LETT, V443, P246, DOI 10.1016/S0014-5793(98)01736-0; Montemartini M, 1999, EUR J BIOCHEM, V264, P516, DOI 10.1046/j.1432-1327.1999.00656.x; Mu ZM, 2002, J BIOL CHEM, V277, P43175, DOI 10.1074/jbc.M206066200; Nagahara N, 2007, J BIOL CHEM, V282, P1561, DOI 10.1074/jbc.M605931200; Nakamura H, 1996, INT IMMUNOL, V8, P603, DOI 10.1093/intimm/8.4.603; Neumann CA, 2003, NATURE, V424, P561, DOI 10.1038/nature01819; Parsonage D, 2005, BIOCHEMISTRY-US, V44, P10583, DOI 10.1021/bi050448i; SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x; Schroder E, 2000, STRUCTURE, V8, P605, DOI 10.1016/S0969-2126(00)00147-7; Uwayama J, 2006, BIOCHEM BIOPH RES CO, V339, P226, DOI 10.1016/j.bbrc.2005.10.192; Wen ST, 1997, GENE DEV, V11, P2456, DOI 10.1101/gad.11.19.2456; Wood ZA, 2002, BIOCHEMISTRY-US, V41, P5493, DOI 10.1021/bi012173m	47	58	58	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					284	293		10.1074/jbc.M705753200	http://dx.doi.org/10.1074/jbc.M705753200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17974571	hybrid			2022-12-27	WOS:000251940300032
J	Darnell, GA; Schroder, WA; Antalis, TM; Lambley, E; Major, L; Gardner, J; Birrell, G; Cid-Arregui, A; Suhrbier, A				Darnell, Grant A.; Schroder, Wayne A.; Antalis, Toni M.; Lambley, Eleanore; Major, Lee; Gardner, Joy; Birrell, Geoff; Cid-Arregui, Angel; Suhrbier, Andreas			Human Papillomavirus E7 requires the protease calpain to degrade the retinoblastoma protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-16; CERVICAL-CANCER CELLS; RNA INTERFERENCE; TUMOR-SUPPRESSOR; E7 PROTEIN; HELA-CELLS; ACTIVATION; MECHANISMS; INHIBITION; EXPRESSION	Cervical cancers transformed by high risk human papilloma virus (HPV) express the E7 oncoprotein, which accelerates the degradation of the retinoblastoma protein (Rb). Here we show that the E7-mediated degradation of Rb requires the calcium-activated cysteine protease, calpain. E7 bound and activated mu-calpain and promoted cleavage at Rb-810, with mutation of this residue preventing E7-mediated degradation. The calpain cleavage product, Rb1-810, was unable to mediate cell cycle arrest but retained the ability to repress E6/E7 transcription. E7 also promoted the accelerated proteasomal degradation of Rb1-810. Calpain inhibitors reduced the viability of HPV-transformed cells and synergized with cisplatin. Calpain, thus, emerges as a central player in E7-mediated degradation of Rb and represents a potential new drug target for the treatment of HPV-associated lesions.	[Darnell, Grant A.; Schroder, Wayne A.; Lambley, Eleanore; Major, Lee; Gardner, Joy; Suhrbier, Andreas] Queensland Inst Med Res, Immunovirol Lab, Brisbane, Qld 4029, Australia; [Antalis, Toni M.] Univ Maryland, Sch Med, Ctr Vasc Biol & Inflammat Dis, Dept Physiol, Baltimore, MD 21201 USA; [Birrell, Geoff] Queensland Inst Med Res, Radiat Biol & Oncol Lab, Brisbane, Qld 4029, Australia; [Cid-Arregui, Angel] Deutsch Krebsforschungszentrum, D-69012 Heidelberg, Germany	QIMR Berghofer Medical Research Institute; University System of Maryland; University of Maryland Baltimore; QIMR Berghofer Medical Research Institute; Helmholtz Association; German Cancer Research Center (DKFZ)	Suhrbier, A (corresponding author), Royal Brisbane Hosp, Queensland Inst Med Res, Brisbane, Qld 4029, Australia.	Suhrbier@qimr.edu.au	Cid-Arregui, Angel/ABC-5812-2021; Cid-Arregui, Angel/AAP-5299-2020	Cid-Arregui, Angel/0000-0003-1433-2922; Suhrbier, Andreas/0000-0001-8986-9025; Birrell, Geoff/0000-0002-6593-1514	NATIONAL CANCER INSTITUTE [R01CA098369, P30CA134274] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA134274, R01 CA098369] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Antalis TM, 1998, J EXP MED, V187, P1799, DOI 10.1084/jem.187.11.1799; Arthur JSC, 2000, MOL CELL BIOL, V20, P4474, DOI 10.1128/MCB.20.12.4474-4481.2000; Banerjee NS, 2006, J VIROL, V80, P6517, DOI 10.1128/JVI.02499-05; Boyer SN, 1996, CANCER RES, V56, P4620; Carragher NO, 2006, CURR PHARM DESIGN, V12, P615, DOI 10.2174/138161206775474314; Chen PL, 1996, P NATL ACAD SCI USA, V93, P465, DOI 10.1073/pnas.93.1.465; Cid-Arregui A, 2003, J VIROL, V77, P4928, DOI 10.1128/JVI.77.8.4928-4937.2003; Darnell GA, 2005, J VIROL, V79, P4246, DOI 10.1128/JVI.79.7.4246-4256.2005; Darnell GA, 2003, MOL CELL BIOL, V23, P6520, DOI 10.1128/MCB.23.18.6520-6532.2003; Downing S, 2003, MOL CARCINOGEN, V38, P130, DOI 10.1002/mc.10154; duPont Nefertiti C, 2006, Clin Adv Hematol Oncol, V4, P279; DYSON N, 1989, SCIENCE, V243, P934, DOI 10.1126/science.2537532; Fernandez-Montalvan A, 2006, BIOL CHEM, V387, P617, DOI 10.1515/BC.2006.079; Frolov MV, 2004, J CELL SCI, V117, P2173, DOI 10.1242/jcs.01227; Garnett GP, 2006, VACCINE, V24, P178, DOI 10.1016/j.vaccine.2006.05.116; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Gonzalez SL, 2001, J VIROL, V75, P7583, DOI 10.1128/JVI.75.16.7583-7591.2001; Guan N, 2006, INT J ONCOL, V29, P655; Hall AHS, 2003, J VIROL, V77, P6066, DOI 10.1128/JVI.77.10.6066-6069.2003; Hebner CM, 2006, REV MED VIROL, V16, P83, DOI 10.1002/rmv.488; Helt AM, 2003, CARCINOGENESIS, V24, P159, DOI 10.1093/carcin/24.2.159; Jang JS, 1999, INT J MOL MED, V4, P487; Kubbutat MHG, 1997, MOL CELL BIOL, V17, P460, DOI 10.1128/MCB.17.1.460; Liu X, 2006, J BIOL CHEM, V281, P578, DOI 10.1074/jbc.M508455200; Longworth MS, 2004, MICROBIOL MOL BIOL R, V68, P362, DOI 10.1128/MMBR.68.2.362-372.2004; Lowy DR, 2006, J CLIN INVEST, V116, P1167, DOI 10.1172/JCI28607; Mailhes John B, 2002, Cell Chromosome, V1, P2, DOI 10.1186/1475-9268-1-2; Munger K, 2002, VIRUS RES, V89, P213, DOI 10.1016/S0168-1702(02)00190-9; Niu XY, 2006, INT J GYNECOL CANCER, V16, P743, DOI 10.1111/j.1525-1438.2006.00384.x; Postovit LM, 2002, BIOCHEM BIOPH RES CO, V297, P294, DOI 10.1016/S0006-291X(02)02187-3; Psyrri A, 2004, CANCER RES, V64, P3079, DOI 10.1158/0008-5472.CAN-03-3739; Putral LN, 2005, MOL PHARMACOL, V68, P1311, DOI 10.1124/mol.105.014191; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; Rojas-Espaillat LA, 2005, CURR OPIN ONCOL, V17, P485, DOI 10.1097/01.cco.0000174049.14515.8d; Rubin SM, 2005, CELL, V123, P1093, DOI 10.1016/j.cell.2005.09.044; Scheffner M, 2003, SEMIN CANCER BIOL, V13, P59, DOI 10.1016/S1044-579X(02)00100-1; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Tompa P, 2004, J BIOL CHEM, V279, P20775, DOI 10.1074/jbc.M313873200; Tremper-Wells B, 2005, J BIOL CHEM, V280, P2165, DOI 10.1074/jbc.M410591200; Volbracht C, 2005, J NEUROCHEM, V93, P1280, DOI 10.1111/j.1471-4159.2005.03122.x; Wang J, 2001, ONCOGENE, V20, P4740, DOI 10.1038/sj.onc.1204655; Wesierska-Gadek J, 2002, INT J CANCER, V101, P128, DOI 10.1002/ijc.10580; Yamato K, 2006, CANCER GENE THER, V13, P234, DOI 10.1038/sj.cgt.7700891	43	25	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37492	37500		10.1074/jbc.M706860200	http://dx.doi.org/10.1074/jbc.M706860200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17977825	hybrid			2022-12-27	WOS:000251833600024
J	Hernandez, J; Matter-Sadzinski, L; Skowronska-Krawczyk, D; Chiodini, F; Alliod, C; Ballivet, M; Matter, JM				Hernandez, Julio; Matter-Sadzinski, Lidia; Skowronska-Krawczyk, Dorota; Chiodini, Florence; Alliod, Christine; Ballivet, Marc; Matter, Jean-Marc			Highly conserved sequences mediate the dynamic interplay of basic helix-loop-helix proteins regulating retinogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINAL GANGLION-CELLS; CENTRAL-NERVOUS-SYSTEM; DOMAIN-DNA COMPLEX; TRANSCRIPTION FACTOR; CRYSTAL-STRUCTURE; RECEPTOR PROMOTER; ZEBRAFISH RETINA; SONIC HEDGEHOG; CHICK RETINA; BHLH	The atonal homolog 5 (ATH5) protein is central to the transcriptional network regulating the specification of retinal ganglion cells, and its expression comes under the spatiotemporal control of several basic helix-loop-helix (bHLH) proteins in the course of retina development. Monitoring the in vivo occupancy of the ATH5 promoter by the ATH5, Ngn2, and NeuroM proteins and analyzing the DNA motifs they bind, we show that three evolutionarily conserved E-boxes are required for the bHLH proteins to control the different phases of ATH5 expression. E-box 4 mediates the activity of Ngn2, ATH5, and NeuroM along the pathway leading to the conversion of progenitors into newborn neurons. E-box 1, by mediating the antagonistic effects of Ngn2 and HES1 in proliferating progenitors, controls the expansion of the ATH5 expression domain in early retina. E-box 2 is required for the positive feedback by ATH5 that underlies the up-regulation of ATH5 expression when progenitors are going through their last cell cycle. The combinatorial nature of the regulation of the ATH5 promoter suggests that the bHLH proteins involved have no assigned E-boxes but use a common set at which they either cooperate or compete to finely tune ATH5 expression as development proceeds.	[Hernandez, Julio; Chiodini, Florence; Alliod, Christine; Ballivet, Marc; Matter, Jean-Marc] Univ Geneva, Sch Med, Dept Biochem, CH-1211 Geneva, Switzerland; [Matter-Sadzinski, Lidia; Skowronska-Krawczyk, Dorota; Matter, Jean-Marc] Univ Geneva, Sch Med, Dept Ophthalmol, CH-1211 Geneva, Switzerland	University of Geneva; University of Geneva	Matter, JM (corresponding author), 30 Quai Ernest-Ansermet, CH-1211 Geneva, Switzerland.	Jean-Marc.Matter@biochem.unige.ch						Brown NL, 1998, DEVELOPMENT, V125, P4821; Brown NL, 2001, DEVELOPMENT, V128, P2497; Brzezinski JA, 2005, INVEST OPHTH VIS SCI, V46, P2540, DOI 10.1167/iovs.04-1123; Castro DS, 2006, DEV CELL, V11, P831, DOI 10.1016/j.devcel.2006.10.006; ELLENBERGER T, 1994, GENE DEV, V8, P970, DOI 10.1101/gad.8.8.970; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; HOGAN BLM, 1986, J EMBRYOL EXP MORPH, V97, P95; Hutcheson DA, 2005, DEVELOPMENT, V132, P829, DOI 10.1242/dev.01653; Inoue T, 2002, DEVELOPMENT, V129, P831; Kanekar S, 1997, NEURON, V19, P981, DOI 10.1016/S0896-6273(00)80391-8; Kay JN, 2005, DEVELOPMENT, V132, P2573, DOI 10.1242/dev.01831; Kay JN, 2001, NEURON, V30, P725, DOI 10.1016/S0896-6273(01)00312-9; Lee HY, 2005, DEV BIOL, V284, P464, DOI 10.1016/j.ydbio.2005.06.010; MA PCM, 1994, CELL, V77, P451, DOI 10.1016/0092-8674(94)90159-7; Martinez-Morales JR, 2005, DEV CELL, V8, P565, DOI 10.1016/j.devcel.2005.01.022; Masai I, 2000, NEURON, V27, P251, DOI 10.1016/S0896-6273(00)00034-9; MATTER JM, 1995, J NEUROSCI, V15, P5919; Matter-Sadzinski L, 2005, DEVELOPMENT, V132, P3907, DOI 10.1242/dev.01960; Matter-Sadzinski L, 2001, DEVELOPMENT, V128, P217; MATTERSADZINSKI L, 1992, EMBO J, V11, P4529, DOI 10.1002/j.1460-2075.1992.tb05554.x; McCabe KL, 1999, DEVELOPMENT, V126, P5713; Neumann CJ, 2000, SCIENCE, V289, P2137, DOI 10.1126/science.289.5487.2137; PRADA C, 1991, EUR J NEUROSCI, V3, P559, DOI 10.1111/j.1460-9568.1991.tb00843.x; Roztocil T, 1997, DEVELOPMENT, V124, P3263; Roztocil T, 1998, J BIOL CHEM, V273, P15131, DOI 10.1074/jbc.273.24.15131; Shimizu T, 1997, EMBO J, V16, P4689, DOI 10.1093/emboj/16.15.4689; Skowronska-Krawczyk D, 2005, MOL CELL BIOL, V25, P10029, DOI 10.1128/MCB.25.22.10029-10039.2005; Skowronska-Krawczyk D, 2004, DEVELOPMENT, V131, P4447, DOI 10.1242/dev.01302; Stenkamp DL, 2003, DEV BIOL, V258, P349, DOI 10.1016/S0012-1606(03)00121-0; Wang SW, 2001, GENE DEV, V15, P24, DOI 10.1101/gad.855301; WEINTRAUB H, 1994, GENE DEV, V8, P2203, DOI 10.1101/gad.8.18.2203; Zhang XM, 2001, DEVELOPMENT, V128, P943	32	16	16	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37894	37905		10.1074/jbc.M703616200	http://dx.doi.org/10.1074/jbc.M703616200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17971452	hybrid			2022-12-27	WOS:000251833600065
J	King-Scott, J; Nowak, E; Mylonas, E; Panjikar, S; Roessle, M; Svergun, DI; Tucker, PA				King-Scott, Jack; Nowak, Elzbieta; Mylonas, Efstratios; Panjikar, Santosh; Roessle, Manfred; Svergun, Dmitri I.; Tucker, Paul A.			The structure of a full-length response regulator from Mycobacterium tuberculosis in a stabilized three-dimensional domain-swapped, activated state	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION; 2-COMPONENT SYSTEM; CRYSTAL-STRUCTURE; MOLECULAR CHARACTERIZATION; BIOLOGICAL MACROMOLECULES; CONFORMATIONAL-CHANGES; SOLUTION SCATTERING; RECEIVER DOMAIN; PROTEINS; BINDING	The full-length, two-domain response regulator RegX3 from Mycobacterium tuberculosis is a dimer stabilized by three-dimensional domain swapping. Dimerization is known to occur in the OmpR/ PhoB subfamily of response regulators upon activation but has previously only been structurally characterized for isolated receiver domains. The RegX3 dimer has a bipartite intermolecular interface, which buries 2357 A 2 per monomer. The two parts of the interface are between the two receiver domains (dimerization interface) and between a composite receiver domain and the effector domain of the second molecule (interdomain interface). The structure provides support for the importance of threonine and tyrosine residues in the signal transduction mechanism. These residues occur in an active-like conformation stabilized by lanthanum ions. In solution, RegX3 exists as both a monomer and a dimer in a concentration-dependent equilibrium. The dimer in solution differs from the active form observed in the crystal, resembling instead the model of the inactive full-length response regulator PhoB.	[King-Scott, Jack; Nowak, Elzbieta; Mylonas, Efstratios; Panjikar, Santosh; Roessle, Manfred; Svergun, Dmitri I.; Tucker, Paul A.] EMBL Hamburg Outstation, D-22603 Hamburg, Germany; [Svergun, Dmitri I.] Russian Acad Sci, Inst Crystallog, Moscow 117333, Russia	European Molecular Biology Laboratory (EMBL); Russian Academy of Sciences; FSRC Crystallography & Photonics RAS	Tucker, PA (corresponding author), EMBL Hamburg Outstation, C-O DESY,Notkestr 85, D-22603 Hamburg, Germany.	tucker@embl-hamburg.de	Panjikar, Santosh/D-2709-2012; Mylonas, Efstratios/AAC-4948-2022	Panjikar, Santosh/0000-0001-7429-3879; Svergun, Dmitri/0000-0003-0830-5696; Mylonas, Efstratios/0000-0003-4476-3010; Rossle, Manfred/0000-0003-4196-0430				Anand GS, 2000, PROTEIN SCI, V9, P898, DOI 10.1110/ps.9.5.898; Bachhawat P, 2005, STRUCTURE, V13, P1353, DOI 10.1016/j.str.2005.06.006; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BELLSOLELL L, 1994, J MOL BIOL, V238, P489, DOI 10.1006/jmbi.1994.1308; Bent CJ, 2004, J BACTERIOL, V186, P2872, DOI 10.1128/JB.186.9.2872-2879.2004; Blanco AG, 2002, STRUCTURE, V10, P701, DOI 10.1016/S0969-2126(02)00761-X; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRENNAN RG, 1993, CELL, V74, P773, DOI 10.1016/0092-8674(93)90456-Z; Buckler DR, 2002, STRUCTURE, V10, P153, DOI 10.1016/S0969-2126(01)00706-7; Cole ST, 2001, LEPROSY REV, V72, P449; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; COWTAN KD, 1993, ACTA CRYSTALLOGR D, V49, P148, DOI 10.1107/S0907444992007698; DELANO WL, 2002, PYMOLL USERS MANUAL; Djordjevic S, 1998, P NATL ACAD SCI USA, V95, P1381, DOI 10.1073/pnas.95.4.1381; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Friedland N, 2007, BIOCHEMISTRY-US, V46, P6733, DOI 10.1021/bi602546q; Glover RT, 2007, J BACTERIOL, V189, P5495, DOI 10.1128/JB.00190-07; Guinier A., 1939, ANN PHYS-NEW YORK, V11, P161, DOI DOI 10.1051/ANPHYS/193911120161; HARLOCKER SL, 1995, J BIOL CHEM, V270, P26849, DOI 10.1074/jbc.270.45.26849; Himpens S, 2000, MICROBIOL-SGM, V146, P3091, DOI 10.1099/00221287-146-12-3091; Jeon Y, 2001, J BIOL CHEM, V276, P40873, DOI 10.1074/jbc.M104855200; KADNER RJ, 1993, J BIOENERG BIOMEMBR, V25, P637; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kondo H, 1997, NAT STRUCT BIOL, V4, P28, DOI 10.1038/nsb0197-28; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Letunic I, 2006, NUCLEIC ACIDS RES, V34, pD257, DOI 10.1093/nar/gkj079; Lewis RJ, 2000, J MOL BIOL, V297, P757, DOI 10.1006/jmbi.2000.3598; Liu Y, 2002, PROTEIN SCI, V11, P1285, DOI 10.1110/ps.0201402; MartinezHackert E, 1997, J MOL BIOL, V269, P301, DOI 10.1006/jmbi.1997.1065; Morth JP, 2005, FEBS LETT, V579, P4145, DOI 10.1016/j.febslet.2005.06.043; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nowak E, 2006, J BIOL CHEM, V281, P9659, DOI 10.1074/jbc.M512004200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Panjikar S, 2005, ACTA CRYSTALLOGR D, V61, P449, DOI 10.1107/S0907444905001307; Parish T, 2003, MICROBIOL-SGM, V149, P1423, DOI 10.1099/mic.0.26245-0; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Robinson VL, 2000, NAT STRUCT BIOL, V7, P626, DOI 10.1038/77915; Robinson VL, 2003, J BACTERIOL, V185, P4186, DOI 10.1128/JB.185.14.4186-4194.2003; Roessle MW, 2007, J APPL CRYSTALLOGR, V40, pS190, DOI 10.1107/S0021889806055506; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Schymkowitz JWH, 2001, NAT STRUCT BIOL, V8, P888, DOI 10.1038/nsb1001-888; SIMON G, 1995, MOL MICROBIOL, V17, P971, DOI 10.1111/j.1365-2958.1995.mmi_17050971.x; Sola M, 1999, J MOL BIOL, V285, P675, DOI 10.1006/jmbi.1998.2326; STOCK AM, 1988, COLD SPRING HARB SYM, V53, P49, DOI 10.1101/SQB.1988.053.01.009; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Toro-Roman A, 2005, PROTEIN SCI, V14, P3077, DOI 10.1110/ps.051722805; Toro-Roman A, 2005, J MOL BIOL, V349, P11, DOI 10.1016/j.jmb.2005.03.059; TORRIANI AM, 1990, BIOESSAYS, V12, P371, DOI 10.1002/bies.950120804; VOLKMAN BF, 1995, BIOCHEMISTRY-US, V34, P1413, DOI 10.1021/bi00004a036; WANNER BL, 1993, J CELL BIOCHEM, V51, P47, DOI 10.1002/jcb.240510110; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; West AH, 2001, TRENDS BIOCHEM SCI, V26, P369, DOI 10.1016/S0968-0004(01)01852-7; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Wosten MMSM, 1999, J BIOL CHEM, V274, P27185, DOI 10.1074/jbc.274.38.27185	60	32	32	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37717	37729		10.1074/jbc.M705081200	http://dx.doi.org/10.1074/jbc.M705081200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17942407	hybrid			2022-12-27	WOS:000251833600048
J	Minshall, N; Reiter, MH; Weil, D; Standart, N				Minshall, Nicola; Reiter, Marie Helene; Weil, Dominique; Standart, Nancy			CPEB interacts with an ovary-specific eIF4E and 4E-T in early Xenopus oocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA TRANSLATION; CAP-DEPENDENT TRANSLATION; ELEMENT-BINDING PROTEIN; DEAD BOX HELICASE; P-BODY FORMATION; CYTOPLASMIC POLYADENYLATION; POLY(A)-BINDING PROTEIN; PROCESSING BODIES; DROSOPHILA CUP; BALBIANI BODY	CPEB (cytoplasmic polyadenylation element-binding protein) is an important regulator of translation in oocytes and neurons. Although previous studies of CPEB in late Xenopus oocytes involve the eIF4E-binding protein maskin as the key factor for the repression of maternal mRNA, a second mechanism must exist, since maskin is absent earlier in oogenesis. Using co-immunoprecipitation and gel filtration assays, we show that CPEB specifically interacts, via protein/protein interactions, with the RNA helicase Xp54, the RNA-binding proteins P100(Pat1) and RAP55, the eIF4E-binding protein 4E-T, and an eIF4E protein. Remarkably, these CPEB complex proteins have been characterized, in one or more organism, as P-body, maternal, or neuronal granule components. We do not detect interactions with eIF4E1a, the canonical cap-binding factor, eIF4G, or eIF4A or with proteins expressed late in oogenesis, including maskin, PARN, and 4E-BP1. The eIF4E protein was identified as eIF4E1b, a close homolog of eIF4E1a, whose expression is restricted to oocytes and early embryos. Although eIF4E1b possesses all residues required for cap and eIF4G binding, it binds m(7)GTP weakly, and in pull-down assays, rather than binding eIF4G, it binds 4E-T, in a manner independent of the consensus eIF4E-binding site, YSKEELL. Wild type and Y-A mutant 4E-T (which binds eIF4E1b but not eIF4E1a), when tethered to a reporter mRNA, represses its translation in a cap-dependent manner, and injection of eIF4E1b antibody accelerates meiotic maturation. Altogether, our data suggest that CPEB, partnered with several highly conserved RNA-binding partners, inhibits protein synthesis in oocytes using a novel pairing of 4E-T and eIF4E1b.	[Minshall, Nicola; Reiter, Marie Helene; Standart, Nancy] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England; [Weil, Dominique] Inst Andre Lwoff, CNRS, FRE 2937, F-94801 Villejuif, France	University of Cambridge; Centre National de la Recherche Scientifique (CNRS)	Minshall, N (corresponding author), Univ Cambridge, Dept Biochem, 80 Tennis Court Rd, Cambridge CB2 1GA, England.	nms@mole.bio.cam.ac.uk	WEIL, Dominique/AAE-4214-2020	WEIL, Dominique/0000-0001-7630-1772; Schernthaner-Reiter, Marie Helene/0000-0002-7972-7610	Biotechnology and Biological Sciences Research Council [BB/C514766/1] Funding Source: Medline; Wellcome Trust Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)		Andrei MA, 2005, RNA, V11, P717, DOI 10.1261/rna.2340405; Audhya A, 2005, J CELL BIOL, V171, P267, DOI 10.1083/jcb.200506124; Barbee SA, 2006, NEURON, V52, P997, DOI 10.1016/j.neuron.2006.10.028; Barnard DC, 2005, MOL CELL BIOL, V25, P7605, DOI 10.1128/MCB.25.17.7605-7615.2005; Barnard DC, 2004, CELL, V119, P641, DOI 10.1016/j.cell.2004.10.029; Barros TP, 2005, J CELL BIOL, V170, P1039, DOI 10.1083/jcb.200504097; Boag PR, 2005, DEVELOPMENT, V132, P4975, DOI 10.1242/dev.02060; Charlesworth A, 2006, EMBO J, V25, P2792, DOI 10.1038/sj.emboj.7601159; Chekulaeva M, 2006, CELL, V124, P521, DOI 10.1016/j.cell.2006.01.031; Cho PF, 2005, CELL, V121, P411, DOI 10.1016/j.cell.2005.02.024; Chu CY, 2006, PLOS BIOL, V4, P1122, DOI 10.1371/journal.pbio.0040210; Colegrove-Otero LJ, 2005, MOL CELL BIOL, V25, P9028, DOI 10.1128/MCB.25.20.9028-9039.2005; Colegrove-Otero LJ, 2005, CRIT REV BIOCHEM MOL, V40, P21, DOI 10.1080/10409230590918612; Coller J, 2005, CELL, V122, P875, DOI 10.1016/j.cell.2005.07.012; Coller JM, 2001, RNA, V7, P1717, DOI 10.1017/S135583820101994X; Copeland PR, 2001, RNA, V7, P875, DOI 10.1017/S1355838201010020; Cougot N, 2004, J CELL BIOL, V165, P31, DOI 10.1083/jcb.200309008; Cox RT, 2003, DEVELOPMENT, V130, P1579, DOI 10.1242/dev.00365; de Moor CH, 1999, EMBO J, V18, P2294, DOI 10.1093/emboj/18.8.2294; de Moor CH, 2005, SEMIN CELL DEV BIOL, V16, P49, DOI 10.1016/j.semcdb.2004.11.007; Dostie J, 2000, EMBO J, V19, P3142, DOI 10.1093/emboj/19.12.3142; Eulalio A, 2007, MOL CELL BIOL, V27, P3970, DOI 10.1128/MCB.00128-07; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Evdokimova V, 2006, CELL CYCLE, V5, P1143, DOI 10.4161/cc.5.11.2784; Evsikov AV, 2006, GENE DEV, V20, P2713, DOI 10.1101/gad.1471006; Ferraiuolo MA, 2005, J CELL BIOL, V170, P913, DOI 10.1083/jcb.200504039; Fraser CS, 1999, J BIOL CHEM, V274, P196, DOI 10.1074/jbc.274.1.196; Gorgoni B, 2005, RNA, V11, P1030, DOI 10.1261/rna.7281305; Gray NK, 2000, EMBO J, V19, P4723, DOI 10.1093/emboj/19.17.4723; Groisman I, 2000, CELL, V103, P435, DOI 10.1016/S0092-8674(00)00135-5; Gross JD, 2003, CELL, V115, P739, DOI 10.1016/S0092-8674(03)00975-9; HAKE LE, 1994, CELL, V79, P617, DOI 10.1016/0092-8674(94)90547-9; Hernandez G, 2005, MECH DEVELOP, V122, P529, DOI 10.1016/j.mod.2004.11.011; Houston DW, 2000, CURR TOP DEV BIOL, V50, P155, DOI 10.1016/S0070-2153(00)50008-8; Huang YS, 2006, EMBO J, V25, P4865, DOI 10.1038/sj.emboj.7601322; JACKSON RJ, 2007, SCI STKE, V367, pRE1, DOI DOI 10.1126/STKE.3672007RE1; Joshi B, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-48; Joshi B, 2004, EUR J BIOCHEM, V271, P2189, DOI 10.1111/j.1432-1033.2004.04149.x; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kim JH, 2006, MOL CELL, V24, P173, DOI 10.1016/j.molcel.2006.08.016; Kiriakidou M, 2007, CELL, V129, P1141, DOI 10.1016/j.cell.2007.05.016; Kloc M, 2004, CURR TOP DEV BIOL, V59, P1, DOI 10.1016/S0070-2153(04)59001-4; Kwak JE, 2004, P NATL ACAD SCI USA, V101, P4407, DOI 10.1073/pnas.0400779101; Ladomery M, 1997, NUCLEIC ACIDS RES, V25, P965, DOI 10.1093/nar/25.5.965; Liu JD, 2005, NAT CELL BIOL, V7, P1261, DOI 10.1038/ncb1333; Mair GR, 2006, SCIENCE, V313, P667, DOI 10.1126/science.1125129; Mansfield JH, 2002, DEVELOPMENT, V129, P197; Marcotrigiano J, 1999, MOL CELL, V3, P707, DOI 10.1016/S1097-2765(01)80003-4; Marcotrigiano J, 1997, CELL, V89, P951, DOI 10.1016/S0092-8674(00)80280-9; McKendrick L, 2001, MOL CELL BIOL, V21, P3632, DOI 10.1128/MCB.21.11.3632-3641.2001; Meijer HA, 2007, BIOL CELL, V99, P239, DOI 10.1042/BC20060112; Mendez R, 2000, MOL CELL, V6, P1253, DOI 10.1016/S1097-2765(00)00121-0; Minshall N, 1999, RNA, V5, P27, DOI 10.1017/S1355838299981220; Minshall N, 2001, RNA, V7, P1728, DOI 10.1017/S135583820101158X; Minshall N, 2004, NUCLEIC ACIDS RES, V32, P1325, DOI 10.1093/nar/gkh303; MURRAY MT, 1992, P NATL ACAD SCI USA, V89, P11, DOI 10.1073/pnas.89.1.11; Nakamura A, 2004, DEV CELL, V6, P69, DOI 10.1016/S1534-5807(03)00400-3; Nakamura A, 2001, DEVELOPMENT, V128, P3233; Nelson MR, 2004, EMBO J, V23, P150, DOI 10.1038/sj.emboj.7600026; O'Brien LL, 2005, MOL BIOL CELL, V16, P2836, DOI 10.1091/mbc.e04-10-0926; Okumura F, 2007, GENE DEV, V21, P255, DOI 10.1101/gad.1521607; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Pepling ME, 2007, P NATL ACAD SCI USA, V104, P187, DOI 10.1073/pnas.0609923104; Pestova TV, 1998, GENE DEV, V12, P67, DOI 10.1101/gad.12.1.67; Pyronnet S, 2001, GENE DEV, V15, P2083, DOI 10.1101/gad.889201; Robalino J, 2004, J BIOL CHEM, V279, P10532, DOI 10.1074/jbc.M313688200; Roper K, 2007, J CELL SCI, V120, P1081, DOI 10.1242/jcs.03407; ROTHER RP, 1992, EUR J BIOCHEM, V206, P673, DOI 10.1111/j.1432-1033.1992.tb16973.x; Rouget C, 2006, J BIOL CHEM, V281, P28687, DOI 10.1074/jbc.M601116200; Rouhana L, 2005, RNA, V11, P1117, DOI 10.1261/rna.2630205; Schmitt A, 2002, J CELL SCI, V115, P2457; Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320; Squirrell JM, 2006, MOL BIOL CELL, V17, P336, DOI 10.1091/mbc.E05-09-0874; Stebbins-Boaz B, 1999, MOL CELL, V4, P1017, DOI 10.1016/S1097-2765(00)80230-0; Tanaka KJ, 2006, J BIOL CHEM, V281, P40096, DOI 10.1074/jbc.M609059200; Theis M, 2003, P NATL ACAD SCI USA, V100, P9602, DOI 10.1073/pnas.1133424100; Thom G, 2003, BIOCHEM J, V370, P91, DOI 10.1042/BJ20021462; Thompson B, 2007, TRANSLATIONAL CONTRO, V48, P507; Villaescusa JC, 2006, GENE, V367, P101, DOI 10.1016/j.gene.2005.09.026; Wakiyama M, 2001, BIOSCI BIOTECH BIOCH, V65, P232, DOI 10.1271/bbb.65.232; Wang LT, 2002, NATURE, V419, P312, DOI 10.1038/nature01039; Weston A, 2006, NUCLEIC ACIDS RES, V34, P3082, DOI 10.1093/nar/gkl409; Wilczynska A, 2005, J CELL SCI, V118, P981, DOI 10.1242/jcs.01692; Wilhelm JE, 2003, J CELL BIOL, V163, P1197, DOI 10.1083/jcb.200309088; Wilhelm JE, 2005, DEV CELL, V9, P675, DOI 10.1016/j.devcel.2005.09.015; Yang WH, 2006, RNA, V12, P547, DOI 10.1261/rna.2302706; Zuberek J, 2007, RNA, V13, P691, DOI 10.1261/rna.453107	88	125	135	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37389	37401		10.1074/jbc.M704629200	http://dx.doi.org/10.1074/jbc.M704629200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17942399	hybrid			2022-12-27	WOS:000251833600013
J	Thaminy, S; Newcomb, B; Kim, J; Gatbonton, T; Foss, E; Simon, J; Bedalov, A				Thaminy, Safia; Newcomb, Benjamin; Kim, Jessica; Gatbonton, Tonibelle; Foss, Eric; Simon, Julian; Bedalov, Antonio			Hst3 is regulated by Mec1-dependent proteolysis and controls the S phase checkpoint and sister chromatid cohesion by deacetylating histone H3 at lysine 56	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-REPLICATION STRESS; CELL-CYCLE; H3K56 ACETYLATION; RTT109; MRC1; IDENTIFICATION; FORK	The SIR2 homologues HST3 and HST4 have been implicated in maintenance of genome integrity in the yeast Saccharomyces cerevisiae. We find that Hst3 has NAD-dependent histone deacetylase activity in vitro and that it functions during S phase to deacetylate the core domain of histone H3 at lysine 56 (H3K56). In response to genotoxic stress, Hst3 undergoes rapid Mec1-dependent phosphorylation and is targeted for ubiquitin-mediated proteolysis, thus providing a mechanism for the previously observed checkpoint-dependent accumulation of Ac-H3K56 at sites of DNA damage. Loss of Hst3-mediated regulation of H3K56 acetylation results in a defect in the S phase DNA damage checkpoint. The pathway that regulates H3K56 acetylation acts in parallel with the Rad9 pathway to transmit a DNA damage signal from Mec1 to Rad53. We also observe that loss of Hst3 function impairs sister chromatid cohesion (SCC). Both S phase checkpoint and SCC defects are phenocopied by H3K56 point mutants. Our findings demonstrate that Hst3-regulated H3K56 acetylation safeguards genome stability by controlling the S phase DNA damage response and promoting SCC.	[Thaminy, Safia; Newcomb, Benjamin; Kim, Jessica; Gatbonton, Tonibelle; Foss, Eric; Simon, Julian; Bedalov, Antonio] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA; [Simon, Julian] Fred Hutchinson Canc Res Ctr, Human Biol Div, Seattle, WA 98109 USA; [Bedalov, Antonio] Univ Washington, Dept Med, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Bedalov, A (corresponding author), Fred Hutchinson Canc Res Ctr, 1100 Fairview Ave N, Seattle, WA 98109 USA.	abedalov@fhcrc.org			NHLBI NIH HHS [HL04211] Funding Source: Medline; NIDDK NIH HHS [DK56465] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL004211] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056465] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alcasabas AA, 2001, NAT CELL BIOL, V3, P958, DOI 10.1038/ncb1101-958; Bedalov A, 2001, P NATL ACAD SCI USA, V98, P15113, DOI 10.1073/pnas.261574398; BRACHMANN CB, 1995, GENE DEV, V9, P2888, DOI 10.1101/gad.9.23.2888; Branzei D, 2005, CURR OPIN CELL BIOL, V17, P568, DOI 10.1016/j.ceb.2005.09.003; Calzada A, 2005, GENE DEV, V19, P1905, DOI 10.1101/gad.337205; Celic I, 2006, CURR BIOL, V16, P1280, DOI 10.1016/j.cub.2006.06.023; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Driscoll R, 2007, SCIENCE, V315, P649, DOI 10.1126/science.1135862; Foss EJ, 2001, GENETICS, V157, P567; Foss EJ, 2000, COLD SPRING HARB SYM, V65, P347, DOI 10.1101/sqb.2000.65.347; Han JH, 2007, SCIENCE, V315, P653, DOI 10.1126/science.1133234; Hyland EA, 2005, MOL CELL BIOL, V25, P10060, DOI 10.1128/MCB.25.22.10060-10070.2005; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Maas NL, 2006, MOL CELL, V23, P109, DOI 10.1016/j.molcel.2006.06.006; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; Mayer ML, 2004, MOL BIOL CELL, V15, P1736, DOI 10.1091/mbc.E03-08-0619; Myung KJ, 2001, CELL, V104, P397, DOI 10.1016/S0092-8674(01)00227-6; Osborn AJ, 2003, GENE DEV, V17, P1755, DOI 10.1101/gad.1098303; Ozdemir A, 2005, J BIOL CHEM, V280, P25949, DOI 10.1074/jbc.C500181200; RECHT J, 2006, MOL CELL, V130, P6988; Redon C, 2006, GENETICS, V172, P67, DOI 10.1534/genetics.105.046128; Sauve AA, 2006, ANNU REV BIOCHEM, V75, P435, DOI 10.1146/annurev.biochem.74.082803.133500; Schneider J, 2006, J BIOL CHEM, V281, P37270, DOI 10.1074/jbc.C600265200; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Sweeney FD, 2005, CURR BIOL, V15, P1364, DOI 10.1016/j.cub.2005.06.063; Tsubota T, 2007, MOL CELL, V25, P703, DOI 10.1016/j.molcel.2007.02.006; Verreault A, 2003, MOL CELL, V11, P283, DOI 10.1016/S1097-2765(03)00052-2; Warren CD, 2004, MOL BIOL CELL, V15, P1724, DOI 10.1091/mbc.E03-09-0637; Xu F, 2005, CELL, V121, P375, DOI 10.1016/j.cell.2005.03.011	30	61	61	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37805	37814		10.1074/jbc.M706384200	http://dx.doi.org/10.1074/jbc.M706384200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17977840	hybrid			2022-12-27	WOS:000251833600056
J	Wu, RF; Ma, ZY; Myers, DP; Terada, LS				Wu, Ru Feng; Ma, Zhenyi; Myers, David P.; Terada, Lance S.			HIV-1 Tat activates dual Nox pathways leading to independent activation of ERK and JNK MAP kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASCULAR ENDOTHELIAL-CELLS; AMINO-TERMINAL KINASE; FOCAL ADHESION; FLK-1/KDR RECEPTOR; NAD(P)H OXIDASE; KAPOSIS-SARCOMA; GROWTH-FACTOR; PROTEIN; AIDS; DIFFERENTIATION	Human immunodeficiency virus, type 1 Tat is known to exert pleiotropic effects on the vascular endothelium through mitogen-activated protein (MAP) kinases, although the signaling pathways leading to MAP kinase activation are incompletely understood. We focused on proximal pathways potentially governing downstream MAP kinase activity by Tat. Within 2 min, Tat activated both Ras and Rho GTPases in endothelial cells, leading to ERK phosphorylation by 10 min. Notably, Rac1 was necessary for downstream activation of RhoA and both Rac1 and RhoA acted upstream of the Ras/ERK cassette. Antioxidants and the oxidase inhibitor diphenylene iodonium blocked ERK phosphorylation, but specific interference with the canonical Nox2 oxidase had no effect on ERK. Instead, knock down of the novel oxidase Nox4 completely suppressed Tat-dependent Ras and ERK activation downstream of Rac1 and RhoA. Conversely, interference with Rac1, PAK1, and Nox2 blocked JNK phosphorylation, whereas RhoA(N19) and Nox4 knock down did not. Further, knock down of Nox2, but not Nox4, blocked Tat-induced cytoskeletal rearrangement, whereas knock down of Nox4, but not Nox2, blocked Tat-dependent proliferation. Rac1, therefore, bifurcates Tat signaling, leading to concurrent but separate Nox4-dependent Ras/ERK activation, and Nox2-dependent JNK activation. Tat signaling, therefore, provides an example of Nox-specific differential control of MAP kinase pathways.	[Wu, Ru Feng; Ma, Zhenyi; Myers, David P.; Terada, Lance S.] Univ Texas SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Terada, LS (corresponding author), UT SW Med Ctr, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	lance.terada@utsouthwestern.edu		Terada, Lance/0000-0001-7441-9734	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061897, R01HL067256] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL067256, R01 HL061897, R01 HL61897] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Albini A, 1996, NAT MED, V2, P1371, DOI 10.1038/nm1296-1371; Avraham HK, 2004, J IMMUNOL, V173, P6228, DOI 10.4049/jimmunol.173.10.6228; Baliga RS, 2005, AM J PHYSIOL-HEART C, V289, pH1373, DOI 10.1152/ajpheart.00304.2005; Cheng GJ, 2001, GENE, V269, P131, DOI 10.1016/S0378-1119(01)00449-8; Croft DR, 2006, MOL CELL BIOL, V26, P4612, DOI 10.1128/MCB.02061-05; Cucoranu I, 2005, CIRC RES, V97, P900, DOI 10.1161/01.RES.0000187457.24338.3D; Dubrovsky T, 1998, NEUROLOGY, V51, P560, DOI 10.1212/WNL.51.2.560; ENSOLI B, 1994, NATURE, V371, P674, DOI 10.1038/371674a0; Furst R, 2005, CIRC RES, V96, P43, DOI 10.1161/01.RES.0000151983.01148.06; Ganju RK, 1998, J VIROL, V72, P6131, DOI 10.1128/JVI.72.7.6131-6137.1998; Geiszt M, 2000, P NATL ACAD SCI USA, V97, P8010, DOI 10.1073/pnas.130135897; Glasgow BJ, 1997, OPHTHALMOLOGY, V104, P753, DOI 10.1016/S0161-6420(97)30237-1; Gorin Y, 2003, AM J PHYSIOL-RENAL, V285, pF219, DOI 10.1152/ajprenal.00414.2002; Gu Y, 2003, J BIOL CHEM, V278, P17210, DOI 10.1074/jbc.M210314200; Gu Y, 2002, EXP CELL RES, V272, P62, DOI 10.1006/excr.2001.5404; Gu Y, 2001, VIROLOGY, V286, P62, DOI 10.1006/viro.2001.0998; Hsue PY, 2004, CIRCULATION, V109, P316, DOI 10.1161/01.CIR.0000114520.38748.AA; Li J, 2006, MOL BIOL CELL, V17, P3978, DOI 10.1091/mbc.E05-06-0532; Mahadev K, 2004, MOL CELL BIOL, V24, P1844, DOI 10.1128/MCB.24.5.1844-1854.2004; Martyn KD, 2006, CELL SIGNAL, V18, P69, DOI 10.1016/j.cellsig.2005.03.023; Mitola S, 2000, J VIROL, V74, P344, DOI 10.1128/JVI.74.1.344-353.2000; NEWSOME DA, 1984, AM J OPHTHALMOL, V98, P590, DOI 10.1016/0002-9394(84)90245-9; Park IW, 2001, J IMMUNOL, V167, P2766, DOI 10.4049/jimmunol.167.5.2766; QIU RG, 1995, P NATL ACAD SCI USA, V92, P11781, DOI 10.1073/pnas.92.25.11781; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Tabib A, 2000, CORONARY ARTERY DIS, V11, P41, DOI 10.1097/00019501-200002000-00008; Terada LS, 2006, J CELL BIOL, V174, P615, DOI 10.1083/jcb.200605036; Terada LS, 2000, AM J MED SCI, V320, P379, DOI 10.1097/00000441-200012000-00005; Toschi E, 2006, MOL BIOL CELL, V17, P1985, DOI 10.1091/mbc.E05-08-0717; Urbinati C, 2005, J CELL SCI, V118, P3949, DOI 10.1242/jcs.02518; Wu RF, 2005, J CELL BIOL, V171, P893, DOI 10.1083/jcb.200507004; Wu RF, 2004, J VIROL, V78, P779, DOI 10.1128/JVI.78.2.779-789.2004; Xu YX, 2002, J BIOL CHEM, V277, P28051, DOI 10.1074/jbc.M202665200; Zietz C, 1996, AM J PATHOL, V149, P1887	34	53	54	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37412	37419		10.1074/jbc.M704481200	http://dx.doi.org/10.1074/jbc.M704481200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17940286	hybrid			2022-12-27	WOS:000251833600015
J	Chupreta, S; Brevig, H; Bai, LC; Merchant, JL; Iniguez-Lluhi, JA				Chupreta, Sergey; Brevig, Holly; Bai, Longchuan; Merchant, Juanita L.; Iniguez-Lluhi, Jorge A.			Sumoylation-dependent control of homotypic and heterotypic synergy by the kruppel-type zinc finger protein ZBP-89	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR ZBP-89; E3 LIGASE ACTIVITY; GENE-EXPRESSION; GLUCOCORTICOID-RECEPTOR; REGULATE TRANSCRIPTION; VIMENTIN GENE; PHOSPHOENOLPYRUVATE CARBOXYKINASE; SUBNUCLEAR LOCALIZATION; SUMO-1 MODIFICATION; MODIFIER-1 SUMO-1	The Kruppel-like transcription factor ZBP-89 is a sswequence-specific regulator that plays key roles in cellular growth and differentiation especially in endodermal and germ cell lineages. ZBP-89 shares with other members of the Sp-like family an overlapping sequence specificity for GC-rich sequences in the regulatory regions of multiple genes. Defining the mechanisms that govern the intrinsic function of ZBP-89 as well as its competitive and non-competitive functional interactions with other regulators is central to understand how ZBP- 89 exerts its biological functions. We now describe that post-translational modification of ZBP-89 by multiple small ubiquitin-like modifier (SUMO) isoforms occurs at two conserved synergy control motifs flanking the DNA binding domain. Functionally sumoylation did not directly alter the ability of ZBP-89 to compete with other Sp-like factors from individual sites. At promoters bearing multiple response elements, however, this modification inhibited the functional cooperation between ZBP-89 and Sp1. Analysis of the properties of ZBP-89 in cellular contexts devoid of competing factors indicated that although on its own it behaves as a modest activator it potently synergizes with heterologous activators such as the glucocorticoid receptor. Notably we found that when conjugated to ZBP-89, SUMO exerts a strong inhibitory effect on such synergistic interactions through a critical conserved functional surface. By regulating higher order functional interactions, sumoylation provides a reversible post-translational mechanism to control the activity of ZBP-89.	Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Iniguez-Lluhi, JA (corresponding author), Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA.	iniguez@umich.edu	Merchant, Juanita/AAF-8277-2019	Merchant, Juanita/0000-0002-6559-8184; Iniguez-Lluhi, Jorge/0000-0001-7010-089X	NIDDK NIH HHS [P30 DK034933-219001, R01 DK55732, P30 DK034933, R01 DK061656, R01 DK055732-05, R01 DK055732, DK61656-01, P60 DK20572] Funding Source: Medline; NIGMS NIH HHS [T32 GM007767] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK061656, R01DK055732, P60DK020572, R01DK061656, P30DK034933] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007767] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Antoine K, 2005, MOL CELL BIOCHEM, V271, P215, DOI 10.1007/s11010-005-6417-2; Bai LC, 2000, J BIOL CHEM, V275, P30725, DOI 10.1074/jbc.M004249200; Bai LC, 2003, NUCLEIC ACIDS RES, V31, P7264, DOI 10.1093/nar/gkg929; Bai LG, 2001, MOL CELL BIOL, V21, P4670, DOI 10.1128/MCB.21.14.4670-4683.2001; Bohren KM, 2004, J BIOL CHEM, V279, P27233, DOI 10.1074/jbc.M402273200; Boopathi E, 2004, J BIOL CHEM, V279, P35242, DOI 10.1074/jbc.M403160200; Cassuto H, 2005, J BIOL CHEM, V280, P33873, DOI 10.1074/jbc.M504119200; Cheng PY, 2000, BIOCHEMISTRY-US, V39, P4347, DOI 10.1021/bi992298f; Chun TH, 2003, CIRC RES, V92, P1201, DOI 10.1161/01.RES.0000076893.70898.36; Chupreta S, 2005, MOL CELL BIOL, V25, P4272, DOI 10.1128/MCB.25.10.4272-4282.2005; COUREY AJ, 1988, CELL, V55, P887, DOI 10.1016/0092-8674(88)90144-4; Gong L, 2006, J BIOL CHEM, V281, P15869, DOI 10.1074/jbc.M511658200; Hasegawa T, 1997, J BIOL CHEM, V272, P4915, DOI 10.1074/jbc.272.8.4915; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Holmstrom S, 2003, P NATL ACAD SCI USA, V100, P15758, DOI 10.1073/pnas.2136933100; Iniguez-Lluhi JA, 2000, MOL CELL BIOL, V20, P6040, DOI 10.1128/MCB.20.16.6040-6050.2000; IniguezLluhi JA, 1997, J BIOL CHEM, V272, P4149, DOI 10.1074/jbc.272.7.4149; JANTZEN HM, 1987, CELL, V49, P29, DOI 10.1016/0092-8674(87)90752-5; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Jones MC, 2006, P NATL ACAD SCI USA, V103, P16272, DOI 10.1073/pnas.0603002103; Komatsu T, 2004, MOL ENDOCRINOL, V18, P2451, DOI 10.1210/me.2004-0173; Law DJ, 2006, MAMM GENOME, V17, P999, DOI 10.1007/s00335-006-0052-4; Law DJ, 2006, NUCLEIC ACIDS RES, V34, P1342, DOI 10.1093/nar/gkl022; Law DJ, 1998, MAMM GENOME, V9, P165, DOI 10.1007/s003359900711; Law GL, 1998, J BIOL CHEM, V273, P19955, DOI 10.1074/jbc.273.32.19955; Lee YK, 2007, J BIOL CHEM, V282, P1595, DOI 10.1074/jbc.M606306200; Li XG, 2006, DEVELOPMENT, V133, P3641, DOI 10.1242/dev.02540; Lin DY, 2006, MOL CELL, V24, P341, DOI 10.1016/j.molcel.2006.10.019; Malo MS, 2006, AM J PHYSIOL-GASTR L, V290, pG737, DOI 10.1152/ajpgi.00394.2005; Merchant JL, 1996, MOL CELL BIOL, V16, P6644; MULLER M, 1991, MOL ENDOCRINOL, V5, P1498, DOI 10.1210/mend-5-10-1498; Nishida T, 2000, EUR J BIOCHEM, V267, P6423, DOI 10.1046/j.1432-1327.2000.01729.x; Owerbach D, 2005, BIOCHEM BIOPH RES CO, V337, P517, DOI 10.1016/j.bbrc.2005.09.090; Park H, 2003, BLOOD, V101, P894, DOI 10.1182/blood-2002-03-0680; Passantino R, 1998, J BIOL CHEM, V273, P484, DOI 10.1074/jbc.273.1.484; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Poukka H, 2000, P NATL ACAD SCI USA, V97, P14145, DOI 10.1073/pnas.97.26.14145; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; Rosendorff A, 2006, P NATL ACAD SCI USA, V103, P5308, DOI 10.1073/pnas.0601066103; Ross S, 2002, MOL CELL, V10, P831, DOI 10.1016/S1097-2765(02)00682-2; Sachdev S, 2001, GENE DEV, V15, P3088, DOI 10.1101/gad.944801; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; Sapetschnig A, 2002, EMBO J, V21, P5206, DOI 10.1093/emboj/cdf510; Song J, 2004, P NATL ACAD SCI USA, V101, P14373, DOI 10.1073/pnas.0403498101; Spengler ML, 2006, J BIOL CHEM, V281, P5567, DOI 10.1074/jbc.M600035200; STRAHLE U, 1988, EMBO J, V7, P3389, DOI 10.1002/j.1460-2075.1988.tb03212.x; Su HL, 2002, GENE, V296, P65, DOI 10.1016/S0378-1119(02)00843-0; Subramanian L, 2003, J BIOL CHEM, V278, P9134, DOI 10.1074/jbc.M210440200; Wang XHL, 2004, J BIOL CHEM, V279, P34191, DOI 10.1074/jbc.M403455200; Wei HJ, 2006, J BIOL CHEM, V281, P16664, DOI 10.1074/jbc.M513135200; Wieczorek E, 2000, J BIOL CHEM, V275, P12879, DOI 10.1074/jbc.275.17.12879; Wu YZ, 2007, GENES CELLS, V12, P905, DOI 10.1111/j.1365-2443.2007.01104.x; Yamada A, 2001, J BIOL CHEM, V276, P18082, DOI 10.1074/jbc.M008387200; Yang SH, 2004, MOL CELL, V13, P611, DOI 10.1016/S1097-2765(04)00060-7; Ye S, 1999, FEBS LETT, V450, P268, DOI 10.1016/S0014-5793(99)00509-8; Yeh ETH, 2000, GENE, V248, P1, DOI 10.1016/S0378-1119(00)00139-6; Zhang XP, 2003, NUCLEIC ACIDS RES, V31, P2900, DOI 10.1093/nar/gkg380	57	24	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36155	36166		10.1074/jbc.M708130200	http://dx.doi.org/10.1074/jbc.M708130200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17940278	hybrid			2022-12-27	WOS:000251458300005
J	Soundararajan, R; Wang, J; Melters, D; Pearce, D				Soundararajan, Rama; Wang, Jian; Melters, Daniel; Pearce, David			Differential activities of glucocorticoid-induced leucine zipper protein isoforms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-TRANSPORT; CELL-DEATH; TRANSCRIPTIONAL REGULATOR; T-LYMPHOCYTES; KAPPA-B; GILZ; GENE; TSC-22; DOMAIN; ACTIVATION	Glucocorticoid-induced leucine zipper protein (GILZ) is expressed in both epithelial and immune tissues and modulates a variety of cellular functions, including proliferation and epithelial sodium channel (ENaC) activity. A number of reports have described various GILZ activities, focusing on a single isoform with molecular mass of similar to 17 kDa, now termed GILZ1. In GILZ immunoblots using a newly developed antiserum, we detected multiple species in extracts from cultured kidney cells. Mass spectrometric analysis revealed that one of these represented a previously uncharacterized distinct isoform of GILZ, GILZ2. Rapid amplification of cDNA ends was used to clone cDNAs corresponding to four isoforms, which, in addition to GILZ1 and GILZ2, included new isoforms GILZ3 and GILZ4. Heterologous expression of these four GILZ isoforms in cultured cells revealed striking functional differences. Notably, GILZ1 was the only isoform that significantly stimulated ENaC-mediated Na+ current in a kidney collecting duct cell line, although GILZ2 and GILZ3 also stimulated ENaC surface expression in HEK 293 cells. GILZ1 and GILZ3, and to a lesser extent GILZ2, inhibited ERK phosphorylation. Interestingly, GILZ4, which had no effect on either ENaC or ERK, potently suppressed cellular proliferation, as did GILZ1, but not GILZ2 or GILZ3. Finally, rat and mouse tissues all expressed multiple GILZ species but varied in the relative abundance of each. These data suggest that multiple GILZ isoforms are expressed in most cells and tissues and that these play distinct roles in regulating key cellular functions, including proliferation and ion transport. Furthermore, GILZ inhibition of ERK appears to play an essential role in stimulation of cell surface ENaC but not in inhibition of proliferation.	Univ Calif San Francisco, Dept Med, Div Nephrol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Pearce, D (corresponding author), 600 16th St,Rm N274H Genentech Hall Mission Bay C, San Francisco, CA 94107 USA.	dpearce@medsfgh.ucsf.edu		Melters, Daniel/0000-0003-4809-0562	NIDDK NIH HHS [K01-DK078679-01, R01-DK51151] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051151, K01DK078679] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Asselin-Labat ML, 2005, MOL ENDOCRINOL, V19, P1752, DOI 10.1210/me.2004-0206; Asselin-Labat ML, 2004, BLOOD, V104, P215, DOI 10.1182/blood-2003-12-4295; Ayroldi E, 2002, MOL CELL BIOL, V22, P7929, DOI 10.1128/MCB.22.22.7929-7941.2002; Ayroldi E, 2001, BLOOD, V98, P743, DOI 10.1182/blood.V98.3.743; Ayroldi E, 2007, J CLIN INVEST, V117, P1605, DOI 10.1172/JCI30724; Bell LM, 2000, J BIOL CHEM, V275, P25262, DOI 10.1074/jbc.M002076200; Bens M, 1999, J AM SOC NEPHROL, V10, P923; Berrebi D, 2003, BLOOD, V101, P729, DOI 10.1182/blood-2002-02-0538; Bhalla V, 2006, AM J PHYSIOL-RENAL, V291, pF714, DOI 10.1152/ajprenal.00061.2006; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; D'Adamio F, 1997, IMMUNITY, V7, P803, DOI 10.1016/S1074-7613(00)80398-2; Di Marco B, 2007, NUCLEIC ACIDS RES, V35, P517, DOI 10.1093/nar/gkl1080; Dohrmann CE, 1999, MECH DEVELOP, V84, P147, DOI 10.1016/S0925-4773(99)00055-6; Fiol DF, 2005, P NATL ACAD SCI USA, V102, P927, DOI 10.1073/pnas.0408956102; Fiol DF, 2007, FEBS J, V274, P109, DOI 10.1111/j.1742-4658.2006.05569.x; Franchimont D, 2002, J IMMUNOL, V168, P2212, DOI 10.4049/jimmunol.168.5.2212; Hino S, 2000, BIOCHEM BIOPH RES CO, V278, P659, DOI 10.1006/bbrc.2000.3840; Inoue J, 2007, CANCER SCI, V98, P268, DOI 10.1111/j.1349-7006.2007.00389.x; Jay P, 1996, BIOCHEM BIOPH RES CO, V222, P821, DOI 10.1006/bbrc.1996.0825; Kikonyogo A, 2001, P NATL ACAD SCI USA, V98, P11199, DOI 10.1073/pnas.201268998; Levine B, 2007, DEV BIOL, V305, P217, DOI 10.1016/j.ydbio.2007.02.013; Liu WH, 1996, MOL ENDOCRINOL, V10, P1399, DOI 10.1210/me.10.11.1399; Meijer OC, 2000, J NEUROENDOCRINOL, V12, P245; Nakashiro K, 1998, CANCER RES, V58, P549; Pearce D, 2003, CELL PHYSIOL BIOCHEM, V13, P13, DOI 10.1159/000070245; Riccardi C, 2000, THERAPIE, V55, P165; Riccardi C, 1999, CELL DEATH DIFFER, V6, P1182, DOI 10.1038/sj.cdd.4400609; Robert-Nicoud M, 2001, P NATL ACAD SCI USA, V98, P2712, DOI 10.1073/pnas.051603198; SHIBANUMA M, 1992, J BIOL CHEM, V267, P10219; SILLARD R, 1993, EUR J BIOCHEM, V216, P429, DOI 10.1111/j.1432-1033.1993.tb18160.x; Snyder PM, 2005, ENDOCRINOLOGY, V146, P5079, DOI 10.1210/en.2005-0894; Soundararajan R, 2005, J BIOL CHEM, V280, P39970, DOI 10.1074/jbc.M508658200; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Takai Daiya, 2003, In Silico Biology, V3, P235; TREISMAN JE, 1995, DEVELOPMENT, V121, P2835; Vogel P, 1996, BBA-GENE STRUCT EXPR, V1309, P200, DOI 10.1016/S0167-4781(96)00177-7; Waldegger S, 1997, P NATL ACAD SCI USA, V94, P4440, DOI 10.1073/pnas.94.9.4440; Wang JC, 2004, P NATL ACAD SCI USA, V101, P15603, DOI 10.1073/pnas.0407008101; Yamamoto T, 2006, CURR BIOL, V16, P1171, DOI 10.1016/j.cub.2006.04.044; Yang SH, 2003, MOL CELL, V12, P63, DOI 10.1016/S1097-2765(03)00265-X	40	59	62	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36303	36313		10.1074/jbc.M707287200	http://dx.doi.org/10.1074/jbc.M707287200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17956870	hybrid			2022-12-27	WOS:000251458300021
J	You, Z; Omura, S; Ikeda, H; Cane, DE; Jogl, G				You, Zheng; Omura, Satoshi; Ikeda, Haruo; Cane, David E.; Jogl, Gerwald			Crystal structure of the non-heme iron dioxygenase PtIH in pentalenolactone biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KETOGLUTARATE-DEPENDENT DIOXYGENASE; SPIN FE(IV) COMPLEX; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; 2-OXOGLUTARATE OXYGENASES; STREPTOMYCES-AVERMITILIS; ACTIVATION; ENZYMES; CRYSTALLOGRAPHY; IDENTIFICATION; INTERMEDIATE	The non-heme iron dioxygenase PtlH from the soil organism Streptomyces avermitilis is a member of the iron(II)/alpha-ketoglutarate- dependent dioxygenase superfamily and catalyzes an essential reaction in the biosynthesis of the sesquiterpenoid antibiotic pentalenolactone. To investigate the structural basis for substrate recognition and catalysis, we have determined the x-ray crystal structure of PtlH in several complexes with the cofactors iron, alpha-ketoglutarate, and the non-reactive enantiomer of the substrate, ent-1-deoxypentalenicacid, in four different crystal forms to up to 1.31 angstrom resolution. The overall structure of PtlH forms a double stranded barrel helix fold, and the cofactor-binding site for iron and alpha-ketoglutarate is similar to other double-stranded barrel helix fold enzymes. Additional secondary structure elements that contribute to the substrate-binding site in PtlH are not conserved in other double-stranded barrel helix fold enzymes. Binding of the substrate enantiomer induces a reorganization of the monoclinic crystal lattice leading to a disorder-order transition of a C-terminal alpha-helix. The newly formed helix blocks the major access to the active site and effectively traps the bound substrate. Kinetic analysis of wild type and site directed mutant proteins confirms a critical function of two arginine residues in substrate binding, while simulated docking of the enzymatic reaction product reveals the likely orientation of bound substrate.	Brown Univ, Dept Mol & Cell Biol, Providence, RI 02912 USA; Brown Univ, Dept Biochem, Providence, RI 02912 USA; Brown Univ, Dept Chem, Providence, RI 02912 USA; Brown Univ, Dept Biochem, Providence, RI 02912 USA; Kitasato Inst, Minato Ku, Tokyo 1088642, Japan; Kitasato Univ, Kitasato Inst Life Sci, Sagamihara, Kanagawa 2288555, Japan	Brown University; Brown University; Brown University; Brown University; Kitasato University	Jogl, G (corresponding author), Brown Univ, Dept Mol & Cell Biol, Box G-E129, Providence, RI 02912 USA.	Gerwald_Jogl@brown.edu	Jogl, Gerwald/AAJ-5783-2021	Jogl, Gerwald/0000-0002-5465-5315	NIGMS NIH HHS [R01 GM030301-25, R37 GM030301, R01 GM030301-27, R01 GM030301, R01 GM030301-26, GM30301] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030301, R37GM030301] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Blasiak LC, 2006, NATURE, V440, P368, DOI 10.1038/nature04544; Borowski T, 2004, CHEM-EUR J, V10, P1031, DOI 10.1002/chem.200305306; CANE DE, 1989, ARCH BIOCHEM BIOPHYS, V270, P50, DOI 10.1016/0003-9861(89)90006-4; CANE DE, 1994, BIOCHEMISTRY-US, V33, P6524, DOI 10.1021/bi00187a020; Clifton IJ, 2006, J INORG BIOCHEM, V100, P644, DOI 10.1016/j.jinorgbio.2006.01.024; Costas M, 2004, CHEM REV, V104, P939, DOI 10.1021/cr020628n; DeLano W.L, PYMOL MOL GRAPHICS S; DUSZENKO M, 1982, BIOCHIM BIOPHYS ACTA, V714, P344, DOI 10.1016/0304-4165(82)90343-9; ENGLISH AR, 1957, ANTIBIOT ANNU, P682; Frohlich KU, 1996, ARCH MICROBIOL, V165, P179, DOI 10.1007/s002030050313; Hausinger RP, 2004, CRIT REV BIOCHEM MOL, V39, P21, DOI 10.1080/10409230490440541; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; Hewitson KS, 2005, PHILOS T R SOC A, V363, P807, DOI 10.1098/rsta.2004.1540; Hoffart LM, 2006, P NATL ACAD SCI USA, V103, P14738, DOI 10.1073/pnas.0604005103; Hogan DA, 2000, J BIOL CHEM, V275, P12400, DOI 10.1074/jbc.275.17.12400; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Ikeda M, 2001, EUR J PHARMACOL, V411, P45, DOI 10.1016/S0014-2999(00)00894-3; Jogl G, 2001, ACTA CRYSTALLOGR D, V57, P1127, DOI 10.1107/S0907444901006783; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KELLERSC.W, 1972, ARCH MIKROBIOL, V84, P301, DOI 10.1007/BF00409079; Kershaw NJ, 2005, CHEM COMMUN, P4251, DOI 10.1039/b505964j; Koe BK, 1957, ANTIBIOT ANNU, P672; Koehntop KD, 2005, J BIOL INORG CHEM, V10, P87, DOI 10.1007/s00775-005-0624-x; MAURER KH, 1983, J BACTERIOL, V153, P930, DOI 10.1128/JB.153.2.930-936.1983; MAURER RH, 1986, J ANTIBIOT, V39, P266; McDonough MA, 2005, J BIOL CHEM, V280, P41101, DOI 10.1074/jbc.M507528200; Muller I, 2004, BIOCHEMISTRY-US, V43, P3075, DOI 10.1021/bi035752v; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAKAGAWA A, 1985, J ANTIBIOT, V38, P1114, DOI 10.7164/antibiotics.38.1114; OKAZAKI T, 1979, Annual Report of Sankyo Research Laboratories, V31, P94; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Price JC, 2003, BIOCHEMISTRY-US, V42, P7497, DOI 10.1021/bi030011f; Price JC, 2003, J AM CHEM SOC, V125, P13008, DOI 10.1021/ja037400h; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; TAKAHASHI S, 1983, J ANTIBIOT, V36, P226, DOI 10.7164/antibiotics.36.226; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Tetzlaff CN, 2006, BIOCHEMISTRY-US, V45, P6179, DOI 10.1021/bi060419n; You Z, 2006, J AM CHEM SOC, V128, P6566, DOI 10.1021/ja061469i	40	23	27	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36552	36560		10.1074/jbc.M706358200	http://dx.doi.org/10.1074/jbc.M706358200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17942405	Green Accepted, hybrid			2022-12-27	WOS:000251458300048
J	Ferdous, Z; Wei, VM; Iozzo, R; Hook, M; Grande-Allen, KJ				Ferdous, Zannatul; Wei, Victoria Mariko; Iozzo, Renato; Hoeoek, Magnus; Grande-Allen, Kathryn Jane			Decorin-transforming growth factor-beta interaction regulates matrix organization and mechanical characteristics of three-dimensional collagen matrices	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADULT SKIN FIBROBLASTS; SMOOTH-MUSCLE-CELLS; EXTRACELLULAR-MATRIX; PROTEOGLYCANS; EXPRESSION; BIGLYCAN; TENDON; OVEREXPRESSION; FIBRILS; FETAL	The small leucine-rich proteoglycan decorin has been demonstrated to be a key regulator of collagen fibrillogenesis; decorin deficiencies lead to irregularly shaped collagen fibrils and weakened material behavior in postnatal murine connective tissues. In an in vitro investigation of the contributions of decorin to tissue organization and material behavior, model tissues were engineered by seeding embryonic fibroblasts, harvested from 12.5-13.5 days gestational aged decorin null (Dcn(-/-)) or wild-type mice, within type I collagen gels. The resulting three-dimensional collagen matrices were cultured for 4 weeks under static tension. The collagen matrices seeded with Dcn(-/-) cells exhibited greater contraction, cell density, ultimate tensile strength, and elastic modulus than those seeded with wild-type cells. Ultrastructurally, the matrices seeded with Dcn(-/-) cells contained a greater density of collagen. The decorin-null tissues contained more biglycan than control tissues, suggesting that this related proteoglycan compensated for the absence of decorin. The effect of transforming growth factor-beta(TGF-beta), which is normally sequestered by decorin, was also investigated in this study. The addition of TGF-beta 1 to the matrices seeded with wild-type cells improved their contraction and mechanical strength, whereas blocking TGF-beta 1 in the Dcn(-/-) cell-seeded matrices significantly reduced the collagen gel contraction. These results indicate that the inhibitory interaction between decorin and TGF-beta 1 significantly influenced the matrix organization and material behavior of these in vitro model tissues.	Rice Univ, Dept Bioengn, Houston, TX 77005 USA; Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA; Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; Texas A&M Univ Syst Hlth Sci Ctr, Inst Biosci & Biotechnol, Ctr Extracellular Matrix Biol, Houston, TX 77030 USA	Rice University; Jefferson University; Jefferson University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Grande-Allen, KJ (corresponding author), Rice Univ, MS 142,POB 1892, Houston, TX 77251 USA.	grande@rice.edu	Grande-Allen, Kathryn/P-4042-2014; Iozzo, Renato/AAS-1980-2020; Ferdous, Zannatul/GZA-6825-2022	Grande-Allen, Kathryn/0000-0003-1533-3767; Ferdous, Zannatul/0000-0002-6007-2183; Iozzo, Renato/0000-0002-5908-5112	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R03EB005444] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		Alberts B., 2008, MOL BIOL CEL, V5th ed.; Ameye L, 2002, GLYCOBIOLOGY, V12, p107R, DOI 10.1093/glycob/cwf065; Ameye L, 2002, FASEB J, V16, DOI 10.1096/fj.01-0848com; Anaguchi Y, 2005, CLIN BIOMECH, V20, P959, DOI 10.1016/j.clinbiomech.2005.05.012; Arora PD, 1999, AM J PATHOL, V154, P871, DOI 10.1016/S0002-9440(10)65334-5; Bates SJ, 2006, J BONE JOINT SURG AM, V88A, P2465, DOI 10.2106/JBJS.E.00143; Bhide VM, 2005, J BIOL CHEM, V280, P23103, DOI 10.1074/jbc.M410060200; BIANCO P, 1990, J HISTOCHEM CYTOCHEM, V38, P1549, DOI 10.1177/38.11.2212616; Bittner K, 1996, BIOCHEM J, V314, P159, DOI 10.1042/bj3140159; CHEN WYJ, 1989, J CELL SCI, V94, P577; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; DeLuca A, 1996, J BIOL CHEM, V271, P18961, DOI 10.1074/jbc.271.31.18961; Derwin KA, 2001, J ORTHOP RES, V19, P269, DOI 10.1016/S0736-0266(00)00032-2; Droguett R, 2006, MATRIX BIOL, V25, P332, DOI 10.1016/j.matbio.2006.04.004; Ellis IR, 1998, CYTOKINE, V10, P281, DOI 10.1006/cyto.1997.0294; Ellis IR, 1996, EXP CELL RES, V228, P326, DOI 10.1006/excr.1996.0332; Evans CH, 1999, SPORTS MED, V28, P71, DOI 10.2165/00007256-199928020-00001; Fischer JW, 2001, ARTERIOSCL THROM VAS, V21, P777, DOI 10.1161/01.ATV.21.5.777; GHAHARY A, 1993, J LAB CLIN MED, V122, P465; Grande-Allen KJ, 2004, GLYCOBIOLOGY, V14, P621, DOI 10.1093/glycob/cwh076; Grassl ED, 2003, J BIOMED MATER RES A, V66A, P550, DOI 10.1002/jbm.a.10589; Grinnell F, 2006, EXP CELL RES, V312, P86, DOI 10.1016/j.yexcr.2005.010.001; Grinnell F, 2003, TRENDS CELL BIOL, V13, P264, DOI 10.1016/S0962-8924(03)00057-6; GRINNELL F, 1994, J CELL BIOL, V124, P401, DOI 10.1083/jcb.124.4.401; Gupta V, 2007, TISSUE ENG, V13, P41, DOI 10.1089/ten.2006.0091; Hakkinen L, 2000, LAB INVEST, V80, P1869, DOI 10.1038/labinvest.3780197; Hay E.D., 1991, CELL BIOL EXTRACELLU, DOI 10.1007/978-1-4615-3770-0; Imai K, 1997, BIOCHEM J, V322, P809, DOI 10.1042/bj3220809; Iozzo RV, 1999, J BIOL CHEM, V274, P18843, DOI 10.1074/jbc.274.27.18843; Iozzo RV, 1999, J BIOL CHEM, V274, P4489, DOI 10.1074/jbc.274.8.4489; Iozzo RV, 1998, ANNU REV BIOCHEM, V67, P609, DOI 10.1146/annurev.biochem.67.1.609; Jarvelainen H, 2004, ARTERIOSCL THROM VAS, V24, P67, DOI 10.1161/01.ATV.0000107026.98626.3b; Kaji T, 2000, J BIOL CHEM, V275, P1463, DOI 10.1074/jbc.275.2.1463; Kinsella MG, 2004, CRIT REV EUKAR GENE, V14, P203, DOI 10.1615/CritRevEukaryotGeneExpr.v14.i3.40; Kresse H, 2001, J CELL PHYSIOL, V189, P266, DOI 10.1002/jcp.10030; LABARCA C, 1980, ANAL BIOCHEM, V102, P344, DOI 10.1016/0003-2697(80)90165-7; Lara S L, 2001, Methods Mol Biol, V171, P271; Liao J, 2007, J BIOMECH, V40, P390, DOI 10.1016/j.jbiomech.2005.12.011; Malmstrom J, 2004, MOL CELL PROTEOMICS, V3, P466, DOI 10.1074/mcp.M300108-MCP200; Markmann A, 2000, MATRIX BIOL, V19, P631, DOI 10.1016/S0945-053X(00)00097-4; MAUVIEL A, 1993, J CELL BIOCHEM, V53, P288, DOI 10.1002/jcb.240530404; Meshel AS, 2005, NAT CELL BIOL, V7, P157, DOI 10.1038/ncb1216; Miura T, 2006, BIOCHEM BIOPH RES CO, V340, P675, DOI 10.1016/j.bbrc.2005.12.060; Moscatello DK, 1998, J CLIN INVEST, V101, P406, DOI 10.1172/JCI846; Nomura Y, 2006, CONNECT TISSUE RES, V47, P249, DOI 10.1080/03008200600846606; NUSGENS B, 1984, COLLAGEN REL RES, V4, P351; Orgel JPRO, 2006, P NATL ACAD SCI USA, V103, P9001, DOI 10.1073/pnas.0502718103; PELTONEN J, 1991, J INVEST DERMATOL, V97, P240, DOI 10.1111/1523-1747.ep12480289; Petridou S, 2000, INVEST OPHTH VIS SCI, V41, P89; Reed CC, 2002, GLYCOCONJUGATE J, V19, P249, DOI 10.1023/A:1025383913444; RIIKONEN T, 1995, J BIOL CHEM, V270, P376, DOI 10.1074/jbc.270.1.376; Robinson PS, 2005, J BIOMECH ENG-T ASME, V127, P181, DOI 10.1115/1.1835363; Scherping SC, 1997, CONNECT TISSUE RES, V36, P1, DOI 10.3109/03008209709160209; Schonherr E, 2005, J BIOL CHEM, V280, P15767, DOI 10.1074/jbc.M500451200; Seidler DG, 2006, J BIOL CHEM, V281, P26408, DOI 10.1074/jbc.M602853200; Seidler DG, 2005, BIOCHEM BIOPH RES CO, V332, P1162, DOI 10.1016/j.bbrc.2005.04.175; Shafritz T. Alex, 1994, Wound Repair and Regeneration, V2, P270, DOI 10.1046/j.1524-475X.1994.20407.x; Sigel AV, 1996, J MOL CELL CARDIOL, V28, P1921, DOI 10.1006/jmcc.1996.0185; Uria JA, 1998, J BIOL CHEM, V273, P9769, DOI 10.1074/jbc.273.16.9769; VOGEL KG, 1987, COLLAGEN REL RES, V7, P105; Wagenseil JE, 2003, J BIOMECH ENG-T ASME, V125, P719, DOI 10.1115/1.1614818; Walsh AJL, 2004, SPINE, V29, P156, DOI 10.1097/01.BRS.0000107231.67854.9F; Zen AAH, 2003, MATRIX BIOL, V22, P251, DOI 10.1016/S0945-053X(03)00018-0; Zhang GY, 2006, J CELL BIOCHEM, V98, P1436, DOI 10.1002/jcb.20776	64	108	108	2	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35887	35898		10.1074/jbc.M705180200	http://dx.doi.org/10.1074/jbc.M705180200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17942398	hybrid			2022-12-27	WOS:000251458100050
J	Zapata, A; Kivell, B; Han, Y; Javitch, JA; Bolan, EA; Kuraguntla, D; Jaligam, V; Oz, M; Jayanthi, LD; Samuvel, DJ; Ramamoorthy, S; Shippenberg, TS				Zapata, Agustin; Kivell, Bronwyn; Han, Yang; Javitch, Jonathan A.; Bolan, Elizabeth A.; Kuraguntla, David; Jaligam, Vanaja; Oz, Murat; Jayanthi, Lankupalle D.; Samuvel, Devadoss J.; Ramamoorthy, Sammanda; Shippenberg, Toni S.			Regulation of dopamine transporter function and cell surface expression by D3 dopamine receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; ELEMENT-BINDING PROTEIN; WILD-TYPE MICE; D-3 RECEPTOR; IN-VIVO; PHOSPHATIDYLINOSITOL 3-KINASE; DEPENDENT MECHANISM; PHORBOL ESTERS; NEUROTRANSMITTER TRANSPORTERS; NOREPINEPHRINE TRANSPORTER	D-3 dopamine receptors are expressed by dopamine neurons and are implicated in the modulation of presynaptic dopamine neurotransmission. The mechanisms underlying this modulation remain ill defined. The dopamine transporter, which terminates dopamine transmission via reuptake of released neurotransmitter, is regulated by receptor- and second messenger-linked signaling pathways. Whether D3 receptors regulate dopamine transporter function is unknown. We addressed this issue using a fluorescent imaging technique that permits real time quantification of dopamine transporter function in living single cells. Accumulation of the fluorescent dopamine transporter substrate trans-4-[4-(dimethylamino) styryl]-1-methylpyridinium (ASP(+)) in human embryonic kidney cells expressing human dopamine transporter was saturable and temperature-dependent. In cells co-expressing dopamine transporter and D3 receptors, the D2/D3 agonist quinpirole produced a rapid, concentration-dependent, and pertussis toxin-sensitive increase of ASP(+) uptake. Similar agonist effects were observed in Neuro2A cells and replicated in human embryonic kidney cells using a radioligand uptake assay in which binding to and activation of D3 receptors by [H-3] dopamine was prevented. D3 receptor stimulation activated phosphoinositide 3-kinase and MAPK. Inhibition of either kinase prevented the quinpirole-induced increase in uptake. D3 receptor activation differentially affected dopamine transporter function and subcellular distribution depending on the duration of agonist exposure. Biotinylation experiments revealed that the rapid increase of uptake was associated with increased cell surface and decreased intracellular expression and increased dopamine transporter exocytosis. In contrast, prolonged agonist exposure reduced uptake and transporter cell surface expression. These results demonstrate that D3 receptors regulate dopamine transporter function and identify a novel mechanism by which D3 receptors regulate extracellular dopamine concentrations.	NIDA, Integrat Neurosci Sect, NIH, Intramural Res Program,Dept Hlth & Human Serv, Baltimore, MD 21224 USA; Columbia Univ, Coll Phys & Surg, Ctr Mol Recognit, Dept Psychiat, New York, NY 10032 USA; Columbia Univ, Coll Phys & Surg, Ctr Mol Recognit, Dept Pharmacol, New York, NY 10032 USA; Med Univ S Carolina, Dept Neurosci, Div Neurosci Res, Charleston, SC 29425 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA); Columbia University; Columbia University; Medical University of South Carolina	Shippenberg, TS (corresponding author), NIDA, Integrat Neurosci Sect, NIH, Intramural Res Program,Dept Hlth & Human Serv, 5500 Nathan Shock Dr, Baltimore, MD 21224 USA.	tshippen@intra.nida.nih.gov	Kivell, Bronwyn M/P-3140-2014; Oz, Murat/E-2148-2012	Kivell, Bronwyn M/0000-0001-9699-553X; Javitch, Jonathan/0000-0001-7395-2967	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081054] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH054137, R01MH062612] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA022413, Z01DA000538, R01DA011495, P50DA015369] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NIDA NIH HHS [K05 DA022413, P50DA015369, DA11495] Funding Source: Medline; NIGMS NIH HHS [GM081054] Funding Source: Medline; NIMH NIH HHS [MH57324, MH54137, MH062612] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; AMARA SG, 1993, ANNU REV NEUROSCI, V16, P73, DOI 10.1146/annurev.ne.16.030193.000445; Apparsundaram S, 2001, J PHARMACOL EXP THER, V299, P666; Batchelor M, 1998, J NEUROSCI, V18, P10304; Beom SR, 2004, J BIOL CHEM, V279, P28304, DOI 10.1074/jbc.M403899200; Bolan EA, 2007, MOL PHARMACOL, V71, P1222, DOI 10.1124/mol.106.027763; Boulay D, 1999, NEUROPHARMACOLOGY, V38, P555, DOI 10.1016/S0028-3908(98)00213-5; Brami-Cherrier K, 2002, J NEUROSCI, V22, P8911; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; Carvelli L, 2002, J NEUROCHEM, V81, P859, DOI 10.1046/j.1471-4159.2002.00892.x; CASS WA, 1994, NEUROSCI LETT, V176, P259, DOI 10.1016/0304-3940(94)90096-5; Cervinski MA, 2005, J BIOL CHEM, V280, P40442, DOI 10.1074/jbc.M501969200; Copeland BJ, 1996, J PHARMACOL EXP THER, V277, P1527; Cussac D, 1999, MOL PHARMACOL, V56, P1025, DOI 10.1124/mol.56.5.1025; Depoortere R, 1999, PSYCHOPHARMACOLOGY, V147, P20, DOI 10.1007/s002130051133; Dickinson SD, 1999, J NEUROCHEM, V72, P148, DOI 10.1046/j.1471-4159.1999.0720148.x; Ekman A, 1998, N-S ARCH PHARMACOL, V358, P342, DOI 10.1007/PL00005263; Elmhurst JL, 2000, MOL BRAIN RES, V80, P63, DOI 10.1016/S0169-328X(00)00120-0; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Foster JD, 2002, J BIOL CHEM, V277, P25178, DOI 10.1074/jbc.M200294200; Fournier KM, 2004, J BIOL CHEM, V279, P34505, DOI 10.1074/jbc.M404032200; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Granas C, 2003, J BIOL CHEM, V278, P4990, DOI 10.1074/jbc.M205058200; Gulley JM, 2003, EUR J PHARMACOL, V479, P139, DOI 10.1016/j.ejphar.2003.08.064; Huff RA, 1997, J NEUROCHEM, V68, P225; Jayanthi LD, 2006, J BIOL CHEM, V281, P23326, DOI 10.1074/jbc.M601156200; Jayanthi LD, 2004, J BIOL CHEM, V279, P19315, DOI 10.1074/jbc.M311172200; Johnson LA, 2005, NEUROPHARMACOLOGY, V49, P750, DOI 10.1016/j.neuropharm.2005.08.018; Joseph JD, 2002, NEUROSCIENCE, V112, P39, DOI 10.1016/S0306-4522(02)00067-2; Joyce JN, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-22; Joyce JN, 2005, DRUG DISCOV TODAY, V10, P917, DOI 10.1016/S1359-6446(05)03491-4; Joyce JN, 2001, PHARMACOL THERAPEUT, V90, P231, DOI 10.1016/S0163-7258(01)00139-5; Kahlig KM, 2004, J BIOL CHEM, V279, P8966, DOI 10.1074/jbc.M303976200; Kelkar DA, 2007, BBA-BIOMEMBRANES, V1768, P2011, DOI 10.1016/j.bbamem.2007.05.011; Khoshbouei H, 2003, J BIOL CHEM, V278, P12070, DOI 10.1074/jbc.M212815200; Kim KM, 2001, J BIOL CHEM, V276, P37409, DOI 10.1074/jbc.M106728200; KITAYAMA S, 1994, EUR J PHARM-MOLEC PH, V268, P115, DOI 10.1016/0922-4106(94)90180-5; KIVELL BM, 2004, SOC NEUROSCI ABSTR V; Koeltzow TE, 1998, J NEUROSCI, V18, P2231; Le Foll B, 2000, EUR PSYCHIAT, V15, P140, DOI 10.1016/S0924-9338(00)00219-4; Lee-Kwon W, 2003, J BIOL CHEM, V278, P16494, DOI 10.1074/jbc.M300580200; Li LB, 2004, J BIOL CHEM, V279, P21012, DOI 10.1074/jbc.M311972200; Lin ZC, 2003, J BIOL CHEM, V278, P20162, DOI 10.1074/jbc.M209584200; Loder MK, 2003, J BIOL CHEM, V278, P22168, DOI 10.1074/jbc.M301845200; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; Mason JN, 2005, J NEUROSCI METH, V143, P3, DOI 10.1016/j.jneumeth.2004.09.028; Mayfield RD, 2001, MOL PHARMACOL, V59, P113, DOI 10.1124/mol.59.1.113; MEIERGERD SM, 1993, J NEUROCHEM, V61, P764; Melikian HE, 2004, PHARMACOL THERAPEUT, V104, P17, DOI 10.1016/j.pharmthera.2004.07.006; Melikian HE, 1999, J NEUROSCI, V19, P7699; Moron JA, 2003, J NEUROSCI, V23, P8480; NEUMEYER JL, 1992, J MED CHEM, V35, P1466, DOI 10.1021/jm00086a016; Neve KA, 2004, J RECEPT SIG TRANSD, V24, P165, DOI 10.1081/LRST-200029981; Prasad BM, 2001, J NEUROSCI, V21, P7561, DOI 10.1523/JNEUROSCI.21-19-07561.2001; Robbins AK, 1998, BIOTECHNIQUES, V25, P240, DOI 10.2144/98252st04; Samuvel DJ, 2005, J NEUROSCI, V25, P29, DOI 10.1523/JNEUROSCI.3754-04.2005; Saunders C, 2000, P NATL ACAD SCI USA, V97, P6850, DOI 10.1073/pnas.110035297; Schwartz JC, 2000, BRAIN RES REV, V31, P277, DOI 10.1016/S0165-0173(99)00043-0; Schwartz JW, 2003, J BIOL CHEM, V278, P9768, DOI 10.1074/jbc.M209824200; SOKOLOFF P, 1990, NATURE, V347, P146, DOI 10.1038/347146a0; STRYER L, 1986, ANNU REV CELL BIOL, V2, P391, DOI 10.1146/annurev.cb.02.110186.002135; Tepper JM, 1997, J NEUROSCI, V17, P2519; Torres GE, 2003, NAT REV NEUROSCI, V4, P13, DOI 10.1038/nrn1008; Versteeg HH, 2000, BIOCHEM J, V350, P717, DOI 10.1042/0264-6021:3500717; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Wang D, 2005, J BIOL CHEM, V280, P18703, DOI 10.1074/jbc.M500381200; Witkin JM, 2004, J PHARMACOL EXP THER, V308, P957, DOI 10.1124/jpet.103.059980; Xu M, 1999, SYNAPSE, V31, P210, DOI 10.1002/(SICI)1098-2396(19990301)31:3<210::AID-SYN6>3.3.CO;2-S; Zahniser NR, 2001, PHARMACOL THERAPEUT, V92, P21, DOI 10.1016/S0163-7258(01)00158-9; Zapata A, 2002, J NEUROCHEM, V81, P1035, DOI 10.1046/j.1471-4159.2002.00893.x; Zapata A, 2001, NEUROPHARMACOLOGY, V41, P351, DOI 10.1016/S0028-3908(01)00069-7	71	82	82	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35842	35854		10.1074/jbc.M611758200	http://dx.doi.org/10.1074/jbc.M611758200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17923483	hybrid			2022-12-27	WOS:000251458100046
J	Mancuso, DJ; Sims, HF; Han, XL; Jenkins, CM; Guan, SP; Yang, K; Moon, SH; Pietka, T; Abumrad, NA; Schlesinger, PH; Gross, RW				Mancuso, David J.; Sims, Harold F.; Han, Xianlin; Jenkins, Christopher M.; Guan, Shao Ping; Yang, Kui; Moon, Sung Ho; Pietka, Terri; Abumrad, Nada A.; Schlesinger, Paul H.; Gross, Richard W.			Genetic ablation of calcium-independent phospholipase A(2)gamma leads to alterations in mitochondrial lipid metabolism and function resulting in a deficient mitochondrial bioenergetic phenotype	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C; SHOTGUN LIPIDOMICS; CALORIC RESTRICTION; SIGNALING PATHWAYS; BARTH-SYNDROME; A(2) IPLA(2); CARDIOLIPIN; BRAIN; IDENTIFICATION; ACCUMULATION	Previously, we identified a novel calcium-independent phospholipase, designated calcium-independent phospholipase A(2) gamma (iPLA(2)gamma),which possesses dual mitochondrial and peroxisomal subcellular localization signals. To identify the roles of iPLA(2)gamma in cellular bioenergetics, we generated mice null for the iPLA(2)gamma gene by eliminating the active site of the enzyme through homologous recombination. Mice null for iPLA(2)gamma display multiple bioenergetic dysfunctional phenotypes, including 1) growth retardation, 2) cold intolerance, 3) reduced exercise endurance, 4) greatly increased mortality from cardiac stress after transverse aortic constriction, 5) abnormal mitochondrial function with a 65% decrease in ascorbate-induced Complex IV-mediated oxygen consumption, and 6) a reduction in myocardial cardiolipin content accompanied by an altered cardiolipin molecular species composition. We conclude that iPLA(2)gamma is essential for maintaining efficient bioenergetic mitochondrial function through tailoring mitochondrial membrane lipid metabolism and composition.	Washington Univ, Sch Med, Dept Med, Div Bioorgan Chem & Mol Pharmacol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Cell Biol & Physiol, Div Nutr Sci, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; Washington Univ, Dept Chem, St Louis, MO 63130 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Gross, RW (corresponding author), Washington Univ, Sch Med, Dept Med, Div Bioorgan Chem & Mol Pharmacol, St Louis, MO 63110 USA.	rgross@wustl.edu	Schlesinger, Paul H/C-6049-2012		NHLBI NIH HHS [5P01HL57278-10, R01 HL041250, P01 HL057278-10, P01 HL057278] Funding Source: Medline; NIDDK NIH HHS [R01 DK033301, P30 DK056341-06, P30 DK056341-07, P30 DK056341, DK56351] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL057278, R01HL041250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK033301, P30DK056341] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bao SZ, 2004, J BIOL CHEM, V279, P38194, DOI 10.1074/jbc.M406489200; BOLHUIS PA, 1991, AM J HUM GENET, V48, P481; Bonventre JV, 1997, NATURE, V390, P622, DOI 10.1038/37635; Breen EP, 2006, J BIOL CHEM, V281, P2114, DOI 10.1074/jbc.M511575200; Brustovetsky T, 2005, J NEUROCHEM, V94, P980, DOI 10.1111/j.1471-4159.2005.03248.x; Budnik LT, 2002, BIOL REPROD, V67, P935, DOI 10.1095/biolreprod.101.003087; Budnik Lygia T, 2003, Reprod Biol Endocrinol, V1, P37, DOI 10.1186/1477-7827-1-37; Chen JL, 2005, J BIOL CHEM, V280, P25396, DOI 10.1074/jbc.M413948200; Dahlberg M, 2007, J PHYS CHEM B, V111, P7194, DOI 10.1021/jp071954f; DiMarzo V, 1996, BIOCHEM BIOPH RES CO, V227, P281, DOI 10.1006/bbrc.1996.1501; Duchen MR, 2004, DIABETES, V53, pS96, DOI 10.2337/diabetes.53.2007.S96; Filosto M, 2007, ACTA NEUROL SCAND, V115, P211, DOI 10.1111/j.1600-0404.2006.00777.x; Fujishima H, 1999, P NATL ACAD SCI USA, V96, P4803, DOI 10.1073/pnas.96.9.4803; Gadd ME, 2006, J BIOL CHEM, V281, P6931, DOI 10.1074/jbc.M510845200; Garlid KD, 1996, J BIOL CHEM, V271, P2615, DOI 10.1074/jbc.271.5.2615; Garrido C, 2006, CELL DEATH DIFFER, V13, P1423, DOI 10.1038/sj.cdd.4401950; Goldenthal MJ, 2004, MOL CELL BIOCHEM, V262, P1, DOI 10.1023/B:MCBI.0000038228.85494.3b; Gomez B, 1999, BIOCHEMISTRY-US, V38, P9031, DOI 10.1021/bi990603r; Haber EP, 2003, J CELL PHYSIOL, V194, P1, DOI 10.1002/jcp.10187; Han XL, 2007, BIOCHEMISTRY-US, V46, P6417, DOI 10.1021/bi7004015; Han XL, 2000, BIOCHEM J, V352, P79, DOI 10.1042/0264-6021:3520079; Han XL, 2006, J LIPID RES, V47, P864, DOI 10.1194/jlr.D500044-JLR200; Han XL, 2005, EXPERT REV PROTEOMIC, V2, P253, DOI 10.1586/14789450.2.2.253; Han XL, 2004, BIOCHEMISTRY-US, V43, P15584, DOI 10.1021/bi048307o; Han XL, 2005, MASS SPECTROM REV, V24, P367, DOI 10.1002/mas.20023; Heath-Engel HM, 2006, BBA-MOL CELL RES, V1763, P549, DOI 10.1016/j.bbamcr.2006.02.006; Huss JM, 2005, J CLIN INVEST, V115, P547, DOI 10.1172/JCI200524405; Kinsey GR, 2007, AM J PHYSIOL-RENAL, V292, pF853, DOI 10.1152/ajprenal.00318.2006; Klingenspor M, 2003, EXP PHYSIOL, V88, P141, DOI 10.1113/eph8802508; Lelliott CJ, 2006, PLOS BIOL, V4, P2042, DOI 10.1371/journal.pbio.0040369; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; MacDonald MJ, 2005, AM J PHYSIOL-ENDOC M, V288, pE1, DOI 10.1152/ajpendo.00218.2004; Mancuso DJ, 2007, J BIOL CHEM, V282, P9216, DOI 10.1074/jbc.M607307200; Mancuso DJ, 2004, EUR J BIOCHEM, V271, P4709, DOI 10.1111/j.1432-1033.2004.04435.x; Mancuso DJ, 2000, J BIOL CHEM, V275, P9937, DOI 10.1074/jbc.275.14.9937; Marin-Garcia J, 2004, J MOL MED, V82, P565, DOI 10.1007/s00109-004-0567-7; McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054; McFarland R, 2007, CURR TOP DEV BIOL, V77, P113, DOI 10.1016/S0070-2153(06)77005-3; Mingrone G, 2004, ANN NY ACAD SCI, V1033, P99, DOI 10.1196/annals.1320.009; Monemdjou S, 2000, AM J PHYSIOL-ENDOC M, V279, pE941, DOI 10.1152/ajpendo.2000.279.4.E941; Mozo J, 2005, BIOSCIENCE REP, V25, P227, DOI 10.1007/s10540-005-2887-4; Nedergaard J, 2001, BIOCHEM SOC T, V29, P756; Nicholls D.G., 2001, BIOENERGETICS, V3; Pete MJ, 1996, J BIOL CHEM, V271, P18114, DOI 10.1074/jbc.271.30.18114; PINHEIRO TJT, 1994, BIOCHEMISTRY-US, V33, P2459, DOI 10.1021/bi00175a014; Porter RK, 2006, BBA-BIOENERGETICS, V1757, P446, DOI 10.1016/j.bbabio.2006.04.012; Ramanadham S, 2004, BIOCHEMISTRY-US, V43, P918, DOI 10.1021/bi035536m; Ricci JE, 2003, J CELL BIOL, V160, P65, DOI 10.1083/jcb.200208089; Ricquier D, 2005, P NUTR SOC, V64, P47, DOI 10.1079/PNS2004408; Ritz P, 2005, CURR OPIN CLIN NUTR, V8, P415, DOI 10.1097/01.mco.0000172582.86890.19; ROBINSON NC, 1993, J BIOENERG BIOMEMBR, V25, P153, DOI 10.1007/BF00762857; ROCKMAN HA, 1991, P NATL ACAD SCI USA, V88, P8277, DOI 10.1073/pnas.88.18.8277; Rosenberger TA, 2003, J LIPID RES, V44, P109, DOI 10.1194/jlr.M200298-JLR200; Schlame M, 2005, CHEM PHYS LIPIDS, V138, P38, DOI 10.1016/j.chemphyslip.2005.08.002; Schlame M, 2002, ANN NEUROL, V51, P634, DOI 10.1002/ana.10176; Schlame M, 2006, FEBS LETT, V580, P5450, DOI 10.1016/j.febslet.2006.07.022; Seleznev K, 2006, J BIOL CHEM, V281, P22275, DOI 10.1074/jbc.M604330200; Shinzawa-Itoh K, 2007, EMBO J, V26, P1713, DOI 10.1038/sj.emboj.7601618; Siciliano G, 2007, BIOSCIENCE REP, V27, P53, DOI 10.1007/s10540-007-9037-0; SIEGEL DP, 1984, BIOPHYS J, V45, P399, DOI 10.1016/S0006-3495(84)84164-8; SIL VAJE, 2006, PHYS REV, V86, P435; SKULACHEV VP, 1991, FEBS LETT, V294, P158, DOI 10.1016/0014-5793(91)80658-P; Sonoda J, 2007, P NATL ACAD SCI USA, V104, P5223, DOI 10.1073/pnas.0611623104; Spencer CT, 2006, PEDIATRICS, V118, pE337, DOI 10.1542/peds.2005-2667; Stewart A, 2002, J BIOL CHEM, V277, P29526, DOI 10.1074/jbc.M204856200; Su X, 2005, BIOCHEMISTRY-US, V44, P5234, DOI 10.1021/bi047773a; Tolwani RJ, 2005, PLOS GENET, V1, P205, DOI 10.1371/journal.pgen.0010023; Tsukihara T, 2003, P NATL ACAD SCI USA, V100, P15304, DOI 10.1073/pnas.2635097100; Turk J, 2004, CAN J PHYSIOL PHARM, V82, P824, DOI 10.1139/Y04-064; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; Vercesi AE, 2006, FRONT BIOSCI-LANDMRK, V11, P2554, DOI 10.2741/1990; Villena JA, 2007, P NATL ACAD SCI USA, V104, P1418, DOI 10.1073/pnas.0607696104; Vreken P, 2000, BIOCHEM BIOPH RES CO, V279, P378, DOI 10.1006/bbrc.2000.3952; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wallace DC, 2001, AM J MED GENET, V106, P71, DOI 10.1002/ajmg.1393; Wallace DC, 2001, MENT RETARD DEV D R, V7, P158, DOI 10.1002/mrdd.1023; Wallace Douglas C, 2002, Methods Mol Biol, V197, P3, DOI 10.1385/1-59259-284-8:003; Wang ZP, 2005, J BIOL CHEM, V280, P6840, DOI 10.1074/jbc.M405287200; Williams SD, 2002, BIOCHEM J, V362, P23, DOI 10.1042/bj3620023; Wilson PA, 2006, J LIPID RES, V47, P1940, DOI 10.1194/jlr.M600185-JLR200; Xing HM, 2000, EMBO J, V19, P349, DOI 10.1093/emboj/19.3.349; Xu Y, 2003, J BIOL CHEM, V278, P51380, DOI 10.1074/jbc.M307382200; Xu Y, 2006, J BIOL CHEM, V281, P39217, DOI 10.1074/jbc.M606100200; Yan W, 2005, J BIOL CHEM, V280, P26669, DOI 10.1074/jbc.M502358200; Zhang M, 2002, J BIOL CHEM, V277, P43553, DOI 10.1074/jbc.C200551200	85	117	118	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					34611	34622		10.1074/jbc.M707795200	http://dx.doi.org/10.1074/jbc.M707795200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17923475	Green Accepted, hybrid			2022-12-27	WOS:000251155200003
J	Torres-Salazar, D; Fahlke, C				Torres-Salazar, Delany; Fahlke, Christoph			Neuronal glutamate transporters vary in substrate transport rate but not in unitary anion channel conductance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID TRANSPORTERS; CEREBELLAR PURKINJE-CELLS; GATED CHLORIDE CHANNEL; INDIVIDUAL SUBUNITS; ION-CHANNEL; CURRENTS; EAAT4; NEURODEGENERATION; TRANSLOCATION; ACTIVATION	Excitatory amino acid transporters (EAATs) not only sustain a secondary active glutamate transport but also function as anion-selective ion channels. The relative proportion of currents generated by glutamate transport or by the chloride conductance varies for each cloned EAAT subtype. For EAAT1, EAAT2, and EAAT3, the anion current is only a small component of the total transporter-associated current amplitude, whereas EAAT4 and EAAT5 transporters mediate predominantly anion currents. We here demonstrate that the distinct current proportions are entirely due to differences in glutamate transport rates. EAAT3 and EAAT4 differ in unitary glutamate transport rates as well as in the voltage and substrate dependence of anion channel opening, but ion conduction properties are very similar. Noise analysis revealed identical unitary current amplitudes and similar absolute open probabilities for the two anion channels. The low glutamate transport rate of EAAT4 allows regulation of cellular excitability without interfering with extracellular glutamate homeostasis and makes this EAAT isoform ideally suited to regulate excitability in dendritic spines of Purkinje neurons.	Inst Neurophysiol, Med Hochschule, D-30625 Hannover, Germany; Zentrum Systemische Neurowissenschaften, D-30625 Hannover, Germany		Fahlke, C (corresponding author), Inst Neurophysiol, Med Hochschule, D-30625 Hannover, Germany.	fahlke.christoph@mh-hannover.de	Fahlke, Christoph/G-3635-2013	Fahlke, Christoph/0000-0001-8602-9952; Torres-Salazar, Delany/0000-0002-6789-9810				Alvarez O, 2002, ADV PHYSIOL EDUC, V26, P327, DOI 10.1152/advan.00006.2002; Aoyama K, 2006, NAT NEUROSCI, V9, P119, DOI 10.1038/nn1609; Callaway JC, 1997, J NEUROPHYSIOL, V77, P145, DOI 10.1152/jn.1997.77.1.145; Dehnes Y, 1998, J NEUROSCI, V18, P3606; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; Fairman WA, 1999, AM J PHYSIOL-RENAL, V277, pF481, DOI 10.1152/ajprenal.1999.277.4.F481; Gendreau S, 2004, J BIOL CHEM, V279, P39505, DOI 10.1074/jbc.M408038200; Grewer C, 2000, P NATL ACAD SCI USA, V97, P9706, DOI 10.1073/pnas.160170397; Grewer C, 2005, BIOCHEMISTRY-US, V44, P11913, DOI 10.1021/bi050987n; Grewer C, 2001, BIOCHEMISTRY-US, V40, P232, DOI 10.1021/bi0015919; HARVEY RJ, 1991, PROG NEUROBIOL, V36, P437, DOI 10.1016/0301-0082(91)90012-P; HODGKIN AL, 1949, J PHYSIOL-LONDON, V108, P37, DOI 10.1113/jphysiol.1949.sp004310; Huang YHH, 2004, J NEUROSCI, V24, P103, DOI 10.1523/JNEUROSCI.4473-03.2004; Koch HP, 2007, J NEUROSCI, V27, P2943, DOI 10.1523/JNEUROSCI.0118-07.2007; Larsson HP, 1996, BIOPHYS J, V70, P733, DOI 10.1016/S0006-3495(96)79613-3; Leary GP, 2007, J NEUROSCI, V27, P2938, DOI 10.1523/JNEUROSCI.4851-06.2007; Levy LM, 1998, J NEUROSCI, V18, P9620, DOI 10.1523/jneurosci.18-23-09620.1998; Melzer N, 2005, P NATL ACAD SCI USA, V102, P19214, DOI 10.1073/pnas.0508837103; Melzer N, 2003, J BIOL CHEM, V278, P50112, DOI 10.1074/jbc.M307990200; Mim C, 2005, J GEN PHYSIOL, V126, P571, DOI 10.1085/jgp.200509365; Otis TS, 1998, J NEUROSCI, V18, P7099; Palmer MJ, 2003, J NEUROSCI, V23, P4831; Peghini P, 1997, EMBO J, V16, P3822, DOI 10.1093/emboj/16.13.3822; Sesti F, 1998, J GEN PHYSIOL, V112, P651, DOI 10.1085/jgp.112.6.651; Shimamoto K, 1998, MOL PHARMACOL, V53, P195, DOI 10.1124/mol.53.2.195; SIGWORTH FJ, 1992, METHOD ENZYMOL, V207, P746; SIGWORTH FJ, 1980, J PHYSIOL-LONDON, V307, P97, DOI 10.1113/jphysiol.1980.sp013426; Torres-Salazar D, 2006, J NEUROSCI, V26, P7513, DOI 10.1523/JNEUROSCI.4545-05.2006; Trotti D, 2001, BRAIN RES, V914, P196, DOI 10.1016/S0006-8993(01)02802-5; Wadiche JI, 1998, J NEUROSCI, V18, P7650; WADICHE JI, 1995, NEURON, V15, P721, DOI 10.1016/0896-6273(95)90159-0; Watzke N, 2001, FEBS LETT, V503, P121, DOI 10.1016/S0014-5793(01)02715-6; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0	33	35	36	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					34719	34726		10.1074/jbc.M704118200	http://dx.doi.org/10.1074/jbc.M704118200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17908688	hybrid			2022-12-27	WOS:000251155200014
J	Wood, JL; Singh, N; Mer, G; Chen, JJ				Wood, Jamie L.; Singh, Namit; Mer, Georges; Chen, Junjie			MCPH1 functions in an H2AX-dependent but MDC1-independent pathway in response to DNA damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHECKPOINT CONTROL; PROTEIN; MDC1; BRCA1; CHK1; MICROCEPHALIN; ACTIVATION; 53BP1; P53	Microcephalin (MCPH1) is one of the causative genes for the autosomal recessive disorder, primary microcephaly, characterized by dramatic reduction in brain size and mental retardation. MCPH1 also functions in the DNA damage response, participating in cell cycle checkpoint control. However, how MCPH1 is regulated in the DNA damage response still remains unknown. Here we report that the ability of MCPH1 to localize to the sites of DNA double-strand breaks depends on its C-terminal tandem BRCT domains. Although MCPH1 foci formation depends on H2AX phosphorylation after DNA damage, it can occur independently of MDC1. We also show that MCPH1 binds to a phospho-H2AX peptide in vitro with an affinity similar to that of MDC1, and overexpression of wild type, but not C-BRCT mutants of MCPH1, can interfere with the foci formation of MDC1 and 53BP1. Collectively, our data suggest MCPH1 is recruited to double-strand breaks via its interaction with gamma H2AX, which is mediated by MCPH1 C-terminal BRCT domains. These observations support that MCPH1 acts early in DNA damage responsive pathways.	Mayo Clin, Coll Med, Dept Mol Pharmacol, Dept Expt Therapeut, Rochester, MN 55905 USA; Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06520 USA	Mayo Clinic; Mayo Clinic; Yale University	Chen, JJ (corresponding author), Mayo Clin, Coll Med, Dept Mol Pharmacol, Dept Expt Therapeut, Rochester, MN 55905 USA.	junjie.chen@yale.edu	Mer, Georges/AAT-4946-2021	Mer, Georges/0000-0002-1900-1578	NATIONAL CANCER INSTITUTE [R01CA092312, R01CA100109, R01CA109449] Funding Source: NIH RePORTER; NCI NIH HHS [CA109449, CA100109, R01 CA100109, R01 CA109449, R01 CA109449-04, R01 CA092312, CA092312] Funding Source: Medline; NIGMS NIH HHS [F31 GM770802] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alderton GK, 2006, NAT CELL BIOL, V8, P725, DOI 10.1038/ncb1431; Au WWY, 2005, J BIOL CHEM, V280, P6993, DOI 10.1074/jbc.M408879200; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Brown EJ, 2000, GENE DEV, V14, P397; Chini C, 2006, ONCOGENE, V25, P4165, DOI 10.1038/sj.onc.1209447; DiTullio RA, 2002, NAT CELL BIOL, V4, P998, DOI 10.1038/ncb892; Garshasbi M, 2006, HUM GENET, V118, P708, DOI 10.1007/s00439-005-0104-y; Goldberg M, 2003, NATURE, V421, P952, DOI 10.1038/nature01445; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Jowsey PA, 2004, J BIOL CHEM, V279, P55562, DOI 10.1074/jbc.M411021200; Lin SY, 2005, P NATL ACAD SCI USA, V102, P15105, DOI 10.1073/pnas.0507722102; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Lou ZK, 2003, NATURE, V421, P957, DOI 10.1038/nature01447; Maser RS, 2001, NAT GENET, V27, P417, DOI 10.1038/86920; O'Driscoll M, 2003, NAT GENET, V33, P497, DOI 10.1038/ng1129; Peschiaroli A, 2006, MOL CELL, V23, P319, DOI 10.1016/j.molcel.2006.06.013; Rai R, 2006, CANCER CELL, V10, P145, DOI 10.1016/j.ccr.2006.07.002; Rappold I, 2001, J CELL BIOL, V153, P613, DOI 10.1083/jcb.153.3.613; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Trimborn Marc, 2005, Hum Mutat, V26, P496, DOI 10.1002/humu.9382; Xu XZ, 2004, J BIOL CHEM, V279, P34091, DOI 10.1074/jbc.C400139200; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753; Yu XC, 2004, MOL CELL BIOL, V24, P9478, DOI 10.1128/MCB.24.21.9478-9486.2004; Yu XC, 2006, GENE DEV, V20, P1721, DOI 10.1101/gad.1431006	26	81	90	2	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					35416	35423		10.1074/jbc.M705245200	http://dx.doi.org/10.1074/jbc.M705245200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17925396	Green Accepted, hybrid			2022-12-27	WOS:000251155200084
J	Haanstra, JR; Stewart, M; Luu, VD; van Tuijl, A; Westerhoff, HV; Clayton, C; Bakker, BM				Haanstra, Jurgen R.; Stewart, Mhairi; Luu, Van-Duc; van Tuijl, Arjen; Westerhoff, Hans V.; Clayton, Christine; Bakker, Barbara M.			Control and regulation of gene expression - Quantitative analysis of the expression of phosphoglycerate kinase in bloodstream form Trypanosoma brucei	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPLICED-LEADER RNA; FRUCTOSE BISPHOSPHATE ALDOLASE; POST-TRANSCRIPTIONAL CONTROL; POLYMERASE-II TRANSCRIPTION; GENOME-WIDE ANALYSIS; MESSENGER-RNA; SACCHAROMYCES-CEREVISIAE; IN-VIVO; METABOLIC-REGULATION; GLYCOLYTIC-ENZYMES	Isoenzymes of phosphoglycerate kinase in Trypanosoma brucei are differentially expressed in its two main life stages. This study addresses how the organism manages to make sufficient amounts of the isoenzyme with the correct localization, which processes (transcription, splicing, and RNA degradation) control the levels of mRNAs, and how the organism regulates the switch in isoform expression. For this, we combined new quantitative measurements of phosphoglycerate kinase mRNA abundance, RNA precursor stability, trans splicing, and ribosome loading with published data and made a kinetic computer model. For the analysis of regulation we extended regulation analysis. Although phosphoglycerate kinase mRNAs are present at surprisingly low concentrations (e. g. 12 molecules per cell), its protein is highly abundant. Substantial control of mRNA and protein levels was exerted by both mRNA synthesis and degradation, whereas splicing and precursor degradation had little control on mRNA and protein concentrations. Yet regulation of mRNA levels does not occur by transcription, but by adjusting mRNA degradation. The contribution of splicing to regulation is negligible, as for all cases where splicing is faster than RNA precursor degradation.	[Haanstra, Jurgen R.; van Tuijl, Arjen; Westerhoff, Hans V.; Bakker, Barbara M.] Vrije Univ Amsterdam, Bioctr, NL-1081 HV Amsterdam, Netherlands; [Stewart, Mhairi; Luu, Van-Duc; Clayton, Christine] Heidelberg Univ, Zentrum Mol Biol, D-69120 Heidelberg, Germany; [Westerhoff, Hans V.] Univ Manchester, SCEAS, MIB, Manchester Ctr Integrat Syst Biol, Manchester M1 7ND, Lancs, England	Vrije Universiteit Amsterdam; Ruprecht Karls University Heidelberg; University of Manchester	Bakker, BM (corresponding author), Vrije Univ Amsterdam, Bioctr, De Boelelaan 1085, NL-1081 HV Amsterdam, Netherlands.	barbara.bakker@falw.vu.nl	Westerhoff, Hans V/I-5762-2012; Clayton, Christine/K-7700-2019	Westerhoff, Hans V/0000-0002-0443-6114; Haanstra, Jurgen/0000-0001-9652-0219; Clayton, Christine/0000-0002-6384-0731; Bakker, Barbara/0000-0001-6274-3633	Biotechnology and Biological Sciences Research Council [BB/C008219/1, BB/D019079/1] Funding Source: Medline; Wellcome Trust Funding Source: Medline; BBSRC [BB/D019079/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Albert MA, 2005, J BIOL CHEM, V280, P28306, DOI 10.1074/jbc.M502403200; ALEXANDER K, 1991, MOL BIOCHEM PARASIT, V46, P1, DOI 10.1016/0166-6851(91)90193-A; ALEXANDER K, 1993, MOL BIOCHEM PARASIT, V60, P265, DOI 10.1016/0166-6851(93)90137-M; ALLEN TE, 1993, NUCLEIC ACIDS RES, V21, P5431, DOI 10.1093/nar/21.23.5431; Arava Y, 2003, P NATL ACAD SCI USA, V100, P3889, DOI 10.1073/pnas.0635171100; Audibert A, 2002, MOL CELL BIOL, V22, P6706, DOI 10.1128/MCB.22.19.6706-6718.2002; Bakker BM, 1997, J BIOL CHEM, V272, P3207, DOI 10.1074/jbc.272.6.3207; Bakker BM, 1999, P NATL ACAD SCI USA, V96, P10098, DOI 10.1073/pnas.96.18.10098; Bentley DL, 2005, CURR OPIN CELL BIOL, V17, P251, DOI 10.1016/j.ceb.2005.04.006; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Biebinger S, 1997, MOL BIOCHEM PARASIT, V85, P99, DOI 10.1016/S0166-6851(96)02815-0; Biton M, 2006, MOL BIOCHEM PARASIT, V150, P132, DOI 10.1016/j.molbiopara.2006.07.004; Blattner J, 1998, P NATL ACAD SCI USA, V95, P11596, DOI 10.1073/pnas.95.20.11596; BLATTNER J, 1995, GENE, V162, P153, DOI 10.1016/0378-1119(95)00366-E; Bon M, 2006, FASEB J, V20, P1721, DOI 10.1096/fj.06-6087fje; BONVEN B, 1979, MOL GEN GENET, V170, P225, DOI 10.1007/BF00337800; Bruggeman FJ, 2007, TRENDS MICROBIOL, V15, P45, DOI 10.1016/j.tim.2006.11.003; Chubb JR, 2006, CURR BIOL, V16, P1018, DOI 10.1016/j.cub.2006.03.092; Clayton CE, 2002, EMBO J, V21, P1881, DOI 10.1093/emboj/21.8.1881; CLAYTON CE, 1988, MOL BIOCHEM PARASIT, V28, P43, DOI 10.1016/0166-6851(88)90178-8; CLAYTON CE, 1987, J CELL BIOL, V105, P2649, DOI 10.1083/jcb.105.6.2649; CLAYTON CE, 1985, EMBO J, V4, P2997, DOI 10.1002/j.1460-2075.1985.tb04035.x; Colasante C, 2007, MOL BIOCHEM PARASIT, V151, P193, DOI 10.1016/j.molbiopara.2006.11.003; Daran-Lapujade P, 2007, P NATL ACAD SCI USA, V104, P15753, DOI 10.1073/pnas.0707476104; Darzacq X, 2007, NAT STRUCT MOL BIOL, V14, P796, DOI 10.1038/nsmb1280; DELANGE T, 1983, CELL, V34, P891, DOI 10.1016/0092-8674(83)90546-9; Djikeng A, 2003, RNA, V9, P802, DOI 10.1261/rna.5270203; Djikeng A, 1998, GENE, V221, P93, DOI 10.1016/S0378-1119(98)00427-2; DOVEY HF, 1988, P NATL ACAD SCI USA, V85, P2598, DOI 10.1073/pnas.85.8.2598; Dundr M, 2002, SCIENCE, V298, P1623, DOI 10.1126/science.1076164; Ersfeld K, 1998, CHROMOSOMA, V107, P237, DOI 10.1007/s004120050302; French SL, 2003, MOL CELL BIOL, V23, P1558, DOI 10.1128/MCB.23.5.1558-1568.2003; Furuya T, 2002, P NATL ACAD SCI USA, V99, P14177, DOI 10.1073/pnas.222454899; GIBSON WC, 1988, J MOL BIOL, V201, P315, DOI 10.1016/0022-2836(88)90140-4; Gornemann J, 2005, MOL CELL, V19, P53, DOI 10.1016/j.molcel.2005.05.007; Grummt I, 2003, GENE DEV, V17, P1691, DOI 10.1101/gad.1098503R; Haile S, 2003, RNA, V9, P1491, DOI 10.1261/rna.5940703; HEINRICH R, 1974, EUR J BIOCHEM, V42, P89, DOI 10.1111/j.1432-1033.1974.tb03318.x; Heinrich R., 1996, REGULATION CELLULAR; Helfert S, 2001, BIOCHEM J, V357, P117, DOI 10.1042/0264-6021:3570117; Hendriks EF, 2003, J BIOL CHEM, V278, P26870, DOI 10.1074/jbc.M302405200; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Hornberg JJ, 2005, FEBS J, V272, P244, DOI 10.1111/j.1432-1033.2004.04404.x; Iyer V, 1996, P NATL ACAD SCI USA, V93, P5208, DOI 10.1073/pnas.93.11.5208; Jackson DA, 2000, FASEB J, V14, P242, DOI 10.1096/fasebj.14.2.242; Kacser H, 1973, Symp Soc Exp Biol, V27, P65; KAHN D, 1991, J THEOR BIOL, V153, P255, DOI 10.1016/S0022-5193(05)80426-6; KAPOTAS N, 1993, NUCLEIC ACIDS RES, V21, P4067, DOI 10.1093/nar/21.17.4067; Kessler PS, 2005, J BIOL CHEM, V280, P9030, DOI 10.1074/jbc.M412033200; Kettenberger H, 2004, MOL CELL, V16, P955, DOI 10.1016/j.molcel.2004.11.040; Kimura H, 2002, J CELL BIOL, V159, P777, DOI 10.1083/jcb.200206019; Lacadie SA, 2005, MOL CELL, V19, P65, DOI 10.1016/j.molcel.2005.05.006; Li CH, 2006, RNA, V12, P2171, DOI 10.1261/rna.291506; Liang XH, 2003, EUKARYOT CELL, V2, P830, DOI 10.1128/EC.2.5.830-840.2003; Liu L, 2002, J BIOL CHEM, V277, P47348, DOI 10.1074/jbc.M207736200; Mandelboim M, 2003, J BIOL CHEM, V278, P51469, DOI 10.1074/jbc.M308997200; Martinez-Calvillo S, 2003, MOL CELL, V11, P1291, DOI 10.1016/S1097-2765(03)00143-6; Martinez-Calvillo S, 2004, EUKARYOT CELL, V3, P506, DOI 10.1128/EC.3.2.506-517.2004; McAndrew M, 1998, EXP PARASITOL, V90, P65, DOI 10.1006/expr.1998.4317; McKean PG, 2003, CURR OPIN MICROBIOL, V6, P600, DOI 10.1016/j.mib.2003.10.010; MCNALLY KP, 1992, MOL CELL BIOL, V12, P4844, DOI 10.1128/MCB.12.11.4844; Michels PAM, 2000, PARASITOL TODAY, V16, P482, DOI 10.1016/S0169-4758(00)01810-X; MISSET O, 1987, EUR J BIOCHEM, V162, P493, DOI 10.1111/j.1432-1033.1987.tb10667.x; MISSET O, 1986, EUR J BIOCHEM, V157, P441, DOI 10.1111/j.1432-1033.1986.tb09687.x; MOTTRAM JC, 1989, MOL BIOCHEM PARASIT, V37, P115, DOI 10.1016/0166-6851(89)90108-4; PALMITER RD, 1975, CELL, V4, P189, DOI 10.1016/0092-8674(75)90167-1; PARSONS M, 1989, MOL BIOCHEM PARASIT, V33, P215, DOI 10.1016/0166-6851(89)90083-2; PAYS E, 1993, MOL BIOCHEM PARASIT, V61, P107, DOI 10.1016/0166-6851(93)90163-R; PAYS E, 1980, NUCLEIC ACIDS RES, V8, P5965, DOI 10.1093/nar/8.24.5965; Quijada L, 2002, NUCLEIC ACIDS RES, V30, P4414, DOI 10.1093/nar/gkf577; Rossell S, 2005, FEMS YEAST RES, V5, P611, DOI 10.1016/j.femsyr.2004.11.003; Sauro Herbert M., 2003, OMICS A Journal of Integrative Biology, V7, P355, DOI 10.1089/153623103322637670; SAURO HM, 2000, ANIMATING CELLULAR M; Schilling M, 2005, FEBS J, V272, P6400, DOI 10.1111/j.1742-4658.2005.05037.x; Siegel TN, 2005, MOL CELL BIOL, V25, P9586, DOI 10.1128/MCB.25.21.9586-9594.2005; Snoep JL, 2002, EUR J BIOCHEM, V269, P1662, DOI 10.1046/j.1432-1327.2002.02803.x; SOBELL HM, 1985, P NATL ACAD SCI USA, V82, P5328, DOI 10.1073/pnas.82.16.5328; Tardiff DF, 2006, MOL CELL, V24, P917, DOI 10.1016/j.molcel.2006.12.002; ter Kuile BH, 2001, FEBS LETT, V500, P169, DOI 10.1016/S0014-5793(01)02613-8; Teusink B, 2000, EUR J BIOCHEM, V267, P5313, DOI 10.1046/j.1432-1327.2000.01527.x; Tu XM, 2005, EUKARYOT CELL, V4, P755, DOI 10.1128/EC.4.4.755-764.2005; ULLU E, 1991, P NATL ACAD SCI USA, V88, P10074, DOI 10.1073/pnas.88.22.10074; ULLU E, 1993, MOL CELL BIOL, V13, P720, DOI 10.1128/MCB.13.1.720; van Deursen FJ, 2001, MOL BIOCHEM PARASIT, V112, P163, DOI 10.1016/S0166-6851(00)00359-5; van Weelden SWH, 2005, J BIOL CHEM, V280, P12451, DOI 10.1074/jbc.M412447200; WALDRON C, 1975, J BACTERIOL, V122, P855, DOI 10.1128/JB.122.3.855-865.1975; Westerhoff H., 1987, THERMODYNAMICS CONTR; WESTERHOFF HV, 1990, NATO ADV SCI I A-LIF, V190, P399; Zhang WW, 2004, MOL MICROBIOL, V54, P1051, DOI 10.1111/j.1365-2958.2004.04327.x; Zomer AWM, 1998, BBA-PROTEIN STRUCT M, V1386, P179, DOI 10.1016/S0167-4838(98)00095-8; ZOMERDIJK JCBM, 1992, NUCLEIC ACIDS RES, V20, P2725, DOI 10.1093/nar/20.11.2725	91	59	58	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2495	2507		10.1074/jbc.M705782200	http://dx.doi.org/10.1074/jbc.M705782200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	17991737	Green Published, hybrid			2022-12-27	WOS:000252622300006
J	Pitt, CW; Valente, LP; Rhodes, D; Simonsson, T				Pitt, Christopher W.; Valente, Luis P.; Rhodes, Daniela; Simonsson, Tomas			Identification and characterization of an essential telomeric repeat binding factor in fission yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; TO-END FUSIONS; SCHIZOSACCHAROMYCES-POMBE; PROTEINS TRF1; LENGTH; CHROMOSOME; POT1; REPLICATION; TELOBOX; TAZ1	Whereas mammalian cells harbor two double strand telomeric repeat binding factors, TRF1 and TRF2, the fission yeast Schizosaccharomyces pombe has been thought to harbor solely the TRF1/TRF2 ortholog Taz1p to perform comparable functions. Here we report the identification of telomeric repeat binding factor 1 (Tbf1), a second TRF1/TRF2 ortholog in S. pombe. Like the Taz1p, the identified Tbf1p shares amino acid sequence similarity, as well as structural and functional characteristics, with the mammalian TRF1 and TRF2 proteins. This family of proteins shares a common architecture with two separate structural domains. An N-terminal domain is necessary and sufficient for the formation of homodimers, and a C-terminal MYB/homeodomain mediates sequence specific recognition of double-stranded telomeric DNA. The identified Tbf1p binds S. pombe telomeric DNA with high sequence specificity in vitro. Targeted deletion of the tbf1 gene reveals that it is essential for survival, and overexpression of the tbf1 gene leads to telomere elongation in vivo, which is dependent upon the MYB domain. These data suggest that fission yeast, like mammals, have two factors that bind double-stranded telomeric DNA and perform distinct roles in telomere length regulation.	[Simonsson, Tomas] Gothenburg Univ, Dept Biomed, SE-40530 Gothenburg, Sweden; [Pitt, Christopher W.; Valente, Luis P.] Canc Res UK, Telomere Biol Lab, London WC2A 3PX, England; [Rhodes, Daniela] MRC, Mol Biol Lab, Cambridge CB2 2QH, England	University of Gothenburg; Cancer Research UK; MRC Laboratory Molecular Biology	Simonsson, T (corresponding author), Gothenburg Univ, Dept Biomed, SE-40530 Gothenburg, Sweden.	tomas.simonsson@gu.se	Valente, Luis/L-4178-2013	Valente, Luis/0000-0003-2387-5435; Valente, Luis/0000-0003-1258-2813	MRC [MC_U105184333] Funding Source: UKRI; Medical Research Council [MC_U105184333] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Arneric M, 2007, EMBO REP, V8, P1080, DOI 10.1038/sj.embor.7401082; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Baumann P, 2001, SCIENCE, V292, P1171, DOI 10.1126/science.1060036; Bianchi A, 1997, EMBO J, V16, P1785, DOI 10.1093/emboj/16.7.1785; Bilaud T, 1997, NAT GENET, V17, P236, DOI 10.1038/ng1097-236; Bilaud T, 1996, NUCLEIC ACIDS RES, V24, P1294, DOI 10.1093/nar/24.7.1294; Broccoli D, 1997, NAT GENET, V17, P231, DOI 10.1038/ng1097-231; Cech TR, 2004, CELL, V116, P273, DOI 10.1016/S0092-8674(04)00038-8; CHONG L, 1995, SCIENCE, V270, P1663, DOI 10.1126/science.270.5242.1663; Colgin LM, 2003, CURR BIOL, V13, P942, DOI 10.1016/S0960-9822(03)00339-7; Cooper JP, 1997, NATURE, V385, P744, DOI 10.1038/385744a0; Court R, 2005, EMBO REP, V6, P39, DOI 10.1038/sj.embor.7400314; DELANGE T, 1990, MOL CELL BIOL, V10, P518, DOI 10.1128/MCB.10.2.518; Fairall L, 2001, MOL CELL, V8, P351, DOI 10.1016/S1097-2765(01)00321-5; Ferreira MG, 2001, MOL CELL, V7, P55, DOI 10.1016/S1097-2765(01)00154-X; Froelich-Ammon SJ, 1998, GENE DEV, V12, P1504, DOI 10.1101/gad.12.10.1504; Greider C W, 2000, Harvey Lect, V96, P33; Griffith J, 1998, J MOL BIOL, V278, P79, DOI 10.1006/jmbi.1998.1686; Hemann MT, 2001, CELL, V107, P67, DOI 10.1016/S0092-8674(01)00504-9; Hiraoka Y, 1998, TRENDS BIOCHEM SCI, V23, P126, DOI 10.1016/S0968-0004(98)01176-1; Kanoh J, 2001, CURR BIOL, V11, P1624, DOI 10.1016/S0960-9822(01)00503-6; Karlseder J, 2003, MOL CELL BIOL, V23, P6533, DOI 10.1128/MCB.23.18.6533-6541.2003; Kim SH, 1999, NAT GENET, V23, P405, DOI 10.1038/70508; Lei M, 2004, NAT STRUCT MOL BIOL, V11, P1223, DOI 10.1038/nsmb867; Lei M, 2003, NATURE, V426, P198, DOI 10.1038/nature02092; Li, 1999, Genome Inform Ser Workshop Genome Inform, V10, P30; Li BB, 2000, CELL, V101, P471, DOI 10.1016/S0092-8674(00)80858-2; LINGNER J, 1995, SCIENCE, V269, P1533, DOI 10.1126/science.7545310; Loayza D, 2003, NATURE, V423, P1013, DOI 10.1038/nature01688; Ly H, 2003, GENE DEV, V17, P1078, DOI 10.1101/gad.1060803; Makarov VL, 1997, CELL, V88, P657, DOI 10.1016/S0092-8674(00)81908-X; McClintock B, 1938, GENETICS, V23, P315; McClintock B, 1939, P NATL ACAD SCI USA, V25, P405, DOI 10.1073/pnas.25.8.405; Miller KM, 2006, NATURE, V440, P824, DOI 10.1038/nature04638; MORENO S, 1991, METHOD ENZYMOL, V194, P795; MORIN GB, 1989, CELL, V59, P521, DOI 10.1016/0092-8674(89)90035-4; Nakamura TM, 1998, SCIENCE, V282, P493, DOI 10.1126/science.282.5388.493; Nishikawa T, 2001, STRUCTURE, V9, P1237, DOI 10.1016/S0969-2126(01)00688-8; Nugent CI, 1996, SCIENCE, V274, P249, DOI 10.1126/science.274.5285.249; O'Reilly Marc, 1999, Current Opinion in Structural Biology, V9, P56, DOI 10.1016/S0959-440X(99)80008-6; Pennock E, 2001, CELL, V104, P387, DOI 10.1016/S0092-8674(01)00226-4; Rhodes D, 2002, EMBO REP, V3, P1139, DOI 10.1093/embo-reports/kvf246; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Rost B, 1996, METHOD ENZYMOL, V266, P525; Simonsson T, 2003, TRENDS BIOCHEM SCI, V28, P632, DOI 10.1016/j.tibs.2003.10.005; Simonsson T, 2001, BIOL CHEM, V382, P621, DOI 10.1515/BC.2001.073; Smith S, 1998, SCIENCE, V282, P1484, DOI 10.1126/science.282.5393.1484; Smogorzewska A, 2000, MOL CELL BIOL, V20, P1659, DOI 10.1128/MCB.20.5.1659-1668.2000; Spink KG, 2000, NUCLEIC ACIDS RES, V28, P527, DOI 10.1093/nar/28.2.527; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; vanSteensel B, 1997, NATURE, V385, P740, DOI 10.1038/385740a0; Vassetzky NS, 1999, NUCLEIC ACIDS RES, V27, P4687, DOI 10.1093/nar/27.24.4687; WATSON JD, 1972, NATURE-NEW BIOL, V239, P197, DOI 10.1038/newbio239197a0; Wenz C, 2001, EMBO J, V20, P3526, DOI 10.1093/emboj/20.13.3526; Wright WE, 2002, NAT BIOTECHNOL, V20, P682, DOI 10.1038/nbt0702-682; Zhou XZ, 2001, CELL, V107, P347, DOI 10.1016/S0092-8674(01)00538-4	56	14	15	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2693	2701		10.1074/jbc.M708784200	http://dx.doi.org/10.1074/jbc.M708784200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	17977837	hybrid			2022-12-27	WOS:000252622300026
J	Zhang, W; Wang, D; Volk, E; Bellen, HJ; Hiesinger, PR; Quiocho, FA				Zhang, Wei; Wang, Dong; Volk, Elzi; Bellen, Hugo J.; Hiesinger, Peter Robin; Quiocho, Florante A.			V-ATPase V-o sector subunit a1 in neurons is a target of calmodulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APICAL SECRETION; LATE STEP; VACUOLAR; RECOGNITION; EXPRESSION; PROTEINS; TRIGGERS; RELEASE; FUSION	The V-o complex forms the proteolipid pore of a vesicular ATPase that acidifies vesicles. In addition, an independent function in membrane fusion has been suggested in vacuolar fusion in yeast and synaptic vesicle exocytosis in fly neurons. Evidence for a direct role in secretion has also recently been presented in mouse and worm. The molecular mechanisms of how the V-o components might act or are regulated are largely unknown. Here we report the identification and characterization of a calmodulin-binding site in the large cytosolic N-terminal region of the Drosophila protein V100, the neuron-specific V-o subunit a1. V100 forms a tight complex with calmodulin in a Ca2+- dependent manner. Mutations in the calmodulin-binding site in Drosophila lead to a loss of calmodulin recruitment to synapses. Neuronal expression of a calmodulin-binding deficient V100 uncovers an incomplete rescue at low levels and cellular toxicity at high levels. Our results suggest a vesicular ATPase V-o-dependent function of calmodulin at synapses.	[Wang, Dong; Volk, Elzi; Hiesinger, Peter Robin] Univ Texas, SW Med Ctr, Dept Physiol & Green Ctr, Div Syst Biol, Dallas, TX 75390 USA; [Zhang, Wei; Quiocho, Florante A.] Baylor Coll Med, Howard Hughes Med Inst, Verna Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Bellen, Hugo J.] Baylor Coll Med, Howard Hughes Med Inst, Dept Human Mol Genet & Neurosci, Houston, TX 77030 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine; Howard Hughes Medical Institute	Hiesinger, PR (corresponding author), Univ Texas, SW Med Ctr, Dept Physiol & Green Ctr, Div Syst Biol, Dallas, TX 75390 USA.	robin.hiesinger@utsouthwestern.edu; faq@bcm.tmc.edu	Wang, Dong/F-8316-2010	Bellen, Hugo/0000-0001-5992-5989	NATIONAL EYE INSTITUTE [R01EY018884] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY018884] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Bayer MJ, 2003, J CELL BIOL, V162, P211, DOI 10.1083/jcb.200212004; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; COHEN P, 1988, CALMODULIN MOL ASPEC; Freeman M, 1996, CELL, V87, P651, DOI 10.1016/S0092-8674(00)81385-9; Hiesinger PR, 2005, CELL, V121, P607, DOI 10.1016/j.cell.2005.03.012; Hurtado-Lorenzo A, 2006, NAT CELL BIOL, V8, P124, DOI 10.1038/ncb1348; ISRAEL M, 1987, J NEUROCHEM, V49, P975, DOI 10.1111/j.1471-4159.1987.tb00989.x; Lee SH, 2006, NAT MED, V12, P1403, DOI 10.1038/nm1514; Liegeois S, 2007, GENETICS, V175, P709, DOI 10.1534/genetics.106.066035; Liegeois S, 2006, J CELL BIOL, V173, P949, DOI 10.1083/jcb.200511072; MANOLSON MF, 1994, J BIOL CHEM, V269, P14064; MEADOR WE, 1993, SCIENCE, V262, P1718, DOI 10.1126/science.8259515; MEADOR WE, 1995, NAT STRUCT BIOL, V2, P943, DOI 10.1038/nsb1195-943; MEADOR WE, 1992, SCIENCE, V257, P1251, DOI 10.1126/science.1519061; Morel N, 2001, J NEUROCHEM, V79, P485, DOI 10.1046/j.1471-4159.2001.00611.x; Murata T, 2005, SCIENCE, V308, P654, DOI 10.1126/science.1110064; Murthy VN, 2003, ANNU REV NEUROSCI, V26, P701, DOI 10.1146/annurev.neuro.26.041002.131445; Nelson N, 1999, PHYSIOL REV, V79, P361, DOI 10.1152/physrev.1999.79.2.361; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; ONEIL KT, 1990, TRENDS BIOCHEM SCI, V15, P59, DOI 10.1016/0968-0004(90)90177-D; Perzov N, 2002, J EXP BIOL, V205, P1209; Peters C, 2001, NATURE, V409, P581, DOI 10.1038/35054500; Peters C, 1998, NATURE, V396, P575, DOI 10.1038/25133; Pujol N, 2001, J BIOL CHEM, V276, P11913, DOI 10.1074/jbc.M009451200; PUTKEY JA, 1985, J BIOL CHEM, V260, P4704; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Saimi Y, 2002, ANNU REV PHYSIOL, V64, P289, DOI 10.1146/annurev.physiol.64.100301.111649; SCHULZE KL, 1995, CELL, V80, P311, DOI 10.1016/0092-8674(95)90414-X; STEINHARDT RA, 1982, NATURE, V295, P154, DOI 10.1038/295154a0; Sun-Wada GH, 2006, J CELL SCI, V119, P4531, DOI 10.1242/jcs.03234; VANELDIK LJ, 1998, CALMODULIN SIGNAL TR; Wickner W, 2000, ANNU REV BIOCHEM, V69, P247, DOI 10.1146/annurev.biochem.69.1.247; Yap Kyoko L., 2000, Journal of Structural and Functional Genomics, V1, P8, DOI 10.1023/A:1011320027914; ZIPURSKY SL, 1984, CELL, V36, P15, DOI 10.1016/0092-8674(84)90069-2	35	25	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					294	300		10.1074/jbc.M708058200	http://dx.doi.org/10.1074/jbc.M708058200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17933871	hybrid, Green Accepted			2022-12-27	WOS:000251940300033
J	Bawa-Khalfe, T; Cheng, JK; Wang, ZX; Yeh, ETH				Bawa-Khalfe, Tasneem; Cheng, Jinke; Wang, Zhengxin; Yeh, Edward T. H.			Induction of the SUMO-specific protease 1 transcription by the androgen receptor in prostate cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIN D1; RESPONSE ELEMENTS; DEPENDENT TRANSCRIPTION; DIFFERENTIAL REGULATION; HISTONE DEACETYLASE-1; STRUCTURAL BASIS; GENE-REGULATION; DNA-BINDING; EXPRESSION; OVEREXPRESSION	Prostate cancer, the most frequently diagnosed carcinoma in males, is readily modulated via the transcriptional activity of androgen receptors. Our recent publication reported that androgen receptor-dependent transcription is significantly elevated with expression of the human sentrin/SUMO-specific protease (SENP1) in the androgen-sensitive human prostate cancer cell line (LNCaP). In situ hybridization studies indicated an elevation of SENP1 message in prostatic intraepithelial neoplasia and prostate cancer lesions as compared with normal prostate epithelia. This study aimed to delineate the mechanism for the regulation of SENP1 message and to determine the pathophysiological consequence of SENP1 induction with respect to prostate cancer. Real-time PCR confirmed the elevation of SENP1 mRNA in prostate cancer cells as compared with normal prostate epithelial cells. Chronic androgen exposure of LNCaP cells prompted an enhancement in the SENP1 transcript selectively. This androgen-mediated augmentation of SENP1 was absent with co-administration of the androgen receptor antagonist bicalutamide and in androgen receptor-negative prostate cancer PC-3 cells, indicating an androgen receptor-dependent event. Activation of the androgen receptor was required for binding an identified androgen response element and positively regulating SENP1 promoter activity. Abrogation of elevated SENP1 mRNA in prostate cancer cells significantly decreased androgen-mediated cell growth. Because increased SENP1 expression directly modulated androgen receptor-dependent cell proliferation and transcription, SENP1 could play an important role in prostate carcinogenesis.	[Wang, Zhengxin; Yeh, Edward T. H.] Univ Texas MD Anderson Canc Ctr, Dept Cardiol, Houston, TX 77030 USA; [Bawa-Khalfe, Tasneem; Yeh, Edward T. H.] Univ Texas Hlth Sci Ctr, Res Ctr Cardiovasc Dis, Brown Fdn Inst Mol Med Prevent Human Dis, Houston, TX 77030 USA; [Cheng, Jinke; Yeh, Edward T. H.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; UTMD Anderson Cancer Center	Yeh, ETH (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Cardiol, 1515 Holcombe Blvd,Unit 449, Houston, TX 77030 USA.	etyeh@mdanderson.org			NCI NIH HHS [F32 CA110620] Funding Source: Medline; NATIONAL CANCER INSTITUTE [F32CA110620] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bailey D, 2004, J BIOL CHEM, V279, P692, DOI 10.1074/jbc.M306195200; Bello D, 1997, CARCINOGENESIS, V18, P1215, DOI 10.1093/carcin/18.6.1215; Burnstein KL, 2005, J CELL BIOCHEM, V95, P657, DOI 10.1002/jcb.20460; Callewaert L, 2004, MOL ENDOCRINOL, V18, P1438, DOI 10.1210/me.2003-0313; Chauchereau A, 2003, J BIOL CHEM, V278, P12335, DOI 10.1074/jbc.M207148200; Chen Y, 1998, ONCOGENE, V16, P1913, DOI 10.1038/sj.onc.1201719; Cheng JK, 2006, NEOPLASIA, V8, P667, DOI 10.1593/neo.06445; Cheng JK, 2005, J BIOL CHEM, V280, P14492, DOI 10.1074/jbc.M412185200; Cheng JK, 2004, MOL CELL BIOL, V24, P6021, DOI 10.1128/MCB.24.13.6021-6028.2004; Claessens F, 2001, J STEROID BIOCHEM, V76, P23, DOI 10.1016/S0960-0760(00)00154-0; Comstock CES, 2007, BRIT J CANCER, V96, P970, DOI 10.1038/sj.bjc.6603615; David G, 2002, J BIOL CHEM, V277, P23658, DOI 10.1074/jbc.M203690200; Dehm SM, 2005, EXPERT REV ANTICANC, V5, P63, DOI 10.1586/14737140.5.1.63; Drobnjak M, 2000, CLIN CANCER RES, V6, P1891; Fu MF, 2004, ENDOCRINOLOGY, V145, P5439, DOI 10.1210/en.2004-0959; Gong L, 2006, J BIOL CHEM, V281, P15869, DOI 10.1074/jbc.M511658200; Gong LM, 1997, J BIOL CHEM, V272, P28198, DOI 10.1074/jbc.272.45.28198; Gong LM, 1999, FEBS LETT, V448, P185, DOI 10.1016/S0014-5793(99)00367-1; Gong LM, 2000, J BIOL CHEM, V275, P3355, DOI 10.1074/jbc.275.5.3355; Halkidou K, 2003, ONCOGENE, V22, P2466, DOI 10.1038/sj.onc.1206342; He Y, 2007, CANCER RES, V67, P8188, DOI 10.1158/0008-5472.CAN-07-0418; Heemers HV, 2007, CANCER RES, V67, P3422, DOI 10.1158/0008-5472.CAN-06-2836; Jacques C, 2005, J CLIN ENDOCR METAB, V90, P2314, DOI 10.1210/jc.2004-1337; Li L, 2004, BIOCHEM CELL BIOL, V82, P460, DOI 10.1139/O04-045; Liu GZ, 2003, J BIOL CHEM, V278, P14956, DOI 10.1074/jbc.M212229200; LUISI BF, 1991, NATURE, V352, P497, DOI 10.1038/352497a0; Mohler JL, 2004, CLIN CANCER RES, V10, P440, DOI 10.1158/1078-0432.CCR-1146-03; Nelson CC, 1999, MOL ENDOCRINOL, V13, P2090, DOI 10.1210/me.13.12.2090; PRESTRIDGE DS, 1995, J MOL BIOL, V249, P923, DOI 10.1006/jmbi.1995.0349; Reid KJ, 2001, J BIOL CHEM, V276, P2943, DOI 10.1074/jbc.M009170200; Reverter D, 2004, STRUCTURE, V12, P1519, DOI 10.1016/j.str.2004.05.023; Richter E, 2007, PROSTATE CANCER P D, V10, P114, DOI 10.1038/sj.pcan.4500936; Scherr D, 2003, UROLOGY, V61, P14, DOI 10.1016/S0090-4295(02)02395-6; Sentis S, 2005, MOL ENDOCRINOL, V19, P2671, DOI 10.1210/me.2005-0042; Shaffer PL, 2004, P NATL ACAD SCI USA, V101, P4758, DOI 10.1073/pnas.0401123101; Shen LN, 2006, BIOCHEM J, V397, P279, DOI 10.1042/BJ20052030; Stacey DW, 2003, CURR OPIN CELL BIOL, V15, P158, DOI 10.1016/S0955-0674(03)00008-5; Stanbrough M, 2001, P NATL ACAD SCI USA, V98, P10823, DOI 10.1073/pnas.191235898; Wang Chenguang, 2004, Cancer Treat Res, V119, P217; Wu Q, 2004, J MOL ENDOCRINOL, V32, P595, DOI 10.1677/jme.0.0320595; Yamaguchi T, 2005, MOL CELL BIOL, V25, P5171, DOI 10.1128/MCB.25.12.5171-5182.2005; Yamashita D, 2004, GENES CELLS, V9, P1017, DOI 10.1111/j.1365-2443.2004.00786.x; Zhang LQ, 2003, CANCER RES, V63, P4552	43	68	77	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37341	37349		10.1074/jbc.M706978200	http://dx.doi.org/10.1074/jbc.M706978200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17932034	hybrid			2022-12-27	WOS:000251833600008
J	Jun, DJ; Kim, J; Jung, SY; Song, R; Noh, JH; Park, YS; Ryu, SH; Kim, JH; Kong, YY; Chung, JM; Kim, KT				Jun, Dong-Jae; Kim, Jaeyoon; Jung, Sang-Yong; Song, Ran; Noh, Ji-Hyun; Park, Yong-Soo; Ryu, Sung-Ho; Kim, Joung-Hun; Kong, Young-Yun; Chung, Jun-Mo; Kim, Kyong-Tai			Extracellular ATP mediates necrotic cell swelling in SN4741 dopaminergic neurons through P2X(7) receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALA POLYMORPHISM; ACTIVATION; RELEASE; APOPTOSIS; DEATH; IMPAIRS; NEUROPROTECTION; DIFFERENTIATION; ANTAGONISTS; MODULATION	Extracellular ATP has recently been identified as an important regulator of cell death in response to pathological insults. When SN4741 cells, which are dopaminergic neurons derived from the substantia nigra of transgenic mouse embryos, are exposed to ATP, cell death occurs. This cell death is associated with prominent cell swelling, loss of ER integrity, the formation of many large cytoplasmic vacuoles, and subsequent cytolysis and DNA release. In addition, the cleavage of caspase-3, a hallmark of apoptosis, is induced by ATP treatment. However, caspase inhibitors do not overcome ATP-induced cell death, indicating that both necrosis and apoptosis are associated with ATP-induced cell death and suggesting that a necrotic event might override the apoptotic process. In this study we also found that P2X(7) receptors (P2X(7)Rs) are abundantly expressed in SN4741 cells, and both ATP-induced swelling and cell death are reversed by pretreatment with the P2X(7)Rs antagonist, KN62, or by knock-down of P2X(7)Rs with small interfering RNAs. Therefore, extracellular ATP release from injured tissues may act as an accelerating factor in necrotic SN4741 dopaminergic cell death via P2X(7)Rs.	[Jun, Dong-Jae; Kim, Jaeyoon; Jung, Sang-Yong; Song, Ran; Park, Yong-Soo; Ryu, Sung-Ho; Kim, Joung-Hun; Kong, Young-Yun; Kim, Kyong-Tai] Pohang Univ Sci & Technol, Dept Life Sci, Div Mol & Life Sci, Pohang 790784, South Korea; [Noh, Ji-Hyun; Chung, Jun-Mo] Ewha Womans Univ, Coll Nat Sci, Dept Life Sci, Seoul 20750, South Korea	Pohang University of Science & Technology (POSTECH); Ewha Womans University	Kim, KT (corresponding author), POSTECH, Dept Life Sci, San-31,Hyoja-Dong,Nam-Gu, Pohang 790784, South Korea.	ktk@postech.ac.kr	Park, Yongsoo/G-9285-2014	Park, Yongsoo/0000-0001-8336-8051; Ryu, Sung Ho/0000-0003-0913-3048; KIM, KYONG-TAI/0000-0001-7292-2627				Adriouch S, 2002, J IMMUNOL, V169, P4108, DOI 10.4049/jimmunol.169.8.4108; Amadio S, 2002, NEUROPHARMACOLOGY, V42, P489, DOI 10.1016/S0028-3908(01)00197-6; Anderson CM, 2006, TRENDS NEUROSCI, V29, P257, DOI 10.1016/j.tins.2006.03.003; Armstrong JN, 2002, J NEUROSCI, V22, P5938; Banfi C, 2005, J MOL CELL CARDIOL, V39, P929, DOI 10.1016/j.yjmcc.2005.09.002; Baraldi PG, 2004, CURR TOP MED CHEM, V4, P1707, DOI 10.2174/1568026043387223; Beigi R, 1999, AM J PHYSIOL-CELL PH, V276, pC267, DOI 10.1152/ajpcell.1999.276.1.C267; Cavaliere F, 2005, NEUROBIOL DIS, V18, P100, DOI 10.1016/j.nbd.2004.09.001; Colomar A, 2003, J BIOL CHEM, V278, P30732, DOI 10.1074/jbc.M304534200; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; Deuchars SA, 2001, J NEUROSCI, V21, P7143, DOI 10.1523/JNEUROSCI.21-18-07143.2001; Di Virgilio F, 2001, BLOOD, V97, P587, DOI 10.1182/blood.V97.3.587; DIVIRGILIO F, 1988, BIOCHEM J, V256, P959, DOI 10.1042/bj2560959; Duan SM, 2003, J NEUROSCI, V23, P1320, DOI 10.1523/JNEUROSCI.23-04-01320.2003; Ferrari D, 1999, FEBS LETT, V447, P71, DOI 10.1016/S0014-5793(99)00270-7; FILIPPINI A, 1990, P NATL ACAD SCI USA, V87, P8267, DOI 10.1073/pnas.87.21.8267; Formigli L, 2000, J CELL PHYSIOL, V182, P41, DOI 10.1002/(SICI)1097-4652(200001)182:1<41::AID-JCP5>3.0.CO;2-7; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Gu B, 1998, BLOOD, V92, P946; Gu BJ, 2004, J BIOL CHEM, V279, P31287, DOI 10.1074/jbc.M313902200; Gu BJ, 2001, J BIOL CHEM, V276, P11135, DOI 10.1074/jbc.M010353200; Humphreys BD, 1998, MOL PHARMACOL, V54, P22, DOI 10.1124/mol.54.1.22; Inoue K, 2002, GLIA, V40, P156, DOI 10.1002/glia.10150; Le Feuvre R, 2002, EUR J PHARMACOL, V447, P261, DOI 10.1016/S0014-2999(02)01848-4; Le Stunff H, 2004, J BIOL CHEM, V279, P16918, DOI 10.1074/jbc.M313064200; Lee H, 2005, J BIOL CHEM, V280, P28556, DOI 10.1074/jbc.M411253200; Liang LH, 2005, AM J PHYSIOL-CELL PH, V288, pC240, DOI 10.1152/ajpcell.00532.2004; Mackenzie AB, 2005, J BIOL CHEM, V280, P33968, DOI 10.1074/jbc.M502705200; Maeno E, 2000, P NATL ACAD SCI USA, V97, P9487, DOI 10.1073/pnas.140216197; Marcus AJ, 2003, J PHARMACOL EXP THER, V305, P9, DOI 10.1124/jpet.102.043729; MINTA A, 1989, J BIOL CHEM, V264, P19449; Moore DJ, 2005, ANNU REV NEUROSCI, V28, P57, DOI 10.1146/annurev.neuro.28.061604.135718; Morale MC, 2006, NEUROSCIENCE, V138, P869, DOI 10.1016/j.neuroscience.2005.07.060; MURGIA M, 1993, J BIOL CHEM, V268, P8199; Namgung U, 2000, J NEUROSCI, V20, P6442, DOI 10.1523/JNEUROSCI.20-17-06442.2000; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Okada Y, 2001, J PHYSIOL-LONDON, V532, P3, DOI 10.1111/j.1469-7793.2001.0003g.x; Park YS, 2006, ENDOCRINOLOGY, V147, P1349, DOI 10.1210/en.2005-0959; PEARSON JD, 1979, NATURE, V281, P384, DOI 10.1038/281384a0; Robson SC, 1997, J EXP MED, V185, P153, DOI 10.1084/jem.185.1.153; Sluyter R, 2004, J IMMUNOL, V172, P3399, DOI 10.4049/jimmunol.172.6.3399; Solini A, 2007, AM J PHYSIOL-RENAL, V292, pF1537, DOI 10.1152/ajprenal.00440.2006; Son JH, 1999, J NEUROSCI, V19, P10, DOI 10.1523/JNEUROSCI.19-01-00010.1999; Sperlagh B, 2006, PROG NEUROBIOL, V78, P327, DOI 10.1016/j.pneurobio.2006.03.007; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Torres GE, 1999, J BIOL CHEM, V274, P6653, DOI 10.1074/jbc.274.10.6653; Virginio C, 1999, J PHYSIOL-LONDON, V519, P335, DOI 10.1111/j.1469-7793.1999.0335m.x; Virginio C, 1997, NEUROPHARMACOLOGY, V36, P1285, DOI 10.1016/S0028-3908(97)00141-X; Wang XH, 2004, NAT MED, V10, P821, DOI 10.1038/nm1082; Whitton PS, 2007, BRIT J PHARMACOL, V150, P963, DOI 10.1038/sj.bjp.0707167; Wiley JS, 2003, J BIOL CHEM, V278, P17108, DOI 10.1074/jbc.M212759200; Wyllie A H, 1980, Int Rev Cytol, V68, P251; Zeng YS, 2000, NEUROSCI RES, V37, P113, DOI 10.1016/S0168-0102(00)00107-3; Zholos A, 2005, J GEN PHYSIOL, V125, P197, DOI 10.1085/jgp.200409161	54	67	73	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37350	37358		10.1074/jbc.M707915200	http://dx.doi.org/10.1074/jbc.M707915200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17962183	hybrid			2022-12-27	WOS:000251833600009
J	Ha, KN; Traaseth, NJ; Verardi, R; Zamoon, J; Cembran, A; Karim, CB; Thomas, DD; Veglia, G				Ha, Kim N.; Traaseth, Nathaniel J.; Verardi, Raffaello; Zamoon, Jamillah; Cembran, Alessandro; Karim, Christine B.; Thomas, David D.; Veglia, Gianluigi			Controlling the inhibition of the sarcoplasmic Ca2+-ATPase by tuning phospholamban structural dynamics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADVANCED HEART-FAILURE; SOLID-STATE NMR; DILATED CARDIOMYOPATHY; CONFORMATIONAL SWITCH; PROTEIN SECONDARY; CALCIUM-PUMP; PHOSPHORYLATION; CA2+; DOMAIN; SITE	Cardiac contraction and relaxation are regulated by conformational transitions of protein complexes that are responsible for calcium trafficking through cell membranes. Central to the muscle relaxation phase is a dynamic membrane protein complex formed by Ca2+-ATPase (SERCA) and phospholamban (PLN), which in humans is responsible for similar to 70% of the calcium re-uptake in the sarcoplasmic reticulum. Dysfunction in this regulatory mechanism causes severe pathophysiologies. In this report, we used a combination of nuclear magnetic resonance, electron paramagnetic resonance, and coupled enzyme assays to investigate how single mutations at position 21 of PLN affects its structural dynamics and, in turn, its interaction with SERCA. We found that it is possible to control the activity of SERCA by tuning PLN structural dynamics. Both increased rigidity and mobility of the PLN backbone cause a reduction of SERCA inhibition, affecting calcium transport. Although the more rigid, loss-of-function (LOF) mutants have lower binding affinities for SERCA, the more dynamic LOF mutants have binding affinities similar to that of PLN. Here, we demonstrate that it is possible to harness this knowledge to design new LOF mutants with activity similar to S16E (a mutant already used in gene therapy) for possible application in recombinant gene therapy. As proof of concept, we show a new mutant of PLN, P21G, with improved LOF characteristics in vitro.	[Verardi, Raffaello; Zamoon, Jamillah; Karim, Christine B.; Thomas, David D.; Veglia, Gianluigi] Univ Minnesota, Dept Biochem Biophys & Mol Biol, Minneapolis, MN 55455 USA; [Ha, Kim N.; Traaseth, Nathaniel J.; Cembran, Alessandro; Veglia, Gianluigi] Univ Minnesota, Dept Chem, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Veglia, G (corresponding author), Univ Minnesota, Dept Biochem Biophys & Mol Biol, 6-155 Jackson Hall, Minneapolis, MN 55455 USA.	veglia@chem.umn.edu	Traaseth, Nathaniel/B-4751-2010; Thomas, David D/B-4257-2012; Cembran, Alessandro/B-1561-2016	Cembran, Alessandro/0000-0002-9868-4994; Thomas, David D./0000-0002-8822-2040; Karim, Christine/0000-0002-7321-7695	NHLBI NIH HHS [K02HL080081, K02 HL080081-02, K02 HL080081] Funding Source: Medline; NIGMS NIH HHS [R01 GM027906-27, R01 GM027906, R01 GM064742, GM64742, R01 GM064742-06A1, GM27906] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K02HL080081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027906, R01GM064742] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Afara MR, 2006, BIOCHEMISTRY-US, V45, P8617, DOI 10.1021/bi0523761; Asahi M, 1999, J BIOL CHEM, V274, P32855, DOI 10.1074/jbc.274.46.32855; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bers DM, 2006, ANN NY ACAD SCI, V1080, P165, DOI 10.1196/annals.1380.015; BODENHAUSEN G, 1980, CHEM PHYS LETT, V69, P185, DOI 10.1016/0009-2614(80)80041-8; Buck B, 2003, PROTEIN EXPRES PURIF, V30, P253, DOI 10.1016/S1046-5928(03)00127-X; CASELLA G, 2001, STAT INFERENCE, P161; Chien K.R, 2006, NOVART FDN SYMP, V274, P272; Chien K.R, 2006, NOVART FDN SYMP, V274, P256; CHIEN KR, 1926, NOVART FDN SYMP, V274, P244; Cornea RL, 1997, BIOCHEMISTRY-US, V36, P2960, DOI 10.1021/bi961955q; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Hagemann D, 2002, TRENDS CARDIOVAS MED, V12, P51, DOI 10.1016/S1050-1738(01)00145-1; Haghighi K, 2006, P NATL ACAD SCI USA, V103, P1388, DOI 10.1073/pnas.0510519103; Haghighi K, 2003, J CLIN INVEST, V111, P869, DOI 10.1172/JCI200317892; Hoshijima M, 2002, NAT MED, V8, P864, DOI 10.1038/nm739; Hoshijima M, 2006, J AM COLL CARDIOL, V48, pA15, DOI 10.1016/j.jacc.2006.06.070; Inesi G, 2006, BIOCHEMISTRY-US, V45, P13769, DOI 10.1021/bi061255d; JAMES P, 1989, NATURE, V342, P90, DOI 10.1038/342090a0; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Karim CB, 1998, BIOCHEMISTRY-US, V37, P12074, DOI 10.1021/bi980642n; Karim CB, 2006, J MOL BIOL, V358, P1032, DOI 10.1016/j.jmb.2006.02.051; Karim CB, 2004, P NATL ACAD SCI USA, V101, P14437, DOI 10.1073/pnas.0402801101; Karim CB, 2007, NAT PROTOC, V2, P42, DOI 10.1038/nprot.2007.2; Kaye DM, 2007, J AM COLL CARDIOL, V50, P253, DOI 10.1016/j.jacc.2007.03.047; Kimura Y, 1997, J BIOL CHEM, V272, P15061, DOI 10.1074/jbc.272.24.15061; Kimura Y, 1998, J BIOL CHEM, V273, P14238, DOI 10.1074/jbc.273.23.14238; Li JH, 2005, BIOCHEMISTRY-US, V44, P16181, DOI 10.1021/bi051075o; MacLennan DH, 2000, EUR J BIOCHEM, V267, P5291, DOI 10.1046/j.1432-1327.2000.01566.x; MacLennan DH, 2003, NAT REV MOL CELL BIO, V4, P566, DOI 10.1038/nrm1151; MacLennan DH, 2002, J MOL CELL CARDIOL, V34, P897, DOI 10.1006/jmcc.2002.2031; MacLennan DH, 1998, ANN NY ACAD SCI, V853, P31, DOI 10.1111/j.1749-6632.1998.tb08254.x; MARION D, 1989, BIOCHEMISTRY-US, V28, P6150, DOI 10.1021/bi00441a004; Mascioni A, 2002, J AM CHEM SOC, V124, P9392, DOI 10.1021/ja026507m; Mattiazzi A, 2006, BRAZ J MED BIOL RES, V39, P563, DOI 10.1590/S0100-879X2006000500001; Meiler J, 2003, P NATL ACAD SCI USA, V100, P12105, DOI 10.1073/pnas.1831973100; Metcalfe EE, 2005, BIOCHEMISTRY-US, V44, P4386, DOI 10.1021/bi047571e; Metcalfe EE, 2004, BIOPHYS J, V87, P1205, DOI 10.1529/biophysj.103.038844; Minamisawa S, 2003, J BIOL CHEM, V278, P9570, DOI 10.1074/jbc.M213132200; Mueller B, 2004, BIOCHEMISTRY-US, V43, P8754, DOI 10.1021/bi049732k; Palmer AG, 2001, METHOD ENZYMOL, V339, P204, DOI 10.1016/S0076-6879(01)39315-1; Reddy LG, 2003, BIOCHEMISTRY-US, V42, P4585, DOI 10.1021/bi026995a; Schmidt AG, 2001, CARDIOVASC DRUG THER, V15, P387, DOI 10.1023/A:1013381204658; Schmitt JP, 2003, SCIENCE, V299, P1410, DOI 10.1126/science.1081578; Simmerman HKB, 1996, J BIOL CHEM, V271, P5941, DOI 10.1074/jbc.271.10.5941; Simmerman HKB, 1998, PHYSIOL REV, V78, P921, DOI 10.1152/physrev.1998.78.4.921; SIMMERMAN HKB, 1986, J BIOL CHEM, V261, P3333; Toyoshima C, 2004, NATURE, V430, P529, DOI 10.1038/nature02680; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; Toyoshima C, 2003, P NATL ACAD SCI USA, V100, P467, DOI 10.1073/pnas.0237326100; Traaseth NJ, 2006, J MOL BIOL, V358, P1041, DOI 10.1016/j.jmb.2006.02.047; Traaseth NJ, 2007, P NATL ACAD SCI USA, V104, P14676, DOI 10.1073/pnas.0701016104; WEGENER AD, 1989, J BIOL CHEM, V264, P11468; WISHART DS, 1991, J MOL BIOL, V222, P311, DOI 10.1016/0022-2836(91)90214-Q; Zamoon J, 2005, P NATL ACAD SCI USA, V102, P4747, DOI 10.1073/pnas.0406039102; Zamoon J, 2003, BIOPHYS J, V85, P2589, DOI 10.1016/S0006-3495(03)74681-5; ZUIDERWEG ERP, 1989, BIOCHEMISTRY-US, V28, P2387, DOI 10.1021/bi00432a008	58	48	49	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					37205	37214		10.1074/jbc.M704056200	http://dx.doi.org/10.1074/jbc.M704056200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17908690	hybrid			2022-12-27	WOS:000251646000046
J	Jurkowski, TP; Anspach, N; Kulishova, L; Nellen, W; Jeltsch, A				Jurkowski, Tomasz P.; Anspach, Nils; Kulishova, Liliya; Nellen, Wolfgang; Jeltsch, Albert			The M.EcoRV DNA-(adenine N-6)-methyltransferase uses DNA bending for recognition of an expanded EcoDam recognition site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEQUENCE-SPECIFIC RECOGNITION; SCANNING FORCE MICROSCOPY; DIRECTED MUTAGENESIS; ESCHERICHIA-COLI; ADENINE METHYLTRANSFERASE; MODIFICATION METHYLASE; ECORV; BINDING; ENZYME; RESTRICTION	The M. EcoRV DNA methyltransferase recognizes GATATC sites. It is related to EcoDam, which methylates GATC sites. The DNA binding domain of M. EcoRV is similar to that of EcoDam suggesting a similar mechanism of DNA recognition. We show that amino acid residue Lys(11) of M. EcoRV is involved in recognition of Gua(1) and Arg(128) contacts the Gua in base pair 6. These residues correspond to Lys(9) and Arg(124) in EcoDam, which recognize the Gua residues in both strands of the Dam recognition sequence, indicating that M. EcoRV and EcoDam make similar contacts to outermost base pairs of their recognition sequences and M. EcoRV recognizes its target site as an expanded GATC site. In contrast to EcoDam, M. EcoRV considerably bends the DNA (59 +/- 4 degrees) suggesting indirect readout of the AT-rich inner sequence. Recognition of an expanded target site by DNA bending is a new principle for changing DNA recognition specificity of proteins during molecular evolution. R128A is inefficient in DNA bending and binding, whereas K11A bends DNA with relaxed sequence specificity. These results suggest a temporal order of the formation of protein-DNA contacts in which the Gua(6)-Arg(128) contact forms early followed by DNA bending and, finally, the formation of the Lys(11)-Gua(1) contact.	[Jurkowski, Tomasz P.; Jeltsch, Albert] Jacobs Univ, Sch Sci & Engn, Biochem Lab, D-28759 Bremen, Germany; [Kulishova, Liliya] Jacobs Univ, Sch Sci & Engn, BioRec Program, D-28759 Bremen, Germany; [Anspach, Nils; Nellen, Wolfgang] Univ Kassel, Genet Abt, CINSaT, D-34132 Kassel, Germany	Jacobs University; Jacobs University; Universitat Kassel	Jeltsch, A (corresponding author), Jacobs Univ, Sch Sci & Engn, Biochem Lab, Campus Ring 1, D-28759 Bremen, Germany.	a.jeltsch@jacobs-university.de	Kulishova, Liliya/M-8942-2016; Kulishova, Liliya/AAE-8903-2019; Jeltsch, Albert/O-7404-2014	Kulishova, Liliya/0000-0003-2077-564X; Kulishova, Liliya/0000-0003-2077-564X; Jeltsch, Albert/0000-0001-6113-9290; Jurkowski, Tomasz/0000-0002-2012-0240				Allan BW, 1999, J BIOL CHEM, V274, P19269, DOI 10.1074/jbc.274.27.19269; Beck C, 2002, BIOCHEMISTRY-US, V41, P14103, DOI 10.1021/bi025979a; Beck C, 2001, BIOCHEMISTRY-US, V40, P10956, DOI 10.1021/bi0155450; Bonin M, 2001, BIOL CHEM, V382, P1157, DOI 10.1515/BC.2001.145; Bonin M, 2000, RNA, V6, P563, DOI 10.1017/S1355838200992318; Cal S, 1997, J BIOL CHEM, V272, P490; Cal S, 1996, J BIOL CHEM, V271, P1008, DOI 10.1074/jbc.271.2.1008; Cheng XD, 2001, NUCLEIC ACIDS RES, V29, P3784, DOI 10.1093/nar/29.18.3784; CHENG XD, 1995, ANNU REV BIOPH BIOM, V24, P293, DOI 10.1146/annurev.bb.24.060195.001453; Dubey AK, 1997, NUCLEIC ACIDS RES, V25, P2025, DOI 10.1093/nar/25.10.2025; Fersht A., 1999, STRUCTURE MECH PROTE; Friedrich T, 1998, BIOL CHEM, V379, P475, DOI 10.1515/bchm.1998.379.4-5.475; Garcia RA, 1996, P NATL ACAD SCI USA, V93, P7618, DOI 10.1073/pnas.93.15.7618; Garvie CW, 2001, MOL CELL, V8, P937, DOI 10.1016/S1097-2765(01)00392-6; Gowher H, 2000, J MOL BIOL, V303, P93, DOI 10.1006/jmbi.2000.4127; HAGERMAN PJ, 1990, ANNU REV BIOCHEM, V59, P755, DOI 10.1146/annurev.biochem.59.1.755; Horton JR, 2005, CELL, V121, P349, DOI 10.1016/j.cell.2005.02.021; Jeltsch A, 1998, J MOL BIOL, V275, P747, DOI 10.1006/jmbi.1997.1492; Jeltsch A, 1999, J MOL BIOL, V285, P1121, DOI 10.1006/jmbi.1998.2389; Jeltsch A, 2002, CHEMBIOCHEM, V3, P275, DOI 10.1002/1439-7633(20020402)3:4<274::AID-CBIC274>3.0.CO;2-S; Jeltsch Albert, 2002, Methods Mol Biol, V182, P85; Klaue Y, 2003, RNA, V9, P839, DOI 10.1261/rna.2167603; LAUSTER R, 1987, FEBS LETT, V220, P167, DOI 10.1016/0014-5793(87)80897-9; Lee SW, 2004, J CELL SCI, V117, P3725, DOI 10.1242/jcs.01342; Liebert K, 2007, J BIOL CHEM, V282, P22848, DOI 10.1074/jbc.M700926200; NWOSU VU, 1988, NUCLEIC ACIDS RES, V16, P3705, DOI 10.1093/nar/16.9.3705; Pingoud A, 2001, NUCLEIC ACIDS RES, V29, P3705, DOI 10.1093/nar/29.18.3705; Rasko T, 2000, NUCLEIC ACIDS RES, V28, P3083, DOI 10.1093/nar/28.16.3083; Roth M, 1998, J BIOL CHEM, V273, P17333, DOI 10.1074/jbc.273.28.17333; Roth M, 2000, BIOL CHEM, V381, P269, DOI 10.1515/BC.2000.035; SEEMAN NC, 1976, P NATL ACAD SCI USA, V73, P804, DOI 10.1073/pnas.73.3.804; Singer B, 1997, CHEM RES TOXICOL, V10, P713, DOI 10.1021/tx970011e; STOVER T, 1993, J BIOL CHEM, V268, P8645; Surby MA, 1996, BIOCHEMISTRY-US, V35, P2201, DOI 10.1021/bi951883n; SZCZELKUN MD, 1995, BIOCHEMISTRY-US, V34, P10724, DOI 10.1021/bi00034a004; TRAVERS AA, 1989, ANNU REV BIOCHEM, V58, P427, DOI 10.1146/annurev.biochem.58.1.427; Urig S, 2002, J MOL BIOL, V319, P1085, DOI 10.1016/S0022-2836(02)00371-6; WINKLER FK, 1993, EMBO J, V12, P1781, DOI 10.1002/j.1460-2075.1993.tb05826.x; Yang Z, 2003, NAT STRUCT BIOL, V10, P849, DOI 10.1038/nsb973	39	14	14	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					36942	36952		10.1074/jbc.M706933200	http://dx.doi.org/10.1074/jbc.M706933200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17977824	hybrid			2022-12-27	WOS:000251646000020
J	Yu, P; Kodadek, T				Yu, Peng; Kodadek, Thomas			Dynamics of the hypoxia-inducible factor-1-vascular endothelial growth factor promoter complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESTROGEN-RECEPTOR-ALPHA; LIGAND-SPECIFIC DYNAMICS; TRANSCRIPTIONAL FUNCTION; REGULATORY PARTICLE; ACTIVATION DOMAIN; BINDING DOMAIN; 26S PROTEASOME; TURNOVER; PROTEINS; COACTIVATOR	Some transactivator-promoter complexes are highly dynamic due to active disruption of the complex by proteolytic or non-proteolytic mechanisms, and this appears to be an important mechanism by which their activity is governed tightly and eventually terminated. However, the generality of these mechanisms is unclear. In this report, we address the dynamics of hypoxia-inducible factor-1 (HIF-1) binding to the vascular endothelial growth factor promoter. HIF-1 is a heterodimeric transcription factor whose activity is triggered by an increase in HIF-1 alpha levels in hypoxic cells. A "competition ChIP" assay is employed to demonstrate that HIF-1 alpha forms a kinetically stable complex with the native vascular endothelial growth factor promoter that has a half-life in excess of 1 h. Thus, HIF-1 activity does not require rapid proteolytic turnover of the promoter-bound transactivator, nor is the activator-promoter complex constantly disassembled by chaperones. However, we do find that after cessation of the inducing signal, HIF-1 activity is slowly returned to basal levels by proteasome-mediated proteolysis of the promoter-bound HIF-1 alpha protein.	Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Translat Res, Dallas, TX 75390 USA; Univ Texas SW Med Ctr Dallas, Dept Biol Mol, Div Translat Res, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Kodadek, T (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Translat Res, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Thomas.kodadek@utsouthwestern.edu		Kodadek, Thomas/0000-0003-1930-4795	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066380] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM66380] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Auld KL, 2006, MOL CELL, V21, P861, DOI 10.1016/j.molcel.2006.02.020; Brady KL, 2005, J BIOL CHEM, V280, P26743, DOI 10.1074/jbc.M502677200; Bres V, 2003, NAT CELL BIOL, V5, P754, DOI 10.1038/ncb1023; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Chavez S, 1997, P NATL ACAD SCI USA, V94, P2885, DOI 10.1073/pnas.94.7.2885; Collins GA, 2006, CURR OPIN GENET DEV, V16, P197, DOI 10.1016/j.gde.2006.02.009; Corton JC, 1998, J BIOL CHEM, V273, P13776, DOI 10.1074/jbc.273.22.13776; Elbi C, 2004, P NATL ACAD SCI USA, V101, P2876, DOI 10.1073/pnas.0400116101; Ezhkova E, 2004, MOL CELL, V13, P435, DOI 10.1016/S1097-2765(04)00026-7; Feil R, 1996, P NATL ACAD SCI USA, V93, P10887, DOI 10.1073/pnas.93.20.10887; Ferdous A, 2002, BIOCHEMISTRY-US, V41, P12798, DOI 10.1021/bi020425t; Ferdous A, 2001, MOL CELL, V7, P981, DOI 10.1016/S1097-2765(01)00250-7; Ferdous A, 2007, GENE DEV, V21, P112, DOI 10.1101/gad.1493207; Freeman BC, 2002, SCIENCE, V296, P2232, DOI 10.1126/science.1073051; Freeman BC, 2001, TRENDS BIOCHEM SCI, V26, P285, DOI 10.1016/S0968-0004(01)01834-5; GOLDBERG MA, 1994, J BIOL CHEM, V269, P4355; Gonzalez F, 2002, SCIENCE, V296, P548, DOI 10.1126/science.1069490; Greer SF, 2003, NAT IMMUNOL, V4, P1074, DOI 10.1038/ni985; Hager GL, 2004, BBA-GENE STRUCT EXPR, V1677, P46, DOI 10.1016/j.bbaexp.2003.09.016; Hirota K, 2006, CRIT REV ONCOL HEMAT, V59, P15, DOI 10.1016/j.critrevonc.2005.12.003; JOHNSTON SA, 1987, CELL, V50, P143, DOI 10.1016/0092-8674(87)90671-4; Kaelin WG, 2005, BIOCHEM BIOPH RES CO, V338, P627, DOI 10.1016/j.bbrc.2005.08.165; Kaluz S, 2006, MOL CELL BIOL, V26, P5895, DOI 10.1128/MCB.00552-06; Klokk TI, 2007, MOL CELL BIOL, V27, P1823, DOI 10.1128/MCB.01297-06; Kodadek T, 2006, CELL, V127, P261, DOI 10.1016/j.cell.2006.10.002; Lassot I, 2007, MOL CELL, V25, P369, DOI 10.1016/j.molcel.2006.12.020; Lee DH, 1998, MOL CELL BIOL, V18, P30, DOI 10.1128/MCB.18.1.30; Lee DY, 2005, CELL, V123, P423, DOI 10.1016/j.cell.2005.08.015; Lipford JR, 2005, NATURE, V438, P113, DOI 10.1038/nature04098; Lonard DM, 2000, MOL CELL, V5, P939, DOI 10.1016/S1097-2765(00)80259-2; LOUVION JF, 1993, GENE, V131, P129, DOI 10.1016/0378-1119(93)90681-R; McNally JG, 2000, SCIENCE, V287, P1262, DOI 10.1126/science.287.5456.1262; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Muratani M, 2003, NAT REV MOL CELL BIO, V4, P192, DOI 10.1038/nrm1049; Muratani M, 2005, CELL, V120, P887, DOI 10.1016/j.cell.2004.12.025; Nalley K, 2006, NATURE, V442, P1054, DOI 10.1038/nature05067; Nawaz Z, 2004, MOL ENDOCRINOL, V18, P493, DOI 10.1210/me.2003-0388; Picard D, 2000, METHOD ENZYMOL, V327, P385, DOI 10.1016/S0076-6879(00)27291-1; Piotrowski J, 1997, J BIOL CHEM, V272, P23712, DOI 10.1074/jbc.272.38.23712; Pritts TA, 2002, AM J PHYSIOL-REG I, V282, pR1016, DOI 10.1152/ajpregu.00492.2001; Rayasam GV, 2005, MOL CELL BIOL, V25, P2406, DOI 10.1128/MCB.25.6.2406-2418.2005; Reid G, 2003, MOL CELL, V11, P695, DOI 10.1016/S1097-2765(03)00090-X; SADOWSKI I, 1988, NATURE, V335, P563, DOI 10.1038/335563a0; Salghetti SE, 2001, SCIENCE, V293, P1651, DOI 10.1126/science.1062079; Salghetti SE, 2000, P NATL ACAD SCI USA, V97, P3118, DOI 10.1073/pnas.050007597; SCHERRER LC, 1993, BIOCHEMISTRY-US, V32, P5381, DOI 10.1021/bi00071a013; Semenza GL, 2002, BIOCHEM PHARMACOL, V64, P993, DOI 10.1016/S0006-2952(02)01168-1; Sikder D, 2006, J BIOL CHEM, V281, P27346, DOI 10.1074/jbc.M604706200; Stenoien DL, 2001, NAT CELL BIOL, V3, P15, DOI 10.1038/35050515; Sulahian R, 2006, NUCLEIC ACIDS RES, V34, P1351, DOI 10.1093/nar/gkl012; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Valley CC, 2005, MOL CELL BIOL, V25, P5417, DOI 10.1128/MCB.25.13.5417-5428.2005; VASHEE S, 1995, P NATL ACAD SCI USA, V92, P10683, DOI 10.1073/pnas.92.23.10683; Wu RC, 2007, CELL, V129, P1125, DOI 10.1016/j.cell.2007.04.039; Yang E, 2002, J BIOL CHEM, V277, P13455, DOI 10.1074/jbc.M112038200; Yao J, 2006, NATURE, V442, P1050, DOI 10.1038/nature05025	56	18	20	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					35035	35045		10.1074/jbc.M707557200	http://dx.doi.org/10.1074/jbc.M707557200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17916562	hybrid			2022-12-27	WOS:000251155200048
J	Bednarek, R; Boncela, J; Smolarczyk, K; Cierniewska-Cieslak, A; Wyroba, E; Cierniewski, CS				Bednarek, Radoslaw; Boncela, Joanna; Smolarczyk, Katarzyna; Cierniewska-Cieslak, Aleksandra; Wyroba, Elzbieta; Cierniewski, Czeslaw S.			Ku80 as a novel receptor for thymosin beta 4 that mediates its intracellular activity different from G-actin sequestering	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; ENDOTHELIAL-CELLS; BETA-4 GENE; METASTASIS; BINDING; PROTEIN; AUTOANTIGEN; EXPRESSION; DNA; OVEREXPRESSION	Our data demonstrate that increased intracellular expression of thymosin beta 4 (T beta 4) is necessary and sufficient to induce plasminogen activator inhibitor type 1 (PAI-1) gene expression in endothelial cells. To describe the mechanism of this effect, we produced T beta 4 mutants with impaired functional motifs and tested their intracellular location and activity. Cytoplasmic distributions of T beta 4((AcSDKPT/4A)), T beta 4((KLKKTET/7A)), and T beta 4((K16A)) mutants fused with green fluorescent protein did not differ significantly from those of wild-type T beta 4. Overexpression of T beta 4, T beta 4((AcSDKPT/4A)), and T beta 4((K16A)) affected intracellular formation of actin filaments. As expected, T beta 4((K16A)) uptake by nuclei was impaired. On the other hand, overexpression of T beta 4((KLKKTET/7A)) resulted in developing the actin filament network typical of adhering cells, indicating that the mutant lacked the actin binding site. The mechanism by which intracellular T beta 4 induced the PAI-1 gene did not depend upon the N-terminal tetrapeptide AcSDKP and depended only partially on its ability to bind G-actin or enter the nucleus. Both T beta 4 and T beta 4((AcSDKPT/4A)) induced the PAI-1 gene to the same extent, whereas mutants T beta 4((KLKKTET/7A)) and T beta 4((K16A)) retained about 60% of the original activity. By proteomic analysis, the Ku80 subunit of ATP-dependent DNA helicase II was found to be associated with T beta 4. Ku80 and T beta 4 consistently co-immunoprecipitated in a complex from endothelial cells. Co-transfection of endothelial cells with the Ku80 deletion mutants and T beta 4 showed that the C-terminal arm domain of Ku80 is directly involved in this interaction. Furthermore, down-regulation of Ku80 by specific short interference RNA resulted in dramatic reduction in PAI-1 expression at the level of both mRNA and protein synthesis. These data suggest that Ku80 functions as a novel receptor for T beta 4 and mediates its intracellular activity.	[Cierniewska-Cieslak, Aleksandra; Cierniewski, Czeslaw S.] Med Univ Lodz, Dept Mol & Med Biophys, PL-92215 Lodz, Poland; [Bednarek, Radoslaw; Boncela, Joanna; Smolarczyk, Katarzyna; Cierniewski, Czeslaw S.] Polish Acad Sci, Ctr Med Biol, PL-93232 Lodz, Poland; [Wyroba, Elzbieta] Polish Acad Sci, M Nencki Inst Expt Biol, PL-02093 Warsaw, Poland	Medical University Lodz; Polish Academy of Sciences; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences	Cierniewski, CS (corresponding author), Med Univ Lodz, Dept Mol & Med Biophys, 6-8 Mazowiecka St, PL-92215 Lodz, Poland.	cciern@zdn.am.lodz.pl	Bednarek, Radoslaw/AAC-9267-2019; Wyroba, Elzbieta/R-7525-2016; Boncela, Joanna/AAU-4481-2020; Bednarek, Radoslaw/Q-2649-2016; Wyroba, Elzbieta/P-4434-2019; Krol, Aleksandra/S-9277-2016	Bednarek, Radoslaw/0000-0003-4505-9498; Boncela, Joanna/0000-0001-8419-7012; Bednarek, Radoslaw/0000-0003-4505-9498; Krol, Aleksandra/0000-0003-0033-1099				Adam L, 2000, BIOCHEM BIOPH RES CO, V267, P692, DOI 10.1006/bbrc.1999.1978; Al-Nedawi KNI, 2004, BLOOD, V103, P1319, DOI 10.1182/blood-2003-04-1015; Bertinato J, 2003, GENE, V302, P53, DOI 10.1016/S0378111902010892; Bock-Marquette I, 2004, NATURE, V432, P466, DOI 10.1038/nature03000; Boncela J, 2006, J BIOL CHEM, V281, P1066, DOI 10.1074/jbc.M506303200; Bouis Diane, 2001, Angiogenesis, V4, P91, DOI 10.1023/A:1012259529167; Cha HJ, 2003, J NATL CANCER I, V95, P1674, DOI 10.1093/jnci/djg100; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Dierks H, 2001, J BIOL CHEM, V276, P37472, DOI 10.1074/jbc.M101502200; DIGNAM JD, 1983, METHOD ENZYMOL, V101, P582; Ding GJF, 1998, J BIOL CHEM, V273, P28897, DOI 10.1074/jbc.273.44.28897; EMEIS JJ, 1988, BLOOD, V71, P1669; Ghosh RN, 2000, BIOTECHNIQUES, V29, P170, DOI 10.2144/00291pf01; Giffin W, 1996, NATURE, V380, P265, DOI 10.1038/380265a0; Goldstein AL, 2005, TRENDS MOL MED, V11, P421, DOI 10.1016/j.molmed.2005.07.004; Golla R, 1997, CELL MOTIL CYTOSKEL, V38, P187, DOI 10.1002/(SICI)1097-0169(1997)38:2<187::AID-CM7>3.0.CO;2-4; Grant D S, 1999, Angiogenesis, V3, P125, DOI 10.1023/A:1009041911493; GRANT DS, 1995, J CELL SCI, V108, P3685; GRILLON C, 1990, FEBS LETT, V274, P30, DOI 10.1016/0014-5793(90)81322-F; GROTE J, 2006, BMC MOL BIOL, V48, P1; Gullo C, 2006, BBA-REV CANCER, V1765, P223, DOI 10.1016/j.bbcan.2006.01.001; HALL AK, 1991, INT J CANCER, V48, P672, DOI 10.1002/ijc.2910480507; Ji P, 2003, ONCOGENE, V22, P8031, DOI 10.1038/sj.onc.1206928; Kobayashi T, 2002, AM J PATHOL, V160, P869, DOI 10.1016/S0002-9440(10)64910-3; Koutrafouri V, 2001, BBA-GEN SUBJECTS, V1568, P60, DOI 10.1016/S0304-4165(01)00200-8; LIU ES, 1991, NUCLEIC ACIDS RES, V19, P5425, DOI 10.1093/nar/19.19.5425; Lynch EM, 2001, AM J PHYSIOL-CELL PH, V280, pC897, DOI 10.1152/ajpcell.2001.280.4.C897; Malinda KM, 1999, J INVEST DERMATOL, V113, P364, DOI 10.1046/j.1523-1747.1999.00708.x; Malinda KM, 1997, FASEB J, V11, P474, DOI 10.1096/fasebj.11.6.9194528; MIMORI T, 1990, P NATL ACAD SCI USA, V87, P1777, DOI 10.1073/pnas.87.5.1777; MOLL T, 1995, J BIOL CHEM, V270, P3849, DOI 10.1074/jbc.270.8.3849; Monferran S, 2004, EMBO J, V23, P3758, DOI 10.1038/sj.emboj.7600403; Morio T, 1999, IMMUNITY, V11, P339, DOI 10.1016/S1074-7613(00)80109-0; Muller C, 2005, CELL CYCLE, V4, P438, DOI 10.4161/cc.4.3.1565; Munakata Y, 2005, BLOOD, V106, P3449, DOI 10.1182/blood-2005-02-0536; Myung K, 2004, MOL CELL BIOL, V24, P5050, DOI 10.1128/MCB.24.11.5050-5059.2004; Niu M, 2000, CELL ADHES COMMUN, V7, P311, DOI 10.3109/15419060009015002; Nussenzweig A, 1996, NATURE, V382, P551, DOI 10.1038/382551a0; Paasinen-Sohns A, 2000, J CELL BIOL, V151, P801, DOI 10.1083/jcb.151.4.801; Philp D, 2003, FASEB J, V17, P385, DOI 10.1096/fj.03-0244fje; Philp D, 2003, FASEB J, V17, P2103, DOI 10.1096/fj.03-0121fje; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Sosne G, 2002, EXP EYE RES, V74, P293, DOI 10.1006/exer.2001.1125; Sosne G, 2001, EXP EYE RES, V72, P605, DOI 10.1006/exer.2000.0985; Swiatkowska M, 2005, FEBS J, V272, P5821, DOI 10.1111/j.1742-4658.2005.04979.x; SYLVIE M, 2004, J MOL BIOL, V26, P503; Tang YQ, 2002, INFECT IMMUN, V70, P6524, DOI 10.1128/IAI.70.12.6524-6533.2002; Teoh G, 1998, J CLIN INVEST, V101, P1379; Thepparit C, 2004, J VIROL, V78, P12647, DOI 10.1128/JVI.78.22.12647-12656.2004; Walker JR, 2001, NATURE, V412, P607, DOI 10.1038/35088000; Wang WS, 2004, ONCOGENE, V23, P6666, DOI 10.1038/sj.onc.1207888; Wang WS, 2003, ONCOGENE, V22, P3297, DOI 10.1038/sj.onc.1206404; Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085; Xie D, 2002, INT J ONCOL, V21, P499; YAMAMOTO T, 1993, BIOCHEM BIOPH RES CO, V193, P706, DOI 10.1006/bbrc.1993.1682; Yarmola EG, 2001, J BIOL CHEM, V276, P45555, DOI 10.1074/jbc.M105723200; Young JD, 1999, NAT MED, V5, P1424	57	33	35	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1534	1544		10.1074/jbc.M707539200	http://dx.doi.org/10.1074/jbc.M707539200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	17984099	hybrid			2022-12-27	WOS:000252282700038
J	Martin, L; Fluhrer, R; Reiss, K; Kremmer, E; Saftig, P; Haass, C				Martin, Lucas; Fluhrer, Regina; Reiss, Karina; Kremmer, Elisabeth; Saftig, Paul; Haass, Christian			Regulated intramembrane proteolysis of Bri2 (Itm2b) by ADAM10 and SPPL2a/SPPL2b	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-SECRETASE ACTIVITY; FAMILIAL BRITISH DEMENTIA; SIGNAL PEPTIDE PEPTIDASE; INTRACELLULAR DOMAIN; PRESENILIN HOMOLOGS; CRYSTAL-STRUCTURE; PROTEASE ACTIVITY; SERINE PROTEASES; AMYLOID PEPTIDE; TNF-ALPHA	Presenilin, the catalytic component of the gamma-secretase complex, type IV prepilin peptidases, and signal peptide peptidase (SPP) are the founding members of the family of intramembrane-cleaving GXGD aspartyl proteases. SPP-like (SPPL) proteases, such as SPPL2a, SPPL2b, SPPL2c, and SPPL3, also belong to the GXGD family. In contrast to gamma-secretase, for which numerous substrates have been identified, very few in vivo substrates are known for SPP and SPPLs. Here we demonstrate that Bri2 (Itm2b), a type II-oriented transmembrane protein associated with familial British and Danish dementia, undergoes regulated intramembrane proteolysis. In addition to the previously described ectodomain processing by furin and related proteases, we now describe that the Bri2 protein, similar to gamma-secretase substrates, undergoes an additional cleavage by ADAM10 in its ectodomain. This cleavage releases a soluble variant of Bri2, the BRICHOS domain, which is secreted into the extracellular space. Upon this shedding event, a membrane-bound Bri2 N-terminal fragment remains, which undergoes intramembrane proteolysis to produce an intracellular domain as well as a secreted low molecular weight C-terminal peptide. By expressing all known SPP/SPPL family members as well as their loss of function variants, we demonstrate that selectively SPPL2a and SPPL2b mediate the intramembrane cleavage, whereas neither SPP nor SPPL3 is capable of processing the Bri2 N-terminal fragment.	[Martin, Lucas; Fluhrer, Regina; Haass, Christian] Univ Munich, Ctr Integrated Prot Sci Munich, Dept Biochem, Lab Neurodegenerat Dis Res, D-80336 Munich, Germany; [Martin, Lucas; Fluhrer, Regina; Haass, Christian] Univ Munich, Adolf Butenandt Inst, Dept Biochem, Lab Neurodegenerat Dis Res, D-80336 Munich, Germany; [Reiss, Karina; Saftig, Paul] Univ Kiel, Inst Biochem, D-24098 Kiel, Germany; [Kremmer, Elisabeth] Gesell Strahlenforsch, Forschungszentrum, Inst Mol Immunol, D-81377 Munich, Germany	University of Munich; University of Munich; University of Kiel	Haass, C (corresponding author), Univ Munich, Ctr Integrated Prot Sci Munich, Dept Biochem, Lab Neurodegenerat Dis Res, D-80336 Munich, Germany.	chaass@med.uni-muenchen.de	Saftig, Paul/A-7966-2010; Fluhrer, Regina/F-2642-2011; Reiss, Karina/B-3175-2010					Arribas J, 1996, J BIOL CHEM, V271, P11376, DOI 10.1074/jbc.271.19.11376; Ben-Shem A, 2007, P NATL ACAD SCI USA, V104, P462, DOI 10.1073/pnas.0609773104; Bentahir M, 2006, J NEUROCHEM, V96, P732, DOI 10.1111/j.1471-4159.2005.03578.x; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Choi SI, 2003, FASEB J, V17, P373, DOI 10.1096/fj.03-0730fje; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Esler WP, 2002, P NATL ACAD SCI USA, V99, P2720, DOI 10.1073/pnas.052436599; Fluhrer R, 2006, NAT CELL BIOL, V8, P894, DOI 10.1038/ncb1450; Foltenyi K, 2007, NAT NEUROSCI, V10, P1160, DOI 10.1038/nn1957; Friedmann E, 2006, NAT CELL BIOL, V8, P843, DOI 10.1038/ncb1440; Grigorenko AP, 2002, BIOCHEMISTRY-MOSCOW+, V67, P826, DOI 10.1023/A:1016365227942; Haass C, 2004, EMBO J, V23, P483, DOI 10.1038/sj.emboj.7600061; Haass C, 2002, TRENDS CELL BIOL, V12, P556, DOI 10.1016/S0962-8924(02)02394-2; Hundhausen C, 2003, BLOOD, V102, P1186, DOI 10.1182/blood-2002-12-3775; Kaether C, 2004, EMBO J, V23, P4738, DOI 10.1038/sj.emboj.7600478; Kim SH, 2002, J BIOL CHEM, V277, P1872, DOI 10.1074/jbc.M108739200; Kim SH, 1999, NAT NEUROSCI, V2, P984, DOI 10.1038/14783; Kirkin V, 2007, CELL DEATH DIFFER, V14, P1678, DOI 10.1038/sj.cdd.4402175; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Krawitz P, 2005, J BIOL CHEM, V280, P39515, DOI 10.1074/jbc.M501645200; LaPointe CF, 2000, J BIOL CHEM, V275, P1502, DOI 10.1074/jbc.275.2.1502; Lee JR, 2001, CELL, V107, P161, DOI 10.1016/S0092-8674(01)00526-8; Lemieux MJ, 2007, P NATL ACAD SCI USA, V104, P750, DOI 10.1073/pnas.0609981104; Loureiro J, 2006, NATURE, V441, P894, DOI 10.1038/nature04830; Mumm JS, 2000, DEV BIOL, V228, P151, DOI 10.1006/dbio.2000.9960; Okochi M, 2002, EMBO J, V21, P5408, DOI 10.1093/emboj/cdf541; PLANT GT, 1990, BRAIN, V113, P721, DOI 10.1093/brain/113.3.721; Ponting CP, 2002, HUM MOL GENET, V11, P1037, DOI 10.1093/hmg/11.9.1037; Rawson RB, 1997, MOL CELL, V1, P47, DOI 10.1016/S1097-2765(00)80006-4; Sakai J, 1996, CELL, V85, P1037, DOI 10.1016/S0092-8674(00)81304-5; Sanchez-Pulido L, 2002, TRENDS BIOCHEM SCI, V27, P329, DOI 10.1016/S0968-0004(02)02134-5; Selkoe D, 2003, ANNU REV NEUROSCI, V26, P565, DOI 10.1146/annurev.neuro.26.041002.131334; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; Steiner H, 2000, NAT CELL BIOL, V2, P848, DOI 10.1038/35041097; Thinakaran G, 1998, NEUROBIOL DIS, V4, P438, DOI 10.1006/nbdi.1998.0171; Urban S, 2001, CELL, V107, P173, DOI 10.1016/S0092-8674(01)00525-6; Vidal R, 2000, P NATL ACAD SCI USA, V97, P4920, DOI 10.1073/pnas.080076097; Vidal R, 1999, NATURE, V399, P776; WANG XD, 1994, CELL, V77, P53, DOI 10.1016/0092-8674(94)90234-8; Wang YC, 2007, P NATL ACAD SCI USA, V104, P2098, DOI 10.1073/pnas.0611080104; Wang YC, 2006, NATURE, V444, P179, DOI 10.1038/nature05255; Weihofen A, 2000, J BIOL CHEM, V275, P30951, DOI 10.1074/jbc.M005980200; Weihofen A, 2003, TRENDS CELL BIOL, V13, P71, DOI 10.1016/S0962-8924(02)00041-7; Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Wu ZR, 2006, NAT STRUCT MOL BIOL, V13, P1084, DOI 10.1038/nsmb1179; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7	51	119	127	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1644	1652		10.1074/jbc.M706661200	http://dx.doi.org/10.1074/jbc.M706661200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	17965014	Green Published, hybrid			2022-12-27	WOS:000252282700051
J	Dellis, O; Rossi, AM; Dedos, SG; Taylor, CW				Dellis, Olivier; Rossi, Ana M.; Dedos, Skarlatos G.; Taylor, Colin W.			Counting functional inositol 1,4,5-trisphosphate receptors into the plasma membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IP3 RECEPTORS; SIGNAL-TRANSDUCTION; ION PERMEATION; CA2+ ENTRY; RELEASE; TRISPHOSPHATE; SELECTIVITY; CHANNELS; TYPE-1; ACID	Inositol 1,4,5-trisphosphate receptors (IP3R) within the endoplasmic reticulum mediate release of Ca2+ from intracellular stores. Different channels usually mediate Ca2+ entry across the plasma membrane. In Blymphocytes and a cell line derived from them (DT40 cells), very few functional IP3R (similar to 2/cell) are invariably expressed in the plasma membrane, where they mediate about half the Ca2+ entry evoked by activation of the B-cell receptor. We show that cells reliably count similar to 2 functional IP3R into the plasma membrane even when their conductance and ability to bind IP3 are massively attenuated. We conclude that very small numbers of functional IP3R can be reliably counted into a specific membrane compartment in the absence of feedback signals from the active protein.	[Dellis, Olivier; Rossi, Ana M.; Dedos, Skarlatos G.; Taylor, Colin W.] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England	University of Cambridge	Taylor, CW (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1PD, England.	cwt1000@cam.ac.uk	Dedos, Skarlatos G./A-5345-2008; Dellis, Olivier/E-8501-2011; Taylor, Colin/G-2447-2010	Dedos, Skarlatos G./0000-0002-0432-338X; Dellis, Olivier/0000-0003-0377-9163; Taylor, Colin/0000-0001-7771-1044	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Boehning D, 2001, J BIOL CHEM, V276, P13509, DOI 10.1074/jbc.C100094200; Borodinsky LN, 2004, NATURE, V429, P523, DOI 10.1038/nature02518; Bosanac I, 2002, NATURE, V420, P696, DOI 10.1038/nature01268; Dellis O, 2006, SCIENCE, V313, P229, DOI 10.1126/science.1125203; Echevarria W, 2003, NAT CELL BIOL, V5, P440, DOI 10.1038/ncb980; FADOOL DA, 1992, NEURON, V9, P907, DOI 10.1016/0896-6273(92)90243-7; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Gerasimenko OV, 1996, CELL, V84, P473, DOI 10.1016/S0092-8674(00)81292-1; Ghanshani S, 2000, J BIOL CHEM, V275, P37137, DOI 10.1074/jbc.M003941200; Haynes LP, 2004, J BIOL CHEM, V279, P547, DOI 10.1074/jbc.M309617200; Hille B., 2001, IONIC CHANNELS EXCIT, P814; Kasri NN, 2004, EMBO J, V23, P312, DOI 10.1038/sj.emboj.7600037; KHAN AA, 1992, P NATL ACAD SCI USA, V89, P2849, DOI 10.1073/pnas.89.7.2849; Laude AJ, 2005, CELL CALCIUM, V38, P45, DOI 10.1016/j.ceca.2005.04.001; LOIRAND G, 1991, J PHYSIOL-LONDON, V437, P461, DOI 10.1113/jphysiol.1991.sp018606; Pinton P, 1998, EMBO J, V17, P5298, DOI 10.1093/emboj/17.18.5298; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Rao CV, 2002, NATURE, V420, P231, DOI 10.1038/nature01258; Riley AM, 2002, J BIOL CHEM, V277, P40290, DOI 10.1074/jbc.M206925200; Sather WA, 2003, ANNU REV PHYSIOL, V65, P133, DOI 10.1146/annurev.physiol.65.092101.142345; Spitzer NC, 2006, NATURE, V444, P707, DOI 10.1038/nature05300; Sugawara H, 1997, EMBO J, V16, P3078, DOI 10.1093/emboj/16.11.3078; Taylor CW, 2004, TRENDS BIOCHEM SCI, V29, P210, DOI 10.1016/j.tibs.2004.02.010; Taylor CW, 2002, CELL CALCIUM, V32, P321, DOI 10.1016/S0143416002001859; Tovey SC, 2006, NAT PROTOC, V1, P259, DOI 10.1038/nprot.2006.40; VACA L, 1995, AM J PHYSIOL-CELL PH, V269, pC733, DOI 10.1152/ajpcell.1995.269.3.C733; van Rossum DB, 2004, P NATL ACAD SCI USA, V101, P2323, DOI 10.1073/pnas.0308565100; VANKAMPLEN NG, 2001, STOCHASTIC PROCESSES; Wang Y, 2005, BIOPHYS J, V89, P256, DOI 10.1529/biophysj.104.056002; White C, 2006, J BIOL CHEM, V281, P20825, DOI 10.1074/jbc.M602175200; Winding P, 2001, J IMMUNOL METHODS, V249, P1, DOI 10.1016/S0022-1759(00)00333-1; Wu JQ, 2005, SCIENCE, V310, P310, DOI 10.1126/science.1113230; Xu L, 2006, BIOPHYS J, V90, P443, DOI 10.1529/biophysj.105.072538; Yang J, 2002, P NATL ACAD SCI USA, V99, P7711, DOI 10.1073/pnas.102006299; Yule DI, 1997, J BIOL CHEM, V272, P9093	35	30	30	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					751	755		10.1074/jbc.M706960200	http://dx.doi.org/10.1074/jbc.M706960200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	17999955	hybrid			2022-12-27	WOS:000252128100013
J	Infante, RE; Abi-Mosleh, L; Radhakrishnan, A; Dale, JD; Brown, MS; Goldstein, JL				Infante, Rodney E.; Abi-Mosleh, Lina; Radhakrishnan, Arun; Dale, Jarrod D.; Brown, Michael S.; Goldstein, Joseph L.			Purified NPC1 protein - I. Binding of cholesterol and oxysterols to a 1278-amino acid membrane protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLEAVAGE-ACTIVATING PROTEIN; LOW-DENSITY-LIPOPROTEIN; STEROL-SENSING DOMAIN; PICK C1 PROTEIN; COMPETITIVE INHIBITOR; ENDOPLASMIC-RETICULUM; REGULATED TRANSPORT; HUMAN FIBROBLASTS; SREBPS; REDUCTASE	The Niemann-Pick, Type C1 protein (NPC1) is required for the transport of lipoprotein-derived cholesterol from lysosomes to endoplasmic reticulum. The 1278-amino acid, polytopic membrane protein has not been purified, and its mechanism of action is unknown. Unexpectedly, we encountered NPC1 in a search for a membrane protein that binds 25-hydroxycholesterol (25-HC) and other oxysterols. A 25-HC-binding protein was purified more than 14,000-fold from rabbit liver membranes and identified as NPC1 by mass spectroscopy. We prepared recombinant human NPC1 and confirmed its ability to bind oxysterols, including those with a hydroxyl group on the 24, 25, or 27 positions. Hydroxyl groups on the 7, 19, or 20 positions failed to confer binding. Recombinant human NPC1 also bound [H-3] cholesterol in a reaction inhibited by Nonidet P-40 above its critical micellar concentration. Low concentrations of unlabeled 25-HC abolished binding of [H-3] cholesterol, but the converse was not true, i.e. unlabeled cholesterol, even at high concentrations, did not abolish binding of [H-3]25-HC. NPC1 is not required for the known regulatory actions of oxysterols. Thus, in NPC1-deficient fibroblasts 25-HC blocked the processing of sterol regulatory element-binding proteins and activated acyl-CoA: cholesterol acyltransferase in a normal fashion. The availability of assays to measure NPC1 binding in vitro may further the understanding of ways in which oxysterols regulate intracellular lipid transport.	[Infante, Rodney E.; Abi-Mosleh, Lina; Radhakrishnan, Arun; Dale, Jarrod D.; Brown, Michael S.; Goldstein, Joseph L.] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Brown, MS (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Genet, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	mike.brown@utsouthwestern.edu; joe.goldstein@utsouthwestern.edu	Radhakrishnan, Arun/Q-7437-2019; Infante, Rodney/ABG-7756-2020	Radhakrishnan, Arun/0000-0002-7266-7336; Infante, Rodney/0000-0003-2605-822X	NHLBI NIH HHS [HL20948] Funding Source: Medline; NIDDK NIH HHS [DK066141] Funding Source: Medline; NIGMS NIH HHS [5T32 GM08014] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T35DK066141] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008014] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams CM, 2004, J BIOL CHEM, V279, P52772, DOI 10.1074/jbc.M410302200; Bjorkhem I, 2004, ARTERIOSCL THROM VAS, V24, P806, DOI 10.1161/01.ATV.0000120374.59826.1b; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; BROWN MS, 1978, J BIOL CHEM, V253, P1121; BROWN MS, 1975, J BIOL CHEM, V250, P4025; Chen Y, 2005, J PROTEOME RES, V4, P998, DOI 10.1021/pr049754t; Cheruku SR, 2006, J BIOL CHEM, V281, P31594, DOI 10.1074/jbc.M602765200; Davies JP, 2000, J BIOL CHEM, V275, P24367, DOI 10.1074/jbc.M002184200; DAWSON PA, 1989, J BIOL CHEM, V264, P16798; DAWSON PA, 1989, J BIOL CHEM, V264, P9046; Fisher LE, 2003, BIOPHYS J, V85, P3097, DOI 10.1016/S0006-3495(03)74728-6; GIL G, 1985, CELL, V41, P249, DOI 10.1016/0092-8674(85)90078-9; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; Hua XX, 1996, CELL, V87, P415, DOI 10.1016/S0092-8674(00)81362-8; Infante RE, 2008, J BIOL CHEM, V283, P1064, DOI 10.1074/jbc.M707944200; KITA T, 1980, J CLIN INVEST, V66, P1094, DOI 10.1172/JCI109938; KOVANEN PT, 1981, P NATL ACAD SCI-BIOL, V78, P1396, DOI 10.1073/pnas.78.3.1396; Liscum L, 2004, BBA-MOL CELL BIOL L, V1685, P22, DOI 10.1016/j.bbalip.2004.08.008; LISCUM L, 1987, J BIOL CHEM, V262, P17002; Loftus SK, 1997, SCIENCE, V277, P232, DOI 10.1126/science.277.5323.232; Millard EE, 2005, J BIOL CHEM, V280, P28581, DOI 10.1074/jbc.M414024200; Nohturfft A, 1998, P NATL ACAD SCI USA, V95, P12848, DOI 10.1073/pnas.95.22.12848; Ohgami N, 2004, P NATL ACAD SCI USA, V101, P12473, DOI 10.1073/pnas.0405255101; Ouellette MM, 1999, BIOCHEM BIOPH RES CO, V254, P795, DOI 10.1006/bbrc.1998.0114; Pentchev P. G., 1995, METABOLIC MOL BASES, P2625; PENTCHEV PG, 1985, P NATL ACAD SCI USA, V82, P8247, DOI 10.1073/pnas.82.23.8247; Pentchev PG, 2004, BBA-MOL CELL BIOL L, V1685, P3, DOI 10.1016/j.bbalip.2004.08.005; Radhakrishnan A, 2004, MOL CELL, V15, P259, DOI 10.1016/j.molcel.2004.06.019; Radhakrishnan A, 2007, P NATL ACAD SCI USA, V104, P6511, DOI 10.1073/pnas.0700899104; Rawson RB, 1999, J BIOL CHEM, V274, P28549, DOI 10.1074/jbc.274.40.28549; Sakai J, 1997, J BIOL CHEM, V272, P20213, DOI 10.1074/jbc.272.32.20213; Sun LP, 2007, P NATL ACAD SCI USA, V104, P6519, DOI 10.1073/pnas.0700907104; VANDRIEL IR, 1987, J BIOL CHEM, V262, P17443; WILLNOW TE, 1994, J CELL SCI, V107, P719; Wood LD, 2001, ONCOGENE, V20, P278, DOI 10.1038/sj.onc.1204072; Xie CL, 2003, J LIPID RES, V44, P1780, DOI 10.1194/jlr.M300164-JLR200	36	163	165	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					1052	1063		10.1074/jbc.M707943200	http://dx.doi.org/10.1074/jbc.M707943200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	17989073	hybrid			2022-12-27	WOS:000252128100045
J	Ruettger, A; Schueler, S; Mollenhauer, JA; Wiederanders, B				Ruettger, Anke; Schueler, Susann; Mollenhauer, Juergen A.; Wiederanders, Bernd			Cathepsins B, K, and L are regulated by a defined collagen type II peptide via activation of classical protein kinase C and p38 MAP kinase in articular chondrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; CARTILAGE DEGRADATION; FIBRONECTIN FRAGMENTS; RHEUMATOID-ARTHRITIS; GENE-EXPRESSION; OSTEOARTHRITIC CARTILAGE; TELOPEPTIDE FRAGMENTS; CONNECTIVE TISSUES; BONE DESTRUCTION; ANNEXIN-V	Degradation of the extracellular matrix (ECM) is a prominent feature in osteoarthritis (OA), which is mainly because of the imbalance between anabolic and catabolic processes in chondrocytes resulting in cartilage and bone destruction. Various proteases act in concert to degrade matrix components, e. g. type II collagen, MMPs, ADAMTS, and cathepsins. Protease-generated collagen fragments may foster the destructive process. However, the signaling pathways associated with the action of collagen fragments on chondrocytes have not been clearly defined. The present data demonstrate that the N-terminal telopeptide of collagen type II enhances expression of cathepsins B, K, and L in articular chondrocytes at mRNA, protein, and activity levels, mediated at least in part through extracellular calcium. We also demonstrate that the induction is associated with the activation of protein kinase C and p38 MAP kinase.	[Ruettger, Anke; Schueler, Susann; Wiederanders, Bernd] Univ Jena, Univ Klinikum, Inst Biochem 1, D-07743 Jena, Germany; [Ruettger, Anke; Mollenhauer, Juergen A.] Univ Jena, Univ Klinikum, Orthopaed Res Unit Eisenberg, D-07743 Jena, Germany; [Mollenhauer, Juergen A.] Rush Univ, Med Ctr, Dept Biochem, Chicago, IL 60612 USA; [Mollenhauer, Juergen A.] Univ Tubingen, Nat & Med Sci Inst, D-72770 Reutlingen, Germany	Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Rush University; Eberhard Karls University of Tubingen	Wiederanders, B (corresponding author), Univ Jena, Univ Klinikum, Inst Biochem 1, D-07743 Jena, Germany.	bwie@mti.uni-jena.de						Afif H, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2151; BAICI A, 1995, ANN RHEUM DIS, V54, P289, DOI 10.1136/ard.54.4.289; Bank RA, 1997, MATRIX BIOL, V16, P233, DOI 10.1016/S0945-053X(97)90012-3; Barilla ML, 2000, SEMIN ARTHRITIS RHEU, V29, P252, DOI 10.1016/S0049-0172(00)80012-8; Billinghurst RC, 1997, J CLIN INVEST, V99, P1534, DOI 10.1172/JCI119316; Bromme D, 1996, J BIOL CHEM, V271, P2126, DOI 10.1074/jbc.271.4.2126; Camper L, 1998, J BIOL CHEM, V273, P20383, DOI 10.1074/jbc.273.32.20383; Christgau S, 2001, BONE, V29, P209, DOI 10.1016/S8756-3282(01)00504-X; Downs JT, 2001, J IMMUNOL METHODS, V247, P25, DOI 10.1016/S0022-1759(00)00302-1; Drake FH, 1996, J BIOL CHEM, V271, P12511, DOI 10.1074/jbc.271.21.12511; Dreier R, 2001, J CELL SCI, V114, P3813; Fernandes JC, 2002, BIORHEOLOGY, V39, P237; Fichter A, 2006, J ORTHOP RES, V24, P63, DOI 10.1002/jor.20001; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Glasson SS, 2005, NATURE, V434, P644, DOI 10.1038/nature03369; Goldring SR, 2004, CLIN ORTHOP RELAT R, pS27, DOI 10.1097/01.blo.0000144854.66565.8f; Hegen M, 2006, J IMMUNOL, V177, P1913, DOI 10.4049/jimmunol.177.3.1913; Hein G, 1997, CLIN RHEUMATOL, V16, P167, DOI 10.1007/BF02247846; HOLLANDER AP, 1994, J CLIN INVEST, V93, P1722, DOI 10.1172/JCI117156; HOMANDBERG GA, 1992, J BIOL CHEM, V267, P3597; Homandberg GA, 2002, OSTEOARTHR CARTILAGE, V10, P938, DOI 10.1053/joca.2002.0854; Homandberg GA, 1997, BIOCHEM J, V321, P751, DOI 10.1042/bj3210751; Hummel KM, 1998, J RHEUMATOL, V25, P1887; Jans R, 2004, ARCH DERMATOL RES, V296, P30, DOI 10.1007/s00403-004-0469-0; Jennings L, 2001, CONNECT TISSUE RES, V42, P71, DOI 10.3109/03008200109014250; Jung M, 2004, PATHOBIOLOGY, V71, P70, DOI 10.1159/000074419; Keyszer G, 1998, ARTHRITIS RHEUM, V41, P1378, DOI 10.1002/1529-0131(199808)41:8<1378::AID-ART6>3.0.CO;2-J; Kim HA, 2006, ARTHRITIS RHEUM-US, V54, P2152, DOI 10.1002/art.21951; Knudson W, 2000, ARTHRITIS RHEUM-US, V43, P1165, DOI 10.1002/1529-0131(200005)43:5<1165::AID-ANR27>3.0.CO;2-H; Konttinen YT, 2002, ARTHRITIS RHEUM, V46, P953, DOI 10.1002/art.10185; KUETTNER KE, 1982, J CELL BIOL, V93, P751, DOI 10.1083/jcb.93.3.751; Kurtis MS, 2001, J ORTHOP RES, V19, P1122, DOI 10.1016/S0736-0266(01)00051-1; Lang A, 2000, J RHEUMATOL, V27, P1970; Le Graverand MPH, 2000, MATRIX BIOL, V19, P431, DOI 10.1016/S0945-053X(00)00093-7; Li ZQ, 2000, BIOCHEMISTRY-US, V39, P529, DOI 10.1021/bi992251u; Liacini A, 2002, MATRIX BIOL, V21, P251, DOI 10.1016/S0945-053X(02)00007-0; Loser R, 2005, J MED CHEM, V48, P7688, DOI 10.1021/jm050686b; Lucic D, 2003, CONNECT TISSUE RES, V44, P225, DOI 10.1080/03008200390248632; MACIEWICZ RA, 1988, BIOCHEM J, V256, P433, DOI 10.1042/bj2560433; Matsumoto M, 2004, J BIOL CHEM, V279, P45969, DOI 10.1074/jbc.M408795200; Morko JP, 2004, ANN RHEUM DIS, V63, P649, DOI 10.1136/ard.2002.004671; Mort JS, 2001, ARTHRITIS RES, V3, P337, DOI 10.1186/ar325; Nguyen J, 2006, IMMUNOL LETT, V106, P34, DOI 10.1016/j.imlet.2006.04.003; Pei Y, 2006, OSTEOARTHR CARTILAGE, V14, P749, DOI 10.1016/j.joca.2006.01.017; Rantakokko J, 1996, FEBS LETT, V393, P307, DOI 10.1016/0014-5793(96)00907-6; RIEDE UN, 1977, BEITR PATHOL, V160, P3; Rodriguez A, 1997, J CELL BIOL, V137, P93, DOI 10.1083/jcb.137.1.93; Ruttgers A, 2006, BIOTECHNIQUES, V41, P469, DOI 10.2144/000112259; Sapolsky A, 1976, Compr Ther, V2, P33; Schuler S, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-144; Soderholm H, 2001, CELL SIGNAL, V13, P95, DOI 10.1016/S0898-6568(00)00141-8; Stanton LA, 2003, DEV BIOL, V263, P165, DOI 10.1016/S0012-1606(03)00321-X; Stojilkovic SS, 2005, TRENDS ENDOCRIN MET, V16, P81, DOI 10.1016/j.tem.2005.02.002; Tchetina EV, 2007, MATRIX BIOL, V26, P247, DOI 10.1016/j.matbio.2007.01.006; Thibault M, 2002, J ORTHOP RES, V20, P1265, DOI 10.1016/S0736-0266(02)00070-0; Troen BR, 2006, ANN NY ACAD SCI, V1068, P165, DOI 10.1196/annals.1346.018; Uusitalo H, 2000, CALCIFIED TISSUE INT, V67, P382, DOI 10.1007/s002230001152; VELASCO G, 1994, J BIOL CHEM, V269, P27136; Wang HL, 2007, CELL BIOL INT, V31, P1027, DOI 10.1016/j.cellbi.2007.03.017; Wang W, 2006, J BIOL CHEM, V281, P30848, DOI 10.1074/jbc.M605937200; Wei L, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1891; Yasuda T, 2002, ARTHRITIS RHEUM, V46, P138, DOI 10.1002/1529-0131(200201)46:1<138::AID-ART10051>3.0.CO;2-K; Yasuda T, 2006, MATRIX BIOL, V25, P419, DOI 10.1016/j.matbio.2006.06.004; Ze P, 2002, J CELL SCI, V115, P3083; Zwerina J, 2006, ARTHRITIS RHEUM-US, V54, P463, DOI 10.1002/art.21626	65	37	39	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					1043	1051		10.1074/jbc.M704915200	http://dx.doi.org/10.1074/jbc.M704915200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	17991740	hybrid			2022-12-27	WOS:000252128100044
J	Bianchetti, CM; Yi, L; Ragsdale, SW; Phillips, GN				Bianchetti, Christopher M.; Yi, Li; Ragsdale, Stephen W.; Phillips, George N., Jr.			Comparison of apo- and heme-bound crystal structures of a truncated human heme oxygenase-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNECHOCYSTIS SP PCC-6803; HYDROGEN-BONDING NETWORK; FERROUS-NO FORMS; PSEUDOMONAS-AERUGINOSA; RAT HEME; TRANSCRIPTIONAL ACTIVATION; CATALYTIC IMPLICATIONS; OXIDATIVE STRESS; GENE-EXPRESSION; DISTAL HELIX	Heme oxygenase (HO) catalyzes the first step in the heme degradation pathway. The crystal structures of apo-and heme-bound truncated human HO-2 reveal a primarily alpha-helical architecture similar to that of human HO-1 and other known HOs. Proper orientation of heme in HO-2 is required for the regioselective oxidation of the alpha-mesocarbon. This is accomplished by interactions within the heme binding pocket, which is made up of two helices. The iron coordinating residue, His(45), resides on the proximal helix. The distal helix contains highly conserved glycine residues that allow the helix to flex and interact with the bound heme. Tyr(154), Lys(199), and Arg(203) orient the heme through direct interactions with the heme propionates. The rearrangements of side chains in heme-bound HO-2 compared with apoHO-2 further elucidate HO-2 heme interactions.	[Bianchetti, Christopher M.; Phillips, George N., Jr.] Univ Wisconsin, Dept Biochem, 433 Babcock Dr, Madison, WI 53706 USA; [Bianchetti, Christopher M.] Univ Wisconsin, Grad Program Biophys, Madison, WI 53706 USA; [Bianchetti, Christopher M.; Phillips, George N., Jr.] Univ Wisconsin, Ctr Eukaryot Struct Genom, Madison, WI 53706 USA; [Yi, Li; Ragsdale, Stephen W.] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Michigan System; University of Michigan	Phillips, GN (corresponding author), Univ Wisconsin, Dept Biochem, 433 Babcock Dr, Madison, WI 53706 USA.	phillips@biochem.wisc.edu	Yi, Li/A-3967-2013		NCI NIH HHS [Y1 CO1020] Funding Source: Medline; NCRR NIH HHS [1 P20 RR17675, P20 RR017675] Funding Source: Medline; NHLBI NIH HHS [R21 HL089837-02, R21 HL089837] Funding Source: Medline; NIGMS NIH HHS [1 U54 GM074901-01, Y1 GM1104, U54 GM074901, P50 GM064598] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017675] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL089837] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM064598, U54GM074901] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALAM J, 1989, J BIOL CHEM, V264, P6371; Baranano DE, 2002, P NATL ACAD SCI USA, V99, P16093, DOI 10.1073/pnas.252626999; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Caignan GA, 2002, J AM CHEM SOC, V124, P14879, DOI 10.1021/ja0274960; Davis SJ, 2001, PLANT PHYSIOL, V126, P656, DOI 10.1104/pp.126.2.656; De Montellano PRO, 1998, ACCOUNTS CHEM RES, V31, P543; Deshmukh R, 2005, BIOCHEMISTRY-US, V44, P13713, DOI 10.1021/bi050810t; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Farombi EO, 2006, J BIOCHEM MOL BIOL, V39, P479; Fondevila C, 2004, HEPATOLOGY, V40, P1333, DOI 10.1002/hep.20480; Friedman J, 2004, BIOCHEMISTRY-US, V43, P5239, DOI 10.1021/bi049687g; Fujii H, 2001, J AM CHEM SOC, V123, P6475, DOI 10.1021/ja010490a; Grosser N, 2004, BIOCHEM BIOPH RES CO, V314, P351, DOI 10.1016/j.bbrc.2003.12.089; Hirotsu S, 2004, J BIOL CHEM, V279, P11937, DOI 10.1074/jbc.M311631200; KEYSE SM, 1990, MOL CELL BIOL, V10, P4967, DOI 10.1128/MCB.10.9.4967; Kim HP, 2006, ANNU REV PHARMACOL, V46, P411, DOI 10.1146/annurev.pharmtox.46.120604.141053; Lad L, 2004, J INORG BIOCHEM, V98, P1686, DOI 10.1016/j.jinorgbio.2004.07.004; Lad L, 2004, BIOCHEMISTRY-US, V43, P3793, DOI 10.1021/bi035451l; Lad L, 2003, J MOL BIOL, V330, P527, DOI 10.1016/S0022-2836(03)00578-3; Lad L, 2003, J BIOL CHEM, V278, P7834, DOI 10.1074/jbc.M211450200; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Levin EJ, 2007, STRUCTURE, V15, P1040, DOI 10.1016/j.str.2007.06.019; Lightning LK, 2001, J BIOL CHEM, V276, P10612, DOI 10.1074/jbc.M010349200; LIN JHC, 1990, EUR J BIOCHEM, V192, P577, DOI 10.1111/j.1432-1033.1990.tb19263.x; Lin Q, 2007, J BIOL CHEM, V282, P20621, DOI 10.1074/jbc.M607954200; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Maines MD, 2005, ANTIOXID REDOX SIGN, V7, P1761, DOI 10.1089/ars.2005.7.1761; Maines MD, 2005, BIOCHEM BIOPH RES CO, V338, P568, DOI 10.1016/j.bbrc.2005.08.121; Maines MD, 1997, ANNU REV PHARMACOL, V37, P517, DOI 10.1146/annurev.pharmtox.37.1.517; Maines MD, 1996, BRAIN RES, V722, P83, DOI 10.1016/0006-8993(96)00184-9; McCoubrey WK, 1997, EUR J BIOCHEM, V247, P725, DOI 10.1111/j.1432-1033.1997.00725.x; Moore BA, 2005, CRIT CARE MED, V33, P1317, DOI 10.1097/01.CCM.0000166349.76514.40; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otterbein LE, 2003, TRENDS IMMUNOL, V24, P449, DOI 10.1016/S1471-4906(03)00181-9; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; PIMSTONE NR, 1971, J CLIN INVEST, V50, P2042, DOI 10.1172/JCI106697; Ragsdale SW, 2006, CHEM REV, V106, P3317, DOI 10.1021/cr0503153; Ratliff M, 2001, J BACTERIOL, V183, P6394, DOI 10.1128/JB.183.21.6394-6403.2001; RIZZARDINI M, 1993, BIOCHEM J, V290, P343, DOI 10.1042/bj2900343; Rodriguez JC, 2007, J AM CHEM SOC, V129, P11730, DOI 10.1021/ja072405q; RYTER SW, 2004, SCI STKE, pRE6; SANO S, 1986, P NATL ACAD SCI USA, V83, P531, DOI 10.1073/pnas.83.3.531; Schuller DJ, 1999, NAT STRUCT BIOL, V6, P860; Schuller DJ, 2001, BIOCHEMISTRY-US, V40, P11552, DOI 10.1021/bi0110239; Sugishima M, 2000, FEBS LETT, V471, P61, DOI 10.1016/S0014-5793(00)01353-3; Sugishima M, 2005, BIOCHEMISTRY-US, V44, P4257, DOI 10.1021/bi0480483; Sugishima M, 2004, EUR J BIOCHEM, V271, P4517, DOI 10.1111/j.1432-1033.2004.04411.x; Sugishima M, 2003, BIOCHEMISTRY-US, V42, P9898, DOI 10.1021/bi027268i; Sugishima M, 2003, J BIOL CHEM, V278, P32352, DOI 10.1074/jbc.M303682200; Sugishima M, 2002, BIOCHEMISTRY-US, V41, P7293, DOI 10.1021/bi025662a; TENHUNEN R, 1970, J LAB CLIN MED, V75, P410; Terry MJ, 2002, BIOCHEM SOC T, V30, P604, DOI 10.1042/BST0300604.; TRAKSHEL GM, 1986, J BIOL CHEM, V261, P1131; Unno M, 2007, NAT PROD REP, V24, P553, DOI 10.1039/b604180a; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wang JL, 2006, BIOCHEMISTRY-US, V45, P61, DOI 10.1021/bi051645k; Wang JL, 2005, J BIOL CHEM, V280, P2797, DOI 10.1074/jbc.M411229200; Watanabe T, 2007, DEV NEUROBIOL, V67, P456, DOI 10.1002/dneu.20359; WILKS A, 1993, J BIOL CHEM, V268, P22357; Wu WT, 2004, BIOCHEM J, V379, P587, DOI 10.1042/BJ20031579; Yachie A, 1999, J CLIN INVEST, V103, P129, DOI 10.1172/JCI4165; Yi L, 2007, J BIOL CHEM, V282, P21056, DOI 10.1074/jbc.M700664200	63	52	57	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37624	37631		10.1074/jbc.M707396200	http://dx.doi.org/10.1074/jbc.M707396200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17965015	Green Accepted, hybrid			2022-12-27	WOS:000251833600038
J	Moustafa-Bayoumi, M; Alhaj, MA; El-Sayed, O; Wisel, S; Chotani, MA; Abouelnaga, ZA; Hassona, MDH; Rigatto, K; Morris, M; Nuovo, G; Zweier, JL; Goldschmidt-Clermont, P; Hassanain, H				Moustafa-Bayoumi, Moustafa; Alhaj, Mazin A.; El-Sayed, Osama; Wisel, Sheik; Chotani, Maqsood A.; Abouelnaga, Zeinb A.; Hassona, Mohamed D. H.; Rigatto, Katya; Morris, Mariana; Nuovo, Gerard; Zweier, Jay L.; Goldschmidt-Clermont, Pascal; Hassanain, Hamdy			Vascular hypertrophy and hypertension caused by transgenic overexpression of profilin 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE CELLS; ACTIN POLYMERIZATION; MOLECULAR REGULATION; CAROTID ARTERIES; DIFFERENTIATION; ACTIVATION; DISEASE; KINASE; RHO; CYTOSKELETON	We have overexpressed either the cDNA of human profilin 1 or expressed the mutant (88R/L) in the blood vessels of transgenic FVB/ N mice. Reverse transcription- PCR indicated selective overexpression of profilin 1 and 88R/L in vascular smooth muscle cells. Polyproline binding showed increased profilin 1 and 88R/L proteins in transgenic mice compared with control (similar to 30%, p < 0.05). Rhodamine- phalloidin staining revealed increase stress fiber formation in vascular smooth muscle cells of profilin 1 compared with 88R/L and control. Hematoxylin and eosin staining showed clear signs of vascular hypertrophy in the aorta of profilin 1 mice versus 88R/L and control. However, there were no differences between 88R/L and control mice. Western blotting confirmed the activation of the hypertrophic signaling cascades in aortas of profilin 1 mice. Phospho- ERK1/2 was significantly higher in profilin 1 than 88R/L and control (512.3 and 361.7%, respectively, p < 0.05). Profilin 1 mice had significant increases in phospho-JNK as compared with 88R/L and control (371.4 and 346%, respectively, p < 0.05). However, there were no differences between 88R/L and control mice in both kinases. There was a significant increase in ROCK II kinase in the aorta of profilin 1 mice compared with controls (> 400%, p < 0.05). Tail cuff and circadian monitoring of blood pressure showed significant increases in systolic and mean arterial blood pressures of profilin 1 mice starting at age 6 months compared with controls (similar to 25 mm Hg, p< 0.05). These results suggest that increased actin polymerization in blood vessels triggers activation of the hypertrophic signaling cascades and results in elevation of blood pressure at advanced age.	[Moustafa-Bayoumi, Moustafa; Hassona, Mohamed D. H.] Calif State Polytech Univ Pomona, Dept Kinesiol & Hlth Promot, Pomona, CA 91768 USA; [Alhaj, Mazin A.; Chotani, Maqsood A.; Abouelnaga, Zeinb A.; Hassona, Mohamed D. H.; Nuovo, Gerard; Zweier, Jay L.; Hassanain, Hamdy] Dorothy M Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Alhaj, Mazin A.; Abouelnaga, Zeinb A.; Hassanain, Hamdy] Dept Anesthesiol, Columbus, OH 43210 USA; [El-Sayed, Osama] Dept Cardiol, Dept Surg, Columbus, OH 43210 USA; [Wisel, Sheik] Ohio State Univ, Ohio State Biochem Program, Columbus, OH 43210 USA; [Moustafa-Bayoumi, Moustafa; Hassona, Mohamed D. H.] Wright State Univ, Dept Pharmacol & Toxicol, Dayton, OH 45435 USA; [Rigatto, Katya; Morris, Mariana] Univ Miami, Miller Sch Med, Miami, FL 33136 USA	California State University System; California State Polytechnic University Pomona; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Wright State University Dayton; University of Miami	Hassanain, H (corresponding author), Ohio State Univ, Med Ctr, Dorothy M Davis Heart & Lung Res Inst, Dept Anesthesiol, 473 W 12th Ave, Columbus, OH 43210 USA.	hamdy.hassanain@osumc.edu	Chotani, Maqsood/E-2891-2011					Amerongen GPV, 2001, ARTERIOSCL THROM VAS, V21, P300, DOI 10.1161/01.ATV.21.3.300; BAUMBACH GL, 1989, HYPERTENSION, V13, P968, DOI 10.1161/01.HYP.13.6.968; Borisy GG, 2000, CURR OPIN CELL BIOL, V12, P104, DOI 10.1016/S0955-0674(99)00063-0; DENG LY, 1991, AM J PHYSIOL, V271, pH1171; FOLKOW B, 1982, PHYSIOL REV, V62, P347, DOI 10.1152/physrev.1982.62.2.347; GALLAGHER SR, 1999, CURRENT PROTOCOLS MO, V2, DOI DOI 10.12B.11-10.12B.15; GEISTERFER AAT, 1988, CIRC RES, V62, P749, DOI 10.1161/01.RES.62.4.749; GIBBONS GH, 1994, NEW ENGL J MED, V330, P1431; GOLDSCHMIDTCLER.PJ, 1991, CURR OPIN BIOL, V2, P669; HAARER BK, 1990, CELL MOTIL CYTOSKEL, V17, P71, DOI 10.1002/cm.970170202; Hannigan GE, 2007, CIRC RES, V100, P1408, DOI 10.1161/01.RES.0000265233.40455.62; Heerkens EHJ, 2007, HYPERTENSION, V49, P1, DOI 10.1161/01.HYP.0000252753.63224.3b; Higgs HN, 2001, ANNU REV BIOCHEM, V70, P649, DOI 10.1146/annurev.biochem.70.1.649; Hogan B., 1986, MANIPULATING MOUSE E, P17; Hu YH, 1997, ARTERIOSCL THROM VAS, V17, P2808, DOI 10.1161/01.ATV.17.11.2808; Intengan HD, 2001, HYPERTENSION, V38, P581, DOI 10.1161/hy09t1.096249; Korenbaum E, 1998, BIOCHEMISTRY-US, V37, P9274, DOI 10.1021/bi9803675; Langille BL, 1996, CAN J PHYSIOL PHARM, V74, P834, DOI 10.1139/cjpp-74-7-834; LUNA EJ, 1992, SCIENCE, V258, P955, DOI 10.1126/science.1439807; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; Merrill DC, 1996, J CLIN INVEST, V97, P1047, DOI 10.1172/JCI118497; Moldovan NI, 1997, CURR BIOL, V7, P24, DOI 10.1016/S0960-9822(06)00024-8; Nuovo GJ, 1998, DIAGN MOL PATHOL, V7, P267, DOI 10.1097/00019606-199810000-00006; NUOVO GJ, 1997, PCR SITU HYBRIDIZATI, P271; Owens GK, 1997, AGENT ACTION SUPPL, V48, P3; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Owens GK, 1996, J HYPERTENS, V14, pS55; OWENS GK, 1995, PHYSIOL REV, V75, P487; PANTALONI D, 1993, CELL, V75, P1007, DOI 10.1016/0092-8674(93)90544-Z; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pyles JM, 1997, CIRC RES, V81, P904; Rolfe BE, 2005, ATHEROSCLEROSIS, V183, P1, DOI 10.1016/j.atherosclerosis.2005.04.023; Ruwhof C, 2000, CARDIOVASC RES, V47, P23, DOI 10.1016/S0008-6363(00)00076-6; Salmon ED, 1989, CURR OPIN CELL BIOL, V1, P541, DOI 10.1016/0955-0674(89)90018-5; Schiffrin EL, 2001, CURR OPIN NEPHROL HY, V10, P617, DOI 10.1097/00041552-200109000-00011; Schmidt A, 1998, ANNU REV CELL DEV BI, V14, P305, DOI 10.1146/annurev.cellbio.14.1.305; Seasholtz TM, 2001, CIRC RES, V89, P488, DOI 10.1161/hh1801.096337; Simon G, 2004, J HYPERTENS, V22, P3, DOI 10.1097/00004872-200401000-00002; Suetsugu S, 1999, FEBS LETT, V457, P470, DOI 10.1016/S0014-5793(99)01086-8; THERIOT JA, 1993, CELL, V75, P835, DOI 10.1016/0092-8674(93)90527-W; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; WANG LC, 1996, CIRC RES, V78, P799; Witke W, 2004, TRENDS CELL BIOL, V14, P461, DOI 10.1016/j.tcb.2004.07.003; Yang CS, 2000, J CELL BIOL, V150, P1001, DOI 10.1083/jcb.150.5.1001	44	38	42	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37632	37639		10.1074/jbc.M703227200	http://dx.doi.org/10.1074/jbc.M703227200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17942408	hybrid			2022-12-27	WOS:000251833600039
J	Neale, EJ; Rong, HL; Cockcroft, CJ; Sivaprasadarao, A				Neale, Edward J.; Rong, Honglin; Cockcroft, Christopher J.; Sivaprasadarao, Asipu			Mapping the membrane-aqueous border for the voltage-sensing domain of a potassium channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT K+ CHANNEL; FOCUSED ELECTRIC-FIELD; ION CHANNELS; GATING PORE; TRANSMEMBRANE MOVEMENT; CHARGE MOVEMENT; SODIUM-CHANNELS; LIPID-BILAYER; SENSOR; DISPLACEMENT	Voltage-sensing domains (VSDs) play diverse roles in biology. As integral components, they can detect changes in the membrane potential of a cell and couple these changes to activity of ion channels and enzymes. As independent proteins, homologues of the VSD can function as voltage-dependent proton channels. To sense voltage changes, the positively charged fourth transmembrane segment, S4, must move across the energetically unfavorable hydrophobic core of the bilayer, which presents a barrier to movement of both charged species and protons. To reduce the barrier to S4 movement, it has been suggested that aqueous crevices may penetrate the protein, reducing the extent of total movement. To investigate this hypothesis in a system containing fully functional channels in a native environment with an intact membrane potential, we have determined the contour of the membrane-aqueous border of the VSD of KvAP in Escherichia coli by examining the chemical accessibility of introduced cysteines. The results revealed the contour of the membrane-aqueous border of the VSD in its activated conformation. The water-inaccessible regions of S1 and S2 correspond to the standard width of the membrane bilayer (similar to 28 angstrom), but those of S3 and S4 are considerably shorter (>= 40%), consistent with aqueous crevices pervading both the extracellular and intracellular ends. One face of S3b and the entire S3a were water-accessible, reducing the water-inaccessible region of S3 to just 10 residues, significantly shorter than for S4. The results suggest a key role for S3 in reducing the distance S4 needs to move to elicit gating.	[Neale, Edward J.; Rong, Honglin; Cockcroft, Christopher J.; Sivaprasadarao, Asipu] Univ Leeds, Fac Biol Sci, Inst Membrane & Syst Biol, Leeds LS2 9JT, W Yorkshire, England	University of Leeds	Sivaprasadarao, A (corresponding author), Univ Leeds, Fac Biol Sci, Inst Membrane & Syst Biol, 6 44d Garstang Bldg, Leeds LS2 9JT, W Yorkshire, England.	a.sivaprasadarao@leeds.ac.uk		Sivaprasadarao, Asipu/0000-0002-6755-3502	Wellcome Trust [076280, 076280/Z/04/Z] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Ahern CA, 2005, NEURON, V48, P25, DOI 10.1016/j.neuron.2005.08.020; Ahern CA, 2004, TRENDS NEUROSCI, V27, P303, DOI 10.1016/j.tins.2004.03.008; Baker OS, 1998, NEURON, V20, P1283, DOI 10.1016/S0896-6273(00)80507-3; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; Bogdanov M, 2002, EMBO J, V21, P2107, DOI 10.1093/emboj/21.9.2107; Bond PJ, 2007, P NATL ACAD SCI USA, V104, P2631, DOI 10.1073/pnas.0606822104; Chanda B, 2005, NATURE, V436, P852, DOI 10.1038/nature03888; Cuello LG, 2004, SCIENCE, V306, P491, DOI 10.1126/science.1101373; de Gier JW, 2001, MOL MICROBIOL, V40, P314, DOI 10.1046/j.1365-2958.2001.02392.x; Elliott DJS, 2004, EMBO J, V23, P4717, DOI 10.1038/sj.emboj.7600484; Freites JA, 2005, P NATL ACAD SCI USA, V102, P15059, DOI 10.1073/pnas.0507618102; Gandhi CS, 2003, NEURON, V40, P515, DOI 10.1016/S0896-6273(03)00646-9; Gonzalez C, 2005, P NATL ACAD SCI USA, V102, P5020, DOI 10.1073/pnas.0501051102; Grisshammer Reinhard, 2005, Journal of Structural and Functional Genomics, V6, P159, DOI 10.1007/s10969-005-1917-6; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Islas LD, 2001, J GEN PHYSIOL, V117, P69, DOI 10.1085/jgp.117.1.69; Jiang YX, 2003, NATURE, V423, P42, DOI 10.1038/nature01581; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jones PC, 1996, MOL MEMBR BIOL, V13, P53, DOI 10.3109/09687689609160575; Krylov AV, 2001, J GEN PHYSIOL, V118, P333, DOI 10.1085/jgp.118.4.333; Larsson HP, 1996, NEURON, V16, P387, DOI 10.1016/S0896-6273(00)80056-2; Lee SY, 2005, P NATL ACAD SCI USA, V102, P15441, DOI 10.1073/pnas.0507651102; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; LOO TW, 1995, J BIOL CHEM, V270, P843, DOI 10.1074/jbc.270.2.843; Lu JL, 2001, BIOCHEMISTRY-US, V40, P13288, DOI 10.1021/bi0107647; Murata Y, 2005, NATURE, V435, P1239, DOI 10.1038/nature03650; Phillips LR, 2005, NATURE, V436, P857, DOI 10.1038/nature03873; Ramsey IS, 2006, NATURE, V440, P1213, DOI 10.1038/nature04700; Ruta V, 2005, CELL, V123, P463, DOI 10.1016/j.cell.2005.08.041; Ruta V, 2003, NATURE, V422, P180, DOI 10.1038/nature01473; Sands ZA, 2007, STRUCTURE, V15, P235, DOI 10.1016/j.str.2007.01.004; Sasaki M, 2006, SCIENCE, V312, P589, DOI 10.1126/science.1122352; Schmidt D, 2006, NATURE, V444, P775, DOI 10.1038/nature05416; SIGWORTH FJ, 1994, Q REV BIOPHYS, V27, P1, DOI 10.1017/S0033583500002894; Sokolov S, 2005, NEURON, V47, P183, DOI 10.1016/j.neuron.2005.06.012; Sokolov S, 2007, NATURE, V446, P76, DOI 10.1038/nature05598; Starace DM, 2004, NATURE, V427, P548, DOI 10.1038/nature02270; TiwariWoodruff SK, 1997, BIOPHYS J, V72, P1489, DOI 10.1016/S0006-3495(97)78797-6; Tombola F, 2007, NATURE, V445, P546, DOI 10.1038/nature05396; Tombola F, 2006, ANNU REV CELL DEV BI, V22, P23, DOI 10.1146/annurev.cellbio.21.020404.145837; Yang NB, 1996, NEURON, V16, P113, DOI 10.1016/S0896-6273(00)80028-8; Yusaf SP, 1996, PFLUG ARCH EUR J PHY, V433, P91, DOI 10.1007/s004240050253	42	13	13	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37597	37604		10.1074/jbc.M706437200	http://dx.doi.org/10.1074/jbc.M706437200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17951256	Green Accepted, hybrid			2022-12-27	WOS:000251833600035
J	Tachibana, C; Biddick, R; Law, GL; Young, ET				Tachibana, Christine; Biddick, Rhiannon; Law, G. Lynn; Young, Elton T.			A poised initiation complex is activated by SNF1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; YEAST SACCHAROMYCES-CEREVISIAE; PROTEIN-KINASE; TRANSCRIPTION ACTIVATION; GENE-EXPRESSION; BUDDING YEAST; IN-VIVO; DROSOPHILA-MELANOGASTER; GLUCONEOGENIC ENZYMES; ADR1-DEPENDENT GENES	Snf1, the yeast AMP kinase homolog, is essential for derepression of glucose-repressed genes that are activated by Adr1. Although required for Adr1 DNA binding, the precise role of Snf1 is unknown. Deletion of histone deacetylase genes allowed constitutive promoter binding of Adr1 and Cat8, another activator of glucose-repressed genes. In repressed conditions, at the Adr1- and Cat8-dependent ADH2 promoter, partial chromatin remodeling had occurred, and the activators recruited a partial preinitiation complex that included RNA polymerase II. Transcription did not occur, however, unless Snf1 was activated, suggesting a Snf1-dependent event that occurs after RNA polymerase II recruitment. Glucose regulation persisted because shifting to low glucose increased expression. Glucose repression could be completely relieved by combining the three elements of 1) chromatin perturbation by mutation of histone deacetylases, 2) activation of Snf1, and 3) the addition of an Adr1 mutant that by itself confers only weak constitutive activity.	[Tachibana, Christine; Biddick, Rhiannon; Law, G. Lynn; Young, Elton T.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Young, ET (corresponding author), Univ Washington, Dept Biochem, Box 357350, Seattle, WA 98195 USA.	ety@u.washington.edu			NIDDK NIH HHS [DK67276] Funding Source: Medline; NIGMS NIH HHS [GM26079, T32 GM07270] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067276] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026079, T32GM007270] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adkins MW, 2007, MOL CELL BIOL, V27, P6372, DOI 10.1128/MCB.00981-07; Agricola E, 2004, BIOCHEMISTRY-US, V43, P8878, DOI 10.1021/bi049577+; Agricola E, 2006, MOL MICROBIOL, V62, P1433, DOI 10.1111/j.1365-2958.2006.05451.x; Boehm AK, 2003, MOL CELL BIOL, V23, P7628, DOI 10.1128/MCB.23.21.7628-7637.2003; Bollen M, 2001, TRENDS BIOCHEM SCI, V26, P426, DOI 10.1016/S0968-0004(01)01836-9; Bryant GO, 2003, MOL CELL, V11, P1301, DOI 10.1016/S1097-2765(03)00144-8; Charbon G, 2004, MOL CELL BIOL, V24, P4083, DOI 10.1128/MCB.24.10.4083-4091.2004; Cho EJ, 2001, GENE DEV, V15, P3319, DOI 10.1101/gad.935901; CIRIACY M, 1979, MOL GEN GENET, V176, P427, DOI 10.1007/BF00333107; COLLART M, 1993, CURRENT PROTOCOLS MO; Cosma MP, 2002, MOL CELL, V10, P227, DOI 10.1016/S1097-2765(02)00604-4; Cosma MP, 2001, MOL CELL, V7, P1213, DOI 10.1016/S1097-2765(01)00266-0; Cross FR, 1997, YEAST, V13, P647, DOI 10.1002/(SICI)1097-0061(19970615)13:7<647::AID-YEA115>3.0.CO;2-#; DENIS CL, 1992, MOL CELL BIOL, V12, P1507, DOI 10.1128/MCB.12.4.1507; Dombek KM, 1997, MOL CELL BIOL, V17, P1450, DOI 10.1128/MCB.17.3.1450; DOMBEK KM, 1993, MOL CELL BIOL, V13, P4391, DOI 10.1128/MCB.13.7.4391; Ducker CE, 2000, EMBO J, V19, P400, DOI 10.1093/emboj/19.3.400; ESTRUCH F, 1992, GENETICS, V132, P639; Featherstone M, 2002, CURR OPIN GENET DEV, V12, P149, DOI 10.1016/S0959-437X(02)00280-0; Fry CJ, 2002, SCIENCE, V295, P1847, DOI 10.1126/science.1070260; Govind CK, 2005, MOL CELL BIOL, V25, P5626, DOI 10.1128/MCB.25.13.5626-5638.2005; GUARENTE L, 1983, METHOD ENZYMOL, V101, P181; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Haurie V, 2001, J BIOL CHEM, V276, P76, DOI 10.1074/jbc.M008752200; HEDGES D, 1995, MOL CELL BIOL, V15, P1915; Hiesinger M, 2001, CURR GENET, V39, P68, DOI 10.1007/s002940000182; Hong SP, 2007, J BIOL CHEM, V282, P16838, DOI 10.1074/jbc.M700146200; Hong SP, 2003, P NATL ACAD SCI USA, V100, P8839, DOI 10.1073/pnas.1533136100; Kingston R., 1997, CURRENT PROTOCOLS MO; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Kuchin S, 2000, P NATL ACAD SCI USA, V97, P7916, DOI 10.1073/pnas.140109897; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Liu CL, 2005, PLOS BIOL, V3, P1753, DOI 10.1371/journal.pbio.0030328; Lo WS, 2001, SCIENCE, V293, P1142, DOI 10.1126/science.1062322; Ludin K, 1998, P NATL ACAD SCI USA, V95, P6245, DOI 10.1073/pnas.95.11.6245; McCartney RR, 2001, J BIOL CHEM, V276, P36460, DOI 10.1074/jbc.M104418200; Nath N, 2003, MOL CELL BIOL, V23, P3909, DOI 10.1128/MCB.23.11.3909-3917.2003; NEIGEBORN L, 1984, GENETICS, V108, P845; NEIGEBORN L, 1987, GENETICS, V115, P247; OBRIEN T, 1993, MOL CELL BIOL, V13, P3456, DOI 10.1128/MCB.13.6.3456; Qian OY, 1999, GENETICS, V152, P89; Rahner A, 1996, NUCLEIC ACIDS RES, V24, P2331, DOI 10.1093/nar/24.12.2331; RandezGil F, 1997, MOL CELL BIOL, V17, P2502, DOI 10.1128/MCB.17.5.2502; ROUGVIE AE, 1990, MOL CELL BIOL, V10, P6041, DOI 10.1128/MCB.10.11.6041; ROUGVIE AE, 1988, CELL, V54, P795, DOI 10.1016/S0092-8674(88)91087-2; Sanz P, 2000, MOL CELL BIOL, V20, P1321, DOI 10.1128/MCB.20.4.1321-1328.2000; Sarma NJ, 2007, GENETICS, V175, P1127, DOI 10.1534/genetics.106.068932; Schuller HJ, 2003, CURR GENET, V43, P139, DOI 10.1007/s00294-003-0381-8; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Shirra MK, 1999, GENETICS, V152, P73; Shirra MK, 2001, MOL CELL BIOL, V21, P5710, DOI 10.1128/MCB.21.17.5710-5722.2001; SIMPSON RT, 1985, CELL, V42, P799, DOI 10.1016/0092-8674(85)90276-4; Sloan JS, 1999, J BIOL CHEM, V274, P37575, DOI 10.1074/jbc.274.53.37575; Song WJ, 1996, MOL CELL BIOL, V16, P115; Steger DJ, 2003, SCIENCE, V299, P114, DOI 10.1126/science.1078062; StrahlBolsinger S, 1997, GENE DEV, V11, P83, DOI 10.1101/gad.11.1.83; Sutherland CM, 2003, CURR BIOL, V13, P1299, DOI 10.1016/S0960-9822(03)00459-7; Tachibana C, 2005, MOL CELL BIOL, V25, P2138, DOI 10.1128/MCB.25.6.2138-2146.2005; THOMPSONJAEGER S, 1991, GENETICS, V129, P697; Treitel MA, 1998, MOL CELL BIOL, V18, P6273, DOI 10.1128/MCB.18.11.6273; TU JL, 1995, EMBO J, V14, P5939, DOI 10.1002/j.1460-2075.1995.tb00282.x; Van Driessche B, 2005, FEBS LETT, V579, P5318, DOI 10.1016/j.febslet.2005.08.057; Verdone L, 2002, EMBO J, V21, P1101, DOI 10.1093/emboj/21.5.1101; Verdone L, 1996, MOL CELL BIOL, V16, P1978; Wilson WA, 1996, CURR BIOL, V6, P1426, DOI 10.1016/S0960-9822(96)00747-6; Young ET, 2003, J BIOL CHEM, V278, P26146, DOI 10.1074/jbc.M301981200; Young ET, 2002, J BIOL CHEM, V277, P38095, DOI 10.1074/jbc.M206158200; Zhang HS, 2007, P NATL ACAD SCI USA, V104, P8833, DOI 10.1073/pnas.0701666104	69	26	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37308	37315		10.1074/jbc.M707363200	http://dx.doi.org/10.1074/jbc.M707363200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17974563	hybrid			2022-12-27	WOS:000251833600005
J	Berdiev, BK; Cormet-Boyaka, E; Tousson, A; Qadri, YJ; Oosterveld-Hut, HMJ; Hong, JS; Gonzales, PA; Fuller, CM; Sorscher, EJ; Lukacs, GL; Benos, DJ				Berdiev, Bakhrom K.; Cormet-Boyaka, Estelle; Tousson, Albert; Qadri, Yawar J.; Oosterveld-Hut, Henderika M. J.; Hong, Jeong S.; Gonzales, Patricia A.; Fuller, Cathy M.; Sorscher, Eric J.; Lukacs, Gergely L.; Benos, Dale J.			Molecular proximity of cystic fibrosis transmembrane conductance regulator and epithelial sodium channel assessed by fluorescence resonance energy transfer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSITIVE NA+ CHANNELS; CHLORIDE CHANNEL; CFTR; PROTEIN; EXPRESSION; GENE; ENAC; IDENTIFICATION; INHIBITION; ACTIVATION	We present the evidence for a direct physical association of cystic fibrosis transmembrane conductance regulator (CFTR) and epithelial sodium channel (ENaC), two major ion channels implicated in the pathophysiology of cystic fibrosis, a devastating inherited disease. We employed fluorescence resonance energy transfer, a distance-dependent imaging technique with capability to detect molecular complexes with near angstrom resolution, to estimate the proximity of CFTR and ENaC, an essential variable for possible physical interaction to occur. Fluorescence resonance energy transfer studies were complemented with a classic biochemical approach: coimmunoprecipitation. Our results place CFTR and ENaC within reach of each other, suggestive of a direct interaction between these two proteins.	Univ Alabama Birmingham, Dept Cell Biol, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Physiol & Biophys, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Cell Biol, Birmingham, AL 35294 USA; Univ Alabama Birmingham, High Resolut Imaging Facil, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Gregory Fleming James Cyst Fibrosis Res Ctr, Birmingham, AL 35294 USA; Ohio State Univ, Davis Heart & Lung Res Inst, Div Pulm & Crit Care & Sleep Med, Columbus, OH 43210 USA; Lambert Instruments, NL-9313 TH Leutingewolde, Netherlands; NIH, NHLBI, Kidney & Electrolyte Metab Lab, Bethesda, MD 20892 USA; Univ Toronto, Hosp Sick Children, Res Inst, Dept Lab Med & Pathobiol Program Cell & Lung Biol, Toronto, ON M5G 1X8, Canada	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University System of Ohio; Ohio State University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Berdiev, BK (corresponding author), Univ Alabama Birmingham, Dept Cell Biol, 1918 Univ Blvd,MCLM 725, Birmingham, AL 35294 USA.	berdiev@uab.edu	Fuller, Cathy/B-4046-2011; Cormet-Boyaka, Estelle/H-5624-2011	Lukacs, Gergely/0000-0003-0900-0675; Sorscher, Eric J./0000-0001-9341-3354; Qadri, Yawar/0000-0003-2138-4018	NIDDK NIH HHS [R01-DK075302, P50 DK53090-05, 2R01-DK37206-15] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075302, R01DK037206, P50DK053090] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aleksandrov AA, 2007, PFLUG ARCH EUR J PHY, V453, P693, DOI 10.1007/s00424-006-0140-z; Bebok Z, 2002, J BIOL CHEM, V277, P43041, DOI 10.1074/jbc.M203154200; Berdiev BK, 2000, BIOPHYS J, V78, P1881, DOI 10.1016/S0006-3495(00)76737-3; Berdiev BK, 1999, CURR TOP MEMBR, V47, P351; Boucher RC, 2004, EUR RESPIR J, V23, P146, DOI 10.1183/09031936.03.00057003; Briel M, 1998, J PHYSIOL-LONDON, V508, P825, DOI 10.1111/j.1469-7793.1998.825bp.x; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; CANESSA CM, 1993, NATURE, V361, P467, DOI 10.1038/361467a0; CLEGG RM, 1992, METHOD ENZYMOL, V211, P353; Clegg RM, 2003, METHOD ENZYMOL, V360, P509; Cormet-Boyaka E, 2002, P NATL ACAD SCI USA, V99, P12477, DOI 10.1073/pnas.192203899; Gadsby DC, 2006, NATURE, V440, P477, DOI 10.1038/nature04712; Greeson JN, 2006, BRAIN RES, V1091, P140, DOI 10.1016/j.brainres.2006.02.084; Grunder S, 1997, EMBO J, V16, P899, DOI 10.1093/emboj/16.5.899; Guggino WB, 2006, NAT REV MOL CELL BIO, V7, P426, DOI 10.1038/nrm1949; Hebeisen S, 2004, J BIOL CHEM, V279, P13140, DOI 10.1074/jbc.M312649200; Helms MN, 2005, J BIOL CHEM, V280, P40885, DOI 10.1074/jbc.M509646200; Ismailov II, 1996, J BIOL CHEM, V271, P4725; Ismailov II, 1997, AM J PHYSIOL-CELL PH, V272, pC1077, DOI 10.1152/ajpcell.1997.272.4.C1077; Ji HL, 2000, J BIOL CHEM, V275, P27947; Karpova TS, 2003, J MICROSC-OXFORD, V209, P56, DOI 10.1046/j.1365-2818.2003.01100.x; Kenworthy AK, 2001, METHODS, V24, P289, DOI 10.1006/meth.2001.1189; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Knepper MA, 2001, ACTA PHYSIOL SCAND, V173, P11, DOI 10.1046/j.1365-201X.2001.00880.x; KNOWLES M, 1981, NEW ENGL J MED, V305, P1489, DOI 10.1056/NEJM198112173052502; KNOWLES MR, 1981, AM REV RESPIR DIS, V124, P484; Konstas AA, 2003, PFLUG ARCH EUR J PHY, V445, P513, DOI 10.1007/s00424-002-0957-z; Kremers GJ, 2006, BIOCHEMISTRY-US, V45, P6570, DOI 10.1021/bi0516273; Kunzelmann K, 1999, J MEMBRANE BIOL, V168, P1, DOI 10.1007/s002329900492; Kunzelmann K., 2003, CYSTIC FIBROSIS TRAN, P55; Lai MZ, 2005, NAT NEUROSCI, V8, P435, DOI 10.1038/nn1418; Letz B, 1997, AM J PHYSIOL-CELL PH, V272, pC657, DOI 10.1152/ajpcell.1997.272.2.C657; Ling BN, 1997, J BIOL CHEM, V272, P594; LINGUEGLIA E, 1993, FEBS LETT, V318, P95, DOI 10.1016/0014-5793(93)81336-X; Mall M, 2004, NAT MED, V10, P487, DOI 10.1038/nm1028; Masilamani S, 1999, J CLIN INVEST, V104, pR19, DOI 10.1172/JCI7840; Meltzer RH, 2007, J BIOL CHEM, V282, P25548, DOI 10.1074/jbc.M703825200; Moyer BD, 1998, J BIOL CHEM, V273, P21759, DOI 10.1074/jbc.273.34.21759; Moyer BD, 1999, J CLIN INVEST, V104, P1353, DOI 10.1172/JCI7453; Nagel G, 2005, J PHYSIOL-LONDON, V564, P671, DOI 10.1113/jphysiol.2004.079046; Nagel G, 2001, EMBO REP, V2, P249, DOI 10.1093/embo-reports/kve045; Nagel Georg, 2004, J Cyst Fibros, V3 Suppl 2, P109, DOI 10.1016/j.jcf.2004.05.043; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; SELVIN PR, 1995, METHOD ENZYMOL, V246, P300; Staruschenko A, 2004, J BIOL CHEM, V279, P27729, DOI 10.1074/jbc.M404169200; STUTTS MJ, 1995, SCIENCE, V269, P847, DOI 10.1126/science.7543698; WELSH MJ, 1993, CELL, V73, P1251, DOI 10.1016/0092-8674(93)90353-R	49	37	38	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36481	36488		10.1074/jbc.M708089200	http://dx.doi.org/10.1074/jbc.M708089200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17913705	hybrid			2022-12-27	WOS:000251458300040
J	Chichili, GR; Rodgers, W				Chichili, Gurunadh R.; Rodgers, William			Clustering of membrane raft proteins by the actin cytoskeleton	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GPI-ANCHORED PROTEINS; CELL ANTIGEN RECEPTOR; LIPID RAFTS; PLASMA-MEMBRANE; LIVING CELLS; TYROSINE KINASE; MICRODOMAINS; DOMAINS; SEGREGATION; ACTIVATION	Cell membranes are laterally organized into functionally discrete domains that include the cholesterol-dependent membrane "rafts." However, how membrane domains are established and maintained remains unresolved and controversial but often requires the actin cytoskeleton. In this study, we used fluorescence resonance energy transfer to measure the role of the actin cytoskeleton in the co-clustering of membrane raft-associated fluorescent proteins (FPs) and FPs targeted to the nonraft membrane fraction. By fitting the fluorescence resonance energy transfer data to an isothermal binding equation, we observed a specific co-clustering of raft-associated donor and acceptor probes that was sensitive to latrunculin B (Lat B), which disrupts the actin cytoskeleton. Conversely, treating with jasplakinolide to enhance actin polymerization increased co-clustering of the raft-associated FPs over that of the nonraft probes. We also observed by immunoblotting experiments that the actindependent co-clustering coincided with regulation of the raft-associated Src family kinase Lck. Specifically, Lat B decreased the phosphorylation of the C-terminal regulatory tyrosine of Lck (Tyr505), and combining the Lat B with filipin further decreased the Tyr505 phosphorylation. Furthermore, the Lat B-dependent changes in Lck regulation required CD45 because no significant changes occurred in treated T cells lacking CD45 expression. These data define a role for the actin cytoskeleton in promoting co-clustering of raft-associated proteins and show that this property is important toward regulating raft-associated signaling proteins such as Lck.	Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, Oklahoma City, OK 73104 USA; Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73104 USA; Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK 73104 USA	Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Rodgers, W (corresponding author), Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, MS 45,825 NE 13th St, Oklahoma City, OK 73104 USA.	william-rodgers@omrf.org			NIGMS NIH HHS [R01 GM070001] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070001] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bodin S, 2005, J CELL SCI, V118, P759, DOI 10.1242/jcs.01648; BOLARD J, 1986, BIOCHIM BIOPHYS ACTA, V864, P257, DOI 10.1016/0304-4157(86)90002-X; Bray D, 1998, ANNU REV BIOPH BIOM, V27, P59, DOI 10.1146/annurev.biophys.27.1.59; Brdicka T, 2000, J EXP MED, V191, P1591, DOI 10.1084/jem.191.9.1591; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Cherukuri A, 2001, IMMUNITY, V14, P657, DOI 10.1016/S1074-7613(01)00156-X; Cumming G, 2007, J CELL BIOL, V177, P7, DOI 10.1083/jcb.200611141; Davidson D, 2003, MOL CELL BIOL, V23, P2017, DOI 10.1128/MCB.23.6.2017-2028.2003; Friedrichson T, 1998, NATURE, V394, P802, DOI 10.1038/29570; Gomez-Mouton C, 2001, P NATL ACAD SCI USA, V98, P9642, DOI 10.1073/pnas.171160298; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Hao MM, 2001, P NATL ACAD SCI USA, V98, P13072, DOI 10.1073/pnas.231377398; Hope HR, 1996, MOL BIOL CELL, V7, P843, DOI 10.1091/mbc.7.6.843; Jacobson K, 2007, NAT CELL BIOL, V9, P7, DOI 10.1038/ncb0107-7; Janes PW, 1999, J CELL BIOL, V147, P447, DOI 10.1083/jcb.147.2.447; Jordan S, 2003, J IMMUNOL, V171, P78, DOI 10.4049/jimmunol.171.1.78; Kabouridis PS, 2000, EUR J IMMUNOL, V30, P954, DOI 10.1002/1521-4141(200003)30:3<954::AID-IMMU954>3.3.CO;2-P; Kabouridis PS, 1997, EMBO J, V16, P4983, DOI 10.1093/emboj/16.16.4983; Kenworthy AK, 1998, J CELL BIOL, V142, P69, DOI 10.1083/jcb.142.1.69; Kusumi A, 1996, CURR OPIN CELL BIOL, V8, P566, DOI 10.1016/S0955-0674(96)80036-6; Lenne PF, 2006, EMBO J, V25, P3245, DOI 10.1038/sj.emboj.7601214; Liu AP, 2006, BIOPHYS J, V91, P4064, DOI 10.1529/biophysj.106.090852; Lo W, 1998, BIOTECHNIQUES, V25, P94, DOI 10.2144/98251st05; Manes S, 2003, NAT REV IMMUNOL, V3, P557, DOI 10.1038/nri1129; Marsh M, 2006, CELL, V124, P729, DOI 10.1016/j.cell.2006.02.007; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Morone N, 2006, J CELL BIOL, V174, P851, DOI 10.1083/jcb.200606007; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; Nishimura SY, 2006, BIOPHYS J, V90, P927, DOI 10.1529/biophysj.105.070524; Pelkmans L, 2004, CELL, V118, P767, DOI 10.1016/j.cell.2004.09.003; Pentcheva T, 2001, J IMMUNOL, V166, P6625, DOI 10.4049/jimmunol.166.11.6625; Pohl J, 2004, BIOCHEMISTRY-US, V43, P4179, DOI 10.1021/bi035743m; Pralle A, 2000, J CELL BIOL, V148, P997, DOI 10.1083/jcb.148.5.997; Press W.H., 2007, NUMERICAL RECIPES AR, P720; Prior IA, 2003, J CELL BIOL, V160, P165, DOI 10.1083/jcb.200209091; Rodgers W, 2005, TRENDS IMMUNOL, V26, P97, DOI 10.1016/j.it.2004.11.016; Rodgers W, 2002, BIOTECHNIQUES, V32, P1044, DOI 10.2144/02325st05; RODGERS W, 1993, BIOCHEMISTRY-US, V32, P12591, DOI 10.1021/bi00210a007; Rodgers W, 1996, J CELL BIOL, V135, P1515, DOI 10.1083/jcb.135.6.1515; Rodgers W, 2001, EXP CELL RES, V267, P173, DOI 10.1006/excr.2001.5253; Rozelle AL, 2000, CURR BIOL, V10, P311, DOI 10.1016/S0960-9822(00)00384-5; SAKO Y, 1994, J CELL BIOL, V125, P1251, DOI 10.1083/jcb.125.6.1251; Samelson LE, 2002, ANNU REV IMMUNOL, V20, P371, DOI 10.1146/annurev.immunol.20.092601.111357; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; Shogomori H, 2005, J BIOL CHEM, V280, P18931, DOI 10.1074/jbc.M500247200; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Sohn HW, 2006, P NATL ACAD SCI USA, V103, P8143, DOI 10.1073/pnas.0509858103; Tolar P, 2005, NAT IMMUNOL, V6, P1168, DOI 10.1038/ni1262; Varma R, 1998, NATURE, V394, P798, DOI 10.1038/29563; Villalba M, 2001, J CELL BIOL, V155, P331, DOI 10.1083/jcb.200107080; Viola A, 1999, SCIENCE, V283, P680, DOI 10.1126/science.283.5402.680; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhang WG, 1998, IMMUNITY, V9, P239, DOI 10.1016/S1074-7613(00)80606-8	55	97	101	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36682	36691		10.1074/jbc.M702959200	http://dx.doi.org/10.1074/jbc.M702959200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17947241	hybrid			2022-12-27	WOS:000251458300061
J	Makarava, N; Lee, CI; Ostapchenko, VG; Baskakov, IV				Makarava, Natallia; Lee, Cheng-I; Ostapchenko, Valeriy G.; Baskakov, Ilia V.			Highly promiscuous nature of prion polymerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES; CELL-FREE CONVERSION; IN-VITRO CONVERSION; SPECIES-BARRIER; AMYLOID FIBRILS; ALPHA-SYNUCLEIN; SCRAPIE INFECTIVITY; SEEDING SPECIFICITY; INCUBATION-TIME; MOLECULAR-BASIS	The primary structure of the prion protein (PrP) is believed to be the key factor in regulating the species barrier of prion transmission. Because the strength of the species barrier was found to be affected by the prion strain, the extent to which the barrier can indeed be attributed to differences in the PrP primary structures of either donor and acceptor species remains unclear. In this study, we exploited the intrinsic property of PrP to polymerize spontaneously into disease-related amyloid conformations in the absence of a strain-specified template and analyzed polymerization of mouse and hamster full-length recombinant PrPs. Unexpectedly, we found no evidence of species specificity in cross-seeding polymerization assays. Even when both recombinant PrP variants were present in mixtures, preformed mouse or hamster fibrils displayed no selectivity in elongation reactions and consumed equally well both homologous and heterologous substrates. Analysis of individual fibrils revealed that fibrils can elongate in a bidirectional or unidirectional manner. Our work revealed that, in the absence of a cellular environment, post-translational modifications, or strain-specified conformational constraints, PrP fibrils are intrinsically promiscuous and capable of utilizing heterologous PrP variants as a substrate in a highly efficient manner. This study suggests that amyloid structures are capable of accommodating local perturbations arising because of a mismatch in amino acid sequences and highlights the promiscuous nature of the self-propagating activity of amyloid fibrils.	Univ Maryland, Inst Biotechnol, Ctr Med Biotechnol, Baltimore, MD 21201 USA; Univ Maryland, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Baskakov, IV (corresponding author), Univ Maryland, Inst Biotechnol, Ctr Med Biotechnol, 725 W Lombard St, Baltimore, MD 21201 USA.	Baskakov@umbi.umd.edu		Ostapchenko, Valeriy/0000-0002-3629-7702	NINDS NIH HHS [NS045585] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045585] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adjou KT, 2007, J COMP PATHOL, V137, P78, DOI 10.1016/j.jcpa.2007.03.007; Asante EA, 2002, EMBO J, V21, P6358, DOI 10.1093/emboj/cdf653; Barron RM, 2005, J GEN VIROL, V86, P859, DOI 10.1099/vir.0.80525-0; BISHOP MF, 1984, BIOPHYS J, V46, P631, DOI 10.1016/S0006-3495(84)84062-X; Bishop MT, 2006, LANCET NEUROL, V5, P393, DOI 10.1016/S1474-4422(06)70413-6; Bocharova OV, 2006, J BIOL CHEM, V281, P2373, DOI 10.1074/jbc.M510840200; Bocharova OV, 2005, BIOCHEMISTRY-US, V44, P6776, DOI 10.1021/bi050251q; Bocharova OV, 2005, PROTEIN SCI, V14, P1222, DOI 10.1110/ps.041186605; Bocharova OV, 2005, J MOL BIOL, V346, P645, DOI 10.1016/j.jmb.2004.11.068; Breydo L, 2005, BIOCHEMISTRY-US, V44, P15534, DOI 10.1021/bi051369+; Cancellotti E, 2007, BBA-MOL BASIS DIS, V1772, P673, DOI 10.1016/j.bbadis.2006.10.013; CHANDLER RL, 1961, LANCET, V1, P1378; Derkatch IL, 2004, P NATL ACAD SCI USA, V101, P12934, DOI 10.1073/pnas.0404968101; Derkatch IL, 1997, GENETICS, V147, P507; Derkatch IL, 2001, CELL, V106, P171, DOI 10.1016/S0092-8674(01)00427-5; Dickinson A. G., 1976, Slow virus diseases of animals and man,, P209; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Galuske RAW, 2004, CLIN NEUROPATHOL, V23, P113; Govaerts C, 2004, P NATL ACAD SCI USA, V101, P8342, DOI 10.1073/pnas.0402254101; Haik S, 2002, ACTA NEUROPATHOL, V103, P516; Hill AF, 1997, NATURE, V389, P448, DOI 10.1038/38925; Hill AF, 2000, P NATL ACAD SCI USA, V97, P10248, DOI 10.1073/pnas.97.18.10248; Horiuchi M, 2000, P NATL ACAD SCI USA, V97, P5836, DOI 10.1073/pnas.110523897; Jean L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000652; Jones EM, 2005, CELL, V121, P63, DOI 10.1016/j.cell.2005.01.034; KIMBERLIN RH, 1979, J GEN VIROL, V42, P107, DOI 10.1099/0022-1317-42-1-107; KIMBERLIN RH, 1978, J GEN VIROL, V39, P487, DOI 10.1099/0022-1317-39-3-487; KIMBERLIN RH, 1977, J GEN VIROL, V34, P295, DOI 10.1099/0022-1317-34-2-295; KIMBERLIN RH, 1989, J GEN VIROL, V70, P2017, DOI 10.1099/0022-1317-70-8-2017; Kirby L, 2003, J GEN VIROL, V84, P1013, DOI 10.1099/vir.0.18903-0; KOCISKO DA, 1995, P NATL ACAD SCI USA, V92, P3923, DOI 10.1073/pnas.92.9.3923; Langedijk JPM, 2006, J MOL BIOL, V360, P907, DOI 10.1016/j.jmb.2006.05.042; Lee LYL, 2007, J AM CHEM SOC, V129, P1644, DOI 10.1021/ja0667413; MIYAZONO M, 1992, ACTA NEUROPATHOL, V83, P333, DOI 10.1007/BF00713522; Morales R, 2007, BBA-MOL BASIS DIS, V1772, P681, DOI 10.1016/j.bbadis.2006.12.006; Nonno R, 2006, PLOS PATHOG, V2, P112, DOI 10.1371/journal.ppat.0020012; Novitskaya V, 2006, J BIOL CHEM, V281, P15536, DOI 10.1074/jbc.M601349200; O'Nuallain B, 2004, J BIOL CHEM, V279, P17490, DOI 10.1074/jbc.M311300200; PATTISON IH, 1968, RES VET SCI, V9, P408; PATTISON IH, 1961, J COMP PATHOL THERAP, V71, P101, DOI 10.1016/S0368-1742(61)80013-1; PRIOLA SA, 1994, J VIROL, V68, P4873, DOI 10.1128/JVI.68.8.4873-4878.1994; PRUSINER SB, 1990, CELL, V63, P673, DOI 10.1016/0092-8674(90)90134-Z; Race R, 1998, NATURE, V392, P770, DOI 10.1038/33834; Rochet JC, 2000, BIOCHEMISTRY-US, V39, P10619, DOI 10.1021/bi001315u; SCOTT M, 1993, CELL, V73, P979, DOI 10.1016/0092-8674(93)90275-U; SCOTT M, 1989, CELL, V59, P847, DOI 10.1016/0092-8674(89)90608-9; Scott Michael, 2004, VVolume 41, P435; Sun Y, 2007, J BIOL CHEM, V282, P9090, DOI 10.1074/jbc.M608623200; Tahiri-Alaoui A, 2006, J BIOL CHEM, V281, P34171, DOI 10.1074/jbc.M606606200; Takahashi M, 1996, VIRCHOWS ARCH, V429, P383; Vanik DL, 2004, MOL CELL, V14, P139, DOI 10.1016/S1097-2765(04)00155-8; WESTAWAY D, 1987, CELL, V51, P651, DOI 10.1016/0092-8674(87)90134-6; WILSON DR, 1950, J COMP PATHOL THERAP, V60, P267, DOI 10.1016/S0368-1742(50)80025-5; Yan JM, 2007, AM J PATHOL, V171, P172, DOI 10.2353/ajpath.2007.060576	54	24	24	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36704	36713		10.1074/jbc.M704926200	http://dx.doi.org/10.1074/jbc.M704926200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17940285	hybrid			2022-12-27	WOS:000251458300063
J	Sugano, Y; Muramatsu, R; Ichiyanagi, A; Sato, T; Shoda, M				Sugano, Yasushi; Muramatsu, Riichi; Ichiyanagi, Atsushi; Sato, Takao; Shoda, Makoto			DyP, a unique dye-decolorizing peroxidase, represents a novel heme peroxidase family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WHITE-ROT BASIDIOMYCETE; CRYSTAL-STRUCTURE; MANGANESE PEROXIDASE; LIGNIN PEROXIDASE; PHANEROCHAETE-CHRYSOSPORIUM; SPECTRAL CHARACTERIZATION; HETEROLOGOUS EXPRESSION; ASPERGILLUS-ORYZAE; OXIDIZED STATES; CDNA CLONING	DyP, a unique dye-decolorizing enzyme from the fungus Thanatephorus cucumeris Dec 1, has been classified as a peroxidase but lacks homology to almost all other known plant peroxidases. The primary structure of DyP shows moderate sequence homology to only two known proteins: the peroxide-dependent phenol oxidase, TAP, and the hypothetical peroxidase, cpop21. Here, we show the first crystal structure of DyP and reveal that this protein has a unique tertiary structure with a distal heme region that differs from that of most other peroxidases. DyP lacks an important histidine residue known to assist in the formation of a Fe4(+) oxoferryl center and a porphyrin-based cation radical intermediate (compound I) during the action of ubiquitous peroxidases. Instead, our tertiary structural and spectrophotometric analyses of DyP suggest that an aspartic acid and an arginine are involved in the formation of compound I. Sequence analysis reveals that the important aspartic acid and arginine mentioned above and histidine of the heme ligand are conserved among DyP, TAP, and cpop21, and structural and phylogenetic analyses confirmed that these three enzymes do not belong to any other families of peroxidase. These findings, which strongly suggest that DyP is a representative heme peroxidase from a novel family, should facilitate the identification of additional new family members and accelerate the classification of this novel peroxidase family.	Tokyo Inst Technol, Chem Resources Lab R1 29, Midori Ku, Yokohama, Kanagawa 2268503, Japan; Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Midori Ku, Yokohama, Kanagawa 2268501, Japan	Tokyo Institute of Technology; Tokyo Institute of Technology	Sugano, Y (corresponding author), Tokyo Inst Technol, Chem Resources Lab R1 29, Midori Ku, 4259 Nagatsuta, Yokohama, Kanagawa 2268503, Japan.	ysugano@res.titech.ac.jp		Sugano, Yasushi/0000-0001-8463-5131				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Banat IM, 1996, BIORESOURCE TECHNOL, V58, P217, DOI 10.1016/S0960-8524(96)00113-7; Bonagura CA, 1999, J BIOL CHEM, V274, P37827, DOI 10.1074/jbc.274.53.37827; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Camarero S, 1999, J BIOL CHEM, V274, P10324, DOI 10.1074/jbc.274.15.10324; Dunford HB, 1999, HEME PEROXIDASE; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FINZEL BC, 1984, J BIOL CHEM, V259, P3027; Gajhede M, 1997, NAT STRUCT BIOL, V4, P1032, DOI 10.1038/nsb1297-1032; GLENN JK, 1985, ARCH BIOCHEM BIOPHYS, V242, P329, DOI 10.1016/0003-9861(85)90217-6; GOLD MH, 1984, ARCH BIOCHEM BIOPHYS, V234, P353, DOI 10.1016/0003-9861(84)90280-7; GOODIN DB, 1993, BIOCHEMISTRY-US, V32, P3313, DOI 10.1021/bi00064a014; Henriksen A, 1998, J BIOL CHEM, V273, P2241, DOI 10.1074/jbc.273.4.2241; Johjima T, 2003, APPL MICROBIOL BIOT, V61, P220, DOI 10.1007/s00253-003-1236-4; Kim SJ, 1999, APPL ENVIRON MICROB, V65, P1029; McRee DE, 1992, J MOL GRAPHICS, V10, P44, DOI DOI 10.1016/0263-7855(92)80022-6; MITTLER R, 1991, FEBS LETT, V289, P257, DOI 10.1016/0014-5793(91)81083-K; POULOS TL, 1993, J BIOL CHEM, V268, P4429; RASMUSSEN CB, 1993, FEBS LETT, V321, P102, DOI 10.1016/0014-5793(93)80630-D; RENGANATHAN V, 1986, BIOCHEMISTRY-US, V25, P1626, DOI 10.1021/bi00355a027; Saijo S, 2005, ACTA CRYSTALLOGR F, V61, P729, DOI 10.1107/S1744309105019469; Sato T, 2004, ACTA CRYSTALLOGR D, V60, P149, DOI 10.1107/S0907444903025472; Shakeri M, 2007, J BIOSCI BIOENG, V103, P129, DOI 10.1263/jbb.103.129; SHANNON LM, 1966, J BIOL CHEM, V241, P2166; SHAW PD, 1961, J BIOL CHEM, V236, P1626; Sturm A, 2006, J BIOL CHEM, V281, P13972, DOI 10.1074/jbc.M511891200; Sugano Y, 2001, J BIOSCI BIOENG, V92, P594, DOI 10.1263/jbb.92.594; Sugano Y, 1999, J BIOSCI BIOENG, V87, P411, DOI 10.1016/S1389-1723(99)80087-5; Sugano Y, 2000, APPL ENVIRON MICROB, V66, P1754, DOI 10.1128/AEM.66.4.1754-1758.2000; Sugano Y, 2006, APPL MICROBIOL BIOT, V73, P862, DOI 10.1007/s00253-006-0545-9; Sundaramoorthy M, 1995, STRUCTURE, V3, P1367, DOI 10.1016/S0969-2126(01)00274-X; SUNDARAMOORTHY M, 1994, J BIOL CHEM, V269, P32759; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; WARIISHI H, 1988, BIOCHEMISTRY-US, V27, P5365, DOI 10.1021/bi00414a061; Welinder KG., 1992, CURR OPIN STRUC BIOL, V2, P388, DOI [10.1016/0959-440x(92)90230-5, DOI 10.1016/0959-440X(92)90230-5]; Yamada Y, 2002, NAT STRUCT BIOL, V9, P691, DOI 10.1038/nsb834	36	159	163	5	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36652	36658		10.1074/jbc.M706996200	http://dx.doi.org/10.1074/jbc.M706996200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17928290	hybrid			2022-12-27	WOS:000251458300058
J	Sharif-Askari, E; Gaucher, D; Halwani, R; Ma, J; Jao, K; Abdallah, A; Haddad, EK; Sekaly, RP				Sharif-Askari, Ehssan; Gaucher, Denis; Halwani, Rabih; Ma, Jennifer; Jao, Kevin; Abdallah, Ali; Haddad, Elias K.; Sekaly, Rafick-Pierre			P56(Lck) tyrosine kinase enhances the assembly of death-inducing signaling complex during fas-mediated apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID RAFTS; CELL-DEATH; ACTIVATION; PROTEIN; LCK; CD95; CASPASE-8; CLEAVAGE; RELEASE; PALMITOYLATION	Although the death-inducing signaling complex (DISC) is rapidly assembled, several lines of evidence suggest that formation of this complex is not the first consequence of cell surface CD95 (Fas) stimulation but rather a later step in this process. Activation of Fas triggers a cascade of signaling events that culminate in cellular apoptosis. Tyrosine kinases are critical effectors in T cell activation. However, their functional involvement in death receptor-mediated apoptosis is unknown. Here, we used p56(Lck)-deficient cells to show that CD95-induced cell death is highly dependent on p56(Lck) activity and its localization within plasma membrane. We found that p56Lck acts upstream of the mitochondria; in the absence of p56(Lck), Bid cleavage and the release of cytochrome c were severely impaired. Moreover, p56(Lck)-deficient cells or cells expressing an inactive form of p56(Lck) displayed defective formation of the DISC post CD95 stimulation. In vivo reconstitution of thymocytes from p56(lck)-deficient mice, which are resistant to apoptosis, with p56(Lck) restored Fas-mediated cell death. Our results support a novel model whereby sensitivity to apoptosis is regulated through quantitative changes in the stoichiometry of DISC components triggered by p56(Lck) activation and localization.	CHUM St Luc, Ctr Rech, Immunol Lab, Montreal, PQ H2X 1P1, Canada; Univ Montreal, Dept Med, Montreal, PQ H3T 3J7, Canada; Univ Montreal, Dept Microbiol & Immunol, Immunol Lab, Montreal, PQ H3T 1J4, Canada; Univ Montreal, INSERM, CR CHUM, U743, Montreal, PQ H2X 1P1, Canada; McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2B4, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montreal; McGill University	Sekaly, RP (corresponding author), CHUM St Luc, Ctr Rech, Immunol Lab, Campus St Luc Pavillon Edouard Asselin 264,Blvd R, Montreal, PQ H2X 1P1, Canada.	rafick-pierre.sekaly@umontreal.ca	Halwani, Rabih/AAN-1568-2021	Halwani, Rabih/0000-0002-6516-7771				Adrain C, 2001, EMBO J, V20, P6627, DOI 10.1093/emboj/20.23.6627; Algeciras-Schimnich A, 2002, MOL CELL BIOL, V22, P207, DOI 10.1128/MCB.22.1.207-220.2002; Aouad SM, 2004, J IMMUNOL, V172, P2316, DOI 10.4049/jimmunol.172.4.2316; Arch RH, 1999, ANNU REV CELL DEV BI, V15, P113, DOI 10.1146/annurev.cellbio.15.1.113; Atkinson EA, 1996, J BIOL CHEM, V271, P5968, DOI 10.1074/jbc.271.11.5968; Belka C, 2003, ONCOGENE, V22, P176, DOI 10.1038/sj.onc.1206103; Boatright KM, 2003, MOL CELL, V11, P529, DOI 10.1016/S1097-2765(03)00051-0; Chakrabandhu K, 2007, EMBO J, V26, P209, DOI 10.1038/sj.emboj.7601456; Chang HY, 1998, SCIENCE, V281, P1860, DOI 10.1126/science.281.5384.1860; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; Clement MV, 1996, EMBO J, V15, P216, DOI 10.1002/j.1460-2075.1996.tb00352.x; Cremesti A, 2001, J BIOL CHEM, V276, P23954, DOI 10.1074/jbc.M101866200; Daigle I, 2002, NAT MED, V8, P61, DOI 10.1038/nm0102-61; DILLON PJ, 1990, BIOTECHNIQUES, V9, P298; Donepudi M, 2003, MOL CELL, V11, P543, DOI 10.1016/S1097-2765(03)00059-5; EISCHEN CM, 1994, J IMMUNOL, V153, P1947; Eramo A, 2004, EUR J IMMUNOL, V34, P1930, DOI 10.1002/eji.200324786; Feig C, 2007, EMBO J, V26, P221, DOI 10.1038/sj.emboj.7601460; Gajate C, 2005, J BIOL CHEM, V280, P11641, DOI 10.1074/jbc.M411781200; Gajate C, 2001, BLOOD, V98, P3860, DOI 10.1182/blood.V98.13.3860; Gajate C, 2007, BLOOD, V109, P711, DOI 10.1182/blood-2006-04-016824; Gomez-Angelats M, 2001, J BIOL CHEM, V276, P44944, DOI 10.1074/jbc.M104919200; GonzalezGarcia A, 1997, J IMMUNOL, V158, P4104; Gruber C, 2004, BIOCHEM PHARMACOL, V67, P1859, DOI 10.1016/j.bcp.2004.01.026; Hawash IY, 2002, J BIOL CHEM, V277, P5683, DOI 10.1074/jbc.M110002200; Henkler F, 2005, J CELL BIOL, V168, P1087, DOI 10.1083/jcb.200501048; Heyninck K, 2006, ONCOGENE, V25, P1693, DOI 10.1038/sj.onc.1209157; Holdorf AD, 2002, NAT IMMUNOL, V3, P259, DOI 10.1038/ni761; Jones RG, 2002, J EXP MED, V196, P335, DOI 10.1084/jem.20020307; Kabouridis PS, 1997, EMBO J, V16, P4983, DOI 10.1093/emboj/16.16.4983; KISCHKEL FC, 1995, EMBO J, V14, P5579, DOI 10.1002/j.1460-2075.1995.tb00245.x; Latinis KM, 1996, BLOOD, V87, P871, DOI 10.1182/blood.V87.3.871.bloodjournal873871; Legembre P, 2006, J IMMUNOL, V176, P716, DOI 10.4049/jimmunol.176.2.716; LENARDO MJ, 1991, NATURE, V353, P858, DOI 10.1038/353858a0; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Lichtenberg D, 2005, TRENDS BIOCHEM SCI, V30, P430, DOI 10.1016/j.tibs.2005.06.004; Lincoln JE, 2006, INVEST OPHTH VIS SCI, V47, P2172, DOI 10.1167/iovs.05-1167; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Malorni W, 2007, APOPTOSIS, V12, P941, DOI 10.1007/s10495-007-0757-1; Medema JP, 1997, EMBO J, V16, P2794, DOI 10.1093/emboj/16.10.2794; Misra RS, 2007, J BIOL CHEM, V282, P19365, DOI 10.1074/jbc.M610610200; MOLINA TJ, 1992, NATURE, V357, P161, DOI 10.1038/357161a0; Muppidi JR, 2004, NAT IMMUNOL, V5, P182, DOI 10.1038/ni1024; Nicolau DV, 2006, MOL CELL BIOL, V26, P313, DOI 10.1128/MCB.26.1.313-323.2006; PENNINGER J, 1993, SCIENCE, V260, P358, DOI 10.1126/science.8469988; Peter ME, 2003, CELL DEATH DIFFER, V10, P26, DOI 10.1038/sj.cdd.4401186; Rohn JL, 1998, ONCOGENE, V17, P2811, DOI 10.1038/sj.onc.1202393; Ruiz-Ruiz C, 1999, J IMMUNOL, V163, P4737; RuizRuiz MD, 1997, EUR J IMMUNOL, V27, P1442, DOI 10.1002/eji.1830270622; Salvesen GS, 1999, P NATL ACAD SCI USA, V96, P10964, DOI 10.1073/pnas.96.20.10964; Samraj AK, 2006, ONCOGENE, V25, P186, DOI 10.1038/sj.onc.1209034; SATO T, 1995, SCIENCE, V268, P411, DOI 10.1126/science.7536343; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Scaffidi C, 1999, CURR OPIN IMMUNOL, V11, P277, DOI 10.1016/S0952-7915(99)80045-4; Schlottmann KE, 1996, J LEUKOCYTE BIOL, V60, P546, DOI 10.1002/jlb.60.4.546; SCHRAVEN B, 1995, FEBS LETT, V368, P491, DOI 10.1016/0014-5793(95)00720-T; Sharif-Askari E, 2001, EMBO J, V20, P3101, DOI 10.1093/emboj/20.12.3101; Shaw AS, 2006, NAT IMMUNOL, V7, P1139, DOI 10.1038/ni1405; Siegel RM, 2000, NAT IMMUNOL, V1, P469, DOI 10.1038/82712; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; Szabo I, 1996, J BIOL CHEM, V271, P20465, DOI 10.1074/jbc.271.34.20465; Varadhachary AS, 1999, J IMMUNOL, V163, P4772; VEILLETTE A, 1992, ONCOGENE, V7, P971; Zhang J, 2004, CELL MOL IMMUNOL, V1, P186	64	9	9	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					36048	36056		10.1074/jbc.M706007200	http://dx.doi.org/10.1074/jbc.M706007200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17932036	hybrid			2022-12-27	WOS:000251458100064
J	Xu, AG; Haines, N; Dlugosz, M; Rana, NA; Takeuchi, H; Haltiwanger, RS; Irvine, KD				Xu, Aiguo; Haines, Nicola; Dlugosz, Malgosia; Rana, Nadia A.; Takeuchi, Hideyuki; Haltiwanger, Robert S.; Irvine, Kenneth D.			In vitro reconstitution of the modulation of Drosophila notch-ligand binding by fringe	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH FACTOR-LIKE; O-LINKED FUCOSE; LUNATIC-FRINGE; DELTA INTERACTIONS; N-GLYCANS; CELLS; GLYCOSYLATION; GLYCOSYLTRANSFERASE; DORSAL; GENE	Notch signaling plays critical roles in animal development and physiology. The activation of Notch receptors by their ligands is modulated by Fringe-dependent glycosylation. Fringe catalyzes the addition of N-acetylglucosamine in a beta 1,3 linkage onto O-fucose on epidermal growth factor-like domains. This modification of Notch by Fringe influences the binding of Notch ligands to Notch receptors. However, prior studies have relied on in vivo glycosylation, leaving unresolved the question of whether addition of N-acetylglucosamine is sufficient to modulate Notch-ligand interactions on its own, or whether instead it serves as a precursor to subsequent post-translational modifications. Here, we describe the results of in vitro assays using purified components of the Drosophila Notch signaling pathway. In vitro glycosylation and ligand binding studies establish that the addition of N-acetylglucosamine onto O-fucose in vitro is sufficient both to enhance Notch binding to the Delta ligand and to inhibit Notch binding to the Serrate ligand. Further elongation by galactose does not detectably influence Notch-ligand binding in vitro. Consistent with these observations, carbohydrate compositional analysis and mass spectrometry on Notch isolated from cells identified only N-acetylglucosamine added onto Notch in the presence of Fringe. These observations argue against models in which Fringe-dependent glycosylation modulates Notch signaling by acting as a precursor to subsequent modifications and instead establish the simple addition of N-acetylglucosamine as a basis for the effects of Fringe on Drosophila Notch-ligand binding.	Rutgers State Univ, Waksman Inst, Howard Hughes Med Inst, Piscataway, NJ 08854 USA; Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA; SUNY Stony Brook, Dept Biochem & Cell Biol, Inst Cell & Dev Biol, Stony Brook, NY 11794 USA	Howard Hughes Medical Institute; Rutgers State University New Brunswick; Rutgers State University New Brunswick; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Irvine, KD (corresponding author), Rutgers State Univ, Waksman Inst, Howard Hughes Med Inst, POB 759, Piscataway, NJ 08854 USA.	irvine@waksman.rutgers.edu	Takeuchi, Hideyuki/AAZ-9210-2020		NIGMS NIH HHS [R01-GM61126, R01 GM061126, R01-GM54594] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061126, R01GM054594] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amado M, 1999, BBA-GEN SUBJECTS, V1473, P35, DOI 10.1016/S0304-4165(99)00168-3; Asano M, 1997, EMBO J, V16, P1850, DOI 10.1093/emboj/16.8.1850; Bruckner K, 2000, NATURE, V406, P411, DOI 10.1038/35019075; Chen JH, 2001, P NATL ACAD SCI USA, V98, P13716, DOI 10.1073/pnas.241398098; Chen JH, 2006, GENE EXPR PATTERNS, V6, P376, DOI 10.1016/j.modgep.2005.09.009; Chen YW, 2007, DEV BIOL, V306, P736, DOI 10.1016/j.ydbio.2007.04.013; Correia T, 2003, P NATL ACAD SCI USA, V100, P6404, DOI 10.1073/pnas.1131007100; Evrard YA, 1998, NATURE, V394, P377, DOI 10.1038/28632; Fleming RJ, 1997, DEVELOPMENT, V124, P2973; Furukawa K, 1999, BBA-GEN SUBJECTS, V1473, P54, DOI 10.1016/S0304-4165(99)00169-5; Guo S, 2001, GLYCOBIOLOGY, V11, P813, DOI 10.1093/glycob/11.10.813; Haines N, 2003, NAT REV MOL CELL BIO, V4, P786, DOI 10.1038/nrm1228; Haines N, 2005, GLYCOBIOLOGY, V15, P335, DOI 10.1093/glycob/cwi017; Haltiwanger RS, 2002, BBA-GEN SUBJECTS, V1573, P328, DOI 10.1016/S0304-4165(02)00400-2; Haltiwanger RS, 1997, J BIOL CHEM, V272, P8752, DOI 10.1074/jbc.272.13.8752; HARDY MR, 1994, METHOD ENZYMOL, V230, P208; Hicks C, 2000, NAT CELL BIOL, V2, P515, DOI 10.1038/35019553; Hofsteenge J, 2001, J BIOL CHEM, V276, P6485, DOI 10.1074/jbc.M008073200; IRVINE KD, 1994, CELL, V79, P595, DOI 10.1016/0092-8674(94)90545-2; Lai EC, 2004, DEVELOPMENT, V131, P965, DOI 10.1242/dev.01074; Li QX, 1997, DEV BIOL, V181, P257, DOI 10.1006/dbio.1996.8444; Moloney DJ, 1997, J BIOL CHEM, V272, P19046, DOI 10.1074/jbc.272.30.19046; Moloney DJ, 2000, J BIOL CHEM, V275, P9604, DOI 10.1074/jbc.275.13.9604; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Nita-Lazar A, 2006, METHOD ENZYMOL, V417, P93, DOI 10.1016/S0076-6879(06)17008-1; Okajima T, 2003, J BIOL CHEM, V278, P42340, DOI 10.1074/jbc.M308687200; Okajima T, 2002, CELL, V111, P893, DOI 10.1016/S0092-8674(02)01114-5; Panin VM, 1997, NATURE, V387, P908, DOI 10.1038/43191; Papayannopoulos V, 1998, SCIENCE, V281, P2031, DOI 10.1126/science.281.5385.2031; Perez L, 2005, MECH DEVELOP, V122, P479, DOI 10.1016/j.mod.2004.12.007; Sasaki N, 2007, BIOCHEM BIOPH RES CO, V354, P522, DOI 10.1016/j.bbrc.2007.01.015; Sasamura T, 2003, DEVELOPMENT, V130, P4785, DOI 10.1242/dev.00679; Schweisguth F, 2004, CURR BIOL, V14, pR129, DOI 10.1016/j.cub.2004.01.023; Shao L, 2003, J BIOL CHEM, V278, P7775, DOI 10.1074/jbc.M212221200; Shimizu K, 2001, J BIOL CHEM, V276, P25753, DOI 10.1074/jbc.M103473200; Stolz A, 2008, GLYCOCONJUGATE J, V25, P167, DOI 10.1007/s10719-007-9069-5; Yang LT, 2005, MOL BIOL CELL, V16, P927, DOI 10.1091/mbc.e04-07-0614; Zhang NA, 1998, NATURE, V394, P374, DOI 10.1038/28625	38	79	81	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					35153	35162		10.1074/jbc.M707040200	http://dx.doi.org/10.1074/jbc.M707040200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17923477	hybrid			2022-12-27	WOS:000251155200060
J	Goldfeder, MB; Oliveira, CC				Goldfeder, Mauricio B.; Oliveira, Carla C.			Cwc24p, a novel Saccharomyces cerevisiae nuclear ring finger protein, affects pre-snoRNA U3 splicing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL NUCLEOLAR RNA; 18S RIBOSOMAL-RNA; EXOSOME SUBUNIT RRP43P; BOX-C/D SNORNP; MESSENGER-RNA; PRP19P-ASSOCIATED COMPLEX; PRP19-ASSOCIATED COMPLEX; SPLICEOSOME ACTIVATION; YEAST; BIOGENESIS	U3 snoRNA is transcribed from two intron-containing genes in yeast, snR17A and snR17B. Although the assembly of the U3 snoRNP has not been precisely determined, at least some of the core box C/D proteins are known to bind pre-U3 co-transcriptionally, thereby affecting splicing and 3 '-end processing of this snoRNA. We identified the interaction between the box C/D assembly factor Nop17p and Cwc24p, a novel yeast RING finger protein that had been previously isolated in a complex with the splicing factor Cef1p. Here we show that, consistent with the protein interaction data, Cwc24p localizes to the cell nucleus, and its depletion leads to the accumulation of both U3 pre-snoRNAs. U3 snoRNA is involved in the early cleavages of 35 S pre-rRNA, and the defective splicing of pre-U3 detected in cells depleted of Cwc24p causes the accumulation of the 35 S precursor rRNA. These results led us to the conclusion that Cwc 24p is involved in pre-U3 snoRNA splicing, indirectly affecting pre-rRNA processing.	[Goldfeder, Mauricio B.; Oliveira, Carla C.] Univ Sao Paulo, Inst Chem, Dept Biochem, BR-05508900 Sao Paulo, Brazil	Universidade de Sao Paulo	Oliveira, CC (corresponding author), Univ Sao Paulo, Inst Chem, Dept Biochem, 748 Av Prof Lineu Prestes, BR-05508900 Sao Paulo, Brazil.	ccoliv@iq.usp.br	Oliveira, Carla C/F-2323-2011	Oliveira, Carla C/0000-0002-1098-9241				Arenas JE, 1997, P NATL ACAD SCI USA, V94, P11798, DOI 10.1073/pnas.94.22.11798; Bachellerie JP, 1997, TRENDS BIOCHEM SCI, V22, P257, DOI 10.1016/S0968-0004(97)01057-8; BARTEL PL, 1995, METHOD ENZYMOL, V254, P241; Bassler J, 2001, MOL CELL, V8, P517, DOI 10.1016/S1097-2765(01)00342-2; BELTRAME M, 1995, EMBO J, V14, P4350, DOI 10.1002/j.1460-2075.1995.tb00109.x; Bleichert F, 2006, P NATL ACAD SCI USA, V103, P9464, DOI 10.1073/pnas.0603673103; Cahill NM, 2002, EMBO J, V21, P3816, DOI 10.1093/emboj/cdf376; Chan SP, 2005, J BIOL CHEM, V280, P31190, DOI 10.1074/jbc.M505060200; Chan SP, 2003, SCIENCE, V302, P279, DOI 10.1126/science.1086602; Chen CH, 2006, RNA, V12, P765, DOI 10.1261/rna.2292106; Clark TA, 2002, SCIENCE, V296, P907, DOI 10.1126/science.1069415; Clery A, 2007, MOL CELL BIOL, V27, P1191, DOI 10.1128/MCB.01287-06; Combs DJ, 2006, MOL CELL BIOL, V26, P523, DOI 10.1128/MCB.26.2.523-534.2006; Dez C, 2002, MOL CELL BIOL, V22, P7053, DOI 10.1128/MCB.22.20.7053-7065.2002; Dobryn HC, 2004, RNA, V10, P308, DOI 10.1261/rna.5970404; Dragon F, 2002, NATURE, V417, P967, DOI 10.1038/nature00769; Fatica A, 2002, CURR OPIN CELL BIOL, V14, P313, DOI 10.1016/S0955-0674(02)00336-8; Fatica A, 2002, MOL CELL, V9, P341, DOI 10.1016/S1097-2765(02)00458-6; Filipowicz W, 2002, CURR OPIN CELL BIOL, V14, P319, DOI 10.1016/S0955-0674(02)00334-4; Gamsjaeger R, 2007, TRENDS BIOCHEM SCI, V32, P63, DOI 10.1016/j.tibs.2006.12.007; Gautier T, 1997, MOL CELL BIOL, V17, P7088, DOI 10.1128/MCB.17.12.7088; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Giorgi C, 2001, EMBO J, V20, P6856, DOI 10.1093/emboj/20.23.6856; Gonzales FA, 2005, J MOL BIOL, V346, P437, DOI 10.1016/j.jmb.2004.11.071; Grandi P, 2002, MOL CELL, V10, P105, DOI 10.1016/S1097-2765(02)00579-8; Granneman S, 2003, NUCLEIC ACIDS RES, V31, P1877, DOI 10.1093/nar/gkg300; Hall DB, 2006, MOL CELL BIOL, V26, P3672, DOI 10.1128/MCB.26.9.3672-3679.2006; HUGHES JMX, 1991, EMBO J, V10, P4231, DOI 10.1002/j.1460-2075.1991.tb05001.x; James P, 1996, GENETICS, V144, P1425; Kufel J, 2000, MOL CELL BIOL, V20, P5415, DOI 10.1128/MCB.20.15.5415-5424.2000; Kufel J, 2003, NUCLEIC ACIDS RES, V31, P6788, DOI 10.1093/nar/gkg904; Kufel J, 2003, J BIOL CHEM, V278, P2147, DOI 10.1074/jbc.M208856200; Lafontaine DLJ, 2000, MOL CELL BIOL, V20, P2650, DOI 10.1128/MCB.20.8.2650-2659.2000; Lafontaine DLJ, 1999, RNA, V5, P455, DOI 10.1017/S135583829998192X; LI HV, 1990, MOL CELL BIOL, V10, P1145, DOI 10.1128/MCB.10.3.1145; Martin A, 2002, J BIOL CHEM, V277, P17743, DOI 10.1074/jbc.M200762200; MAXWELL ES, 1995, ANNU REV BIOCHEM, V64, P897, DOI 10.1146/annurev.bi.64.070195.004341; Morlando M, 2004, EMBO J, V23, P2392, DOI 10.1038/sj.emboj.7600254; Morrissey JP, 1997, CHROMOSOMA, V105, P515, DOI 10.1007/BF02510488; Mougin A, 1996, RNA, V2, P1079; Nazar RN, 2004, IUBMB LIFE, V56, P457, DOI 10.1080/15216540400010867; Nicoloso M, 1996, J MOL BIOL, V260, P178, DOI 10.1006/jmbi.1996.0391; Niedenthal RK, 1996, YEAST, V12, P773, DOI 10.1002/(SICI)1097-0061(19960630)12:8<773::AID-YEA972>3.3.CO;2-C; Nissan TA, 2002, EMBO J, V21, P5539, DOI 10.1093/emboj/cdf547; Ohi MD, 2005, MOL CELL BIOL, V25, P451, DOI 10.1128/MCB.25.1.451-460.2005; Ohi MD, 2002, MOL CELL BIOL, V22, P2011, DOI 10.1128/MCB.22.7.2011-2024.2002; Ohi MD, 2002, RNA, V8, P798, DOI 10.1017/S1355838202025050; Oliveira CC, 2002, NUCLEIC ACIDS RES, V30, P4186, DOI 10.1093/nar/gkf545; Pleiss JA, 2007, PLOS BIOL, V5, P745, DOI 10.1371/journal.pbio.0050090; Preti M, 2006, BIOCHEM BIOPH RES CO, V351, P468, DOI 10.1016/j.bbrc.2006.10.053; Rudra D, 2007, MOL CELL BIOL, V27, P4815, DOI 10.1128/MCB.02062-06; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SCHIMMANG T, 1989, EMBO J, V8, P4015, DOI 10.1002/j.1460-2075.1989.tb08584.x; Sharma K, 1999, MOL CELL BIOL, V19, P6012; Sherman F, 1986, LAB COURSE MANUAL ME; Stevens SW, 2001, RNA, V7, P1543; TOLLERVEY D, 1991, EMBO J, V10, P573, DOI 10.1002/j.1460-2075.1991.tb07984.x; TOLLERVEY D, 1993, CELL, V72, P443, DOI 10.1016/0092-8674(93)90120-F; Tollervey D, 1997, CURR OPIN CELL BIOL, V9, P337, DOI 10.1016/S0955-0674(97)80005-1; Tsai WY, 1999, J BIOL CHEM, V274, P9455, DOI 10.1074/jbc.274.14.9455; Venema J, 1999, ANNU REV GENET, V33, P261, DOI 10.1146/annurev.genet.33.1.261; VOJTEK AB, 1995, METHOD ENZYMOL, V255, P331; Warner JR, 2001, CELL, V107, P133, DOI 10.1016/S0092-8674(01)00531-1; Watkins NJ, 2004, MOL CELL, V16, P789, DOI 10.1016/j.molcel.2004.11.012; Watkins NJ, 2002, MOL CELL BIOL, V22, P8342, DOI 10.1128/MCB.22.23.8342-8352.2002; Wu P, 1998, J BIOL CHEM, V273, P16453, DOI 10.1074/jbc.273.26.16453; Zanchin NIT, 1997, MOL CELL BIOL, V17, P5001, DOI 10.1128/MCB.17.9.5001; Zanchin NIT, 1999, MOL CELL BIOL, V19, P1518	68	16	16	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2644	2653		10.1074/jbc.M707885200	http://dx.doi.org/10.1074/jbc.M707885200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	17974558	hybrid			2022-12-27	WOS:000252622300021
J	Ferguson, BJ; Alexander, C; Rossi, SW; Liiv, I; Rebane, A; Worth, CL; Wong, J; Laan, M; Peterson, P; Jenkinson, EJ; Anderson, G; Scott, HS; Cooke, A; Rich, T				Ferguson, Brian J.; Alexander, Clare; Rossi, Simona W.; Liiv, Ingrid; Rebane, Ana; Worth, Catherine L.; Wong, Joyce; Laan, Martti; Peterson, Paert; Jenkinson, Eric J.; Anderson, Graham; Scott, Hamish S.; Cooke, Anne; Rich, Tina			AIRE's CARD revealed, a new structure for central tolerance provokes transcriptional plasticity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOIMMUNE REGULATOR PROTEIN; CREB-BINDING-PROTEIN; NUCLEAR-BODIES; SUBCELLULAR-LOCALIZATION; FUNCTIONAL DOMAINS; THYMIC EXPRESSION; EPITHELIAL-CELLS; GENE; PML; PATHWAY	Developing T cells encounter peripheral self-antigens in the thymus in order to delete autoreactive clones. It is now known that the autoimmune regulator protein ( AIRE), which is expressed in thymic medullary epithelial cells, plays a key role in regulating the thymic transcription of these peripheral tissue-specific antigens. Mutations in the AIRE gene are associated with a severe multiorgan autoimmune syndrome ( APECED), and autoimmune reactivities are manifest in AIRE-deficient mice. Functional AIRE protein is expressed as distinct nuclear puncta, although no structural basis existed to explain their relevance to disease. In addressing the cell biologic basis for APECED, we made the unexpected discovery that an AIRE mutation hot spot lies in a caspase recruitment domain. Combined homology modeling and in vitro data now show how APECED mutations influence the activity of this transcriptional regulator. We also provide novel in vivo evidence for AIRE's association with a global transcription cofactor, which may underlie AIRE's focal, genome-wide, alteration of the transcriptome.	[Ferguson, Brian J.; Alexander, Clare; Cooke, Anne; Rich, Tina] Univ Cambridge, Dept Pathol, Div Immunol & Cellular Pathol, Cambridge CB2 1QP, England; [Rossi, Simona W.; Jenkinson, Eric J.; Anderson, Graham] Univ Birmingham, MRC, Ctr Immune Regulat, Inst Biomed Res, Birmingham B15 2TT, W Midlands, England; [Liiv, Ingrid; Rebane, Ana; Laan, Martti; Peterson, Paert] Univ Tartu, EE-50411 Tartu, Estonia; [Worth, Catherine L.; Wong, Joyce] Univ Cambridge, Dept Biochem, Cambridge CB2 1QP, England; [Scott, Hamish S.] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia	University of Cambridge; University of Birmingham; University of Tartu; University of Cambridge; Walter & Eliza Hall Institute	Rich, T (corresponding author), Univ Glasgow, Inst Comparat Med, Glasgow G61 1QH, Lanark, Scotland.	T.Rich@vet.gla.ac.uk	Cooke, Anne/S-4763-2019; Cooke, Anne/E-8709-2012; Scott, Hamish/B-2122-2009; Rebane, Ana/D-4279-2013; Laan, Martti/J-5031-2014; Peterson, Pärt/A-5788-2009	Cooke, Anne/0000-0003-3327-6081; Scott, Hamish/0000-0002-5813-631X; Rebane, Ana/0000-0001-6051-1361; Laan, Martti/0000-0002-0448-8627; Peterson, Pärt/0000-0001-6755-791X; anderson, graham/0000-0002-2917-4085; Worth, Catherine/0000-0002-1796-9606; Ferguson, Brian/0000-0002-6873-1032; Rossi, Simona W/0000-0002-8212-0502	MRC [G0401620] Funding Source: UKRI; Medical Research Council [G0401620] Funding Source: Medline; Wellcome Trust Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Aaltonen J, 1997, NAT GENET, V17, P399, DOI 10.1038/ng1297-399; Akiyoshi H, 2004, J BIOL CHEM, V279, P33984, DOI 10.1074/jbc.M400702200; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Blechschmidt K, 1999, GENOME RES, V9, P158; Chin RK, 2003, NAT IMMUNOL, V4, P1121, DOI 10.1038/ni982; DeLano W.L, PYMOL MOL GRAPHICS S; DeVoss J, 2006, J EXP MED, V203, P2727, DOI 10.1084/jem.20061864; Doucas V, 1999, P NATL ACAD SCI USA, V96, P2627, DOI 10.1073/pnas.96.6.2627; Dunker AK, 2005, FEBS J, V272, P5129, DOI 10.1111/j.1742-4658.2005.04948.x; Fata JE, 2000, CELL, V103, P41, DOI 10.1016/S0092-8674(00)00103-3; Gavanescu I, 2007, P NATL ACAD SCI USA, V104, P4583, DOI 10.1073/pnas.0700259104; Grotzinger T, 1996, MOL CELL BIOL, V16, P1150; Halonen M, 2004, HUM MUTAT, V23, P245, DOI 10.1002/humu.20003; Hamazaki Y, 2007, NAT IMMUNOL, V8, P304, DOI 10.1038/ni1438; Heino M, 1999, BIOCHEM BIOPH RES CO, V257, P821, DOI 10.1006/bbrc.1999.0308; Johnnidis JB, 2005, P NATL ACAD SCI USA, V102, P7233, DOI 10.1073/pnas.0502670102; Kwok RPS, 2006, MOL REPROD DEV, V73, P885, DOI 10.1002/mrd.20440; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Li J, 2000, P NATL ACAD SCI USA, V97, P1566, DOI 10.1073/pnas.97.4.1566; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Mariathasan S, 2007, NAT REV IMMUNOL, V7, P31, DOI 10.1038/nri1997; Martinez GL, 2000, J ELECTRON MATER, V29, P325, DOI 10.1007/s11664-000-0072-x; Maul GG, 2000, J STRUCT BIOL, V129, P278, DOI 10.1006/jsbi.2000.4239; McManus KJ, 2006, PLOS COMPUT BIOL, V2, P1271, DOI 10.1371/journal.pcbi.0020139; Milovic-Holm K, 2007, EMBO J, V26, P391, DOI 10.1038/sj.emboj.7601504; Nagamine K, 1997, NAT GENET, V17, P393, DOI 10.1038/ng1297-393; Negorev DG, 2006, J VIROL, V80, P8019, DOI 10.1128/JVI.02164-05; Novack DV, 2003, J EXP MED, V198, P771, DOI 10.1084/jem.20030116; Park HH, 2007, CELL, V128, P533, DOI 10.1016/j.cell.2007.01.019; Park HH, 2007, ANNU REV IMMUNOL, V25, P561, DOI 10.1146/annurev.immunol.25.022106.141656; PEARSON W, 1997, COMPUT APPL BIOSCI, P325; Pitkanen J, 2005, BIOCHEM BIOPH RES CO, V333, P944, DOI 10.1016/j.bbrc.2005.05.187; Pitkanen J, 2001, J BIOL CHEM, V276, P19597, DOI 10.1074/jbc.M008322200; Pitkanen J, 2000, J BIOL CHEM, V275, P16802, DOI 10.1074/jbc.M908944199; Ponting CP, 2002, ANNU REV BIOPH BIOM, V31, P45, DOI 10.1146/annurev.biophys.31.082901.134314; Qin HX, 1999, NATURE, V399, P549, DOI 10.1038/21124; Ramsey C, 2002, HUM MOL GENET, V11, P3299, DOI 10.1093/hmg/11.26.3299; Rossi SW, 2007, J EXP MED, V204, P1267, DOI 10.1084/jem.20062497; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Siegel RM, 1998, J CELL BIOL, V141, P1243, DOI 10.1083/jcb.141.5.1243; Sternsdorf T, 1999, J BIOL CHEM, V274, P12555, DOI 10.1074/jbc.274.18.12555; Sternsdorf T, 1997, IMMUNOBIOLOGY, V198, P307, DOI 10.1016/S0171-2985(97)80051-4; Su MA, 2004, CURR OPIN IMMUNOL, V16, P746, DOI 10.1016/j.coi.2004.09.009; Tang J, 2005, CANCER BIOL THER, V4, P645, DOI 10.4161/cbt.4.6.1729; Taubert R, 2007, EUR J IMMUNOL, V37, P838, DOI 10.1002/eji.200636962; Topham CM, 1997, PROTEIN ENG, V10, P7, DOI 10.1093/protein/10.1.7; Varadaraj A, 2007, J PATHOL, V211, P471, DOI 10.1002/path.2126; Venanzi ES, 2004, CURR OPIN IMMUNOL, V16, P197, DOI 10.1016/j.coi.2004.01.008; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wang ZG, 1998, NAT GENET, V20, P266, DOI 10.1038/3073; WORTH CL, 2007, IN PRESS J BIOINFORM; Zhu MZ, 2006, J CLIN INVEST, V116, P2964, DOI 10.1172/JCI28326	52	67	68	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1723	1731		10.1074/jbc.M707211200	http://dx.doi.org/10.1074/jbc.M707211200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	17974569	hybrid, Green Accepted			2022-12-27	WOS:000252282700059
J	Chen, S; Hu, T; Zhang, J; Chen, J; Chen, K; Ding, J; Jiang, H; Shen, X				Chen, Shuai; Hu, Tiancen; Zhang, Jian; Chen, Jing; Chen, Kaixian; Ding, Jianping; Jiang, Hualiang; Shen, Xu			Mutation of Gly-11 on the dimer interface results in the complete crystallographic dimer dissociation of severe acute respiratory syndrome coronavirus 3C-like protease - Crystal structure with molecular dynamics simulations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COV MAIN PROTEINASE; SUBSTRATE-SPECIFICITY; ENZYMATIC-ACTIVITY; M-PRO; SARS; DIMERIZATION; PURIFICATION; INHIBITOR; DESIGN; SYSTEM	SARS-CoV 3C-like protease (3CL(pro)) is an attractive target for anti-severe acute respiratory syndrome (SARS) drug discovery, and its dimerization has been extensively proved to be indispensable for enzymatic activity. However, the reason why the dissociated monomer is inactive still remains unclear due to the absence of the monomer structure. In this study, we showed that mutation of the dimer-interface residue Gly-11 to alanine entirely abolished the activity of SARS-CoV 3CL(pro). Subsequently, we determined the crystal structure of this mutant and discovered a complete crystallographic dimer dissociation of SARS-CoV 3CL(pro). The mutation might shorten the alpha-helix A' of domain I and cause a mis-oriented N-terminal finger that could not correctly squeeze into the pocket of another monomer during dimerization, thus destabilizing the dimer structure. Several structural features essential for catalysis and substrate recognition are severely impaired in the G11A monomer. Moreover, domain III rotates dramatically against the chymotrypsin fold compared with the dimer, from which we proposed a putative dimerization model for SARS-CoV 3CL(pro). As the first reported monomer structure for SARS-CoV 3CL(pro), the crystal structure of G11A mutant might provide insight into the dimerization mechanism of the protease and supply direct structural evidence for the incompetence of the dissociated monomer.	[Chen, Shuai; Hu, Tiancen; Zhang, Jian; Chen, Jing; Chen, Kaixian; Jiang, Hualiang; Shen, Xu] Chinese Acad Sci, Shanghai Inst Mat Med, Drug Discovery & Design Ctr, State Key Lab Drug Res, Shanghai 201203, Peoples R China; [Ding, Jianping] Chinese Acad Sci, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, State Key Lab Mol, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Jiang, H (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, Drug Discovery & Design Ctr, State Key Lab Drug Res, 555 Zuchongzhi Rd, Shanghai 201203, Peoples R China.	hljiang@mail.shcnc.ac.cn; xshen@mail.shcnc.ac.cn	Zhang, Jian/GXA-1303-2022	Zhang, Jian/0000-0002-6558-791X; ding, jian ping/0000-0001-7029-7346				Anand K, 2003, SCIENCE, V300, P1763, DOI 10.1126/science.1085658; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barrila J, 2006, BIOCHEMISTRY-US, V45, P14908, DOI 10.1021/bi0616302; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen H, 2006, J BIOL CHEM, V281, P13894, DOI 10.1074/jbc.M510745200; Chen S, 2005, ACTA PHARMACOL SIN, V26, P99, DOI 10.1111/j.1745-7254.2005.00010.x; Chen S, 2005, J BIOL CHEM, V280, P164, DOI 10.1074/jbc.M408211200; Chou CY, 2004, BIOCHEMISTRY-US, V43, P14958, DOI 10.1021/bi0490237; Ding L, 2005, ANAL BIOCHEM, V343, P159, DOI 10.1016/j.ab.2005.04.027; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fan KQ, 2005, BIOCHEM BIOPH RES CO, V329, P934, DOI 10.1016/j.bbrc.2005.02.061; Fan KQ, 2004, J BIOL CHEM, V279, P1637, DOI 10.1074/jbc.M310875200; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P6212, DOI 10.1073/pnas.0400762101; Gao F, 2003, FEBS LETT, V553, P451, DOI 10.1016/S0014-5793(03)01091-3; Graziano V, 2006, BIOCHEMISTRY-US, V45, P14632, DOI 10.1021/bi061746y; Graziano V, 2006, FEBS LETT, V580, P2577, DOI 10.1016/j.febslet.2006.04.004; Hsu MF, 2005, J BIOL CHEM, V280, P31257, DOI 10.1074/jbc.M502577200; Hsu WC, 2005, J BIOL CHEM, V280, P22741, DOI 10.1074/jbc.M502556200; Huang CK, 2004, BIOCHEMISTRY-US, V43, P4568, DOI 10.1021/bi036022q; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee TW, 2005, J MOL BIOL, V353, P1137, DOI 10.1016/j.jmb.2005.09.004; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Shi JH, 2006, FEBS J, V273, P1035, DOI 10.1111/j.1742-4658.2006.05130.x; Shi JH, 2004, J BIOL CHEM, V279, P24765, DOI 10.1074/jbc.M311744200; Sun HF, 2003, PROTEIN EXPRES PURIF, V32, P302, DOI 10.1016/j.pep.2003.08.016; Tan JZ, 2005, J MOL BIOL, V354, P25, DOI 10.1016/j.jmb.2005.09.012; Thiel V, 2003, J GEN VIROL, V84, P2305, DOI 10.1099/vir.0.19424-0; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Wei P, 2006, BIOCHEM BIOPH RES CO, V339, P865, DOI 10.1016/j.bbrc.2005.11.102; Xu T, 2005, ACTA CRYSTALLOGR F, V61, P964, DOI 10.1107/S1744309105033257; Xue XY, 2007, J MOL BIOL, V366, P965, DOI 10.1016/j.jmb.2006.11.073; Yang HT, 2003, P NATL ACAD SCI USA, V100, P13190, DOI 10.1073/pnas.1835675100; Zheng KW, 2007, PROTEINS, V66, P467, DOI 10.1002/prot.21160	40	57	58	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					554	564		10.1074/jbc.M705240200	http://dx.doi.org/10.1074/jbc.M705240200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17977841	hybrid, Green Published			2022-12-27	WOS:000251940300060
J	Han, Z; Zhong, L; Srivastava, A; Stacpoole, PW				Han, Zongchao; Zhong, Li; Srivastava, Arun; Stacpoole, Peter W.			Pyruvate dehydrogenase complex deficiency caused by ubiquitination and proteasome-mediated degradation of the E1 beta subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE KINASE; GROWTH-FACTOR RECEPTOR; TRANSGENE EXPRESSION; GENE; MUTATIONS; PATHWAY; CANCER; PHOSPHORYLATION; INHIBITORS; SUBSTRATE	Congenital deficiencies of the human pyruvate dehydrogenase (PDH) complex are considered to be due to loss of function mutations in one of the component enzymes. Here we describe a case of PDH deficiency associated with the PDH E1 beta subunit ( PDHB) gene. The clinical phenotype of the patient was consistent with reported cases of PDH deficiency. Cultured skin fibroblasts demonstrated a 55% reduction in PDH activity and markedly decreased immunoreactivity for PDHB protein, compared with healthy controls. Surprisingly, nucleotide sequence analyses of cDNAs corresponding to the patient PDH E1 alpha (PDHA1) and PDHB genes revealed no pathological mutations. Moreover, the relative expression level of PDHB mRNA and the rates of transcription and translation of the PDHB gene were normal. However, PDC activity could be restored in cells from this patient following treatment with MG132, a specific proteasome inhibitor, and normal levels of E1 beta could be detected in MG132-treated cells. Similar results were obtained following treatment with Tyrphostin 23 (Tyr23), a specific inhibitor of epidermal growth factor receptor-protein-tyrosine kinase (EGFR-PTK), which also restored E1 beta protein levels to those in cells from healthy subjects or from patients with PDHA1 deficiency. The index patient's cells contained a high basal level of EGFR-PTK activity that correlated with the high level of ubiquitination of cellular proteins, although the total EGFR protein levels were similar to those in cells from E1 alpha- deficient subjects and healthy subjects. These data indicate that PDH deficiency in our patient involves a post-translational modification in which EGFR-PTK-mediated tyrosine phosphorylation of the E1 beta protein leads to enhanced ubiquitination followed by proteasome-mediated degradation. They also provide a novel mechanism accounting for congenital deficiency of the PDH complex and perhaps other inborn errors of metabolism.	[Han, Zongchao; Zhong, Li; Srivastava, Arun] Univ Florida, Coll Med, Dept Pediat, Div Mol & Cellular Therapy, Gainesville, FL 32610 USA; [Srivastava, Arun] Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL 32610 USA; [Srivastava, Arun; Stacpoole, Peter W.] Univ Florida, Coll Med, Gen Clin Res Ctr, Gainesville, FL 32610 USA; [Stacpoole, Peter W.] Univ Florida, Coll Med, Dept Med, Div Endocrinol & Metab, Gainesville, FL 32610 USA; [Stacpoole, Peter W.] Univ Florida, Coll Med, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Stacpoole, PW (corresponding author), Dept Med, Div Endocrinol & Metab, 1600 SW Archer Rd, Gainesville, FL 32610 USA.	peter.stacpoole@medicine.ufl.edu	Zhong, Li/GZM-4358-2022	Zhong, Li/0000-0003-1611-5171; Han, Zongchao/0000-0002-2019-395X	NIDDK NIH HHS [P01 DK 058237] Funding Source: Medline; PHS HHS [M01 000082] Funding Source: Medline	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Andersen KM, 2005, ESSAYS BIOCHEM, V41, P49, DOI 10.1042/EB0410049; Arias EE, 2007, GENE DEV, V21, P497, DOI 10.1101/gad.1508907; Bishop AC, 1999, PHARMACOL THERAPEUT, V82, P337, DOI 10.1016/S0163-7258(98)00060-6; Bose R, 2006, CURR OPIN STRUC BIOL, V16, P668, DOI 10.1016/j.sbi.2006.10.012; Briggs SD, 2002, NATURE, V418, P498, DOI 10.1038/nature00970; Brown RM, 2006, DEV MED CHILD NEUROL, V48, P756, DOI 10.1017/S0012162206001617; Brown RM, 2004, HUM GENET, V115, P123, DOI 10.1007/s00439-004-1124-8; Burger AM, 2005, CANCER RES, V65, P10401, DOI 10.1158/0008-5472.CAN-05-2103; Cameron JM, 2004, AM J MED GENET A, V131A, P59, DOI 10.1002/ajmg.a.30287; Fouque F, 2003, PEDIATR RES, V53, P793, DOI 10.1203/01.PDR.0000057987.46622.64; GalchevaGargova Z, 1995, ONCOGENE, V11, P2649; GAZIT A, 1989, J MED CHEM, V32, P2344, DOI 10.1021/jm00130a020; Han ZC, 2007, MITOCHONDRION, V7, P253, DOI 10.1016/j.mito.2007.02.003; Head RA, 2005, ANN NEUROL, V58, P234, DOI 10.1002/ana.20550; HUQ AHMM, 1991, PEDIATR RES, V30, P11, DOI 10.1203/00006450-199107000-00003; Jennings K, 2005, MOL THER, V11, P600, DOI 10.1016/j.ymthe.2004.10.020; Letoha T, 2005, FREE RADICAL BIO MED, V39, P1142, DOI 10.1016/j.freeradbiomed.2005.06.003; Lissens W, 2000, HUM MUTAT, V15, P209, DOI 10.1002/(SICI)1098-1004(200003)15:3<209::AID-HUMU1>3.0.CO;2-K; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mah C, 1998, J VIROL, V72, P9835, DOI 10.1128/JVI.72.12.9835-9843.1998; Maj MC, 2005, J CLIN ENDOCR METAB, V90, P4101, DOI 10.1210/jc.2005-0123; Meller R, 2006, J BIOL CHEM, V281, P7429, DOI 10.1074/jbc.M512138200; Minegishi N, 2005, GENES CELLS, V10, P693, DOI 10.1111/j.1365-2443.2005.00864.x; Morten KJ, 1999, NEUROLOGY, V53, P612, DOI 10.1212/WNL.53.3.612; OKAJIMAA K, 2007, MOL GENET METAB, V90, P49; Ostman A, 2006, NAT REV CANCER, V6, P307, DOI 10.1038/nrc1837; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; Reinstein E, 2006, ANN INTERN MED, V145, P676, DOI 10.7326/0003-4819-145-9-200611070-00010; ROBINSON BH, 2001, LACTIC ACIDEMIA DISO, P2275; Schemarova IV, 2006, CURR ISSUES MOL BIOL, V8, P27; Sebastian S, 2006, BBA-REV CANCER, V1766, P120, DOI 10.1016/j.bbcan.2006.06.001; Sehat B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000340; STACPOOLE PW, 2006, CLIN CASES MED BIOCH, P77; Urbe S, 2000, MOL CELL BIOL, V20, P7685, DOI 10.1128/MCB.20.20.7685-7692.2000; YAISH P, 1988, SCIENCE, V242, P933, DOI 10.1126/science.3263702; Zhong L, 2007, MOL THER, V15, P1323, DOI 10.1038/sj.mt.6300170	36	24	24	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					237	243		10.1074/jbc.M704748200	http://dx.doi.org/10.1074/jbc.M704748200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17923481	hybrid			2022-12-27	WOS:000251940300027
J	Scott, DA; Hickerson, SM; Vickers, TJ; Beverley, SM				Scott, David A.; Hickerson, Suzanne M.; Vickers, Tim J.; Beverley, Stephen M.			The role of the mitochondrial glycine cleavage complex in the metabolism and virulence of the protozoan parasite Leishmania major	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REDUCTASE-THYMIDYLATE SYNTHASE; ONE-CARBON METABOLISM; DIHYDROFOLATE-REDUCTASE; SERINE HYDROXYMETHYLTRANSFERASE; SUBCELLULAR-LOCALIZATION; AMASTIGOTE VIRULENCE; FOLATE COENZYMES; P-PROTEIN; GENE; DECARBOXYLASE	For the human pathogen Leishmania major, a key metabolic function is the synthesis of thymidylate, which requires 5,10-methylenetetrahydrofolate (5,10-CH2-THF). 5,10-CH2-THF can be synthesized from glycine by the mitochondrial glycine cleavage complex (GCC). Bioinformatic analysis revealed the four subunits of the GCC in the L. major genome, and the role of the GCC in parasite metabolism and virulence was assessed through studies of the P subunit (glycine decarboxylase (GCVP)). First, a tagged GCVP protein was expressed and localized to the parasite mitochondrion. Second, a gcvP(-) mutant was generated and shown to lack significant GCC activity using an indirect in vivo assay after incorporation of label from [2-C-14] glycine into DNA. The gcvP(-) mutant grew poorly in the presence of excess glycine or minimal serine; these studies also established that L. major promastigotes require serine for optimal growth. Although gcvP(-) promastigotes and amastigotes showed normal virulence in macrophage infections in vitro, both forms of the parasite showed substantially delayed replication and lesion pathology in infections of both genetically susceptible or resistant mice. These data suggest that, as the physiology of the infection site changes during the course of infection, so do the metabolic constraints on parasite replication. This conclusion has great significance to the interpretation of metabolic requirements for virulence. Last, these studies call attention in trypanosomatid protozoa to the key metabolic intermediate 5,10-CH2-THF, situated at the junction of serine, glycine, and thymidylate metabolism. Notably, genome-based predictions suggest the related parasite Trypanosoma brucei is totally dependent on the GCC for 5,10-CH2-THF synthesis.	[Scott, David A.; Hickerson, Suzanne M.; Vickers, Tim J.; Beverley, Stephen M.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Beverley, SM (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, Campus Box 8230, 660 S Euclid Ave, St Louis, MO 63110 USA.	beverley@borcim.wustl.edu		Scott, David/0000-0002-8668-2449; Beverley, Stephen/0000-0001-5319-0811	NIAID NIH HHS [AI 21903, R37 AI021903, R01 AI021903-26, R01 AI021903] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI021903, R01AI021903] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bauwe H, 2003, J EXP BOT, V54, P1523, DOI 10.1093/jxb/erg171; Belkaid Y, 2000, J IMMUNOL, V165, P969, DOI 10.4049/jimmunol.165.2.969; Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152; Berman J, 2006, T ROY SOC TROP MED H, V100, pS41, DOI 10.1016/j.trstmh.2006.02.009; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Bogdan C, 2000, J EXP MED, V191, P2121, DOI 10.1084/jem.191.12.2121; Capul AA, 2007, INFECT IMMUN, V75, P4629, DOI 10.1128/IAI.00735-07; Chandok MR, 2003, CELL, V113, P469, DOI 10.1016/S0092-8674(03)00350-7; Chaudhary K, 2005, NAT BIOTECHNOL, V23, P1089, DOI 10.1038/nbt0905-1089; Christensen KE, 2006, BIOESSAYS, V28, P595, DOI 10.1002/bies.20420; Chu E, 2003, CANCER CHEMOTH PHARM, V52, pS80, DOI 10.1007/s00280-003-0625-9; Clayton CE, 2002, EMBO J, V21, P1881, DOI 10.1093/emboj/21.8.1881; COOMBS GH, 1986, PARASITOLOGY, V92, P13, DOI 10.1017/S0031182000063411; CRUZ A, 1991, P NATL ACAD SCI USA, V88, P7170, DOI 10.1073/pnas.88.16.7170; De Koning TJ, 2003, BIOCHEM J, V371, P653, DOI 10.1042/BJ20021785; Douce R, 2001, TRENDS PLANT SCI, V6, P167, DOI 10.1016/S1360-1385(01)01892-1; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Engel N, 2007, PLANT PHYSIOL, V144, P1328, DOI 10.1104/pp.107.099317; Ferraro P, 2006, P NATL ACAD SCI USA, V103, P18586, DOI 10.1073/pnas.0609020103; Gagnon D, 2006, MOL BIOCHEM PARASIT, V150, P63, DOI 10.1016/j.molbiopara.2006.06.009; GARRETT CE, 1984, MOL BIOCHEM PARASIT, V11, P257, DOI 10.1016/0166-6851(84)90070-7; Ha DS, 1996, MOL BIOCHEM PARASIT, V77, P57, DOI 10.1016/0166-6851(96)02580-7; HAMMOND DJ, 1984, MOL BIOCHEM PARASIT, V13, P243, DOI 10.1016/0166-6851(84)90117-8; Hardy LW, 1997, EXP PARASITOL, V87, P157, DOI 10.1006/expr.1997.4207; Herwaldt BL, 1999, LANCET, V354, P1191, DOI 10.1016/S0140-6736(98)10178-2; Hong PC, 2000, INFECT IMMUN, V68, P4102, DOI 10.1128/IAI.68.7.4102-4107.2000; HORNE DW, 1992, J NUTR, V122, P2204, DOI 10.1093/jn/122.11.2204; HORNE DW, 1989, ARCH BIOCHEM BIOPHYS, V270, P729, DOI 10.1016/0003-9861(89)90556-0; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; KAPLER GM, 1990, MOL CELL BIOL, V10, P1084, DOI 10.1128/MCB.10.3.1084; Kastanos EK, 1997, BIOCHEMISTRY-US, V36, P14956, DOI 10.1021/bi971610n; Klessig DF, 2004, CELL, V119, P445, DOI 10.1016/j.cell.2004.10.007; KNIGHTON DR, 1994, NAT STRUCT BIOL, V1, P186, DOI 10.1038/nsb0394-186; Lira R, 1999, J INFECT DIS, V180, P564, DOI 10.1086/314896; Luo MZ, 1997, PLANT MOL BIOL, V33, P709, DOI 10.1023/A:1005798207693; McConville MJ, 2007, TRENDS PARASITOL, V23, P368, DOI 10.1016/j.pt.2007.06.009; McNeil JB, 1996, GENETICS, V142, P371; MEDINAACOSTA E, 1993, MOL BIOCHEM PARASIT, V59, P327, DOI 10.1016/0166-6851(93)90231-L; Melchior D, 2004, J ANIM SCI, V82, P1091; Nagarajan L, 1997, J BIOL CHEM, V272, P4444, DOI 10.1074/jbc.272.7.4444; Nakai T, 2005, EMBO J, V24, P1523, DOI 10.1038/sj.emboj.7600632; Nare B, 1997, J BIOL CHEM, V272, P13883, DOI 10.1074/jbc.272.21.13883; Neuburger M, 1996, J BIOL CHEM, V271, P9466, DOI 10.1074/jbc.271.16.9466; Opperdoes FR, 2007, TRENDS PARASITOL, V23, P149, DOI 10.1016/j.pt.2007.02.004; Payne SH, 2006, EUKARYOT CELL, V5, P272, DOI 10.1128/EC.5.2.272-276.2006; Peacock CS, 2007, NAT GENET, V39, P839, DOI 10.1038/ng2053; Piper MD, 2000, J BIOL CHEM, V275, P30987, DOI 10.1074/jbc.M004248200; Remick DG, 2007, AM J PATHOL, V170, P1435, DOI 10.2353/ajpath.2007.060872; Robinson KA, 2003, MOL BIOCHEM PARASIT, V128, P217, DOI 10.1016/S0166-6851(03)00079-3; SACKS DL, 1984, SCIENCE, V223, P1417, DOI 10.1126/science.6701528; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Schirch L. V., 1984, FOLATES PTERINS CHEM, V1, P399; Spath GF, 2000, P NATL ACAD SCI USA, V97, P9258, DOI 10.1073/pnas.160257897; Spath GF, 2001, EXP PARASITOL, V99, P97, DOI 10.1006/expr.2001.4656; Stechmann A, 2002, SCIENCE, V297, P89, DOI 10.1126/science.1071196; SWAFFORD JR, 1990, 12 P C EL MICR, P610; TITUS RG, 1985, PARASITE IMMUNOL, V7, P545, DOI 10.1111/j.1365-3024.1985.tb00098.x; WALKER JL, 1986, J BIOL CHEM, V261, P2214; Weiss DS, 2007, P NATL ACAD SCI USA, V104, P6037, DOI 10.1073/pnas.0609675104; Zhang K, 2005, MOL MICROBIOL, V55, P1566, DOI 10.1111/j.1365-2958.2005.04493.x; Zufferey R, 2003, J BIOL CHEM, V278, P44708, DOI 10.1074/jbc.M308063200	61	28	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					155	165		10.1074/jbc.M708014200	http://dx.doi.org/10.1074/jbc.M708014200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17981801	hybrid, Green Accepted			2022-12-27	WOS:000251940300018
J	Hatakeyama, T; Unno, H; Kouzuma, Y; Uchida, T; Eto, S; Hidemura, H; Kato, N; Yonekura, M; Kusunoki, M				Hatakeyama, Tomomitsu; Unno, Hideaki; Kouzuma, Yoshiaki; Uchida, Tatsuya; Eto, Seiichiro; Hidemura, Haruki; Kato, Norihisa; Yonekura, Masami; Kusunoki, Masami			C-type lectin-like carbohydrate recognition of the hemolytic lectin CEL-III containing ricin-type beta-trefoil folds	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INVERTEBRATE CUCUMARIA-ECHINATA; MARINE INVERTEBRATE; LIGAND-BINDING; CRYSTAL-STRUCTURE; B-CHAIN; PROTEINS; DOMAIN; SEEDS	CEL-III is a Ca2+ dependent hemolytic lectin, isolated from the marine invertebrate Cucumaria echinata. The three-dimensional structure of CEL-III/GalNAc and CEL-III/ methyl alpha-galactoside complexes was solved by x-ray crystallographic analysis. In these complexes, five carbohydrate molecules were found to be bound to two carbohydrate-binding domains (domains 1 and 2) located in the N-terminal 2/3 portion of the polypeptide and that contained beta-trefoil folds similar to ricin B-chain. The 3-OH and 4-OH of bound carbohydrate molecules were coordinated with Ca2+ located at the subdomains 1 alpha, 1 gamma, 2 alpha, 2 beta, and 2 gamma, simultaneously forming hydrogen bond networks with nearby amino acid side chains, which is similar to carbohydrate binding in C-type lectins. The binding of carbohydrates was further stabilized by aromatic amino acid residues, such as tyrosine and tryptophan, through a stacking interaction with the hydrophobic face of carbohydrates. The importance of amino acid residues in the carbohydrate-binding sites was confirmed by the mutational analyses. The orientation of bound GalNAc and methyl alpha-galactoside was similar to the galactose moiety of lactose bound to the carbohydrate-binding site of the ricin B-chain, although the ricin B-chain does not require Ca2+ ions for carbohydrate binding. The binding of the carbohydrates induced local structural changes in carbohydrate-binding sites in subdomains 2 alpha and 2 beta. Binding of GalNAc also induced a slight change in the main chain structure of domain 3, which could be related to the conformational change upon binding of specific carbohydrates to induce oligomerization of the protein.	[Hatakeyama, Tomomitsu; Unno, Hideaki; Eto, Seiichiro; Hidemura, Haruki] Nagasaki Univ, Fac Engn, Dept Appl Chem, Nagasaki 8528521, Japan; [Kouzuma, Yoshiaki; Kato, Norihisa; Yonekura, Masami] Ibaraki Univ, Coll Agr, Dept Res Biol Sci, Ibaraki 3000393, Japan; [Uchida, Tatsuya; Kusunoki, Masami] Osaka Univ, Inst Prot Res, Res Ctr Struct & Funct Proteom, Suita, Osaka 5650871, Japan	Nagasaki University; Ibaraki University; Osaka University	Hatakeyama, T (corresponding author), Nagasaki Univ, Fac Engn, Dept Appl Chem, 1-14 Bunkyo-machi, Nagasaki 8528521, Japan.	thata@nagasaki-u.ac.jp	Hideaki, UNNO/ABG-9471-2020	Hideaki, UNNO/0000-0001-5917-269X; Hatakeyama, Tomomitsu/0000-0002-9505-1980				Abrami L, 2003, J CELL BIOL, V160, P321, DOI 10.1083/jcb.200211018; ARAKI T, 1987, BIOCHIM BIOPHYS ACTA, V911, P191, DOI 10.1016/0167-4838(87)90008-2; Armstrong PB, 1996, J BIOL CHEM, V271, P14717, DOI 10.1074/jbc.271.25.14717; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; DeLano W.L, PYMOL MOL GRAPHICS S; DENG WP, 1992, ANAL BIOCHEM, V200, P81, DOI 10.1016/0003-2697(92)90280-K; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fivaz M, 1999, TRENDS CELL BIOL, V9, P212, DOI 10.1016/S0962-8924(99)01567-6; FUNATSU G, 1979, AGR BIOL CHEM TOKYO, V43, P2221, DOI 10.1080/00021369.1979.10863794; Guo Y, 2004, NAT STRUCT MOL BIOL, V11, P591, DOI 10.1038/nsmb784; Hatakeyama T, 1997, J BIOCHEM, V121, P63; HATAKEYAMA T, 1995, J BIOL CHEM, V270, P3560, DOI 10.1074/jbc.270.8.3560; Hatakeyama T, 1999, J BIOCHEM, V125, P277, DOI 10.1093/oxfordjournals.jbchem.a022284; HATAKEYAMA T, 1994, J BIOCHEM, V116, P209, DOI 10.1093/oxfordjournals.jbchem.a124495; Hatakeyama T, 1996, J BIOL CHEM, V271, P16915, DOI 10.1074/jbc.271.28.16915; Hazes B, 1996, PROTEIN SCI, V5, P1490, DOI 10.1002/pro.5560050805; KIMURA M, 1993, BIOSCI BIOTECH BIOCH, V57, P166, DOI 10.1271/bbb.57.166; KONSKA G, 1994, J BIOCHEM-TOKYO, V116, P519, DOI 10.1093/oxfordjournals.jbchem.a124555; Kouzuma Y, 2003, J BIOCHEM, V134, P395, DOI 10.1093/jb/mvg157; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEPPLA SH, 2006, COMPREHENSIVE SOURCE, P323; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakano M, 1999, BBA-PROTEIN STRUCT M, V1435, P167, DOI 10.1016/S0167-4838(99)00212-5; Ng KKS, 2002, J BIOL CHEM, V277, P16088, DOI 10.1074/jbc.M200493200; Oda T, 1997, J BIOCHEM, V121, P560; Oda T, 1999, J BIOCHEM, V125, P713, DOI 10.1093/oxfordjournals.jbchem.a022341; Olson R, 1999, NAT STRUCT BIOL, V6, P134; Parker MW, 2005, PROG BIOPHYS MOL BIO, V88, P91, DOI 10.1016/j.pbiomolbio.2004.01.009; PARKER MW, 1994, NATURE, V367, P292, DOI 10.1038/367292a0; Poget SF, 2001, BIOCHEMISTRY-US, V40, P10966, DOI 10.1021/bi002698z; Powell HR, 1999, ACTA CRYSTALLOGR D, V55, P1690, DOI 10.1107/S0907444999009506; Rossjohn J, 1998, J STRUCT BIOL, V121, P92, DOI 10.1006/jsbi.1997.3947; Satoh F, 2002, J NAT TOXINS, V11, P297; Shrive AK, 2003, J MOL BIOL, V331, P509, DOI 10.1016/S0022-2836(03)00761-7; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Sugawara H, 2004, J BIOL CHEM, V279, P45219, DOI 10.1074/jbc.M408840200; Tateno H, 2003, J BIOL CHEM, V278, P40455, DOI 10.1074/jbc.M306836200; Uchida T, 2004, J BIOL CHEM, V279, P37133, DOI 10.1074/jbc.M404065200; WEIS WI, 1992, NATURE, V360, P127, DOI 10.1038/360127a0	41	34	35	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37826	37835		10.1074/jbc.M705604200	http://dx.doi.org/10.1074/jbc.M705604200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17977832	hybrid			2022-12-27	WOS:000251833600058
J	Lemeshko, VV; Kugler, W				Lemeshko, Victor V.; Kugler, Wilfried			Synergistic inhibition of mitochondrial respiration by anticancer agent erucylphosphohomocholine and cyclosporin A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ERUCYLPHOSPHOCHOLINE-INDUCED APOPTOSIS; PERMEABILITY TRANSITION PORE; LINES IN-VITRO; CELL-LINES; BENZODIAZEPINE-RECEPTOR; CASPASE ACTIVATION; DOWN-REGULATION; CYTOCHROME-C; GLIOMA-CELLS; INVOLVEMENT	Alkylphosphocholines are a new class of anticancer agents. The mechanisms by which these drugs display their antitumor activities are not known. In this work, we show that erucylphosphohomocholine, a new antineoplastic compound, significantly decreased ATP synthesis in isolated rat liver mitochondria at a concentration of 50 mu M or higher via permeabilization of the inner membrane. At a concentration of 25 mu M, it induced a moderate swelling of mitochondria, a slight decrease of the inner membrane potential, and an increase in state 4 respiration without an essential influence on state 3 respiration or the outer membrane permeability to cytochrome c. We found that cyclosporin A did not prevent mitochondrial swelling induced by 25-100 mu M erucylphosphohomocholine. Moreover, cyclosporin A induced a fast drop of the inner membrane potential in the presence of 25-50 mu M erucylphosphohomocholine that seems to be due to a strong synergistic inhibition of the respiratory activity. The ratio of uncoupled to state 3 respiration rates increased from 1.3 +/- 0.1 with 25 mu M erucylphosphohomocholine and from 1.5 +/- 0.1 with 1 mu M cyclosporin A to 4.5 +/- 0.3 in the presence of both drugs. On the other hand, oligomycin or cyclosporin A protected certain cancer cell lines against erucylphosphohomocholine-induced apoptosis. This protection might be related to a prevention of cellular ATP hydrolysis by permeabilized mitochondria and to the inhibition of the classical permeability transition pore, respectively. Our findings provide new insight into the mechanisms by which these unusual alterations of mitochondria might be involved in anticancer activity of alkylphosphocholines.	Univ Nacl Colombia, Fac Ciencias, Escuela Fis, Medellin 3840, Colombia; [Kugler, Wilfried] Univ Gottingen, ZentrumKinderheilkunde & Jugendmed, D-37075 Gottingen, Germany	Universidad Nacional de Colombia; University of Gottingen	Lemeshko, VV (corresponding author), Univ Nacl Colombia, Fac Ciencias, Escuela Fis, Calle 59A,63-20, Medellin 3840, Colombia.	vvasilie@unal.edu.co						AZZONE GF, 1984, BIOCHEM SOC T, V12, P414, DOI 10.1042/bst0120414; Bernardi P, 2001, TRENDS BIOCHEM SCI, V26, P112, DOI 10.1016/S0968-0004(00)01745-X; Di Paola M, 2006, BBA-BIOENERGETICS, V1757, P1330, DOI 10.1016/j.bbabio.2006.03.024; GUNTER TE, 1990, AM J PHYSIOL, V258, P755; Handrick R, 2006, RADIOTHER ONCOL, V80, P199, DOI 10.1016/j.radonc.2006.07.021; He LH, 2002, FEBS LETT, V512, P1, DOI 10.1016/S0014-5793(01)03314-2; Held-Kuznetsov V, 2005, REV NEUROSCIENCE, V16, pS30; HILGARD P, 1993, CANCER CHEMOTH PHARM, V32, P90, DOI 10.1007/BF00685608; Jendrossek V, 2002, CANCER CHEMOTH PHARM, V50, P71, DOI 10.1007/s00280-002-0440-8; Jendrossek V, 2001, ANTICANCER RES, V21, P3389; Jendrossek V, 1999, INT J ONCOL, V14, P15; Kokoszka JE, 2004, NATURE, V427, P461, DOI 10.1038/nature02229; Konstantinov SM, 1998, INT J CANCER, V77, P778, DOI 10.1002/(SICI)1097-0215(19980831)77:5<778::AID-IJC18>3.0.CO;2-Y; Konstantinov SM, 2002, MOL CANCER THER, V1, P877; Kugler W, 2005, APOPTOSIS, V10, P1163, DOI 10.1007/s10495-005-1190-y; Kugler W, 2002, J NEUROCHEM, V82, P1160, DOI 10.1046/j.1471-4159.2002.01034.x; KUGLER W, 2006, 15 ANN M ISR SOC NEU, P56; KUGLER W, 2006, 7 C EUR ASS NEUR ONC, P293; Lemeshko VV, 2006, ARCH BIOCHEM BIOPHYS, V454, P114, DOI 10.1016/j.abb.2006.08.008; LEMESHKO VV, 1982, BIOCHEMISTRY-MOSCOW+, V47, P465; Lemeshko VV, 2005, J BIOL CHEM, V280, P15579, DOI 10.1074/jbc.M414064200; Lemeshko VV, 2002, J BIOL CHEM, V277, P17751, DOI 10.1074/jbc.M201002200; Lemeshko VV, 2001, ARCH BIOCHEM BIOPHYS, V388, P60, DOI 10.1006/abbi.2000.2214; Levin E, 2005, BIOCHEMISTRY-US, V44, P9924, DOI 10.1021/bi050150s; Rasola A, 2007, APOPTOSIS, V12, P815, DOI 10.1007/s10495-007-0723-y; Rubel A, 2006, RADIAT ONCOL, V1, DOI 10.1186/1748-717X-1-6; SCHNEIDER WC, 1950, J BIOL CHEM, V183, P123; Veenman L, 2000, DRUG DEVELOP RES, V50, P355, DOI 10.1002/1098-2299(200007/08)50:3/4<355::AID-DDR18>3.0.CO;2-W	28	14	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37303	37307		10.1074/jbc.C700134200	http://dx.doi.org/10.1074/jbc.C700134200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17993460	hybrid			2022-12-27	WOS:000251833600004
J	Spira, D; Stypmann, J; Tobin, DJ; Petermann, I; Mayer, C; Hagemann, S; Vasiljeva, O; Gunther, T; Schule, R; Peters, C; Reinheckel, T				Spira, Daniel; Stypmann, Joerg; Tobin, Desmond J.; Petermann, Ivonne; Mayer, Christian; Hagemann, Sascha; Vasiljeva, Olga; Guenther, Thomas; Schuele, Roland; Peters, Christoph; Reinheckel, Thomas			Cell type-specific functions of the lysosomal protease cathepsin L in the heart	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAIR FOLLICLE MORPHOGENESIS; DILATED CARDIOMYOPATHY; CYSTEINE PROTEASES; MICE DEFICIENT; MOUSE; PEPTIDE; SECRETION; ECHOCARDIOGRAPHY; DIFFERENTIATION; KERATINOCYTE	Deficiency of the lysosomal cysteine protease cathepsin L (Ctsl) in mice results in a phenotype affecting multiple tissues, including thymus, epidermis, and hair follicles, and in the heart develops as a progressive dilated cardiomyopathy (DCM). To understand the role of Ctsl in the maintenance of regular heart morphology and function, it is critical to determine whether the DCM in Ctsl(-/-) mice is primarily because of the lack of Ctsl expression and activity in the cardiomyocytes or is caused by the additional extracardiac pathologies. Cardiomyocyte-specific expression of Ctsl in Ctsl(-/-) mice, using an alpha-myosin heavy chain promoter-Ctsl transgene, results in improved cardiac contraction, normal mRNA expression of atrionatriuretic peptide, normal heart weight, and regular ultrastructure of cardiomyocytes. Epithelial expression of cathepsin L2 (CTSL2) by a K14 promoter-CTSL2-transgene resulted in rescue of the Ctsl(-/-) hair loss phenotype. In these mice, cardiac atrionatriuretic peptide expression and end systolic heart dimensions were also significantly attenuated. However, cardiac contraction was not improved, and increased heart weight as well as the typical changes in lysosomal ultrastructure of Ctsl(-/-) hearts persisted. Myocardial fibrosis was detected in all Ctsl(-/-) mice irrespective of transgene-mediated cardiac Ctsl expression or extracardiac CTSL2 expression. Expression of collagen 1 was not enhanced in Ctsl(-/-) hearts, but a reduced collagenolytic activity suggests a role for Ctsl in collagen turnover by cardiac fibroblasts. We conclude that the DCM of Ctsl(-/-) mice is primarily caused by absence of the protease in cardiomyocytes, whereas the complex gross phenotype of Ctsl-deficient mice, i.e. the fur defect, results in additional stress to the heart.	[Spira, Daniel; Petermann, Ivonne; Mayer, Christian; Hagemann, Sascha; Vasiljeva, Olga; Peters, Christoph; Reinheckel, Thomas] Univ Freiburg, Inst Mol Med & Zellforsch, D-79104 Freiburg, Germany; [Stypmann, Joerg] Univ Klinikum Munster, Med Klin & Poliklin C Kardiol & Angiol, Klin Forsch Munster, D-48149 Munster, Germany; [Stypmann, Joerg] Univ Klinikum Munster, Klin Forsch Munster, Interdisziplinaren Zentrums, Zen Projektgrp Kleintierdiag 4A, D-48149 Munster, Germany; [Tobin, Desmond J.] Univ Bradford, Sch Life Sci, Bradford BD7 1DP, W Yorkshire, England; [Guenther, Thomas; Schuele, Roland] Univ Frauenklin, D-79106 Freiburg, Germany; [Guenther, Thomas; Schuele, Roland] Klinikum Albert Ludwigs Univ Freiburg, Zentrum Klin Forsch, D-79106 Freiburg, Germany	University of Freiburg; University of Munster; University of Munster; University of Bradford; University of Freiburg; University of Freiburg	Reinheckel, T (corresponding author), Univ Freiburg, Inst Mol Med & Zellforsch, Stefan Meier Str 17, D-79104 Freiburg, Germany.	thomas.reinheckel@uniklinikfreiburg.freiburg.de	Reinheckel, Thomas/AAL-9761-2021; Tobin, Desmond/A-5228-2009	Reinheckel, Thomas/0000-0001-9866-9105; Vasiljeva, Olga/0000-0003-3648-5460; Tobin, Desmond/0000-0003-4566-9392; Gunther, Thomas/0000-0003-3903-9490				Aikawa R, 2002, J BIOL CHEM, V277, P18979, DOI 10.1074/jbc.M201257200; BARRETT AJ, 1992, ANN NY ACAD SCI, V674, P1; Benavides F, 2002, AM J PATHOL, V161, P693, DOI 10.1016/S0002-9440(10)64225-3; Bestvater F, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-16; Cirman T, 2004, J BIOL CHEM, V279, P3578, DOI 10.1074/jbc.M308347200; Everts V, 2006, J BONE MINER RES, V21, P1399, DOI 10.1359/JBMR.060614; Felbor U, 2000, EMBO J, V19, P1187, DOI 10.1093/emboj/19.6.1187; FIGULLA HR, 1991, CARDIOLOGY, V78, P282, DOI 10.1159/000174795; Friedrichs B, 2003, J CLIN INVEST, V111, P1733, DOI 10.1172/JCI200315990; Frosch BA, 1999, APMIS, V107, P28, DOI 10.1111/j.1699-0463.1999.tb01523.x; Gocheva V, 2006, GENE DEV, V20, P543, DOI 10.1101/gad.1407406; Goulet B, 2004, MOL CELL, V14, P207, DOI 10.1016/S1097-2765(04)00209-6; Greenbaum D, 2000, CHEM BIOL, V7, P569, DOI 10.1016/S1074-5521(00)00014-4; Guertl B, 2000, INT J EXP PATHOL, V81, P349, DOI 10.1046/j.1365-2613.2000.00186.x; Guicciardi ME, 2000, J CLIN INVEST, V106, P1127, DOI 10.1172/JCI9914; GULICK J, 1991, J BIOL CHEM, V266, P9180; Hagemann S, 2004, EUR J CELL BIOL, V83, P775, DOI 10.1078/0171-9335-00404; Honey K, 2002, J EXP MED, V195, P1349, DOI 10.1084/jem.20011904; Hughes SE, 2005, HEART, V91, P257, DOI 10.1136/hrt.2004.040337; Hughes SE, 2004, HISTOPATHOLOGY, V44, P412, DOI 10.1111/j.1365-2559.2004.01835.x; Langenickel T, 2000, AM J PHYSIOL-HEART C, V278, pH1500, DOI 10.1152/ajpheart.2000.278.5.H1500; Linke M, 2002, BIOL CHEM, V383, P773, DOI 10.1515/BC.2002.081; Loennechen JP, 2001, AM J PHYSIOL-HEART C, V280, pH2902, DOI 10.1152/ajpheart.2001.280.6.H2902; MACIEWICZ RA, 1988, BIOCHEM J, V256, P433, DOI 10.1042/bj2560433; Mohamed MM, 2006, NAT REV CANCER, V6, P764, DOI 10.1038/nrc1949; MOWRY RW, 1958, LAB INVEST, V7, P566; Muntener K, 2004, J BIOL CHEM, V279, P41012, DOI 10.1074/jbc.M405333200; Nakagawa T, 1998, SCIENCE, V280, P450, DOI 10.1126/science.280.5362.450; Nishino I, 2000, NATURE, V406, P906, DOI 10.1038/35022604; Petermann I, 2006, FASEB J, V20, P1266, DOI 10.1096/fj.05-5517fje; Potts W, 2004, INT J EXP PATHOL, V85, P85, DOI 10.1111/j.0959-9673.2004.00373.x; Rawlings ND, 2006, NUCLEIC ACIDS RES, V34, pD270, DOI 10.1093/nar/gkj089; Reinheckel T, 2005, J CELL SCI, V118, P3387, DOI 10.1242/jcs.02469; Reinheckel T, 2001, BIOL CHEM, V382, P735, DOI 10.1515/BC.2001.089; Roth W, 2000, FASEB J, V14, P2075, DOI 10.1096/fj.99-0970com; SAHN DJ, 1978, CIRCULATION, V58, P1072, DOI 10.1161/01.CIR.58.6.1072; Shimomura H, 2001, JPN CIRC J, V65, P965, DOI 10.1253/jcj.65.965; Strauch OF, 2003, PEDIATR RES, V54, P701, DOI 10.1203/01.PDR.0000084085.65972.3F; Stypmann J, 2002, P NATL ACAD SCI USA, V99, P6234, DOI 10.1073/pnas.092637699; Stypmann J, 2006, BASIC RES CARDIOL, V101, P281, DOI 10.1007/s00395-006-0591-6; Stypmann J, 2006, INT J CARDIOVAS IMAG, V22, P353, DOI 10.1007/s10554-005-9052-9; Tanaka Y, 2000, NATURE, V406, P902, DOI 10.1038/35022595; Tobin DJ, 2002, AM J PATHOL, V160, P1807, DOI 10.1016/S0002-9440(10)61127-3; Towbin JA, 2002, NATURE, V415, P227, DOI 10.1038/415227a; Turk B, 2000, BBA-PROTEIN STRUCT M, V1477, P98, DOI 10.1016/S0167-4838(99)00263-0; Turk V, 2001, EMBO J, V20, P4629, DOI 10.1093/emboj/20.17.4629; Urbich C, 2005, NAT MED, V11, P206, DOI 10.1038/nm1182; Yasothornsrikul S, 2003, P NATL ACAD SCI USA, V100, P9590, DOI 10.1073/pnas.1531542100; YOSHIMURA M, 1993, CIRCULATION, V87, P464, DOI 10.1161/01.CIR.87.2.464	49	43	45	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					37045	37052		10.1074/jbc.M703447200	http://dx.doi.org/10.1074/jbc.M703447200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17942402	hybrid			2022-12-27	WOS:000251646000031
J	Torres-Bacete, J; Nakamaru-Ogiso, E; Matsuno-Yagi, A; Yagi, T				Torres-Bacete, Jesus; Nakamaru-Ogiso, Eiko; Matsuno-Yagi, Akemi; Yagi, Takao			Characterization of the NuoM (ND4) subunit in Escherichia coli NDH-1 - Conserved charged residues essential for energy-coupled activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADH-QUINONE OXIDOREDUCTASE; HEREDITARY OPTIC NEUROPATHY; MITOCHONDRIAL COMPLEX-I; MEMBRANE DOMAIN SUBUNIT; UBIQUINONE REDUCTASE-ACTIVITY; CONVERTING NIFE HYDROGENASES; AEROBIC RESPIRATORY-CHAIN; PARACOCCUS-DENITRIFICANS; PROTEIN-STRUCTURE; SUBMITOCHONDRIAL PARTICLES	The proton-translocating NADH-quinone ( Q) oxidoreductase (NDH-1) from Escherichia coli is composed of two segments: a peripheral arm and a membrane arm. The membrane arm contains 7 hydrophobic subunits. Of these subunits, NuoM, a homolog of the mitochondrial ND4 subunit, is proposed to be involved in proton translocation and Q-binding. Therefore, we conducted site-directed mutation of 15 amino acid residues of NuoM and investigated their properties. In all mutants, the assembly of the whole enzyme seemed intact. Mutation of highly conserved Glu(144) and Lys(234) leads to almost total elimination of energy-transducing NDH-1 activities as well as increased production of superoxide radicals. Their NADH dehydrogenase activities were almost normal. Because these two residues are predicted to be located in the transmembrane segments of NuoM, the results strongly suggest that they participate in proton translocation. Although it is hypothesized that His interacts with a Q head group, mutations at four His moderately inhibited NDH-1 activities and had almost no effect on the K-m values for Q or IC50 values of capsaicin-40, a competitive inhibitor for the Q binding site. The data suggest that these His are not involved in the catalytic Q-binding. Functional roles of NuoM and advantages of NDH-1 research as a model for mitochondrial complex I study have been discussed.	[Torres-Bacete, Jesus; Nakamaru-Ogiso, Eiko; Matsuno-Yagi, Akemi; Yagi, Takao] Scripps Res Inst, Dept Mol & Expt Med, Div Biochem, La Jolla, CA 92037 USA	Scripps Research Institute	Yagi, T (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, Div Biochem, La Jolla, CA 92037 USA.	yagi@scripps.edu		Torres, Jesus/0000-0003-3410-6930	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033712] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01GM033712] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abramson J, 2000, NAT STRUCT BIOL, V7, P910; Amarneh B, 2003, BIOCHEMISTRY-US, V42, P4800, DOI 10.1021/bi0340346; Baranova EA, 2007, J STRUCT BIOL, V159, P238, DOI 10.1016/j.jsb.2007.01.009; Baranova EA, 2007, J MOL BIOL, V366, P140, DOI 10.1016/j.jmb.2006.11.026; Branden M, 2002, BIOCHEMISTRY-US, V41, P10794, DOI 10.1021/bi026093; Cardol P, 2006, EUKARYOT CELL, V5, P1460, DOI 10.1128/EC.00118-06; Carroll J, 2006, J BIOL CHEM, V281, P32724, DOI 10.1074/jbc.M607135200; CHOMYN A, 1986, SCIENCE, V234, P614, DOI 10.1126/science.3764430; CHOMYN A, 1985, NATURE, V314, P591; CLAROS MG, 1994, COMPUT APPL BIOSCI, V10, P685; Clason T, 2007, J STRUCT BIOL, V159, P433, DOI 10.1016/j.jsb.2007.05.002; Di Bernardo S, 2000, BIOCHEMISTRY-US, V39, P9411; Di Bernardo S, 2001, FEBS LETT, V508, P385, DOI 10.1016/S0014-5793(01)03111-8; Fillingame RH, 1999, SCIENCE, V286, P1687, DOI 10.1126/science.286.5445.1687; Fisher N, 2000, J MOL BIOL, V296, P1153, DOI 10.1006/jmbi.2000.3509; Friedrich T, 1998, BBA-BIOENERGETICS, V1365, P215, DOI 10.1016/S0005-2728(98)00070-X; Galkin AS, 1999, FEBS LETT, V451, P157, DOI 10.1016/S0014-5793(99)00575-X; Ghelli A, 1997, J BIOCHEM, V121, P746; Gong X, 2003, J BIOL CHEM, V278, P25731, DOI 10.1074/jbc.M302361200; GRAY KA, 1994, BIOCHEMISTRY-US, V33, P723, DOI 10.1021/bi00169a014; Guenebaut V, 1998, J MOL BIOL, V276, P105, DOI 10.1006/jmbi.1997.1518; HAN AL, 1988, ARCH BIOCHEM BIOPHYS, V267, P490, DOI 10.1016/0003-9861(88)90055-0; Hedderich R, 2005, J MOL MICROB BIOTECH, V10, P92, DOI 10.1159/000091557; Hedderich R, 2004, J BIOENERG BIOMEMBR, V36, P65, DOI 10.1023/B:JOBB.0000019599.43969.33; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Hirst J, 2005, BIOCHEM SOC T, V33, P525, DOI 10.1042/BST0330525; Hofhaus G, 1996, J BIOL CHEM, V271, P13155, DOI 10.1074/jbc.271.22.13155; Hofmann K., 1993, BIOL CHEM H-S, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Kao MC, 2005, BIOCHEMISTRY-US, V44, P9545, DOI 10.1021/bi050708w; Kao MC, 2005, BIOCHEMISTRY-US, V44, P3562, DOI 10.1021/bi0476477; Kao MC, 2004, J BIOL CHEM, V279, P32360, DOI 10.1074/jbc.M403885200; Kao MC, 2004, BIOCHEMISTRY-US, V43, P3750, DOI 10.1021/bi049927s; Kao MC, 2003, BIOCHEMISTRY-US, V42, P4534, DOI 10.1021/bi034166z; Kao MC, 2002, BIOCHEMISTRY-US, V41, P4377, DOI 10.1021/bi025525d; Kervinen M, 2004, BIOCHEMISTRY-US, V43, P773, DOI 10.1021/bi0355903; KIKUNO R, 1985, FEBS LETT, V189, P85, DOI 10.1016/0014-5793(85)80847-4; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kushnareva Y, 2002, BIOCHEM J, V368, P545, DOI 10.1042/BJ20021121; Link AJ, 1997, J BACTERIOL, V179, P6228, DOI 10.1128/jb.179.20.6228-6237.1997; Lunardi J, 1998, BBA-MOL BASIS DIS, V1407, P114, DOI 10.1016/S0925-4439(98)00036-2; Majander A, 1996, EUR J BIOCHEM, V239, P201, DOI 10.1111/j.1432-1033.1996.0201u.x; Marella M, 2007, J BIOL CHEM, V282, P24146, DOI 10.1074/jbc.M701819200; Mathiesen C, 2002, BBA-BIOENERGETICS, V1556, P121, DOI 10.1016/S0005-2728(02)00343-2; Mathiesen C, 2003, FEBS LETT, V549, P7, DOI 10.1016/S0014-5793(03)00767-1; MATSUSHITA K, 1987, BIOCHEMISTRY-US, V26, P7732, DOI 10.1021/bi00398a029; Messner KR, 1999, J BIOL CHEM, V274, P10119, DOI 10.1074/jbc.274.15.10119; MILLER MJ, 1990, P NATL ACAD SCI USA, V87, P4900, DOI 10.1073/pnas.87.13.4900; Mitaku S, 2002, BIOINFORMATICS, V18, P608, DOI 10.1093/bioinformatics/18.4.608; Mitaku S, 1999, PROTEIN ENG, V12, P953, DOI 10.1093/protein/12.11.953; Murai M, 2007, BIOCHEMISTRY-US, V46, P6409, DOI 10.1021/bi7003697; MURPHY E, 1985, EMBO J, V4, P3357, DOI 10.1002/j.1460-2075.1985.tb04089.x; Nakamaru-Ogiso E, 2005, J BIOL CHEM, V280, P301, DOI 10.1074/jbc.M410377200; Nakamaru-Ogiso E, 2003, FEBS LETT, V549, P43, DOI 10.1016/S0014-5793(03)00766-X; Nakamaru-Ogiso E, 2003, BIOCHEMISTRY-US, V42, P746, DOI 10.1021/bi0269660; Park JS, 2007, BBA-MOL BASIS DIS, V1772, P533, DOI 10.1016/j.bbadis.2007.01.009; PEARSON WR, 1990, METHOD ENZYMOL, V183, P63; Remacle C, 2006, P NATL ACAD SCI USA, V103, P4771, DOI 10.1073/pnas.0509501103; Rost B, 1996, PROTEIN SCI, V5, P1704, DOI 10.1002/pro.5560050824; Satoh T, 1996, BBA-BIOENERGETICS, V1273, P21, DOI 10.1016/0005-2728(95)00131-X; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Steuber J, 2003, J BIOL CHEM, V278, P26817, DOI 10.1074/jbc.M301682200; Takano S, 1996, BIOCHEMISTRY-US, V35, P9120, DOI 10.1021/bi9605853; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Valiyaveetil FI, 1997, J BIOL CHEM, V272, P32635, DOI 10.1074/jbc.272.51.32635; VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231; YAGI T, 1993, J BIOENERG BIOMEMBR, V25, P339, DOI 10.1007/BF00762459; YAGI T, 1986, ARCH BIOCHEM BIOPHYS, V250, P302, DOI 10.1016/0003-9861(86)90731-9; YAGI T, 1990, ARCH BIOCHEM BIOPHYS, V281, P305, DOI 10.1016/0003-9861(90)90448-8; Yagi T, 1998, BBA-BIOENERGETICS, V1364, P125, DOI 10.1016/S0005-2728(98)00023-1; Yano T, 1999, J BIOL CHEM, V274, P28606, DOI 10.1074/jbc.274.40.28606	72	71	73	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					36914	36922		10.1074/jbc.M707855200	http://dx.doi.org/10.1074/jbc.M707855200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17977822	hybrid			2022-12-27	WOS:000251646000017
J	Vadysirisack, DD; Chen, ESW; Zhang, Z; Tsai, MD; Chang, GD; Jhiang, SM				Vadysirisack, Douangsone D.; Chen, Eric S. -W.; Zhang, Zhaoxia; Tsai, Ming-Daw; Chang, Geen-Dong; Jhiang, Sissy M.			Identification of in Vivo phosphorylation sites and their functional significance in the sodium iodide symporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYROID NA+/I-SYMPORTER; SODIUM/IODIDE SYMPORTER; POTASSIUM CHANNEL; TRANSPORT; ATP; NIS; DEGRADATION; EXPRESSION; MUTATION; SERINE	The Na+/I- symporter (NIS)-mediated iodide uptake activity is the basis for targeted radioiodide ablation of thyroid cancers. Although it has been shown that NIS protein is phosphorylated, neither the in vivo phosphorylation sites nor their functional significance has been reported. In this study, Ser-43, Thr-49, Ser-227, Thr-577, and Ser-581 were identified as in vivo NIS phosphorylation sites by mass spectrometry. Kinetic analysis of NIS mutants of the corresponding phosphorylated amino acid residue indicated that the velocity of iodide transport of NIS is modulated by the phosphorylation status of Ser-43 and Ser-581. We also found that the phosphorylation status of Thr-577 may be important for NIS protein stability and that the phosphorylation status of Ser-227 is functionally silent. Thr-49 appears to be critical for proper local structure/conformation of NIS because mutation of Thr-49 to alanine, aspartic acid, or serine results in reduced NIS activity without alterations in total or cell surface NIS protein levels. Taken together, we showed that NIS protein levels and functional activity could be modulated by phosphorylation through distinct mechanisms.	[Vadysirisack, Douangsone D.; Jhiang, Sissy M.] Ohio State Univ, Integrated Biomed Sci Grad Program, Columbus, OH 43210 USA; [Zhang, Zhaoxia; Jhiang, Sissy M.] Ohio State Univ, Ohio State Biochem Program, Columbus, OH 43210 USA; [Vadysirisack, Douangsone D.; Zhang, Zhaoxia; Jhiang, Sissy M.] Ohio State Univ, Dept Physiol & Cell Biol, Columbus, OH 43210 USA; [Jhiang, Sissy M.] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA; [Tsai, Ming-Daw] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Chang, Geen-Dong] Natl Taiwan Univ, Grad Inst Biochem Sci, Taipei 106, Taiwan	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Academia Sinica - Taiwan; National Taiwan University	Jhiang, SM (corresponding author), Ohio State Univ, Integrated Biomed Sci Grad Program, Columbus, OH 43210 USA.	jhiang.1@osu.edu	Tsai, Ming-Daw/G-4689-2019; Chen, Eric (Sheng-Wen)/G-8258-2014	Tsai, Ming-Daw/0000-0003-1374-0414; 	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB001876] Funding Source: NIH RePORTER; NIBIB NIH HHS [1 R01 EB001876] Funding Source: Medline	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		Apasov SG, 1996, J BIOL CHEM, V271, P25677, DOI 10.1074/jbc.271.41.25677; Breitschopf K, 2000, MOL CELL BIOL, V20, P1886, DOI 10.1128/MCB.20.5.1886-1896.2000; Castro MR, 2001, J CLIN ENDOCR METAB, V86, P5627, DOI 10.1210/jc.86.11.5627; De la Vieja A, 2007, J BIOL CHEM, V282, P25290, DOI 10.1074/jbc.M700147200; De la Vleja A, 2004, J CELL SCI, V117, P677, DOI 10.1242/jcs.00898; Dohan O, 2002, MOL ENDOCRINOL, V16, P1893, DOI 10.1210/me.2002-0071; Eskandari S, 1997, J BIOL CHEM, V272, P27230, DOI 10.1074/jbc.272.43.27230; Glavy JS, 2000, J BIOL CHEM, V275, P1479, DOI 10.1074/jbc.275.2.1479; Han XB, 1999, J AM SOC NEPHROL, V10, P1874; Hinsby AM, 2003, MOL CELL PROTEOMICS, V2, P29, DOI 10.1074/mcp.M200075-MCP200; HOU JZ, 1993, PROTEIN SCI, V2, P86; Huff RA, 1997, J NEUROCHEM, V68, P225; Jayanthi LD, 2006, J BIOL CHEM, V281, P23326, DOI 10.1074/jbc.M601156200; Law RM, 2000, J BIOL CHEM, V275, P23986, DOI 10.1074/jbc.M910283199; Lee TS, 2006, J BIOL CHEM, V281, P25560, DOI 10.1074/jbc.M508661200; Levy O, 1998, J BIOL CHEM, V273, P22657, DOI 10.1074/jbc.273.35.22657; Levy O, 1998, FEBS LETT, V429, P36, DOI 10.1016/S0014-5793(98)00522-5; Martinez LO, 2003, J BIOL CHEM, V278, P37368, DOI 10.1074/jbc.M307161200; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Park KS, 2006, SCIENCE, V313, P976, DOI 10.1126/science.1124254; Ren YJ, 2006, J BIOL CHEM, V281, P11769, DOI 10.1074/jbc.M513125200; Riedel C, 2001, J BIOL CHEM, V276, P21458, DOI 10.1074/jbc.M100561200; Rolli-Derkinderen M, 2005, CIRC RES, V96, P1152, DOI 10.1161/01.RES.0000170084.88780.ea; Roosbeek S, 2004, J BIOL CHEM, V279, P37779, DOI 10.1074/jbc.M401821200; Smanik PA, 1996, BIOCHEM BIOPH RES CO, V226, P339, DOI 10.1006/bbrc.1996.1358; Surti TS, 2005, P NATL ACAD SCI USA, V102, P17828, DOI 10.1073/pnas.0509122102; Tonacchera M, 2002, J CLIN ENDOCR METAB, V87, P352, DOI 10.1210/jc.87.1.352; Vadysirisack DD, 2007, ENDOCR-RELAT CANCER, V14, P421, DOI 10.1677/erc.1.01263; Wu SL, 2006, MOL CELL PROTEOMICS, V5, P1610, DOI 10.1074/mcp.M600105-MCP200; Xu ZC, 1996, J BIOL CHEM, V271, P9313, DOI 10.1074/jbc.271.16.9313; Zhang ZX, 2005, J CLIN ENDOCR METAB, V90, P6131, DOI 10.1210/jc.2005-0895	31	30	31	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					36820	36828		10.1074/jbc.M706817200	http://dx.doi.org/10.1074/jbc.M706817200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17913707	hybrid, Green Published			2022-12-27	WOS:000251646000006
J	Wu, G; Ortiz-Flores, G; Ortiz-Lopez, A; Ort, DR				Wu, Guosheng; Ortiz-Flores, Guadalupe; Ortiz-Lopez, Adriana; Ort, Donald R.			A point mutation in atpC1 raises the redox potential of the Arabidopsis chloroplast ATP synthase gamma-subunit regulatory disulfide above the range of thioredoxin modulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COUPLING FACTOR REDUCTION; ENERGY-DEPENDENT CHANGES; THIOL MODULATION; ACTIVATION; CONFORMATION; LEAVES; PHOTOPHOSPHORYLATION; PHOTOSYNTHESIS; DEACTIVATION; DOMAIN	The light-dependent regulation of chloroplast ATP synthase activity depends on an intricate but ill defined interplay between the proton electrochemical potential across the thylakoid membrane and thioredoxin-mediated redox modulation of a cysteine bridge located on the ATP synthase gamma-subunit. The abnormal light-dependent regulation of the chloroplast ATP synthase in the Arabidopsis thaliana cfq (coupling factor quick recovery) mutant was caused by a point mutation (G to A) in the atpC1 gene, which caused an amino acid substitution (E244K) in the vicinity of the redox modulation domain in the gamma-subunit of ATP synthase. Equilibrium redox titration revealed that this mutation made the regulatory sulfhydryl group energetically much more difficult to reduce relative to the wild type (i.e. raised the E-m,E-7.9 by 39 mV). Enzymatic studies using isolated chloroplasts showed significantly lower light-induced ATPase and ATP synthase activity in the mutant compared with the wild type. The lower ATP synthesis capacity in turn restricted overall rates of leaf photosynthesis in the cfq mutant under low light. This work provides in situ validation of the concept that thioredoxin-dependent reduction of the gamma-subunit regulatory disulfide modulates the proton electrochemical potential energy requirement for activation of the chloroplast ATP synthase and that the activation state of the ATP synthase can limit leaf level photosynthesis.	[Wu, Guosheng; Ortiz-Flores, Guadalupe; Ortiz-Lopez, Adriana; Ort, Donald R.] Univ Illinois, Dept Plant Biol, Inst Genom Biol 1406, Urbana, IL 61801 USA; [Ortiz-Lopez, Adriana; Ort, Donald R.] USDA ARS, Photosynth Res Unit, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; United States Department of Agriculture (USDA)	Ort, DR (corresponding author), Univ Illinois, Dept Plant Biol, Inst Genom Biol 1406, 1206 W Gregory Dr, Urbana, IL 61801 USA.	d-ort@uiuc.edu						CHIFFLET S, 1988, ANAL BIOCHEM, V168, P1, DOI 10.1016/0003-2697(88)90002-4; Chung DW, 2006, PLANT PHYSIOL, V142, P88, DOI 10.1104/pp.106.084483; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dal Bosco C, 2004, J BIOL CHEM, V279, P1060, DOI 10.1074/jbc.M308435200; DAVENPORT JW, 1981, J BIOL CHEM, V256, P8947; FARQUHAR GD, 1980, PLANTA, V149, P78, DOI 10.1007/BF00386231; GABRYS H, 1994, PLANT PHYSIOL, V104, P769, DOI 10.1104/pp.104.2.769; GAO F, 1995, J BIOL CHEM, V270, P9763, DOI 10.1074/jbc.270.17.9763; Gong P, 2006, PHOTOSYNTH RES, V88, P133, DOI 10.1007/s11120-006-9041-4; GRAAN T, 1984, J BIOL CHEM, V259, P4003; HANGARTER RP, 1987, J BIOL CHEM, V262, P13513; Hightower KE, 1996, BIOCHEMISTRY-US, V35, P4846, DOI 10.1021/bi952913p; HUTCHISON RS, 1995, METHOD ENZYMOL, V252, P220; Hutchison RS, 2000, BIOCHEMISTRY-US, V39, P6679, DOI 10.1021/bi0001978; INOHARA N, 1991, J BIOL CHEM, V266, P7333; KETCHAM SR, 1984, J BIOL CHEM, V259, P7286; KLEEFELD S, 1990, BIOCHIM BIOPHYS ACTA, V1019, P11, DOI 10.1016/0005-2728(90)90119-O; KOMATSUTAKAKI M, 1992, J BIOL CHEM, V267, P2360; Konno H, 2000, BIOCHEM J, V352, P783, DOI 10.1042/0264-6021:3520783; KRAMER DM, 1990, PHOTOSYNTH RES, V26, P213, DOI 10.1007/BF00033134; KRAMER DM, 1989, BIOCHIM BIOPHYS ACTA, V976, P28, DOI 10.1016/S0005-2728(89)80186-0; Leakey ADB, 2006, PLANT PHYSIOL, V140, P779, DOI 10.1104/pp.105.073957; LEES WJ, 1993, J ORG CHEM, V58, P642, DOI 10.1021/jo00055a016; McCarty RE, 2005, J BIOENERG BIOMEMBR, V37, P289, DOI 10.1007/s10863-005-8640-7; MIKI J, 1988, FEBS LETT, V232, P221, DOI 10.1016/0014-5793(88)80421-6; MILLS JD, 1982, FEBS LETT, V144, P63, DOI 10.1016/0014-5793(82)80569-3; MORONEY JV, 1984, J BIOL CHEM, V259, P7281; MORONEY JV, 1982, J BIOL CHEM, V257, P5910; NALIN CM, 1984, J BIOL CHEM, V259, P7275; NOCTOR G, 1988, BIOCHIM BIOPHYS ACTA, V935, P53, DOI 10.1016/0005-2728(88)90107-7; ORT DR, 1992, ANNU REV PLANT PHYS, V43, P269, DOI 10.1146/annurev.pp.43.060192.001413; ORTIZLOPEZ A, 1991, PLANT PHYSIOL, V96, P1018, DOI 10.1104/pp.96.4.1018; Richter ML, 2005, J BIOENERG BIOMEMBR, V37, P467, DOI 10.1007/s10863-005-9493-9; Richter ML, 2004, PHOTOSYNTH RES, V79, P319, DOI 10.1023/B:PRES.0000017157.08098.36; RICHTER ML, 1987, J BIOL CHEM, V262, P15037; Samra HS, 2006, J BIOL CHEM, V281, P31041, DOI 10.1074/jbc.M603315200; SCHUMANN J, 1985, J BIOL CHEM, V260, P1817; WERDAN K, 1975, BIOCHIM BIOPHYS ACTA, V396, P276, DOI 10.1016/0005-2728(75)90041-9; WHITMARSH J, 1984, ARCH BIOCHEM BIOPHYS, V231, P378, DOI 10.1016/0003-9861(84)90401-6; WOLOSIUK RA, 1977, NATURE, V266, P565, DOI 10.1038/266565a0	40	38	37	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					36782	36789		10.1074/jbc.M707007200	http://dx.doi.org/10.1074/jbc.M707007200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17959606	hybrid			2022-12-27	WOS:000251646000002
J	Lee, OH; Jain, AK; Papusha, V; Jaiswal, AK				Lee, Ok-Hee; Jain, Abhinav K.; Papusha, Victor; Jaiswal, Anil K.			An auto-regulatory loop between stress sensors INrf2 and Nrf2 controls their cellular abundance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEMENT-MEDIATED EXPRESSION; PROTEIN-KINASE-C; GENE-EXPRESSION; OXIDOREDUCTASE-1 GENE; ANTIOXIDANT INDUCTION; INDUCIBLE EXPRESSION; RESPONSIVE ELEMENT; NUCLEAR EXPORT; KEAP1; ACTIVATION	INrf2:Nrf2 are sensors of chemical/radiation stress. Nrf2 dissociates from INrf2 in response to a stress and translocates in the nucleus. This leads to induction of a battery of antioxidant genes that protect cells. Nrf2 is then exported out and degraded. INrf2 functions as an adaptor of ubiquitin ligase for ubiquitination and degradation of Nrf2. Here we demonstrate the presence of a novel feedback autoregulatory loop between INrf2 and Nrf2 that controls cellular abundance of INrf2 and Nrf2. Nrf2 controls its own degradation by regulating expression and induction of the INrf2 gene. The antioxidant treatment of cells led to nuclear localization and stabilization of Nrf2 and induction of INrf2 gene expression. Mutagenesis, transfection, and chromatin immunoprecipitation assays identified an antioxidant-response element in the reverse strand of the proximal INrf2 promoter that binds to Nrf2 and regulates expression and antioxidant induction of the INrf2 gene. In addition, short interfering RNA inhibition or overexpression of Nrf2 led to a respective decrease and increase in INrf2 gene expression. These results implicated Nrf2 in the regulation of expression and induction of INrf2. The induction of INrf2 followed ubiquitination and degradation of Nrf2 and suppression of INrf2 gene expression. In conclusion, Nrf2 regulates INrf2 by controlling its transcription, and INrf2 controls Nrf2 by degrading it.	Baylor Coll Med, Dept Pharmacol, Houston, TX 77030 USA	Baylor College of Medicine	Jaiswal, AK (corresponding author), Univ Maryland, Sch Med, Dept Pharmacol & Expt Therapeut, 655 W Baltimore St, Baltimore, MD 21201 USA.	ajaiswal@som.umaryland.edu	Jain, Abhinav K/A-2540-2013	Jain, Abhinav/0000-0003-3268-514X	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012265] Funding Source: NIH RePORTER; NIEHS NIH HHS [R01 ES012265] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Banning A, 2005, MOL CELL BIOL, V25, P4914, DOI 10.1128/MCB.25.12.4914-4923.2005; Bloom DA, 2003, J BIOL CHEM, V278, P44675, DOI 10.1074/jbc.M307633200; BREEN AP, 1995, FREE RADICAL BIO MED, V18, P1033, DOI 10.1016/0891-5849(94)00209-3; Dhakshinamoorthy S, 2001, ONCOGENE, V20, P3906, DOI 10.1038/sj.onc.1204506; Dhakshinamoorthy S, 2000, CURR TOP CELL REGUL, V36, P201; Hayes JD, 2001, CANCER LETT, V174, P103, DOI 10.1016/S0304-3835(01)00695-4; Huang HC, 2002, J BIOL CHEM, V277, P42769, DOI 10.1074/jbc.M206911200; Ikeda H, 2004, BIOCHEM J, V380, P515, DOI 10.1042/BJ20031948; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Itoh K, 2003, GENES CELLS, V8, P379, DOI 10.1046/j.1365-2443.2003.00640.x; Jain AK, 2007, J BIOL CHEM, V282, P16502, DOI 10.1074/jbc.M611336200; Jain AK, 2006, J BIOL CHEM, V281, P12132, DOI 10.1074/jbc.M511198200; Jain AK, 2005, J BIOL CHEM, V280, P29158, DOI 10.1074/jbc.M502083200; Jaiswal AK, 2004, FREE RADICAL BIO MED, V36, P1199, DOI 10.1016/j.freeradbiomed.2004.02.074; Kang MI, 2004, P NATL ACAD SCI USA, V101, P2046, DOI 10.1073/pnas.0308347100; Kim YJ, 2007, CANCER RES, V67, P546, DOI 10.1158/0008-5472.CAN-06-2401; Kobayashi M, 2006, ADV ENZYME REGUL, V46, P113, DOI 10.1016/j.advenzreg.2006.01.007; Kwak MK, 2003, J BIOL CHEM, V278, P8135, DOI 10.1074/jbc.M211898200; McMahon M, 2003, J BIOL CHEM, V278, P21592, DOI 10.1074/jbc.M300931200; Nguyen T, 2005, J BIOL CHEM, V280, P32485, DOI 10.1074/jbc.M503074200; Padmanabhan B, 2006, MOL CELL, V21, P689, DOI 10.1016/j.molcel.2006.01.013; Ramos-Gomez M, 2001, P NATL ACAD SCI USA, V98, P3410, DOI 10.1073/pnas.051618798; RUSHMORE TH, 1990, J BIOL CHEM, V265, P14648; Singh A, 2006, PLOS MED, V3, P1865, DOI 10.1371/journal.pmed.0030420; THELEN M, 1993, PHYSIOL REV, V73, P797, DOI 10.1152/physrev.1993.73.4.797; Venugopal R, 1996, P NATL ACAD SCI USA, V93, P14960, DOI 10.1073/pnas.93.25.14960; Wakabayashi N, 2004, P NATL ACAD SCI USA, V101, P2040, DOI 10.1073/pnas.0307301101; Wakabayashi N, 2003, NAT GENET, V35, P238, DOI 10.1038/ng1248; Wang W, 2006, FREE RADICAL BIO MED, V40, P1119, DOI 10.1016/j.freeradbiomed.2005.10.063; Zhang DD, 2003, MOL CELL BIOL, V23, P8137, DOI 10.1128/MCB.23.22.8137-8151.2003; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004	31	147	155	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36412	36420		10.1074/jbc.M706517200	http://dx.doi.org/10.1074/jbc.M706517200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17925401	hybrid			2022-12-27	WOS:000251458300033
J	Rajagopalan, L; Greeson, JN; Xia, A; Liu, H; Sturm, A; Raphael, RM; Davidson, AL; Oghalai, JS; Pereira, FA; Brownell, WE				Rajagopalan, Lavanya; Greeson, Jennifer N.; Xia, Anping; Liu, Haiying; Sturm, Angela; Raphael, Robert M.; Davidson, Amy L.; Oghalai, John S.; Pereira, Fred A.; Brownell, William E.			Tuning of the outer hair cell motor by membrane cholesterol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID RAFTS; LATERAL WALL; AUDITORY DYSFUNCTION; VOLTAGE-DEPENDENCE; SUGAR TRANSPORTER; PRESTIN; PROTEIN; EXPRESSION; ELECTROMOTILITY; CHLORPROMAZINE	Cholesterol affects diverse biological processes, in many cases by modulating the function of integral membrane proteins. We observed that alterations of cochlear cholesterol modulate hearing in mice. Mammalian hearing is powered by outer hair cell (OHC) electromotility, a membrane-based motor mechanism that resides in the OHC lateral wall. We show that membrane cholesterol decreases during maturation of OHCs. To study the effects of cholesterol on hearing at the molecular level, we altered cholesterol levels in the OHC wall, which contains the membrane protein prestin. We show a dynamic and reversible relationship between membrane cholesterol levels and voltage dependence of prestin-associated charge movement in both OHCs and prestin-transfected HEK 293 cells. Cholesterol levels also modulate the distribution of prestin within plasma membrane microdomains and affect prestin self-association in HEK 293 cells. These findings indicate that alterations in membrane cholesterol affect prestin function and functionally tune the outer hair cell.	Baylor Coll Med, Huffington Ctr Aging & Mol & Cellular Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; Baylor Coll Med, Bobby R Alford Dept Otolaryngol Head & Neck Surg, Houston, TX 77030 USA; WM Keck Ctr Interdisciplinary Biosci Training, Houston, TX 77005 USA; Rice Univ, Dept Bioengn, Houston, TX 77005 USA; Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Rice University; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Brownell, WE (corresponding author), Baylor Coll Med, Huffington Ctr Aging & Mol & Cellular Biol, 1 Baylor Plaza, Houston, TX 77030 USA.	brownell@bcm.tmc.edu		Pereira, Fred/0000-0003-2100-0280	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F32DC000354, R21DC008134, F31DC007563, R01DC009622, K08DC006671, R01DC000354] Funding Source: NIH RePORTER; NIDCD NIH HHS [K08 DC006671, R21 DC008134, R01 DC000354, DC006671, DC008134, K08 DC006671-04, R01 DC009622, DC00354, F31 DC007563-01, R01 DC000354-20, DC07563-01, F32 DC000354, R21 DC008134-02] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Addona GH, 2003, BBA-BIOMEMBRANES, V1609, P177, DOI 10.1016/S0005-2736(02)00685-5; Addona GH, 1998, BBA-BIOMEMBRANES, V1370, P299, DOI 10.1016/S0005-2736(97)00280-0; Adler HJ, 2003, HEARING RES, V184, P27, DOI 10.1016/S0378-5955(03)00192-8; Albert AD, 2005, PROG LIPID RES, V44, P99, DOI 10.1016/j.plipres.2005.02.001; Allende D, 2004, TRENDS BIOCHEM SCI, V29, P325, DOI 10.1016/j.tibs.2004.04.002; Barenholz Y, 2004, SUB CELL BIOCHEM, V37, P167; Barenholz Y, 2002, PROG LIPID RES, V41, P1, DOI 10.1016/S0163-7827(01)00016-9; Belyantseva IA, 2000, J NEUROSCI, V20, part. no.; BOESZEBATTAGLIA K, 1990, J BIOL CHEM, V265, P20727; Brownell WE, 2006, SPR HDB AUD, V27, P313; Brownell WE, 2000, CELL AND MOLECULAR BIOLOGY OF THE EAR, P69; Brownell WE, 2001, ANNU REV BIOMED ENG, V3, P169, DOI 10.1146/annurev.bioeng.3.1.169; Burger K, 2000, CELL MOL LIFE SCI, V57, P1577, DOI 10.1007/PL00000643; Chattopadhyay A, 2005, BIOCHEM BIOPH RES CO, V327, P1036, DOI 10.1016/j.bbrc.2004.12.102; de Monvel JB, 2006, BIOPHYS J, V91, P364, DOI 10.1529/biophysj.105.076331; DING JP, 1991, HEARING RES, V56, P19, DOI 10.1016/0378-5955(91)90149-4; Evans MB, 2006, OTOL NEUROTOL, V27, P609, DOI 10.1097/01.mao.0000226286.19295.34; Farrell B, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.041930; Geleoc GSG, 1999, NAT NEUROSCI, V2, P713, DOI 10.1038/11174; Greeson JN, 2006, BRAIN RES, V1091, P140, DOI 10.1016/j.brainres.2006.02.084; Hajdu P, 2003, PFLUG ARCH EUR J PHY, V445, P674, DOI 10.1007/s00424-002-0974-y; Hinzpeter A, 2007, J BIOL CHEM, V282, P2423, DOI 10.1074/jbc.M608251200; IWASA KH, 1991, NEUROSCI LETT, V133, P171, DOI 10.1016/0304-3940(91)90562-8; IWASA KH, 1993, BIOPHYS J, V65, P492, DOI 10.1016/S0006-3495(93)81053-1; JONES OT, 1988, BIOCHEMISTRY-US, V27, P2364, DOI 10.1021/bi00407a018; KAKEHATA S, 1995, BIOPHYS J, V68, P2190, DOI 10.1016/S0006-3495(95)80401-7; Kalinec F, 1997, HEARING RES, V110, P141, DOI 10.1016/S0378-5955(97)00076-2; Lee AG, 2004, BBA-BIOMEMBRANES, V1666, P62, DOI 10.1016/j.bbamem.2004.05.012; Liao ZJ, 2005, J ACOUST SOC AM, V118, P3737, DOI 10.1121/1.2118387; Liberman MC, 2002, NATURE, V419, P300, DOI 10.1038/nature01059; Lucero HA, 2004, ARCH BIOCHEM BIOPHYS, V426, P208, DOI 10.1016/j.abb.2004.03.020; Ludwig J, 2001, P NATL ACAD SCI USA, V98, P4178, DOI 10.1073/pnas.071613498; Lue AJC, 2001, OTOLARYNG HEAD NECK, V125, P71, DOI 10.1067/mhn.2001.116446; Marcucci R, 2005, J THROMB HAEMOST, V3, P929, DOI 10.1111/j.1538-7836.2005.01310.x; MORIZONO T, 1985, ACTA OTO-LARYNGOL, V99, P516, DOI 10.3109/00016488509182255; MORIZONO T, 1978, ANN OTO RHINOL LARYN, V87, P804, DOI 10.1177/000348947808700607; Murdock DR, 2005, BIOPHYS J, V89, P4090, DOI 10.1529/biophysj.105.069872; NAKAZAWA K, 1995, HEARING RES, V82, P93; Navaratnam D, 2005, BIOPHYS J, V89, P3345, DOI 10.1529/biophysj.105.068759; NEEDHAM D, 1990, BIOPHYS J, V58, P997, DOI 10.1016/S0006-3495(90)82444-9; Nguyen TVN, 1998, OTOLARYNG HEAD NECK, V119, P14, DOI 10.1016/S0194-5998(98)70167-6; Niemela PS, 2007, PLOS COMPUT BIOL, V3, P304, DOI 10.1371/journal.pcbi.0030034; Oghalai JS, 2004, HEARING RES, V198, P59, DOI 10.1016/j.heares.2004.03.013; Oghalai JS, 1999, HEARING RES, V135, P19, DOI 10.1016/S0378-5955(99)00077-5; Oghalai JS, 1998, J NEUROSCI, V18, P48; Oghalai JS, 2000, SCIENCE, V287, P658, DOI 10.1126/science.287.5453.658; Ohvo-Rekila H, 2002, PROG LIPID RES, V41, P66, DOI 10.1016/S0163-7827(01)00020-0; Oliver D, 2001, SCIENCE, V292, P2340, DOI 10.1126/science.1060939; Oliver D, 1999, J PHYSIOL-LONDON, V519, P791, DOI 10.1111/j.1469-7793.1999.0791n.x; OLLILA OHS, 2008, J STRUCT BIOL; Pike LJ, 2004, BIOCHEM J, V378, P281, DOI 10.1042/BJ20031672; Pike LJ, 2003, J LIPID RES, V44, P655, DOI 10.1194/jlr.R200021-JLR200; Preyer S, 2001, HEARING RES, V152, P139, DOI 10.1016/S0378-5955(00)00245-8; Pucadyil TJ, 2006, PROG LIPID RES, V45, P295, DOI 10.1016/j.plipres.2006.02.002; Radhakrishnan A, 2004, MOL CELL, V15, P259, DOI 10.1016/j.molcel.2004.06.019; Rajagopalan L, 2006, J NEUROSCI, V26, P12727, DOI 10.1523/JNEUROSCI.2734-06.2006; Rajendran L, 2003, P NATL ACAD SCI USA, V100, P8241, DOI 10.1073/pnas.1331629100; Rankin SE, 1997, BIOPHYS J, V73, P2446, DOI 10.1016/S0006-3495(97)78273-0; Raphael RM, 2000, BIOPHYS J, V78, P2844, DOI 10.1016/S0006-3495(00)76827-5; Romanenko VG, 2004, BIOPHYS J, V87, P3850, DOI 10.1529/biophysj.104.043273; Rybalchenko V, 2003, J PHYSIOL-LONDON, V547, P873, DOI 10.1113/jphysiol.2002.036434; SAITO T, 1986, ARCH OTO-RHINO-LARYN, V243, P242, DOI 10.1007/BF00464438; SANTI PA, 1994, J HISTOCHEM CYTOCHEM, V42, P705, DOI 10.1177/42.6.8189033; Santos-Sacchi J, 2004, J MEMBRANE BIOL, V200, P83, DOI 10.1007/s00232-004-0699-2; SANTOS-SACCHI J, 1991, J NEUROSCI, V11, P3096, DOI 10.1523/jneurosci.11-10-03096.1991; Santos-Sacchi J, 2001, J PHYSIOL-LONDON, V531, P661, DOI 10.1111/j.1469-7793.2001.0661h.x; Santos-Sacchi J, 1998, J PHYSIOL-LONDON, V510, P225, DOI 10.1111/j.1469-7793.1998.225bz.x; Scanlon SM, 2001, BIOCHEMISTRY-US, V40, P10507, DOI 10.1021/bi010730z; SHEHATA WE, 1991, ACTA OTO-LARYNGOL, V111, P707, DOI 10.3109/00016489109138403; SIKORA MA, 1986, ACTA OTO-LARYNGOL, V102, P372, DOI 10.3109/00016488609119420; Simons K, 2000, SCIENCE, V290, P1721, DOI 10.1126/science.290.5497.1721; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SONG JB, 1993, BIOPHYS J, V64, P1967, DOI 10.1016/S0006-3495(93)81566-2; Starke-Peterkovic T, 2006, BIOPHYS J, V90, P4060, DOI 10.1529/biophysj.105.074666; Sturm AK, 2007, OTOLARYNG HEAD NECK, V136, P434, DOI 10.1016/j.otohns.2006.10.030; Suckfull M, 2001, THER APHER, V5, P377, DOI 10.1046/j.1526-0968.2001.00369.x; Syka J, 2007, NEUROSCI LETT, V411, P112, DOI 10.1016/j.neulet.2006.10.032; TAMI TA, 1985, OTOLARYNG HEAD NECK, V93, P235, DOI 10.1177/019459988509300221; Vetrivel KS, 2004, J BIOL CHEM, V279, P44945, DOI 10.1074/jbc.M407986200; Wu M, 1998, J MEMBRANE BIOL, V166, P111, DOI 10.1007/s002329900453; Yu N, 2006, BRAIN RES, V1095, P51, DOI 10.1016/j.brainres.2006.04.017; Zhang PC, 2001, NATURE, V413, P428, DOI 10.1038/35096578; Zheng J, 2000, NATURE, V405, P149, DOI 10.1038/35012009; Zheng J, 2006, J BIOL CHEM, V281, P19916, DOI 10.1074/jbc.M513854200	84	81	81	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36659	36670		10.1074/jbc.M705078200	http://dx.doi.org/10.1074/jbc.M705078200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17933870	Green Accepted, hybrid			2022-12-27	WOS:000251458300059
J	Ryo, A; Hirai, A; Nishi, M; Liou, YC; Perrem, K; Lin, SC; Hirano, H; Lee, SW; Aoki, I				Ryo, Akihide; Hirai, Akiko; Nishi, Mayuko; Liou, Yih-Cherng; Perrem, Kilian; Lin, Sheng-Cai; Hirano, Hisashi; Lee, Sam W.; Aoki, Ichiro			A suppressive role of the prolyl isomerase Pin1 in cellular apoptosis mediated by the death-associated protein Daxx	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER; ACTIVATION; INHIBITION; MACHINERY; ADAPTER; ALPHA; CELLS; LINKS; PML; JNK	The death-associated protein Daxx is a multifunctional factor that regulates a variety of cellular processes, including transcription and apoptosis. Several previous reports have indicated that Daxx is induced upon oxidative stress and is then subjected to phosphorylation-based functional modification. However, the precise molecular events underlying these phosphorylation events remain largely unknown. We report in our current study that the peptidyl-prolyl isomerase Pin1 is highly overexpressed in malignant human gliomas and inhibits Daxx-mediated cellular apoptosis. The targeted inhibition of Pin1 by small interfering RNA in A172 glioblastoma cells significantly enhances the apoptotic response induced by hydrogen peroxide or stimulatory Fas antibodies. This is in turn accompanied by the increased induction of Daxx and the activation of the apoptosis signal-regulating kinase 1/c-Jun N-terminal kinase pathway. Furthermore, Pin1 binds to the phosphorylated Ser(178)-Pro motif in the Daxx protein, and Pin1 overexpression results in the rapid degradation of Daxx via the ubiquitin-proteasome pathway. Moreover, a Daxx-S178A mutant, which cannot interact with Pin1, demonstrates higher proapoptotic activity and is refractory to Pin1-mediated antiapoptotic effects. We further found that the expression levels of Pin1 inversely correlate with the degree of Daxx nuclear accumulation in human glioblastoma tissues. These results together indicate that Pin1-mediated prolyl isomerization plays an important role in the negative regulation of Daxx and thereby inhibits the oxidative stress-induced cellular apoptotic response, particularly in malignant tumor cells where Pin1 is often overexpressed.	Yokohama City Univ, Sch Med, Dept Pathol, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; Beaumont Hosp, Mol Oncol Lab, Dept Pathol, Royal Coll Surg Ireland, Dublin 9, Ireland; Xiamen Univ, Sch Life Sci, Key Lab Minist Educ Cell Biol, Xiamen 361005, Peoples R China; Yokohama City Univ, Int Grad Sch Arts & Sci, Yokohama, Kanagawa 2300045, Japan; Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Charlestown, MA 02129 USA	Yokohama City University; National University of Singapore; Royal College of Surgeons - Ireland; Xiamen University; Yokohama City University; Harvard University; Massachusetts General Hospital; Harvard University	Ryo, A (corresponding author), Yokohama City Univ, Sch Med, Dept Pathol, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan.	aryo@yokohama-cu.ac.jp	Lin, SC/G-4666-2010					Becker EBE, 2006, NEURON, V49, P655, DOI 10.1016/j.neuron.2006.01.034; Bremer E, 2006, TRENDS MOL MED, V12, P382, DOI 10.1016/j.molmed.2006.06.002; Chang HY, 1998, SCIENCE, V281, P1860, DOI 10.1126/science.281.5384.1860; Charette SJ, 2000, MOL CELL BIOL, V20, P7602, DOI 10.1128/MCB.20.20.7602-7612.2000; Duan L, 2004, CLIN CANCER RES, V10, P234, DOI 10.1158/1078-0432.CCR-1004-2; Guha A, 2004, CURR OPIN NEUROL, V17, P655, DOI 10.1097/00019052-200412000-00004; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Junn E, 2005, P NATL ACAD SCI USA, V102, P9691, DOI 10.1073/pnas.0409635102; Khelifi AF, 2005, CELL DEATH DIFFER, V12, P724, DOI 10.1038/sj.cdd.4401559; Kitagawa D, 2006, EMBO J, V25, P3286, DOI 10.1038/sj.emboj.7601212; Kwon JE, 2006, J BIOL CHEM, V281, P12664, DOI 10.1074/jbc.M600204200; Li H, 2000, MOL CELL BIOL, V20, P1784, DOI 10.1128/MCB.20.5.1784-1796.2000; Lu KP, 2002, TRENDS CELL BIOL, V12, P164, DOI 10.1016/S0962-8924(02)02253-5; Mantovani F, 2004, MOL CELL, V14, P625, DOI 10.1016/j.molcel.2004.05.007; Pathan N, 2001, NEOPLASIA, V3, P550, DOI 10.1038/sj.neo.7900213; Rodriguez-Nieto S, 2006, CURR PHARM DESIGN, V12, P4411, DOI 10.2174/138161206779010495; Ryo A, 2003, J CELL SCI, V116, P773, DOI 10.1242/jcs.00276; Ryo A, 2006, J BIOL CHEM, V281, P4117, DOI 10.1074/jbc.M507026200; Ryo A, 2005, CLIN CANCER RES, V11, P7523, DOI 10.1158/1078-0432.CCR-05-0457; Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8; Ryo A, 2001, NAT CELL BIOL, V3, P793, DOI 10.1038/ncb0901-793; Salomoni P, 2006, TRENDS CELL BIOL, V16, P97, DOI 10.1016/j.tcb.2005.12.002; Sasaki T, 2006, PATHOL RES PRACT, V202, P357, DOI 10.1016/j.prp.2005.12.007; Song JJ, 2004, J BIOL CHEM, V279, P30573, DOI 10.1074/jbc.M404512200; Torii S, 1999, EMBO J, V18, P6037, DOI 10.1093/emboj/18.21.6037; Tsuruta F, 2002, J BIOL CHEM, V277, P14040, DOI 10.1074/jbc.M108975200; Wulf GM, 2001, EMBO J, V20, P3459, DOI 10.1093/emboj/20.13.3459; Yamamoto K, 1999, MOL CELL BIOL, V19, P8469; Yang XL, 1997, CELL, V89, P1067, DOI 10.1016/S0092-8674(00)80294-9; Zacchi P, 2002, NATURE, V419, P853, DOI 10.1038/nature01120; Zheng HW, 2002, NATURE, V419, P849, DOI 10.1038/nature01116	31	50	53	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36671	36681		10.1074/jbc.M704145200	http://dx.doi.org/10.1074/jbc.M704145200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17938171	hybrid			2022-12-27	WOS:000251458300060
J	Youard, ZA; Mislin, GLA; Majcherczyk, PA; Schalk, IJ; Reimmann, C				Youard, Zeb A.; Mislin, Gaeetan L. A.; Majcherczyk, Paul A.; Schalk, Isabelle J.; Reimmann, Cornelia			Pseudomonas fluorescens CHA0 produces enantio-pyochelin, the optical antipode of the pseudomonas aeruginosa siderophore pyochelin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLETE GENOME SEQUENCE; IN-VITRO RECONSTITUTION; SALICYLATE BIOSYNTHESIS; BURKHOLDERIA-CEPACIA; IRON-TRANSPORT; RECEPTOR; FERRIPYOCHELIN; AGENTS; GENES; FUNGI	The siderophore pyochelin is made by a thiotemplate mechanism from salicylate and two molecules of cysteine. In Pseudomonas aeruginosa, the first cysteine residue is converted to its D-isoform during thiazoline ring formation whereas the second cysteine remains in its L-configuration, thus determining the stereochemistry of the two interconvertible pyochelin diastereoisomers as 4 ' R, 2 '' R, 4 '' R (pyochelin I) and 4 ' R, 2 ' S, 4 '' R (pyochelin II). Pseudomonas fluorescens CHA0 was found to make a different stereoisomeric mixture, which promoted growth under iron limitation in strain CHA0 and induced the expression of its biosynthetic genes, but was not recognized as a siderophore and signaling molecule by P. aeruginosa. Reciprocally, pyochelin promoted growth and induced pyochelin gene expression in P. aeruginosa, but was not functional in P. fluorescens. The structure of the CHA0 siderophore was determined by mass spectrometry, thin-layer chromatography, NMR, polarimetry, and chiral HPLC as enantio-pyochelin, the optical antipode of the P. aeruginosa siderophore pyochelin. Enantio-pyochelin was chemically synthesized and confirmed to be active in CHA0. Its potential biosynthetic pathway in CHA0 is discussed.	Univ Strasbourg 1, CNRS, UMR7175, LC1,ESBS, F-67400 Illkirch Graffenstaden, France; Univ Lausanne, Dept Microbiol Fondamentale, Quartier UNIL Sorge, CH-1015 Lausanne, Switzerland	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Lausanne	Reimmann, C (corresponding author), Univ Lausanne, Dept Microbiol Fondamentale, Quartier UNIL Sorge, Batiment Biophore, CH-1015 Lausanne, Switzerland.	Cornelia.Reimmann@unil.ch						ANKENBAUER RG, 1994, J BACTERIOL, V176, P307, DOI 10.1128/JB.176.2.307-319.1994; ANKENBAUER RG, 1988, J BACTERIOL, V170, P5344, DOI 10.1128/jb.170.11.5344-5351.1988; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; BERGERON RJ, 1985, J BIOL CHEM, V260, P7936; Bergeron RJ, 2001, J MED CHEM, V44, P2469, DOI 10.1021/jm010019s; BERGERON RJ, 1991, J MED CHEM, V34, P2072, DOI 10.1021/jm00111a023; BLONDEAU P, 1967, CAN J CHEMISTRY, V45, P49, DOI 10.1139/v67-009; Budzikiewicz H, 2004, PROG CH ORG NAT PROD, V87, P81; BUDZIKIEWICZ H, 2003, PROGR CHEM ORGANIC N, V87; CARMI R, 1994, J NAT PROD, V57, P1200, DOI 10.1021/np50111a002; Castignetti D, 1997, CURR MICROBIOL, V34, P250, DOI 10.1007/s002849900178; Cobessi D, 2005, J MOL BIOL, V352, P893, DOI 10.1016/j.jmb.2005.08.004; COX CD, 1980, J BACTERIOL, V142, P581, DOI 10.1128/JB.142.2.581-587.1980; COX CD, 1979, J BACTERIOL, V137, P357, DOI 10.1128/JB.137.1.357-364.1979; COX CD, 1981, P NATL ACAD SCI-BIOL, V78, P4256, DOI 10.1073/pnas.78.7.4256; Cuiv PO, 2004, J BACTERIOL, V186, P2996, DOI 10.1128/JB.186.10.2996-3005.2004; Darling P, 1998, INFECT IMMUN, V66, P874, DOI 10.1128/IAI.66.2.874-877.1998; DRECHSEL H, 1992, BIOMETALS, V5, P141, DOI 10.1007/BF01061320; FARINHA MA, 1990, FEMS MICROBIOL LETT, V58, P221; Gaille C, 2003, J BIOL CHEM, V278, P16893, DOI 10.1074/jbc.M212324200; Gaille C, 2002, J BIOL CHEM, V277, P21768, DOI 10.1074/jbc.M202410200; GUERINOT ML, 1994, ANNU REV MICROBIOL, V48, P743, DOI 10.1146/annurev.micro.48.1.743; HEINRICHS DE, 1993, J BACTERIOL, V175, P5882, DOI 10.1128/JB.175.18.5882-5889.1993; Hutt AJ, 1996, J ANTIMICROB CHEMOTH, V37, P7, DOI 10.1093/jac/37.1.7; Hutt Andrew J., 2007, Drug Metabolism and Drug Interactions, V22, P79; Ino A, 2001, TETRAHEDRON, V57, P1897, DOI 10.1016/S0040-4020(01)00012-6; KEEL C, 1989, PHYTOPATHOLOGY, V79, P584, DOI 10.1094/Phyto-79-584; Kobayashi S, 1998, J ANTIBIOT, V51, P328, DOI 10.7164/antibiotics.51.328; Laville J, 1998, J BACTERIOL, V180, P3187, DOI 10.1128/JB.180.12.3187-3196.1998; LIU PV, 1978, INFECT IMMUN, V22, P878, DOI 10.1128/IAI.22.3.878-890.1978; Meyer JM, 2000, ARCH MICROBIOL, V174, P135, DOI 10.1007/s002030000188; Michel L, 2005, MOL MICROBIOL, V58, P495, DOI 10.1111/j.1365-2958.2005.04837.x; Michel L, 2007, MICROBIOL-SGM, V153, P1508, DOI 10.1099/mic.0.2006/002915-0; Miller WG, 2000, MOL PLANT MICROBE IN, V13, P1243, DOI 10.1094/MPMI.2000.13.11.1243; Mislin GLA, 2006, J MOL BIOL, V357, P1437, DOI 10.1016/j.jmb.2006.01.080; MULLER G, 1985, J BIOL CHEM, V26, P13921; Munzinger M, 1999, BIOMETALS, V12, P189, DOI 10.1023/A:1009259118034; NEILANDS JB, 1981, J BIOL CHEM, V256, P3831; Patel HM, 2001, BIOCHEMISTRY-US, V40, P9023, DOI 10.1021/bi010519n; Patel HM, 2003, BIOCHEMISTRY-US, V42, P10514, DOI 10.1021/bi034840c; Paulsen IT, 2005, NAT BIOTECHNOL, V23, P873, DOI 10.1038/nbt1110; Phoebe CH, 2001, J ANTIBIOT, V54, P56; Quadri LEN, 1999, BIOCHEMISTRY-US, V38, P14941, DOI 10.1021/bi991787c; Reimmann C, 1998, MICROBIOL-UK, V144, P3135, DOI 10.1099/00221287-144-11-3135; Reimmann C, 2001, J BACTERIOL, V183, P813, DOI 10.1128/JB.183.3.813-820.2001; RINEHART KL, 1995, J ORG CHEM, V60, P2786, DOI 10.1021/jo00114a029; Sambrook J., 2001, MOL CLONING LAB MANU; Sasaki T, 2002, J ANTIBIOT, V55, P249, DOI 10.7164/antibiotics.55.249; Schlegel K, 2004, BIOMETALS, V17, P409, DOI 10.1023/B:BIOM.0000029437.42633.73; Schlegel K, 2006, Z NATURFORSCH C, V61, P263; SCHNIDER U, 1995, J BACTERIOL, V177, P5387, DOI 10.1128/jb.177.18.5387-5392.1995; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; SERINO L, 1995, MOL GEN GENET, V249, P217, DOI 10.1007/BF00290369; Serino L, 1997, J BACTERIOL, V179, P248, DOI 10.1128/jb.179.1.248-257.1997; SHINDO K, 1989, J ANTIBIOT, V42, P1526, DOI 10.7164/antibiotics.42.1526; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; SOKOL PA, 1986, J CLIN MICROBIOL, V23, P560, DOI 10.1128/JCM.23.3.560-562.1986; STANISICH VA, 1972, GENET RES, V19, P91, DOI 10.1017/S0016672300014294; Tseng CF, 2006, J BIOL INORG CHEM, V11, P419, DOI 10.1007/s00775-006-0088-7; VOISARD C, 1994, MOLECULAR ECOLOGY OF RHIZOSPHERE MICROORGANISMS, P67, DOI 10.1002/9783527615810.ch6; Wandersman C, 2004, ANNU REV MICROBIOL, V58, P611, DOI 10.1146/annurev.micro.58.030603.123811; WINKELMANN G, 1979, FEBS LETT, V97, P43, DOI 10.1016/0014-5793(79)80048-4; WINKELMANN G, 1981, FEMS MICROBIOL LETT, V11, P237, DOI 10.1016/0378-1097(81)90068-9; YE RW, 1995, J BACTERIOL, V177, P3606, DOI 10.1128/jb.177.12.3606-3609.1995; Zamri A, 2000, TETRAHEDRON, V56, P9397, DOI 10.1016/S0040-4020(00)00875-9; Zamri A, 2000, TETRAHEDRON, V56, P249, DOI 10.1016/S0040-4020(99)00946-1	67	87	91	3	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35546	35553		10.1074/jbc.M707039200	http://dx.doi.org/10.1074/jbc.M707039200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17938167	hybrid			2022-12-27	WOS:000251458100014
J	Sajish, M; Tiwari, D; Rananaware, D; Nandicoori, VK; Prakash, B				Sajish, Mathew; Tiwari, Divya; Rananaware, Dimple; Nandicoori, Vinay Kumar; Prakash, Balaji			A charge reversal differentiates (p) ppGpp synthesis by monofunctional and bifunctional Rel proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; STATIONARY-PHASE; GLOBAL REGULATOR; (P)PPGPP; TRANSCRIPTION; REL(MTB); DNA	A major regulatory mechanism evolved by microorganisms to combat stress is the regulation mediated by ( p) ppGpp ( the stringent response molecule), synthesized and hydrolyzed by Rel proteins. These are divided into bifunctional and monofunctional proteins based on the presence or absence of the hydrolysis activity. Although these proteins require Mg2+ for ( p) ppGpp synthesis, high Mg2+ was shown to inhibit this reaction in bifunctional Rel proteins from Mycobacterium tuberculosis and Streptococcus equisimilis. This is not a characteristic feature in enzymes that use a dual metal ion mechanism, such as DNA polymerases that are known to carry out a similar pyrophosphate transfer reaction. Comparison of polymerase Pol beta and Rel(Seq) structures that share a common fold led to the proposal that the latter would follow a single metal ion mechanism. Surprisingly, in contrast to bifunctional Rel, we did not find inhibition of guanosine 5'-triphosphate, 3'-diphosphate ( pppGpp) synthesis at higher Mg2+ in the monofunctional RelA from Escherichia coli. We show that a charge reversal in a conserved motif in the synthesis domains explains this contrast; an RXKD motif in the bifunctional proteins is reversed to an EXDD motif. The differential response of these proteins to Mg2+ could also be noticed in fluorescent nucleotide binding and circular dichroism experiments. In mutants where the motifs were reversed, the differential effect could also be reversed. We infer that although a catalytic Mg2+ is common to both bifunctional and monofunctional proteins, the latter would utilize an additional metal binding site formed by EXDD. This work, for the first time, brings out differences in (p)ppGpp synthesis by the two classes of Rel proteins.	Natl Inst Immunol, New Delhi 110067, India; Indian Inst Technol, Dept Biol Sci & Engn, Kanpur 208016, Uttar Pradesh, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kanpur	Nandicoori, VK (corresponding author), Natl Inst Immunol, Aruna Asaf Ali Marg, New Delhi 110067, India.	vinaykn@nii.res.in; bprakash@iitk.ac.in		Tiwari, Divya/0000-0001-7631-2471; Mathew, Sajish/0000-0001-6715-5953; Nandicoori, Vinay/0000-0002-5682-4178	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P469, DOI 10.1016/S0968-0004(98)01293-6; Artsimovitch I, 2004, CELL, V117, P299, DOI 10.1016/S0092-8674(04)00401-5; Avarbock A, 2005, BIOCHEMISTRY-US, V44, P9913, DOI 10.1021/bi0505316; Avarbock D, 2000, BIOCHEMISTRY-US, V39, P11640, DOI 10.1021/bi001256k; Black CB, 1998, J BIOL INORG CHEM, V3, P292, DOI 10.1007/s007750050234; Braeken K, 2006, TRENDS MICROBIOL, V14, P45, DOI 10.1016/j.tim.2005.11.006; Cashel M., 1996, ESCHERICHIA COLI SAL, P1458; Dahl JL, 2003, P NATL ACAD SCI USA, V100, P10026, DOI 10.1073/pnas.1631248100; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Gralla JD, 2005, MOL MICROBIOL, V55, P973, DOI 10.1111/j.1365-2958.2004.04455.x; Hammer BK, 2002, MOL MICROBIOL, V44, P107, DOI 10.1046/j.1365-2958.2002.02884.x; Hogg T, 2004, CELL, V117, P57, DOI 10.1016/S0092-8674(04)00260-0; Jain V, 2007, BIOPHYS CHEM, V127, P41, DOI 10.1016/j.bpc.2006.12.003; Kelly SM, 2000, CURR PROTEIN PEPT SC, V1, P349, DOI 10.2174/1389203003381315; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Kuhar I, 2001, MOL MICROBIOL, V41, P207, DOI 10.1046/j.1365-2958.2001.02508.x; Magnusson LU, 2005, TRENDS MICROBIOL, V13, P236, DOI 10.1016/j.tim.2005.03.008; Mechold U, 2002, J BACTERIOL, V184, P2878, DOI 10.1128/JB.184.11.2878-2888.2002; Primm TP, 2000, J BACTERIOL, V182, P4889, DOI 10.1128/JB.182.17.4889-4898.2000; REMMERS AE, 1994, J BIOL CHEM, V269, P13771; Sawaya MR, 1997, BIOCHEMISTRY-US, V36, P11205, DOI 10.1021/bi9703812; Steitz TA, 1998, NATURE, V391, P231, DOI 10.1038/34542; Sun JH, 2001, J BACTERIOL, V183, P3488, DOI 10.1128/JB.183.11.3488-3498.2001; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Van Delden C, 2001, J BACTERIOL, V183, P5376, DOI 10.1128/JB.183.18.5376-5384.2001; van der Biezen EA, 2000, P NATL ACAD SCI USA, V97, P3747, DOI 10.1073/pnas.060392397; Wagner R, 2002, J MOL MICROB BIOTECH, V4, P331	27	36	37	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					34977	34983		10.1074/jbc.M704828200	http://dx.doi.org/10.1074/jbc.M704828200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17911108	hybrid			2022-12-27	WOS:000251155200042
J	Shinde, AV; Bystroff, C; Wang, C; Vogelezang, MG; Vincent, PA; Hynes, RO; Van De Water, L				Shinde, Arti V.; Bystroff, Christopher; Wang, Chunyu; Vogelezang, Mariette G.; Vincent, Peter A.; Hynes, Richard O.; Van De Water, Livingston			Identification of the peptide sequences within the EIIIA (EDA) segment of fibronectin that mediate integrin alpha 9 beta 1-dependent cellular activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALTERNATIVELY SPLICED SEGMENTS; CRYSTAL-STRUCTURE; III REPEAT; EMBRYONIC FIBRONECTINS; EXTRACELLULAR-MATRIX; ADHESION MOLECULE-1; PLASMA FIBRONECTIN; CYCLE PROGRESSION; RAT FIBRONECTIN; MESSENGER-RNA	Alternative splicing of the fibronectin (FN) gene transcript provides an efficient mechanism for generating functionally appropriate forms of this adhesive glycoprotein in situ. Cellular FNs that include the EIIIA and/or EIIIB FN-III segments are prominently expressed during embryogenesis, wound healing, tumor progression, and inflammation. However, the roles of this domain in altering overall FN protein structure and regulating cellular function remain unclear. We previously reported that two integrins, alpha 9 beta 1 and alpha 4 beta 1, ligate the EIIIA segment (Liao, Y. F., Gotwals, P. J., Koteliansky, V. E., Sheppard, D., and Van De Water, L. (2002) J. Biol. Chem. 277, 14467 - 14474) and that the epitopes for function-blocking monoclonal antibodies lie within the C-C' loop of EIIIA (Liao, Y. F., Wieder, K. G., Classen, J. M., and Van De Water, L. (1999) J. Biol. Chem. 274, 17876 - 17884). We have now performed site-directed mutagenesis within the EIIIA segment and carried out cell adhesion assays on these mutant EIIIAs. We find that the Asp(41) and Gly(42) residues within the C-C' loop of EIIIA are necessary for integrin alpha 9 beta 1 binding. Synthetic peptides based on the predicted important amino acid sequence from the C-C' loop encode sufficient information to completely inhibit alpha 9 beta 1-mediated cell adhesion. We also report that EIIIA promotes filopodial formation in alpha 9 beta 1-expressing cells accompanied by Cdc42 activation. Our data provide a cellular activity for the EIIIA segment, evidence for conformational lability, and peptide sequences for probing EIIIA functions in vitro and in vivo.	[Shinde, Arti V.; Van De Water, Livingston] Albany Med Coll, Ctr Cell Biol & Canc Res, Albany, NY 12208 USA; [Vincent, Peter A.] Albany Med Coll, Ctr Cardiovasc Sci, Albany, NY 12208 USA; [Bystroff, Christopher; Wang, Chunyu] Rensselaer Polytech Inst, Dept Biol, Troy, NY 12180 USA; [Wang, Chunyu] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA; [Hynes, Richard O.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Hynes, Richard O.] Howard Hughes Med Inst, Ctr Canc Res, Cambridge, MA 02139 USA	Albany Medical College; Albany Medical College; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute	Van De Water, L (corresponding author), Albany Med Coll, Ctr Cell Biol & Canc Res, MC-165, Albany, NY 12208 USA.	vandewl@mail.amc.edu	Wang, Chunyu/AAH-5952-2019	Wang, Chunyu/0000-0001-5165-7959; Van De Water, Livingston/0000-0002-3825-9224	NHLBI NIH HHS [P01 HL 066105] Funding Source: Medline; NIGMS NIH HHS [R01 GM056442, GM 56442] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL066105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056442] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arnaout MA, 2005, ANNU REV CELL DEV BI, V21, P381, DOI 10.1146/annurev.cellbio.21.090704.151217; Astrof S, 2004, MOL CELL BIOL, V24, P8662, DOI 10.1128/MCB.24.19.8662-8670.2004; Astrof S, 2007, DEV BIOL, V311, P11, DOI 10.1016/j.ydbio.2007.07.005; Bloom L, 1999, MOL BIOL CELL, V10, P1521, DOI 10.1091/mbc.10.5.1521; Bourdoulous S, 1998, J CELL BIOL, V143, P267, DOI 10.1083/jcb.143.1.267; BROWN LF, 1993, AM J PATHOL, V142, P793; Bystroff C, 1998, J MOL BIOL, V281, P565, DOI 10.1006/jmbi.1998.1943; CARNEMOLLA B, 1992, J BIOL CHEM, V267, P24689; Coito AJ, 1997, AM J PATHOL, V150, P1757; Copie V, 1998, J MOL BIOL, V277, P663; Davis GE, 2000, AM J PATHOL, V156, P1489, DOI 10.1016/S0002-9440(10)65020-1; DUBIN D, 1995, ARTERIOSCL THROM VAS, V15, P1958, DOI 10.1161/01.ATV.15.11.1958; Dugina V, 2001, J CELL SCI, V114, P3285; ERICKSON HP, 1994, P NATL ACAD SCI USA, V91, P10114, DOI 10.1073/pnas.91.21.10114; Eto B, 2000, J BIOL CHEM, V275, P34922, DOI 10.1074/jbc.M001953200; FFRENCHCONSTANT C, 1995, EXP CELL RES, V221, P261, DOI 10.1006/excr.1995.1374; FFRENCHCONSTANT C, 1989, J CELL BIOL, V109, P903, DOI 10.1083/jcb.109.2.903; Fukuda T, 2002, CANCER RES, V62, P5603; Gehris AL, 1997, DEV BIOL, V190, P191, DOI 10.1006/dbio.1997.8693; GEORGE EL, 1993, DEVELOPMENT, V119, P1079; GLUKHOVA MA, 1989, J CELL BIOL, V109, P357, DOI 10.1083/jcb.109.1.357; GUAN JL, 1990, J CELL BIOL, V110, P833, DOI 10.1083/jcb.110.3.833; HINO K, 1995, ARTHRITIS RHEUM-US, V38, P678, DOI 10.1002/art.1780380516; Hocking DC, 1996, J CELL BIOL, V133, P431, DOI 10.1083/jcb.133.2.431; HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9; Hynes RO, 1999, P NATL ACAD SCI USA, V96, P2588, DOI 10.1073/pnas.96.6.2588; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Hynes RO, 1990, FIBRONECTINS; JARNAGIN WR, 1994, J CELL BIOL, V127, P2037, DOI 10.1083/jcb.127.6.2037; Leahy DJ, 1996, CELL, V84, P155, DOI 10.1016/S0092-8674(00)81002-8; Liao YF, 2002, J BIOL CHEM, V277, P14467, DOI 10.1074/jbc.M201100200; Liao YF, 1999, J BIOL CHEM, V274, P17876, DOI 10.1074/jbc.274.25.17876; Litvinovich SV, 1998, J MOL BIOL, V280, P245, DOI 10.1006/jmbi.1998.1863; MAIN AL, 1992, CELL, V71, P671, DOI 10.1016/0092-8674(92)90600-H; Manabe R, 1997, J CELL BIOL, V139, P295, DOI 10.1083/jcb.139.1.295; Manabe R, 1999, J BIOL CHEM, V274, P5919, DOI 10.1074/jbc.274.9.5919; Muro AF, 2003, J CELL BIOL, V162, P149, DOI 10.1083/jcb.200212079; Niimi T, 2001, J BIOMOL NMR, V21, P281, DOI 10.1023/A:1012947209393; OSBORN L, 1994, J CELL BIOL, V124, P601, DOI 10.1083/jcb.124.4.601; OYAMA F, 1989, J BIOL CHEM, V264, P10331; PAGANI F, 1991, J CELL BIOL, V113, P1223, DOI 10.1083/jcb.113.5.1223; PALMER EL, 1993, J CELL BIOL, V123, P1289, DOI 10.1083/jcb.123.5.1289; PETERS DMP, 1990, J CELL BIOL, V111, P249, DOI 10.1083/jcb.111.1.249; Peters JH, 2002, OSTEOARTHR CARTILAGE, V10, P831, DOI 10.1053/joca.2002.0845; Peters JH, 1996, CELL ADHES COMMUN, V4, P103, DOI 10.3109/15419069609010766; PETERSEN TE, 1983, P NATL ACAD SCI-BIOL, V80, P137, DOI 10.1073/pnas.80.1.137; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619; Saito S, 1999, J BIOL CHEM, V274, P30756, DOI 10.1074/jbc.274.43.30756; Schenk S, 2003, TRENDS CELL BIOL, V13, P366, DOI 10.1016/S0962-8924(03)00129-6; SCHWARZBAUER JE, 1987, EMBO J, V6, P2573, DOI 10.1002/j.1460-2075.1987.tb02547.x; Serini G, 1998, J CELL BIOL, V142, P873, DOI 10.1083/jcb.142.3.873; Silletti S, 2000, J CELL BIOL, V149, P1485, DOI 10.1083/jcb.149.7.1485; Singh P, 2004, J INVEST DERMATOL, V123, P1176, DOI 10.1111/j.0022-202X.2004.23485.x; Smith LL, 1996, J BIOL CHEM, V271, P28485, DOI 10.1074/jbc.271.45.28485; Staniszewska I, 2007, CIRC RES, V100, P1308, DOI 10.1161/01.RES.0000266662.98355.66; Takahashi H, 2000, J BIOL CHEM, V275, P23589, DOI 10.1074/jbc.M003526200; Tan K, 1998, STRUCTURE, V6, P793, DOI 10.1016/S0969-2126(98)00080-X; Tan MH, 2004, BLOOD, V104, P11, DOI 10.1182/blood-2003-09-3363; Vlahakis NE, 2005, J BIOL CHEM, V280, P4544, DOI 10.1074/jbc.M412816200; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Wang CY, 2004, J MOL BIOL, V342, P525, DOI 10.1016/j.jmb.2004.07.001; WANG JH, 1995, P NATL ACAD SCI USA, V92, P5714, DOI 10.1073/pnas.92.12.5714; XIA P, 1995, EXP CELL RES, V217, P517, DOI 10.1006/excr.1995.1117; XIA P, 1994, EXP CELL RES, V213, P253, DOI 10.1006/excr.1994.1197; YOKOSAKI Y, 1994, J BIOL CHEM, V269, P26691; Yokosaki Y, 1998, J BIOL CHEM, V273, P11423, DOI 10.1074/jbc.273.19.11423; Yokosaki Y, 1999, J BIOL CHEM, V274, P36328, DOI 10.1074/jbc.274.51.36328; Zhong CL, 1998, J CELL BIOL, V141, P539, DOI 10.1083/jcb.141.2.539; Zhu XL, 2002, BIOL REPROD, V66, P1193, DOI 10.1095/biolreprod66.4.1193	71	84	92	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2858	2870		10.1074/jbc.M708306200	http://dx.doi.org/10.1074/jbc.M708306200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	17967897	hybrid			2022-12-27	WOS:000252622300043
J	Guo, ZH; Jiang, HY; Xu, XR; Duan, WZ; Mattson, MP				Guo, Zhihong; Jiang, Haiyang; Xu, Xiangru; Duan, Wenzhen; Mattson, Mark P.			Leptin-mediated cell survival signaling in hippocampal neurons mediated by JAK STAT3 and mitochondrial stabilization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MANGANESE SUPEROXIDE-DISMUTASE; AMPA RECEPTOR SUBUNITS; NEUROTROPHIC FACTOR; LIPID-PEROXIDATION; NITRIC-OXIDE; PHOSPHOINOSITIDE 3-KINASE; PEROXYNITRITE PRODUCTION; REPRODUCTIVE FUNCTION; INDUCED APOPTOSIS; OXIDATIVE STRESS	Leptin plays a pivotal role in the regulation of energy homeostasis and metabolism, primarily by acting on neurons in the hypothalamus that control food intake. However, leptin receptors are more widely expressed in the brain suggesting additional, as yet unknown, functions of leptin. Here we show that both embryonic and adult hippocampal neurons express leptin receptors coupled to activation of STAT3 and phosphatidylinositol 3-kinase-Akt signaling pathways. Leptin protects hippocampal neurons against cell death induced by neurotrophic factor withdrawal and excitotoxic and oxidative insults. The neuroprotective effect of leptin is antagonized by the JAK2-STAT3 inhibitor AG-490, STAT3 decoy DNA, and phosphatidylinositol 3-kinase/Akt inhibitors but not by an inhibitor of MAPK. Leptin induces the production of manganese superoxide dismutase and the anti-apoptotic protein Bcl-xL, and stabilizes mitochondrial membrane potential and lessens mitochondrial oxidative stress. Leptin receptor-deficient mice (db/db mice) are more vulnerable to seizure-induced hippocampal damage, and intraventricular administration of leptin protects neurons against seizures. By enhancing mitochondrial resistance to apoptosis and excitotoxicity, our findings suggest that leptin signaling serves a neurotrophic function in the developing and adult hippocampus.	[Guo, Zhihong; Jiang, Haiyang; Xu, Xiangru; Duan, Wenzhen; Mattson, Mark P.] NIA, Neurosci Lab, Baltimore, MD 21224 USA; [Guo, Zhihong; Jiang, Haiyang; Xu, Xiangru; Duan, Wenzhen; Mattson, Mark P.] NIA, Intramural Res Program, Baltimore, MD 21224 USA; [Mattson, Mark P.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Johns Hopkins University	Mattson, MP (corresponding author), NIA, Neurosci Lab, Baltimore, MD 21224 USA.	mattsonm@grc.nia.nih.gov	Mattson, Mark P/F-6038-2012		Intramural NIH HHS Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Ahima RS, 2000, ANNU REV PHYSIOL, V62, P413, DOI 10.1146/annurev.physiol.62.1.413; Attoub S, 2000, FASEB J, V14, P2329, DOI 10.1096/fj.00-0162; Beal MF, 1998, ANN NEUROL, V44, pS110; Boston BA, 1997, SCIENCE, V278, P1641, DOI 10.1126/science.278.5343.1641; Bouret SG, 2004, SCIENCE, V304, P108, DOI 10.1126/science.1095004; Chan SL, 1999, J NEUROSCI RES, V57, P315, DOI 10.1002/(SICI)1097-4547(19990801)57:3<315::AID-JNR3>3.3.CO;2-R; Cheng AW, 2003, DEV BIOL, V258, P319, DOI 10.1016/S0012-1606(03)00120-9; Cheng AW, 2003, J BIOL CHEM, V278, P7591, DOI 10.1074/jbc.M207232200; Darnowski JW, 2006, J BIOL CHEM, V281, P17707, DOI 10.1074/jbc.M600088200; Deshmukh M, 2000, J CELL BIOL, V150, P131, DOI 10.1083/jcb.150.1.131; Dicou E, 2001, NEUROREPORT, V12, P3947, DOI 10.1097/00001756-200112210-00019; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Durakoglugil M, 2005, J NEUROCHEM, V95, P396, DOI 10.1111/j.1471-4159.2005.03375.x; Fiskum G, 2000, J NEUROTRAUM, V17, P843, DOI 10.1089/neu.2000.17.843; Funahashi H, 2003, INT REV CYTOL, V224, P1, DOI 10.1016/S0074-7696(05)24001-9; Furmaga-Jablonska W, 2003, ANN HUM BIOL, V30, P250, DOI 10.1080/0301446031000064521; Gabriel B, 2003, EXP CELL RES, V289, P195, DOI 10.1016/S0014-4827(03)00255-6; Gillessen T, 2002, BIOMED PHARMACOTHER, V56, P186, DOI 10.1016/S0753-3322(02)00184-1; Glazner GW, 2000, J NEUROSCI, V20, P3641, DOI 10.1523/JNEUROSCI.20-10-03641.2000; Gonzalez-Zulueta M, 1998, J NEUROSCI, V18, P2040; GREENLUND LJS, 1995, NEURON, V14, P303, DOI 10.1016/0896-6273(95)90287-2; Harvey J, 2000, J BIOL CHEM, V275, P4660, DOI 10.1074/jbc.275.7.4660; HEIS FC, 2005, BIOCHEM BIOPH RES CO, V335, P292; Heshka JT, 2001, LIFE SCI, V69, P987, DOI 10.1016/S0024-3205(01)01201-2; Houseknecht KL, 1998, DOMEST ANIM ENDOCRIN, V15, P457, DOI 10.1016/S0739-7240(98)00035-6; Huang XF, 1996, NEUROREPORT, V7, P2635, DOI 10.1097/00001756-199611040-00045; Ishihara K, 2001, BBA-MOL BASIS DIS, V1536, P73, DOI 10.1016/S0925-4439(01)00035-7; Keller JN, 1998, J NEUROSCI, V18, P687; Leong PL, 2003, P NATL ACAD SCI USA, V100, P4138, DOI 10.1073/pnas.0534764100; Li XL, 2002, NEUROSCIENCE, V113, P607, DOI 10.1016/S0306-4522(02)00162-8; Magni P, 2000, REGUL PEPTIDES, V92, P51, DOI 10.1016/S0167-0115(00)00149-X; Mark RJ, 1997, J NEUROSCI, V17, P1046; Matsuoka N, 2002, NEUROSURGERY, V50, P857, DOI 10.1097/00006123-200204000-00032; Mattson MP, 1997, J NEUROSCI RES, V49, P681, DOI 10.1002/(SICI)1097-4547(19970915)49:6<681::AID-JNR3>3.0.CO;2-3; Mattson MP, 2003, NEUROMOL MED, V3, P65, DOI 10.1385/NMM:3:2:65; Mattson MP, 1998, TRENDS NEUROSCI, V21, P53, DOI 10.1016/S0166-2236(97)01188-0; MATTSON MP, 1995, J NEUROCHEM, V65, P1740; Mercer JG, 1996, FEBS LETT, V387, P113, DOI 10.1016/0014-5793(96)00473-5; Miike S, 1999, J LEUKOCYTE BIOL, V65, P700, DOI 10.1002/jlb.65.5.700; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; Najib S, 2002, CELL IMMUNOL, V220, P143, DOI 10.1016/S0008-8749(03)00027-3; Negoro S, 2001, CIRCULATION, V104, P979, DOI 10.1161/hc3401.095947; Nicholls DG, 1999, BIOCHEM SOC SYMP, V66, P55, DOI 10.1042/bss0660055; Orike N, 2001, J CELL BIOL, V154, P995, DOI 10.1083/jcb.200101068; Peterson WM, 2000, J NEUROSCI, V20, P4081; Qiu J, 2001, ENDOCRINOLOGY, V142, P3421, DOI 10.1210/en.142.8.3421; Rothstein JD, 1996, CURR OPIN NEUROBIOL, V6, P679, DOI 10.1016/S0959-4388(96)80103-6; Sanchez-Margalet V, 2003, CLIN EXP IMMUNOL, V133, P11, DOI 10.1046/j.1365-2249.2003.02190.x; Scariano JK, 2003, MECH AGEING DEV, V124, P281, DOI 10.1016/S0047-6374(02)00195-1; Schinder AF, 1996, J NEUROSCI, V16, P6125; Shanley LJ, 2002, NAT NEUROSCI, V5, P299, DOI 10.1038/nn824; Shioda S, 1998, NEUROSCI LETT, V243, P41, DOI 10.1016/S0304-3940(98)00082-2; Sloviter R S, 1996, Neurologia, V11 Suppl 4, P29; Smith GD, 2002, THERIOGENOLOGY, V57, P73, DOI 10.1016/S0093-691X(01)00658-6; Takeda S, 2002, CELL, V111, P305, DOI 10.1016/S0092-8674(02)01049-8; Terui K, 2004, J HEPATOL, V41, P957, DOI 10.1016/j.jhep.2004.08.019; Turkson J, 2005, J BIOL CHEM, V280, P32979, DOI 10.1074/jbc.M502694200; Waelput W., 2002, Current Drug Targets - Inflammation and Allergy, V1, P277, DOI 10.2174/1568010023344634; White RJ, 1996, J NEUROSCI, V16, P5688; ZHAN AZ, 2000, J BIOL CHEM, V275, P11348	60	149	155	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1754	1763		10.1074/jbc.M703753200	http://dx.doi.org/10.1074/jbc.M703753200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	17993459	hybrid			2022-12-27	WOS:000252282700062
J	Li, DH; Tang, HY; Speicher, DW				Li, Donghai; Tang, Hsin-Yao; Speicher, David W.			A structural model of the erythrocyte spectrin heterodimer initiation site determined using homology modeling and chemical cross-linking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RED-CELL SPECTRIN; PROTEIN-PROTEIN INTERACTIONS; MASS-SPECTROMETRY; ALPHA-SPECTRIN; CRYSTAL-STRUCTURE; BETA-SPECTRIN; SWISS-MODEL; DOCKING; SEQUENCE; ELECTROSTATICS	Spectrin assembles into an anti-parallel heterodimeric flexible rod-like molecule through a multistep process initiated by a high affinity interaction between discrete complementary homologous motifs or "repeats" near the actin binding domain. Attempts to determine crystallographic structures of this critical dimer initiation complex have so far been unsuccessful. Therefore, in this study we determined the subunit-subunit docking interface and a plausible medium resolution structure of the heterodimer initiation site using homology modeling coupled with structural refinement based on experimentally determined distance constraints. Intramolecular and intermolecular cross-links formed by the "zero length" cross-linking reagent, 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide were identified after trypsin digestion of cross-linked heterodimer complex using liquid chromatography-tandem mass spectrometry analysis. High confidence assignment of cross-linked peptides was facilitated by determination of cross-linked peptide masses with an uncertainty of a few parts per million using a high sensitivity linear ion trap mass spectrometer equipped with a Fourier-transform ion cyclotron resonance detector. Six interchain cross-links distinguished between alternative docking models, and these distance constraints, as well as three intrachain crosslinks, were used to further refine an initial homology-based structure. The final model is consistent with all available physical data, including protease protection experiments, isothermal titration calorimetry analyses, and location of a common polymorphism that destabilizes dimerization. This model supports the hypothesis that initial docking of the correct alpha and beta repeats from among many very similar repeats in both subunits is driven primarily by long range electrostatic interactions.	[Li, Donghai; Tang, Hsin-Yao; Speicher, David W.] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA	The Wistar Institute	Speicher, DW (corresponding author), Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA.	speicher@wistar.org		Tang, Hsin-Yao/0000-0003-1838-018X	NCI NIH HHS [CA 10815] Funding Source: Medline; NHLBI NIH HHS [HL 38794, R01 HL038794] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA010815] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL038794] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BARLOW DJ, 1983, J MOL BIOL, V168, P867, DOI 10.1016/S0022-2836(83)80079-5; Begg GE, 2000, J BIOL CHEM, V275, P3279, DOI 10.1074/jbc.275.5.3279; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Chen R, 2003, PROTEINS, V51, P397, DOI 10.1002/prot.10334; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; DeLano WL, 2002, PYMOL USERS MANUAL; Delaunay J, 2007, BLOOD REV, V21, P1, DOI 10.1016/j.blre.2006.03.005; El-Shafey A, 2006, PROTEIN SCI, V15, P429, DOI 10.1110/ps.051685706; FLOOD G, 1995, J MOL BIOL, V252, P227, DOI 10.1006/jmbi.1995.0490; Flood G, 1997, EUR BIOPHYS J BIOPHY, V25, P431, DOI 10.1007/s002490050057; Gallagher PG, 2004, SEMIN HEMATOL, V41, P142, DOI 10.1053/j.seminhematol.2004.01.003; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Harper SL, 2001, BIOCHEMISTRY-US, V40, P9935, DOI 10.1021/bi0107795; HONIG B, 1995, SCIENCE, V268, P1144, DOI 10.1126/science.7761829; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Kalkhof S, 2005, ANAL CHEM, V77, P495, DOI 10.1021/ac0487294; Kusunoki H, 2004, J MOL BIOL, V344, P495, DOI 10.1016/j.jmb.2004.09.019; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li DH, 2007, BIOCHEMISTRY-US, V46, P10585, DOI 10.1021/bi7007905; Mandell JG, 2001, PROTEIN ENG, V14, P105, DOI 10.1093/protein/14.2.105; MOHANDAS N, 1993, SEMIN HEMATOL, V30, P171; Mohindas N, 2006, TRANSFUS CLIN BIOL, V13, P29, DOI 10.1016/j.tracli.2006.02.017; NASH GB, 1993, BIORHEOLOGY, V30, P397; SAHR KE, 1990, J BIOL CHEM, V265, P4434; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schilling B, 2003, J AM SOC MASS SPECTR, V14, P834, DOI 10.1016/S1044-0305(03)00327-1; Sinz A, 2003, J MASS SPECTROM, V38, P1225, DOI 10.1002/JMS.559; SPEICHER DW, 1992, J BIOL CHEM, V267, P14775; SPEICHER DW, 1984, NATURE, V311, P177, DOI 10.1038/311177a0; SPEICHER DW, 1993, J BIOL CHEM, V268, P4227; Speicher K D, 2000, J Biomol Tech, V11, P74; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TSU WT, 2000, BRIT J HAEMATOL, V104, P2; Ursitti JA, 1996, J BIOL CHEM, V271, P6636, DOI 10.1074/jbc.271.12.6636; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wilmotte R, 1997, BLOOD, V90, P4188, DOI 10.1182/blood.V90.10.4188; WILMOTTE R, 1993, J CLIN INVEST, V91, P2091, DOI 10.1172/JCI116432; WINKELMANN JC, 1990, J BIOL CHEM, V265, P11827; YAN Y, 1993, SCIENCE, V262, P2027, DOI 10.1126/science.8266097; Ylanne J, 2001, STRUCTURE, V9, P597, DOI 10.1016/S0969-2126(01)00619-0; Young MM, 2000, P NATL ACAD SCI USA, V97, P5802, DOI 10.1073/pnas.090099097	43	20	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1553	1562		10.1074/jbc.M706981200	http://dx.doi.org/10.1074/jbc.M706981200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	17977835	hybrid			2022-12-27	WOS:000252282700040
J	Silversmith, RE; Levin, MD; Schilling, E; Bourret, RB				Silversmith, Ruth E.; Levin, Matthew D.; Schilling, Elmar; Bourret, Robert B.			Kinetic characterization of catalysis by the chemotaxis phosphatase CheZ - Modulation of activity by the phosphorylated CheY substrate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPONSE REGULATOR CHEY; BACTERIAL CHEMOTAXIS; SIGNALING PROTEINS; BINDING; FLUORESCENT; LOCALIZATION; COMPONENTS; MECHANISM; MUTANTS; DOMAIN	CheZ catalyzes the dephosphorylation of the response regulator CheY in the two-component regulatory system that mediates chemotaxis in Escherichia coli. CheZ is a homodimer with two active sites for dephosphorylation. To gain insight into cellular mechanisms for the precise regulation of intracellular phosphorylated CheY (CheYp) levels, we evaluated the kinetic properties of CheZ. The steady state rate of CheZ-mediated dephosphorylation of CheYp displayed marked sigmoidicity with respect to CheYp concentration and a k(cat) of 4.9 s(-1). In contrast, the gain of function mutant CheZ-I21T with an amino acid substitution far from the active site gave hyperbolic kinetics and required far lower CheYp for half-saturation but had a similar kcat value as the wild type enzyme. Stopped flow fluorescence measurements demonstrated a 6-fold faster CheZ/CheYp association rate for CheZ-I21T (k(assoc) = 3.4 x 107 M-1 s(-1)) relative to wild type CheZ (k(assoc) = 5.6 x 10(6) M-1 s(-1)). Dissociation of the CheZ center dot CheYBeF(3) complex was slow for both wild type CheZ (k(dissoc) = 0.040 s(-1)) and CheZ-I21T (kdissoc = 0.023 s(-1)) and, when taken with the kassoc values, implied K-d values of 7.1 and 0.68 nM, respectively. However, comparison of the kdissoc and kcat values implied that CheZ and CheYp are not at binding equilibrium during catalysis and that once CheYp binds, it is almost always dephosphorylated. The rate constants were collated to formulate a kinetic model for CheZ-mediated dephosphorylation that includes autoregulation by CheYp and allowed prediction of CheZ activities at CheZ and CheYp concentrations likely to be present in cells.	[Silversmith, Ruth E.; Schilling, Elmar; Bourret, Robert B.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Levin, Matthew D.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3EJ, England	University of North Carolina; University of North Carolina Chapel Hill; University of Cambridge	Silversmith, RE (corresponding author), Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA.	silversr@med.unc.edu	Bourret, Robert/X-3606-2019	Bourret, Robert/0000-0002-6666-9220	NIGMS NIH HHS [GM 064713, R01 GM050860, R01 GM050860-14, GM 050860] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064713, R01GM050860] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Almogy G, 2001, BIOPHYS J, V81, P3016, DOI 10.1016/S0006-3495(01)75942-5; BERG HC, 1972, NATURE, V239, P500, DOI 10.1038/239500a0; Blat Y, 1998, J MOL BIOL, V284, P1191, DOI 10.1006/jmbi.1998.2224; Blat Y, 1996, BIOCHEMISTRY-US, V35, P5679, DOI 10.1021/bi9530447; Boesch KC, 2000, J BACTERIOL, V182, P3544, DOI 10.1128/JB.182.12.3544-3552.2000; Bourret RB, 2002, J BIOL CHEM, V277, P9625, DOI 10.1074/jbc.R100066200; Boxrud PD, 2000, J BIOL CHEM, V275, P14579, DOI 10.1074/jbc.275.19.14579; Cantwell BJ, 2003, J BACTERIOL, V185, P2354, DOI 10.1128/JB.185.7.2354-2361.2003; Cluzel P, 2000, SCIENCE, V287, P1652, DOI 10.1126/science.287.5458.1652; Guhaniyogi J, 2006, J MOL BIOL, V359, P624, DOI 10.1016/j.jmb.2006.03.050; Hammarstrom P, 2001, BIOPHYS J, V80, P2867, DOI 10.1016/S0006-3495(01)76253-4; HESS JF, 1991, METHOD ENZYMOL, V200, P188; HUANG CX, 1993, BIOCHIM BIOPHYS ACTA, V1202, P297, DOI 10.1016/0167-4838(93)90019-N; Janin J, 1997, PROTEINS, V28, P153, DOI 10.1002/(SICI)1097-0134(199706)28:2<153::AID-PROT4>3.0.CO;2-G; Kollmann M, 2005, NATURE, V438, P504, DOI 10.1038/nature04228; Lee SY, 2001, NAT STRUCT BIOL, V8, P52; Li MS, 2004, J BACTERIOL, V186, P3687, DOI 10.1128/JB.186.12.3687-3694.2004; Lipkow K, 2005, J BACTERIOL, V187, P45, DOI 10.1128/JB.187.1.45-53.2005; Lipkow K, 2006, PLOS COMPUT BIOL, V2, P301, DOI 10.1371/journal.pcbi.0020039; Lovdok L, 2007, J BIOTECHNOL, V129, P173, DOI 10.1016/j.jbiotec.2007.01.024; LUKAT GS, 1991, J BIOL CHEM, V266, P8348; LUKAT GS, 1990, BIOCHEMISTRY-US, V29, P5436, DOI 10.1021/bi00475a004; McEvoy MM, 1999, J MOL BIOL, V289, P1423, DOI 10.1006/jmbi.1999.2830; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Rao CV, 2005, PHYS BIOL, V2, P148, DOI 10.1088/1478-3975/2/3/002; RATHLEV T, 1956, ARCH BIOCHEM BIOPHYS, V65, P319, DOI 10.1016/0003-9861(56)90197-7; Sanna MG, 1996, J BIOL CHEM, V271, P7357, DOI 10.1074/jbc.271.13.7357; SANNA MG, 1995, MOL MICROBIOL, V15, P1069, DOI 10.1111/j.1365-2958.1995.tb02282.x; Sanna MG, 1996, J BACTERIOL, V178, P6275, DOI 10.1128/jb.178.21.6275-6280.1996; Scharf BE, 1998, J BACTERIOL, V180, P5123, DOI 10.1128/JB.180.19.5123-5128.1998; Sheridan R. C., 2007, INORG SYN, P23; Silversmith RE, 2005, BIOCHEMISTRY-US, V44, P7768, DOI 10.1021/bi0501636; Silversmith RE, 2003, J BACTERIOL, V185, P1495, DOI 10.1128/JB.185.5.1495-1502.2003; Silversmith RE, 2001, J BIOL CHEM, V276, P18478, DOI 10.1074/jbc.M011418200; Smith JG, 2004, MOL MICROBIOL, V51, P887, DOI 10.1046/j.1365-2958.2003.03882.x; Sourjik V, 2004, TRENDS MICROBIOL, V12, P569, DOI 10.1016/j.tim.2004.10.003; Sourjik V, 2002, P NATL ACAD SCI USA, V99, P123, DOI 10.1073/pnas.011589998; Sourjik V, 2000, MOL MICROBIOL, V37, P740, DOI 10.1046/j.1365-2958.2000.02044.x; STOCK AM, 1993, BIOCHEMISTRY-US, V32, P13375, DOI 10.1021/bi00212a001; Szurmant L, 2004, MICROBIOL MOL BIOL R, V68, P301, DOI 10.1128/MMBR.68.2.301-319.2004; Thompson JR, 2005, BIOCHEMISTRY-US, V44, P5763, DOI 10.1021/bi047944b; Turner L, 2000, J BACTERIOL, V182, P2793, DOI 10.1128/JB.182.10.2793-2801.2000; Vaknin A, 2004, P NATL ACAD SCI USA, V101, P17072, DOI 10.1073/pnas.0407812101; Wadhams GH, 2004, NAT REV MOL CELL BIO, V5, P1024, DOI 10.1038/nrm1524; Zhao R, 2002, NAT STRUCT BIOL, V9, P570	45	32	35	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					756	765		10.1074/jbc.M704400200	http://dx.doi.org/10.1074/jbc.M704400200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	17998207	hybrid			2022-12-27	WOS:000252128100014
J	Keramaris, E; Ruzhynsky, VA; Callaghan, SM; Wong, E; Davis, RJ; Flavell, R; Slack, RS; Park, DS				Keramaris, Elizabeth; Ruzhynsky, Vladamir A.; Callaghan, Steve M.; Wong, Estelle; Davis, Roger J.; Flavell, Richard; Slack, Ruth S.; Park, David S.			Required roles of Bax and JNKs in central and peripheral nervous system death of retinoblastoma-deficient mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL PHOSPHORYLATION; ACTIVATED PROTEIN-KINASES; CYCLIN-DEPENDENT KINASES; JUN NH2-TERMINAL KINASE; C-JUN; CELL-DEATH; SIGNAL-TRANSDUCTION; PARKINSONS-DISEASE; CORTICAL-NEURONS; TUMOR-SUPPRESSOR	Retinoblastoma-deficient mice show massive neuronal damage and deficits in both CNS and PNS tissue. Previous work in the field has shown that death is regulated through distinct processes where CNS tissue undergoes death regulated by the tumor suppressor p53 and the apoptosome component, APAF1. Death in the PNS, however, is independent of p53 and reliant on the death protease, caspase 3. In the present study, we more carefully delineated the common and distinct mechanisms of death regulation by examining the stress-activated kinases, JNK2 and 3, the conserved Bcl-2 member Bax, and the relationship among these elements including p53. By use of genetic modeling, we show that death in various regions of the CNS and DRGs of the PNS is reliant on Bax. In the CNS, Bax acts downstream of p53. The relevance of the JNKs is more complex, however. Surprisingly, JNK3 deficiency by itself does not inhibit c-Jun phosphorylation and instead, aggravates death in both CNS and PNS tissue. However, JNK2/3 double deficiency blocks death due to Rb loss in both the PNS and CNS. Importantly, the relationships between JNKs, p53, and Bax exhibit regional differences. In the medulla region of the hindbrain in the CNS, JNK2/3 deficiency blocks p53 activation. Moreover, Bax deficiency does not affect c-Jun phosphorylation. This indicates that a JNK- p53-Bax pathway is central in the hindbrain. However, in the diencephalon regions of the forebrain (thalamus), Bax deficiency blocks c-Jun activation, indicating that a Bax-JNK pathway of death is more relevant. In the DRGs of the PNS, a third pathway is present. In this case, a JNK- Bax pathway, independent of p53, regulates damage. Accordingly, our results show that a death regulator Bax is common to death in both PNS and CNS tissue. However, it is regulated by or itself regulates different effectors including the JNKs and p53 depending upon the specific region of the nervous system.	[Keramaris, Elizabeth; Ruzhynsky, Vladamir A.; Callaghan, Steve M.; Wong, Estelle; Slack, Ruth S.; Park, David S.] Univ Ottawa, Ottawa Hlth Res Inst, Dept Cellular Mol Med Neurosci E, Ottawa, ON K1H 8M5, Canada; [Davis, Roger J.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Dept Biochem & Mol Biol, Worcester, MA 01605 USA; [Flavell, Richard] Yale Univ, Sch Med, Howard Hughes Med Inst, Immunobiol Sect, New Haven, CT 06520 USA	University of Ottawa; Ottawa Hospital Research Institute; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; Yale University	Park, DS (corresponding author), Univ Ottawa, Ottawa Hlth Res Inst, Dept Cellular Mol Med Neurosci E, Ottawa, ON K1H 8M5, Canada.	dpark@uottawa.ca		Slack, Ruth/0000-0002-1552-2835; Davis, Roger/0000-0002-0130-1652; Park, David/0000-0002-4490-3784				Buschmann T, 2001, MOL CELL BIOL, V21, P2743, DOI 10.1128/MCB.21.8.2743-2754.2001; CLARKE AR, 1992, NATURE, V359, P328, DOI 10.1038/359328a0; Cregan SP, 2002, J CELL BIOL, V158, P507, DOI 10.1083/jcb.200202130; Cregan SP, 1999, J NEUROSCI, V19, P7860; Crocker SJ, 2001, P NATL ACAD SCI USA, V98, P13385, DOI 10.1073/pnas.231177098; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Ferguson KL, 2002, EMBO J, V21, P3337, DOI 10.1093/emboj/cdf338; Fuchs SY, 1998, P NATL ACAD SCI USA, V95, P10541, DOI 10.1073/pnas.95.18.10541; Ghahremani MH, 2002, J BIOL CHEM, V277, P35586, DOI 10.1074/jbc.M204362200; Giovanni A, 2000, J BIOL CHEM, V275, P11553, DOI 10.1074/jbc.275.16.11553; Guo Z, 2001, CANCER RES, V61, P8395; Harris CA, 2002, J NEUROSCI, V22, P103, DOI 10.1523/JNEUROSCI.22-01-00103.2002; Hayley S, 2004, J NEUROSCI, V24, P2045, DOI 10.1523/JNEUROSCI.4564-03.2004; Herdegen T, 2001, ONCOGENE, V20, P2424, DOI 10.1038/sj.onc.1204387; Herdegen T, 1998, J NEUROSCI, V18, P5124, DOI 10.1523/JNEUROSCI.18-14-05124.1998; Hunot S, 2004, P NATL ACAD SCI USA, V101, P665, DOI 10.1073/pnas.0307453101; JACKS T, 1992, NATURE, V359, P295, DOI 10.1038/359295a0; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Kuan CY, 2003, P NATL ACAD SCI USA, V100, P15184, DOI 10.1073/pnas.2336254100; LEE EYHP, 1992, NATURE, V359, P288, DOI 10.1038/359288a0; Lei K, 2002, MOL CELL BIOL, V22, P4929, DOI 10.1128/MCB.22.13.4929-4942.2002; Lei K, 2003, P NATL ACAD SCI USA, V100, P2432, DOI 10.1073/pnas.0438011100; LIN AN, 1995, SCIENCE, V268, P286, DOI 10.1126/science.7716521; Lipinski MM, 2001, EMBO J, V20, P3402, DOI 10.1093/emboj/20.13.3402; Macleod KF, 1996, EMBO J, V15, P6178, DOI 10.1002/j.1460-2075.1996.tb01006.x; MINDEN A, 1994, MOL CELL BIOL, V14, P6683, DOI 10.1128/MCB.14.10.6683; Morris EJ, 2001, ADV CANCER RES, V82, P1, DOI 10.1016/S0065-230X(01)82001-7; Morris EJ, 2001, J NEUROSCI, V21, P5017, DOI 10.1523/JNEUROSCI.21-14-05017.2001; Mulligan G, 1998, TRENDS GENET, V14, P223, DOI 10.1016/S0168-9525(98)01470-X; Oliva AA, 2006, J NEUROSCI, V26, P9462, DOI 10.1523/JNEUROSCI.2625-06.2006; Pan HC, 1998, MOL CELL, V2, P283, DOI 10.1016/S1097-2765(00)80273-7; Park DS, 1996, J BIOL CHEM, V271, P21898, DOI 10.1074/jbc.271.36.21898; Putcha GV, 2003, NEURON, V38, P899, DOI 10.1016/S0896-6273(03)00355-6; Raivich G, 2004, NEURON, V43, P57, DOI 10.1016/j.neuron.2004.06.005; Simpson MTW, 2001, J NEUROSCI, V21, P7089, DOI 10.1523/JNEUROSCI.21-18-07089.2001; Slack RS, 1996, DEV GENET, V18, P81, DOI 10.1002/(SICI)1520-6408(1996)18:1<81::AID-DVG9>3.0.CO;2-Y; Tsai KY, 1998, MOL CELL, V2, P293, DOI 10.1016/S1097-2765(00)80274-9; Whitfield J, 2001, NEURON, V29, P629, DOI 10.1016/S0896-6273(01)00239-2; Ziebold U, 2001, GENE DEV, V15, P386, DOI 10.1101/gad.858801	40	9	10	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					405	415		10.1074/jbc.M701552200	http://dx.doi.org/10.1074/jbc.M701552200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17984095	hybrid			2022-12-27	WOS:000251940300045
J	Schuler, T; Mesic, I; Madry, C; Bartholomaus, I; Laube, B				Schueler, Thomas; Mesic, Ivana; Madry, Christian; Bartholomaeus, Ingo; Laube, Bodo			Formation of NR1/NR2 and NR1/NR3 heterodimers constitutes the initial step in N-methyl-D-aspartate receptor assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; LIGAND-BINDING PROPERTIES; NMDA RECEPTOR; MOLECULAR DETERMINANTS; MUTATIONAL ANALYSIS; SURFACE EXPRESSION; ZN2+ MODULATION; TERMINAL DOMAIN; SUBUNIT; NR1	N-Methyl-D-aspartate (NMDA) receptors are tetrameric protein complexes composed of the glycine-binding NR1 subunit with a glutamate-binding NR2 and/or glycine-binding NR3 subunit. Tri-heteromeric receptors containing NR1, NR2, and NR3 subunits reconstitute channels, which differ strikingly in many properties from the respective glycine- and glutamate-gated NR1/NR2 complexes and the NR1/NR3 receptors gated by glycine alone. Therefore, an accurate oligomerization process of the different subunits has to assure proper NMDA receptor assembly, which has been assumed to occur via the oligomerization of homodimers. Indeed, using fluorescence resonance energy transfer analysis of differentially fluorescence-tagged subunits and blue native polyacrylamide gel electrophoresis after metabolic labeling and affinity purification revealed that the NR1 subunit is capable of forming homo-oligomeric aggregates. In contrast, both the NR2 and the NR3 subunits formed homo- and hetero-oligomers only in the presence of the NR1 subunit indicating differential roles of the subunits in NMDA receptor assembly. However, co-expression of the NR3A subunit with an N-terminal domain-deleted NR1 subunit (NR1(Delta NTD)) abrogating NR1 homo-oligomerization did not affect NR1/NR3A receptor stoichiometry or function. Hence, homo-oligomerization of the NR1 subunit is not essential for proper NR1/NR3 receptor assembly. Because identical results were obtained for NR1(Delta NTD)/NR2 NMDA receptors (Madry, C., Mesic, I., Betz, H., and Laube, B. ( 2007) Mol. Pharmacol., 72, 1535-1544) and NR1-containing hetero-oligomers are readily formed, we assume that heterodimerization of the NR1 with an NR3 or NR2 subunit, which is followed by the subsequent association of two heterodimers, is the key step in determining proper NMDA receptor subunit assembly and stoichiometry.	[Schueler, Thomas; Mesic, Ivana; Madry, Christian; Bartholomaeus, Ingo; Laube, Bodo] Max Planck Inst Hirnforsch, D-60528 Frankfurt, Germany; [Schueler, Thomas; Mesic, Ivana; Laube, Bodo] Tech Univ Darmstadt, AG Mol & Zellulare Neurophysiol, D-64287 Darmstadt, Germany	Max Planck Society; Technical University of Darmstadt	Laube, B (corresponding author), Max Planck Inst Hirnforsch, D-60528 Frankfurt, Germany.	laube@mpih-frankfurt.mpg.de	Madry, Christian/ABA-8050-2021	Madry, Christian/0000-0002-0522-7197				Al-Hallaq RA, 2002, MOL PHARMACOL, V62, P1119, DOI 10.1124/mol.62.5.1119; Atlason PT, 2007, J BIOL CHEM, V282, P25299, DOI 10.1074/jbc.M702778200; Ayalon G, 2001, NEURON, V31, P103, DOI 10.1016/S0896-6273(01)00333-6; Chatterton JE, 2002, NATURE, V415, P793, DOI 10.1038/nature715; Choi YB, 2001, J NEUROSCI, V21, P392, DOI 10.1523/JNEUROSCI.21-02-00392.2001; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; Das S, 1998, NATURE, V393, P377, DOI 10.1038/30748; Furukawa H, 2005, NATURE, V438, P185, DOI 10.1038/nature04089; Grudzinska J, 2005, NEURON, V45, P727, DOI 10.1016/j.neuron.2005.01.028; Hall RA, 1997, J BIOL CHEM, V272, P4135, DOI 10.1074/jbc.272.7.4135; Herin GA, 2004, EUR J PHARMACOL, V500, P101, DOI 10.1016/j.ejphar.2004.07.015; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; Karpova TS, 2003, J MICROSC-OXFORD, V209, P56, DOI 10.1046/j.1365-2818.2003.01100.x; Kenworthy AK, 2001, METHODS, V24, P289, DOI 10.1006/meth.2001.1189; KURYATOV A, 1994, NEURON, V12, P1291, DOI 10.1016/0896-6273(94)90445-6; Kuusinen A, 1999, J BIOL CHEM, V274, P28937, DOI 10.1074/jbc.274.41.28937; Laube B, 1997, NEURON, V18, P493, DOI 10.1016/S0896-6273(00)81249-0; Laube B, 2000, J PHYSIOL-LONDON, V522, P215, DOI 10.1111/j.1469-7793.2000.t01-1-00215.x; LAUBE B, 1993, FEBS LETT, V335, P331, DOI 10.1016/0014-5793(93)80412-N; Laube B, 1998, J NEUROSCI, V18, P2954; LAUBE B, 1995, J PHYSIOL-LONDON, V483, P613, DOI 10.1113/jphysiol.1995.sp020610; Leuschner WD, 1999, J BIOL CHEM, V274, P16907, DOI 10.1074/jbc.274.24.16907; Madden DR, 2002, NAT REV NEUROSCI, V3, P91, DOI 10.1038/nrn725; Madry C, 2007, MOL PHARMACOL, V72, P1535, DOI 10.1124/mol.107.040071; Madry C, 2007, BIOCHEM BIOPH RES CO, V354, P102, DOI 10.1016/j.bbrc.2006.12.153; Matsuda S, 2005, J BIOL CHEM, V280, P20021, DOI 10.1074/jbc.M410513200; Meddows E, 2001, J BIOL CHEM, V276, P18795, DOI 10.1074/jbc.M101382200; Paoletti P, 2000, NEURON, V28, P911, DOI 10.1016/S0896-6273(00)00163-X; Papadakis M, 2004, J BIOL CHEM, V279, P14703, DOI 10.1074/jbc.M313446200; Perez-Otano I, 2001, J NEUROSCI, V21, P1228; Qiu S, 2005, J BIOL CHEM, V280, P24923, DOI 10.1074/jbc.M413915200; Sadtler S, 2003, J BIOL CHEM, V278, P16782, DOI 10.1074/jbc.M213077200; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; Schorge S, 2003, J NEUROSCI, V23, P1151, DOI 10.1523/JNEUROSCI.23-04-01151.2003; Stephenson FA, 2006, BIOCHEM SOC T, V34, P877, DOI 10.1042/BST0340877; Tichelaar W, 2004, J MOL BIOL, V344, P435, DOI 10.1016/j.jmb.2004.09.048; Zimmermann T, 2002, FEBS LETT, V531, P245, DOI 10.1016/S0014-5793(02)03508-1	37	71	74	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					37	46		10.1074/jbc.M703539200	http://dx.doi.org/10.1074/jbc.M703539200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17959602	hybrid			2022-12-27	WOS:000251940300006
J	Ali, N; Knauper, V				Ali, Nazim; Knaeuper, Vera			Phorbol ester-induced shedding of the prostate cancer marker transmembrane protein with epidermal growth factor and two follistatin motifs 2 is mediated by the disintegrin and metalloproteinase-17	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CELL ADHESION; FACTOR-RECEPTOR; IN-VITRO; TISSUE INHIBITOR; BREAST-CANCER; UP-REGULATION; NUDE-MICE; CLEAVAGE; EGFR; TACE	The transmembrane protein with epidermal growth factor and two follistatin motifs 2 (TMEFF2) is expressed in prostate and brain and shed from the cell surface in a metalloproteinase-dependent fashion. Neither the sheddase(s) responsible for TMEFF2 shedding nor the physiological significance or activity of the soluble TMEFF2 ectodomain (TMEFF2-ECD) has been identified. In the present study we present new evidence that a disintegrin and metalloproteinase-17 (ADAM17) is responsible for phorbol 12-myristate 13-acetate-induced release of TMEFF2-ECD using small interfering RNA to ablate ADAM17 expression or by inhibiting enzymatic activity. A single well shedding assay monitoring the release of alkaline phosphatase-tagged TMEFF2-ECD into medium and the generation of 22- and 14-kDa C-terminal fragments in lysates were dependent on ADAM17 activity. A gamma-secretase inhibitor prevented the formation of a 10-kDa fragment in cell lysates, thus establishing TMEFF2 as a novel substrate for regulated intramembrane proteolysis. We assigned proliferation-inducing activity to TMEFF2. Inhibition of TMEFF2 shedding using synthetic metalloproteinase inhibitors or small interfering RNA targeting TMEFF2 expression yielded a statistically significant reduction of cell proliferation in the lymph node-derived prostate cancer cells (LNCaPs) and a human embryonic kidney (HEK293) cell line overexpressing TMEFF2. The TMEFF2-ECD was able to induce ERK1/2 phosphorylation in an epidermal growth factor receptor(or ErbB1)-dependent manner in HEK293 cells. Our data suggest that TMEFF2 contributes to cell proliferation in an ADAM17-dependent autocrine fashion in cells expressing this protein.	[Ali, Nazim; Knaeuper, Vera] Cardiff Univ, Sch Dent, Metalloproteinase Res Grp, Matrix Biol & Tissue Repair Res Unit, Cardiff CF14 4XY, Wales	Cardiff University	Knauper, V (corresponding author), Cardiff Univ, Sch Dent, Metalloproteinase Res Grp, Matrix Biol & Tissue Repair Res Unit, Heath Pk, Cardiff CF14 4XY, Wales.	KnauperV@cf.ac.uk		Ali, Nazim/0000-0002-0088-5115; Knauper, Vera/0000-0002-3965-9924				Adam RM, 1999, ENDOCRINOLOGY, V140, P5866, DOI 10.1210/en.140.12.5866; Afar DEH, 2004, MOL CANCER THER, V3, P921; Amour A, 2000, FEBS LETT, V473, P275, DOI 10.1016/S0014-5793(00)01528-3; Amour A, 1998, FEBS LETT, V435, P39, DOI 10.1016/S0014-5793(98)01031-X; Anders L, 2006, MOL CELL BIOL, V26, P3917, DOI 10.1128/MCB.26.10.3917-3934.2006; Angelucci A, 2006, ENDOCR-RELAT CANCER, V13, P197, DOI 10.1677/erc.1.01100; Arribas J, 2006, CANCER METAST REV, V25, P57, DOI 10.1007/s10555-006-7889-6; Baselga J, 2001, EUR J CANCER, V37, pS18, DOI 10.1016/S0959-8049(00)00404-4; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Borrell-Pages M, 2003, EMBO J, V22, P1114, DOI 10.1093/emboj/cdg111; Chen Q, 2006, CANCER LETT, V244, P274, DOI 10.1016/j.canlet.2005.12.027; Dempsey Peter J, 2002, Mol Interv, V2, P136, DOI 10.1124/mi.2.3.136; Dong JY, 2005, MOL BIOL CELL, V16, P2984, DOI 10.1091/mbc.E04-11-0994; Dong JY, 1999, P NATL ACAD SCI USA, V96, P6235, DOI 10.1073/pnas.96.11.6235; Ehlers MRW, 1996, BIOCHEMISTRY-US, V35, P9549, DOI 10.1021/bi9602425; El Sheikh SS, 2004, NEOPLASIA, V6, P846, DOI 10.1593/neo.04379; Endres K, 2005, FEBS J, V272, P5808, DOI 10.1111/j.1742-4658.2005.04976.x; Eto K, 2006, BIOCHEM BIOPH RES CO, V350, P263, DOI 10.1016/j.bbrc.2006.09.028; Fedak PWM, 2004, CIRCULATION, V110, P2401, DOI 10.1161/01.CIR.0000134959.83967.2D; Fischer OM, 2003, BIOCHEM SOC T, V31, P1203; Fitzgerald ML, 2000, J CELL BIOL, V148, P811, DOI 10.1083/jcb.148.4.811; Garton KJ, 2001, J BIOL CHEM, V276, P37993; Ge WT, 2006, J BIOL CHEM, V281, P7406, DOI 10.1074/jbc.M510687200; Gery S, 2002, ONCOGENE, V21, P4739, DOI 10.1038/sj.onc.1205142; Glynne-Jones E, 2001, INT J CANCER, V94, P178, DOI 10.1002/ijc.1450; Grasso AW, 1997, ONCOGENE, V15, P2705, DOI 10.1038/sj.onc.1201447; Gschwind A, 2003, EMBO J, V22, P2411, DOI 10.1093/emboj/cdg231; Hartmann D, 2002, HUM MOL GENET, V11, P2615, DOI 10.1093/hmg/11.21.2615; Hojilla CV, 2007, J CELL SCI, V120, P1050, DOI 10.1242/jcs.003335; Horie M, 2000, GENOMICS, V67, P146, DOI 10.1006/geno.2000.6228; Horiuchi K, 2005, DEV BIOL, V283, P459, DOI 10.1016/j.ydbio.2005.05.004; Horiuchi K, 2007, MOL BIOL CELL, V18, P176, DOI 10.1091/mbc.E06-01-0014; Hundhausen C, 2003, BLOOD, V102, P1186, DOI 10.1182/blood-2002-12-3775; Hynes NE, 2006, CANCER CELL, V10, P7, DOI 10.1016/j.ccr.2006.06.012; Janes PW, 2005, CELL, V123, P291, DOI 10.1016/j.cell.2005.08.014; Karan D, 2003, INT J ONCOL, V23, P1365; Kenny PA, 2007, J CLIN INVEST, V117, P337, DOI 10.1172/JCI29518; Kuefer R, 2006, NEOPLASIA, V8, P319, DOI 10.1593/neo.05682; Liang GN, 2000, CANCER RES, V60, P4907; Lin H, 2003, LIFE SCI, V73, P1617, DOI 10.1016/S0024-3205(03)00514-9; Maretzky T, 2005, P NATL ACAD SCI USA, V102, P9182, DOI 10.1073/pnas.0500918102; McCulloch DR, 2000, MOL CELL ENDOCRINOL, V167, P11, DOI 10.1016/S0303-7207(00)00305-1; Mohammed FF, 2004, NAT GENET, V36, P969, DOI 10.1038/ng1413; Mohler JL, 2002, PROSTATE, V51, P247, DOI 10.1002/pros.10086; Mosesson Y, 2004, SEMIN CANCER BIOL, V14, P262, DOI 10.1016/j.semcancer.2004.04.005; Murphy G, 2003, BIOCHEM SOC SYMP, V70, P65, DOI 10.1042/bss0700065; Nakamura H, 2004, CANCER RES, V64, P876, DOI 10.1158/0008-5472.CAN-03-3502; Peduto L, 2006, ONCOGENE, V25, P5462, DOI 10.1038/sj.onc.1209536; Peduto L, 2005, CANCER RES, V65, P9312, DOI 10.1158/0008-5472.CAN-05-1063; Quayle SN, 2006, GENOMICS, V87, P633, DOI 10.1016/j.ygeno.2005.12.004; Reiss K, 2005, EMBO J, V24, P742, DOI 10.1038/sj.emboj.7600548; Reiss K, 2006, PHARMACOL THERAPEUT, V111, P985, DOI 10.1016/j.pharmthera.2006.02.009; Reiss K, 2006, J BIOL CHEM, V281, P21735, DOI 10.1074/jbc.M602663200; Sahebjam S, 2007, ARTHRITIS RHEUM, V56, P905, DOI 10.1002/art.22427; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Sahin Umut, 2006, V327, P99; Santiago-Josefat B, 2007, J BIOL CHEM, V282, P8325, DOI 10.1074/jbc.M608826200; Siegel DA, 2006, J NEUROCHEM, V98, P34, DOI 10.1111/j.1471-4159.2006.03801.x; Singh RJR, 2005, CARDIOVASC RES, V67, P39, DOI 10.1016/j.cardiores.2005.02.020; Smith BL, 2004, BRIT J CANCER, V91, P1190, DOI 10.1038/sj.bjc.6602090; Smookler DS, 2006, J IMMUNOL, V176, P721, DOI 10.4049/jimmunol.176.2.721; Sternlicht MD, 2005, DEVELOPMENT, V132, P3923, DOI 10.1242/dev.01966; Takeuchi T, 1999, P NATL ACAD SCI USA, V96, P11054, DOI 10.1073/pnas.96.20.11054; Uchida T, 1999, BIOCHEM BIOPH RES CO, V266, P593, DOI 10.1006/bbrc.1999.1873; Vicentini C, 2003, J CANCER RES CLIN, V129, P165, DOI 10.1007/s00432-003-0420-3; Vincent B, 2001, J BIOL CHEM, V276, P37743; Weskamp G, 2004, J BIOL CHEM, V279, P4241, DOI 10.1074/jbc.M307974200; Xia WM, 2003, J CELL SCI, V116, P2839, DOI 10.1242/jcs.00651; Yamazaki S, 2003, J CELL BIOL, V163, P469, DOI 10.1083/jcb.200307035; Yazici S, 2005, PROSTATE, V65, P203, DOI 10.1002/pros.20283; Young J, 2001, P NATL ACAD SCI USA, V98, P265, DOI 10.1073/pnas.011415298; Zhao LC, 2001, J BIOL CHEM, V276, P30631, DOI 10.1074/jbc.M103748200; Zhao XY, 2005, CANCER RES, V65, P2846, DOI 10.1158/0008-5472.CAN-04-4019	73	30	32	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37378	37388		10.1074/jbc.M702170200	http://dx.doi.org/10.1074/jbc.M702170200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17942404	hybrid, Green Accepted			2022-12-27	WOS:000251833600012
J	Bluem, R; Schmidt, E; Corvey, C; Karas, M; Schlicksupp, A; Kirsch, J; Kuhse, J				Bluem, Raphael; Schmidt, Enrico; Corvey, Carsten; Karas, Michael; Schlicksupp, Andrea; Kirsch, Joachim; Kuhse, Jochen			Components of the translational machinery are associated with juvenile glycine receptors and are redistributed to cytoskeleton upon aging and synaptic activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELONGATION-FACTOR 1A; RAT SPINAL-CORD; POSTSYNAPTIC DENSITY; SPLICE VARIANTS; FACTOR 1-ALPHA; GEPHYRIN; PROTEIN; IDENTIFICATION; EXPRESSION; ACTIN	The translation eukaryotic elongation factor 1 alpha(eEF1A) is a monomeric GTPase involved in protein synthesis. In addition, this protein is thought to participate in other cellular functions such as actin bundling, cell cycle regulation, and apoptosis. Here we show that eEF1A is associated with the alpha 2 subunit of the inhibitory glycine receptor in pulldown experiments with rat brain extracts. Moreover, additional proteins involved in translation like ribosomal S6 protein and p70 ribosomal S6 protein kinase as well as ERK1/2 and calcineurin were identified in the same pulldown approaches. Glycine receptor activation in spinal cordneurons cultured for 1 week resulted in an increased phosphorylation of ribosomal S6 protein. Immunocytochemistry showed that eEF1A and ribosomal S6 protein are localized in the soma, dendrites, and at synapses of cultured hippocampal and spinal cord neurons. Consistent with our biochemical data, immunoreactivities of both proteins were partially overlapping with glycine receptor immunoreactivity in cultured spinal cord and hippocampal neurons. After 5 weeks in culture, eEF1A immunoreactivity was redistributed to the cytoskeleton in about 45% of neurons. Interestingly, the degree of redistribution could be increased at earlier stages of in vitro differentiation by inhibition of either the ERK1/2 pathway or glycine receptors and simultaneousN-methyl-D-aspartate receptor activation. Our findings suggest a functional coupling of eEF1A with both inhibitory and excitatory receptors, possibly involving the ERK-signaling pathway.	[Bluem, Raphael; Schmidt, Enrico; Schlicksupp, Andrea; Kirsch, Joachim; Kuhse, Jochen] Univ Heidelberg, Dept Anat & Cell Biol, D-69120 Heidelberg, Germany; [Corvey, Carsten; Karas, Michael] Univ Frankfurt, Dept Pharmaceut Chem, D-60438 Frankfurt, Germany	Ruprecht Karls University Heidelberg; Goethe University Frankfurt	Kuhse, J (corresponding author), Univ Heidelberg, Dept Anat & Cell Biol, Neuenheimer Feld 307, D-69120 Heidelberg, Germany.	jochen.kuhse@urz.uni-heidelberg.de	Kuhse, Jochen/T-3864-2019					Bader AG, 2005, NAT REV CANCER, V5, P921, DOI 10.1038/nrc1753; Blackstone C, 1999, CELL CALCIUM, V26, P181, DOI 10.1054/ceca.1999.0071; Bunai F, 2006, J BIOCHEM, V140, P393, DOI 10.1093/jb/mvj169; Cho SJ, 2004, NEUROSCI LETT, V366, P29, DOI 10.1016/j.neulet.2004.05.036; Chuang SM, 2005, MOL CELL BIOL, V25, P403, DOI 10.1128/MCB.25.1.403-413.2005; Dresbach T, 2003, MOL CELL NEUROSCI, V23, P279, DOI 10.1016/S1044-7431(03)00015-0; Feng GP, 1998, SCIENCE, V282, P1321, DOI 10.1126/science.282.5392.1321; Giustetto M, 2003, P NATL ACAD SCI USA, V100, P13680, DOI 10.1073/pnas.1835674100; Gong R, 2006, J BIOL CHEM, V281, P18802, DOI 10.1074/jbc.M512524200; GRENNINGLOH G, 1990, EMBO J, V9, P771, DOI 10.1002/j.1460-2075.1990.tb08172.x; Gross SR, 2005, NAT STRUCT MOL BIOL, V12, P772, DOI 10.1038/nsmb979; HOCH W, 1989, NEURON, V3, P339, DOI 10.1016/0896-6273(89)90258-4; HONGBROWN LQ, 2004, AM J PHYSIOL, V287, P482; KELLY PT, 1978, J CELL BIOL, V79, P173, DOI 10.1083/jcb.79.1.173; Kins S, 2000, NAT NEUROSCI, V3, P22, DOI 10.1038/71096; KIRSCH J, 1993, NATURE, V366, P745, DOI 10.1038/366745a0; KIRSCH J, 1995, J NEUROSCI, V15, P4148; McClatchy DB, 2006, NEUROCHEM RES, V31, P975, DOI 10.1007/s11064-006-9103-1; MEYER G, 1995, NEURON, V15, P563, DOI 10.1016/0896-6273(95)90145-0; Moore RC, 2000, CELL MOTIL CYTOSKEL, V45, P279, DOI 10.1002/(SICI)1097-0169(200004)45:4<279::AID-CM4>3.3.CO;2-W; Newbery HJ, 2007, J BIOL CHEM, V282, P28951, DOI 10.1074/jbc.M703962200; Pauly T, 2005, NEUROSCIENCE, V131, P99, DOI 10.1016/j.neuroscience.2004.10.039; PFEIFFER F, 1981, BRAIN RES, V226, P273, DOI 10.1016/0006-8993(81)91099-4; PFEIFFER F, 1984, P NATL ACAD SCI-BIOL, V81, P7224, DOI 10.1073/pnas.81.22.7224; PRIOR P, 1992, NEURON, V8, P1161, DOI 10.1016/0896-6273(92)90136-2; Reid T, 1999, J BIOL CHEM, V274, P33587, DOI 10.1074/jbc.274.47.33587; ROSENFELD J, 1992, ANAL BIOCHEM, V203, P173, DOI 10.1016/0003-2697(92)90061-B; Ruest LB, 2002, J BIOL CHEM, V277, P5418, DOI 10.1074/jbc.M110685200; Sabatini DM, 1999, SCIENCE, V284, P1161, DOI 10.1126/science.284.5417.1161; SHEPHERD JCW, 1989, P NATL ACAD SCI USA, V86, P7520, DOI 10.1073/pnas.86.19.7520; Shevchenko A, 1996, P NATL ACAD SCI USA, V93, P14440, DOI 10.1073/pnas.93.25.14440; SHIINA N, 1994, SCIENCE, V266, P282, DOI 10.1126/science.7939665; Yoshida M, 2004, J NEUROBIOL, V60, P166, DOI 10.1002/neu.20003	33	13	13	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37783	37793		10.1074/jbc.M708301200	http://dx.doi.org/10.1074/jbc.M708301200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17965018	hybrid			2022-12-27	WOS:000251833600054
J	Carman, GM; Henry, SA				Carman, George M.; Henry, Susan A.			Phosphatidic acid plays a central role in the transcriptional regulation of glycerophospholipid synthesis in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							PHOSPHATIDYLETHANOLAMINE METHYLATION PATHWAY; CDP-DIACYLGLYCEROL SYNTHASE; LIPID-BINDING PROTEINS; PHOSPHOLIPID BIOSYNTHESIS; PHOSPHATIDYLCHOLINE BIOSYNTHESIS; ENDOPLASMIC-RETICULUM; INO1 EXPRESSION; SIGNALING FUNCTIONS; NEGATIVE REGULATOR; INOSITOL SYNTHESIS		Rutgers State Univ, Rutgers Ctr Lipid Res, Dept Food Sci, New Brunswick, NJ 08901 USA; Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	Rutgers State University New Brunswick; Cornell University	Carman, GM (corresponding author), Rutgers State Univ, Dept Food Sci, 65 Dudley Rd, New Brunswick, NJ 08901 USA.	carman@aesop.rutgers.edu	Henry, Susan/K-5464-2014		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM019629, R01GM028140, R01GM019629, F32GM019629, R37GM028140] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM19629, R01 GM019629-35, R37 GM019629, R01 GM028140, R01 GM019629, R37 GM028140, F32 GM019629, GM28140] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMBROZIAK J, 1994, J BIOL CHEM, V269, P15344; ATKINSON K, 1980, J BIOL CHEM, V255, P6653; ATKINSON KD, 1980, J BACTERIOL, V141, P558, DOI 10.1128/JB.141.2.558-564.1980; BACHHAWAT N, 1995, J BIOL CHEM, V270, P25087, DOI 10.1074/jbc.270.42.25087; Brindley DN, 2004, J CELL BIOCHEM, V92, P900, DOI 10.1002/jcb.20126; Carman GM, 2007, BBA-MOL CELL BIOL L, V1771, P322, DOI 10.1016/j.bbalip.2006.05.006; Carman GM, 1999, PROG LIPID RES, V38, P361, DOI 10.1016/S0163-7827(99)00010-7; Carman GM, 2004, BIOCHEM CELL BIOL, V82, P62, DOI 10.1139/o03-064; CARMAN GM, 1989, ANNU REV BIOCHEM, V58, P635, DOI 10.1146/annurev.biochem.58.1.635; Carman GM, 1996, J BIOL CHEM, V271, P13293, DOI 10.1074/jbc.271.23.13293; Chang HJ, 2004, GENETICS, V168, P1899, DOI 10.1534/genetics.104.032961; Chang YF, 2006, J BIOL CHEM, V281, P4754, DOI 10.1074/jbc.M513064200; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; Czabany T, 2007, BBA-MOL CELL BIOL L, V1771, P299, DOI 10.1016/j.bbalip.2006.07.001; Foster DA, 2007, CANCER RES, V67, P1, DOI 10.1158/0008-5472.CAN-06-3016; Gaspar ML, 2007, BBA-MOL CELL BIOL L, V1771, P241, DOI 10.1016/j.bbalip.2006.06.011; Greenberg ML, 1996, MICROBIOL REV, V60, P1; GREENBERG ML, 1982, GENETICS, V100, P19; Griac P, 1996, J BIOL CHEM, V271, P25692, DOI 10.1074/jbc.271.41.25692; Griac P, 1999, NUCLEIC ACIDS RES, V27, P2043, DOI 10.1093/nar/27.9.2043; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Han SH, 2005, J BIOL CHEM, V280, P29017, DOI 10.1074/jbc.M505881200; Henry S. A., 1982, MOL BIOL YEAST SACCH, P101; Henry SA, 1998, PROG NUCLEIC ACID RE, V61, P133, DOI 10.1016/S0079-6603(08)60826-0; HIRSCH JP, 1986, MOL CELL BIOL, V6, P3320, DOI 10.1128/MCB.6.10.3320; HOSAKA K, 1984, BIOCHIM BIOPHYS ACTA, V796, P110; HOSHIZAKI DK, 1990, J BIOL CHEM, V265, P4736; Howe AG, 2006, CAN J PHYSIOL PHARM, V84, P29, DOI 10.1139/Y05-138; Iwanyshyn WM, 2004, J BIOL CHEM, V279, P21976, DOI 10.1074/jbc.M402047200; IWANYSHYN WM, 2005, THESIS RUTGERS U NEW; Jesch SA, 2005, J BIOL CHEM, V280, P9106, DOI 10.1074/jbc.M411770200; Jesch SA, 2006, J BIOL CHEM, V281, P24070, DOI 10.1074/jbc.M604541200; Kagiwada S, 2003, J BIOCHEM, V133, P515, DOI 10.1093/jb/mvg068; Kagiwada S, 1998, J BACTERIOL, V180, P1700, DOI 10.1128/JB.180.7.1700-1708.1998; KELLEY MJ, 1988, J BIOL CHEM, V263, P18078; Kim KH, 1998, J BIOL CHEM, V273, P6844, DOI 10.1074/jbc.273.12.6844; Kim KS, 1999, J BIOL CHEM, V274, P14857, DOI 10.1074/jbc.274.21.14857; KLIG LS, 1988, J BACTERIOL, V170, P1878, DOI 10.1128/jb.170.4.1878-1886.1988; KODAKI T, 1987, J BIOL CHEM, V262, P15428; KODAKI T, 1989, EUR J BIOCHEM, V185, P243, DOI 10.1111/j.1432-1033.1989.tb15109.x; KODAKI T, 1991, J BACTERIOL, V173, P7992, DOI 10.1128/jb.173.24.7992-7995.1991; Lo WS, 2001, SCIENCE, V293, P1142, DOI 10.1126/science.1062322; Lo WS, 2005, EMBO J, V24, P997, DOI 10.1038/sj.emboj.7600577; Loewen CJR, 2005, J BIOL CHEM, V280, P14097, DOI 10.1074/jbc.M500147200; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; Loewen CJR, 2003, EMBO J, V22, P2025, DOI 10.1093/emboj/cdg201; LOEWY BS, 1984, MOL CELL BIOL, V4, P2479, DOI 10.1128/MCB.4.11.2479; LOPES JM, 1991, NUCLEIC ACIDS RES, V19, P1687, DOI 10.1093/nar/19.7.1687; MCGEE TP, 1994, J CELL BIOL, V124, P273, DOI 10.1083/jcb.124.3.273; MCGRAW P, 1989, GENETICS, V122, P317; MCMASTER CR, 1994, J BIOL CHEM, V269, P14776; MCMASTER CR, 1994, J BIOL CHEM, V269, P28010; MORASH SC, 1994, J BIOL CHEM, V269, P28769; MORLOCK KR, 1988, J BACTERIOL, V170, P3561, DOI 10.1128/jb.170.8.3561-3566.1988; Nakanishi H, 2006, J CELL SCI, V119, P1406, DOI 10.1242/jcs.02841; NIKAWA J, 1995, J BIOCHEM, V118, P39, DOI 10.1093/oxfordjournals.jbchem.a124889; NIKAWA JI, 1992, MOL MICROBIOL, V6, P1441, DOI 10.1111/j.1365-2958.1992.tb00864.x; NIKOLOFF DM, 1992, NUCLEIC ACIDS RES, V20, P3253, DOI 10.1093/nar/20.12.3253; NUNEZ L, 2006, THESIS CORNELL U ITH; O'Hara L, 2006, J BIOL CHEM, V281, P34537, DOI 10.1074/jbc.M606654200; Ostrander DB, 1998, J BIOL CHEM, V273, P18992, DOI 10.1074/jbc.273.30.18992; PALTAUF F, 1992, MOL CELLULAR BIOL YE, P415; PattonVogt JL, 1997, J BIOL CHEM, V272, P20873, DOI 10.1074/jbc.272.33.20873; RATTRAY JBM, 1975, BACTERIOL REV, V39, P197, DOI 10.1128/MMBR.39.3.197-231.1975; Rudge SA, 2004, MOL BIOL CELL, V15, P207, DOI 10.1091/mbc.e03-04-0245; Santiago TC, 2003, J BIOL CHEM, V278, P38723, DOI 10.1074/jbc.M303008200; Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672; SCHULLER HJ, 1992, EMBO J, V11, P107, DOI 10.1002/j.1460-2075.1992.tb05033.x; SCHULLER HJ, 1995, FEBS LETT, V370, P149, DOI 10.1016/0014-5793(95)00818-T; SCHWANK S, 1995, NUCLEIC ACIDS RES, V23, P230, DOI 10.1093/nar/23.2.230; Sciorra VA, 2002, BBA-MOL CELL BIOL L, V1582, P45, DOI 10.1016/S1388-1981(02)00136-1; Shen H, 1996, J BIOL CHEM, V271, P29043, DOI 10.1074/jbc.271.46.29043; Shen HF, 1996, J BIOL CHEM, V271, P789, DOI 10.1074/jbc.271.2.789; Shirra MK, 2001, MOL CELL BIOL, V21, P5710, DOI 10.1128/MCB.21.17.5710-5722.2001; Sreenivas A, 1998, J BIOL CHEM, V273, P16635, DOI 10.1074/jbc.273.27.16635; Sreenivas A, 2003, J BIOL CHEM, V278, P20673, DOI 10.1074/jbc.M300132200; Sreenivas A, 2001, J BIOL CHEM, V276, P29915, DOI 10.1074/jbc.M105147200; SUMMERS EF, 1988, GENETICS, V120, P909; TAYLOR FR, 1979, BIOCHIM BIOPHYS ACTA, V575, P204, DOI 10.1016/0005-2760(79)90022-5; Testerink C, 2005, TRENDS PLANT SCI, V10, P368, DOI 10.1016/j.tplants.2005.06.002; TROTTER PJ, 1995, J BIOL CHEM, V270, P6071, DOI 10.1074/jbc.270.11.6071; TROTTER PJ, 1995, J BIOL CHEM, V270, P6062, DOI 10.1074/jbc.270.11.6062; Waggoner DW, 1999, BBA-MOL CELL BIOL L, V1439, P299, DOI 10.1016/S1388-1981(99)00102-X; Wagner C, 2001, MOL MICROBIOL, V41, P155, DOI 10.1046/j.1365-2958.2001.02495.x; Wang XM, 2006, PROG LIPID RES, V45, P250, DOI 10.1016/j.plipres.2006.01.005; WHITE MJ, 1991, J BIOL CHEM, V266, P863; WOODS A, 1994, J BIOL CHEM, V269, P19509; Xie ZG, 1998, P NATL ACAD SCI USA, V95, P12346, DOI 10.1073/pnas.95.21.12346	88	152	156	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37293	37297		10.1074/jbc.R700038200	http://dx.doi.org/10.1074/jbc.R700038200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17981800	Green Accepted, hybrid			2022-12-27	WOS:000251833600002
J	Wang, HB; Xie, HR; Sun, XF; Tranguch, S; Zhang, H; Jia, XX; Wang, DZ; Das, SK; Desvergne, B; Wahli, W; DuBois, RN; Dey, SK				Wang, Haibin; Xie, Huirong; Sun, Xiaofei; Tranguch, Susanne; Zhang, Hao; Jia, Xiangxu; Wang, Dingzhi; Das, Sanjoy K.; Desvergne, Beatrice; Wahli, Walter; DuBois, Raymond N.; Dey, Sudhansu K.			Stage-specific integration of maternal and embryonic peroxisome proliferator-activated receptor delta signaling is critical to pregnancy success	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERIIMPLANTATION MOUSE UTERUS; TARGETED DISRUPTION; TROPHOBLAST DIFFERENTIATION; MICE LACKING; PLACENTAL DEVELOPMENT; TRANSCRIPTION FACTOR; DEFICIENT MICE; GROWTH-FACTOR; EGF-RECEPTOR; PPAR-DELTA	Successful pregnancy depends on well coordinated developmental events involving both maternal and embryonic components. Although a host of signaling pathways participate in implantation, decidualization, and placentation, whether there is a common molecular link that coordinates these processes remains unknown. By exploiting genetic, molecular, pharmacological, and physiological approaches, we show here that the nuclear transcription factor peroxisome proliferator-activated receptor (PPAR)delta plays a central role at various stages of pregnancy, whereas maternal PPAR delta is critical to implantation and decidualization, and embryonic PPAR delta is vital for placentation. Using trophoblast stem cells, we further elucidate that a reciprocal relationship between PPAR delta-AKT and leukemia inhibitory factor-STAT3 signaling pathways serves as a cell lineage sensor to direct trophoblast cell fates during placentation. This novel finding of stage-specific integration of maternal and embryonic PPAR delta signaling provides evidence that PPAR delta is a molecular link that coordinates implantation, decidualization, and placentation crucial to pregnancy success. This study is clinically relevant because deferral of on time implantation leads to spontaneous pregnancy loss, and defective trophoblast invasion is one cause of preeclampsia in humans.	[Wang, Haibin; Xie, Huirong; Sun, Xiaofei; Tranguch, Susanne; Zhang, Hao; Jia, Xiangxu; Das, Sanjoy K.; Dey, Sudhansu K.] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA; [Sun, Xiaofei; Dey, Sudhansu K.] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA; [Tranguch, Susanne; DuBois, Raymond N.; Dey, Sudhansu K.] Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, Nashville, TN 37232 USA; [Wang, Dingzhi; DuBois, Raymond N.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN 37232 USA; [Das, Sanjoy K.] Vanderbilt Univ, Med Ctr, Dept Canc Biol, Div Reprod & Dev Biol, Nashville, TN 37232 USA; [Desvergne, Beatrice; Wahli, Walter] Univ Lausanne, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; University of Lausanne	Dey, SK (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA.	sk.dey@vanderbilt.edu	Wahli, Walter/I-3194-2019; DuBois, Raymond N./AAX-8869-2020; Wahli, Walter/B-1398-2009; Desvergne, Beatrice/C-8892-2016	Wahli, Walter/0000-0002-5966-9089; Tranguch, Susanne/0000-0001-9496-7260; Desvergne, Beatrice/0000-0001-5483-288X	NCI NIH HHS [P01 CA77839] Funding Source: Medline; NICHD NIH HHS [HD12304, HD37830, HD050315] Funding Source: Medline; NIDA NIH HHS [F31 DA021062, DA06668] Funding Source: Medline; NIEHS NIH HHS [ES07814] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD012304, R03HD050315, R01HD012304, R01HD037830] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA077839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES007814] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA006668, R01DA006668, F31DA021062] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Adamson SL, 2002, DEV BIOL, V250, P358, DOI 10.1006/dbio.2002.0773; Barak Y, 2002, P NATL ACAD SCI USA, V99, P303, DOI 10.1073/pnas.012610299; Barak Y, 2007, PPAR RES, V2007, DOI 10.1155/2007/12781; Chakraborty I, 1996, J MOL ENDOCRINOL, V16, P107, DOI 10.1677/jme.0.0160107; Cheng LH, 2004, NAT MED, V10, P1245, DOI 10.1038/nm1116; Coan PM, 2006, DEV DYNAM, V235, P3280, DOI 10.1002/dvdy.20981; Dahl KDC, 2005, MOL CELL BIOL, V25, P10479, DOI 10.1128/MCB.25.23.10479-10491.2005; Daikoku T, 2007, CANCER RES, V67, P5285, DOI 10.1158/0008-5472.CAN-07-0828; Das SK, 1997, DEV GENET, V21, P44, DOI 10.1002/(SICI)1520-6408(1997)21:1&lt;44::AID-DVG5&gt;3.0.CO;2-8; DAS SK, 1994, DEVELOPMENT, V120, P1071; Davis S, 1999, CURR TOP MICROBIOL, V237, P173; Di-Poi N, 2002, MOL CELL, V10, P721, DOI 10.1016/S1097-2765(02)00646-9; Duval D, 2000, FASEB J, V14, P1577, DOI 10.1096/fj.14.11.1577; Fowler KJ, 2000, GENOME RES, V10, P30; GUILLEMOT F, 1994, NATURE, V371, P333, DOI 10.1038/371333a0; Gupta RA, 2004, NAT MED, V10, P245, DOI 10.1038/nm993; GURTNER GC, 1995, GENE DEV, V9, P1, DOI 10.1101/gad.9.1.1; Halder JB, 2000, GENESIS, V26, P213, DOI 10.1002/(SICI)1526-968X(200003)26:3<213::AID-GENE7>3.0.CO;2-M; Hizaki H, 1999, P NATL ACAD SCI USA, V96, P10501, DOI 10.1073/pnas.96.18.10501; Kersten S, 2000, NATURE, V405, P421, DOI 10.1038/35013000; KWEE L, 1995, DEVELOPMENT, V121, P489; Lee CH, 2003, SCIENCE, V302, P453, DOI 10.1126/science.1087344; LEE SST, 1995, MOL CELL BIOL, V15, P3012; LESCISIN KR, 1988, GENE DEV, V2, P1639, DOI 10.1101/gad.2.12a.1639; Li AC, 2004, J CLIN INVEST, V114, P1564, DOI 10.1172/JCI200418730; Lim H, 1997, CELL, V91, P197, DOI 10.1016/S0092-8674(00)80402-X; Lim H, 1999, GENE DEV, V13, P1561, DOI 10.1101/gad.13.12.1561; Luquet S, 2003, FASEB J, V17, P2299, DOI 10.1096/fj.03-0269fje; Ma W, 2001, MOL ENDOCRINOL, V15, P1983, DOI 10.1210/me.15.11.1983; Matsumoto H, 2002, J BIOL CHEM, V277, P29260, DOI 10.1074/jbc.M203996200; Michalik L, 2001, J CELL BIOL, V154, P799, DOI 10.1083/jcb.200011148; Murata T, 1997, NATURE, V388, P678, DOI 10.1038/41780; Nadra K, 2006, MOL CELL BIOL, V26, P3266, DOI 10.1128/MCB.26.8.3266-3281.2006; Natale DRC, 2006, METH MOLEC MED, V121, P275; Oliver WR, 2001, P NATL ACAD SCI USA, V98, P5306, DOI 10.1073/pnas.091021198; PARIA BC, 1993, P NATL ACAD SCI USA, V90, P10159, DOI 10.1073/pnas.90.21.10159; Peters JM, 2000, MOL CELL BIOL, V20, P5119, DOI 10.1128/MCB.20.14.5119-5128.2000; Red-Horse K, 2004, J CLIN INVEST, V114, P744, DOI 10.1172/JCI200422991; Riley P, 1998, NAT GENET, V18, P271, DOI 10.1038/ng0398-271; Robb L, 2005, P NATL ACAD SCI USA, V102, P16333, DOI 10.1073/pnas.0508023102; Roberts AW, 2001, P NATL ACAD SCI USA, V98, P9324, DOI 10.1073/pnas.161271798; Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570; Scherle PA, 2000, J BIOL CHEM, V275, P37086, DOI 10.1074/jbc.M006168200; Scott IC, 2000, MOL CELL BIOL, V20, P530, DOI 10.1128/MCB.20.2.530-541.2000; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Simmons DG, 2005, DEV BIOL, V284, P12, DOI 10.1016/j.ydbio.2005.05.010; Song H, 2002, DEVELOPMENT, V129, P2879; Takahashi T, 2006, J BIOL CHEM, V281, P37117, DOI 10.1074/jbc.M608202200; Takahashi Y, 2003, EMBO J, V22, P372, DOI 10.1093/emboj/cdg057; Tan NS, 2001, GENE DEV, V15, P3263, DOI 10.1101/gad.207501; Tanaka M, 1997, DEV BIOL, V190, P55, DOI 10.1006/dbio.1997.8685; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; THREADGILL DW, 1995, SCIENCE, V269, P230, DOI 10.1126/science.7618084; Wang DZ, 2006, P NATL ACAD SCI USA, V103, P19069, DOI 10.1073/pnas.0607948103; Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808; Wang HB, 2004, J BIOL CHEM, V279, P10649, DOI 10.1074/jbc.M312203200; Wang XH, 2002, DEVELOPMENT, V129, P4125; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294; Wang YX, 2003, CELL, V113, P159, DOI 10.1016/S0092-8674(03)00269-1; WARE CB, 1995, DEVELOPMENT, V121, P1283; Yan JL, 2001, DEV BIOL, V235, P422, DOI 10.1006/dbio.2001.0300; Yang ZM, 1997, BIOL REPROD, V56, P368, DOI 10.1095/biolreprod56.2.368; Yang ZZ, 2003, J BIOL CHEM, V278, P32124, DOI 10.1074/jbc.M302847200; Ye XQ, 2005, NATURE, V435, P104, DOI 10.1038/nature03505	64	48	52	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37770	37782		10.1074/jbc.M706577200	http://dx.doi.org/10.1074/jbc.M706577200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17965409	hybrid			2022-12-27	WOS:000251833600053
J	Berg, DT; Gupta, A; Richardson, MA; O'Brien, LA; Calnek, D; Grinnell, BW				Berg, David T.; Gupta, Akanksha; Richardson, Mark A.; O'Brien, Lee A.; Calnek, David; Grinnell, Brian W.			Negative regulation of inducible nitric-oxide synthase expression mediated through transforming growth factor-beta-dependent modulation of transcription factor TCF11	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-C; ENDOTOXIN-INDUCED HYPOTENSION; SMOOTH-MUSCLE-CELLS; KINASE; INHIBITION; DELTA; PKC; PHOSPHORYLATION; THROMBOMODULIN; FIBROBLASTS	Inducible nitric-oxide synthase ( iNOS) plays a central role in the regulation of vascular function and response to injury. A central mediator controlling iNOS expression is transforming growth factor-beta (TGF-beta), which represses its expression through a mechanism that is poorly understood. We have identified a binding site in the iNOS promoter that interacts with the nuclear heterodimer TCF11/MafG using chromatin immunoprecipitation and mutation analyses. We demonstrate that binding at this site acts to repress the induction of iNOS gene expression by cytokines. We show that this repressor is induced by TGF-beta 1 and by Smad6-short, which enhances TGF-beta signaling. In contrast, the up-regulation of TCF11/MafG binding could be suppressed by overexpression of the TGF-beta inhibitor Smad7, and a small interfering RNA to TCF11 blocked the suppression of iNOS by TGF-beta. The binding of TCF11/MafG to the iNOS promoter could be enhanced by phorbol 12-myristate 13-acetate and suppressed by the protein kinase C inhibitor staurosporine. Moreover, the induction of TCF11/MafG binding by TGF-beta and Smad6-short could be blocked by staurosporine, and the effect of TGF-beta was blocked by the selective protein kinase C inhibitor calphostin C. Consistent with the in vitro data, we found suppression of TCF11 coincident with iNOS upregulation in a rat model of endotoxemia, and we observed a highly significant negative correlation between TCF11 and nitric oxide production. Furthermore, treatment with activated protein C, a serine protease effective in septic shock, blocked the down-regulation of TCF11 and suppressed endotoxin-induced iNOS. Overall, our results demonstrate a novel mechanism by which iNOS expression is regulated in the context of inflammatory activation.	[Berg, David T.; Gupta, Akanksha; Richardson, Mark A.; O'Brien, Lee A.; Calnek, David; Grinnell, Brian W.] Lilly Corp Ctr, Lilly Res Labs, Div Biotechnol Discovery Res, Indianapolis, IN 46285 USA	Eli Lilly	Grinnell, BW (corresponding author), Lilly Corp Ctr, Lilly Res Labs, Div Biotechnol Discovery Res, Indianapolis, IN 46285 USA.	bgrinnell@lilly.com						Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Berg DT, 2005, J BIOL CHEM, V280, P14943, DOI 10.1074/jbc.C400579200; BERG DT, 1995, J BIOL CHEM, V270, P15447, DOI 10.1074/jbc.270.26.15447; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Calnek DS, 1998, EXP CELL RES, V238, P294, DOI 10.1006/excr.1997.3812; Chen CA, 2006, TRANSL RES, V148, P134, DOI 10.1016/j.trsl.2006.03.008; Farre AL, 1996, ARTERIOSCL THROM VAS, V16, P1263, DOI 10.1161/01.ATV.16.10.1263; Feinberg MW, 2004, J BIOL CHEM, V279, P16388, DOI 10.1074/jbc.M309664200; FINDER J, 1995, AM J PHYSIOL-LUNG C, V268, pL862, DOI 10.1152/ajplung.1995.268.5.L862; GENG YJ, 1994, BBA-MOL CELL RES, V1223, P125, DOI 10.1016/0167-4889(94)90081-7; GRINNELL BW, 1988, MOL CELL BIOL, V8, P3448, DOI 10.1128/MCB.8.8.3448; Gupta A, 2003, SHOCK, V20, P375, DOI 10.1097/01.shk.0000087202.34916.0c; Gupta AK, 2002, AM J PHYSIOL-CELL PH, V283, pC1065, DOI 10.1152/ajpcell.00100.2002; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; Hoffmann JN, 2004, CRIT CARE MED, V32, P1011, DOI 10.1097/01.CCM.0000120058.88975.42; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Isobe H, 2001, CIRCULATION, V104, P1171, DOI 10.1161/hc3501.093799; Johnsen O, 1996, NUCLEIC ACIDS RES, V24, P4289, DOI 10.1093/nar/24.21.4289; Johnsen O, 1998, NUCLEIC ACIDS RES, V26, P512, DOI 10.1093/nar/26.2.512; Kalil AC, 2004, SHOCK, V21, P222, DOI 10.1097/01.shk.0000116778.27924.79; Lee MS, 2005, MOL CELL BIOL, V25, P6921, DOI 10.1128/MCB.25.16.6921-6936.2005; Li HG, 2000, J PATHOL, V190, P244, DOI 10.1002/(SICI)1096-9896(200002)190:3<244::AID-PATH575>3.0.CO;2-8; Lim JY, 2005, J MOL CELL CARDIOL, V39, P627, DOI 10.1016/j.yjmcc.2005.06.016; Lirk Philipp, 2002, Current Drug Targets - Inflammation and Allergy, V1, P89, DOI 10.2174/1568010023344913; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Matejovic M, 2004, SHOCK, V21, P458, DOI 10.1097/00024382-200405000-00010; Mizutani A, 2000, BLOOD, V95, P3781; MUHL H, 1994, BIOCHEM J, V303, P607; Mulsow JJW, 2005, ANN SURG, V242, P880, DOI 10.1097/01.sla.0000189606.58343.cd; Murphy P, 2000, MECH DEVELOP, V97, P141, DOI 10.1016/S0925-4773(00)00413-5; Perrella MA, 1996, P NATL ACAD SCI USA, V93, P2054, DOI 10.1073/pnas.93.5.2054; Pullamsetti SS, 2006, THROMB HAEMOSTASIS, V95, P720, DOI 10.1160/TH05-07-0518; REIFELMILLER AE, 1991, J BIOL CHEM, V266, P13873; Richardson MA, 2000, ENDOCRINOLOGY, V141, P3908, DOI 10.1210/en.141.10.3908; Runyan CE, 2003, AM J PHYSIOL-RENAL, V285, pF413, DOI 10.1152/ajprenal.00082.2003; Russo MT, 2004, DEV BIOL, V267, P517, DOI 10.1016/j.ydbio.2003.11.005; Sakaguchi M, 2004, J CELL BIOL, V164, P979, DOI 10.1083/jcb.200312041; SCHINI VB, 1992, EUR J PHARMACOL, V216, P379, DOI 10.1016/0014-2999(92)90434-6; Taylor BS, 1998, BIOCHEMISTRY-MOSCOW+, V63, P766; Tazi KA, 2002, LIVER, V22, P178, DOI 10.1034/j.1600-0676.2002.01616.x; Vila-del Sol V, 2007, J LEUKOCYTE BIOL, V81, P272, DOI DOI 10.1189/JLB.0905529; Vodovotz Yoram, 1994, Progress in Growth Factor Research, V5, P341, DOI 10.1016/0955-2235(94)00004-5; Wang HS, 2005, J CELL BIOCHEM, V95, P256, DOI 10.1002/jcb.20405; Zhang L, 2004, J BIOL CHEM, V279, P28315, DOI 10.1074/jbc.C400115200	44	48	50	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					36837	36844		10.1074/jbc.M706909200	http://dx.doi.org/10.1074/jbc.M706909200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17928287	hybrid			2022-12-27	WOS:000251646000008
J	Danfelter, M; Onnerfjord, P; Heinegard, D				Danfelter, Mikael; Onnerfjord, Patrik; Heinegard, Dick			Fragmentation of proteins in cartilage treated with interleukin-1 - Specific cleavage of type IX collagen by matrix metalloproteinase 13 releases the NC4 domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OLIGOMERIC MATRIX PROTEIN; MULTIPLE EPIPHYSEAL DYSPLASIA; RICH REPEAT PROTEOGLYCANS; NECROSIS-FACTOR-ALPHA; CROSS-LINKING SITES; II COLLAGEN; OSTEOARTHRITIC CARTILAGE; SUBSTRATE-SPECIFICITY; RHEUMATOID-ARTHRITIS; EXTRACELLULAR-MATRIX	Degradation of bovine nasal cartilage induced by interleukin-1 (IL-1) was used to study catabolic events in the tissue over 16 days. Culture medium was fractionated by two-dimensional electrophoresis (isoelectric focusing and SDS-PAGE). Identification of components by peptide mass fingerprinting revealed released fragments representing the NC4 domain of the type IX collagen alpha 1 chain at days 12 and 16. A novel peptide antibody against a near N-terminal epitope of the NC4 domain confirmed the finding and indicated the presence of one of the fragments already at day 9. Mass spectrometric analysis of the two most abundant fragments revealed that the smallest one contained almost the entire NC4 domain cleaved between arginine 258 and isoleucine 259 in the sequence-ETCNELPAR(258)-COOHNH2-ITP-. A larger fragment contained the NC4 domain and the major part of the COL3 domain with a cleavage site between glycine 400 and threonine 401 in COL3(-RGPPGPPGPPGPSG(400)-COOH NH2-TIG-). The presence of multiple collagen alpha 1 (IX) N-terminal sequences demonstrates that the released molecules were cleaved at sites very close to the original N terminus either prior to or due to IL-1 treatment. Matrix metalloproteinase 13(MMP-13) is active and cleaves fibromodulin in the time interval studied. Cartilage explants treated with MMP-13 were shown to release collagen alpha 1 (IX) fragments with the same sizes and with the same cleavage sites as those obtained upon IL-1 treatment. These data describe cleavage by an MMP-13 activity toward non-collagenous and triple helix domains. These potentially important degradation events precede the major loss of type II collagen.	[Danfelter, Mikael; Onnerfjord, Patrik; Heinegard, Dick] Lund Univ, Dept Expt Med Sci, BMC, SE-22184 Lund, Sweden	Lund University	Heinegard, D (corresponding author), Lund Univ, Dept Expt Med Sci, BMC, Plan C12, SE-22184 Lund, Sweden.	dick.heinegard@med.lu.se	Onnerfjord, Patrik/R-3131-2019	Onnerfjord, Patrik/0000-0002-2345-2937	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [U01AR050926] Funding Source: NIH RePORTER; NIAMS NIH HHS [U01 AR050926] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Aurich M, 2006, ARTHRITIS RHEUM-US, V54, P244, DOI 10.1002/art.21535; Billinghurst RC, 2000, ARTHRITIS RHEUM, V43, P664, DOI 10.1002/1529-0131(200003)43:3<664::AID-ANR24>3.0.CO;2-D; Billinghurst RC, 1997, J CLIN INVEST, V99, P1534, DOI 10.1172/JCI119316; Borden P, 1996, J BIOL CHEM, V271, P23577, DOI 10.1074/jbc.271.38.23577; Briggs MD, 2002, HUM MUTAT, V19, P465, DOI 10.1002/humu.10066; Budde B, 2005, MOL CELL BIOL, V25, P10465, DOI 10.1128/MCB.25.23.10465-10478.2005; Carlsen S, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1989; Dahlberg L, 2000, ARTHRITIS RHEUM, V43, P673, DOI 10.1002/1529-0131(200003)43:3<673::AID-ANR25>3.0.CO;2-8; Deng SJ, 2000, J BIOL CHEM, V275, P31422, DOI 10.1074/jbc.M004538200; Diab M, 1996, BIOCHEM J, V314, P327, DOI 10.1042/bj3140327; Eyre DR, 2004, J BIOL CHEM, V279, P2568, DOI 10.1074/jbc.M311653200; FASSLER R, 1994, P NATL ACAD SCI USA, V91, P5070, DOI 10.1073/pnas.91.11.5070; Fosang AJ, 1996, FEBS LETT, V380, P17, DOI 10.1016/0014-5793(95)01539-6; GOLDBERG RL, 1995, ORTHOPAEDIC RES SOC, P125; Hagg R, 1997, J BIOL CHEM, V272, P20650, DOI 10.1074/jbc.272.33.20650; Hagg R, 1998, J CELL BIOL, V142, P285, DOI 10.1083/jcb.142.1.285; Heathfield TF, 2004, J BIOL CHEM, V279, P6286, DOI 10.1074/jbc.M307765200; Holden P, 2001, J BIOL CHEM, V276, P6046, DOI 10.1074/jbc.M009507200; Hu K, 2006, ARTHRITIS RHEUM-US, V54, P2891, DOI 10.1002/art.22040; Johansson N, 1997, DEV DYNAM, V208, P387, DOI 10.1002/(SICI)1097-0177(199703)208:3<387::AID-AJA9>3.0.CO;2-E; Kapyla J, 2004, J BIOL CHEM, V279, P51677, DOI 10.1074/jbc.M409412200; Knauper V, 1996, J BIOL CHEM, V271, P1544, DOI 10.1074/jbc.271.3.1544; Knauper V, 1997, J BIOL CHEM, V272, P7608, DOI 10.1074/jbc.272.12.7608; Kojima T, 2001, ARTHRITIS RHEUM, V44, P120, DOI 10.1002/1529-0131(200101)44:1<120::AID-ANR16>3.0.CO;2-X; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leeman MF, 2002, CRIT REV BIOCHEM MOL, V37, P149, DOI 10.1080/10409230290771483; Lorenzo P, 2001, J BIOL CHEM, V276, P12201, DOI 10.1074/jbc.M010932200; Mitchell PG, 1996, J CLIN INVEST, V97, P761, DOI 10.1172/JCI118475; Monfort J, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1873; MONFORT J, 2006, ARTHRITIS RES THER, V8, P1; Mwale F, 2002, J BONE MINER RES, V17, P275, DOI 10.1359/jbmr.2002.17.2.275; Mwale F, 2000, DEV DYNAM, V218, P648, DOI 10.1002/1097-0177(200008)218:4<648::AID-DVDY1022>3.0.CO;2-P; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; Neuhold LA, 2001, J CLIN INVEST, V107, P35, DOI 10.1172/JCI10564; NINOMIYA Y, 1984, P NATL ACAD SCI-BIOL, V81, P3014, DOI 10.1073/pnas.81.10.3014; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; OKADA Y, 1989, FEBS LETT, V244, P473, DOI 10.1016/0014-5793(89)80586-1; Olsen BR, 1997, INT J BIOCHEM CELL B, V29, P555, DOI 10.1016/S1357-2725(96)00100-8; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pihlajamaa T, 2004, J BIOL CHEM, V279, P24265, DOI 10.1074/jbc.M402865200; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; SAKLATVALA J, 1984, BIOCHEM J, V224, P461, DOI 10.1042/bj2240461; SAKLATVALA J, 1986, NATURE, V322, P547, DOI 10.1038/322547a0; SAKLATVALA J, 1983, BIOCHEM J, V215, P385, DOI 10.1042/bj2150385; Sarioglu H, 2000, ELECTROPHORESIS, V21, P2209, DOI 10.1002/1522-2683(20000601)21:11<2209::AID-ELPS2209>3.0.CO;2-T; SAXNE T, 1988, ARTHRITIS RHEUM, V31, P1041, DOI 10.1002/art.1780310816; SAXNE T, 1988, J AUTOIMMUN, V1, P373, DOI 10.1016/0896-8411(88)90007-8; SAXNE T, 2006, RHEUMATOID ARTHRITIS, P301; StahleBackdahl M, 1997, LAB INVEST, V76, P717; Sztrolovics R, 1999, BIOCHEM J, V339, P571, DOI 10.1042/0264-6021:3390571; Thur J, 2001, J BIOL CHEM, V276, P6083, DOI 10.1074/jbc.M009512200; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VANDERREST M, 1985, J BIOL CHEM, V260, P220; VASIOS G, 1988, J BIOL CHEM, V263, P2324; VAUGHAN L, 1988, J CELL BIOL, V106, P991, DOI 10.1083/jcb.106.3.991; WU JJ, 1992, J BIOL CHEM, V267, P23007	56	26	30	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					36933	36941		10.1074/jbc.M702491200	http://dx.doi.org/10.1074/jbc.M702491200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17951262	hybrid			2022-12-27	WOS:000251646000019
J	Doyle, SL; Jefferies, CA; Feighery, C; O'Neill, LAJ				Doyle, Sarah L.; Jefferies, Caroline A.; Feighery, Con; O'Neill, Luke A. J.			Signaling by Toll-like receptors 8 and 9 requires Bruton's tyrosine kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-LINKED AGAMMAGLOBULINEMIA; NF-KAPPA-B; BINDING PROTEIN; ACTIVATION; BTK; PHOSPHORYLATION; DOMAIN; GENE; DNA; MECHANISMS	Toll-like receptors (TLRs) are a primary surveillance system for the detection of pathogens and are crucial to the activation of host defense. TLR7 and TLR8 sense single-stranded RNA from viruses or host ribonucleoproteins and synthetic imidazoquinolines such as R848, whereas TLR9 senses unmethylated CpG motifs in viral and bacterial DNA and in host DNA. Here we report the endogenous interaction between Brutons's tyrosine kinase (Btk) and human TLR8 and TLR9 in the monocytic cell line THP1. We also show that R848, single-stranded RNA, and CpGB-DNA activate Btk in THP1 cells as shown by phosphorylation of the tyrosine 223 residue of Btk and also by increased autokinase activity. We demonstrate that Btk is required for NF kappa B activation, participating in the pathway to increased phosphorylation of p65 on serine 536 activated by TLR8 and TLR9. Finally we demonstrate that peripheral blood mononuclear cells from patients with X-linked agammaglobulinaemia (XLA) that have dysfunctional Btk are impaired in the induction of interleukin-6 by CpGB-DNA. This study therefore establishes Btk as a key signaling molecule that interacts with and acts downstream of TLR8 and TLR9. Lack of functioning Btk in XLA patients downstream of TLR8 and TLR9 might explain the susceptibility of XLA patients to viral infections.	[Doyle, Sarah L.; Feighery, Con; O'Neill, Luke A. J.] Univ Dublin Trinity Coll, Sch Biochem & Immunol, Dublin 2, Ireland; [Feighery, Con] Univ Dublin Trinity Coll, Dept Immunol, Dublin 2, Ireland; [Jefferies, Caroline A.] Royal Coll Surgeons Ireland, Dublin 2, Ireland	Trinity College Dublin; Trinity College Dublin; Royal College of Surgeons - Ireland	Doyle, SL (corresponding author), Univ Dublin Trinity Coll, Sch Biochem & Immunol, Dublin 2, Ireland.	Sarah.Doyle@tcd.ie	Doyle, Sarah/C-1453-2014; Jefferies, Caroline/AAI-1543-2021	Jefferies, Caroline/0000-0002-8879-6722; O'Neill, Luke/0000-0002-4333-2748; Doyle, Sarah/0000-0002-6294-9380				BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; BRADLEY LAD, 1994, HUM MOL GENET, V3, P79, DOI 10.1093/hmg/3.1.79; Buss H, 2004, J BIOL CHEM, V279, P55633, DOI 10.1074/jbc.M409825200; Chuang TH, 2000, EUR CYTOKINE NETW, V11, P372; Dasari P, 2005, CELL IMMUNOL, V236, P140, DOI 10.1016/j.cellimm.2005.08.020; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Doyle SL, 2006, BIOCHEM PHARMACOL, V72, P1102, DOI 10.1016/j.bcp.2006.07.010; Doyle SL, 2005, J BIOL CHEM, V280, P23496, DOI 10.1074/jbc.C500053200; Hashimoto S, 1996, BLOOD, V88, P561, DOI 10.1182/blood.V88.2.561.bloodjournal882561; Heil F, 2003, EUR J IMMUNOL, V33, P2987, DOI 10.1002/eji.200324238; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Horwood NJ, 2006, J IMMUNOL, V176, P3635, DOI 10.4049/jimmunol.176.6.3635; Jefferies CA, 2004, IMMUNOL LETT, V92, P15, DOI 10.1016/j.imlet.2003.11.017; Jefferies CA, 2003, J BIOL CHEM, V278, P26258, DOI 10.1074/jbc.M301484200; Kurosaki T, 1997, CURR OPIN IMMUNOL, V9, P309, DOI 10.1016/S0952-7915(97)80075-1; Latz E, 2004, J ENDOTOXIN RES, V10, P406, DOI 10.1179/096805104225006525; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; LEDERMAN HM, 1985, MEDICINE, V64, P145, DOI 10.1097/00005792-198505000-00001; MCKINNEY RE, 1987, REV INFECT DIS, V9, P334; Moore ML, 2004, J VIROL, V78, P5584, DOI 10.1128/JVI.78.11.5584-5590.2004; O'Neill LAJ, 2000, IMMUNOL TODAY, V21, P206, DOI 10.1016/S0167-5699(00)01611-X; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Park H, 1996, IMMUNITY, V4, P515, DOI 10.1016/S1074-7613(00)80417-3; Sanna PP, 2000, J VIROL, V74, P9813, DOI 10.1128/JVI.74.21.9813-9817.2000; Schlaepfer E, 2006, J IMMUNOL, V176, P2888, DOI 10.4049/jimmunol.176.5.2888; Schmitz ML, 2001, TRENDS BIOCHEM SCI, V26, P186, DOI 10.1016/S0968-0004(00)01753-9; Sochorova K, 2007, BLOOD, V109, P2553, DOI 10.1182/blood-2006-07-037960; Stiehm ER, 2006, PEDIATRICS, V117, P184, DOI 10.1542/peds.2004-2773; Subramanian S, 2006, P NATL ACAD SCI USA, V103, P9970, DOI 10.1073/pnas.0603912103; Winkelstein JA, 2006, MEDICINE, V85, P193, DOI 10.1097/01.md.0000229482.27398.ad; Zheng M, 2002, P NATL ACAD SCI USA, V99, P8944, DOI 10.1073/pnas.132605599; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X	33	96	105	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					36953	36960		10.1074/jbc.M707682200	http://dx.doi.org/10.1074/jbc.M707682200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17932028	Green Published, hybrid			2022-12-27	WOS:000251646000021
J	Han, GS; Siniossoglou, S; Carman, GM				Han, Gil-Soo; Siniossoglou, Symeon; Carman, George M.			The cellular functions of the yeast lipin homolog pah1p are dependent on its phosphatidate phosphatase activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIACYLGLYCEROL PYROPHOSPHATE PHOSPHATASE; SACCHAROMYCES-CEREVISIAE; PHOSPHOLIPID BIOSYNTHESIS; ESCHERICHIA-COLI; SUBCELLULAR-LOCALIZATION; GENETIC-REGULATION; SHUTTLE VECTORS; SEQUENCE MOTIF; METABOLISM; ACID	The Saccharomyces cerevisiae PAH1-encoded Mg2+-dependent phosphatidate phosphatase (PAP1, 3-sn-phosphatidate phosphohydrolase, EC 3.1.3.4) catalyzes the dephosphorylation of phosphatidate to yield diacylglycerol and Pi. This enzyme plays a major role in the synthesis of triacylglycerols and phospholipids in S. cerevisiae. PAP1 contains the DXDX(T/V) catalytic motif (DIDGT at residues 398-402) that is shared by the mammalian fat-regulating protein lipin 1 and the superfamily of haloacid dehalogenase-like proteins. The yeast enzyme also contains a conserved glycine residue (Gly(80)) that is essential for the fat-regulating function of lipin 1 in a mouse model. In this study, we examined the roles of the putative catalytic motif and the conserved glycine for PAP1 activity by a mutational analysis. The PAP1 activities of the D398E and D400E mutant enzymes were reduced by > 99.9%, and the activity of the G80R mutant enzyme was reduced by 98%. The mutant PAH1 alleles whose products lacked PAP1 activity were nonfunctional in vivo and failed to complement the pah1 Delta mutant phenotypes of temperature sensitivity, respiratory deficiency, nuclear/endoplasmic reticulum membrane expansion, derepression of INO1 expression, and alterations in lipid composition. These results demonstrated that the PAP1 activity of the PAH1 gene product is essential for its roles in lipid metabolism and cell physiology.	[Han, Gil-Soo; Carman, George M.] Rutgers State Univ, Dept Food Sci, New Brunswick, NJ 08901 USA; [Han, Gil-Soo; Carman, George M.] Rutgers State Univ, Rutgers Ctr Lipid Res, New Brunswick, NJ 08901 USA; [Siniossoglou, Symeon] Univ Cambridge, Cambridge Inst Med Res, Wellcome Trust, Cambridge CB2 2XY, England	Rutgers State University New Brunswick; Rutgers State University New Brunswick; University of Cambridge; Wellcome Trust Sanger Institute	Carman, GM (corresponding author), Rutgers State Univ, Dept Food Sci, 65 Dudley Rd, New Brunswick, NJ 08901 USA.	carman@aesop.rutgers.edu			Medical Research Council [G0701446] Funding Source: Medline; NIGMS NIH HHS [R01 GM028140, GM-28140] Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM028140, R01GM028140] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wellcome Trust(Wellcome Trust); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carman GM, 2006, TRENDS BIOCHEM SCI, V31, P694, DOI 10.1016/j.tibs.2006.10.003; Carman GM, 1999, PROG LIPID RES, V38, P361, DOI 10.1016/S0163-7827(99)00010-7; CARMAN GM, 1991, METHOD ENZYMOL, V197, P548; Carman GM, 1996, J BIOL CHEM, V271, P13293, DOI 10.1074/jbc.271.23.13293; Carman GM, 1997, BBA-LIPID LIPID MET, V1348, P45, DOI 10.1016/S0005-2760(97)00095-7; Chen M, 2007, BBA-MOL CELL BIOL L, V1771, P310, DOI 10.1016/j.bbalip.2006.05.017; Collet JF, 1999, J BIOL CHEM, V274, P33985, DOI 10.1074/jbc.274.48.33985; Collet JF, 1998, J BIOL CHEM, V273, P14107, DOI 10.1074/jbc.273.23.14107; CULBERTSON MR, 1975, GENETICS, V80, P23; Czabany T, 2007, BBA-MOL CELL BIOL L, V1771, P299, DOI 10.1016/j.bbalip.2006.07.001; Donkor J, 2007, J BIOL CHEM, V282, P3450, DOI 10.1074/jbc.M610745200; English D, 1996, CHEM PHYS LIPIDS, V80, P117, DOI 10.1016/0009-3084(96)02549-2; ESKO JD, 1980, J BIOL CHEM, V255, P4474; Faulkner A, 1999, J BIOL CHEM, V274, P14831, DOI 10.1074/jbc.274.21.14831; Finck BN, 2006, CELL METAB, V4, P199, DOI 10.1016/j.cmet.2006.08.005; Foster DA, 2007, CANCER RES, V67, P1, DOI 10.1158/0008-5472.CAN-06-3016; Furneisen JM, 2000, BBA-MOL CELL BIOL L, V1484, P71, DOI 10.1016/S1388-1981(99)00202-4; Greenberg ML, 1996, MICROBIOL REV, V60, P1; HAID A, 1983, METHOD ENZYMOL, V96, P192; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Han GS, 2004, J BIOL CHEM, V279, P5338, DOI 10.1074/jbc.M311779200; Han GS, 2001, J BIOL CHEM, V276, P10126, DOI 10.1074/jbc.M011421200; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Harris TE, 2007, J BIOL CHEM, V282, P277, DOI 10.1074/jbc.M609537200; Hemrika W, 1997, P NATL ACAD SCI USA, V94, P2145, DOI 10.1073/pnas.94.6.2145; Henderson RJ, 1992, LIPID ANAL PRACTICAL, P65; Henry SA, 1998, PROG NUCLEIC ACID RE, V61, P133, DOI 10.1016/S0079-6603(08)60826-0; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; HOSAKA K, 1984, BIOCHIM BIOPHYS ACTA, V796, P110; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Huijbregts RPH, 2000, TRAFFIC, V1, P195, DOI 10.1034/j.1600-0854.2000.010301.x; Innis MA, 1990, PCR PROTOCOLS GUIDE, P3; IRIE K, 1993, MOL GEN GENET, V236, P283, DOI 10.1007/BF00277124; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; KELLEY MJ, 1988, J BIOL CHEM, V263, P18078; KLIG LS, 1985, J BACTERIOL, V162, P1135, DOI 10.1128/JB.162.3.1135-1141.1985; Kooijman EE, 2003, TRAFFIC, V4, P162, DOI 10.1034/j.1600-0854.2003.00086.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li GL, 2007, BBA-MOL CELL BIOL L, V1771, P432, DOI 10.1016/j.bbalip.2006.06.007; LIN YP, 1989, J BIOL CHEM, V264, P8641; Loewen CJR, 2005, J BIOL CHEM, V280, P14097, DOI 10.1074/jbc.M500147200; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; LOPES JM, 1991, NUCLEIC ACIDS RES, V19, P1687, DOI 10.1093/nar/19.7.1687; MORLOCK KR, 1988, J BACTERIOL, V170, P3561, DOI 10.1128/jb.170.8.3561-3566.1988; Neuwald AF, 1997, PROTEIN SCI, V6, P1764, DOI 10.1002/pro.5560060817; O'Hara L, 2006, J BIOL CHEM, V281, P34537, DOI 10.1074/jbc.M606654200; Ostrander DB, 1998, J BIOL CHEM, V273, P18992, DOI 10.1074/jbc.273.30.18992; PERRELLA FW, 1988, ANAL BIOCHEM, V174, P437, DOI 10.1016/0003-2697(88)90042-5; Peterfy M, 2005, J BIOL CHEM, V280, P32883, DOI 10.1074/jbc.M503885200; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; Phan J, 2005, CELL METAB, V1, P73, DOI 10.1016/j.cmet.2004.12.002; Rose MD., 1990, METHODS YEAST GENETI; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672; Shemesh T, 2003, BIOPHYS J, V85, P3813, DOI 10.1016/S0006-3495(03)74796-1; SIKORSKI RS, 1989, GENETICS, V122, P19; Sorger D, 2003, APPL MICROBIOL BIOT, V61, P289, DOI 10.1007/s00253-002-1212-4; Stukey J, 1997, PROTEIN SCI, V6, P469; TAYLOR FR, 1979, BIOCHIM BIOPHYS ACTA, V575, P204, DOI 10.1016/0005-2760(79)90022-5; Toke DA, 1998, J BIOL CHEM, V273, P3278, DOI 10.1074/jbc.273.6.3278; Toke DA, 1998, J BIOL CHEM, V273, P14331, DOI 10.1074/jbc.273.23.14331; Toke DA, 1999, BIOCHEMISTRY-US, V38, P14606, DOI 10.1021/bi991472x; Wang XM, 2006, PROG LIPID RES, V45, P250, DOI 10.1016/j.plipres.2006.01.005; Wu WI, 1996, J BIOL CHEM, V271, P1868, DOI 10.1074/jbc.271.4.1868; WU WI, 1994, J BIOL CHEM, V269, P29495; WU WI, 1993, J BIOL CHEM, V268, P13830; Wu WI, 1996, BIOCHEMISTRY-US, V35, P3790, DOI 10.1021/bi952808f	69	125	139	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					37026	37035		10.1074/jbc.M705777200	http://dx.doi.org/10.1074/jbc.M705777200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17971454	hybrid			2022-12-27	WOS:000251646000029
J	Huang, L; Yu, YY; Kirschke, CP; Gertz, ER; Lloyd, KKC				Huang, Liping; Yu, Yan Yiu; Kirschke, Catherine P.; Gertz, Erik R.; Lloyd, Kent K. C.			Znt7 (Slc30a7)-deficient mice display reduced body zinc status and body fat accumulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LETHAL MILK; FUNCTIONAL-CHARACTERIZATION; MAMMALIAN ZINC; ALKALINE-PHOSPHATASES; CONFERS RESISTANCE; EPITHELIAL-CELLS; LIV-1 SUBFAMILY; TRANSPORTER; GENE; DEFICIENCY	In vitro studies have demonstrated that ZNT7 is involved in transporting the cytoplasmic zinc into the Golgi apparatus of the cell for zinc storage or to be incorporated into newly synthesized zinc-requiring enzymes/proteins. To evaluate the physiological role of ZNT7, we created a mouse model of Znt7 deficiency by a gene-trap approach. Znt7-deficient mice were zinc-deficient based on their low zinc content in serum, liver, bone, kidney, and small intestine. In embryonic fibroblasts isolated from Znt7-deficient mice, cellular zinc was similar to 50% that of wild-type controls. Znt7-deficient mice also displayed some classic manifestations of dietary zinc deficiency, such as reduced food intake and poor body weight gain. However, the mutant mice did not show any sign of hair abnormality and dermatitis that are commonly associated with dietary zinc deficiency. A radioactive feeding study suggested that Znt7-deficient mice had reduced zinc absorption in the gut resulting in decreased zinc accumulations in other organs in the body. The poor growth found in Znt7-deficient mice could not be corrected by feeding the mutant mice with a diet containing 6-fold higher zinc (180 mg/kg) than the suggested adequate intake amount (30 mg/kg). Furthermore, the reduced body weight gain of the mutant mice was largely due to the decrease in body fat accumulation. We conclude that ZNT7 has essential functions in dietary zinc absorption and in regulation of body adiposity.	[Huang, Liping; Yu, Yan Yiu; Kirschke, Catherine P.; Gertz, Erik R.] Univ Calif Davis, USDA, Agr Res Serv, Western Human Nutr Res Ctr, Davis, CA 95616 USA; [Huang, Liping; Yu, Yan Yiu] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [Lloyd, Kent K. C.] Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA; [Huang, Liping] Univ Calif Davis, Rowe Program Genet, Davis, CA 95616 USA	United States Department of Agriculture (USDA); University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Huang, L (corresponding author), Univ Calif Davis, USDA, Agr Res Serv, Western Human Nutr Res Ctr, 430 W Hlth Sci Dr, Davis, CA 95616 USA.	liping.huang@ars.usda.gov						ACKLAND ML, 1992, J NUTR, V122, P1214, DOI 10.1093/jn/122.6.1214; Andree KB, 2004, J NUTR, V134, P1716, DOI 10.1093/jn/134.7.1716; Andrews GK, 2004, GENESIS, V40, P74, DOI 10.1002/gene.20067; BURGUNDER JM, 1984, J HERED, V75, P480; Chi ZH, 2006, NEUROREPORT, V17, P1807, DOI 10.1097/01.wnr.0000239968.06438.c5; Chimienti F, 2004, DIABETES, V53, P2330, DOI 10.2337/diabetes.53.9.2330; Chimienti F, 2005, BIOMETALS, V18, P313, DOI 10.1007/s10534-005-3687-9; Chimienti F, 2006, J CELL SCI, V119, P4199, DOI 10.1242/jcs.03164; Cole TB, 1999, P NATL ACAD SCI USA, V96, P1716, DOI 10.1073/pnas.96.4.1716; DASILVA FDF, 2001, BIOL CHEM ELEMENTS, P315; DAVIES NT, 1980, BRIT J NUTR, V43, P189, DOI 10.1079/BJN19800078; DICKIE MM, 1969, MOUSE NEWS LETT, V41, P30; Eder K, 2000, J ANIM PHYSIOL AN N, V83, P65, DOI 10.1046/j.1439-0396.2000.00230.x; Eng BH, 1998, J MEMBRANE BIOL, V166, P1, DOI 10.1007/s002329900442; Frayling TM, 2007, NAT REV GENET, V8, P657, DOI 10.1038/nrg2178; Gaither LA, 2000, J BIOL CHEM, V275, P5560, DOI 10.1074/jbc.275.8.5560; Gaither LA, 2001, J BIOL CHEM, V276, P22258, DOI 10.1074/jbc.M101772200; Hall AG, 2005, J PEDIATR GASTR NUTR, V41, P72, DOI 10.1097/01.mpg.0000166800.54085.9c; Huang LP, 2006, CANCER CELL INT, V6, DOI 10.1186/1475-2867-6-10; Huang LP, 2005, J BIOL CHEM, V280, P15456, DOI 10.1074/jbc.M412188200; Huang LP, 2002, J BIOL CHEM, V277, P26389, DOI 10.1074/jbc.M200462200; Huang LP, 1997, NAT GENET, V17, P292, DOI 10.1038/ng1197-292; HURLEY LS, 1981, JOHNS HOPKINS MED J, V148, P1; Inoue K, 2002, HUM MOL GENET, V11, P1775, DOI 10.1093/hmg/11.15.1775; Jackson KA, 2007, J BIOL CHEM, V282, P10423, DOI 10.1074/jbc.M610535200; JACKSON MJ, 1981, BRIT J NUTR, V46, P15, DOI 10.1079/BJN19810005; Kelleher SL, 2005, AM J PHYSIOL-CELL PH, V288, pC1042, DOI 10.1152/ajpcell.00471.2004; Kirschke CP, 2003, J BIOL CHEM, V278, P4096, DOI 10.1074/jbc.M207644200; Langmade SJ, 2000, J BIOL CHEM, V275, P34803, DOI 10.1074/jbc.M007339200; LEE DY, 1992, J NUTR, V122, P2233, DOI 10.1093/jn/122.11.2233; MacDonald RS, 2000, J NUTR, V130, p1500S, DOI 10.1093/jn/130.5.1500S; McMahon RJ, 1998, P NATL ACAD SCI USA, V95, P4841, DOI 10.1073/pnas.95.9.4841; Mitchell KJ, 2001, NAT GENET, V28, P241, DOI 10.1038/90074; Norii T, 2005, J NUTR SCI VITAMINOL, V51, P433, DOI 10.3177/jnsv.51.433; Palmiter RD, 2004, P NATL ACAD SCI USA, V101, P4918, DOI 10.1073/pnas.0401022101; Palmiter RD, 2004, PFLUG ARCH EUR J PHY, V447, P744, DOI 10.1007/s00424-003-1070-7; Palmiter RD, 1996, P NATL ACAD SCI USA, V93, P14934, DOI 10.1073/pnas.93.25.14934; PALMITER RD, 1995, EMBO J, V14, P639, DOI 10.1002/j.1460-2075.1995.tb07042.x; Palmiter RD, 1996, EMBO J, V15, P1784, DOI 10.1002/j.1460-2075.1996.tb00527.x; PILETZ JE, 1978, AM J CLIN NUTR, V31, P560, DOI 10.1093/ajcn/31.4.560; Prasad AS, 1996, ANN INTERN MED, V125, P142, DOI 10.7326/0003-4819-125-2-199607150-00012; PRASAD AS, 1985, ANNU REV NUTR, V5, P341, DOI 10.1146/annurev.nu.05.070185.002013; PRASAD AS, 1985, J PHARMACOL-PARIS, V16, P344; SKARNES WC, 1995, P NATL ACAD SCI USA, V92, P6592, DOI 10.1073/pnas.92.14.6592; SMITH KT, 1980, J NUTR, V110, P316, DOI 10.1093/jn/110.2.316; Smith SJ, 2000, NAT GENET, V25, P87, DOI 10.1038/75651; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Stryke D, 2003, NUCLEIC ACIDS RES, V31, P278, DOI 10.1093/nar/gkg064; Suzuki T, 2005, J BIOL CHEM, V280, P637, DOI 10.1074/jbc.M411247200; Suzuki T, 2005, J BIOL CHEM, V280, P30956, DOI 10.1074/jbc.M506902200; Taylor KM, 2005, FEBS LETT, V579, P427, DOI 10.1016/j.febslet.2004.12.006; Taylor KM, 2004, BIOCHEM J, V377, P131, DOI 10.1042/BJ20031183; Taylor KM, 2003, BIOCHEM J, V375, P51, DOI 10.1042/BJ20030478; Valentine RA, 2007, J BIOL CHEM, V282, P14389, DOI 10.1074/jbc.M701752200; VanWouwe JP, 1996, BIOL TRACE ELEM RES, V55, P71, DOI 10.1007/BF02784169; Wang FD, 2004, J BIOL CHEM, V279, P24631, DOI 10.1074/jbc.M400680200; Wang K, 2002, AM J HUM GENET, V71, P66, DOI 10.1086/341125; York B, 1996, MAMM GENOME, V7, P677, DOI 10.1007/s003359900204; Yu YY, 2007, J HISTOCHEM CYTOCHEM, V55, P223, DOI 10.1369/jhc.6A7032.2006	59	71	74	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					37053	37063		10.1074/jbc.M706631200	http://dx.doi.org/10.1074/jbc.M706631200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17954933	hybrid			2022-12-27	WOS:000251646000032
J	Iben, LG; Olson, RE; Balanda, LA; Jayachandra, S; Robertson, BJ; Hay, V; Corradi, J; Prasad, CVC; Zaczek, R; Albright, CF; Toyn, JH				Iben, Lawrence G.; Olson, Richard E.; Balanda, Lynn A.; Jayachandra, Sukhanya; Robertson, Barbara J.; Hay, Vanessa; Corradi, John; Prasad, C. V. C.; Zaczek, Robert; Albright, Charles F.; Toyn, Jeremy H.			Signal peptide peptidase and gamma-secretase share equivalent inhibitor binding pharmacology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; ALZHEIMERS-DISEASE; ACTIVE-SITE; INTRAMEMBRANE PROTEOLYSIS; TRANSMEMBRANE DOMAIN; PRESENILIN HOMOLOGS; ASPARTIC PROTEASE; ZETA-CLEAVAGE; IDENTIFICATION	The enzyme gamma-secretase has long been considered a potential pharmaceutical target for Alzheimer disease. Presenilin ( the catalytic subunit of gamma-secretase) and signal peptide peptidase (SPP) are related transmembrane aspartyl proteases that cleave transmembrane substrates. SPP and gamma-secretase are pharmacologically similar in that they are targeted by many of the same small molecules, including transition state analogs, non-transition state inhibitors, and amyloid beta-peptide modulators. One difference between presenilin and SPP is that the proteolytic activity of presenilin functions only within a multisubunit complex, whereas SPP requires no additional protein cofactors for activity. In this study, gamma-secretase inhibitor radioligands were used to evaluate SPP and gamma-secretase inhibitor binding pharmacology. We found that the SPP enzyme exhibited distinct binding sites for transition state analogs, non-transition state inhibitors, and the nonsteroidal anti-inflammatory drug sulindac sulfide, analogous to those reported previously for gamma-secretase. In the course of this study, cultured cells were found to contain an abundance of SPP binding activity, most likely contributed by several of the SPP family proteins. The number of SPP binding sites was in excess of gamma-secretase binding sites, making it essential to use selective radioligands for evaluation of gamma-secretase binding under these conditions. This study provides further support for the idea that SPP is a useful model of inhibitory mechanisms and structure in the SPP/presenilin protein family.	[Iben, Lawrence G.; Olson, Richard E.; Prasad, C. V. C.; Zaczek, Robert; Albright, Charles F.; Toyn, Jeremy H.] Bristol Myers Squibb Res & Dev, Dept Neurosci Drug Discovery, Wallingford, CT 06492 USA; [Balanda, Lynn A.; Jayachandra, Sukhanya; Robertson, Barbara J.; Corradi, John] Bristol Myers Squibb Res & Dev, Dept Appl Biotechnol, Wallingford, CT 06492 USA; [Hay, Vanessa] Bristol Myers Squibb Res & Dev, Dept Appl Biotechnol, Pennington, NJ 08534 USA	Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb	Toyn, JH (corresponding author), Bristol Myers Squibb Res & Dev, Dept Neurosci Drug Discovery, 5 Res Pkwy, Wallingford, CT 06492 USA.	jeremy.toyn@bms.com		Corradi, John/0000-0003-3456-4974				Barten DM, 2005, J PHARMACOL EXP THER, V312, P635, DOI 10.1124/jpet.104.075408; Barten Donna M, 2006, Drugs R D, V7, P87, DOI 10.2165/00126839-200607020-00003; Beher D, 2004, J BIOL CHEM, V279, P43419, DOI 10.1074/jbc.M404937200; Berezovska O, 2003, J NEUROSCI, V23, P4560; Clarke EE, 2006, J BIOL CHEM, V281, P31279, DOI 10.1074/jbc.M605051200; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Esler WP, 2000, NAT CELL BIOL, V2, P428, DOI 10.1038/35017062; Fluhrer R, 2006, NAT CELL BIOL, V8, P894, DOI 10.1038/ncb1450; Fraering PC, 2004, BIOCHEMISTRY-US, V43, P9774, DOI 10.1021/bi0494976; Funamoto S, 2004, BIOCHEMISTRY-US, V43, P13532, DOI 10.1021/bi049399k; GRIGORENKO AP, 2002, BIOKHIMIYA, V67, P995; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Herreman A, 2000, NAT CELL BIOL, V2, P461, DOI 10.1038/35017105; Kornilova AY, 2005, P NATL ACAD SCI USA, V102, P3230, DOI 10.1073/pnas.0407640102; Kornilova AY, 2003, J BIOL CHEM, V278, P16470, DOI 10.1074/jbc.C300019200; Krawitz P, 2005, J BIOL CHEM, V280, P39515, DOI 10.1074/jbc.M501645200; Lemberg MK, 2001, J IMMUNOL, V167, P6441, DOI 10.4049/jimmunol.167.11.6441; Li YM, 2000, NATURE, V405, P689, DOI 10.1038/35015085; Martoglio B, 2003, HUM MOL GENET, V12, pR201, DOI 10.1093/hmg/ddg303; Martoglio B, 1998, TRENDS CELL BIOL, V8, P410, DOI 10.1016/S0962-8924(98)01360-9; McLauchlan J, 2002, EMBO J, V21, P3980, DOI 10.1093/emboj/cdf414; Morohashi Y, 2006, J BIOL CHEM, V281, P14670, DOI 10.1074/jbc.M513012200; Nyborg AC, 2004, J BIOL CHEM, V279, P43148, DOI 10.1074/jbc.M405879200; Nyborg AC, 2004, J BIOL CHEM, V279, P15153, DOI 10.1074/jbc.M309305200; Ponting CP, 2002, HUM MOL GENET, V11, P1037, DOI 10.1093/hmg/11.9.1037; Prasad CVC, 2007, BIOORG MED CHEM LETT, V17, P4006, DOI 10.1016/j.bmcl.2007.04.082; Qi-Takahara Y, 2005, J NEUROSCI, V25, P436, DOI 10.1523/JNEUROSCI.1575-04.2005; Sato T, 2006, BIOCHEMISTRY-US, V45, P8649, DOI 10.1021/bi060597g; SEITTERT D, 2000, J BIOL CHEM, V275, P34086; Selkoe D, 2003, ANNU REV NEUROSCI, V26, P565, DOI 10.1146/annurev.neuro.26.041002.131334; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; Steiner H, 2000, NAT CELL BIOL, V2, P848, DOI 10.1038/35041097; Tian GC, 2003, J BIOL CHEM, V278, P28968, DOI 10.1074/jbc.M300905200; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; Weihofen A, 2000, J BIOL CHEM, V275, P30951, DOI 10.1074/jbc.M005980200; Weihofen A, 2003, J BIOL CHEM, V278, P16528, DOI 10.1074/jbc.M301372200; Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Wu CM, 2004, BIOCHEM BIOPH RES CO, V322, P585, DOI 10.1016/j.bbrc.2004.07.160; Yagishita S, 2006, BIOCHEMISTRY-US, V45, P3952, DOI 10.1021/bi0521846; Yan XX, 2004, J NEUROSCI, V24, P2942, DOI 10.1523/JNEUROSCI.0092-04.2004; Zhang ZH, 2000, NAT CELL BIOL, V2, P463, DOI 10.1038/35017108; Zhao GJ, 2005, J BIOL CHEM, V280, P37689, DOI 10.1074/jbc.M507993200; Zhao GJ, 2004, J BIOL CHEM, V279, P50647, DOI 10.1074/jbc.C400473200	47	24	32	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					36829	36836		10.1074/jbc.M707002200	http://dx.doi.org/10.1074/jbc.M707002200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17932033	hybrid			2022-12-27	WOS:000251646000007
J	Wende, AR; Schaeffer, PJ; Parker, GJ; Zechner, C; Han, DH; Chen, MM; Hancock, CR; Lehman, JJ; Huss, JM; McClain, DA; Holloszy, JO; Kelly, DP				Wende, Adam R.; Schaeffer, Paul J.; Parker, Glendon J.; Zechner, Christoph; Han, Dong-Ho; Chen, May M.; Hancock, Chad R.; Lehman, John J.; Huss, Janice M.; McClain, Donald A.; Holloszy, John O.; Kelly, Daniel P.			A role for the transcriptional coactivator PGC-1 alpha in muscle refueling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROLIFERATOR-ACTIVATED RECEPTOR; MESSENGER-RNA EXPRESSION; HUMAN SKELETAL-MUSCLE; FATTY-ACID OXIDATION; GENE-EXPRESSION; ENERGY-METABOLISM; MITOCHONDRIAL BIOGENESIS; HEPATIC GLUCONEOGENESIS; GAMMA COACTIVATOR-1; GLUCOSE-TRANSPORT	The transcriptional coactivator peroxisome proliferator-activated receptor gamma coactivator-1 alpha(PGC-1 alpha) has been identified as an inducible regulator of mitochondrial function. Skeletal muscle PGC-1 alpha expression is induced post-exercise. Therefore, we sought to determine its role in the regulation of muscle fuel metabolism. Studies were performed using conditional, muscle-specific, PGC-1 alpha gain-of-function and constitutive, generalized, loss-of-function mice. Forced expression of PGC-1 alpha increased muscle glucose uptake concomitant with augmentation of glycogen stores, a metabolic response similar to post-exercise recovery. Induction of muscle PGC-1 alpha expression prevented muscle glycogen depletion during exercise. Conversely, PGC-1 alpha-deficient animals exhibited reduced rates of muscle glycogen repletion post-exercise. PGC-1 alpha was shown to increase muscle glycogen stores via several mechanisms including stimulation of glucose import, suppression of glycolytic flux, and by down-regulation of the expression of glycogen phosphorylase and its activating kinase, phosphorylase kinase alpha. These findings identify PGC-1 alpha as a critical regulator of skeletal muscle fuel stores.	Washington Univ, Sch Med, Cardiovasc Res Ctr, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; Univ Utah, Sch Med, Vet Affairs Med Ctr, Salt Lake City, UT 84112 USA; Univ Utah, Sch Med, Div Endocrinol, Salt Lake City, UT 84112 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); US Department of Veterans Affairs; Veterans Health Administration (VHA); Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Kelly, DP (corresponding author), Washington Univ, Sch Med, Cardiovasc Res Ctr, 660 S Euclid Ave, St Louis, MO 63110 USA.	dkelly@im.wustl.edu	Hancock, Chad R./X-4803-2018; Kelly, Daniel/ABG-2056-2021; Wende, Adam/AFG-8878-2022; Zechner, Christoph/AAW-7249-2021	Hancock, Chad R./0000-0002-1578-5301; Wende, Adam/0000-0002-5536-4675; Zechner, Christoph/0000-0002-2829-9935; McClain, Don/0000-0002-3310-2359	NHLBI NIH HHS [T32 HL007275] Funding Source: Medline; NIA NIH HHS [R01 AG000425] Funding Source: Medline; NIDDK NIH HHS [P30 DK052574, P30 DK056341-07, P30 DK056341, R01 DK074700, P30 DK056341-06, R01 DK045416, P60 DK020579] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341, R01DK074700, R01DK045416, P30DK052574, P60DK020579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG000425] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Al-Khalili L, 2005, DIABETOLOGIA, V48, P1173, DOI 10.1007/s00125-005-1741-3; Baar K, 2002, FASEB J, V16, P1879, DOI 10.1096/fj.02-0367com; BARNARD RJ, 1992, FASEB J, V6, P3238, DOI 10.1096/fasebj.6.14.1426762; Booth FW, 2002, J PHYSIOL-LONDON, V543, P399, DOI 10.1113/jphysiol.2002.019265; Brooks GA, 1998, COMP BIOCHEM PHYS B, V120, P89, DOI 10.1016/S0305-0491(98)00025-X; Burgess SC, 2006, J BIOL CHEM, V281, P19000, DOI 10.1074/jbc.M600050200; Burke L M, 1999, Curr Opin Clin Nutr Metab Care, V2, P515, DOI 10.1097/00075197-199911000-00015; CHI MMY, 1983, AM J PHYSIOL, V244, pC276, DOI 10.1152/ajpcell.1983.244.3.C276; COGGAN AR, 1991, SPORTS MED, V11, P102, DOI 10.2165/00007256-199111020-00003; DOUEN AG, 1990, J BIOL CHEM, V265, P13427; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Finck BN, 2005, CELL METAB, V1, P133, DOI 10.1016/j.cmet.2005.01.006; Gasa R, 2000, J BIOL CHEM, V275, P26396, DOI 10.1074/jbc.M002427200; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Ghersa P, 1998, GENE THER, V5, P1213, DOI 10.1038/sj.gt.3300713; Goto M, 2000, BIOCHEM BIOPH RES CO, V274, P350, DOI 10.1006/bbrc.2000.3134; Handschin C, 2007, GENE DEV, V21, P770, DOI 10.1101/gad.1525107; HANSEN PA, 1994, J APPL PHYSIOL, V76, P979, DOI 10.1152/jappl.1994.76.2.979; Hargreaves M, 2004, P NUTR SOC, V63, P217, DOI 10.1079/PNS2004344; Hawley JA, 2002, CLIN EXP PHARMACOL P, V29, P218, DOI 10.1046/j.1440-1681.2002.03623.x; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; HOLLOSZY JO, 1984, J APPL PHYSIOL, V56, P831, DOI 10.1152/jappl.1984.56.4.831; Holloszy JO, 1998, FRONT BIOSCI, V3, pD1011, DOI DOI 10.2741/A342; Huss JM, 2004, MOL CELL BIOL, V24, P9079, DOI 10.1128/MCB.24.20.9079-9091.2004; Huss JM, 2002, J BIOL CHEM, V277, P40265, DOI 10.1074/jbc.M206324200; KARLSSON J, 1971, J APPL PHYSIOL, V31, P203, DOI 10.1152/jappl.1971.31.2.203; Kelley DE, 2002, ANN NY ACAD SCI, V967, P135; Koval JA, 1998, AM J PHYSIOL-ENDOC M, V274, pE304, DOI 10.1152/ajpendo.1998.274.2.E304; LAWRENCE JC, 1983, J BIOL CHEM, V258, P710; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Michael LF, 2001, P NATL ACAD SCI USA, V98, P3820, DOI 10.1073/pnas.061035098; Mootha VK, 2004, P NATL ACAD SCI USA, V101, P6570, DOI 10.1073/pnas.0401401101; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Mortensen O. H., 2006, AM J PHYSIOL-ENDOC M, V291, pE807, DOI DOI 10.1152/AJPENDO.00591.2005; Mourtzakis M, 2006, J APPL PHYSIOL, V100, P1822, DOI 10.1152/japplphysiol.00571.2005; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; Nielsen JN, 2004, P NUTR SOC, V63, P233, DOI 10.1079/PNS2004348; Nielsen JN, 2003, ACTA PHYSIOL SCAND, V178, P309, DOI 10.1046/j.1365-201X.2003.01165.x; Norrbom J, 2004, J APPL PHYSIOL, V96, P189, DOI 10.1152/japplphysiol.00765.2003; ODoherty RM, 1996, J APPL PHYSIOL, V81, P789, DOI 10.1152/jappl.1996.81.2.789; Passonneau J.V., 1972, FLEXIBLE SYSTEM ENZY; PASSONNEAU JV, 1974, ANAL BIOCHEM, V60, P405, DOI 10.1016/0003-2697(74)90248-6; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Petersen KF, 2004, J CLIN ENDOCR METAB, V89, P4656, DOI 10.1210/jc.2004-0408; Pilegaard H, 2003, J PHYSIOL-LONDON, V546, P851, DOI 10.1113/jphysiol.2002.034850; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Puigserver P, 2005, INT J OBESITY, V29, pS5, DOI 10.1038/sj.ijo.0802905; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; REN JM, 1993, J BIOL CHEM, V268, P16113; Rhee J, 2003, P NATL ACAD SCI USA, V100, P4012, DOI 10.1073/pnas.0730870100; Roach Peter J., 2002, Current Molecular Medicine (Hilversum), V2, P101, DOI 10.2174/1566524024605761; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Russell AP, 2003, DIABETES, V52, P2874, DOI 10.2337/diabetes.52.12.2874; Russell LK, 2004, CIRC RES, V94, P525, DOI 10.1161/01.RES.0000117088.36577.EB; SAKS VA, 1985, J BIOL CHEM, V260, P7757; Sambandam N, 2006, AM J PHYSIOL-HEART C, V290, pH87, DOI 10.1152/ajpheart.00285.2005; Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103; Schreiber SN, 2003, J BIOL CHEM, V278, P9013, DOI 10.1074/jbc.M212923200; TANNER JW, 1992, BIOCHEM J, V282, P99, DOI 10.1042/bj2820099; Taylor EB, 2005, AM J PHYSIOL-ENDOC M, V289, pE960, DOI 10.1152/ajpendo.00237.2005; Terada S, 2004, AM J PHYSIOL-ENDOC M, V286, pE208, DOI 10.1152/ajpendo.00051.2003; Terada S, 2002, BIOCHEM BIOPH RES CO, V296, P350, DOI 10.1016/S0006-291X(02)00881-1; Trimmer JK, 2002, J APPL PHYSIOL, V93, P233, DOI 10.1152/japplphysiol.01050.2001; Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000; Wende AR, 2005, MOL CELL BIOL, V25, P10684, DOI 10.1128/MCB.25.24.10684-10694.2005; WILKINSON DA, 1994, J MOL BIOL, V235, P974, DOI 10.1006/jmbi.1994.1051; Wu PF, 1998, BIOCHEM J, V329, P197, DOI 10.1042/bj3290197; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X	72	193	209	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36642	36651		10.1074/jbc.M707006200	http://dx.doi.org/10.1074/jbc.M707006200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17932032	hybrid			2022-12-27	WOS:000251458300057
J	Derbyshire, ER; Marletta, MA				Derbyshire, Emily R.; Marletta, Michael A.			Butyl isocyanide as a probe of the activation mechanism of soluble guanylate cyclase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITROSYL-HEME COMPLEX; NITRIC-OXIDE; CARBON-MONOXIDE; PARAMAGNETIC-RESONANCE; DISSOCIATION; MYOGLOBIN; BINDING; HEMOGLOBIN; EQUILIBRIA; DOMAINS	Nitric oxide (NO) is a physiologically relevant activator of the hemoprotein soluble guanylate cyclase (sGC). In the presence of NO, sGC is activated several hundredfold above the basal level by a mechanism that remains to be elucidated. The heme ligand n-butyl isocyanide (BIC) was used to probe the mechanism of NO activation of sGC. Electronic absorption spectroscopy was used to show that BIC binds to the sGC heme, forming a 6-coordinate complex with an absorbance maximum at 429 nm. BIC activates sGC 2-5-fold, and synergizes with the allosteric activator YC-1, to activate the enzyme 15-25-fold. YC-1 activates the sGC-BIC complex, and leads to an increase in both the V-max and K-m. BIC was also used to probe the mechanism of NO activation. The activity of the sGC-BIC complex increases 15-fold in the presence of NO, without displacing BIC at the heme, which is consistent with previous reports that proposed the involvement of a non-heme NO binding site in the activation process.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Div Phys Biosci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Marletta, MA (corresponding author), 570 Stanley Hall, Berkeley, CA 94720 USA.	marletta@berkeley.edu			NIGMS NIH HHS [R01 GM077365-02, GM077365, R01 GM077365] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077365] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Antonini E., 1971, HEMOGLOBIN MYOGLOBIN; BUECHLER WA, 1994, ANN NY ACAD SCI, V714, P151; Cary SPL, 2006, TRENDS BIOCHEM SCI, V31, P231, DOI 10.1016/j.tibs.2006.02.003; Cary SPL, 2005, P NATL ACAD SCI USA, V102, P13064, DOI 10.1073/pnas.0506289102; CRAVEN PA, 1978, J BIOL CHEM, V253, P8433; Denninger JW, 2000, BIOCHEMISTRY-US, V39, P4191, DOI 10.1021/bi992332q; Denninger JW, 1999, BBA-BIOENERGETICS, V1411, P334, DOI 10.1016/S0005-2728(99)00024-9; Derbyshire ER, 2005, BIOCHEMISTRY-US, V44, P16257, DOI 10.1021/bi0515671; Friebe A, 1996, EMBO J, V15, P6863, DOI 10.1002/j.1460-2075.1996.tb01078.x; Friebe A, 1997, BIOCHEMISTRY-US, V36, P1194, DOI 10.1021/bi962047w; GEORGE RCC, 1951, SCIENCE, V114, P629, DOI 10.1126/science.114.2972.629; Karow DS, 2005, BIOCHEMISTRY-US, V44, P16266, DOI 10.1021/bi051601b; Kharitonov VG, 1999, BIOCHEMISTRY-US, V38, P10699, DOI 10.1021/bi990277f; Kharitonov VG, 1997, BIOCHEM BIOPH RES CO, V239, P284, DOI 10.1006/bbrc.1997.7470; Lee DS, 2001, BIOCHEMISTRY-US, V40, P2669, DOI 10.1021/bi002225s; LEIN A, 1956, P NATL ACAD SCI USA, V42, P51, DOI 10.1073/pnas.42.2.51; MANSUY D, 1977, EUR J BIOCHEM, V76, P617, DOI 10.1111/j.1432-1033.1977.tb11632.x; Milani M, 2004, J BIOL CHEM, V279, P21520, DOI 10.1074/jbc.M401320200; MOORE EG, 1976, J BIOL CHEM, V251, P2788; Munzel T, 2003, CIRCULATION, V108, P2172, DOI 10.1161/01.CIR.0000094403.78467.C3; Poulos TL, 2006, CURR OPIN STRUC BIOL, V16, P736, DOI 10.1016/j.sbi.2006.09.006; ROMBERG RW, 1979, BIOCHEMISTRY-US, V18, P5387, DOI 10.1021/bi00591a020; Roy B, 2006, P NATL ACAD SCI USA, V103, P12185, DOI 10.1073/pnas.0602544103; Russwurm M, 2004, EMBO J, V23, P4443, DOI 10.1038/sj.emboj.7600422; Sayed N, 2007, P NATL ACAD SCI USA, V104, P12312, DOI 10.1073/pnas.0703944104; Segel IH, 1975, ENZYME KINETICS BEHA; STONE JR, 1994, BIOCHEMISTRY-US, V33, P5636, DOI 10.1021/bi00184a036; STONE JR, 1995, BIOCHEM BIOPH RES CO, V207, P572, DOI 10.1006/bbrc.1995.1226; Stone JR, 1996, BIOCHEMISTRY-US, V35, P1093, DOI 10.1021/bi9519718; Stone JR, 1995, BIOCHEMISTRY-US, V34, P16397, DOI 10.1021/bi00050a021; SZABO A, 1976, BIOCHEMISTRY-US, V15, P4427, DOI 10.1021/bi00665a013; Ubbink M, 2002, ANNU REV BIOPH BIOM, V31, P393, DOI 10.1146/annurev.biophys.31.091701.171000; WEDEL B, 1994, P NATL ACAD SCI USA, V91, P2592, DOI 10.1073/pnas.91.7.2592; Winger JA, 2005, BIOCHEMISTRY-US, V44, P4083, DOI 10.1021/bi047601d; Winger JA, 2007, J BIOL CHEM, V282, P897, DOI 10.1074/jbc.M606327200; Zhao Y, 1999, P NATL ACAD SCI USA, V96, P14753, DOI 10.1073/pnas.96.26.14753; Zhao YD, 1998, BIOCHEMISTRY-US, V37, P12458, DOI 10.1021/bi9811563	37	25	31	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35741	35748		10.1074/jbc.M705557200	http://dx.doi.org/10.1074/jbc.M705557200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17916555	hybrid			2022-12-27	WOS:000251458100035
J	Donini, S; Clerici, M; Wengel, J; Vester, B; Peracchi, A				Donini, Stefano; Clerici, Marcello; Wengel, Jesper; Vester, Birte; Peracchi, Alessio			The advantages of being locked - Assessing the cleavage of short and long RNAs by locked nucleic acid-containing 8-17 deoxyribozymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE NUCLEOTIDE POLYMORPHISM; CLEAVING DNA ENZYME; IN-VITRO SELECTION; DUPLEX FORMATION; CATALYTIC DNA; MESSENGER-RNA; LNA; DNAZYMES; RECOGNITION; STABILITY	RNA-cleaving deoxyribozymes can be used for the sequence-specific knockdown of mRNAs. It was previously shown that activity of these deoxyribozymes is enhanced when their substrate-binding arms include some locked nucleic acid (LNA) residues, but the mechanistic basis of this enhancement was not explored. Here we dissected the kinetics and thermodynamics underlying the reaction of LNA-containing 8-17 deoxyribozymes. Four 8-17 constructs were designed to target sequences within the E6 mRNA from human papillomavirus type 16. When one of these deoxyribozymes (DNAzymes) and the corresponding LNA-armed enzyme (LNAzyme) were tested against a minimal RNA substrate, they showed similar rates of substrate binding and similar rates of intramolecular cleavage, but the LNAzyme released its substrate more slowly. The superior thermodynamic stability of the LNAzyme-substrate complex led to improved performances in reactions carried out at low catalyst concentrations. The four DNAzymes and the corresponding LNAzymes were then tested against extended E6 transcripts (> 500 nucleotides long). With these structured substrates, the LNAzymes retained full activity, whereas the DNAzymes cleaved extremely poorly, unless they were allowed to pre-anneal to their targets. These results imply that LNAzymes can easily overcome the kinetic barrier represented by local RNA structure and bind to folded targets with a faster association rate as compared with DNAzymes. Such faster annealing to structured targets can be explained by a model whereby LNA monomers favor the initial hybridization to short stretches of unpaired residues ("nucleation"), which precedes disruption of the local mRNA structure and completion of the binding process.	Univ So Denmark, Dept Biochem & Mol Biol, Nucle Acid Ctr, DK-5230 Odense M, Denmark; Univ Parma, Dept Biochem & Mol Biol, I-43100 Parma, Italy; Univ So Denmark, Dept Chem, Nucle Acid Ctr, DK-5230 Odense M, Denmark	University of Southern Denmark; University of Parma; University of Southern Denmark	Vester, B (corresponding author), Univ So Denmark, Dept Biochem & Mol Biol, Nucle Acid Ctr, DK-5230 Odense M, Denmark.	b.vester@bmb.sdu.dk; peracchi@unipr.it	Peracchi, Alessio/G-5167-2012; Peracchi, Alessio/Q-5173-2019; wengel, jesper/K-1177-2013	Peracchi, Alessio/0000-0003-3254-4099; Peracchi, Alessio/0000-0003-3254-4099; Vester, Birte/0000-0002-5368-0500; Wengel, Jesper/0000-0001-9835-1009				Bonaccio M, 2004, NUCLEIC ACIDS RES, V32, P916, DOI 10.1093/nar/gkh250; Bondensgaard K, 2000, CHEM-EUR J, V6, P2687, DOI 10.1002/1521-3765(20000804)6:15<2687::AID-CHEM2687>3.0.CO;2-U; Cairns MJ, 1999, NAT BIOTECHNOL, V17, P480, DOI 10.1038/8658; Cairns MJ, 2002, CURR DRUG TARGETS, V3, P269, DOI 10.2174/1389450023347722; Cairns Murray J, 2004, Methods Mol Biol, V252, P267; CANTOR CR, 1970, BIOPOLYMERS, V9, P1059, DOI 10.1002/bip.1970.360090909; Christensen U, 2001, BIOCHEM J, V354, P481, DOI 10.1042/0264-6021:3540481; Dass C, 2006, DRUG DEV IND PHARM, V32, P1, DOI 10.1080/03639040500387872; Dass CR, 2004, TRENDS PHARMACOL SCI, V25, P395, DOI 10.1016/j.tips.2004.06.001; Fahmy RG, 2004, NUCLEIC ACIDS RES, V32, P2281, DOI 10.1093/nar/gkh543; Ferrari D, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf111; FERSHT A, 1985, ENZYME STRUCTURE MEC, P137; Fluiter K, 2005, OLIGONUCLEOTIDES, V15, P246, DOI 10.1089/oli.2005.15.246; Jakobsen MR, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-29; Joyce GF, 2001, METHOD ENZYMOL, V341, P503, DOI 10.1016/S0076-6879(01)41173-6; Kaur H, 2006, BIOCHEMISTRY-US, V45, P7347, DOI 10.1021/bi060307w; Kurreck J, 2002, J BIOL CHEM, V277, P7099, DOI 10.1074/jbc.M107206200; Li J, 2000, NUCLEIC ACIDS RES, V28, P481, DOI 10.1093/nar/28.2.481; Liu Y, 2004, J MOL BIOL, V341, P887, DOI 10.1016/j.jmb.2004.06.060; Long D, 2007, NAT STRUCT MOL BIOL, V14, P287, DOI 10.1038/nsmb1226; McTigue PM, 2004, BIOCHEMISTRY-US, V43, P5388, DOI 10.1021/bi035976d; Mouritzen P, 2003, EXPERT REV MOL DIAGN, V3, P27, DOI 10.1586/14737159.3.1.27; Nakano S, 1999, NUCLEIC ACIDS RES, V27, P2957, DOI 10.1093/nar/27.14.2957; Ormond TK, 2006, J BIOMOL STRUCT DYN, V24, P171, DOI 10.1080/07391102.2006.10507110; Pan WH, 2003, MOL THER, V7, P129, DOI 10.1016/S0000-000X(00)00000-0; Peracchi A, 2005, J MOL BIOL, V352, P783, DOI 10.1016/j.jmb.2005.07.059; Reynaldo LP, 2000, J MOL BIOL, V297, P511, DOI 10.1006/jmbi.2000.3573; Santoro SW, 1998, BIOCHEMISTRY-US, V37, P13330, DOI 10.1021/bi9812221; Santoro SW, 1997, P NATL ACAD SCI USA, V94, P4262, DOI 10.1073/pnas.94.9.4262; Schubert S, 2003, NUCLEIC ACIDS RES, V31, P5982, DOI 10.1093/nar/gkg791; Schubert S, 2004, J MOL BIOL, V339, P355, DOI 10.1016/j.jmb.2004.03.064; Silverman SK, 2005, NUCLEIC ACIDS RES, V33, P6151, DOI 10.1093/nar/gki930; Singh SK, 1998, CHEM COMMUN, P1247, DOI 10.1039/a801571f; Singh SK, 1998, CHEM COMMUN, P455, DOI 10.1039/a708608c; Venturini F, 1999, NUCLEIC ACIDS RES, V27, P1585, DOI 10.1093/nar/27.7.1585; Vester B, 2002, J AM CHEM SOC, V124, P13682, DOI 10.1021/ja0276220; Vester B, 2004, BIOCHEMISTRY-US, V43, P13233, DOI 10.1021/bi0485732; Vester B, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-19; Walton SP, 2002, BIOPHYS J, V82, P366, DOI 10.1016/S0006-3495(02)75401-5; Wengel J, 1999, ACCOUNTS CHEM RES, V32, P301, DOI 10.1021/ar980051p; You Y, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl175; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	42	23	25	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35510	35518		10.1074/jbc.M706993200	http://dx.doi.org/10.1074/jbc.M706993200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17908692	hybrid			2022-12-27	WOS:000251458100010
J	Guay, C; Madiraju, SRM; Aumais, A; Joly, E; Prentki, M				Guay, Claudiane; Madiraju, S. R. Murthy; Aumais, Alexandre; Joly, Erik; Prentki, Marc			A role for ATP-citrate lyase, malic enzyme, and pyruvate/citrate cycling in glucose-induced insulin secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELLS; CHAIN ACYL-COA; PALMITOYLTRANSFERASE-I INTERACTION; HORMONE-SENSITIVE LIPASE; FATTY-ACID SYNTHESIS; MALONYL-COA; TRICARBOXYLATE CARRIER; REGULATED ANAPLEROSIS; ISLETS; SHUTTLE	In pancreatic beta-cells, metabolic coupling factors generated during glucose metabolism and pyruvate cycling through anaplerosis/cataplerosis processes contribute to the regulation of insulin secretion. Pyruvate/citrate cycling across the mitochondrial membrane leads to the production of malonyl-CoA and NADPH, two candidate coupling factors. To examine the implication of pyruvate/citrate cycling in glucose-induced insulin secretion (GIIS), different steps of the cycle were inhibited in INS 832/13 cells by pharmacological inhibitors and/or RNA interference (RNAi) technology: mitochondrial citrate export, ATP-citrate lyase (ACL), and cytosolic malic enzyme (ME1). The inhibitors of the di- and tri-carboxylate carriers, n-butylmalonate and 1,2,3-benzenetricarboxylate, respectively, reduced GIIS, indicating the importance of transmitochondrial transport of tri-and dicarboxylates in the action of glucose. To directly test the role of ACL and ME1 in GIIS, small hairpinRNA (shRNA) were used to selectively decrease ACL or ME1 expression in transfected INS 832/13 cells. shRNA-ACL reduced ACL protein levels by 67%, and this was accompanied by a reduction in GIIS. The amplification/K-ATP-independent pathway of GIIS was affected by RNAi knockdown of ACL. The ACL inhibitor radicicol also curtailed GIIS. shRNA-ME1 reduced ME1 activity by 62% and decreased GIIS. RNAi suppression of either ACL or ME1 did not affect glucose oxidation. However, because ACL is required for malonyl-CoA formation, inhibition of ACL expression by shRNA-ACL decreased glucose incorporation into palmitate and increased fatty acid oxidation in INS 832/13 cells. Taken together, the results underscore the importance of pyruvate/citrate cycling in pancreatic beta-cell metabolic signaling and the regulation of GIIS.	Ctr Hosp Univ Montreal, Ctr Rech, Mol Nutr Unit, Montreal, PQ H1W 4A4, Canada; Ctr Hosp Univ Montreal, Ctr Rech, Montreal Diabet Res Ctr, Montreal, PQ H1W 4A4, Canada; Univ Montreal, Dept Nutr, Montreal, PQ H1W 4A4, Canada; Univ Montreal, Dept Biochem, Montreal, PQ H1W 4A4, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal	Prentki, M (corresponding author), MDRC CR CHUM, Technopole Angus,Rm 401,2901 Rachel St, Montreal, PQ H1W 4A4, Canada.	marc.prentki@umontreal.ca	Guay, Claudiane/AAF-5381-2019	Guay, Claudiane/0000-0002-6478-8744				AGUILARBRYAN L, 1995, SCIENCE, V268, P423, DOI 10.1126/science.7716547; ASHCROFT F M, 1991, Current Opinion in Cell Biology, V3, P671, DOI 10.1016/0955-0674(91)90040-6; ASHCROFT FM, 1984, NATURE, V312, P446, DOI 10.1038/312446a0; AZZI A, 1993, J BIOENERG BIOMEMBR, V25, P515, DOI 10.1007/BF01108408; Bauer DE, 2005, ONCOGENE, V24, P6314, DOI 10.1038/sj.onc.1208773; BEST L, 1988, BIOCHEM PHARMACOL, V37, P2019, DOI 10.1016/0006-2952(88)90550-3; BISACCIA F, 1993, BIOCHIM BIOPHYS ACTA, V1142, P139, DOI 10.1016/0005-2728(93)90095-W; Brun T, 1996, DIABETES, V45, P190, DOI 10.2337/diabetes.45.2.190; CHEN SY, 1994, DIABETES, V43, P878, DOI 10.2337/diabetes.43.7.878; CORKEY BE, 1989, J BIOL CHEM, V264, P21608; Dabrowski M, 2003, J PHYSIOL-LONDON, V550, P357, DOI 10.1113/jphysiol.2003.041715; Fahien LA, 2002, DIABETES, V51, P2669, DOI 10.2337/diabetes.51.9.2669; Farfari S, 2000, DIABETES, V49, P718, DOI 10.2337/diabetes.49.5.718; Flamez D, 2002, DIABETES, V51, P2018, DOI 10.2337/diabetes.51.7.2018; Fransson U, 2006, DIABETOLOGIA, V49, P1578, DOI 10.1007/s00125-006-0263-y; Fulgencio JP, 1996, DIABETES, V45, P1556, DOI 10.2337/diabetes.45.11.1556; Hatzivassiliou G, 2005, CANCER CELL, V8, P311, DOI 10.1016/j.ccr.2005.09.008; HEDESKOV CJ, 1987, BIOCHEM J, V241, P161, DOI 10.1042/bj2410161; Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751; Herrero L, 2005, DIABETES, V54, P462, DOI 10.2337/diabetes.54.2.462; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Ivarsson R, 2005, DIABETES, V54, P2132, DOI 10.2337/diabetes.54.7.2132; Joseph JW, 2006, J BIOL CHEM, V281, P35624, DOI 10.1074/jbc.M602606200; Khan A, 1996, J BIOL CHEM, V271, P2539, DOI 10.1074/jbc.271.5.2539; Ki SW, 2000, J BIOL CHEM, V275, P39231, DOI 10.1074/jbc.M006192200; Lajoix AD, 2001, DIABETES, V50, P1311, DOI 10.2337/diabetes.50.6.1311; Liu YQ, 2004, J BIOL CHEM, V279, P7470, DOI 10.1074/jbc.M307921200; Liu YQ, 2002, J BIOL CHEM, V277, P39163, DOI 10.1074/jbc.M207157200; Lu DH, 2002, P NATL ACAD SCI USA, V99, P2708, DOI 10.1073/pnas.052005699; MacDonald MJ, 2005, AM J PHYSIOL-ENDOC M, V288, pE1, DOI 10.1152/ajpendo.00218.2004; MACDONALD MJ, 1993, METABOLISM, V42, P1229, DOI 10.1016/0026-0495(93)90118-8; MACDONALD MJ, 1992, HORM METAB RES, V24, P158, DOI 10.1055/s-2007-1003284; MacDonald MJ, 2002, AM J PHYSIOL-ENDOC M, V283, pE302, DOI 10.1152/ajpendo.00041.2002; MACDONALD MJ, 1995, J BIOL CHEM, V270, P20051; MacDonald PE, 2003, DIABETOLOGIA, V46, P1046, DOI 10.1007/s00125-003-1159-8; Maechler P, 1999, NATURE, V402, P685, DOI 10.1038/45280; Mizuarai S, 2005, J BIOL CHEM, V280, P32434, DOI 10.1074/jbc.M503152200; Nolan CJ, 2006, DIABETES, V55, pS16, DOI 10.2337/db06-S003; Owen OE, 2002, J BIOL CHEM, V277, P30409, DOI 10.1074/jbc.R200006200; Peyot ML, 2004, DIABETES, V53, P1733, DOI 10.2337/diabetes.53.7.1733; Pi JB, 2007, DIABETES, V56, P1783, DOI 10.2337/db06-1601; Pongratz RL, 2007, J BIOL CHEM, V282, P200, DOI 10.1074/jbc.M602954200; PRENTKI M, 1992, J BIOL CHEM, V267, P5802; PRENTKI M, 1987, PHYSIOL REV, V67, P1185, DOI 10.1152/physrev.1987.67.4.1185; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Roduit R, 2004, DIABETES, V53, P1007, DOI 10.2337/diabetes.53.4.1007; Roduit R, 2001, DIABETES, V50, P1970, DOI 10.2337/diabetes.50.9.1970; Roduit R, 2000, J BIOL CHEM, V275, P35799, DOI 10.1074/jbc.M006001200; Ronnebaum SM, 2006, J BIOL CHEM, V281, P30593, DOI 10.1074/jbc.M511908200; Salehi A, 1996, AM J PHYSIOL-CELL PH, V270, pC1634, DOI 10.1152/ajpcell.1996.270.6.C1634; Schuit F, 1997, J BIOL CHEM, V272, P18572, DOI 10.1074/jbc.272.30.18572; SENER A, 1991, BIOCHIMIE, V73, P1287, DOI 10.1016/0300-9084(91)90090-N; Straub SG, 2002, DIABETES-METAB RES, V18, P451, DOI 10.1002/dmrr.329	53	120	126	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35657	35665		10.1074/jbc.M707294200	http://dx.doi.org/10.1074/jbc.M707294200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17928289	hybrid			2022-12-27	WOS:000251458100026
J	Hatta, M; Cirillo, LA				Hatta, Mitsutoki; Cirillo, Lisa Ann			Chromatin opening and stable perturbation of core histone: DNA contacts by FoxO1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-BINDING PROTEIN-1; TRANSCRIPTION FACTOR FKHR; INSULIN-RESPONSE SEQUENCES; RAT HEPATOMA-CELLS; FORKHEAD TRANSCRIPTION; CRYSTAL-STRUCTURE; MMTV PROMOTER; ALVEOLAR RHABDOMYOSARCOMA; GENE-EXPRESSION; KINASE-B	FoxO1, a member of the forkhead rabdomyosarcoma (FoxO) subfamily of transcription factors, binds DNA via a highly conserved winged-helix "forkhead box" motif used by other regulatory proteins to mediate their effects through chromatin binding and remodeling. To examine how FoxO1 regulates target genes in chromatin, we studied the binding of purified recombinant FoxO1 protein to nucleosome particles and chromatin arrays containing the insulin-like growth factor-binding protein 1 promoter. We found that FoxO1 is able to bind to its cognate sites within the insulin-like growth factor-binding protein 1 promoter on a nucleosome. This binding stably perturbs core histone: DNA contacts extending up- and downstream from sites of FoxO1 binding without disrupting the underlying core particle. FoxO1 is able to harness these capabilities to bind to and de-condense linker histone-compacted chromatin arrays. Chromatin opening by FoxO1 requires both the N and C termini of the protein, which are also required for high affinity core histone binding and, in the case of the N terminus, nucleosome perturbation. We suggest that the chromatin binding and remodeling functions revealed here for FoxO1 endow all FoxO factors with the ability to initiate and dynamically modulate active chromatin states, enabling their diverse roles as gene regulatory factors in metabolism, cell survival, apoptosis, cell cycle progression, DNA repair, and protection against oxidative stress.	Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA	Medical College of Wisconsin	Cirillo, LA (corresponding author), Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	lcirillo@mcw.edu	HATTA, MOCHAMMAD/D-3742-2019	HATTA, MOCHAMMAD/0000-0002-8456-4203				ADAMS CC, 1995, MOL CELL BIOL, V15, P1405; ARCHER TK, 1992, SCIENCE, V255, P1573, DOI 10.1126/science.1347958; Ayala JE, 1999, DIABETES, V48, P1885, DOI 10.2337/diabetes.48.9.1885; Barthel A, 2005, TRENDS ENDOCRIN MET, V16, P183, DOI 10.1016/j.tem.2005.03.010; BAXEVANIS AD, 1991, BIOCHEMISTRY-US, V30, P8817, DOI 10.1021/bi00100a013; Becker PB, 2002, ANNU REV BIOCHEM, V71, P247, DOI 10.1146/annurev.biochem.71.110601.135400; Bednar J, 1998, P NATL ACAD SCI USA, V95, P14173, DOI 10.1073/pnas.95.24.14173; Belikov S, 2001, EMBO J, V20, P2802, DOI 10.1093/emboj/20.11.2802; Bennicelli JL, 1996, P NATL ACAD SCI USA, V93, P5455, DOI 10.1073/pnas.93.11.5455; BENNICELLI JL, 1995, ONCOGENE, V11, P119; Berger SL, 2001, ONCOGENE, V20, P3007, DOI 10.1038/sj.onc.1204324; Biggs WH, 2001, MAMM GENOME, V12, P416, DOI 10.1007/s003350020002; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Birkenkamp KU, 2003, BIOCHEM SOC T, V31, P292, DOI 10.1042/bst0310292; Boura E, 2007, J BIOL CHEM, V282, P8265, DOI 10.1074/jbc.M605682200; Boyes J, 1998, J MOL BIOL, V279, P529, DOI 10.1006/jmbi.1998.1783; Cirillo LA, 1999, MOL CELL, V4, P961, DOI 10.1016/S1097-2765(00)80225-7; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; Cirillo LA, 1998, EMBO J, V17, P244, DOI 10.1093/emboj/17.1.244; CLARK KL, 1993, NATURE, V364, P412, DOI 10.1038/364412a0; CORDINGLEY MG, 1987, CELL, V48, P261, DOI 10.1016/0092-8674(87)90429-6; Crissey MAS, 1999, HEPATOLOGY, V30, P1187, DOI 10.1002/hep.510300520; Daitoku H, 2003, DIABETES, V52, P642, DOI 10.2337/diabetes.52.3.642; Furuyama T, 2004, J BIOL CHEM, V279, P34741, DOI 10.1074/jbc.M314214200; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Hollenhorst PC, 2000, GENETICS, V154, P1533; Hosaka T, 2004, P NATL ACAD SCI USA, V101, P2975, DOI 10.1073/pnas.0400093101; Kaestner KH, 2000, GENE DEV, V14, P142; Karantza V, 1996, BIOCHEMISTRY-US, V35, P2037, DOI 10.1021/bi9518858; Katoh M, 2004, INT J ONCOL, V25, P1495; Kingston RE, 1999, GENE DEV, V13, P2339, DOI 10.1101/gad.13.18.2339; Koranda M, 2000, NATURE, V406, P94, DOI 10.1038/35017589; Lee CS, 2005, NATURE, V435, P944, DOI 10.1038/nature03649; LEE JY, 1994, HEPATOLOGY, V19, P656, DOI 10.1002/hep.1840190317; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; McPherson CE, 1996, NUCLEIC ACIDS RES, V24, P397, DOI 10.1093/nar/24.3.397; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Nakae J, 1999, J BIOL CHEM, V274, P15982, DOI 10.1074/jbc.274.23.15982; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI200112876; Nasrin N, 2000, P NATL ACAD SCI USA, V97, P10412, DOI 10.1073/pnas.190326997; ORLOWSKI CC, 1991, MOL ENDOCRINOL, V5, P1180, DOI 10.1210/mend-5-8-1180; ORLOWSKI CC, 1990, MOL ENDOCRINOL, V4, P1592, DOI 10.1210/mend-4-10-1592; OwenHughes T, 1996, SCIENCE, V273, P513, DOI 10.1126/science.273.5274.513; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; RAMAKRISHNAN V, 1993, NATURE, V362, P219, DOI 10.1038/362219a0; Rena G, 1999, J BIOL CHEM, V274, P17179, DOI 10.1074/jbc.274.24.17179; SCHULLER AGP, 1993, ENDOCRINOLOGY, V132, P2544, DOI 10.1210/en.132.6.2544; Schwarz PM, 1996, BIOCHEMISTRY-US, V35, P4009, DOI 10.1021/bi9525684; SIMPSON RT, 1985, CELL, V42, P799, DOI 10.1016/0092-8674(85)90276-4; So CW, 2003, BLOOD, V101, P633, DOI 10.1182/blood-2002-06-1785; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; SVAREN J, 1994, EMBO J, V13, P4856, DOI 10.1002/j.1460-2075.1994.tb06812.x; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; Tomizawa M, 2000, J BIOL CHEM, V275, P7289, DOI 10.1074/jbc.275.10.7289; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; TRUSS M, 1995, EMBO J, V14, P1737, DOI 10.1002/j.1460-2075.1995.tb07163.x; Usachenko SI, 1996, J BIOL CHEM, V271, P3831; Vander Kooi BT, 2003, J BIOL CHEM, V278, P11782, DOI 10.1074/jbc.M212570200; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Weigelt J, 2001, BIOCHEMISTRY-US, V40, P5861, DOI 10.1021/bi001663w; White CL, 2004, J MOL BIOL, V342, P1391, DOI 10.1016/j.jmb.2004.07.080; WORKMAN JL, 1992, SCIENCE, V258, P1780, DOI 10.1126/science.1465613; Yan JZ, 2006, MOL CELL BIOL, V26, P155, DOI 10.1128/MCB.26.1.155-168.2006; Yeagley D, 2001, J BIOL CHEM, V276, P33705, DOI 10.1074/jbc.M101215200; Zaret K, 1999, DEV BIOL, V209, P1, DOI 10.1006/dbio.1999.9228; Zhang XH, 2002, J BIOL CHEM, V277, P45276, DOI 10.1074/jbc.M208063200	66	83	85	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35583	35593		10.1074/jbc.M704735200	http://dx.doi.org/10.1074/jbc.M704735200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17923482	hybrid			2022-12-27	WOS:000251458100018
J	Cadieux, N; Barekzi, N; Bradbeer, C				Cadieux, Nathalie; Barekzi, Nazir; Bradbeer, Clive			Observations on the calcium dependence and reversibility of cobalamin transport across the outer membrane Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENERGY TRANSDUCTION; BTUB AFFECT; TONB; PROTEIN; VITAMIN-B12; GENE; FEPA; MUTATIONS; SEQUENCE; BINDING	The calcium dependence of cobalamin (Cbl) binding to the BtuB protein of Escherichia coli and the reversibility of its function in the transport of Cbl across the outer membrane have been examined. The results show that the two calcium-binding sites in BtuB that were identified previously by others are responsible for the calcium dependence of high affinity Cbl binding. The affinity of the pure BtuB protein for Cbl was similar to 1000-fold higher in the presence of saturating levels of calcium than in its absence. The affinities of BtuB for both Cbl and calcium were decreased by insertion of alanine residues at position 51 of the mature protein and were increased by several mutations and deletions in the TonB box. Experiments on the uptake of Cbl into the periplasmic space showed that this process is reversible and that the exit of Cbl back into the medium does not require the protonmotive force. Our interpretation of these results is that the role of the TonB-ExbB-ExbD complex, potentiated by the protonmotive force, is to reduce the affinity of the Cbl-binding site, thus increasing the rate of Cbl release into the periplasmic space. The evidence also indicates that access of the Cbl-binding site of BtuB to the periplasmic space does not require removal of the hatch domain from the barrel.	Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA; Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia	Bradbeer, C (corresponding author), Univ Virginia, Dept Biochem & Mol Genet, POB 800733, Charlottesville, VA 22908 USA.	cb7f@virginia.edu			NIGMS NIH HHS [GM019078] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Boyd D, 2000, J BACTERIOL, V182, P842, DOI 10.1128/JB.182.3.842-847.2000; Bradbeer C., 1999, Chemistry and biochemistry of B12., P489; BRADBEER C, 1978, J BIOL CHEM, V253, P1347; BRADBEER C, 1990, J BACTERIOL, V172, P4919, DOI 10.1128/jb.172.9.4919-4926.1990; BRADBEER C, 1976, J BACTERIOL, V128, P99, DOI 10.1128/JB.128.1.99-104.1976; BRADBEER C, 1986, J BIOL CHEM, V261, P2520; BRADBEER C, 1993, J BACTERIOL, V175, P3146, DOI 10.1128/JB.175.10.3146-3150.1993; Cadieux N, 1999, P NATL ACAD SCI USA, V96, P10673, DOI 10.1073/pnas.96.19.10673; Cadieux N, 2000, J BACTERIOL, V182, P5954, DOI 10.1128/JB.182.21.5954-5961.2000; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; Cascales E, 2001, MOL MICROBIOL, V42, P795, DOI 10.1046/j.1365-2958.2001.02673.x; Chimento DP, 2003, J MOL BIOL, V332, P999, DOI 10.1016/j.jmb.2003.07.005; DAVIS BD, 1950, J BACTERIOL, V60, P17, DOI 10.1128/JB.60.1.17-28.1950; GUDMUNDSDOTTIR A, 1989, J BACTERIOL, V171, P6526, DOI 10.1128/jb.171.12.6526-6533.1989; HELLER K, 1985, J BACTERIOL, V161, P904, DOI 10.1128/JB.161.3.904-908.1985; HELLER KJ, 1988, GENE, V64, P147, DOI 10.1016/0378-1119(88)90488-X; Higgs PI, 2002, MOL MICROBIOL, V44, P271, DOI 10.1046/j.1365-2958.2002.02880.x; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Ma L, 2007, J BIOL CHEM, V282, P397, DOI 10.1074/jbc.M605333200; PORTZEHL H, 1964, BIOCHIM BIOPHYS ACTA, V79, P581, DOI 10.1016/0926-6577(64)90224-4; Postle K, 2002, SCIENCE, V295, P1658; REYNOLDS PR, 1980, J BIOL CHEM, V255, P4313; Shultis DD, 2006, SCIENCE, V312, P1396, DOI 10.1126/science.1127694; SKARE JT, 1993, J BIOL CHEM, V268, P16302	24	11	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					34921	34928		10.1074/jbc.M707426200	http://dx.doi.org/10.1074/jbc.M707426200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17908684	hybrid			2022-12-27	WOS:000251155200035
J	Dustin, ML; Starr, T; Coombs, D; Majeau, GR; Meier, W; Hochman, PS; Douglass, A; Vale, R; Goldstein, B; Whitty, A				Dustin, Michael L.; Starr, Toby; Coombs, Daniel; Majeau, Gerard R.; Meier, Werner; Hochman, Paula S.; Douglass, Adam; Vale, Ron; Goldstein, Byron; Whitty, Adrian			Quantification and modeling of tripartite CD2-, CD58FC chimera (Alefacept)-, and CD16-mediated cell adhesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTION-ASSOCIATED ANTIGEN-3; 2-DIMENSIONAL DISSOCIATION-CONSTANT; FC-GAMMA-RIII; T-LYMPHOCYTES; LOW-AFFINITY; MONOCLONAL-ANTIBODY; FUSION PROTEINS; LEUKEMIA-CELLS; MOLECULE CD2; RECEPTOR	Alefacept is a chimeric protein combining CD58 immuno-globulin-like domain 1 with human IgG1 Fc. Alefacept mediates adhesion by bridging CD2 on T cells to activating Fc receptors on effector cells, but the equilibrium binding parameters have not been determined. Alefacept mediated T cell killing by NK cells and adhesion between CD2- and CD16-expressing cells at an optimum concentration of 100 nM. We introduce novel measurements with supported planer bilayers, from which key two-dimensional and three-dimensional parameters can be determined by data fitting. Alefacept competitively inhibited cell bilayer adhesion mediated by the CD2-CD58 interaction. Alefacept mediated maximal adhesion of CD2(+) T cells to CD16B, an Fc receptor, in planar bilayers at 500 nM. A mechanistic model for alefacept-mediated cell-bilayer adhesion allowed fitting of the data and determination of two-dimensional binding parameters. These included the density of bonds in the adhesion area, which grew to maintain a consistent average bond density of 200 molecules/mu m(2) and two-dimensional association constants of 3.1 and 630 mu m(2) for bivalently and monovalently bound forms of alefacept, respectively. The maximum number of CD16 bound and the fit value of 4,350 CD2 per cell are much lower than the 40,000 CD2 per cell measured with anti-CD2 Fab. These results suggest that additional information is needed to correctly predict Alefacept-mediated bridge formation.	NYU, Sch Med, Ctr Med Biol, Skirball Inst Biomol Med,Dept Pathol, New York, NY 10016 USA; Univ British Columbia, Dept Math, Vancouver, BC V6T 1Z2, Canada; Biogen Inc, Cambridge, MA 02142 USA; Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; Los Alamos Natl Lab, Div Theoret, Los Alamos, NM 87545 USA	New York University; University of British Columbia; Biogen; University of California System; University of California San Francisco; United States Department of Energy (DOE); Los Alamos National Laboratory	Dustin, ML (corresponding author), NYU, Sch Med, Ctr Med Biol, Skirball Inst Biomol Med,Dept Pathol, New York, NY 10016 USA.	dustin@saturn.med.nyu.edu	Dustin, Michael/AAM-4611-2020	Dustin, Michael/0000-0003-4983-6389; Coombs, Daniel/0000-0002-8038-6278	NIAID NIH HHS [R37-1 AI043542] Funding Source: Medline; NIGMS NIH HHS [R37 GM035556] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI043542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM035556] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baselga J, 2001, SEMIN ONCOL, V28, P4, DOI 10.1053/sonc.2001.28544; BELL GI, 1984, BIOPHYS J, V45, P1051, DOI 10.1016/S0006-3495(84)84252-6; Bromley SK, 2001, NAT IMMUNOL, V2, P1159, DOI 10.1038/ni737; BYRN RA, 1990, NATURE, V344, P667, DOI 10.1038/344667a0; Cartron G, 2002, BLOOD, V99, P754, DOI 10.1182/blood.V99.3.754; CROTHERS DM, 1972, IMMUNOCHEMISTRY, V9, P341, DOI 10.1016/0019-2791(72)90097-3; da Silva AJ, 2002, J IMMUNOL, V168, P4462, DOI 10.4049/jimmunol.168.9.4462; Douglass AD, 2005, CELL, V121, P937, DOI 10.1016/j.cell.2005.04.009; Dustin ML, 1997, J BIOL CHEM, V272, P15782, DOI 10.1074/jbc.272.25.15782; Dustin ML, 1997, J BIOL CHEM, V272, P30889, DOI 10.1074/jbc.272.49.30889; DUSTIN ML, 1987, J EXP MED, V165, P677, DOI 10.1084/jem.165.3.677; Dustin ML, 1996, J CELL BIOL, V132, P465, DOI 10.1083/jcb.132.3.465; DUSTIN ML, 1989, J EXP MED, V169, P503, DOI 10.1084/jem.169.2.503; Ellis CN, 2001, NEW ENGL J MED, V345, P248, DOI 10.1056/NEJM200107263450403; Galon J, 1997, EUR J IMMUNOL, V27, P1928, DOI 10.1002/eji.1830270816; Gong Q, 2005, J IMMUNOL, V174, P817, DOI 10.4049/jimmunol.174.2.817; Green JM, 1997, J CELL BIOL, V139, P1209, DOI 10.1083/jcb.139.5.1209; HIBBS ML, 1989, SCIENCE, V246, P1608, DOI 10.1126/science.2531918; KATO K, 1992, J EXP MED, V176, P1241, DOI 10.1084/jem.176.5.1241; Klopfenstein DR, 2002, CELL, V109, P347, DOI 10.1016/S0092-8674(02)00708-0; LIU SJ, 1995, BIOPHYS J, V68, P459, DOI 10.1016/S0006-3495(95)80207-9; Louis E, 2004, ALIMENT PHARM THER, V19, P511, DOI 10.1111/j.1365-2036.2004.01871.x; Majeau GR, 1999, CELL ADHES COMMUN, V7, P267, DOI 10.3109/15419069909010808; MAJEAU GR, 1994, J IMMUNOL, V152, P2753; MEUER SC, 1984, CELL, V36, P897, DOI 10.1016/0092-8674(84)90039-4; MILLER GT, 1993, J EXP MED, V178, P211, DOI 10.1084/jem.178.1.211; POSNER RG, 1992, BIOCHEMISTRY-US, V31, P5350, DOI 10.1021/bi00138a015; SAFFMAN PG, 1975, P NATL ACAD SCI USA, V72, P3111, DOI 10.1073/pnas.72.8.3111; SANDERS ME, 1988, J IMMUNOL, V140, P1401; SCHLESSINGER J, 1977, P NATL ACAD SCI USA, V74, P1110, DOI 10.1073/pnas.74.3.1110; Shao JY, 2005, ANN BIOMED ENG, V33, P483, DOI 10.1007/s10439-005-2504-5; Uchida JJ, 2004, J EXP MED, V199, P1659, DOI 10.1084/jem.20040119; VANDERMERWE PA, 1994, BIOCHEMISTRY-US, V33, P10149, DOI 10.1021/bi00199a043; WEIS RM, 1982, J BIOL CHEM, V257, P6440; WELLS AF, 1966, APPL MICROBIOL, V14, P271, DOI 10.1128/AEM.14.2.271-275.1966; Williams TE, 2001, J BIOL CHEM, V276, P13283, DOI 10.1074/jbc.M010427200; Winckler B, 1999, NATURE, V397, P698, DOI 10.1038/17789; ZETTLMEISSL G, 1990, DNA CELL BIOL, V9, P347, DOI 10.1089/dna.1990.9.347; Zhang Z, 2003, CANCER RES, V63, P6453; Zhu DM, 2007, BIOPHYS J, V92, P1022, DOI 10.1529/biophysj.106.089649	40	21	21	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					34748	34757		10.1074/jbc.M705616200	http://dx.doi.org/10.1074/jbc.M705616200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17911103	hybrid			2022-12-27	WOS:000251155200017
J	Pilecka, I; Patrignani, C; Pescini, R; Curchod, ML; Perrin, D; Xue, Y; Yasenchak, J; Clark, A; Magnone, MC; Zaratin, P; Valenzuela, D; Rommel, C; van Huijsduijnen, RH				Pilecka, Iwona; Patrignani, Claudia; Pescini, Rosanna; Curchod, Marie-Laure; Perrin, Dominique; Xue, Yingzi; Yasenchak, Jason; Clark, Ann; Magnone, Maria Chiara; Zaratin, Paola; Valenzuela, David; Rommel, Christian; van Huijsduijnen, Rob Hooft			Protein-tyrosine phosphatase H1 controls growth hormone receptor signaling and systemic growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; SUBSTRATE-TRAPPING MUTANTS; MOTH-EATEN MICE; INSULIN-RECEPTOR; FACTOR-I; NEGATIVE REGULATOR; STAT5 ACTIVATION; ADIPOSE-TISSUE; FOCAL ADHESION; BETA-RECEPTOR	Several protein-tyrosine phosphatases (PTPs) have been implicated in the control of growth hormone receptor (GHR) signaling, but none have been shown to affect growth in vivo. We have applied a battery of molecular and cellular approaches to test a family-wide panel of PTPs for interference with GHR signaling. Among the subset of PTPs that showed activity in multiple readouts, we selected PTP-H1/PTPN3 for further in vivo studies and found that mice lacking the PTP-H1 catalytic domain show significantly enhanced growth over their wild type littermates. In addition, PTP-H1 mutant animals had enhanced plasma and liver mRNA expression of insulin-like growth factor 1, as well as increased bone density and mineral content. These observations point to a controlling role for PTP-H1 in modulating GHR signaling and systemic growth through insulin-like growth factor 1 secretion.	Merck Serono Int, CH-1211 Geneva, Switzerland; Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA; EMD Serono Res Inst, Rockland, MA 02370 USA	Merck KGaA; EMD Serono Inc.; Regeneron	van Huijsduijnen, RH (corresponding author), Merck Serono Int, CH-1211 Geneva, Switzerland.	rob.hooft@merckserono.net	Pilecka, Iwona/AAT-9114-2021; van Huijsduijnen, Rob A.M. Hooft/B-3653-2009	Pilecka, Iwona/0000-0002-5057-346X; van Huijsduijnen, Rob A.M. Hooft/0000-0002-2261-9424				Ahima RS, 1996, NATURE, V382, P250, DOI 10.1038/382250a0; AHMAD F, 1995, J CLIN INVEST, V95, P2806, DOI 10.1172/JCI117985; Aoki N, 2002, MOL ENDOCRINOL, V16, P58, DOI 10.1210/me.16.1.58; Aoki N, 2000, J BIOL CHEM, V275, P39718, DOI 10.1074/jbc.M005615200; Arrandale JM, 1996, J BIOL CHEM, V271, P21353, DOI 10.1074/jbc.271.35.21353; AYLING CM, 1989, J ENDOCRINOL, V123, P429, DOI 10.1677/joe.0.1230429; Bauler TJ, 2007, J IMMUNOL, V178, P3680, DOI 10.4049/jimmunol.178.6.3680; Baum HBA, 1996, ANN INTERN MED, V125, P883, DOI 10.7326/0003-4819-125-11-199612010-00003; Ben-Yair L, 2002, PROTEIN EXPRES PURIF, V25, P456, DOI 10.1016/S1046-5928(02)00044-X; Berneis K, 1996, BAILLIERE CLIN ENDOC, V10, P337, DOI 10.1016/S0950-351X(96)80470-8; Blair ER, 2006, BIOORGAN MED CHEM, V14, P464, DOI 10.1016/j.bmc.2005.08.025; Bluher S, 2005, BEST PRACT RES CL EN, V19, P577, DOI 10.1016/j.beem.2005.07.011; Chase K, 2005, GENOME RES, V15, P1820, DOI 10.1101/gr.3712705; Cheng A, 2002, DEV CELL, V2, P497, DOI 10.1016/S1534-5807(02)00149-1; Chiarugi P, 2002, J BIOL CHEM, V277, P37331, DOI 10.1074/jbc.M205203200; Chiarugi P, 1997, BIOCHEM BIOPH RES CO, V238, P676, DOI 10.1006/bbrc.1997.7355; Cook WS, 2002, DEV CELL, V2, P385, DOI 10.1016/S1534-5807(02)00158-2; Elchebly M, 2000, J MOL MED-JMM, V78, P473, DOI 10.1007/s001090000141; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Engstrom BE, 2002, SCAND J CLIN LAB INV, V62, P25, DOI 10.1080/003655102753517172; Engstrom BE, 2000, J INTERN MED, V247, P570, DOI 10.1046/j.1365-2796.2000.00672.x; Espanel X, 2002, PROTEIN SCI, V11, P2326, DOI 10.1110/ps.0213402; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; Flores-Morales A, 2006, MOL ENDOCRINOL, V20, P241, DOI 10.1210/me.2005-0170; Gjorloff-Wingren A, 2000, EUR J IMMUNOL, V30, P2412, DOI 10.1002/1521-4141(2000)30:8<2412::AID-IMMU2412>3.0.CO;2-J; GORDON JA, 1991, METHOD ENZYMOL, V201, P477; Govers R, 1999, EMBO J, V18, P28, DOI 10.1093/emboj/18.1.28; Gu F, 2003, MOL CELL BIOL, V23, P3753, DOI 10.1128/MCB.23.11.3753-3762.2003; Hackett RH, 1997, J BIOL CHEM, V272, P11128; Han SL, 2000, EUR J IMMUNOL, V30, P1318, DOI 10.1002/(SICI)1521-4141(200005)30:5<1318::AID-IMMU1318>3.0.CO;2-G; Hansen LH, 1996, J BIOL CHEM, V271, P12669, DOI 10.1074/jbc.271.21.12669; Hawkins PT, 2006, BIOCHEM SOC T, V34, P647, DOI 10.1042/BST0340647; Heinonen KM, 2004, BLOOD, V103, P3457, DOI 10.1182/blood-2003-09-3153; Herrington J, 2000, ONCOGENE, V19, P2585, DOI 10.1038/sj.onc.1203526; Jespersen T, 2006, BIOCHEM BIOPH RES CO, V348, P1455, DOI 10.1016/j.bbrc.2006.08.014; Jing M, 2007, J VIROL, V81, P2231, DOI 10.1128/JVI.01979-06; Johansson A. G., 1999, Journal of Endocrinological Investigation, V22, P58; Kappert K, 2007, FASEB J, V21, P523, DOI 10.1096/fj.06-6219com; Karlsson S, 2006, MOL BIOL CELL, V17, P4846, DOI 10.1091/mbc.E06-04-0306; Kasuga M, 1996, DIABETIC MED, V13, pS87; Kaszubska W, 2002, MOL CELL ENDOCRINOL, V195, P109, DOI 10.1016/S0303-7207(02)00178-8; Katsumata M, 2000, J NUTR, V130, P2482, DOI 10.1093/jn/130.10.2482; KHARITONENKOV A, 1995, J BIOL CHEM, V270, P29189, DOI 10.1074/jbc.270.49.29189; Kim SO, 1998, J BIOL CHEM, V273, P2344, DOI 10.1074/jbc.273.4.2344; Klaman LD, 2000, MOL CELL BIOL, V20, P5479, DOI 10.1128/MCB.20.15.5479-5489.2000; KOZLOWSKI M, 1993, J EXP MED, V178, P2157, DOI 10.1084/jem.178.6.2157; KULAS DT, 1995, J BIOL CHEM, V270, P2435, DOI 10.1074/jbc.270.6.2435; Lammers R, 1997, FEBS LETT, V404, P37, DOI 10.1016/S0014-5793(97)00080-X; Lavoie C, 2000, P NATL ACAD SCI USA, V97, P13637, DOI 10.1073/pnas.240278097; Li PM, 1996, CELL SIGNAL, V8, P467, DOI 10.1016/S0898-6568(96)00101-5; LOBIE PE, 1995, J BIOL CHEM, V270, P21745, DOI 10.1074/jbc.270.37.21745; MOLLER NPH, 1995, J BIOL CHEM, V270, P23126, DOI 10.1074/jbc.270.39.23126; Mooney RA, 1997, BIOCHEM BIOPH RES CO, V235, P709, DOI 10.1006/bbrc.1997.6889; Morinville A, 1998, TRENDS PHARMACOL SCI, V19, P452, DOI 10.1016/S0165-6147(98)01257-7; Nakashima N, 2000, J BIOL CHEM, V275, P12889, DOI 10.1074/jbc.275.17.12889; OGUNKOLADE B, 2005, END ABSTR, V9, P85; Ouwens DM, 1996, BIOCHEM J, V318, P609, DOI 10.1042/bj3180609; PALMITER RD, 1982, NATURE, V300, P611, DOI 10.1038/300611a0; Pasquali C, 2003, MOL ENDOCRINOL, V17, P2228, DOI 10.1210/me.2003-0011; Persson C, 2004, MOL CELL BIOL, V24, P2190, DOI 10.1128/MCB.24.5.2190-2201.2004; Pilecka I, 2007, TRENDS ENDOCRIN MET, V18, P12, DOI 10.1016/j.tem.2006.11.004; Rocchi S, 1996, ENDOCRINOLOGY, V137, P4944, DOI 10.1210/en.137.11.4944; Saxton TM, 2000, NAT GENET, V24, P420, DOI 10.1038/74279; Sotiropoulos A, 1996, MOL ENDOCRINOL, V10, P998, DOI 10.1210/me.10.8.998; Sozio MS, 2004, J BIOL CHEM, V279, P7760, DOI 10.1074/jbc.M309994200; Stofega MR, 2000, MOL ENDOCRINOL, V14, P1338, DOI 10.1210/me.14.9.1338; Strous GJ, 1997, J BIOL CHEM, V272, P40; Sutter NB, 2007, SCIENCE, V316, P112, DOI 10.1126/science.1137045; ten Hoeve J, 2002, MOL CELL BIOL, V22, P5662, DOI 10.1128/MCB.22.16.5662-5668.2002; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; TSUI HW, 1993, NAT GENET, V4, P124, DOI 10.1038/ng0693-124; Umeda S, 1999, AM J PATHOL, V155, P223, DOI 10.1016/S0002-9440(10)65116-4; VACARESSE N, 2006, APMIS, V114, P163; Valenzuela DM, 2003, NAT BIOTECHNOL, V21, P652, DOI 10.1038/nbt822; van Huijsduijnen RH, 2002, DRUG DISCOV TODAY, V7, P1013, DOI 10.1016/S1359-6446(02)02438-8; VANDERKUUR JA, 1995, J BIOL CHEM, V270, P21738, DOI 10.1074/jbc.270.37.21738; Walchli S, 2000, J BIOL CHEM, V275, P9792, DOI 10.1074/jbc.275.13.9792; Walenkamp MJE, 2006, HORM RES, V66, P221, DOI 10.1159/000095161; Wang XZ, 1996, MOL ENDOCRINOL, V10, P1249, DOI 10.1210/me.10.10.1249; WANG YD, 1995, J BIOL CHEM, V270, P7021, DOI 10.1074/jbc.270.13.7021; Warabi M, 2000, EXP MOL PATHOL, V68, P187, DOI 10.1006/exmp.2000.2303; YouTen KE, 1997, J EXP MED, V186, P683, DOI 10.1084/jem.186.5.683; Yu DH, 1998, J BIOL CHEM, V273, P21125, DOI 10.1074/jbc.273.33.21125; Zabolotny JM, 2002, DEV CELL, V2, P489, DOI 10.1016/S1534-5807(02)00148-X; Zheng YF, 2002, J BIOL CHEM, V277, P42463, DOI 10.1074/jbc.M207459200	85	34	34	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					35405	35415		10.1074/jbc.M705814200	http://dx.doi.org/10.1074/jbc.M705814200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17921143	hybrid			2022-12-27	WOS:000251155200083
J	Cremades, N; Bueno, M; Neira, JL; Velazquez-Campoy, A; Sancho, J				Cremades, Nunilo; Bueno, Marta; Neira, Jose Luis; Velazquez-Campoy, Adrian; Sancho, Javier			Conformational stability of Helicobacter pylori flavodoxin - Fit to function at pH 5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DESULFOVIBRIO-DESULFURICANS FLAVODOXIN; STUDYING TRANSLATIONAL DIFFUSION; MOLTEN GLOBULE INTERMEDIATE; NUCLEAR-MAGNETIC-RESONANCE; FOLDING INTERMEDIATE; PROTEIN STABILITY; ALPHA-HELICES; FMN BINDING; APOFLAVODOXIN; ACID	Flavodoxin is an essential protein for Helicobacter pylori, a pathogen living in the very acidic environment of the gastric tract and responsible for several diseases. We report the conformational stability of the protein in neutral and acidic pH. The apoprotein remains native between pH 12 and 5 and adopts a monomeric molten globule conformation at more acidic pH values. The equilibrium unfolding in urea appears two-state for either conformation, but the native one coexists with a hidden equilibrium intermediate of very similar properties. The stability of H. pylori apoflavodoxin is higher than that of the Anabaena homologue throughout the entire pH interval, which may be related to better charge compensation. H. pylori apoflavodoxin is strongly stabilized by its FMN cofactor. A global analysis of apo- and holoflavodoxin equilibrium unfolding, with and without excess FMN, indicates that the cofactor only binds to the native state. Some physical-chemical properties of the protein may represent an adaptation to the acidic environment. Unlike the apoflavodoxin from Anabaena, which becomes highly insoluble at pH 5.0, that from H. pylori remains soluble to at least 40 mu M. This fact, together with the high stability of the apoprotein at this low pH that can arise in the bacteria cytoplasm, seems useful to allow newly synthesized apoflavodoxin molecules to fold and remain soluble to accomplish cofactor binding, which in turn increases the stability. Also, whenever the cytoplasmic pH drops to 5, preexisting flavodoxin molecules will remain folded and soluble and will retain the FMN cofactor, thus remaining functional.	[Cremades, Nunilo; Bueno, Marta; Neira, Jose Luis; Velazquez-Campoy, Adrian; Sancho, Javier] Univ Zaragoza, Fac Ciencias, Biocomp & Complex Syst Phys Inst, E-50009 Zaragoza, Spain; [Cremades, Nunilo; Bueno, Marta; Sancho, Javier] Univ Zaragoza, Fac Ciencias, Dept Bioquim & Biol Mol & Celular, E-50009 Zaragoza, Spain; [Neira, Jose Luis] Univ Miguel Hernandez, Inst Biol Mol & Celular, Alicante 03202, Spain	University of Zaragoza; University of Zaragoza; Universidad Miguel Hernandez de Elche	Sancho, J (corresponding author), Univ Zaragoza, Fac Ciencias, Biocomp & Complex Syst Phys Inst, E-50009 Zaragoza, Spain.	jsancho@unizar.es	Sancho, javier/AAA-1225-2019; Cremades, Nunilo/F-9634-2015; Neira, Jose/ABF-4210-2021; Velazquez-Campoy, Adrian/E-7946-2012; Bueno, Marta/GXM-7181-2022	Sancho, javier/0000-0002-2879-9200; Cremades, Nunilo/0000-0002-9138-6687; Velazquez-Campoy, Adrian/0000-0001-5702-4538; Bueno, Marta/0000-0001-7140-9899; Neira, Jose Luis/0000-0002-4933-0428				Apiyo D, 2002, PROTEIN SCI, V11, P1129, DOI 10.1110/ps.3840102; Apiyo D, 2000, BBA-PROTEIN STRUCT M, V1479, P214, DOI 10.1016/S0167-4838(00)00032-7; BARTIK K, 1994, BIOPHYS J, V66, P1180, DOI 10.1016/S0006-3495(94)80900-2; BLASER MJ, 1992, GASTROENTEROLOGY, V102, P720, DOI 10.1016/0016-5085(92)90126-J; Bollen YJM, 2006, P NATL ACAD SCI USA, V103, P4095, DOI 10.1073/pnas.0509133103; Bollen YJM, 2005, J BIOL CHEM, V280, P7836, DOI 10.1074/jbc.M412871200; BYCHKOVA VE, 1988, FEBS LETT, V238, P231, DOI 10.1016/0014-5793(88)80485-X; Campos LA, 2006, PROTEINS, V63, P581, DOI 10.1002/prot.20855; Campos LA, 2004, J MOL BIOL, V344, P239, DOI 10.1016/j.jmb.2004.08.081; CANTOR CR, 1980, BIOPHYSICAL CHEM 2, P452; CAVANAGH JF, 1996, PROTEIN NMR SPECTROS, P31; Creighton T. E., 1993, PROTEINS STRUCTURES, P141; Cremades N, 2005, BIOPHYS CHEM, V115, P267, DOI 10.1016/j.bpc.2004.12.045; CREMADES N, 2007, BIOCHEMISTRY    1221; Cremades N, 2006, TRENDS BIOCHEM SCI, V31, P494, DOI 10.1016/j.tibs.2006.07.001; Devi VS, 2006, BIOCHEMISTRY-US, V45, P1599, DOI 10.1021/bi052352u; Dubey VK, 2003, BIOCHEMISTRY-US, V42, P12287, DOI 10.1021/bi035047m; EDMONDSON DE, 1971, BIOCHEMISTRY-US, V10, P124; FernandezRecio J, 1997, J MOL BIOL, V267, P184, DOI 10.1006/jmbi.1996.0831; FERRERO R L, 1991, Microbial Ecology in Health and Disease, V4, P121; Freigang J, 2002, PROTEIN SCI, V11, P253, DOI 10.1110/ps.28602; Freire E, 1998, ADV PROTEIN CHEM, V51, P255; Genzor CG, 1996, NAT STRUCT BIOL, V3, P329, DOI 10.1038/nsb0496-329; Genzor CG, 1996, PROTEIN SCI, V5, P1376, DOI 10.1002/pro.5560050716; GOTO Y, 1990, P NATL ACAD SCI USA, V87, P573, DOI 10.1073/pnas.87.2.573; Hammarstrom P, 1999, J BIOL CHEM, V274, P32897, DOI 10.1074/jbc.274.46.32897; HUGHES NJ, 1995, J BACTERIOL, V177, P3953, DOI 10.1128/jb.177.14.3953-3959.1995; Irun MP, 2001, PROTEIN ENG, V14, P173, DOI 10.1093/protein/14.3.173; Lapham J, 1997, J BIOMOL NMR, V10, P255, DOI 10.1023/A:1018310702909; LOEWENTHAL R, 1992, J MOL BIOL, V224, P759, DOI 10.1016/0022-2836(92)90560-7; Lopez-Llano J, 2006, J MOL BIOL, V356, P354, DOI 10.1016/j.jmb.2005.10.086; Lopez-Llano J, 2004, J BIOL CHEM, V279, P47177, DOI 10.1074/jbc.M405792200; Maldonado S, 2002, PROTEIN SCI, V11, P1260, DOI 10.1110/ps.2980102; Maldonado S, 1998, BIOCHEMISTRY-US, V37, P10589, DOI 10.1021/bi980368x; MARSHALL BJ, 1990, GASTROENTEROLOGY, V99, P697, DOI 10.1016/0016-5085(90)90957-3; Martinez-Julvez M, 2007, PROTEINS, V69, P581, DOI 10.1002/prot.21410; MATTHEW JB, 1985, CRC CR REV BIOCH MOL, V18, P91, DOI 10.3109/10409238509085133; Muraidhara BK, 2005, BBA-PROTEINS PROTEOM, V1747, P239, DOI 10.1016/j.bbapap.2004.11.012; Muralidhara BK, 2004, BIOCHEMISTRY-US, V43, P12855, DOI 10.1021/bi048944e; Naseem F, 2004, BBA-PROTEINS PROTEOM, V1699, P191, DOI 10.1016/j.bbapap.2004.02.011; Nuallain BO, 2002, EUR J BIOCHEM, V269, P212, DOI 10.1046/j.0014-2956.2002.02637.x; Pace C N, 1986, Methods Enzymol, V131, P266; Pan H, 1997, PROTEIN SCI, V6, P1985, DOI 10.1002/pro.5560060919; Park SJ, 2004, J BIOCHEM, V135, P337, DOI 10.1093/jb/mvh041; PARSONNET J, 1995, ALIMENT PHARM THERAP, V9, P45; PARSONNET J, 1991, NEW ENGL J MED, V325, P1127, DOI 10.1056/NEJM199110173251603; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Price WS, 1997, CONCEPT MAGNETIC RES, V9, P299, DOI 10.1002/(SICI)1099-0534(1997)9:5<299::AID-CMR2>3.3.CO;2-2; Price WS, 1998, CONCEPT MAGNETIC RES, V10, P197, DOI 10.1002/(SICI)1099-0534(1998)10:4<197::AID-CMR1>3.0.CO;2-S; Ptitsyn OB, 1995, ADV PROTEIN CHEM, V47, P83, DOI 10.1016/S0065-3233(08)60546-X; PTITSYN OB, 1987, J PROTEIN CHEM, V6, P273; RAO ST, 1992, PROTEIN SCI, V1, P1413, DOI 10.1002/pro.5560011103; Saeki K, 2004, J MOL BIOL, V341, P589, DOI 10.1016/j.jmb.2004.06.010; Sancho J, 2006, CELL MOL LIFE SCI, V63, P855, DOI 10.1007/s00018-005-5514-4; SANCHO J, 1992, BIOCHEMISTRY-US, V31, P2253, DOI 10.1021/bi00123a006; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Schaefer M, 1998, ADV PROTEIN CHEM, V51, P1; SEMISOTNOV GV, 1991, BIOPOLYMERS, V31, P119, DOI 10.1002/bip.360310111; Shortle D, 1999, NAT STRUCT BIOL, V6, P203, DOI 10.1038/6640; St Maurice M, 2007, J BACTERIOL, V189, P4764, DOI 10.1128/JB.00287-07; Stingl K, 2002, J BACTERIOL, V184, P3053, DOI 10.1128/JB.184.11.3053-3060.2002; Stingl K, 2002, TRENDS MICROBIOL, V10, P70, DOI 10.1016/S0966-842X(01)02287-9; Sutovsky H, 2004, J BIOL CHEM, V279, P17190, DOI 10.1074/jbc.M311225200; SVENSSON M, 1995, BIOCHEMISTRY-US, V34, P8606, DOI 10.1021/bi00027a010; Van Der Goot Francoise G., 1992, Trends in Cell Biology, V2, P343; Van Mierlo CPM, 1998, PROTEIN SCI, V7, P2331, DOI 10.1002/pro.5560071110; VUILLEUMIER S, 1993, BIOCHEMISTRY-US, V32, P10303, DOI 10.1021/bi00090a005; Wen Y, 2003, INFECT IMMUN, V71, P5921, DOI 10.1128/IAI.71.10.5921-5939.2003; WOTHERSPOON AC, 1993, LANCET, V342, P575, DOI 10.1016/0140-6736(93)91409-F; Wu CH, 2006, NUCLEIC ACIDS RES, V34, pD187, DOI 10.1093/nar/gkj161; ZORRILLA S, 1998, THESIS U ZARAGOZA ZA	71	14	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2883	2895		10.1074/jbc.M705677200	http://dx.doi.org/10.1074/jbc.M705677200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	17998211	hybrid			2022-12-27	WOS:000252622300045
J	Nagata, M; Kaito, C; Sekimizu, K				Nagata, Makiko; Kaito, Chikara; Sekimizu, Kazuhisa			Phosphodiesterase activity of CvfA is required for virulence in Staphylococcus aureus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EAL DOMAIN PROTEIN; BACILLUS-SUBTILIS; ESCHERICHIA-COLI; GENE-EXPRESSION; 2',3'-CYCLIC PHOSPHODIESTERASE; HD DOMAIN; DI-GMP; SYSTEM; AGR; IDENTIFICATION	We previously identified the cvfA gene (SA1129) as a novel virulence regulator in Staphylococcus aureus using the silkworm infection model. The cvfA gene, which is conserved among various pathogenic bacteria, contributes to the expression of the agr locus, a global virulence regulator that controls the expression of genes encoding various exoproteins, such as hemolysin. CvfA protein has a transmembrane domain, an RNA binding domain (KH domain), and a metal-dependent phosphohydrolase domain (HD domain). We report here the purification of recombinant CvfA protein from a membrane fraction of Escherichia coli by measuring its phosphodiesterase activity. Purified CvfA protein hydrolyzed the phosphodiester linkage of 2 ', 3 '-cyclic AMP, 2 ', 3 '-cyclic GMP, and 2 ', 3 '-cyclic phosphate at the 3 '-terminal of RNA in the presence of Mn2+. CvfA mutant proteins with amino acid substitutions in the HD domain had significantly decreased phosphodiesterase activity. Furthermore, mutated cvfA genes encoding proteins with low phosphodiesterase activity did not complement the decreased hemolysin production or the attenuated killing ability against silkworms in the cvfA deletion mutant. These results suggest that the phosphodiesterase activity of CvfA protein is required for virulence in S. aureus.	[Nagata, Makiko; Kaito, Chikara; Sekimizu, Kazuhisa] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo	Sekimizu, K (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, 3-1-7 Chome, Tokyo 1130033, Japan.	sekimizu@mol.f.u-tokyo.ac.jp	Kaito, Chikara/W-1815-2019; Kaito, Chikara/G-1248-2017	Kaito, Chikara/0000-0002-2895-3386; Kaito, Chikara/0000-0002-2895-3386				Ades SE, 2004, CURR OPIN MICROBIOL, V7, P157, DOI 10.1016/j.mib.2004.02.010; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P469, DOI 10.1016/S0968-0004(98)01293-6; CHEUNG AL, 1992, P NATL ACAD SCI USA, V89, P6462, DOI 10.1073/pnas.89.14.6462; Crossly KB, 1997, STAPHYLOCOCCI HUMAN; Dinges MM, 2000, CLIN MICROBIOL REV, V13, P16, DOI 10.1128/CMR.13.1.16-34.2000; Fabret C, 2002, MOL MICROBIOL, V46, P25, DOI 10.1046/j.1365-2958.2002.03140.x; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; Fournier B, 2001, MOL MICROBIOL, V41, P247, DOI 10.1046/j.1365-2958.2001.02515.x; Giraudo AT, 1997, ARCH MICROBIOL, V168, P53, DOI 10.1007/s002030050469; Gonzalez TN, 1999, EMBO J, V18, P3119, DOI 10.1093/emboj/18.11.3119; Hisert KB, 2005, MOL MICROBIOL, V56, P1234, DOI 10.1111/j.1365-2958.2005.04632.x; Hunt A, 2006, MICROBIOL-SGM, V152, P2895, DOI 10.1099/mic.0.29152-0; Inoue R, 2001, MOL GENET GENOMICS, V266, P564, DOI 10.1007/s004380100564; Kaito C, 2005, MOL MICROBIOL, V56, P934, DOI 10.1111/j.1365-2958.2005.04596.x; Kaito C, 2002, MICROB PATHOGENESIS, V32, P183, DOI 10.1006/mpat.2002.0494; Kaito C, 2006, MOL MICROBIOL, V62, P1601, DOI 10.1111/j.1365-2958.2006.05480.x; Kennell D, 2002, J BACTERIOL, V184, P4645, DOI 10.1128/JB.184.17.4645-4657.2002; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; Li SL, 1997, BIOTECHNIQUES, V23, P588, DOI 10.2144/97234bm05; Li ZW, 1998, P NATL ACAD SCI USA, V95, P2856, DOI 10.1073/pnas.95.6.2856; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Matsumoto Y, 2007, INFECT IMMUN, V75, P1964, DOI 10.1128/IAI.01552-06; NOVICK R, 1967, VIROLOGY, V33, P155, DOI 10.1016/0042-6822(67)90105-5; Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x; NOVICK RP, 1993, EMBO J, V12, P3967, DOI 10.1002/j.1460-2075.1993.tb06074.x; PENG HL, 1988, J BACTERIOL, V170, P4365, DOI 10.1128/jb.170.9.4365-4372.1988; Romling U, 2005, MOL MICROBIOL, V57, P629, DOI 10.1111/j.1365-2958.2005.04697.x; Ryan RP, 2006, P NATL ACAD SCI USA, V103, P6712, DOI 10.1073/pnas.0600345103; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Tamayo R, 2005, J BIOL CHEM, V280, P33324, DOI 10.1074/jbc.M506500200; TAO L, 1992, GENE, V120, P105, DOI 10.1016/0378-1119(92)90016-I; Tischler AD, 2005, INFECT IMMUN, V73, P5873, DOI 10.1128/IAI.73.9.5873-5882.2005; Traber K, 2006, MOL MICROBIOL, V59, P1519, DOI 10.1111/j.1365-2958.2006.04986.x; Trulzsch K, 2001, MICROBIOL-UK, V147, P203; Turko IV, 1998, J BIOL CHEM, V273, P6460, DOI 10.1074/jbc.273.11.6460; TYC K, 1987, J BIOL CHEM, V262, P12994; Vagner V, 1998, MICROBIOL-SGM, V144, P3097, DOI 10.1099/00221287-144-11-3097; VANDENESCH F, 1991, J BACTERIOL, V173, P6313, DOI 10.1128/jb.173.20.6313-6320.1991; Yakunin AF, 2004, J BIOL CHEM, V279, P36819, DOI 10.1074/jbc.M405120200; Yarwood JM, 2001, J BACTERIOL, V183, P1113, DOI 10.1128/JB.183.4.1113-1123.2001	40	52	54	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					2176	2184		10.1074/jbc.M705309200	http://dx.doi.org/10.1074/jbc.M705309200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	17951247	hybrid			2022-12-27	WOS:000252501000045
J	Yoshimochi, T; Fujikane, R; Kawanami, M; Matsunaga, F; Ishino, Y				Yoshimochi, Takehiro; Fujikane, Ryosuke; Kawanami, Miyuki; Matsunaga, Fujihiko; Ishino, Yoshizumi			The GINS complex from Pyrococcus furiosus stimulates the MCM helicase activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MINICHROMOSOME MAINTENANCE PROTEIN; DNA-REPLICATION; CRYSTAL-STRUCTURE; INITIATION; ORGANIZATION; POLYMORPHISM; ASSOCIATION; CDC6/ORC1; CDC45	Pyrococcus furiosus, a hyperthermophilic Archaea, has homologs of the eukaryotic MCM (mini-chromosome maintenance) helicase and GINS complex. The MCM and GINS proteins are both essential factors to initiate DNA replication in eukaryotic cells. Many biochemical characterizations of the replication-related proteins have been reported, but it has not been proved that the homologs of each protein are also essential for replication in archaeal cells. Here, we demonstrated that the P. furiosus GINS complex interacts with P. furiosus MCM. A chromatin immunoprecipitation assay revealed that the GINS complex is detected preferentially at the oriC region on Pyrococcus chromosomal DNA during the exponential growth phase but not in the stationary phase. Furthermore, the GINS complex stimulates both the ATPase and DNA helicase activities of MCM in vitro. These results strongly suggest that the archaeal GINS is involved in both the initiation and elongation processes of DNA replication in P. furiosus, as observed in eukaryotic cells.	[Ishino, Yoshizumi] BIRD Japan Sci & Technol Agcy, Higashi Ku, Fukuoka 8128581, Japan; [Yoshimochi, Takehiro; Fujikane, Ryosuke; Kawanami, Miyuki; Matsunaga, Fujihiko; Ishino, Yoshizumi] Kyushu Univ, Fac Agr, Dept Genet Resources Technol, Fukuoka 8128581, Japan	Kyushu University	Ishino, Y (corresponding author), BIRD Japan Sci & Technol Agcy, Higashi Ku, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.	ishino@agr.kyushu-u.ac.jp		Fujikane, Ryosuke/0000-0002-6621-3848; Ishino, Yoshizumi/0000-0001-9419-0826				Barry ER, 2006, MICROBIOL MOL BIOL R, V70, P876, DOI 10.1128/MMBR.00029-06; Boskovic J, 2007, EMBO REP, V8, P678, DOI 10.1038/sj.embor.7401002; Carpentieri F, 2002, J BIOL CHEM, V277, P12118, DOI 10.1074/jbc.M200091200; Chang YP, 2007, P NATL ACAD SCI USA, V104, P12685, DOI 10.1073/pnas.0705558104; Chen YJ, 2005, J MOL BIOL, V346, P389, DOI 10.1016/j.jmb.2004.11.076; Choi JM, 2007, GENE DEV, V21, P1316, DOI 10.1101/gad.1548107; Chong JPJ, 2000, P NATL ACAD SCI USA, V97, P1530, DOI 10.1073/pnas.030539597; Costa A, 2006, J STRUCT BIOL, V156, P210, DOI 10.1016/j.jsb.2006.04.001; De Falco M, 2007, EMBO REP, V8, P99, DOI 10.1038/sj.embor.7400870; Fletcher RJ, 2005, J BIOL CHEM, V280, P42405, DOI 10.1074/jbc.M509773200; Fletcher RJ, 2003, NAT STRUCT BIOL, V10, P160, DOI 10.1038/nsb893; Fujita M, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-22; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Gomez-Llorente Y, 2005, J BIOL CHEM, V280, P40909, DOI 10.1074/jbc.M509760200; Grainge I, 2003, NUCLEIC ACIDS RES, V31, P4888, DOI 10.1093/nar/gkg662; Haugland GT, 2006, NUCLEIC ACIDS RES, V34, P6337, DOI 10.1093/nar/gkl864; Ishimi Y, 1997, J BIOL CHEM, V272, P24508, DOI 10.1074/jbc.272.39.24508; KARMADA K, 2007, NAT STRUCT MOL BIOL, V14, P388; Kelman Z, 1999, P NATL ACAD SCI USA, V96, P14783, DOI 10.1073/pnas.96.26.14783; Kubota Y, 2003, GENE DEV, V17, P1141, DOI 10.1101/gad.1070003; Labib K, 2007, TRENDS CELL BIOL, V17, P271, DOI 10.1016/j.tcb.2007.04.002; Liu LD, 2001, J BIOL CHEM, V276, P45484, DOI 10.1074/jbc.M106391200; Makarova KS, 2005, NUCLEIC ACIDS RES, V33, P4626, DOI 10.1093/nar/gki775; Marinsek N, 2006, EMBO REP, V7, P539, DOI 10.1038/sj.embor.7400649; Masuda T, 2003, GENES CELLS, V8, P145, DOI 10.1046/j.1365-2443.2003.00621.x; Matsunaga F, 2001, P NATL ACAD SCI USA, V98, P11152, DOI 10.1073/pnas.191387498; Matsunaga F, 2007, NUCLEIC ACIDS RES, V35, P3214, DOI 10.1093/nar/gkm212; McGeoch AT, 2005, NAT STRUCT MOL BIOL, V12, P756, DOI 10.1038/nsmb974; Mott ML, 2007, NAT REV MICROBIOL, V5, P343, DOI 10.1038/nrmicro1640; Moyer SE, 2006, P NATL ACAD SCI USA, V103, P10236, DOI 10.1073/pnas.0602400103; ORLANDO V, 1993, CELL, V75, P1187, DOI 10.1016/0092-8674(93)90328-N; Pacek M, 2006, MOL CELL, V21, P581, DOI 10.1016/j.molcel.2006.01.030; Pape T, 2003, EMBO REP, V4, P1079, DOI 10.1038/sj.embor.7400010; Shechter DF, 2000, J BIOL CHEM, V275, P15049, DOI 10.1074/jbc.M000398200; Takayama Y, 2003, GENE DEV, V17, P1153, DOI 10.1101/gad.1065903; Tercero JA, 2000, EMBO J, V19, P2082, DOI 10.1093/emboj/19.9.2082; UEMORI T, 1993, NUCLEIC ACIDS RES, V21, P259, DOI 10.1093/nar/21.2.259; YABUUCHI H, 2007, EMBO J, V8, P99	38	55	55	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1601	1609		10.1074/jbc.M707654200	http://dx.doi.org/10.1074/jbc.M707654200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	17986447	hybrid			2022-12-27	WOS:000252282700046
J	Freel, CD; Richardson, DA; Thomenius, MJ; Gan, EC; Horn, SR; Olson, MR; Kornbluth, S				Freel, Christopher D.; Richardson, D. Ashley; Thomenius, Michael J.; Gan, Eugene C.; Horn, Sarah R.; Olson, Michael R.; Kornbluth, Sally			Mitochondrial localization of reaper to promote inhibitors of apoptosis protein degradation conferred by GH3 domain-lipid interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRAMMED CELL-DEATH; CYTOCHROME-C; DROSOPHILA-REAPER; CASPASE ACTIVATION; GRIM; INDUCTION; HID; GENE; BAX; STRESS	Morphological hallmarks of apoptosis result from activation of the caspase family of cysteine proteases, which are opposed by a pro-survival family of inhibitors of apoptosis proteins (IAPs). In Drosophila, disruption of IAP function by Reaper, HID, and Grim (RHG) proteins is sufficient to induce cell death. RHG proteins have been reported to localize to mitochondria, which, in the case of both Reaper and Grim proteins, is mediated by an amphipathic helical domain known as the GH3. Through direct binding, Reaper can bring the Drosophila IAP (DIAP1) to mitochondria, concomitantly promoting IAP auto-ubiquitination and destruction. Whether this localization is sufficient to induce DIAP1 auto-ubiquitination has not been reported. In this study we characterize the interaction between Reaper and the mitochondria using both Xenopus and Drosophila systems. We find that Reaper concentrates on the outer surface of mitochondria in a nonperipheral manner largely mediated by GH3-lipid interactions. Importantly, we show that mitochondrial targeting of DIAP1 alone is not sufficient for degradation and requires Reaper binding. Conversely, Reaper able to bind IAPs, but lacking a mitochondrial targeting GH3 domain (Delta GH3 Reaper), can induce DIAP1 turnover only if DIAP1 is otherwise targeted to membranes. Surprisingly, targeting DIAP1 to the endoplasmic reticulum instead of mitochondria is partially effective in allowing Delta GH3 Reaper to promote DIAP1 degradation, suggesting that co-localization of DIAP and Reaper at a membrane surface is critical for the induction of DIAP degradation. Collectively, these data provide a specific function for the GH3 domain in conferring protein-lipid interactions, demonstrate that both Reaper binding and mitochondrial localization are required for accelerated IAP degradation, and suggest that membrane localization per se contributes to DIAP1 auto-ubiquitination and degradation.	[Freel, Christopher D.; Richardson, D. Ashley; Thomenius, Michael J.; Gan, Eugene C.; Horn, Sarah R.; Olson, Michael R.; Kornbluth, Sally] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA	Duke University	Kornbluth, S (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Box 3813, Durham, NC 27710 USA.	kornb001@mc.duke.edu			NIGMS NIH HHS [5F32 GM 072165, R01 GM 061919, 5F31GM 073574] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM072165, F31GM073574, R01GM061919] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abdelwahid E, 2007, DEV CELL, V12, P793, DOI 10.1016/j.devcel.2007.04.004; Arama E, 2003, DEV CELL, V4, P687, DOI 10.1016/S1534-5807(03)00120-5; Chen P, 2004, CELL DEATH DIFFER, V11, P704, DOI 10.1038/sj.cdd.4401406; Chen P, 1996, GENE DEV, V10, P1773, DOI 10.1101/gad.10.14.1773; Claveria C, 2002, EMBO J, V21, P3327, DOI 10.1093/emboj/cdf354; Claveria C, 1998, EMBO J, V17, P7199, DOI 10.1093/emboj/17.24.7199; Colon-Ramos DA, 2006, NAT STRUCT MOL BIOL, V13, P103, DOI 10.1038/nsmb1052; Colon-Ramos DA, 2003, MOL BIOL CELL, V14, P4162, DOI 10.1091/mbc.E03-03-0139; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Dorstyn L, 2002, J CELL BIOL, V156, P1089, DOI 10.1083/jcb.200111107; Dorstyn L, 2004, J CELL BIOL, V167, P405, DOI 10.1083/jcb.200408054; Evans EK, 1997, EMBO J, V16, P7372, DOI 10.1093/emboj/16.24.7372; Goyal G, 2007, DEV CELL, V12, P807, DOI 10.1016/j.devcel.2007.02.002; Goyal L, 2000, EMBO J, V19, P589, DOI 10.1093/emboj/19.4.589; GRETHER ME, 1995, GENE DEV, V9, P1694, DOI 10.1101/gad.9.14.1694; Haining WN, 1999, P NATL ACAD SCI USA, V96, P4936, DOI 10.1073/pnas.96.9.4936; Holley CL, 2002, NAT CELL BIOL, V4, P439, DOI 10.1038/ncb798; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Jonas EA, 2004, P NATL ACAD SCI USA, V101, P13590, DOI 10.1073/pnas.0401372101; Kaufmann T, 2003, J CELL BIOL, V160, P53, DOI 10.1083/jcb.200210084; Kim TH, 2004, MOL BIOL CELL, V15, P3061, DOI 10.1091/mbc.E03-12-0864; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Lisi S, 2000, GENETICS, V154, P669; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Lutter M, 2000, NAT CELL BIOL, V2, P754, DOI 10.1038/35036395; McCarthy JV, 1998, J BIOL CHEM, V273, P24009, DOI 10.1074/jbc.273.37.24009; Means J, 2006, CELL DEATH DIFFER, V13, P1222, DOI 10.1038/sj.cdd.4401821; Olson MR, 2003, J BIOL CHEM, V278, P44758, DOI 10.1074/jbc.M308055200; Olson MR, 2003, J BIOL CHEM, V278, P4028, DOI 10.1074/jbc.M209734200; Pedersen P L, 1978, Methods Cell Biol, V20, P411, DOI 10.1016/S0091-679X(08)62030-0; Robey RB, 2005, CELL CYCLE, V4, P654, DOI 10.4161/cc.4.5.1678; Rodriguez A, 1999, NAT CELL BIOL, V1, P272, DOI 10.1038/12984; Ryoo HD, 2002, NAT CELL BIOL, V4, P432, DOI 10.1038/ncb795; Schwarze SR, 1998, FREE RADICAL BIO MED, V25, P740, DOI 10.1016/S0891-5849(98)00153-1; VAN MEER G, 1989, ANNU REV CELL BIOL, V5, P247, DOI 10.1146/annurev.cellbio.5.1.247; van Meer G, 2005, EMBO J, V24, P3159, DOI 10.1038/sj.emboj.7600798; Varkey J, 1999, J CELL BIOL, V144, P701, DOI 10.1083/jcb.144.4.701; von Ahsen O, 2000, J CELL BIOL, V150, P1027, DOI 10.1083/jcb.150.5.1027; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; WHITE K, 1994, SCIENCE, V264, P677, DOI 10.1126/science.8171319; White K, 1996, SCIENCE, V271, P805, DOI 10.1126/science.271.5250.805; Wing JP, 2002, NAT CELL BIOL, V4, P451, DOI 10.1038/ncb800; Wing JP, 1998, CELL DEATH DIFFER, V5, P930, DOI 10.1038/sj.cdd.4400423; Yan N, 2006, J BIOL CHEM, V281, P8667, DOI 10.1074/jbc.M513232200; Yokokura T, 2004, J BIOL CHEM, V279, P52603, DOI 10.1074/jbc.M409691200; Yoo SJ, 2002, NAT CELL BIOL, V4, P416, DOI 10.1038/ncb793; Zimmermann KC, 2002, J CELL BIOL, V156, P1077, DOI 10.1083/jcb.20112068	47	25	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					367	379		10.1074/jbc.M708931200	http://dx.doi.org/10.1074/jbc.M708931200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17998202	hybrid			2022-12-27	WOS:000251940300041
J	Galkin, A; Moncada, S				Galkin, Alexander; Moncada, Salvador			S-nitrosation of mitochondrial complex I depends on its structural conformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADH-UBIQUINONE REDUCTASE; ACTIVE/DE-ACTIVE TRANSITION; NITRIC-OXIDE; CATALYTIC-PROPERTIES; ELECTRON-TRANSPORT; PERSISTENT INHIBITION; OXYGEN-CONSUMPTION; RELAXING FACTOR; RAT-HEART; PEROXYNITRITE	Nitric oxide is known to cause persistent inhibition of mitochondrial respiration as a result of S-nitrosation of NADH: ubiquinone oxidoreductase (complex I) (Clementi, E., Brown, G. C., Feelisch, M., and Moncada, S. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 7631-7636). Little is known about whether such nitrosation occurs in physiological conditions and, if so, what are the possible cellular mechanisms. We have now found that the conformational state (active/deactive transition (Vinogradov, A. D. (1998) Biochim. Biophys. Acta 1364, 169-185)) of mitochondrial complex I is an important factor for the interaction of the enzyme with nitrosothiols and peroxynitrite. Only the deactivated, idle form of complex I was susceptible to inhibition by nitrosothiols and peroxynitrite. In contrast, the active form of the enzyme was insensitive to such treatment. Neither form of complex I was inhibited by nitric oxide itself. Our data suggest that the process of active/deactive transition plays an important role in the regulation of complex I activity and cellular respiration by nitric oxide. The implications of this finding for hypoxic or pathophysiological conditions in vivo are discussed.	[Galkin, Alexander; Moncada, Salvador] UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England	University of London; University College London	Galkin, A (corresponding author), UCL, Wolfson Inst Biomed Res, Gower St, London WC1E 6BT, England.	a.galkin@ucl.ac.uk						AKAIKE T, 1993, BIOCHEMISTRY-US, V32, P827, DOI 10.1021/bi00054a013; Alvarez B, 1999, J BIOL CHEM, V274, P842, DOI 10.1074/jbc.274.2.842; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; Beer SM, 2004, J BIOL CHEM, V279, P47939, DOI 10.1074/jbc.M408011200; Beltran B, 2000, BRIT J PHARMACOL, V129, P953, DOI 10.1038/sj.bjp.0703147; Borutaite V, 2000, BBA-BIOENERGETICS, V1459, P405, DOI 10.1016/S0005-2728(00)00178-X; Brealey D, 2002, LANCET, V360, P219, DOI 10.1016/S0140-6736(02)09459-X; Burwell LS, 2006, BIOCHEM J, V394, P627, DOI 10.1042/BJ20051435; Carroll J, 2006, J BIOL CHEM, V281, P32724, DOI 10.1074/jbc.M607135200; Cassina A, 1996, ARCH BIOCHEM BIOPHYS, V328, P309, DOI 10.1006/abbi.1996.0178; Clementi E, 1998, P NATL ACAD SCI USA, V95, P7631, DOI 10.1073/pnas.95.13.7631; CUDD A, 1982, J BIOL CHEM, V257, P1443; Dahm CC, 2006, J BIOL CHEM, V281, P10056, DOI 10.1074/jbc.M512203200; Gavrikova EV, 1999, FEBS LETT, V455, P36, DOI 10.1016/S0014-5793(99)00850-9; Giustarini D, 2005, ANTIOXID REDOX SIGN, V7, P930, DOI 10.1089/ars.2005.7.930; GOSTIMSKAYA IS, BIOCH BIOPHYS ACTA, V1757, P1155; GRANGER DL, 1982, J CELL BIOL, V95, P527, DOI 10.1083/jcb.95.2.527; Grivennikova VG, 2001, J BIOL CHEM, V276, P9038, DOI 10.1074/jbc.M009661200; HAYES JE, 1954, J BIOL CHEM, V207, P225; HUGHES MN, 1968, J CHEM SOC A, V2, P450; HUIE RE, 1993, FREE RADICAL RES COM, V18, P195, DOI 10.3109/10715769309145868; Konorev EA, 2000, FREE RADICAL BIO MED, V28, P1671, DOI 10.1016/S0891-5849(00)00281-1; KOTLYAR AB, 1990, BIOCHIM BIOPHYS ACTA, V1019, P151, DOI 10.1016/0005-2728(90)90137-S; KOTLYAR AB, 1984, BIOCHIM BIOPHYS ACTA, V784, P24, DOI 10.1016/0167-4838(84)90168-7; Lizasoain I, 1996, BIOCHEM J, V314, P877, DOI 10.1042/bj3140877; Maklashina E, 2003, BBA-BIOENERGETICS, V1606, P95, DOI 10.1016/S0005-2728(03)00087-2; Maklashina E, 2004, FEBS LETT, V556, P64, DOI 10.1016/S0014-5793(03)01369-3; Maklashina E, 2002, BBA-BIOENERGETICS, V1556, P6, DOI 10.1016/S0005-2728(02)00280-3; Maklashina E. O., 1994, Biokhimiya, V59, P946; Moncada S, 2002, NAT REV MOL CELL BIO, V3, P214, DOI 10.1038/nrm762; Monnet X, 2006, CARDIOVASC RES, V70, P391, DOI 10.1016/j.cardiores.2005.07.005; Orsi A, 2000, BIOCHEM J, V346, P407, DOI 10.1042/0264-6021:3460407; Palacios-Callender M, 2004, P NATL ACAD SCI USA, V101, P7630, DOI 10.1073/pnas.0401723101; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; Pearce LL, 2005, NITRIC OXIDE-BIOL CH, V13, P254, DOI 10.1016/j.niox.2005.07.010; RADI R, 1991, J BIOL CHEM, V266, P4244; RADI R, 1994, ARCH BIOCHEM BIOPHYS, V308, P89, DOI 10.1006/abbi.1994.1013; Riobo NA, 2001, BIOCHEM J, V359, P139, DOI 10.1042/0264-6021:3590139; STADLER J, 1991, AM J PHYSIOL, V260, P910; STUEHR DJ, 1989, J EXP MED, V169, P1543, DOI 10.1084/jem.169.5.1543; Tao LM, 2004, BIOCHEMISTRY-US, V43, P4028, DOI 10.1021/bi035924o; Tompkins AJ, 2006, BBA-MOL BASIS DIS, V1762, P223, DOI 10.1016/j.bbadis.2005.10.001; Vinogradov AD, 1998, BBA-BIOENERGETICS, V1364, P169, DOI 10.1016/S0005-2728(98)00026-7; Vinogradov AD, 2001, IUBMB LIFE, V52, P129, DOI 10.1080/15216540152845920; Vinogradov AD, 1999, BIOCHEMISTRY-MOSCOW+, V64, P136; Vogel R, 2004, CURR OPIN NEUROL, V17, P179, DOI 10.1097/00019052-200404000-00016; White MY, 2006, PROTEOMICS, V6, P6221, DOI 10.1002/pmic.200600219	47	100	104	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37448	37453		10.1074/jbc.M707543200	http://dx.doi.org/10.1074/jbc.M707543200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17956863	hybrid			2022-12-27	WOS:000251833600019
J	Yang, T; Allen, PD; Pessah, IN; Lopez, JR				Yang, Tianzhong; Allen, Paul D.; Pessah, Isaac N.; Lopez, Jose R.			Enhanced excitation-coupled calcium entry in myotubes is associated with expression of RyR1 malignant hyperthermia mutations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE MUSCLE FIBRES; OPERATED CA2+ ENTRY; SKELETAL-MUSCLE; RYANODINE RECEPTOR; DIHYDROPYRIDINE RECEPTOR; POTASSIUM CONTRACTURES; CHARGE MOVEMENT; CHANNEL; FIBERS; INFLUX	Myotubes expressing wild type RyR1 (WT) or RyR1 with one of three malignant hyperthermia mutations R615C, R2163C, and T4826I (MH) were exposed sequentially to 60 mM KCl in Ca2+-replete and Ca2+-free external buffers (Ca+ and Ca-, respectively) with 3 min of rest between exposures. Although the maximal peak amplitude of the Ca2+ transients during K+ depolarization was similar for WT and MH in both external buffers, the rate of decay of the sustained phase of the transient during K+ depolarization (decay rate) in Ca+ was 50% slower for MH. This difference was eliminated in Ca-, and the relative decay rates were faster for both genotypes than in Ca+. The integrated Ca2+ transient in Ca- compared with Ca+ was reduced by 50-60% for MH and 20% for WT. The decay rate was not affected by [ K+] x [ Cl-] product or NiCl2 (2 mM) supplementation of Ca-. The addition of La2+ (0.1mM), or SKF 96365 (20 mu M) to Ca+ significantly accelerated decay rates for both WT and MH, but their effect was significantly greater in MH. Nifedipine (1 mu M) had no effect, suggesting that the mechanism for this difference was not a reduction in L-type Ca2+ channel Ca2+ current. These data strongly suggest: 1) the decay rate in skeletal myotubes is related in part to Ca2+ entry through the ECCE channel; 2) the MH mutations enhance ECCE compared with wild type; and 3) the increased Ca2+ entry might play a significant role in the pathophysiology of MH.	[Yang, Tianzhong; Allen, Paul D.; Lopez, Jose R.] Brigham & Womens Hosp, Dept Anesthesiol & Perioperat & Pain Med, Boston, MA 02115 USA; [Pessah, Isaac N.] Univ Calif Davis, Sch Vet Med, Dept Mol Biosci, Davis, CA 95606 USA; [Lopez, Jose R.] Inst Venezolano Invest Cient, Ctr Biofis & Bioquim, Caracas 21827, Venezuela	Harvard University; Brigham & Women's Hospital; University of California System; University of California Davis; Venezuelan Institute Science Research	Allen, PD (corresponding author), Brigham & Womens Hosp, Dept Anesthesiol & Perioperat & Pain Med, 75 Francis St, Boston, MA 02115 USA.	pdallen@partners.org	Tuluc, Petronel/C-2527-2011; Pessah, Isaac N/K-7985-2017	Pessah, Isaac N/0000-0002-8149-588X				ANDERSON K, 1994, AM J PHYSIOL, V266, pC462, DOI 10.1152/ajpcell.1994.266.2.C462; ARMSTRONG CM, 1972, BIOCHIM BIOPHYS ACTA, V267, P605, DOI 10.1016/0005-2728(72)90194-6; BARRETT JN, 1978, SCIENCE, V200, P1270, DOI 10.1126/science.96524; BEAM KG, 1989, ANN NY ACAD SCI, V560, P127, DOI 10.1111/j.1749-6632.1989.tb24090.x; BERRIDGE MJ, 1995, BIOESSAYS, V17, P491, DOI 10.1002/bies.950170605; BIANCHI CP, 1959, J GEN PHYSIOL, V42, P803, DOI 10.1085/jgp.42.4.803; CAPUTO C, 1967, J GEN PHYSIOL, V50, P2177, DOI 10.1085/jgp.50.9.2177; CAPUTO C, 1994, J PHYSIOL-LONDON, V481, P119, DOI 10.1113/jphysiol.1994.sp020423; CHEN W, 1991, J PHYSIOL-LONDON, V444, P579, DOI 10.1113/jphysiol.1991.sp018895; Cherednichenko G, 2004, P NATL ACAD SCI USA, V101, P15793, DOI 10.1073/pnas.0403485101; FISCHMAN DA, 1967, J GEN PHYSIOL, V50, P1709, DOI 10.1085/jgp.50.6.1709; Flucher BE, 1996, P NATL ACAD SCI USA, V93, P8101, DOI 10.1073/pnas.93.15.8101; Fraefel C, 1996, J VIROL, V70, P7190, DOI 10.1128/JVI.70.10.7190-7197.1996; FranziniArmstrong C, 1997, PHYSIOL REV, V77, P699, DOI 10.1152/physrev.1997.77.3.699; Gallant EM, 1996, MUSCLE NERVE, V19, P68, DOI 10.1002/(SICI)1097-4598(199601)19:1<68::AID-MUS9>3.3.CO;2-0; GALLANT EM, 1982, NEUROSCI LETT, V28, P181, DOI 10.1016/0304-3940(82)90149-5; GALLANT EM, 1992, AM J PHYSIOL, V262, P422; GONZALEZSERRATOS H, 1982, NATURE, V298, P292, DOI 10.1038/298292a0; GOODMAN FR, 1974, ARCH INT PHARMACOD T, V209, P14; Grabner M, 1999, J BIOL CHEM, V274, P21913, DOI 10.1074/jbc.274.31.21913; HODGKIN AL, 1960, J PHYSIOL-LONDON, V153, P386, DOI 10.1113/jphysiol.1960.sp006541; HODGKIN AL, 1959, J PHYSIOL-LONDON, V148, P127, DOI 10.1113/jphysiol.1959.sp006278; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; Hurne AM, 2005, J BIOL CHEM, V280, P36994, DOI 10.1074/jbc.M506441200; Jurkat-Rott K, 2000, MUSCLE NERVE, V23, P4, DOI 10.1002/(SICI)1097-4598(200001)23:1<4::AID-MUS3>3.0.CO;2-D; Kurebayashi N, 2001, J PHYSIOL-LONDON, V533, P185, DOI 10.1111/j.1469-7793.2001.0185b.x; Leung YM, 1999, JPN J PHARMACOL, V81, P253, DOI 10.1254/jjp.81.253; Lopez JR, 2000, ANESTHESIOLOGY, V92, P1799, DOI 10.1097/00000542-200006000-00040; LORKOVIC H, 1962, AM J PHYSIOL, V202, P440, DOI 10.1152/ajplegacy.1962.202.3.440; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; Ma JJ, 2003, CELL CALCIUM, V33, P375, DOI 10.1016/S0143-4160(03)00050-2; MARTY I, 1994, P NATL ACAD SCI USA, V91, P2270, DOI 10.1073/pnas.91.6.2270; Nelson Thomas E., 2002, Current Molecular Medicine (Hilversum), V2, P347, DOI 10.2174/1566524023362429; Ong HL, 2007, J BIOL CHEM, V282, P27556; Ong HL, 2007, J BIOL CHEM, V282, P9105, DOI 10.1074/jbc.M608942200; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Protasi F, 1998, J CELL BIOL, V140, P831, DOI 10.1083/jcb.140.4.831; RIOS E, 1987, NATURE, V325, P717, DOI 10.1038/325717a0; RIOS E, 1991, PHYSIOL REV, V71, P849, DOI 10.1152/physrev.1991.71.3.849; Robinson LC, 2006, CURR BIOL, V16, pR548, DOI 10.1016/j.cub.2006.06.036; Robinson R, 2006, HUM MUTAT, V27, P977, DOI 10.1002/humu.20356; SCHNEIDER MF, 1973, NATURE, V242, P244, DOI 10.1038/242244a0; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; TANABE T, 1993, ANN NY ACAD SCI, V707, P81, DOI 10.1111/j.1749-6632.1993.tb38044.x; Treves S, 2005, NEUROMUSCULAR DISORD, V15, P577, DOI 10.1016/j.nmd.2005.06.008; Wang Y, 2000, AM J PHYSIOL-CELL PH, V278, pC619, DOI 10.1152/ajpcell.2000.278.3.C619; Yang TZ, 2007, AM J PHYSIOL-CELL PH, V292, pC1591, DOI 10.1152/ajpcell.00133.2006; Yang TZ, 2003, J BIOL CHEM, V278, P25722, DOI 10.1074/jbc.M302165200	48	47	49	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37471	37478		10.1074/jbc.M701379200	http://dx.doi.org/10.1074/jbc.M701379200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17942409	hybrid			2022-12-27	WOS:000251833600022
J	Aachmann, FL; Fomenko, DE; Soragni, A; Gladyshev, VN; Dikiy, A				Aachmann, Finn L.; Fomenko, Dmitri E.; Soragni, Alice; Gladyshev, Vadim N.; Dikiy, Alexander			Solution structure of selenoprotein W and NMR analysis of its interaction with 14-3-3 proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-MAGNETIC-RESONANCE; 14-3-3 PROTEINS; BACKBONE DYNAMICS; THIOREDOXIN; PURIFICATION; SPECTROSCOPY; DATABASE; PROGRAM; BIOLOGY; MUSCLE	Selenium is a trace element with significant biomedical potential. It is essential in mammals due to its occurrence in several proteins in the form of selenocysteine ( Sec). One of the most abundant mammalian Sec-containing proteins is selenoprotein W (SelW). This protein of unknown function has a broad expression pattern and contains a candidate CXXU ( where U represents Sec) redox motif. Here, we report the solution structure of the Sec(13)-> Cys variant of mouse SelW determined through high resolution NMR spectroscopy. The protein has a thioredoxin-like fold with the CXXU motif located in an exposed loop similarly to the redox-active site in thioredoxin. Protein dynamics studies revealed the rigidity of the protein backbone and mobility of two external loops and suggested a role of these loops in interaction with SelW partners. Molecular modeling of structures of other members of the Rdx family based on the SelW structure identified new conserved features in these proteins, including an aromatic cluster and interacting loops. Our previous study suggested an interaction between SelW and 14-3-3 proteins. In the present work, with the aid of NMR spectroscopy, we demonstrated specificity of this interaction and identified mobile loops in SelW as interacting surfaces. This finding suggests that 14-3-3 are redox-regulated proteins.	[Aachmann, Finn L.; Soragni, Alice; Dikiy, Alexander] Norwegian Univ Sci & Technol, Dept Biotechnol, N-7491 Trondheim, Norway; [Fomenko, Dmitri E.; Gladyshev, Vadim N.] Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA	Norwegian University of Science & Technology (NTNU); University of Nebraska System; University of Nebraska Lincoln	Dikiy, A (corresponding author), Norwegian Univ Sci & Technol, Dept Biotechnol, N-7491 Trondheim, Norway.	alex.dikiy@biotech.ntnu.no	Aachmann, Finn/G-4136-2015; Gladyshev, Vadim N/A-9894-2013; Gladyshev, Vadim N/J-6187-2013	Aachmann, Finn/0000-0003-1613-4663; Soragni, Alice/0000-0002-6634-2885; Gladyshev, Vadim/0000-0002-0372-7016	NIGMS NIH HHS [GM061603] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061603] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Beilstein MA, 1996, J INORG BIOCHEM, V61, P117, DOI 10.1016/0162-0134(95)00045-3; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Darling DL, 2005, CURR TOP DEV BIOL, V68, P281, DOI 10.1016/S0070-2153(05)68010-6; DeLano WL, 2002, PYMOL USERS MANUAL; Dikiy A, 2007, BIOCHEMISTRY-US, V46, P6871, DOI 10.1021/bi602462q; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Ferguson AD, 2006, J BIOL CHEM, V281, P3536, DOI 10.1074/jbc.M511386200; Flohe L, 2005, DEV OPHTHALMOL, V38, P89, DOI 10.1159/000082770; Fomenko DE, 2007, SCIENCE, V315, P387, DOI 10.1126/science.1133114; Gu QP, 2000, MOL CELL BIOCHEM, V204, P49, DOI 10.1023/A:1007065829068; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; GUNTERT P, 1991, J MOL BIOL, V217, P531, DOI 10.1016/0022-2836(91)90755-U; Halliwell B, 2006, PLANT PHYSIOL, V141, P312, DOI 10.1104/pp.106.077073; HATFIELD DL, 2006, SELENIUM MOL BIOL RO; Homans SW, 2004, ANGEW CHEM INT EDIT, V43, P290, DOI 10.1002/anie.200300581; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; KELLER R, 2004, THESIS SWISSS FEDERA; KLINE AD, 1988, J MOL BIOL, V204, P675, DOI 10.1016/0022-2836(88)90364-6; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Lillig CH, 2007, ANTIOXID REDOX SIGN, V9, P25, DOI 10.1089/ars.2007.9.25; Loflin J, 2006, J INORG BIOCHEM, V100, P1679, DOI 10.1016/j.jinorgbio.2006.05.018; MARTIN JL, 1995, STRUCTURE, V3, P245, DOI 10.1016/S0969-2126(01)00154-X; Novoselov SV, 2007, J BIOL CHEM, V282, P11960, DOI 10.1074/jbc.M701605200; Pellecchia M, 2002, NAT REV DRUG DISCOV, V1, P211, DOI 10.1038/nrd748; Qi Y, 2005, PROTEINS, V58, P376, DOI 10.1002/prot.20329; Rittinger K, 1999, MOL CELL, V4, P153, DOI 10.1016/S1097-2765(00)80363-9; Rubio MP, 2004, BIOCHEM J, V379, P395, DOI 10.1042/bj20031797; Stadtman TC, 1996, ANNU REV BIOCHEM, V65, P83, DOI 10.1146/annurev.bi.65.070196.000503; Sun Y, 2001, J INORG BIOCHEM, V84, P151, DOI 10.1016/S0162-0134(00)00219-1; van Heusden GPH, 2005, IUBMB LIFE, V57, P623, DOI 10.1080/15216540500252666; VENDELAND SC, 1993, J BIOL CHEM, V268, P17103; Yaffe MB, 2002, FEBS LETT, V513, P53, DOI 10.1016/S0014-5793(01)03288-4; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Zhang HY, 2003, J BIOMOL NMR, V25, P173, DOI 10.1023/A:1022836027055	36	71	80	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					37036	37044		10.1074/jbc.M705410200	http://dx.doi.org/10.1074/jbc.M705410200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17928294	hybrid, Green Published			2022-12-27	WOS:000251646000030
J	Phelps, CB; Gaudet, R				Phelps, Christopher B.; Gaudet, Rachelle			The role of the N terminus and transmembrane domain of TRPM8 in channel localization and tetramerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MENTHOL RECEPTOR TRPM8; COLD RECEPTOR; CATION CHANNELS; ION-CHANNEL; ACTIVATION; REVEALS; TRPV1; THERMOSENSATION; DESENSITIZATION; TRAFFICKING	Transient receptor potential (TRP) channels are a family of cation channels involved in diverse cellular functions. They are composed of a transmembrane domain of six putative transmembrane segments flanked by large N- and C-terminal cytoplasmic domains. The melastatin subfamily (TRPM) channels have N- terminal domains of similar to 700 amino acids with four regions of shared homology and C-terminal domains containing the conserved TRP domain followed by a coiled-coil region. Here we investigated the effects of N- and C-terminal deletions on the cold and menthol receptor, TRPM8, expressed heterologously in Sf21 insect cells. Patch-clamp electrophysiology was used to study channel activity and revealed that only deletion of the first 39 amino acids was tolerated by the channel. Further N- terminal truncation or any C-terminal deletions prevented proper TRPM8 function. Confocal microscopy with immunofluorescence revealed that amino acids 40-86 are required for localization to the plasma membrane. Furthermore, analysis of deletion mutant oligomerization shows that the transmembrane domain is sufficient for TPRM8 assembly into tetramers. TRPM8 channels with C-terminal deletions tetramerize and localize properly but are inactive, indicating that although not essential for tetramerization and localization, the C terminus is critical for proper function of the channel sensor and/or gate.	Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University	Phelps, CB (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, 7 Divinity Ave, Cambridge, MA 02138 USA.	gaudet@mcb.harvard.edu	Gaudet, Rachelle/I-4133-2014; Gaudet, Rachelle/Y-3985-2019	Gaudet, Rachelle/0000-0002-9177-054X; Gaudet, Rachelle/0000-0002-9177-054X				Andersson DA, 2004, J NEUROSCI, V24, P5364, DOI 10.1523/JNEUROSCI.0890-04.2004; Bandell M, 2006, NAT NEUROSCI, V9, P493, DOI 10.1038/nn1665; Bautista DM, 2007, NATURE, V448, P204, DOI 10.1038/nature05910; Brauchi S, 2006, J NEUROSCI, V26, P4835, DOI 10.1523/JNEUROSCI.5080-05.2006; Brauchi S, 2004, P NATL ACAD SCI USA, V101, P15494, DOI 10.1073/pnas.0406773101; Brauchi S, 2007, P NATL ACAD SCI USA, V104, P10246, DOI 10.1073/pnas.0703420104; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chuang HH, 2004, NEURON, V43, P859, DOI 10.1016/j.neuron.2004.08.038; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Colburn RW, 2007, NEURON, V54, P379, DOI 10.1016/j.neuron.2007.04.017; Dhaka A, 2007, NEURON, V54, P371, DOI 10.1016/j.neuron.2007.02.024; Dragoni I, 2006, J BIOL CHEM, V281, P37353, DOI 10.1074/jbc.M607227200; Erler I, 2006, J BIOL CHEM, V281, P38396, DOI 10.1074/jbc.M607756200; Fleig A, 2004, TRENDS PHARMACOL SCI, V25, P633, DOI 10.1016/j.tips.2004.10.004; Harteneck C, 2005, N-S ARCH PHARMACOL, V371, P307, DOI 10.1007/s00210-005-1034-x; Hui KY, 2005, BIOCHEM BIOPH RES CO, V333, P374, DOI 10.1016/j.bbrc.2005.05.123; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Kraft R, 2005, PFLUG ARCH EUR J PHY, V451, P204, DOI 10.1007/s00424-005-1428-0; Kwon Y, 2007, MOL CELL, V25, P491, DOI 10.1016/j.molcel.2007.01.021; Launay P, 2004, SCIENCE, V306, P1374, DOI 10.1126/science.1098845; Lis A, 2005, N-S ARCH PHARMACOL, V371, P315, DOI 10.1007/s00210-005-1050-x; Lishko PV, 2007, NEURON, V54, P905, DOI 10.1016/j.neuron.2007.05.027; Liu BY, 2005, J NEUROSCI, V25, P4835, DOI 10.1523/JNEUROSCI.1296-05.2005; Liu BY, 2005, J NEUROSCI, V25, P1674, DOI 10.1523/JNEUROSCI.3632-04.2005; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Mei ZZ, 2006, J BIOL CHEM, V281, P38748, DOI 10.1074/jbc.M607591200; Minor DL, 2000, CELL, V102, P657, DOI 10.1016/S0092-8674(00)00088-X; MONTELL C, 2005, SCI STKE, P1; MONTELL C, 2001, SCI STKE, V90, P1; Nilius B, 2006, EMBO J, V25, P467, DOI 10.1038/sj.emboj.7600963; Nilius B, 2005, PFLUG ARCH EUR J PHY, V451, P1, DOI 10.1007/s00424-005-1462-y; Nilius B, 2005, J BIOL CHEM, V280, P6423, DOI 10.1074/jbc.M411089200; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Perraud AL, 2003, CELL CALCIUM, V33, P519, DOI 10.1016/S0143-4160(03)00057-5; Phelps Christopher B, 2007, Channels (Austin), V1, P148; Reid G, 2005, PFLUG ARCH EUR J PHY, V451, P250, DOI 10.1007/s00424-005-1437-z; Rohacs T, 2005, NAT NEUROSCI, V8, P626, DOI 10.1038/nn1451; Stein AT, 2006, J GEN PHYSIOL, V128, P509, DOI 10.1085/jgp.200609576; Tsuruda PR, 2006, NEURON, V51, P201, DOI 10.1016/j.neuron.2006.06.023; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Voets T, 2007, NAT CHEM BIOL, V3, P174, DOI 10.1038/nchembio862; Zerangue N, 2000, P NATL ACAD SCI USA, V97, P3591, DOI 10.1073/pnas.060016797; Zhang L, 2004, CANCER RES, V64, P8365, DOI 10.1158/0008-5472.CAN-04-2146	44	56	58	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36474	36480		10.1074/jbc.M707205200	http://dx.doi.org/10.1074/jbc.M707205200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17908685	hybrid, Green Published			2022-12-27	WOS:000251458300039
J	Ho, WW; Li, HY; Eakanunkul, S; Tong, Y; Wilks, A; Guo, ML; Poulos, TL				Ho, Winny W.; Li, Huiying; Eakanunkul, Suntara; Tong, Yong; Wilks, Angela; Guo, Maolin; Poulos, Thomas L.			Holo-and apo-bound structures of bacterial periplasmic heme-binding proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PSEUDOMONAS-AERUGINOSA; BTUF; TRANSPORT; CATALASE; SYSTEM; SUITE	An essential component of heme transport in Gram-negative bacterial pathogens is the periplasmic protein that shuttles heme between outer and inner membranes. We have solved the first crystal structures of two such proteins, ShuT from Shigella dysenteriae and PhuT from Pseudomonas aeruginosa. Both share a common architecture typical of Class III periplasmic binding proteins. The heme binds in a narrow cleft between the N-and C-terminal binding domains and is coordinated by a Tyr residue. A comparison of the heme-free (apo) and -bound (holo) structures indicates little change in structure other than minor alterations in the heme pocket and movement of the Tyr heme ligand from an "in" position where it can coordinate the heme iron to an "out" orientation where it points away from the heme pocket. The detailed architecture of the heme pocket is quite different in ShuT and PhuT. Although Arg(228) in PhuT H-bonds with a heme propionate, in ShuT a peptide loop partially takes up the space occupied by Arg228, and there is no Lys or Arg H-bonding with the heme propionates. A comparison of PhuT/ShuT with the vitamin B-12-binding protein BtuF and the hydroxamic-type siderophore-binding protein FhuD, the only two other structurally characterized Class III periplasmic binding proteins, demonstrates that PhuT/ShuT more closely resembles BtuF, which reflects the closer similarity in ligands, heme and B-12, compared with ligands for FhuD, a peptide siderophore.	Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Chem, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Pharmaceut Sci, Irvine, CA 92697 USA; Univ Maryland, Dept Pharmaceut Sci, Baltimore, MD 21201 USA; Univ Massachusetts, Dept Chem & Biochem, Dartmouth, MA 02747 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University System of Maryland; University of Maryland Baltimore; University of Massachusetts System; University Massachusetts Dartmouth	Poulos, TL (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, 2206 Nat Sci 1, Irvine, CA 92697 USA.	poulos@uci.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048551] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042614] Funding Source: NIH RePORTER; NIAID NIH HHS [AI48551] Funding Source: Medline; NIGMS NIH HHS [GM42614] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Borths EL, 2002, P NATL ACAD SCI USA, V99, P16642, DOI 10.1073/pnas.262659699; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Clarke TE, 2002, J BIOL CHEM, V277, P13966, DOI 10.1074/jbc.M109385200; Cowtan KD, 1999, PROG BIOPHYS MOL BIO, V72, P245, DOI 10.1016/S0079-6107(99)00008-5; Eakanunkul S, 2005, BIOCHEMISTRY-US, V44, P13179, DOI 10.1021/bi050422r; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; Kandt C, 2006, BIOCHEMISTRY-US, V45, P13284, DOI 10.1021/bi061280j; Karpowich NK, 2003, J BIOL CHEM, V278, P8429, DOI 10.1074/jbc.M212239200; LESLIE AGW, 1992, JOINT CCP4 PLUS ESF, V26; Loewen PC, 2004, BIOCHEMISTRY-US, V43, P3089, DOI 10.1021/bi035663i; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; MURTHY MRN, 1981, J MOL BIOL, V152, P465, DOI 10.1016/0022-2836(81)90254-0; Niyogi SK, 2005, J MICROBIOL, V43, P133; Ochsner UA, 2000, MICROBIOL-UK, V146, P185, DOI 10.1099/00221287-146-1-185; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Quiocho FA, 1996, MOL MICROBIOL, V20, P17, DOI 10.1111/j.1365-2958.1996.tb02484.x; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Tong Y, 2007, J BIOL INORG CHEM, V12, P735, DOI 10.1007/s00775-007-0226-x; Zhu HZ, 2003, BIOCHEM J, V376, P35, DOI 10.1042/BJ20031283	24	66	67	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35796	35802		10.1074/jbc.M706761200	http://dx.doi.org/10.1074/jbc.M706761200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17925389	hybrid			2022-12-27	WOS:000251458100041
J	Abid, MR; Spokes, KC; Shih, SC; Aird, WC				Abid, Md. Ruhul; Spokes, Katherine C.; Shih, Shou-Ching; Aird, William C.			NADPH oxidase activity selectively modulates vascular endothelial growth factor signaling pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; OXYGEN SPECIES PRODUCTION; ACTIVATED PROTEIN-KINASE; FOCAL ADHESION KINASE; ANGIOTENSIN-II; NAD(P)H OXIDASE; FACTOR-RECEPTOR; FACTOR VEGF; TYROSINE PHOSPHORYLATION; SUPEROXIDE-PRODUCTION	Vascular endothelial growth factor (VEGF) and reactive oxygen species (ROS) play critical roles in vascular physiology and pathophysiology. We have demonstrated previously that NADPH oxidase-derived ROS are required for VEGF-mediated migration and proliferation of endothelial cells. The goal of this study was to determine the extent to which VEGF signaling is coupled to NADPH oxidase activity. Human umbilical vein endothelial cells and/or human coronary artery endothelial cells were transfected with short interfering RNA against the p(47phox) subunit of NADPH oxidase, treated in the absence or presence of VEGF, and assayed for signaling, gene expression, and function. We show that NADPH oxidase activity is required for VEGF activation of phosphoinositide 3-kinase-Akt-forkhead, and p38 MAPK, but not ERK1/2 or JNK. The permissive role of NADPH oxidase on phosphoinositide 3-kinase-Akt-forkhead signaling is mediated at post-VEGF receptor levels and involves the nonreceptor tyrosine kinase Src. DNA microarrays revealed the existence of two distinct classes of VEGF-responsive genes, one that is ROS-dependent and another that is independent of ROS levels. VEGF-induced, thrombomodulin-dependent activation of protein C was dependent on NADPH oxidase activity, whereas VEGF-induced decay-accelerating factor-mediated protection of endothelial cells against complement- mediated lysis was not. Taken together, these findings suggest that NADPH oxidase-derived ROS selectively modulate some but not all the effects of VEGF on endothelial cell phenotypes.	Beth Israel Deaconess Med Ctr, Harvard Med Sch, Dept Med, Div Mol & Vasc Med, Boston, MA 02215 USA; Beth Israel Deaconess Med Ctr, Harvard Med Sch, Dept Pathol, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Abid, MR (corresponding author), Beth Israel Deaconess Med Ctr, Harvard Med Sch, Dept Med, Div Mol & Vasc Med, Boston, MA 02215 USA.	rabid@bidmc.harvard.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082927, R01HL077348] Funding Source: NIH RePORTER; NHLBI NIH HHS [5R01HL077348, 5R01HL082927] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abid MR, 2006, J BIOL CHEM, V281, P35544, DOI 10.1074/jbc.M608620200; Abid MR, 2004, J BIOL CHEM, V279, P44030, DOI 10.1074/jbc.M408285200; Abid MR, 2001, FASEB J, V15, P2548, DOI 10.1096/fj.01-0338fje; Abid MR, 2000, FEBS LETT, V486, P252, DOI 10.1016/S0014-5793(00)02305-X; Abid R, 2004, ARTERIOSCL THROM VAS, V24, P294, DOI 10.1161/01.ATV.0000110502.10593.06; Ago T, 2004, CIRCULATION, V109, P227, DOI 10.1161/01.CIR.0000105680.92873.70; Al-Mehdi AB, 1998, CIRC RES, V83, P730, DOI 10.1161/01.RES.83.7.730; Alavi A, 2003, SCIENCE, V301, P94, DOI 10.1126/science.1082015; Ashton AW, 2004, CIRC RES, V95, P372, DOI 10.1161/01.RES.0000138300.41642.15; Bae YS, 1997, J BIOL CHEM, V272, P217, DOI 10.1074/jbc.272.1.217; Barash Y, 2004, BIOINFORMATICS, V20, P839, DOI 10.1093/bioinformatics/btg487; Bayraktutan U, 1998, CARDIOVASC RES, V38, P256, DOI 10.1016/S0008-6363(98)00003-0; Brandes RP, 2001, THROMB HAEMOSTASIS, V85, P1104; CALALB MB, 1995, MOL CELL BIOL, V15, P954; Calnek DS, 1998, EXP CELL RES, V238, P294, DOI 10.1006/excr.1997.3812; Catarzi S, 2005, BBA-MOL CELL RES, V1745, P166, DOI 10.1016/j.bbamcr.2005.03.004; Chen JX, 2007, AM J PHYSIOL-HEART C, V292, pH1664, DOI 10.1152/ajpheart.01138.2006; Chen JX, 2006, AM J PHYSIOL-HEART C, V291, pH1563, DOI 10.1152/ajpheart.01081.2005; Chen Y, 2004, NITRIC OXIDE-BIOL CH, V11, P121; Chen ZQ, 1997, CANCER RES, V57, P2013; Claesson-Welsh L, 2003, BIOCHEM SOC T, V31, P20, DOI 10.1042/bst0310020; Colavitti R, 2002, J BIOL CHEM, V277, P3101, DOI 10.1074/jbc.M107711200; DANGELO G, 1995, P NATL ACAD SCI USA, V92, P6374, DOI 10.1073/pnas.92.14.6374; De Keulenaer GW, 1998, CIRC RES, V82, P1094, DOI 10.1161/01.RES.82.10.1094; Djordjevic T, 2005, ARTERIOSCL THROM VAS, V25, P519, DOI 10.1161/01.ATV.0000154279.98244.eb; Duerrschmidt N, 2000, BIOCHEM BIOPH RES CO, V269, P713, DOI 10.1006/bbrc.2000.2354; Dvorak HF, 2000, SEMIN PERINATOL, V24, P75, DOI 10.1016/S0146-0005(00)80061-0; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Folkman J, 2004, APMIS, V112, P496, DOI 10.1111/j.1600-0463.2004.apm11207-0809.x; Gorlach A, 2000, CIRC RES, V87, P26, DOI 10.1161/01.RES.87.1.26; GRIENDLING KK, 1994, CIRC RES, V74, P1141, DOI 10.1161/01.RES.74.6.1141; GUO DQ, 1995, J BIOL CHEM, V270, P6729, DOI 10.1074/jbc.270.12.6729; Guzik TJ, 2000, CIRC RES, V86, pE85, DOI 10.1161/01.RES.86.9.e85; Harfouche R, 2005, FASEB J, V19, P1728, DOI 10.1096/fj.04-3621fje; Heeneman S, 2000, J BIOL CHEM, V275, P15926, DOI 10.1074/jbc.M909616199; Holland JA, 1998, ENDOTHELIUM-NEW YORK, V6, P113, DOI 10.3109/10623329809072198; Holmqvist K, 2004, J BIOL CHEM, V279, P22267, DOI 10.1074/jbc.M312729200; HOWARD AB, 1997, AM J PHYSIOL, V272, pC4221; Hu TS, 2005, AM J PHYSIOL-RENAL, V289, pF816, DOI 10.1152/ajprenal.00024.2005; HUNTER T, 1987, CELL, V49, P1, DOI 10.1016/0092-8674(87)90745-8; Johnson EN, 2003, J BIOL CHEM, V278, P1686, DOI 10.1074/jbc.M210250200; Jones SA, 1996, AM J PHYSIOL-HEART C, V271, pH1626, DOI 10.1152/ajpheart.1996.271.4.H1626; Kanno S, 2000, ONCOGENE, V19, P2138, DOI 10.1038/sj.onc.1203533; Kerlin BA, 2003, BLOOD, V102, P3085, DOI 10.1182/blood-2003-06-1789; Korpelainen EI, 1999, ONCOGENE, V18, P1, DOI 10.1038/sj.onc.1202288; Kroll J, 1997, J BIOL CHEM, V272, P32521, DOI 10.1074/jbc.272.51.32521; Landmesser U, 2003, J CLIN INVEST, V111, P1201, DOI 10.1172/JCI200314172; Li JM, 2005, MOL CELL BIOL, V25, P2320, DOI 10.1128/MCB.25.6.2320-2330.2005; Li JM, 2004, CIRCULATION, V109, P1307, DOI 10.1161/01.CIR.0000118463.23388.B9; Li JM, 2003, J AM SOC NEPHROL, V14, pS221, DOI 10.1097/01.ASN.0000077406.67663.E7; Li JM, 2003, J BIOL CHEM, V278, P12094, DOI 10.1074/jbc.M209793200; Li JM, 2004, AM J PHYSIOL-REG I, V287, pR1014, DOI 10.1152/ajpregu.00124.2004; Li JM, 2001, CARDIOVASC RES, V52, P477, DOI 10.1016/S0008-6363(01)00407-2; Lin MT, 2003, MOL PHARMACOL, V64, P1029, DOI 10.1124/mol.64.5.1029; Mahadev K, 2001, J BIOL CHEM, V276, P21938, DOI 10.1074/jbc.C100109200; Marumo T, 1999, DIABETES, V48, P1131, DOI 10.2337/diabetes.48.5.1131; Mason JC, 2004, J BIOL CHEM, V279, P41611, DOI 10.1074/jbc.M407981200; Matsumoto T, 2005, EMBO J, V24, P2342, DOI 10.1038/sj.emboj.7600709; Matsumoto T, 2001, Sci STKE, V2001, pre21, DOI 10.1126/stke.2001.112.re21; Matsumoto T, 2006, J ATHEROSCLER THROMB, V13, P130, DOI 10.5551/jat.13.130; Mechtcheriakova D, 1999, BLOOD, V93, P3811, DOI 10.1182/blood.V93.11.3811.411k40_3811_3823; Mukhopadhyay D, 2004, MOL CELL BIOCHEM, V264, P51, DOI 10.1023/B:MCBI.0000044374.85095.df; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Osawa M, 2004, J BIOL CHEM, V279, P29691, DOI 10.1074/jbc.M309371200; Rousseau S, 1997, ONCOGENE, V15, P2169, DOI 10.1038/sj.onc.1201380; SCHLAEPFER DD, 1994, NATURE, V372, P786; Shih SC, 2002, AM J PATHOL, V161, P35, DOI 10.1016/S0002-9440(10)64154-5; Simoncini T, 2000, CIRC RES, V87, P19, DOI 10.1161/01.RES.87.1.19; Stupack DG, 2004, CURR TOP DEV BIOL, V64, P207, DOI 10.1016/S0070-2153(04)64009-9; Tanimoto T, 2002, J BIOL CHEM, V277, P42997, DOI 10.1074/jbc.M204764200; Tojo T, 2005, CIRCULATION, V111, P2347, DOI 10.1161/01.CIR.0000164261.62586.14; Ushio-Fukai M, 2002, CIRC RES, V91, P1160, DOI 10.1161/01.RES.0000046227.65158.F8; Ushio-Fukai M, 2001, ARTERIOSCL THROM VAS, V21, P489, DOI 10.1161/01.ATV.21.4.489; Van Buul JD, 2005, ANTIOXID REDOX SIGN, V7, P308, DOI 10.1089/ars.2005.7.308; Wada Y, 2005, FASEB J, V19, P1914, DOI 10.1096/fj.05-4037fje; Wu RF, 2003, J BIOL CHEM, V278, P36830, DOI 10.1074/jbc.M302251200; Xia P, 1996, J CLIN INVEST, V98, P2018, DOI 10.1172/JCI119006; Xie ZL, 2001, J CELL PHYSIOL, V188, P132, DOI 10.1002/jcp.1104; Yamaoka-Tojo M, 2004, CIRC RES, V95, P276, DOI 10.1161/01.RES.0000136522.58649.60; Zachary I, 2000, ARTERIOSCL THROM VAS, V20, P1512, DOI 10.1161/01.ATV.20.6.1512; Zelzer E, 2005, CURR TOP DEV BIOL, V65, P169; Zhang JJ, 2004, KIDNEY INT, V66, P722, DOI 10.1111/j.1523-1755.2004.00794.x; Zhuo L, 1997, DEV BIOL, V187, P36, DOI 10.1006/dbio.1997.8601	83	123	127	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					35373	35385		10.1074/jbc.M702175200	http://dx.doi.org/10.1074/jbc.M702175200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17908694	hybrid			2022-12-27	WOS:000251155200080
J	Li, JL; Wei, H; Chesley, A; Moon, C; Krawczyk, M; Volkova, M; Ziman, B; Margulies, KB; Talan, M; Crow, MT; Boheler, KR				Li, Jinliang; Wei, Hong; Chesley, Alan; Moon, Chanil; Krawczyk, Melissa; Volkova, Maria; Ziman, Bruce; Margulies, Kenneth B.; Talan, Mark; Crow, Michael T.; Boheler, Kenneth R.			The pro-angiogenic cytokine pleiotrophin potentiates cardiomyocyte apoptosis through inhibition of endogenous AKT/PKB activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-ASSOCIATED MOLECULE; ANAPLASTIC LYMPHOMA KINASE; GENE-EXPRESSION; PROTEIN-KINASE; BREAST-CANCER; IN-VITRO; HB-GAM; BINDING; RECEPTOR; CELLS	Pleiotrophin is a development-regulated cytokine and growth factor that can promote angiogenesis, cell proliferation, or differentiation, and it has been reported to have neovasculogenic effects in damaged heart. Developmentally, it is prominently expressed in fetal and neonatal hearts, but it is minimally expressed in normal adult heart. Conversely, we show in a rat model of myocardial infarction and in human dilated cardiomyopathy that pleiotrophin is markedly up-regulated. To elucidate the effects of pleiotrophin on cardiac contractile cells, we employed primary cultures of rat neonatal and adult cardiomyocytes. We show that pleiotrophin is released from cardiomyocytes in vitro in response to hypoxia and that the addition of recombinant pleiotrophin promotes caspase-mediated genomic DNA fragmentation in a dose-and time-dependent manner. Functionally, it potentiates the apoptotic response of neonatal cardiomyocytes to hypoxic stress and to ultraviolet irradiation and of adult cardiomyocytes to hypoxia-reoxygenation. Moreover, UV-induced apoptosis in neonatal cardiomyocytes can be partially inhibited by small interfering RNA-mediated knockdown of endogenous pleiotrophin. Mechanistically, pleiotrophin antagonizes IGF-1 associated Ser-473 phosphorylation of AKT/PKB, and it concomitantly decreases both BAD and GSK3 beta phosphorylation. Adenoviral expression of constitutively active AKT and lithium chloride-mediated inhibition of GSK3 beta reduce the potentiated programmed cell death elicited by pleiotrophin. These latter data indicate that pleiotrophin potentiates cardiomyocyte cell death, at least partially, through inhibition of AKT signaling. In conclusion, we have uncovered a novel function for pleiotrophin on heart cells following injury. It fosters cardiomyocyte programmed cell death in response to pro-apoptotic stress, which may be critical to myocardial injury repair.	NIA, NIH, GRC LCS, Cardiovasc Sci Lab, Baltimore, MD 21224 USA; Johns Hopkins Univ, Dept Med, Baltimore, MD 21224 USA; Univ Penn, Sch Med, Philadelphia, PA 19104 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Johns Hopkins University; University of Pennsylvania	Boheler, KR (corresponding author), NIA, NIH, GRC LCS, Cardiovasc Sci Lab, 5600 Nathan Shock Dr, Baltimore, MD 21224 USA.	bohelerk@grc.nia.nih.gov		Li, Jinliang/0000-0002-3018-0570	NHLBI NIH HHS [HL-073935] Funding Source: Medline; NIA NIH HHS [R01-AG017022] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073935] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [Z01AG000283, Z01AG000867, R01AG017022] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Anisimov SV, 2002, MECH DEVELOP, V117, P25, DOI 10.1016/S0925-4773(02)00177-6; Bao XF, 2005, J BIOL CHEM, V280, P9180, DOI 10.1074/jbc.M413423200; Bastias J, 2002, ANTICANCER RES, V22, P1603; Bernard-Pierrot I, 2002, J BIOL CHEM, V277, P32071, DOI 10.1074/jbc.M202747200; Boheler KR, 2003, P NATL ACAD SCI USA, V100, P2754, DOI 10.1073/pnas.0436564100; Bowden ET, 2002, J BIOL CHEM, V277, P35862, DOI 10.1074/jbc.M203963200; Chang YC, 2007, P NATL ACAD SCI USA, V104, P10888, DOI 10.1073/pnas.0704366104; Chen HW, 2004, HEART, V90, P927, DOI 10.1136/hrt.2002.006734; Chesley A, 2000, CIRC RES, V87, P1172, DOI 10.1161/01.RES.87.12.1172; Choudhuri R, 1997, CANCER RES, V57, P1814; Christman KL, 2005, BIOCHEM BIOPH RES CO, V332, P1146, DOI 10.1016/j.bbrc.2005.04.174; Christman KL, 2005, BIOMATERIALS, V26, P1139, DOI 10.1016/j.biomaterials.2004.04.025; Communal C, 1998, CIRCULATION, V98, P1329, DOI 10.1161/01.CIR.98.13.1329; Czubayko F, 1996, P NATL ACAD SCI USA, V93, P14753, DOI 10.1073/pnas.93.25.14753; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Deuel TF, 2002, ARCH BIOCHEM BIOPHYS, V397, P162, DOI 10.1006/abbi.2001.2705; FANG WJ, 1992, J BIOL CHEM, V267, P25889; HAMPTON BS, 1992, MOL BIOL CELL, V3, P85, DOI 10.1091/mbc.3.1.85; Hida H, 2003, EUR J NEUROSCI, V17, P2127, DOI 10.1046/j.1460-9568.2003.02661.x; IWAKI K, 1990, J BIOL CHEM, V265, P13809; Li JA, 1997, CIRC RES, V81, P785; Maeda N, 1996, J BIOL CHEM, V271, P21446, DOI 10.1074/jbc.271.35.21446; Margulies KB, 2005, CIRC RES, V96, P592, DOI 10.1161/01.RES.0000159390.03503.c3; Milev P, 1998, J BIOL CHEM, V273, P6998, DOI 10.1074/jbc.273.12.6998; MITSIADIS TA, 1995, DEVELOPMENT, V121, P37; Moon C, 2003, P NATL ACAD SCI USA, V100, P11612, DOI 10.1073/pnas.1930406100; Powers C, 2002, J BIOL CHEM, V277, P14153, DOI 10.1074/jbc.M112354200; Pufe T, 2003, ARTHRITIS RHEUM, V48, P660, DOI 10.1002/art.10839; RAUVALA H, 1989, EMBO J, V8, P2933, DOI 10.1002/j.1460-2075.1989.tb08443.x; RIEGEL AT, 1994, BREAST CANCER RES TR, V31, P309; Sato M, 1997, BIOCHEM BIOPH RES CO, V238, P831, DOI 10.1006/bbrc.1997.7403; Souttou B, 1997, J BIOL CHEM, V272, P19588, DOI 10.1074/jbc.272.31.19588; Souttou B, 2001, J CELL PHYSIOL, V187, P59, DOI 10.1002/1097-4652(2001)9999:9999<00::AID-JCP1051>3.0.CO;2-F; Spinale FG, 1996, J MOL CELL CARDIOL, V28, P1591, DOI 10.1006/jmcc.1996.0150; Stoica GE, 2001, J BIOL CHEM, V276, P16772, DOI 10.1074/jbc.M010660200; Taravini IRE, 2005, BRAIN RES, V1066, P196, DOI 10.1016/j.brainres.2005.10.055; TEZUKA K, 1990, BIOCHEM BIOPH RES CO, V173, P246, DOI 10.1016/S0006-291X(05)81048-4; Wang DJ, 2003, HYPERTENSION, V42, P88, DOI 10.1161/01.HYP.0000074905.22908.A6; Wu H, 2005, J CUTAN PATHOL, V32, P125, DOI 10.1111/j.0303-6987.2005.00282.x; Yeh HJ, 1998, J NEUROSCI, V18, P3699; Yin H, 2005, J BIOL CHEM, V280, P8022, DOI 10.1074/jbc.M407179200; Zhang YF, 2003, AM J PHYSIOL-HEART C, V284, pH2078, DOI 10.1152/ajpheart.00942.2001	43	32	33	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					34984	34993		10.1074/jbc.M703513200	http://dx.doi.org/10.1074/jbc.M703513200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17925408	hybrid			2022-12-27	WOS:000251155200043
